variant_id,relationship_type,bao_format,assay_category,description,assay_id,curated_by,tissue_id,confidence_score,assay_subcellular_fraction,assay_test_type,cell_id,src_assay_id,assay_tax_id,src_id,assay_cell_type,tid,assay_type,assay_organism,assay_strain,chembl_id,doc_id,assay_tissue
,H,BAO_0000019,,The compound was tested for the in vitro inhibition of platelet 12-lipoxygenase at a concentration of 30 uM,1,Autocuration,,8,,,,,,1,,12052,B,,,CHEMBL615117,11087,
,U,BAO_0000219,,Compound was evaluated for its ability to mobilize calcium in 1321NI cells,2,Autocuration,,0,,,,,,1,,22226,F,,,CHEMBL615118,684,
,U,BAO_0000019,,,3,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL615119,15453,
,H,BAO_0000249,,Binding affinity against A2 adenosine receptor in bovine striatal membranes using [3H]CGS-21680,4,Autocuration,,4,,,,,9913.0,1,,104729,B,Bos taurus,,CHEMBL615120,17841,
,N,BAO_0000219,,In vitro cell cytotoxicity against 143-B cell lines (Human osteosarcoma cell line),5,Intermediate,,1,,,163.0,,9606.0,1,143B,80001,F,Homo sapiens,,CHEMBL615121,17430,
,N,BAO_0000219,,In vitro cell cytotoxicity against 143-B cell lines (Human osteosarcoma cell line),6,Intermediate,,1,,,163.0,,9606.0,1,143B,80001,F,Homo sapiens,,CHEMBL615122,17430,
,N,BAO_0000219,,Cytotoxic Activity was evaluated against 143B (TK-) tumor cells,7,Intermediate,,1,,,163.0,,10090.0,1,143B,80001,F,Mus musculus,,CHEMBL615123,13799,
,N,BAO_0000219,,In vitro cell cytotoxicity was determined against 143B cell line,8,Expert,,1,,,163.0,,9606.0,1,143B,80001,F,Homo sapiens,,CHEMBL615124,17774,
,N,BAO_0000219,,Inhibitory activity against tumor osteosarcoma cell line 143B after 72 hr continuous exposure to compound,9,Intermediate,,1,,,163.0,,9606.0,1,143B,80001,F,Homo sapiens,,CHEMBL615125,3801,
,N,BAO_0000219,,In vitro cell cytotoxicity against 143B-LTK cell lines expressed in HSV-1 TK,10,Intermediate,,1,,,163.0,,9606.0,1,143B,80001,F,Homo sapiens,,CHEMBL615126,17430,
,N,BAO_0000219,,In vitro cell cytotoxicity against 143B-LTK cell lines expressed in HSV-1 TK,11,Intermediate,,1,,,163.0,,9606.0,1,143B,80001,F,Homo sapiens,,CHEMBL615127,17430,
,N,BAO_0000219,,In vitro cell cytotoxicity was determined against 143B-LTK cell line,12,Expert,,1,,,163.0,,9606.0,1,143B,80001,F,Homo sapiens,,CHEMBL615128,17774,
,N,BAO_0000218,,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",13,Intermediate,,1,,,,,1280.0,1,,50185,F,Staphylococcus aureus,,CHEMBL857900,11324,
,N,BAO_0000218,,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",14,Intermediate,,1,,,,,1280.0,1,,50185,F,Staphylococcus aureus,,CHEMBL615129,11324,
,N,BAO_0000218,,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",15,Intermediate,,1,,,,,1280.0,1,,50185,F,Staphylococcus aureus,,CHEMBL615130,11324,
,N,BAO_0000218,,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",16,Intermediate,,1,,,,,1280.0,1,,50185,F,Staphylococcus aureus,,CHEMBL615131,11324,
,D,BAO_0000357,,Inhibition of cytochrome P450 progesterone 15-alpha hydroxylase,17,Expert,,9,,,,,10116.0,1,,100122,A,Rattus norvegicus,,CHEMBL884521,11347,
,H,BAO_0000357,,Concentration that cause 50% activation of human reticulocyte 15-lipoxygenase (15-HLO),18,Autocuration,,8,,,,,,1,,12054,B,,,CHEMBL615132,16474,
,H,BAO_0000019,,Inhibition of partially purified 15-lipoxygenase from human leukocytes,19,Autocuration,,8,,,,,,1,,12054,B,,,CHEMBL615133,10091,
,H,BAO_0000357,,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO),20,Autocuration,,8,,,,,,1,,12054,B,,,CHEMBL615134,16474,
,H,BAO_0000357,,Compound was evaluated for the percent increase in activation concentration of human reticulocyte 15-lipoxygenase (15-HLO),21,Autocuration,,8,,,,,,1,,12054,B,,,CHEMBL615135,16474,
,H,BAO_0000357,,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO),22,Autocuration,,8,,,,,,1,,12054,B,,,CHEMBL615136,16474,
,H,BAO_0000357,,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO); NI is no inhibition,23,Autocuration,,8,,,,,,1,,12054,B,,,CHEMBL615137,16474,
,H,BAO_0000357,,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO); NI is no inhibition,24,Autocuration,,8,,,,,,1,,12054,B,,,CHEMBL615138,16474,
,U,BAO_0000219,,"Inhibitory concentration against 15-lipoxygenase, by inhibiting 15-HETE production by human umbilical vein endothelial cells (HUVEC) stimulated by calcium ionophore A 23187 at concentration of 10e-5 M.",25,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL836324,14352,
,H,BAO_0000357,,In vitro inhibitory activity of compound on rabbit reticulocyte 15-lipoxygenase,26,Autocuration,,8,,,,,9986.0,1,,12054,B,Oryctolagus cuniculus,,CHEMBL615139,5646,
,H,BAO_0000357,,Inhibition of rabbit reticulocyte 15-lipoxygenase by compound (30 uM),27,Autocuration,,8,,,,,9986.0,1,,12054,B,Oryctolagus cuniculus,,CHEMBL615140,5646,
,H,BAO_0000219,,Inhibitory activity against 15-lipoxygenase in rat polymorphonuclear leukocytes,28,Autocuration,,8,,,,,,1,,12426,B,,,CHEMBL615141,10997,
,H,BAO_0000357,,Inhibitory activity against 15-lipoxygenase was determined obtained from soya bean,29,Autocuration,,8,,,,,3847.0,1,,12054,B,soya bean,,CHEMBL615142,6309,
,H,BAO_0000357,,Inhibitory activity against soybean 15-lipoxygenase was evaluated,30,Autocuration,,8,,,,,3847.0,1,,12054,B,Glycine max,,CHEMBL615143,167,
,H,BAO_0000357,,Inhibitory activity against soybean 15-lipoxygenase was evaluated at 100 uM,31,Autocuration,,8,,,,,3847.0,1,,12054,B,Glycine max,,CHEMBL615144,167,
,H,BAO_0000357,,The compound was tested for the in vitro inhibition of 15-lipoxygenase of soybean at a concentration of 10 uM,32,Autocuration,,8,,,,,3847.0,1,,12054,B,Glycine max,,CHEMBL872867,11087,
,H,BAO_0000357,,The compound was tested for the in vitro inhibition of 15-lipoxygenase of soybean at a concentration of 100 uM,33,Autocuration,,8,,,,,3847.0,1,,12054,B,Glycine max,,CHEMBL615145,11087,
,H,BAO_0000357,,Compound was tested in vitro for inhibition of 15-lipoxygenase soybean,34,Autocuration,,8,,,,,3847.0,1,,12054,B,Glycine max,,CHEMBL615146,13622,
,H,BAO_0000357,,Compound at 100 uM was tested in vitro for inhibition of 15-lipoxygenase soybean,35,Autocuration,,8,,,,,3847.0,1,,12054,B,Glycine max,,CHEMBL615147,13622,
,U,BAO_0000019,,Inhibition of cytochrome P450 progesterone 16-alpha hydroxylase,36,Autocuration,,0,,,,,10116.0,1,,22226,A,Rattus norvegicus,,CHEMBL615148,11347,
,U,BAO_0000019,,Binding affinity against bacterial 16S rRNA using mass spectrometry based assay,37,Autocuration,,0,,,,,562.0,1,,22226,B,Escherichia coli,,CHEMBL615149,5926,
,U,BAO_0000019,,Dissociation constant with dimeric 16S rRNA RNA construct B,38,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL615150,4567,
,M,BAO_0000225,,Dissociation constant towards 16S rRNA construct A,39,Intermediate,,3,,,,,,1,,22222,B,,,CHEMBL615151,3782,
,M,BAO_0000225,,Dissociation constant towards 16S rRNA construct B,40,Intermediate,,3,,,,,,1,,22222,B,,,CHEMBL615152,3782,
,M,BAO_0000225,,Binding affinity of aminoglycoside to 16S ribosomal RNA A-site in Escherichia coli,41,Expert,,3,,,,,562.0,1,,100263,B,Escherichia coli,,CHEMBL615153,4466,
,M,BAO_0000225,,Binding affinity for the 16S ribosomal RNA A-site of Escherichia coli,42,Expert,,3,,,,,562.0,1,,100263,B,Escherichia coli,,CHEMBL615154,6592,
,H,BAO_0000019,,Inhibitory activity against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),43,Autocuration,,8,,,,,,1,,13053,B,,,CHEMBL615155,898,
,H,BAO_0000019,,Inhibitory constant against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),44,Autocuration,,8,,,,,,1,,13053,B,,,CHEMBL615156,898,
,H,BAO_0000019,,The compound was tested at a concentration of 1 uM for inhibitory activity against 17 beta-hydroxysteroid dehydrogenase from human placental microsomes,45,Autocuration,,8,,,,,9606.0,1,,20001,B,Homo sapiens,,CHEMBL615157,13163,
,H,BAO_0000019,,The compound was tested at a concentration of 1 uM for inhibitory activity against 17 beta-hydroxysteroid dehydrogenase from human placental microsomes,46,Autocuration,,8,,,,,9606.0,1,,20001,B,Homo sapiens,,CHEMBL615158,13163,
,D,BAO_0000019,,"Inhibition of 17-alpha-hydroxylase/17,20 lyase from rat testes microsomal preparation",47,Expert,,9,,,,,10116.0,1,,12971,B,Rattus norvegicus,,CHEMBL615159,10691,
,D,BAO_0000019,,"Inhibition of 17-alpha-hydroxylase/17,20 lyase from rat testes microsomal preparation",48,Expert,,9,,,,,10116.0,1,,12971,B,Rattus norvegicus,,CHEMBL615172,10691,
,D,BAO_0000019,,"Percent inhibition of 17-alpha-hydroxylase/17,20 lyase of rat testes microsomes at 100 uM",49,Expert,,9,,,,,10116.0,1,,12971,B,Rattus norvegicus,,CHEMBL615173,10691,
,D,BAO_0000019,,"Percent inhibition of Steroid 17-alpha-hydroxylase/17,20 lyase of rat testes microsomes at 100 uM",50,Expert,,9,,,,,10116.0,1,,12971,B,Rattus norvegicus,,CHEMBL615174,10691,
,H,BAO_0000019,,Inhibitory activity against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),51,Autocuration,,8,,,,,,1,,13053,B,,,CHEMBL884518,898,
,H,BAO_0000357,,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1),52,Autocuration,,8,,,,,,1,,11512,B,,,CHEMBL615175,912,
,H,BAO_0000357,,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1) at 1 uM concentration,53,Autocuration,,8,,,,,,1,,11512,B,,,CHEMBL615176,912,
,H,BAO_0000357,,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1) at 10 uM concentration,54,Autocuration,,8,,,,,,1,,11512,B,,,CHEMBL615177,912,
,D,BAO_0000249,,Selectivity ratio of binding affinity towards mu to delta receptors of rat brain membranes,55,Autocuration,,5,Membranes,,,,10116.0,1,,104740,B,Rattus norvegicus,,CHEMBL615178,15103,
,N,BAO_0000219,,Cytotoxicity against ovarian cancer cell line (1A-9) of humans was determined,56,Intermediate,,1,,,506.0,,9606.0,1,1A9,80002,F,Homo sapiens,,CHEMBL615179,5116,
,D,BAO_0000219,,Functional antagonism by electrical assays in Xenopus oocytes expressing 1A/2A NMDA receptor subtype,57,Autocuration,,7,,,,,10116.0,1,Oocytes,104835,F,Rattus norvegicus,,CHEMBL615180,14578,
,D,BAO_0000219,,Functional antagonism by electrical assays in Xenopus oocytes expressing the 1A/2B NMDA receptor,58,Autocuration,,7,,,,,10116.0,1,Oocytes,104821,F,Rattus norvegicus,,CHEMBL615181,14578,
,D,BAO_0000219,,Functional antagonism by electrical assays in Xenopus oocytes expressing the 1A/2C NMDA receptor,59,Autocuration,,7,,,,,10116.0,1,Oocytes,104848,F,Rattus norvegicus,,CHEMBL615182,14578,
,N,BAO_0000219,,In vitro effective concentration required to reduce the number of human ovarian cancer (1A9) after 3-day incubation,60,Expert,,1,,,506.0,,9606.0,1,1A9,80002,F,Homo sapiens,,CHEMBL615183,4787,
,N,BAO_0000219,,In vitro effective concentration required to reduce the number of human ovarian cancer cells (1A9) after 3-day incubation,61,Intermediate,,1,,,506.0,,9606.0,1,1A9,80002,F,Homo sapiens,,CHEMBL615184,4787,
,N,BAO_0000219,,Cytotoxic activity against human ovarian cancer (1A9) cell line,62,Intermediate,,1,,,506.0,,9606.0,1,1A9,80002,F,Homo sapiens,,CHEMBL615185,3547,
,N,BAO_0000219,,Cytotoxic activity against human ovarian cancer (1A9) cell line; ND=Not determined,63,Intermediate,,1,,,506.0,,9606.0,1,1A9,80002,F,Homo sapiens,,CHEMBL615186,3547,
,N,BAO_0000219,,Effective dose of compound against replication of 1A9 cell line was evaluated,64,Intermediate,,1,,,506.0,,9606.0,1,1A9,80002,F,Homo sapiens,,CHEMBL615187,6726,
,N,BAO_0000219,,In vitro cytotoxic activity was determined against ovarian cancer (1A9) cell line,65,Expert,,1,,,506.0,,9606.0,1,1A9,80002,F,Homo sapiens,,CHEMBL885343,3455,
,N,BAO_0000219,,In vitro cytotoxicity evaluated against human ovarian cancer (1A9 cell line),66,Intermediate,,1,,,506.0,,9606.0,1,1A9,80002,F,Homo sapiens,,CHEMBL615188,5726,
,N,BAO_0000219,,In vitro cytotoxicity evaluated against human ovarian cancer (1A9 cell line); NA is not active,67,Intermediate,,1,,,506.0,,9606.0,1,1A9,80002,F,Homo sapiens,,CHEMBL615189,5726,
,N,BAO_0000219,,In vitro percent inhibition evaluated against human ovarian cancer (1A9 cell line) at >20 ug/mL,68,Intermediate,,1,,,506.0,,9606.0,1,1A9,80002,F,Homo sapiens,,CHEMBL615190,5726,
,N,BAO_0000219,,Inhibitory activity against Taxol resistant 1A9 cell lines,69,Intermediate,,1,,,506.0,,9606.0,1,1A9,80002,F,Homo sapiens,,CHEMBL615191,3395,
,N,BAO_0000219,,Cytotoxicity against human ovarian cancer (1A9) cell lines.,70,Expert,,1,,,506.0,,9606.0,1,1A9,80002,F,Homo sapiens,,CHEMBL615192,3415,
,N,BAO_0000219,,Percentage inhibition of human ovarian cancer (1A9) cell lines.,71,Expert,,1,,,506.0,,9606.0,1,1A9,80002,F,Homo sapiens,,CHEMBL827083,3415,
,N,BAO_0000219,,Effective dose required for inhibitory activity against 1A9 human tumor cell line.,72,Expert,,1,,,506.0,,9606.0,1,1A9,80002,F,Homo sapiens,,CHEMBL615193,17099,
,N,BAO_0000219,,Percent inhibition against 1A9 human tumor cell line at 0.10 ug/mL,73,Intermediate,,1,,,506.0,,9606.0,1,1A9,80002,F,Homo sapiens,,CHEMBL615194,17099,
,N,BAO_0000219,,Percent inhibition against 1A9 human tumor cell line at <0.00008 ug/mL,74,Intermediate,,1,,,506.0,,9606.0,1,1A9,80002,F,Homo sapiens,,CHEMBL615195,17099,
,N,BAO_0000219,,Percent inhibition against 1A9 human tumor cell line at >10 ug/mL,75,Intermediate,,1,,,506.0,,9606.0,1,1A9,80002,F,Homo sapiens,,CHEMBL615196,17099,
,N,BAO_0000219,,Inhibitory concentration against Jurkat cells,76,Intermediate,,1,,,503.0,,9606.0,1,Jurkat,81072,F,Homo sapiens,,CHEMBL615197,17721,
,U,BAO_0000019,,In vitro anticancer activity against 2 NCI SCLC cell lines; inactive,77,Intermediate,,0,,,,,,1,,22226,F,,,CHEMBL615198,1229,
,D,BAO_0000357,,Inhibition of cytochrome P450 progesterone 2-alpha-hydroxylase,78,Expert,,9,,,,,10116.0,1,,100121,A,Rattus norvegicus,,CHEMBL615199,11347,
,H,BAO_0000357,,"In vitro inhibition of human 2,3-oxidosqualene cyclase.",79,Expert,,8,,,,,,1,,11231,B,,,CHEMBL615200,17117,
,H,BAO_0000357,,"In vitro inhibition of human 2,3-oxidosqualene cyclase.",80,Expert,,8,,,,,,1,,11231,B,,,CHEMBL615201,17117,
,H,BAO_0000357,,"In vitro inhibition of human 2,3-oxidosqualene cyclase at 100 nM.",81,Expert,,8,,,,,,1,,11231,B,,,CHEMBL615202,17117,
,H,BAO_0000251,,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in Candida albicans microsomes",82,Autocuration,,8,Microsomes,,,,5476.0,1,,11231,B,Candida albicans,,CHEMBL615203,11375,
,H,BAO_0000251,,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in Candida albicans microsomes",83,Autocuration,,8,Microsomes,,,,5476.0,1,,11231,B,Candida albicans,,CHEMBL615204,11375,
,H,BAO_0000251,,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in Saccharomyces cerevisiae microsomes",84,Autocuration,,8,Microsomes,,,,4932.0,1,,11231,B,Saccharomyces cerevisiae,,CHEMBL615205,11375,
,H,BAO_0000251,,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in Saccharomyces cerevisiae microsomes",85,Autocuration,,8,Microsomes,,,,4932.0,1,,11231,B,Saccharomyces cerevisiae,,CHEMBL615206,11375,
,H,BAO_0000251,,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in pig liver microsomes",86,Autocuration,2107.0,8,Microsomes,,,,9823.0,1,,12083,B,Sus scrofa,,CHEMBL615207,11375,Liver
,H,BAO_0000019,,"Concentration required to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase",87,Autocuration,,8,,,,,10116.0,1,,11231,B,Rattus norvegicus,,CHEMBL827084,791,
,H,BAO_0000019,,"Concentration required to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase (OSC)",88,Autocuration,,8,,,,,10116.0,1,,11231,B,Rattus norvegicus,,CHEMBL615208,791,
,H,BAO_0000019,,"Evaluated for its activity to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase, activity expressed as Ki",89,Autocuration,,8,,,,,10116.0,1,,11231,B,Rattus norvegicus,,CHEMBL615209,791,
,D,BAO_0000251,,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in rat liver microsomes",90,Autocuration,2107.0,9,Microsomes,,,,10116.0,1,,12083,B,Rattus norvegicus,,CHEMBL615210,11375,Liver
,D,BAO_0000251,,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in rat liver microsomes",91,Autocuration,2107.0,9,Microsomes,,,,10116.0,1,,12083,B,Rattus norvegicus,,CHEMBL615211,11375,Liver
,D,BAO_0000251,,"Compound was evaluated for inhibitory activity against 2,3-oxidosqualene-lanosterol cyclase in rat liver microsomes",92,Autocuration,2107.0,9,Microsomes,,,,10116.0,1,,12083,B,Rattus norvegicus,,CHEMBL615212,153,Liver
,H,BAO_0000357,,Molar concentration needed to give 50% prevention of 2-5A (Adenosine dependent endoribonuclease),93,Expert,,8,,,,,,1,,11377,B,,,CHEMBL615213,8269,
,H,BAO_0000357,,Molar concentration required to displace 50% of the radiolabeled probe from 2-5A (Adenosine dependent endoribonuclease) in endonuclease-nitrocellulose complex,94,Expert,,8,,,,,,1,,11377,B,,,CHEMBL615273,8269,
,N,BAO_0000219,,In vitro cytotoxic concentration required to inhibit hepatitisB virus (HBV) replication in 2.2.15 cell line,95,Expert,,1,,,726.0,,9606.0,1,HepG2,81020,F,Homo sapiens,,CHEMBL615274,17653,
,N,BAO_0000219,,50% Effective concentration of compound required for inhibiting intracellular viral replicative intermediate DNA in HBV-transfected 2.2.15 cell line.,96,Intermediate,,1,,,726.0,,9606.0,1,HepG2,81020,F,Homo sapiens,,CHEMBL615275,14277,
,N,BAO_0000219,,Antiviral activity against Hepatitis B virus in 2.2.15 cell line,97,Intermediate,,1,,,726.0,,9606.0,1,HepG2,81020,F,Homo sapiens,,CHEMBL615276,1717,
,N,BAO_0000219,,In vitro effective concentration against hepatitis B virus was determined in 2.2.15 cells,98,Intermediate,,1,,,726.0,,9606.0,1,HepG2,81020,F,Homo sapiens,,CHEMBL615277,14091,
,N,BAO_0000219,,In vitro effective concentration against hepatitis B virus was determined in 2.2.15 cells; Not determined,99,Intermediate,,1,,,726.0,,9606.0,1,HepG2,81020,F,Homo sapiens,,CHEMBL615326,14091,
,N,BAO_0000218,,In vitro effective concentration required to inhibit hepatitisB virus (HBV) replication in 2.2.15 cell line,100,Expert,,1,,,,,10407.0,1,,50606,F,Hepatitis B virus,,CHEMBL883130,17653,
,N,BAO_0000219,,Ability to inhibit the episomal HBV-DNA in 2.2.15 cells.,101,Intermediate,,1,,,726.0,,9606.0,1,HepG2,81020,F,Homo sapiens,,CHEMBL884519,13105,
,N,BAO_0000219,,Concentration required to inhibit 50% of 2.2.15 cell line,102,Intermediate,,1,,,726.0,,9606.0,1,HepG2,81020,F,Homo sapiens,,CHEMBL615327,1717,
,N,BAO_0000219,,Anti viral activity against 2.2.15 cells (concentration required to reduce the log phase cell growth by 50%).,103,Intermediate,,1,,,726.0,,9606.0,1,HepG2,81020,A,Homo sapiens,,CHEMBL615328,13105,
,N,BAO_0000218,,Cytotoxic activity of compound against uninfected 2.2.15 cells.,104,Intermediate,,1,,,,,9606.0,1,2.2.15,50587,F,Homo sapiens,,CHEMBL615329,13600,
,N,BAO_0000218,,Anti hepatitis-B virus activity was evaluated in 2.2.15 cells.,105,Intermediate,,1,,,,,9606.0,1,2.2.15,50587,F,Homo sapiens,,CHEMBL615330,13467,
,N,BAO_0000218,,"Inhibition of the replication of HBV in 2.2.15 cells, by DNA hybridization assay",106,Expert,,1,,,,,10407.0,1,2.2.15,50606,F,Hepatitis B virus,,CHEMBL615331,17477,
,N,BAO_0000218,,In vitro anti-HBV activity in 2.2.15 cells,107,Intermediate,,1,,,,,9606.0,1,2.2.15,50587,F,Homo sapiens,,CHEMBL615332,1593,
,N,BAO_0000218,,In vitro anti-HBV activity in 2.2.15 cells; Not determined,108,Intermediate,,1,,,,,9606.0,1,2.2.15,50587,F,Homo sapiens,,CHEMBL615333,1593,
,N,BAO_0000218,,The compound was tested in vitro for the anti-HBV activity against 2.2.15 cells,109,Intermediate,,1,,,,,9606.0,1,2.2.15,50587,F,Homo sapiens,,CHEMBL615334,15089,
,N,BAO_0000218,,The compound was tested in vitro for the anti-HBV activity in 2.2.15 cells,110,Intermediate,,1,,,,,9606.0,1,2.2.15,50587,F,Homo sapiens,,CHEMBL615335,15089,
,N,BAO_0000218,,Cytotoxicity in 2.2.15 cells,111,Intermediate,,1,,,,,9606.0,1,2.2.15,50587,F,Homo sapiens,,CHEMBL615336,1593,
,N,BAO_0000218,,Cytotoxicity in 2.2.15 cells; Not determined,112,Intermediate,,1,,,,,9606.0,1,2.2.15,50587,F,Homo sapiens,,CHEMBL615337,1593,
,N,BAO_0000218,,Inhibitory activity of compound against hepatitis B virus (HBV) in growing cultures of 2.2.15 cells,113,Intermediate,,1,,,,,9606.0,1,2.2.15,50587,F,Homo sapiens,,CHEMBL615338,13600,
,N,BAO_0000218,,The growth inhibition activity for the compound was evaluated in 2.2.15 cells.,114,Intermediate,,1,,,,,9606.0,1,2.2.15,50587,F,Homo sapiens,,CHEMBL615339,13467,
,N,BAO_0000218,,Selectivity index was determined from the ratio of IC50 to the EC50 values evaluated in 2.2.15 cells.,115,Intermediate,,1,,,,,9606.0,1,2.2.15,50587,F,Homo sapiens,,CHEMBL615340,13467,
,N,BAO_0000219,,Antiviral activity against HBV was determined in 2.215 cell line,116,Intermediate,,1,,,726.0,,9606.0,1,HepG2,81020,F,Homo sapiens,,CHEMBL615341,14764,
,U,BAO_0000251,,Inhibition of 20-HETE synthesis in human renal microsomes,117,Autocuration,,0,Microsomes,,,,9606.0,1,,22226,B,Homo sapiens,,CHEMBL615342,6531,
,U,BAO_0000019,,Inhibitory activity against 20-HETE production from arachidonic acid using human renal microsome 20-HETE synthase.,118,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL615343,17322,
,N,BAO_0000219,,Inhibitory concentration against 2008 (ovarian) cells,119,Intermediate,,1,,,388.0,,9606.0,1,2008,80612,F,Homo sapiens,,CHEMBL615344,17072,
,N,BAO_0000219,,50% Growth inhibitory concentration( GI 50 ) by using 2008 human ovarian carcinoma cell lines.,120,Intermediate,,1,,,388.0,,9606.0,1,2008,80612,F,Homo sapiens,,CHEMBL615345,16936,
,N,BAO_0000219,,Compound was tested for 50% growth inhibitory concentration by using human ovarian carcinoma cell lines (2008),121,Intermediate,,1,,,388.0,,9606.0,1,2008,80612,F,Homo sapiens,,CHEMBL615346,16936,
,N,BAO_0000219,,Direct cytotoxicity against the selected tumor cell line 2008 was determined especially on ovarian adenocarcinoma derived cells,122,Intermediate,,1,,,388.0,,9606.0,1,2008,80612,F,Homo sapiens,,CHEMBL615347,17146,
,N,BAO_0000219,,Direct cytotoxicity against the selected tumor cell line 2008 was determined especially on ovarian adenocarcinoma derived cells; not detected,123,Intermediate,,1,,,388.0,,9606.0,1,2008,80612,F,Homo sapiens,,CHEMBL615348,17146,
,N,BAO_0000219,,In vitro inhibition of 2008/R ovarian cancer cell line,124,Intermediate,,1,,,561.0,,9606.0,1,2008/R,80613,F,Homo sapiens,,CHEMBL827085,10797,
,N,BAO_0000219,,In vitro inhibition of 2008/R ovarian cancer cell line; NA= Not achievable,125,Intermediate,,1,,,561.0,,9606.0,1,2008/R,80613,F,Homo sapiens,,CHEMBL615349,10797,
,N,BAO_0000219,,In vitro inhibition of 2008/S ovarian cancer cell line,126,Intermediate,,1,,,389.0,,9606.0,1,2008/S,80614,F,Homo sapiens,,CHEMBL615350,10797,
,N,BAO_0000219,,In vitro inhibition of 2008/S ovarian cancer cell line; NA= Not achievable,127,Intermediate,,1,,,389.0,,9606.0,1,2008/S,80614,F,Homo sapiens,,CHEMBL615351,10797,
,S,BAO_0000220,,Tested in vitro for inhibition of chymotrypsin like activity of purified human 20S proteasome,128,Expert,,2,,,,,9606.0,1,,100256,B,Homo sapiens,,CHEMBL615352,4823,
,S,BAO_0000220,,Compound was evaluated for inhibitory activity against 20S proteasome from human liver and brain,129,Intermediate,,2,,,,,9606.0,1,,100256,B,Homo sapiens,,CHEMBL615353,12912,
,S,BAO_0000220,,Inhibition of chymotrypsin-like activity of 20S proteasome,130,Expert,,2,,,,,,1,,100256,B,,,CHEMBL615354,2957,
,S,BAO_0000220,,Inhibition of chymotrypsin-like activity of 20S proteasome; value ranges from 10-20 uM,131,Expert,,2,,,,,,1,,100256,B,,,CHEMBL615355,2957,
,S,BAO_0000220,,Inhibitory activity against 20S proteosome,132,Intermediate,,2,,,,,,1,,100256,B,,,CHEMBL615356,3260,
,U,BAO_0000019,,Compound was tested for inhibitory activity against tryptase,133,Autocuration,,0,,,,,9606.0,1,,22226,B,Homo sapiens,,CHEMBL615357,3451,
,N,BAO_0000219,,Concentration required to inhibit 50% of extracellular circular replication of HBV DNA using 2215 cell line,134,Intermediate,,1,,,726.0,,9606.0,1,HepG2,81020,F,Homo sapiens,,CHEMBL615358,13885,
,N,BAO_0000219,,Concentration required to inhibit 50% of intracellular circular replication of HBV DNA using 2215 cell line,135,Intermediate,,1,,,726.0,,9606.0,1,HepG2,81020,F,Homo sapiens,,CHEMBL827086,13885,
,U,BAO_0000019,,Compound was tested for the inhibition of Alpha-glucosidase,136,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL615359,3676,
,H,BAO_0000357,,Inhibitory concentration against human neutrophil elastase (HNE),137,Autocuration,,8,,,,,,1,,235,B,,,CHEMBL615360,6043,
,U,BAO_0000218,,Change in heart rate was expressed in percent at at a dose 0.002 mg/kg iv in anesthetized rat,138,Autocuration,948.0,0,,,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL615361,11140,Heart
,H,BAO_0000019,,90% inhibition of the 20 Mycobacterium avium complex (MAC) clinical isolates,139,Autocuration,,8,,,,,,1,,19640,F,,,CHEMBL615362,10543,
,H,BAO_0000019,,Minimum inhibitory concentration of compound against 20 Mycobacterium avium complex (MAC) clinical isolates,140,Expert,,8,,,,,,1,,19640,F,,,CHEMBL615363,10543,
,H,BAO_0000357,,Minimum inhibitory concentration of compound against 20 Mycobacterium avium complex (MAC) clinical isolates,141,Autocuration,,8,,,,,,1,,19640,B,,,CHEMBL615364,10543,
,H,BAO_0000019,,90% inhibition of the 20 Mycobacterium avium complex (MAC) clinical isolates,142,Expert,,8,,,,,,1,,19640,F,,,CHEMBL615365,10543,
,N,BAO_0000219,,In Vitro evaluation for the growth inhibition of Subline (P388/AMSA) Leukemia cell lines,143,Intermediate,,1,,,524.0,,10090.0,1,P338,80360,F,Mus musculus,,CHEMBL615366,11365,
,N,BAO_0000219,,In Vitro evaluation for the growth inhibition of Subline (P388/CP) Leukemia cell lines,144,Intermediate,,1,,,524.0,,10090.0,1,P338,80360,F,Mus musculus,,CHEMBL615367,11365,
,N,BAO_0000219,,Compound was evaluated for the inhibition of cell replication human peripheral blood lymphocytes (PBL's).,145,Intermediate,,1,,,554.0,,9606.0,1,PBL,80384,F,Homo sapiens,,CHEMBL615368,11803,
,U,BAO_0000019,,Compound was evaluated for the inhibition of cell replication sheep choroid plexus (SCP) cells,146,Autocuration,,0,,,,,9940.0,1,,22226,F,Ovis aries,,CHEMBL615369,11803,
,U,BAO_0000019,,Compound was evaluated for the inhibition of cell replication sheep choroid plexus (SCP) cells.,147,Autocuration,,0,,,,,9940.0,1,,22226,F,Ovis aries,,CHEMBL615370,11803,
,H,BAO_0000357,,Compound is evaluated in vitro for the inhibition single mutant of HIV-1 RT (Y181C),148,Autocuration,,8,,,,,,1,,191,B,,,CHEMBL615673,12278,
,U,BAO_0000019,,Compound was evaluated for its inhibitory effect on thymidine [3H]dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-5,149,Autocuration,,0,,,,,9606.0,1,,22226,F,Homo sapiens,,CHEMBL615674,8249,
,U,BAO_0000019,,Compound was evaluated for its inhibitory effect on thymidine [3H]-dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-6,150,Autocuration,,0,,,,,9606.0,1,,22226,F,Homo sapiens,,CHEMBL615675,8249,
,U,BAO_0000219,,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in at conc. 10e-7,151,Autocuration,,0,,,635.0,,9606.0,1,CCRF-CEM,22226,F,Homo sapiens,,CHEMBL615676,8249,
,U,BAO_0000219,,Compound was evaluated for its inhibitory effect on thymidine ([3H]-dThd) incorporation into DNA of CEM cells in culture at conc. 10e-4,152,Autocuration,,0,,,635.0,,9606.0,1,CCRF-CEM,22226,F,Homo sapiens,,CHEMBL615677,8249,
,U,BAO_0000219,,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in culture at conc. 10e-5,153,Autocuration,,0,,,635.0,,9606.0,1,CCRF-CEM,22226,F,Homo sapiens,,CHEMBL615678,8249,
,U,BAO_0000219,,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in culture at conc. 10e-6,154,Autocuration,,0,,,635.0,,9606.0,1,CCRF-CEM,22226,F,Homo sapiens,,CHEMBL615679,8249,
,U,BAO_0000019,,Compound was evaluated for its inhibitory effect on thymidine ([3H]-dThd) incorporation into DNA of CEM/MTX cells in at conc. 10e-7.,155,Autocuration,,0,,,,,9606.0,1,,22226,F,Homo sapiens,,CHEMBL615680,8249,
,U,BAO_0000019,,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-4,156,Autocuration,,0,,,,,9606.0,1,,22226,F,Homo sapiens,,CHEMBL615681,8249,
,H,BAO_0000249,,In vitro binding affinity towards (alpha-4)2(beta-2)3 neuronal nicotinic acetylcholine receptor in P2 membrane fractions of rat forebrain,157,Autocuration,,6,,,,,,1,,104290,B,,,CHEMBL857972,16992,
,N,BAO_0000218,,Minimum inhibitory concentration of compound against Streptococcus pyogenus septicemia in the mouse,158,Intermediate,,1,,,,,1314.0,1,,50264,F,Streptococcus pyogenes,,CHEMBL857899,10543,
,N,BAO_0000218,,Antiviral activity against 07/1 strain of thymidine kinase negative (TK-) Varicella-Zoster Virus (VZV),159,Intermediate,,1,,,,,10335.0,1,,50527,F,Human herpesvirus 3,,CHEMBL615371,17833,
,N,BAO_0000218,,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,160,Expert,,1,,,468.0,,10335.0,1,HEL,50527,F,vericilla zoster virus,,CHEMBL615372,17290,
,N,BAO_0000218,,Antiviral activity against 07/1 strain of VZV; ND: No data,161,Intermediate,,1,,,,,10335.0,1,,50527,F,vericilla zoster virus,,CHEMBL615373,17290,
,N,BAO_0000218,,Antiviral activity against 07/1 strain of VZV; ND=No data,162,Intermediate,,1,,,,,10335.0,1,,50527,F,vericilla zoster virus,,CHEMBL615374,17290,
,N,BAO_0000218,,"Antibacterial activity was determined against gram negative organism, Enterobacter cloacae (MA2646)",163,Intermediate,,1,,,,,561.0,1,,50145,F,escherichia cloac,,CHEMBL615375,10932,
,U,BAO_0000019,,Ratio of Ki at A2 to Ki at A1 receptors,164,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL615376,9707,
,H,BAO_0000249,,"In vitro inhibition of 1,3-beta-glucan synthase in Candida albicans membrane assay.",165,Expert,,8,,,,,5476.0,1,,11143,B,Candida albicans,,CHEMBL615377,2346,
,H,BAO_0000357,,"Inhibition of 1,3-beta-glucan synthase",166,Expert,,8,,,,,284593.0,1,,18077,B,Candida glabrata CBS 138,,CHEMBL615378,2205,
,N,BAO_0000219,,Inhibition of growth of 1-87 human tumor cell line,167,Intermediate,,1,,,832.0,,9606.0,1,1-87 tumor cell line,80609,F,Homo sapiens,,CHEMBL615379,11900,
,D,BAO_0000219,,Inhibition of 1-lipoxygenase (LOX)in RBL cells,168,Expert,,9,,,,,10116.0,1,,12166,B,Rattus norvegicus,,CHEMBL615380,14864,
,D,BAO_0000357,,Inhibitory activity against soybean 1-lipoxygenase (SLO),169,Autocuration,,9,,,,,3847.0,1,,100171,B,Glycine max,,CHEMBL615381,16474,
,D,BAO_0000357,,Inhibitory activity against soybean 1-lipoxygenase (SLO); no effect,170,Autocuration,,9,,,,,3847.0,1,,100171,B,Glycine max,,CHEMBL615382,16474,
,D,BAO_0000357,,% inhibition against soybean 1-lipoxygenase (SLO),171,Autocuration,,9,,,,,3847.0,1,,100171,B,Glycine max,,CHEMBL615383,16474,
,D,BAO_0000357,,percent inhibition against soybean 1-lipoxygenase (SLO);NI is no inhibition,172,Autocuration,,9,,,,,3847.0,1,,100171,B,Glycine max,,CHEMBL615384,16474,
,D,BAO_0000357,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 10:90,173,Autocuration,,9,,,,,3847.0,1,,100171,B,Glycine max,,CHEMBL615385,3094,
,D,BAO_0000357,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 1:99,174,Autocuration,,9,,,,,3847.0,1,,100171,B,Glycine max,,CHEMBL615386,3094,
,D,BAO_0000357,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 25:75,175,Autocuration,,9,,,,,3847.0,1,,100171,B,Glycine max,,CHEMBL615387,3094,
,D,BAO_0000357,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 35:65,176,Autocuration,,9,,,,,3847.0,1,,100171,B,Glycine max,,CHEMBL615388,3094,
,D,BAO_0000357,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 50:50,177,Autocuration,,9,,,,,3847.0,1,,100171,B,Glycine max,,CHEMBL615214,3094,
,D,BAO_0000357,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 76:24,178,Autocuration,,9,,,,,3847.0,1,,100171,B,Glycine max,,CHEMBL827087,3094,
,D,BAO_0000357,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 87:13,179,Autocuration,,9,,,,,3847.0,1,,100171,B,Glycine max,,CHEMBL615215,3094,
,D,BAO_0000357,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 89:11,180,Autocuration,,9,,,,,3847.0,1,,100171,B,Glycine max,,CHEMBL615216,3094,
,D,BAO_0000357,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 95:5,181,Autocuration,,9,,,,,3847.0,1,,100171,B,Glycine max,,CHEMBL615217,3094,
,D,BAO_0000357,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 97:3,182,Autocuration,,9,,,,,3847.0,1,,100171,B,Glycine max,,CHEMBL615218,3094,
,D,BAO_0000357,,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 99:1,183,Autocuration,,9,,,,,3847.0,1,,100171,B,Glycine max,,CHEMBL615219,3094,
,U,BAO_0000019,,Evaluated for inhibitory activity on 10-formyltetrahydrofolate synthetase(L cell) at folate substrate concentration of 100 uM,184,Autocuration,,0,,,,,10090.0,1,,22226,B,Mus musculus,,CHEMBL615220,10413,
,N,BAO_0000219,,Cells were harvested and were assayed for luciferase and -galactosidase activities (Transcriptional activity),185,Intermediate,,1,,,294.0,,10090.0,1,C3H 10T1/2,80049,F,Mus musculus,,CHEMBL615221,16929,
,U,BAO_0000019,,In vitro anticancer activity against 11 NCI NSCLC cell lines; inactive,186,Intermediate,,0,,,,,,1,,22226,F,,,CHEMBL615222,1229,
,H,BAO_0000357,,In vitro inhibitory activity against human 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA),187,Autocuration,,8,,,,,,1,,11489,B,,,CHEMBL615223,16587,
,H,BAO_0000357,,In vitro inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA),188,Autocuration,,8,,,,,,1,,11862,B,,,CHEMBL615224,16587,
,H,BAO_0000357,,In vitro inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA).,189,Autocuration,,8,,,,,,1,,11862,B,,,CHEMBL615225,16587,
,H,BAO_0000357,,Ability to convert [3H]cortisol to the tritium labeled cortisone in the presence of human 11 beta hydroxysteroid dehydrogenase type 2,190,Autocuration,,8,,,,,,1,,11489,B,,,CHEMBL615226,16587,
,H,BAO_0000357,,Inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 2 at a concentration of 0.2 mM; NI means no inhibition,191,Autocuration,,8,,,,,,1,,11862,B,,,CHEMBL615227,16587,
,D,BAO_0000019,,Evaluated for inhibition of bovine adrenal cortical mitochondrial 11 beta-hydroxylase,192,Expert,,9,,,,,9913.0,1,,12347,F,Bos taurus,,CHEMBL615228,8058,
,D,BAO_0000357,,Effect on adrenal 11-beta-hydroxylase activity at 10e-4 M; No significant effect,193,Expert,,9,,,,,10116.0,1,,100120,B,Rattus norvegicus,,CHEMBL615229,9065,
,D,BAO_0000357,,Inhibition of 11 beta-hydroxylase from rat adrenal gland,194,Expert,2369.0,9,,,,,10116.0,1,,100120,B,Rattus norvegicus,,CHEMBL615230,8865,Adrenal gland
,D,BAO_0000357,,Inhibition of rat adrenal 11-beta-hydroxylase,195,Expert,,9,,,,,10116.0,1,,100120,B,Rattus norvegicus,,CHEMBL615231,9066,
,D,BAO_0000357,,Inhibition of rat adrenal 11-beta-hydroxylase,196,Expert,,9,,,,,10116.0,1,,100120,B,Rattus norvegicus,,CHEMBL884520,8394,
,D,BAO_0000357,,Inhibition of rat adrenal 11-beta-hydroxylase at 10e-5 M,197,Expert,,9,,,,,10116.0,1,,100120,B,Rattus norvegicus,,CHEMBL615232,8394,
,H,BAO_0000019,,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 1 of wistar rat liver cytosol at 10 uM was determined using [3H]cortisone,198,Autocuration,,8,,,,,,1,,10328,B,,,CHEMBL615233,6431,
,H,BAO_0000357,,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 2 of wistar rat kidney at 10 uM was determined using [3H]cortisol,199,Autocuration,,8,,,,,,1,,11490,B,,,CHEMBL827088,6431,
,H,BAO_0000357,,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 2 of wistar rat kidney at 10 uM was determined using [3H]cortisol,200,Autocuration,,8,,,,,,1,,11490,B,,,CHEMBL615234,6431,
,H,BAO_0000019,,Compound was tested for the percent of inhibition against 12-LO at 10 uM,201,Autocuration,,8,,,,,,1,,11134,F,,,CHEMBL615235,9295,
,H,BAO_0000019,,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,202,Autocuration,,8,,,,,,1,,12052,B,,,CHEMBL615236,10193,
,H,BAO_0000019,,Compound was tested in vitro for inhibition of 12-LO human platelet,203,Autocuration,,8,,,,,,1,,11134,B,,,CHEMBL615237,13622,
,H,BAO_0000019,,Inhibitory concentration against human platelet 12-lipoxygenase,204,Autocuration,,8,,,,,,1,,11134,F,,,CHEMBL615238,12079,
,H,BAO_0000019,,Compound at 100 uM was tested in vitro for inhibition of 12-LO human platelet,205,Autocuration,,8,,,,,,1,,11134,B,,,CHEMBL615239,13622,
,D,BAO_0000019,,Inhibitory concentration against human platelet 12-lipoxygenase,206,Autocuration,,9,,,,,9606.0,1,,11134,F,Homo sapiens,,CHEMBL615240,12079,
,H,BAO_0000019,,Tested for inhibition of 12-LO (12-lipoxygenase) as an inhibitor of 12(S)-HETE biosynthesis in mouse epidermal homogenates,207,Expert,,8,,,,,,1,,11835,B,,,CHEMBL615241,13500,
,H,BAO_0000357,,Inhibitory activity against conversion of [1-14C]arachidonic acid to 12-HPETE and its reduction product 12-HETE by porcine leukocyte type 12-lipoxygenase,208,Expert,,8,,,,,,1,,11601,B,,,CHEMBL615242,13723,
,H,BAO_0000019,,Inhibitory activity against human platelet 12-lipoxygenase (12-HLO),209,Autocuration,,8,,,,,,1,,11134,B,,,CHEMBL615243,16474,
,H,BAO_0000019,,Inhibitory activity against human platelet 12-lipoxygenase,210,Autocuration,,8,,,,,,1,,11134,B,,,CHEMBL615244,1630,
,H,BAO_0000019,,Inhibitory activity against human platelet 12-lipoxygenase was evaluated,211,Autocuration,,8,,,,,,1,,11134,B,,,CHEMBL615245,167,
,H,BAO_0000019,,% inhibition against human platelet 12-lipoxygenase (12-HLO),212,Autocuration,,8,,,,,,1,,11134,B,,,CHEMBL615246,16474,
,H,BAO_0000019,,Inhibitory activity against human platelet 12-lipoxygenase was evaluated at 100 uM,213,Autocuration,,8,,,,,,1,,11134,B,,,CHEMBL615247,167,
,H,BAO_0000019,,percent inhibition against human platelet 12-lipoxygenase (12-HLO); NI is no inhibition,214,Autocuration,,8,,,,,,1,,11134,B,,,CHEMBL615248,16474,
,H,BAO_0000357,,Inhibitory activity towards porcine 12-lipoxygenase,215,Autocuration,,8,,,,,,1,,11601,B,,,CHEMBL615249,10091,
,H,BAO_0000357,,Tested for inhibition against porcine 12-LO,216,Autocuration,,8,,,,,,1,,11601,B,,,CHEMBL615250,11966,
,H,BAO_0000019,,Inhibition of 12-lipoxygenase was evaluated in rat platelets stimulated by thrombin up to a concentration of 10 uM; NE means No effect,217,Autocuration,,8,,,,,,1,,12052,B,,,CHEMBL615251,951,
,H,BAO_0000019,,Inhibitory activity against 12-lipoxygenase in rat platelet rich plasma,218,Autocuration,,8,,,,,,1,,12052,B,,,CHEMBL615252,10997,
,H,BAO_0000019,,In vitro inhibition of rat platelet 12-lipoxygenase,219,Expert,,8,,,,,,1,,12052,B,,,CHEMBL828340,10193,
,H,BAO_0000019,,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,220,Autocuration,,8,,,,,,1,,12052,B,,,CHEMBL615253,10193,
,H,BAO_0000019,,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 100 uM,221,Autocuration,,8,,,,,,1,,12052,B,,,CHEMBL615254,10193,
,H,BAO_0000019,,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 30 uM,222,Autocuration,,8,,,,,,1,,12052,B,,,CHEMBL615255,10193,
,H,BAO_0000019,,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,223,Autocuration,,8,,,,,,1,,12052,B,,,CHEMBL615256,10193,
,H,BAO_0000019,,In vitro inhibitory activity against rat platelet 12-lipoxygenase,224,Autocuration,,8,,,,,,1,,12052,B,,,CHEMBL615257,10193,
,H,BAO_0000019,,The compound was tested for the in vitro inhibition of platelet 12-lipoxygenase at a concentration of 100 uM,225,Autocuration,,8,,,,,,1,,12052,B,,,CHEMBL615258,11087,
,N,BAO_0000219,,Cytotoxic activity in a panel of Human ovarian tumor 41M cell line after 96h of drug exposure,226,Intermediate,,1,,,621.0,,9606.0,1,41M,80007,F,Homo sapiens,,CHEMBL615259,15569,
,N,BAO_0000219,,In vitro antitumor activity against 41M cell line.,227,Expert,,1,,,621.0,,9606.0,1,41M,80007,F,Homo sapiens,,CHEMBL615260,12989,
,N,BAO_0000219,,cytotoxicity against 41M cells incubated for 24 hr in MTT assay.,228,Intermediate,,1,,,621.0,,9606.0,1,41M,80007,F,Homo sapiens,,CHEMBL615261,16745,
,N,BAO_0000219,,Cytotoxic activity in a panel of Human ovarian tumor 41M/CDDP cell line after 96h of drug exposure,229,Intermediate,,1,,,621.0,,9606.0,1,41M,80007,F,Homo sapiens,,CHEMBL615262,15569,
,N,BAO_0000219,,In vitro antitumor activity against 41McisR cell line.,230,Expert,,1,,,621.0,,9606.0,1,41M,80007,F,Homo sapiens,,CHEMBL615263,12989,
,N,BAO_0000219,,Resistant factor was determined between IC50 of cisplatin-resistant human tumor cell lines to that of 41McisR cell line,231,Expert,,1,,,621.0,,9606.0,1,41M,80007,F,Homo sapiens,,CHEMBL838393,12989,
,N,BAO_0000219,,cytotoxicity against 41McisR cells incubated for 24 hr in MTT assay,232,Intermediate,,1,,,621.0,,9606.0,1,41M,80007,F,Homo sapiens,,CHEMBL615264,16745,
,D,BAO_0000357,,Inhibition of 5'-inosine monophosphate dehydrogenase type I (IMPDH I),233,Expert,,9,,,,,9606.0,1,,84,B,Homo sapiens,,CHEMBL615265,6210,
,D,BAO_0000357,,Inhibition of 5'-inosine monophosphate dehydrogenase type II (IMPDH II),234,Expert,,9,,,,,9606.0,1,,68,B,Homo sapiens,,CHEMBL615266,6210,
,H,BAO_0000357,,Inhibitory activity against inosine 5'-inosine monophosphate dehydrogenase type II (IMPDH II),235,Expert,,8,,,,,,1,,68,B,,,CHEMBL615267,6226,
,H,BAO_0000357,,Equilibrium dissociation constant towards human 5'-methylthioadenosine phosphorylase,236,Expert,,8,,,,,,1,,10201,B,,,CHEMBL615268,17855,
,H,BAO_0000357,,Equilibrium dissociation constant towards human 5'-methylthioadenosine phosphorylase; nd = Not determined,237,Expert,,8,,,,,,1,,10201,B,,,CHEMBL615269,17855,
,H,BAO_0000357,,Initial dissociation constant towards human 5'-methylthioadenosine phosphorylase,238,Expert,,8,,,,,,1,,10201,B,,,CHEMBL615270,17855,
,H,BAO_0000357,,"Evaluated for inhibitory activity on 5,10-Methenyl Tetrahydrofolate Cyclohydrolase(L cell) at folate substrate concentration of 100 uM",239,Autocuration,,8,,,,,,1,,12220,B,,,CHEMBL615271,10413,
,H,BAO_0000357,,"Inhibitory activity against 5,10-methylenetetrahydrofolate dehydrogenase from Escherichia coli at a concentration of 0.1 mM; NT=Not tested",240,Autocuration,,8,,,,,562.0,1,,11303,B,Escherichia coli,,CHEMBL615272,10413,
,H,BAO_0000357,,"Inhibitory activity against 5,10-Methylene Tetrahydrofolate Cyclohydrolase from Escherichia coli at a concentration of 0.1 mM; NT=Not tested",241,Autocuration,,8,,,,,562.0,1,,11303,B,Escherichia coli,,CHEMBL615103,10413,
,H,BAO_0000357,,"Inhibitory activity against 5,10-Methylene Tetrahydrofolate Cyclohydrolase from Escherichia coli at a concentration of 0.1 mM;NT=Not tested",242,Autocuration,,8,,,,,562.0,1,,11303,B,Escherichia coli,,CHEMBL615104,10413,
,H,BAO_0000357,,"Evaluated for inhibitory activity on 5,10-Methylene Tetrahydrofolate Cyclohydrolase(L cell) at folate substrate concentration of 100 uM",243,Autocuration,,8,,,,,,1,,12220,B,,,CHEMBL615105,10413,
,H,BAO_0000357,,"Evaluated for inhibitory activity on 5,10-methylenetetrahydrofolate dehydrogenase(L cell) at folate substrate concentration of 100 uM",244,Autocuration,,8,,,,,,1,,12220,B,,,CHEMBL872866,10413,
,H,BAO_0000357,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",245,Autocuration,,8,,,,,9823.0,1,,11303,B,Sus scrofa,,CHEMBL615106,7587,
,H,BAO_0000019,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (A,porcine liver) enzyme.",246,Autocuration,,8,,,,,9823.0,1,,11303,B,Sus scrofa,,CHEMBL615107,7587,
,H,BAO_0000357,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-4 M inhibitory concentration",247,Autocuration,,8,,,,,9823.0,1,,11303,B,Sus scrofa,,CHEMBL615108,7587,
,H,BAO_0000357,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-5 M inhibitory concentration",248,Autocuration,,8,,,,,9823.0,1,,11303,B,Sus scrofa,,CHEMBL615109,7587,
,H,BAO_0000357,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",249,Autocuration,,8,,,,,9823.0,1,,11303,B,Sus scrofa,,CHEMBL615110,7587,
,H,BAO_0000019,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-4 M inhibitory concentration",250,Autocuration,,8,,,,,9823.0,1,,11303,B,Sus scrofa,,CHEMBL840105,7587,
,H,BAO_0000019,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-5 M inhibitory concentration",251,Autocuration,,8,,,,,9823.0,1,,11303,B,Sus scrofa,,CHEMBL615111,7587,
,H,BAO_0000019,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-6 M inhibitory concentration",252,Autocuration,,8,,,,,9823.0,1,,11303,B,Sus scrofa,,CHEMBL615112,7587,
,H,BAO_0000019,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-7 M inhibitory concentration",253,Autocuration,,8,,,,,9823.0,1,,11303,B,Sus scrofa,,CHEMBL615113,7587,
,H,BAO_0000019,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme.",254,Autocuration,,8,,,,,9823.0,1,,11303,B,Sus scrofa,,CHEMBL615114,7587,
,H,BAO_0000357,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",255,Autocuration,,8,,,,,9823.0,1,,11303,B,Sus scrofa,,CHEMBL615115,7587,
,H,BAO_0000019,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-4 M inhibitory concentration",256,Autocuration,,8,,,,,9823.0,1,,11303,B,Sus scrofa,,CHEMBL615116,7587,
,H,BAO_0000357,,"Compound was tested for in vitro inhibition of 5,10-Methylene Tetrahydrofolate Cyclohydrolase, competitive against (+)-L-5,10-methenyltetrahydrofolate",257,Autocuration,,8,,,,,,1,,11303,B,,,CHEMBL615698,7323,
,U,BAO_0000019,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Reductase (porcine kidney) enzyme at 10E-4 M inhibitory concentration",258,Autocuration,,0,,,,,9823.0,1,,22226,B,Sus scrofa,,CHEMBL615699,7587,
,U,BAO_0000019,,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Reductase (porcine kidney) enzyme.",259,Autocuration,,0,,,,,9823.0,1,,22226,B,Sus scrofa,,CHEMBL615700,7587,
,H,BAO_0000357,,Inhibition of 5-Desaturase involved in ergosterol biosynthesis,260,Expert,,8,,,,,4932.0,1,,100249,B,Saccharomyces cerevisiae,,CHEMBL615701,13750,
,U,BAO_0000019,,Ability for reversible inhibition of Walker 256 5-Fluoro-2'-deoxyuridine Phosphorylase,261,Autocuration,,0,,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL615702,7662,
,U,BAO_0000019,,Ability for reversible inhibition of Walker 256 5-Fluoro-2'-deoxyuridine Phosphorylase,262,Autocuration,,0,,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL615703,7662,
,U,BAO_0000019,,"Irreversible inhibition of Walker 256 FUDR phosphorylase; expressed as Vo/Vi, velocity without inhibitor to that of velocity with inhibitor",263,Autocuration,,0,,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL615704,7662,
,H,BAO_0000019,,"Tested for 5-HT 3 receptor antagonist potency by ability to inhibit the reflex bradycardia, the Bezold-Jarisch reflex in the rat",264,Autocuration,,6,,,,,,1,,104698,F,,,CHEMBL615705,12211,
,H,BAO_0000019,,"Compound was tested for its 5-HT 3 receptor antagonist potency by their ability to inhibit the reflex bradycardia, the Bezold-Jarisch reflex in the rat",265,Autocuration,,6,,,,,,1,,104698,F,,,CHEMBL615706,12211,
,D,BAO_0000221,,Relative ability to increase cholinergically mediated contractions in isolated ileum of guinea pig,266,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL615707,12211,Ileum
,H,BAO_0000019,,Stimulatory activity of intragastric pressure was tested in the rat,267,Expert,,8,,,,,,1,,10623,F,,,CHEMBL615708,12211,
,H,BAO_0000357,,% Decrease of 5-HT carrier-receptor -bound radioactivity using paroxetine as a radioligand.,268,Autocuration,,8,,,,,,1,,121,B,,,CHEMBL615709,15453,
,U,BAO_0000218,,Dose to reduce neuronal firing against 5-HT cells in rats (iv),269,Autocuration,,0,,,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL615710,11884,
,H,BAO_0000019,,Antagonistic activity of corresponding methoxy compound against serotonin 5-HT receptor,270,Autocuration,,8,,,,,,1,,12688,F,,,CHEMBL615711,7185,
,D,BAO_0000357,,Binding affinity at 5-HT reuptake site labeled with [3H]paroxetine,271,Expert,,9,,,,,9606.0,1,,121,B,Homo sapiens,,CHEMBL615712,6876,
,D,BAO_0000357,,Binding affinity at 5-HT reuptake site labeled with [3H]paroxetine; No data,272,Expert,,9,,,,,9606.0,1,,121,B,Homo sapiens,,CHEMBL836325,6876,
,H,BAO_0000019,,Inhibition of high affinity 5-HT uptake at concentration of 1 uM,273,Autocuration,,8,,,,,,1,,12198,F,,,CHEMBL615713,11863,
,H,BAO_0000357,,Inhibition constant of high-affinity 5-HT uptake,274,Autocuration,,8,,,,,,1,,12198,B,,,CHEMBL615714,11863,
,H,BAO_0000019,,Michaelis-Menten constant was reported for high affinity transport of 5-HT,275,Autocuration,,8,,,,,,1,,12198,F,,,CHEMBL615715,11863,
,H,BAO_0000019,,Maximum rate was determined for high affinity transport of 5-HT,276,Autocuration,,8,,,,,,1,,12198,F,,,CHEMBL615716,11863,
,H,BAO_0000019,,Compound was tested for agonistic activity against 5-HT uptake,277,Autocuration,,4,,,,,,1,,104714,F,,,CHEMBL615717,4639,
,H,BAO_0000019,,Inhibition affinity against 5-HT-1B receptor in rat frontal cortex using radio binding assay,278,Expert,,8,,,,,,1,,10577,B,,,CHEMBL881818,15796,
,H,BAO_0000357,,Inhibition affinity against 5-HT-1D receptor in bovine caudate nucleus using radio binding assay,279,Expert,,8,,,,,9913.0,1,,105,B,Bos taurus,,CHEMBL884540,15796,
,D,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand,280,Autocuration,,5,,,,,10116.0,1,,104744,B,Rattus norvegicus,,CHEMBL615718,12801,
,H,BAO_0000224,,The compound was evaluated for the binding affinity towards 5-hydroxytryptamine 1 using [3H]5-HT as radioligand,281,Autocuration,,4,,,,,,1,,104744,B,,,CHEMBL615719,12801,
,H,BAO_0000249,,Percent inhibition of binding of 3.0 nM [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat caudate membranes at 10 e -5 M,282,Autocuration,,4,Membranes,,,,,1,,104744,B,,,CHEMBL615720,12120,
,H,BAO_0000249,,Percent inhibition of binding of 3.0 nM [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat caudate membranes at 10 e -5 M.,283,Autocuration,,4,Membranes,,,,,1,,104744,B,,,CHEMBL615721,12120,
,H,BAO_0000019,,Displacement of binding of [3H]-5-HT to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,284,Autocuration,,4,,,,,,1,,104744,B,,,CHEMBL615722,11963,
,H,BAO_0000019,,Dose required to reduce neuronal firing of 5-HT1A cells by 50%,285,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL615723,11701,
,H,BAO_0000221,,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,286,Autocuration,10000000.0,8,,,,,,1,,51,B,,,CHEMBL615724,9995,Hippocampus
,H,BAO_0000221,,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,287,Autocuration,10000000.0,8,,,,,,1,,51,B,,,CHEMBL615725,9995,Hippocampus
,H,BAO_0000221,,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,288,Autocuration,10000000.0,8,,,,,,1,,51,B,,,CHEMBL615726,9995,Hippocampus
,H,BAO_0000218,,Antagonistic activity at postsynaptic 5-HT1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (.26-3.52),289,Autocuration,,8,,In vivo,,,,1,,10576,F,,,CHEMBL615727,16394,
,D,BAO_0000019,,Effect on forskolin stimulated adenylate cyclase activity at 5-HT1D receptor of guinea pig substantia nigra.,290,Intermediate,,9,,,,,10141.0,1,,105570,F,Cavia porcellus,,CHEMBL615728,11574,
,H,BAO_0000219,,Binding affinity towards 5-HT1F (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,291,Autocuration,,8,,,449.0,,,1,CHO,279,B,,,CHEMBL857971,15779,
,H,BAO_0000357,,Compound was tested for the displacement of [125I]DOI from clone human 5-hydroxytryptamine 2A receptor,292,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL615729,15363,
,D,BAO_0000019,,Efficacy against 5-hydroxytryptamine 2A receptor,293,Expert,,9,,,,,10116.0,1,,12687,F,Rattus norvegicus,,CHEMBL615730,15363,
,H,BAO_0000019,,Intrinsic activity towards 5-HT2A receptor of rat tail artery,294,Expert,,8,,,,,,1,,12687,F,,,CHEMBL615731,15329,
,H,BAO_0000019,,Relative potency towards 5-HT2A receptor of rat tail artery,295,Expert,,8,,,,,,1,,12687,F,,,CHEMBL615732,15329,
,H,BAO_0000019,,Blocking 5-HT2A receptor-mediated contractions of rat tail artery,296,Expert,,8,,,,,,1,,12687,F,,,CHEMBL615733,15329,
,H,BAO_0000019,,Partial agonism at 5-HT2A receptor was evaluated in presence of ketanserin (3-10 nM) in isolated rat tail artery,297,Expert,,8,,,,,,1,,12687,F,,,CHEMBL615734,15329,
,H,BAO_0000019,,Compound was tested for the intrinsic activity against 5-HT2A receptors of rat tail artery.,298,Autocuration,,8,,,,,,1,,12687,F,,,CHEMBL615735,15329,
,H,BAO_0000019,,Effectiveness in blocking 5-HT2A receptor-mediated contractions of rat tail artery,299,Expert,,8,,,,,,1,,12687,F,,,CHEMBL615736,15329,
,D,BAO_0000221,,Evaluated for the agonistic activity against 5-HT4 receptor in non-electrically stimulated guinea-pig ileum.,300,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL615737,273,Ileum
,D,BAO_0000221,,Agonistic activity against Serotonin 5-HT4 receptor in low frequency field stimulation of guinea-pig ileum (FSGPI),301,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL615738,273,Ileum
,D,BAO_0000221,,Evaluated for the agonistic activity against Serotonin 5-HT4 receptor in non-electrically stimulated guinea-pig ileum.,302,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL615739,273,Ileum
,H,BAO_0000357,,The binding affinity was measured on 5-hydroxytryptamine 4 receptor using [3H]- GR-113808 as radioligand.,303,Autocuration,,8,,,,,,1,,10623,B,,,CHEMBL615278,12092,
,D,BAO_0000019,,Antagonist activity against 5-HT4 receptor mediated relaxation of rat carbachol contracted esophageal muscularis mucosae,304,Expert,,9,,,,,10116.0,1,,10623,F,Rattus norvegicus,,CHEMBL615279,1317,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 4 receptor,305,Expert,,8,,,,,,1,,168,B,,,CHEMBL615280,12409,
,U,BAO_0000019,,Relative competitive index values for binding to 25-OH-D3-1-hydroxylase of chick intestine,306,Autocuration,,0,,,,,9031.0,1,,22226,B,Gallus gallus,,CHEMBL615281,11126,
,U,BAO_0000019,,Inhibitory effect (10e-6 M) on the 25-OH-D3-1-hydroxylase activity,307,Autocuration,,0,,,,,9606.0,1,,22226,F,Homo sapiens,,CHEMBL615282,11126,
,U,BAO_0000019,,25-OH-D3-1-hydroxylase activity (10e-6 M) was measured as %control,308,Autocuration,,0,,,,,9606.0,1,,22226,F,Homo sapiens,,CHEMBL615283,11126,
,N,BAO_0000219,,Relative competitive index values for binding to 25-OH-D3-1-hydroxylase of human HL-60 cells,309,Autocuration,,1,,,649.0,,9606.0,1,HL-60,80156,B,Homo sapiens,,CHEMBL615284,11126,
,U,BAO_0000019,,Inhibitory effect (10e-6 M) on the 25-hydroxyvitamin D3-1-hydroxylase activity,310,Autocuration,,0,,,,,9606.0,1,,22226,B,Homo sapiens,,CHEMBL615285,11126,
,U,BAO_0000019,,25-hydroxyvitamin D3-1-hydroxylase activity (10e-6 M) was measured as %control,311,Autocuration,,0,,,,,9606.0,1,,22226,B,Homo sapiens,,CHEMBL615286,11126,
,D,BAO_0000219,,Displacement of [3H]-Ro- 15-1788 from human GABA-A alpha-1-beta-3-gamma-2 receptor subunits expressed in Xenopus oocytes,312,Autocuration,,7,,,,,9606.0,1,Oocytes,104703,B,Homo sapiens,,CHEMBL615287,17807,
,S,BAO_0000220,,Chymotryptic inhibitory activity against 26S proteasome,313,Intermediate,,2,,,,,,1,,100256,F,,,CHEMBL615288,16575,
,S,BAO_0000220,,Inhibitory activity against 26S proteasome degradation of IkB,314,Intermediate,,2,,,,,,1,,100256,B,,,CHEMBL615289,15407,
,N,BAO_0000219,,In vitro inhibition of 2780/DOX ovarian cancer cell line,315,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL615290,10797,
,N,BAO_0000219,,In vitro inhibition of 2780/S ovarian cancer cell line,316,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL884522,10797,
,U,BAO_0000019,,Relative activity on the cellular accumulation of vincristine in multidrug-resistant (MDR) human ovarian cancer 2780AD cells,317,Autocuration,,0,,,,,9606.0,1,,22226,F,Homo sapiens,,CHEMBL615291,3469,
,M,BAO_0000225,,Association constant for binding to AATT 28-mer AATT hairpin,318,Intermediate,,3,,,,,,1,,22222,B,,,CHEMBL615292,16037,
,M,BAO_0000225,,Kinetically Defined Association Constant for 28-mer AATT hairpin.,319,Intermediate,,3,,,,,,1,,22222,B,,,CHEMBL615293,16037,
,M,BAO_0000225,,Reaction Rate Parameter for 28-mer AATT hairpin,320,Intermediate,,3,,,,,,1,,22222,B,,,CHEMBL615294,16037,
,M,BAO_0000225,,Reaction Rate Parameter for 28-mer AATT hairpin,321,Intermediate,,3,,,,,,1,,22222,B,,,CHEMBL615295,16037,
,U,BAO_0000019,,Antiviral activity against envelope deficient HIV-1 in a single cycle replication assay (experiment 1),322,Autocuration,,0,,,,,9606.0,1,,22226,F,Homo sapiens,,CHEMBL825021,16524,
,U,BAO_0000019,,Antiviral activity against envelope deficient HIV-1 in a single cycle replication assay (experiment 2),323,Autocuration,,0,,,,,9606.0,1,,22226,F,Homo sapiens,,CHEMBL615296,16524,
,U,BAO_0000019,,Inhibitory concentration by single cycle replication assay using envelope deficient HIV-1,324,Autocuration,,0,,,,,9606.0,1,,22226,F,Homo sapiens,,CHEMBL615297,16524,
,U,BAO_0000019,,Cytotoxicity against cell line 2SC/20 determined by MTT test,325,Autocuration,,0,,,,,10029.0,1,,22226,F,Cricetulus griseus,,CHEMBL615298,16758,
,U,BAO_0000019,,Cytotoxicity against cell line 2SC/20 of hamster determined by MTT test,326,Autocuration,,0,,,,,10029.0,1,,22226,F,Cricetulus griseus,,CHEMBL615299,16758,
,U,BAO_0000019,,Inhibitory concentration against the growth of 2SC/20 cell line after 72 hr of drug exposure by MTT test,327,Autocuration,,0,,,,,10029.0,1,,22226,F,Cricetulus griseus,,CHEMBL615300,16758,
,H,BAO_0000357,,Binding affinity on 3 beta-hydroxysteroid dehydrogenase,328,Autocuration,,8,,,,,,1,,241,B,,,CHEMBL615301,14360,
,D,BAO_0000357,,Binding affinity for 3-beta-hydroxysteroid dehydrogenase,329,Expert,,9,,,,,9606.0,1,,241,B,Homo sapiens,,CHEMBL615302,14360,
,U,BAO_0000019,,Selectivity ratio of ID50 in liver and heart,330,Autocuration,,0,,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL615303,9964,
,H,BAO_0000019,,"Selectivity, ratio of relative ID50 in liver and heart",331,Autocuration,,8,,,,,,1,,12132,B,,,CHEMBL615304,9964,
,H,BAO_0000019,,Binding affinity to the receptor was determined in isolated nuclei of heart(In vitro) relative to T3,332,Autocuration,,8,,,,,,1,,12132,B,,,CHEMBL615305,9964,
,H,BAO_0000218,,"Binding affinity to the receptor was determined in nuclei of heart In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",333,Autocuration,,8,,,,,,1,,12132,B,,,CHEMBL615306,9964,
,H,BAO_0000218,,"Binding affinity to the receptor was determined in nuclei of liver In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",334,Autocuration,,8,,,,,,1,,12132,B,,,CHEMBL615307,9964,
,H,BAO_0000218,,"Binding affinity to the receptor was determined in nuclei of liver in vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",335,Autocuration,,8,,In vivo,,,,1,,12132,B,,,CHEMBL615308,9964,
,H,BAO_0000218,,"Binding affinity to the receptor was determined in nuclei of liver in vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",336,Autocuration,,8,,In vivo,,,,1,,12132,F,,,CHEMBL615309,9964,
,U,BAO_0000019,,"Binding affinity to the thyroid hormone receptor was determined in vitro in isolated nuclei of rat liver relative to 3,5,3' triiodothyronine",337,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL615310,9964,
,H,BAO_0000019,,Binding affinity to the receptor was determined in vitro in isolated nuclei of rat liver relative to T3,338,Autocuration,,8,,,,,,1,,12132,B,,,CHEMBL615311,9964,
,U,BAO_0000019,,"Binding affinity to thyroid hormone receptor beta, relative to 3,5,3' triiodothyronine receptor, in isolated nuclei of heart",339,Autocuration,,0,,,,,9606.0,1,,22226,B,Homo sapiens,,CHEMBL615312,9964,
,H,BAO_0000019,,In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to T3,340,Autocuration,,8,,,,,,1,,12132,B,,,CHEMBL615313,9964,
,H,BAO_0000019,,In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to T3,341,Autocuration,,8,,,,,,1,,12132,F,,,CHEMBL615314,9964,
,H,BAO_0000019,,"Binding affinity to the receptor was determined in isolated nuclei of heart(In vitro) relative to 3,5,3' triiodothyronine receptor",342,Autocuration,,8,,,,,,1,,12132,B,,,CHEMBL615315,9964,
,U,BAO_0000218,,"In vivo binding affinity for 3,5,3'' triiodothyronine receptor of heart nuclei 1 hr after intravenous administration",343,Autocuration,,0,,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL615316,9964,
,H,BAO_0000218,,Binding affinity to the receptor was determined in nuclei of heart in vivo 1 hour after intravenous administration relative to T3,344,Autocuration,,8,,In vivo,,,,1,,12132,B,,,CHEMBL615317,9964,
,H,BAO_0000218,,"Binding affinity to the receptor was determined in nuclei of liver In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",345,Autocuration,,8,,,,,,1,,12132,B,,,CHEMBL615318,9964,
,U,BAO_0000218,,"In vivo binding affinity for 3,5,3' triiodothyronine receptor of liver nuclei 1 hour after intravenous administration",346,Autocuration,,0,,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL615319,9964,
,H,BAO_0000019,,"In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to 3,5,3' triiodothyronine receptor",347,Autocuration,,8,,,,,,1,,12132,B,,,CHEMBL615320,9964,
,H,BAO_0000019,,"In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to 3,5,3' triiodothyronine receptor",348,Autocuration,,8,,,,,,1,,12132,F,,,CHEMBL615321,9964,
,U,BAO_0000019,,"Inhibition of [125I]L-T3 binding to rat hepatic 3,5,3''-triiodo-L-thyronine receptor",349,Autocuration,,0,,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL615322,3796,
,H,BAO_0000357,,Inhibition constant for binding to Co2+ form of 3-dehydroquinate synthase (DHQ) purified from Escherichia coli,350,Autocuration,,8,,,,,562.0,1,,19690,B,Escherichia coli,,CHEMBL615323,4251,
,H,BAO_0000357,,Inhibition constant for binding to Zn2+ form of 3-dehydroquinate synthase (DHQ) purified from Escherichia coli,351,Autocuration,,8,,,,,562.0,1,,19690,B,Escherichia coli,,CHEMBL615407,4251,
,H,BAO_0000357,,Kinetics expressed as Michaelis-Menten constant against Co2+ form of 3-dehydroquinate synthase purified from Escherichia coli,352,Autocuration,,8,,,,,562.0,1,,19690,B,Escherichia coli,,CHEMBL857267,4251,
,H,BAO_0000357,,Kinetics expressed as Michaelis-Menten constant against Zn2+ form of 3-dehydroquinate synthase purified from Escherichia coli,353,Autocuration,,8,,,,,562.0,1,,19690,B,Escherichia coli,,CHEMBL615408,4251,
,H,BAO_0000357,,Type of inhibition of 3-dehydroquinate synthase was determined; R - Slowly reversible,354,Autocuration,,8,,,,,,1,,19690,B,,,CHEMBL615409,166,
,H,BAO_0000357,,Compound was evaluated for its inhibitory constant against 3-dehydroquinate synthase,355,Autocuration,,8,,,,,,1,,19690,B,,,CHEMBL615410,17861,
,H,BAO_0000357,,Inhibition constant against 3-dehydroquinate synthase,356,Autocuration,,8,,,,,,1,,19690,B,,,CHEMBL615411,166,
,H,BAO_0000357,,Association rate constant against 3-dehydroquinate synthase,357,Autocuration,,8,,,,,,1,,19690,B,,,CHEMBL615412,166,
,H,BAO_0000357,,Rate constant against 3-dehydroquinate synthase,358,Autocuration,,8,,,,,,1,,19690,B,,,CHEMBL615413,166,
,U,BAO_0000019,,Inhibitory activity against fuc-TVII,359,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL615414,3548,
,D,BAO_0000251,,Ability of compound (2.5 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,360,Autocuration,2107.0,9,Microsomes,,,,10116.0,1,,12236,B,Rattus norvegicus,,CHEMBL615415,9877,Liver
,D,BAO_0000251,,Ability of compound (2500 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,361,Autocuration,2107.0,9,Microsomes,,,,10116.0,1,,12236,B,Rattus norvegicus,,CHEMBL615416,9877,Liver
,D,BAO_0000251,,Ability of compound (250 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,362,Autocuration,2107.0,9,Microsomes,,,,10116.0,1,,12236,B,Rattus norvegicus,,CHEMBL615417,9877,Liver
,D,BAO_0000251,,Ability of compound (25 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,363,Autocuration,2107.0,9,Microsomes,,,,10116.0,1,,12236,B,Rattus norvegicus,,CHEMBL615418,9877,Liver
,D,BAO_0000251,,Ability of compound at 0 uM to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,364,Autocuration,2107.0,9,Microsomes,,,,10116.0,1,,12236,B,Rattus norvegicus,,CHEMBL615419,9877,Liver
,D,BAO_0000251,,Ability of compound to inhibit the activity of 3-hydroxy-3-methylglutarylcoenzyme A(HMGR) reductase in rat liver microsomes,365,Autocuration,2107.0,9,Microsomes,,,,10116.0,1,,12236,B,Rattus norvegicus,,CHEMBL615420,9877,Liver
,D,BAO_0000251,,Percentage inhibition of 3-hydroxy-3-methyl glutaryl coenzyme A reductase in rat liver microsomes at 250 uM,366,Autocuration,2107.0,9,Microsomes,,,,10116.0,1,,12236,B,Rattus norvegicus,,CHEMBL615421,9877,Liver
,D,BAO_0000251,,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 0 uM,367,Autocuration,2107.0,9,Microsomes,,,,10116.0,1,,12236,B,Rattus norvegicus,,CHEMBL615422,9877,Liver
,D,BAO_0000251,,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 2.5 uM,368,Autocuration,2107.0,9,Microsomes,,,,10116.0,1,,12236,B,Rattus norvegicus,,CHEMBL615423,9877,Liver
,D,BAO_0000251,,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 2500 uM,369,Autocuration,2107.0,9,Microsomes,,,,10116.0,1,,12236,B,Rattus norvegicus,,CHEMBL872868,9877,Liver
,D,BAO_0000251,,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 25 uM,370,Autocuration,2107.0,9,Microsomes,,,,10116.0,1,,12236,B,Rattus norvegicus,,CHEMBL615424,9877,Liver
,H,BAO_0000224,,Inhibitory activity against 3-phosphoglycerate kinase.,371,Autocuration,,4,,,,,,1,,104832,B,,,CHEMBL825022,3003,
,H,BAO_0000224,,Binding affinity was evaluated towards 3-phosphoglycerate kinase at 37 degrees Celsius in 0.1 m NaCl pH 7.1,372,Autocuration,,4,,,,,,1,,104832,B,,,CHEMBL615425,3003,
,H,BAO_0000224,,"Michaelis-Menten constant with 1,3-bisphosphoglyceric acid (1,3-BPG) against 3-phosphoglycerate kinase",373,Autocuration,,4,,,,,,1,,104832,B,,,CHEMBL615426,3003,
,D,BAO_0000357,,Inhibition of human 3-phosphoinositide-dependent protein kinase 1 at 10 uM,374,Expert,,9,,,,,9606.0,1,,10612,B,Homo sapiens,,CHEMBL615427,17185,
,N,BAO_0000219,,Cytotoxicity on 3677 melanoma cells,375,Intermediate,,1,,,844.0,,9606.0,1,3677 melanoma cell line,80616,F,Homo sapiens,,CHEMBL615428,6072,
,N,BAO_0000219,,Cytotoxicity on 3677 melanoma cells in combination with L-49-sFv-bL,376,Intermediate,,1,,,844.0,,9606.0,1,3677 melanoma cell line,80616,F,Homo sapiens,,CHEMBL615429,6072,
,N,BAO_0000219,,Antitumor activity against Mouse colon 38 at 500 ug/disk in disk diffusion assay,377,Intermediate,,1,,,700.0,,10090.0,1,MC-38,80617,F,Mus musculus,,CHEMBL615430,5018,
,U,BAO_0000019,,Compound was evaluated for inhibition of tumor cell growth using sulforhodamine-B assay in 38 human cell lines,378,Intermediate,,0,,,,,9606.0,1,,22226,F,Homo sapiens,,CHEMBL615431,2852,
,U,BAO_0000218,,In vivo antitumor activity against 3B131 intraperitoneally implanted B16 melanoma cells; NT= Not tested,379,Autocuration,,0,,,798.0,,,1,B16,22226,F,,,CHEMBL615432,8663,
,U,BAO_0000218,,In vivo antitumor activity against 3B131 intraperitoneally implanted B16 melanoma cells; reproducible significant activity.,380,Autocuration,,0,,,798.0,,,1,B16,22226,F,,,CHEMBL615433,8663,
,D,BAO_0000019,,Inhibitory activity against Human RhinoVirus serotype-14 3C Protease,381,Expert,,9,,,,,12131.0,1,,12464,F,Human rhinovirus 14,,CHEMBL615434,3245,
,N,BAO_0000218,,Inhibitory activity against Human RhinoVirus serotype-14 3C Protease; NI means No inhibition to 50 uM,382,Intermediate,,1,,,,,169066.0,1,,50085,F,Human rhinovirus sp.,,CHEMBL615435,3245,
,N,BAO_0000218,,Compound was evaluated for the inactivation of HRV 14 3C protease activity expressed as KI,383,Intermediate,,1,,,,,169066.0,1,,50679,F,human rhinovirus type 14,,CHEMBL615436,3877,
,N,BAO_0000218,,Compound was evaluated for the inactivation of HRV 14 3C protease activity expressed as kinact,384,Intermediate,,1,,,,,169066.0,1,,50679,F,human rhinovirus type 14,,CHEMBL615437,3877,
,D,BAO_0000019,,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,385,Expert,,9,,,,,12131.0,1,,12464,F,Human rhinovirus 14,,CHEMBL615438,5861,
,D,BAO_0000019,,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,386,Expert,,9,,,,,12131.0,1,,12464,F,Human rhinovirus 14,,CHEMBL615439,5861,
,D,BAO_0000019,,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,387,Expert,,9,,,,,12131.0,1,,12464,F,Human rhinovirus 14,,CHEMBL615440,5861,
,D,BAO_0000019,,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay; inactive,388,Expert,,9,,,,,12131.0,1,,12464,F,Human rhinovirus 14,,CHEMBL615441,5861,
,N,BAO_0000218,,Compound was tested for the inhibitory activity of compound towards human rhinovirus 3C protease,389,Intermediate,,1,,,,,12059.0,1,,50665,F,Enterovirus,,CHEMBL615641,13748,
,N,BAO_0000218,,Compound was tested for the inhibitory activity of compound towards human rhinovirus-16 3C protease,390,Intermediate,,1,,,,,12059.0,1,,50665,F,Enterovirus,,CHEMBL872065,13748,
,N,BAO_0000218,,Compound was tested for the inhibitory activity of compound towards human rhinovirus-2 3C protease,391,Intermediate,,1,,,,,12059.0,1,,50665,F,Enterovirus,,CHEMBL825023,13748,
,N,BAO_0000218,,Compound was tested for the inhibitory activity of compound towards human rhinovirus-89 3C protease,392,Intermediate,,1,,,,,12059.0,1,,50665,F,Enterovirus,,CHEMBL615642,13748,
,H,BAO_0000357,,Inhibition of human rhinovirus 3C protease,393,Expert,,8,,,,,147712.0,1,,12464,B,Human rhinovirus B,,CHEMBL615643,13748,
,U,BAO_0000019,,Compound was tested for inhibition of a proteinase 3CL pro of human coronavirus; Inhibited,394,Autocuration,,0,,,,,9606.0,1,,22226,B,Homo sapiens,,CHEMBL615644,17699,
,N,BAO_0000218,,Compound tested for activity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose of 100 mg/kg (Dose range 200-12.5),395,Intermediate,,1,,,833.0,,10090.0,1,3EM 37,80619,F,Mus musculus,,CHEMBL615645,7145,
,N,BAO_0000218,,Compound tested for activity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose of 128 mg/kg (Dose range 256-16),396,Intermediate,,1,,,833.0,,10090.0,1,3EM 37,80619,F,Mus musculus,,CHEMBL615646,7145,
,N,BAO_0000218,,Compound tested for toxicity against 3EM 37 Mouse Ependymoblastoma after single ip injection on day 1 at optimal dose (OD) of 100 mg/kg on the 5th day after the injection of the compound; (10/10),397,Intermediate,,1,,,833.0,,10090.0,1,3EM 37,80619,F,Mus musculus,,CHEMBL615647,7145,
,N,BAO_0000218,,Compound tested for toxicity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose (OD) of 100 mg/kg on the 5th day after the injection of the compound; (6/6),398,Intermediate,,1,,,833.0,,10090.0,1,3EM 37,80619,F,Mus musculus,,CHEMBL615648,7145,
,N,BAO_0000218,,Effect of compound on 3EM 37 mouse ependymoblastoma after single ip injection on day 1 recorded as animal weight difference of the treated and the control (T-C) at OD of 100 mg/kg,399,Intermediate,,1,,,833.0,,10090.0,1,3EM 37,80619,F,Mus musculus,,CHEMBL615649,7145,
,N,BAO_0000218,,Effect of compound on 3EM 37 mouse ependymoblastoma after single ip injection on day 1 recorded as percentage of cured animals at OD of 100 mg/kg,400,Intermediate,,1,,,833.0,,10090.0,1,3EM 37,80619,F,Mus musculus,,CHEMBL615650,7145,
,N,BAO_0000218,,In vivo anti-tumor and anti-metastatic activity was measured after oral dosing 15 mg/kg b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor,401,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615651,5325,
,N,BAO_0000218,,In vivo anti-tumor and anti-metastatic activity was measured after oral dosing b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor,402,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615652,5325,
,N,BAO_0000218,,In vivo anti-tumor and anti-metastatic activity following p.o. administration b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor; Not tested.,403,Expert,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615653,5325,
,N,BAO_0000219,,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 1 uM dose,404,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615654,16169,
,N,BAO_0000219,,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 10 uM dose,405,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615655,16169,
,N,BAO_0000219,,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 250 uM dose,406,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL825024,16169,
,N,BAO_0000219,,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 50 uM dose,407,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615656,16169,
,N,BAO_0000219,,accumulation of compound in 3LL cells was measured with DFMO by ICP-AES at 50 uM dose,408,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615657,16169,
,N,BAO_0000219,,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 1 uM dose,409,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615658,16169,
,N,BAO_0000219,,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 10 uM dose,410,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615659,16169,
,N,BAO_0000219,,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 250 uM dose,411,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615660,16169,
,N,BAO_0000219,,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 50 uM dose,412,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615661,16169,
,N,BAO_0000219,,accumulation of compound in 3LL cells was measured without DFMO by ICP-AES at 50 uM dose,413,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615662,16169,
,N,BAO_0000219,,Effect on the growth of 3LL cells by DFMO pretreatment at 48 hr incubation,414,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615663,16169,
,N,BAO_0000219,,Effect on the growth of 3LL cells was evaluated using an MTT assay at 48 hour incubation,415,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615664,16169,
,N,BAO_0000219,,Effect on the growth of 3LL cells was evaluated using an MTT assay at 72 hour incubation,416,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615665,16169,
,N,BAO_0000219,,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 50 uM dose,417,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615666,16169,
,N,BAO_0000219,,putrescine levels in 3LL cells after the treatment of 1 uM of Compound,418,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615667,16169,
,N,BAO_0000219,,putrescine levels in 3LL cells after the treatment of 10 uM of Compound,419,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615668,16169,
,N,BAO_0000219,,putrescine levels in 3LL cells after the treatment of 250 uM of Compound,420,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615669,16169,
,N,BAO_0000219,,putrescine levels in 3LL cells after the treatment of 50 uM of Compound,421,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615670,16169,
,N,BAO_0000219,,spermidine levels in 3LL cells after the treatment of 1 uM of Compound,422,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL836739,16169,
,N,BAO_0000219,,spermidine levels in 3LL cells after the treatment of 10 uM of Compound,423,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615671,16169,
,N,BAO_0000219,,spermidine levels in 3LL cells after the treatment of 250 uM of Compound,424,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615672,16169,
,N,BAO_0000219,,spermidine levels in 3LL cells after the treatment of 50 uM of Compound,425,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615791,16169,
,N,BAO_0000219,,spermine levels in 3LL cells after the treatment of 1 uM of Compound,426,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615792,16169,
,N,BAO_0000219,,spermine levels in 3LL cells after the treatment of 10 uM of Compound,427,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615793,16169,
,N,BAO_0000219,,spermine levels in 3LL cells after the treatment of 250 uM of Compound,428,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615794,16169,
,N,BAO_0000219,,spermine levels in 3LL cells after the treatment of 50 uM of Compound,429,Intermediate,,1,,,847.0,,10090.0,1,3LL cell line,80620,F,Mus musculus,,CHEMBL615795,16169,
,N,BAO_0000219,,Concentration required to inhibit the colony formation of lung carcinoma (3LLD122) cell lines by 50%,430,Intermediate,,1,,,971.0,,9606.0,1,3LLD122,80621,F,Homo sapiens,,CHEMBL615590,15547,
,U,BAO_0000218,,In vivo antitumor activity against 3M531 is the sarcoma M5076; reproducible minimal activity,431,Autocuration,,0,,,,,,1,,22226,F,,,CHEMBL615591,8663,
,U,BAO_0000218,,In vivo antitumor activity against 3M531 is the sarcoma M5076; reproducible significant activity.,432,Autocuration,,0,,,,,,1,,22226,F,,,CHEMBL615592,8663,
,U,BAO_0000218,,In vivo antitumor activity against 3MBG5 subrenal capsule mammary carcinoma MX-1 xenograft; NT= Not tested,433,Autocuration,,0,,,,,,1,,22226,F,,,CHEMBL615593,8663,
,U,BAO_0000218,,In vivo antitumor activity against 3MBG5 subrenal capsule mammary carcinoma MX-1 xenograft; reproducible significant activity.,434,Autocuration,,0,,,,,,1,,22226,F,,,CHEMBL615594,8663,
,N,BAO_0000219,,Effective dose required against Trypanosoma cruzi amastigotes in 3T3 Fibroblasts,435,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615595,4504,
,N,BAO_0000219,,Effective dose required against Trypanosoma cruzi amastigotes in 3T3 Fibroblasts,436,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615596,4504,
,H,BAO_0000219,,Inhibition of 6 nM bombesin induced [3H]thymidine incorporation measured in swiss 3T3 cells using a mitogenicity assay,437,Expert,,8,,,723.0,,,1,NIH3T3,11169,F,,,CHEMBL615597,12695,
,N,BAO_0000219,,Ability of the peptide to inhibit 6 nM bombesin induced [3H]thymidine incorporation was measured in swiss 3T3 cells using mitogenicity assay; na=Not active,438,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615598,12695,
,N,BAO_0000219,,Ability of the peptide to inhibit 6 nM bombesin induced [3H]thymidine incorporation was measured in swiss 3T3 cells using mitogenicity assay; nt=Not tested,439,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615599,12695,
,N,BAO_0000219,,Effective dose against murine 3T3 fibroblasts cells,440,Expert,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615600,17642,
,N,BAO_0000219,,Dose required against murine 3T3 fibroblasts cells; 1-10 uM,441,Expert,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615601,17642,
,N,BAO_0000219,,Cytotoxic effect on 3T3 cells,442,Expert,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615602,12340,
,N,BAO_0000219,,Cytotoxic effect on 3T3 cells,443,Expert,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615603,12340,
,N,BAO_0000219,,Compound was tested for the concentration necessary to inhibit swiss 3T3 Mouse Fibroblast cell growth rate by 50%.,444,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615604,12716,
,N,BAO_0000219,,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration,445,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615605,6277,
,N,BAO_0000219,,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration; nd=No data,446,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615606,6277,
,N,BAO_0000219,,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration,447,Expert,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL884526,6277,
,N,BAO_0000219,,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration; n.d.=no data,448,Expert,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615607,6277,
,N,BAO_0000219,,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration; n.t.=not tested,449,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615608,6277,
,N,BAO_0000219,,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration,450,Expert,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615609,6277,
,N,BAO_0000219,,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration; n.d.=no data,451,Expert,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615682,6277,
,N,BAO_0000219,,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration; n.t.=not tested,452,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615683,6277,
,N,BAO_0000218,,In vivo inhibition of H-ras-transformed 3T3 fibroblasts in nude mouse tumor models,453,Expert,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615684,17780,
,D,BAO_0000219,,Inhibition of PDGF-dependent autophosphorylation of PDGF-R in mouse BALB/c3T3 cells,454,Autocuration,,7,,,,,10090.0,1,,104860,F,Mus musculus,,CHEMBL615685,12751,
,N,BAO_0000219,,Inhibition of Swiss 3T3 Mouse fibroblast proliferation,455,Expert,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615686,12380,
,N,BAO_0000219,,Inhibitory activity against 3T3 cell line,456,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615687,14892,
,N,BAO_0000219,,The ability of the peptide to inhibit the binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane was measured,457,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL884523,12695,
,H,BAO_0000019,,Ability of peptide to inhibit binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane.,458,Expert,,8,,,,,,1,,11169,F,,,CHEMBL615688,12695,
,N,BAO_0000219,,The ability of the peptide to inhibit the binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane was measured; nt=Not tested,459,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615689,12695,
,N,BAO_0000219,,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells was measured,460,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615690,12695,
,H,BAO_0000019,,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells,461,Expert,,8,,,,,,1,,11169,F,,,CHEMBL615691,12695,
,H,BAO_0000019,,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells; nt=Not tested,462,Expert,,8,,,,,,1,,11169,F,,,CHEMBL615692,12695,
,N,BAO_0000219,,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration,463,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615693,6277,
,N,BAO_0000219,,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line was determined using NR coloration; n.d.=no data,464,Expert,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615324,6277,
,D,BAO_0000219,,Inhibition of ligand-induced proliferation in human EGF-R Kinase expressing 3T3 cells,465,Expert,,9,,,723.0,,9606.0,1,NIH3T3,9,F,Homo sapiens,,CHEMBL615325,4959,
,D,BAO_0000219,,Inhibition of ligand-induced proliferation in human EGF-R Kinase expressing 3T3 cells (Not tested),466,Expert,,9,,,723.0,,9606.0,1,NIH3T3,9,F,Homo sapiens,,CHEMBL615490,4959,
,D,BAO_0000219,,Inhibition of ligand induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells,467,Expert,,9,,,723.0,,9606.0,1,NIH3T3,188,F,Homo sapiens,,CHEMBL615491,4959,
,D,BAO_0000219,,Inhibition of ligand-induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells (Not tested),468,Expert,,9,,,723.0,,9606.0,1,NIH3T3,188,F,Homo sapiens,,CHEMBL615492,4959,
,N,BAO_0000219,,Inhibitory concentration of compound rwas calculated on 3T3 cells by [3H]Thd incorporation,469,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615493,12082,
,N,BAO_0000219,,Inhibitory concentration of compound was calculated on 3T3 cells by [14C]Leu incorporation,470,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615494,12082,
,N,BAO_0000219,,Inhibitory concentration of compound was calculated on 3T3 cells by using clonal assay,471,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615495,12082,
,N,BAO_0000219,,Inhibitory concentration was calculated on 3T3 cells by using growth assay,472,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615496,12082,
,N,BAO_0000219,,In vitro cytotoxicity was evaluated in mouse embryo BALB/c 3T3 cells,473,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615497,2643,
,N,BAO_0000219,,Inhibition of Swiss 3T3 mouse fibroblast proliferation,474,Expert,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615498,11926,
,N,BAO_0000219,,The compound was tested for cytotoxicity against 3T3 fibroblast murine cell line.,475,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,A,Mus musculus,,CHEMBL615499,15204,
,N,BAO_0000219,,Effective concentration required to inhibit the growth of murine 3T3 fibroblasts,476,Expert,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL835522,15992,
,N,BAO_0000219,,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014); Not tested,477,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615500,16279,
,N,BAO_0000219,,Cytotoxicity against 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),478,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615501,16279,
,N,BAO_0000219,,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),479,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615502,16279,
,N,BAO_0000219,,cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),480,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615503,16279,
,N,BAO_0000219,,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),481,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615504,16279,
,N,BAO_0000219,,Cytotoxicity against 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),482,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615505,16279,
,N,BAO_0000219,,Inhibition of swiss 3T3 mouse fibroblast proliferation,483,Expert,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615506,12831,
,N,BAO_0000219,,Compound was tested for sublethal concentrations in 3T3 mouse fibroblast lysis.,484,Intermediate,,1,,,723.0,,10090.0,1,NIH3T3,80951,F,Mus musculus,,CHEMBL615507,13497,
,N,BAO_0000218,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,485,Intermediate,,1,,,620.0,,,1,3T3-L1,80006,F,,,CHEMBL615508,13715,
,N,BAO_0000219,,Concentration required to stimulate glucose uptake in 3T3-L1 adipocytes after 48 hr incubation,486,Intermediate,,1,,,620.0,,10090.0,1,3T3-L1,80006,F,Mus musculus,,CHEMBL615509,13618,
,N,BAO_0000219,,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 0.3 uM,487,Intermediate,,1,,,620.0,,10090.0,1,3T3-L1,80006,F,Mus musculus,,CHEMBL615510,11902,
,N,BAO_0000219,,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 3 uM,488,Intermediate,,1,,,620.0,,10090.0,1,3T3-L1,80006,F,Mus musculus,,CHEMBL615511,11902,
,N,BAO_0000219,,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 30 uM,489,Intermediate,,1,,,620.0,,10090.0,1,3T3-L1,80006,F,Mus musculus,,CHEMBL615512,11902,
,N,BAO_0000218,,"In vitro ability to stimulate glucose transport in 3T3-L1 adipocytes, given at 100 mg/kg in mouse, after 24 hr",490,Intermediate,,1,,,620.0,,10090.0,1,3T3-L1,80006,F,Mus musculus,,CHEMBL615513,14840,
,N,BAO_0000218,,"In vitro ability to stimulate glucose transport in 3T3-L1 adipocytes, given at 100 mg/kg in mouse, after 3 hr",491,Intermediate,,1,,,620.0,,10090.0,1,3T3-L1,80006,F,Mus musculus,,CHEMBL615514,14840,
,N,BAO_0000219,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes,492,Intermediate,,1,,,620.0,,,1,3T3-L1,80006,F,,,CHEMBL615515,13715,
,N,BAO_0000219,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 10 micro M,493,Intermediate,,1,,,620.0,,,1,3T3-L1,80006,F,,,CHEMBL615516,13715,
,N,BAO_0000219,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,494,Intermediate,,1,,,620.0,,,1,3T3-L1,80006,F,,,CHEMBL615517,13715,
,N,BAO_0000219,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 30 micro M,495,Intermediate,,1,,,620.0,,,1,3T3-L1,80006,F,,,CHEMBL615518,13715,
,N,BAO_0000219,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,496,Intermediate,,1,,,620.0,,,1,3T3-L1,80006,F,,,CHEMBL615519,13715,
,N,BAO_0000218,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 0.3 uM dose.,497,Intermediate,,1,,,620.0,,,1,3T3-L1,80006,F,,,CHEMBL615520,13715,
,N,BAO_0000218,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 0.5 uM dose.,498,Intermediate,,1,,,620.0,,,1,3T3-L1,80006,F,,,CHEMBL615521,13715,
,N,BAO_0000218,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 1 uM dose.,499,Intermediate,,1,,,620.0,,,1,3T3-L1,80006,F,,,CHEMBL615522,13715,
,N,BAO_0000218,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,500,Intermediate,,1,,,620.0,,,1,3T3-L1,80006,F,,,CHEMBL615523,13715,
,N,BAO_0000218,,In vitro measurements 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 100 uM dose.,501,Expert,,1,,,620.0,,,1,3T3-L1,80006,F,,,CHEMBL615524,13715,
,N,BAO_0000218,,Acute effects in vitro by measuring 2-deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,502,Expert,,1,,,620.0,,,1,3T3-L1,80006,F,,,CHEMBL615525,13715,
,N,BAO_0000218,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 1 uM dose.,503,Intermediate,,1,,,620.0,,,1,3T3-L1,80006,F,,,CHEMBL615526,13715,
,N,BAO_0000218,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,504,Intermediate,,1,,,620.0,,,1,3T3-L1,80006,F,,,CHEMBL615527,13715,
,N,BAO_0000218,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 300 uM dose.,505,Intermediate,,1,,,620.0,,,1,3T3-L1,80006,F,,,CHEMBL615528,13715,
,N,BAO_0000218,,Acute effects in vitro by measuring 2-deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,506,Expert,,1,,,620.0,,,1,3T3-L1,80006,F,,,CHEMBL615529,13715,
,N,BAO_0000218,,In vitro by measurements of 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,507,Expert,,1,,,620.0,,,1,3T3-L1,80006,F,,,CHEMBL615530,13715,
,N,BAO_0000218,,In vitro measurements of 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 60 uM dose.,508,Expert,,1,,,620.0,,,1,3T3-L1,80006,F,,,CHEMBL615531,13715,
,N,BAO_0000219,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 10 micro M,509,Intermediate,,1,,,620.0,,,1,3T3-L1,80006,F,,,CHEMBL615532,13715,
,N,BAO_0000219,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,510,Intermediate,,1,,,620.0,,,1,3T3-L1,80006,F,,,CHEMBL615533,13715,
,N,BAO_0000219,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 30 micro M,511,Intermediate,,1,,,620.0,,,1,3T3-L1,80006,F,,,CHEMBL615534,13715,
,N,BAO_0000218,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 100 uM dose.,512,Intermediate,,1,,,620.0,,,1,3T3-L1,80006,F,,,CHEMBL615535,13715,
,N,BAO_0000218,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,513,Intermediate,,1,,,620.0,,,1,3T3-L1,80006,F,,,CHEMBL615536,13715,
,N,BAO_0000218,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,514,Intermediate,,1,,,620.0,,,1,3T3-L1,80006,F,,,CHEMBL615537,13715,
,N,BAO_0000218,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,515,Intermediate,,1,,,620.0,,,1,3T3-L1,80006,F,,,CHEMBL615538,13715,
,N,BAO_0000218,,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 60 uM dose.,516,Intermediate,,1,,,620.0,,,1,3T3-L1,80006,F,,,CHEMBL836166,13715,
,H,BAO_0000219,,Inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells,517,Expert,,8,,,620.0,,,1,3T3-L1,11214,F,,,CHEMBL615539,6411,
,N,BAO_0000219,,Evaluated for the inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells; ND = No data,518,Intermediate,,1,,,620.0,,10090.0,1,3T3-L1,80006,F,Mus musculus,,CHEMBL615540,6411,
,H,BAO_0000219,,Evaluated for the inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells; Na = Not active,519,Expert,,8,,,620.0,,,1,3T3-L1,11214,F,,,CHEMBL615541,6411,
,N,BAO_0000219,,Insulin-sensitizing activity; triglyceride accumulation from insulin regulated differentiation of 3T3-L1 cells at 1 uM expressed as percent activity of pioglitazone,520,Expert,,1,,,620.0,,10090.0,1,3T3-L1,80006,F,Mus musculus,,CHEMBL615542,3966,
,N,BAO_0000219,,Compound was tested for insulin-sensitizing activity by measuring triglyceride accumulation from insulin regulated differentiation of 3T3-L1 cells at 10 uM expressed as percent activity of pioglitazone,521,Intermediate,,1,,,620.0,,10090.0,1,3T3-L1,80006,F,Mus musculus,,CHEMBL615543,3966,
,N,BAO_0000219,,Stimulation of adipogenesis in 3T3-L1 cells is expressed as concentration equivalent to the [ 1-14C] uptake counts after treatment with 0.2 ug/mL troglitazone,522,Expert,,1,,,620.0,,10090.0,1,3T3-L1,80006,F,Mus musculus,,CHEMBL615544,15556,
,N,BAO_0000219,,Effective concentration for enhancement of insulin-induced triglyceride accumulation in 3T3-L1 cells,523,Expert,,1,,,620.0,,10090.0,1,3T3-L1,80006,F,Mus musculus,,CHEMBL615545,5845,
,N,BAO_0000219,,Effective concentration for 50% enhancement of insulin-induced triglyceride accumulation in 3T3-L1 cells,524,Expert,,1,,,620.0,,10090.0,1,3T3-L1,80006,F,Mus musculus,,CHEMBL615546,14422,
,N,BAO_0000219,,Percentage of rosiglitazone response for insulin-sensitizing activity at 1 uM concentration in 3T3-L1 cells,525,Expert,,1,,,620.0,,10090.0,1,3T3-L1,80006,F,Mus musculus,,CHEMBL615547,5845,
,N,BAO_0000219,,In vitro glucose transport activity in 3T3-LI adipocytes at 10 uM concentration.,526,Expert,,1,,,620.0,,10090.0,1,3T3-L1,80006,F,Mus musculus,,CHEMBL615548,14508,
,N,BAO_0000219,,In vitro glucose transport activity in 3T3-LI adipocytes at 3 uM concentration.,527,Expert,,1,,,620.0,,10090.0,1,3T3-L1,80006,F,Mus musculus,,CHEMBL615549,14508,
,N,BAO_0000219,,In vitro glucose transport activity in 3T3-LI adipocytes at 30 uM concentration.,528,Expert,,1,,,620.0,,10090.0,1,3T3-L1,80006,F,Mus musculus,,CHEMBL615550,14508,
,N,BAO_0000219,,Inhibitory activity against rat fibroblast (3Y1) cell line,529,Intermediate,,1,,,1118.0,,10116.0,1,3Y1 cell line,80622,F,Rattus norvegicus,,CHEMBL615551,6349,
,N,BAO_0000219,,Mean concentration causing inhibition of cell growth in 3Y1 cells.,530,Expert,,1,,,1118.0,,10116.0,1,3Y1 cell line,80622,F,Rattus norvegicus,,CHEMBL615552,15899,
,N,BAO_0000219,,Cytotoxicity in 3Y1 cells.,531,Expert,,1,,,1118.0,,10116.0,1,3Y1 cell line,80622,F,Rattus norvegicus,,CHEMBL615553,15899,
,N,BAO_0000219,,Cytostatic effect in 3Y1 cells.,532,Expert,,1,,,1118.0,,10116.0,1,3Y1 cell line,80622,F,Rattus norvegicus,,CHEMBL615554,15899,
,N,BAO_0000219,,"Mean averaged concentration for total growth inhibition, which signifies cytostatic effect",533,Intermediate,,1,,,1118.0,,10116.0,1,3Y1 cell line,80622,F,Rattus norvegicus,,CHEMBL615555,15899,
,N,BAO_0000219,,Concentration to inhibit growth of normal rat fibroblast cells (3Y1-B cells) after 72 h exposure,534,Expert,,1,,,1118.0,,10116.0,1,3Y1 cell line,80622,F,Rattus norvegicus,,CHEMBL615556,17038,
,U,BAO_0000019,,In vitro inhibitory activity against human adrenal 3-beta hydroxy-delta 5-teroid isomerase,535,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL615557,12421,
,U,BAO_0000019,,Inhibition of recombinant human adrenal 3-beta-hydroxy-delta-5-steroid dehydrogenase,536,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL615558,12947,
,U,BAO_0000019,,Inhibition of recombinant rat adrenal 3-beta-hydroxy-delta-5-steroid dehydrogenase,537,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL872066,12947,
,D,BAO_0000019,,In vitro inhibition against of 4-Hydroxyphenylpyruvate dioxygenase (4-HPPD) from pig liver by the enol borate method,538,Expert,,9,,,,,9823.0,1,,11607,B,Sus scrofa,,CHEMBL615559,4896,
,H,BAO_0000019,,In vitro inhibitory concentration required against 4-hydroxyphenylpyruvate dioxygenase (4-HPPD) taken from pig liver,539,Autocuration,,8,,,,,,1,,11607,B,,,CHEMBL615560,6148,
,H,BAO_0000019,,Inhibition of pig liver 4-Hydroxyphenylpyruvate dioxygenase (4-HPPD) enzyme,540,Autocuration,,8,,,,,,1,,11607,B,,,CHEMBL615561,16432,
,H,BAO_0000019,,Concentration required to achieve 50% inhibition against 4-Hydroxyphenylpyruvate dioxygenase (HPPD) from pig liver,541,Expert,,8,,,,,,1,,11607,B,,,CHEMBL857062,4978,
,H,BAO_0000019,,Concentration required to achieve 50% inhibition against 4-Hydroxyphenylpyruvate dioxygenase (HPPD) from pig liver; (observed value),542,Expert,,8,,,,,,1,,11607,B,,,CHEMBL615562,4978,
,H,BAO_0000019,,In vitro inhibitory activity against HPPD(4-hydroxyphenylpyruvate Dioxygenase) from pig liver using enol borate assay method,543,Autocuration,,8,,,,,,1,,11607,B,,,CHEMBL615563,3723,
,H,BAO_0000357,,Compound was evaluated for complete competitive inhibition of 4-hydroxyphenylpyruvate dioxygenase (HPPD),544,Autocuration,,8,,,,,,1,,11607,B,,,CHEMBL615564,3518,
,H,BAO_0000019,,In vitro inhibition of 4-hydroxyphenylpyruvate dioxygenase obtained from purified pig liver by enol-borate method,545,Autocuration,,8,,,,,,1,,11607,B,,,CHEMBL615565,4164,
,H,BAO_0000019,,Inhibitory activity on pig liver 4-hydroxyphenylpyruvate dioxygenase (HPPD) was evaluated,546,Autocuration,,8,,,,,,1,,11607,B,,,CHEMBL615566,3518,
,D,BAO_0000019,,Inhibition of 4-hydroxyphenylpyruvate dioxygenase of purified pig liver by enol-borate method,547,Expert,,9,,,,,9823.0,1,,11607,B,Sus scrofa,,CHEMBL615567,4164,
,H,BAO_0000019,,The inhibitory activity on pig liver 4-hydroxyphenylpyruvate dioxygenase (HPPD) was evaluated.,548,Autocuration,,8,,,,,,1,,11607,B,,,CHEMBL615568,3518,
,H,BAO_0000357,,Compound was evaluated for competitive inhibition of 4-hydroxyphenylpyruvate dioxygenase (HPPD) (complete inhibition was observed at a concentration of 0.5-1.0 mM),549,Autocuration,,8,,,,,,1,,11607,B,,,CHEMBL615569,3518,
,H,BAO_0000019,,Concentration required to achieve 50% inhibition against 4-hydroxyphenylpyruvate dioxygenase from pig liver,550,Autocuration,,8,,,,,,1,,11607,B,,,CHEMBL615570,4978,
,H,BAO_0000019,,Concentration required to achieve 50% inhibition against 4-hydroxyphenylpyruvate dioxygenase from pig liver; (observed value),551,Autocuration,,8,,,,,,1,,11607,B,,,CHEMBL615571,4978,
,H,BAO_0000224,,Binding affinity against melatonin (MT1) receptor (pC1),552,Autocuration,,4,,,,,,1,,104733,B,,,CHEMBL615572,6455,
,U,BAO_0000019,,Compound was tested for inhibitory activity against 5-hydroxytryptamine 1 receptor,553,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL615573,2222,
,U,BAO_0000019,,Inhibition of [3H]- 5-HT binding to 5-hydroxytryptamine 1 receptor at 10e-5 M,554,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL615574,13020,
,U,BAO_0000019,,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1 receptor of central nervous system,555,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL615575,13021,
,H,BAO_0000357,,Inhibitory activity against 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand at 10e-5 M concentration,556,Autocuration,,8,,,,,,1,,10619,B,,,CHEMBL615576,14532,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand,557,Autocuration,,8,,,,,,1,,10619,B,,,CHEMBL615577,14118,
,H,BAO_0000221,,Binding affinity at 5-hydroxytryptamine 1A receptor in bovine hippocampal preparation using [3H]8-OH-DPAT,558,Autocuration,10000000.0,8,,,,,,1,,51,B,,,CHEMBL615578,11884,Hippocampus
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1A receptor was measured using [3H]8-OH-DPAT as radioligand,559,Expert,,8,,,,,,1,,51,B,,,CHEMBL615579,13969,
,H,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1A receptor,560,Expert,,8,,,,,,1,,51,B,,,CHEMBL615580,13392,
,H,BAO_0000019,,Affinity towards 5-hydroxytryptamine 1A receptor in membranes from bovine hippocampus using [3H]OH-DPAT,561,Expert,,8,,,,,,1,,51,B,,,CHEMBL615581,14430,
,H,BAO_0000221,,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,562,Autocuration,10000000.0,8,,,,,,1,,51,B,,,CHEMBL615582,12248,Hippocampus
,H,BAO_0000221,,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,563,Autocuration,10000000.0,8,,,,,,1,,51,B,,,CHEMBL615583,12249,Hippocampus
,H,BAO_0000221,,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-HT1A receptor from bovine hippocampus,564,Autocuration,10000000.0,8,,,,,,1,,51,B,,,CHEMBL615584,9995,Hippocampus
,H,BAO_0000221,,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,565,Autocuration,10000000.0,8,,,,,,1,,51,B,,,CHEMBL833691,9995,Hippocampus
,H,BAO_0000221,,In vitro inhibition of azido-[125I]-IPAPP (0.25 nM) binding to 5-HT1A receptor from bovine hippocampus,566,Autocuration,10000000.0,8,,,,,,1,,51,B,,,CHEMBL615585,9995,Hippocampus
,H,BAO_0000221,,In vitro inhibition of [125I]IPAPP (0.25 nM) binding to 5-HT1A receptor from bovine hippocampus,567,Autocuration,10000000.0,8,,,,,,1,,51,B,,,CHEMBL615586,9995,Hippocampus
,H,BAO_0000221,,In vitro inhibition of [125I]IPAPP (2.5 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,568,Autocuration,10000000.0,8,,,,,,1,,51,B,,,CHEMBL884524,9995,Hippocampus
,H,BAO_0000221,,Inhibitory concentration against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,569,Autocuration,10000000.0,8,,,,,,1,,51,B,,,CHEMBL615587,12249,Hippocampus
,H,BAO_0000221,,"Compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor from bovine hippocampus, used [3H]8-OH-DPAT as radioligand",570,Autocuration,10000000.0,8,,,,,,1,,51,B,,,CHEMBL615588,11799,Hippocampus
,D,BAO_0000249,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampal membranes,571,Expert,,9,Membranes,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL615589,14331,
,H,BAO_0000221,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of bovine hippocampus.,572,Expert,10000000.0,8,,,,,9913.0,1,,51,B,Bos taurus,,CHEMBL615442,11884,Hippocampus
,H,BAO_0000221,,Binding affinity of compound towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT (0.5 nM) ligand in hippocampus + frontal bovine was determined,573,Autocuration,10000000.0,8,,,,,,1,,51,B,,,CHEMBL615443,14331,Hippocampus
,H,BAO_0000221,,Compound was evaluated for its ability to displace [3H]DPAT from 5-HT1A receptor in homogenates of bovine hippocampus,574,Autocuration,10000000.0,8,,,,,,1,,51,B,,,CHEMBL615444,11701,Hippocampus
,H,BAO_0000221,,Ability to displace [3H]-DPAT from 5-hydroxytryptamine 1A receptor in homogenates of bovine hippocampus.,575,Expert,10000000.0,8,,,,,,1,,51,B,,,CHEMBL615445,11701,Hippocampus
,H,BAO_0000221,,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor in bovine hippocampus,576,Autocuration,10000000.0,8,,,,,,1,,51,B,,,CHEMBL615446,12248,Hippocampus
,H,BAO_0000219,,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in CHO cells,577,Autocuration,,8,,,449.0,,,1,CHO,51,B,,,CHEMBL615447,12248,
,H,BAO_0000221,,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,578,Expert,10000000.0,8,,,,,,1,,51,B,,,CHEMBL615448,12248,Hippocampus
,H,BAO_0000221,,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,579,Expert,10000000.0,8,,,,,,1,,51,B,,,CHEMBL615449,12249,Hippocampus
,H,BAO_0000219,,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,580,Autocuration,,8,,,449.0,,,1,CHO,51,B,,,CHEMBL615450,12248,
,H,BAO_0000221,,"Binding affinity against 5-hydroxytryptamine 1A receptor from bovine hippocampus, used [3H]8-OH-DPAT as radioligand",581,Expert,10000000.0,8,,,,,,1,,51,B,,,CHEMBL615451,11799,Hippocampus
,H,BAO_0000357,,Compound was tested for its binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand,582,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615452,634,
,H,BAO_0000221,,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-HT1A receptor from bovine hippocampus,583,Autocuration,10000000.0,8,,,,,,1,,51,B,,,CHEMBL615453,9995,Hippocampus
,H,BAO_0000221,,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,584,Autocuration,10000000.0,8,,,,,,1,,51,B,,,CHEMBL615454,9995,Hippocampus
,H,BAO_0000221,,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,585,Autocuration,10000000.0,8,,,,,,1,,51,B,,,CHEMBL615455,9995,Hippocampus
,H,BAO_0000221,,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,586,Autocuration,10000000.0,8,,,,,,1,,51,B,,,CHEMBL615456,9995,Hippocampus
,H,BAO_0000221,,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,587,Autocuration,10000000.0,8,,,,,,1,,51,B,,,CHEMBL615457,9995,Hippocampus
,H,BAO_0000218,,In vivo binding affinity towards [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus.,588,Expert,10000000.0,8,,,,,,1,,51,B,,,CHEMBL615458,12210,Hippocampus
,H,BAO_0000221,,Tested for activity against 5-hydroxytryptamine 1A receptor from bovine hippocampus,589,Expert,10000000.0,8,,,,,,1,,51,B,,,CHEMBL615459,13311,Hippocampus
,D,BAO_0000219,,"Tested in vitro for the inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor, expressed in cloned CHO cells.",590,Expert,,9,,,449.0,,9606.0,1,CHO,51,B,Homo sapiens,,CHEMBL615460,2331,
,H,BAO_0000019,,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor in guinea pig,591,Autocuration,,8,,,,,10141.0,1,,51,F,Cavia porcellus,,CHEMBL615461,1375,
,H,BAO_0000019,,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor in guinea pig; NT means not tested,592,Autocuration,,8,,,,,10141.0,1,,51,F,Cavia porcellus,,CHEMBL615462,1375,
,H,BAO_0000221,,Effect on forskolin stimulated adenylate cyclase activity at 5-hydroxytryptamine 1A receptor of guinea pig hippocampus.,593,Autocuration,10000000.0,8,,,,,10141.0,1,,51,F,Cavia porcellus,,CHEMBL615463,11574,Hippocampus
,H,BAO_0000221,,Ability to antagonize Acetylcholine induced contractile responses in Guinea pig ileum for 5-HT1A receptor.,594,Autocuration,2116.0,8,,,,,10141.0,1,,51,B,Cavia porcellus,,CHEMBL615464,12867,Ileum
,H,BAO_0000221,,Ability to antagonize Acetylcholine induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,595,Autocuration,2116.0,8,,,,,10141.0,1,,51,B,Cavia porcellus,,CHEMBL615465,12867,Ileum
,H,BAO_0000221,,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor.,596,Autocuration,2116.0,8,,,,,10141.0,1,,51,B,Cavia porcellus,,CHEMBL615466,12867,Ileum
,H,BAO_0000221,,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,597,Autocuration,2116.0,8,,,,,10141.0,1,,51,B,Cavia porcellus,,CHEMBL615467,12867,Ileum
,H,BAO_0000221,,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,598,Autocuration,2116.0,8,,,,,10141.0,1,,51,B,Cavia porcellus,,CHEMBL615468,12867,Ileum
,H,BAO_0000221,,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor; Inactive at dose level of 1.0 uM,599,Autocuration,2116.0,8,,,,,10141.0,1,,51,B,Cavia porcellus,,CHEMBL615469,12867,Ileum
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1A receptor,600,Autocuration,,8,,,,,10141.0,1,,51,B,Cavia porcellus,,CHEMBL615470,11574,
,H,BAO_0000357,,Compound is evaluated for in vitro receptor binding affinity against 5-hydroxytryptamine 1A receptor,601,Autocuration,,8,,,,,10141.0,1,,51,B,Cavia porcellus,,CHEMBL615471,13114,
,H,BAO_0000357,,Binding affinity was determined against 5-hydroxytryptamine 1A receptor,602,Autocuration,,8,,,,,10141.0,1,,51,B,Cavia porcellus,,CHEMBL615472,13181,
,H,BAO_0000221,,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1A receptor of guinea pig hippocampus,603,Autocuration,10000000.0,8,,,,,10141.0,1,,106,B,Cavia porcellus,,CHEMBL883242,10639,Hippocampus
,H,BAO_0000221,,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1A receptor of guinea pig hippocampus,604,Autocuration,10000000.0,8,,,,,10141.0,1,,106,F,Cavia porcellus,,CHEMBL615473,10639,Hippocampus
,H,BAO_0000218,,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand in CHO cells (sc),605,Autocuration,,8,,,449.0,,10029.0,1,CHO,11863,B,Cricetulus griseus,,CHEMBL615474,11883,
,H,BAO_0000357,,Fraction involved in salt bridge interactions with Asp3:11 part of the 5-hydroxytryptamine 1A receptor,606,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615475,17785,
,H,BAO_0000219,,Compound was tested for its ability to inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-HT 1A receptor in HeLa cells; value ranges from 85-370,607,Autocuration,,8,,,308.0,,,1,HeLa,51,F,,,CHEMBL615476,1558,
,H,BAO_0000219,,Compound was tested for its ability to inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1A receptor in HeLa cells; value ranges from 95-320,608,Autocuration,,8,,,308.0,,,1,HeLa,51,F,,,CHEMBL615477,1558,
,H,BAO_0000019,,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor,609,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL615478,15740,
,H,BAO_0000219,,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor,610,Autocuration,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL615160,17624,
,H,BAO_0000219,,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor,611,Expert,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL615161,17624,
,H,BAO_0000219,,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor; nd=Not determined,612,Autocuration,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL615162,17624,
,H,BAO_0000219,,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor; nd=not determined,613,Autocuration,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL615163,17624,
,H,BAO_0000219,,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,614,Expert,,8,,,449.0,,,1,CHO,51,B,,,CHEMBL615164,17624,
,H,BAO_0000219,,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,615,Expert,,8,,,449.0,,,1,CHO,51,B,,,CHEMBL615165,17624,
,H,BAO_0000219,,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells; nd=not determined,616,Autocuration,,8,,,449.0,,,1,CHO,51,B,,,CHEMBL615166,17624,
,H,BAO_0000219,,In vitro potency at human 5-hydroxytryptamine 1A receptor in inhibiting forskolin-stimulated accumulation of intracellular cAMP,617,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL615167,14256,
,D,BAO_0000219,,Stimulation of [35S]- GIPyS binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells,618,Expert,,9,,,308.0,,9606.0,1,HeLa,51,B,Homo sapiens,,CHEMBL615168,3445,
,D,BAO_0000219,,Stimulation of [35S]- GIPyS binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells; Inverse,619,Expert,,9,,,308.0,,9606.0,1,HeLa,51,B,Homo sapiens,,CHEMBL615169,3445,
,D,BAO_0000219,,Tested for functional response on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor,620,Expert,,9,,,449.0,,9606.0,1,CHO,51,B,Homo sapiens,,CHEMBL615170,17200,
,D,BAO_0000219,,Tested for functional response on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor; Not determined,621,Expert,,9,,,449.0,,9606.0,1,CHO,51,B,Homo sapiens,,CHEMBL615171,17200,
,H,BAO_0000019,,Eudisimic ratio(ER) is the antilog of the defference between the pKb and pD2 values against 5-hydroxytryptamine 1A receptor,622,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL615694,15180,
,H,BAO_0000019,,Eudisimic ratio(ER) is the antilog of the difference between the pKb and pD2 values against 5-hydroxytryptamine 1A receptor,623,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL615695,15180,
,H,BAO_0000019,,"Percent of maximum effect on binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor",624,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL615696,16026,
,H,BAO_0000219,,Agonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,625,Autocuration,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL615697,2759,
,D,BAO_0000219,,Agonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 1),626,Expert,,9,,,449.0,,9606.0,1,CHO,51,F,Homo sapiens,,CHEMBL859410,2759,
,H,BAO_0000219,,Agonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 2),627,Autocuration,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL615841,2759,
,D,BAO_0000219,,Agonistic efficacy in adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 2),628,Expert,,9,,,449.0,,9606.0,1,CHO,51,F,Homo sapiens,,CHEMBL615842,2759,
,H,BAO_0000219,,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,629,Autocuration,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL835003,2759,
,H,BAO_0000219,,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 1),630,Autocuration,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL615843,2759,
,D,BAO_0000219,,Antagonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 1),631,Expert,,9,,,449.0,,9606.0,1,CHO,51,F,Homo sapiens,,CHEMBL615979,2759,
,H,BAO_0000219,,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 2),632,Autocuration,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL615980,2759,
,D,BAO_0000219,,Antagonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 2),633,Expert,,9,,,449.0,,9606.0,1,CHO,51,F,Homo sapiens,,CHEMBL615981,2759,
,D,BAO_0000019,,Percent efficacy against cloned human 5-hydroxytryptamine 1A receptor normalized to the maximal 5-HT response,634,Expert,,9,,,,,9606.0,1,,51,F,Homo sapiens,,CHEMBL615982,3445,
,D,BAO_0000019,,"Agonist activity at the 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",635,Expert,,9,,,,,9606.0,1,,51,F,Homo sapiens,,CHEMBL615983,5272,
,D,BAO_0000019,,"Agonist activity at the 5-hydroxytryptamine 1A receptor in vitro using a [35S]GTP-gamma-S, No data",636,Expert,,9,,,,,9606.0,1,,51,F,Homo sapiens,,CHEMBL615984,5272,
,D,BAO_0000019,,"Agonist activity at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S,",637,Expert,,9,,,,,9606.0,1,,51,F,Homo sapiens,,CHEMBL615985,5272,
,H,BAO_0000219,,Agonistic effect against 5-HT1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,638,Autocuration,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL615986,17624,
,H,BAO_0000219,,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,639,Autocuration,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL615987,17624,
,H,BAO_0000219,,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=Not determined,640,Autocuration,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL615988,17624,
,H,BAO_0000219,,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,641,Expert,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL615989,17624,
,H,BAO_0000219,,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=Not determined,642,Autocuration,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL615990,17624,
,H,BAO_0000219,,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=not determined,643,Autocuration,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL615991,17624,
,H,BAO_0000219,,Agonistic effect against 5-HT 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,644,Autocuration,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL615992,17624,
,H,BAO_0000219,,Agonistic effect against 5-HT 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT; nd=Not determined,645,Autocuration,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL615993,17624,
,H,BAO_0000219,,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,646,Expert,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL615994,17624,
,H,BAO_0000219,,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT; nd=not determined,647,Autocuration,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL615995,17624,
,H,BAO_0000219,,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,648,Autocuration,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL615996,17624,
,H,BAO_0000219,,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35]GTPgammaS as radioligand in CHO cells relative to 5-HT; nd=Not determined,649,Autocuration,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL615997,17624,
,H,BAO_0000019,,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",650,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL615998,6563,
,H,BAO_0000019,,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",651,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL615999,6563,
,H,BAO_0000019,,Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by forskolin stimulated cAMP assay,652,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616000,6563,
,H,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,653,Autocuration,,8,,,722.0,,,1,HEK293,51,F,,,CHEMBL616001,17296,
,D,BAO_0000019,,"Evaluated for stimulation at 1 uM concentration expressed as percent of the maximal [35S]GTP-gamma-S, binding induced by 5-hydroxytryptamine",654,Expert,,9,,,,,9606.0,1,,51,F,Homo sapiens,,CHEMBL616002,6876,
,H,BAO_0000019,,"Stimulation of percent maximal [35S]GTP-gamma-S, binding induced by 5-hydroxytryptamine at 1 uM; nd = not determined",655,Expert,,8,,,,,,1,,51,F,,,CHEMBL616003,6876,
,D,BAO_0000019,,In vitro agonist activity at the 5-hydroxytryptamine 1A receptor,656,Expert,,9,,,,,9606.0,1,,51,F,Homo sapiens,,CHEMBL616004,5272,
,D,BAO_0000019,,In vitro agonist activity at the 5-hydroxytryptamine 1A receptor; No data,657,Expert,,9,,,,,9606.0,1,,51,F,Homo sapiens,,CHEMBL616005,5272,
,H,BAO_0000019,,"Maximal response as a result of 5-HT1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",658,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616006,5548,
,H,BAO_0000019,,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding",659,Expert,,8,,,,,,1,,51,F,,,CHEMBL616007,5548,
,H,BAO_0000019,,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",660,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616008,5548,
,H,BAO_0000019,,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",661,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616009,5548,
,H,BAO_0000019,,"Maximal stimulation of expressed human 5-hydroxytryptamine 1A receptor assayed by [35S]GTP-gamma-S, binding",662,Expert,,8,,,,,,1,,51,F,,,CHEMBL616010,5929,
,D,BAO_0000019,,"Maximal response towards 5-hydroxytryptamine 1A receptor in human using [35S]GTP-gamma-S, as radioligand; ND means not determined",663,Expert,,9,,,,,9606.0,1,,51,F,Homo sapiens,,CHEMBL616011,5929,
,D,BAO_0000019,,"Maximal response towards 5-hydroxytryptamine 1A receptor in human using [35S]GTP-gamma-S, as radioligand; ND=Not determined",664,Expert,,9,,,,,9606.0,1,,51,F,Homo sapiens,,CHEMBL615740,5929,
,H,BAO_0000019,,"Maximal stimulation was expressed as percentage of the maximal 5-HT response in the [35S]GTP-gamma-S, binding assay on 5-hydroxytryptamine 1A receptor",665,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL615741,16245,
,H,BAO_0000019,,"Inhibition of 5-HT induced [35S]GTP-gamma-S, binding at human cloned 5-HT 1A receptors.",666,Expert,,8,,,,,,1,,51,F,,,CHEMBL615742,5640,
,H,BAO_0000019,,"5-hydroxytryptamine 1A receptor antagonism was evaluated by the ability to inhibit [35S]GTP-gamma-S, binding that was induced by 5-HT; Emin (%): not determined",667,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL615743,5640,
,H,BAO_0000219,,Antagonist activity was measured against CHO cells expressing the human 5-hydroxytryptamine 1A receptor in a forskolin stimulated adenylate cyclase (FSC) assay,668,Autocuration,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL615744,14509,
,H,BAO_0000219,,Antagonist activity against CHO cells expressing the human 5-hydroxytryptamine 1A receptor in a forskolin stimulated adenylate cyclase (FSC) assay.,669,Expert,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL615745,14509,
,H,BAO_0000357,,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,670,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615746,15331,
,H,BAO_0000357,,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,671,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615747,15331,
,H,BAO_0000019,,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",672,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL615748,6563,
,H,BAO_0000019,,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay; NA indicates not available",673,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL615749,6563,
,H,BAO_0000019,,Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by forskolin stimulated cAMP assay,674,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL615750,6563,
,D,BAO_0000019,,Forskolin stimulated cAMP assessment of agonist activity for 5-hydroxytryptamine 1A receptor,675,Expert,,9,,,,,9606.0,1,,51,F,Homo sapiens,,CHEMBL616259,6563,
,H,BAO_0000019,,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",676,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616260,6563,
,D,BAO_0000019,,Antagonism of 5-hydroxytryptamine 1A receptor determined in vitro,677,Expert,,9,,,,,9606.0,1,,51,F,Homo sapiens,,CHEMBL616261,5272,
,D,BAO_0000019,,"Antagonism of 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",678,Expert,,9,,,,,9606.0,1,,51,F,Homo sapiens,,CHEMBL616262,5272,
,D,BAO_0000019,,"Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S, No data",679,Expert,,9,,,,,9606.0,1,,51,F,Homo sapiens,,CHEMBL616263,5272,
,D,BAO_0000019,,Antagonism at the 5-hydroxytryptamine 1A receptor was determined in vitro; No data,680,Expert,,9,,,,,9606.0,1,,51,F,Homo sapiens,,CHEMBL616264,5272,
,D,BAO_0000019,,Antagonism at the 5-hydroxytryptamine 1A receptor in vitro,681,Expert,,9,,,,,9606.0,1,,51,F,Homo sapiens,,CHEMBL616265,5272,
,D,BAO_0000019,,"Antagonism at the 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",682,Expert,,9,,,,,9606.0,1,,51,F,Homo sapiens,,CHEMBL616266,5272,
,D,BAO_0000019,,"Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S, No data",683,Expert,,9,,,,,9606.0,1,,51,F,Homo sapiens,,CHEMBL616267,5272,
,D,BAO_0000019,,Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro; No data,684,Expert,,9,,,,,9606.0,1,,51,F,Homo sapiens,,CHEMBL616268,5272,
,D,BAO_0000357,,Inhibition of human 5-hydroxytryptamine 1A receptor,685,Expert,,9,,,,,9606.0,1,,51,B,Homo sapiens,,CHEMBL616269,16146,
,H,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,686,Autocuration,,8,,,449.0,,,1,CHO,51,B,,,CHEMBL884528,17624,
,D,BAO_0000219,,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor alpha expressed in HEK 293 cells,687,Expert,,9,,,722.0,,,1,HEK293,105,B,,,CHEMBL616270,13706,
,H,BAO_0000219,,Compound was tested for the displacement of [3H]5-HT binding to cloned 5-hydroxytryptamine 1A receptor stably expressed in CHO cells,688,Autocuration,,8,,,449.0,,,1,CHO,51,B,,,CHEMBL616271,15250,
,H,BAO_0000219,,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,689,Autocuration,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL616272,17624,
,H,BAO_0000357,,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in human CYP3A4 assay,690,Expert,,8,,,,,,1,,51,B,,,CHEMBL616273,6861,
,D,BAO_0000357,,In vitro inhibitory concentration required against [3H]8-OH-DPAT binding to cloned human 5-hydroxytryptamine 1A receptor,691,Expert,,9,,,,,9606.0,1,,51,B,Homo sapiens,,CHEMBL616274,17200,
,H,BAO_0000219,,Inhibition concentration against 5-HT 1A receptor using cAMP as radioligand in CHO cells,692,Autocuration,,8,,,449.0,,,1,CHO,51,B,,,CHEMBL616275,17624,
,H,BAO_0000219,,Inhibition concentration against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,693,Autocuration,,8,,,449.0,,,1,CHO,51,B,,,CHEMBL616276,17624,
,U,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration,694,Autocuration,,0,,In vivo,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL616277,12058,
,U,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration; Inactive,695,Autocuration,,0,,In vivo,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL616278,12058,
,U,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration,696,Autocuration,,0,,In vivo,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL616279,12058,
,U,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Inactive,697,Autocuration,,0,,In vivo,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL616280,12058,
,U,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Partial response at the highest dose tested,698,Autocuration,,0,,In vivo,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL616281,12058,
,U,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Inactive,699,Autocuration,,0,,In vivo,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL616282,12058,
,U,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by po administration,700,Autocuration,,0,,In vivo,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL616283,12058,
,U,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by po administration; Inactive,701,Autocuration,,0,,In vivo,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL616284,12058,
,U,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration,702,Autocuration,,0,,In vivo,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL616285,12058,
,U,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration; Inactive,703,Autocuration,,0,,In vivo,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL616286,12058,
,U,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration; partial response at the highest dose tested,704,Autocuration,,0,,In vivo,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL616287,12058,
,U,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration,705,Autocuration,,0,,In vivo,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL616288,12058,
,U,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration; Inactive,706,Autocuration,,0,,In vivo,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL616289,12058,
,U,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration; Partial response at the highest dose tested,707,Autocuration,,0,,In vivo,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL615610,12058,
,U,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration,708,Autocuration,,0,,In vivo,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL615611,12058,
,U,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; Inactive,709,Autocuration,,0,,In vivo,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL615612,12058,
,U,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; Partial response at the highest dose tested,710,Autocuration,,0,,In vivo,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL615613,12058,
,U,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; partial response at the highest dose tested,711,Autocuration,,0,,In vivo,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL615614,12058,
,U,BAO_0000218,,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration,712,Autocuration,,0,,In vivo,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL615615,12058,
,H,BAO_0000019,,Affinity in displacing [125I](R)-DOI from rat cortical homogenate 5-HT2 receptor.,713,Autocuration,,4,,,,,,1,,105093,B,,,CHEMBL615616,11440,
,H,BAO_0000249,,Binding affinity towards 5-HT 7 receptor in rat hypothalamus membranes using [3H]5-CT as radioligand,714,Autocuration,1898.0,8,,,,,,1,,11923,B,,,CHEMBL615617,6238,Hypothalamus
,H,BAO_0000019,,Inhibitory activity against 5-HT1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand; nd is No Data,715,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL615618,10046,
,H,BAO_0000019,,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand; nd is No Data.,716,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL615619,10046,
,H,BAO_0000019,,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand.,717,Expert,,8,,,,,,1,,10577,B,,,CHEMBL615620,10046,
,H,BAO_0000357,,"Inhibitory activity against human whole blood, LTB4 5-lipoxygenase was evaluated",718,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL615621,167,
,H,BAO_0000357,,"Inhibitory activity against intact human PMNL, LTB4 5-lipoxygenase was evaluated",719,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL615622,167,
,H,BAO_0000019,,Compound was evaluated for the inhibition of 5-LO (lipoxygenase),720,Autocuration,,8,,,,,,1,,12166,F,,,CHEMBL615623,11520,
,H,BAO_0000019,,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,721,Autocuration,,8,,,,,,1,,12166,F,,,CHEMBL615624,11520,
,H,BAO_0000019,,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,722,Autocuration,,8,,,,,,1,,12166,F,,,CHEMBL615625,11520,
,H,BAO_0000019,,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,723,Autocuration,,8,,,,,,1,,12166,F,,,CHEMBL767045,11520,
,H,BAO_0000019,,Inhibition of [14C]arachidonic acid conversion to 5-HETE by broken cell 5-LO isolated from guinea pig PMN,724,Autocuration,,8,,,,,10141.0,1,,55,F,Cavia porcellus,,CHEMBL615626,135,
,H,BAO_0000019,,Inhibition of [14C]arachidonic acid conversion to 5-HETE by broken cell 5-LO isolated from guinea pig PMN; not active at the highest concentration (3 ug/mL) tested; No activity,725,Autocuration,,8,,,,,10141.0,1,,55,F,Cavia porcellus,,CHEMBL615627,135,
,H,BAO_0000019,,The compound was tested for inhibitory activity against 5-Lipoxygenase in guinea pig polymorphonuclear leukocytes,726,Autocuration,,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL615628,11311,
,H,BAO_0000357,,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase using guinea pig supernatant at 10 uM,727,Autocuration,,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL615629,10193,
,D,BAO_0000357,,Inhibitory concentration against 5-lipoxygenase from human whole blood,728,Expert,,9,,,,,9606.0,1,,55,B,Homo sapiens,,CHEMBL615630,12281,
,H,BAO_0000219,,The compound was tested for inhibitory activity against 5-Lipoxygenase in human polymorphonuclear leukocytes[PMNS],729,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL615631,11311,
,H,BAO_0000218,,In vivo inhibition of 5-lipoxygenase (LTC4) in the mouse zymosan peritonitis assay at an oral dose of 30 mg/Kg,730,Autocuration,,8,,,,,,1,,17087,F,,,CHEMBL615632,12576,
,H,BAO_0000357,,Inhibitory concentration against 5-lipoxygenase from mouse macrophage,731,Autocuration,,8,,,,,,1,,17087,B,,,CHEMBL615633,12281,
,H,BAO_0000218,,In vivo inhibition of 5-lipoxygenase (LTC4) in the mouse zymosan peritonitis assay at an oral dose of 30 mg/Kg,732,Autocuration,,8,,,,,,1,,17087,F,,,CHEMBL615634,12576,
,H,BAO_0000019,,Inhibition of arachidonate 5-lipoxygenase purified from porcine leukocytes.,733,Expert,,8,,,,,9823.0,1,,55,B,Sus scrofa,,CHEMBL615635,11089,
,H,BAO_0000357,,In vitro inhibition of rat 5-Lipoxygenase,734,Expert,,8,,,,,,1,,12166,B,,,CHEMBL615636,11006,
,D,BAO_0000357,,Inhibitory activity against 5-Lipoxygenase,735,Expert,,9,,,,,10116.0,1,,12166,B,Rattus norvegicus,,CHEMBL615637,11481,
,H,BAO_0000219,,Inhibitory activity against 5-lipoxygenase in rat basophilic leukemia cells,736,Expert,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL615638,10864,
,H,BAO_0000219,,Inhibitory activity against 5-lipoxygenase (5-LO) in intact rat barophilic leukemia cells (RBL-1),737,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL615639,3595,
,H,BAO_0000219,,The compound was tested for inhibitory activity against 5-Lipoxygenase in rat RBL-1,738,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL615640,11311,
,H,BAO_0000019,,The compound was tested for inhibitory activity against 5-Lipoxygenase in rat blood,739,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL615796,11311,
,H,BAO_0000219,,The compound was tested for inhibitory activity against 5-Lipoxygenase receptor in rat polymorphonuclear leukocytes[PMNS],740,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL615845,11311,
,H,BAO_0000357,,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM,741,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL615846,11006,
,H,BAO_0000219,,Inhibitory activity against 5-lipoxygenase (5-LO) using broken rat barophilic leukemia cells (RBL-1)at 10 uM,742,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL615847,3595,
,H,BAO_0000357,,The compound was tested for inhibition of isolated 5-Lipoxygenase,743,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL615848,11311,
,U,BAO_0000019,,Ratio of IC50 against 5-LO and COX,744,Autocuration,,0,,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL615849,11481,
,H,BAO_0000357,,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM,745,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL615850,11006,
,H,BAO_0000357,,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM; range is 20-35%,746,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL615851,11006,
,H,BAO_0000219,,The compound was tested for inhibition against 5-Lipoxygenase in rat polymorphonuclear leukocytes at 10 uM concentration,747,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL615852,11311,
,H,BAO_0000019,,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) ex vivo,748,Autocuration,,8,,,,,,1,,12166,F,,,CHEMBL615853,11006,
,H,BAO_0000357,,Compound was tested for the inhibition of type 2 5-alpha-reductase of human prostates,749,Autocuration,2367.0,8,,,,,,1,,120,B,,,CHEMBL884527,4288,Prostate gland
,U,BAO_0000019,,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme at 10E-4 M inhibitory concentration,750,Autocuration,,0,,,,,8932.0,1,,22226,B,Columba livia,,CHEMBL872871,7587,
,U,BAO_0000019,,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme at 10E-5 M inhibitory concentration,751,Autocuration,,0,,,,,8932.0,1,,22226,B,Columba livia,,CHEMBL615854,7587,
,U,BAO_0000019,,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme.,752,Autocuration,,0,,,,,8932.0,1,,22226,B,Columba livia,,CHEMBL767046,7587,
,H,BAO_0000357,,Compound was evaluated for the inhibition of 5-aminoimidazole-4-carboxamide ribonucleotide transformylase obtained from human at 100 uM,753,Autocuration,,8,,,,,,1,,10732,B,,,CHEMBL615855,11249,
,D,BAO_0000019,,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT); NT = Not Tested,754,Expert,,9,,,,,10116.0,1,,12198,F,Rattus norvegicus,,CHEMBL615856,8003,
,D,BAO_0000019,,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT),755,Expert,,9,,,,,10116.0,1,,12198,F,Rattus norvegicus,,CHEMBL615857,8003,
,D,BAO_0000019,,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT),756,Expert,,9,,,,,10116.0,1,,12198,F,Rattus norvegicus,,CHEMBL615858,8003,
,H,BAO_0000221,,In vitro affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in hippocampus,757,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615859,12416,Hippocampus
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1 receptor,758,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615860,16293,
,U,BAO_0000019,,Intrinsic activity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,759,Autocuration,,0,,,,,9986.0,1,,22226,B,Oryctolagus cuniculus,,CHEMBL615861,13047,
,U,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,760,Autocuration,,0,,,,,9986.0,1,,22226,B,Oryctolagus cuniculus,,CHEMBL615862,13047,
,U,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1D receptor using rabbit saphenous vein assay.,761,Autocuration,,0,,,,,9986.0,1,,22226,B,Oryctolagus cuniculus,,CHEMBL615863,13047,
,U,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 4 receptor using rabbit saphenous vein assay.,762,Autocuration,,0,,,,,9986.0,1,,22226,B,Oryctolagus cuniculus,,CHEMBL615864,13047,
,H,BAO_0000221,,Ability to bind at 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,763,Autocuration,10000000.0,4,,,,,,1,,104744,B,,,CHEMBL615865,10085,Hippocampus
,H,BAO_0000221,,Ability to bind at 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,764,Autocuration,10000000.0,4,,,,,,1,,104744,B,,,CHEMBL615866,10085,Hippocampus
,H,BAO_0000221,,Ability to bind at serotonin 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,765,Autocuration,10000000.0,4,,,,,,1,,104744,B,,,CHEMBL615867,10085,Hippocampus
,H,BAO_0000249,,Ability to inhibit binding of titreated serotonin to the 5-hydroxytryptamine 1 receptor in rat brain frontal cortex membranes,766,Autocuration,,4,Membranes,,,,,1,,104744,B,,,CHEMBL615868,9841,
,D,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 1 receptor in brain cortical membranes of rat,767,Autocuration,,5,,,,,10116.0,1,,104744,B,Rattus norvegicus,,CHEMBL615869,8822,
,D,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1 receptor in rat frontal cortex homogenates using [3H]5-HT as a radioligand,768,Autocuration,,5,,,,,10116.0,1,,104744,B,Rattus norvegicus,,CHEMBL615870,9806,
,D,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT as a radioligand from rat frontal cortex homogenates,769,Autocuration,,5,,,,,10116.0,1,,104744,B,Rattus norvegicus,,CHEMBL615871,9806,
,H,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 1 receptor was measured using radioligand ([3H]5-HT) binding assay,770,Autocuration,,4,,,,,,1,,104744,B,,,CHEMBL615872,8868,
,H,BAO_0000221,,Binding affinity towards hippocampus 5-hydroxytryptamine 1 receptor was measured using radioligand [3H]5-HT,771,Autocuration,10000000.0,4,,,,,,1,,104744,B,,,CHEMBL833492,9036,Hippocampus
,H,BAO_0000221,,Compound was evaluated for the inhibition of [3H]5-HT (concentration of 12 nM) specific binding to rat hippocampus,772,Autocuration,10000000.0,4,,,,,,1,,104744,B,,,CHEMBL615873,11374,Hippocampus
,H,BAO_0000224,,Inhibitory activity against 5-hydroxytryptamine 1 receptor by 3H ligand binding experiments.,773,Autocuration,,4,,,,,,1,,104744,B,,,CHEMBL615479,10881,
,H,BAO_0000019,,Tested for its binding affinity towards 5-hydroxytryptamine 1 receptor in rat,774,Autocuration,,4,,,,,,1,,104744,B,,,CHEMBL615480,8822,
,D,BAO_0000249,,Tested for its binding affinity towards 5-hydroxytryptamine 1 receptor in rat cortical membrane homogenates using radioligand ([3H]5-HT) binding assay.,775,Autocuration,,5,,,,,10116.0,1,,104744,B,Rattus norvegicus,,CHEMBL615481,9806,
,H,BAO_0000019,,Compound at 1 uM was tested for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,776,Autocuration,,4,,,,,,1,,104744,B,,,CHEMBL872869,15463,
,H,BAO_0000019,,Compound at 1 uM was tested for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,777,Autocuration,,4,,,,,,1,,104744,B,,,CHEMBL615482,15463,
,H,BAO_0000221,,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,778,Autocuration,955.0,4,,,,,,1,,104744,B,,,CHEMBL615483,14542,Brain
,H,BAO_0000221,,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,779,Autocuration,955.0,4,,,,,,1,,104744,B,,,CHEMBL615484,14542,Brain
,H,BAO_0000019,,Percent inhibition of 5-hydroxytryptamine 1 receptor from rat cortex membrane using [3H]- serotonin as radioligand at 33 uM,780,Autocuration,,4,,,,,,1,,104744,B,,,CHEMBL615485,8569,
,D,BAO_0000224,,Inhibition of [3H]5-HT radioligand binding against 5-hydroxytryptamine 1 receptor,781,Autocuration,,5,,,,,10116.0,1,,104744,B,Rattus norvegicus,,CHEMBL615486,10062,
,H,BAO_0000224,,Ancillary Binding affinity towards rat 5-hydroxytryptamine 1 receptor,782,Autocuration,,4,,,,,,1,,104744,B,,,CHEMBL615487,4771,
,H,BAO_0000224,,Binding affinity determined in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,783,Autocuration,,4,,,,,,1,,104744,B,,,CHEMBL615488,10062,
,H,BAO_0000224,,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,784,Autocuration,,4,,,,,,1,,104744,B,,,CHEMBL615489,10062,
,H,BAO_0000224,,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,785,Autocuration,,4,,,,,,1,,104744,B,,,CHEMBL615389,10062,
,H,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1 receptor was determined in rat cerebral cortex using [3H]5-HT as radioligand,786,Autocuration,,4,,,,,,1,,104744,B,,,CHEMBL615390,15463,
,H,BAO_0000019,,Binding affinity towards central 5-hydroxytryptamine 1 receptor was determined in rat cerebral cortex using [3H]5-HT as radioligand,787,Autocuration,,4,,,,,,1,,104744,B,,,CHEMBL615391,15463,
,H,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 1 receptor was determined,788,Autocuration,,4,,,,,,1,,104744,B,,,CHEMBL615392,9098,
,U,BAO_0000019,,Affinity for 5-hydroxytryptamine 1 receptor,789,Autocuration,,0,,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL615393,3070,
,H,BAO_0000221,,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex,790,Autocuration,955.0,4,,,,,,1,,104744,B,,,CHEMBL615394,14542,Brain
,H,BAO_0000221,,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,791,Autocuration,955.0,4,,,,,,1,,104744,B,,,CHEMBL615395,14542,Brain
,H,BAO_0000224,,Compound was evaluated for 5-hydroxytryptamine 1 receptor binding,792,Autocuration,,4,,,,,,1,,104744,B,,,CHEMBL615396,6398,
,H,BAO_0000221,,Compound was evaluated for its binding affinity to 5-hydroxytryptamine 1 receptor in rat brain using [3H]HT radioligand assay,793,Autocuration,955.0,4,,,,,,1,,104744,B,,,CHEMBL615397,1344,Brain
,H,BAO_0000019,,Displacement of binding of [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,794,Autocuration,,4,,,,,,1,,104744,B,,,CHEMBL615398,11963,
,U,BAO_0000019,,Displacement of [3H]spiperone from 5-hydroxytryptamine 1 receptor of rat cortex,795,Autocuration,,0,,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL615399,8908,
,H,BAO_0000019,,Evaluated for binding affinity towards rat cortical membranes at 5-hydroxytryptamine 1 receptor binding site by using [3H]-5-HT as a radioligand.,796,Autocuration,,4,,,,,,1,,104744,B,,,CHEMBL615400,9098,
,D,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 1 receptor of rat prefrontal cortex,797,Autocuration,,5,,,,,10116.0,1,,104744,B,Rattus norvegicus,,CHEMBL615401,8841,
,U,BAO_0000019,,Displacement of [3H]5-HT from 5-hydroxytryptamine 1 receptor of rat cortical membrane homogenates,798,Autocuration,,0,,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL615402,8814,
,H,BAO_0000019,,The ability to inhibit [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cortex,799,Autocuration,,4,,,,,,1,,104744,B,,,CHEMBL615403,11752,
,H,BAO_0000221,,The binding affinity was measured on serotonin 5-hydroxytryptamine 1 receptor in rat brain tissue,800,Autocuration,955.0,4,,,,,,1,,104744,B,,,CHEMBL615404,11642,Brain
,H,BAO_0000019,,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1 receptor by displacing [3H]5-HT radioligand in rat cerebral cortex,801,Autocuration,,4,,,,,,1,,104744,B,,,CHEMBL615781,11642,
,H,BAO_0000220,,Tested for 5-hydroxytryptamine 1 receptor binding ability by displacement of [3H]5-HT from rat brain synaptosomes,802,Autocuration,955.0,4,,,,,,1,,104744,B,,,CHEMBL615782,9231,Brain
,H,BAO_0000221,,Inhibition constant (1 uM) was measured on 5-hydroxytryptamine 1 receptor/uptake using [3H]- serotonin as radioligand in rat brain cortex.,803,Autocuration,955.0,4,,,,,,1,,104744,B,,,CHEMBL615783,11351,Brain
,U,BAO_0000019,,Compound was tested for binding affinity against 5-HT1 receptor,804,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL873481,4639,
,U,BAO_0000019,,Inhibitory concentration against 5-hydroxytryptamine 1 receptor,805,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL615784,1205,
,H,BAO_0000357,,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor at 1 uM,806,Expert,,8,,,,,,1,,10576,B,,,CHEMBL615785,10025,
,H,BAO_0000249,,"Ability to inhibit 5-HT sensitive,forskolin-stimulated adenylyl cyclase(FSC) activity in rat hippocampal membranes mediated through 5-hydroxytryptamine 1A receptor",807,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL615786,13241,
,H,BAO_0000218,,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while iv administration,808,Autocuration,,8,,In vivo,,,,1,,10576,F,,,CHEMBL615787,16245,
,H,BAO_0000218,,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while subcutaneous administration,809,Autocuration,,8,,In vivo,,,,1,,10576,F,,,CHEMBL615788,16245,
,H,BAO_0000019,,Inhibition of forskolin stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor,810,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL767044,12438,
,H,BAO_0000218,,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while iv administration,811,Autocuration,,8,,In vivo,,,,1,,10576,F,,,CHEMBL615789,16245,
,H,BAO_0000218,,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while subcutaneous administration,812,Autocuration,,8,,In vivo,,,,1,,10576,F,,,CHEMBL615790,16245,
,H,BAO_0000019,,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats,813,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL615813,15740,
,H,BAO_0000219,,Percent of maximum response by 5-HT when tested for inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation assessed in GH4ZD10 cells at 10 uM concentration,814,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL615814,15535,
,H,BAO_0000219,,Percent inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation in GH4ZD10 cells expressing 5-HT1A receptor at 50 uM relative to 5-HT,815,Expert,,8,,,,,,1,,51,F,,,CHEMBL615815,15535,
,H,BAO_0000219,,Percent of maximum response by 5-HT when tested for inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation assessed in GH4ZD10 cells at 50 uM concentration; No effect,816,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL615816,15535,
,H,BAO_0000249,,Binding affinity at [3H]8-OH-DPAT-Labeled 5-hydroxytryptamine 1A receptor sites in rat brain hippocampal membranes expressed as Hill values,817,Expert,,8,,,,,,1,,10576,B,,,CHEMBL615817,9888,
,H,BAO_0000221,,Ability to bind at 5-hydroxytryptamine 1A receptor of rat hippocampus by displacing [3H]8-OH-DPAT,818,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615818,10085,Hippocampus
,H,BAO_0000221,,Ability to bind at serotonin 5-hydroxytryptamine 1A receptors of rat hippocampus by displacing [3H]8-OH-DPAT,819,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615819,10085,Hippocampus
,H,BAO_0000249,,Binding affinity against 5-hydroxytryptamine 1A receptor (5-HT1A) by displacement of [3H]8-OH-DPAT from rat hippocampus membranes,820,Expert,,8,Membranes,,,,,1,,10576,B,,,CHEMBL615820,17331,
,D,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]8-OH-DPAT,821,Expert,10000000.0,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL615821,10845,Hippocampus
,D,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]5-HT,822,Expert,10000000.0,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL615822,10845,Hippocampus
,H,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 1A receptor using in rat hippocampal tissue using [3H]8-OH-DPAT as radioligand,823,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615823,10845,Hippocampus
,D,BAO_0000221,,Displacement of [3H]8-OH-DPAT from rat hippocampal 5-hydroxytryptamine 1A receptor; IA-Inactive,824,Expert,10000000.0,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL615824,10845,Hippocampus
,D,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]5-HT,825,Expert,10000000.0,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL615825,10845,Hippocampus
,H,BAO_0000357,,Binding affinity towards rat 5-hydroxytryptamine 1A receptor was evaluated using [3H]8-OH-DPAT as radioligand,826,Expert,,8,,,,,,1,,10576,B,,,CHEMBL615826,13730,
,H,BAO_0000249,,Binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampus membranes using [3H]8-OH-DPAT as radioligand,827,Expert,,8,,,,,,1,,10576,B,,,CHEMBL615827,13508,
,H,BAO_0000249,,Binding affinity against serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus membrane using [3H]8-OH-DPAT as radioligand,828,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615828,13508,Hippocampus
,H,BAO_0000221,,Binding affinity by measuring displacement of [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,829,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615829,12073,Hippocampus
,H,BAO_0000221,,Binding affinity to 5-hydroxytryptamine 1A receptor of rat hippocampus with [3H]8-OH-DPAT as radioligand,830,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615830,4671,Hippocampus
,H,BAO_0000221,,Binding affinity towards serotonin 5-HT1A receptor was determined in rat hippocampus using [3H]8-OH-DPAT as ligand,831,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615831,13631,Hippocampus
,H,BAO_0000357,,Binding affinity was measured against serotonin 5-hydroxytryptamine 1A receptor,832,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL615832,12438,
,H,BAO_0000019,,Binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]-8-OH- DPAT as radioligand,833,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL615833,10483,
,H,BAO_0000221,,Binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampus using [3H]-8-OH- DPAT as radioligand,834,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615834,10483,Hippocampus
,H,BAO_0000249,,Binding affinity against 5-hydroxytryptamine 1A (5-HT1A) receptor in rat hippocampus membranes,835,Intermediate,,8,,,,,,1,,10576,B,,,CHEMBL615835,12352,
,H,BAO_0000249,,Binding affinity was measured at the serotonin 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in rat hippocampal membrane.,836,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615836,14732,Hippocampus
,D,BAO_0000019,,Binding affinity to 5-hydroxytryptamine 1A receptor in the rat brain using [3H]8-hydroxy-2-(di-n-propylamine)tetralin as radioligand.,837,Expert,,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL615837,11049,
,D,BAO_0000019,,Binding affinity to 5-hydroxytryptamine 1A receptor in the rat brain using [3H]8-hydroxy-2-(di-n-propylamine)tetralin as radioligand; ND-Not determined,838,Expert,,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL615838,11049,
,H,BAO_0000249,,"Binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampus membranes,3H-8-OH-DPAT and buspirone for nonspecific binding (NSB)",839,Expert,,8,,,,,,1,,10576,B,,,CHEMBL615839,13657,
,H,BAO_0000019,,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor in rat cortex using [3H]-8-OH-DPAT as radioligand,840,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL884525,11473,
,H,BAO_0000249,,Compound was evaluated for its ability to displace [3H]8-OH-DPAT from serotonin 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes,841,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL615840,2014,
,H,BAO_0000221,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,842,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615405,3086,Hippocampus
,H,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex using [125I]iodocyanopindolol as radio-ligand.,843,Expert,,8,,,,,,1,,10576,B,,,CHEMBL615406,15854,
,H,BAO_0000221,,Affinity for 5-hydroxytryptamine 1A receptor labeled with [3H]8-OH-DPAT radioligand in hippocampus tissue,844,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615900,10922,Hippocampus
,H,BAO_0000221,,Inhibition of [3H]8-OH-DPAT binding at serotonin 5-hydroxytryptamine 1A receptor from rat hippocampus tissue.,845,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615901,13346,Hippocampus
,H,BAO_0000357,,In vitro inhibition of [3H]8-OH-DPAT binding to rat 5-HT 1a receptors.,846,Expert,,8,,,,,,1,,10576,B,,,CHEMBL615902,15311,
,H,BAO_0000221,,Compound was measured for affinity at 5-hydroxytryptamine 1A receptor labeled with [3H]8-OH-DPAT radioligand in hippocampus tissue,847,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615903,10922,Hippocampus
,H,BAO_0000357,,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor<br>at 1 uM,848,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL615904,10025,
,H,BAO_0000357,,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor at 1 uM,849,Expert,,8,,,,,,1,,10576,B,,,CHEMBL615905,10025,
,H,BAO_0000019,,In vitro Inhibitory activity tested at 5-hydroxytryptamine 1A receptor binding site in rat,850,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL615906,9742,
,H,BAO_0000019,,In vitro Inhibitory activity tested at 5-hydroxytryptamine 1A receptor binding site in rat,851,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL615907,9742,
,H,BAO_0000019,,In vitro ability to inhibit binding of radioligand [3H]8-OH-DPAT to 5-hydroxytryptamine 1A receptor in rat cerebral cortex,852,Expert,,8,,,,,,1,,10576,B,,,CHEMBL615908,12304,
,H,BAO_0000221,,In vitro affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT in rat hippocampus,853,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615909,15789,Hippocampus
,H,BAO_0000019,,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]-8-OH-DPAT as the radioligand",854,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL615910,9912,
,H,BAO_0000019,,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]8-OH-DPAT as the radioligand.",855,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL615911,9912,
,H,BAO_0000019,,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]8-OH-DPAT as the radioligand",856,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL615912,9912,
,H,BAO_0000019,,In vitro binding affinity for serotonin 5-hydroxytryptamine 1A receptor fof rat cerebral cortex using [3H]8-OH-DPAT as radioligand,857,Expert,,8,,,,,,1,,10576,B,,,CHEMBL615913,16693,
,H,BAO_0000357,,In vitro binding affinity measured on serotonin 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand.,858,Expert,,8,,,,,,1,,10576,B,,,CHEMBL615914,13276,
,H,BAO_0000221,,In vitro binding affinity to 5-hydroxytryptamine 1A receptor using [125I](R)-(+)-trans-8-OH-PIPAT as radioligand in rat hippocampal homogenate,859,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615915,12678,Hippocampus
,H,BAO_0000357,,In vitro binding affinity towards the 5-hydroxytryptamine 1A receptor was evaluated,860,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL615916,11825,
,H,BAO_0000357,,In vitro binding affinity was measured on serotonergic 5-hydroxytryptamine 1A receptor by displacement of [3H]- tetralin,861,Expert,,8,,,,,,1,,10576,B,,,CHEMBL615917,12443,
,H,BAO_0000357,,In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor,862,Expert,,8,,,,,,1,,10576,B,,,CHEMBL615918,13830,
,H,BAO_0000249,,In vitro inhibitory concentration against radioligand [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membrane.,863,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615919,14286,Hippocampus
,D,BAO_0000221,,In vitro radioligand binding assay on 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in rat hippocampus,864,Expert,10000000.0,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL615920,14356,Hippocampus
,H,BAO_0000357,,Inhibition concentration against 5-hydroxytryptamine 1A receptor,865,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL615921,15306,
,H,BAO_0000357,,Inhibitory concentration against 5-hydroxytryptamine 1A receptor (Inactive at >1000 nM concentration),866,Expert,,8,,,,,,1,,10576,B,,,CHEMBL615922,15306,
,D,BAO_0000249,,"Inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor in hippocampal membranes",867,Expert,,9,,,,,10116.0,1,,10576,F,Rattus norvegicus,,CHEMBL881290,16616,
,H,BAO_0000221,,"Inhibition of [3H]8-hydroxy-2-dipropylamino-1,2,3,4-tetrahydronaphthalene binding to 5-hydroxytryptamine 1A receptor in hippocampus region of rat brain; Residual radioligand binding higher than 50%",868,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615923,3651,Hippocampus
,H,BAO_0000221,,Inhibition of forskolin-activated adenylate cyclase (cAMP) activity at 5-hydroxytryptamine 1A receptor in rat hippocampus,869,Autocuration,10000000.0,8,,,,,,1,,10576,F,,,CHEMBL615924,14331,Hippocampus
,H,BAO_0000221,,Inhibition of forskolin-activated adenylate cyclase (cAMP) activity at 5-hydroxytryptamine 1A receptor in rat hippocampus,870,Autocuration,10000000.0,8,,,,,,1,,10576,F,,,CHEMBL615925,14331,Hippocampus
,D,BAO_0000357,,Inhibition of radiolabeled [3H]-8-OH-DPAT ligand binding to 5-hydroxytryptamine 1A receptor,871,Expert,,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL615926,14178,
,D,BAO_0000019,,Displacement of [3H]8-OH-DPAT from rat cortex 5-hydroxytryptamine 1A receptor,872,Expert,,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL615927,10639,
,H,BAO_0000221,,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,873,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615928,12306,Hippocampus
,D,BAO_0000357,,Inhibitory activity against 5-hydroxytryptamine 1A receptor subtype,874,Expert,,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL615929,1348,
,H,BAO_0000221,,Inhibitory activity against [3H]DPAT binding to 5-HT1A receptor in rat hippocampus,875,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615930,13605,Hippocampus
,H,BAO_0000219,,Inhibition concentration against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,876,Autocuration,,8,,,449.0,,,1,CHO,51,B,,,CHEMBL615931,17624,
,H,BAO_0000219,,Inhibition concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,877,Autocuration,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL615932,17624,
,H,BAO_0000219,,Inhibition concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,878,Autocuration,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL615933,17624,
,H,BAO_0000357,,Inhibition of [3H]- 8-OH-DAPT binding against human recombinant 5-hydroxytryptamine 1A receptor,879,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615934,15267,
,H,BAO_0000357,,The binding affinity at the 5-hydroxytryptamine 1A receptor determined using [3H]5-CT; Not tested,880,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615935,16532,
,H,BAO_0000019,,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",881,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL615936,6563,
,H,BAO_0000219,,Ability to displace [3H]-8-OH-DPAT from CHO cells stably transfected with human 5-hydroxytryptamine 1A receptor at a concentration of 1 uM,882,Autocuration,,8,,,449.0,,,1,CHO,51,B,,,CHEMBL615937,4751,
,H,BAO_0000357,,Compound at 1 uM was tested for the inhibition of radioligand [3H]8-OH-DPAT binding to recombinant human 5-hydroxytryptamine 1A receptor,883,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615938,15463,
,H,BAO_0000357,,In vitro binding affinity against human 5-hydroxytryptamine 1A receptor at a concentration of 100 (nM),884,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615797,3805,
,H,BAO_0000357,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,885,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615798,5640,
,H,BAO_0000357,,Inhibition of [3H]8-OH-DPAT binding to human 5-hydroxytryptamine 1A receptor at 1000 nM compound concentration,886,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL872870,6563,
,H,BAO_0000357,,Inhibitory activity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand at 100 nM concentration,887,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615799,5548,
,H,BAO_0000357,,Percent binding affinity against 5-hydroxytryptamine 1A receptor,888,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615800,6347,
,H,BAO_0000219,,Intrinsic activity for human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,889,Autocuration,,8,,,722.0,,,1,HEK293,51,F,,,CHEMBL615801,17296,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit jugular vein assay in the absence of endothelium,890,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615802,13047,
,H,BAO_0000357,,Dissociation constant against human 5-hydroxytryptamine 1A receptor receptor,891,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615803,15740,
,H,BAO_0000019,,"Inhibition of 5-HT induced [35S]GTP-gamma-S, binding at human cloned 5-HT 1A receptors.",892,Expert,,8,,,,,,1,,51,F,,,CHEMBL835002,5640,
,H,BAO_0000019,,"5-hydroxytryptamine 1A receptor antagonism was evaluated by the ability to inhibit [35S]GTP-gamma-S, binding that was induced by 5-HT; Ki (nM): not determined",893,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL615804,5640,
,H,BAO_0000219,,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor,894,Expert,,8,,,308.0,,,1,HeLa,51,B,,,CHEMBL615805,17211,
,H,BAO_0000219,,Ability to displace [3H]8-OH-DPAT from CHO cells stably transfected with human 5-hydroxytryptamine 1A receptor,895,Autocuration,,8,,,449.0,,,1,CHO,51,B,,,CHEMBL615806,4751,
,D,BAO_0000357,,Affinity towards human 5-hydroxytryptamine 1A serotonin receptor,896,Expert,,9,,,,,9606.0,1,,51,B,Homo sapiens,,CHEMBL615807,6491,
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT-as radioligand,897,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615808,4707,
,D,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1A receptor,898,Expert,,9,,,,,9606.0,1,,51,B,Homo sapiens,,CHEMBL615809,13910,
,H,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 1A receptor in HeLa cells was determined using [3H]5-HT,899,Autocuration,,8,,,308.0,,,1,HeLa,51,B,,,CHEMBL615810,16190,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,900,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615811,16633,
,H,BAO_0000219,,Binding affinity against [3H]- -8-OH-DPAT -labeled 5-hydroxytryptamine 1A sites in cloned CHO cells,901,Autocuration,,8,,,449.0,,,1,CHO,51,B,,,CHEMBL615812,11898,
,H,BAO_0000219,,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,902,Autocuration,,8,,,449.0,,,1,CHO,51,B,,,CHEMBL615751,11898,
,H,BAO_0000357,,Binding affinity against human 5-hydroxytryptamine 1A receptor,903,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615752,14331,
,H,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 1A receptor in CHO cells labeled with [3H]8-OH-DPAT radioligand,904,Expert,,8,,,449.0,,,1,CHO,51,B,,,CHEMBL615753,17624,
,H,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 1A receptor in CHO cells labeled with [3H]8-OH-DPAT radioligand; nd=not determined,905,Autocuration,,8,,,449.0,,,1,CHO,51,B,,,CHEMBL615754,17624,
,H,BAO_0000357,,Binding affinity of compound to human 5-hydroxytryptamine 1A receptor,906,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615755,3307,
,D,BAO_0000219,,Displacement of [3H]8-OH-DPAT from human 5-hydroxytryptamine 1A receptor expressed in CHO cells,907,Expert,,9,,,449.0,,9606.0,1,CHO,51,B,Homo sapiens,,CHEMBL615756,6563,
,H,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 1A receptor in HeLa transfected cell type using [3H]8-OH-DPAT as radioligand,908,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615757,14165,
,H,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 1A receptor was determined,909,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615758,5732,
,H,BAO_0000357,,In vitro affinity at human cloned 5-hydroxytryptamine 1A receptor by [3H]8-OH-DPAT displacement.,910,Expert,,8,,,,,,1,,51,B,,,CHEMBL615759,13366,
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1A receptor,911,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615760,17626,
,H,BAO_0000219,,Binding affinity towards human 5-hydroxytryptamine 1A receptor by the displacement of [3H]5-HT radioligand from the cloned receptor expressed in HeLa cells,912,Expert,,8,,,308.0,,,1,HeLa,51,B,,,CHEMBL615761,6588,
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1A receptor was determined using [3H]-5-HT as radioligand,913,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL872104,16209,
,H,BAO_0000357,,Binding affinity towards recombinant human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,914,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615762,15463,
,H,BAO_0000357,,Binding affinity towards recombinant human Compound at 1 uM was tested for the inhibition of radioligand [3H]8-OH-DPAT binding to recombinant human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,915,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615763,15463,
,H,BAO_0000357,,Binding affinity for recombinant human 5-hydroxytryptamine 1A receptor using [3H]5-HT as radioligand.,916,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615764,14770,
,H,BAO_0000219,,Binding affinity on human cloned 5-hydroxytryptamine 1A receptor transfected in human cell lines (He La),917,Autocuration,,8,,,1167.0,,,1,Cell line,51,B,,,CHEMBL615765,16245,
,H,BAO_0000019,,Binding affinity on human cloned 5-hydroxytryptamine 1A receptor transfected in human cell lines(He La),918,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615766,16245,
,H,BAO_0000357,,Binding affinity towards 5-HT1A receptor using [3H]8-OH-DPAT as radioligand,919,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615767,5548,
,H,BAO_0000357,,Binding affinity was determined towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,920,Expert,,8,,,,,,1,,51,B,,,CHEMBL615768,5548,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,921,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615769,5548,
,H,BAO_0000357,,Binding affinity was evaluated at 5-hydroxytryptamine 1A receptor labeled with [3H]-8-OH-DPAT,922,Expert,,8,,,,,,1,,51,B,,,CHEMBL615770,6876,
,H,BAO_0000357,,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,923,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615771,2598,
,H,BAO_0000357,,Binding affinity to human 5-hydroxytryptamine 1A receptor was measured using [3H]-8-hydroxy-2-(di-n-propylamine) tetraline [3H]8-OH-DPAT) as radioligand,924,Expert,,8,,,,,,1,,51,B,,,CHEMBL615772,17785,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor,925,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615773,6013,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor in human using [3H]8-OH-DPAT as radioligand,926,Expert,,8,,,,,,1,,51,B,,,CHEMBL615774,5929,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,927,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615775,16633,
,H,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 1A receptor was determined,928,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615776,1558,
,H,BAO_0000357,,Binding affinity towards human cloned 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,929,Expert,,8,,,,,,1,,51,B,,,CHEMBL615777,16026,
,H,BAO_0000219,,Binding affinity was measured on 5-hydroxytryptamine 1A receptor in AK cells transfected with human 5-HT1A gene labeled with [3H]-8-OH-DPAT,930,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615778,12469,
,D,BAO_0000357,,Binding affinity was measured on cloned Human 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,931,Expert,,9,,,,,9606.0,1,,51,B,Homo sapiens,,CHEMBL615779,15874,
,H,BAO_0000357,,Binding affinity was measured on cloned human 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,932,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL615780,15874,
,H,BAO_0000357,,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 1A receptor,933,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616298,3935,
,H,BAO_0000357,,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 1A receptor,934,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616299,15818,
,H,BAO_0000219,,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells.,935,Autocuration,,8,,,485.0,,,1,CHO-K1,51,B,,,CHEMBL616300,13706,
,H,BAO_0000219,,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1A receptor in CHO-K1 cells,936,Expert,,8,,,485.0,,,1,CHO-K1,51,F,,,CHEMBL616301,13729,
,H,BAO_0000019,,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor,937,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616302,15413,
,H,BAO_0000019,,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor (Experiment 1),938,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616117,15413,
,H,BAO_0000019,,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor (Experiment 2),939,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616118,15413,
,H,BAO_0000019,,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor by Panlabs assay,940,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616119,15413,
,D,BAO_0000219,,Displacement of specific [3H]- 5-HT binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells,941,Expert,,9,,,308.0,,9606.0,1,HeLa,51,B,Homo sapiens,,CHEMBL616120,3445,
,H,BAO_0000357,,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor,942,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616121,15740,
,H,BAO_0000357,,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor receptor,943,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616122,15740,
,H,BAO_0000357,,In vitro binding affinity tested on human 5-hydroxytryptamine 1A receptor,944,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616123,17626,
,D,BAO_0000357,,In vitro binding affinity to human 5-hydroxytryptamine 1A receptor,945,Expert,,9,,,,,9606.0,1,,51,B,Homo sapiens,,CHEMBL616124,4234,
,H,BAO_0000357,,In vitro binding affinity at 5-hydroxytryptamine 1A receptor by [3H]8-OH-DPAT displacement.,946,Expert,,8,,,,,,1,,51,B,,,CHEMBL616125,5640,
,H,BAO_0000357,,In vitro binding affinity towards Human 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT,947,Expert,,8,,,,,10116.0,1,,51,B,Rattus norvegicus,,CHEMBL616126,5272,
,H,BAO_0000219,,In vitro binding affinity towards cloned human 5-hydroxytryptamine 1A receptor expressed in Chinese hamster ovary (CHO) cells using [3H]8-OH-DPAT as radioligand,948,Autocuration,,8,,,449.0,,,1,CHO,51,B,,,CHEMBL616127,4622,
,H,BAO_0000019,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1A receptor,949,Expert,,8,,,,,,1,,51,B,,,CHEMBL616128,17085,
,H,BAO_0000357,,In vitro binding affinity was determined towards cloned human 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand,950,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616129,3025,
,H,BAO_0000357,,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1A receptor,951,Expert,,8,,,,,,1,,51,B,,,CHEMBL616130,15315,
,H,BAO_0000357,,Inhibition of [3H]- OH-DPAT binding against 5-hydroxytryptamine 1A receptor from human recombinant,952,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616131,15267,
,H,BAO_0000219,,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor serotonergic receptor in human HeLa cells,953,Autocuration,,8,,,308.0,,,1,HeLa,51,B,,,CHEMBL616132,17158,
,D,BAO_0000219,,Receptor binding affinity for cloned human 5-hydroxytryptamine 1A receptor in HeLa cells,954,Expert,,9,,,308.0,,9606.0,1,HeLa,51,B,Homo sapiens,,CHEMBL616133,14214,
,H,BAO_0000357,,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,955,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616134,17133,
,H,BAO_0000357,,The binding affinity at the 5-hydroxytryptamine 1A receptor determined using [3H]5-CT,956,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616135,16532,
,D,BAO_0000357,,Affinity for 5-hydroxytryptamine 1A receptor subtype,957,Expert,,9,,,,,9606.0,1,,51,B,Homo sapiens,,CHEMBL616136,2391,
,H,BAO_0000019,,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1A receptor from cloned Human membranes,958,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616137,14447,
,H,BAO_0000019,,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1A receptor from cloned Human membranes.,959,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL872105,14447,
,H,BAO_0000357,,The compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor receptor,960,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616138,15086,
,D,BAO_0000357,,Binding affinity for cloned human 5-hydroxytryptamine 1A receptor,961,Expert,,9,,,,,9606.0,1,,51,B,Homo sapiens,,CHEMBL616139,13051,
,H,BAO_0000019,,"Ability to influence the binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor; Not active",962,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616140,16026,
,H,BAO_0000019,,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1A receptor; ND means not determined,963,Expert,,8,,,,,,1,,51,B,,,CHEMBL616141,17085,
,H,BAO_0000357,,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,964,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616142,17133,
,H,BAO_0000357,,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand; ND means Not determined,965,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616143,17133,
,H,BAO_0000219,,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,966,Autocuration,,8,,,308.0,,,1,HeLa,51,B,,,CHEMBL616144,17211,
,H,BAO_0000219,,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT=not tested,967,Autocuration,,8,,,308.0,,,1,HeLa,51,B,,,CHEMBL616145,17211,
,H,BAO_0000219,,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,968,Autocuration,,8,,,308.0,,,1,HeLa,51,B,,,CHEMBL616012,17211,
,H,BAO_0000219,,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,969,Autocuration,,8,,,308.0,,,1,HeLa,51,B,,,CHEMBL616013,17211,
,H,BAO_0000019,,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",970,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616014,16394,
,H,BAO_0000019,,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",971,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616015,16394,
,H,BAO_0000019,,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",972,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616016,16394,
,H,BAO_0000218,,Antagonist induction of hypothermia by 8-OH-DPAT in 5-hydroxytryptamine 1A receptor after subcutaneous administration; NT is not tested,973,Autocuration,,8,,In vivo,,,,1,,51,F,,,CHEMBL616017,16394,
,H,BAO_0000019,,Binding affinity at human 5-hydroxytryptamine 1A receptor by inhibition of [3H]-8-OH-DPAT binding in Chinese hamster ovary cell line; NT is not tested,974,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616018,16394,
,H,BAO_0000019,,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor receptor; Not tested,975,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616019,15740,
,H,BAO_0000019,,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor; Not tested,976,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616020,15740,
,H,BAO_0000357,,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor,977,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL858018,15740,
,H,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,978,Autocuration,,8,,,722.0,,,1,HEK293,51,F,,,CHEMBL616021,17296,
,H,BAO_0000019,,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at 1 uM.",979,Expert,,8,,,,,,1,,51,F,,,CHEMBL616022,5640,
,H,BAO_0000019,,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; ND means Not determined",980,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616023,5640,
,H,BAO_0000019,,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; ND means not determined",981,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616024,5640,
,H,BAO_0000019,,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; Not determined",982,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616025,5640,
,H,BAO_0000219,,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,983,Autocuration,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL616026,2759,
,H,BAO_0000019,,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT",984,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616027,16394,
,D,BAO_0000019,,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared to 5-HT",985,Expert,,9,,,,,9606.0,1,,51,F,Homo sapiens,,CHEMBL616028,16394,
,D,BAO_0000019,,Percent efficacy against human 5-hydroxytryptamine 1A receptor relative to maximal 5-HT response,986,Expert,,9,,,,,9606.0,1,,51,F,Homo sapiens,,CHEMBL616029,3445,
,H,BAO_0000219,,Binding affinity for 5-hydroxytryptamine 1A receptor was determined by incubating human 5-hydroxytryptamine 1A receptor transfected CHO cells with [3H]8-OH-DPAT,987,Expert,,8,,,449.0,,,1,CHO,51,B,,,CHEMBL616030,4316,
,H,BAO_0000019,,In vitro inhibition of [3H]8-OH-DPAT binding to human cloned 5-hydroxytryptamine 1A receptor on CHO cell membranes.,988,Expert,,8,,,,,,1,,51,B,,,CHEMBL616031,4316,
,D,BAO_0000019,,Agonist efficacy on 5-hydroxytryptamine 1A receptor subtype,989,Expert,,9,,,,,9606.0,1,,51,F,Homo sapiens,,CHEMBL616032,15180,
,D,BAO_0000019,,Agonist efficacy on 5-hydroxytryptamine 1A receptor subtype,990,Expert,,9,,,,,9606.0,1,,51,F,Homo sapiens,,CHEMBL616033,15180,
,H,BAO_0000019,,Maximum binding affinity was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,991,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616034,15042,
,H,BAO_0000019,,Maximum binding affinity was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,992,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616035,15042,
,H,BAO_0000019,,Maximum binding affinity was evaluated as ([35S]GTP binding on cloned human 5-hydroxytryptamine 1A receptor,993,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616036,15042,
,H,BAO_0000019,,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,994,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616037,15042,
,H,BAO_0000019,,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,995,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616038,15042,
,H,BAO_0000019,,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,996,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616039,15042,
,H,BAO_0000019,,Agonist efficacy was evaluated as [35S]GTP binding on cloned human 5-hydroxytryptamine 1A receptor,997,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616040,15042,
,D,BAO_0000219,,Concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,998,Expert,,9,,,308.0,,9606.0,1,HeLa,51,F,Homo sapiens,,CHEMBL616041,15180,
,D,BAO_0000219,,Negative logarithm of concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,999,Expert,,9,,,308.0,,9606.0,1,HeLa,51,F,Homo sapiens,,CHEMBL616042,15180,
,D,BAO_0000219,,Negative logarithm of concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,1000,Expert,,9,,,308.0,,9606.0,1,HeLa,51,F,Homo sapiens,,CHEMBL616043,15180,
,H,BAO_0000019,,"Potency (pD2) for the stimulation of [35S]GTP-gamma-S, binding on 5-hydroxytryptamine 1A receptor",1001,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616044,16245,
,H,BAO_0000019,,"Ability to influence the binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor",1002,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616045,16026,
,H,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,1003,Autocuration,,8,,,722.0,,,1,HEK293,51,F,,,CHEMBL616046,17296,
,H,BAO_0000219,,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor expressed in CHO cells (experiment 2),1004,Autocuration,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL616047,2759,
,H,BAO_0000219,,Compound was tested for its potency against human 5-hydroxytryptamine 1A receptor expressed in CHO cells,1005,Autocuration,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL616048,2759,
,D,BAO_0000219,,Potency against human 5-hydroxytryptamine 1A receptor expressed in CHO cells (experiment 1),1006,Expert,,9,,,449.0,,9606.0,1,CHO,51,F,Homo sapiens,,CHEMBL616049,2759,
,H,BAO_0000219,,Compound was tested for its potency against human 5-hydroxytryptamine 1A receptor expressed in CHO cells (experiment 2),1007,Autocuration,,8,,,449.0,,,1,CHO,51,F,,,CHEMBL616050,2759,
,H,BAO_0000219,,In vitro effective concentration required to inhibit forskolin-stimulated cAMP levels in HA7 cells expressing human 5-HT1A receptor,1008,Expert,,8,,,,,,1,,51,F,,,CHEMBL616051,15419,
,H,BAO_0000219,,In vitro effective concentration required to inhibit forskolin-stimulated cAMP levels in HA7 cells expressing human 5-HT1A receptor; Not tested,1009,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616212,15419,
,H,BAO_0000019,,"ability to influence the binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor",1010,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616213,16026,
,H,BAO_0000219,,Ability to bind to 5-hydroxytryptamine 1A receptor from cloned human expressed in Ha7 cells,1011,Expert,,8,,In vitro,,,,1,,51,B,,,CHEMBL616214,1414,
,H,BAO_0000219,,Ability to bind to 5-hydroxytryptamine 1A receptor subtype from cloned human expressed in Ha7 cells,1012,Expert,,8,,In vitro,,,,1,,51,B,,,CHEMBL616215,1414,
,H,BAO_0000357,,Binding activity radioligand.,1013,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616216,12861,
,H,BAO_0000019,,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,1014,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616217,12861,
,H,BAO_0000357,,Binding affinity for human cloned 5-hydroxytryptamine 1A receptor,1015,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616218,5104,
,H,BAO_0000357,,Binding affinity for human cloned 5-hydroxytryptamine 1A receptor,1016,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616219,5105,
,H,BAO_0000357,,binding affinity towards human recombinant 5-hydroxytryptamine 1A receptor,1017,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616220,16312,
,D,BAO_0000357,,Displacement of [3H]8-hydroxy-2-(di-n-propylamino)tetralin from human 5-hydroxytryptamine 1A receptor,1018,Expert,,9,,,,,9606.0,1,,51,B,Homo sapiens,,CHEMBL833493,15180,
,H,BAO_0000357,,Ability to displace the radioligand [3H]-8-OH-DPAT from human 5-hydroxytryptamine 1A receptor,1019,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616221,5033,
,D,BAO_0000219,,Affinity constant on CHO cells expressing Human recombinant 5-hydroxytryptamine receptor 1A,1020,Expert,,9,,,449.0,,9606.0,1,CHO,51,B,Homo sapiens,,CHEMBL616222,16909,
,H,BAO_0000019,,Antagonistic affinity against cloned human 5-hydroxytryptamine 1A receptor,1021,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616223,2590,
,H,BAO_0000019,,Antagonistic affinity against cloned human 5-hydroxytryptamine 1A receptor; Not determined,1022,Autocuration,,8,,,,,,1,,51,F,,,CHEMBL616224,2590,
,H,BAO_0000019,,Binding affinity at human 5-hydroxytryptamine 1A receptor by inhibition of [3H]8-OH-DPAT binding in Chinese hamster ovary cell line,1023,Expert,,8,,,,,,1,,51,B,,,CHEMBL616225,16394,
,D,BAO_0000219,,Binding affinity to human cloned 5-hydroxytryptamine 1A receptor in HEK 293 cells using [3H]-8-OH- DPAT as radioligand,1024,Expert,,9,,,722.0,,9606.0,1,HEK293,51,B,Homo sapiens,,CHEMBL616226,4540,
,H,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 1A human cloned receptors in HEK293 cells,1025,Autocuration,,8,,,722.0,,,1,HEK293,51,B,,,CHEMBL616227,17296,
,H,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 1A human cloned receptors in HEK293 cells using [3H]8-OH-DPAT as radioligand,1026,Autocuration,,8,,,722.0,,,1,HEK293,51,B,,,CHEMBL616228,17296,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand;,1027,Autocuration,,8,,,722.0,,,1,HEK293,51,B,,,CHEMBL616229,15779,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand; ND means no data,1028,Autocuration,,8,,,722.0,,,1,HEK293,51,B,,,CHEMBL616230,15779,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand;ND means no data.,1029,Autocuration,,8,,,722.0,,,1,HEK293,51,B,,,CHEMBL616231,15779,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor in human using [3H]8-OH-DPAT as radioligand,1030,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616232,6166,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand;,1031,Autocuration,,8,,,722.0,,,1,HEK293,51,B,,,CHEMBL616233,15779,
,H,BAO_0000219,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1A receptor in HEK 293 cells using [3H]8-OH-DPAT as the radioligand,1032,Autocuration,,8,,,722.0,,,1,HEK293,51,B,,,CHEMBL857973,4199,
,H,BAO_0000219,,Compound was evaluated for its ability to displace [3H]8-OH-DPAT binding from human 5-hydroxytryptamine 1A receptor in mammalian cells,1033,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616234,15316,
,H,BAO_0000357,,Compound was tested for binding affinity against human 5-hydroxytryptamine 1A receptor,1034,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616235,14875,
,H,BAO_0000219,,Binding affinity at human cloned 5-hydroxytryptamine 1A receptor expressed in HeLa cells by [3H]8-hydroxy-2-(di-n-propylamino)tetraline displacement.,1035,Expert,,8,,,308.0,,,1,HeLa,51,B,,,CHEMBL616236,14727,
,H,BAO_0000019,,Binding affinity at native 5-hydroxytryptamine 1A receptor in rat by [3H]8-hydroxy-2-(di-n-propylamino)tetraline displacement.,1036,Expert,,8,,,,,,1,,51,B,,,CHEMBL616237,14727,
,H,BAO_0000219,,Compound was tested for its binding affinity against 5-hydroxytryptamine 1A receptor in human cloned receptors in HEK 293 cells using [3H]8-OH-DPAT,1037,Autocuration,,8,,,722.0,,,1,HEK293,51,B,,,CHEMBL616238,15146,
,H,BAO_0000219,,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1A receptor in HEK 293 using [3H]5-CT as a radioligand,1038,Autocuration,,8,,,722.0,,,1,HEK293,51,B,,,CHEMBL616239,5213,
,H,BAO_0000219,,In vitro binding affinity at human recombinant 5-hydroxytryptamine 1A receptor in mammalian cells using 3[H]8-OH-DPAT as the radioligand,1039,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616240,16429,
,D,BAO_0000219,,The binding affinity was evaluated on cloned human 5-hydroxytryptamine 1A receptor expressed in HeLa cells by using DPAT as radioligand.,1040,Expert,,9,,,308.0,,9606.0,1,HeLa,51,B,Homo sapiens,,CHEMBL616241,15042,
,H,BAO_0000219,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1A receptor in HEK 293 cells using [3H]8-OH-DPAT.,1041,Autocuration,,8,,,722.0,,,1,HEK293,51,B,,,CHEMBL616242,14818,
,H,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1A receptor in HEK293 cells, using [3H]8-OH-DPAT as radioligand",1042,Autocuration,,8,,,722.0,,,1,HEK293,51,B,,,CHEMBL616243,4829,
,D,BAO_0000357,,In vitro inhibitory concentration required against [3H]8-OH-DPAT binding to cloned human 5-hydroxytryptamine 1A receptor,1043,Expert,,9,,,,,,1,,51,B,,,CHEMBL616244,17200,
,D,BAO_0000357,,The compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1A receptor,1044,Autocuration,,9,,,,,9606.0,1,,51,B,Homo sapiens,,CHEMBL616245,13051,
,H,BAO_0000357,,Binding affinity towards 5-HT1B receptor by the displacement of [3H]-5-CT] in human recombinant receptors in mammalian cell,1045,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616246,5486,
,H,BAO_0000357,,Binding affinity against 5-HT1D receptor,1046,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616247,5254,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1A receptor,1047,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616248,5254,
,H,BAO_0000357,,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,1048,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL616249,15331,
,H,BAO_0000357,,Binding affinity against serotonin 5-hydroxytryptamine 1A receptor using radioligand [3H]8-OH-DPAT binding assay,1049,Autocuration,,8,,,,,9606.0,1,,10576,B,Homo sapiens,,CHEMBL616250,13506,
,H,BAO_0000357,,Inhibition of [3H]- 8-OH-DAPT binding against human recombinant 5-hydroxytryptamine 1A receptor,1050,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616251,15267,
,H,BAO_0000218,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice 15 min after administration of the compound,1051,Autocuration,,8,,In vivo,,,,1,,11863,F,,,CHEMBL616252,16616,
,H,BAO_0000218,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice 30 min after administration of the compound,1052,Autocuration,,8,,In vivo,,,,1,,11863,F,,,CHEMBL616253,16616,
,H,BAO_0000218,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice 60 min after administration of the compound,1053,Autocuration,,8,,In vivo,,,,1,,11863,F,,,CHEMBL616254,16616,
,D,BAO_0000218,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 10 mg/kg after 15 min,1054,Expert,,9,,,,,10090.0,1,,11863,F,Mus musculus,,CHEMBL616255,16616,
,D,BAO_0000218,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 10 mg/kg after 30 min,1055,Expert,,9,,,,,10090.0,1,,11863,F,Mus musculus,,CHEMBL832872,16616,
,D,BAO_0000218,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 10 mg/kg after 60 min,1056,Expert,,9,,,,,10090.0,1,,11863,F,Mus musculus,,CHEMBL616256,16616,
,D,BAO_0000218,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 1 mg/kg after 15 min,1057,Expert,,9,,,,,10090.0,1,,11863,F,Mus musculus,,CHEMBL616257,16616,
,D,BAO_0000218,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 1 mg/kg after 30 min,1058,Expert,,9,,,,,10090.0,1,,11863,F,Mus musculus,,CHEMBL616258,16616,
,D,BAO_0000218,,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 1 mg/kg after 60 min,1059,Expert,,9,,,,,10090.0,1,,11863,F,Mus musculus,,CHEMBL616384,16616,
,H,BAO_0000221,,Hill number was determined for inhibition of of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in mouse hippocampus,1060,Autocuration,10000000.0,8,,,,,,1,,11863,B,,,CHEMBL616385,10297,Hippocampus
,H,BAO_0000357,,Inhibitory activity against serotonin 5-hydroxytryptamine 1A receptor from mice.,1061,Expert,,8,,,,,,1,,11863,B,,,CHEMBL616386,13704,
,D,BAO_0000221,,Inhibitory activity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus,1062,Expert,10000000.0,9,,,,,10090.0,1,,11863,B,Mus musculus,,CHEMBL616387,10297,Hippocampus
,H,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus; Not determined,1063,Autocuration,10000000.0,8,,,,,,1,,11863,B,,,CHEMBL616388,10297,Hippocampus
,D,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus,1064,Expert,10000000.0,9,,,,,10090.0,1,,11863,B,Mus musculus,,CHEMBL616389,10297,Hippocampus
,H,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus; Not determined,1065,Autocuration,10000000.0,8,,,,,,1,,11863,B,,,CHEMBL616390,10297,Hippocampus
,H,BAO_0000357,,Compound was tested for binding affinity to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as a radioligand,1066,Autocuration,,8,,,,,,1,,11863,B,,,CHEMBL616391,217,
,D,BAO_0000221,,Hill number was determined for inhibition of of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in mouse hippocampus,1067,Expert,10000000.0,9,,,,,10090.0,1,,11863,B,Mus musculus,,CHEMBL616392,10297,Hippocampus
,H,BAO_0000357,,Ability to displace [3H]8-OH-DPAT radioligand from porcine 5-hydroxytryptamine 1A receptor,1068,Autocuration,,8,,,,,9823.0,1,,51,B,Sus scrofa,,CHEMBL616393,4921,
,H,BAO_0000357,,Ability to displace [3H]8-OH-DPAT radioligand from porcine 5-hydroxytryptamine 1A receptor; ND denotes not determined,1069,Autocuration,,8,,,,,9823.0,1,,51,B,Sus scrofa,,CHEMBL616394,4921,
,H,BAO_0000019,,Binding affinity of compound measured for 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT-labeled porcine brain homogenates,1070,Autocuration,,8,,,,,9823.0,1,,51,B,Sus scrofa,,CHEMBL616395,4996,
,H,BAO_0000357,,Compound was evaluated for the binding affinity at 5- HT1A receptor,1071,Autocuration,,8,,,,,9823.0,1,,51,B,Sus scrofa,,CHEMBL616396,12918,
,H,BAO_0000019,,Compound was tested in vitro for its ability to compete with [3H]8-OH-DPAT at 5-hydroxytryptamine 1A receptor in porcine brain homogenate,1072,Autocuration,,8,,,,,9823.0,1,,51,B,Sus scrofa,,CHEMBL872907,5333,
,H,BAO_0000019,,In vitro for its ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in porcine brain homogenate,1073,Autocuration,,8,,,,,9823.0,1,,51,B,Sus scrofa,,CHEMBL616397,4437,
,H,BAO_0000019,,Compound was tested for its ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in pig cortex,1074,Autocuration,,8,,,,,9823.0,1,,51,B,Sus scrofa,,CHEMBL616398,1742,
,H,BAO_0000357,,Displacement of [3H]- 8-OH-DPAT from porcine 5-hydroxytryptamine 1A receptor,1075,Expert,,8,,,,,9823.0,1,,51,B,Sus scrofa,,CHEMBL616399,16688,
,H,BAO_0000357,,Binding activity radioligand.,1076,Autocuration,,8,,,,,9823.0,1,,51,B,Sus scrofa,,CHEMBL857065,12861,
,H,BAO_0000019,,Binding activity against 5-hydroxytryptamine 1A receptor from pig cortex membrane using [3H]8-OH-DPAT-HT as radioligand.,1077,Expert,,8,,,,,9823.0,1,,51,B,Sus scrofa,,CHEMBL616400,12861,
,H,BAO_0000019,,Binding activity against 5-hydroxytryptamine 1A receptor from pig cortex membrane using [3H]8-OH-DPAT-HT as radioligand.,1078,Autocuration,,8,,,,,9823.0,1,,51,B,Sus scrofa,,CHEMBL616401,12861,
,H,BAO_0000019,,Displacement of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor from pig cortex,1079,Expert,,8,,,,,,1,,10624,B,,,CHEMBL616402,12490,
,H,BAO_0000019,,Displacement of [3H]8-OH-DPAT from pig cortex 5-hydroxytryptamine 1A receptor,1080,Expert,,8,,,,,9823.0,1,,51,B,Sus scrofa,,CHEMBL616403,11828,
,H,BAO_0000221,,Binding affinity for 5-hydroxytryptamine 1A receptor in piglet hippocampus using [3H]8-OH-DPAT,1081,Autocuration,10000000.0,8,,,,,9823.0,1,,51,B,Sus scrofa,,CHEMBL616404,11866,Hippocampus
,H,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 1A receptor in pig frontal cortex membranes using [8H]-OH-DPAT,1082,Autocuration,,8,,,,,9823.0,1,,51,B,Sus scrofa,,CHEMBL616405,12827,
,H,BAO_0000019,,Binding affinity was evaluated by 5-hydroxytryptamine 1A receptor agonism in the pig cortex by displacing 8-OH-DPAT,1083,Autocuration,,8,,,,,9823.0,1,,51,B,Sus scrofa,,CHEMBL616406,12918,
,H,BAO_0000019,,Agonistic activity against 5-hydroxytryptamine 1A receptor in pig cortex using [3H]8-OH-DPAT,1084,Expert,,8,,,,,9823.0,1,,51,F,Sus scrofa,,CHEMBL616407,12919,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit jugular vein assay in the presence of endothelium,1085,Autocuration,,8,,,,,9986.0,1,,51,B,Oryctolagus cuniculus,,CHEMBL616408,13047,
,D,BAO_0000249,,Inhibition activity against 5-hydroxytryptamine 1A receptor in rat hippocampus membranes using radio binding assays,1086,Expert,,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616409,15796,
,D,BAO_0000221,,"Inhibition of [3H]8-hydroxy-2-dipropylamino-1,2,3,4-tetrahydronaphthalene binding to 5-hydroxytryptamine 1A receptor in hippocampus region of rat brain; Less active",1087,Expert,10000000.0,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616410,3651,Hippocampus
,H,BAO_0000357,,Tested for the effect on binding at 5-hydroxytryptamine 1A receptor; No activity,1088,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616411,188,
,D,BAO_0000249,,"Antagonist activity to stimulate binding of [35S]GTP-gamma-S, to 5-hydroxytryptamine 1A receptor in isolated rat hippocampal membranes",1089,Expert,,9,Membranes,,,,10116.0,1,,10576,F,Rattus norvegicus,,CHEMBL616412,16616,
,D,BAO_0000249,,"Inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding in rat hippocampal membranes",1090,Expert,10000000.0,9,Membranes,,,,10116.0,1,,10576,F,Rattus norvegicus,,CHEMBL616413,16616,Hippocampus
,H,BAO_0000221,,The binding of [125I]MPPI ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,1091,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616414,12306,Hippocampus
,D,BAO_0000221,,Binding affinity for rat hippocampus 5-hydroxytryptamine 1A receptor by inhibition of [3H]8-OH-DPAT binding,1092,Expert,10000000.0,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616415,17167,Hippocampus
,H,BAO_0000019,,Binding affinity measured at the 5-hydroxytryptamine 1A receptor by the inhibition of [3H]8-OH-DPAT binding to rat cortex using unlabeled buspirone for nonspecific binding.,1093,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616416,14776,
,H,BAO_0000357,,Binding affinity of 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand.,1094,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616417,12158,
,H,BAO_0000357,,Binding affinity of [3H]- -8-OH-DPAT labelled towards Rat Hippocampal 5-hydroxytryptamine 1A receptor using radioligand binding assay,1095,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616418,13481,
,H,BAO_0000219,,Binding affinity of [3H]-8-OH-DPAT towards 5-hydroxytryptamine 1A receptor in cloned mammalian receptor expressed in cultured cells or from rat whole brain.,1096,Autocuration,,8,,In vitro,,,,1,,10576,B,,,CHEMBL616419,13427,
,H,BAO_0000357,,Binding affinity of compound against 5-hydroxytryptamine 1A receptor binding site using radioligand [3H]8-OH-DPAT,1097,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616420,10210,
,H,BAO_0000249,,Binding affinity of compound towards 5-HT 1A receptor by measuring ability to displace [3H]OH-DPAT from 5-hydroxytryptamine 1A receptor in rat striatal membranes,1098,Autocuration,,8,Membranes,,,,,1,,10576,B,,,CHEMBL616421,10205,
,H,BAO_0000249,,Binding affinity of compound towards 5-HT 1A receptor by measuring ability to displace [3H]OH-DPAT from 5-hydroxytryptamine 1A receptor in rat striatal membranes,1099,Autocuration,,8,Membranes,,,,,1,,10576,B,,,CHEMBL616422,10205,
,H,BAO_0000249,,Binding affinity of compound towards 5-hydroxytryptamine 1A receptor in rat striatal membranes by [3H]OH-DPAT displacement.,1100,Expert,,8,Membranes,,,,,1,,10576,B,,,CHEMBL616423,10205,
,D,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1A receptor with [3H]5-HT,1101,Expert,,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616424,12280,
,H,BAO_0000357,,Binding affinity to the rat 5-hydroxytryptamine 1A receptor,1102,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616425,17386,
,H,BAO_0000357,,Binding affinity was tested on 5-hydroxytryptamine 1A receptor using radioligand [3H]5-HT binding assay.,1103,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616426,13654,
,H,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as the radioligand.,1104,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616427,14423,Hippocampus
,H,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampus tissue.,1105,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616428,15412,Hippocampus
,H,BAO_0000221,,Binding affinity by measuring displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,1106,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616290,12073,Hippocampus
,D,BAO_0000357,,Displacement of [3H]8-OH-DPAT from rat striata 5-hydroxytryptamine 1A receptor,1107,Expert,,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616052,4101,
,H,BAO_0000357,,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1A receptor,1108,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616053,10062,
,H,BAO_0000249,,Binding affinity towards 5-HT 1A receptor in rat cerebral cortex membranes using [3H]8-OH-DPAT as radioligand,1109,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616054,6238,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor,1110,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616055,16273,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in competitive binding assay,1111,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616056,11139,
,H,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampal membranes,1112,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616057,16796,
,D,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain,1113,Expert,955.0,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616058,9548,Brain
,H,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain,1114,Autocuration,955.0,8,,,,,,1,,10576,B,,,CHEMBL616059,10381,Brain
,H,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat hypocampus membrane using [3H]8-OH-DPAT as radioligand,1115,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616060,13408,
,D,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 1A receptor in the rat brain (hippocampus) using [3H]8-OH-DPAT,1116,Expert,10000000.0,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616061,13825,Hippocampus
,H,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 1A receptor of rat hippocampus using [3H]-8-hydroxy-2-(di-n-propylamine) tetralin (8-OH-DPAT) as a radioligand,1117,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616062,11147,Hippocampus
,H,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 1A receptor sites in cortical membranes using [3H]8-OH-DPAT as radioligand,1118,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616063,10552,
,H,BAO_0000249,,"Binding affinity towards 5-hydroxytryptamine 1A receptor sites, in rat striatum membranes using [3H]- sandoz 205-501 as radioligand",1119,Autocuration,2435.0,8,,,,,,1,,10576,B,,,CHEMBL616064,10552,Striatum
,D,BAO_0000249,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat cortex membranes,1120,Expert,,9,Membranes,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616065,17136,
,D,BAO_0000249,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat cerebral cortex membranes,1121,Expert,,9,Membranes,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616066,5778,
,H,BAO_0000221,,Binding affinity towards rat hippocampal 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,1122,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616067,13481,Hippocampus
,H,BAO_0000221,,Binding affinity towards rat hippocampal 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand; Not tested,1123,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616068,13481,Hippocampus
,H,BAO_0000221,,Binding affinity against rat hippocampal 5-hydroxytryptamine 1A (5-HT1A) receptor determined using [3H]8-OH-DPAT as radioligand,1124,Intermediate,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616069,13630,Hippocampus
,H,BAO_0000249,,Binding was determined on 5-hydroxytryptamine 1A receptor in rat hippocampal membranes,1125,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616070,16245,
,H,BAO_0000221,,Binding affinity was evaluated against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand,1126,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616071,14509,Hippocampus
,H,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand.,1127,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616072,14509,Hippocampus
,H,BAO_0000221,,Binding affinity was evaluated against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand.; ND = Not determined,1128,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616073,14509,Hippocampus
,H,BAO_0000221,,Binding affinity was evaluated against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand; ND = Not determined,1129,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616074,14509,Hippocampus
,H,BAO_0000019,,Binding affinity was evaluated by determining in vitro displacement of [3H]8-OH-DPAT from the central 5-hydroxytryptamine 1A receptor recognition site in rat frontal cortex homogenate.,1130,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616075,14256,
,H,BAO_0000357,,Binding affinity was evaluated by using [3H]8-OH-DPAT radioligand by using competitive binding assay on 5-hydroxytryptamine 1A receptor,1131,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616076,11139,
,D,BAO_0000019,,Binding affinity for 5-HT1A measured by displacing [3H]8-OH-DPAT from rat cortical membranes; Not determined,1132,Expert,,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616077,11047,
,D,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 1A receptor measured by displacing [3H]8-OH-DPAT from rat cortical membranes,1133,Expert,,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616078,11047,
,D,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 1A receptor measured by displacing [3H]8-OH-DPAT from rat cortical membranes;ND-Not determined,1134,Expert,,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616079,11047,
,D,BAO_0000219,,Binding affinity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells,1135,Expert,,9,,,485.0,,10116.0,1,CHO-K1,10576,B,Rattus norvegicus,,CHEMBL616080,2395,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor,1136,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616081,9699,
,D,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [125I]trans-8-OH-PIPAT in membrane homogenates of hippocampal tissue of rat brain,1137,Expert,10000000.0,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616082,12028,Hippocampus
,H,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in membrane homogenates of hippocampal tissue of rat brain,1138,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616083,12028,Hippocampus
,H,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat cerebral cortex,1139,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616084,5815,
,H,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenates,1140,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616085,16616,
,H,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat cerebral cortex using [3H]-8-OH-DPAT,1141,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616086,5815,
,H,BAO_0000221,,"Binding affinity towards 5-hydroxytryptamine 1A receptor using 0.1 nM [3H]-8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tet-ralin), from rat hippocampal homogenate",1142,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616087,2761,Hippocampus
,H,BAO_0000357,,Binding affinity was determined against 5-hydroxytryptamine 1A receptor using [3H]WB-4101,1143,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616088,13133,
,H,BAO_0000019,,Binding affinity was determined against 5-hydroxytryptamine 1A receptor was determined in male Sprague-Dawley rat brain.,1144,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616089,10444,
,D,BAO_0000357,,Binding affinity was measured against 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT by lysergic acid amides,1145,Expert,,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616090,13278,
,H,BAO_0000357,,Binding affinity was measured on cloned rat 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,1146,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616091,15874,
,H,BAO_0000249,,"Binding affinity of the compound towards 5-hydroxytryptamine 1A receptor sites, in rat striatum membranes using [3H]- sandoz 205-501 as radioligand",1147,Autocuration,2435.0,8,Membranes,,,,,1,,10576,B,,,CHEMBL616092,10552,Striatum
,H,BAO_0000357,,Binding constant against 5-hydroxytryptamine 1A receptor (in vitro),1148,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616093,11130,
,H,BAO_0000218,,Binding constant against 5-hydroxytryptamine 1A receptor (in vivo),1149,Autocuration,,8,,In vivo,,,,1,,10576,B,,,CHEMBL616094,11130,
,H,BAO_0000221,,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]-8-OH- -DPAT in rat brain cortex,1150,Autocuration,955.0,8,,,,,,1,,10576,B,,,CHEMBL616095,14542,Brain
,D,BAO_0000357,,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor,1151,Expert,,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616096,13670,
,H,BAO_0000249,,Binding affinity at [3H]8-OH-DPAT-Labeled 5-hydroxytryptamine 1A receptor sites in rat brain hippocampal membranes,1152,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616097,9888,
,D,BAO_0000249,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampus membranes,1153,Expert,,9,Membranes,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616098,3678,
,H,BAO_0000221,,Compound was evaluated for in vitro binding affinity towards 5-hydroxytryptamine 1A receptor in rat hippocampus using [3H]8-OH-DPAT as radioligand,1154,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616099,11332,Hippocampus
,H,BAO_0000221,,Compound was evaluated for in vitro binding affinity towards serotonin 5-hydroxytryptamine 1A receptor receptor in rat hippocampus using [3H]8-OH-DPAT as radioligand,1155,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616100,11332,Hippocampus
,H,BAO_0000357,,Ability to displace [3H]-8-OH-DPAT from serotonergic 5-hydroxytryptamine 1A receptor,1156,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616101,1185,
,H,BAO_0000249,,Binding affinity at 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes by [3H]8-OH-DPAT displacement.,1157,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616102,2014,
,H,BAO_0000357,,Compound was evaluated for its ability to displace [3H]8-OH-DPAT from serotonergic 5-hydroxytryptamine 1A receptor,1158,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616103,1185,
,H,BAO_0000019,,Compound was evaluated for its binding affinity against 5-hydroxytryptamine 1A receptor from rat cerebral cortex,1159,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616104,14429,
,H,BAO_0000019,,"Binding affinity to 5-hydroxytryptamine 1A receptor (5-HT 1A receptor, serotonin receptor) from rat cortex using [3H]8-OH-DPAT as radioligand",1160,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616105,16288,
,D,BAO_0000019,,Displacement of [3H]prazosin from rat cortex membrane 5-hydroxytryptamine 1A receptor,1161,Expert,,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616106,5432,
,H,BAO_0000019,,Compound was evaluated for its binding affinity with 5-hydroxytryptamine 1A receptor using membranes prepared from rat cerebral cortex,1162,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616107,14429,
,H,BAO_0000357,,Binding affinity towards rat 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand.,1163,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616108,13672,
,H,BAO_0000221,,In vitro ability to displace [3H]8-hydroxy-2-(di-n-propylamino) tetralin binding from 5-hydroxytryptamine 1A receptor site in rat brain hippocampus,1164,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616109,11296,Hippocampus
,H,BAO_0000357,,In vitro ability to displace [3H]8-hydroxy-2-(di-n-propylamino) tetralin binding from 5-hydroxytryptamine 1A receptor site.,1165,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616110,11296,
,H,BAO_0000219,,Binding affinity against rat 5-hydroxytryptamine 1A receptor in CHO cells.,1166,Expert,,8,,,449.0,,,1,CHO,10576,B,,,CHEMBL616111,14749,
,H,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1A receptor from rat brain using [3H]-8-OH-DPAT as radioligand,1167,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616112,15086,
,H,BAO_0000221,,Compound was tested for the Binding affinity against rat hippocampal 5-hydroxytryptamine 1A receptor by Radio ligand [3H]8-OH-DPAT binding assay.,1168,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616113,13462,Hippocampus
,H,BAO_0000019,,Compound was tested for the displacement of [3H]-8-OH- DPAT from rat brain 5-hydroxytryptamine 1A receptor,1169,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616114,15363,
,H,BAO_0000019,,Compound was tested for the displacement of [3H]-8-OH- DPAT from rat brain 5-hydroxytryptamine 1A receptor,1170,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616115,15363,
,H,BAO_0000357,,Compound was tested in vitro for binding affinity for 5-hydroxytryptamine 1A receptor,1171,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616116,10796,
,H,BAO_0000221,,Binding affinity for 5-hydroxytryptamine 1A receptor in rat brain tissue using [3H]8-OH-DPAT as radioligand,1172,Expert,955.0,8,,,,,,1,,10576,B,,,CHEMBL615844,12816,Brain
,H,BAO_0000221,,In vitro displacement of [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor,1173,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615939,13542,Hippocampus
,H,BAO_0000019,,In vitro ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor sites of rat brain cortex.,1174,Expert,,8,,,,,,1,,10576,B,,,CHEMBL615940,13308,
,H,BAO_0000221,,In vitro affinity at 5-hydroxytryptamine 1A receptor of rat hippocampus by [3H]8-OH-DPAT displacement.,1175,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615941,13541,Hippocampus
,H,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-HT1A receptor of rat hippocampus and the value ranges from 9 - 12,1176,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615942,10058,Hippocampus
,H,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus,1177,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615943,10058,Hippocampus
,H,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus (94%CI) from 12 to 17,1178,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615944,10058,Hippocampus
,H,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus (94%CI) from 391-841,1179,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615945,10058,Hippocampus
,H,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 12 to 17.,1180,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615946,10058,Hippocampus
,H,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 12 to 20.,1181,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615947,10058,Hippocampus
,H,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 245 to 736,1182,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615948,10058,Hippocampus
,H,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 25 - 84,1183,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615949,10058,Hippocampus
,H,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 48 to 59,1184,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615950,10058,Hippocampus
,H,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 3 -5,1185,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615951,10058,Hippocampus
,H,BAO_0000221,,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and value ranges from 15 - 31,1186,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615952,10058,Hippocampus
,H,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and value ranges from 27 - 42,1187,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615953,10058,Hippocampus
,H,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and value ranges from 6 - 13,1188,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615954,10058,Hippocampus
,D,BAO_0000221,,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus,1189,Expert,10000000.0,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL615955,10058,Hippocampus
,H,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus.; ND is No Data.,1190,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615956,10058,Hippocampus
,H,BAO_0000221,,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus. and the value ranges from 16 - 27,1191,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL615957,10058,Hippocampus
,H,BAO_0000019,,Displacement of [3H]2-(di-N-propylamino)-8-hydroxytetralin from central 5-hydroxytryptamine 1A receptor recognition sites in rat frontal cortex homogenates.,1192,Expert,,8,,,,,,1,,10576,B,,,CHEMBL615958,12879,
,H,BAO_0000019,,Displacement of radioligand [3H]2-(di-N-propylamino)-8-hydroxytetralin from 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenate,1193,Expert,,8,,,,,,1,,10576,B,,,CHEMBL615959,11964,
,H,BAO_0000019,,Displacement of radioligand [3H]2-(di-N-propylamino)-8-hydroxytetralin from 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenate (experiment 1),1194,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL615960,11964,
,H,BAO_0000019,,Displacement of radioligand [3H]2-(di-N-propylamino)-8-hydroxytetralin from 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenate (experiment 2),1195,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL615961,11964,
,H,BAO_0000221,,Evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain,1196,Expert,955.0,8,,,,,,1,,10576,B,,,CHEMBL615962,9548,Brain
,H,BAO_0000019,,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand.,1197,Expert,,8,,,,,,1,,10576,B,,,CHEMBL615963,9098,
,H,BAO_0000019,,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand; ND is no data.,1198,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL615964,9098,
,H,BAO_0000019,,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand;ND means no data,1199,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL615965,9098,
,H,BAO_0000219,,In vitro displacement of radioactively labeled ligand [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor site in CHO cells,1200,Expert,,8,,,449.0,,,1,CHO,10576,B,,,CHEMBL615966,13248,
,H,BAO_0000249,,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat cortical membranes,1201,Expert,,8,,,,,,1,,10576,B,,,CHEMBL615967,3147,
,H,BAO_0000019,,In vitro binding affinity against 5-hydroxytryptamine 1A receptor of rat cerebral cortex using [3H]8-OH-DPAT as radioligand.,1202,Expert,,8,,,,,,1,,10576,B,,,CHEMBL615968,13949,
,H,BAO_0000218,,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand in CHO cells (sc),1203,Autocuration,,8,,,449.0,,,1,CHO,10576,B,,,CHEMBL615969,11883,
,H,BAO_0000218,,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT (agonist) as radioligand (sc),1204,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL615970,11883,
,D,BAO_0000357,,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT,1205,Expert,,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL615971,11883,
,H,BAO_0000249,,In vitro binding affinity at 5-HT1A receptors assayed by displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membranes,1206,Expert,,8,Membranes,,,,,1,,10576,B,,,CHEMBL615972,15535,
,H,BAO_0000249,,In vitro binding affinity at 5-HT1A receptor by measuring its ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membranes + cortex,1207,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL615973,15535,
,H,BAO_0000249,,In vitro binding affinity at 5-HT1A receptor by measuring its ability to displace [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membranes+cortex,1208,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL615974,15535,
,D,BAO_0000219,,Displacement of [3H]8-OH-DPAT from human 5-hydroxytryptamine 1A receptor expressed in CHO cells,1209,Expert,,9,,,449.0,,9606.0,1,CHO,51,B,Homo sapiens,,CHEMBL615975,16372,
,H,BAO_0000249,,In vitro binding affinity for 5-hydroxytryptamine 1A receptor in rat hippocampal membranes by [125I]-labeled agonist displacement.,1210,Expert,,8,,,,,,1,,10576,B,,,CHEMBL615976,14608,
,D,BAO_0000221,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampus,1211,Expert,10000000.0,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL872106,4795,Hippocampus
,H,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,1212,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL615977,13863,
,H,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=100-230,1213,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL615978,13863,
,H,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=12-14,1214,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616166,13863,
,H,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=16-20,1215,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616167,13863,
,H,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=160-430,1216,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616168,13863,
,H,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=174-224,1217,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616169,13863,
,H,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=184-503,1218,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616170,13863,
,H,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=19-23,1219,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616171,13863,
,H,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=2.2-3.2,1220,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616172,13863,
,H,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=2.7-3.6,1221,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616173,13863,
,H,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=20-23,1222,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616174,13863,
,H,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=21-28,1223,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616175,13863,
,H,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=240-760,1224,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616176,13863,
,H,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=39-87,1225,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616177,13863,
,H,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=4.6-5.2,1226,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616178,13863,
,H,BAO_0000019,,Inhibitory activity tested in vitro at 5-hydroxytryptamine 1A receptor binding site in rat,1227,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616179,9742,
,H,BAO_0000357,,Inhibitory concentration against 5-hydroxytryptamine 1A receptor,1228,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616180,12073,
,H,BAO_0000357,,Inhibitory concentration against binding of 5-hydroxytryptamine 1A receptor from striata of male Wistar rats by displacement of [3H]8-OH-DPAT,1229,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616181,4101,
,H,BAO_0000019,,Inhibitory concentration against radioligand [3H]hydroxy-2-(di-n-propylamino)-tetralin binding to 5-hydroxytryptamine 1A receptor in rat,1230,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616182,15360,
,H,BAO_0000221,,Inhibitory concentration against radioligand [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor,1231,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616183,11576,Hippocampus
,H,BAO_0000019,,Inhibition of the 5-hydroxytryptamine 1A receptor in rat dorsal raphe,1232,Expert,,8,,,,,,1,,10576,B,,,CHEMBL615874,5834,
,D,BAO_0000219,,Inhibitory concentration against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells,1233,Expert,,9,,,485.0,,10116.0,1,CHO-K1,10576,B,Rattus norvegicus,,CHEMBL615875,2395,
,H,BAO_0000019,,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]OH-DPAT radioligand,1234,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL615876,1375,
,H,BAO_0000019,,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]OH-DPAT radioligand; NT means not tested,1235,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL615877,1375,
,H,BAO_0000357,,The compound was evaluated for the ability to displace [3H]- 8-OH -DPAT from 5-hydroxytryptamine 1A receptor ( striata of male wistar rats),1236,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL615878,3967,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor binding site using [3H]8-OH-DPAT. ,1237,Expert,,8,,,,,,1,,10576,B,,,CHEMBL615879,12884,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor using receptor binding assay,1238,Expert,,8,,,,,,1,,10576,B,,,CHEMBL615880,2343,
,H,BAO_0000019,,"The compound was tested in vitro for inhibitory activity against 5-HT1A receptor in rats, using [3H]8-OH-DPAT as radioligand",1239,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL615881,11511,
,D,BAO_0000019,,"Inhibitory activity against 5-hydroxytryptamine 1A receptor in rats, using [3H]8-OH-DPAT as radioligand",1240,Expert,,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL615882,11511,
,H,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat,1241,Autocuration,,8,,In vivo,,,,1,,10576,F,,,CHEMBL615883,16394,
,H,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.10-6.20),1242,Autocuration,,8,,In vivo,,,,1,,10576,F,,,CHEMBL615884,16394,
,H,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.20-1.60),1243,Autocuration,,8,,In vivo,,,,1,,10576,F,,,CHEMBL615885,16394,
,H,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.20-1.80),1244,Autocuration,,8,,In vivo,,,,1,,10576,F,,,CHEMBL615886,16394,
,H,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.37-4.27),1245,Autocuration,,8,,In vivo,,,,1,,10576,F,,,CHEMBL615887,16394,
,H,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.40-2.70),1246,Autocuration,,8,,In vivo,,,,1,,10576,F,,,CHEMBL615888,16394,
,H,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.40-4),1247,Autocuration,,8,,In vivo,,,,1,,10576,F,,,CHEMBL615889,16394,
,H,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.45-4.51),1248,Autocuration,,8,,In vivo,,,,1,,10576,F,,,CHEMBL615890,16394,
,H,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.50-5.30),1249,Autocuration,,8,,In vivo,,,,1,,10576,F,,,CHEMBL615891,16394,
,H,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.60-1.60),1250,Autocuration,,8,,In vivo,,,,1,,10576,F,,,CHEMBL615892,16394,
,H,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.72-2.87),1251,Autocuration,,8,,In vivo,,,,1,,10576,F,,,CHEMBL615893,16394,
,H,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.80-5.80),1252,Autocuration,,8,,In vivo,,,,1,,10576,F,,,CHEMBL615894,16394,
,H,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (1.50-16.5),1253,Autocuration,,8,,In vivo,,,,1,,10576,F,,,CHEMBL615895,16394,
,H,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (2.20-30.5),1254,Autocuration,,8,,In vivo,,,,1,,10576,F,,,CHEMBL615896,16394,
,H,BAO_0000218,,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges is not computable,1255,Autocuration,,8,,In vivo,,,,1,,10576,F,,,CHEMBL615897,16394,
,D,BAO_0000249,,"Percent increase of R(+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor in isolated rat hippocampal membranes",1256,Expert,,9,Membranes,,,,10116.0,1,,10576,F,Rattus norvegicus,,CHEMBL615898,16616,
,H,BAO_0000019,,% inhibition towards 5-HT1A receptor from rat hippocampal membranes,1257,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL615899,16796,
,H,BAO_0000019,,% inhibition towards 5-hydroxytryptamine 1A receptor from rat hippocampal membranes,1258,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616291,16796,
,H,BAO_0000357,,Tested in vitro for % inhibition against (serotonin)5-HT 1A receptor.,1259,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616292,15629,
,H,BAO_0000249,,"Ability to inhibit 5-HT sensitive,forskolin-stimulated adenylyl cyclase(FSC) activity in rat hippocampal membranes mediated through 5-hydroxytryptamine 1A receptor",1260,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL616293,13241,
,H,BAO_0000221,,Measurement of binding affinity by displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,1261,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616294,12073,Hippocampus
,H,BAO_0000249,,Compound at 10E-5 M was tested in vitro for the inhibition of radioligand [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membrane,1262,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616295,14286,Hippocampus
,H,BAO_0000221,,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]-8-OH- -DPAT in rat brain cortex at 10 uM,1263,Autocuration,955.0,8,,,,,,1,,10576,B,,,CHEMBL616296,14542,Brain
,H,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 10 uM 5-HT.,1264,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL616297,13630,
,H,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0+ 1 uM 5-HT.,1265,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL616605,13630,
,H,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.01 uM+ 1 uM 5-HT.,1266,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL616606,13630,
,H,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.05 uM,1267,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL616607,13630,
,H,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.05 uM,1268,Expert,,8,,,,,,1,,10576,F,,,CHEMBL616608,13630,
,H,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.05 uM+ 1 uM 5-HT.,1269,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL616609,13630,
,D,BAO_0000019,,Effect against 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at 0.1 uM dose,1270,Expert,,9,,,,,10116.0,1,,10576,F,Rattus norvegicus,,CHEMBL616610,13630,
,H,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 10 uM 5-HT.,1271,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL616611,13630,
,H,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 1 uM 5-HT.,1272,Expert,,8,,,,,,1,,10576,F,,,CHEMBL616612,13630,
,H,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 0.1 uM 5-HT.,1273,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL616613,13630,
,H,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 10 uM,1274,Expert,,8,,,,,,1,,10576,F,,,CHEMBL616614,13630,
,H,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 10 uM+ 10 uM 5-HT.,1275,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL616615,13630,
,H,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM,1276,Expert,,8,,,,,,1,,10576,F,,,CHEMBL616616,13630,
,H,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 0.1 uM 5-HT.,1277,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL616617,13630,
,H,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 10 uM 5-HT.,1278,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL616618,13630,
,H,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 1 uM 5-HT.,1279,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL616619,13630,
,H,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 3 uM 5-HT.,1280,Expert,,8,,,,,,1,,10576,F,,,CHEMBL616620,13630,
,H,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 50 uM 5-HT.,1281,Expert,,8,,,,,,1,,10576,F,,,CHEMBL616621,13630,
,H,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 30 uM,1282,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL616622,13630,
,H,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 50 uM,1283,Expert,,8,,,,,,1,,10576,F,,,CHEMBL616146,13630,
,H,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 50 uM+ 50 uM 5-HT.,1284,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL832873,13630,
,H,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor-mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM,1285,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL616147,13630,
,H,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor-mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 10 uM 5-HT.,1286,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL872872,13630,
,H,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM,1287,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL616148,13630,
,H,BAO_0000221,,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue,1288,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616149,9783,Hippocampus
,H,BAO_0000221,,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue at 1 uM,1289,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616150,9783,Hippocampus
,D,BAO_0000249,,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membranes at 10e-7 M,1290,Expert,,9,Membranes,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616151,14331,
,H,BAO_0000221,,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue at 1 uM,1291,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL872873,15260,Hippocampus
,H,BAO_0000221,,Inhibitory activity against rat hippocampal tissue 5-hydroxytryptamine 1A receptor at 0.1 uM concentration,1292,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616670,15260,Hippocampus
,H,BAO_0000221,,Inhibitory activity against rat hippocampal tissue 5-hydroxytryptamine 1A receptor at 1 uM concentration,1293,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616671,15260,Hippocampus
,D,BAO_0000249,,"Percent inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor in hippocampal membranes",1294,Expert,,9,,,,,10116.0,1,,10576,F,Rattus norvegicus,,CHEMBL884861,16616,
,H,BAO_0000357,,Tested in vitro for % inhibition against (serotonin)5-HT 1A receptor,1295,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616672,15629,
,H,BAO_0000019,,The compound was tested binding affinity against 5-hydroxytryptamine 1A receptor from rat brain using [3H]8-OH-DPAT as radioligand at 10e-6 M.,1296,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616673,15086,
,H,BAO_0000019,,Antagonistic activity against 5-hydroxytryptamine 1A receptor in rat cerebral cortex using [3H]8-OH-DPAT as radioligand.,1297,Expert,,8,,,,,,1,,10576,F,,,CHEMBL616674,5717,
,H,BAO_0000357,,Binding affinity against the site labelled by the 5-hydroxytryptamine 1A receptor agonist [3H]- 8-OH-DPAT,1298,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616675,12652,
,H,BAO_0000221,,In vitro binding affinity for 5-hydroxytryptamine 1A receptor was determined by measuring specific inhibition of [125I]-binding to rat hippocampal membrane preparations,1299,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616676,14608,Hippocampus
,H,BAO_0000221,,Inhibition of binding of [125I]-8-OH-PIPAT ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,1300,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616677,12306,Hippocampus
,H,BAO_0000221,,The binding of [125I]MPPI ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,1301,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616678,12306,Hippocampus
,D,BAO_0000357,,Ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor,1302,Expert,,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616679,15247,
,H,BAO_0000221,,Ability to bind to central serotonin 5-hydroxytryptamine 1A receptor in vitro in hippocampus of the rat brain using [3H]8-OH-DPAT radioligand,1303,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616680,17529,Hippocampus
,H,BAO_0000221,,Ability to displace [3H]- -OH-DPAT bound to 5-hydroxytryptamine 1A receptor in rat hippocampus,1304,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616681,14826,Hippocampus
,H,BAO_0000221,,Ability to displace [3H]- -(OH)-DPAT bound to 5-hydroxytryptamine 1A receptor in rat hippocampus,1305,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616682,14826,Hippocampus
,H,BAO_0000221,,Ability to displace [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor,1306,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616683,13241,Hippocampus
,H,BAO_0000221,,Ability to displace [3H]-8-OH-DPAT from rat hippocampal homogenate 5-hydroxytryptamine 1A receptor,1307,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616684,14093,Hippocampus
,H,BAO_0000221,,Ability to displace [3H]-8-OH-DPAT from rat hippocampal homogenate 5-hydroxytryptamine 1A receptor; Not tested,1308,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616685,14093,Hippocampus
,H,BAO_0000221,,Affinity at [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor in rat brain homogenate was determined,1309,Autocuration,955.0,8,,,,,,1,,10576,B,,,CHEMBL616686,14442,Brain
,H,BAO_0000357,,Affinity for 5-hydroxytryptamine 1A receptor site,1310,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616687,9919,
,H,BAO_0000357,,Affinity for 5-hydroxytryptamine 1A receptor site,1311,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616688,9919,
,H,BAO_0000221,,Affinity in displacing [3H]8-OH-DPAT from rat hippocampal 5-HT1A receptor.,1312,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616689,11440,Hippocampus
,H,BAO_0000357,,Affinity on 5-hydroxytryptamine 1A receptor labeled by [3H]8-OH-DPAT,1313,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616690,11257,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand,1314,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616691,10330,
,D,BAO_0000221,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampus mambranes,1315,Expert,10000000.0,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616692,17331,Hippocampus
,H,BAO_0000249,,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane,1316,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616693,16567,
,D,BAO_0000019,,"Binding affinity against 5-hydroxytryptamine 1A receptor in homogenated rat brain tissue, using by [3H]8-OH-DPAT as radioligand",1317,Expert,,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616694,12058,
,H,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampal tissue,1318,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616695,9699,Hippocampus
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1A receptor of rat was determined using [3H]8-OH-DPAT in binding assay,1319,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616696,9547,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]DOB as radioligand,1320,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616697,10330,
,H,BAO_0000357,,Binding affinity against rat 5-hydroxytryptamine 1A receptor,1321,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616698,14331,
,D,BAO_0000019,,Binding affinity against rat brain 5-hydroxytryptamine 1A receptor,1322,Expert,,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616949,14060,
,H,BAO_0000221,,Binding affinity against the 5-hydroxytryptamine 1A receptor labelled with [3H]8-OH-DPAT in rat hippocampal homogenates,1323,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616950,14744,Hippocampus
,H,BAO_0000357,,Binding affinity against serotonin 5-hydroxytryptamine 1A receptor using radioligand [3H]8-OH-DPAT binding assay,1324,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL832875,13506,
,H,BAO_0000221,,Binding affinity at 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in rat brain.,1325,Expert,955.0,8,,,,,,1,,10576,B,,,CHEMBL616951,10862,Brain
,H,BAO_0000221,,Binding affinity at 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in rat brain.,1326,Expert,955.0,8,,,,,,1,,10576,B,,,CHEMBL616952,10862,Brain
,H,BAO_0000357,,Binding affinity at rat 5-hydroxytryptamine 1A receptor by [3H]WB-4101 displacement.,1327,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616953,10062,
,H,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1A receptor by use of [3H]8-OH-DPAT in male rat,1328,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616954,12073,
,H,BAO_0000357,,GTPgammaS radioligand binding assay,1329,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616955,14875,
,H,BAO_0000357,,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Not determined,1330,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616956,2391,
,H,BAO_0000019,,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Partial agonist,1331,Autocuration,,8,,,,,,1,,106,F,,,CHEMBL616957,2391,
,H,BAO_0000019,,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Slient antagonist,1332,Autocuration,,8,,,,,,1,,106,F,,,CHEMBL616958,2391,
,H,BAO_0000357,,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor,1333,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616959,2391,
,H,BAO_0000357,,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Not determined,1334,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616960,2391,
,H,BAO_0000019,,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; silent antagonist,1335,Autocuration,,8,,,,,,1,,106,F,,,CHEMBL616961,2391,
,H,BAO_0000219,,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor,1336,Expert,,8,,,308.0,,,1,HeLa,106,B,,,CHEMBL616962,17211,
,H,BAO_0000219,,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor receptor,1337,Autocuration,,8,,,308.0,,,1,HeLa,106,B,,,CHEMBL616963,17211,
,D,BAO_0000357,,Affinity towards human 5-hydroxytryptamine 1B serotonin receptor,1338,Expert,,9,,,,,9606.0,1,,106,B,Homo sapiens,,CHEMBL616524,6491,
,H,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT as radioligand,1339,Autocuration,,8,,,449.0,,,1,CHO,106,B,,,CHEMBL616525,16190,
,H,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 1B receptor in C6-glial transfected cell type using [3H]5-CT as radioligand,1340,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL872908,14165,
,H,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 1B receptor in C6-glial transfected cell type using [3H]GR-125743 as radioligand,1341,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616526,14165,
,D,BAO_0000357,,Binding affinity to cloned human 5-hydroxytryptamine 1B receptor,1342,Expert,,9,,,,,9606.0,1,,106,B,Homo sapiens,,CHEMBL616527,4234,
,H,BAO_0000219,,Binding affinity towards human 5-hydroxytryptamine 1B receptor in L-M(tk-) cells using [3H]GR-125743 as radioligand,1343,Expert,,8,,,,,,1,,106,B,,,CHEMBL616528,6328,
,H,BAO_0000357,,Binding affinity for recombinant human 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand.,1344,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616529,14770,
,H,BAO_0000357,,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1B receptor using [3H]5-CT as radioligand,1345,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616530,2598,
,H,BAO_0000357,,Binding affinity was evaluated at the cloned human 5-hydroxytryptamine 1B receptor,1346,Expert,,8,,,,,,1,,106,B,,,CHEMBL616531,6897,
,H,BAO_0000357,,Binding affinity was evaluated at the cloned human 5-hydroxytryptamine 1B receptor,1347,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616532,6897,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1B receptor,1348,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616533,6013,
,H,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 1B receptor,1349,Expert,,8,,,,,,1,,106,B,,,CHEMBL616534,5843,
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1B receptor using [3H]5-HT trifluoroacetate as radioligand,1350,Expert,,8,,,,,,1,,106,B,,,CHEMBL616535,14454,
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1B receptor using [3H]5-HT radioligand,1351,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616536,16209,
,H,BAO_0000357,,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 1B receptor,1352,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616537,3935,
,H,BAO_0000219,,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1B receptor in CHO-K1 cells,1353,Expert,,8,,,485.0,,,1,CHO-K1,106,F,,,CHEMBL616538,13729,
,H,BAO_0000019,,Agonist activity to the human recombinant 5-hydroxytryptamine 1B receptor,1354,Expert,,8,,,,,,1,,106,F,,,CHEMBL616539,14251,
,H,BAO_0000019,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1B receptor,1355,Expert,,8,,,,,,1,,106,B,,,CHEMBL616540,17085,
,H,BAO_0000357,,In vitro binding affinity was determined towards cloned human 5-hydroxytryptamine 1B receptor using [3H]5-CT radioligand,1356,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616429,3025,
,H,BAO_0000357,,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1B receptor,1357,Expert,,8,,,,,,1,,106,B,,,CHEMBL616430,15315,
,D,BAO_0000219,,Receptor binding affinity for cloned human 5-hydroxytryptamine 1B receptor in Cos-7 cells,1358,Expert,,9,,,,,9606.0,1,,106,B,Homo sapiens,,CHEMBL616431,14214,
,D,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 1B receptor,1359,Expert,,9,,,,,9606.0,1,,106,B,Homo sapiens,,CHEMBL616432,3804,
,D,BAO_0000357,,Affinity for 5-hydroxytryptamine 1B receptor subtype,1360,Expert,,9,,,,,9606.0,1,,106,B,Homo sapiens,,CHEMBL616433,2391,
,D,BAO_0000357,,Binding affinity for human 5-hydroxytryptamine 1B receptor,1361,Expert,,9,,,,,9606.0,1,,106,B,Homo sapiens,,CHEMBL616434,4175,
,H,BAO_0000219,,Binding affinity against cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-CT as radioligand; Not determined,1362,Autocuration,,8,,,449.0,,,1,CHO,106,B,,,CHEMBL616435,17296,
,H,BAO_0000019,,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1B receptor; ND means not determined,1363,Expert,,8,,,,,,1,,106,B,,,CHEMBL616436,17085,
,H,BAO_0000219,,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor; NT denotes not tested,1364,Autocuration,,8,,,308.0,,,1,HeLa,106,B,,,CHEMBL616437,17211,
,H,BAO_0000219,,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor; NT=not tested,1365,Autocuration,,8,,,308.0,,,1,HeLa,106,B,,,CHEMBL616438,17211,
,H,BAO_0000219,,Ability to displace [3H]-5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor; NT denotes not tested,1366,Autocuration,,8,,,308.0,,,1,HeLa,106,B,,,CHEMBL616439,17211,
,D,BAO_0000357,,Binding activity against human 5-hydroxytryptamine 1B receptor; NT means not tested,1367,Expert,,9,,,,,9606.0,1,,106,B,Homo sapiens,,CHEMBL616440,15926,
,H,BAO_0000219,,Binding affinity in CHO-K1 cells transfected with human recombinant 5-hydroxytryptamine 1B receptor; not tested,1368,Autocuration,,8,,,485.0,,,1,CHO-K1,106,B,,,CHEMBL616441,16312,
,H,BAO_0000357,,Selectivity ratio against cloned human 5-HT1B receptor to that of h5-HT1D receptor,1369,Expert,,8,,,,,,1,,106,B,,,CHEMBL616442,5843,
,H,BAO_0000357,,Selectivity ratio against cloned human 5-hydroxytryptamine 1B receptor to that of human 5-hydroxytryptamine 1D receptor,1370,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616443,5843,
,H,BAO_0000219,,Binding affinity in CHO-K1 cells transfected with human recombinant 5-hydroxytryptamine 1B receptor,1371,Expert,,8,,,485.0,,,1,CHO-K1,106,B,,,CHEMBL616444,16312,
,D,BAO_0000357,,Binding activity against human 5-hydroxytryptamine 1B receptor,1372,Expert,,9,,,,,9606.0,1,,106,B,Homo sapiens,,CHEMBL616445,15926,
,D,BAO_0000357,,Binding activity against human 5-hydroxytryptamine 1B receptor,1373,Expert,,9,,,,,9606.0,1,,106,B,Homo sapiens,,CHEMBL616446,15926,
,D,BAO_0000219,,Binding affinity to human cloned 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT as radioligand,1374,Expert,,9,,,449.0,,9606.0,1,CHO,106,B,Homo sapiens,,CHEMBL616447,4540,
,H,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 1B receptor was determined,1375,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616448,6166,
,H,BAO_0000219,,Binding affinity against cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-CT as radioligand,1376,Autocuration,,8,,,449.0,,,1,CHO,106,B,,,CHEMBL616449,17296,
,H,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 1B receptor cloned receptors in CHO cells,1377,Autocuration,,8,,,449.0,,,1,CHO,106,B,,,CHEMBL616450,17296,
,H,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 1B receptor cloned receptors in CHO cells using [3H]5-CT as radioligand,1378,Autocuration,,8,,,449.0,,,1,CHO,106,B,,,CHEMBL857974,17296,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 1B (human cloned receptor) in CHO cells using [3H]5-HT as radioligand,1379,Autocuration,,8,,,449.0,,,1,CHO,106,B,,,CHEMBL616451,15779,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 1B receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand,1380,Autocuration,,8,,,449.0,,,1,CHO,106,B,,,CHEMBL616452,15779,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 1B receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand;ND means no data.,1381,Autocuration,,8,,,449.0,,,1,CHO,106,B,,,CHEMBL616453,15779,
,H,BAO_0000219,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT as the radioligand,1382,Autocuration,,8,,,449.0,,,1,CHO,106,B,,,CHEMBL616454,4199,
,D,BAO_0000357,,Binding affinity for human 5-hydroxytryptamine 1B receptor,1383,Expert,,9,,,,,9606.0,1,,106,B,Homo sapiens,,CHEMBL616455,14875,
,H,BAO_0000219,,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT,1384,Autocuration,,8,,,449.0,,,1,CHO,106,B,,,CHEMBL616456,15146,
,H,BAO_0000357,,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1B receptor in CHO using [3H]5-HT as a radioligand,1385,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616457,5213,
,H,BAO_0000219,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT,1386,Autocuration,,8,,,449.0,,,1,CHO,106,B,,,CHEMBL616458,14818,
,H,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1B receptor in CHO cells, using [3H]5-HT as radioligand",1387,Autocuration,,8,,,449.0,,,1,CHO,106,B,,,CHEMBL616459,4829,
,H,BAO_0000019,,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1B receptor at concentration 1 uM,1388,Expert,,8,,,,,,1,,106,F,,,CHEMBL616460,14454,
,H,BAO_0000019,,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1B receptor at concentration 10 uM,1389,Expert,,8,,,,,,1,,106,F,,,CHEMBL616461,14454,
,H,BAO_0000219,,"Effect of compound on [35S]GTP-gamma-S, radioligand binding CHO cells expressing human 5-hydroxytryptamine 1B receptor",1390,Autocuration,,8,,,449.0,,,1,CHO,106,F,,,CHEMBL616462,14875,
,H,BAO_0000219,,"Effect of compound on [35S]GTP-gamma-S, radioligand binding in CHO cells expressing human 5-hydroxytryptamine 1B receptor",1391,Autocuration,,8,,,449.0,,,1,CHO,106,F,,,CHEMBL616463,14875,
,H,BAO_0000019,,"Compound was tested for maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect produced by 5-HT.",1392,Autocuration,,8,,,,,,1,,105,F,,,CHEMBL616464,15250,
,H,BAO_0000219,,Compound was tested for the displacement of [3H]5-HT binding to cloned 5-hydroxytryptamine 1D receptor stably expressed in CHO cells.,1393,Autocuration,,8,,,449.0,,,1,CHO,105,B,,,CHEMBL616465,15250,
,H,BAO_0000357,,The compound was tested for binding affinity against 5-hydroxytryptamine 1B receptor,1394,Autocuration,,8,,,,,,1,,17105,B,,,CHEMBL832874,15086,
,H,BAO_0000019,,5-hydroxytryptamine 1B receptor agonist potency determined in rabbit saphenous vein contraction model,1395,Autocuration,,8,,,,,9986.0,1,,106,F,Oryctolagus cuniculus,,CHEMBL616184,3025,
,H,BAO_0000019,,The vascular 5-hydroxytryptamine 1B receptor affinity was assessed using ring preparations of rabbit saphenous vein (RbSV).,1396,Autocuration,,8,,,,,9986.0,1,,106,B,Oryctolagus cuniculus,,CHEMBL616185,14998,
,H,BAO_0000019,,"Binding affinity against vascular 5-hydroxytryptamine 1B receptor, measured using ring preparations of rabbit saphenous vein (RbSV)",1397,Intermediate,,8,,,,,9986.0,1,,106,B,Oryctolagus cuniculus,,CHEMBL616186,14998,
,H,BAO_0000019,,The vascular 5-hydroxytryptamine 1B receptor affinity was assessed using ring preparations of rabbit saphenous vein(RbSV).,1398,Autocuration,,8,,,,,9986.0,1,,106,B,Oryctolagus cuniculus,,CHEMBL616187,14998,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1B receptor was measured using [3H]5-HT as radioligand,1399,Expert,,8,,,,,,1,,10577,B,,,CHEMBL616188,13969,
,D,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1B receptor,1400,Intermediate,,9,,,,,,1,,10577,B,,,CHEMBL873475,13392,
,D,BAO_0000019,,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatum; Less active,1401,Expert,2435.0,9,,,,,10116.0,1,,10577,B,Rattus norvegicus,,CHEMBL616189,3651,Striatum
,H,BAO_0000357,,Concentration necessary to achieve half maximal inhibition of [125I]- Iodocyanopindolol binding to 5-hydroxytryptamine 1B receptor at 1 uM,1402,Expert,,8,,,,,,1,,10577,B,,,CHEMBL616190,10025,
,H,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=48-77,1403,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616191,13863,
,H,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=63-95,1404,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616192,13863,
,H,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=710-980,1405,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616193,13863,
,H,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=78-140,1406,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616194,13863,
,H,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=85-130,1407,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616195,13863,
,H,BAO_0000357,,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=89-280,1408,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616196,13863,
,H,BAO_0000249,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in rat hippocampus membrane.,1409,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616197,4622,Hippocampus
,H,BAO_0000019,,Binding affinity at 5-hydroxytryptamine 1A (5-HT1A) receptor in rat cerebral cortex using [3H]8-OH-DPAT as radioligand,1410,Intermediate,,8,,,,,,1,,10576,B,,,CHEMBL616198,14911,
,H,BAO_0000221,,In vitro binding affinity to 5-hydroxytryptamine 1A receptor using [125I](R)-(+)-trans-8-OH-PIPAT as radioligand in rat hippocampal homogenate,1411,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616199,12678,Hippocampus
,H,BAO_0000221,,In vitro binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampal homogenate by [125I](R)-(+)-trans-8-OH-PIPAT displacement.,1412,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616200,12678,Hippocampus
,H,BAO_0000221,,In vitro binding affinity to rat hippocampal 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,1413,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616201,14235,Hippocampus
,H,BAO_0000221,,In vitro binding affinity towards 5-hydroxytryptamine 1A r receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates,1414,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616202,14949,Hippocampus
,H,BAO_0000221,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates,1415,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616203,14949,Hippocampus
,H,BAO_0000221,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates; ND=not determined,1416,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616204,14949,Hippocampus
,H,BAO_0000221,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates; Not determined,1417,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616205,14949,Hippocampus
,H,BAO_0000221,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates; not determined,1418,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616206,14949,Hippocampus
,H,BAO_0000249,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes,1419,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616207,16118,
,H,BAO_0000249,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand in rat cerebral cortex membranes,1420,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616208,3268,
,H,BAO_0000249,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand in rat cerebral cortex membranes; Inactive,1421,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616209,3268,
,H,BAO_0000357,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor was determined using radioligand [3H]-8-OH-DPAT,1422,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616210,16117,
,H,BAO_0000221,,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue.,1423,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616211,9783,Hippocampus
,H,BAO_0000221,,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue; NT=Not tested,1424,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616504,9783,Hippocampus
,D,BAO_0000221,,Displacement of [3H]8-OH-DPAT from rat hippocampal 5-hydroxytryptamine 1A receptor,1425,Expert,10000000.0,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616505,14356,Hippocampus
,H,BAO_0000019,,Inhibition constant of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor,1426,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL616506,15740,
,H,BAO_0000221,,Inhibition of binding of [125I]8-OH-PIPAT ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,1427,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL872107,12306,Hippocampus
,D,BAO_0000221,,Displacement of [3H]5-HT from rat hippocampal 5-hydroxytryptamine 1A receptor with 10e-6 M ketanserin,1428,Expert,10000000.0,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616507,13348,Hippocampus
,H,BAO_0000249,,Inhibitory activity against 5-hydroxytryptamine 1A receptor in rat cortical membranes using [3H]8-OH-DPAT as a radioligand,1429,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616303,10394,
,H,BAO_0000221,,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue,1430,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616304,15260,Hippocampus
,H,BAO_0000221,,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue using [3H]OH-DPAT as radioligand.,1431,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616305,10046,Hippocampus
,H,BAO_0000221,,Antagonist activity against rat hippocampal tissue 5-hydroxytryptamine 1A receptor,1432,Intermediate,10000000.0,8,,,,,,1,,10576,F,,,CHEMBL616306,15260,Hippocampus
,H,BAO_0000357,,Inhibitory affinity constant against 5-hydroxytryptamine 1A receptor,1433,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616307,12851,
,D,BAO_0000221,,Displacement of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat brain hippocampus,1434,Expert,10000000.0,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL881829,2148,Hippocampus
,H,BAO_0000357,,Affinity against the 5-hydroxytryptamine receptor 1A using [3H]WB-4101.,1435,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616308,13134,
,H,BAO_0000019,,Tested for affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in homogenized rat brain,1436,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616309,12462,
,H,BAO_0000019,,Tested for affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in homogenized rat brain tissue,1437,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616310,12462,
,H,BAO_0000219,,Tested for affinity against 5-hydroxytryptamine 1A receptors using [3H]8-OH-DPAT in homogenized rat cloned CHO cells,1438,Autocuration,,8,,,449.0,,,1,CHO,10576,B,,,CHEMBL616311,12462,
,H,BAO_0000357,,Tested for binding affinity against 5-hydroxytryptamine 1A receptor from rat frontal cortical regions using [3H]8-OH-DPAT as radioligand,1439,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616312,11933,
,H,BAO_0000357,,Tested for binding affinity against 5-hydroxytryptamine 1A receptor from rat frontal cortical regions using [3H]8-OH-DPAT as radioligand; ND is Not Determined,1440,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616313,11933,
,D,BAO_0000221,,Displacement of [3H]8-OH-DPAT from rat hippocampal 5-hydroxytryptamine 1A receptor,1441,Expert,10000000.0,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616314,403,Hippocampus
,H,BAO_0000221,,Tested for binding affinity by measuring displacement of [3H]8-OH-DPAT from rat serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus,1442,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616315,15538,Hippocampus
,H,BAO_0000221,,Tested for binding affinity by measuring displacement of [3H]8-OH-DPAT from rat serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus; NA means Not Active,1443,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616567,15538,Hippocampus
,H,BAO_0000221,,Tested for binding affinity by measuring displacement of [3H]-8-OH-DPAT from rat serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus; ND means Not Determined,1444,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616568,15538,Hippocampus
,H,BAO_0000019,,Binding affinity to displace [3H]2-(di-N-propylamino)-8-hydroxy-tetralin from 5-hydroxytryptamine 1A (5-HT1A) receptor in rat frontal cortex homogenates,1445,Intermediate,,8,,,,,,1,,10576,B,,,CHEMBL616569,12464,
,H,BAO_0000357,,Binding affinity to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand assay.,1446,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616570,1455,
,H,BAO_0000357,,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 1A receptor agonist [3H]- 8-OH-DPAT,1447,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616571,12652,
,H,BAO_0000221,,Tested for the inhibitory activity against 5-hydroxytryptamine 1A receptor in rat hippocampal,1448,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616572,12639,Hippocampus
,H,BAO_0000249,,Tested in vitro for binding affinity by measuring its ability to inhibit [3H]8-OH-DPAT binding at 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes.,1449,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616573,13949,
,D,BAO_0000357,,Tested in vitro for receptor binding affinity against 5-hydroxytryptamine 1A receptor using radioligand [3H]8-OH-DPAT,1450,Expert,,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616574,12463,
,H,BAO_0000221,,The binding affinity by measuring its ability to displace [3H]8-OH-DPAT radioligand in 5-hydroxytryptamine 1A receptor on rat hippocampal preparation,1451,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616575,14829,Hippocampus
,H,BAO_0000221,,The binding affinity by measuring its ability to displace [3H]8-OH-DPAT radioligand in 5-hydroxytryptamine 1A receptor on rat hippocampal preparation; ND=not determined,1452,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL872108,14829,Hippocampus
,H,BAO_0000357,,The binding affinity was measured on 5-hydroxytryptamine 1A receptor using [3H]- 8-OH-DPAT as radioligand.,1453,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616576,12092,
,H,BAO_0000249,,The compound was evaluated for binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampal membranes using [3H]8-OH-DPAT as radioligand in the presence of 1 mM of MnCl2,1454,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616577,403,
,H,BAO_0000249,,The compound was evaluated for binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampal membranes using [3H]8-OH-DPAT as radioligand in the presence of 3*10e-5 M GTP gamma S,1455,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616578,403,
,H,BAO_0000357,,Binding affinity at 5-hydroxytryptamine 1A receptor from striata of wistar rats by [3H]- 8-OH -DPAT displacement.,1456,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616579,3967,
,D,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1A receptor of rat brain synaptosomal preparations,1457,Expert,,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616580,12771,
,H,BAO_0000019,,The compound was tested binding affinity against 5-hydroxytryptamine 1A receptor from rat brain using [3H]8-OH-DPAT as radioligand at 10e-6 M.,1458,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616581,15086,
,H,BAO_0000221,,The compound was tested for binding affinity on [3H]8-OH-DPAT as specific ligand on 5-hydroxytryptamine 1A receptor in rat hippocampus,1459,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616582,14909,Hippocampus
,H,BAO_0000221,,The compound was tested for binding affinity on [3H]8-OH-DPAT as specific ligand on 5-hydroxytryptamine 1A receptor in rat hippocampus,1460,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616583,14949,Hippocampus
,D,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampus using [3H]8-OH-DPAT,1461,Expert,10000000.0,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616584,2309,Hippocampus
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor,1462,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616585,4170,
,D,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 1A receptor by displacing [3H]WB-4101 from rat hippocampus,1463,Expert,10000000.0,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616586,11642,Hippocampus
,H,BAO_0000221,,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1A receptor by displacing [3H]WB-4101 radioligand in rat hippocampus,1464,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616587,11642,Hippocampus
,H,BAO_0000221,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]-8-OH-DPAT as radioligand,1465,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616588,12953,Hippocampus
,H,BAO_0000221,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as radioligand.,1466,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616589,12953,Hippocampus
,H,BAO_0000221,,Binding affinity for 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as radioligand,1467,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616590,12953,Hippocampus
,H,BAO_0000219,,"In vitro binding affinity against cloned mammalian 5-hydroxytryptamine 1A receptor expressed in CHO cells, by using [3H]8-OH-DPAT as radioligand.",1468,Expert,,8,,,449.0,,,1,CHO,10576,B,,,CHEMBL616591,12903,
,H,BAO_0000357,,Displacement of the radioligand [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor,1469,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616592,12536,
,H,BAO_0000357,,The inhibition activity of 5-HT1A at 1 uM,1470,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616593,10058,
,H,BAO_0000219,,"Binding affinity against 5-hydroxytryptamine 1A receptor from CHO-K1 cells, using [3H]8-OH-DPAT as the radioligand.",1471,Expert,,8,,,485.0,,,1,CHO-K1,10576,B,,,CHEMBL616594,12902,
,H,BAO_0000249,,Binding affinities against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in rat cerebral cortex membrane,1472,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616595,14057,
,H,BAO_0000357,,Compound was evaluated for its ability to displace the protonated form of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding from labeled 5-HT 1A receptor site.,1473,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616596,11296,
,H,BAO_0000221,,Compound was evaluated for its ability to displace the protonated form of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding from labeled 5-hydroxytryptamine 1A receptor site in rat brain hippocampus,1474,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616597,11296,Hippocampus
,H,BAO_0000221,,Ability to displace the protonated form of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding from labeled 5-hydroxytryptamine 1A receptor site in rat brain hippocampus,1475,Expert,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616598,11296,Hippocampus
,D,BAO_0000249,,Antagonist activity to stimulate binding of [35S]-GTP-gamma S binding to 5-hydroxytryptamine 1A receptor in isolated rat hippocampal membranes,1476,Expert,,9,Membranes,,,,10116.0,1,,10576,F,Rattus norvegicus,,CHEMBL616599,16616,
,D,BAO_0000249,,"Inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding in rat hippocampal membranes",1477,Expert,10000000.0,9,Membranes,,,,10116.0,1,,10576,F,Rattus norvegicus,,CHEMBL616600,16616,Hippocampus
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is defined as not -determined.,1478,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616601,16567,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is defined as not defined.,1479,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616602,16567,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is defined as not determined.,1480,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616603,16567,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND means not determined.,1481,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616604,16567,
,H,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 1A receptor was determined in rat cortex membranes using [3H]8-OH-DPAT as radioligand; No data,1482,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616316,17136,
,H,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 1A receptor was determined in rat cortex membranes using [3H]8-OH-DPAT as radioligand; Not determined,1483,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616317,17136,
,D,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenates; ND means No data,1484,Expert,,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616318,16616,
,H,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT from rat hippocampus mambranes,1485,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616319,17331,Hippocampus
,H,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT from rat hippocampus mambranes; Not tested,1486,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616320,17331,Hippocampus
,D,BAO_0000221,,Binding affinity for rat hippocampus 5-hydroxytryptamine 1A receptor by inhibition of [3H]8-OH-DPAT binding; Not tested,1487,Expert,10000000.0,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616321,17167,Hippocampus
,H,BAO_0000019,,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats; Not tested,1488,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL616322,15740,
,H,BAO_0000019,,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats; not tested,1489,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL616323,15740,
,H,BAO_0000357,,Ratio of binding affinity to 5-HT 1A and D2 receptor,1490,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616324,4671,
,H,BAO_0000221,,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus at 1 uM,1491,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616325,10058,Hippocampus
,H,BAO_0000221,,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus at 1 uM,1492,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616326,10058,Hippocampus
,H,BAO_0000221,,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus.,1493,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616327,10058,Hippocampus
,H,BAO_0000357,,Percentage inhibition against 5-hydroxytryptamine 1A receptor,1494,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616328,12073,
,H,BAO_0000249,,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 1),1495,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL858110,2759,
,H,BAO_0000249,,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 1),1496,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL616329,2759,
,H,BAO_0000249,,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 2),1497,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616330,2759,
,H,BAO_0000249,,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 2),1498,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL616331,2759,
,H,BAO_0000249,,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes.,1499,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL616332,2759,
,H,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,1500,Autocuration,955.0,8,,,,,,1,,10576,B,,,CHEMBL857063,9737,Brain
,H,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex using [3H]8-OH-DPAT as a radioligand,1501,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616333,9737,
,H,BAO_0000019,,Antagonistic activity against 5-hydroxytryptamine 1A receptor in rat cerebral cortex using [3H]-8-OH-DPAT as radioligand.,1502,Expert,,8,,,,,,1,,10576,F,,,CHEMBL616334,5717,
,H,BAO_0000221,,Binding affinity of 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in rat hippocampus,1503,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616335,12253,Hippocampus
,H,BAO_0000019,,Affinity pKi for 5-hydroxytryptamine 1A receptor was measured in rat cortex homogenates.,1504,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616336,14025,
,H,BAO_0000249,,Binding affinity against 5-hydroxytryptamine 1A receptor in rat cerebral cortical membrane using [3H]-8-OH-DPAT as radioligand.,1505,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616337,10425,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1A receptor in rat cortex homogenates.,1506,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616338,14998,
,H,BAO_0000221,,Binding affinity against native 5-HT1A-receptors from rat hippocampus using radioligand ([3H]- 8-hydri\oxy-2-(di-n-propylamino)tetraline) binding assay,1507,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616339,13694,Hippocampus
,H,BAO_0000221,,Binding affinity against native 5-HT1A-receptors from rat hippocampus using radioligand ([3H]8-hydroxy-2-(di-n-propylamino)-tetraline) binding assay,1508,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616340,13694,Hippocampus
,H,BAO_0000357,,Binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined,1509,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616341,4342,
,D,BAO_0000357,,Binding affinity against rat 5-hydroxytryptamine 1A receptor,1510,Expert,,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616342,12936,
,D,BAO_0000019,,Inhibition of [3H]2-(di-N-propylamino)-8-hydroxytetralin binding to 5-HT1A receptor of rat frontal cortex homogenates,1511,Expert,,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616343,13144,
,H,BAO_0000019,,Binding affinity of a compound to rat brain 5-hydroxytryptamine 1A (serotonin) receptor assayed by radiolabeled [3H]-8-OH-DPAT ligand displacement,1512,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616344,13343,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand.,1513,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616345,12132,
,H,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat cortex using [3H]8-OH-DPAT as a radioligand,1514,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616346,15419,
,H,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in rat hippocampus,1515,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616347,1479,Hippocampus
,H,BAO_0000019,,In vitro by displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor on rat cortical membrane,1516,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616348,14287,
,H,BAO_0000357,,Binding affinity at 5-hydroxytryptamine 1A receptor,1517,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616349,13116,
,D,BAO_0000249,,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat frontal cortex membranes,1518,Expert,,9,Membranes,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616152,2759,
,H,BAO_0000249,,Compound was tested for inhibition constant against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes.,1519,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616153,2759,
,H,BAO_0000019,,"Binding affinity for rat cortex 5-hydroxytryptamine 1A receptor, by displacement of 0.2 nM [3H]8-OH-DPAT radioligand",1520,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616154,14748,
,H,BAO_0000019,,In vitro ability to inhibit binding of radioligand [3H]8-OH-DPAT to 5-hydroxytryptamine 1A receptor in rat cerebral cortex,1521,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616155,12304,
,D,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat hippocampus using [3H]8-OH-DPAT,1522,Expert,10000000.0,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616156,12409,Hippocampus
,D,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat hippocampus with [3H]8-OH-DPAT,1523,Expert,10000000.0,9,,,,,10116.0,1,,10576,B,Rattus norvegicus,,CHEMBL616157,12409,Hippocampus
,H,BAO_0000221,,The binding affinity (pKi) was measured against 5-hydroxytryptamine 4 receptor of piglet hippocampus using [125I]-SB 207710 as radioligand,1524,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL616158,13267,Hippocampus
,H,BAO_0000357,,The compound was tested for the binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand.,1525,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616159,15194,
,H,BAO_0000357,,pKi value against rat 5-hydroxytryptamine 1A receptor.,1526,Expert,,8,,,,,,1,,10576,B,,,CHEMBL616160,14256,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is define as non-determined.,1527,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616161,16567,
,H,BAO_0000019,,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats; Not tested,1528,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL616162,15740,
,D,BAO_0000357,,Binding affinity was measured against 5-hydroxytryptamine 2A receptor by displacement of [3H]- ketanserin by lysergic acid amides,1529,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL616163,13278,
,H,BAO_0000249,,Inhibition of specific [3H]OH-DPAT binding at 5-hydroxytryptamine 1A receptor in rat hippocampal membranes,1530,Expert,,8,Membranes,,,,,1,,10626,B,,,CHEMBL616164,1970,
,H,BAO_0000221,,Concentration of compound required to inhibit cortical 5-hydroxytryptamine 1A receptor binding sites in rat brain was evaluated,1531,Autocuration,955.0,8,,,,,,1,,10576,B,,,CHEMBL616165,10034,Brain
,H,BAO_0000019,,Inhibitory activity against 5-hydroxytryptamine 1A receptor isolated from rat hippocampus membranes membrane using [3H]5-HT as radioligand in the presence of 10e-6 M ketanserin as 5-HT2 blocker,1532,Autocuration,,8,,,,,10116.0,1,,51,B,Rattus norvegicus,,CHEMBL616355,13348,
,H,BAO_0000019,,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 50 uM 5-HT.,1533,Autocuration,,8,,,,,,1,,10576,F,,,CHEMBL616356,13630,
,H,BAO_0000221,,Binding affinity at 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in rat brain.,1534,Autocuration,955.0,8,,,,,,1,,10576,B,,,CHEMBL616357,10862,Brain
,H,BAO_0000019,,"Binding affinity against 5-hydroxytryptamine 1A receptor in homogenated rat brain tissue, using by [3H]8-OH-DPAT as radioligand",1535,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL616358,12058,
,H,BAO_0000357,,Compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor,1536,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616359,4639,
,H,BAO_0000357,,Percent decrease in 5-hydroxytryptamine 1A receptor binding using 8-OH-DPAT,1537,Expert,,8,,,,,,1,,51,B,,,CHEMBL616360,15453,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor,1538,Expert,,8,,,,,,1,,51,B,,,CHEMBL616361,4820,
,H,BAO_0000357,,Tested for binding affinity for 5-hydroxytryptamine 1A receptor,1539,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616362,1089,
,H,BAO_0000249,,The compound was evaluated for its ability to displace [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in cellular brain membranes,1540,Autocuration,,8,Brain membranes,,,,,1,,51,B,,,CHEMBL616363,386,
,H,BAO_0000357,,Inhibition of binding towards 5-hydroxytryptamine 1A receptor at 100 nM concentration,1541,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616364,6011,
,H,BAO_0000357,,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1A receptor,1542,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616365,5014,
,H,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1A receptor determined using [3H]8-OH-DPAT as radioligand,1543,Expert,,8,,,,,,1,,51,B,,,CHEMBL616366,4402,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor,1544,Expert,,8,,,,,,1,,51,B,,,CHEMBL872906,17066,
,H,BAO_0000357,,Binding affinity of compound towards serotonin 5-hydroxytryptamine 1A receptor; inactive at 10 uM,1545,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616367,17515,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1A receptor,1546,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616368,2474,
,H,BAO_0000357,,Binding affinity to 5-hydroxytryptamine 1A receptor was determined,1547,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616369,4775,
,D,BAO_0000357,,Binding affinity towards Serotonin 5-hydroxytryptamine 1A receptor by displacement of [3H]-(+)-8-OH-DPAT.,1548,Expert,,9,,,,,9606.0,1,,51,B,Homo sapiens,,CHEMBL616370,14294,
,D,BAO_0000357,,Binding affinity towards Serotonin 5-hydroxytryptamine 1A receptor by displacement of [3H](+)-8-OH-DPAT; inactive,1549,Expert,,9,,,,,9606.0,1,,51,B,Homo sapiens,,CHEMBL616371,14294,
,H,BAO_0000219,,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,1550,Autocuration,,8,,,449.0,,,1,CHO,51,B,,,CHEMBL616372,12249,
,H,BAO_0000219,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor expressed in CHO cell membranes,1551,Expert,,8,,,,,,1,,51,B,,,CHEMBL616373,11376,
,H,BAO_0000218,,Compound was measured in vivo for its binding affinity at 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,1552,Autocuration,,8,,In vivo,,,,1,,51,B,,,CHEMBL616374,2474,
,H,BAO_0000221,,Tested for activity against 5-hydroxytryptamine 1A receptor from bovine hippocampus,1553,Autocuration,10000000.0,8,,,,,,1,,51,B,,,CHEMBL616375,13311,Hippocampus
,H,BAO_0000357,,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1A receptor was determined,1554,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616376,4373,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT.,1555,Expert,,8,,,,,,1,,51,B,,,CHEMBL857064,1633,
,H,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1A receptor was determined,1556,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616377,11866,
,H,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1A receptor was determined,1557,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616378,4373,
,H,BAO_0000357,,Evaluated for the binding affinity to 5-hydroxytryptamine 1A receptor,1558,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616379,4687,
,H,BAO_0000357,,Ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor,1559,Autocuration,,8,,,,,,1,,11863,B,,,CHEMBL616380,16946,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT radioligand,1560,Autocuration,,8,,,,,,1,,11863,B,,,CHEMBL616381,13291,
,H,BAO_0000357,,Compound was evaluated for the affinity at 5-hydroxytryptamine 1A receptor,1561,Autocuration,,8,,,,,,1,,11863,B,,,CHEMBL616382,14159,
,H,BAO_0000357,,Compound was tested for the binding affinity against 5-hydroxytryptamine 1A receptor by using [3H]DPAT as radioligand,1562,Autocuration,,8,,,,,,1,,11863,B,,,CHEMBL616383,10812,
,D,BAO_0000219,,In vitro binding affinity against 5-hydroxytryptamine 1A receptor in CHO cells,1563,Expert,,9,,,449.0,,10090.0,1,CHO,11863,B,Mus musculus,,CHEMBL616350,3032,
,H,BAO_0000357,,Inhibition of 5-OH-DPAT binding to 5-hydroxytryptamine 1A receptor,1564,Autocuration,,8,,,,,,1,,11863,B,,,CHEMBL616351,16655,
,H,BAO_0000357,,Inhibitory activity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand at 10e-5 M concentration,1565,Autocuration,,8,,,,,,1,,11863,B,,,CHEMBL616352,14532,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1A receptor,1566,Autocuration,,8,,,,,,1,,11863,B,,,CHEMBL616353,13944,
,H,BAO_0000357,,Binding affinity against serotonergic 5-HT1a receptor,1567,Autocuration,,8,,,,,,1,,11863,B,,,CHEMBL616354,13033,
,H,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1A receptor was determined by using [3H]8-OH-DPAT as radioligand,1568,Autocuration,,8,,,,,,1,,11863,B,,,CHEMBL616508,10321,
,D,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1A receptor,1569,Expert,,9,,,,,10090.0,1,,11863,B,Mus musculus,,CHEMBL616559,2968,
,H,BAO_0000357,,Binding affinity at 5-hydroxytryptamine 1A receptor,1570,Autocuration,,8,,,,,,1,,11863,B,,,CHEMBL616560,13964,
,H,BAO_0000357,,"Binding affinity towards 5-hydroxytryptamine 1A receptor receptor, using [3H]5-HT as radioligand.",1571,Autocuration,,8,,,,,,1,,11863,B,,,CHEMBL616561,15527,
,H,BAO_0000219,,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,1572,Autocuration,,8,,,449.0,,,1,CHO,11863,B,,,CHEMBL616562,12248,
,H,BAO_0000219,,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,1573,Autocuration,,8,,,449.0,,,1,CHO,11863,B,,,CHEMBL616563,12249,
,H,BAO_0000357,,Compound was tested for binding affinity using [3H]8-OH-DPAT against 5-hydroxytryptamine 1A receptor,1574,Autocuration,,8,,,,,,1,,11863,B,,,CHEMBL616564,15120,
,H,BAO_0000357,,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by using [3H]-8-OH-DPAT as radioligand,1575,Autocuration,,8,,,,,,1,,11863,B,,,CHEMBL616565,13313,
,H,BAO_0000218,,In vivo binding affinity was evaluated against 5-hydroxytryptamine 1A receptor,1576,Autocuration,,8,,,,,,1,,11863,B,,,CHEMBL616566,2613,
,H,BAO_0000357,,The binding affinity towards 5-hydroxytryptamine 1A receptor; No affinity,1577,Autocuration,,8,,,,,,1,,11863,B,,,CHEMBL616989,16700,
,H,BAO_0000357,,Ability to displace [125I]iodosulpiride from 5-hydroxytryptamine 1A receptor,1578,Autocuration,,8,,,,,,1,,11863,B,,,CHEMBL857975,2201,
,D,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1A receptor,1579,Expert,,9,,,,,10090.0,1,,11863,B,Mus musculus,,CHEMBL616990,1274,
,H,BAO_0000357,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 1A receptor using radioligand binding assay,1580,Autocuration,,8,,,,,,1,,11863,B,,,CHEMBL616991,1317,
,H,BAO_0000357,,Tested against 5-hydroxytryptamine 1A receptor,1581,Autocuration,,8,,,,,,1,,11863,B,,,CHEMBL616992,12146,
,H,BAO_0000357,,The compound's binding affinity against 5-hydroxytryptamine 1A receptor,1582,Autocuration,,8,,,,,,1,,11863,B,,,CHEMBL616993,14059,
,H,BAO_0000019,,Dissociation equilibrium constant against the vascular 5-hydroxytryptamine 1B like receptor in the rabbit saphenous vein,1583,Expert,,8,,,,,9986.0,1,,106,B,Oryctolagus cuniculus,,CHEMBL616994,14025,
,H,BAO_0000019,,The dissociation equilibrium constant (pKB=-log KB) of compound was determined against the vascular 5-hydroxytryptamine 1B like receptor in the rabbit saphenous vein(RbSV); NS=non surmountable,1584,Autocuration,,8,,,,,9986.0,1,,106,B,Oryctolagus cuniculus,,CHEMBL616995,14025,
,D,BAO_0000219,,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1B receptor from cloned gorilla membranes expressed in cultured HEK 293 cells,1585,Intermediate,,9,,,722.0,,9593.0,1,HEK293,105571,B,Gorilla gorilla,,CHEMBL616996,14447,
,H,BAO_0000218,,5-HT1B agonist potency was evaluated as effective dose that induced hypothermia in the guinea-pig upon intraperitoneal administration,1586,Autocuration,,8,,In vivo,,,10141.0,1,,106,F,Cavia porcellus,,CHEMBL616997,3025,
,H,BAO_0000218,,5-hydroxytryptamine 1B receptor agonist potency was evaluated as effective dose that induced hypothermia in the guinea-pig upon intraperitoneal administration,1587,Autocuration,,8,,In vivo,,,10141.0,1,,106,F,Cavia porcellus,,CHEMBL616998,3025,
,H,BAO_0000019,,Affinity of compound towards 5-hydroxytryptamine 1B receptor in isolated guinea-pig iliac artery,1588,Autocuration,,8,,,,,10141.0,1,,106,F,Cavia porcellus,,CHEMBL616999,15329,
,H,BAO_0000019,,Affinity of compound towards 5-hydroxytryptamine 1B receptor in isolated guinea-pig iliac artery; n.d. indicates Not determined,1589,Autocuration,,8,,,,,10141.0,1,,106,F,Cavia porcellus,,CHEMBL617000,15329,
,H,BAO_0000019,,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 1B receptor of guinea pig,1590,Autocuration,,8,,,,,10141.0,1,,106,F,Cavia porcellus,,CHEMBL617001,15847,
,H,BAO_0000019,,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 1B receptor of guinea pig; ND means not done,1591,Autocuration,,8,,,,,10141.0,1,,106,F,Cavia porcellus,,CHEMBL858111,15847,
,H,BAO_0000019,,Intrinsic activity for Antagonism of 5-hydroxytryptamine 1B receptor-mediated stimulation of [35S]GTP gamma S binding,1592,Autocuration,,8,,,,,,1,,106,F,,,CHEMBL617002,14165,
,H,BAO_0000019,,Antagonism tested at 1 uM against the agonist-induced inhibitory effect of 10 nM 5-carbamoyltryptamine (5-CT),1593,Autocuration,,8,,,,,,1,,106,F,,,CHEMBL617003,14214,
,H,BAO_0000019,,Antagonism tested at 1 uM against the agonist-induced inhibitory effect of 10 nM 5-carbamoyltryptamine(5-CT),1594,Autocuration,,8,,,,,,1,,106,F,,,CHEMBL617004,14214,
,D,BAO_0000019,,Agonist activity at 5-hydroxytryptamine 1B receptor by measuring the inhibition of forskolin-stimulated cAMP formation,1595,Expert,,9,,,,,9606.0,1,,106,F,Homo sapiens,,CHEMBL617005,14214,
,D,BAO_0000219,,Inhibition of forskolin-stimulated c-AMP formation by human 5-hydroxytryptamine 1B receptor expressed in CHO-K1 cells,1596,Expert,,9,,,485.0,,9606.0,1,CHO-K1,106,F,Homo sapiens,,CHEMBL616623,13729,
,H,BAO_0000219,,Effective concentration determined by measuring inhibition of forskolin-stimulated c-AMP formation at 5-hydroxytryptamine 1B receptor stably transfected in CHO cell lines,1597,Autocuration,,8,,,449.0,,,1,CHO,106,F,,,CHEMBL616624,3025,
,H,BAO_0000357,,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor,1598,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL883243,2391,
,H,BAO_0000019,,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; full agonist,1599,Autocuration,,8,,,,,,1,,106,F,,,CHEMBL616625,2391,
,H,BAO_0000219,,"Agonist-induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with human 5-hydroxytryptamine 1B receptor",1600,Expert,,8,,,449.0,,,1,CHO,106,F,,,CHEMBL616626,14956,
,H,BAO_0000219,,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line,1601,Autocuration,,8,,,449.0,,,1,CHO,106,F,,,CHEMBL616627,2598,
,H,BAO_0000219,,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Antagonist,1602,Autocuration,,8,,,449.0,,,1,CHO,106,F,,,CHEMBL616628,2598,
,H,BAO_0000219,,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Full Agonist,1603,Autocuration,,8,,,449.0,,,1,CHO,106,F,,,CHEMBL616629,2598,
,H,BAO_0000219,,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Partial Agonist,1604,Autocuration,,8,,,449.0,,,1,CHO,106,F,,,CHEMBL616630,2598,
,H,BAO_0000019,,"Efficacy was evaluated relative to human 5-HT1B receptor using [35S]GTP-gamma-S, as radioligand",1605,Expert,,8,,,,,,1,,106,F,,,CHEMBL616631,14956,
,H,BAO_0000019,,"Efficacy of compound was evaluated relative to human 5-hydroxytryptamine 1B receptor using [35S]GTP-gamma-S, as radioligand",1606,Autocuration,,8,,,,,,1,,106,F,,,CHEMBL616632,14956,
,D,BAO_0000357,,Percentage Maximal inhibition obtained with 1 uM 5-HT against 5-hydroxytryptamine 1B receptor,1607,Expert,,9,,,,,9606.0,1,,106,B,Homo sapiens,,CHEMBL616633,14214,
,H,BAO_0000219,,Ability to displace [3H]5-HT from recombinant human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells determined in vitro,1608,Expert,,8,,,449.0,,,1,CHO,106,B,,,CHEMBL616634,3463,
,H,BAO_0000357,,Affinity of compound towards 5-hydroxytryptamine 1B receptor was evaluated using radioligand binding technique,1609,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616635,15331,
,D,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1B receptor,1610,Expert,,9,,,,,9606.0,1,,106,B,Homo sapiens,,CHEMBL885358,16146,
,D,BAO_0000219,,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1B receptor expressed in CHO cells,1611,Expert,,9,,,449.0,,9606.0,1,CHO,106,B,Homo sapiens,,CHEMBL616636,14159,
,H,BAO_0000219,,Binding affinity to human cloned 5-hydroxytryptamine 1B receptor in CHO cells by [3H]5-HT binding displacement.,1612,Expert,,8,,,449.0,,,1,CHO,106,B,,,CHEMBL616637,14158,
,H,BAO_0000357,,Compound was evaluated for the affinity at 5-hydroxytryptamine 1B receptor,1613,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616638,14159,
,H,BAO_0000219,,Displacement of [3H]5-HT binding to cloned 5-hydroxytryptamine 1B receptor stably expressed in CHO cells,1614,Expert,,8,,,449.0,,,1,CHO,106,B,,,CHEMBL616639,15250,
,H,BAO_0000219,,Binding affinity at cloned human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells by [3H]5-HT displacement.,1615,Expert,,8,,,449.0,,,1,CHO,106,B,,,CHEMBL616640,15250,
,H,BAO_0000219,,Displacement of [3H]5-HT binding from the cloned human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells,1616,Expert,,8,,,449.0,,,1,CHO,106,B,,,CHEMBL616641,15331,
,H,BAO_0000219,,Displacement of [3H]5-HT binding from cloned human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells.,1617,Expert,,8,,,449.0,,,1,CHO,106,B,,,CHEMBL616642,15332,
,H,BAO_0000219,,Displacement of specific [3H]5-HT binding to cloned human 5-hydroxytryptamine 1B receptor expressed in CHO cells,1618,Expert,,8,,,449.0,,,1,CHO,106,B,,,CHEMBL616643,14956,
,H,BAO_0000357,,In vitro binding affinity against human 5-hydroxytryptamine 1B receptor at a concentration of 100 (nM),1619,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616644,3805,
,H,BAO_0000357,,Intrinsic activity for each compound is calculated as a percentage of the 5-hydroxytryptamine 1B receptor response,1620,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616645,14875,
,H,BAO_0000019,,Compound was tested for 5-hydroxytryptamine 1D like receptor-mediated vascular effect in rabbit saphenous vein (RSV),1621,Autocuration,,8,,,,,9986.0,1,,105,F,Oryctolagus cuniculus,,CHEMBL616646,14454,
,H,BAO_0000019,,Tested for 5-hydroxytryptamine 1D like receptor-mediated vascular effect in rabbit saphenous vein (RSV),1622,Expert,,8,,,,,9986.0,1,,105,F,Oryctolagus cuniculus,,CHEMBL616647,14454,
,H,BAO_0000357,,Affinity at 5-hydroxytryptamine 1D receptor (For sumatriptan = Ki (nM)-12+/-1.9),1623,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616509,16288,
,H,BAO_0000357,,Affinity at 5-hydroxytryptamine 1D receptor from calf caudate using [3H]5-HT as radioligand (For sumatriptan = Ki(nM)-12+/-1.9),1624,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616510,16288,
,H,BAO_0000357,,Binding affinity against calf caudate 5-hydroxytryptamine 1D receptor,1625,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616511,16312,
,H,BAO_0000357,,Inhibitory activity against 5-hydroxytryptamine 1D receptor subtype,1626,Expert,,8,,,,,9913.0,1,,105,B,Bos taurus,,CHEMBL616512,1348,
,H,BAO_0000357,,Inhibitory concentration required against 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT,1627,Autocuration,,8,,,,,9913.0,1,,105,B,Bos taurus,,CHEMBL616513,5834,
,H,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1D receptor was determined in calf striatum homogenate,1628,Autocuration,2435.0,8,,,,,9913.0,1,,105,B,Bos taurus,,CHEMBL616514,13366,Striatum
,H,BAO_0000357,,Ability to bind to 5-hydroxytryptamine 1D receptor of calf substantia nigra,1629,Expert,,8,,,,,9913.0,1,,105,B,Bos taurus,,CHEMBL616515,1414,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1D receptor in calf caudate homogenates.,1630,Autocuration,,8,,,,,9913.0,1,,105,B,Bos taurus,,CHEMBL616516,14998,
,H,BAO_0000357,,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]- serotonin as radioligand,1631,Autocuration,,8,,,,,9913.0,1,,105,B,Bos taurus,,CHEMBL616517,11473,
,H,BAO_0000357,,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]- serotonin as radioligand,1632,Autocuration,,8,,,,,9913.0,1,,105,B,Bos taurus,,CHEMBL616518,11473,
,H,BAO_0000357,,Compound was evaluated for its inhibitory activity against 5-hydroxytryptamine 1D receptor of bovine caudate using [3H]5-HT as the radioligand,1633,Autocuration,,8,,,,,9913.0,1,,105,B,Bos taurus,,CHEMBL616519,10639,
,H,BAO_0000357,,Inhibitory activity against 5-hydroxytryptamine 1D receptor of bovine caudate using [3H]5-HT as the radioligand,1634,Autocuration,,8,,,,,9913.0,1,,105,B,Bos taurus,,CHEMBL616520,10639,
,H,BAO_0000357,,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT radioligand,1635,Autocuration,,8,,,,,9913.0,1,,105,B,Bos taurus,,CHEMBL616521,1375,
,H,BAO_0000357,,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT radioligand; NT means not tested,1636,Autocuration,,8,,,,,9913.0,1,,105,B,Bos taurus,,CHEMBL616522,1375,
,H,BAO_0000357,,The binding affinity at 5-hydroxytryptamine 1D receptor was determined using [3H]5-CT; Not tested,1637,Autocuration,,8,,,,,9913.0,1,,105,B,Bos taurus,,CHEMBL884531,16532,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1D receptor using [3H]5-HT as radioligand,1638,Autocuration,,8,,,,,9913.0,1,,105,B,Bos taurus,,CHEMBL616523,11147,
,H,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1D receptor was determined in calf striatum homogenate,1639,Autocuration,2435.0,8,,,,,9913.0,1,,105,B,Bos taurus,,CHEMBL616731,13366,Striatum
,H,BAO_0000019,,Binding affinity was determined against 5-hydroxytryptamine 1D receptor in bovine caudate homogenate,1640,Autocuration,,8,,,,,9913.0,1,,105,B,Bos taurus,,CHEMBL616732,10444,
,H,BAO_0000357,,The binding affinity at 5-hydroxytryptamine 1D receptor was determined using [3H]5-CT,1641,Autocuration,,8,,,,,9913.0,1,,105,B,Bos taurus,,CHEMBL616733,16532,
,H,BAO_0000357,,The binding affinity at 5-hydroxytryptamine 1D receptor was determined using [3H]5-CT; Not tested,1642,Autocuration,,8,,,,,9913.0,1,,105,B,Bos taurus,,CHEMBL616734,16532,
,H,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat frontal cortex membranes using [125]ICYP,1643,Autocuration,,8,,,,,9913.0,1,,105,B,Bos taurus,,CHEMBL616735,12827,
,H,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat frontal cortex membranes using [125]ICYP; Not determined,1644,Autocuration,,8,,,,,9913.0,1,,105,B,Bos taurus,,CHEMBL616736,12827,
,H,BAO_0000019,,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,1645,Expert,,8,,,,,9913.0,1,,105,F,Bos taurus,,CHEMBL616737,12919,
,H,BAO_0000019,,Affinity pKi for 5-hydroxytryptamine 1D receptor was measured in calf caudate homogenate,1646,Autocuration,,8,,,,,9913.0,1,,105,B,Bos taurus,,CHEMBL616738,14025,
,H,BAO_0000019,,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,1647,Expert,,8,,,,,9913.0,1,,105,F,Bos taurus,,CHEMBL616739,12919,
,H,BAO_0000019,,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,1648,Expert,,8,,,,,9913.0,1,,105,F,Bos taurus,,CHEMBL616740,12919,
,H,BAO_0000019,,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,1649,Expert,,8,,,,,9913.0,1,,105,F,Bos taurus,,CHEMBL616741,12919,
,H,BAO_0000219,,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1D receptor from cloned gorilla membranes expressed in cultured HEK 293 cells,1650,Autocuration,,8,,,722.0,,9593.0,1,HEK293,105,B,Gorilla gorilla,,CHEMBL616742,14447,
,D,BAO_0000019,,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor in guinea pig substantia nigra,1651,Intermediate,,9,,,,,10141.0,1,,105570,B,Cavia porcellus,,CHEMBL616743,1375,
,D,BAO_0000019,,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor in guinea pig substantia nigra; NT means not tested,1652,Intermediate,,9,,,,,10141.0,1,,105570,B,Cavia porcellus,,CHEMBL616744,1375,
,D,BAO_0000019,,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptor by the agonist GR-46611,1653,Intermediate,,9,,,,,10141.0,1,,105570,F,Cavia porcellus,,CHEMBL616745,12409,
,D,BAO_0000019,,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,1654,Intermediate,,9,,,,,10141.0,1,,105570,F,Cavia porcellus,,CHEMBL616746,12409,
,D,BAO_0000019,,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611; range is 2-9,1655,Intermediate,,9,,,,,10141.0,1,,105570,F,Cavia porcellus,,CHEMBL616747,12409,
,D,BAO_0000019,,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611;range is 0.2-0.4,1656,Intermediate,,9,,,,,10141.0,1,,105570,F,Cavia porcellus,,CHEMBL616748,12409,
,D,BAO_0000019,,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611;range is 0.2-1.2,1657,Intermediate,,9,,,,,10141.0,1,,105570,F,Cavia porcellus,,CHEMBL616648,12409,
,D,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1D receptor,1658,Intermediate,,9,,,,,10141.0,1,,105570,B,Cavia porcellus,,CHEMBL616649,11574,
,D,BAO_0000357,,Binding affinity towards guinea pig 5-hydroxytryptamine 1D receptor was determined,1659,Intermediate,,9,,,,,10141.0,1,,105570,B,Cavia porcellus,,CHEMBL616650,1558,
,D,BAO_0000218,,Compound at 3 mg/kg was tested for the inhibition of hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,1660,Intermediate,,9,,,,,10141.0,1,,105570,F,Cavia porcellus,,CHEMBL616651,12409,
,D,BAO_0000218,,Compound at 45 mg/kg was tested for the inhibition of hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,1661,Intermediate,,9,,,,,10141.0,1,,105570,F,Cavia porcellus,,CHEMBL616652,12409,
,D,BAO_0000218,,Compound at 50 mg/kg was tested for the inhibition of hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,1662,Intermediate,,9,,,,,10141.0,1,,105570,F,Cavia porcellus,,CHEMBL616653,12409,
,D,BAO_0000218,,Compound at oral dose of 45 mg/kg was tested for percent inhibition against 5-hydroxytryptamine 1D receptor causes hypothermia in guinea pig,1663,Intermediate,,9,,,,,10141.0,1,,105570,F,Cavia porcellus,,CHEMBL616654,12409,
,D,BAO_0000019,,Binding affinity of 5-hydroxytryptamine 1D receptor using [3H]-8-HT in guinea pig cortex,1664,Intermediate,,9,,,,,10141.0,1,,105570,B,Cavia porcellus,,CHEMBL616655,12253,
,D,BAO_0000357,,Binding affinity against guinea pig 5-hydroxytryptamine 1D receptor,1665,Intermediate,,9,,,,,10141.0,1,,105570,B,Cavia porcellus,,CHEMBL616656,12936,
,H,BAO_0000019,,Binding affinity was determined against 5-hydroxytryptamine 4 receptor using [125I]SB 207710 as radioligand from piglet hippocampal membranes,1666,Autocuration,,8,,,,,10141.0,1,,105,B,Cavia porcellus,,CHEMBL616657,13181,
,D,BAO_0000357,,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor in guinea-pig striatum in presence of BMY-7378 and mesulergine,1667,Intermediate,2435.0,9,,,,,10141.0,1,,105570,B,Cavia porcellus,,CHEMBL616658,12409,Striatum
,D,BAO_0000357,,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1D receptor of guinea pig substantia nigra,1668,Intermediate,,9,,,,,10141.0,1,,105570,B,Cavia porcellus,,CHEMBL616659,10639,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1D receptor,1669,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL616660,5254,
,H,BAO_0000357,,The compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor beta,1670,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616661,13051,
,H,BAO_0000019,,Maximum stimulation of [35S]GTP gamma-S binding expressed relative to the maximal effect produced by 5-hydroxytryptamine 1D receptor,1671,Expert,,8,,,,,,1,,105,F,,,CHEMBL616662,3463,
,H,BAO_0000019,,Ability to inhibit forskolin-stimulated adenylate cyclase in a cell line expressing human 5-hydroxytryptamine 1D receptor,1672,Autocuration,,8,,,,,,1,,105,F,,,CHEMBL616663,15315,
,H,BAO_0000019,,Ability to inhibit forskolin-stimulated adenylate cyclase activity in Chinese hamster ovary (CHO) stable cell lines expressing human 5-hydroxytryptamine 1D receptor,1673,Autocuration,,8,,,,,,1,,105,F,,,CHEMBL616664,6011,
,D,BAO_0000219,,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing 5-hydroxytryptamine 1D receptor",1674,Expert,,9,,,449.0,,9606.0,1,CHO,105,F,Homo sapiens,,CHEMBL881820,14159,
,H,BAO_0000219,,"Compound was evaluated for the stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the 5-hydroxytryptamine 1D receptor.",1675,Autocuration,,8,,,449.0,,,1,CHO,105,F,,,CHEMBL616665,14159,
,H,BAO_0000219,,Agonist-induced [35S]- GTPgammaS binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor,1676,Expert,,8,,,449.0,,,1,CHO,105,B,,,CHEMBL616666,15250,
,H,BAO_0000219,,Compound was tested for measuring agonist-induced [35S]- GTPgammaS binding in CHO cells stably transfected with human 5-hydroxytryptamine 1D receptor,1677,Autocuration,,8,,,449.0,,,1,CHO,105,B,,,CHEMBL616667,15250,
,H,BAO_0000219,,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the 5-hydroxytryptamine 1D receptor",1678,Expert,,8,,,449.0,,,1,CHO,105,F,,,CHEMBL616668,15331,
,D,BAO_0000219,,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the 5-hydroxytryptamine 1D receptor",1679,Expert,,9,,,449.0,,9606.0,1,CHO,105,F,Homo sapiens,,CHEMBL616669,15332,
,H,BAO_0000219,,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the human 5-hydroxytryptamine 1D receptor.",1680,Expert,,8,,,449.0,,,1,CHO,105,F,,,CHEMBL617040,15332,
,H,BAO_0000219,,"Measurement of agonist induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor",1681,Autocuration,,8,,,449.0,,,1,CHO,105,F,,,CHEMBL617041,3294,
,H,BAO_0000219,,"Measurement of agonist induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor.",1682,Expert,,8,,,449.0,,,1,CHO,105,F,,,CHEMBL617042,14158,
,H,BAO_0000219,,"Agonist-induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with human 5-hydroxytryptamine 1D receptor",1683,Expert,,8,,,449.0,,,1,CHO,105,F,,,CHEMBL617043,14956,
,H,BAO_0000019,,Compound was evaluated for its agonistic activity on 5-hydroxytryptamine 1D receptor,1684,Autocuration,,8,,,,,,1,,105,F,,,CHEMBL617044,12469,
,H,BAO_0000219,,Measurement of agonist-induced [35S]-GTP gamma-S binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor,1685,Expert,,8,,,449.0,,,1,CHO,105,F,,,CHEMBL617045,3463,
,D,BAO_0000219,,"Maximum stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing human 5-HT-1d relative to 5-HT",1686,Expert,,9,,,449.0,,9606.0,1,CHO,105,F,Homo sapiens,,CHEMBL617046,15250,
,D,BAO_0000219,,"Maximum stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing human 5-HT-1d relative to 5-HT",1687,Expert,,9,,,449.0,,9606.0,1,CHO,105,F,Homo sapiens,,CHEMBL617047,15250,
,H,BAO_0000019,,"Efficacy was evaluated relative to human 5-hydroxytryptamine 1D receptor using [35S]GTP-gamma-S, as radioligand",1688,Expert,,8,,,,,,1,,105,F,,,CHEMBL617048,14956,
,H,BAO_0000019,,"Maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect produced by 5-hydroxytryptamine 1D receptor.",1689,Autocuration,,8,,,,,,1,,105,F,,,CHEMBL616897,14159,
,D,BAO_0000019,,"Maximum stimulation of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1D receptor relative to 5-HT",1690,Expert,,9,,,,,9606.0,1,,105,F,Homo sapiens,,CHEMBL616898,14159,
,D,BAO_0000219,,Percent efficacy relative to 5-HT treatment of CHO cells expressing 5-HT 1d receptor,1691,Expert,,9,,,449.0,,9606.0,1,CHO,105,F,Homo sapiens,,CHEMBL858201,14499,
,H,BAO_0000019,,Intrinsic activity for 5-hydroxytryptamine 1D receptor,1692,Autocuration,,8,,,,,,1,,105,F,,,CHEMBL616899,15315,
,H,BAO_0000219,,Ability to displace [3H]- -5-HT binding to cloned 5-hydroxytryptamine 1D receptor stably expressed in chinese hamster cells (CHO cells),1693,Autocuration,,8,,In vitro,,,,1,,105,B,,,CHEMBL616900,3294,
,H,BAO_0000219,,Ability to displace [3H]-5-HT from recombinant human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells determined in vitro,1694,Expert,,8,,,449.0,,,1,CHO,105,B,,,CHEMBL616901,3463,
,H,BAO_0000357,,Affinity of compound towards 5-hydroxytryptamine 1D receptor was evaluated using radioligand binding technique,1695,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616902,15331,
,D,BAO_0000219,,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1D receptor expressed in CHO cells,1696,Expert,,9,,,449.0,,9606.0,1,CHO,105,B,Homo sapiens,,CHEMBL616903,14159,
,H,BAO_0000219,,Binding affinity by displacement to human cloned 5-hydroxytryptamine 1D receptor in CHO cells by [3H]5-HT displacement.,1697,Expert,,8,,,449.0,,,1,CHO,105,B,,,CHEMBL616904,14158,
,H,BAO_0000357,,Compound was evaluated for the affinity at 5-hydroxytryptamine 1D receptor,1698,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616905,14159,
,H,BAO_0000219,,Binding affinity at human cloned 5-hydroxytryptamine 1D receptor stably expressed in CHO cells by [3H]5-HT displacement.,1699,Expert,,8,,,449.0,,,1,CHO,105,B,,,CHEMBL616906,15250,
,H,BAO_0000219,,Displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells,1700,Expert,,8,,,449.0,,,1,CHO,105,B,,,CHEMBL616907,15250,
,H,BAO_0000219,,Displacement of [3H]5-HT binding from the cloned human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells,1701,Expert,,8,,,449.0,,,1,CHO,105,B,,,CHEMBL616908,15331,
,D,BAO_0000219,,Displacement of [3H]5-HT binding from human 5-hydroxytryptamine 1D receptor expressed in CHO cells,1702,Expert,,9,,,449.0,,9606.0,1,CHO,105,B,Homo sapiens,,CHEMBL616909,15332,
,D,BAO_0000219,,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1D receptor expressed in CHO cells,1703,Expert,,9,,,449.0,,9606.0,1,CHO,105,B,Homo sapiens,,CHEMBL616910,14499,
,H,BAO_0000219,,Displacement of [3H]5-HT binding to the cloned human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells,1704,Expert,,8,,,449.0,,,1,CHO,105,B,,,CHEMBL616911,15332,
,H,BAO_0000219,,Displacement of specific [3H]5-HT binding to cloned human 5-hydroxytryptamine 1D receptor expressed in CHO cells,1705,Expert,,8,,,449.0,,,1,CHO,105,B,,,CHEMBL616912,14956,
,H,BAO_0000357,,In vitro binding affinity against human 5-hydroxytryptamine 1D receptor at a concentration of 100 (nM),1706,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616913,3805,
,D,BAO_0000219,,Inhibition of [3H]5-HT binding to human 5-hydroxytryptamine 1D receptor expressed in CHO cells at 1 uM,1707,Expert,,9,,,449.0,,9606.0,1,CHO,105,B,Homo sapiens,,CHEMBL616914,6011,
,H,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as radioligand,1708,Autocuration,,8,,,449.0,,,1,CHO,105,B,,,CHEMBL616915,16190,
,H,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 1D receptor in Cos-7 transfected cell type using [3H]5-CT as radioligand,1709,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616916,14165,
,D,BAO_0000357,,Binding affinity to cloned human 5-hydroxytryptamine 1D receptor,1710,Expert,,9,,,,,9606.0,1,,105,B,Homo sapiens,,CHEMBL616917,4234,
,H,BAO_0000357,,"Binding affinity towards 5-HT1D receptor, using [3H]5-HT as radioligand.",1711,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616918,15527,
,H,BAO_0000219,,Binding affinity towards human 5-hydroxytryptamine 1D receptor in L-M(tk-) cells using [3H]GR-125743 as radioligand,1712,Expert,,8,,,,,,1,,105,B,,,CHEMBL616919,6328,
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1D receptor was determined using [3H]5-HT as radioligand,1713,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616920,16209,
,H,BAO_0000357,,Binding affinity for recombinant human 5-hydroxytryptamine 1D receptor using [3H]5-HT as radioligand.,1714,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL872914,14770,
,H,BAO_0000357,,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1D receptor using [3H]-5-CT as radioligand,1715,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616921,2598,
,H,BAO_0000357,,Binding affinity was evaluated at the cloned human 5-hydroxytryptamine 1D receptor,1716,Expert,,8,,,,,,1,,105,B,,,CHEMBL616922,6897,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1D receptor,1717,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616923,6013,
,H,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor,1718,Expert,,8,,,,,,1,,105,B,,,CHEMBL616924,5843,
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1D receptor using [3H]5-HT trifluoroacetate as radioligand,1719,Expert,,8,,,,,,1,,105,B,,,CHEMBL875909,14454,
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1D receptor using [3H]5-HT trifluoroacetate as radioligand; Not determined,1720,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616925,14454,
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1D receptor using [3H]5-HT trifluoroacetate as radioligand; not determined,1721,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616926,14454,
,H,BAO_0000357,,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 1D receptor,1722,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616927,15818,
,H,BAO_0000219,,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1D receptor in CHO-K1 cells,1723,Expert,,8,,,485.0,,,1,CHO-K1,105,F,,,CHEMBL616928,13729,
,D,BAO_0000219,,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1D receptor expressed in Chinese hamster ovary cells (CHO cells),1724,Expert,,9,,In vitro,,,9606.0,1,,105,B,Homo sapiens,,CHEMBL616929,6011,
,D,BAO_0000357,,In vitro binding affinity to human 5-hydroxytryptamine 1D receptor,1725,Expert,,9,,,,,9606.0,1,,105,B,Homo sapiens,,CHEMBL616930,4234,
,H,BAO_0000019,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1D receptor,1726,Expert,,8,,,,,,1,,105,B,,,CHEMBL616931,17085,
,H,BAO_0000357,,In vitro binding affinity was determined towards cloned human 5-hydroxytryptamine 1D receptor using [3H]5-CT radioligand,1727,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616932,3025,
,H,BAO_0000357,,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1D receptor,1728,Expert,,8,,,,,,1,,105,B,,,CHEMBL616933,15315,
,D,BAO_0000219,,Receptor binding affinity for cloned human 5-hydroxytryptamine 1D receptor in Cos-7 cells,1729,Expert,,9,,,,,9606.0,1,,105,B,Homo sapiens,,CHEMBL616934,14214,
,D,BAO_0000357,,Binding affinity for human 5-hydroxytryptamine 1D receptor,1730,Expert,,9,,,,,9606.0,1,,105,B,Homo sapiens,,CHEMBL616935,3804,
,H,BAO_0000357,,The binding affinity towards the 5-hydroxytryptamine 1D receptor; No affinity,1731,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616936,16700,
,D,BAO_0000357,,Affinity for 5-hydroxytryptamine 1D receptor subtype,1732,Expert,,9,,,,,9606.0,1,,105,B,Homo sapiens,,CHEMBL616937,2391,
,D,BAO_0000357,,Binding affinity for human 5-hydroxytryptamine 1D receptor,1733,Expert,,9,,,,,9606.0,1,,105,B,Homo sapiens,,CHEMBL616938,4175,
,H,BAO_0000019,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1D receptor,1734,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616939,17085,
,H,BAO_0000019,,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1D receptor; ND means not determined,1735,Expert,,8,,,,,,1,,105,B,,,CHEMBL616940,17085,
,D,BAO_0000357,,Binding activity against human 5-hydroxytryptamine 1D receptor; NT means not tested,1736,Expert,,9,,,,,9606.0,1,,105,B,Homo sapiens,,CHEMBL616941,15926,
,H,BAO_0000219,,Binding affinity in CHO-K1 cells transfected with human 5-hydroxytryptamine 1D receptor; Not tested,1737,Autocuration,,8,,,485.0,,,1,CHO-K1,105,B,,,CHEMBL616942,16312,
,H,BAO_0000219,,Binding affinity in CHO-K1 cells transfected with human 5-hydroxytryptamine 1D receptor; not tested,1738,Autocuration,,8,,,485.0,,,1,CHO-K1,105,B,,,CHEMBL616943,16312,
,H,BAO_0000219,,Selectivity towards 5-HT1D and to that of 5-HT1B in CHO cells,1739,Autocuration,,4,,,449.0,,,1,CHO,104802,B,,,CHEMBL616944,14956,
,H,BAO_0000019,,"Maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect produced by the 5-HT",1740,Autocuration,,8,,,,,,1,,105,F,,,CHEMBL616945,3294,
,H,BAO_0000357,,Binding activity radioligand.,1741,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616946,12861,
,H,BAO_0000019,,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,1742,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616947,12861,
,H,BAO_0000219,,Binding affinity in CHO-K1 cells transfected with human 5-hydroxytryptamine 1D receptor,1743,Expert,,8,,,485.0,,,1,CHO-K1,105,B,,,CHEMBL616948,16312,
,H,BAO_0000357,,Binding affinity for human cloned 5-hydroxytryptamine 1D receptor,1744,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616851,5104,
,H,BAO_0000357,,Binding affinity for human cloned 5-hydroxytryptamine 1D receptor,1745,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616852,5105,
,H,BAO_0000357,,Measured as -log Ka on 5-hydroxytryptamine 1D receptor,1746,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616853,14499,
,D,BAO_0000357,,Binding activity against human 5-hydroxytryptamine 1D receptor,1747,Expert,,9,,,,,9606.0,1,,105,B,Homo sapiens,,CHEMBL616854,15926,
,D,BAO_0000219,,Binding affinity to human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as radioligand,1748,Expert,,9,,,449.0,,9606.0,1,CHO,105,B,Homo sapiens,,CHEMBL616855,4540,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 1D (human cloned receptor) in CHO cells using [3H]-5-HT as radioligand.,1749,Autocuration,,8,,,449.0,,,1,CHO,105,B,,,CHEMBL616856,15779,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 1D (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,1750,Autocuration,,8,,,449.0,,,1,CHO,105,B,,,CHEMBL616857,15779,
,H,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor,1751,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616858,6166,
,H,BAO_0000219,,Binding affinity towards human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as radioligand.,1752,Autocuration,,8,,,449.0,,,1,CHO,105,B,,,CHEMBL616859,15779,
,H,BAO_0000219,,Binding affinity towards human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]-5-HT as radioligand.;ND means no data.,1753,Autocuration,,8,,,449.0,,,1,CHO,105,B,,,CHEMBL616860,15779,
,H,BAO_0000219,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 1D receptor expressed in HEK 293 cells using [3H]LSD as radioligand,1754,Autocuration,,8,,,722.0,,,1,HEK293,105,B,,,CHEMBL616861,17451,
,H,BAO_0000219,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 1D receptor expressed in HEK 293 cells using [3H]LSD as radioligand,1755,Autocuration,,8,,,722.0,,,1,HEK293,105,B,,,CHEMBL616541,17451,
,H,BAO_0000219,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 1D receptor expressed in HEK 293 cells using [3H]LSD as radioligand; Not determined,1756,Autocuration,,8,,,722.0,,,1,HEK293,105,B,,,CHEMBL616542,17451,
,H,BAO_0000219,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as the radioligand,1757,Autocuration,,8,,,449.0,,,1,CHO,105,B,,,CHEMBL616543,4199,
,D,BAO_0000357,,Binding affinity for human 5-hydroxytryptamine 1D receptor,1758,Expert,,9,,,,,9606.0,1,,105,B,Homo sapiens,,CHEMBL616544,14875,
,H,BAO_0000219,,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT,1759,Autocuration,,8,,,449.0,,,1,CHO,105,B,,,CHEMBL616545,15146,
,H,BAO_0000357,,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1D receptor in CHO using [3H]5-HT as a radioligand,1760,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616546,5213,
,H,BAO_0000219,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT.,1761,Autocuration,,8,,,449.0,,,1,CHO,105,B,,,CHEMBL616547,14818,
,H,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1D receptor in CHO cells, using [3H]5-HT as radioligand",1762,Autocuration,,8,,,449.0,,,1,CHO,105,B,,,CHEMBL616548,4829,
,H,BAO_0000019,,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1D receptor at concentration 1 uM,1763,Expert,,8,,,,,,1,,105,F,,,CHEMBL616549,14454,
,H,BAO_0000019,,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1D receptor at concentration 10 uM,1764,Expert,,8,,,,,,1,,105,F,,,CHEMBL616550,14454,
,H,BAO_0000357,,Binding affinity against 5-HT2C receptor,1765,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL857066,5254,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1D receptor,1766,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL616551,5254,
,H,BAO_0000357,,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1B receptor of rat substantia nigra,1767,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616552,10639,
,H,BAO_0000019,,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1B receptor of rat substantia nigra,1768,Autocuration,,8,,,,,,1,,10577,F,,,CHEMBL832876,10639,
,H,BAO_0000019,,"Binding affinity for 5-hydroxytryptamine 1B receptor in rat cortex, striatum and globus pallidus",1769,Expert,,8,,,,,,1,,10577,B,,,CHEMBL616553,12352,
,H,BAO_0000357,,Binding affinity towards 5-HT1B was determined,1770,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616554,9098,
,H,BAO_0000019,,Affinity towards 5-hydroxytryptamine 1B receptor in membranes from rat frontal cortex using [3H]5-HT,1771,Expert,,8,,,,,,1,,10577,B,,,CHEMBL616555,14430,
,H,BAO_0000019,,"Binding affinity to 5-HT1B receptors using rat cortex+striatum + globus pallidus,[3H]-5-OH-tryptamine, and serotonin for NSB",1772,Expert,,8,,,,,,1,,10577,B,,,CHEMBL616556,13657,
,H,BAO_0000019,,"Compound was evaluated for binding affinity on 5-HT1B receptors using rat cortex+striatum+ globus pallidus,[ 3H]-5-OH-tryptamine, and serotonin for NSB.",1773,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616557,13657,
,H,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat frontal cortex using [125I]iodocyanopindolol as radio-ligand.,1774,Expert,,8,,,,,,1,,10577,B,,,CHEMBL616558,15854,
,D,BAO_0000019,,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat cortex using [3H]5-HT,1775,Expert,,9,,,,,10116.0,1,,10577,B,Rattus norvegicus,,CHEMBL616749,10639,
,H,BAO_0000357,,Concentration necessary to achieve half maximal inhibition of [125I]- Iodocyanopindolol binding to 5-hydroxytryptamine 1B receptor at 1 uM,1776,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616750,10025,
,H,BAO_0000357,,"Concentration necessary to achieve half maximal inhibition of [125I]- Iodocyanopindolol, binds to 5-hydroxytryptamine 1B receptor at 1 uM",1777,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616751,10025,
,H,BAO_0000249,,In vitro inhibitory concentration against radioligand [3H]5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatal membrane,1778,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616752,14286,
,H,BAO_0000019,,Inhibition of [3H]-5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatum; Residual radioligand binding higher than 50%,1779,Autocuration,2435.0,8,,,,,,1,,10577,B,,,CHEMBL616753,3651,Striatum
,D,BAO_0000357,,Inhibition of radiolabeled [3H]-5-HT ligand binding to 5-hydroxytryptamine 1B receptor,1780,Expert,,9,,,,,10116.0,1,,10577,B,Rattus norvegicus,,CHEMBL616754,14178,
,H,BAO_0000019,,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat cortex using [3H]5-HT as the radioligand.,1781,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616755,10639,
,H,BAO_0000019,,Inhibitory activity against [3H]5-HT binding to 5-HT1B receptor in rat striatum,1782,Autocuration,2435.0,8,,,,,,1,,10577,B,,,CHEMBL616756,13605,Striatum
,H,BAO_0000019,,Inhibitory concentration required against 5-hydroxytryptamine 1B receptor in rat striatum using [3H]5-HT,1783,Autocuration,2435.0,8,,,,,,1,,10577,B,,,CHEMBL616757,5834,Striatum
,H,BAO_0000357,,compound was measured for affinity against 5-hydroxytryptamine 1B receptor labelled with [3H]5-HT radioligand in striatum tissue,1784,Autocuration,2435.0,8,,,,,,1,,10577,B,,,CHEMBL616758,10922,Striatum
,H,BAO_0000249,,Compound at 10E-5 M was tested in vitro for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatal membrane,1785,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616759,14286,
,H,BAO_0000357,,In vitro binding affinity towards the 5-hydroxytryptamine 1B receptor at 10 e-6 M,1786,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616760,11825,
,H,BAO_0000019,,Ability to displace [3H]5-HT bound to 5-hydroxytryptamine 1B receptor in rat striatum,1787,Autocuration,2435.0,8,,,,,,1,,10577,B,,,CHEMBL616761,14826,Striatum
,H,BAO_0000019,,Binding affinity against 5-HT1B serotonin receptor in rat striatum,1788,Autocuration,2435.0,8,,,,,,1,,10577,B,,,CHEMBL616762,9699,Striatum
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1B receptor in membranes of Rat cerebral cortex,1789,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616763,14423,
,H,BAO_0000357,,Binding affinity at rat 5-hydroxytryptamine 1B receptor by [3H]5-HT displacement.,1790,Expert,,8,,,,,,1,,10577,B,,,CHEMBL872909,10062,
,H,BAO_0000357,,Binding affinity determined in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1B receptor,1791,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616764,10062,
,D,BAO_0000357,,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1B receptor,1792,Expert,,9,,,,,10116.0,1,,10577,B,Rattus norvegicus,,CHEMBL616765,12280,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1B receptor of rat striatum,1793,Autocuration,2435.0,8,,,,,,1,,10577,B,,,CHEMBL616766,15412,Striatum
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1B receptor of rat striatum.,1794,Autocuration,2435.0,8,,,,,,1,,10577,B,,,CHEMBL616767,15412,Striatum
,H,BAO_0000357,,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1B receptor,1795,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616768,10062,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand,1796,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616769,11147,
,H,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat was determined using 50 uL of [125I]ICYP in binding assay,1797,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616770,9547,
,H,BAO_0000019,,Binding affinity was determined against 5-hydroxytryptamine 1B receptor was determined in male Sprague-Dawley rat brain.,1798,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616771,10444,
,H,BAO_0000019,,Binding affinity was measured on 5-hydroxytryptamine 1B receptor in rat striatum labeled with [3H]5-HT,1799,Autocuration,2435.0,8,,,,,,1,,10577,B,,,CHEMBL616772,12469,Striatum
,H,BAO_0000019,,Binding affinity (Ki) to rat cortical membranes at 5-HT1B binding site by using [125 I] ICYP as a radioligand.,1800,Expert,,8,,,,,,1,,10577,B,,,CHEMBL616773,9098,
,H,BAO_0000019,,Compound was evaluated for the binding affinity (Ki) to rat cortical membranes at 5-HT1B binding site by using [125 I] ICYP as a radioligand; ND is no data.,1801,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616774,9098,
,H,BAO_0000357,,Evaluated for binding affinity towards 5-hydroxytryptamine 1B receptor,1802,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616775,9699,
,H,BAO_0000249,,Inhibitory activity against 5-hydroxytryptamine 1B receptor in rat cortical membranes using [3H]5-HT as a radioligand,1803,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616776,10394,
,H,BAO_0000357,,The binding affinity was measured on 5-hydroxytryptamine 1B receptor using [3H]- serotonin as radioligand.,1804,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616777,12092,
,H,BAO_0000357,,The binding affinity towards the receptor rat 5-hydroxytryptamine 1B receptor; No affinity,1805,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616778,16700,
,D,BAO_0000249,,Binding affinity against 5-hydroxytryptamine 1B receptor in rat striatal membranes using [3H]5-HT as radioligand,1806,Expert,,9,,,,,10116.0,1,,10577,B,Rattus norvegicus,,CHEMBL616779,403,
,D,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1B receptor,1807,Expert,,9,,,,,10116.0,1,,10577,B,Rattus norvegicus,,CHEMBL616780,12771,
,H,BAO_0000019,,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1B receptor by displacing [3H]serotonin radioligand in rat cerebral cortex,1808,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616781,11642,
,H,BAO_0000357,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand,1809,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616782,12953,
,H,BAO_0000357,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand.,1810,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616783,12953,
,H,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 1B receptor in rat striatum using [3H]5-HT as radioligand,1811,Expert,2435.0,8,,,,,,1,,10577,B,,,CHEMBL616784,12953,Striatum
,H,BAO_0000357,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand; Nonactive at 10 uM,1812,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616785,12953,
,H,BAO_0000249,,Binding affinity against 5-HT1B receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,1813,Autocuration,955.0,8,,,,,,1,,10577,B,,,CHEMBL857067,9737,Brain
,H,BAO_0000019,,Binding affinity against 5-HT1B receptor in rat frontal cortex using [3H]-5-HT in presence of 0.1 uM [3H]-8-OH-DPAT as a radioligand,1814,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616786,9737,
,H,BAO_0000249,,Binding affinity towards 5-HT1B receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,1815,Autocuration,955.0,8,,,,,,1,,10577,B,,,CHEMBL616787,9737,Brain
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2C receptor of porcine choroid plexus using [3H]mesulergine,1816,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616788,12827,
,H,BAO_0000357,,Ability to displace the radioligand [125I](-)-iodocyanopindolol from rat striatal 5-hydroxytryptamine 1B receptor,1817,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616789,5033,
,D,BAO_0000019,,Displacement of [3H]5-HT from 5-HT1B receptor of rat frontal cortex homogenate,1818,Expert,,9,,,,,10116.0,1,,10577,B,Rattus norvegicus,,CHEMBL616790,9786,
,H,BAO_0000357,,Binding affinity at 5-hydroxytryptamine 1B receptor,1819,Expert,,8,,,,,,1,,10577,B,,,CHEMBL616791,13116,
,H,BAO_0000019,,In vitro binding affinity at 5-hydroxytryptamine 1B receptor in rat striatal muscles using [125I](-)-iodocyanopindolol as the radioligand,1820,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616792,16429,
,D,BAO_0000249,,In vitro binding affinity towards 5-hydroxytryptamine 1B receptor in rat striatal membrane with [125I]- iodocyanopindolol,1821,Expert,,9,,,,,10116.0,1,,10577,B,Rattus norvegicus,,CHEMBL616793,12409,
,H,BAO_0000357,,The compound was tested for the binding affinity against 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand,1822,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616794,15194,
,H,BAO_0000357,,The compound was tested for the binding affinity against 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand.,1823,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL616795,15194,
,H,BAO_0000019,,Binding affinity towards 5-HT2 receptor by the displacement of [3H]-ketanserin] in rat cerebral cortex,1824,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616796,5486,
,H,BAO_0000357,,Compound was tested for binding affinity against 5-hydroxytryptamine 1B receptor,1825,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616797,4639,
,H,BAO_0000249,,The compound was evaluated for its ability to displace [3H]5-HT from 5-hydroxytryptamine 1B receptor in cellular brain membranes,1826,Autocuration,,8,Brain membranes,,,,,1,,106,B,,,CHEMBL616798,386,
,H,BAO_0000357,,Compound was measured for its binding affinity at 5-hydroxytryptamine 1B receptor at a concentration of 100 nM using [125I]CYP as radioligand,1827,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616799,2474,
,H,BAO_0000357,,Inhibition of binding towards 5-hydroxytryptamine 1B receptor at 100 nM concentration,1828,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616800,6011,
,H,BAO_0000357,,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1B receptor,1829,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616801,5014,
,H,BAO_0000357,,Binding affinity of compound towards serotonin 5-hydroxytryptamine 1B receptor; inactive at 10 uM,1830,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616802,17515,
,H,BAO_0000357,,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1B receptor was determined,1831,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616803,4373,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1B receptor by displacement of [3H]5-HT.,1832,Expert,,8,,,,,,1,,106,B,,,CHEMBL857068,1633,
,H,BAO_0000357,,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 1B receptor by displacement of [3H]ketanserin.,1833,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616804,1633,
,H,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1B receptor was determined,1834,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616805,4373,
,H,BAO_0000357,,Evaluated for the binding affinity to 5-hydroxytryptamine 1B receptor,1835,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616806,4687,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1B receptor,1836,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616807,11574,
,H,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1B receptor was determined by using [3H]5-HT as radioligand,1837,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616808,10321,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand.,1838,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616809,15527,
,H,BAO_0000357,,Inhibitory constant against 5-hydroxytryptamine 1B receptor using with [125I]- cyanopindolol radioligand,1839,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616810,17200,
,H,BAO_0000224,,Binding affinity against 5-hydroxytryptamine 1B receptor - 5-hydroxytryptamine 1D receptor using [3H]5-HT as the radioligand.,1840,Autocuration,,4,,,,,,1,,104802,B,,,CHEMBL616811,14423,
,H,BAO_0000357,,Inhibitory concentration required against 5-hydroxytryptamine 1C receptor in bovine choroid plexus using [3H]mesulergine,1841,Autocuration,,8,,,,,9913.0,1,,108,B,Bos taurus,,CHEMBL616812,5834,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1C receptor using [3H]mesulergine as radioligand,1842,Autocuration,,8,,,,,9823.0,1,,108,B,Sus scrofa,,CHEMBL616813,11473,
,H,BAO_0000357,,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1C receptor in pig choroid plexus using [3H]mesulergine as radioligand,1843,Autocuration,,8,,,,,9823.0,1,,108,B,Sus scrofa,,CHEMBL616814,11473,
,H,BAO_0000357,,Compound was evaluated for its inhibitory activity against 5-hydroxytryptamine 1C receptor of pig choroid plexus using [3H]mesulergine as the radioligand,1844,Autocuration,,8,,,,,9823.0,1,,108,B,Sus scrofa,,CHEMBL616815,10639,
,H,BAO_0000357,,inhibitory activity against 5-hydroxytryptamine 1C receptor of pig choroid plexus using [3H]mesulergine as the radioligand,1845,Autocuration,,8,,,,,9823.0,1,,108,B,Sus scrofa,,CHEMBL616816,10639,
,H,BAO_0000357,,Binding affinity of compound towards 5-hydroxytryptamine 1C receptor using [3H]mesulergine (1.2 nM) ligand in choroid Plexus pig was determined,1846,Autocuration,,8,,,,,9823.0,1,,108,B,Sus scrofa,,CHEMBL616817,14331,
,H,BAO_0000357,,Compound was tested in vitro for binding affinity for 5-hydroxytryptamine 1C receptor,1847,Autocuration,,8,,,,,9823.0,1,,108,B,Sus scrofa,,CHEMBL616818,10796,
,H,BAO_0000357,,Evaluated for the binding affinity to porcine choroid plexus at 5-hydroxytryptamine 2C receptor binding site by using [3H]-MES as a radioligand.,1848,Expert,,8,,,,,9823.0,1,,108,B,Sus scrofa,,CHEMBL616819,9098,
,H,BAO_0000357,,Inhibition of [3H]mesulergine binding to 5-hydroxytryptamine 1C receptor of pig choroid Plexus,1849,Expert,,8,,,,,9823.0,1,,108,B,Sus scrofa,,CHEMBL616820,14331,
,H,BAO_0000019,,Displacement of [3H]mesulergine from pig cortex 5-hydroxytryptamine 1C receptor,1850,Expert,,8,,,,,9823.0,1,,108,B,Sus scrofa,,CHEMBL616821,11828,
,H,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1C receptor in piglet choroid plexus using [3H]5-HT,1851,Autocuration,,8,,,,,9823.0,1,,108,B,Sus scrofa,,CHEMBL616822,11866,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1D receptor alpha using rabbit saphenous vein assay.,1852,Autocuration,,8,,,,,9986.0,1,,108,B,Oryctolagus cuniculus,,CHEMBL616823,13047,
,D,BAO_0000357,,Tested for the effect on binding at 5-hydroxytryptamine 1C receptor; No activity,1853,Autocuration,,9,,,,,10116.0,1,,12689,B,Rattus norvegicus,,CHEMBL616824,188,
,D,BAO_0000357,,In vitro binding affinity towards the 5-hydroxytryptamine 1C receptor at 10 e-6 M,1854,Autocuration,,9,,,,,10116.0,1,,12689,B,Rattus norvegicus,,CHEMBL616825,11825,
,D,BAO_0000357,,In vitro binding affinity towards the 5-hydroxytryptamine 1C receptor at 10 e-6 M,1855,Autocuration,,9,,,,,10116.0,1,,12689,B,Rattus norvegicus,,CHEMBL616826,11825,
,D,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1C receptor in rat using [3H]mesulergine as radioligand,1856,Expert,,9,,,,,10116.0,1,,12689,B,Rattus norvegicus,,CHEMBL616827,11624,
,D,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1C receptor using [125 I]-SCH23982 as radioligand in competitive binding assay,1857,Autocuration,,9,,,,,10116.0,1,,12689,B,Rattus norvegicus,,CHEMBL616828,11139,
,D,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1C receptor using [3H]mesulergine as radioligand,1858,Autocuration,,9,,,,,10116.0,1,,12689,B,Rattus norvegicus,,CHEMBL616829,11147,
,D,BAO_0000019,,Binding affinity was determined against 5-hydroxytryptamine 1C receptor was determined in male Sprague-Dawley rat brain.,1859,Autocuration,,9,,,,,10116.0,1,,12689,B,Rattus norvegicus,,CHEMBL616830,10444,
,D,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1C receptor,1860,Expert,,9,,,,,10116.0,1,,12689,B,Rattus norvegicus,,CHEMBL616831,11624,
,D,BAO_0000019,,"Compound was tested for binding affinity towards 5-HT1C (5-HT1C) receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",1861,Autocuration,,9,,,,,10116.0,1,,12689,B,Rattus norvegicus,,CHEMBL616832,11662,
,D,BAO_0000019,,"Compound was tested for binding affinity towards 5-hydroxytryptamine 1C receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",1862,Autocuration,,9,,,,,10116.0,1,,12689,B,Rattus norvegicus,,CHEMBL616833,11662,
,D,BAO_0000019,,"Binding affinity towards 5-hydroxytryptamine 1C receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",1863,Expert,,9,,,,,10116.0,1,,12689,B,Rattus norvegicus,,CHEMBL616834,11662,
,D,BAO_0000019,,"Compound was tested for binding affinity towards 5-hydroxytryptamine 1C receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",1864,Autocuration,,9,,,,,10116.0,1,,12689,B,Rattus norvegicus,,CHEMBL829595,11662,
,D,BAO_0000357,,Evaluated for the binding affinity to porcine choroid plexus at 5-hydroxytryptamine 1C receptor binding site by using [3H]- MES as a radioligand.,1865,Autocuration,,9,,,,,10116.0,1,,12689,B,Rattus norvegicus,,CHEMBL616835,9098,
,D,BAO_0000249,,Inhibitory activity against 5-hydroxytryptamine 1C receptor in rat cortical membranes using [3H]mesulergine as a radioligand,1866,Autocuration,,9,,,,,10116.0,1,,12689,B,Rattus norvegicus,,CHEMBL872910,10394,
,H,BAO_0000357,,Tested for binding affinity against 5-hydroxytryptamine 1C receptor from rat frontal cortical regions using [3H]mesulergine as radioligand,1867,Expert,,8,,,,,,1,,12689,B,,,CHEMBL616836,11933,
,D,BAO_0000357,,The binding affinity was measured on 5-hydroxytryptamine 1C receptor using [3H]- serotonin as radioligand.,1868,Autocuration,,9,,,,,10116.0,1,,12689,B,Rattus norvegicus,,CHEMBL616837,12092,
,D,BAO_0000019,,Binding affinity of 5-hydroxytryptamine 1C receptor using [3H]- ketanserin in rat frontal cortex,1869,Autocuration,,9,,,,,10116.0,1,,12689,B,Rattus norvegicus,,CHEMBL616466,12253,
,D,BAO_0000219,,Binding affinity towards rat 5-hydroxytryptamine 1C receptor using [3H]mesulergine as radioligand expressed in 293 cells,1870,Autocuration,,9,,,722.0,,10116.0,1,HEK293,12689,B,Rattus norvegicus,,CHEMBL616467,12253,
,H,BAO_0000357,,Compound was tested for its affinity towards 5-hydroxytryptamine 1C receptor,1871,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL616468,1558,
,H,BAO_0000357,,Compound was measured for its binding affinity at 5-hydroxytryptamine 1C receptor at a concentration of 100 nM using [3H]mesulergine as radioligand,1872,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL616469,2474,
,H,BAO_0000357,,Compound was measured for its binding affinity at 5-hydroxytryptamine 1C receptor at a concentration of 100 nM using [3H]mesulergine as radioligand,1873,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL616470,2474,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1C receptor,1874,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL616471,11574,
,H,BAO_0000357,,Compound was tested for its affinity towards 5-hydroxytryptamine 1C receptor,1875,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL616472,1558,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1C receptor,1876,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL616473,13944,
,H,BAO_0000357,,Binding affinity against serotonergic 5-HT1c receptor,1877,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL616474,13033,
,H,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1C receptor was determined by using [3H]- mesulergine as radioligand,1878,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL616475,10321,
,H,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1C receptor was determined,1879,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL616476,11866,
,H,BAO_0000019,,Compound was tested for 5-hydroxytryptamine 1D like receptor-mediated vascular effect in rabbit saphenous vein (RSV),1880,Autocuration,,8,,,,,9986.0,1,,105,B,Oryctolagus cuniculus,,CHEMBL616477,14454,
,H,BAO_0000224,,Binding affinity against 5-hydroxytryptamine 2 receptor using [125I]DOI as radioligand.,1881,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616478,11574,
,H,BAO_0000224,,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ket as radioligand.,1882,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616479,11574,
,H,BAO_0000019,,Binding affinity towards serotonin 5-HT2 receptor was determined in rat cortex using [3H]spiperone as ligand,1883,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616480,13631,
,D,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 2 receptor as antagonism of serotonin-induced contractions in rat jugular vein,1884,Autocuration,,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL616481,9630,
,D,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat brain cortical membranes,1885,Autocuration,,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL616482,8822,
,D,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat brain using [3H]spiroperidol,1886,Autocuration,955.0,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL884713,9064,Brain
,H,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor measured using radioligand ([3H]spiperone) binding assay,1887,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616483,8868,
,H,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- spiroperidol,1888,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616484,9064,
,H,BAO_0000019,,Binding affinity at 5-hydroxytryptamine 2 receptor from rat frontal cortex homogenates by [3H]-spiperone displacement.,1889,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616485,9806,
,H,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor was determined,1890,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616486,9098,
,H,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor was measured using radioligand ([3H]spiperone) binding assay,1891,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616487,8868,
,H,BAO_0000224,,Binding affinity at serotonin 5-hydroxytryptamine 2 receptor by [3H]ketanserin displacement.,1892,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616488,12765,
,H,BAO_0000019,,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,1893,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616489,11049,
,H,BAO_0000019,,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,1894,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616490,11049,
,H,BAO_0000019,,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]-Ketanserin as radioligand; not determined,1895,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616491,11049,
,H,BAO_0000019,,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand; ND-Not determined,1896,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616492,11049,
,H,BAO_0000019,,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,1897,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616493,11049,
,H,BAO_0000019,,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor in rat anterior cortex using [125I]DOI as radioligand,1898,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616494,11473,
,H,BAO_0000019,,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor in rat anterior cortex using [3H]ketanserin as radioligand,1899,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616495,11473,
,H,BAO_0000019,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor in rat pre frontal cortex,1900,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616496,3086,
,H,BAO_0000019,,Compound was evaluated for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,1901,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616497,11049,
,H,BAO_0000019,,Compound was evaluated for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,1902,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616498,11049,
,H,BAO_0000019,,Compound was evaluated for its inhibitory activity against 5-hydroxytryptamine 2 receptor of rat anterior cortex using [3H]ketanserin as the radioligand,1903,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616499,10639,
,H,BAO_0000019,,Compound was measured for affinity at 5-hydroxytryptamine 2 receptor in rat cortical by [3H]spiroperidol displacement.,1904,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616500,10922,
,D,BAO_0000221,,Binding affinity against serotonin-2 receptor in rat brain using [3H]spiroperidol,1905,Autocuration,955.0,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL616501,9064,Brain
,H,BAO_0000221,,Compound was tested for its inhibitory effect on the binding profile in 5-hydroxytryptamine 2 receptor using [3H]spiroperidol in rat brain.,1906,Autocuration,955.0,4,,,,,,1,,104686,B,,,CHEMBL616502,10748,Brain
,H,BAO_0000249,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor from rat cortical membranes.,1907,Autocuration,,4,Membranes,,,,,1,,104686,B,,,CHEMBL884529,11614,
,H,BAO_0000249,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor in rat cortical membranes,1908,Autocuration,,4,Membranes,,,,,1,,104686,B,,,CHEMBL616503,11615,
,H,BAO_0000224,,Compound was tested for the displacement of [3H]ketanserin from serotonin 5-hydroxytryptamine 2 receptor,1909,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616964,11615,
,H,BAO_0000249,,Compound was tested for the displacement of [3H]ketanserin from serotonin 5-hydroxytryptamine 2 receptor from rat cortical membranes.,1910,Autocuration,,4,Membranes,,,,,1,,104686,B,,,CHEMBL616965,11614,
,H,BAO_0000224,,Inhibition of [3H]ketanserin binding to rat 5-hydroxytryptamine 2 receptors.,1911,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616966,11702,
,H,BAO_0000224,,Compound was tested for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor; NT=Not tested,1912,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616967,11702,
,D,BAO_0000224,,Inhibition of [3H]ketanserin binding to dopamine 5-hydroxytryptamine 2 receptor,1913,Autocuration,,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL616968,11702,
,H,BAO_0000224,,Compound was tested for the inhibition of [3H]ketanserin binding to dopamine 5-hydroxytryptamine 2 receptor; NT=Not tested,1914,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616969,11702,
,H,BAO_0000019,,Inhibition of [3H]ketanserin binding at 5-hydroxytryptamine 2 receptor from rat frontal cortex.,1915,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL884530,13346,
,H,BAO_0000224,,Concentration necessary to achieve half maximal inhibition of [3H]-ketanserin binding to 5-hydroxytryptamine 2 receptor,1916,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616970,10025,
,H,BAO_0000224,,Concentration necessary to achieve half maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor at 1 uM,1917,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616971,10025,
,H,BAO_0000224,,"Concentration necessary to achieve half maximal inhibition of [3H]ketanserin, binds to 5-hydroxytryptamine 2 receptor at 1 uM",1918,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616972,10025,
,H,BAO_0000224,,Evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor using radioligand [3H]-spiperone,1919,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616973,9036,
,H,BAO_0000224,,Evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor using radioligand [3H]spiperone; IA=Inactive,1920,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616974,9036,
,H,BAO_0000019,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue.,1921,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616975,9161,
,H,BAO_0000019,,Inhibition of binding of radioligand [3H]ketanserin to 5-hydroxytryptamine 2 receptor in rat cerebral cortex,1922,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616976,12304,
,H,BAO_0000224,,In vitro binding affinity measured on serotonin 5-hydroxytryptamine 2 receptor using [3H]ketanserin as radioligand.,1923,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616977,13276,
,H,BAO_0000224,,In vitro binding affinity towards the 5-hydroxytryptamine 2 receptor at 10 e-6 M,1924,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616978,11825,
,H,BAO_0000224,,In vitro binding affinity was measured on serotonergic 5-hydroxytryptamine 2 receptor by displacement of [3H]- ketanserin,1925,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616979,12443,
,H,BAO_0000224,,In vitro inhibitory activity against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor,1926,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616980,13830,
,H,BAO_0000249,,Inhibition of [3H]spiperone binding to 5-hydroxytryptamine 2 receptor from rat cortical membranes,1927,Autocuration,,4,Membranes,,,,,1,,104686,B,,,CHEMBL616981,9592,
,H,BAO_0000249,,Inhibition of [3H]spiperone binding to 5-hydroxytryptamine 2 receptor from rat cortical membranes; Not tested,1928,Autocuration,,4,Membranes,,,,,1,,104686,B,,,CHEMBL616982,9592,
,H,BAO_0000224,,Inhibitory activity against 5-hydroxytryptamine 2 receptor by 3H ligand binding experiments.,1929,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616983,10881,
,H,BAO_0000019,,Inhibitory activity against [3H]spiroperidol binding to 5-HT2 receptor in rat cortex,1930,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616984,13605,
,D,BAO_0000224,,Inhibitory activity against 5-hydroxytryptamine 2 receptor,1931,Autocuration,,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL616985,11624,
,H,BAO_0000224,,Inhibitory concentration against 5-hydroxytryptamine 2 receptor from striata of male Wistar rats by displacement of [3H]-ketanserin,1932,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616986,4101,
,H,BAO_0000224,,Inhibitory concentration against binding of 5-hydroxytryptamine 2 receptor from striata of male Wistar rats by displacement of [3H]-ketanserin,1933,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616987,4101,
,H,BAO_0000019,,Inhibitory concentration against radioligand [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in rat,1934,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL616988,15360,
,H,BAO_0000019,,Inhibitory concentration against radioligand [3H]spiperone binding to 5-hydroxytryptamine 2 receptor in rat cortex,1935,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617243,11576,
,H,BAO_0000019,,Inhibitory concentration required against 5-hydroxytryptamine 2 receptor in rat cortex using [3H]spiperone,1936,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617244,5834,
,D,BAO_0000219,,Inhibitory concentration against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor expressed in CHO-K1 cells,1937,Autocuration,,5,,,485.0,,10116.0,1,CHO-K1,104686,B,Rattus norvegicus,,CHEMBL617245,2395,
,H,BAO_0000249,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor in rat cortical membranes,1938,Autocuration,,4,Membranes,,,,,1,,104686,B,,,CHEMBL617246,11965,
,H,BAO_0000224,,The compound was evaluated for the ability to displace [3H]ketanserin from 5-hydroxytryptamine 2 receptor ( striata of male wistar rats),1939,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617546,3967,
,H,BAO_0000249,,The concentration required to inhibit [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in rat brain membranes (in vitro),1940,Autocuration,,4,Brain membranes,,,,,1,,104686,B,,,CHEMBL617547,11130,
,H,BAO_0000219,,Binding affinity of [3H]ketanserin towards 5-hydroxytryptamine 2 receptor in cloned mammalian receptor expressed in cultured cells or from rat whole brain.,1941,Autocuration,,4,,In vitro,,,,1,,104686,B,,,CHEMBL617548,13427,
,H,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor,1942,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617549,9443,
,H,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor at 1.0 uM concentration,1943,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617550,9443,
,H,BAO_0000224,,In vitro binding affinity towards the 5-hydroxytryptamine 2 receptor at 10 e-6 M,1944,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617551,11825,
,H,BAO_0000249,,Percent inhibition of binding of 1.0 nM [3H]ketanserin to 5-hydroxytryptamine 2 receptor in rat cortical membranes at 10 e -5 M,1945,Autocuration,,4,Membranes,,,,,1,,104686,B,,,CHEMBL617552,12120,
,H,BAO_0000249,,Percent inhibition of binding of 1.0 nM [3H]-ketanserin to 5-hydroxytryptamine 2 receptor in rat cortical membranes at 10 e-5 M.,1946,Autocuration,,4,Membranes,,,,,1,,104686,B,,,CHEMBL617553,12120,
,H,BAO_0000019,,Tested for antagonistic activity against 5-hydroxytryptamine 2 receptor from rat thoracic aorta,1947,Autocuration,1515.0,4,,,,,,1,,104686,F,,,CHEMBL617554,11963,Thoracic aorta
,H,BAO_0000019,,Binding affinity for membrane-bound 5-hydroxytryptamine 2 receptor,1948,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617555,9069,
,H,BAO_0000224,,Compound was tested for its effect on 5-hydroxytryptamine 2 receptor saturation analysis,1949,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617556,8868,
,H,BAO_0000357,,Inhibitory constant against human 5-hydroxytryptamine 1B receptor using [3H]5-CT radioligand,1950,Autocuration,,8,,,,,,1,,10624,B,,,CHEMBL617557,17200,
,H,BAO_0000357,,Inhibitory constant against human 5-hydroxytryptamine 1D receptor using [3H]5-CT radioligand,1951,Autocuration,,8,,,,,,1,,10624,B,,,CHEMBL617558,17200,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1D receptor was measured using [3H]5-HT as radioligand,1952,Expert,,8,,,,,,1,,17106,B,,,CHEMBL617559,13969,
,D,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1D receptor,1953,Expert,,9,,,,,,1,,17106,B,,,CHEMBL617560,13392,
,H,BAO_0000249,,Compound was tested for its ability to displace [125I]GTI binding to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes,1954,Autocuration,,8,,,,,,1,,17106,B,,,CHEMBL617561,1742,
,H,BAO_0000249,,Compound was tested for its ability to displace [3H]-5-HT binding to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes,1955,Autocuration,,8,,,,,,1,,17106,B,,,CHEMBL617562,1742,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1D receptor using [3H]5-HT in pig striatum + frontalCortex,1956,Autocuration,2435.0,8,,,,,,1,,17106,B,,,CHEMBL617563,14331,Striatum
,H,BAO_0000019,,Relative agonist efficacy against 1 uM 5-hydroxytryptamine 1D receptor,1957,Autocuration,,8,,,,,,1,,17106,F,,,CHEMBL617564,12861,
,H,BAO_0000019,,Binding activity against 5-hydroxytryptamine 1D receptor from pig caudate membrane using [3H]5-HT as radioligand,1958,Expert,,8,,,,,,1,,17106,B,,,CHEMBL617565,12861,
,H,BAO_0000357,,Binding activity radioligand.,1959,Autocuration,,8,,,,,,1,,17106,B,,,CHEMBL856076,12861,
,H,BAO_0000019,,Binding activity against 5-hydroxytryptamine 2C receptor from human brain cortex using [3H]mesulergine as radioligand.,1960,Autocuration,,8,,,,,,1,,17106,B,,,CHEMBL617566,12861,
,H,BAO_0000019,,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,1961,Expert,,8,,,,,,1,,17106,B,,,CHEMBL875911,12861,
,H,BAO_0000019,,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand; NA Not Available,1962,Autocuration,,8,,,,,,1,,17106,B,,,CHEMBL617567,12861,
,H,BAO_0000249,,Compound was tested for the displacement of [3H]-5-HT to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes,1963,Autocuration,,8,,,,,,1,,17106,B,,,CHEMBL617568,675,
,H,BAO_0000019,,Displacement of [3H]5-HT binding to 5-hydroxytryptamine 1D receptor from pig caudate membrane,1964,Expert,,8,,,,,,1,,17106,B,,,CHEMBL617569,12490,
,H,BAO_0000249,,Displacement of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1D receptor in pig caudate membrane,1965,Expert,,8,,,,,,1,,17106,B,,,CHEMBL617570,11828,
,H,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1D receptor in piglet caudate using [3H]5-HT,1966,Autocuration,,8,,,,,,1,,17106,B,,,CHEMBL617571,11866,
,H,BAO_0000357,,In Vitro Binding affinity againist 5-hydroxytryptamine 1D receptor by displacing [125I]GTI from pig caudate,1967,Autocuration,,8,,,,,9823.0,1,,105,B,Sus scrofa,,CHEMBL617572,773,
,H,BAO_0000357,,The compound was tested for intrinsic activity against 5-HT1D receptor,1968,Expert,,8,,,,,9986.0,1,,105,B,Oryctolagus cuniculus,,CHEMBL617573,13047,
,H,BAO_0000019,,Intrinsic activity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,1969,Autocuration,,8,,,,,9986.0,1,,105,B,Oryctolagus cuniculus,,CHEMBL617574,13047,
,H,BAO_0000357,,The compound was tested for binding affinity against 5-HT1D receptor,1970,Expert,,8,,,,,9986.0,1,,105,B,Oryctolagus cuniculus,,CHEMBL617575,13047,
,H,BAO_0000357,,Tested for the effect on binding at 5-hydroxytryptamine 1D receptor; No activity,1971,Autocuration,,8,,,,,,1,,10578,B,,,CHEMBL617576,188,
,H,BAO_0000019,,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1D receptor of rat substantia nigra,1972,Autocuration,,8,,,,,,1,,10578,F,,,CHEMBL617577,10639,
,H,BAO_0000019,,Inhibition of forskolin stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor,1973,Autocuration,,8,,,,,,1,,10578,F,,,CHEMBL617578,12438,
,H,BAO_0000357,,Binding affinity was measured against serotonin 5-hydroxytryptamine 1D receptor,1974,Autocuration,,8,,,,,,1,,10578,B,,,CHEMBL617579,12438,
,H,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 1D receptor in rat frontal cortex using [125I]iodocyanopindolol as radio-ligand.,1975,Expert,,8,,,,,,1,,10578,B,,,CHEMBL617580,15854,
,H,BAO_0000249,,Inhibitory activity against 5-hydroxytryptamine 1D receptor in rat cortical membranes using [3H]5-HT as a radioligand,1976,Autocuration,,8,,,,,,1,,10578,B,,,CHEMBL617581,10394,
,H,BAO_0000357,,The binding affinity was measured on 5-hydroxytryptamine 1D receptor using [3H]- serotonin as radioligand.,1977,Autocuration,,8,,,,,,1,,10578,B,,,CHEMBL617582,12092,
,H,BAO_0000019,,Binding affinity to 5-hydroxytryptamine 1D receptor in the rat forebrain by [3H]- SB-204269 displacement.,1978,Expert,,8,,,,,,1,,10578,B,,,CHEMBL617583,3389,
,H,BAO_0000357,,Inhibition of binding towards 5-hydroxytryptamine 1D receptor at 100 nM concentration,1979,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL617584,6011,
,H,BAO_0000357,,Compound was tested for binding affinity against 5-hydroxytryptamine 1D receptor,1980,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL617585,4639,
,H,BAO_0000357,,Compound was measured for its binding affinity at 5-hydroxytryptamine 1D receptor at a concentration of 10 uM using [3H]5-HT as radioligand,1981,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL875912,2474,
,H,BAO_0000357,,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1D receptor,1982,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL617586,5014,
,H,BAO_0000357,,Binding affinity of compound towards serotonin 5-hydroxytryptamine 1D receptor; inactive at 10 uM,1983,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL617587,17515,
,H,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1D receptor was determined,1984,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL617588,11866,
,H,BAO_0000357,,Evaluated for the binding affinity against 5-hydroxytryptamine 1D receptor,1985,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL857980,4687,
,H,BAO_0000357,,Tested against 5-hydroxytryptamine 1D receptor,1986,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL617589,12146,
,H,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1D receptor was determined by using [3H]5-HT as radioligand,1987,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL617590,10321,
,H,BAO_0000219,,Antagonistic binding affinity measured against 5-hydroxytryptamine 2A receptor (human clone expressed in 293 cells) using [3H]ketanserin as radioligand,1988,Autocuration,,8,,,722.0,,,1,HEK293,105,B,,,CHEMBL617591,13267,
,D,BAO_0000357,,Binding affinity against 5-Hydroxytryptamine 1D receptor,1989,Expert,,9,,,,,9606.0,1,,105,B,Homo sapiens,,CHEMBL617592,1274,
,H,BAO_0000357,,,1990,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL617593,15250,
,H,BAO_0000219,,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells.,1991,Autocuration,,8,,,485.0,,,1,CHO-K1,106,B,,,CHEMBL617594,13706,
,H,BAO_0000219,,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells.,1992,Autocuration,,8,,,485.0,,,1,CHO-K1,105,B,,,CHEMBL617595,13706,
,H,BAO_0000219,,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor alpha clones expressed in human embryonic kidney (HEK 293) cells line.,1993,Autocuration,,8,,,722.0,,,1,HEK293,105,B,,,CHEMBL617596,13706,
,H,BAO_0000219,,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor alpha clones expressed in human embryonic kidney (HEK 293) cells line; NT= not tested,1994,Autocuration,,8,,,722.0,,,1,HEK293,105,B,,,CHEMBL617597,13706,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1D receptor beta using rabbit saphenous vein assay.,1995,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL617598,13047,
,H,BAO_0000357,,Binding affinity of compound against 5-HT1Dalpha Binding affinity of compound against 5-HT1D alpha receptors in human,1996,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL872916,13366,
,H,BAO_0000357,,In vitro affinity human cloned 5-hydroxytryptamine 1D receptor alpha by [3H]5-HT displacement.,1997,Expert,,8,,,,,,1,,105,B,,,CHEMBL617599,13366,
,H,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor alpha was determined,1998,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL617091,1558,
,H,BAO_0000219,,"Binding affinity against 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells, using [3H]-5-HT as the radioligand.",1999,Expert,,8,,,485.0,,,1,CHO-K1,105,B,,,CHEMBL617092,12902,
,H,BAO_0000219,,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells.,2000,Autocuration,,8,,,485.0,,,1,CHO-K1,105,B,,,CHEMBL617093,13706,
,H,BAO_0000019,,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor alpha measured as the reduction of forskolin-stimulated cAMP.,2001,Autocuration,,8,,,,,,1,,105,F,,,CHEMBL617094,13706,
,H,BAO_0000019,,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor beta measured as the reduction of forskolin-stimulated cAMP.,2002,Autocuration,,8,,,,,,1,,105,F,,,CHEMBL617095,13706,
,H,BAO_0000019,,Compound was tested for its agonist activity against human 5-hydroxytryptamine 1D receptor alpha for comparison purpose.,2003,Autocuration,,8,,,,,,1,,105,F,,,CHEMBL617096,14251,
,H,BAO_0000019,,Compound was tested for its agonist activity against human recombinant 5-hydroxytryptamine 1D receptor alpha for comparison purpose.,2004,Autocuration,,8,,,,,,1,,105,F,,,CHEMBL617097,14251,
,H,BAO_0000019,,Compound was tested for its agonist activity against human recombinant 5-hydroxytryptamine 1D receptor alpha for comparison purpose.,2005,Autocuration,,8,,,,,,1,,105,F,,,CHEMBL617098,14251,
,H,BAO_0000357,,In vitro binding affinity towards 5-HT1D alpha receptor by using [3H]5-HT as radioligand,2006,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL617301,13313,
,H,BAO_0000357,,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor alpha by using [3H]5-HT as radioligand,2007,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL617302,13313,
,H,BAO_0000357,,Selectivity towards 5-hydroxytryptamine 1D receptor beta to that of 5-hydroxytryptamine 1D receptor alpha,2008,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL617303,13366,
,H,BAO_0000357,,Binding affinity to recombinant human 5-hydroxytryptamine 1D receptor alpha,2009,Expert,,8,,,,,,1,,105,B,,,CHEMBL617304,13051,
,H,BAO_0000219,,"In vitro binding affinity against cloned mammalian 5-hydroxytryptamine 1D receptor alpha expressed in CHO cells, by using [3H]5-HT as radioligand",2010,Expert,,8,,,449.0,,,1,CHO,105,B,,,CHEMBL617305,12903,
,D,BAO_0000219,,Binding affinity was measured on 5-hydroxytryptamine 1D receptor alpha in COS cells transfected with human 5-HT1D alpha gene labeled with [3H]5-HT,2011,Autocuration,,9,,,,,9606.0,1,,105,B,Homo sapiens,,CHEMBL617306,12469,
,H,BAO_0000357,,Binding affinity (in vitro) against 5-hydroxytryptamine 1D receptor alpha using radio-ligand binding assay,2012,Autocuration,,8,,,,,,1,,17106,B,,,CHEMBL617307,5619,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 4 receptor using rabbit saphenous vein assay.,2013,Autocuration,,8,,,,,9986.0,1,,105,B,Oryctolagus cuniculus,,CHEMBL617308,13047,
,H,BAO_0000357,,Binding affinities against 5-hydroxytryptamine 1D receptor alpha,2014,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL617309,16633,
,H,BAO_0000357,,Binding affinities towards 5-hydroxytryptamine 1D receptor alpha,2015,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL617310,16633,
,H,BAO_0000357,,Binding affinities towards 5-hydroxytryptamine 1D receptor alpha,2016,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL617311,16633,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1D receptor alpha using [3H]8-OH-DPAT as radioligand,2017,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL617312,16633,
,H,BAO_0000357,,Affinity against 5-hydroxytryptamine 1D receptor alpha,2018,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL617313,3269,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1D receptor alpha,2019,Expert,,8,,,,,,1,,105,B,,,CHEMBL617314,12409,
,H,BAO_0000019,,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor beta measured as the reduction of forskolin-stimulated cAMP.,2020,Autocuration,,8,,,,,,1,,106,F,,,CHEMBL617315,13706,
,H,BAO_0000219,,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor beta clones expressed in human embryonic kidney (HEK 293) cells line.,2021,Autocuration,,8,,,722.0,,,1,HEK293,106,B,,,CHEMBL617316,13706,
,H,BAO_0000219,,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor beta clones expressed in human embryonic kidney (HEK 293) cells line; NT= not tested,2022,Autocuration,,8,,,722.0,,,1,HEK293,106,B,,,CHEMBL617317,13706,
,H,BAO_0000219,,"The compound was tested in vitro for binding affinity against cloned mammalian 5-hydroxytryptamine 1D receptor beta expressed in CHO cells, by using [3H]5-HT as radioligand",2023,Autocuration,,8,,,449.0,,,1,CHO,106,B,,,CHEMBL617318,12903,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1D receptor beta using rabbit saphenous vein assay.,2024,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL617319,13047,
,D,BAO_0000357,,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor beta,2025,Expert,,9,,,,,,1,,106,B,,,CHEMBL617320,13366,
,D,BAO_0000357,,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor beta,2026,Expert,,9,,,,,,1,,106,B,,,CHEMBL617321,13366,
,D,BAO_0000357,,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor beta,2027,Expert,,9,,,,,,1,,106,B,,,CHEMBL617322,13366,
,H,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor beta was determined using [3H]8-OH-DPAT as radioligand,2028,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616862,13366,
,H,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor was determined using [3H]8-OH-DPAT as radioligand,2029,Autocuration,,8,,,,,,1,,106,B,,,CHEMBL616863,13366,
,H,BAO_0000219,,Binding affinity was measured on 5-hydroxytryptamine 1D receptor beta in CHO cells transfected with human 5-HT1D beta gene labeled with [3H]5-HT,2030,Autocuration,,8,,,449.0,,,1,CHO,106,B,,,CHEMBL616864,12469,
,H,BAO_0000219,,Compound was tested for binding affinity against cloned human 5-HT1D beta receptor expressed in CHO-K1 cells.,2031,Autocuration,,8,,,485.0,,,1,CHO-K1,106,B,,,CHEMBL616865,13706,
,H,BAO_0000219,,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor beta expressed in CHO-K1 cells.,2032,Autocuration,,8,,,485.0,,,1,CHO-K1,106,B,,,CHEMBL616866,13706,
,H,BAO_0000019,,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor beta measured as the reduction of forskolin-stimulated cAMP.,2033,Autocuration,,8,,,,,,1,,106,F,,,CHEMBL616867,13706,
,H,BAO_0000219,,"Binding affinity against 5-hydroxytryptamine 1D receptor beta expressed in CHO-K1 cells, using [3H]5-HT as the radioligand.",2034,Expert,,8,,,485.0,,,1,CHO-K1,106,B,,,CHEMBL616868,12902,
,H,BAO_0000357,,Binding affinity for cloned human 5-hydroxytryptamine 1D receptor beta,2035,Expert,,8,,,,,,1,,105,B,,,CHEMBL616869,13051,
,H,BAO_0000219,,"In vitro binding affinity against cloned mammalian 5-hydroxytryptamine 1D receptor beta expressed in CHO cells, by using [3H]5-HT as radioligand",2036,Expert,,8,,,449.0,,,1,CHO,106,B,,,CHEMBL616870,12903,
,H,BAO_0000219,,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 0.24-0.55,2037,Autocuration,,8,,,485.0,,,1,CHO-K1,105,F,,,CHEMBL616871,1558,
,H,BAO_0000219,,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 0.6-2.0,2038,Autocuration,,8,,,485.0,,,1,CHO-K1,105,F,,,CHEMBL616872,1558,
,H,BAO_0000219,,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 2.8-6.5,2039,Autocuration,,8,,,485.0,,,1,CHO-K1,105,F,,,CHEMBL616873,1558,
,H,BAO_0000219,,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 30-70,2040,Autocuration,,8,,,485.0,,,1,CHO-K1,105,F,,,CHEMBL616838,1558,
,H,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor beta was determined,2041,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616839,1558,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 3 receptor using rabbit saphenous vein assay.,2042,Autocuration,,8,,,,,9986.0,1,,106,B,Oryctolagus cuniculus,,CHEMBL616840,13047,
,H,BAO_0000357,,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor alpha by using [3H]-5-HT as radioligand,2043,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616841,13313,
,H,BAO_0000357,,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor beta by using [3H]5-HT as radioligand,2044,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL616842,13313,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1D receptor beta,2045,Expert,,8,,,,,,1,,105,B,,,CHEMBL857976,12409,
,H,BAO_0000219,,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 1E receptor stably expressed in CHO cells,2046,Autocuration,,8,,,449.0,,,1,CHO,10618,B,,,CHEMBL616843,15250,
,D,BAO_0000357,,Inhibitory activity against 5-hydroxytryptamine 1E receptor subtype,2047,Expert,,9,,,,,9606.0,1,,10618,B,Homo sapiens,,CHEMBL616844,1348,
,H,BAO_0000357,,Inhibitory activity against 5-hydroxytryptamine 1E receptor subtype; NA denotes data not available,2048,Autocuration,,8,,,,,,1,,10618,B,,,CHEMBL616845,1348,
,D,BAO_0000357,,Binding affinity to cloned human 5-hydroxytryptamine 1E receptor,2049,Expert,,9,,,,,9606.0,1,,10618,B,Homo sapiens,,CHEMBL616846,4234,
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1E receptor was determined using [3H]5-HT as radioligand,2050,Autocuration,,8,,,,,,1,,10618,B,,,CHEMBL616847,16209,
,H,BAO_0000019,,Binding affinity was determined against 5-hydroxytryptamine 1E receptor in human cortical homogenate,2051,Autocuration,,8,,,,,,1,,10618,B,,,CHEMBL616848,10444,
,H,BAO_0000357,,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 1E receptor,2052,Autocuration,,8,,,,,,1,,10618,B,,,CHEMBL616849,3935,
,H,BAO_0000357,,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 1E receptor,2053,Autocuration,,8,,,,,,1,,10618,B,,,CHEMBL872911,15818,
,H,BAO_0000019,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1E receptor,2054,Autocuration,,8,,,,,,1,,10618,B,,,CHEMBL616850,17085,
,D,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 1E receptor expressed in CHO cells,2055,Expert,,9,,,449.0,,9606.0,1,CHO,10618,B,Homo sapiens,,CHEMBL616699,12936,
,H,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 1E receptor was determined,2056,Autocuration,,8,,,,,,1,,10618,B,,,CHEMBL616700,6166,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 1E receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,2057,Autocuration,,8,,,449.0,,,1,CHO,10618,B,,,CHEMBL616701,15779,
,H,BAO_0000219,,Binding affinity towards human cloned 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT as radioligand.,2058,Autocuration,,8,,,449.0,,,1,CHO,10618,B,,,CHEMBL616702,15779,
,H,BAO_0000219,,Binding affinity towards human cloned 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT as radioligand;ND means no data.,2059,Autocuration,,8,,,449.0,,,1,CHO,10618,B,,,CHEMBL616703,15779,
,H,BAO_0000357,,Binding affinity was determined against 5-hydroxytryptamine 1D receptor,2060,Autocuration,,8,,,,,,1,,10618,B,,,CHEMBL616704,13181,
,H,BAO_0000219,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT as the radioligand,2061,Autocuration,,8,,,449.0,,,1,CHO,10618,B,,,CHEMBL616705,4199,
,H,BAO_0000357,,Compound was tested for binding affinity against human 5-hydroxytryptamine 1E receptor,2062,Autocuration,,8,,,,,,1,,10618,B,,,CHEMBL616706,14875,
,H,BAO_0000219,,Compound was tested for its binding affinity against cloned human 5-hydroxytryptamine 1E receptor in CHO cells using [3H]-5-HT,2063,Autocuration,,8,,,449.0,,,1,CHO,10618,B,,,CHEMBL616707,15146,
,H,BAO_0000357,,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1E receptor in CHO using [3H]5-HT as a radioligand,2064,Autocuration,,8,,,,,,1,,10618,B,,,CHEMBL616708,5213,
,H,BAO_0000357,,Tested for binding affinity towards cloned human 5-hydroxytryptamine 1E receptor using [3H]5-HT as radioligand,2065,Autocuration,,8,,,,,,1,,10618,B,,,CHEMBL616709,12146,
,H,BAO_0000219,,The binding affinity (pKi) measured against 5-hydroxytryptamine 1E receptor (cloned human receptors in CHO cells) using [3H]5-HT1E as radioligand,2066,Autocuration,,8,,,449.0,,,1,CHO,10618,B,,,CHEMBL616710,13267,
,H,BAO_0000219,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT.,2067,Autocuration,,8,,,449.0,,,1,CHO,10618,B,,,CHEMBL616711,14818,
,H,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1E receptor in CHO cells, using [3H]5-HT as radioligand",2068,Autocuration,,8,,,449.0,,,1,CHO,10618,B,,,CHEMBL616712,4829,
,H,BAO_0000357,,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1E receptor was determined,2069,Autocuration,,8,,,,,,1,,10618,B,,,CHEMBL616713,4373,
,H,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1E receptor was determined,2070,Autocuration,,8,,,,,,1,,10618,B,,,CHEMBL616714,4373,
,H,BAO_0000357,,Compound was evaluated for the affinity at 5-hydroxytryptamine 1E receptor,2071,Autocuration,,8,,,,,,1,,10618,B,,,CHEMBL616715,14159,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 1E receptor,2072,Autocuration,,8,,,,,,1,,10618,B,,,CHEMBL616716,16633,
,H,BAO_0000019,,"In vitro effective concentration for stimulation of [35S]GTP-gamma-S, binding in mouse LM(tk-)cells expressing the human 5-HT1F receptor",2073,Autocuration,,8,,,,,,1,,279,F,,,CHEMBL616717,17085,
,H,BAO_0000019,,"In vitro effective concentration for stimulation of [35S]GTP-gamma-S, binding in mouse LM(tk-)cells expressing the human 5-hydroxytryptamine 1F receptor",2074,Expert,,8,,,,,,1,,279,F,,,CHEMBL616718,17085,
,H,BAO_0000019,,In vitro effective concentration for inhibition of skolin-stimulated adenylate cyclase in cell line expressing human 5-hydroxytryptamine 1F receptor,2075,Autocuration,,8,,,,,,1,,279,F,,,CHEMBL875905,16209,
,H,BAO_0000019,,In vitro agonist potency against human 5-hydroxytryptamine 1F receptor,2076,Autocuration,,8,,,,,,1,,279,F,,,CHEMBL616719,16209,
,H,BAO_0000019,,"Maximum stimulation of of [35S]GTP-gamma-S, binding expressed relative to the maximal effect of 5-hydroxytryptamine 1F receptor",2077,Expert,,8,,,,,,1,,279,F,,,CHEMBL616720,17085,
,H,BAO_0000357,,Compound was evaluated for the affinity at 5-hydroxytryptamine 1F receptor,2078,Autocuration,,8,,,,,,1,,279,B,,,CHEMBL616721,14159,
,H,BAO_0000219,,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 1F receptor stably expressed in CHO cells,2079,Autocuration,,8,,,449.0,,,1,CHO,279,B,,,CHEMBL616722,15250,
,H,BAO_0000357,,In vitro binding affinity against human 5-hydroxytryptamine 1F receptor at a concentration of 100 (nM),2080,Autocuration,,8,,,,,,1,,279,B,,,CHEMBL616723,3805,
,H,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 1F receptor in CHO cells using [3H]5-HT radioligand,2081,Autocuration,,8,,,449.0,,,1,CHO,279,B,,,CHEMBL616724,16190,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1F receptor in CHO using [3H]5-HT radioligand,2082,Autocuration,,8,,,,,,1,,279,B,,,CHEMBL616725,16190,
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1F receptor,2083,Autocuration,,8,,,,,,1,,279,B,,,CHEMBL616726,16209,
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1F receptor was determined,2084,Autocuration,,8,,,,,,1,,279,B,,,CHEMBL616727,16209,
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 1F receptor using [3H]-5-HT radioligand,2085,Autocuration,,8,,,,,,1,,279,B,,,CHEMBL616728,16209,
,H,BAO_0000357,,In vitro binding affinity for human 5-hydroxytryptamine 1F receptor,2086,Autocuration,,8,,,,,,1,,279,B,,,CHEMBL616729,6866,
,H,BAO_0000019,,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1F receptor,2087,Expert,,8,,,,,,1,,279,B,,,CHEMBL616730,17085,
,H,BAO_0000357,,Binding affinity towards human recombinant 5-hydroxytryptamine 1F receptor,2088,Autocuration,,8,,,,,,1,,279,B,,,CHEMBL617125,16312,
,H,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 1F receptor was determined,2089,Autocuration,,8,,,,,,1,,279,B,,,CHEMBL857977,6166,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 1F receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,2090,Autocuration,,8,,,449.0,,,1,CHO,279,B,,,CHEMBL617126,15779,
,H,BAO_0000219,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1F receptor in CHO cells using [3H]-5-HT as the radioligand,2091,Autocuration,,8,,,449.0,,,1,CHO,279,B,,,CHEMBL617127,4199,
,H,BAO_0000357,,Compound was tested for binding affinity against human 5-hydroxytryptamine 1F receptor,2092,Autocuration,,8,,,,,,1,,279,B,,,CHEMBL617128,14875,
,H,BAO_0000219,,Compound was tested for its binding affinity against 5-hydroxytryptamine 1F receptor in human cloned receptors in CHO cells using [3H]5-HT,2093,Autocuration,,8,,,449.0,,,1,CHO,279,B,,,CHEMBL617129,15146,
,H,BAO_0000357,,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1F receptor in CHO using [3H]5-HT as a radioligand,2094,Autocuration,,8,,,,,,1,,279,B,,,CHEMBL617130,5213,
,H,BAO_0000219,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1F receptor in CHO cells using [3H]5-HT.,2095,Autocuration,,8,,,449.0,,,1,CHO,279,B,,,CHEMBL617131,14818,
,H,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1F receptor in CHO cells, using [3H]5-HT as radioligand",2096,Autocuration,,8,,,449.0,,,1,CHO,279,B,,,CHEMBL617132,4829,
,H,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1F receptor in CHO cells, using [3H]5-HT as radioligand",2097,Autocuration,,8,,,449.0,,,1,CHO,279,B,,,CHEMBL617133,4829,
,H,BAO_0000357,,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1F receptor was determined,2098,Autocuration,,8,,,,,,1,,279,B,,,CHEMBL617134,4373,
,H,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 1F receptor was determined,2099,Autocuration,,8,,,,,,1,,279,B,,,CHEMBL617135,4373,
,H,BAO_0000357,,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1F receptor,2100,Autocuration,,8,,,,,,1,,279,B,,,CHEMBL617136,5014,
,H,BAO_0000019,,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 (5-hydroxytryptamine-2) receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]-ketanserin as radioligand",2101,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617137,11662,
,H,BAO_0000019,,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand",2102,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617138,11662,
,H,BAO_0000019,,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 (5-hydroxytryptamine-2) receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand; Not Determined",2103,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617139,11662,
,H,BAO_0000019,,Ability to displace [3H]ketanserin from rat cortical homogenate 5-hydroxytryptamine 2A receptor,2104,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617140,14093,
,H,BAO_0000218,,"In vivo inhibitory activity of 10 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-HT2 receptor 1 hr after oral administration",2105,Autocuration,,4,,In vivo,,,,1,,104686,F,,,CHEMBL617141,11200,
,H,BAO_0000019,,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,2106,Autocuration,,4,,,,,,1,,104686,F,,,CHEMBL858112,11200,
,H,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 2 receptor in calf frontal cortex,2107,Intermediate,,8,,,,,,1,,17005,B,,,CHEMBL617142,12352,
,U,BAO_0000019,,"Binding affinity to 5-hydroxytryptamine 2 receptor using calf frontal cortex, [3H]- ketanserin, and spiperone for NSB",2108,Autocuration,,0,,,,,9913.0,1,,22226,B,Bos taurus,,CHEMBL617143,13657,
,U,BAO_0000019,,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of bovine frontal cortex at 10e-7 M,2109,Autocuration,,0,,,,,9913.0,1,,22226,B,Bos taurus,,CHEMBL617144,14331,
,U,BAO_0000019,,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of bovine frontal cortex,2110,Autocuration,,0,,,,,9913.0,1,,22226,B,Bos taurus,,CHEMBL617145,14331,
,U,BAO_0000019,,Binding affinity of compound towards 5-hydroxytryptamine 2 receptor using [3H]ketanserin (0.8 nM) ligand in frontal cortex bovine was determined,2111,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL617146,14331,
,H,BAO_0000019,,Binding affinity for serotonin 5-hydroxytryptamine 2 receptor using [3H]ketanserin in guinea pig frontal cortex,2112,Autocuration,,4,,,,,10141.0,1,,104784,B,Cavia porcellus,,CHEMBL617147,12685,
,H,BAO_0000019,,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of guinea pig frontal cortex membranes,2113,Autocuration,,4,,,,,10141.0,1,,104784,B,Cavia porcellus,,CHEMBL617148,14389,
,H,BAO_0000019,,Compound was tested for its binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]ketanserin from guinea pig frontal cortex,2114,Autocuration,,4,,,,,10141.0,1,,104784,B,Cavia porcellus,,CHEMBL617149,14386,
,H,BAO_0000224,,Binding affinity towards cloned human 5-hydroxytryptamine 2 receptor was determined,2115,Autocuration,,4,,,,,,1,,104784,B,,,CHEMBL617150,5732,
,H,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor was determined,2116,Autocuration,,4,,,,,,1,,104784,B,,,CHEMBL617151,16293,
,H,BAO_0000224,,In vitro binding affinity of compound against neuronal 5-hydroxytryptamine 2 receptor,2117,Autocuration,,4,,,,,,1,,104784,B,,,CHEMBL617201,2078,
,H,BAO_0000357,,Binding affinity towards 5-HT7 receptor by the displacement of [3H]-5-CT] in human recombinant receptors in mammalian cell,2118,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL617202,5486,
,H,BAO_0000218,,Effective dose through peroral route for in vivo inhibition against 5-hydroxytryptamine 2 receptor in male CF-1 mice by using radioligand [3H]ketanserin,2119,Autocuration,,4,,In vivo,,,,1,,104826,B,,,CHEMBL617203,11820,
,H,BAO_0000019,,Hill number was determined for inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in mouse cerebral cortex,2120,Autocuration,,4,,,,,,1,,104826,B,,,CHEMBL617204,10297,
,H,BAO_0000224,,Inhibitory activity against serotonin 5-hydroxytryptamine 2 receptor from mice.,2121,Autocuration,,4,,,,,,1,,104826,B,,,CHEMBL617205,13704,
,D,BAO_0000019,,Inhibitory activity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]ketanserin in mouse cerebral cortex,2122,Autocuration,,5,,,,,10090.0,1,,104826,B,Mus musculus,,CHEMBL617206,10297,
,H,BAO_0000218,,Effective dose through peroral route for in vivo inhibition against 5-hydroxytryptamine 2 receptor in male CF-1 mice by using radioligand [3H]ketanserin,2123,Autocuration,,4,,In vivo,,,,1,,104826,B,,,CHEMBL617207,11820,
,D,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]-ketanserin in mouse cerebral cortex,2124,Autocuration,,5,,,,,10090.0,1,,104826,B,Mus musculus,,CHEMBL617208,10297,
,H,BAO_0000224,,The compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2 receptor,2125,Autocuration,,4,,,,,,1,,104826,B,,,CHEMBL617209,11555,
,H,BAO_0000224,,In vitro binding affinity for serotonin 5-hydroxytryptamine (5-HT) 2 receptors,2126,Autocuration,,4,,,,,,1,,104826,B,,,CHEMBL617210,11555,
,H,BAO_0000224,,The compound was tested in vitro for its binding affinity towards serotonin 5-hydroxytryptamine 2 receptor; nd = no data,2127,Autocuration,,4,,,,,,1,,104826,B,,,CHEMBL617211,11555,
,D,BAO_0000019,,Hill number was determined for inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in mouse cerebral cortex,2128,Autocuration,,5,,,,,10090.0,1,,104826,B,Mus musculus,,CHEMBL617212,10297,
,H,BAO_0000224,,Binding affinity for porcine 5-hydroxytryptamine 2 receptor using [3H]- ketanserin,2129,Autocuration,,4,,,,,9823.0,1,,104784,B,Sus scrofa,,CHEMBL617213,16688,
,H,BAO_0000224,,Binding affinity for porcine 5-hydroxytryptamine 2 receptor using [3H]- ketanserin with 10 uM prazosin,2130,Autocuration,,4,,,,,9823.0,1,,104784,B,Sus scrofa,,CHEMBL617214,16688,
,U,BAO_0000221,,Compound was tested in vitro for its ability to compete with [3H]-ketanserin at 5-hydroxytryptamine 2 receptor in porcine brain homogenate,2131,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL617215,5333,
,U,BAO_0000221,,In vitro for its ability to displace [3H]- ketanserin from 5-hydroxytryptamine 2 receptor in porcine brain homogenate,2132,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL617216,4437,
,H,BAO_0000357,,Ability to displace the radioligand [3H]mesulergine from pig choroid plexus 5-hydroxytryptamine 2 receptor,2133,Autocuration,,8,,,,,9823.0,1,,17005,B,Sus scrofa,,CHEMBL617217,5033,
,H,BAO_0000019,,Inhibition of [3H]- Ketanserin binding against rat brain 5-hydroxytryptamine 2 receptor,2134,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617218,15267,
,H,BAO_0000019,,Inhibition of [3H]- Ketanserin binding against rat brain 5-hydroxytryptamine 2 receptor,2135,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL872913,15267,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2 receptor from rat cortical synaptosomal membrane using radioligand [3H]ketanserin.,2136,Autocuration,,4,,,,,,1,,104826,B,,,CHEMBL617219,11820,
,H,BAO_0000224,,Evaluated for binding activity against [3H]ketanserin as radioligand for 5-hydroxytryptamine 2 receptor,2137,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL873482,9069,
,D,BAO_0000019,,Affinity towards 5-hydroxytryptamine 2 receptor by measuring its ability to antagonize serotonin-induced contractions in the rat jugular vein; ND means no data,2138,Autocuration,,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL617220,9162,
,H,BAO_0000019,,Affinity towards 5-hydroxytryptamine 2 receptor by measuring its ability to antagonize serotonin-induced contractions in the rat jugular vein.,2139,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617221,9162,
,H,BAO_0000019,,Affinity towards 5-hydroxytryptamine 2 receptor by measuring its ability to antagonize serotonin-induced contractions in the rat jugular vein; no appreciable 5-HT2 receptor affinity,2140,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617222,9162,
,H,BAO_0000019,,Antagonistic activity against (5-hydroxytryptamine 2 receptor) serotonin-induced contractions in the rat jugular vein,2141,Autocuration,,4,,,,,,1,,104686,F,,,CHEMBL875906,10428,
,H,BAO_0000019,,Binding affinity to the 5-hydroxytryptamine 2 receptor assayed by antagonism of serotonin-induced contractions in the rat jugular vein,2142,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617223,9628,
,H,BAO_0000224,,Binding affinity against serotonin 5-hydroxytryptamine 2 receptor,2143,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617224,12704,
,D,BAO_0000224,,Percent decrease in 5-hydroxytryptamine 2 receptor binding using ketanserin,2144,Autocuration,,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL617225,15453,
,H,BAO_0000224,,Tested for the effect on binding at 5-hydroxytryptamine 2 receptor; No activity,2145,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617226,188,
,H,BAO_0000224,,Effect of 2 week administration of compound on 5-hydroxytryptamine 2 receptor binding by using 0.4 nM dose of [3H]- spiperone as a radioligand.,2146,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617227,10349,
,H,BAO_0000224,,Effect of 2 week administration of compound on 5-hydroxytryptamine 2 receptor binding by using 0.6 nM dose of [3H]- spiperone as a radioligand.,2147,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617228,10349,
,H,BAO_0000224,,Compound was tested for its effect on 5-hydroxytryptamine 2 receptor saturation analysis,2148,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617229,8868,
,H,BAO_0000224,,Concentration necessary to achieve half maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor at 1 uM,2149,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617230,10025,
,H,BAO_0000224,,"Concentration necessary to achieve half maximal inhibition of [3H]ketanserin, binds to 5-hydroxytryptamine 2 receptor at 1 uM",2150,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617231,10025,
,H,BAO_0000224,,Compound was tested for the inhibition of quipazine binding at 5-HT2 receptor,2151,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617232,11702,
,H,BAO_0000224,,Compound was tested for the inhibition of quipazine binding at 5-hydroxytryptamine 2 receptor,2152,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617233,11702,
,H,BAO_0000224,,Compound was tested for the inhibition of quipazine binding at 5-hydroxytryptamine 2 receptor; NT=Not tested,2153,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617234,11702,
,H,BAO_0000019,,Compound was tested for the inhibition of quipazine induced head twitches in rats,2154,Autocuration,,4,,,,,,1,,104686,F,,,CHEMBL617235,11702,
,H,BAO_0000019,,Compound was tested for the inhibition of quipazine induced head twitches in rats; NT=Not tested,2155,Autocuration,,4,,,,,,1,,104686,F,,,CHEMBL617236,11702,
,H,BAO_0000221,,Ability to bind at 5-hydroxytryptamine 2 receptor of rat hippocampus by displacing [3H]spiperone,2156,Autocuration,10000000.0,4,,,,,,1,,104686,B,,,CHEMBL617237,10085,Hippocampus
,H,BAO_0000221,,Ability to bind at serotonin 5-hydroxytryptamine 2 receptors of rat hippocampus by displacing [3H]spiperone,2157,Autocuration,10000000.0,4,,,,,,1,,104686,B,,,CHEMBL617238,10085,Hippocampus
,D,BAO_0000221,,Displacement of [3H]spiroperidol from 5-hydroxytryptamine 2 receptor in rat brain,2158,Autocuration,955.0,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL617239,9630,Brain
,H,BAO_0000019,,Ability to inhibit binding of [3H]KET to 5-hydroxytryptamine 2 receptor in rat cortex,2159,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617240,11070,
,H,BAO_0000249,,Ability to inhibit binding of titreated spiperone to 5-hydroxytryptamine 2 receptor in rat brain frontal cortex membranes,2160,Autocuration,,4,Membranes,,,,,1,,104686,B,,,CHEMBL617241,9841,
,H,BAO_0000249,,Ability to inhibit binding of titreated spiperone to the 5-hydroxytryptamine 2 receptor in rat brain frontal cortex membranes,2161,Autocuration,,4,Membranes,,,,,1,,104686,B,,,CHEMBL875907,9841,
,H,BAO_0000019,,Affinity for 5-hydroxytryptamine 2 receptor binding sites by its ability to displace [3H]spiperone from rat frontal cortex.,2162,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617242,13291,
,H,BAO_0000019,,Antagonistic activity against 5-hydroxytryptamine 2 receptor on rat frontal cortex membrane.,2163,Autocuration,,4,,,,,,1,,104686,F,,,CHEMBL617152,10590,
,D,BAO_0000221,,Binding affinity against serotonin-2 receptor in rat brain using [3H]spiroperidol,2164,Autocuration,955.0,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL617153,9064,Brain
,D,BAO_0000249,,Binding affinity at 5-hydroxytryptamine 2 receptor by the inhibition of binding to [3H]ketanserin in rat cortical membranes,2165,Autocuration,,5,Membranes,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL617154,12268,
,H,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 2 receptor in rat brain using [3H]ketanserin as radioligand,2166,Autocuration,955.0,4,,,,,,1,,104686,B,,,CHEMBL617155,13508,Brain
,H,BAO_0000019,,5-hydroxytryptamine 2 receptor antagonistic activity on the rat tail artery determined by Schild plot.,2167,Autocuration,,4,,,,,,1,,104686,F,,,CHEMBL617156,11279,
,H,BAO_0000019,,In vitro antagonistic activity against the contraction induced by 5-HT through 5-HT2 receptor in rat thoracic aortic strips,2168,Autocuration,,4,,,,,,1,,104686,F,,,CHEMBL617157,11200,
,H,BAO_0000019,,In vitro antagonistic activity tested against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,2169,Autocuration,,4,,,,,,1,,104686,F,,,CHEMBL617158,11200,
,H,BAO_0000019,,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips; NC=non competitive antagonism,2170,Autocuration,,4,,,,,,1,,104686,F,,,CHEMBL617159,11200,
,H,BAO_0000019,,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips; NC=non competitive antagonism,2171,Autocuration,,4,,,,,,1,,104686,F,,,CHEMBL617160,11200,
,H,BAO_0000019,,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,2172,Autocuration,,4,,,,,,1,,104686,F,,,CHEMBL858113,11200,
,H,BAO_0000220,,Tested for 5-hydroxytryptamine 2 receptor binding ability by displacement of [3H]spiperone from rat brain frontal cortex synaptosomes,2173,Autocuration,955.0,4,,,,,,1,,104686,B,,,CHEMBL617247,9231,Brain
,H,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat frontal cortex using [3H]ketanserin as radioligand,2174,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617248,9737,
,H,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,2175,Autocuration,955.0,4,,,,,,1,,104686,B,,,CHEMBL617249,9737,Brain
,H,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat frontal cortex,2176,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617250,9737,
,H,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat frontal cortex using [3H]ketanserin as radioligand,2177,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617251,9737,
,D,BAO_0000019,,isplacement of [3H]DOB from rat cortex homogenate 5-hydroxytryptamine 2 receptor,2178,Autocuration,,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL617252,11828,
,H,BAO_0000019,,Binding affinity of 5-hydroxytryptamine 2 receptor using [3H]- ketanserin in rat frontal cortex,2179,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617006,12253,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ketanserin in rat frontal cortex,2180,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617007,12253,
,H,BAO_0000019,,"5-hydroxytryptamine 2 receptor antagonistic activity at concentrations of<br>3,10 and 30 uM on the rat tail artery.",2181,Autocuration,,4,,,,,,1,,104686,F,,,CHEMBL617008,11279,
,H,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 2 receptor in rat cortex using [3H]- ketanserin,2182,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617009,11866,
,D,BAO_0000224,,Binding affinity against 5-hydroxytryptamine 2 receptor in serotonin-induced contraction of the rat aorta,2183,Autocuration,,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL617010,14424,
,D,BAO_0000019,,Displacement of [3H]ketanserin from rat brain 5-hydroxytryptamine 2 receptor,2184,Autocuration,,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL857978,15180,
,D,BAO_0000019,,Displacement of [3H]ketanserin from rat brain 5-hydroxytryptamine 2 receptor,2185,Autocuration,,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL617011,15180,
,D,BAO_0000019,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat frontal cortex homogenate,2186,Autocuration,,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL617012,9786,
,H,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]-ketanserin as radioligand.,2187,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617013,12132,
,H,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]ketanserin in rat cerebral cortex membrane,2188,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617014,5486,
,H,BAO_0000019,,Compound was evaluated for its ability to displace [3H]ketanserin binding from cloned rat cerebral cortex membranes 5-hydroxytryptamine 2 receptor,2189,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617015,15316,
,H,BAO_0000019,,In vitro binding affinity to 5-hydroxytryptamine 2 receptor of rat cerebral cortex membranes using [3H]ketanserin as the radioligand,2190,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617016,16429,
,H,BAO_0000224,,pKi value for 5-hydroxytryptamine 2 receptor binding site,2191,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617017,14617,
,H,BAO_0000221,,Inhibitory constant (1 uM) was measured on 5-hydroxytryptamine 2 receptor/uptake using [3H]- ketanserin as radioligand in rat brain cortex.,2192,Autocuration,955.0,4,,,,,,1,,104686,B,,,CHEMBL617018,11351,Brain
,H,BAO_0000019,,5-hydroxytryptamine 2 receptor antagonistic activity on the rat tail artery determined by Schild plot.,2193,Autocuration,,4,,,,,,1,,104686,F,,,CHEMBL617019,11279,
,H,BAO_0000019,,Binding affinity at 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,2194,Autocuration,,4,,,,,,1,,105075,B,,,CHEMBL617020,9523,
,H,BAO_0000019,,Binding affinity at 5-hydroxytryptamine 2 receptor was determined using [125I]- DOI as radioligand in rat frontal cortex,2195,Autocuration,,4,,,,,,1,,105075,B,,,CHEMBL617021,9523,
,H,BAO_0000019,,Binding affinity at [3H]DOB labeled sites of 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,2196,Autocuration,,4,,,,,,1,,105075,B,,,CHEMBL617022,9523,
,H,BAO_0000019,,Binding affinity at [3H]DOB labeled sites of 5-hydroxytryptamine 2 receptor was determined using [125I]- DOI as radioligand in rat frontal cortex,2197,Autocuration,,4,,,,,,1,,105075,B,,,CHEMBL617023,9523,
,H,BAO_0000019,,Binding affinity at [3H]KET labeled sites of 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,2198,Autocuration,,4,,,,,,1,,105075,B,,,CHEMBL617024,9523,
,H,BAO_0000019,,Binding affinity at [3H]KET labeled sites of 5-hydroxytryptamine 2 receptor was determined using [125I]- DOI as radioligand in rat frontal cortex,2199,Autocuration,,4,,,,,,1,,105075,B,,,CHEMBL617025,9523,
,H,BAO_0000224,,Hill coefficient of compound was determined,2200,Autocuration,,4,,,,,,1,,105075,B,,,CHEMBL617026,9523,
,U,BAO_0000019,,Ancillary Binding affinity towards rat 5-hydroxytryptamine 2 receptor,2201,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL617027,4771,
,D,BAO_0000019,,Ability to displace the radioligand [3H]5-carboximidotryptamine ([3H]-ketanserin) from 5-hydroxytryptamine 2 receptor of rat cerebral cortex membrane,2202,Autocuration,,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL617028,5033,
,H,BAO_0000019,,Binding affinity against rat 5-hydroxytryptamine 2 receptor in rat cerebral cortex tissue using [3H]spiperone as radioligand,2203,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617029,10845,
,H,BAO_0000019,,Binding affinity against rat 5-hydroxytryptamine 2 receptor in rat cerebral cortex tissue using [3H]spiperone as radioligand; IA-Inactive,2204,Expert,,8,,,,,,1,,12687,B,,,CHEMBL875908,10845,
,H,BAO_0000357,,Affinity at 5-hydroxytryptamine 2 receptor (For ketanserin = Ki(nM)= 0.7+/-0.09),2205,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617030,16288,
,H,BAO_0000019,,Affinity at 5-hydroxytryptamine 2 receptor from rat frontal cortex using [3H]ketanserin as radioligand (For ketanserin = Ki(nM)=0.7+/-0.09),2206,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617031,16288,
,H,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 2 receptor of rat cortical membrane using [3H]DOB radioligand,2207,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617032,16190,
,D,BAO_0000224,,Tested in vitro for receptor binding affinity against 5-hydroxytryptamine 2 receptor using radioligand [3H]ketanserin,2208,Autocuration,,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL617033,12463,
,H,BAO_0000224,,"Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- 1-(4-bromo-2,5-dimethoxy-phenyl)-2-aminopropane (D) as radioligand",2209,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617034,9699,
,H,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- ketanserin as radioligand,2210,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617035,9699,
,H,BAO_0000019,,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand; Not Determined",2211,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617036,11662,
,H,BAO_0000224,,Inhibitory concentration against 5-hydroxytryptamine 2 receptor,2212,Autocuration,,4,,,,,,1,,104784,B,,,CHEMBL617037,1205,
,U,BAO_0000219,,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2 receptor from mammalian clones expressed in CHO cell membranes using [3H]-ketanserin as radioligand,2213,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL617038,11376,
,H,BAO_0000219,,"Binding affinity towards 5-hydroxytryptamine 2 receptor expressed in CHO cell membranes using [3H]ketanserin (60 Ci/mmol, 1 nM)",2214,Autocuration,,4,,,,,,1,,104784,B,,,CHEMBL617039,11376,
,H,BAO_0000224,,Compound was tested for binding affinity against 5-hydroxytryptamine 2 receptor,2215,Autocuration,,4,,,,,,1,,104784,B,,,CHEMBL617161,4639,
,H,BAO_0000224,,Compound was tested for inhibitory activity against 5-hydroxytryptamine 2 receptor,2216,Autocuration,,4,,,,,,1,,104784,B,,,CHEMBL617162,2222,
,H,BAO_0000224,,Compound was tested for its affinity towards 5-hydroxytryptamine 2 receptor,2217,Autocuration,,4,,,,,,1,,104784,B,,,CHEMBL617163,1558,
,H,BAO_0000224,,Tested for binding affinity for 5-hydroxytryptamine 2 receptor,2218,Autocuration,,4,,,,,,1,,104784,B,,,CHEMBL617164,1089,
,H,BAO_0000249,,The compound was evaluated for its ability to displace [3H]ketanserin from 5-hydroxytryptamine 2 receptor in cellular brain membranes,2219,Autocuration,,4,Brain membranes,,,,,1,,104784,B,,,CHEMBL617165,386,
,H,BAO_0000224,,Compound was measured for its binding affinity at 5-hydroxytryptamine 2 receptor at a concentration of 10 uM using [3H]ketanserin as radioligand,2220,Autocuration,,4,,,,,,1,,104784,B,,,CHEMBL617166,2474,
,H,BAO_0000224,,Binding affinity towards 5-HT2 receptor,2221,Autocuration,,4,,,,,,1,,104784,B,,,CHEMBL617167,17066,
,H,BAO_0000224,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor,2222,Autocuration,,4,,,,,,1,,104784,B,,,CHEMBL872912,959,
,H,BAO_0000224,,Compound was evaluated for 5-hydroxytryptamine 2 receptor binding,2223,Autocuration,,4,,,,,,1,,104784,B,,,CHEMBL617168,6398,
,H,BAO_0000224,,In vitro binding affinity against rat 5-hydroxytryptamine 2 receptor.,2224,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617169,11889,
,H,BAO_0000224,,In vitro binding affinity for 5-hydroxytryptamine 2 receptor,2225,Autocuration,,4,,,,,,1,,104784,B,,,CHEMBL617170,4221,
,H,BAO_0000224,,The compound was tested for binding affinity against 5-hydroxytryptamine 2 receptor using ketanserin as radioligand,2226,Autocuration,,4,,,,,,1,,104784,B,,,CHEMBL617171,11026,
,H,BAO_0000224,,Binding affinity for 5-hydroxytryptamine 2 receptor was determined,2227,Autocuration,,4,,,,,,1,,104784,B,,,CHEMBL617172,11866,
,H,BAO_0000224,,In vitro binding affinity for 5-hydroxytryptamine 2 receptor,2228,Autocuration,,4,,,,,,1,,104784,B,,,CHEMBL617173,4221,
,U,BAO_0000019,,In Vitro binding affinity for 5-hydroxytryptamine 2 receptor,2229,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL617174,13950,
,H,BAO_0000224,,5-hydroxytryptamine 2 receptor binding affinity,2230,Autocuration,,4,,,,,,1,,104784,B,,,CHEMBL617175,1263,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2 receptor was determined using [ [3H]spiperone radioligand,2231,Autocuration,,8,,,,,,1,,17005,B,,,CHEMBL617176,13291,
,H,BAO_0000357,,Compound was tested for the binding affinity against 5-hydroxytryptamine 2 receptor by using [3H]ketanserin as radioligand,2232,Autocuration,,8,,,,,,1,,17005,B,,,CHEMBL617177,10812,
,H,BAO_0000224,,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor at 10e-5 M,2233,Autocuration,,4,,,,,,1,,104784,B,,,CHEMBL617178,13020,
,H,BAO_0000224,,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of central nervous system,2234,Autocuration,,4,,,,,,1,,104784,B,,,CHEMBL617179,13021,
,H,BAO_0000224,,Ketanserin binding to 5-hydroxytryptamine 2 receptor at 10e-5 M,2235,Autocuration,,4,,,,,,1,,104784,B,,,CHEMBL617180,13020,
,H,BAO_0000357,,Inhibitory activity against 5-hydroxytryptamine 2 receptor using [3H]-ketanserin as radioligand at 10e-5 M concentration,2236,Autocuration,,8,,,,,,1,,17005,B,,,CHEMBL617181,14532,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2 receptor,2237,Autocuration,,8,,,,,,1,,17005,B,,,CHEMBL617182,13944,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2 receptor,2238,Autocuration,,8,,,,,,1,,17005,B,,,CHEMBL617183,14331,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ketanserin as radioligand,2239,Autocuration,,8,,,,,,1,,17005,B,,,CHEMBL617184,14118,
,H,BAO_0000357,,Binding affinity against serotonergic 5-HT2 receptor,2240,Autocuration,,8,,,,,,1,,17005,B,,,CHEMBL617185,13033,
,H,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 2 receptor was determined by using [3H]ketanserin as radioligand,2241,Autocuration,,8,,,,,,1,,17005,B,,,CHEMBL617186,10321,
,H,BAO_0000357,,Compound was evaluated for the binding affinity at 5- HT2 receptor,2242,Autocuration,,8,,,,,,1,,17005,B,,,CHEMBL617187,12918,
,H,BAO_0000357,,Compound was tested for binding affinity using [3H]ketanserin against 5-hydroxytryptamine 2 receptor,2243,Autocuration,,8,,,,,,1,,17005,B,,,CHEMBL617188,15120,
,H,BAO_0000218,,In vivo binding affinity was evaluated against 5-hydroxytryptamine 2 receptor,2244,Autocuration,,8,,,,,,1,,17005,B,,,CHEMBL617189,2613,
,D,BAO_0000224,,Inhibitory activity against cloned human 5-HT2 receptor,2245,Autocuration,,5,,,,,9606.0,1,,104784,B,Homo sapiens,,CHEMBL617190,13378,
,D,BAO_0000219,,"Tested in vitro for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells",2246,Autocuration,,5,,,449.0,,9606.0,1,CHO,104784,B,Homo sapiens,,CHEMBL617191,2331,
,D,BAO_0000219,,"Tested in vitro for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells.",2247,Autocuration,,5,,,449.0,,9606.0,1,CHO,104784,B,Homo sapiens,,CHEMBL617192,2331,
,D,BAO_0000219,,"Tested in vitro for the inhibition of [3H]-ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells; Inactive",2248,Autocuration,,5,,,449.0,,9606.0,1,CHO,104784,B,Homo sapiens,,CHEMBL617193,2331,
,D,BAO_0000219,,"Tested in vitro for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells; not tested",2249,Autocuration,,5,,,449.0,,9606.0,1,CHO,104784,B,Homo sapiens,,CHEMBL617194,2331,
,H,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor,2250,Autocuration,,4,,,,,,1,,104784,B,,,CHEMBL617195,4170,
,H,BAO_0000224,,Percent decrease in 5-hydroxytryptamine 2 receptor binding using ketanserin,2251,Autocuration,,4,,,,,,1,,104784,B,,,CHEMBL881830,15453,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2 receptor,2252,Autocuration,,8,,,,,,1,,17005,B,,,CHEMBL617196,1479,
,H,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2- receptor using [3H]ketanserin as radioligand in competitive binding assay,2253,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617197,11139,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2A receptor was measured using [3H]ketanserin as radioligand,2254,Expert,,8,,,,,,1,,17005,B,,,CHEMBL617198,13969,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor,2255,Expert,,8,,,,,,1,,17005,B,,,CHEMBL873476,13392,
,H,BAO_0000019,,Affinity towards 5-hydroxytryptamine 2A receptor in membranes from bovine frontal cortex using [3H]ketanserin,2256,Expert,,8,,,,,,1,,17005,B,,,CHEMBL617199,14430,
,H,BAO_0000357,,Binding affinity was determined against 5-hydroxytryptamine 2A receptor,2257,Autocuration,,8,,,,,10141.0,1,,107,B,Cavia porcellus,,CHEMBL617200,13181,
,H,BAO_0000357,,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,2258,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL617484,17200,
,H,BAO_0000357,,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,2259,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617485,17200,
,H,BAO_0000357,,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,2260,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL617486,17200,
,H,BAO_0000357,,Binding affinity analysed on 5-HT 2A human clone using [3H]ketanserin as radioligand,2261,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL858022,13463,
,H,BAO_0000219,,Effective concentration against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand,2262,Autocuration,,8,,,449.0,,,1,CHO,107,B,,,CHEMBL617049,6347,
,D,BAO_0000219,,Functional activity against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader,2263,Expert,,9,,,449.0,,9606.0,1,CHO,107,F,Homo sapiens,,CHEMBL617050,6857,
,H,BAO_0000219,,Functional agonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2a receptor cell line,2264,Autocuration,,8,,,,,,1,,107,F,,,CHEMBL617051,4176,
,H,BAO_0000219,,Functional agonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2a receptor cell line; no data,2265,Autocuration,,8,,,,,,1,,107,F,,,CHEMBL617052,4176,
,H,BAO_0000219,,Functional antagonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2a receptor cell line,2266,Autocuration,,8,,,,,,1,,107,F,,,CHEMBL617053,4176,
,H,BAO_0000219,,"Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand, expressed as Emax",2267,Autocuration,,8,,,449.0,,,1,CHO,107,B,,,CHEMBL617054,6347,
,H,BAO_0000219,,"Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells, expressed as Emax",2268,Autocuration,,8,,,449.0,,,1,CHO,107,B,,,CHEMBL617055,6347,
,H,BAO_0000357,,Affinity of compound towards human 5-hydroxytryptamine 2A receptor was evaluated using radioligand binding technique,2269,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL882924,15331,
,D,BAO_0000357,,Inhibition of human 5-hydroxytryptamine 2A receptor,2270,Expert,,9,,,,,9606.0,1,,107,B,Homo sapiens,,CHEMBL617056,16146,
,H,BAO_0000219,,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,2271,Autocuration,,8,,,449.0,,,1,CHO,107,B,,,CHEMBL617057,15250,
,H,BAO_0000219,,Inhibitory concentration against human 5-HT2A receptor in BEK cells,2272,Expert,,8,,,,,,1,,107,B,,,CHEMBL617058,13631,
,H,BAO_0000357,,In vitro binding affinity against human 5-hydroxytryptamine 2A receptor at a concentration of 100 (nM),2273,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617059,3805,
,H,BAO_0000219,,Ability to displace [3H]ketanserin from CHO cells expressing human 5-hydroxytryptamine 2A receptor was determined,2274,Autocuration,,8,,,449.0,,,1,CHO,107,B,,,CHEMBL617060,4011,
,H,BAO_0000219,,Displacement of [3H]ketanserin from CHO cells expressing human 5-hydroxytryptamine 2A receptor.,2275,Expert,,8,,,449.0,,,1,CHO,107,B,,,CHEMBL617061,4012,
,H,BAO_0000219,,Ability to displace [125I]R91150 from human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells,2276,Expert,,8,,,307.0,,,1,L929,107,B,,,CHEMBL617062,6366,
,H,BAO_0000219,,Ability to displace [3H]ketanserin binding to human 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,2277,Expert,,8,,,449.0,,,1,CHO,107,B,,,CHEMBL617063,15949,
,H,BAO_0000019,,Agonist activity at cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI radioligand,2278,Autocuration,,8,,,,,,1,,107,F,,,CHEMBL617064,14093,
,H,BAO_0000019,,Agonistic activity at cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,2279,Autocuration,,8,,,,,,1,,107,F,,,CHEMBL617065,13481,
,H,BAO_0000219,,Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand,2280,Autocuration,,8,,,449.0,,,1,CHO,107,B,,,CHEMBL617066,6347,
,H,BAO_0000219,,Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand; Nd means not done,2281,Autocuration,,8,,,449.0,,,1,CHO,107,B,,,CHEMBL617067,6347,
,H,BAO_0000019,,Antagonist activity at cloned human 5-hydroxytryptamine 2A receptor using [3H]-Ketanserin radioligand,2282,Autocuration,,8,,,,,,1,,107,F,,,CHEMBL617068,14093,
,H,BAO_0000019,,Antagonist activity at cloned human 5-hydroxytryptamine 2A receptor using [3H]ketanserin radioligand; Not tested,2283,Autocuration,,8,,,,,,1,,107,F,,,CHEMBL617069,14093,
,H,BAO_0000019,,Antagonistic activity at cloned human 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,2284,Autocuration,,8,,,,,,1,,107,F,,,CHEMBL617070,13481,
,H,BAO_0000357,,Binding ability of compound at cloned human 5-hydroxytryptamine 2A receptor using [125 I]DOI as radioligand,2285,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617071,14442,
,H,BAO_0000357,,Binding ability of compound at cloned human 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,2286,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL872915,14442,
,H,BAO_0000357,,Binding activity against cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI as the radioligand.,2287,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617072,14755,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2A receptor in humans,2288,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617073,16441,
,H,BAO_0000357,,Binding affinity against the cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI as the radioligand,2289,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617074,14744,
,H,BAO_0000219,,Binding affinity for displacement of [3H]ketanserin to human 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,2290,Expert,,8,,,449.0,,,1,CHO,107,B,,,CHEMBL617075,16659,
,H,BAO_0000357,,Binding affinity of compound to human 5-hydroxytryptamine 2A receptor,2291,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617076,3307,
,D,BAO_0000019,,Affinity for human 5-hydroxytryptamine 2A receptor expressed in mammalian cell line,2292,Expert,,9,,,,,9606.0,1,,107,B,Homo sapiens,,CHEMBL617077,6857,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2A receptor using [125I]DOI radioligand.,2293,Expert,,8,,,,,,1,,107,B,,,CHEMBL617078,5635,
,D,BAO_0000357,,Binding affinity to cloned human 5-hydroxytryptamine 2A receptor,2294,Expert,,9,,,,,9606.0,1,,107,B,Homo sapiens,,CHEMBL617079,4234,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]5-HT as radioligand.,2295,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617080,15527,
,H,BAO_0000219,,Binding affinity towards human 5-hydroxytryptamine 2A receptor by the displacement of [3H]ketanserin radioligand from the cloned receptor expressed in CHO cells,2296,Expert,,8,,,449.0,,,1,CHO,107,B,,,CHEMBL617081,6588,
,H,BAO_0000219,,Binding affinity towards human 5-HT2A receptor in BEK cells,2297,Expert,,8,,,,,,1,,107,B,,,CHEMBL617082,13631,
,H,BAO_0000357,,Binding affinity towards human serotonin 5-hydroxytryptamine 2A receptor,2298,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617083,17723,
,H,BAO_0000357,,Binding affinity for recombinant human 5-hydroxytryptamine 2A receptor using [3H]5-HT as radioligand.,2299,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617084,14770,
,D,BAO_0000357,,Binding affinity for human 5-hydroxytryptamine 2A receptor,2300,Expert,,9,,,,,9606.0,1,,107,B,Homo sapiens,,CHEMBL617085,16293,
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,2301,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617086,16209,
,H,BAO_0000219,,Binding affinity was measured on 5-hydroxytryptamine 2A receptor in GF6 cells transfected with human 5-HT2A gene labeled with [3H]ketanserin,2302,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617087,12469,
,H,BAO_0000357,,Compound was tested for the displacement of [125I]-DOI from clone human 5-hydroxytryptamine 2A receptor,2303,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617088,15363,
,H,BAO_0000357,,Compound was tested for the displacement of [125I]DOI from cloned human 5-hydroxytryptamine 2A receptor,2304,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617089,15363,
,H,BAO_0000019,,"Tested on genetically transfected COS7 cell membranes selectively expressing human 5-hydroxytryptamine 2A receptor, using [3H]ketanserin as radioligand",2305,Expert,,8,,,,,,1,,107,B,,,CHEMBL617090,16441,
,H,BAO_0000357,,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor in human using [3H]ketanserin as radioligand,2306,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617513,8,
,H,BAO_0000219,,In vitro binding affinity towards human 5-hydroxytryptamine 2A receptor expressed in HEK293 cells was determined using [3H]ketanserin as radioligand,2307,Autocuration,,8,,,722.0,,,1,HEK293,107,B,,,CHEMBL617514,4176,
,H,BAO_0000019,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 2A receptor,2308,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617515,17085,
,H,BAO_0000357,,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,2309,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617516,17200,
,D,BAO_0000357,,Inhibitory constant determined against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,2310,Expert,,9,,,,,9606.0,1,,107,B,Homo sapiens,,CHEMBL617517,17200,
,D,BAO_0000219,,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2A receptor expressed in CHO cells,2311,Expert,,9,,,449.0,,9606.0,1,CHO,107,B,Homo sapiens,,CHEMBL617518,4013,
,H,BAO_0000357,,Tested for binding affinity towards 5-hydroxytryptamine 2A receptor,2312,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617519,5088,
,D,BAO_0000357,,Displacement of [3H]DOB from human 5-hydroxytryptamine 2A receptor,2313,Expert,,9,,,,,9606.0,1,,107,B,Homo sapiens,,CHEMBL617520,5088,
,H,BAO_0000357,,Tested for binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]DOB as labeled ligand; binding data not obtained,2314,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617521,5088,
,D,BAO_0000357,,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2A receptor,2315,Expert,,9,,,,,9606.0,1,,107,B,Homo sapiens,,CHEMBL617522,5088,
,H,BAO_0000357,,Tested for binding affinity towards human 5-hydroxytryptamine 2A receptor using [3H]5-HT as radioligand,2316,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617523,5088,
,H,BAO_0000357,,Tested for binding affinity towards human 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,2317,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617524,5088,
,H,BAO_0000019,,Ability to displace 0.75 nM [3H]ketanserin in 5-hydroxytryptamine 2 receptor from rat frontal cortex homogenate,2318,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617525,9786,
,D,BAO_0000019,,Ability to inhibit [3H]spiperone binding to 5-hydroxytryptamine 2 receptor determined in rat,2319,Autocuration,,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL617526,9205,
,H,BAO_0000224,,Affinity on 5-hydroxytryptamine 2 receptor labeled by [125I]DOI,2320,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617527,11257,
,H,BAO_0000019,,Affinity towards [3H]- DOB -labeled 5-hydroxytryptamine 2 receptor sites in rat cortical homogenates,2321,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617528,9362,
,H,BAO_0000019,,Affinity towards [3H]- ketanserin-labeled 5-hydroxytryptamine 2 receptor sites in rat cortical homogenates,2322,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617529,9362,
,H,BAO_0000224,,Inhibition of 5-hydroxytryptamine 2 induced vasoconstriction of rat caudal artery.,2323,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617530,10590,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2 receptor of rat frontal cortex using [3H]ketanserin radioligand,2324,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617531,10468,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2 receptor from rat frontal cortex using [125]-(R)-DOI as radioligand,2325,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617532,13050,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2 receptor in rat using [3H]ketanserin as radioligand,2326,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617533,11624,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2 receptor of rat frontal cortex using [3H]ketanserin radioligand,2327,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617534,10468,
,H,BAO_0000224,,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ketanserin as radioligand,2328,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617535,10330,
,H,BAO_0000224,,Binding affinity at rat 5-hydroxytryptamine 2 receptor by [3H]ketanserin displacement.,2329,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617536,10062,
,H,BAO_0000224,,Binding affinity determined in radioreceptor binding assay by using [3H]ketanserin radioligand against 5-hydroxytryptamine 2 receptor,2330,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617537,11642,
,H,BAO_0000224,,Binding affinity determined in radioreceptor binding assay by using [3H]ketanserin radioligand against 5-hydroxytryptamine 2 receptor,2331,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617538,10062,
,H,BAO_0000219,,Binding affinity of [3H]ketanserin towards 5-hydroxytryptamine 2 receptor in cloned mammalian receptor expressed in cultured cells or from rat whole brain.,2332,Autocuration,,4,,In vitro,,,,1,,104686,B,,,CHEMBL617539,13427,
,D,BAO_0000224,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor,2333,Autocuration,,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL617540,12280,
,D,BAO_0000224,,Binding affinity for 5-hydroxytryptamine 2 receptor from striata of male Wistar rats by displacement of [3H]ketanserin,2334,Autocuration,,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL617541,4101,
,H,BAO_0000224,,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 2 receptor,2335,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617542,10062,
,H,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]DOB as,2336,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617543,11147,
,D,BAO_0000219,,Binding affinity against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor expressed in CHO-K1 cells,2337,Autocuration,,5,,,485.0,,10116.0,1,CHO-K1,104686,B,Rattus norvegicus,,CHEMBL617544,2395,
,D,BAO_0000219,,Binding affinity against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor expressed in CHO-K1 cells,2338,Autocuration,,5,,,485.0,,10116.0,1,CHO-K1,104686,B,Rattus norvegicus,,CHEMBL617545,2395,
,D,BAO_0000019,,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- DOB as a radioligand,2339,Autocuration,,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL617413,9098,
,H,BAO_0000019,,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- DOB as a radioligand.,2340,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617414,9098,
,D,BAO_0000019,,Binding affinity to 5-hydroxytryptamine 2 receptor of rat cortical membranes using [3H]- DOB; ND means no data.,2341,Autocuration,,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL617415,9098,
,H,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor,2342,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617416,9443,
,H,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor at 1.0 uM concentration,2343,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617417,9443,
,H,BAO_0000019,,"Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- 1-(4-bromo-2,5-dimethoxy-phenyl)-2-aminopropane (D) as radioligand in rat frontal cortex",2344,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617418,9699,
,H,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- ketanserin as radioligand in rat frontal cortex,2345,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617419,9699,
,H,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor was determined,2346,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617420,9098,
,D,BAO_0000224,,Affinity for 5-hydroxytryptamine 2 receptor,2347,Autocuration,,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL617421,3070,
,H,BAO_0000224,,Binding affinity towards serotonin 5-hydroxytryptamine 2 receptor of rat determined using 0.5 nM of [3H]ketanserin in binding assay,2348,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617422,9547,
,H,BAO_0000019,,Binding affinity was determined against 5-hydroxytryptamine 2 receptor from male Sprague-Dawley rat brain.,2349,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617423,10444,
,H,BAO_0000019,,Binding affinity which represents concentration giving half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor from rat tissue homogenate,2350,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617424,14617,
,H,BAO_0000019,,Binding affinity which represents concentration giving half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor rat tissue homogenate,2351,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617425,14617,
,H,BAO_0000224,,Binding constant against 5-hydroxytryptamine 2 receptor (in vitro),2352,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617426,11130,
,H,BAO_0000218,,Binding constant against 5-hydroxytryptamine 2 receptor (in vivo),2353,Autocuration,,4,,In vivo,,,,1,,104686,B,,,CHEMBL617427,11130,
,H,BAO_0000221,,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]ketanserin in rat brain,2354,Autocuration,955.0,4,,,,,,1,,104686,B,,,CHEMBL617428,14542,Brain
,H,BAO_0000224,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2 receptor from rat,2355,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617429,2797,
,H,BAO_0000019,,Compound was evaluated for in vitro binding affinity towards 5-hydroxytryptamine 2 receptor in rat cortex using [3H]- spiperone as radioligand,2356,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617430,11332,
,H,BAO_0000019,,Compound was evaluated for in vitro binding affinity towards serotonin 5-hydroxytryptamine 2 receptor in rat cortex using [3H]- spiperone as radioligand,2357,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617431,11332,
,H,BAO_0000019,,Compound was evaluated for its ability to displace 0.25 nM [125I](R)-DOI from binding sites in rat frontal cortex.,2358,Autocuration,1870.0,4,,,,,,1,,104686,B,,,CHEMBL617432,10752,Frontal cortex
,H,BAO_0000224,,Ability to displace [3H]ketanserin from serotonergic 5-hydroxytryptamine 2 receptor,2359,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617433,1185,
,H,BAO_0000224,,Compound was evaluated for its ability to displace [3H]ketanserin from serotonergic 5-hydroxytryptamine 2 receptor,2360,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617434,1185,
,D,BAO_0000224,,Binding affinity against 5-Hydroxy tryptamine 2 (5-hydroxytryptamine 2)receptor,2361,Autocuration,,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL617435,11624,
,H,BAO_0000019,,Compound was evaluated for its binding affinity to 5-hydroxytryptamine 2 receptor in rat cortex using [3H]ketanserin radioligand assay,2362,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617436,1344,
,D,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2 receptor in rat striatum using [3H]-RP62203,2363,Autocuration,2435.0,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL617437,15453,Striatum
,H,BAO_0000019,,"Binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand",2364,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617438,11662,
,H,BAO_0000019,,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand; Not Determined",2365,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617439,11662,
,H,BAO_0000224,,Compound was tested in vitro for binding affinity for 5-hydroxytryptamine 2 receptor,2366,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617440,10796,
,H,BAO_0000224,,Evaluated for binding activity against [3H]ketanserin as radioligand for 5-hydroxytryptamine 2 receptor,2367,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617441,9069,
,D,BAO_0000019,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat cortical membrane homogenates,2368,Autocuration,,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL872918,8814,
,D,BAO_0000019,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat cortex,2369,Autocuration,,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL617442,8908,
,H,BAO_0000019,,Evaluated for the binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand; ND means no data.,2370,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617443,9098,
,H,BAO_0000019,,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 (5-HT2) receptor using [3H]KET as a radioligand,2371,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617444,9098,
,H,BAO_0000019,,Evaluated for the binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand; ND means no data.,2372,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617445,9098,
,H,BAO_0000019,,Evaluated for the binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand.,2373,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617446,9098,
,H,BAO_0000249,,Binding affinity to 5-hydroxytryptamine 2 receptor in rat frontal cortical membranes by [3H]- KET displacement.,2374,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617447,9098,
,H,BAO_0000019,,Evaluated for the binding affinity to rat frontal cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand.;ND is not determined,2375,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617448,9098,
,H,BAO_0000019,,Evaluated for the binding affinity to rat frontal cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand;ND means no data,2376,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617449,9098,
,H,BAO_0000019,,In vitro binding affinity at 5-hydroxytryptamine 2 receptor in rat cortical tissue by [3H]spiperone displacement; No data.,2377,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617450,9161,
,H,BAO_0000019,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 165 to 263,2378,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617451,9161,
,H,BAO_0000019,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 2.4 to 5.3,2379,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617452,9161,
,H,BAO_0000019,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]-Spiperone as the radioligand in rat cortical tissue.,2380,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617453,9161,
,H,BAO_0000019,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue.; value may range from 140 to 980,2381,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617660,9161,
,H,BAO_0000019,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue.; value may range from 76 to 299,2382,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617661,9161,
,H,BAO_0000019,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]-Spiperone as the radioligand in rat cortical tissue; value may range from 12 to 66,2383,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617662,9161,
,H,BAO_0000019,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 136 to 220,2384,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL872919,9161,
,H,BAO_0000019,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 197 to 341,2385,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617663,9161,
,H,BAO_0000019,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 23 to 187,2386,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617664,9161,
,H,BAO_0000019,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 29 to 132,2387,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617665,9161,
,H,BAO_0000019,,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 6 to 75,2388,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617666,9161,
,H,BAO_0000019,,In vitro binding affinity on 5-hydroxytryptamine 2 receptor is inhibition of binding of [125I]- I-LSD to P11 cells,2389,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617667,12094,
,H,BAO_0000249,,In vitro binding affinity towards 5-hydroxytryptamine 2 receptor in rat striatal membranes by [3H]ketanserin displacement.,2390,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617668,12018,
,H,BAO_0000249,,Inhibitory activity against 5-hydroxytryptamine 2 receptor in rat cortical membranes using [3H]ketanserin as a radioligand,2391,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617669,10394,
,H,BAO_0000224,,Inhibitory activity against rat cortical 5-hydroxytryptamine 2 receptor,2392,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617670,15260,
,D,BAO_0000224,,Inhibitory constant against 5-hydroxytryptamine 2 receptor,2393,Autocuration,,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL617671,11624,
,H,BAO_0000224,,Percentage specific displacement of radioligand [3H]-ketanserin from 5-hydroxytryptamine 2 receptor,2394,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617672,13654,
,H,BAO_0000019,,Potency to displace [3H]- Spiperone from 5-hydroxytryptamine 2 receptor in rat striatum,2395,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617673,9541,
,H,BAO_0000224,,Tested for binding affinity against 5-hydroxytryptamine 2 receptor from rat frontal cortical regions using [3H]ketanserin as radioligand,2396,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617674,11933,
,H,BAO_0000019,,Tested for binding affinity by measuring displacement of [3H]ketanserin from rat serotonin 5-hydroxytryptamine 2 receptor in rat cortex,2397,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617675,15538,
,H,BAO_0000019,,Tested for binding affinity by measuring displacement of [3H]ketanserin from rat serotonin 5-hydroxytryptamine 2 receptor in rat cortex; NA means Not Active,2398,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617676,15538,
,H,BAO_0000019,,Tested for binding affinity by measuring displacement of [3H]ketanserin from rat serotonin 5-hydroxytryptamine 2 receptor in rat cortex; not determined,2399,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617677,15538,
,D,BAO_0000019,,Displacement of [3H]ketanserin from rat prefrontal cortex 5-hydroxytryptamine 2 receptor,2400,Autocuration,,5,,,,,,1,,104686,B,,,CHEMBL617678,8841,
,H,BAO_0000224,,Binding affinity to 5-hydroxytryptamine 2 receptor using [3H]ketanserin radioligand assay.,2401,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617679,1455,
,H,BAO_0000224,,Tested for its binding affinity to Tested for its binding affinity to 5-hydroxytryptamine 2 receptor using [3H]-ketanserin radioligand assay using [3H]-ketanserin radioligand assay,2402,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617680,1455,
,H,BAO_0000019,,The ability to inhibit [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in rat whole brain,2403,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617681,11752,
,H,BAO_0000221,,The binding affinity was measured on 5-hydroxytryptamine 2 receptor in rat brain tissue,2404,Autocuration,955.0,4,,,,,,1,,104686,B,,,CHEMBL617682,11642,Brain
,H,BAO_0000224,,The binding affinity was measured on 5-hydroxytryptamine 2 receptor using [3H]- spiperone as radioligand.,2405,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617683,12092,
,H,BAO_0000224,,Binding affinity at 5-hydroxytryptamine 2 receptor from striata wistar rats by [3H]ketanserin displacement.,2406,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617684,3967,
,D,BAO_0000224,,Binding affinity towards 5-hydroxytryptamine 2 receptor,2407,Autocuration,,5,,,,,10116.0,1,,104686,B,Rattus norvegicus,,CHEMBL617685,12771,
,H,BAO_0000019,,The compound was tested for its binding affinity towards 5-hydroxytryptamine 2 receptor by displacing [3H]ketanserin radioligand in rat cerebral cortex,2408,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617686,11642,
,H,BAO_0000224,,The compound was tested in vitro for binding affinity towards 5-hydroxytryptamine 2 receptor by displacing [125]I-LSD radioligand,2409,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617687,11628,
,H,BAO_0000224,,Percentage specific displacement of radioligand [3H]ketanserin from 5-hydroxytryptamine 2 receptor,2410,Autocuration,,4,,,,,,1,,104686,B,,,CHEMBL617688,13654,
,H,BAO_0000019,,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,2411,Autocuration,,4,,,,,,1,,104686,F,,,CHEMBL617689,11200,
,H,BAO_0000019,,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,2412,Autocuration,,4,,,,,,1,,104686,F,,,CHEMBL617690,11200,
,H,BAO_0000218,,"In vivo inhibitory activity of 10 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 1 hr after oral administration",2413,Autocuration,,4,,In vivo,,,,1,,104686,F,,,CHEMBL617691,11200,
,H,BAO_0000218,,"In vivo inhibitory activity of 10 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 3h after oral administration",2414,Autocuration,,4,,In vivo,,,,1,,104686,F,,,CHEMBL617692,11200,
,H,BAO_0000218,,"In vivo inhibitory activity of 3 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 1 hr after oral administration",2415,Autocuration,,4,,In vivo,,,,1,,104686,F,,,CHEMBL617693,11200,
,H,BAO_0000218,,"In vivo inhibitory activity of 3 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 3h after oral administration",2416,Autocuration,,4,,In vivo,,,,1,,104686,F,,,CHEMBL617694,11200,
,H,BAO_0000221,,Affinity for 5-hydroxytryptamine 2A receptor in rat brain cortex by ability to displace [3H]ketanserin,2417,Expert,955.0,8,,,,,,1,,12687,B,,,CHEMBL857985,15436,Brain
,D,BAO_0000019,,Affinity at 5-hydroxytryptamine 2A receptor of the rat brain cortex was assessed on the basis of their ability to displace [3H]ketanserin,2418,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL617695,15436,
,H,BAO_0000019,,Affinity pKi for 5-hydroxytryptamine 2A receptor was measured in rat cortex homogenates,2419,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617696,14025,
,H,BAO_0000357,,Binding affinity of compound towards serotonin 5-hydroxytryptamine 2A receptor was determined,2420,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617697,4342,
,D,BAO_0000019,,Displacement of [3H]ketanserin from 5-HT2A receptor of rat frontal cortex,2421,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL617257,13735,
,D,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]ketanserin,2422,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL617258,5816,
,H,BAO_0000019,,Binding affinity was evaluated in vitro by displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor on rat cortical membrane,2423,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617259,14287,
,H,BAO_0000357,,In vitro affinity against serotonin ( 5-hydroxytryptamine 2A receptor ) receptor,2424,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617260,15738,
,D,BAO_0000357,,In vitro affinity against serotonin 5-hydroxytryptamine 2A receptor,2425,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL617261,15738,
,H,BAO_0000019,,Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2A receptor from rat frontal cortex using [3H]-ketanserin as radioligand,2426,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617262,15026,
,H,BAO_0000019,,Half-maximal inhibition of [3H]- Ketanserin binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex homogenate,2427,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617263,16647,
,H,BAO_0000019,,Half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat tissue homogenate,2428,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617264,16647,
,D,BAO_0000019,,Displacement of [3H]-ketanserin from rat brain 5-hydroxytryptamine 2A receptor,2429,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL617265,13345,
,H,BAO_0000249,,Inhibition constant for in vitro inhibition of [3H]ketanserin binding to rat frontal cortex membranes 5-hydroxytryptamine 2A receptor,2430,Autocuration,,8,Membranes,,,,,1,,12687,B,,,CHEMBL617266,1543,
,H,BAO_0000019,,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor rat frontal cortex membrane,2431,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617267,12444,
,H,BAO_0000019,,Inhibitory constant on 5-hydroxytryptamine 2A receptor of Rat frontal cortex,2432,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617268,16404,
,H,BAO_0000219,,Inhibitory constant on human 5-hydroxytryptamine 2A receptor transfected in to CHO cells,2433,Autocuration,,8,,,449.0,,,1,CHO,12687,B,,,CHEMBL617269,16404,
,H,BAO_0000357,,Kinetic inhibition constant evaluated by measuring serotonergic activity,2434,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617323,15577,
,H,BAO_0000357,,Serotonergic activity of the compound.,2435,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617324,15577,
,H,BAO_0000249,,Tested in vitro for its ability to inhibit [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat frontal cortex membranes,2436,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617325,2495,
,D,BAO_0000019,,The binding affinity was evaluated on 5-hydroxytryptamine 2A receptor expressed in rat cortex by using [3H]ketanserin as radioligand.,2437,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL617326,15042,
,H,BAO_0000249,,In vitro ability to displace [3H]ketanserin binding from 5-hydroxytryptamine 2A receptor in rat striatal membrane.,2438,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617327,15026,
,D,BAO_0000019,,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,2439,Expert,,9,,,,,10116.0,1,,12687,F,Rattus norvegicus,,CHEMBL617328,12919,
,D,BAO_0000019,,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,2440,Expert,,9,,,,,10116.0,1,,12687,F,Rattus norvegicus,,CHEMBL617329,12919,
,D,BAO_0000019,,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,2441,Expert,,9,,,,,10116.0,1,,12687,F,Rattus norvegicus,,CHEMBL617330,12919,
,H,BAO_0000357,,The compound was tested for the binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,2442,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617331,15194,
,H,BAO_0000357,,The compound was tested for the binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand.,2443,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617332,15194,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor,2444,Expert,,8,,,,,,1,,107,B,,,CHEMBL617333,4820,
,H,BAO_0000357,,Binding affinity against serotonin 5-hydroxytryptamine 2A receptor was determined using human [125I]-eotaxin,2445,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617334,6736,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor was determined at a concentration of 0.000001 mol/L,2446,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617335,5163,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor was determined at a concentration of 0.00001 mol/L,2447,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617336,5163,
,H,BAO_0000357,,Inhibition of binding towards 5-hydroxytryptamine 2A receptor at 100 nM concentration,2448,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617337,6011,
,D,BAO_0000357,,Percent inhibition against 5-hydroxytryptamine 2A receptor using [3H]ketanserin at 1 uM,2449,Expert,,9,,,,,9606.0,1,,107,B,Homo sapiens,,CHEMBL617338,14294,
,H,BAO_0000357,,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 2A receptor,2450,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617339,5014,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor,2451,Expert,,8,,,,,,1,,107,B,,,CHEMBL617340,17066,
,H,BAO_0000357,,Binding affinity of compound towards serotonin 5-hydroxytryptamine 2A receptor; inactive at 10 uM,2452,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617341,17515,
,H,BAO_0000357,,Inhibition of [125I]-eotaxin binding to serotonin 5-hydroxytryptamine 2A receptor,2453,Expert,,8,,,,,,1,,107,B,,,CHEMBL617342,6736,
,H,BAO_0000357,,Affinity for 5-hydroxytryptamine 2A receptor,2454,Expert,,8,,,,,,1,,107,B,,,CHEMBL617343,5163,
,H,BAO_0000219,,Binding affinity was performed using [3H]ketanserin as the radioligand and stably transfected NIH3T3 cells expressing the 5-hydroxytryptamine 2A receptor (GF-62 cells).,2455,Expert,,8,,,723.0,,,1,NIH3T3,107,B,,,CHEMBL617344,16911,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]ketanserin,2456,Expert,,8,,,,,,1,,107,B,,,CHEMBL617345,6841,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand.,2457,Expert,,8,,,,,,1,,107,B,,,CHEMBL617346,6119,
,H,BAO_0000357,,Compound was evaluated for its binding against 5-hydroxytryptamine 2A receptor,2458,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617347,3962,
,H,BAO_0000357,,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 2A receptor was determined,2459,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617348,4373,
,H,BAO_0000357,,Binding affinity relative to indolopiperidine (compound 1)for 5-hydroxytryptamine 2A receptor was determined,2460,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617349,4373,
,H,BAO_0000019,,Compound was evaluated for its inverse agonist activity against 5-hydroxytryptamine 2A receptor,2461,Autocuration,,8,,,,,,1,,107,F,,,CHEMBL617350,3962,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor by displacement of [3H]ketanserin,2462,Expert,,8,,,,,,1,,107,B,,,CHEMBL872339,1633,
,H,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 2A receptor was determined,2463,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617351,4373,
,H,BAO_0000357,,Binding affinity towards serotonin 5-hydroxytryptamine 2A receptor,2464,Expert,,8,,,,,,1,,107,B,,,CHEMBL617352,6576,
,H,BAO_0000357,,Evaluated for the binding affinity towards 5-hydroxytryptamine 2A receptor,2465,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617353,4687,
,H,BAO_0000357,,Ability to displace [3H]-ketanserin from 5-hydroxytryptamine 2A receptor,2466,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617354,16946,
,H,BAO_0000357,,Compound was evaluated for the affinity at 5-hydroxytryptamine 2A receptor,2467,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617355,14159,
,H,BAO_0000219,,In vitro binding affinity against 5-hydroxytryptamine 2A receptor in CHO cells,2468,Expert,,8,,,449.0,,10090.0,1,CHO,107,B,Mus musculus,,CHEMBL617356,3032,
,H,BAO_0000357,,Inhibition of ketanserin binding to 5-hydroxytryptamine 2A receptor,2469,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617357,16655,
,H,BAO_0000357,,Binding affinity at 5-hydroxytryptamine 2A receptor,2470,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617358,13964,
,H,BAO_0000357,,Binding affinity towards Serotonin 5-hydroxytryptamine 2A receptor,2471,Expert,,8,,,,,,1,,107,B,,,CHEMBL617359,16989,
,H,BAO_0000357,,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor was determined,2472,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617360,16117,
,H,BAO_0000357,,The binding affinity towards 5-hydroxytryptamine 2A receptor; No affinity,2473,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL875913,16700,
,H,BAO_0000357,,Affinity against 5-hydroxytryptamine 2A receptor,2474,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617361,3269,
,D,BAO_0000357,,Binding affinity against 5-Hydroxytryptamine 2A receptor,2475,Expert,,9,,,,,9606.0,1,,107,B,Homo sapiens,,CHEMBL617362,1274,
,H,BAO_0000357,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2A receptor using radioligand binding assay,2476,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617363,1317,
,H,BAO_0000357,,Tested against 5-hydroxytryptamine 2A receptor,2477,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617364,12146,
,H,BAO_0000224,,Binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor antagonist [3H]- ketanserin,2478,Autocuration,,4,,,,,,1,,105075,B,,,CHEMBL617365,12652,
,H,BAO_0000224,,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor antagonist [3H] ketanserin,2479,Autocuration,,4,,,,,,1,,105075,B,,,CHEMBL617366,12652,
,H,BAO_0000224,,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor agonist [125I]- - (+/-)DOI,2480,Autocuration,,4,,,,,,1,,105075,B,,,CHEMBL617367,12652,
,H,BAO_0000224,,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor antagonist [3H]- ketanserin,2481,Autocuration,,4,,,,,,1,,105075,B,,,CHEMBL617368,12652,
,H,BAO_0000357,,Selectivity ratio towards 5-hydroxytryptamine 2A receptor to Dopamine receptor D2 (5-HT2A/D2 ),2482,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617369,16647,
,D,BAO_0000219,,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; ND means no data,2483,Expert,,9,,,722.0,,9606.0,1,HEK293,227,B,Homo sapiens,,CHEMBL617370,15851,
,D,BAO_0000219,,Functional activity against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader,2484,Expert,,9,,,449.0,,9606.0,1,CHO,227,F,Homo sapiens,,CHEMBL617371,6857,
,H,BAO_0000357,,In vitro binding affinity against human 5-HT2B receptor at a concentration of 100 (nM),2485,Autocuration,,8,,,,,,1,,227,B,,,CHEMBL617372,3805,
,D,BAO_0000357,,Affinity towards human 5-hydroxytryptamine 2B serotonin receptor,2486,Expert,,9,,,,,9606.0,1,,227,B,Homo sapiens,,CHEMBL617373,6491,
,H,BAO_0000019,,Agonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT radioligand,2487,Autocuration,,8,,,,,,1,,227,F,,,CHEMBL617374,14093,
,H,BAO_0000019,,Agonistic activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]-5-HT as radioligand,2488,Autocuration,,8,,,,,,1,,227,F,,,CHEMBL617375,13481,
,H,BAO_0000019,,Antagonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]- rauwolscine radioligand,2489,Autocuration,,8,,,,,,1,,227,F,,,CHEMBL617376,14093,
,H,BAO_0000019,,Antagonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]- rauwolscine radioligand; Not tested,2490,Autocuration,,8,,,,,,1,,227,F,,,CHEMBL617377,14093,
,H,BAO_0000019,,Antagonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine radioligand,2491,Autocuration,,8,,,,,,1,,227,F,,,CHEMBL617378,14093,
,H,BAO_0000019,,Antagonistic activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine as radioligand,2492,Autocuration,,8,,,,,,1,,227,F,,,CHEMBL617379,13481,
,H,BAO_0000357,,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]- rauwolscine as radioligand,2493,Autocuration,,8,,,,,,1,,227,B,,,CHEMBL617380,14442,
,H,BAO_0000357,,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT 2B as radioligand,2494,Autocuration,,8,,,,,,1,,227,B,,,CHEMBL617381,14442,
,H,BAO_0000357,,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine as radioligand,2495,Autocuration,,8,,,,,,1,,227,B,,,CHEMBL617382,14442,
,H,BAO_0000357,,The compound evaluated for its affinity against 5-hydroxytryptamine 2A receptor,2496,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617383,12369,
,H,BAO_0000357,,Affinity against 5-hydroxytryptamine 2A receptor (D) labeled with [125I]DOI.,2497,Expert,,8,,,,,,1,,107,B,,,CHEMBL617384,12369,
,H,BAO_0000357,,Affinity against 5-hydroxytryptamine 2A receptor (K) labeled with [3H]ketanserin.,2498,Expert,,8,,,,,,1,,107,B,,,CHEMBL617385,12369,
,H,BAO_0000019,,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 2A receptor from cloned Human membranes,2499,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617386,14447,
,H,BAO_0000019,,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 2A receptor from cloned Human membranes.,2500,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617387,14447,
,H,BAO_0000219,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,2501,Autocuration,,8,,,723.0,,,1,NIH3T3,107,B,,,CHEMBL617388,17451,
,H,BAO_0000219,,Relative efficacy against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,2502,Autocuration,,8,,,449.0,,,1,CHO,107,F,,,CHEMBL617389,6857,
,D,BAO_0000219,,Relative efficacy against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,2503,Expert,,9,,,449.0,,9606.0,1,CHO,107,F,Homo sapiens,,CHEMBL617390,6857,
,H,BAO_0000224,,Selectivity ratio of binding affinity of 5-hydroxytryptamine 2A receptor to that of 5-hydroxytryptamine 2C receptor.,2504,Autocuration,,4,,,,,,1,,104817,B,,,CHEMBL617391,5635,
,H,BAO_0000357,,Binding activity radioligand.,2505,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617392,12861,
,H,BAO_0000019,,Binding activity against 5-hydroxytryptamine 2C receptor from human brain cortex using [3H]mesulergine as radioligand.,2506,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617393,12861,
,H,BAO_0000219,,Binding affinity for human cloned 5-HT2A receptor expressed in L929 cells using [125I]R91150 as radioligand,2507,Autocuration,,8,,,307.0,,,1,L929,107,B,,,CHEMBL617394,5105,
,H,BAO_0000219,,Binding affinity for human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells using [125I]R91150 as radioligand,2508,Expert,,8,,,307.0,,,1,L929,107,B,,,CHEMBL617395,5104,
,H,BAO_0000219,,Binding affinity at human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells by [125I]R91150 displacement.,2509,Expert,,8,,,307.0,,,1,L929,107,B,,,CHEMBL617396,5105,
,H,BAO_0000219,,Binding affinity for human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells using [125I]R91150 as radioligand; Not tested,2510,Autocuration,,8,,,307.0,,,1,L929,107,B,,,CHEMBL617397,5105,
,H,BAO_0000357,,Binding affinity against 5-HT2A receptor,2511,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617398,5254,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2A receptor,2512,Autocuration,,8,,,,,,1,,107,B,,,CHEMBL617399,5254,
,H,BAO_0000219,,Antagonistic binding affinity measured against 5-hydroxytryptamine 2A receptor (human clone expressed in 293 cells) using [3H]ketanserin as radioligand,2513,Autocuration,,8,,,722.0,,,1,HEK293,107,B,,,CHEMBL617400,13267,
,H,BAO_0000219,,Antagonistic binding affinity measured against 5-hydroxytryptamine 2C receptor (human clone expressed in 293 cells) using [3H]mesulergine as radioligand,2514,Autocuration,,8,,,722.0,,,1,HEK293,107,B,,,CHEMBL617401,13267,
,D,BAO_0000219,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor expressed in HEK 293 cells,2515,Expert,,9,,,722.0,,9606.0,1,HEK293,107,B,Homo sapiens,,CHEMBL617402,14157,
,D,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,2516,Expert,,9,,,722.0,,9606.0,1,HEK293,107,B,Homo sapiens,,CHEMBL617403,12936,
,H,BAO_0000357,,Binding affinity against human 5-hydroxytryptamine 2A receptor using displacement of [3H]5-HT,2517,Expert,,8,,,,,,1,,107,B,,,CHEMBL617404,14068,
,D,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,2518,Expert,,9,,,722.0,,9606.0,1,HEK293,107,B,Homo sapiens,,CHEMBL857981,12936,
,D,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,2519,Expert,,9,,,722.0,,9606.0,1,HEK293,107,B,Homo sapiens,,CHEMBL617405,12936,
,D,BAO_0000219,,Binding affinity to human cloned 5-hydroxytryptamine 2A receptor in HEK 293 cells using [3H]- ketanserin as radioligand,2520,Expert,,9,,,722.0,,9606.0,1,HEK293,107,B,Homo sapiens,,CHEMBL617253,4540,
,H,BAO_0000357,,Binding affinity at human cloned 5-hydroxytryptamine 2A receptor.,2521,Expert,,8,,,,,,1,,107,B,,,CHEMBL617254,6166,
,H,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptors in HEK 293 cells using [3H]ketanserin as radioligand,2522,Autocuration,,8,,,722.0,,,1,HEK293,107,B,,,CHEMBL617255,17296,
,H,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptors in HEK 293 cells using [3H]ketanserin as radioligand,2523,Autocuration,,8,,,722.0,,,1,HEK293,107,B,,,CHEMBL617256,17296,
,H,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptorswithouteffect in HEK 293 cells using [3H]ketanserin as radioligand,2524,Autocuration,,8,,,722.0,,,1,HEK293,107,B,,,CHEMBL616874,17296,
,D,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 2A receptor (human cloned receptor) in HEK 293 cells using [3H]ketanserin as radioligand.,2525,Expert,,9,,,722.0,,9606.0,1,HEK293,107,B,Homo sapiens,,CHEMBL616875,15779,
,H,BAO_0000219,,Binding affinity towards human 5-hydroxytryptamine 2A receptor expressed in HEK 293 cells using [3H]ketanserin as radioligand,2526,Expert,,8,,,722.0,,,1,HEK293,107,B,,,CHEMBL616876,14391,
,H,BAO_0000219,,"Binding affinity towards human cloned 5-hydroxytryptamine receptor 2A in HEK293 cells, using [3H]ketanserin as radioligand.",2527,Expert,,8,,,722.0,,,1,HEK293,107,B,,,CHEMBL616877,15851,
,D,BAO_0000219,,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2A receptor expressed in HEK293 cells; compound is insoluble,2528,Expert,,9,,,722.0,,9606.0,1,HEK293,107,B,Homo sapiens,,CHEMBL616878,15851,
,H,BAO_0000219,,Binding affinity towards human cloned 5-hydroxytryptamine 2A receptor of HEK293 cells by displacement of [3H]ketanserin,2529,Expert,,8,,,722.0,,,1,HEK293,107,B,,,CHEMBL616879,3832,
,H,BAO_0000219,,In vitro binding affinity at human cloned 5-hydroxytryptamine 2A receptor of HEK293 cells by [3H]ketanserin displacement.,2530,Expert,,8,,,722.0,,,1,HEK293,107,B,,,CHEMBL616880,3833,
,D,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,2531,Expert,,9,,,722.0,,9606.0,1,HEK293,107,B,Homo sapiens,,CHEMBL616881,12936,
,H,BAO_0000219,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand,2532,Autocuration,,8,,,723.0,,,1,NIH3T3,107,B,,,CHEMBL616882,17451,
,H,BAO_0000219,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,2533,Autocuration,,8,,,723.0,,,1,NIH3T3,107,B,,,CHEMBL616883,17451,
,H,BAO_0000219,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,2534,Autocuration,,8,,,723.0,,,1,NIH3T3,107,B,,,CHEMBL616884,17451,
,H,BAO_0000219,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 2A receptor in HEK 293 cells using [3H]ketanserin as the radioligand,2535,Autocuration,,8,,,722.0,,,1,HEK293,107,B,,,CHEMBL616885,4199,
,H,BAO_0000219,,Compound was evaluated for displacement of [3H]ketanserin from human cloned 5-hydroxytryptamine 2A receptor in transfected CHO-K1 cells,2536,Autocuration,,8,,,485.0,,,1,CHO-K1,107,B,,,CHEMBL616886,1883,
,H,BAO_0000219,,Displacement of [3H]-ketanserin from human cloned 5-hydroxytryptamine 2A receptor expressed in CHO-K1 cells.,2537,Expert,,8,,,485.0,,,1,CHO-K1,107,B,,,CHEMBL616887,1883,
,D,BAO_0000357,,Binding affinity for human 5-hydroxytryptamine 2A receptor,2538,Expert,,9,,,,,9606.0,1,,107,B,Homo sapiens,,CHEMBL616888,14875,
,H,BAO_0000219,,Compound was tested for its binding affinity against 5-hydroxytryptamine 2A receptor in human cloned receptors in HEK 293 cells using [3H]ketanserin,2539,Autocuration,,8,,,722.0,,,1,HEK293,107,B,,,CHEMBL616889,15146,
,H,BAO_0000219,,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 2A receptor in HEK 293 using [3H]ketanserin as a radioligand,2540,Autocuration,,8,,,722.0,,,1,HEK293,107,B,,,CHEMBL616890,5213,
,D,BAO_0000219,,Inhibitory constant for human 5-hydroxytryptamine 2A receptor transfected in to CHO cells,2541,Expert,,9,,,449.0,,9606.0,1,CHO,107,B,Homo sapiens,,CHEMBL616891,16404,
,H,BAO_0000219,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 2A receptor in HEK293 cells using [3H]-ketanserin.,2542,Autocuration,,8,,,722.0,,,1,HEK293,107,B,,,CHEMBL616892,14818,
,H,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2A receptor in HEK293 cells, using [3H]ketanserin as radioligand",2543,Autocuration,,8,,,722.0,,,1,HEK293,107,B,,,CHEMBL616893,4829,
,H,BAO_0000219,,Percent of maximum stimulation of phosphatidylinositol turnover at cloned 5-hydroxytryptamine 2A receptor in 3T3 cells,2544,Autocuration,,8,,,723.0,,,1,NIH3T3,10620,F,,,CHEMBL616894,12652,
,H,BAO_0000219,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor expressed NIH3T3 cells,2545,Expert,,8,,,723.0,,,1,NIH3T3,107,B,,,CHEMBL616895,4682,
,H,BAO_0000019,,The maximum responses of [3H]- inositol monophosphate accumulation in cells expressing the 5-hydroxytryptamine 2A receptor,2546,Autocuration,,8,,,,,,1,,10620,F,,,CHEMBL616896,12652,
,H,BAO_0000357,,Ability to displace [3H]-Ketanserin radioligand from porcine 5-hydroxytryptamine 2A receptor,2547,Autocuration,,8,,,,,,1,,10621,B,,,CHEMBL617099,4921,
,H,BAO_0000357,,Ability to displace [3H]ketanserin radioligand from porcine 5-hydroxytryptamine 2A receptor; ND denotes not determined,2548,Autocuration,,8,,,,,,1,,10621,B,,,CHEMBL617100,4921,
,H,BAO_0000357,,Binding affinity against rabbit aorta 5-HT2A receptor,2549,Autocuration,,8,,,,,9986.0,1,,107,B,Oryctolagus cuniculus,,CHEMBL884532,16312,
,H,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 2A receptor of rabbit aorta ring preparations,2550,Expert,,8,,,,,9986.0,1,,107,B,Oryctolagus cuniculus,,CHEMBL617101,14998,
,H,BAO_0000357,,Dissociation equilibrium constant against the vascular 5-hydroxytryptamine 2A receptor in the rabbit saphenous aorta,2551,Expert,,8,,,,,9986.0,1,,107,B,Oryctolagus cuniculus,,CHEMBL617102,14025,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 1D receptor alpha using rabbit saphenous vein assay.,2552,Autocuration,,8,,,,,9986.0,1,,107,B,Oryctolagus cuniculus,,CHEMBL617103,13047,
,H,BAO_0000357,,The compound was tested for binding affinity against 5-HT2A receptor,2553,Expert,,8,,,,,9986.0,1,,107,B,Oryctolagus cuniculus,,CHEMBL617104,13047,
,H,BAO_0000219,,Compound was evaluated for displacement of [3H]ketanserin from cloned rat 5-hydroxytryptamine 2A receptor in transfected CHO-K1 cells.,2554,Autocuration,,8,,,485.0,,,1,CHO-K1,10576,B,,,CHEMBL857979,1883,
,H,BAO_0000019,,Binding affinity analysed towards 5-HT 2A in rat jugular vein,2555,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL857502,13463,
,H,BAO_0000019,,Binding affinity analysed towards 5-HT 2A in rat jugular vein.,2556,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617105,13463,
,H,BAO_0000019,,Binding affinity analysed on 5-HT 2A in rat stomach fundus.,2557,Autocuration,945.0,8,,,,,,1,,12687,B,,,CHEMBL858021,13463,Stomach
,D,BAO_0000019,,Binding affinity for 5-HT 2A in rat stomach fundus,2558,Expert,945.0,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL875910,13463,Stomach
,H,BAO_0000019,,Binding affinity analysed towards 5-HT 2A in rat jugular vein.,2559,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617106,13463,
,H,BAO_0000219,,Ability to stimulate phosphoinositide hydrolysis in NIH3T3 cells expressing the 5-hydroxytryptamine 2A receptor,2560,Expert,,8,,,723.0,,,1,NIH3T3,12687,B,,,CHEMBL617107,16326,
,H,BAO_0000019,,Effect on phosphoinositide hydrolysis in NIH 3T3 fibroblast 5-hydroxytryptamine 2A receptor,2561,Autocuration,,8,,,,,,1,,12687,F,,,CHEMBL617108,14093,
,H,BAO_0000019,,Effect on phosphoinositide hydrolysis in NIH 3T3 fibroblast expressing 5-hydroxytryptamine 2A receptor,2562,Autocuration,,8,,,,,,1,,12687,F,,,CHEMBL617109,14093,
,H,BAO_0000357,,Evaluated for the effective concentration at [125I]-DOI-labeled rat 5-hydroxytryptamine 2A receptor,2563,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617110,15740,
,H,BAO_0000357,,Functional potency at the rat 5-hydroxytryptamine 2A receptor as effective concentration EC50 for stimulating Phosphoinositide accumulation,2564,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617111,16633,
,D,BAO_0000019,,In vitro relative agonist activity against 5-hydroxytryptamine 2A using PI assay in rat vascular smooth muscle cells,2565,Expert,,9,,,,,10116.0,1,,12687,F,Rattus norvegicus,,CHEMBL617112,17200,
,H,BAO_0000357,,Tested for its ability to activate phospholipase C by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor,2566,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617113,17133,
,H,BAO_0000357,,Tested for its ability to activate phospholipase C by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor,2567,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617114,17133,
,H,BAO_0000357,,Tested for its ability to activate phospholipase c by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor,2568,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617115,17133,
,H,BAO_0000219,,The receptor (5-hydroxytryptamine 2A ) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells,2569,Autocuration,,8,,,,,,1,,12687,F,,,CHEMBL617116,17200,
,H,BAO_0000019,,Efficacy at 5-hydroxytryptamine 2A receptor,2570,Autocuration,,8,,,,,,1,,12687,F,,,CHEMBL617117,15363,
,H,BAO_0000357,,In vitro efficacy against rat 5-hydroxytryptamine 2A receptor was determined by using CA+ assay (Emax),2571,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617118,17200,
,D,BAO_0000357,,In vitro efficacy against rat 5-hydroxytryptamine 2A receptor was determined by using CA+ assay (Emax),2572,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL617119,17200,
,D,BAO_0000357,,In vitro efficacy against rat 5-hydroxytryptamine 2A receptor determined by using PI assay (Emax),2573,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL617120,17200,
,D,BAO_0000219,,The receptor (5-hydroxytryptamine 2A ) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells,2574,Expert,,9,,,,,10116.0,1,,12687,F,Rattus norvegicus,,CHEMBL617121,17200,
,H,BAO_0000219,,The receptor (5-hydroxytryptamine 2A) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells,2575,Autocuration,,8,,,,,,1,,12687,F,,,CHEMBL617122,17200,
,H,BAO_0000019,,Ability to displace [3H]ketanserin (0.5 nM) from cerebral cortex of rat 5-hydroxytryptamine 2A receptor,2576,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617123,17211,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2A receptor by displacement of [3H]-ketanserin from rat prefrontal cerebral cortex mambranes,2577,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617124,17331,
,H,BAO_0000249,,Binding affinity to serotonin 5-hydroxytryptamine 2A receptors using a radioligand [3H]ketanserin binding assay in rat cortical membranes,2578,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617600,13565,
,H,BAO_0000357,,Binding affinity towards rat 5-hydroxytryptamine 2A receptor was evaluated using [3H]- ketanserin as radioligand,2579,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617601,13730,
,H,BAO_0000019,,In vitro affinity towards 5-hydroxytryptamine 2A receptor using [3H]spiroperidol as radioligand in cortex,2580,Expert,,8,,,,,,1,,12687,B,,,CHEMBL882923,12416,
,H,BAO_0000357,,Compound was tested for it's binding affinity towards 5-hydroxytryptamine 2A receptor,2581,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617602,15295,
,H,BAO_0000019,,Compound was tested for its ability to displace [3H]DOB from 5-hydroxytryptamine 2A receptor in rat cortex homogenates,2582,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617603,1742,
,H,BAO_0000357,,Compound was tested for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor,2583,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617604,15295,
,H,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 2A receptor from rat frontal cortex using [3H]ketanserin as radioligand,2584,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617605,14970,
,H,BAO_0000019,,In vitro binding affinity for serotonin 5-hydroxytryptamine 2A receptor of rat cerebral cortex using [3H]ketanserin as radioligand,2585,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617606,16693,
,D,BAO_0000019,,Inhibition of [3H]ketanserin binding to rat frontal cortex membrane 5-hydroxytryptamine 2A receptor,2586,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL617607,14776,
,H,BAO_0000249,,In vitro inhibitory concentration against radioligand [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat cortical membrane,2587,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617455,14286,
,D,BAO_0000019,,In vitro inhibition of [125I]DOI binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex,2588,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL617456,17200,
,H,BAO_0000357,,Inhibitory concentration against 5-hydroxytryptamine 2A receptor (Inactive at >1000 nM concentration),2589,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617457,15306,
,D,BAO_0000357,,Inhibition of radiolabeled [3H]-Ketanserin ligand binding to 5-hydroxytryptamine 2A receptor,2590,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL617458,14178,
,D,BAO_0000019,,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor from rat brain,2591,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL617459,14229,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor binding site using [3H]ketanserin. ,2592,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617460,12884,
,H,BAO_0000357,,"Binding affinity for 5-hydroxytryptamine 2A receptor, activity is expressed as IC50 values.",2593,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617461,13149,
,D,BAO_0000019,,Displacement of [3H]ketanserin from rat cortical membrane 5-hydroxytryptamine 2A receptor at 10e-7 M,2594,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL617462,15295,
,H,BAO_0000357,,Intrinsic activity was determined at 5-hydroxytryptamine 2A receptor which is percentage response given compared with the response produced by 10 uM serotonin.,2595,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617463,15740,
,H,BAO_0000019,,"Compound was tested for binding affinity at 5-hydroxytryptamine 2A receptor sites in rat cortical homogenate using [125I]-2,5-Dimethoxy -4-iodoamphetamine (DOI).",2596,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617464,15185,
,H,BAO_0000019,,"Compound was tested for binding affinity using [3H]MDL-100,907 at 5-hydroxytryptamine 2A receptor sites in rat cortical homogenate.",2597,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617465,15185,
,H,BAO_0000019,,Ability to bind to central serotonin 5-hydroxytryptamine 2A receptor in vitro in cortex of the rat brain using [3H]ketanserin radioligand,2598,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617466,17529,
,H,BAO_0000019,,Ability to displace [3H]- ketanserin bound to 5-hydroxytryptamine 2A receptor in rat pre-frontal cortex,2599,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617467,14826,
,H,BAO_0000019,,Displacement of [3H]ketanserin (0.5 nM) from rat cerebral cortex 5-hydroxytryptamine 2A receptors,2600,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617468,17211,
,H,BAO_0000019,,Ability to displace [3H]ketanserin bound to 5-hydroxytryptamine 2A receptor in rat pre-frontal cortex,2601,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617469,14826,
,H,BAO_0000019,,Ability to displace [3H]ketanserin from rat cortical homogenate 5-hydroxytryptamine 2A receptor,2602,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617470,14093,
,H,BAO_0000019,,Ability to displace [3H]ketanserin from rat cortical homogenate 5-hydroxytryptamine 2A receptor; Not tested,2603,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617471,14093,
,H,BAO_0000219,,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2A serotonin receptor in NIH3T3 cell line membranes,2604,Expert,,8,,,723.0,,,1,NIH3T3,12687,B,,,CHEMBL617472,13246,
,H,BAO_0000357,,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2A serotonin receptor.,2605,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617473,13246,
,D,BAO_0000019,,Affinity 5-hydroxytryptamine 2A receptor of the rat brain cortex was assessed on the basis of their ability to displace [3H]ketanserin,2606,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL617474,15436,
,D,BAO_0000019,,Affinity at 5-hydroxytryptamine 2A receptor of the rat brain cortex was assessed on the basis of their ability to displace [3H]ketanserin,2607,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL617475,15436,
,H,BAO_0000221,,Affinity at [3H]ketanserin-labeled 5-hydroxytryptamine 2A receptor in rat brain homogenate was determined,2608,Autocuration,955.0,8,,,,,,1,,12687,B,,,CHEMBL617476,14442,Brain
,H,BAO_0000357,,Affinity was evaluated as inhibition constant for serotonin 5-hydroxytryptamine 2A receptor,2609,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617477,12457,
,H,BAO_0000219,,Affinity was evaluated by inhibition of [125I]LSD binding to NIH 3T3 cells transfected with cloned rat 5-hydroxytryptamine 2A receptor,2610,Expert,,8,,,723.0,,,1,NIH3T3,12687,B,,,CHEMBL617478,12457,
,H,BAO_0000221,,"Antagonistic activity measured for 5-hydroxytryptamine 2A receptor using [3H]-MDL- 100,907 as radioligand in rat cortical homogenates.",2611,Autocuration,,8,,,,,,1,,12687,F,,,CHEMBL617479,14755,
,H,BAO_0000357,,Binding affinity towards rat 5-hydroxytryptamine 2A receptor was determined using [125I]- DOI as radioligand,2612,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617480,4707,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2A receptor,2613,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617481,13297,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2A receptor by displacement of [3H]ketanserin from rat prefrontal cerebral cortex mambranes,2614,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617482,17331,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2A receptor from rat forebrain using [3H]ketanserin as radioligand,2615,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617483,4664,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,2616,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL621528,16633,
,D,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 2A receptor expressed NIH3T3 cells using [3H]ketanserin,2617,Expert,,9,,,723.0,,10116.0,1,NIH3T3,12687,B,Rattus norvegicus,,CHEMBL621529,4664,
,H,BAO_0000357,,Binding affinity against rat 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,2618,Expert,,8,,,,,,1,,12687,B,,,CHEMBL621530,16133,
,H,BAO_0000357,,Binding affinity against rat 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,2619,Expert,,8,,,,,,1,,12687,B,,,CHEMBL621531,16133,
,D,BAO_0000019,,Binding affinity against rat brain 5-hydroxytryptamine 2A receptor,2620,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL621532,14060,
,H,BAO_0000357,,Binding affinity at cloned rat 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,2621,Expert,,8,,,,,,1,,12687,B,,,CHEMBL621533,16326,
,H,BAO_0000219,,Binding affinity for displacement of [3H]ketanserin to rat 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,2622,Expert,,8,,,449.0,,,1,CHO,12687,B,,,CHEMBL621534,16659,
,H,BAO_0000019,,Binding affinity measured at the 5-hydroxytryptamine 2A receptor by the inhibition of [3H]ketanserin binding to rat cortex using unlabeled mianserin for nonspecific binding.,2623,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL621535,14776,
,H,BAO_0000357,,Binding affinity of [3H]- ketanserin labelled towards Rat cortical 5-hydroxytryptamine 2A receptor using radioligand binding assay,2624,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL621536,13481,
,H,BAO_0000357,,Binding affinity of compound was tested for 5-hydroxytryptamine 2A receptor,2625,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL621537,17386,
,D,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 2A receptor,2626,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL621538,6611,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2A receptor from rat cortex using [3H]ketanserin as the radioligand.,2627,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL621539,14423,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2A receptor of rat pre-frontal cortex,2628,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL621540,15412,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2A receptor of rat pre-frontal cortex.,2629,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL621541,15412,
,H,BAO_0000019,,Binding affinity towards 5-HT 2A receptor in rat cerebral frontal cortex membranes using [3H]ketanserin as radioligand,2630,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL621542,6238,
,H,BAO_0000357,,Binding affinity at 5-hydroxytryptamine 2A receptor of rat.,2631,Expert,,8,,,,,,1,,12687,B,,,CHEMBL621543,6648,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor sites by using [3H]ketanserin as radioligand,2632,Expert,,8,,,,,,1,,12687,B,,,CHEMBL621544,5667,
,D,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 2A serotonin receptor,2633,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL621545,6611,
,H,BAO_0000357,,Binding affinity towards rat cortical 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,2634,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL621546,13481,
,H,BAO_0000357,,Binding affinity towards rat cortical 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand; Not tested,2635,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL621547,13481,
,H,BAO_0000219,,Displacement of [3H]ketanserin from NIH3T3 cells stably expressing rat 5-hydroxytryptamine 2A receptor,2636,Expert,,8,,,723.0,,,1,NIH3T3,12687,B,,,CHEMBL618692,15558,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor,2637,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL618693,6013,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,2638,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL872922,16633,
,H,BAO_0000357,,Binding affinity towards cloned rat 5-hydroxytryptamine 2A receptor from fundus tissue was determined using [3H]mesulergine as radioligand,2639,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL618694,6013,
,D,BAO_0000357,,Binding affinity for rat 5-hydroxytryptamine 2A receptor using [3H]DOB,2640,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL618695,6013,
,H,BAO_0000357,,Binding affinity towards cloned rat 5-hydroxytryptamine 2A receptor was determined using [3H]DOB as radioligand; ND=No data,2641,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL618696,6013,
,H,BAO_0000357,,Binding affinity towards cloned rat 5-hydroxytryptamine 2A receptor by [3H]ketanserin displacement.,2642,Expert,,8,,,,,,1,,12687,B,,,CHEMBL618697,6013,
,H,BAO_0000357,,Binding affinity towards cloned rat Inhibition of binding towards 5-hydroxytryptamine 2A receptor at 100 nM concentration was determined using [3H]DOB as radioligand,2643,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL618892,6013,
,H,BAO_0000357,,Binding affinity towards cloned rat Inhibition of binding towards 5-hydroxytryptamine 2A receptor at 100 nM concentration was determined using [3H]ketanserin as radioligand,2644,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL618893,6013,
,H,BAO_0000357,,Binding affinity towards rat 5-hydroxytryptamine 2A receptor,2645,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL618894,16293,
,H,BAO_0000219,,Binding affinity towards rat 5-hydroxytryptamine 2A receptor expressed in NIH3T3 cells using [3H]ketanserin as radioligand,2646,Expert,,8,,,723.0,,,1,NIH3T3,12687,B,,,CHEMBL618895,17175,
,D,BAO_0000357,,Binding affinity was measured against 5-hydroxytryptamine 2A receptor by displacement of [3H]- ketanserin by lysergic acid amides,2647,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL618896,13278,
,H,BAO_0000019,,Compound was evaluated for affinity towards cerebral 5-hydroxytryptamine 2A receptor in homogenate of caudate putamen tissue from rat brain,2648,Autocuration,5383.0,8,,,,,,1,,12687,B,,,CHEMBL618897,3682,Caudate-putamen
,H,BAO_0000357,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as a radioligand,2649,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL618898,2014,
,H,BAO_0000357,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as a radioligand; Not determined,2650,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL618899,2014,
,H,BAO_0000357,,Compound was evaluated for its ability to displace (+/-)[125I]-DOI from 5-hydroxytryptamine 2A receptor in cloned rat cell culture,2651,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL618900,4932,
,H,BAO_0000019,,Compound was evaluated for its ability to displace [125I](R)-DOI from 5-hydroxytryptamine 2A receptor in cloned rat prefrontal cortex homogenate,2652,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL618901,4932,
,H,BAO_0000357,,Compound was evaluated for its binding affinity for rat 5-hydroxytryptamine 2A receptor,2653,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL618902,3935,
,D,BAO_0000221,,Displacement of [3H]8-OH-DPAT from rat hippocampus membrane 5-hydroxytryptamine 2A receptor,2654,Expert,10000000.0,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL618903,5432,Hippocampus
,H,BAO_0000357,,Compound was evaluated for its binding affinity towards rat 5-hydroxytryptamine 2A receptor,2655,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL618904,15818,
,H,BAO_0000357,,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]ketanserin radioligand.,2656,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL618905,13672,
,H,BAO_0000357,,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]-ketanserin radioligand.,2657,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL618906,13672,
,H,BAO_0000219,,Binding affinity against rat 5-hydroxytryptamine 2A receptor in NIH3T3 cells.,2658,Expert,,8,,,723.0,,,1,NIH3T3,12687,B,,,CHEMBL618907,14749,
,H,BAO_0000019,,Compound was tested for the Binding affinity against rat frontal cortex 5-hydroxytryptamine 2A receptor by Radio ligand [3H]ketanserin binding assay.,2659,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL618908,13462,
,H,BAO_0000357,,Evaluated for the binding constant at [125I]-DOI-labeled rat 5-hydroxytryptamine 2A receptor,2660,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617909,15740,
,H,BAO_0000019,,Half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex homogenate,2661,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617910,16647,
,H,BAO_0000221,,In vitro ability to displace [3H]ketanserin from 5-hydroxytryptamine 2A receptor in rat brain.,2662,Autocuration,955.0,8,,,,,,1,,12687,B,,,CHEMBL617911,13345,Brain
,H,BAO_0000249,,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,2663,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL872923,16740,
,H,BAO_0000249,,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,2664,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617912,16740,
,D,BAO_0000019,,In vitro binding affinity at 5-hydroxytryptamine 2A receptor by displacement of [3H]ketanserin from rat cortex,2665,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL617913,15535,
,H,BAO_0000249,,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,2666,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617914,16740,
,H,BAO_0000249,,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,2667,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617915,16740,
,H,BAO_0000249,,In vitro binding affinity at serotonin 5-hydroxytryptamine 2A receptor in rat cortical membrane,2668,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617916,16740,
,D,BAO_0000019,,Displacement of [3H]- Ketanserin from rat cortex 5-hydroxytryptamine 2A receptor,2669,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL617917,4795,
,H,BAO_0000019,,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor in rat tissue homogenate using [3H]ketanserin as radioligand,2670,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617918,8,
,H,BAO_0000019,,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor in rat tissue homogenate using [3H]ketanserin as radioligand; Not active at 10-5 M,2671,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617919,8,
,D,BAO_0000019,,In vitro inhibitory constant against [125I]DOI binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex,2672,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL617920,17200,
,D,BAO_0000019,,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor of rat brain cortex,2673,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL617921,2148,
,D,BAO_0000224,,"Relative binding affinity for D2 receptor and 5-hydroxytryptamine 2A receptor, ratio of Ki",2674,Expert,,5,,,,,10116.0,1,,105102,B,Rattus norvegicus,,CHEMBL617922,13345,
,H,BAO_0000357,,Tested for binding affinity towards rat 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,2675,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617923,5088,
,H,BAO_0000357,,Tested for binding affinity towards rat 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,2676,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617924,5088,
,H,BAO_0000357,,Tested in vitro for its ability to bind to 5-hydroxytryptamine 2A receptor using [125 I]-DOI as radioligand,2677,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617925,17133,
,D,BAO_0000357,,In vitro binding to 5-hydroxytryptamine 2A receptor using [125 I]-DOI,2678,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL617926,17133,
,H,BAO_0000357,,The binding affinity at 5-hydroxytryptamine 2A receptor was determined using [3H]ketanserin,2679,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617927,16532,
,H,BAO_0000357,,The compound was tested for binding affinity against 5-hydroxytryptamine 2A receptor,2680,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617928,15086,
,D,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,2681,Expert,,9,,,,,10116.0,1,,12687,B,Rattus norvegicus,,CHEMBL617929,2309,
,H,BAO_0000019,,Binding affinity to 5-hydroxytryptamine 2A receptor from rat cortex assayed using [3H]ketanserin as radioligand.,2682,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617930,12953,
,H,BAO_0000019,,The compound was tested for its binding affinity towards 5-hydroxytryptamine 2A receptor from rat cortex using [3H]ketanserin as radioligand.; Nonactive at 10 uM,2683,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617931,12953,
,H,BAO_0000019,,The compound was tested for its binding affinity towards 5-hydroxytryptamine 2A receptor from rat cortex using [3H]-ketanserin as radioligand; Nonactive at 10 uM,2684,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617932,12953,
,H,BAO_0000219,,Binding affinity for displacement of [3H]ketanserin to rat 5-hydroxytryptamine 2A receptor stably expressed in CHO cells; ND is No Data,2685,Autocuration,,8,,,449.0,,,1,CHO,12687,B,,,CHEMBL617933,16659,
,H,BAO_0000019,,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane; ND means no data,2686,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617934,16740,
,H,BAO_0000019,,In vitro binding affinity at serotonin 5-hydroxytryptamine 2A receptor in rat cortical membrane; ND means no data,2687,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617935,16740,
,H,BAO_0000357,,Tested for its ability to activate phospholipase C by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor; Not determined,2688,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617936,17133,
,H,BAO_0000019,,Ability to displace [3H]ketanserin (0.5 nM) from cerebral cortex of rat 5-hydroxytryptamine 2A receptor; NT=not tested,2689,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617937,17211,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2A receptor by displacement of [3H]-ketanserin from rat prefrontal cerebral cortex mambranes; Not tested,2690,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617938,17331,
,H,BAO_0000218,,Compound was evaluated for effective dose measured in nmol/kg following a dose of 0.04 mg/kg and 0.093 uM/kg (95%CI); range 32-63,2691,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617939,16633,
,H,BAO_0000218,,Compound was evaluated for the percentage of rats disrupted following a dose of 0.04 mg/kg and 0.097 uM/kg,2692,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617940,16633,
,H,BAO_0000218,,Compound was evaluated for the percentage of rats disrupted following a dose of 0.08 mg/kg and 0.194 uM/kg,2693,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617941,16633,
,H,BAO_0000357,,Ratio of pKi of 5-HT2A to that of 5-HT2C receptor,2694,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617942,15026,
,H,BAO_0000357,,Ratio of pKi of 5-HT2A to that of D2 receptor,2695,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617943,15026,
,H,BAO_0000224,,Selectivity ratio towards KB of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2B receptor,2696,Expert,,4,,,,,,1,,105093,B,,,CHEMBL617944,16404,
,H,BAO_0000224,,Selectivity ratio towards KB of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2B receptor,2697,Expert,,4,,,,,,1,,105093,B,,,CHEMBL617945,16404,
,H,BAO_0000224,,Selectivity ratio towards Ki of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2C receptor,2698,Expert,,4,,,,,,1,,105075,B,,,CHEMBL617946,16404,
,H,BAO_0000357,,Selectivity ratio towards Ki of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2C receptor; ND is no data,2699,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617947,16404,
,H,BAO_0000357,,Percent maximal 5-HT stimulation at cloned rat 5-hydroxytryptamine 2A receptor (phosphoinositide hydrolysis study) at a conc of 100 uM,2700,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617948,16326,
,H,BAO_0000019,,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 2A receptor of rat,2701,Autocuration,,8,,,,,,1,,12687,F,,,CHEMBL858116,15847,
,H,BAO_0000019,,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 2A receptor of rat; ND means not done,2702,Autocuration,,8,,,,,,1,,12687,F,,,CHEMBL617949,15847,
,H,BAO_0000019,,Effectiveness of compound in blocking 5-hydroxytryptamine 2A receptor-mediated contractions of rat tail artery,2703,Autocuration,,8,,,,,,1,,12687,F,,,CHEMBL617950,15329,
,H,BAO_0000019,,Negative log concentration of antagonist on 5-hydroxytryptamine 2A receptor in rat thoracic aorta,2704,Expert,1515.0,8,,,,,,1,,12687,F,,,CHEMBL617951,16404,Thoracic aorta
,H,BAO_0000019,,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2A receptor of Rat thoracic aorta,2705,Expert,1515.0,8,,,,,,1,,12687,F,,,CHEMBL617952,16404,Thoracic aorta
,H,BAO_0000019,,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2A receptor of Rat thoracic aorta; ND is not determined.,2706,Autocuration,1515.0,8,,,,,,1,,12687,F,,,CHEMBL617953,16404,Thoracic aorta
,H,BAO_0000357,,Binding activity radioligand.,2707,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617954,12861,
,H,BAO_0000019,,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand.,2708,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617955,12861,
,H,BAO_0000019,,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand; NA Not Available,2709,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL857071,12861,
,H,BAO_0000019,,Displacement of [3H]DOB binding to 5-hydroxytryptamine 2A receptor from rat cortex homogenate,2710,Expert,,8,,,,,,1,,12687,B,,,CHEMBL617270,12490,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 3 receptor in membranes of N1E-115 neuroblastoma cells using [3H]-ICS 205-930,2711,Autocuration,,8,,,339.0,,,1,N1E-115,12687,B,,,CHEMBL617271,12827,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 3 receptor in membranes of N1E-115 neuroblastoma cells using [3H]-ICS 205-930; Not determined,2712,Autocuration,,8,,,339.0,,,1,N1E-115,12687,B,,,CHEMBL617272,12827,
,H,BAO_0000019,,Binding affinity was evaluated by 5-hydroxytryptamine 2A receptor agonism in the rat cortex by displacing ketanserin,2713,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617273,12918,
,D,BAO_0000019,,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]-ketanserin,2714,Expert,,9,,,,,10116.0,1,,12687,F,Rattus norvegicus,,CHEMBL617274,12919,
,H,BAO_0000357,,Binding affinity towards human serotonin 5-hydroxytryptamine 2C receptor,2715,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617275,17723,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2C receptor,2716,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617276,6013,
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 2C receptor,2717,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617277,16293,
,H,BAO_0000019,,Binding affinity using [125I]DOI as radioligand with membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor,2718,Expert,,8,,,,,,1,,108,B,,,CHEMBL617278,3857,
,H,BAO_0000019,,Binding affinity using [125I]DOI as radioligand with membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor; Not determined,2719,Expert,,8,,,,,,1,,108,B,,,CHEMBL617279,3857,
,H,BAO_0000019,,Binding affinity using [3H]mesulergine as radioligand with receptor membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor,2720,Expert,,8,,,,,,1,,108,B,,,CHEMBL617280,3857,
,H,BAO_0000357,,Compound was tested for the displacement of [125I]DOI from cloned human 5-hydroxytryptamine 2C receptor,2721,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617281,15363,
,H,BAO_0000357,,Compound was tested for the displacement of [125I]DOI from cloned human 5-hydroxytryptamine 2C receptor,2722,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617282,15363,
,H,BAO_0000019,,Tested on transfected cell membranes selectively expressing human 5-hydroxytryptamine 2C receptor using [3H]mesulergine,2723,Expert,,8,,,,,,1,,108,B,,,CHEMBL617283,16441,
,H,BAO_0000019,,Tested on transfected cell membranes selectively expressing human 5-hydroxytryptamine 2C receptor using [3H]-mesulergine; ND is No Data.,2724,Expert,,8,,,,,,1,,108,B,,,CHEMBL617284,16441,
,H,BAO_0000219,,In vitro binding affinity towards human 5-hydroxytryptamine 2C receptor expressed in HEK293 cells was determined using [3H]mesulergine as radioligand,2725,Autocuration,,8,,,722.0,,,1,HEK293,108,B,,,CHEMBL617285,4176,
,H,BAO_0000019,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 2C receptor,2726,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617286,17085,
,D,BAO_0000357,,Inhibitory constant against cloned human 5-hydroxytryptamine 2C receptor using with [125I]- DOI radioligand,2727,Expert,,9,,,,,9606.0,1,,108,B,Homo sapiens,,CHEMBL617287,17200,
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 2C receptor.,2728,Expert,,8,,,,,,1,,108,B,,,CHEMBL617288,5088,
,H,BAO_0000357,,Tested for binding affinity towards human 5-hydroxytryptamine 2C receptor using [3H]DOB as radioligand,2729,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617289,5088,
,H,BAO_0000357,,Tested for binding affinity towards human 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,2730,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL872917,5088,
,H,BAO_0000357,,Tested for binding affinity towards human 5-hydroxytryptamine 2C receptor using [3H]5-HT as radioligand,2731,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617290,5088,
,H,BAO_0000219,,Binding affinity for displacement of [3H]mesulergine to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells,2732,Autocuration,,8,,,449.0,,,1,CHO,108,B,,,CHEMBL617291,16659,
,H,BAO_0000219,,Binding affinity for displacement of [3H]mesulergine to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells; ND is no data,2733,Autocuration,,8,,,449.0,,,1,CHO,108,B,,,CHEMBL617292,16659,
,H,BAO_0000219,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2C receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,2734,Autocuration,,8,,,723.0,,,1,NIH3T3,108,B,,,CHEMBL617293,17451,
,D,BAO_0000219,,Relative efficacy against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,2735,Expert,,9,,,449.0,,9606.0,1,CHO,108,F,Homo sapiens,,CHEMBL617294,6857,
,H,BAO_0000019,,Inhibitory activity using [3H]mesulergine as radioligand with receptor membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor at a concentration of 1 uM,2736,Expert,,8,,,,,,1,,108,B,,,CHEMBL617295,3857,
,H,BAO_0000357,,Binding activity radioligand.,2737,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617296,12861,
,H,BAO_0000019,,Binding activity against 5-hydroxytryptamine 2C receptor from human brain cortex using [3H]mesulergine as radioligand.,2738,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617297,12861,
,H,BAO_0000219,,Binding affinity for human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells using [3H]mesulergine as radioligand,2739,Expert,,8,,,449.0,,,1,CHO,108,B,,,CHEMBL617298,5104,
,H,BAO_0000219,,Binding affinity at human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells by [3H]mesulergine displacement.,2740,Expert,,8,,,449.0,,,1,CHO,108,B,,,CHEMBL617299,5105,
,H,BAO_0000219,,Binding affinity for human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells using [3H]mesulergine as radioligand; NT means not tested,2741,Autocuration,,8,,,449.0,,,1,CHO,108,B,,,CHEMBL617300,5105,
,H,BAO_0000357,,Binding affinity against 5-HT2C receptor,2742,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617454,5254,
,H,BAO_0000219,,Antagonistic binding affinity measured against 5-hydroxytryptamine 2C receptor (human clone expressed in 293 cells) using [3H]mesulergine as radioligand,2743,Autocuration,,8,,,722.0,,,1,HEK293,108,B,,,CHEMBL617505,13267,
,D,BAO_0000219,,Displacement of [3H]mesulergine from 5-hydroxytryptamine 2C receptor expressed in HEK 293 cells,2744,Expert,,9,,,722.0,,9606.0,1,HEK293,108,B,Homo sapiens,,CHEMBL617506,14157,
,D,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 2C receptor expressed in 293 cells using [3H]mesulergine,2745,Expert,,9,,,722.0,,9606.0,1,HEK293,108,B,Homo sapiens,,CHEMBL617507,12936,
,H,BAO_0000357,,Binding affinity against human 5-hydroxytryptamine 2C receptor using displacement of [3H]DOB,2746,Expert,,8,,,,,,1,,108,B,,,CHEMBL617508,14068,
,D,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 2C receptor expressed in 293 cells using [3H]mesulergine,2747,Expert,,9,,,722.0,,9606.0,1,HEK293,108,B,Homo sapiens,,CHEMBL857982,12936,
,D,BAO_0000219,,Binding affinity to human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]- mesulergine as radioligand,2748,Expert,,9,,,722.0,,9606.0,1,HEK293,108,B,Homo sapiens,,CHEMBL617509,4540,
,D,BAO_0000219,,Binding affinity to human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]- mesulergine as radioligand; Nd means not determined,2749,Expert,,9,,,722.0,,9606.0,1,HEK293,108,B,Homo sapiens,,CHEMBL617510,4540,
,H,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 2C receptor was determined,2750,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617511,6166,
,H,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 2C receptor human cloned receptors in HEK 293 cells using [3H]mesulergine as radioligand,2751,Autocuration,,8,,,722.0,,,1,HEK293,108,B,,,CHEMBL617512,17296,
,H,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 2C receptor human cloned receptorswithouteffect in HEK 293 cells using [3H]mesulergine as radioligand,2752,Autocuration,,8,,,722.0,,,1,HEK293,108,B,,,CHEMBL617749,17296,
,H,BAO_0000219,,Binding affinity towards 5-HT2C (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,2753,Autocuration,,8,,,722.0,,,1,HEK293,108,B,,,CHEMBL617750,15779,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 2C receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,2754,Autocuration,,8,,,722.0,,,1,HEK293,108,B,,,CHEMBL617751,15779,
,H,BAO_0000219,,Binding affinity towards cloned human 5-hydroxytryptamine 2C receptor expressed in HEK 293 cells using [3H]mesulergine as radioligand,2755,Expert,,8,,,722.0,,,1,HEK293,108,B,,,CHEMBL617752,14391,
,H,BAO_0000219,,"Binding affinity towards human cloned 5-hydroxytryptamine 2C receptor in HEK293 cells, using [3H]mesulergine as radioligand",2756,Autocuration,,8,,,722.0,,,1,HEK293,108,B,,,CHEMBL617753,15779,
,H,BAO_0000219,,"Binding affinity towards human cloned 5-hydroxytryptamine receptor 2C in HEK293 cells, using [3H]mesulergine as radioligand.",2757,Expert,,8,,,722.0,,,1,HEK293,108,B,,,CHEMBL617754,15851,
,D,BAO_0000219,,Displacement of [3H]mesulergine from human 5-hydroxytryptamine 2C receptor expressed in HEK293 cells; compound insoluble,2758,Expert,,9,,,722.0,,9606.0,1,HEK293,108,B,Homo sapiens,,CHEMBL617755,15851,
,H,BAO_0000219,,"Binding affinity towards human cloned 5-hydroxytryptamine 2C receptor in HEK293 cells, using [3H]mesulergine as radioligand; no data",2759,Autocuration,,8,,,722.0,,,1,HEK293,108,B,,,CHEMBL617756,15779,
,H,BAO_0000219,,Binding affinity towards human cloned 5-hydroxytryptamine 2C receptor of HEK293 cells by displacement of [3H]mesulergine,2760,Expert,,8,,,722.0,,,1,HEK293,108,B,,,CHEMBL617757,3832,
,H,BAO_0000219,,In vitro binding affinity at human cloned 5-hydroxytryptamine 2C receptor of HEK293 cells by [3H]mesulergine displacement.,2761,Expert,,8,,,722.0,,,1,HEK293,108,B,,,CHEMBL617758,3833,
,H,BAO_0000219,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2C receptor expressed in 3T3 cells using [3H]5-HT as radioligand,2762,Autocuration,,8,,,723.0,,,1,NIH3T3,108,B,,,CHEMBL617759,17451,
,H,BAO_0000219,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]mesulergine as the radioligand,2763,Autocuration,,8,,,722.0,,,1,HEK293,108,B,,,CHEMBL617760,4199,
,H,BAO_0000219,,Displacement of [3H]mesulergine from human cloned 5-hydroxytryptamine 2C receptor expressed in CHO-K1 cells,2764,Expert,,8,,,485.0,,,1,CHO-K1,108,B,,,CHEMBL617761,1883,
,D,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2C receptor,2765,Expert,,9,,,,,9606.0,1,,108,B,Homo sapiens,,CHEMBL617762,4321,
,H,BAO_0000357,,Compound was tested for binding affinity against human 5-hydroxytryptamine 2C receptor,2766,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617763,14875,
,H,BAO_0000219,,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]mesulergine,2767,Autocuration,,8,,,722.0,,,1,HEK293,108,B,,,CHEMBL857983,15146,
,H,BAO_0000219,,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 2C receptor in HEK 293 using [3H]mesulergine as a radioligand,2768,Autocuration,,8,,,722.0,,,1,HEK293,108,B,,,CHEMBL617764,5213,
,H,BAO_0000219,,Inhibitory constant on human 5-hydroxytryptamine 2C receptor transfected in to HeLa cells,2769,Autocuration,,8,,,308.0,,,1,HeLa,108,B,,,CHEMBL617765,16404,
,H,BAO_0000019,,Selectivity as the ratio of Ki value towards 5-hydroxytryptamine 2C receptor to that of pA2 value towards 5-hydroxytryptamine 2B receptor,2770,Autocuration,,8,,,,,,1,,108,F,,,CHEMBL617766,13267,
,H,BAO_0000221,,The binding affinity (pKi) measured against 5-hydroxytryptamine 3 receptor of rat hippocampus and entorhinal cortex using [3H]granisetron as radioligand,2771,Autocuration,10000000.0,8,,,,,,1,,108,F,,,CHEMBL617767,13267,Hippocampus
,H,BAO_0000219,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 2C receptor in HEK293 cells using [3H]mesulergine.,2772,Autocuration,,8,,,722.0,,,1,HEK293,108,B,,,CHEMBL617768,14818,
,H,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2C receptor in HEK293 cells, using [3H]5-mesulergine as radioligand",2773,Autocuration,,8,,,722.0,,,1,HEK293,108,B,,,CHEMBL617769,4829,
,H,BAO_0000357,,Binding affinity analysed on 5-HT 2C in human clone using [3H]mesulergine as radioligand,2774,Autocuration,,8,,,,,,1,,11864,B,,,CHEMBL858023,13463,
,H,BAO_0000019,,Binding affinity analysed on 5-HT 2C in rat stomach fundus,2775,Autocuration,945.0,8,,,,,,1,,11864,B,,,CHEMBL617770,13463,Stomach
,H,BAO_0000019,,Binding affinity analysed towards 5-HT 2C in rat stomach fundus,2776,Autocuration,945.0,8,,,,,,1,,11864,B,,,CHEMBL617771,13463,Stomach
,H,BAO_0000219,,Percent of maximum stimulation of phosphatidylinositol turnover at cloned 5-hydroxytryptamine 2C receptor in A9 cells,2777,Autocuration,,8,,,625.0,,,1,A9,11864,F,,,CHEMBL617772,12652,
,H,BAO_0000219,,Binding affinity to 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand in stably transfected NIH3T3 cells,2778,Autocuration,,8,,,723.0,,,1,NIH3T3,11864,B,,,CHEMBL617773,4682,
,H,BAO_0000219,,Binding affinity to 5-hydroxytryptamine 2C receptor measured using radioligand [3H]Mesulergine in stably transfected NIH3T3 cells,2779,Autocuration,,8,,,723.0,,,1,NIH3T3,11864,B,,,CHEMBL617850,4682,
,H,BAO_0000219,,Binding affinity to 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand in stably transfected NIH3T3 cells,2780,Autocuration,,8,,,723.0,,,1,NIH3T3,11864,B,,,CHEMBL617851,4682,
,H,BAO_0000019,,The maximum responses of [3H]- inositol monophosphate accumulation in cells expressing the 5-hydroxytryptamine 2C receptor,2781,Autocuration,,8,,,,,,1,,11864,F,,,CHEMBL617852,12652,
,H,BAO_0000019,,Binding affinity analysed on 5-HT 2C in rat stomach fundus.,2782,Autocuration,945.0,8,,,,,10090.0,1,,12689,B,Mus musculus,,CHEMBL858024,13463,Stomach
,D,BAO_0000019,,Binding affinity towards 5-HT 2C receptor in rat stomach fundus,2783,Expert,945.0,9,,,,,10116.0,1,,12689,B,Rattus norvegicus,,CHEMBL617853,13463,Stomach
,H,BAO_0000357,,Binding affinity against 5-Hydroxytryptamine 2C Receptor was measured using [3H]N-methyl-mesulergine as radioligand,2784,Expert,,8,,,,,,1,,108,B,,,CHEMBL617854,13969,
,H,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 2C receptor,2785,Expert,,8,,,,,9823.0,1,,108,B,Sus scrofa,,CHEMBL873477,13392,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2C receptor,2786,Expert,,8,,,,,,1,,108,B,,,CHEMBL617855,13392,
,H,BAO_0000019,,Affinity towards 5-hydroxytryptamine 2C receptor in membranes from pig choroid plexus using [3H]N-methyl-mesulergine,2787,Expert,,8,,,,,,1,,108,B,,,CHEMBL617856,14430,
,H,BAO_0000019,,Compound was tested for its ability to displace [3H]mesulergine from 5-hydroxytryptamine 2C receptor in pig cortex,2788,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617857,1742,
,H,BAO_0000249,,In vitro inhibitory concentration against radioligand [3H]mesulergine binding to 5-hydroxytryptamine 2C receptor in pig cortical membrane,2789,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617858,14286,
,H,BAO_0000357,,Binding affinity towards pig 5-hydroxytryptamine 2C receptor,2790,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617859,5619,
,H,BAO_0000357,,The compound was tested for binding affinity against 5-hydroxytryptamine 2C receptor,2791,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617860,15086,
,H,BAO_0000357,,Binding activity radioligand.,2792,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617861,12861,
,H,BAO_0000019,,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand.,2793,Expert,,8,,,,,,1,,108,B,,,CHEMBL617862,12861,
,H,BAO_0000019,,Binding activity against 5-hydroxytryptamine 3 receptor from pig cortex membrane using [3H]mesulergine as radioligand; NA Not Available,2794,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617863,12861,
,H,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 1D receptor in calf caudate membranes using [3H]5-HT,2795,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617864,12827,
,H,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 1D receptor in calf caudate membranes using [3H]5-HT; Not determined,2796,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617649,12827,
,H,BAO_0000019,,Agonistic activity against 5-hydroxytryptamine 2C receptor in pig choroid plexus using [3H]mesulergine,2797,Expert,,8,,,,,9823.0,1,,108,F,Sus scrofa,,CHEMBL617650,12919,
,H,BAO_0000019,,Agonistic activity against 5-hydroxytryptamine 2C receptor in pig choroid plexus using [3H]mesulergine,2798,Expert,,8,,,,,9823.0,1,,108,F,Sus scrofa,,CHEMBL617651,12919,
,H,BAO_0000357,,In vitro binding affinity at 5-hydroxytryptamine 2C receptor in pig choroid plexus using 3[H]mesulergine as the radioligand,2799,Autocuration,,8,,,,,9823.0,1,,108,B,Sus scrofa,,CHEMBL617652,16429,
,H,BAO_0000019,,In Vitro Binding affinity againist 5-hydroxytryptamine 2C receptor by displacing [3H]mesulergine from pig cortex,2800,Autocuration,,8,,,,,9823.0,1,,108,B,Sus scrofa,,CHEMBL857072,773,
,H,BAO_0000357,,Ability to displace the radioligand [3H]mesulergine from pig choroid plexus 5-hydroxytryptamine 2C receptor,2801,Autocuration,,8,,,,,9823.0,1,,108,B,Sus scrofa,,CHEMBL617653,5033,
,H,BAO_0000019,,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand.,2802,Autocuration,,8,,,,,,1,,12687,B,,,CHEMBL617654,12861,
,H,BAO_0000019,,Effect on phosphoinositide hydrolysis in NIH 3T3 fibroblast 5-hydroxytryptamine 2C receptor,2803,Autocuration,,8,,,,,,1,,12689,F,,,CHEMBL617655,14093,
,H,BAO_0000357,,Binding affinity towards 5-HT2C receptor from rat using [3H]mesulergine as radioligand,2804,Expert,,8,,,,,,1,,12689,B,,,CHEMBL617656,14970,
,H,BAO_0000357,,Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2C receptor from rat using [3H]mesulergine as radioligand,2805,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL617657,14970,
,H,BAO_0000357,,Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2C receptor from rat using [3H]mesulergine as radioligand; Not tested,2806,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL617658,14970,
,D,BAO_0000357,,Inhibition of radiolabeled [3H]-Ketanserin ligand binding to 5-hydroxytryptamine 2C receptor,2807,Expert,,9,,,,,10116.0,1,,12689,B,Rattus norvegicus,,CHEMBL617659,14178,
,D,BAO_0000357,,Inhibition of radiolabeled [3H]mesulergine ligand binding to 5-hydroxytryptamine 2C receptor,2808,Expert,,9,,,,,10116.0,1,,12689,B,Rattus norvegicus,,CHEMBL617838,14178,
,D,BAO_0000249,,Inhibition of [3H]mesulergine binding to 5-hydroxytryptamine 2C receptor in rat brain membranes,2809,Expert,,9,Brain membranes,,,,10116.0,1,,12689,B,Rattus norvegicus,,CHEMBL617839,14229,
,H,BAO_0000357,,The binding affinity at 5-hydroxytryptamine 2C receptor was determined using [3H]mesulergine; Not tested,2810,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL617840,16532,
,H,BAO_0000019,,Ability to displace [3H]mesulergine bound to 5-hydroxytryptamine 2C receptor in rat cortex,2811,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL617841,14826,
,H,BAO_0000019,,Ability to displace [3H]mesulergine (0.5 nM) from SR-3T3 cells of rat 5-HT2C receptor,2812,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL875915,17211,
,H,BAO_0000219,,Displacement of [3H]mesulergine (0.5 nM) from rat 5-hydroxytryptamine 2C receptor expressed in SR-3T3 cells,2813,Expert,,8,,In vitro,,,,1,,12689,B,,,CHEMBL617842,17211,
,H,BAO_0000219,,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2C serotonin receptor in NIH3T3 cell line membranes,2814,Expert,,8,,,723.0,,,1,NIH3T3,12689,B,,,CHEMBL617843,13246,
,H,BAO_0000357,,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2C serotonin receptor.,2815,Expert,,8,,,,,,1,,12689,B,,,CHEMBL617844,13246,
,H,BAO_0000357,,Affinity was evaluated as inhibition constant for serotonin 5-hydroxytryptamine 2C receptor,2816,Expert,,8,,,,,,1,,12689,B,,,CHEMBL617845,12457,
,H,BAO_0000219,,Affinity was evaluated by inhibition of [125I]LSD binding to NIH 3T3 cells transfected with cloned rat 5-hydroxytryptamine 2C receptor,2817,Expert,,8,,,723.0,,,1,NIH3T3,12689,B,,,CHEMBL617846,12457,
,H,BAO_0000357,,Binding affinity towards rat 5-hydroxytryptamine 2C receptor was determined using [125I]- DOI as radioligand,2818,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL617847,4707,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2C receptor,2819,Expert,,8,,,,,,1,,12689,B,,,CHEMBL617848,13297,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand,2820,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL617849,16633,
,H,BAO_0000357,,Binding affinity against rat 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,2821,Expert,,8,,,,,,1,,12689,B,,,CHEMBL621507,16133,
,H,BAO_0000357,,Binding affinity at cloned rat 5-hydroxytryptamine 2C receptor using [3H]DOI as radioligand,2822,Expert,,8,,,,,,1,,12689,B,,,CHEMBL621508,16326,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2C receptor from rat cortex using [3H]mesulergine as the radioligand.,2823,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL621509,14423,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2C receptor of rat cortex,2824,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL621510,15412,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2C receptor of rat cortex.,2825,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL621511,15412,
,H,BAO_0000219,,Displacement of [3H]mesulergine from A9 cells stably expressing rat 5-hydroxytryptamine 2C receptor,2826,Expert,,8,,,625.0,,,1,A9,12689,B,,,CHEMBL621512,15558,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand,2827,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL621513,16633,
,H,BAO_0000357,,Binding affinity towards cloned rat 5-hydroxytryptamine 2C receptor from fundus tissue by [3H]mesulergine displacement.,2828,Expert,,8,,,,,,1,,12689,B,,,CHEMBL621514,6013,
,H,BAO_0000219,,Binding affinity towards rat 5-hydroxytryptamine 2C receptor expressed in A-9 cells using [3H]mesulergine as radioligand,2829,Expert,,8,,In vitro,,,,1,,12689,B,,,CHEMBL621515,17175,
,H,BAO_0000219,,Binding affinity was measured on 5-hydroxytryptamine 2C receptor in J1 cells transfected with rat 5-HT2C gene labeled with [3H]mesulergine,2830,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL621516,12469,
,H,BAO_0000019,,Compound was evaluated for affinity towards cerebral 5-hydroxytryptamine 2C receptor in homogenate of caudate putamen tissue from rat brain,2831,Autocuration,5383.0,8,,,,,,1,,12689,B,,,CHEMBL621517,3682,Caudate-putamen
,H,BAO_0000357,,Compound was evaluated for its ability to displace (+/-)[125I]-DOI from 5-hydroxytryptamine 2C receptor in cloned rat cell culture,2832,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL621518,4932,
,H,BAO_0000019,,Compound was evaluated for its ability to displace [125I](R)-DOI from 5-hydroxytryptamine 2C receptor in cloned rat prefrontal cortex homogenate; ND denotes no data,2833,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL621519,4932,
,H,BAO_0000357,,Compound was evaluated for its binding affinity for rat 5-hydroxytryptamine 2C receptor,2834,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL621520,3935,
,H,BAO_0000357,,Compound was evaluated for its binding affinity towards rat 5-hydroxytryptamine 2C receptor,2835,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL621521,15818,
,H,BAO_0000357,,Compound was evaluated for its binding affinity towards rat r5-hydroxytryptamine 2C receptor,2836,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL621522,15818,
,H,BAO_0000219,,Binding affinity against rat 5-hydroxytryptamine 2C receptor in A-9 cells.,2837,Expert,,8,,,,,,1,,12689,B,,,CHEMBL621523,14749,
,H,BAO_0000357,,Evaluated for the binding constant at [125I]-DOI-labeled rat 5-hydroxytryptamine 2C receptor,2838,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL621524,15740,
,D,BAO_0000357,,In vitro binding to 5-hydroxytryptamine 2C receptor using [125 I]-DOI,2839,Expert,,9,,,,,10116.0,1,,12689,B,Rattus norvegicus,,CHEMBL621525,17133,
,H,BAO_0000357,,The binding affinity at 5-hydroxytryptamine 2C receptor was determined using [3H]mesulergine,2840,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL872921,16532,
,H,BAO_0000357,,The compound evaluated for its affinity against 5-hydroxytryptamine 2C receptor,2841,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL621526,12369,
,H,BAO_0000219,,Affinity against 5-hydroxytryptamine 2C receptor in J1 cells transfected with the rat 5-HT2C gene labeled with [3H]mesulergine.,2842,Expert,,8,,,,,,1,,12689,B,,,CHEMBL621527,12369,
,D,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2C receptor in rat choroid plexus using [3H]N-methyl-mesulergine,2843,Expert,,9,,,,,10116.0,1,,12689,B,Rattus norvegicus,,CHEMBL617865,2309,
,H,BAO_0000357,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 2C receptor,2844,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL617866,12953,
,H,BAO_0000019,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 2C receptor from rat cortex using [3H]-citalopram as radioligand; Nonactive at 10 uM,2845,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL617867,12953,
,H,BAO_0000357,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand; Nonactive at 10 uM,2846,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL617487,12953,
,H,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 2C receptor,2847,Expert,,8,,,,,,1,,12689,B,,,CHEMBL617488,12953,
,H,BAO_0000357,,Tested in vitro for its ability to bind to 5-hydroxytryptamine 2C receptor using [125 I]-DOI as radioligand; Not determined,2848,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL617489,17133,
,H,BAO_0000019,,Ability to displace [3H]mesulergine (0.5 nM) from SR-3T3 cells of rat 5-hydroxytryptamine 2C receptor; NT denotes not tested,2849,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL617490,17211,
,H,BAO_0000019,,Ability to displace [3H]mesulergine (0.5 nM) from SR-3T3 cells of rat 5-hydroxytryptamine 2C receptor; NT=not tested,2850,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL617491,17211,
,H,BAO_0000019,,Affinity pKi for 5-hydroxytryptamine 2C receptor was measured in rat cortex homogenates.,2851,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL617492,14025,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2C receptor in rat cortex homogenates.,2852,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL617493,14998,
,H,BAO_0000357,,Binding affinity of compound towards serotonin 5-hydroxytryptamine 2C receptor was determined,2853,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL617494,4342,
,D,BAO_0000019,,Displacement of [3H]mesulergine from rat 5-HT2C receptor expressed in HEK293,2854,Expert,,9,,,,,10116.0,1,,12689,B,Rattus norvegicus,,CHEMBL617495,13735,
,H,BAO_0000357,,Binding affinity was determined against cloned human 5-hydroxytryptamine 2C receptor using [3H]5-HT as radioligand,2855,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL617496,13181,
,H,BAO_0000219,,Compound was evaluated for displacement of [3H]mesulergine from cloned rat 5-hydroxytryptamine 2C receptor in transfected CHO-K1 cells.,2856,Autocuration,,8,,,485.0,,,1,CHO-K1,12689,B,,,CHEMBL617497,1883,
,H,BAO_0000357,,The compound was tested for the binding affinity against 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,2857,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL617498,15194,
,H,BAO_0000357,,The compound was tested for the binding affinity against 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand.,2858,Autocuration,,8,,,,,,1,,12689,B,,,CHEMBL617499,15194,
,H,BAO_0000019,,Compound tested for relative response using 0.1 uM 5-HT as agonist against 5-hydroxytryptamine 2C receptor,2859,Autocuration,,8,,,,,,1,,12689,F,,,CHEMBL617500,14579,
,H,BAO_0000357,,Compound was tested for binding affinity against 5-hydroxytryptamine 2C receptor,2860,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617501,4639,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2C receptor,2861,Expert,,8,,,,,,1,,108,B,,,CHEMBL617502,4820,
,H,BAO_0000357,,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine as radioligand; Not Tested,2862,Autocuration,,8,,,,,,1,,227,B,,,CHEMBL617503,14442,
,H,BAO_0000357,,Binding activity against cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT as the radioligand.,2863,Autocuration,,8,,,,,,1,,227,B,,,CHEMBL617504,14755,
,H,BAO_0000357,,Binding affinity against the cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT as the radioligand,2864,Autocuration,,8,,,,,,1,,227,B,,,CHEMBL617406,14744,
,D,BAO_0000019,,Affinity for human 5-hydroxytryptamine 2B receptor expressed in mammalian cell line,2865,Expert,,9,,,,,9606.0,1,,227,B,Homo sapiens,,CHEMBL617407,6857,
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 2B receptor using [3H]5-HT as radioligand,2866,Autocuration,,8,,,,,,1,,227,B,,,CHEMBL617408,16209,
,H,BAO_0000357,,Compound was tested for the displacement of [3H]5-HT from clone human 5-hydroxytryptamine 2B receptor,2867,Autocuration,,8,,,,,,1,,227,B,,,CHEMBL617409,15363,
,H,BAO_0000357,,Compound was tested for the displacement of [3H]5-HT from clone human 5-hydroxytryptamine 2B receptor,2868,Autocuration,,8,,,,,,1,,227,B,,,CHEMBL617410,15363,
,H,BAO_0000357,,Compound was tested for the displacement of [3H]5-HT from cloned human 5-hydroxytryptamine 2B receptor,2869,Autocuration,,8,,,,,,1,,227,B,,,CHEMBL617411,15363,
,H,BAO_0000019,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 2B receptor,2870,Autocuration,,8,,,,,,1,,227,B,,,CHEMBL617412,17085,
,D,BAO_0000357,,Inhibitory constant against cloned human 5-hydroxytryptamine 2B receptor using with [125I]- DOI radioligand,2871,Expert,,9,,,,,9606.0,1,,227,B,Homo sapiens,,CHEMBL617774,17200,
,D,BAO_0000219,,Displacement of [3H]5-HT from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; ND = no data,2872,Expert,,9,,,722.0,,9606.0,1,HEK293,227,B,Homo sapiens,,CHEMBL617775,15851,
,D,BAO_0000219,,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; ND = no data,2873,Expert,,9,,,722.0,,9606.0,1,HEK293,227,B,Homo sapiens,,CHEMBL617776,15851,
,D,BAO_0000219,,Relative efficacy against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,2874,Expert,,9,,,449.0,,9606.0,1,CHO,227,F,Homo sapiens,,CHEMBL617777,6857,
,D,BAO_0000219,,Rleative efficacy against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,2875,Expert,,9,,,449.0,,9606.0,1,CHO,227,F,Homo sapiens,,CHEMBL617778,6857,
,H,BAO_0000219,,"Binding affinities towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand",2876,Autocuration,,8,,,722.0,,,1,HEK293,227,B,,,CHEMBL617779,15779,
,H,BAO_0000219,,Binding affinities towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells using [3H]5-HT as radioligand.,2877,Expert,,8,,,722.0,,,1,HEK293,227,B,,,CHEMBL617780,15851,
,H,BAO_0000219,,"Binding affinities towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand; no data",2878,Autocuration,,8,,,722.0,,,1,HEK293,227,B,,,CHEMBL617781,15779,
,D,BAO_0000219,,Displacement of [3H]5-HT from 5-hydroxytryptamine 2B receptor expressed in HEK 293 cells,2879,Expert,,9,,,722.0,,9606.0,1,HEK293,227,B,Homo sapiens,,CHEMBL617782,14157,
,D,BAO_0000219,,Binding affinity to human cloned 5-HT2B receptor in HEK 293 cells using [3H]- -5-HT as radioligand,2880,Expert,,9,,,722.0,,9606.0,1,HEK293,227,B,Homo sapiens,,CHEMBL617783,4540,
,H,BAO_0000357,,Binding affinity towards cloned human 5-hydroxytryptamine 2B receptor was determined,2881,Autocuration,,8,,,,,,1,,227,B,,,CHEMBL617784,6166,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 2B receptor (human cloned receptor) in HEK 293 cells using [3H]5-HT as radioligand.,2882,Autocuration,,8,,,722.0,,,1,HEK293,227,B,,,CHEMBL617785,15779,
,H,BAO_0000219,,Binding affinity towards cloned human 5-hydroxytryptamine 2B receptor expressed in HEK 293 cells using [3H]5-HT as radioligand,2883,Expert,,8,,,722.0,,,1,HEK293,227,B,,,CHEMBL857984,14391,
,H,BAO_0000219,,Binding affinity towards human cloned 5-HT2B receptor of HEK293 cells by displacement of [3H]5-HT,2884,Expert,,8,,,722.0,,,1,HEK293,227,B,,,CHEMBL617786,3832,
,H,BAO_0000219,,In vitro binding affinity at human cloned 5-hydroxytryptamine 2B receptor of HEK293 cells by [3H]5-HT displacement.,2885,Expert,,8,,,722.0,,,1,HEK293,227,B,,,CHEMBL617787,3833,
,D,BAO_0000219,,Displacement of [3H]5-HT from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells,2886,Expert,,9,,,722.0,,9606.0,1,HEK293,227,B,Homo sapiens,,CHEMBL617788,15851,
,D,BAO_0000219,,Displacement of [3H]5-HT from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; compound is insoluble,2887,Expert,,9,,,722.0,,9606.0,1,HEK293,227,B,Homo sapiens,,CHEMBL617789,15851,
,H,BAO_0000219,,Compound was evaluated for binding affinity against human cloned 5-HT2B receptor in HEK 293 cells using [3H]5-HT as the radioligand,2888,Autocuration,,8,,,722.0,,,1,HEK293,227,B,,,CHEMBL617790,4199,
,H,BAO_0000219,,Displacement of [3H]-5-5HT from human cloned 5-hydroxytryptamine 2B receptor expressed in CHO-K1 cells,2889,Expert,,8,,,485.0,,,1,CHO-K1,227,B,,,CHEMBL617791,1883,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2B receptor,2890,Expert,,8,,,,,,1,,227,B,,,CHEMBL617608,4321,
,H,BAO_0000219,,Compound was tested for its binding affinity against cloned human 5-hydroxytryptamine 2B receptor in HEK 293 cells using [3H]5-HT,2891,Autocuration,,8,,,722.0,,,1,HEK293,227,B,,,CHEMBL617609,15146,
,H,BAO_0000219,,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 2B receptor in HEK 293 using [3H]ketanserin as a radioligand,2892,Autocuration,,8,,,722.0,,,1,HEK293,227,B,,,CHEMBL617610,5213,
,H,BAO_0000219,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 2B receptors in HEK293 cells using [3H]5-HT.,2893,Autocuration,,8,,,722.0,,,1,HEK293,227,B,,,CHEMBL617611,14818,
,H,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand",2894,Autocuration,,8,,,722.0,,,1,HEK293,227,B,,,CHEMBL617612,4829,
,H,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand",2895,Autocuration,,8,,,722.0,,,1,HEK293,227,B,,,CHEMBL617613,4829,
,H,BAO_0000019,,The dissociation equilibrium constant (pKB=-log KB) of compound was determined against the vascular 5-hydroxytryptamine 2B receptor in the endothelium intact rabbit jugular vein.,2896,Autocuration,,8,,,,,9986.0,1,,227,B,Oryctolagus cuniculus,,CHEMBL617614,14025,
,H,BAO_0000019,,Binding affinity analysed for 5-HT 2B receptor in rat stomach fundus,2897,Expert,945.0,8,,,,,,1,,12688,B,,,CHEMBL617615,13463,Stomach
,H,BAO_0000357,,Affinity against 5-hydroxytryptamine 2B receptor in the isolated rat stomach fundus,2898,Expert,945.0,8,,,,,,1,,12688,B,,,CHEMBL858114,7259,Stomach
,H,BAO_0000357,,Affinity against serotonergic receptor in the isolated rat stomach fundus,2899,Autocuration,945.0,8,,,,,,1,,12688,B,,,CHEMBL617616,7259,Stomach
,D,BAO_0000019,,Antagonistic activity against 5-hydroxytryptamine 2B receptor obtained from rat stomach fundus preparation,2900,Expert,945.0,9,,,,,10116.0,1,,12688,F,Rattus norvegicus,,CHEMBL617617,7185,Stomach
,D,BAO_0000019,,Antagonistic against 5-hydroxytryptamine 2B receptor,2901,Expert,,9,,,,,10116.0,1,,12688,F,Rattus norvegicus,,CHEMBL875914,7185,
,H,BAO_0000019,,Antagonistic affinity measured as pA2 value on 5-hydroxytryptamine 2B receptor of the rat stomach fundus,2902,Autocuration,945.0,8,,,,,,1,,12688,F,,,CHEMBL617618,13267,Stomach
,D,BAO_0000357,,Inhibition of 5-HT binding to 5-HT2B receptor of Rat stomach fundus,2903,Expert,945.0,9,,,,,10116.0,1,,12688,B,Rattus norvegicus,,CHEMBL617619,13735,Stomach
,H,BAO_0000019,,Compound was evaluated for antagonism against serotonin (5-hydroxytryptamine 2B receptor ) receptor,2904,Autocuration,,8,,,,,,1,,12688,F,,,CHEMBL617620,15738,
,H,BAO_0000019,,Compound was evaluated for antagonism against serotonin (5-hydroxytryptamine 2B receptor ) receptor; No data,2905,Autocuration,,8,,,,,,1,,12688,F,,,CHEMBL617621,15738,
,H,BAO_0000019,,Compound was evaluated for antagonism against serotonin (5-hydroxytryptamine 2B) receptor,2906,Autocuration,,8,,,,,,1,,12688,F,,,CHEMBL617622,15738,
,D,BAO_0000357,,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,2907,Expert,945.0,9,,,,,10116.0,1,,12688,B,Rattus norvegicus,,CHEMBL617623,12936,Stomach
,D,BAO_0000357,,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,2908,Expert,945.0,9,,,,,10116.0,1,,12688,B,Rattus norvegicus,,CHEMBL617624,12936,Stomach
,D,BAO_0000357,,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,2909,Expert,945.0,9,,,,,10116.0,1,,12688,B,Rattus norvegicus,,CHEMBL617625,12936,Stomach
,D,BAO_0000357,,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,2910,Expert,945.0,9,,,,,10116.0,1,,12688,B,Rattus norvegicus,,CHEMBL617626,12936,Stomach
,H,BAO_0000019,,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus,2911,Autocuration,945.0,8,,,,,,1,,12688,F,,,CHEMBL617627,16404,Stomach
,H,BAO_0000019,,Negative log concentration of antagonist was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus,2912,Expert,945.0,8,,,,,,1,,12688,F,,,CHEMBL617628,16404,Stomach
,H,BAO_0000019,,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus; ND is No Data.,2913,Autocuration,945.0,8,,,,,,1,,12688,F,,,CHEMBL617629,16404,Stomach
,H,BAO_0000019,,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus; ND is not determined.,2914,Autocuration,945.0,8,,,,,,1,,12688,F,,,CHEMBL858115,16404,Stomach
,D,BAO_0000019,,Antagonistic activity on 5-hydroxytryptamine 2B receptor of Rat stomach fundus;ND is not determined,2915,Expert,945.0,9,,,,,10116.0,1,,12688,F,Rattus norvegicus,,CHEMBL617630,16404,Stomach
,H,BAO_0000019,,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat thoracic aorta; ND is not determined,2916,Autocuration,1515.0,8,,,,,,1,,12688,F,,,CHEMBL617631,16404,Thoracic aorta
,H,BAO_0000357,,The binding affinity of compound to 5-HT receptor of rat fundus was expressed as pA2 value; Unable to determine valid PA2 value due to slope of Schild plot,2917,Autocuration,,8,,,,,,1,,12688,B,,,CHEMBL617632,7483,
,H,BAO_0000357,,The binding affinity to 5-hydroxytryptamine 2B receptor of rat fundus,2918,Expert,,8,,,,,,1,,12688,B,,,CHEMBL617633,7483,
,H,BAO_0000357,,The binding affinity of compound to 5-hydroxytryptamine 2B receptor of rat fundus was expressed as pA2 value; Unable to determine valid PA2 value due to slope of Schild plot,2919,Autocuration,,8,,,,,,1,,12688,B,,,CHEMBL617634,7483,
,H,BAO_0000357,,The binding affinity of compound to 5-hydroxytryptamine 2B receptor of rat fundus; Unable to determine valid PA2 value due to slope of Schild plot,2920,Autocuration,,8,,,,,,1,,12688,B,,,CHEMBL617635,7483,
,D,BAO_0000019,,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus,2922,Autocuration,945.0,9,,,,,10116.0,1,,12688,F,Rattus norvegicus,,CHEMBL617637,16404,Stomach
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 1A receptor,2923,Autocuration,,8,,,,,,1,,227,B,,,CHEMBL617638,6347,
,H,BAO_0000357,,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 2B receptor was determined,2924,Autocuration,,8,,,,,,1,,227,B,,,CHEMBL617639,4373,
,H,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 2B receptor was determined,2925,Autocuration,,8,,,,,,1,,227,B,,,CHEMBL617640,4373,
,H,BAO_0000357,,Evaluated for the binding affinity to 5-HT 2B receptor,2926,Autocuration,,8,,,,,,1,,227,B,,,CHEMBL617641,4687,
,H,BAO_0000357,,Ability to displace [3H]5-HT from 5-hydroxytryptamine 2B receptor,2927,Autocuration,,8,,,,,,1,,227,B,,,CHEMBL617642,16946,
,H,BAO_0000357,,Binding affinities against 5-hydroxytryptamine 2B receptor,2928,Autocuration,,8,,,,,,1,,227,B,,,CHEMBL617643,16633,
,H,BAO_0000357,,Binding affinities towards 5-hydroxytryptamine 2B receptor,2929,Autocuration,,8,,,,,,1,,227,B,,,CHEMBL617644,16633,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2B receptor using [125I]DOI as radioligand,2930,Autocuration,,8,,,,,,1,,227,B,,,CHEMBL617645,16633,
,H,BAO_0000357,,In vitro ability to displace [3H]mesulergine binding from 5-hydroxytryptamine 2C receptor from bovine choroid plexus.,2931,Expert,,8,,,,,,1,,108,B,,,CHEMBL617646,15026,
,H,BAO_0000357,,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor,2932,Autocuration,,8,,,,,9913.0,1,,108,B,Bos taurus,,CHEMBL617647,15738,
,H,BAO_0000357,,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor at a concentration of 10E-6 M,2933,Autocuration,,8,,,,,9913.0,1,,108,B,Bos taurus,,CHEMBL617648,15738,
,H,BAO_0000357,,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor at a concentration of 10e-6 M,2934,Autocuration,,8,,,,,9913.0,1,,108,B,Bos taurus,,CHEMBL617875,15738,
,H,BAO_0000357,,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor at concentration of 10e-6 M,2935,Autocuration,,8,,,,,9913.0,1,,108,B,Bos taurus,,CHEMBL617876,15738,
,H,BAO_0000357,,Inhibitory constant was determined on 5-hydroxytryptamine 2C receptor of Bovine choroid plexus,2936,Expert,,8,,,,,9913.0,1,,108,B,Bos taurus,,CHEMBL617877,16404,
,H,BAO_0000357,,In vitro ability to displace [3H]mesulergine binding from 5-hydroxytryptamine 2C receptor from bovine choroid plexus.,2937,Expert,,8,,,,,9913.0,1,,108,B,Bos taurus,,CHEMBL617878,15026,
,H,BAO_0000357,,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor,2938,Autocuration,,8,,,,,9913.0,1,,108,B,Bos taurus,,CHEMBL617879,15738,
,H,BAO_0000019,,Binding affinity against guinea pig cortex 5-HT2C receptor in the presence of [3H]mesulergine,2939,Autocuration,,8,,,,,10141.0,1,,108,B,Cavia porcellus,,CHEMBL617880,16312,
,D,BAO_0000357,,Binding affinity towards 5-HT4 receptor by the displacement of [3H]GR-113808 in guinea-pig striatum,2940,Intermediate,2435.0,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL617881,5486,Striatum
,H,BAO_0000357,,Binding affinity against 5-HT1A receptor,2941,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL857073,5254,
,H,BAO_0000219,,Agonistic activity for 5-HT2c (5-HT2C) by measuring [3H]inositol monophosphate fromation in CHO cells in which the human 5-HT2C receptor subtype was stably expressed,2942,Expert,,8,,,449.0,,,1,CHO,108,F,,,CHEMBL617882,3857,
,D,BAO_0000219,,Functional activity against human 5-hydroxytryptamine 2C receptor expressed in CHO cells using fluorometric imaging plate reader,2943,Expert,,9,,,449.0,,9606.0,1,CHO,108,F,Homo sapiens,,CHEMBL617883,6857,
,H,BAO_0000219,,Functional agonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2c receptor cell line,2944,Autocuration,,8,,,,,,1,,108,F,,,CHEMBL617884,4176,
,H,BAO_0000219,,Agonistic binding efficacy against human 5-hydroxytryptamine 2C receptor in CHO cells using [125I]- DOI radioligand,2945,Autocuration,,8,,,449.0,,,1,CHO,108,B,,,CHEMBL617885,6347,
,H,BAO_0000219,,"Agonistic binding affinity against human 5-hydroxytryptamine 2C receptor in CHO cells using [125I]- DOI radioligand, expressed as Emax",2946,Autocuration,,8,,,449.0,,,1,CHO,108,B,,,CHEMBL617886,6347,
,D,BAO_0000357,,Inhibition of human 5-hydroxytryptamine 2C receptor,2947,Expert,,9,,,,,9606.0,1,,108,B,Homo sapiens,,CHEMBL617887,16146,
,H,BAO_0000357,,In vitro binding affinity against human 5-hydroxytryptamine 2C receptor at a concentration of 100 (nM),2948,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617888,3805,
,H,BAO_0000019,,Inhibitory activity using [3H]mesulergine as radioligand with receptor membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor at a concentration of 1 uM,2949,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617889,3857,
,H,BAO_0000357,,Intrinsic efficacy against 5-hydroxytryptamine 2C receptor,2950,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617890,5635,
,H,BAO_0000357,,Intrinsic efficacy against 5-hydroxytryptamine 2C receptor Intrinsic efficacy against 5-hydroxytryptamine 2C receptor; Intrinsic efficacy (%) not determined,2951,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617891,5635,
,H,BAO_0000357,,Intrinsic efficacy against 5-hydroxytryptamine 2C receptor; Intrinsic efficacy (%) not determined,2952,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617892,5635,
,H,BAO_0000219,,Displacement of [H]-mesulergine from CHO cells expressing human 5-hydroxytryptamine 2C receptor.,2953,Expert,,8,,,449.0,,,1,CHO,108,B,,,CHEMBL617893,4012,
,H,BAO_0000219,,Ability to displace [3H]- mesulergine from human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells,2954,Expert,,8,,,449.0,,,1,CHO,108,B,,,CHEMBL617894,6366,
,H,BAO_0000219,,Ability to displace [3H]mesulergine binding to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells,2955,Expert,,8,,,449.0,,,1,CHO,108,B,,,CHEMBL617895,15949,
,H,BAO_0000219,,Ability to displace [3H]mesulergine (0.5 nM) from CHO cells of human 5-hydroxytryptamine 2C receptor,2956,Autocuration,,8,,,449.0,,,1,CHO,108,B,,,CHEMBL617896,17211,
,D,BAO_0000357,,Affinity towards human 5-hydroxytryptamine 2C serotonin receptor,2957,Expert,,9,,,,,9606.0,1,,108,B,Homo sapiens,,CHEMBL617897,6491,
,H,BAO_0000019,,Agonist activity at cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI radioligand,2958,Autocuration,,8,,,,,,1,,108,F,,,CHEMBL617898,14093,
,H,BAO_0000019,,Agonistic activity at cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand,2959,Autocuration,,8,,,,,,1,,108,F,,,CHEMBL617899,13481,
,H,BAO_0000219,,Agonistic binding affinity against human 5-hydroxytryptamine 2C receptor in CHO cells using [125I]- DOI ,2960,Expert,,8,,,449.0,,10116.0,1,CHO,108,B,Rattus norvegicus,,CHEMBL617900,6347,
,H,BAO_0000019,,Antagonist activity at cloned human 5-hydroxytryptamine 2C receptor using [3H]mesulergine radioligand,2961,Autocuration,,8,,,,,,1,,108,F,,,CHEMBL617901,14093,
,H,BAO_0000019,,Antagonist activity at cloned human 5-hydroxytryptamine 2C receptor using [3H]mesulergine radioligand; Not tested,2962,Autocuration,,8,,,,,,1,,108,F,,,CHEMBL617902,14093,
,H,BAO_0000019,,Antagonistic activity at cloned human 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,2963,Autocuration,,8,,,,,,1,,108,F,,,CHEMBL617903,13481,
,H,BAO_0000357,,Binding ability of compound at cloned human 5-hydroxytryptamine 2C receptor using [125 I]DOI as radioligand,2964,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617904,14442,
,H,BAO_0000357,,Binding ability of compound at cloned human 5-hydroxytryptamine 2C receptor using [3H]- mesulergine as radioligand,2965,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617905,14442,
,H,BAO_0000357,,Binding ability of compound at cloned human 5-hydroxytryptamine 2C receptor using [3H]- mesulergine as radioligand;not tested,2966,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617906,14442,
,H,BAO_0000357,,Binding activity against cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI as the radioligand.,2967,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617907,14755,
,H,BAO_0000357,,Binding affinity against the cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI as the radioligand,2968,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL617908,14744,
,H,BAO_0000219,,Binding affinity for displacement of [3H]mesulergine to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells,2969,Expert,,8,,,449.0,,,1,CHO,108,B,,,CHEMBL620617,16659,
,D,BAO_0000019,,Affinity for human 5-hydroxytryptamine 2C receptor expressed in mammalian cell line,2970,Expert,,9,,,,,9606.0,1,,108,B,Homo sapiens,,CHEMBL620618,6857,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2C receptor using [125I]DOI radioligand.,2971,Expert,,8,,,,,,1,,108,B,,,CHEMBL620619,5635,
,D,BAO_0000357,,Binding affinity to cloned human 5-hydroxytryptamine 2C receptor,2972,Expert,,9,,,,,9606.0,1,,108,B,Homo sapiens,,CHEMBL620620,4234,
,H,BAO_0000357,,Binding affinity towards human 5-HT2C receptor was determined using [125I]- DOI as radioligand,2973,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL620621,16209,
,D,BAO_0000249,,Binding affinity for 5-HT3 receptor by displacement of [3H]-LY 278584 in rat cerebral cortex membranes,2974,Autocuration,,7,Membranes,,,,10116.0,1,,104698,B,Rattus norvegicus,,CHEMBL872920,5778,
,H,BAO_0000223,,Binding affinity towards rat 5-hydroxytryptamine 3 receptor was evaluated,2975,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL620622,5094,
,D,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 in rat posterior cortex,2976,Autocuration,,7,,,,,10116.0,1,,104698,B,Rattus norvegicus,,CHEMBL620623,809,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 as radioligand in rat posterior cortex,2977,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL620624,1578,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 as radioligand in rat posterior cortex; Not tested,2978,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL620625,809,
,H,BAO_0000219,,Binding affinity was measured on 5-hydroxytryptamine 3 receptor in NG-108 cells labeled with [3H]GR-65630,2979,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL620626,12469,
,H,BAO_0000019,,Binding affinity was measured on 5-hydroxytryptamine 3 receptor using [3H]-BRL 43694 as radioligand in rat posterior cortex,2980,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL621307,14290,
,H,BAO_0000019,,Binding affinity was measured on 5-hydroxytryptamine 3 receptor using [3H]-BRL 43694 as radioligand in rat posterior cortex.,2981,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL621308,14290,
,H,BAO_0000223,,Binding affinity for central 5-hydroxytryptamine 3 receptor was determined by displacement of [3H]-5-HT,2982,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL621309,10609,
,H,BAO_0000223,,Binding affinity for central 5-hydroxytryptamine 3 receptor was determined by displacement of [3H]GR-65630,2983,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL621310,10609,
,H,BAO_0000223,,Binding affinity for central 5-hydroxytryptamine 3 receptor was determined by displacement of [3H]-ketanserin,2984,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL621311,10609,
,H,BAO_0000249,,"Compound was evaluated for its in vitro affinity at serotonergic 5-hydroxytryptamine 3 receptor by radioligand binding assay, using [3H]-LY 278584 in rat cerebral cortex membranes.",2985,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL621502,15253,
,H,BAO_0000249,,"In vitro affinity at serotonergic 5-hydroxytryptamine 3 receptor by radioligand binding assay, using [3H]-LY 278584 in rat cerebral cortex membranes.",2986,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL621503,15253,
,H,BAO_0000249,,Displacement of the 5-hydroxytryptamine 3 receptor ligand [3H]GR-65630 from rat brain cortical membranes.,2987,Autocuration,,6,Membranes,,,,,1,,104698,B,,,CHEMBL621504,11683,
,H,BAO_0000223,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 3 receptor,2988,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL621505,12092,
,H,BAO_0000019,,Binding affinity at 5-hydroxytryptamine 3 receptor in rat entorhinal cortex by [3H]BRL-43694 displacement.,2989,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL621506,1946,
,H,BAO_0000223,,Ability to displace [3H]quipazine binding to 5-hydroxytryptamine 3 receptor sites in NG 108-15.,2990,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL619781,11623,
,H,BAO_0000223,,Compound was evaluated for its ability to displace [3H]quipazine binding to 5-hydroxytryptamine 3 receptor sites in NG 108-15. ,2991,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL619782,11623,
,H,BAO_0000019,,Compound was evaluated for its binding affinity for 5-hydroxytryptamine 3 receptor by measuring displacement [3H]GR-65630 in rat cerebral cortex,2992,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL619783,14788,
,D,BAO_0000019,,Displacement of [3H]ketanserin from rat cortex 5-HT3 receptor,2993,Autocuration,,7,,,,,10116.0,1,,104698,B,Rattus norvegicus,,CHEMBL619784,5432,
,H,BAO_0000249,,Ability to displace [3H]granisetron specifically bound to 5-hydroxytryptamine 3 receptor in rat cortical membrane,2994,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL619785,14826,
,H,BAO_0000223,,Compound was tested for its binding affinity for the 5-hydroxytryptamine 3 receptor,2995,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL619786,2222,
,H,BAO_0000019,,Displacement of binding of [3H]-BRL 43694 to 5-hydroxytryptamine 3 receptor in rat cerebral cortex,2996,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL619787,11963,
,H,BAO_0000019,,In vitro affinity for 5-hydroxytryptamine 3 (5-HT3) receptor by displacement of [3H]BRL-43694 from rat entorhinal cortex,2997,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL872925,14145,
,H,BAO_0000019,,In vitro binding affinity at serotonin 5-hydroxytryptamine 3 receptor in rat cortex by [3H]granisetron displacement.,2998,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL619788,17819,
,H,BAO_0000249,,Inhibitory activity against 5-hydroxytryptamine 3 receptor in rat cortical membranes using [3H]- 1-Methyl-1H-indazole-3-carboxylic acid (8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-amide as a radioligand,2999,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL619789,10394,
,H,BAO_0000249,,Inhibitory activity against 5-hydroxytryptamine 3 receptor in rat cortical membranes using [3H]-1-Methyl-1H-indazole-3-carboxylic acid (8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-amide as a radioligand,3000,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL619790,10394,
,H,BAO_0000019,,Inhibitory concentration against 5-hydroxytryptamine 3 receptor in rat entorhinal cortex using [3H]-LY 278584 as radioligand,3001,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL619791,15034,
,H,BAO_0000019,,Binding affinity at 5-hydroxytryptamine 3 receptor in rat entorhinal cortex by [3H]BRL-43694 displacement.,3002,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL619792,691,
,H,BAO_0000249,,Displacement of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor in rat brain cortical membranes,3003,Autocuration,,6,Membranes,,,,,1,,104698,B,,,CHEMBL619793,12092,
,D,BAO_0000223,,Inhibition of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor,3004,Autocuration,,7,,,,,10116.0,1,,104698,B,Rattus norvegicus,,CHEMBL619794,11752,
,H,BAO_0000221,,The ability to inhibit [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor in rat brain cortices,3005,Autocuration,955.0,6,,,,,,1,,104698,B,,,CHEMBL619795,11752,Brain
,H,BAO_0000019,,Binding affinity at 5-hydroxytryptamine 3 receptor in rat posterior cortex by [3H]-BRL 43694 displacement.,3006,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL619796,301,
,H,BAO_0000223,,The binding affinity at 5-hydroxytryptamine 3 receptor was determined using [3H]LY-278584,3007,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL620448,16532,
,H,BAO_0000223,,The binding affinity at 5-hydroxytryptamine 3 receptor was determined using [3H]LY-278584; Not tested,3008,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL620449,16532,
,H,BAO_0000223,,The binding affinity was measured on 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand.,3009,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL620450,12092,
,H,BAO_0000223,,The compound was evaluated for the binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of radioligand [3H]GR-65630,3010,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL620451,11684,
,H,BAO_0000223,,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of radioligand [3H]GR-65630.,3011,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL620631,11684,
,H,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 3 receptor from rat cortex using [3H]BRL-43694 as radioligand,3012,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL620632,12953,
,H,BAO_0000019,,The compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor from rat cortex using [3H]BRL-43694 as radioligand; NA means Not active,3013,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL620633,12953,
,H,BAO_0000223,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 3 receptor; Nonactive at 10 uM,3014,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL620634,12953,
,H,BAO_0000019,,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand; NA Not Available,3015,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL620635,12861,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 0.5 hours in urethane-anesthetized rats,3016,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL620636,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 1 hour in urethane-anesthetized rats,3017,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL620637,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 3 hours in urethane-anesthetized rats,3018,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL620638,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 6 hours in urethane-anesthetized rats,3019,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL620639,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 0.5 hours in urethane-anesthetized rats,3020,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL620640,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 1 hour in urethane-anesthetized rats,3021,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL620641,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 16 hours in urethane-anesthetized rats,3022,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL620642,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 3 hours in urethane-anesthetized rats,3023,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL620643,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 6 hours in urethane-anesthetized rats,3024,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL620644,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 0.5 hours in urethane-anesthetized rats,3025,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL620645,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 1 hour in urethane-anesthetized rats,3026,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL620646,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 3 hours in urethane-anesthetized rats,3027,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL620647,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 6 hours in urethane-anesthetized rats,3028,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL620648,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1 mg/kg at 0.5 hours in urethane-anesthetized rats,3029,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL620649,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1 mg/kg at 3 hours in urethane-anesthetized rats,3030,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL620650,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 mg/kg at 1 hour in urethane-anesthetized rats,3031,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL620651,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 mg/kg at 3 hours in urethane-anesthetized rats,3032,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL872875,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1 mg/kg at 1 hour in urethane-anesthetized rats,3033,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL620652,11454,
,H,BAO_0000019,,5-hydroxytryptamine 3 receptor antagonist activity was confirmed by its ability to antagonize 5-HT evoked tachycardia of rabbit isolated heart,3034,Autocuration,,6,,,,,,1,,104698,F,,,CHEMBL620653,10609,
,H,BAO_0000019,,Binding activity against 5-hydroxytryptamine 2A receptor from rat cortex homogenates using [3H]DOB as radioligand.,3035,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL857076,12861,
,D,BAO_0000019,,Inhibition of [3H]-Q-ICS 205-930 binding to rat cortex homogenate 5-hydroxytryptamine 3 receptor,3036,Autocuration,,7,,,,,10116.0,1,,104698,B,Rattus norvegicus,,CHEMBL620654,12861,
,H,BAO_0000223,,Binding activity radioligand.,3037,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL620655,12861,
,H,BAO_0000249,,Compound was evaluated for the displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 receptor in rat brain membranes,3038,Autocuration,,6,Brain membranes,,,,,1,,104698,B,,,CHEMBL620656,10728,
,H,BAO_0000249,,Displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 receptor recognition sites in rat brain membranes.,3039,Autocuration,,6,Brain membranes,,,,,1,,104698,B,,,CHEMBL620657,10728,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2C receptor was determined at a concentration of 0.000001 mol/L,3040,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL620658,5163,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2C receptor was determined at a concentration of 0.00001 mol/L,3041,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL620659,5163,
,H,BAO_0000357,,Inhibition of binding towards 5-hydroxytryptamine 2C receptor at 100 nM concentration,3042,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL620660,6011,
,H,BAO_0000357,,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 2C receptor,3043,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL620661,5014,
,H,BAO_0000357,,Binding affinity of compound towards 5-hydroxytryptamine 2C receptor,3044,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL620662,5635,
,H,BAO_0000357,,Affinity for 5-hydroxytryptamine 2C receptor,3045,Expert,,8,,,,,,1,,108,B,,,CHEMBL620663,5163,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,3046,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL620664,6841,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand.,3047,Expert,,8,,,,,,1,,108,B,,,CHEMBL620665,6119,
,H,BAO_0000357,,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 2C receptor was determined,3048,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL620666,4373,
,H,BAO_0000357,,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2C receptor by displacement of [3H]-Ketanserin,3049,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL620667,1633,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 2C receptor by displacement of [3H]N-methyl-mesulergine,3050,Expert,,8,,,,,,1,,108,B,,,CHEMBL620668,1633,
,H,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 2C receptor was determined,3051,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL620669,4373,
,H,BAO_0000357,,Binding affinity towards serotonin 5-hydroxytryptamine 2C receptor,3052,Expert,,8,,,,,,1,,108,B,,,CHEMBL620670,6576,
,H,BAO_0000357,,Evaluated for the binding affinity to 5-hydroxytryptamine 2C receptor,3053,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL620671,4687,
,H,BAO_0000357,,Tested agains t5-hydroxytryptamine 2C receptor in experiment 1,3054,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL620672,12146,
,H,BAO_0000357,,Tested against 5-hydroxytryptamine 2C receptor in experiment 2,3055,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL620673,12146,
,H,BAO_0000357,,Ability to displace [3H]mesulergine from 5-hydroxytryptamine 2C receptor,3056,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL620674,16946,
,H,BAO_0000357,,Compound was evaluated for the affinity at 5-hydroxytryptamine 2C receptor,3057,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL620675,14159,
,H,BAO_0000357,,The binding affinity towards 5-hydroxytryptamine 2C receptor; No affinity,3058,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL620676,16700,
,H,BAO_0000357,,Affinity against 5-hydroxytryptamine 2C receptor,3059,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL621382,3269,
,D,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 2C receptor,3060,Expert,,9,,,,,9606.0,1,,108,B,Homo sapiens,,CHEMBL621383,1274,
,H,BAO_0000357,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2C receptor using radioligand binding assay,3061,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL621384,1317,
,H,BAO_0000357,,Inhibitory concentration required against 5-HT3 receptor in bovine area postrema using [3H]GR-65630,3062,Autocuration,,8,,,,,9913.0,1,,144,B,Bos taurus,,CHEMBL621385,5834,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand,3063,Autocuration,,8,,,,,9913.0,1,,144,B,Bos taurus,,CHEMBL617989,11147,
,H,BAO_0000019,,Antagonistic potency against serotonin 5-hydroxytryptamine 3 receptor in GPI assay,3064,Expert,,4,,,,,10141.0,1,,104714,F,Cavia porcellus,,CHEMBL617990,14145,
,H,BAO_0000221,,Binding affinity to 5-hydroxytryptamine 3 receptor entirely in guinea pig ileum,3065,Autocuration,2116.0,4,,,,,10141.0,1,,104714,B,Cavia porcellus,,CHEMBL875085,10561,Ileum
,H,BAO_0000019,,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 3 receptor of guinea pig,3066,Autocuration,,4,,,,,10141.0,1,,104714,F,Cavia porcellus,,CHEMBL617991,15847,
,H,BAO_0000019,,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 3 receptor of guinea pig; ND means not done,3067,Autocuration,,4,,,,,10141.0,1,,104714,F,Cavia porcellus,,CHEMBL617992,15847,
,H,BAO_0000221,,Potency to 5-hydroxytryptamine 3 receptor entirely in guinea pig ileum,3068,Autocuration,2116.0,4,,,,,10141.0,1,,104714,B,Cavia porcellus,,CHEMBL617993,10561,Ileum
,H,BAO_0000221,,In vitro binding affinity was measured for 5-hydroxytryptamine 3 receptor in the guinea pig ileum.,3069,Autocuration,2116.0,4,,,,,10141.0,1,,104714,B,Cavia porcellus,,CHEMBL617994,11454,Ileum
,H,BAO_0000019,,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea colon at a concentration 0.01 uM,3070,Autocuration,,4,,,,,10141.0,1,,104714,F,Cavia porcellus,,CHEMBL617995,4639,
,H,BAO_0000019,,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 0.1 uM,3071,Autocuration,,4,,,,,10141.0,1,,104714,F,Cavia porcellus,,CHEMBL617996,4639,
,H,BAO_0000019,,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 1 uM,3072,Autocuration,,4,,,,,10141.0,1,,104714,F,Cavia porcellus,,CHEMBL617997,4639,
,H,BAO_0000019,,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 1 uM in the presence of 30 uM MDL 72222,3073,Autocuration,,4,,,,,10141.0,1,,104714,F,Cavia porcellus,,CHEMBL617998,4639,
,H,BAO_0000019,,Percent of control response to 5-HT3 antagonistic activity on guinea colon at a concentration 0.01 uM,3074,Autocuration,,4,,,,,10141.0,1,,104714,F,Cavia porcellus,,CHEMBL617999,4639,
,H,BAO_0000019,,Percent of control response to 5-HT3 antagonistic activity on guinea colon at a concentration 1 uM,3075,Autocuration,,4,,,,,10141.0,1,,104714,F,Cavia porcellus,,CHEMBL618000,4639,
,H,BAO_0000221,,"Concentration required to produce 50% of maximal contraction induced by 5-HT through 5-HT3 receptors in the presence of the compound, in isolated guinea pig ileum",3076,Autocuration,2116.0,4,,,,,10141.0,1,,104714,F,Cavia porcellus,,CHEMBL617815,15253,Ileum
,H,BAO_0000221,,"Concentration required to produce 50% of maximal contraction induced by 5-HT through 5-HT3 receptors in the presence of the compound, in isolated guinea pig ileum.",3077,Autocuration,2116.0,4,,,,,10141.0,1,,104714,F,Cavia porcellus,,CHEMBL617816,15253,Ileum
,H,BAO_0000221,,Tested for the antagonistic activity against 5-hydroxytryptamine 3 receptor from guinea pig ileum,3078,Autocuration,2116.0,4,,,,,10141.0,1,,104714,F,Cavia porcellus,,CHEMBL617817,11963,Ileum
,H,BAO_0000221,,In vitro 5-hydroxytryptamine 3 receptor activity in guinea pig ileum,3079,Autocuration,2116.0,4,,,,,10141.0,1,,104714,B,Cavia porcellus,,CHEMBL617818,1946,Ileum
,H,BAO_0000221,,In vitro 5-hydroxytryptamine 3 receptor activity in guinea pig ileum; Not tested,3080,Autocuration,2116.0,4,,,,,10141.0,1,,104714,B,Cavia porcellus,,CHEMBL617819,1946,Ileum
,H,BAO_0000223,,Binding affinity towards [3H]quipazine labeled 5-hydroxytryptamine 3 receptor sites in HG108-15,3081,Autocuration,,4,,,,,10141.0,1,,104714,B,Cavia porcellus,,CHEMBL617820,12045,
,H,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum,3082,Autocuration,2116.0,4,,,,,10141.0,1,,104714,B,Cavia porcellus,,CHEMBL617821,1559,Ileum
,H,BAO_0000221,,Evaluated for the antagonistic activity against 5-hydroxytryptamine 3 receptor in isolated guinea pig ileum (GPI),3083,Autocuration,2116.0,4,,,,,10141.0,1,,104714,F,Cavia porcellus,,CHEMBL617822,273,Ileum
,H,BAO_0000221,,Antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor of isolated guinea pig ileum (GPI),3084,Autocuration,2116.0,4,,,,,10141.0,1,,104714,F,Cavia porcellus,,CHEMBL617823,273,Ileum
,H,BAO_0000221,,Tested for antagonistic activity on 5-hydroxytryptamine 3 receptor mediated effects of 5-HT in guinea pig isolated ileum,3085,Autocuration,2116.0,4,,,,,10141.0,1,,104714,F,Cavia porcellus,,CHEMBL617824,188,Ileum
,H,BAO_0000221,,Agonistic activity against 5-hydroxytryptamine 3 receptor in guinea pig ileum assay,3086,Autocuration,2116.0,4,,,,,10141.0,1,,104714,F,Cavia porcellus,,CHEMBL617825,12919,Ileum
,H,BAO_0000221,,5-hydroxytryptamine 3 receptor agonism in the guinea pig ileum by functional 5-HT3 receptor assay,3087,Autocuration,2116.0,4,,,,,10141.0,1,,104714,F,Cavia porcellus,,CHEMBL617826,12918,Ileum
,H,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum,3088,Autocuration,2116.0,4,,,,,10141.0,1,,104714,B,Cavia porcellus,,CHEMBL617827,1559,Ileum
,H,BAO_0000221,,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated guinea pig ileum (GPI),3089,Autocuration,2116.0,4,,,,,10141.0,1,,104714,F,Cavia porcellus,,CHEMBL617828,273,Ileum
,H,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum,3090,Autocuration,2116.0,4,,,,,10141.0,1,,104714,B,Cavia porcellus,,CHEMBL617829,1559,Ileum
,H,BAO_0000221,,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum; Not determined,3091,Autocuration,2116.0,4,,,,,10141.0,1,,104714,B,Cavia porcellus,,CHEMBL617830,1559,Ileum
,H,BAO_0000221,,Binding affinity towards 5-hydroxytryptamine 3 receptor of guinea pig ileum; not determined,3092,Autocuration,2116.0,4,,,,,10141.0,1,,104714,B,Cavia porcellus,,CHEMBL617831,1559,Ileum
,H,BAO_0000221,,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor in guinea pig ileum.,3093,Autocuration,2116.0,4,,,,,10141.0,1,,104714,B,Cavia porcellus,,CHEMBL617832,14424,Ileum
,U,BAO_0000019,,Binding affinity was determined against 5-hydroxytryptamine 2A receptor,3094,Autocuration,,0,,,,,10141.0,1,,22226,B,Cavia porcellus,,CHEMBL617833,13181,
,H,BAO_0000357,,Binding affinity towards 5-HT1A receptor by the displacement of [3H]-8-OH-DPAT] in human recombinant receptors in mammalian cell,3095,Autocuration,,8,,,,,,1,,51,B,,,CHEMBL617834,5486,
,D,BAO_0000223,,Affinity towards human 5-hydroxytryptamine 3 serotonin receptor,3096,Expert,,5,,,,,9606.0,1,,104714,B,Homo sapiens,,CHEMBL617835,6491,
,H,BAO_0000223,,Binding affinity towards 5-HT3 receptor,3097,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL617836,6013,
,H,BAO_0000223,,Binding activity radioligand.,3098,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL617837,12861,
,H,BAO_0000019,,Binding activity against 5-hydroxytryptamine 1A receptor from human brain cortex using [3H]8-OH-DPAT-HT as radioligand.,3099,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL620392,12861,
,H,BAO_0000223,,Binding affinity for human cloned 5-hydroxytryptamine 3 receptor,3100,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL620393,5104,
,H,BAO_0000223,,Binding affinity for human cloned 5-hydroxytryptamine 3 receptor,3101,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL620394,5105,
,H,BAO_0000223,,Binding affinity for human cloned 5-hydroxytryptamine 3 receptor; NT means Not tested,3102,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL620395,5104,
,U,BAO_0000019,,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 3 receptor,3103,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL620396,3935,
,H,BAO_0000219,,Displacement of [3H]-BRC 36694 from 5-hydroxytryptamine 3 receptor in NG108-15 cells,3104,Expert,,4,,,433.0,,,1,NG108-15,105030,B,,,CHEMBL620582,13657,
,H,BAO_0000218,,"Percent inhibition of [3H]5 binding to 5-hydroxytryptamine 3 receptor was evaluated by injection of compound (75 microCi/kg, 1.32 ug/kg) into the tail vein of mice (in vivo)",3105,Autocuration,,4,,In vivo,,,,1,,105030,B,,,CHEMBL620583,10369,
,H,BAO_0000019,,The binding affinity was measured for 5-hydroxytryptamine 3 receptor on NG 108-15 cell line of mouse neuroblastoma-glioma cells in presence of [3H]5 radioligand (in vitro),3106,Autocuration,,4,,,,,,1,,105030,B,,,CHEMBL620584,10369,
,H,BAO_0000224,,Compound was evaluated for the binding affinity at 5- HT3 receptor subtype,3107,Autocuration,,4,,,,,,1,,105030,B,,,CHEMBL620585,12918,
,H,BAO_0000224,,Compound was evaluated for the binding affinity at 5- HT3 receptor,3108,Autocuration,,4,,,,,,1,,105030,B,,,CHEMBL620586,12918,
,H,BAO_0000019,,The binding affinity was measured for 5-hydroxytryptamine 3 receptor on NG 108-15 cell line of mouse neuroblastoma-glioma cells in presence of [3H]5 radioligand (in vitro),3109,Autocuration,,4,,,,,,1,,105030,B,,,CHEMBL620587,10369,
,H,BAO_0000019,,In Vitro Binding affinity againist 5-hydroxytryptamine 3 receptor by displacing [3H]-Q-ICS 205-930 from rat cortex homogenates,3110,Autocuration,,4,,,,,,1,,105030,B,,,CHEMBL620588,773,
,H,BAO_0000218,,5-hydroxytryptamine 3 receptor agonism in mouse,3111,Autocuration,,4,,,,,,1,,105030,F,,,CHEMBL620589,12918,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 3 receptor was determined by using [3H]-ICS 205-930 as radioligand in mouse N1E 115 cells,3112,Autocuration,,4,,,,,,1,,105030,B,,,CHEMBL620590,10561,
,H,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 2A receptor in rat cortex preparations using [3H]ketanserin,3113,Autocuration,,4,,,,,,1,,105030,B,,,CHEMBL617956,12827,
,H,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 2A receptor in rat cortex preparations using [3H]ketanserin,3114,Autocuration,,4,,,,,,1,,105030,B,,,CHEMBL617957,12827,
,H,BAO_0000224,,Binding affinity was evaluated by 5-hydroxytryptamine 3 receptor agonism in the mouse NIE-115 by displacing tropisetron,3115,Autocuration,,4,,,,,,1,,105030,B,,,CHEMBL617958,12918,
,H,BAO_0000219,,Compound was evaluated for binding to 5-hydroxytryptamine 3 receptor in N1E cells using [3H]- -Tropisetron as radioligand,3116,Autocuration,,4,,,,,,1,,105030,B,,,CHEMBL617959,273,
,H,BAO_0000219,,Compound was evaluated for binding to Serotonin 5-hydroxytryptamine 3 receptor in N1E cells using [3H]- -Tropisetron as radioligand,3117,Autocuration,,4,,,,,,1,,105030,B,,,CHEMBL617960,273,
,H,BAO_0000224,,Potency at neuronal 5-hydroxytryptamine 3 receptor in the rabbit heart,3118,Autocuration,,4,,,,,,1,,105030,B,,,CHEMBL617961,10561,
,H,BAO_0000219,,Ability to displace the radioligand [3H]GR-65630 from 5-hydroxytryptamine 3 receptor expressed in NIE-115 cells,3119,Autocuration,,4,,In vitro,,,,1,,105030,B,,,CHEMBL617962,5033,
,H,BAO_0000219,,In vitro binding affinity at 5-hydroxytryptamine 3 receptor in N1E-115 cells using 3[H]GR-65630 as the radioligand,3120,Autocuration,,4,,,339.0,,,1,N1E-115,105030,B,,,CHEMBL617963,16429,
,H,BAO_0000019,,In vitro binding affinity for the 5-hydroxytryptamine 3 receptor was determined with NG-108-15 mouse neuroblastoma-glioma cells,3121,Autocuration,,8,,,,,,1,,11765,B,,,CHEMBL617964,10322,
,H,BAO_0000219,,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor in NG cells 108-15,3122,Autocuration,,8,,,,,,1,,11765,B,,,CHEMBL617965,14331,
,D,BAO_0000357,,Compound was tested for the Binding affinity against N1e-115 neuroblastoma 5-hydroxytryptamine 3 receptor by Radio ligand [3H]GR-65630 binding assay.,3123,Autocuration,,9,,,,,10090.0,1,,10630,B,Mus musculus,,CHEMBL617966,13462,
,H,BAO_0000019,,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,3124,Autocuration,,8,,,,,,1,,17106,B,,,CHEMBL857074,12861,
,H,BAO_0000357,,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor,3125,Autocuration,,8,,,,,9823.0,1,,144,B,Sus scrofa,,CHEMBL617967,15086,
,H,BAO_0000357,,Binding activity radioligand.,3126,Autocuration,,8,,,,,9823.0,1,,144,B,Sus scrofa,,CHEMBL617968,12861,
,H,BAO_0000223,,Binding affinity to 5-hydroxytryptamine 3 receptor of neuronal in the afferent rabbit vagus,3127,Autocuration,,4,,,,,9986.0,1,,104714,B,Oryctolagus cuniculus,,CHEMBL617969,10561,
,H,BAO_0000223,,Potency at neuronal 5-hydroxytryptamine 3 receptor in the rabbit heart,3128,Autocuration,,4,,,,,9986.0,1,,104714,B,Oryctolagus cuniculus,,CHEMBL617970,10561,
,H,BAO_0000223,,Potency at neuronal 5-hydroxytryptamine 3 receptors in the rabbit heart,3129,Autocuration,,4,,,,,9986.0,1,,104714,B,Oryctolagus cuniculus,,CHEMBL617971,10561,
,H,BAO_0000019,,Potency to 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand in rat cortex,3130,Autocuration,,4,,,,,9986.0,1,,104714,B,Oryctolagus cuniculus,,CHEMBL617972,10561,
,H,BAO_0000019,,Evaluated for the antagonistic activity against 5-hydroxytryptamine 3 receptor in isolated perfused rabbit heart (RH),3131,Autocuration,,4,,,,,9986.0,1,,104714,F,Oryctolagus cuniculus,,CHEMBL617973,273,
,H,BAO_0000019,,Evaluated for the antagonistic activity against 5-hydroxytryptamine 3 receptor in isolated rabbit vagus nerve (RVN),3132,Autocuration,,4,,,,,9986.0,1,,104714,F,Oryctolagus cuniculus,,CHEMBL617974,273,
,H,BAO_0000221,,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated guinea pig ileum (GPI),3133,Autocuration,2116.0,4,,,,,9986.0,1,,104714,F,Oryctolagus cuniculus,,CHEMBL617975,273,Ileum
,H,BAO_0000019,,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated perfused rabbit heart (RH),3134,Autocuration,,4,,,,,9986.0,1,,104714,F,Oryctolagus cuniculus,,CHEMBL617976,273,
,H,BAO_0000019,,Antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated rabbit vagus nerve (RVN),3135,Autocuration,,4,,,,,9986.0,1,,104714,F,Oryctolagus cuniculus,,CHEMBL617977,273,
,H,BAO_0000019,,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated perfused rabbit heart (RH),3136,Autocuration,,4,,,,,9986.0,1,,104714,F,Oryctolagus cuniculus,,CHEMBL617978,273,
,H,BAO_0000019,,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated rabbit vagus nerve (RVN),3137,Autocuration,,4,,,,,9986.0,1,,104714,F,Oryctolagus cuniculus,,CHEMBL617979,273,
,H,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 3 receptor in CHO cells using [3H]5-HT as radioligand,3138,Autocuration,,4,,,449.0,,9986.0,1,CHO,104714,B,Oryctolagus cuniculus,,CHEMBL617980,13047,
,D,BAO_0000019,,In vitro displacement of [3H]-LY 278584 from rat cerebral cortex 5-hydroxytryptamine 3 receptor,3139,Autocuration,,7,,,,,10116.0,1,,104698,B,Rattus norvegicus,,CHEMBL617981,1650,
,H,BAO_0000019,,Affinity at 5-hydroxytryptamine 3 receptor from rat frontal cortex using [3H]granisetron as radioligand (For granisetron = Ki(nM)=0.3+/-0.01),3140,Autocuration,,8,,,,,,1,,12020,B,,,CHEMBL617982,16288,
,H,BAO_0000357,,Affinity at 5-hydroxytryptamine 3 receptor (For granisetron = Ki (nM)=0.3+/-0.01),3141,Autocuration,,8,,,,,,1,,12020,B,,,CHEMBL617983,16288,
,D,BAO_0000019,,In vitro displacement of [3H]ICS-205-930 from 5-hydroxytryptamine 3 receptor in cultured NG-108-15 rat glioma cells,3142,Autocuration,,7,,,,,10116.0,1,,104698,B,Rattus norvegicus,,CHEMBL617984,10254,
,H,BAO_0000019,,"Binding affinity for 5-hydroxytryptamine 3 receptor in rat cerebral cortex, determined by displacement of [3H]GR-65630",3143,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL617985,14532,
,H,BAO_0000218,,"5-Hydroxy tryptamine 3 receptor showing agonist activity (in vivo) in Von Bezold-Jarisch Reflex in rats at 120 (ug/kg), evaluated as change in heart rate",3144,Autocuration,948.0,6,,In vivo,,,,1,,104698,F,,,CHEMBL617986,13392,Heart
,H,BAO_0000019,,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 100 (ug/kg), evaluated as change in heart rate",3145,Autocuration,948.0,6,,,,,,1,,104698,F,,,CHEMBL617987,13392,Heart
,H,BAO_0000019,,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 120 (ug/kg), evaluated as change in heart rate",3146,Autocuration,948.0,6,,,,,,1,,104698,F,,,CHEMBL617988,13392,Heart
,H,BAO_0000019,,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 60 (ug/kg), evaluated as change in heart rate",3147,Autocuration,948.0,6,,,,,,1,,104698,F,,,CHEMBL617792,13392,Heart
,H,BAO_0000019,,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptorr in Von Bezold-Jarisch Reflex in rats at 100 (ug/kg), evaluated as change in heart rate",3148,Autocuration,948.0,6,,,,,,1,,104698,F,,,CHEMBL617793,13392,Heart
,H,BAO_0000019,,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 100(ug/kg), evaluated as percent inhibition of bradycardia",3149,Autocuration,,6,,,,,,1,,104698,F,,,CHEMBL617794,13392,
,H,BAO_0000019,,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 60 (ug/kg), evaluated as percent inhibition of bradycardia",3150,Autocuration,,6,,,,,,1,,104698,F,,,CHEMBL617795,13392,
,H,BAO_0000019,,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch reflex in rats at 60 (ug/kg), evaluated as percent inhibition of bradycardia",3151,Autocuration,,6,,,,,,1,,104698,F,,,CHEMBL617796,13392,
,H,BAO_0000019,,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch reflex in rats at 60(ug/kg), evaluated as percent inhibition of bradycardia",3152,Autocuration,,6,,,,,,1,,104698,F,,,CHEMBL617797,13392,
,D,BAO_0000218,,Antagonism of 5-HT-induced Von Bezold-Jarisch reflex in rat after intravenous administration of 30 ug/kg of HT (5-hydroxytryptamine 3 receptor antagonism),3153,Autocuration,,7,,In vivo,,,10116.0,1,,104698,F,Rattus norvegicus,,CHEMBL617798,1089,
,H,BAO_0000218,,Ability to antagonise the 5-HT- induced Von Bezold-Jarisch reflex in the rat after intravenous administration of 30 ug/kg of HT (5-hydroxytryptamine 3 receptor),3154,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617799,1089,
,D,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1000 ug/kg dose in urethane-anesthetized rats,3155,Autocuration,,7,,In vivo,,,10116.0,1,,104698,F,Rattus norvegicus,,CHEMBL617800,11454,
,D,BAO_0000019,,Inhibition of 5-HT-induced bradycardia by 5-hydroxytryptamine 3+,3156,Autocuration,,7,,,,,10116.0,1,,104698,F,Rattus norvegicus,,CHEMBL617801,11454,
,D,BAO_0000218,,In vivo inhibitory concentration after 5 minutes against 5-hydroxytryptamine 3 receptor induced bradycardia [bezold-jarisch (B-J) reflex test] in rat by intravenous administration,3157,Autocuration,,7,,In vivo,,,10116.0,1,,104698,F,Rattus norvegicus,,CHEMBL617802,12205,
,D,BAO_0000019,,Inhibition of 5-HT (1 ug/mL) induced depolarization in rat vagus nerve (5-hydroxytryptamine 3 receptor antagonism),3158,Autocuration,,7,,,,,10116.0,1,,104698,F,Rattus norvegicus,,CHEMBL617803,1089,
,H,BAO_0000019,,Binding affinity towards 5-HT3 receptor in rat was evaluated,3159,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL617804,5094,
,D,BAO_0000019,,Inhibition of [3H]GR-65630 binding to rat cortical membrane 5-hydroxytryptamine 3 receptor,3160,Autocuration,,7,,,,,10116.0,1,,104698,B,Rattus norvegicus,,CHEMBL617805,2622,
,H,BAO_0000223,,Binding affinity was evaluated in vitro by displacement of [3H]zacopride radioligand from 5-hydroxytryptamine 3 receptor,3161,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL617806,245,
,H,BAO_0000019,,Compound was evaluated for its binding affinity for 5-hydroxytryptamine 3 receptor by measuring displacement [3H]GR-65630 in rat cerebral cortex.,3162,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL617807,14788,
,H,BAO_0000019,,Compound was evaluated for its binding affinity for 5-hydroxytryptamine 3 receptor by measuring displacement of [3H]granisetron from rat cerebral cortex,3163,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL617808,14788,
,H,BAO_0000249,,Binding affinity against 5-hydroxytryptamine 3 receptor in rat cortical membrane using [3H]GR-65630 as radioligand,3164,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL617809,3020,
,H,BAO_0000019,,Compound was tested for its ability to displace [3H]-Q-ICS 205-930 from 5-hydroxytryptamine 3 receptor in rat cortex homogenates,3165,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL617810,1742,
,H,BAO_0000249,,Concentration of compound required to inhibit the binding of radioligand [3H]GR-65630 to 5-hydroxytryptamine 3 receptor in rat brain cortical membrane,3166,Autocuration,955.0,6,,,,,,1,,104698,B,,,CHEMBL617811,17394,Brain
,H,BAO_0000221,,Concentration required to inhibit the binding of radioligand [3H]GR-65630 to serotonin 5-hydroxytryptamine-3 receptor (5-HT 3 receptor)in rat brain cortical membrane,3167,Autocuration,955.0,6,,,,,,1,,104698,B,,,CHEMBL617812,17394,Brain
,H,BAO_0000249,,Concentration of compound required to inhibit the binding of radioligand [3H]GR-65630 to serotonin 5-hydroxytryptamine 3 receptor in rat cortical membrane,3168,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL617813,17394,
,H,BAO_0000249,,In vitro inhibitory concentration against radioligand [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor in rat cortical membrane,3169,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL617814,14286,
,H,BAO_0000019,,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate.,3170,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL617698,14178,
,D,BAO_0000019,,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate; Not active at 10000 nm,3171,Autocuration,,7,,,,,10116.0,1,,104698,B,Rattus norvegicus,,CHEMBL617699,14178,
,D,BAO_0000019,,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate; not active at 10000 nM,3172,Autocuration,,7,,,,,10116.0,1,,104698,B,Rattus norvegicus,,CHEMBL617700,14178,
,D,BAO_0000223,,Inhibition of radiolabeled [3H]-Zacopride ligand binding to 5-hydroxytryptamine 3 receptor,3173,Autocuration,,7,,,,,10116.0,1,,104698,B,Rattus norvegicus,,CHEMBL617701,14178,
,H,BAO_0000019,,Inhibitory concentration against 5-hydroxytryptamine 3 receptor in rat entorhinal cortex using [3H]-LY 278584 as radioligand,3174,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL617702,15034,
,H,BAO_0000249,,"Tested for inhibition of binding of [3H]GR-65630 to rat cortical membranes, expressed as IC50",3175,Autocuration,,6,Membranes,,,,,1,,104698,B,,,CHEMBL617703,1089,
,D,BAO_0000019,,Inhibition of [3H]GR-65630 binding to rat cortical membrane serotonin 3 receptor,3176,Autocuration,,7,,,,,10116.0,1,,104698,B,Rattus norvegicus,,CHEMBL617704,1089,
,H,BAO_0000223,,The binding affinity at 5-hydroxytryptamine 3 receptor was determined using [3H]LY-278584; Not tested,3177,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL617705,16532,
,D,BAO_0000223,,Inhibition of [3H]BRL-43694 binding to rat 5-hydroxytryptamine 3 receptor,3178,Autocuration,,7,,,,,10116.0,1,,104698,B,Rattus norvegicus,,CHEMBL617706,12801,
,H,BAO_0000219,,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from NG108-15 cells (using [3H]zacopride as radioligand),3179,Autocuration,,6,,,433.0,,,1,NG108-15,104698,B,,,CHEMBL617707,15194,
,H,BAO_0000219,,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from NG108-15 cells using [3H]zacopride as radioligand,3180,Autocuration,,6,,,433.0,,,1,NG108-15,104698,B,,,CHEMBL617708,15194,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 3 (5-HT3) receptor from rat cortical homogenate using [3H]zacopride as radioligand,3181,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL617709,15194,
,H,BAO_0000019,,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from rat cortical homogenate using [3H]zacopride as radioligand; NA= Not active,3182,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL617710,15194,
,H,BAO_0000019,,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from rat cortical homogenate using [3H]zacopride as radioligand; NA=Not active,3183,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL882925,15194,
,H,BAO_0000019,,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from rat cortical homogenate using [3H]zacopride as radioligand; not active,3184,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL617711,15194,
,H,BAO_0000019,,Antagonist potency to 5-hydroxytryptamine 3 receptor was assayed by antagonism of the 5-HT-evoked reflex bradycardia [Bezold-Jarisch(BJ) reflex] in rats,3185,Autocuration,,6,,,,,,1,,104698,F,,,CHEMBL617712,10610,
,D,BAO_0000019,,Antagonistic activity against 5-hydroxytryptamine 3 receptor as inhibition of 5-HT-induced bradycardia (von Bezold-jarisch reflex) in anesthetized rat,3186,Autocuration,,7,,,,,10116.0,1,,104698,F,Rattus norvegicus,,CHEMBL617713,10355,
,H,BAO_0000019,,"Compound was tested as a 5-hydroxytryptamine 3 receptor antagonist in the rat by assessment of the inhibition of the Bezold-Jarisch effect, when administered intravenously",3187,Autocuration,,6,,,,,,1,,104698,F,,,CHEMBL617714,691,
,H,BAO_0000218,,In vivo 5-hydroxytryptamine 3 receptor (5-HT 3 receptor) antagonistic activity expressed as ability to inhibit Bezold-Jarich reflex evoked by 5-HT in rats,3188,Autocuration,,6,,,,,,1,,104698,F,,,CHEMBL617715,10611,
,H,BAO_0000218,,Inhibition dose for 50 percent antagonism for 5-hydroxytryptamine 3 receptor in vivo in rats,3189,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617716,12801,
,H,BAO_0000218,,Inhibition of 5-HT evoked reflex bradycardia in rat.,3190,Autocuration,,6,,,,,,1,,104698,F,,,CHEMBL617717,10609,
,H,BAO_0000218,,5-HT3 receptor antagonistic activity was measured by the inhibition of 5-HT-induced bradycardia after iv administration of 1000 ug/kg dose in urethane-anesthetized rats,3191,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617718,11454,
,H,BAO_0000218,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 1 ug/kg dose in urethane-anesthetized rats,3192,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617719,11454,
,H,BAO_0000218,,5-hydroxytryptamine 3 receptor antagonistic activity measured by inhibition of 5-HT-induced bradycardia (iv administration 10 ug/kg dose in urethane-anesthetized rats),3193,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617720,11454,
,D,BAO_0000218,,5-hydroxytryptamine 3 receptor antagonistic activity as inhibition of 5-HT-induced bradycardia after iv administration of 100 ug/kg dose in urethane-anesthetized rats,3194,Autocuration,,7,,In vivo,,,10116.0,1,,104698,F,Rattus norvegicus,,CHEMBL617721,11454,
,H,BAO_0000218,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 1000 ug/kg dose in urethane-anesthetized rats,3195,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617722,11454,
,H,BAO_0000218,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 1000 ug/kgetized rats,3196,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617723,11454,
,H,BAO_0000218,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 3 ug/kg dose in urethane-anesthetized rats,3197,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617724,11454,
,H,BAO_0000218,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 10 ug/kg dose in urethane-anesthetized rats,3198,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617725,11454,
,H,BAO_0000218,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 100 ug/kg dose in urethane-anesthetized rats,3199,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617726,11454,
,H,BAO_0000218,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 1000 ug/kg dose in urethane-anesthetized rats,3200,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617727,11454,
,H,BAO_0000218,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 30 ug/kg dose in urethane-anesthetized rats,3201,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617728,11454,
,H,BAO_0000218,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 300 ug/kg dose in urethane-anesthetized rats,3202,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617729,11454,
,H,BAO_0000218,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 3ug/kg dose in urethane-anesthetized rats,3203,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617730,11454,
,H,BAO_0000218,,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5-HT-induced bradycardia after iv administration of 1000 ug/kg dose in urethane-anesthetized rats,3204,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617731,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after intravenous administration of 0.3 ug/kg dose in urethane-anesthetized rats,3205,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617732,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after intravenous administration of 1 ug/kg dose in urethane-anesthetized rats,3206,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617733,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after intravenous administration of 30 ug/kg dose in urethane-anesthetized rats,3207,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617734,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 0.05 hour,3208,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL872874,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 1 hour,3209,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617735,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 16 hour,3210,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617736,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 3 hour,3211,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617737,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 6 hour,3212,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617738,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 ug/kg dose in urethane-anesthetized rats,3213,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617739,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 100 ug/kg dose in urethane-anesthetized rats,3214,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617740,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1000 ug/kg dose in urethane-anesthetized rats,3215,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617741,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 ug/kg dose in urethane-anesthetized rats,3216,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617742,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 3 ug/kg dose in urethane-anesthetized rats,3217,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617743,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 30 ug/kg dose in urethane-anesthetized rats,3218,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617744,11454,
,H,BAO_0000218,,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 300 ug/kg dose in urethane-anesthetized rats,3219,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617745,11454,
,H,BAO_0000218,,"In vivo 5-hydroxytryptamine 3 receptor antagonist activity by antagonism of the von Bezold-Jarisch (B-J) reflex in anesthetized rats, (i.v.)",3220,Autocuration,,6,,,,,,1,,104698,F,,,CHEMBL617746,670,
,H,BAO_0000218,,"In vivo 5-hydroxytryptamine 3 receptor antagonist activity by antagonism of the von Bezold-Jarisch (B-J) reflex in anesthetized rats, (i.v.); Not tested",3221,Autocuration,,6,,,,,,1,,104698,F,,,CHEMBL617747,670,
,H,BAO_0000218,,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 10 ug/Kg,3222,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL617748,10321,
,H,BAO_0000218,,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 100 ug/Kg,3223,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL618909,10321,
,H,BAO_0000218,,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 2 ug/Kg,3224,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL618910,10321,
,H,BAO_0000218,,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 20 ug/Kg,3225,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL618911,10321,
,H,BAO_0000218,,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 5 ug/Kg,3226,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL618912,10321,
,H,BAO_0000218,,Tested for inhibition of Bezold-Jarisch (B-J) reflex mediated by 5-hydroxytryptamine 3 receptor in rats after intravenous administration (2.0 ug/kg),3227,Autocuration,,6,,In vivo,,,,1,,104698,F,,,CHEMBL618913,10322,
,H,BAO_0000019,,Intrinsic efficacy against 5-hydroxytryptamine 3 receptor; A means pure agonist,3228,Autocuration,,6,,,,,,1,,104698,F,,,CHEMBL618914,15412,
,H,BAO_0000019,,Intrinsic efficacy against 5-hydroxytryptamine 3 receptor; A means pure agonist,3229,Autocuration,,6,,,,,,1,,104698,F,,,CHEMBL618915,15412,
,D,BAO_0000223,,Intrinsic efficacy for rat 5-hydroxytryptamine 3 receptor,3230,Autocuration,,7,,,,,10116.0,1,,104698,B,Rattus norvegicus,,CHEMBL618916,15412,
,H,BAO_0000019,,Intrinsic efficacy against 5-hydroxytryptamine 3 receptor; PA means partial agonist,3231,Autocuration,,6,,,,,,1,,104698,F,,,CHEMBL618917,15412,
,D,BAO_0000221,,Inhibition of [3H]granisetron binding to 5-hydroxytryptamine 3 receptor (5-HT 3 receptor) of rat cortex and hippocampus tissue,3232,Intermediate,10000000.0,7,,,,,,1,,104698,B,,,CHEMBL618918,15412,Hippocampus
,D,BAO_0000019,,Inhibition of [3H]granisetron binding to 5-hydroxytryptamine 3 receptor of rat cortical membrane,3233,Autocuration,,7,,,,,10116.0,1,,104698,B,Rattus norvegicus,,CHEMBL618919,15412,
,D,BAO_0000019,,Inhibition of [3H]GR-65630 binding to rat cortical membrane serotonin 5-hydroxytryptamine 3 receptor,3234,Autocuration,,7,,,,,10116.0,1,,104698,B,Rattus norvegicus,,CHEMBL618920,17394,
,H,BAO_0000223,,Affinity was evaluated as inhibition constant for serotonin 5-hydroxytryptamine 3 receptor,3235,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL618921,12457,
,H,BAO_0000019,,Affinity was evaluated by inhibition of [3H]GR-65630 binding to NG108-15 cell transfected with cloned rat 5-hydroxytryptamine 3 receptor,3236,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL618922,12457,
,H,BAO_0000019,,Binding affinity against radioligand [3H]quipazine labeled 5-hydroxytryptamine 3 receptor sites in neuroblastoma-glioma (NG108-15) cells.,3237,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL618923,12205,
,H,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 3 receptor was determined by measuring displacement of [3H]GR-65630 from rat brain cortices,3238,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL618924,14532,
,H,BAO_0000019,,Binding affinity to 5-hydroxytryptamine 3 receptor in rat entorhinal cortex using [3H]-BRL 43694 as radioligand,3239,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL618925,1122,
,H,BAO_0000019,,Binding affinity towards 5-HT3 receptor in rat was evaluated,3240,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL618926,5094,
,D,BAO_0000221,,5-hydroxytryptamine 4 receptor agonist activity as increased response to electrical stimulation in guinea pig ileum,3241,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL618927,809,Ileum
,D,BAO_0000221,,5-hydroxytryptamine 4 receptor agonist activity expressed as the concentration which gave a 50% increase in the response to the electrical stimulation in male guinea pig ileum; Not tested,3242,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL618928,809,Ileum
,D,BAO_0000221,,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum",3243,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL618929,14290,Ileum
,D,BAO_0000221,,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum; Inactive up to 10E-5 M",3244,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL618930,14290,Ileum
,D,BAO_0000221,,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum; Not tested",3245,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL618931,14290,Ileum
,D,BAO_0000221,,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum; Not tested",3246,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL619594,14290,Ileum
,D,BAO_0000221,,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Not capable of evaluation",3247,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL619595,14290,Ileum
,D,BAO_0000221,,concentration which gave a 50% increase in the response to electrical stimulation against 5-hydroxytryptamine 4 receptor in the guinea pig ileum.,3248,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL619596,13961,Ileum
,D,BAO_0000221,,concentration which gave a 50% increase in the response to electrical stimulation against 5-hydroxytryptamine 4 receptor in the guinea pig ileum. Activity expressed as percent of the maximum 5-HT response given in brackets.,3249,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL619755,13961,Ileum
,D,BAO_0000221,,5-hydroxytryptamine 4 receptor antagonist activity expressed as the concentration which produced a 50% reduction of 5-HT induced contraction in guinea pig ileum,3250,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL619756,809,Ileum
,D,BAO_0000221,,5-hydroxytryptamine 4 receptor antagonist activity expressed as the concentration which produced a 50% reduction of 5-HT induced contraction in guinea pig ileum; Not evaluable,3251,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL619757,809,Ileum
,D,BAO_0000221,,5-hydroxytryptamine 4 receptor antagonist activity expressed as the concentration which produced a 50% reduction of 5-HT induced contraction in guinea pig ileum; Not tested,3252,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL619758,809,Ileum
,D,BAO_0000221,,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum",3253,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL619759,14290,Ileum
,D,BAO_0000221,,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Inactive up to 10-5 M",3254,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL619760,14290,Ileum
,D,BAO_0000221,,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Inactive up to 10E-5 M",3255,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL619761,14290,Ileum
,D,BAO_0000221,,5-hydroxytryptamine 4 receptor antagonist activity as inhibition of 5-HT-induced contractions in guinea pig ileum; Not capable of evaluation.,3256,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL619762,14290,Ileum
,D,BAO_0000221,,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Not tested",3257,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL619763,14290,Ileum
,D,BAO_0000221,,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Not tested",3258,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL617868,14290,Ileum
,D,BAO_0000357,,Displacement of [3H]GR-113808 from 5-hydroxytryptamine 4 receptor in guinea pig striatum,3259,Intermediate,,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL617869,15034,
,D,BAO_0000249,,Binding affinity towards 5-HT4 receptor in striatum membranes of guinea-pig brain was evaluated,3260,Intermediate,2435.0,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL882926,5094,Striatum
,D,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 4 receptor in striatum membranes of guinea-pig brain was evaluated,3261,Intermediate,2435.0,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL617870,5094,Striatum
,D,BAO_0000357,,Inhibitory activity against 5-hydroxytryptamine 4 receptor of guinea pig striatum using [3H]GR-113808 as radioligand,3262,Intermediate,2435.0,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL617871,5399,Striatum
,D,BAO_0000357,,Concentration of compound required to inhibit the binding of radioligand [3H]GR-113808 to 5-hydroxytryptamine 4 receptor in guinea pig striatum,3263,Intermediate,2435.0,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL617872,17394,Striatum
,D,BAO_0000357,,Concentration of compound required to inhibit the binding of radioligand [3H]GR-113808 to 5-hydroxytryptamine 4 receptor in guinea-pig striatum,3264,Intermediate,2435.0,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL617873,17394,Striatum
,D,BAO_0000357,,Concentration of compound required to inhibit the binding of radioligand [3H]GR-113808 to serotonin 5-hydroxytryptamine 4 receptor in guinea-pig striatum,3265,Intermediate,2435.0,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL617874,17394,Striatum
,D,BAO_0000221,,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum.,3266,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL619067,13961,Ileum
,D,BAO_0000221,,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum. 95% confidence limits are in brackets.,3267,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL619068,13961,Ileum
,D,BAO_0000221,,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum;ne=not capable of evaluation.,3268,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL619069,13961,Ileum
,D,BAO_0000357,,Ability to displace [3H]GR-113808 from 5-hydroxytryptamine 4 receptor at concentration of 10e-6 M in guinea pig,3269,Intermediate,,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL619070,16946,
,D,BAO_0000357,,Ability to displace [3H]GR-113808 from 5-hydroxytryptamine 4 receptor at concentration of 10e-8 M in guinea pig,3270,Intermediate,,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL619071,16946,
,D,BAO_0000019,,Agonistic activity against 5-hydroxytryptamine 4 receptor,3271,Intermediate,,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL619072,15034,
,D,BAO_0000019,,Agonistic activity against 5-hydroxytryptamine 4 receptor; not tested,3272,Intermediate,,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL619073,15034,
,D,BAO_0000019,,Compound was evaluated for the relative potency with respect to serotonin against 5-hydroxytryptamine 4 receptor,3273,Intermediate,,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL619074,12918,
,D,BAO_0000357,,Ability to displace [3H]GR-113808 from 5-hydroxytryptamine 4 receptor,3274,Intermediate,,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL619075,16946,
,D,BAO_0000357,,Inhibition of [3H]GR-113808 binding to guinea pig striatum 5-hydroxytryptamine 4 receptor,3275,Intermediate,2435.0,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL619076,17394,Striatum
,D,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 4 receptor in guinea pig striatum using [3H]GR-113808 as radioligand,3276,Intermediate,2435.0,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL619077,15034,Striatum
,D,BAO_0000249,,Binding affinity towards 5-HT4 receptor in striatum membranes of guinea-pig brain was evaluated,3277,Intermediate,2435.0,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL619078,5094,Striatum
,D,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 4 receptor in striatum membranes of guinea-pig brain was evaluated,3278,Intermediate,2435.0,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL619079,5094,Striatum
,D,BAO_0000221,,Tested for affinity against 5-hydroxytryptamine 4 receptor in the myenteric plexus of the guinea pig ileum.,3279,Intermediate,2116.0,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL619080,17358,Ileum
,D,BAO_0000357,,Displacement of [3H]-GR113808 from 5-HT4 receptor of guinea pig striatum,3280,Expert,,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL619081,12953,
,D,BAO_0000357,,The compound was tested for their binding affinity towards 5-HT4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand; Nonactive at 10 uM,3281,Intermediate,,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL619082,12953,
,D,BAO_0000357,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand.,3282,Intermediate,,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL619083,12953,
,D,BAO_0000357,,The compound was tested for their binding affinity towards 5-hydroxytryptamine 4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand; Nonactive at 10 uM,3283,Intermediate,,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL619084,12953,
,D,BAO_0000221,,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 4 receptor in non-electrically stimulated guinea-pig ileum.,3284,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL859397,273,Ileum
,D,BAO_0000221,,5-hydroxytryptamine 4 receptor agonist activity in the guinea pig ileum assay,3285,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL619085,12918,Ileum
,D,BAO_0000221,,5-hydroxytryptamine 4 receptor agonistic activity was measured by twitch response enhancing activity in electrically stimulated guinea pig ileum preparation,3286,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL619086,12919,Ileum
,D,BAO_0000221,,Agonistic activity against Serotonin 5-hydroxytryptamine 4 receptor in low frequency field stimulation of guinea-pig ileum (FSGPI).,3287,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL619087,273,Ileum
,D,BAO_0000221,,Agonistic activity against Serotonin 5-hydroxytryptamine 4 receptor in non-electrically stimulated guinea-pig ileum.,3288,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL619088,273,Ileum
,D,BAO_0000357,,Ability to antagonize 5-HT-evoked contractions mediated through 5-hydroxytryptamine 4 receptor activation in the guinea pig distal colon LMMP,3289,Intermediate,,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL619089,13181,
,H,BAO_0000357,,Binding affinity was determined against 5-hydroxytryptamine 3 receptor,3290,Autocuration,,8,,,,,10141.0,1,,168,B,Cavia porcellus,,CHEMBL619090,13181,
,D,BAO_0000019,,Antagonistic activity against 5-hydroxytryptamine 4 receptor,3291,Intermediate,,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL619091,15034,
,D,BAO_0000357,,Ability to displace the radioligand [3H]GR-113808 from guinea pig striatum 5-hydroxytryptamine 4 receptor,3292,Intermediate,,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL619092,5033,
,D,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 4 receptor by displacement of [3H]GR-113808 from guinea pig brain striatum.,3293,Intermediate,,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL619093,1980,
,H,BAO_0000219,,Binding affinity was determined against 5-hydroxytryptamine 2C receptor using cloned rat receptors expressed in 293 cells radiolabeled with [3H]mesulergine,3294,Autocuration,,8,,,722.0,,10141.0,1,HEK293,168,B,Cavia porcellus,,CHEMBL619094,13181,
,D,BAO_0000019,,In vitro by displacement of [3H]GR-113808 from 5-hydroxytryptamine 4 receptor on guinea pig striatal membrane,3295,Intermediate,,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL619095,14287,
,D,BAO_0000357,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 4 receptor using radioligand binding assay using [3H]GR as radioligand,3296,Intermediate,,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL857988,1317,
,D,BAO_0000357,,Compound was evaluated for its ability to displace [3H]GR-113808 binding from 5-hydroxytryptamine 4 receptor in guinea pig striatum.,3297,Intermediate,,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL619096,15316,
,D,BAO_0000357,,In vitro binding affinity at 5-hydroxytryptamine 4 receptor in guinea pig striatum using 3[H]GR-113808 as the radioligand,3298,Intermediate,2435.0,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL619097,16429,Striatum
,D,BAO_0000221,,The compound was tested for its binding affinity towards 5-hydroxytryptamine 4 receptor in guinea pig hippocampus using [125I]SB-207710.,3299,Intermediate,10000000.0,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL619098,14818,Hippocampus
,D,BAO_0000357,,The compound was tested for the binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand,3300,Intermediate,,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL619751,15194,
,D,BAO_0000357,,The compound was tested for the binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand.,3301,Intermediate,,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL619752,15194,
,D,BAO_0000221,,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum;ne=not capable of evaluation.,3302,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL875096,13961,Ileum
,H,BAO_0000357,,Binding affinity towards 5-HT2C receptor by the displacement of [3H]mesulergine] in human recombinant receptors in mammalian cell,3303,Autocuration,,8,,,,,,1,,108,B,,,CHEMBL619004,5486,
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 4 receptor using [3H]5-HT as radioligand,3304,Autocuration,,8,,,,,,1,,168,B,,,CHEMBL619005,16209,
,H,BAO_0000019,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 4 receptor,3305,Autocuration,,8,,,,,,1,,168,B,,,CHEMBL619006,17085,
,H,BAO_0000219,,Compound was evaluated for the binding affinity against human cloned 5-hydroxytryptamine 4 receptor in HeLa cells using [3H]-LSD as the radioligand,3306,Autocuration,,8,,,308.0,,,1,HeLa,168,B,,,CHEMBL619007,4199,
,H,BAO_0000357,,Compound was tested for its binding affinity against 5-hydroxytryptamine 4 receptor,3307,Autocuration,,8,,,,,,1,,168,B,,,CHEMBL619008,15146,
,H,BAO_0000357,,Compound was tested for its binding affinity for 5-hydroxytryptamine 4 receptor,3308,Autocuration,,8,,,,,,1,,168,B,,,CHEMBL619009,5213,
,H,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 4 receptor in HeLa cells, using [3H]LSD as radioligand",3309,Autocuration,,8,,,308.0,,,1,HeLa,168,B,,,CHEMBL619010,4829,
,H,BAO_0000357,,Tested for ability to stimulate production of cAMP mediated by 5-hydroxytryptamine 4 receptor in mouse Coliculi neurons,3310,Autocuration,,8,,,,,,1,,10622,B,,,CHEMBL619011,17358,
,H,BAO_0000357,,Tested for ability to stimulate production of cAMP mediated by 5-hydroxytryptamine 4 receptor in mouse Coliculi neurons; IA means inactive,3311,Autocuration,,8,,,,,,1,,10622,B,,,CHEMBL619012,17358,
,H,BAO_0000219,,Ability to displace [3H]GR-113808 from mouse 5-hydroxytryptamine 4 receptor in COS7 cells,3312,Autocuration,,8,,,,,,1,,10622,B,,,CHEMBL619013,16946,
,H,BAO_0000357,,Tested for ability to stimulate 5-hydroxytryptamine 4 receptors in mouse Coliculi neurons,3313,Autocuration,,8,,,,,,1,,10622,B,,,CHEMBL619014,17358,
,H,BAO_0000019,,Evaluated for the 5-hydroxytryptamine 4 receptor antagonistic activity in piglet atrium model,3314,Autocuration,2081.0,8,,,,,,1,,11249,F,,,CHEMBL857503,268,Cardiac atrium
,H,BAO_0000019,,Evaluated for the 5-hydroxytryptamine 4 receptor antagonistic activity in piglet atrium model; compound found inactive at 1 uM,3315,Autocuration,2081.0,8,,,,,,1,,11249,F,,,CHEMBL619015,268,Cardiac atrium
,H,BAO_0000357,,The compound was tested for binding affinity against 5-hydroxytryptamine 4 receptor,3316,Autocuration,,8,,,,,,1,,11249,B,,,CHEMBL619016,15086,
,H,BAO_0000221,,Compound was tested for binding affinity against piglet hippocampus 5-hydroxytryptamine 4 receptor,3317,Autocuration,10000000.0,8,,,,,,1,,11249,B,,,CHEMBL619017,14875,Hippocampus
,H,BAO_0000221,,The binding affinity (pKi) was measured against 5-hydroxytryptamine 4 receptor of piglet hippocampus using [125I]SB 207710 as radioligand,3318,Autocuration,10000000.0,8,,,,,9823.0,1,,168,B,Sus scrofa,,CHEMBL619018,13267,Hippocampus
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 2A receptor using rabbit saphenous vein assay.,3319,Autocuration,,8,,,,,9986.0,1,,168,B,Oryctolagus cuniculus,,CHEMBL619019,13047,
,D,BAO_0000357,,Displacement of [3H]GR-113808 from rat striatum 5-hydroxytryptamine 4 receptor,3320,Expert,,9,,,,,10116.0,1,,10623,B,Rattus norvegicus,,CHEMBL619020,1650,
,H,BAO_0000019,,Tested for its agonist potency against the 5-hydroxytryptamine 4 receptor located in the rat esophageal tunica muscularis mucosae,3321,Autocuration,,8,,,,,,1,,10623,F,,,CHEMBL619021,567,
,H,BAO_0000357,,Tested for affinity towards 5-hydroxytryptamine 4 receptor in relaxation of rat oesophagus,3322,Autocuration,,8,,,,,,1,,10623,B,,,CHEMBL619022,17358,
,H,BAO_0000357,,Tested for the effect on binding at 5-hydroxytryptamine 4 receptor; No activity,3323,Autocuration,,8,,,,,,1,,10623,B,,,CHEMBL619023,188,
,H,BAO_0000019,,lntrinsic activity relative to 5-HT receptor,3324,Autocuration,,8,,,,,,1,,10623,F,,,CHEMBL619024,670,
,H,BAO_0000019,,Compound was evaluated for the agonistic activity towards 5-hydroxytryptamine 4 receptor using the rat tunica muscularis mucosae (TMM) esophagus strip assay,3325,Autocuration,,8,,,,,,1,,10623,F,,,CHEMBL619025,204,
,H,BAO_0000019,,In vitro relaxation of carbachol pre-contracted rat oesophageal TMM.,3326,Expert,,8,,,,,,1,,10623,F,,,CHEMBL619026,1946,
,H,BAO_0000019,,Compound was tested for agonist activity at the 5-hydroxytryptamine 4 receptor in the rat tunica muscularis mucosae (TMM) assay,3327,Autocuration,,8,,,,,,1,,10623,F,,,CHEMBL619027,6398,
,H,BAO_0000019,,Compound was tested for agonist activity at the 5-hydroxytryptamine 4 receptor in the rat tunica muscularis mucosae (TMM) assay; IN = Inactive,3328,Autocuration,,8,,,,,,1,,10623,F,,,CHEMBL619028,6398,
,H,BAO_0000019,,Efficient 5-hydroxytryptamine 4 agonist in the rat tunica muscularis mucosae,3329,Autocuration,,8,,,,,,1,,10623,F,,,CHEMBL619029,17358,
,H,BAO_0000019,,Tested for agonist activity at the 5-hydroxytryptamine 4 receptor in the rat tunica muscularis mucosae (TMM) assay of racemate mixture,3330,Autocuration,,8,,,,,,1,,10623,F,,,CHEMBL619030,6398,
,H,BAO_0000357,,Relaxation of carbachol induced contractions of rat tunica muscularis mucosae,3331,Expert,,8,,,,,,1,,10623,B,,,CHEMBL619031,11752,
,H,BAO_0000019,,5-hydroxytryptamine 4 receptor agonist activity was determined by the relaxation of the carbachol-contracted rat esophageal tunica muscularis mucosae,3332,Autocuration,,8,,,,,,1,,10623,F,,,CHEMBL619032,809,
,D,BAO_0000357,,Inhibition of radiolabeled [3H]GR-113808 ligand binding to 5-hydroxytryptamine 4 receptor,3333,Expert,,9,,,,,10116.0,1,,10623,B,Rattus norvegicus,,CHEMBL619033,14178,
,H,BAO_0000357,,Tested for its efficacy against the 5-hydroxytryptamine 4 receptor located in the rat esophageal tunica muscularis mucosae,3334,Autocuration,,8,,,,,,1,,10623,B,,,CHEMBL619034,567,
,H,BAO_0000357,,In vitro 5-hydroxytryptamine 4 receptor activity by using carbachol-precontracted esophageal tunica muscularis mucosae.,3335,Autocuration,,8,,,,,,1,,10623,B,,,CHEMBL619035,1946,
,H,BAO_0000357,,In vitro 5-hydroxytryptamine 4 receptor activity by using carbachol-precontracted esophageal tunica muscularis mucosae; No activity up to 104M concentration,3336,Autocuration,,8,,,,,,1,,10623,B,,,CHEMBL619036,1946,
,D,BAO_0000019,,Binding affinity (Ki+/-SEM) against 5-hydroxytryptamine 4 receptor from cheng Prusoff equation by using [3H]GR-113808 in rat striatum,3337,Expert,,9,,,,,10116.0,1,,10623,B,Rattus norvegicus,,CHEMBL619037,13961,
,H,BAO_0000249,,Binding affinity towards 5-HT 4 receptor in rat striatum membranes using [3H]GR-113808 as radioligand,3338,Autocuration,2435.0,8,,,,,,1,,10623,B,,,CHEMBL619038,6238,Striatum
,H,BAO_0000249,,Binding affinity towards 5-HT4 receptor was determined in rat striatal membranes using [3H]GR-113808 as radioligand; Not tested,3339,Autocuration,,8,,,,,,1,,10623,B,,,CHEMBL619039,14290,
,H,BAO_0000249,,Binding affinity towards 5-hydroxytryptamine 4 receptor was determined in rat striatal membranes using [3H]GR-113808 as radioligand,3340,Expert,,8,,,,,,1,,10623,B,,,CHEMBL619040,14290,
,D,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum,3341,Expert,2435.0,9,,,,,10116.0,1,,10623,B,Rattus norvegicus,,CHEMBL619041,809,Striatum
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum,3342,Autocuration,2435.0,8,,,,,,1,,10623,B,,,CHEMBL619042,1578,Striatum
,H,BAO_0000249,,Binding affinity to 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum membrane,3343,Expert,2435.0,8,,,,,,1,,10623,B,,,CHEMBL619043,16709,Striatum
,H,BAO_0000019,,Binding affinity at 5-hydroxytryptamine 4 receptor in rat striatum by [3H]GR-113808 displacement.,3344,Expert,2435.0,8,,,,,,1,,10623,B,,,CHEMBL619044,1946,Striatum
,H,BAO_0000249,,In vitro affinity at serotonergic 5-hydroxytryptamine 4 receptor by radioligand binding assay using [3H]GR-113808 in rat striatum membranes.,3345,Expert,2435.0,8,,,,,,1,,10623,B,,,CHEMBL619045,15253,Striatum
,H,BAO_0000249,,In vitro binding affinity to 5-hydroxytryptamine 4 receptor in rat striatum membrane,3346,Expert,2435.0,8,,,,,,1,,10623,B,,,CHEMBL619046,4535,Striatum
,H,BAO_0000249,,Binding affinity at 5-hydroxytryptamine 4 receptor in rat striatal membranes by [3H]GR-113808 displacement.,3347,Expert,,8,,,,,,1,,10623,B,,,CHEMBL619047,13961,
,H,BAO_0000221,,Tested for potency against 5-hydroxytryptamine 4 receptor agonist in rat brain,3348,Autocuration,955.0,8,,,,,,1,,10623,F,,,CHEMBL619048,17358,Brain
,H,BAO_0000019,,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 4 receptor of rat,3349,Autocuration,,8,,,,,,1,,10623,F,,,CHEMBL859398,15847,
,H,BAO_0000019,,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 4 receptor of rat; ND means not done,3350,Autocuration,,8,,,,,,1,,10623,F,,,CHEMBL619049,15847,
,H,BAO_0000019,,5-hydroxytryptamine 4 receptor agonist activity in the rat esophageal muscularis mucosae,3351,Autocuration,,8,,,,,,1,,10623,F,,,CHEMBL857886,670,
,H,BAO_0000019,,5-hydroxytryptamine 4 receptor agonist activity in the rat esophageal muscularis mucosae; Not tested,3352,Autocuration,,8,,,,,,1,,10623,F,,,CHEMBL619050,670,
,H,BAO_0000019,,Antagonist activity against 5-hydroxytryptamine 4 receptor mediated relaxation of rat carbachol contracted esophageal muscularis mucosae,3353,Autocuration,,8,,,,,,1,,10623,F,,,CHEMBL620591,1317,
,D,BAO_0000357,,Binding affinity against rat 5-hydroxytryptamine 4 receptor,3354,Expert,,9,,,,,10116.0,1,,10623,B,Rattus norvegicus,,CHEMBL620592,12936,
,H,BAO_0000249,,pKi against 5-hydroxytryptamine 4 receptor in rat striatum membrane,3355,Expert,2435.0,8,,,,,,1,,10623,B,,,CHEMBL620593,4535,Striatum
,D,BAO_0000019,,Antagonistic activity evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-5 M.,3356,Expert,,9,,,,,10116.0,1,,10623,F,Rattus norvegicus,,CHEMBL620594,14424,
,H,BAO_0000019,,Antagonistic activity by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-6 M.,3357,Expert,,8,,,,,,1,,10623,F,,,CHEMBL875079,14424,
,H,BAO_0000019,,Antagonistic activity by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-7 M.,3358,Expert,,8,,,,,,1,,10623,F,,,CHEMBL620595,14424,
,D,BAO_0000019,,Antagonistic activity evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-8 M.,3359,Expert,,9,,,,,10116.0,1,,10623,F,Rattus norvegicus,,CHEMBL620596,14424,
,H,BAO_0000019,,Antagonistic activity of compound was evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 3*10e-7 M.,3360,Autocuration,,8,,,,,,1,,10623,F,,,CHEMBL620597,14424,
,H,BAO_0000019,,Antagonistic activity evaluated by ability to block serotonin induced relaxation (via 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 3*10e-8 M.,3361,Expert,,8,,,,,,1,,10623,F,,,CHEMBL620598,14424,
,H,BAO_0000218,,Antagonistic activity evaluated by ability to block serotonin induced relaxation via 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 0.1 mg/kg (p.o.),3362,Expert,,8,,,,,,1,,10623,F,,,CHEMBL620599,14424,
,H,BAO_0000019,,Antagonistic activity of compound was evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-7 M.,3363,Autocuration,,8,,,,,,1,,10623,F,,,CHEMBL620600,14424,
,H,BAO_0000019,,Estimate from relaxation of carbachol-contracted rat esophageal muscularis mucosae,3364,Autocuration,,8,,,,,10116.0,1,,168,F,Rattus norvegicus,,CHEMBL620601,1980,
,H,BAO_0000019,,Compound was tested for agonistic activity against 5-hydroxytryptamine 4 receptor on guinea colon at a concentration 0.1 uM,3365,Autocuration,,8,,,,,,1,,168,F,,,CHEMBL620602,4639,
,H,BAO_0000357,,Tested for affinity towards 5-hydroxytryptamine 4 receptor,3366,Autocuration,,8,,,,,,1,,168,B,,,CHEMBL620603,17358,
,H,BAO_0000357,,Tested for affinity towards 5-hydroxytryptamine 4 receptor.,3367,Autocuration,,8,,,,,,1,,168,B,,,CHEMBL620604,17358,
,H,BAO_0000357,,Compound was tested for 5-hydroxytryptamine 4 binding affinity,3368,Autocuration,,8,,,,,,1,,168,B,,,CHEMBL620605,17358,
,H,BAO_0000357,,Compound was tested for its affinity towards 5-hydroxytryptamine 4 receptor,3369,Autocuration,,8,,,,,,1,,168,B,,,CHEMBL620606,1558,
,H,BAO_0000019,,Tested for 5-hydroxytryptamine 4 receptor antagonist activity,3370,Autocuration,,8,,,,,,1,,168,F,,,CHEMBL620607,17358,
,H,BAO_0000357,,In vitro binding affinity towards 5-HT4 receptor was determined,3371,Autocuration,,8,,,,,,1,,168,B,,,CHEMBL620608,16117,
,H,BAO_0000019,,Tested for 5-hydroxytryptamine 4 receptor antagonist activity,3372,Autocuration,,8,,,,,,1,,168,F,,,CHEMBL620609,17358,
,H,BAO_0000019,,Tested for agonist activity against 5-hydroxytryptamine 4 receptor,3373,Autocuration,,8,,,,,,1,,168,F,,,CHEMBL620610,17358,
,H,BAO_0000357,,Tested for selectivity for 5-hydroxytryptamine 4 receptor,3374,Autocuration,,8,,,,,,1,,168,B,,,CHEMBL620611,17358,
,H,BAO_0000357,,Tested for 5-hydroxytryptamine 4 binding affinity against cisapride,3375,Autocuration,,8,,,,,,1,,168,B,,,CHEMBL620612,17358,
,H,BAO_0000357,,Tested for 5-hydroxytryptamine 4 binding affinity against renzapride,3376,Autocuration,,8,,,,,,1,,168,B,,,CHEMBL620613,17358,
,H,BAO_0000357,,Tested for 5-hydroxytryptamine 4 binding affinity against zacopride,3377,Autocuration,,8,,,,,,1,,168,B,,,CHEMBL620614,17358,
,H,BAO_0000357,,Binding affinity against 5-Hydroxytryptamine 4 receptor,3378,Expert,,8,,,,,,1,,168,B,,,CHEMBL620615,1274,
,H,BAO_0000249,,Compound was evaluated for the displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 recognition sites in rat brain membranes,3379,Autocuration,,6,Brain membranes,,,,,1,,104698,B,,,CHEMBL857075,10728,
,H,BAO_0000249,,Compound was evaluated for the displacement of [3H]Q-ICS-205-930 from 5-HT3 recognition sites in rat brain membranes,3380,Autocuration,,6,Brain membranes,,,,,1,,104698,B,,,CHEMBL620616,11695,
,H,BAO_0000249,,Displacement of [3H]Q-ICS-205-930 from 5-hydroxytryptamine 3 receptor recognition sites in rat brain membranes,3381,Autocuration,,6,Brain membranes,,,,,1,,104698,B,,,CHEMBL619411,11695,
,H,BAO_0000019,,Displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 receptor from rat cortex homogenate,3382,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL619412,12490,
,D,BAO_0000019,,Displacement of [3H]-Q-ICS 205-930 from rat cortex homogenate 5-hydroxytryptamine 3 receptor,3383,Autocuration,,7,,,,,10116.0,1,,104698,B,Rattus norvegicus,,CHEMBL619413,11828,
,H,BAO_0000221,,Binding affinity of 5-hydroxytryptamine 3 receptor using [3H]granisetron in rat hippocampus and entorhinal cortex,3384,Autocuration,10000000.0,6,,,,,,1,,104698,B,,,CHEMBL619414,12253,Hippocampus
,H,BAO_0000019,,Binding affinity to 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand in rat cortex,3385,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL619415,10561,
,H,BAO_0000019,,Binding affinity to 5-hydroxytryptamine 3 receptor using [3H]quipazine as radioligand in rat cortex,3386,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL619416,10561,
,H,BAO_0000019,,Rat 5-hydroxytryptamine 3 receptor (5-HT3) antagonist,3387,Autocuration,,6,,,,,,1,,104698,F,,,CHEMBL619417,14432,
,D,BAO_0000223,,Binding affinity against rat 5-hydroxytryptamine 3 receptor,3388,Autocuration,,7,,,,,10116.0,1,,104698,B,Rattus norvegicus,,CHEMBL619418,12936,
,D,BAO_0000223,,Binding affinity against 5-Hydroxytryptamine 3 receptor,3389,Autocuration,,7,,,,,10116.0,1,,104698,B,Rattus norvegicus,,CHEMBL619419,1274,
,H,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of racemic [3H]zacopride from rat cortex,3390,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL619420,1980,
,H,BAO_0000249,,Binding affinity to 5-hydroxytryptamine 3 receptor was determined in rat cerebro cortical membranes using [3H]quipazine.,3391,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL619421,670,
,D,BAO_0000019,,Displacement of [3H]granisetron from 5-hydroxytryptamine 3 receptor of rat cortex,3392,Autocuration,,7,,,,,10116.0,1,,104698,B,Rattus norvegicus,,CHEMBL619422,968,
,H,BAO_0000019,,In vitro by displacement of [3H]LY-278584 from 5-hydroxytryptamine 3 receptor on rat entorhinal cortex,3393,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL619423,14287,
,H,BAO_0000019,,Tested for its binding affinity by measuring its ability to displace [3H]granisetron from 5-hydroxytryptamine 3 receptor in rat cortex,3394,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL875080,567,
,H,BAO_0000019,,The binding affinity (pKi) measured against 5-hydroxytryptamine 1A receptor of rat cortex using [3H]8-OH-DPAT as radioligand,3395,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL619424,13267,
,H,BAO_0000249,,Binding affinity at 5-hydroxytryptamine 3 receptor in rat cortical membrane by [3H]graniestron displacement.,3396,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL619425,14826,
,H,BAO_0000223,,The compound was tested for the binding affinity against 5-hydroxytryptamine 3 receptor using [3H]zacopride as radioligand,3397,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL619426,15194,
,H,BAO_0000223,,The compound was tested for the binding affinity against 5-hydroxytryptamine 3 receptor using [3H]zacopride as radioligand.,3398,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL619427,15194,
,D,BAO_0000223,,pKi value for inhibition of [3H]LY-278584 binding to 5-hydroxytryptamine 3 receptor,3399,Autocuration,,7,,,,,10116.0,1,,104698,B,Rattus norvegicus,,CHEMBL619645,10394,
,D,BAO_0000249,,"Compound was evaluated for binding affinity on 5-hydroxytryptamine 1A receptor in rat hippocampus membranes,3H-8-OH-DPAT and buspirone for nonspecific binding",3400,Expert,,9,,,,,,1,,10576,B,,,CHEMBL619646,13657,
,H,BAO_0000221,,Compound was tested for its antagonistic activity against 5-hydroxytryptamine 3 receptor in rat brain using [3H]zacopride as the radioligand.,3401,Autocuration,955.0,8,,,,,,1,,12020,F,,,CHEMBL619647,1879,Brain
,H,BAO_0000019,,Compound was tested in vitro for its antagonistic activity against 5-hydroxytryptamine 3 receptor,3402,Autocuration,,8,,,,,,1,,12020,F,,,CHEMBL619648,1879,
,H,BAO_0000019,,Compound was tested in vitro for its antagonistic activity against 5-hydroxytryptamine 3 receptor in rat CNS.,3403,Autocuration,,8,,,,,,1,,12020,F,,,CHEMBL619165,1879,
,H,BAO_0000218,,Compound was evaluated in vivo for the antagonistic activity towards 5-hydroxytryptamine 3 receptor,3404,Autocuration,,8,,In vivo,,,,1,,12020,F,,,CHEMBL620719,204,
,H,BAO_0000019,,Compound was tested for its binding affinity towards 5-HT-3 receptor in whole rat brain using (S)-[125I]-zacopride as the radioligand.,3405,Autocuration,,8,,,,,,1,,12020,B,,,CHEMBL872924,1879,
,H,BAO_0000357,,Compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor,3406,Autocuration,,8,,,,,,1,,12020,B,,,CHEMBL620720,1879,
,H,BAO_0000019,,Compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor in whole rat brain using (S)-[125I]-zacopride as the radioligand.,3407,Autocuration,,8,,,,,,1,,12020,B,,,CHEMBL620721,1879,
,H,BAO_0000019,,Compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor in whole rat brain using [125I]DAIZAC as the radioligand.,3408,Autocuration,,8,,,,,,1,,12020,B,,,CHEMBL620722,1879,
,H,BAO_0000019,,"Concentration that inhibits the binding of radioligand, [3H]-ICS 205930, to 5-hydroxytryptamine 3 receptor from rat cortex",3409,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL620723,10641,
,H,BAO_0000019,,In Vitro Binding affinity againist 5-hydroxytryptamine 3 receptor by displacing [3H]-Q-ICS 205-930 from rat cortex homogenates,3410,Autocuration,,8,,,,,,1,,12020,B,,,CHEMBL620724,773,
,H,BAO_0000249,,Binding affinity against 5-hydroxytryptamine 3 (5-HT3) receptor in rat brain cortical membranes using radioligand [3H]quipazine,3411,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL620725,11952,
,D,BAO_0000019,,Antagonist activity (100 ug/kg) for the Bezold Jarisch reflex evoked by 30 (ug/Kg) of 5-hydroxytryptamine 3 receptor in ethylurethane anesthetized rats i.v.,3412,Autocuration,,9,,,,,10116.0,1,,12020,F,Rattus norvegicus,,CHEMBL620726,14145,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 3 receptor,3413,Expert,,8,,,,,,1,,144,B,,,CHEMBL620727,17066,
,H,BAO_0000223,,Compound was evaluated for 5-hydroxytryptamine 3 receptor binding,3414,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL620728,6398,
,U,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,3415,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL620729,10321,
,H,BAO_0000019,,Tested for 5-hydroxytryptamine 3 receptor antagonist activity by inhibiting the 5-HT evoked Bezold-Jarisch reflex,3416,Autocuration,,4,,,,,,1,,104714,F,,,CHEMBL858288,511,
,H,BAO_0000223,,Compound was tested for binding affinity towards 5-hydroxytryptamine 3 receptor,3417,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL620730,4639,
,H,BAO_0000223,,Binding affinity towards 5-hydroxytryptamine 3 receptor,3418,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL620731,4639,
,H,BAO_0000019,,Compound was tested for antagonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 0.3 uM,3419,Autocuration,,4,,,,,10141.0,1,,104714,F,Cavia porcellus,,CHEMBL620732,4639,
,H,BAO_0000019,,Compound was tested for antagonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 3 uM,3420,Autocuration,,4,,,,,10141.0,1,,104714,F,Cavia porcellus,,CHEMBL618042,4639,
,H,BAO_0000019,,Compound was tested for antagonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 30 uM,3421,Autocuration,,4,,,,,10141.0,1,,104714,F,Cavia porcellus,,CHEMBL618043,4639,
,H,BAO_0000223,,Compound was tested for its affinity towards 5-hydroxytryptamine 3 receptor,3422,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL618044,1558,
,H,BAO_0000019,,Evaluated for the 5-hydroxytryptamine 3 receptor antagonistic activity in Bezold-Jarisch model expressed as inhibition of the reflex bradycardia induced by an intravenous injection,3423,Autocuration,,4,,,,,,1,,104714,F,,,CHEMBL618045,268,
,H,BAO_0000223,,Compound was measured for its binding affinity at 5-hydroxytryptamine 3 receptor at a concentration of 10 uM using [3H]BRL-43694 as radioligand,3424,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL618046,2474,
,H,BAO_0000019,,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); A: agonist,3425,Autocuration,,4,,,,,,1,,104714,F,,,CHEMBL618047,5067,
,H,BAO_0000019,,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); ANT: agonist,3426,Autocuration,,4,,,,,,1,,104714,F,,,CHEMBL875084,5067,
,H,BAO_0000019,,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); ANT: antagonist,3427,Autocuration,,4,,,,,,1,,104714,F,,,CHEMBL618048,5067,
,H,BAO_0000223,,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); NA means data not available,3428,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL618049,5067,
,H,BAO_0000019,,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); PA: Partial agonist,3429,Autocuration,,4,,,,,,1,,104714,F,,,CHEMBL619764,5067,
,H,BAO_0000019,,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; A: agonist,3430,Autocuration,,4,,,,,,1,,104714,F,,,CHEMBL619765,5067,
,H,BAO_0000019,,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; ANT: Antagonist,3431,Autocuration,,4,,,,,,1,,104714,F,,,CHEMBL619766,5067,
,H,BAO_0000223,,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; NA: not active,3432,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL619767,5067,
,H,BAO_0000223,,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; NA means data not available,3433,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL619768,5067,
,H,BAO_0000019,,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; PA: Partial agonist,3434,Autocuration,,4,,,,,,1,,104714,F,,,CHEMBL619769,5067,
,H,BAO_0000223,,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; na means data not available,3435,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL619770,5067,
,H,BAO_0000223,,Binding affinity towards 5-hydroxytryptamine 3 receptor,3436,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL619771,5067,
,H,BAO_0000219,,Binding affinity of compound towards 5-hydroxytryptamine 3 receptor using [3H]-BRL-43694 (1 nM) ligand in NG cells 108-15 was determined,3437,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL619772,14331,
,H,BAO_0000223,,Binding affinity of compound towards 5-hydroxytryptamine 3 receptor; NA: not active,3438,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL619773,5067,
,H,BAO_0000219,,Binding affinity for 5-HT3 receptor of NG108-15 cells using [3H]GR-65630,3439,Autocuration,,4,,,433.0,,,1,NG108-15,104714,B,,,CHEMBL619774,6179,
,H,BAO_0000019,,Binding affinity to 5-HT3 serotonin receptor in NG 108-15 neuroblastoma glioma cells using [3H]GR-65630 radioligand.,3440,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL875083,4265,
,H,BAO_0000219,,Binding affinity to 5-HT3 serotonin receptor in NG108-15 neuroblastoma glioma cells using [3H]GR-65630 radioligand,3441,Autocuration,,4,,,433.0,,,1,NG108-15,104714,B,,,CHEMBL620718,4265,
,H,BAO_0000223,,Compound was tested for 5-hydroxytryptamine 3 receptor binding affinity,3442,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL618127,17358,
,H,BAO_0000223,,Compound was tested for selectivity against 5-hydroxytryptamine 3 receptor binding affinity,3443,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL618128,17358,
,H,BAO_0000219,,Compound was tested for the inhibition of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor expressed in NG 108-15 cells,3444,Autocuration,,4,,In vitro,,,,1,,104714,B,,,CHEMBL618129,13628,
,H,BAO_0000223,,In vitro Binding affinity towards 5-hydroxytryptamine 3 receptor was determined,3445,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL618130,4612,
,H,BAO_0000019,,Tested for 5-hydroxytryptamine 3 receptor antagonist activity,3446,Autocuration,,4,,,,,,1,,104714,F,,,CHEMBL618131,17358,
,H,BAO_0000019,,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 1 uM,3447,Autocuration,,4,,,,,10141.0,1,,104714,F,Cavia porcellus,,CHEMBL618132,4639,
,H,BAO_0000019,,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 10 uM,3448,Autocuration,,4,,,,,10141.0,1,,104714,F,Cavia porcellus,,CHEMBL618133,4639,
,H,BAO_0000019,,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 10 uM in the presence of 30 uM MDL 72222,3449,Autocuration,,4,,,,,10141.0,1,,104714,F,Cavia porcellus,,CHEMBL618134,4639,
,H,BAO_0000019,,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 3 uM,3450,Autocuration,,4,,,,,10141.0,1,,104714,F,Cavia porcellus,,CHEMBL618135,4639,
,H,BAO_0000223,,Binding affinity for the 5-hydroxytryptamine 3 receptor was evaluated in vitro by examining its ability to displace [3H]-BRL 43694.,3451,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL618136,511,
,H,BAO_0000223,,Binding affinity towards 5-hydroxytryptamine 3 receptor,3452,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL618137,1479,
,H,BAO_0000223,,Compound was evaluated for binding affinity against 5-hydroxytryptamine 3 receptor using radioligand binding assay,3453,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL618138,1317,
,H,BAO_0000223,,Tested against 5-hydroxytryptamine 3 receptor in experiment 1,3454,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL618139,12146,
,H,BAO_0000223,,Tested against 5-hydroxytryptamine 3 receptor in experiment 2,3455,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL618140,12146,
,H,BAO_0000223,,Binding affinity against 5-hydroxytryptamine 3 receptor was measured using [3H]granisetron as radioligand,3456,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL618141,13969,
,H,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 2C receptor,3457,Expert,,8,,,,,,1,,108,B,,,CHEMBL873478,13392,
,H,BAO_0000223,,Binding affinity towards 5-hydroxytryptamine 3 receptor,3458,Autocuration,,6,,,,,,1,,104698,B,,,CHEMBL618142,13392,
,H,BAO_0000357,,Compound was evaluated for the affinity at 5-hydroxytryptamine 3 receptor,3459,Autocuration,,8,,,,,,1,,144,B,,,CHEMBL618143,14159,
,H,BAO_0000357,,Compound was tested for its affinity towards 5-hydroxytryptamine 3 receptor,3460,Autocuration,,8,,,,,,1,,144,B,,,CHEMBL618144,1558,
,H,BAO_0000357,,Inhibition of GR-65630 binding to 5-hydroxytryptamine 3 receptor,3461,Autocuration,,8,,,,,,1,,144,B,,,CHEMBL618145,16655,
,H,BAO_0000223,,Inhibition of [3H]- BRL 43 694 binding to 5-hydroxytryptamine 3 receptor at 10e-5 M,3462,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL618146,13020,
,H,BAO_0000223,,Inhibition of [3H]-BRL 43 694 binding to 5-hydroxytryptamine 3 receptor of central nervous system,3463,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL618147,13021,
,H,BAO_0000223,,Inhibition of [3H]- BRL 43 694 binding to 5-hydroxytryptamine 3 receptor at 10e-5 M,3464,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL618148,13020,
,H,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,3465,Autocuration,,8,,,,,,1,,144,B,,,CHEMBL618149,10321,
,H,BAO_0000357,,Compound was evaluated for its binding affinity towards 5-hydroxytryptamine 3 receptor,3466,Autocuration,,8,,,,,,1,,144,B,,,CHEMBL872927,15818,
,H,BAO_0000357,,Compound was evaluated for its binding affinity towards 5-hydroxytryptamine 3 receptor,3467,Autocuration,,8,,,,,,1,,144,B,,,CHEMBL618150,15818,
,H,BAO_0000357,,Compound was tested for 5-hydroxytryptamine 3 receptor binding affinity,3468,Autocuration,,8,,,,,,1,,144,B,,,CHEMBL618151,17358,
,H,BAO_0000357,,Compound was tested for its binding affinity for the 5-hydroxytryptamine 3 receptor,3469,Autocuration,,8,,,,,,1,,144,B,,,CHEMBL875094,2222,
,H,BAO_0000019,,In vitro binding affinity for the 5-hydroxytryptamine 3 receptor was determined with NG-108-15 mouse neuroblastoma-glioma cells,3470,Autocuration,,8,,,,,,1,,144,B,,,CHEMBL618152,10322,
,H,BAO_0000357,,In vitro binding affinity towards 5-hydroxytryptamine 3 receptor was determined,3471,Autocuration,,8,,,,,,1,,144,B,,,CHEMBL618153,16117,
,H,BAO_0000357,,Inhibitory constant against 5-hydroxytryptamine 3 receptor using [3H]GR-65630 radioligand,3472,Autocuration,,8,,,,,,1,,144,B,,,CHEMBL618888,17200,
,H,BAO_0000019,,Tested for 5-hydroxytryptamine 3 receptor agonist activity,3473,Autocuration,,8,,,,,,1,,144,F,,,CHEMBL618889,17358,
,H,BAO_0000357,,The binding affinity towards 5-hydroxytryptamine 3 receptor; No affinity,3474,Autocuration,,8,,,,,,1,,144,B,,,CHEMBL618890,16700,
,H,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H](R)-zacopride from ondansetron-treated NG-108-15 cell membranes,3475,Autocuration,,8,,,,,,1,,144,B,,,CHEMBL618891,1980,
,H,BAO_0000019,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H]-BRL 43694 from NG-108-15 cell membranes,3476,Autocuration,,8,,,,,,1,,144,B,,,CHEMBL619054,1980,
,H,BAO_0000223,,Binding affinity against the 5-hydroxytryptamine 3 receptor,3477,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL619055,12409,
,H,BAO_0000357,,Binding affinity against human 5-hydroxytryptamine 3A receptor,3478,Autocuration,,8,,,,,,1,,144,B,,,CHEMBL619056,4365,
,H,BAO_0000019,,Percent efficacy against 5-hydroxytryptamine 3A receptor,3479,Autocuration,,8,,,,,,1,,144,F,,,CHEMBL619057,4365,
,H,BAO_0000357,,Binding affinity against human 5-hydroxytryptamine 3A receptor,3480,Autocuration,,8,,,,,,1,,144,B,,,CHEMBL619058,4365,
,D,BAO_0000219,,Response at rat 5-hydroxytryptamine 3a receptor expressed in xenopus oocytes,3481,Expert,,9,,,,,10116.0,1,Oocytes,12020,F,Rattus norvegicus,,CHEMBL619059,6769,
,D,BAO_0000219,,Ability to block serotonin (30 uM)-evoked responses at rat 5HT3-alpha receptor expressed in xenopus oocytes,3482,Expert,,9,,,,,10116.0,1,Oocytes,12020,F,Rattus norvegicus,,CHEMBL619060,6769,
,D,BAO_0000219,,Effect on rat 5-hydroxytryptamine 3a receptor expressed in xenopus oocytes at concentration up to 100 uM,3483,Expert,,9,,,,,10116.0,1,Oocytes,12020,F,Rattus norvegicus,,CHEMBL875095,6769,
,D,BAO_0000221,,5-hydroxytryptamine 4 receptor agonist activity as percent maximum 5-HT effect in response to electrical stimulation in male guinea pig ileum,3484,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL619061,809,Ileum
,D,BAO_0000221,,5-hydroxytryptamine 4 receptor agonist activity expressed as the concentration which gave a 50% increase in the response to the electrical stimulation in male guinea pig ileum,3485,Intermediate,2116.0,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL619062,809,Ileum
,D,BAO_0000019,,5-hydroxytryptamine 4 receptor agonist activity is expressed as percent of the maximum 5-HT response,3486,Intermediate,,9,,,,,10141.0,1,,20033,F,Cavia porcellus,,CHEMBL619063,14290,
,D,BAO_0000221,,Tested for affinity towards 5-hydroxytryptamine 4 receptor in electrically stimulated longitudinal muscle preparation of guinea pig ileum,3487,Intermediate,2116.0,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL619064,17358,Ileum
,D,BAO_0000357,,Tested for affinity towards 5-hydroxytryptamine 4 receptor in guinea pig distal colon preparation,3488,Intermediate,,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL619065,17358,
,D,BAO_0000221,,Tested for affinity towards 5-hydroxytryptamine 4 receptor in isolated guinea pig ileum longitudinal muscle preparation,3489,Intermediate,2116.0,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL619066,17358,Ileum
,H,BAO_0000221,,Maximal relaxation effect induced by 3 uM compound on substance P stimulated guinea pig ileum with 5-hydroxytryptamine 7 receptor nondesensitization,3490,Autocuration,2116.0,8,,,,,,1,,10209,B,,,CHEMBL619775,17386,Ileum
,H,BAO_0000357,,Affinity against 5-hydroxytryptamine 7 receptor,3491,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL619776,3269,
,H,BAO_0000224,,Ability to displace [3H]5-HT binding from 5-hydroxytryptamine receptor site using 1 uM LSD as masking ligand,3492,Autocuration,,4,,,,,10141.0,1,,104841,B,Cavia porcellus,,CHEMBL619777,7721,
,H,BAO_0000224,,Ability to displace [3H]5-HT binding to 5-hydroxytryptamine receptor site using 1 uM LSD as masking ligand,3493,Autocuration,,4,,,,,10141.0,1,,104841,B,Cavia porcellus,,CHEMBL619778,7721,
,H,BAO_0000221,,Evaluated for inhibition of 5-hydroxytryptamine receptor on guinea pig ileum at 10 uM; No effect,3494,Autocuration,2116.0,4,,,,,10141.0,1,,104841,B,Cavia porcellus,,CHEMBL619779,9117,Ileum
,H,BAO_0000224,,"Ability to displace [3H]5-HT binding to 5-hydroxytryptamine receptor site using 1 uM LSD as masking ligand, activity is expressed as Kd.",3495,Autocuration,,4,,,,,10141.0,1,,104841,B,Cavia porcellus,,CHEMBL619780,7721,
,H,BAO_0000224,,"Ability to displace [3H]5-HT binding to 5-hydroxytryptamine receptor using 1 uM LSD as masking ligand, activity is expressed as Kd.",3496,Autocuration,,4,,,,,10141.0,1,,104841,B,Cavia porcellus,,CHEMBL619166,7721,
,H,BAO_0000019,,5-HT level in K+ induced 5-hydroxytryptamine release in guinea pig cortex.,3497,Autocuration,,4,,,,,10141.0,1,,104841,F,Cavia porcellus,,CHEMBL619167,15796,
,H,BAO_0000019,,5-hydroxytryptamine level in K+ induced 5-hydroxytryptamine release in guinea pig cortex.,3498,Autocuration,,4,,,,,10141.0,1,,104841,F,Cavia porcellus,,CHEMBL619168,15796,
,D,BAO_0000219,,Concentration required to produce half-maximal response against 5-hydroxytryptamine receptor in the presence of 10 nM compound in isolated human atrial myocytes,3499,Expert,2081.0,9,,,,,9606.0,1,,168,B,Homo sapiens,,CHEMBL619169,15650,Cardiac atrium
,D,BAO_0000219,,Concentration required to produce half-maximal response against 5-hydroxytryptamine receptor on the L-type calcium current (I Ca) in isolated human atrial myocytes,3500,Expert,2081.0,9,,,,,9606.0,1,,168,B,Homo sapiens,,CHEMBL619170,15650,Cardiac atrium
,D,BAO_0000019,,"Maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect of 5-hydroxytryptamine",3501,Autocuration,,5,,,,,9606.0,1,,104841,F,Homo sapiens,,CHEMBL619171,6866,
,D,BAO_0000219,,",Antagonism of stimulation of 5-hydroxytryptamine receptor on the L-type calcium current (I Ca) in isolated human atrial myocytes",3502,Expert,2081.0,9,,,,,9606.0,1,,168,F,Homo sapiens,,CHEMBL619172,15650,Cardiac atrium
,U,BAO_0000019,,Ability (10 ug/kg) to inhibit binding of [125I]iododexetimide to 5-hydroxytryptamine receptor in mice,3503,Autocuration,,0,,,,,10090.0,1,,22226,B,Mus musculus,,CHEMBL619173,10063,
,U,BAO_0000019,,Percent inhibition of radioligand [3H]-LSD binding to 5-HT receptor at 10 uM concentration,3504,Autocuration,,0,,,,,10090.0,1,,22226,B,Mus musculus,,CHEMBL619174,12665,
,H,BAO_0000019,,5-hydroxytryptamine receptor binding affinity was determined in rats,3505,Autocuration,,4,,,,,,1,,104705,B,,,CHEMBL619175,7504,
,H,BAO_0000224,,Binding affinity at rat 5-hydroxytryptamine receptor.,3506,Autocuration,,4,,,,,,1,,104705,B,,,CHEMBL619176,7504,
,H,BAO_0000019,,Affinity against 5-hydroxytryptamine receptors in rat fundus model,3507,Autocuration,,4,,,,,,1,,104705,B,,,CHEMBL619177,7038,
,H,BAO_0000224,,Affinity for 5-hydroxytryptamine receptor was determined using male Dawley rat fundus preparation,3508,Autocuration,,4,,,,,,1,,104705,B,,,CHEMBL619178,7626,
,H,BAO_0000224,,Affinity for 5-hydroxytryptamine receptor was determined using male Dawley rat fundus preparation; Not determined,3509,Autocuration,,4,,,,,,1,,104705,B,,,CHEMBL619179,7626,
,H,BAO_0000019,,Antagonistic activity against serotonin 5-HT receptor obtained from rat stomach fundus preparation,3510,Autocuration,945.0,4,,,,,,1,,104705,F,,,CHEMBL619180,7185,Stomach
,H,BAO_0000019,,Antagonistic activity against serotonin 5-HT receptor obtained from rat stomach fundus preparation (resulted in discoloration in the oxygenated muscle bath to give varying results).,3511,Autocuration,945.0,4,,,,,,1,,104705,F,,,CHEMBL619181,7185,Stomach
,H,BAO_0000019,,Antagonistic activity of corresponding methoxy compound against serotonin 5-HT receptor,3512,Autocuration,,4,,,,,,1,,104705,F,,,CHEMBL619182,7185,
,H,BAO_0000224,,Compound was evaluated for binding affinity towards 5-hydroxytryptamine receptor in isolated rat fundus preparation measured as pA2,3513,Autocuration,,4,,,,,,1,,104705,B,,,CHEMBL619183,6960,
,H,BAO_0000224,,"Compound was evaluated for binding affinity towards 5-hydroxytryptamine receptor in isolated rat fundus preparation measured as pA2; Valid pA2, can not be determined because of slope of Schild plot.",3514,Autocuration,,4,,,,,,1,,104705,B,,,CHEMBL619184,6960,
,H,BAO_0000221,,In vitro affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in hippocampus,3515,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL619185,12416,Hippocampus
,H,BAO_0000357,,Binding affinity for rat 5-hydroxytryptamine transporter.,3516,Expert,,8,,,,,,1,,12198,B,,,CHEMBL619186,15753,
,H,BAO_0000019,,Evaluated for inhibition of specific [3H]5-HT receptor binding in rat cortex.,3517,Autocuration,,4,,,,,,1,,104705,B,,,CHEMBL619187,8062,
,D,BAO_0000019,,Binding affinity at serotonin 5-HT1-type site receptor in rat cortex by displacing [3H]5-HT,3518,Autocuration,,5,,,,,10116.0,1,,104705,B,Rattus norvegicus,,CHEMBL619188,9036,
,D,BAO_0000224,,Compound was tested for its inhibitory activity against 5-hydroxytryptamine receptor,3519,Autocuration,,5,,,,,10116.0,1,,104705,B,Rattus norvegicus,,CHEMBL619189,15067,
,D,BAO_0000019,,Inhibitory activity against [3H]- 5-hydroxytryptamine reuptake in whole rat brain minus cerebellum,3520,Expert,955.0,9,,,,,10116.0,1,,12198,F,Rattus norvegicus,,CHEMBL619190,15753,Brain
,D,BAO_0000221,,Inhibition of [3H]5-HT reuptake in whole rat brain (minus cerebellum) homogenate.,3521,Expert,2037.0,9,,,,,10116.0,1,,12198,F,Rattus norvegicus,,CHEMBL619191,15753,Cerebellum
,D,BAO_0000019,,Displacement of [3H]-citalopram from rat forebrain membrane 5-hydroxytryptamine receptor at 10e-7 M,3522,Autocuration,,5,,,,,10116.0,1,,104705,B,Rattus norvegicus,,CHEMBL619192,15295,
,D,BAO_0000224,,Percent binding affinity against 5-hydroxytryptamine receptor,3523,Autocuration,,5,,,,,10116.0,1,,104705,B,Rattus norvegicus,,CHEMBL619193,6347,
,U,BAO_0000019,,Ability to displace 0.4 nM [3H]paroxetine binding to 5-hydroxytryptamine receptor in rat frontal cortex,3524,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL619194,6763,
,D,BAO_0000224,,The binding affinity was measured on 5-hydroxytryptamine receptor uptake receptor using [3H]- paroxetine as radioligand.,3525,Autocuration,,5,,,,,10116.0,1,,104705,B,Rattus norvegicus,,CHEMBL619195,12092,
,D,BAO_0000224,,Affinity against 5-hydroxytryptamine receptor was determined,3526,Autocuration,,5,,,,,10116.0,1,,104705,B,Rattus norvegicus,,CHEMBL619196,1579,
,D,BAO_0000019,,Affinity against 5-hydroxytryptamine receptor was determined in rat stomach fundus strip,3527,Autocuration,945.0,5,,,,,10116.0,1,,104705,B,Rattus norvegicus,,CHEMBL619197,1579,Stomach
,D,BAO_0000219,,Inhibition of [3H]5-HT uptake in HEK cells expressing human SERT,3528,Expert,,9,,In vitro,,,9606.0,1,,121,B,Homo sapiens,,CHEMBL619198,5963,
,D,BAO_0000219,,Inhibition of [3H]5-HT uptake in HEK cells expressing human SERT,3529,Expert,,9,,In vitro,,,9606.0,1,,121,B,Homo sapiens,,CHEMBL875081,5963,
,H,BAO_0000357,,Ability to compete with radioactive ligands specific to the Serotonergic 5-HT receptor at 10 uM; NA means compound failed to compete,3530,Autocuration,,8,,,,,,1,,18065,B,,,CHEMBL884712,5030,
,H,BAO_0000357,,Inhibition of 5-hydroxytryptamine reuptake,3531,Expert,,8,,,,,,1,,121,B,,,CHEMBL884710,15796,
,H,BAO_0000019,,"Receptor-linked G protein activation at 5-hydroxytryptamine receptor was determined by measuring the stimulation of [35S]GTP-gamma-S, binding",3532,Autocuration,,8,,,,,,1,,18065,F,,,CHEMBL619199,15413,
,H,BAO_0000019,,"Receptor-linked G protein activation at 5-hydroxytryptamine receptor was determined by measuring the stimulation of [35S]GTP-gamma-S, binding (Experiment 1)",3533,Autocuration,,8,,,,,,1,,18065,F,,,CHEMBL619200,15413,
,H,BAO_0000019,,"Receptor-linked G protein activation at 5-hydroxytryptamine receptor was determined by measuring the stimulation of [35S]GTP-gamma-S, binding (Experiment 2)",3534,Autocuration,,8,,,,,,1,,18065,F,,,CHEMBL619201,15413,
,H,BAO_0000019,,Tested for 5-hydroxytryptamine receptor uptake,3535,Autocuration,,8,,,,,,1,,18065,F,,,CHEMBL619202,12409,
,D,BAO_0000219,,Affinity constant on CHO cells expressing Human recombinant 5-hydroxytryptamine receptor 1A,3536,Expert,,9,,,449.0,,9606.0,1,CHO,51,B,Homo sapiens,,CHEMBL619203,16909,
,D,BAO_0000019,,Antagonistic affinity tested against isolated human cloned alpha-1d adrenoceptor subtype,3537,Expert,,9,,,,,9606.0,1,,51,F,Homo sapiens,,CHEMBL619204,16909,
,H,BAO_0000249,,In vitro binding affinity towards 5-hydroxytryptamine receptor 1A receptor by using [3H]8-OH-DPAT in rat hippocampal membranes.,3538,Autocuration,,8,,,,,9606.0,1,,10576,B,Homo sapiens,,CHEMBL619205,15629,
,H,BAO_0000357,,Tested in vitro for % inhibition against 5-hydroxytryptamine receptor 1A,3539,Autocuration,,8,,,,,,1,,10576,B,,,CHEMBL619206,15629,
,H,BAO_0000249,,In vitro binding affinity at 5-hydroxytryptamine receptor 1A receptor in rat hippocampal membranes by [3H]8-OH-DPAT displacement.,3540,Expert,,8,,,,,,1,,10576,B,,,CHEMBL619207,15629,
,H,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats corpus striatum at a dosage of 0.10 umol/kg,3541,Autocuration,2435.0,8,,,,,,1,,10825,F,,,CHEMBL619208,10034,Striatum
,H,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats corpus striatum at a dosage of 10 umol/kg,3542,Autocuration,2435.0,8,,,,,,1,,10825,F,,,CHEMBL619209,10034,Striatum
,H,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats in corpus striatum at a dosage of 0.32 umol/kg,3543,Autocuration,2435.0,8,,,,,,1,,10825,F,,,CHEMBL619210,10034,Striatum
,H,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats in corpus striatum at a dosage of 3.2 umol/kg,3544,Autocuration,2435.0,8,,,,,,1,,10825,F,,,CHEMBL619211,10034,Striatum
,H,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats in corpus striatum at a dosage of 32 umol/kg,3545,Autocuration,2435.0,8,,,,,,1,,10825,F,,,CHEMBL619212,10034,Striatum
,H,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 0.032 umol/kg,3546,Autocuration,2435.0,8,,,,,,1,,10825,F,,,CHEMBL620681,10034,Striatum
,H,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 1.0 umol/kg,3547,Autocuration,2435.0,8,,,,,,1,,10825,F,,,CHEMBL620682,10034,Striatum
,H,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 10 umol/kg,3548,Autocuration,2435.0,8,,,,,,1,,10825,F,,,CHEMBL620683,10034,Striatum
,H,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 100 umol/kg,3549,Autocuration,2435.0,8,,,,,,1,,10825,F,,,CHEMBL620684,10034,Striatum
,H,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 3.2 umol/kg,3550,Autocuration,2435.0,8,,,,,,1,,10825,F,,,CHEMBL620685,10034,Striatum
,H,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 32 umol/kg,3551,Autocuration,2435.0,8,,,,,,1,,10825,F,,,CHEMBL620686,10034,Striatum
,H,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.032 umol/kg,3552,Autocuration,349.0,8,,,,,,1,,10825,F,,,CHEMBL620687,10034,Limbic system
,H,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.10 umol/kg,3553,Autocuration,349.0,8,,,,,,1,,10825,F,,,CHEMBL620688,10034,Limbic system
,H,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.32 umol/kg,3554,Autocuration,349.0,8,,,,,,1,,10825,F,,,CHEMBL620689,10034,Limbic system
,H,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 1.0 umol/kg,3555,Autocuration,349.0,8,,,,,,1,,10825,F,,,CHEMBL620690,10034,Limbic system
,H,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 10 umol/kg,3556,Autocuration,349.0,8,,,,,,1,,10825,F,,,CHEMBL620691,10034,Limbic system
,H,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 100 umol/kg,3557,Autocuration,349.0,8,,,,,,1,,10825,F,,,CHEMBL620692,10034,Limbic system
,H,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 3.2 umol/kg,3558,Autocuration,349.0,8,,,,,,1,,10825,F,,,CHEMBL620693,10034,Limbic system
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 4 receptor,3559,Expert,,8,,,,,,1,,168,B,,,CHEMBL620694,1274,
,H,BAO_0000019,,Tested for 5-hydroxytryptamine 4 receptor antagonist activity,3560,Autocuration,,8,,,,,,1,,168,F,,,CHEMBL857986,17358,
,H,BAO_0000357,,Inhibitory activity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand at 10e-5 M concentration,3561,Autocuration,,8,,,,,,1,,168,B,,,CHEMBL620695,14532,
,H,BAO_0000357,,Binding affinity towards Serotonin 5-hydroxytryptamine 4 receptor,3562,Expert,,8,,,,,,1,,168,B,,,CHEMBL620696,16989,
,H,BAO_0000357,,Inhibitory constant against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 radioligand,3563,Autocuration,,8,,,,,,1,,168,B,,,CHEMBL620697,17200,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 4 receptor,3564,Autocuration,,8,,,,,,1,,168,B,,,CHEMBL620698,15779,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 4 receptor; ND means no data.,3565,Autocuration,,8,,,,,,1,,168,B,,,CHEMBL620699,15779,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 4 receptor; ND means no data.,3566,Autocuration,,8,,,,,,1,,168,B,,,CHEMBL620700,15779,
,H,BAO_0000219,,Binding affinity was determined against cloned 5-hydroxytryptamine 4A receptor isoform expressed in COS-7 cells,3567,Autocuration,,8,,,643.0,,,1,COS-7,168,B,,,CHEMBL620701,15650,
,H,BAO_0000219,,Binding affinity was determined against cloned 5-hydroxytryptamine 4B receptor isoform expressed in COS-7 cells,3568,Autocuration,,8,,,643.0,,,1,COS-7,168,B,,,CHEMBL875082,15650,
,H,BAO_0000219,,Binding affinity was determined against cloned 5-hydroxytryptamine 4C receptor isoform expressed in COS-7 cells,3569,Autocuration,,8,,,643.0,,,1,COS-7,168,B,,,CHEMBL620702,15650,
,H,BAO_0000219,,Binding affinity was determined against cloned 5-hydroxytryptamine 4D receptor isoform expressed in COS-7 cells,3570,Autocuration,,8,,,643.0,,,1,COS-7,168,B,,,CHEMBL620703,15650,
,H,BAO_0000219,,Binding affinity of compound towards cloned human 5-hydroxytryptamine 4E receptor expressed in C6 glial cells using [3H]GR-113808 as radioligand,3571,Autocuration,,8,,,673.0,,,1,C6,168,B,,,CHEMBL620704,17046,
,H,BAO_0000219,,Binding affinity towards cloned human 5-hydroxytryptamine 4E receptor expressed in C6 glial cells using [3H]GR-113808 as radioligand,3572,Expert,,8,,,673.0,,,1,C6,168,B,,,CHEMBL620705,17046,
,H,BAO_0000219,,Binding affinity was determined against cloned 5-hydroxytryptamine 4E receptor isoform expressed in C6 glial cells incubated with 0.2 nM [3H]GR-113808,3573,Expert,,8,,,673.0,,,1,C6,168,B,,,CHEMBL620706,15650,
,H,BAO_0000219,,Binding affinity towards cloned human 5-hydroxytryptamine 4E receptor expressed in C6 glial cells using [3H]GR-113808 as radioligand; Not determined,3574,Expert,,8,,,673.0,,,1,C6,168,B,,,CHEMBL620707,17046,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 5 receptor,3575,Expert,,8,,,,,,1,,10624,B,,,CHEMBL620708,17066,
,H,BAO_0000357,,Inhibitory constant against human 5-hydroxytryptamine 5A receptor using [3H]LSD radioligand,3576,Autocuration,,8,,,,,,1,,105,B,,,CHEMBL620709,17200,
,D,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 5A receptor,3577,Expert,,9,,,,,9606.0,1,,10624,B,Homo sapiens,,CHEMBL620710,16146,
,H,BAO_0000219,,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 5A receptor stably expressed in CHO cells,3578,Autocuration,,8,,,449.0,,,1,CHO,10624,B,,,CHEMBL620711,15250,
,D,BAO_0000357,,Affinity towards human 5-hydroxytryptamine 5A serotonin receptor,3579,Expert,,9,,,,,9606.0,1,,10624,B,Homo sapiens,,CHEMBL620712,6491,
,D,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 5A receptor,3580,Expert,,9,,,,,9606.0,1,,10624,B,Homo sapiens,,CHEMBL620713,17066,
,D,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 5A receptor was evaluated using [3H]-5-CT as radioligand,3581,Expert,,9,,,,,9606.0,1,,10624,B,Homo sapiens,,CHEMBL620714,17066,
,D,BAO_0000357,,Binding affinity to cloned human 5-hydroxytryptamine 5A receptor,3582,Expert,,9,,,,,9606.0,1,,10624,B,Homo sapiens,,CHEMBL620715,4234,
,H,BAO_0000357,,Binding affinity towards 5-HT5A receptor,3583,Autocuration,,8,,,,,,1,,10624,B,,,CHEMBL620716,6013,
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 5A receptor using LSD as radioligand,3584,Expert,,8,,,,,,1,,10624,B,,,CHEMBL620717,17175,
,H,BAO_0000357,,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 5A receptor,3585,Autocuration,,8,,,,,,1,,10624,B,,,CHEMBL618072,15818,
,H,BAO_0000357,,Binding affinity towards cloned human 5-HT5A receptor was determined,3586,Autocuration,,8,,,,,,1,,10624,B,,,CHEMBL857987,6166,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 5A receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,3587,Autocuration,,8,,,722.0,,,1,HEK293,10624,B,,,CHEMBL618073,15779,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 5A receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand;ND means no data.,3588,Autocuration,,8,,,722.0,,,1,HEK293,10624,B,,,CHEMBL618074,15779,
,H,BAO_0000219,,Compound was tested for its binding affinity in 5-hydroxytryptamine 5A receptor (using human cloned receptors in HEK 293 and [3H]5-CTas a radioligand ),3589,Autocuration,,8,,,722.0,,,1,HEK293,10624,B,,,CHEMBL618075,5213,
,D,BAO_0000357,,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor,3590,Expert,,9,,,,,10090.0,1,,10625,B,Mus musculus,,CHEMBL618076,17066,
,D,BAO_0000357,,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor was evaluated using [125I]-2-iodo LSD as radioligand,3591,Expert,,9,,,,,10090.0,1,,10625,B,Mus musculus,,CHEMBL618077,17066,
,D,BAO_0000357,,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor was evaluated using [3H]- LSD as radioligand,3592,Expert,,9,,,,,10090.0,1,,10625,B,Mus musculus,,CHEMBL618078,17066,
,D,BAO_0000357,,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor was evaluated using [3H]LSD as radioligand,3593,Expert,,9,,,,,10090.0,1,,10625,B,Mus musculus,,CHEMBL881821,17066,
,D,BAO_0000357,,Binding affinity towards murine 5-hydroxytryptamine 5A receptor,3594,Expert,,9,,,,,10090.0,1,,10625,B,Mus musculus,,CHEMBL618079,17066,
,H,BAO_0000357,,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor using LSD as radioligand,3595,Expert,,8,,,,,,1,,10625,B,,,CHEMBL618080,17175,
,H,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 5A receptor in HEK 293 cells was determined using [3H]LSD as radioligand,3596,Autocuration,,8,,,722.0,,,1,HEK293,10576,B,,,CHEMBL618081,16190,
,H,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 5A receptor in HEK 293 cells was determined using [3H]LSD as radioligand,3597,Autocuration,,8,,,722.0,,,1,HEK293,10626,B,,,CHEMBL618082,16190,
,H,BAO_0000357,,Binding affinity towards 5-HT5a receptor,3598,Expert,,8,,,,,,1,,10624,B,,,CHEMBL618083,4820,
,D,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 5A receptor,3599,Expert,,9,,,,,9606.0,1,,10624,B,Homo sapiens,,CHEMBL618084,17066,
,H,BAO_0000357,,Binding affinity for rodent 5-hydroxytryptamine 5A receptor,3600,Expert,,8,,,,,,1,,10624,B,,,CHEMBL618085,17066,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 5A receptor using lysergic acid diethylamide (LSD) as radioligand,3601,Expert,,8,,,,,,1,,10624,B,,,CHEMBL618086,17175,
,H,BAO_0000357,,Binding affinities against 5-hydroxytryptamine 5A receptor,3602,Autocuration,,8,,,,,,1,,10624,B,,,CHEMBL875092,16633,
,H,BAO_0000357,,Binding affinities towards 5-hydroxytryptamine 5A receptor,3603,Autocuration,,8,,,,,,1,,10624,B,,,CHEMBL618087,16633,
,H,BAO_0000357,,The binding affinity towards 5-hydroxytryptamine 5A receptor; No affinity,3604,Autocuration,,8,,,,,,1,,10624,B,,,CHEMBL872926,16700,
,H,BAO_0000019,,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 0.01 uM,3605,Autocuration,,4,,,,,10141.0,1,,104714,F,Cavia porcellus,,CHEMBL618088,4639,
,H,BAO_0000223,,Binding affinity towards 5-HT3 receptor by the displacement of [3H]GR-65630] in human recombinant receptors in mammalian cell,3606,Autocuration,,4,,,,,,1,,104714,B,,,CHEMBL618089,5486,
,D,BAO_0000357,,Inhibition of human 5-hydroxytryptamine 6 receptor,3607,Expert,,9,,,,,9606.0,1,,10627,B,Homo sapiens,,CHEMBL618090,16146,
,D,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 6 receptor using [3H]- LSD as radioligand,3608,Expert,,9,,,,,9606.0,1,,10627,B,Homo sapiens,,CHEMBL618091,17273,
,H,BAO_0000357,,Inhibition against human 5-hydroxytryptamine 6 receptor,3609,Autocuration,,8,,,,,,1,,10627,B,,,CHEMBL618092,17687,
,D,BAO_0000357,,Affinity towards human 5-hydroxytryptamine 6 serotonin receptor,3610,Expert,,9,,,,,9606.0,1,,10627,B,Homo sapiens,,CHEMBL618093,6491,
,H,BAO_0000219,,Binding affinity as displacement of [3H]5-HT binding to 5-hydroxytryptamine 6 receptor in HeLa cells.,3611,Expert,,8,,,308.0,,,1,HeLa,10627,B,,,CHEMBL618094,16190,
,D,BAO_0000357,,Binding affinity towards [3H]LSD-labeled human 5-hydroxytryptamine 6 receptor,3612,Expert,,9,,,,,9606.0,1,,10627,B,Homo sapiens,,CHEMBL618095,17066,
,D,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 6 receptor,3613,Expert,,9,,,,,9606.0,1,,10627,B,Homo sapiens,,CHEMBL875093,17066,
,D,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 6 receptor was evaluated using [125I]-2-iodo LSD as radioligand,3614,Expert,,9,,,,,9606.0,1,,10627,B,Homo sapiens,,CHEMBL618096,17066,
,D,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 6 receptor was evaluated using [3H]-LSD as radioligand,3615,Expert,,9,,,,,9606.0,1,,10627,B,Homo sapiens,,CHEMBL618118,17066,
,D,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 6 receptor,3616,Expert,,9,,,,,9606.0,1,,10627,B,Homo sapiens,,CHEMBL618119,3555,
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 6 receptor,3617,Expert,,8,,,,,,1,,10627,B,,,CHEMBL618120,5808,
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 6 receptor,3618,Autocuration,,8,,,,,,1,,10627,B,,,CHEMBL618121,6013,
,H,BAO_0000219,,"Binding affinity for human 5-hydroxytryptamine 6 receptor expressed in HEK 293 human embryonic kidney cells, [3H]-lysergic acid diethylamide as radioligand",3619,Expert,,8,,,722.0,,,1,HEK293,10627,B,,,CHEMBL618122,15818,
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 6 receptor using [3H]LSD as radioligand,3620,Autocuration,,8,,,,,,1,,10627,B,,,CHEMBL618123,16209,
,H,BAO_0000219,,Binding affinity against human 5-hydroxytryptamine 6 receptor stably transfected to HEK 293 human embryonic kidney cells using [3H]-lysergic acid diethylamide as radioligand,3621,Expert,,8,,,722.0,,,1,HEK293,10627,B,,,CHEMBL618124,3935,
,H,BAO_0000357,,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 6 receptor,3622,Autocuration,,8,,,,,,1,,10627,B,,,CHEMBL618125,15818,
,D,BAO_0000219,,Displacement of [3H]LSD from human 5-hydroxytryptamine 6 receptor expressed in HEK 293 cells,3623,Expert,,9,,,722.0,,9606.0,1,HEK293,10627,B,Homo sapiens,,CHEMBL618126,3805,
,H,BAO_0000019,,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 6 receptor incubated with 1 nM [3H]LSD,3624,Expert,,8,,,,,,1,,10627,B,,,CHEMBL618236,16441,
,H,BAO_0000019,,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 6 receptor incubated with 1 nM [3H]LSD; ND is No Data.,3625,Expert,,8,,,,,,1,,10627,B,,,CHEMBL618237,16441,
,H,BAO_0000219,,Ability to displace [3H]LSD from human 5-hydroxytryptamine 6 receptor transiently expressed in COS-7 cells,3626,Expert,,8,,,643.0,,,1,COS-7,10627,B,,,CHEMBL618238,6786,
,D,BAO_0000357,,In vitro binding affinity to human 5-hydroxytryptamine 6 receptor,3627,Expert,,9,,,,,9606.0,1,,10627,B,Homo sapiens,,CHEMBL618239,4234,
,H,BAO_0000019,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 6 receptor,3628,Autocuration,,8,,,,,,1,,10627,B,,,CHEMBL618240,17085,
,H,BAO_0000357,,Inhibitory constant against human 5-hydroxytryptamine 6 receptor using [3H]LSD radioligand,3629,Autocuration,,8,,,,,,1,,10627,B,,,CHEMBL618241,17200,
,H,BAO_0000219,,Antagonism assessed in a functional cAMP binding assay using 5-CT to stimulate human 5-hydroxytryptamine 6 receptor expressed in HEK 293 cells,3630,Autocuration,,8,,,722.0,,,1,HEK293,10627,B,,,CHEMBL859399,17451,
,H,BAO_0000019,,The compound was tested for antagonist activity by inhibition of human 5-HT6 stimulated adenylate cyclase,3631,Autocuration,,8,,,,,,1,,10627,F,,,CHEMBL618242,3935,
,H,BAO_0000357,,Ability to displace the radioligand [3H]LSD from human 5-hydroxytryptamine 6 receptor,3632,Autocuration,,8,,,,,,1,,10627,B,,,CHEMBL857991,5033,
,H,BAO_0000357,,Binding affinity against human 5-hydroxytryptamine 6 receptor,3633,Expert,,8,,,,,,1,,10627,B,,,CHEMBL619951,4540,
,D,BAO_0000219,,Binding affinity to human cloned 5-HT6 receptor in HeLa cells using [3H]- LSD as radioligand,3634,Expert,,9,,,308.0,,9606.0,1,HeLa,10627,B,Homo sapiens,,CHEMBL619952,4540,
,D,BAO_0000219,,Binding affinity to human cloned 5-hydroxytryptamine 6 receptor in HeLa cells using [3H]- LSD as radioligand,3635,Expert,,9,,,308.0,,9606.0,1,HeLa,10627,B,Homo sapiens,,CHEMBL619953,4540,
,H,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells,3636,Autocuration,,8,,,308.0,,,1,HeLa,10627,B,,,CHEMBL619954,17296,
,H,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells using [3H]LSD as radioligand,3637,Autocuration,,8,,,308.0,,,1,HeLa,10627,B,,,CHEMBL619955,17296,
,H,BAO_0000219,,Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells using [3H]LSD as radioligand,3638,Autocuration,,8,,,308.0,,,1,HeLa,10627,B,,,CHEMBL619956,17296,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand,3639,Autocuration,,8,,,449.0,,,1,CHO,10627,B,,,CHEMBL619957,15779,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,3640,Autocuration,,8,,,722.0,,,1,HEK293,10627,B,,,CHEMBL619958,15779,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand; ND means no data.,3641,Autocuration,,8,,,722.0,,,1,HEK293,10627,B,,,CHEMBL620627,15779,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand;ND means no data.,3642,Autocuration,,8,,,722.0,,,1,HEK293,10627,B,,,CHEMBL620628,15779,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HeLa cells using [3H]LSD as radioligand;ND means no data.,3643,Autocuration,,8,,,308.0,,,1,HeLa,10627,B,,,CHEMBL620629,15779,
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 6 receptor,3644,Autocuration,,8,,,,,,1,,10627,B,,,CHEMBL620630,6166,
,H,BAO_0000219,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 6 receptor expressed in HeLa cells using [3H]LSD as radioligand,3645,Autocuration,,8,,,308.0,,,1,HeLa,10627,B,,,CHEMBL620782,17451,
,H,BAO_0000357,,Compound was evaluated for its ability to displace [3H]LSD binding from human recombinant 5-hydroxytryptamine 6 receptor,3646,Autocuration,,8,,,,,,1,,10627,B,,,CHEMBL620783,15316,
,H,BAO_0000357,,Binding affinity against human 5-hydroxytryptamine 6 receptor,3647,Expert,,8,,,,,,1,,10627,B,,,CHEMBL620784,4199,
,H,BAO_0000219,,Binding affinity against human cloned 5-hydroxytryptamine 6 receptor in HeLa cells using [3H]LSD,3648,Expert,,8,,,308.0,,,1,HeLa,10627,B,,,CHEMBL620785,15146,
,H,BAO_0000357,,Compound was tested for its binding affinity in 5-hydroxytryptamine 6 receptor (using human cloned receptors in HeLa and [3H]LSD as a radioligand ),3649,Autocuration,,8,,,,,,1,,10627,B,,,CHEMBL857992,5213,
,H,BAO_0000219,,In vitro binding affinity at human recombinant 5-hydroxytryptamine 6 receptor in mammalian cells using 3[H]LSD as the radioligand,3650,Autocuration,,8,,,,,,1,,10627,B,,,CHEMBL620786,16429,
,H,BAO_0000219,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 6 receptor in HeLa cells using [3H]5-LSD.,3651,Autocuration,,8,,,308.0,,,1,HeLa,10627,B,,,CHEMBL620787,14818,
,H,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 6 receptor in HeLa cells, using [3H]5-LSD as radioligand; n=3",3652,Autocuration,,8,,,308.0,,,1,HeLa,10627,B,,,CHEMBL620788,4829,
,H,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 6 receptor in HeLa cells, using [3H]5-LSD as radioligand; n=9",3653,Autocuration,,8,,,308.0,,,1,HeLa,10627,B,,,CHEMBL620789,4829,
,H,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 6 receptor in HeLa cells, using [3H]LSD as radioligand; n=3",3654,Autocuration,,8,,,308.0,,,1,HeLa,10627,B,,,CHEMBL620790,4829,
,H,BAO_0000219,,Compound was tested for the displacement of [3H]5-HT binding to cloned rat 5-hydroxytryptamine 6 receptor stably expressed in CHO cells,3655,Autocuration,,8,,,449.0,,,1,CHO,10628,B,,,CHEMBL620791,15250,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 6 receptor from CHO cell membranes using [3H]5-HT as the radioligand.,3656,Autocuration,,8,,,,,,1,,10628,B,,,CHEMBL620792,14423,
,H,BAO_0000357,,The compound was tested for binding affinity against 5-hydroxytryptamine 6 receptor,3657,Autocuration,,8,,,,,,1,,10628,B,,,CHEMBL620793,15086,
,H,BAO_0000357,,Binding affinity of compound towards serotonin 5-hydroxytryptamine 6 receptor was determined,3658,Autocuration,,8,,,,,,1,,10628,B,,,CHEMBL620794,4342,
,D,BAO_0000219,,Binding affinity as displacement of [3H]5-HT binding to 5-hydroxytryptamine 6 receptor in HeLa cells,3659,Autocuration,,9,,,308.0,,9606.0,1,HeLa,10627,B,Homo sapiens,,CHEMBL620795,16190,
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 6 receptor,3660,Expert,,8,,,,,,1,,10627,B,,,CHEMBL620796,4820,
,H,BAO_0000357,,Percentage of displacement at 5-hydroxytryptamine 6 receptor at 10e-8 M,3661,Autocuration,,8,,,,,,1,,10627,B,,,CHEMBL620797,4639,
,D,BAO_0000019,,Antagonistic activity towards 5-hydroxytryptamine 6 receptor was evaluated in cAMP assay,3662,Expert,,9,,,,,9606.0,1,,10627,F,Homo sapiens,,CHEMBL620798,17066,
,H,BAO_0000357,,Inhibition of binding towards 5-hydroxytryptamine 6 receptor at 100 nM concentration,3663,Autocuration,,8,,,,,,1,,10627,B,,,CHEMBL620799,6011,
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 6 receptor,3664,Expert,,8,,,,,,1,,10627,B,,,CHEMBL620800,17066,
,H,BAO_0000357,,Binding affinity of compound towards serotonin 5-hydroxytryptamine 6 receptor; inactive at 10 uM,3665,Autocuration,,8,,,,,,1,,10627,B,,,CHEMBL620801,17515,
,H,BAO_0000357,,Compound was tested for its binding affinity towards 5-hydroxytryptamine 6 receptor,3666,Autocuration,,8,,,,,,1,,10627,B,,,CHEMBL875100,5014,
,H,BAO_0000357,,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 6 receptor was determined,3667,Autocuration,,8,,,,,,1,,10627,B,,,CHEMBL620802,4373,
,H,BAO_0000019,,Antagonistic activity towards 5-hydroxytryptamine 6 receptor,3668,Expert,,8,,,,,,1,,10627,F,,,CHEMBL620803,17066,
,H,BAO_0000019,,Antagonistic activity towards 5-hydroxytryptamine 6 receptor was evaluated in cAMP assay,3669,Expert,,8,,,,,,1,,10627,F,,,CHEMBL620804,17066,
,H,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 6 receptor was determined,3670,Autocuration,,8,,,,,,1,,10627,B,,,CHEMBL620805,4373,
,H,BAO_0000357,,Evaluated for the binding affinity towards 5-hydroxytryptamine 6 receptor,3671,Autocuration,,8,,,,,,1,,10627,B,,,CHEMBL620806,4687,
,H,BAO_0000357,,Ability to displace [125I]LSD 113808 from 5-hydroxytryptamine 6 receptor at concentration of 10e-6 M,3672,Autocuration,,8,,,,,,1,,10627,B,,,CHEMBL620807,16946,
,H,BAO_0000357,,Ability to displace [125I]LSD 113808 from 5-hydroxytryptamine 6 receptor at concentration of 10e-8 M,3673,Autocuration,,8,,,,,,1,,10627,B,,,CHEMBL620808,16946,
,H,BAO_0000357,,Binding affinities against 5-hydroxytryptamine 6 receptor,3674,Autocuration,,8,,,,,,1,,10627,B,,,CHEMBL620809,16633,
,H,BAO_0000357,,Binding affinities towards 5-hydroxytryptamine 6 receptor,3675,Autocuration,,8,,,,,,1,,10627,B,,,CHEMBL620810,16633,
,D,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 6 receptor,3676,Expert,,9,,,,,9606.0,1,,10627,B,Homo sapiens,,CHEMBL620811,17066,
,H,BAO_0000357,,The binding affinity towards 5-hydroxytryptamine 6 receptor; No affinity,3677,Autocuration,,8,,,,,,1,,10627,B,,,CHEMBL620812,16700,
,H,BAO_0000357,,Affinity against 5-hydroxytryptamine 6 receptor,3678,Autocuration,,8,,,,,,1,,10627,B,,,CHEMBL620813,3269,
,H,BAO_0000357,,Binding affinity towards human recombinant 5-hydroxytryptamine 7 receptor by the displacement of [3H]-5-CT],3679,Autocuration,,8,,,,,,1,,10627,B,,,CHEMBL620814,5486,
,D,BAO_0000357,,Inhibition of human 5-hydroxytryptamine 7 receptor,3680,Expert,,9,,,,,9606.0,1,,10209,B,Homo sapiens,,CHEMBL620815,16146,
,H,BAO_0000219,,Compound was tested for its binding affinity towards human 5-hydroxytryptamine 7 receptor from HEK293 cells using radioligand [3H]LSD,3681,Autocuration,,8,,,722.0,,,1,HEK293,10209,B,,,CHEMBL620816,5014,
,H,BAO_0000357,,Compound at 1 uM was tested for the inhibition of radioligand [3H]LSD binding to recombinant human 5-hydroxytryptamine 7 receptor,3682,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL620817,15463,
,H,BAO_0000357,,In vitro binding affinity against human 5-hydroxytryptamine 7 receptor at a concentration of 100 (nM),3683,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL620818,3805,
,H,BAO_0000219,,Inhibition (at 1 uM) of radioligand [3H]LSD binding to human 5-hydroxytryptamine 7 receptor on HEK293 cells,3684,Expert,,8,,,722.0,,,1,HEK293,10209,B,,,CHEMBL620819,5014,
,D,BAO_0000357,,Affinity towards human 5-hydroxytryptamine 7 serotonin receptor,3685,Expert,,9,,,,,9606.0,1,,10209,B,Homo sapiens,,CHEMBL620820,6491,
,H,BAO_0000219,,Binding affinity for 5-hydroxytryptamine 7 receptor human cloned receptors in CHO cells using [3H]5-HT,3686,Autocuration,,8,,,449.0,,,1,CHO,10209,B,,,CHEMBL620821,16190,
,D,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 7 receptor,3687,Expert,,9,,,,,9606.0,1,,10209,B,Homo sapiens,,CHEMBL620822,17066,
,D,BAO_0000357,,Displacement of [3H]5-HT from human 5-hydroxytryptamine 7 receptor,3688,Expert,,9,,,,,9606.0,1,,10209,B,Homo sapiens,,CHEMBL620823,17066,
,D,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 7 receptor,3689,Expert,,9,,,,,9606.0,1,,10209,B,Homo sapiens,,CHEMBL620824,3555,
,H,BAO_0000219,,Binding affinity towards human 5-hydroxytryptamine 7 receptor by the displacement of [3H]-5-HT radioligand from the cloned receptor expressed in CHO cells,3690,Expert,,8,,,449.0,,,1,CHO,10209,B,,,CHEMBL620825,6588,
,H,BAO_0000357,,Binding affinity towards recombinant human 5-hydroxytryptamine 7 receptor was determined using [3H]LSD as radioligand,3691,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL872930,15463,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 7 receptor,3692,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL620826,6013,
,H,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 7 receptor using [3H]5-HT as radioligand,3693,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL620827,16209,
,H,BAO_0000357,,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 7 receptor,3694,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL620828,3935,
,H,BAO_0000357,,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 7 receptor,3695,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL620829,15818,
,H,BAO_0000219,,Binding affinity towards human 5-hydroxytryptamine 7 receptor on HEK293 cells using radioligand [3H]LSD,3696,Expert,,8,,,722.0,,,1,HEK293,10209,B,,,CHEMBL620830,5014,
,H,BAO_0000019,,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 7 receptor incubated with 1 nM [3H]LSD,3697,Expert,,8,,,,,,1,,10209,B,,,CHEMBL620831,16441,
,H,BAO_0000019,,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 7 receptor incubated with 1 nM [3H]LSD; ND is No Data.,3698,Expert,,8,,,,,,1,,10209,B,,,CHEMBL620832,16441,
,D,BAO_0000357,,In vitro binding affinity to human 5-hydroxytryptamine 7 receptor,3699,Expert,,9,,,,,9606.0,1,,10209,B,Homo sapiens,,CHEMBL621548,4234,
,H,BAO_0000019,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 7 receptor,3700,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL621549,17085,
,H,BAO_0000357,,Inhibitory constant against human 5-hydroxytryptamine 7 receptor using [3H]LSD radioligand,3701,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL621550,17200,
,H,BAO_0000219,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 7 receptor expressed in CHO cells using [3H]-LSD as radioligand; Not determined,3702,Autocuration,,8,,,449.0,,,1,CHO,10209,B,,,CHEMBL621551,17451,
,H,BAO_0000019,,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 7 receptor; ND means not determined,3703,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL621552,17085,
,H,BAO_0000357,,Binding affinity for human cloned 5-hydroxytryptamine 7 receptor,3704,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL857077,5104,
,H,BAO_0000357,,Binding affinity for human cloned 5-hydroxytryptamine 7 receptor; Not tested,3705,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL618158,5104,
,D,BAO_0000219,,Ability to displace the radioligand [3H]5-carboxyamidotryptamine ([3H]5-CT) from human 5-hydroxytryptamine 7 receptor expressed in COS-7 cells,3706,Expert,,9,,,643.0,,9606.0,1,COS-7,10209,B,Homo sapiens,,CHEMBL618159,5033,
,H,BAO_0000219,,Ability to displace the radioligand [3H]5-carboximidotryptamine ([3H]-5-CT) from cloned human 5-hydroxytryptamine 7 receptor expressed in COS-7 cells,3707,Autocuration,,8,,,643.0,,,1,COS-7,10209,B,,,CHEMBL875101,5486,
,D,BAO_0000219,,Binding affinity to human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]-5-CT as radioligand,3708,Expert,,9,,,722.0,,9606.0,1,HEK293,10209,B,Homo sapiens,,CHEMBL618160,4540,
,H,BAO_0000357,,Binding affinity at human cloned 5-hydroxytryptamine 7 receptor.,3709,Expert,,8,,,,,,1,,10209,B,,,CHEMBL618161,6166,
,H,BAO_0000219,,Binding affinity towards cloned human 5-hydroxytryptamine 7 receptor was determined in HEK293 cells using [3H]5-CT as radioligand,3710,Expert,,8,,,722.0,,,1,HEK293,10209,B,,,CHEMBL618162,17342,
,H,BAO_0000357,,Binding affinity towards human recombinant 5-hydroxytryptamine 7 receptor was determined using [3H]5-CT as radioligand,3711,Expert,,8,,,,,,1,,10209,B,,,CHEMBL618163,17342,
,H,BAO_0000357,,Binding affinity against 5-hydroxytryptamine 7 human receptors,3712,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL618164,17296,
,H,BAO_0000219,,Binding affinity to human recombinant 5-hydroxytryptamine 7 receptor in mammalian cells using [3H]5-CT as radioligand,3713,Expert,,8,,,,,,1,,10209,B,,,CHEMBL618165,16429,
,H,BAO_0000219,,Binding affinity toward 5-hydroxytryptamine 7 receptor (human cloned receptor) in HEK 293 cells using [3H]-5-CT as radioligand.,3714,Autocuration,,8,,,722.0,,,1,HEK293,10209,B,,,CHEMBL618166,15779,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 7 receptor (a) (human cloned receptor) in HEK 293 cells using [3H]5-CT as radioligand.,3715,Autocuration,,8,,,722.0,,,1,HEK293,10209,B,,,CHEMBL857989,15779,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 7 receptor (human cloned receptor) in HEK 293 cells using [3H]5-CT as radioligand.,3716,Autocuration,,8,,,722.0,,,1,HEK293,10209,B,,,CHEMBL619888,15779,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 7 receptor (human cloned receptor) in HEK 293 cells using [3H]5-CT as radioligand.,3717,Autocuration,,8,,,722.0,,,1,HEK293,10209,B,,,CHEMBL619889,15779,
,H,BAO_0000219,,Binding affinity towards 5-hydroxytryptamine 7 receptor 7(a) (human cloned receptor in HEK 293 cells using [3H]5-CT as radioligand.,3718,Autocuration,,8,,,722.0,,,1,HEK293,10209,B,,,CHEMBL619890,15779,
,H,BAO_0000219,,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 7 receptor expressed in CHO cells using [3H]LSD as radioligand,3719,Autocuration,,8,,,449.0,,,1,CHO,10209,B,,,CHEMBL619891,17451,
,H,BAO_0000219,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT as the radioligand (n=3),3720,Autocuration,,8,,,722.0,,,1,HEK293,10209,B,,,CHEMBL619892,4199,
,D,BAO_0000219,,Displacement of [3H]-5-CT from human 5-hydroxytryptamine 7 receptor expressed in HEK-293 cells,3721,Expert,,9,,,722.0,,,1,HEK293,10209,B,,,CHEMBL619893,4199,
,H,BAO_0000219,,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT as the radioligand(n=6),3722,Autocuration,,8,,,722.0,,,1,HEK293,10209,B,,,CHEMBL619894,4199,
,D,BAO_0000219,,Binding affinity towards cloned human 5-hydroxytryptamine 7 receptor in HEK 293 cells,3723,Intermediate,,9,,,722.0,,,1,HEK293,10209,B,,,CHEMBL619895,3680,
,D,BAO_0000357,,Binding affinity towards human recombinant 5-hydroxytryptamine 7 receptor using [3H]5-CT as radioligand,3724,Intermediate,,9,,,,,,1,,10209,B,,,CHEMBL619896,3680,
,H,BAO_0000219,,Compound was evaluated for its ability to displace [3H]5-CT binding from cloned human 5-hydroxytryptamine 7 receptor expressed in COS-7 cells.,3725,Autocuration,,8,,,643.0,,,1,COS-7,10209,B,,,CHEMBL619897,15316,
,H,BAO_0000219,,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT,3726,Autocuration,,8,,,722.0,,,1,HEK293,10209,B,,,CHEMBL619898,15146,
,H,BAO_0000219,,Binding affinity for human cloned 5-hydroxytryptamine 7 receptor in HEK 293 using [3H]5-CT as a radioligand,3727,Expert,,8,,,722.0,,,1,HEK293,10209,B,,,CHEMBL619899,5213,
,H,BAO_0000219,,Compound was tested for its binding affinity in 5-hydroxytryptamine 7 receptor (using human cloned receptors in HEK 293 and [3H]5-CT as a radioligand ),3728,Autocuration,,8,,,722.0,,,1,HEK293,10209,B,,,CHEMBL619900,5213,
,D,BAO_0000219,,Binding affinity towards cloned human 5-hydroxytryptamine 7 receptor expressed in HEK 293 cells using [3H]5-CT,3729,Expert,,9,,,722.0,,9606.0,1,HEK293,10209,B,Homo sapiens,,CHEMBL619901,14818,
,H,BAO_0000219,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 7 receptor expressed in HEK 293 cells using [3H]5-CT. ,3730,Autocuration,,8,,,722.0,,,1,HEK293,10209,B,,,CHEMBL620580,14818,
,H,BAO_0000219,,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT.,3731,Autocuration,,8,,,722.0,,,1,HEK293,10209,B,,,CHEMBL620581,14818,
,H,BAO_0000219,,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 7 receptor in HEK293 cells, using [3H]5-CT as radioligand",3732,Autocuration,,8,,,722.0,,,1,HEK293,10209,B,,,CHEMBL620733,4829,
,D,BAO_0000357,,Inhibitory constant against human 5-hydroxytryptamine 7 receptor using [3H]-LSD radioligand; Not determined,3733,Autocuration,,9,,,,,9606.0,1,,10209,B,Homo sapiens,,CHEMBL620734,17200,
,D,BAO_0000357,,Binding affinity towards mouse 5-hydroxytryptamine 7 receptor was evaluated using [3H]5-HT as radioligand,3734,Expert,,9,,,,,10090.0,1,,10022,B,Mus musculus,,CHEMBL620735,17066,
,H,BAO_0000019,,The dissociation equilibrium constant (pKB=-log KB) of compound was determined against the vascular 5-hydroxytryptamine 7 receptor in the endothelium denuded rabbit jugular vein.,3735,Autocuration,,8,,,,,9986.0,1,,10209,B,Oryctolagus cuniculus,,CHEMBL620736,14025,
,H,BAO_0000219,,Compound was tested for the displacement of [3H]5-HT binding to cloned rat 5-hydroxytryptamine 7 receptor stably expressed in CHO cells,3736,Autocuration,,8,,,449.0,,,1,CHO,11923,B,,,CHEMBL620737,15250,
,H,BAO_0000219,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors at a concentration of 10000 nM,3737,Autocuration,,8,,,449.0,,,1,CHO,11923,B,,,CHEMBL620738,16372,
,H,BAO_0000219,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors at a concentration of 100 nM,3738,Autocuration,,8,,,449.0,,,1,CHO,11923,B,,,CHEMBL620739,16372,
,H,BAO_0000219,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors at a concentration of 1 nM,3739,Autocuration,,8,,,449.0,,,1,CHO,11923,B,,,CHEMBL620740,16372,
,H,BAO_0000219,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors by 10000 nM 5-HT.,3740,Autocuration,,8,,,449.0,,,1,CHO,11923,B,,,CHEMBL620741,16372,
,H,BAO_0000219,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors by 100 nM 5-HT.,3741,Autocuration,,8,,,449.0,,,1,CHO,11923,B,,,CHEMBL620742,16372,
,H,BAO_0000219,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors by 1 nM 5-HT,3742,Autocuration,,8,,,449.0,,,1,CHO,11923,B,,,CHEMBL620743,16372,
,H,BAO_0000219,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 10000 nM,3743,Autocuration,,8,,,449.0,,,1,CHO,11923,B,,,CHEMBL620744,16372,
,H,BAO_0000219,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 100 nM,3744,Autocuration,,8,,,449.0,,,1,CHO,11923,B,,,CHEMBL620745,16372,
,H,BAO_0000219,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 1 nM,3745,Autocuration,,8,,,449.0,,,1,CHO,11923,B,,,CHEMBL620746,16372,
,H,BAO_0000219,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 10000 nM 5-HT.,3746,Autocuration,,8,,,449.0,,,1,CHO,11923,B,,,CHEMBL620747,16372,
,H,BAO_0000219,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 100 nM 5-HT.,3747,Autocuration,,8,,,449.0,,,1,CHO,11923,B,,,CHEMBL620748,16372,
,H,BAO_0000219,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 1 nM 5-HT.,3748,Autocuration,,8,,,449.0,,,1,CHO,11923,B,,,CHEMBL620749,16372,
,H,BAO_0000357,,Binding affinity towards rat 5-hydroxytryptamine 7 receptor,3749,Expert,,8,,,,,,1,,11923,B,,,CHEMBL620750,17066,
,D,BAO_0000357,,Binding affinity towards rat 5-hydroxytryptamine 7 receptor was evaluated using [3H]5-HT as radioligand,3750,Expert,,9,,,,,10116.0,1,,11923,B,Rattus norvegicus,,CHEMBL620751,17066,
,H,BAO_0000357,,Binding affinity to the rat 5-hydroxytryptamine 7 receptor,3751,Expert,,8,,,,,,1,,11923,B,,,CHEMBL620752,17386,
,H,BAO_0000019,,Binding affinity against 5-hydroxytryptamine 7 receptor using from CHO cell membranes [3H]5-HT as the radioligand.,3752,Autocuration,,8,,,,,,1,,11923,B,,,CHEMBL872929,14423,
,D,BAO_0000357,,Binding affinity against Rat 5-hydroxytryptamine 7 receptor using [3H]5-HT,3753,Expert,,9,,,,,10116.0,1,,11923,B,Rattus norvegicus,,CHEMBL620753,15874,
,D,BAO_0000357,,Displacement of [3H]5-HT from over-expressed rat 5-hydroxytryptamine 7 receptor,3754,Expert,,9,,,,,10116.0,1,,11923,B,Rattus norvegicus,,CHEMBL620754,15874,
,D,BAO_0000219,,Displacement of [3H]5-HT from rat 5-hydroxytryptamine 7 receptor expressed in CHO cells,3755,Expert,,9,,,449.0,,10116.0,1,CHO,11923,B,Rattus norvegicus,,CHEMBL620755,16372,
,H,BAO_0000357,,In vitro binding affinity towards cloned rat 5-hydroxytryptamine 7 receptor using [3H]5-HT as radioligand,3756,Autocuration,,8,,,,,,1,,11923,B,,,CHEMBL620756,4622,
,H,BAO_0000357,,The compound was tested for binding affinity against 5-hydroxytryptamine 7 receptor,3757,Autocuration,,8,,,,,,1,,11923,B,,,CHEMBL620757,15086,
,H,BAO_0000219,,"Effect of compound on stimulation of cAMP production in CHO cells expressing rat 5-HT7 receptors at 1, 10, 100 1000 and 10000 nM conc; Not tested",3758,Autocuration,,8,,,449.0,,,1,CHO,11923,B,,,CHEMBL620758,16372,
,H,BAO_0000219,,"Effect of compound on stimulation of cAMP production in CHO cells expressing rat 5-HT7 receptors at 1, 10, 100 1000 and 10000 nM conc; not tested",3759,Autocuration,,8,,,449.0,,,1,CHO,11923,B,,,CHEMBL620759,16372,
,H,BAO_0000219,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 1 nM; not tested,3760,Autocuration,,8,,,449.0,,,1,CHO,11923,B,,,CHEMBL620760,16372,
,H,BAO_0000219,,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 1 nM 5-HT; Not tested,3761,Autocuration,,8,,,449.0,,,1,CHO,11923,B,,,CHEMBL620761,16372,
,H,BAO_0000221,,Maximal relaxation effect induced by 3 uM compound on substance P stimulated guinea pig ileum with 5-hydroxytryptamine 7 receptor desensitization,3762,Autocuration,2116.0,8,,,,,,1,,11923,F,,,CHEMBL620762,17386,Ileum
,H,BAO_0000221,,Maximal relaxation effect induced by 3 uM compound on substance P stimulated guinea pig ileum with 5-hydroxytryptamine 7 receptor nondesensitization,3763,Autocuration,2116.0,8,,,,,,1,,11923,F,,,CHEMBL620763,17386,Ileum
,H,BAO_0000221,,Maximal relaxation effect induced by 3 uM compound on substance P stimulated guinea pig ileum with 5-hydroxytryptamine receptor desensitization,3764,Autocuration,2116.0,8,,,,,,1,,11923,F,,,CHEMBL620764,17386,Ileum
,D,BAO_0000249,,Inhibition of [3H]-5-CT binding to 5-hydroxytryptamine 7 receptor of rat cortical membranes,3765,Expert,,9,Membranes,,,,10116.0,1,,11923,B,Rattus norvegicus,,CHEMBL857990,5831,
,H,BAO_0000357,,Binding affinity of compound towards serotonin 5-hydroxytryptamine 7 receptor was determined,3766,Autocuration,,8,,,,,,1,,11923,B,,,CHEMBL620765,4342,
,H,BAO_0000357,,Binding affinity at rat 5-hydroxytryptamine 7 receptor.,3767,Expert,,8,,,,,,1,,11923,B,,,CHEMBL620766,17319,
,H,BAO_0000019,,Binding affinity towards 5-hydroxytryptamine receptor 7 on rat hypothalamus membranes using [3H]5-CT as radioligand.,3768,Expert,1898.0,8,,,,,,1,,11923,B,,,CHEMBL620767,17342,Hypothalamus
,H,BAO_0000357,,Binding affinity towards cloned rat 5-hydroxytryptamine 7 receptor was determined using [3H]5-HT as radioligand,3769,Autocuration,,8,,,,,,1,,11923,B,,,CHEMBL620768,17342,
,H,BAO_0000249,,Binding affinity against 5-hydroxytryptamine 7 receptor using [3H]-5-CT in rat hypothalamus membranes,3770,Expert,1898.0,8,,,,,,1,,11923,B,,,CHEMBL619051,3680,Hypothalamus
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 7 receptor,3771,Expert,,8,,,,,,1,,11923,B,,,CHEMBL619052,3680,
,D,BAO_0000219,,Agonistic activity against rat 5-HT7 adenyl cyclase expressed by HEK293 cells,3772,Expert,,9,,,722.0,,10116.0,1,HEK293,11923,F,Rattus norvegicus,,CHEMBL619053,17319,
,D,BAO_0000219,,Agonistic activity against rat 5-HT7 adenyl cyclase expressed in HEK293 cells; Active,3773,Expert,,9,,,722.0,,10116.0,1,HEK293,11923,F,Rattus norvegicus,,CHEMBL619703,17319,
,D,BAO_0000219,,Agonistic activity against rat 5-HT7-adenyl cyclase expressed by HEK293 cells; Active,3774,Autocuration,,9,,,722.0,,10116.0,1,HEK293,11923,F,Rattus norvegicus,,CHEMBL619704,17319,
,H,BAO_0000357,,Binding affinity towards 5-hydroxytryptamine 7 receptor,3775,Expert,,8,,,,,,1,,10209,B,,,CHEMBL619851,4820,
,H,BAO_0000357,,Percentage of displacement at 5-hydroxytryptamine 7 receptor at 10e-8 M,3776,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL619852,4639,
,H,BAO_0000357,,Inhibition of binding towards 5-hydroxytryptamine 7 receptor at 100 nM concentration,3777,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL619853,6011,
,D,BAO_0000357,,Binding affinity towards human 5-hydroxytryptamine 7 receptor,3778,Expert,,9,,,,,9606.0,1,,10209,B,Homo sapiens,,CHEMBL619854,17066,
,H,BAO_0000357,,Binding affinity of compound towards rodent 5-hydroxytryptamine 7 receptor,3779,Expert,,8,,,,,,1,,10209,B,,,CHEMBL619855,17066,
,H,BAO_0000357,,Binding affinity of compound towards serotonin 5-hydroxytryptamine 7 receptor; inactive at 10 uM,3780,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL619856,17515,
,H,BAO_0000357,,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 7 receptor was determined,3781,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL619857,4373,
,H,BAO_0000019,,Antagonistic activity towards 5-hydroxytryptamine 7 receptor was evaluated by cAMP assay,3782,Expert,,8,,,,,,1,,10209,F,,,CHEMBL619858,17066,
,H,BAO_0000357,,Binding affinity for 5-hydroxytryptamine 7 receptor was determined,3783,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL619859,4373,
,H,BAO_0000357,,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 7 receptor was determined,3784,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL619860,4373,
,H,BAO_0000357,,Evaluated for the binding affinity to 5-hydroxytryptamine 7 receptor,3785,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL619861,4687,
,H,BAO_0000357,,Non-selective inhibitory activity was determined against 5-hydroxytryptamine 7 receptor,3786,Expert,,8,,,,,,1,,10209,B,,,CHEMBL619862,17342,
,H,BAO_0000357,,Ability to displace [125I]LSD 113808 from 5-hydroxytryptamine 7 receptor at concentration of 10e-6 M,3787,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL619863,16946,
,H,BAO_0000357,,Ability to displace [125I]LSD 113808 from 5-hydroxytryptamine 7 receptor at concentration of 10e-8 M,3788,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL619864,16946,
,H,BAO_0000357,,Binding affinities against 5-hydroxytryptamine 7 receptor,3789,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL872928,16633,
,H,BAO_0000357,,Binding affinities towards 5-hydroxytryptamine 7 receptor,3790,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL619865,16633,
,H,BAO_0000357,,Binding affinity towards rodent 5-hydroxytryptamine 7 receptor,3791,Expert,,8,,,,,,1,,10209,B,,,CHEMBL619866,17066,
,H,BAO_0000357,,The binding affinity towards 5-hydroxytryptamine 7 receptor; No affinity,3792,Autocuration,,8,,,,,,1,,10209,B,,,CHEMBL619867,16700,
,H,BAO_0000221,,Maximal relaxation effect induced by 3 uM compound on substance P stimulated guinea pig ileum with 5-hydroxytryptamine 7 receptor desensitization,3793,Autocuration,2116.0,8,,,,,,1,,10209,B,,,CHEMBL619868,17386,Ileum
,H,BAO_0000019,,Compound was evaluated for the potency to inhibit oxidation of arachidonic acid by human recombinant 5-Lipoxygenase using a spectrophotometric assay,3794,Autocuration,,8,,,,,,1,,55,F,,,CHEMBL619869,14080,
,D,BAO_0000019,,Inhibition of oxidation of arachidonic acid by human 5-Lipoxygenase using spectrophotometric assay,3795,Expert,,9,,,,,9606.0,1,,55,F,Homo sapiens,,CHEMBL619870,14080,
,H,BAO_0000357,,In vitro inhibition of human recombinant 5-lipoxygenase enzyme,3796,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL619871,409,
,H,BAO_0000357,,In vitro inhibition of human recombinant lipoxygenase enzyme,3797,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL619872,409,
,H,BAO_0000357,,In vitro inhibition of human recombinant lipoxygenase enzyme; No inhibition,3798,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL619873,409,
,H,BAO_0000357,,Inhibition of 5-lipoxygenase in human whole blood.,3799,Expert,178.0,8,,,,,,1,,55,B,,,CHEMBL619874,11090,Blood
,H,BAO_0000357,,Inhibition of 5-lipoxygenase in human whole blood.,3800,Expert,178.0,8,,,,,,1,,55,B,,,CHEMBL619875,11090,Blood
,H,BAO_0000357,,Compound was tested for the inhibition of 5-lipoxygenase of human PMN stimulated by calcium ionophore A-23187 for the formation of 5-HETE,3801,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL619876,948,
,H,BAO_0000357,,Compound was tested for the inhibition of 5-lipoxygenase of human PMN stimulated by calcium ionophore A-23187 for the formation of leukotriene B4 (LTB4),3802,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL619877,948,
,H,BAO_0000219,,In vitro 5-lipoxygenase inhibitory activity against calcium ionophore (A23187) induced LTB4 formation in human polymorphonuclear leukocytes.,3803,Expert,,8,,,,,,1,,55,F,,,CHEMBL619878,13622,
,H,BAO_0000019,,In vitro 5-lipoxygenase inhibitory activity against calcium ionophore (A23187) induced LTB4 formation in human whole blood,3804,Autocuration,178.0,8,,,,,,1,,55,F,,,CHEMBL619879,13622,Blood
,H,BAO_0000357,,In vitro inhibition of 5-lipoxygenase from human polymorphs,3805,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL619880,9637,
,H,BAO_0000357,,In vitro inhibition of leukotriene B4 synthesis in human whole blood by inhibiting 5-LPO (5-lipoxygenase),3806,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL619881,11320,
,H,BAO_0000357,,In vitro inhibition of leukotriene B4 synthesis in human whole blood by inhibiting 5-lipoxygenase,3807,Expert,,8,,,,,,1,,55,B,,,CHEMBL619882,11320,
,H,BAO_0000357,,In vitro inhibitory activity against 5-lipoxygenase in a human whole blood assay,3808,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL619883,6838,
,D,BAO_0000357,,Inhibition of 5-Lipoxygenase (5-LO) of human whole blood (HWB),3809,Expert,178.0,9,,,,,9606.0,1,,55,B,Homo sapiens,,CHEMBL619884,17667,Blood
,H,BAO_0000357,,In vitro potency against human 5-Lipoxygenase,3810,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL619885,12703,
,D,BAO_0000019,,Inhibitory activity against 5-lipoxygenase in Human whole blood (HWBL) stimulated with calcium ionophore (A23187) and LTB4 measured by enzyme immunoassay,3811,Expert,,9,,,,,9606.0,1,,55,F,Homo sapiens,,CHEMBL619886,14312,
,H,BAO_0000019,,Inhibition activity against 5-lipoxygenase in Human whole blood (HWBL) stimulated with calcium ionophore (A23187) and LTB4 measured by enzyme immunoassay; No data,3812,Autocuration,178.0,8,,,,,,1,,55,F,,,CHEMBL619887,14312,Blood
,H,BAO_0000019,,Inhibition of 5-lipoxygenase activity of compound evaluated as determined by the inhibition of calcium ionophore-induced leukotriene B4 production in human blood.,3813,Autocuration,,8,,,,,,1,,55,F,,,CHEMBL875097,5364,
,H,BAO_0000219,,Inhibition of 5-lipoxygenase was evaluated in human polymorphonuclear leukocytes stimulated by calcium ionophore A-23187 for formation of 5-HETE,3814,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618001,951,
,H,BAO_0000219,,Inhibition of 5-lipoxygenase was evaluated in human polymorphonuclear leukocytes stimulated by calcium ionophore A-23187 for formation of 5-HETE; NA means Not active,3815,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618002,951,
,H,BAO_0000219,,Inhibition of 5-lipoxygenase was evaluated in human polymorphonuclear leukocytes stimulated by calcium ionophore A-23187 for formation of LTB4,3816,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618003,951,
,H,BAO_0000219,,Inhibition of 5-lipoxygenase was evaluated in human polymorphonuclear leukocytes stimulated by calcium ionophore A-23187 for formation of LTB4; NA means Not active,3817,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618004,951,
,H,BAO_0000219,,Inhibition of human 5-lipoxygenase in human cells,3818,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618005,12365,
,H,BAO_0000357,,Inhibition of human neutrophil 5-lipoxygenase,3819,Expert,,8,,,,,,1,,55,B,,,CHEMBL618006,10603,
,H,BAO_0000019,,Inhibitory activity against 5-lipoxygenase expressed from human polymorphonuclear cells,3820,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL875086,10501,
,H,BAO_0000357,,Inhibition of 5-lipoxygenase from human whole blood,3821,Expert,178.0,8,,,,,,1,,55,B,,,CHEMBL618007,12281,Blood
,H,BAO_0000357,,Inhibitory concentration required against 5-lipoxygenase activity in cytosolic fractions of human neutrophils,3822,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618008,2567,
,H,BAO_0000219,,Inhibitory concentration required against 5-lipoxygenase activity in intact cells of human neutrophils,3823,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618009,2567,
,H,BAO_0000357,,In vitro inhibition of polymorphonuclear leukocyte derived human 5-lipoxygenase,3824,Expert,,8,,,,,,1,,55,B,,,CHEMBL618010,10193,
,H,BAO_0000357,,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in human cell at 10 uM,3825,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618011,10193,
,H,BAO_0000357,,Potency to inhibit oxidation of arachidonic acid by recombinant human 5-lipoxygenase,3826,Expert,,8,,,,,,1,,55,B,,,CHEMBL618012,13623,
,H,BAO_0000357,,Tested against 5-lipoxygenase,3827,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL882927,12780,
,H,BAO_0000357,,Tested for activity against 5-Lipoxygenase (5-LO),3828,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618013,12780,
,H,BAO_0000357,,Tested for activity against 5-lipoxygenase,3829,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618014,12780,
,H,BAO_0000357,,Tested for inhibition of 5-HPETE production by human 5-LO,3830,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618015,11966,
,H,BAO_0000019,,The 5-lipoxygenase activity by the inhibition of calcium ionophore-induced leukotriene B4 production in human blood.,3831,Autocuration,,8,,,,,,1,,55,F,,,CHEMBL618016,5364,
,H,BAO_0000357,,Inhibition of Human 5-lipoxygenase,3832,Expert,,8,,,,,,1,,55,B,,,CHEMBL618017,13165,
,H,BAO_0000019,,The compound was evaluated for its inhibitory activity against 5-lipoxygenase using granulocytes-type cells,3833,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618018,5364,
,H,BAO_0000219,,The compound was tested for inhibitory activity against 5-lipoxygenase in human polymorphonuclear leukocytes[PMNS],3834,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL875087,11311,
,H,BAO_0000219,,The compound was tested for inhibitory activity against LT synthesis in human polymorphonuclear leukocytes[PMNS],3835,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618019,11311,
,H,BAO_0000019,,The compound was tested for the concentration (in uM) to inhibit 50% of 5-Lipoxygenase (5-LOX) and is expressed in IC50.,3836,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618020,14863,
,H,BAO_0000019,,The compound was tested for the concentration (in uM) to inhibit 50% of 5-Lipoxygenase (5-LOX) and is expressed in IC50; Not tested,3837,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618021,14863,
,H,BAO_0000357,,The compound was tested for the inhibition of 5-lipoxygenase (5-lo) in human whole blood (HWBL),3838,Autocuration,178.0,8,,,,,,1,,55,B,,,CHEMBL618022,11087,Blood
,H,BAO_0000357,,The compound was tested in vitro for inhibition against 5-lipoxygenase in intact human neutrophils,3839,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618023,455,
,H,BAO_0000357,,5-lipoxygenase Inhibitory activity was measured by enzyme immunoassay using human whole blood stimulated with calcium ionophore (A23187) and LTB4 (leukotriene B4),3840,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618024,13183,
,H,BAO_0000019,,In vitro inhibitory activity against 5-lipoxygenase in human polymorphonuclear (PMN) cells,3841,Expert,,8,,,,,,1,,55,B,,,CHEMBL873950,10319,
,H,BAO_0000357,,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in human cell at 10 uM,3842,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618025,10193,
,H,BAO_0000219,,Inhibition of 5-lipoxygenase was evaluated in human polymorphonuclear leukocytes stimulated by calcium ionophore A-23187 for formation of 5-HETE at 10 uM,3843,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618026,951,
,H,BAO_0000219,,Inhibition of 5-lipoxygenase was evaluated in human polymorphonuclear leukocytes stimulated by calcium ionophore A-23187 for formation of 5-HETE at 10 uM; NA means Inactive,3844,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618027,951,
,H,BAO_0000219,,Inhibition of 5-lipoxygenase was evaluated in human polymorphonuclear leukocytes stimulated by calcium ionophore A-23187 for formation of LTB4 at 10 uM,3845,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618028,951,
,H,BAO_0000219,,Inhibition of 5-lipoxygenase was evaluated in human polymorphonuclear leukocytes stimulated by calcium ionophore A-23187 for formation of LTB4 at 10 uM; NA means Inactive,3846,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618029,951,
,H,BAO_0000357,,Inhibitory activity against 5-lipoxygenase at 10 uM concentration,3847,Expert,,8,,,,,,1,,55,B,,,CHEMBL618030,9859,
,H,BAO_0000357,,Inhibitory activity against 5-lipoxygenase at 1 uM concentration,3848,Expert,,8,,,,,,1,,55,B,,,CHEMBL618031,9859,
,H,BAO_0000357,,Inhibitory activity against lipoxygenase (LO) at 10 uM concentration,3849,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618032,9859,
,H,BAO_0000357,,Inhibitory concentration required against 5-lipoxygenase activity in cytosolic fractions of human neutrophils,3850,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618033,2567,
,H,BAO_0000357,,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in human cell at 1 uM,3851,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618034,10193,
,H,BAO_0000357,,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in human cell at 10 uM,3852,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL875088,10193,
,H,BAO_0000019,,Tested for the inhibition of 5-lipoxygenase from human polymorphonuclear leukocytes(PMN) at 10 uM concentration of the compound; IA= Inactive,3853,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618035,949,
,H,BAO_0000019,,Tested for the inhibition of 5-lipoxygenase from human polymorphonuclear leukocytes(PMN) at 10 uM concentration of the compound; value ranges from 70-90,3854,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618036,949,
,H,BAO_0000357,,Inhibition of human neutrophil 5-lipoxygenase at the concentration of 0.1 uM,3855,Expert,,8,,,,,,1,,55,B,,,CHEMBL618037,10603,
,H,BAO_0000357,,Inhibition of human neutrophil 5-lipoxygenase at the concentration of 1 uM,3856,Expert,,8,,,,,,1,,55,B,,,CHEMBL618038,10603,
,H,BAO_0000019,,Inhibition of human neutrophil 5-lipoxygenase at the concentration of 1 uM,3857,Autocuration,,8,,,,,,1,,55,F,,,CHEMBL618761,10603,
,H,BAO_0000357,,Inhibition of lipoxygenase at the concentration of 0.1 uM,3858,Expert,,8,,,,,,1,,55,B,,,CHEMBL618762,10603,
,H,BAO_0000357,,Inhibition of lipoxygenase at the concentration of 1 uM,3859,Expert,,8,,,,,,1,,55,B,,,CHEMBL618763,10603,
,H,BAO_0000357,,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in human cell,3860,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618764,10193,
,D,BAO_0000357,,Inhibition of 5-Lipoxygenase (5-LOX),3861,Expert,,9,,,,,9606.0,1,,55,B,Homo sapiens,,CHEMBL618765,14580,
,H,BAO_0000357,,Inhibition of 5-lipoxygenase in mouse macrophages.,3862,Expert,,8,,,,,,1,,17087,B,,,CHEMBL618766,11090,
,H,BAO_0000357,,Inhibition of 5-lipoxygenase in mouse macrophages.,3863,Expert,,8,,,,,,1,,17087,B,,,CHEMBL618767,11090,
,H,BAO_0000357,,Inhibitory activity against lipoxygenase-2 in mice,3864,Autocuration,,8,,,,,,1,,17087,B,,,CHEMBL619380,6339,
,H,BAO_0000357,,Inhibitory activity against murine lipoxygenase-2.,3865,Expert,,8,,,,,,1,,17087,B,,,CHEMBL619381,6339,
,D,BAO_0000357,,Inhibition of 5-lipoxygenase from mouse macrophage,3866,Expert,,9,,,,,10090.0,1,,17087,B,Mus musculus,,CHEMBL619382,12281,
,H,BAO_0000357,,The compound was tested for inhibitory activity against 5-lipoxygenase in mouse macrophages,3867,Autocuration,,8,,,,,,1,,17087,B,,,CHEMBL619383,11311,
,H,BAO_0000019,,The compound was tested for the inhibition of Arachidonate 5-lipoxygenase purified from porcine leukocytes.,3868,Autocuration,,8,,,,,9823.0,1,,55,B,Sus scrofa,,CHEMBL619384,11089,
,H,BAO_0000019,,Inhibition of 5-lipoxygenase reaction catalyzed by purified enzyme from porcine leukocytes,3869,Autocuration,,8,,,,,9823.0,1,,55,B,Sus scrofa,,CHEMBL619385,10091,
,H,BAO_0000019,,Inhibitory concentration against 5-lipoxygenase from isolated rabbit granulocytes,3870,Autocuration,,8,,,,,9986.0,1,,55,B,Oryctolagus cuniculus,,CHEMBL882928,14352,
,D,BAO_0000019,,5-lipoxygenase Inhibitory activity against rat polymorphonuclear leucocytes using 5-HETE,3871,Expert,,9,,,,,10116.0,1,,12166,B,Rattus norvegicus,,CHEMBL619386,13329,
,H,BAO_0000019,,"5-lipoxygenase inhibitory activity against rat polymorphonuclear leucocytes from female wistar rat, by using 5-HETE. ",3872,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619387,13329,
,H,BAO_0000019,,"5-lipoxygenase inhibitory activity against rat polymorphonuclear leucocytes from female wistar rat, by using 5-HETE.",3873,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619388,13329,
,H,BAO_0000019,,"5-lipoxygenase inhibitory activity against rat polymorphonuclear leucocytes from female wistar rat, by using LTB4.",3874,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619389,13329,
,H,BAO_0000019,,Inhibition of 5-lipoxygenase pathway in rat polymorphonuclear assay (inhibition of 5-HETE formation),3875,Expert,,8,,,,,,1,,12166,B,,,CHEMBL619390,13329,
,H,BAO_0000019,,"Inhibition of 5-lipoxygenase pathway in rat polymorphonuclear assay, by ability to inhibit formation of LTB4 AT 10 uM",3876,Expert,,8,,,,,,1,,12166,B,,,CHEMBL619391,13329,
,H,BAO_0000019,,Inhibition of 5-lipoxygenase pathway was evaluated in rat polymorphonuclear assay by compound (50 uM) ability to inhibit formation of 5-HETE,3877,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619392,13329,
,H,BAO_0000019,,The effective dose for inhibition of 5-lipoxygenase in rat blood leukocyte (ex vivo),3878,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619393,11311,
,H,BAO_0000019,,The effective dose for inhibition of 5-lipoxygenase in rat passive Arthus model after oral administration,3879,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619394,11311,
,H,BAO_0000219,,"In vitro inhibition of 5-lipoxygenase HETE (5-hydroperoxyeicosatetraenoic acid) in RBL-1 macrophage, a cell-free enzyme assay",3880,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619395,105,
,H,BAO_0000219,,"In vitro inhibition of 5-lipoxygenase HETE (5-hydroperoxyeicosatetraenoic acid) in RBL-1 macrophage, a cell-free enzyme assay",3881,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619396,105,
,H,BAO_0000357,,Inhibition of rat neutrophil 5- Lipoxygenase (5-LO),3882,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619397,9138,
,H,BAO_0000357,,"Inhibition of rat neutrophil 5- Lipoxygenase (5-LO),",3883,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619398,9138,
,H,BAO_0000357,,"Inhibition of rat neutrophil 5- Lipoxygenase (5-LO), (at a concentration of 0.2 nM ),",3884,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619399,9138,
,H,BAO_0000357,,5-LO inhibitory activity determined by measuring the conversion of [14C]arachidonic acid to leukotrienes in RBL-2H3 cell using thin-layer chromatography; Not determined,3885,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619400,14427,
,H,BAO_0000019,,"5-lipoxygenase inhibitory activity against rat polymorphonuclear leucocytes from female wistar rat, by using 5-HETE.",3886,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619401,13329,
,H,BAO_0000019,,"5-lipoxygenase inhibitory activity against rat polymorphonuclear leucocytes from female wistar rat, by using LTB4. ",3887,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619402,13329,
,D,BAO_0000219,,Inhibition of 5-lipoxygenase mediated conversion of [14C]arachidonic acid to leukotrienes in RBL-2H3 cells,3888,Expert,,9,,,663.0,,10116.0,1,RBL-2H3,12166,B,Rattus norvegicus,,CHEMBL619403,14427,
,H,BAO_0000357,,5-lipoxygenase inhibitory activity determined by measuring the conversion of [14C]arachidonic acid to leukotrienes in RBL-2H3 cell using thin-layer chromatography; Not determined,3889,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619404,14427,
,H,BAO_0000357,,5-lipoxygenase inhibitory activity determined by measuring the conversion of [14C]arachidonic acid to leukotrienes in RBL-2H3 cell using thin-layer chromatography.,3890,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619405,14427,
,H,BAO_0000219,,Ability to inhibit 5-lipoxygenase by using a crude preparation of the cytosolic enzyme from the rat basophilic leukemia (RBL-1) cell line,3891,Expert,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619406,10293,
,D,BAO_0000219,,Inhibition of 5-Lipoxygenase of rat basophilic leukemia cells,3892,Expert,,9,,,702.0,,10116.0,1,RBL-1,12166,B,Rattus norvegicus,,CHEMBL619407,338,
,H,BAO_0000357,,Compound was evaluated for its inhibitory activity against 5-LO (5-lipoxygenase),3893,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619408,303,
,H,BAO_0000219,,Compound was evaluated for its inhibitory activity against 5-LO (5-lipoxygenase) in intact RBL-1 cell line assay,3894,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619409,303,
,H,BAO_0000219,,Inhibition of rat basophilic leukemia-1 (RBL-1) 5-lipoxygenase,3895,Expert,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619410,9247,
,H,BAO_0000219,,Compound was evaluated for the inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 100 uM; NS = no significant activity,3896,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619753,9247,
,H,BAO_0000219,,Compound was evaluated in an intact RBL-1 cell line for inhibition of 5-lipoxygenase,3897,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619754,137,
,H,BAO_0000357,,Evaluated in vitro for its inhibitory activity against 5-lipoxygenase,3898,Expert,,8,,,,,,1,,12166,B,,,CHEMBL619903,11481,
,H,BAO_0000357,,"Evaluated in vitro for its inhibitory activity against 5-lipoxygenase; N=Inactive, <50% inhibition at 10 uM concentration",3899,Expert,,8,,,,,,1,,12166,B,,,CHEMBL619904,11481,
,H,BAO_0000357,,Inhibition of rat polymorphonuclear leukocyte (PMN) 5-Lipoxygenase in vitro,3900,Expert,,8,,,,,,1,,12166,B,,,CHEMBL619905,9029,
,H,BAO_0000019,,Compound was tested for inhibition of 5-lipoxygenase activity in a broken cell supernatant rat basophilic leukemia cells,3901,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619906,1701,
,H,BAO_0000019,,Compound was tested for inhibition of 5-lipoxygenase activity in a broken cell supernatant rat basophilic leukemia cells at concentration of 32 uM; Not active,3902,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619907,1701,
,H,BAO_0000019,,Compound was tested for inhibition of 5-lipoxygenase activity in a broken cell supernatant rat basophilic leukemia cells at concentration of 50 uM; Not active,3903,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619908,1701,
,H,BAO_0000019,,Compound was tested for inhibition of 5-lipoxygenase activity in a broken cell supernatant rat basophilic leukemia cells; No data,3904,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619909,1701,
,H,BAO_0000219,,Inhibition of 5-lipoxygenase by measuring 5-HETE levels in RBL-1 cell-free supernatant,3905,Expert,,8,,,702.0,,,1,RBL-1,12166,F,,,CHEMBL619910,13358,
,H,BAO_0000219,,Inhibitory activity against 5-lipoxygenase enzyme from RBL-1 cells,3906,Expert,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL882929,1175,
,H,BAO_0000219,,Ability to inhibit 5-lipoxygenase in rat basophilic leukemia cells.,3907,Expert,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619911,8797,
,H,BAO_0000019,,Compound was tested for its ability to inhibit 5-lipoxygenase in rat basophilic leukemia cells; No data,3908,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619912,8797,
,D,BAO_0000357,,Inhibition of rat basophilic leukemia cell 5-lipoxygenase,3909,Expert,,9,,,,,10116.0,1,,12166,B,Rattus norvegicus,,CHEMBL619913,577,
,H,BAO_0000219,,In vitro inhibitory activity against RBL-1 5-LO,3910,Expert,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619914,9295,
,H,BAO_0000219,,Compound was tested for its in vitro inhibitory activity against RBL-1 5-LO (insoluble above 45 uM),3911,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619915,9295,
,H,BAO_0000219,,Compound was tested for its in vitro inhibitory activity against RBL-1 5-LO (time dependent),3912,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619916,9295,
,H,BAO_0000218,,Compound was tested for its inhibition activity against 5-LO of the whole cell in vitro in rat.,3913,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619917,9295,
,H,BAO_0000357,,Compound was tested for its inhibition activity against the 5-LO in isolated enzyme,3914,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619918,9295,
,H,BAO_0000218,,Compound was tested for its inhibitory activity against 5-lipoxygenase in rat.,3915,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619919,216,
,H,BAO_0000219,,Compound was tested for the inhibition of 5-lipoxygenase (5-LPO) in rat basophilic leukemia (RBL) cells.,3916,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL883710,11090,
,H,BAO_0000019,,Compound was tested for the inhibition of 5-lipoxygenase (5-Lpo) in rat whole blood.,3917,Autocuration,178.0,8,,,,,,1,,12166,B,,,CHEMBL619920,11090,Blood
,H,BAO_0000357,,Concentration required for 50 % inhibition of arachidonic acid oxidation by rat 5-lipoxygenase,3918,Expert,,8,,,,,,1,,12166,B,,,CHEMBL619921,10091,
,H,BAO_0000019,,Concentration that produces 50% inhibition of A-23187-stimulated radiolabeled 5-HETE and TXB2 synthesis by PMN 5-lipoxygenase.,3919,Autocuration,,8,,,,,,1,,12166,F,,,CHEMBL619922,10274,
,H,BAO_0000219,,In vitro 5-lipoxygenase inhibitory activity against calcium ionophore (A23187) induced LTB4 formation in rat polymorphonuclear leukocytes,3920,Autocuration,,8,,,,,,1,,12166,F,,,CHEMBL619923,13622,
,H,BAO_0000219,,In vitro inhibition against 5-lipoxygenase in RBL-1 cells was determined,3921,Expert,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619924,12118,
,H,BAO_0000357,,In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay,3922,Expert,,8,,,,,,1,,12166,B,,,CHEMBL619925,12576,
,H,BAO_0000219,,In vitro inhibition of 5-lipoxygenase from RBL-1 cells,3923,Expert,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619926,9546,
,H,BAO_0000219,,In vitro inhibition of 5-lipoxygenase in RBL-1 cells,3924,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619927,9521,
,H,BAO_0000219,,In vitro inhibition of 5-lipoxygenase pathway in rat basophilic leukemia (RBL-1) cells,3925,Expert,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619928,10626,
,H,BAO_0000219,,In vitro inhibition of RBL-1 5-lipoxygenase,3926,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619929,9225,
,H,BAO_0000219,,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 0.18-0.31,3927,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL875089,9225,
,H,BAO_0000219,,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 0.3-1.6,3928,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619930,9225,
,H,BAO_0000219,,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 0.4-2.2,3929,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619931,9225,
,H,BAO_0000219,,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 0.72-1.07,3930,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619932,9225,
,H,BAO_0000219,,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 0.9-4.0,3931,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619933,9225,
,H,BAO_0000219,,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.0-1.5,3932,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619934,9225,
,H,BAO_0000219,,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.0-1.7,3933,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619935,9225,
,H,BAO_0000219,,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.0-2.4,3934,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619936,9225,
,H,BAO_0000219,,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.07-5.54,3935,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619937,9225,
,H,BAO_0000219,,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.1-1.6,3936,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619938,9225,
,H,BAO_0000219,,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.3-2.8,3937,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619939,9225,
,H,BAO_0000219,,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.4-3.2,3938,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619940,9225,
,H,BAO_0000219,,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.7-2.6,3939,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL875090,9225,
,H,BAO_0000219,,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.8-2.8,3940,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619941,9225,
,H,BAO_0000219,,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.8-5.7,3941,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619942,9225,
,H,BAO_0000219,,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.9-2.4,3942,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL883711,9225,
,H,BAO_0000219,,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 2.3-.8,3943,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619943,9225,
,H,BAO_0000219,,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 2.46-2.63,3944,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619944,9225,
,H,BAO_0000219,,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 3.3-3.5,3945,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619945,9225,
,H,BAO_0000219,,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 3.8-7.1,3946,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619946,9225,
,H,BAO_0000219,,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 4.0-6.4,3947,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619947,9225,
,H,BAO_0000219,,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 4.9-11.6,3948,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619948,9225,
,H,BAO_0000219,,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 7.5-11.8,3949,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619949,9225,
,H,BAO_0000019,,In vitro inhibitory activity against 5-lipoxygenase from rat basophilic leukemia cells.,3950,Expert,,8,,,,,,1,,12166,B,,,CHEMBL619950,9401,
,H,BAO_0000019,,In vitro inhibitory activity against 5-Lipoxygenase in rat by Peritoneal 5-lipoxygenase assay,3951,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL618050,10325,
,H,BAO_0000219,,In vitro inhibition of 5-lipoxygenase in RBL-2H3 (Rat basophilic leukemia) cells.,3952,Expert,,8,,,663.0,,,1,RBL-2H3,12166,F,,,CHEMBL875091,1556,
,H,BAO_0000219,,In vitro inhibition of 5-lipoxygenase in RBL-2H3 (Rat basophilic leukemia) cells; Not tested,3953,Expert,,8,,,663.0,,,1,RBL-2H3,12166,F,,,CHEMBL618051,1556,
,D,BAO_0000219,,Inhibition of 5-lipoxygenase from rat basophilic leukemia(RBL-1) cells,3954,Expert,,9,,,702.0,,10116.0,1,RBL-1,12166,B,Rattus norvegicus,,CHEMBL618052,961,
,H,BAO_0000019,,In vitro inhibitory activity against 5-lipoxygenase in an RBL-2H3 cell lysate,3955,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL618053,6838,
,H,BAO_0000019,,In vitro inhibition of 5-lipoxygenase in rat (peritoneal assay),3956,Expert,,8,,,,,,1,,12166,B,,,CHEMBL618054,10325,
,D,BAO_0000219,,In vitro inhibitory activity against 5-lipoxygenase in rat RBL-1 cells,3957,Expert,,9,,,702.0,,10116.0,1,RBL-1,12166,B,Rattus norvegicus,,CHEMBL618055,9209,
,H,BAO_0000219,,inhibitory activity against 5-lipoxygenase in rat basophilic leukemia cell line.,3958,Expert,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL618056,11520,
,H,BAO_0000357,,In vitro inhibitory activity against 5-lipoxygenase was determined,3959,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL618057,137,
,H,BAO_0000219,,In vitro inhibitory concentration against 5-lipoxygenase in RBL-1 cells,3960,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL618058,4717,
,H,BAO_0000219,,Inhibition of 5-lipoxygenase in intact RBL-1 cell line,3961,Expert,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL618059,10636,
,D,BAO_0000019,,Inhibitory activity against 5-lipoxygenase catalysis (5-LO) in sonicated rat basophilic leukemia cell lysate,3962,Expert,,9,,,,,10116.0,1,,12166,F,Rattus norvegicus,,CHEMBL618060,14312,
,H,BAO_0000219,,Inhibition of 5-Lipoxygenase (5-LO) in rat basophilic leukemia cells,3963,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL618061,1203,
,H,BAO_0000019,,Inhibition of 5-Lipoxygenase (5-LO) in rat basophilic leukemic cells,3964,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL618062,1203,
,H,BAO_0000219,,Inhibition of 5-lipoxygenase catalysis in rat basophilic leukemia (RBL) cells by measuring 5-HETE product formation,3965,Expert,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL618063,13622,
,H,BAO_0000357,,Inhibition of 5-lipoxygenase from rat peritoneal neutrophils after oral administration,3966,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL618064,9793,
,D,BAO_0000219,,Inhibition of 5-lipoxygenase of rat basophilic leukemia (RBL) cell cytosolic enzymes,3967,Expert,,9,,,702.0,,10116.0,1,RBL-1,12166,B,Rattus norvegicus,,CHEMBL618065,1143,
,D,BAO_0000219,,Inhibition 5-lipoxygenase mediated LTB4 formation in rat basophilic leukemia (RBL-1) cells,3968,Expert,,9,,,702.0,,10116.0,1,RBL-1,12166,B,Rattus norvegicus,,CHEMBL618066,11854,
,H,BAO_0000219,,Inhibitory activity against 5-lipoxygenase (5-LO) in intact rat barophilic leukemia cells (RBL-1),3969,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL618067,3595,
,H,BAO_0000219,,Inhibitory activity against 5-lipoxygenase (5-LO) using broken rat barophilic leukemia cells (RBL-1),3970,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL618068,3595,
,D,BAO_0000219,,Inhibition of 5-lipoxygenase in rat RBL-1 cells,3971,Expert,,9,,,702.0,,10116.0,1,RBL-1,12166,B,Rattus norvegicus,,CHEMBL618069,10501,
,H,BAO_0000219,,Inhibition of 5-lipoxygenase in intact rat basophilic leukemia cells stimulated with the calcium ionophore A-23187,3972,Expert,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL618070,12526,
,H,BAO_0000019,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 32 umol/kg,3973,Autocuration,349.0,8,,,,,,1,,10825,F,,,CHEMBL618071,10034,Limbic system
,H,BAO_0000019,,Compound was tested for its effects on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.10 umol/kg,3974,Autocuration,349.0,8,,,,,,1,,10825,F,,,CHEMBL619247,10034,Limbic system
,H,BAO_0000019,,Approximate dose levels for a half maximal reduction of 5-HTP levels,3975,Autocuration,,8,,,,,,1,,10825,F,,,CHEMBL619248,10034,
,H,BAO_0000221,,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue using [3H]OH-DPAT as radioligand.,3976,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL619249,10046,Hippocampus
,H,BAO_0000221,,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue using [3H]OH-DPAT as radioligand.,3977,Autocuration,10000000.0,8,,,,,,1,,10576,B,,,CHEMBL619250,10046,Hippocampus
,H,BAO_0000019,,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand.,3978,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL619251,10046,
,H,BAO_0000019,,Inhibitory concentration against human platelet 5-lipoxygenase in dog whole blood,3979,Autocuration,178.0,8,,,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL619252,12079,Blood
,H,BAO_0000019,,Inhibitory concentration against human platelet 5-lipoxygenase in human whole blood,3980,Autocuration,178.0,8,,,,,,1,,55,F,,,CHEMBL619253,12079,Blood
,H,BAO_0000219,,The compound was tested for inhibitory activity against 5-Lipoxygenase in rat polymorphonuclear leukocytes[PMNS],3981,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619254,11311,
,H,BAO_0000219,,Inhibition of 5-lipoxygenase in bovine polymorphonuclear leukocytes,3982,Expert,,8,,,,,,1,,17140,B,,,CHEMBL619255,12338,
,H,BAO_0000219,,Inhibitory activity against 5-lipoxygenase (inhibition of 5-HETE and LTB4 biosynthesis) in bovine polymorphonuclear leukocytes (PMNL).,3983,Expert,,8,,,,,,1,,17140,B,,,CHEMBL619256,12143,
,H,BAO_0000219,,Inhibitory activity against 5-lipoxygenase (inhibition of 5-HETE and LTB4 biosynthesis) in bovine polymorphonuclear leukocytes (PMNL),3984,Autocuration,,8,,,,,,1,,17140,B,,,CHEMBL875418,12143,
,H,BAO_0000219,,Inhibitory activity against 5-lipoxygenase (inhibition of 5-HETE and LTB4 biosynthesis) in bovine polymorphonuclear leukocytes (PMNL) at 30 uM,3985,Expert,,8,,,,,,1,,17140,B,,,CHEMBL619257,12143,
,H,BAO_0000219,,Inhibitory activity against 5-lipoxygenase (inhibition of 5-HETE and LTB4 biosynthesis) in bovine polymorphonuclear leukocytes (PMNL) at 30 uM,3986,Autocuration,,8,,,,,,1,,17140,B,,,CHEMBL619258,12143,
,H,BAO_0000357,,Inhibition of 5-lipoxygenase in bovine PMNL cell assay.,3987,Expert,,8,,,,,,1,,17140,B,,,CHEMBL619259,12365,
,H,BAO_0000357,,Tested for inhibition of 5-lipoxygenase as inhibition of 5-HETE and LTB4 biosynthesis in bovine PMNL,3988,Expert,,8,,,,,,1,,17140,B,,,CHEMBL619260,13500,
,H,BAO_0000218,,"Ex vivo inhibition of 5-LO was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.08h, following intravenous administration at the dose of 1.0 mg/kg",3989,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL619261,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-LO was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.25h, following intravenous administration at the dose of 1.0 mg/kg",3990,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL619263,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-LO was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.5h, following intravenous administration at the dose of 1.0 mg/kg",3991,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL619264,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-LO was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 1.0h, following intravenous administration at the dose of 1.0 mg/kg",3992,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL619265,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-LO was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 24h, following intravenous administration at the dose of 1.0 mg/kg",3993,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL619266,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-LO was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 3.0h, following intravenous administration at the dose of 1.0 mg/kg",3994,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL619902,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-LO was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 6.0h, following intravenous administration at the dose of 1.0 mg/kg",3995,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620058,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-LO was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 9.0h, following intravenous administration at the dose of 1.0 mg/kg",3996,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620059,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.08h, following intravenous administration at the dose of 1.0 mg/kg",3997,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620060,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.25h, following intravenous administration at the dose of 1.0 mg/kg",3998,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620061,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.25h, following peroral administration at the dose of 0.3 mg/kg",3999,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620062,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.25h, following peroral administration at the dose of 1.0 mg/kg",4000,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620063,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.25h, following peroral administration at the dose of 3.0 mg/kg",4001,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620064,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.5h, following intravenous administration at the dose of 1.0 mg/kg",4002,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620065,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.5h, following peroral administration at the dose of 0.3 mg/kg",4003,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620066,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.5h, following peroral administration at the dose of 1.0 mg/kg",4004,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620067,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.5h, following peroral administration at the dose of 3.0 mg/kg",4005,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620068,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 1.0h, following intravenous administration at the dose of 1.0 mg/kg",4006,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620069,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 1.0h, following peroral administration at the dose of 0.3 mg/kg",4007,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620070,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 1.0h, following peroral administration at the dose of 1.0 mg/kg",4008,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620071,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 1.0h, following peroral administration at the dose of 3.0 mg/kg",4009,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620072,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 24h, following intravenous administration at the dose of 1.0 mg/kg",4010,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620036,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 24h, following peroral administration at the dose of 0.3 mg/kg",4011,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL857702,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 24h, following peroral administration at the dose of 1.0 mg/kg",4012,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620037,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 24h, following peroral administration at the dose of 3.0 mg/kg",4013,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620038,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 3.0h, following intravenous administration at the dose of 1.0 mg/kg",4014,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620039,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 3.0h, following peroral administration at the dose of 0.3 mg/kg",4015,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620040,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 3.0h, following peroral administration at the dose of 1.0 mg/kg",4016,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620041,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 3.0h, following peroral administration at the dose of 3.0 mg/kg",4017,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620042,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 6.0h, following intravenous administration at the dose of 1.0 mg/kg",4018,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620043,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 6.0h, following peroral administration at the dose of 0.3 mg/kg",4019,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620044,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 6.0h, following peroral administration at the dose of 1.0 mg/kg",4020,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620045,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 6.0h, following peroral administration at the dose of 3.0 mg/kg",4021,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620046,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 9.0h, following intravenous administration at the dose of 1.0 mg/kg",4022,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620047,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 9.0h, following peroral administration at the dose of 0.3 mg/kg",4023,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620048,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 9.0h, following peroral administration at the dose of 1.0 mg/kg",4024,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL857703,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 9.0h, following peroral administration at the dose of 3.0 mg/kg",4025,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620049,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.08h, following intravenous administration at the dose of 1.0 mg/kg",4026,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620050,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.25h, following intravenous administration at the dose of 1.0 mg/kg",4027,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL620051,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.5h, following intravenous administration at the dose of 1.0 mg/kg",4028,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL619213,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 1.0h, following intravenous administration at the dose of 1.0 mg/kg",4029,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL619214,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 3.0h, following intravenous administration at the dose of 1.0 mg/kg",4030,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL619804,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.25h, following peroral administration at the dose of 1.0 mg/kg",4031,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL619805,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 24h, following intravenous administration at the dose of 1.0 mg/kg",4032,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL619806,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 6.0h, following intravenous administration at the dose of 1.0 mg/kg",4033,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL619807,12832,Blood
,H,BAO_0000218,,"Ex vivo inhibition was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 9.0h, following intravenous administration at the dose of 1.0 mg/kg",4034,Autocuration,178.0,8,,In vivo,,,9615.0,1,,55,F,Canis lupus familiaris,,CHEMBL619808,12832,Blood
,H,BAO_0000218,,Inhibitory activity against 5-lipoxygenase (5-LO) in after oral administration of 5 mg/kg at 24 hr r,4035,Autocuration,,8,,,,,9615.0,1,,55,B,Canis lupus familiaris,,CHEMBL619809,3595,
,H,BAO_0000218,,Inhibitory activity against 5-lipoxygenase (5-LO) in after oral administration of 5 mg/kg at 24 hr r to canine,4036,Autocuration,,8,,,,,9615.0,1,,55,B,Canis lupus familiaris,,CHEMBL619810,3595,
,H,BAO_0000218,,Inhibitory activity against 5-lipoxygenase (5-LO) in after oral administration of 5 mg/kg at 2 hr,4037,Autocuration,,8,,,,,9615.0,1,,55,B,Canis lupus familiaris,,CHEMBL619811,3595,
,H,BAO_0000218,,Inhibitory activity against 5-lipoxygenase (5-LO) in after oral administration of 5 mg/kg at 2 hr to canine,4038,Autocuration,,8,,,,,9615.0,1,,55,B,Canis lupus familiaris,,CHEMBL620769,3595,
,H,BAO_0000218,,Inhibitory activity against 5-lipoxygenase (5-LO) in after oral administration of 5 mg/kg at 4 hr,4039,Autocuration,,8,,,,,9615.0,1,,55,B,Canis lupus familiaris,,CHEMBL620770,3595,
,H,BAO_0000218,,Inhibitory activity against 5-lipoxygenase (5-LO) in after oral administration of 5 mg/kg at 4 hr to canine,4040,Autocuration,,8,,,,,9615.0,1,,55,B,Canis lupus familiaris,,CHEMBL620771,3595,
,H,BAO_0000218,,Inhibitory activity against 5-lipoxygenase (5-LO) in after oral administration of 5 mg/kg at 8 hr,4041,Autocuration,,8,,,,,9615.0,1,,55,B,Canis lupus familiaris,,CHEMBL620772,3595,
,H,BAO_0000218,,Inhibitory activity against 5-lipoxygenase (5-LO) in after oral administration of 5 mg/kg at 8 hr to canine,4042,Autocuration,,8,,,,,9615.0,1,,55,B,Canis lupus familiaris,,CHEMBL620773,3595,
,H,BAO_0000357,,Ability to inhibit 5-lipoxygenase in guinea pig,4043,Autocuration,,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL620774,9203,
,H,BAO_0000357,,Inhibition of [14C]arachidonic acid conversion to 5-HETE by broken cell 5-lipoxygenase in vitro (guinea pig PMN),4044,Expert,,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL620775,82,
,H,BAO_0000357,,Compound was tested for the inhibition of 5-lipoxygenase (5-Lpo) in guinea pig.,4045,Autocuration,,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL620776,11090,
,H,BAO_0000218,,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 12 h, following intravenous administration at the dose of 1.0 mg/kg",4046,Autocuration,178.0,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL620777,12832,Blood
,H,BAO_0000357,,In vitro 5-lipoxygenase inhibition in guinea pig PMNs was determined based on 5-hydroxyeicosapentaenoic acid (5-HETE) production,4047,Autocuration,,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL620778,1065,
,H,BAO_0000357,,In vitro 5-lipoxygenase inhibition in guinea pig PMNs was determined based on LTB4 production,4048,Autocuration,,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL620779,1065,
,H,BAO_0000019,,In vitro 5-lipoxygenase inhibitory activity against A-23187-stimulated conversion of [14C]-AA to 5-HETE in guinea pig peritoneal polymorphonuclear leukocytes,4049,Expert,,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL621500,12832,
,H,BAO_0000019,,In vitro 5-lipoxygenase inhibitory activity against A-23187-stimulated conversion of [14C]AA to LTB4 in guinea pig peritoneal polymorphonuclear leukocytes,4050,Expert,,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL621501,12832,
,H,BAO_0000019,,In vitro 5-lipoxygenase inhibitory activity against A-23187-stimulated conversion of [14C]AA to LTB4 in guinea pig peritoneal polymorphonuclear leukocytes,4051,Autocuration,,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL618098,12832,
,H,BAO_0000019,,Inhibition against 5-lipoxygenase from guinea pig polymorphonuclear lymphocytes,4052,Autocuration,,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL618099,10504,
,H,BAO_0000357,,Inhibitory activity against 5-lipoxygenase,4053,Autocuration,,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL618100,7788,
,H,BAO_0000357,,Inhibitory activity against 5-lipoxygenase in guinea pig leukocyte,4054,Autocuration,,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL618101,10001,
,H,BAO_0000357,,Inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase using guinea pig supernatant,4055,Autocuration,,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL618102,10193,
,H,BAO_0000357,,Inhibitory activity against partially-purified Guinea pig PMN 5-lipoxygenase,4056,Autocuration,,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL618103,13243,
,H,BAO_0000357,,Inhibitory activity uM,4057,Autocuration,,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL618104,13243,
,H,BAO_0000219,,Inhibitory activity against 5-lipoxygenase in guinea pig leukocytes was determined,4058,Autocuration,,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL883712,969,
,H,BAO_0000357,,Inhibitory activity against 5-lipoxygenase at 10 uM,4059,Autocuration,,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL618105,10001,
,H,BAO_0000357,,Inhibitory activity against 5-lipoxygenase at a dose of 0.1 mM,4060,Autocuration,,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL618106,7788,
,H,BAO_0000357,,Inhibitory activity against 5-lipoxygenase in guinea pig leukocyte at 30 uM,4061,Autocuration,,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL618107,10001,
,H,BAO_0000357,,Inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase using guinea pig supernatant at 10 uM,4062,Autocuration,,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL618108,10193,
,H,BAO_0000357,,Inhibitory activity uM,4063,Autocuration,,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL618109,13243,
,H,BAO_0000357,,Inhibitory activity against partially-purified Guinea pig PMN 5-lipoxygenase at 10 uM,4064,Autocuration,,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL618110,13243,
,H,BAO_0000357,,Inhibitory activity uM,4065,Expert,,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL618111,13243,
,H,BAO_0000019,,Inhibitory activity uM,4066,Autocuration,,8,,,,,10141.0,1,,55,F,Cavia porcellus,,CHEMBL618112,13243,
,H,BAO_0000019,,Percent inhibition against 5-lipoxygenase from guinea pig polymorphonuclear lymphocytes,4067,Autocuration,,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL618113,10504,
,H,BAO_0000357,,Inhibitory activity against 5-lipoxygenase at a dose of 0.1 mM,4068,Autocuration,,8,,,,,10141.0,1,,55,B,Cavia porcellus,,CHEMBL618114,7788,
,H,BAO_0000221,,Evaluated for inhibition of the formation and release of 5-lipoxygenase in isolated guinea pig ileum,4069,Expert,2116.0,8,,,,,10141.0,1,,55,F,Cavia porcellus,,CHEMBL620871,10546,Ileum
,H,BAO_0000357,,5-lipoxygenase Inhibitory activity was measured by enzyme immunoassay using human whole blood stimulated with calcium ionophore (A23187) and LTB4 (leukotriene B4),4070,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL620872,13183,
,H,BAO_0000357,,5-lipoxygenase Inhibitory activity was measured by enzyme immunoassay using human whole blood stimulated with calcium ionophore (A23187) and LTB4 (leukotriene B4),4071,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL620873,13183,
,H,BAO_0000357,,Compound was evaluated for in vitro inhibition of recombinant human 5-lipoxygenase (5-LO),4072,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL620874,2578,
,H,BAO_0000357,,In vitro inhibition of human 5-Lipoxygenase.,4073,Expert,,8,,,,,,1,,55,B,,,CHEMBL620875,12780,
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 75 uM,4074,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL620876,7411,Liver
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 1 uM,4075,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL620877,7411,Liver
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 10 uM,4076,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL857854,7411,Liver
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 10 uM exposed 100 uM,4077,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL620878,7411,Liver
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 100 uM,4078,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL620879,7411,Liver
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 1000 uM,4079,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL620880,7411,Liver
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 1000 uM,4080,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL620881,7411,Liver
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 150 uM,4081,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL620882,7411,Liver
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 1500 uM,4082,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL620883,7411,Liver
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 2.5 uM,4083,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL620884,7411,Liver
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 200 uM,4084,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL620885,7411,Liver
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 27.5 uM,4085,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL620886,7411,Liver
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 5 uM,4086,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL620887,7411,Liver
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 50 uM,4087,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL618039,7411,Liver
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 500 uM,4088,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL618040,7411,Liver
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to exposed to 3-methylcholanthrene at concentration of 200 uM,4089,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL618041,7411,Liver
,U,BAO_0000251,,"Compound was evaluated for inhibition constant, in liver microsomes from 3-methylcholanthrene-exposed rats",4090,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL618216,7411,Liver
,U,BAO_0000251,,"Compound was evaluated for inhibition constant, in liver microsomes from beta-naphthoflavone-exposed rats",4091,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL618217,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes 3-methylcholanthrene at concentration of 100 uM,4092,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL618218,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes 3-methylcholanthrene at concentration of 200 uM,4093,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL618219,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes 3-methylcholanthrene at concentration of 50 uM,4094,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL618220,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at 5 uM,4095,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL618221,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at 50 uM,4096,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL618222,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at a concentration of 10 uM,4097,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL618223,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 100 uM,4098,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL618224,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 1 uM,4099,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL618225,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 20 uM,4100,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL618226,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 200 uM,4101,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL618227,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 25 uM,4102,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL618228,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 50 uM,4103,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL618229,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 75 uM,4104,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL618230,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 1 uM,4105,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL618231,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 10 uM,4106,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL618232,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 100 uM,4107,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL618233,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 1000 uM,4108,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL618234,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 150 uM,4109,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL618235,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 1500 uM,4110,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL618115,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 2.5 uM,4111,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL618116,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 200 uM,4112,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL618117,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 5 uM,4113,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL619968,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 50 uM,4114,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL619969,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 500 uM,4115,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL619970,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at concentration of 1000 uM,4116,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL619971,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at concentration of 1500 uM,4117,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL619972,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at concentration of 27.5 uM,4118,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL619973,7411,Liver
,U,BAO_0000251,,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at concentration of 500 uM,4119,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL619974,7411,Liver
,U,BAO_0000251,,Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 50 uM,4120,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL619975,7411,Liver
,U,BAO_0000251,,Vmax determined by 7-ethoxycoumarin deethylation in the presence by liver microsomes from rats exposed to 3-methylcholanthrene at concentration of 10 uM,4121,Autocuration,,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL619976,7411,
,U,BAO_0000251,,"Compound was evaluated for alpha -rate constant, in liver microsomes from 3-methylcholanthrene-exposed rats",4122,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL619977,7411,Liver
,U,BAO_0000251,,"Compound was evaluated for alpha -rate constant, in liver microsomes from beta-naphthoflavone-exposed rats",4123,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL619978,7411,Liver
,U,BAO_0000251,,"Compound was evaluated for alpha -rate constant, in liver microsomes from beta-naphthoflavone-exposed rats; competitive inhibition",4124,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL619979,7411,Liver
,U,BAO_0000251,,"Compound was evaluated for alpha inhibition constant, in liver microsomes from 3-methylcholanthrene-exposed rats",4125,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL619980,7411,Liver
,U,BAO_0000251,,"Compound was evaluated for alpha inhibition constant, in liver microsomes from beta-naphthoflavone-exposed rats",4126,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL619981,7411,Liver
,N,BAO_0000219,,In vitro inhibition of 7226/S myeloma cancer cell line,4127,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL619982,10797,
,N,BAO_0000219,,In vitro antitumor activity of compound against 7404 cell line (human liver carcinoma cells),4128,Intermediate,,1,,,993.0,,9606.0,1,BEL-7404 tumor cell line,80698,F,Homo sapiens,,CHEMBL619983,6881,
,N,BAO_0000219,,In vitro growth inhibition of compound was determined against 768-0 cell lines of Renal cancer,4129,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL620031,3838,
,N,BAO_0000219,,In vitro growth inhibition of compound was determined against 768-0 cell lines of Renal cancer,4130,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL620032,3838,
,N,BAO_0000219,,Net accumulation of the [99mTc]Isonitrile complex was measured in 77A cell lines in the presence of Verapamil.,4131,Expert,,1,,,505.0,,10029.0,1,V79,81264,F,Cricetulus griseus,,CHEMBL620033,12981,
,N,BAO_0000219,,Verapamil index represents the ratio of net uptake in the presense of verapamil over control in 77A cell lines.,4132,Expert,,1,,,505.0,,10029.0,1,V79,81264,F,Cricetulus griseus,,CHEMBL620034,12981,
,N,BAO_0000219,,Tested for its cytotoxic effect on the growth of the cell strain 7800C1 (1 x 10e 4 (MEM)) at 10 ug/mL dose,4133,Intermediate,,1,,,1119.0,,10116.0,1,7800C1 cell line,80635,F,Rattus norvegicus,,CHEMBL620035,7653,
,N,BAO_0000219,,Tested for its cytotoxic effect on the growth of the cell strain 7800C1 (1 x 10e 4 (MEM)) at 2 ug/mL dose,4134,Intermediate,,1,,,1119.0,,10116.0,1,7800C1 cell line,80635,F,Rattus norvegicus,,CHEMBL618318,7653,
,N,BAO_0000219,,Tested for its cytotoxic effect on the growth of the cell strain 7800C1 (1 x 10e 4 (MEM)) at 20 ug/mL dose,4135,Intermediate,,1,,,1119.0,,10116.0,1,7800C1 cell line,80635,F,Rattus norvegicus,,CHEMBL618319,7653,
,N,BAO_0000219,,Tested for its cytotoxic effect on the growth of the cell strain 7800C1 (1 x 10e 4 (MEM)) at 5 ug/mL dose,4136,Intermediate,,1,,,1119.0,,10116.0,1,7800C1 cell line,80635,F,Rattus norvegicus,,CHEMBL618320,7653,
,N,BAO_0000219,,Tested for its cytotoxic effect on the growth of the cell strain 7800C1 (1 x 10e 4 (MEM)) at 50 ug/mL dose,4137,Intermediate,,1,,,1119.0,,10116.0,1,7800C1 cell line,80635,F,Rattus norvegicus,,CHEMBL618321,7653,
,N,BAO_0000219,,Tested for its cytotoxic effect on the growth of the cell strain 7800C1 (1 x 10e 4 (MEM)) at 75 ug/mL dose,4138,Intermediate,,1,,,1119.0,,10116.0,1,7800C1 cell line,80635,F,Rattus norvegicus,,CHEMBL883118,7653,
,N,BAO_0000219,,In vitro antitumor activity against renal 786-0 tumor cell lines,4139,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL883795,17229,
,N,BAO_0000219,,Cytotoxic activity against 786-0 Renal cancer cell line,4140,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL618322,12858,
,N,BAO_0000219,,Growth inhibitory activity was determined against 786-0 cancer cell line of Renal cancer,4141,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL618323,16325,
,N,BAO_0000219,,Growth inhibitory activity was determined against 786-0 cancer cell line of renal cancer,4142,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL618324,16325,
,N,BAO_0000219,,In vitro antitumor activity against human renal 786-0 cell line,4143,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL618325,5858,
,N,BAO_0000219,,Inhibition of Renal cancer in 786-0 cancer cell lines,4144,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL875416,16325,
,N,BAO_0000219,,Inhibition of the growth of renal cancer(786-0) cell line. value in parentheses is percent inhibition at 0.01 uM,4145,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL618326,14696,
,N,BAO_0000219,,The compound was tested for its cytotoxic activity against the following renal cancer cell lines 786-0,4146,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL618327,3786,
,N,BAO_0000219,,inhibition of the growth of renal cancer(786-0) cell line,4147,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL619215,14696,
,N,BAO_0000219,,Compound was evaluated for in vitro activity against 786-0 kidney cell lines (Human tumor cells ),4148,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL619216,14769,
,N,BAO_0000219,,Compound was tested for the growth inhibition of 786-0 renal tumor cell line,4149,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL619217,15354,
,N,BAO_0000219,,The IC50 value was measured on 786-0 cell line in ovarian tumor,4150,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL619218,14255,
,N,BAO_0000219,,The IC50 value was measured on 786-0 cell line in ovarian tumor t,4151,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL619219,14255,
,N,BAO_0000219,,The IC50 value was measured on 786-0 cell line in renal tumor type.,4152,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL619220,14255,
,N,BAO_0000219,,Inhibition of the growth of renal cancer(786-0) cell line at 0.01 uM,4153,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL619221,14696,
,N,BAO_0000219,,Tested for cytotoxic activity against renal cancer 786-0 cell line,4154,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL619222,12016,
,N,BAO_0000219,,Compound was tested for growth inhibitory activity against 786-0 cell line,4155,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL857454,2597,
,H,BAO_0000219,,Inhibitory activity against 5-lipoxygenase in intact rat basophilic leukemia cells stimulated with the calcium ionophore A-23187; Inactive(N)= <50% inhibition at 10 uM,4156,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619223,12526,
,H,BAO_0000219,,Inhibitory activity against 5-lipoxygenase in intact rat basophilic leukemia cells stimulated with the calcium ionophore A-23187; N=Inactive,4157,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619224,12526,
,H,BAO_0000019,,Inhibitory activity against 5-lipoxygenase obtained from rat basophilic leukemia cells,4158,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619225,14799,
,H,BAO_0000219,,Inhibitory activity against 5-lipoxygenase (5-LO) in intact rat barophilic leukemia cells (RBL-1),4159,Expert,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619226,3595,
,H,BAO_0000219,,Inhibitory activity against 5-lipoxygenase (5-LO) using broken rat barophilic leukemia cells (RBL-1),4160,Expert,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619227,3595,
,H,BAO_0000357,,Inhibitory activity against rat basophilic leukemia 5-lipoxygenase,4161,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619228,12767,
,H,BAO_0000219,,Inhibitory activity against 5-lipoxygenase in rat polymorphonuclear leukocytes,4162,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619229,10997,
,H,BAO_0000219,,Inhibitory activity against 5-lipoxygenase of RBL-1 cell line,4163,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619230,11388,
,H,BAO_0000357,,Inhibitory activity against RBL broken cell-supematant 5-lipoxygenase was evaluated,4164,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619231,167,
,H,BAO_0000357,,"Inhibitory activity against intact rat PMNL, LTB4 5-lipoxygenase was evaluated",4165,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619232,167,
,H,BAO_0000357,,Inhibitory activity against rat 5-lipoxygenase by using continuous oxygen consumption assay.,4166,Expert,,8,,,,,,1,,12166,B,,,CHEMBL619233,13744,
,H,BAO_0000357,,Inhibitory activity against rat basophilic leukemia cell 5-lipoxygenase,4167,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619234,1630,
,H,BAO_0000357,,Inhibitory activity against rat basophilic leukemia cell 5-lipoxygenase (5-LO),4168,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619235,1630,
,D,BAO_0000019,,"Inhibitory activity against 5-lipoxygenase in rat neutrophils as inhibition of A 23,187-induced LTB4 production",4169,Expert,,9,,,,,10116.0,1,,12166,B,Rattus norvegicus,,CHEMBL619236,969,
,H,BAO_0000219,,Inhibitory concentration against 5-lipoxygenase in rat RBL-1 cells,4170,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619237,13621,
,H,BAO_0000357,,Inhibitory concentration to inhibit 5-lipoxygenase in the rat,4171,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619238,10089,
,H,BAO_0000357,,In vitro inhibition of rat polymorphonuclear leukocyte 5-lipoxygenase,4172,Expert,,8,,,,,,1,,12166,B,,,CHEMBL619239,10193,
,H,BAO_0000357,,Tested for inhibition of 5-HPETE production by rat 5-LO; value ranges from 16-36 nM,4173,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619240,11966,
,H,BAO_0000019,,Tested for inhibition of 5-LO by measuring the reduction of leukotriene B4 (LTB4) in intact basophilic rat leukemia cells,4174,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL875417,12251,
,H,BAO_0000219,,Tested for inhibition of 5-Lipoxygenase (ARBL) in calcium-stimulated rat basophilic leukemia cells(RBL-1),4175,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619241,211,
,H,BAO_0000019,,Inhibition of 5-lipoxygenase measured by the reduction of leukotriene B4 (LTB4) in intact basophilic rat leukemia cells,4176,Expert,,8,,,,,,1,,12166,F,,,CHEMBL619242,12251,
,H,BAO_0000219,,Tested for inhibitory activity against 5-lipoxygenase in microsome of RBL-1 cells,4177,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL883796,12495,
,H,BAO_0000357,,Tested for its inhibitory activity against 5-lipoxygenase,4178,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619243,414,
,H,BAO_0000357,,Tested for its inhibitory activity against 5-lipoxygenase; Not determined,4179,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619244,414,
,H,BAO_0000019,,"Iin vitro inhibition of 5-lipoxygenase activity in rat basophil leukemia type 1(RBL1) cell homogenates, (reduction of [14C]-5-HETE formation)",4180,Expert,,8,,,,,,1,,12166,B,,,CHEMBL619245,10325,
,H,BAO_0000019,,In vitro test for inhibition of 5-lipoxygenase in cell-free preparations from rat PMN leukocytes,4181,Expert,,8,,,,,,1,,12166,B,,,CHEMBL619246,11966,
,H,BAO_0000219,,In vitro inhibition of 5-lipoxygenase activity in RBL-1 cells.,4182,Expert,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619984,165,
,H,BAO_0000219,,The compound was evaluated in vitro for inhibition of 5-lipoxygenase activity in RBL-1 cells; No significant inhibitory activity up to 30 uM,4183,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619985,165,
,H,BAO_0000219,,The compound was evaluated in vitro for inhibition of 5-lipoxygenase activity in RBL-1 cells.,4184,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619986,165,
,H,BAO_0000219,,In vitro for inhibition of 5-lipoxygenase activity in RBL-1 cells.,4185,Expert,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619987,165,
,H,BAO_0000218,,The compound was tested for inhibitory activity against 5-lipoxygenase in mouse,4186,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619988,11311,
,H,BAO_0000219,,The compound was tested for inhibitory activity against 5-lipoxygenase in rat RBL-1,4187,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619989,11311,
,H,BAO_0000219,,The compound was tested for inhibitory activity against 5-lipoxygenase in rat RBL-1 cells,4188,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL619990,11311,
,H,BAO_0000219,,The compound was tested for inhibitory activity against 5-lipoxygenase in rat polymorphonuclear leukocytes[PMNS],4189,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619991,11311,
,H,BAO_0000219,,The compound was tested for inhibitory activity against 5-lipoxygenase in rat polymorphonuclear leukocytes[PMNS] (in vitro),4190,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619992,11311,
,H,BAO_0000218,,The compound was tested for inhibitory activity against 5-lipoxygenase in rat polymorphonuclear leukocytes[PMNS] (in vivo),4191,Autocuration,,8,,In vivo,,,,1,,12166,B,,,CHEMBL619993,11311,
,H,BAO_0000219,,The compound was tested for inhibitory activity against 5-lipoxygenase translocation inhibitor in RBL-2H3 cells,4192,Autocuration,,8,,,663.0,,,1,RBL-2H3,12166,F,,,CHEMBL619994,11311,
,H,BAO_0000219,,The compound was tested for inhibitory activity against 5-lipoxygenase translocation inhibitor in rat RBL-2H3 cells,4193,Autocuration,,8,,,663.0,,,1,RBL-2H3,12166,F,,,CHEMBL619995,11311,
,H,BAO_0000019,,The compound was tested for inhibitory activity against 5-lipoxygenase using rat polymorphonuclear leukocytes[PMNS],4194,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619996,11311,
,H,BAO_0000019,,The compound was tested for its inhibitory activity against arachidonic acid in rat 5-lipoxygenase,4195,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619997,11732,
,H,BAO_0000019,,Tested for its inhibitory activity against arachidonic acid in rat 5-lipoxygenase.,4196,Expert,,8,,,,,,1,,12166,B,,,CHEMBL619998,11732,
,H,BAO_0000019,,In vitro inhibition of 5-lipoxygenase (5-lo) from the 20000 g supernatant of RBI-1 cells,4197,Expert,,8,,,,,,1,,12166,B,,,CHEMBL619999,11087,
,H,BAO_0000019,,The compound was tested for the in vitro inhibition of 5-lipoxygenase from the 20000 g supernatant of RBI-1 cells,4198,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL620000,11087,
,H,BAO_0000219,,The compound was tested for the inhibition of 5-lipoxygenase (5-lo) in homogenized rat basophilic leukemia (RBL-1) cells,4199,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620001,11087,
,D,BAO_0000357,,Inhibition of 5-lipoxygenase (5-lo) in intact rat polymorphonuclear leukocyte RPMNL,4200,Expert,,9,,,,,10116.0,1,,12166,B,Rattus norvegicus,,CHEMBL620002,11087,
,H,BAO_0000219,,The compound was tested for the inhibition of 5-lipoxygenase in intact basophilic rat leukemia cells,4201,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620003,496,
,H,BAO_0000219,,Inhibition of 5-lipoxygenase on rat basophil leukemia cell line lysate (RBL-1 2H3 subline) by measuring 5-HETE production,4202,Expert,,8,,,702.0,,,1,RBL-1,12166,F,,,CHEMBL620004,13986,
,H,BAO_0000357,,Compound was evaluated for the inhibition of 5-lipoxygenase,4203,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL874063,11520,
,H,BAO_0000219,,Ability to inhibit 5-lipoxygenase by using a crude preparation of the cytosolic enzyme from the rat basophilic leukemia (RBL-1) cell line at a concentration of 25 uM,4204,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620005,10293,
,H,BAO_0000219,,Compound was evaluated for its inhibitory activity against 5-LO (5-lipoxygenase) at 10 uM concentration in intact RBL-1 cell line assay,4205,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620006,303,
,H,BAO_0000219,,Compound was evaluated for its inhibitory activity against 5-LO (5-lipoxygenase) at 10 uM concentration in intact RBL-1 cell line assay; Less than 5% inhibition at 10 uM reported as not active,4206,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620007,303,
,H,BAO_0000219,,Compound was evaluated for the inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 10 uM,4207,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620008,9247,
,D,BAO_0000219,,Inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 100 uM,4208,Expert,,9,,,702.0,,10116.0,1,RBL-1,12166,B,Rattus norvegicus,,CHEMBL620009,9247,
,H,BAO_0000219,,Compound was evaluated for the inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 100 uM; NS = no significant activity,4209,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620010,9247,
,H,BAO_0000219,,Compound was evaluated for the inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 30 uM,4210,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620011,9247,
,H,BAO_0000219,,Compound was evaluated for the inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 300 uM,4211,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620677,9247,
,H,BAO_0000219,,Compound was evaluated for the inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 33 uM,4212,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620678,9247,
,H,BAO_0000219,,Compound was evaluated for the inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 40 uM,4213,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620679,9247,
,H,BAO_0000219,,Compound was evaluated for the inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 75 uM,4214,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620680,9247,
,D,BAO_0000357,,Inhibitory activity against 5-lipoxygenase at 10 uM,4215,Expert,,9,,,,,10116.0,1,,12166,B,Rattus norvegicus,,CHEMBL620838,11481,
,H,BAO_0000357,,In vitro inhibition of 5-lipoxygenase; NS means no significant inhibition,4216,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL620839,105,
,H,BAO_0000357,,In vitro inhibition of rat polymorphonuclear leukocyte (PMN) 5-Lipoxygenase at 10 uM,4217,Expert,,8,,,,,,1,,12166,B,,,CHEMBL620840,9029,
,H,BAO_0000219,,Inhibitory activity against 5-lipoxygenase enzyme from RBL-1 cells at 20 uM,4218,Expert,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620841,1175,
,H,BAO_0000219,,In vitro inhibition against 5-lipoxygenase in RBL-1 cells was determined at 100 uM,4219,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620842,12118,
,H,BAO_0000219,,In vitro inhibition against 5-lipoxygenase in RBL-1 cells was determined at 10e-4 M,4220,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620843,12118,
,H,BAO_0000219,,In vitro inhibition against 5-lipoxygenase in RBL-1 cells was determinedb at 100 uM,4221,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620844,12118,
,H,BAO_0000219,,In vitro inhibition of RBL-1 5-lipoxygenase at 20 uM,4222,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620845,9225,
,H,BAO_0000019,,In vitro inhibitory activity against 5-Lipoxygenase from rat basophilic leukemia cells at 30 uM concentration,4223,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL620846,9401,
,H,BAO_0000357,,In vitro inhibitory activity against 5-lipoxygenase was determined at 16 uM,4224,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL873951,137,
,H,BAO_0000357,,In vitro inhibitory activity against 5-lipoxygenase was determined at 16 uM,4225,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL620847,137,
,H,BAO_0000219,,In vitro percent inhibition against 5-lipoxygenase in RBL-1 cells at 10 uM concentration,4226,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620848,4717,
,H,BAO_0000219,,Inhibitory activity against 5-lipoxygenase (5-LO) using broken rat barophilic leukemia cells (RBL-1) at 10 uM,4227,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620849,3595,
,H,BAO_0000219,,Inhibitory activity against 5-lipoxygenase in RBL-1 cells at 40 uM concentration,4228,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620850,10501,
,H,BAO_0000219,,Inhibitory activity against 5-lipoxygenase in RBL-1 cells at a concentration 40 uM,4229,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620851,10501,
,H,BAO_0000219,,Inhibitory activity against 5-lipoxygenase in RBL-1 cells at a concentration 40 uM.,4230,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620852,10501,
,H,BAO_0000219,,Inhibitory activity against 5-lipoxygenase in intact rat basophilic leukemia cells stimulated with the calcium ionophore A-23187,4231,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL875098,12526,
,D,BAO_0000219,,Inhibition of 5-lipoxygenase of rat basophilic leukemia cells at 30 uM,4232,Expert,,9,,,702.0,,10116.0,1,RBL-1,12166,B,Rattus norvegicus,,CHEMBL620853,14799,
,H,BAO_0000019,,Inhibitory activity against 5-lipoxygenase obtained from rat basophilic leukemia cells at 30 uM concentration; NT=Not tested,4233,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL620854,14799,
,H,BAO_0000219,,Inhibitory activity against 5-lipoxygenase (5-LO) using broken rat barophilic leukemia cells (RBL-1) at 10 uM,4234,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620855,3595,
,H,BAO_0000219,,Inhibitory activity against 5-lipoxygenase (5-LO) using broken rat barophilic leukemia cells (RBL-1)at 10 uM,4235,Expert,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL839884,3595,
,H,BAO_0000219,,Inhibitory activity at 10 uM against 5-lipoxygenase in intact rat basophilic leukemia cells stimulated with the calcium ionophore A-23187,4236,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620856,12526,
,H,BAO_0000219,,Inhibitory activity at 1 uM against 5-lipoxygenase in intact rat basophilic leukemia cells stimulated with the calcium ionophore A-23187,4237,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620857,12526,
,H,BAO_0000019,,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in rat cell at 1 uM,4238,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL620858,10193,
,H,BAO_0000019,,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in rat cell at 10 uM,4239,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL620859,10193,
,H,BAO_0000019,,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in rat cell at 1 uM,4240,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL620860,10193,
,H,BAO_0000019,,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in rat cell at 3 uM,4241,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL620861,10193,
,H,BAO_0000357,,Percent inhibition of rat neutrophil 5-lipoxygenase (5-LO),4242,Expert,,8,,,,,,1,,12166,B,,,CHEMBL620862,9138,
,H,BAO_0000357,,Percent inhibition of rat neutrophil 5- Lipoxygenase (5-LO) at 100 uM,4243,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL620863,9138,
,H,BAO_0000019,,Tested in vitro for the inhibition of 5-lipoxygenase in cell-free preparations from rat PMN leukocytes,4244,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL620864,11966,
,H,BAO_0000219,,The compound was evaluated in vitro for inhibition of 5-lipoxygenase activity in RBL-1 cells at 100 uM,4245,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620865,165,
,H,BAO_0000219,,The compound was evaluated in vitro for inhibition of 5-lipoxygenase activity in RBL-1 cells at 30 uM,4246,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620866,165,
,H,BAO_0000219,,The compound was tested for inhibition of 5-lipoxygenase in rat RBL-2H3 cells,4247,Autocuration,,8,,,663.0,,,1,RBL-2H3,12166,B,,,CHEMBL620867,11311,
,H,BAO_0000219,,The compound was tested for inhibition of 5-lipoxygenase translocation in SAR in rat RBL-2H3 cells,4248,Autocuration,,8,,,663.0,,,1,RBL-2H3,12166,B,,,CHEMBL620868,11311,
,H,BAO_0000219,,The compound was tested for inhibition of 5-lipoxygenase translocation in SAR in rat RBL-2H3 cells,4249,Autocuration,,8,,,663.0,,,1,RBL-2H3,12166,F,,,CHEMBL620869,11311,
,H,BAO_0000019,,The compound was tested for inhibition of LTB4 synthesis on isolated 5-lipoxygenase,4250,Autocuration,,8,,,,,,1,,12166,F,,,CHEMBL873952,11311,
,H,BAO_0000357,,The compound was tested for inhibition of isolated 5-lipoxygenase,4251,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL875099,11311,
,H,BAO_0000219,,The compound was tested for inhibition of isolated 5-lipoxygenase translocation into rat RBL-2H3 cells,4252,Autocuration,,8,,,663.0,,,1,RBL-2H3,12166,F,,,CHEMBL620870,11311,
,H,BAO_0000019,,The compound was tested for the in vitro inhibition of 5-lipoxygenase (5-lo) from the 20000 g supernatant of RBI-1 cells at a concentration of 30 uM,4253,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL618261,11087,
,H,BAO_0000019,,The compound was tested for the in vitro inhibition of 5-lipoxygenase (5-lo) from the 20000 g supernatant of RBI-1 cells at a concentration of 32 uM,4254,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL618262,11087,
,H,BAO_0000019,,The compound was tested for the in vitro inhibition of 5-lipoxygenase (5-lo) from the 20000 g supernatant of RBI-1 cells measured at a concentration of 30 uM,4255,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619428,11087,
,H,BAO_0000019,,The compound was tested for the in vitro inhibition of 5-lipoxygenase (5-lo) from the 20000 g supernatant of RBI-1 cells; NS indicates nonsignificant inhibition at 32 uM concentration,4256,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619429,11087,
,H,BAO_0000019,,The compound was tested for the in vitro inhibition of 5-lipoxygenase from the 20000 g supernatant of RBI-1 cells; NS indicates nonsignificant inhibition at 32 uM concentration,4257,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL619430,11087,
,H,BAO_0000219,,The compound was tested for the inhibition of 5-lipoxygenase in intact basophilic rat leukemia cells at 1.0 uM,4258,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620017,496,
,H,BAO_0000219,,The compound was tested for the inhibition of 5-lipoxygenase in intact basophilic rat leukemia cells at 10 uM,4259,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL620018,496,
,H,BAO_0000219,,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by 5-HETE production at 0.1 uM,4260,Autocuration,,8,,,702.0,,,1,RBL-1,12166,F,,,CHEMBL620019,13986,
,H,BAO_0000219,,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by 5-HETE production at 0.195 uM,4261,Autocuration,,8,,,702.0,,,1,RBL-1,12166,F,,,CHEMBL620020,13986,
,H,BAO_0000219,,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by 5-HETE production at 0.2 at uM,4262,Autocuration,,8,,,702.0,,,1,RBL-1,12166,F,,,CHEMBL620021,13986,
,H,BAO_0000219,,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by 5-HETE production at 0.25 uM,4263,Autocuration,,8,,,702.0,,,1,RBL-1,12166,F,,,CHEMBL620022,13986,
,H,BAO_0000219,,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by 5-HETE production at 0.39,4264,Autocuration,,8,,,702.0,,,1,RBL-1,12166,F,,,CHEMBL620023,13986,
,H,BAO_0000219,,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by 5-HETE production at 0.39 uM,4265,Autocuration,,8,,,702.0,,,1,RBL-1,12166,F,,,CHEMBL620024,13986,
,H,BAO_0000219,,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by measuring 5-HETE production at 0.195 uM,4266,Autocuration,,8,,,702.0,,,1,RBL-1,12166,F,,,CHEMBL620025,13986,
,H,BAO_0000219,,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by measuring 5-HETE production at 0.2 uM,4267,Autocuration,,8,,,702.0,,,1,RBL-1,12166,F,,,CHEMBL620026,13986,
,H,BAO_0000219,,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by measuring 5-HETE production at 0.39 uM,4268,Autocuration,,8,,,702.0,,,1,RBL-1,12166,F,,,CHEMBL620027,13986,
,D,BAO_0000019,,Inhibition of 5-lipoxygenase on rat basophil leukemia cell (RBL-2H3) lysate as 5-HETE production at 32 uM,4269,Expert,,9,,,,,10116.0,1,,12166,F,Rattus norvegicus,,CHEMBL620028,13986,
,H,BAO_0000357,,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase,4270,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL620029,10193,
,H,BAO_0000357,,Compound was tested for the percent of inhibition against 5-LO at 10 uM,4271,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL620030,9295,
,H,BAO_0000219,,In vitro percent inhibition against 5-lipoxygenase in RBL-1 cells at 1 uM concentration,4272,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL875415,4717,
,H,BAO_0000219,,In vitro percent inhibition against 5-lipoxygenase in RBL-1 cells at 10 uM concentration,4273,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL618256,4717,
,H,BAO_0000219,,Inhibition of LTB4 in whole cell 5-lipoxygenase assay in an intact rat basophilic leukemia (RBL-1) cell line,4274,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL618257,11854,
,H,BAO_0000219,,Inhibition of LTB4 in whole cell 5-lipoxygenase assay in an intact rat basophilic leukemia (RBL-1) cell line at 10 uM,4275,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL618258,11854,
,H,BAO_0000219,,Inhibition of LTB4 in whole cell 5-lipoxygenase assay in an intact rat basophilic leukemia (RBL-1) cell line at 16 uM,4276,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL618259,11854,
,H,BAO_0000019,,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in rat cell at 10 uM,4277,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL618260,10193,
,H,BAO_0000219,,Percent inhibition against RBL-1 5-LO in vitro at 10 uM,4278,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL618215,9295,
,H,BAO_0000219,,Percent inhibition against RBL-1 5-LO in vitro at 100 uM,4279,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL618390,9295,
,H,BAO_0000219,,Percent inhibition against RBL-1 5-LO in vitro at 30 uM,4280,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL618391,9295,
,H,BAO_0000219,,Percent inhibition against RBL-1 5-LO in vitro at 300 uM,4281,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL618392,9295,
,H,BAO_0000219,,The compound was evaluated in vitro for inhibition of 5-lipoxygenase activity in RBL-1 cells at 20 uM,4282,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL618393,165,
,H,BAO_0000219,,The compound was tested for inhibition against 5-lipoxygenase in rat polymorphonuclear leukocytes[PMNS] at 10 uM concentration,4283,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL618394,11311,
,H,BAO_0000219,,In vitro inhibitory activity against 5-lipoxygenase in rat basophilic leukemia cells(RBL-1),4284,Expert,,8,,,702.0,,9606.0,1,RBL-1,12166,B,Homo sapiens,,CHEMBL618395,10489,
,D,BAO_0000219,,In vitro inhibitory activity against 5-lipoxygenase in rat basophilic leukemia cells(RBL-1),4285,Expert,,9,,,702.0,,10116.0,1,RBL-1,12166,B,Rattus norvegicus,,CHEMBL618396,10489,
,D,BAO_0000219,,Logarithmic value of inhibitory concentration against 5-lipoxygenase in rat basophilic leukemia cells (RBL-1),4286,Expert,,9,,,702.0,,10116.0,1,RBL-1,12166,B,Rattus norvegicus,,CHEMBL858253,10489,
,D,BAO_0000019,,Inhibitory activity against 5-lipoxygenase obtained from rat basophilic leukemia cells,4287,Autocuration,,9,,,,,10116.0,1,,12166,B,Rattus norvegicus,,CHEMBL618397,14799,
,H,BAO_0000357,,Compound was tested for the percent of inhibition against soybean 15-LO (at 100 uM),4288,Autocuration,,8,,,,,3847.0,1,,12054,B,Glycine max,,CHEMBL618398,9295,
,U,BAO_0000019,,"Inhibitory activity against 5-lipoxygenase, by using soybean lipoxygenase spectrophotometric assay",4289,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL618399,16811,
,H,BAO_0000357,,In vitro inhibition of 5-Lipoxygenase; Inactive.,4290,Expert,,8,,,,,,1,,55,B,,,CHEMBL618400,168,
,H,BAO_0000357,,Inhibitory concentration against 5-lipoxygenase was determined; No inhibition,4291,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618401,6309,
,H,BAO_0000357,,Inhibitory concentration against 5-lipoxygenase; No inhibition,4292,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618402,6309,
,H,BAO_0000219,,Evaluated for inhibitory activity against RBL-1 cell 5-lipoxygenase in guinea pig,4293,Autocuration,,8,,,702.0,,,1,RBL-1,55,B,,,CHEMBL876400,3092,
,H,BAO_0000357,,Inhibitory activity against 5-lipoxygenase.,4294,Expert,,8,,,,,,1,,55,B,,,CHEMBL618403,168,
,H,BAO_0000357,,Inhibitory Activity against 5-Lipoxygenase was determined; IA=Inactive,4295,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618404,168,
,H,BAO_0000357,,Inhibitory Activity against 5-Lipoxygenase was determined; IA=Inactive at concentrations less than 32 uM,4296,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618405,168,
,H,BAO_0000357,,Inhibitory Activity against 5-Lipoxygenase was determined; NA=No significant inhibitory activity up to 300 uM,4297,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618406,168,
,H,BAO_0000019,,Inhibitory concentration against arachidonic acid 5-lipoxygenation,4298,Expert,,8,,,,,,1,,55,F,,,CHEMBL618407,12338,
,H,BAO_0000357,,Tested for the inhibitory activity against 5-lipoxygenase,4299,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618408,4501,
,H,BAO_0000357,,Compound was tested for its inhibitory activity against 5-lipoxygenase,4300,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618409,1132,
,H,BAO_0000357,,Compound was tested for inhibition of 5-lipoxygenase at 50 uM; NI means no inhibition was observed,4301,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618410,2117,
,H,BAO_0000357,,Inhibitory Activity against 5-Lipoxygenase at 30 uM was determined; Weakly active,4302,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618411,168,
,H,BAO_0000357,,Inhibitory Activity against 5-Lipoxygenase at concentration 32 uM was determined,4303,Autocuration,,8,,,,,,1,,55,B,,,CHEMBL618412,168,
,H,BAO_0000219,,Concentration required to inhibit RBL-1 supernatant 5-lipoxygenase,4304,Autocuration,,8,,,702.0,,,1,RBL-1,12166,B,,,CHEMBL618413,13575,
,H,BAO_0000357,,,4305,Autocuration,,8,,,,,,1,,12166,B,,,CHEMBL618414,11089,
,H,BAO_0000357,,Compound was tested for its binding activity towards 5-lipoxygenase activating protein (FLAP),4306,Autocuration,,8,,,,,,1,,10102,B,,,CHEMBL618415,216,
,H,BAO_0000019,,Inhibition of 5-lipoxygenase activating protein using human leukocyte membrane preparations,4307,Autocuration,,8,,,,,,1,,10102,B,,,CHEMBL618416,13165,
,H,BAO_0000357,,Measuring the affinity of leukotriene synthesis inhibitor for 5-Lipoxygenase activating protein (FLAP) by using [125I]L-691831 as radioligand.,4308,Autocuration,,8,,,,,,1,,10102,B,,,CHEMBL876401,3278,
,H,BAO_0000357,,Measuring the affinity of leukotriene synthesis inhibitor for 5-lipoxygenase activating protein by using [125I]L-691831 as radioligand.,4309,Expert,,8,,,,,,1,,10102,B,,,CHEMBL618417,3278,
,H,BAO_0000357,,Tested for inhibition of leukotriene biosynthesis by binding to 5-lipoxygenase activating protein,4310,Autocuration,,8,,,,,,1,,10102,B,,,CHEMBL618418,11966,
,H,BAO_0000357,,"The compound was tested for the inhibition of binding of [125I]- L- 691,831 binding to 5-lipoxygenase activating protein",4311,Autocuration,,8,,,,,,1,,10102,B,,,CHEMBL618419,175,
,H,BAO_0000357,,"The compound was tested for the inhibition of binding of [125I]- L- 691,831 binding to 5-lipoxygenase activating protein (FLAP)",4312,Autocuration,,8,,,,,,1,,10102,B,,,CHEMBL618420,175,
,H,BAO_0000357,,Binding affinity of compound for 5-lipoxygenase activating protein protein by FLAP binding assay,4313,Autocuration,,8,,,,,,1,,10102,B,,,CHEMBL618421,13449,
,H,BAO_0000019,,Tested for inhibition of 5-phosphatase isolated from human erythrocyte membrane,4314,Autocuration,,8,,,,,,1,,11238,B,,,CHEMBL618422,12014,
,H,BAO_0000019,,Tested for inhibition of 5-phosphatase isolated from human erythrocyte membrane (R metabolically resistant),4315,Autocuration,,8,,,,,,1,,11238,B,,,CHEMBL618423,12014,
,H,BAO_0000019,,Tested for inhibition of 5-phosphatase isolated from human erythrocyte membrane (S substrate),4316,Autocuration,,8,,,,,,1,,11238,B,,,CHEMBL618424,12014,
,S,BAO_0000220,,Inhibition of protein biosynthesis at the level of the peptidyl transferase center of the 50 s ribosomal subunit,4317,Intermediate,,2,,,,,,1,,100284,B,,,CHEMBL618425,99,
,U,BAO_0000019,,The dark toxicity against 543 human galactophore carcinoma cells,4318,Autocuration,,0,,,,,9606.0,1,,22226,F,Homo sapiens,,CHEMBL618426,4349,
,N,BAO_0000219,,Tested in vitro for cytotoxicity against 56 human tumor cell lines,4319,Expert,,1,,,390.0,,9606.0,1,Panel (56 tumour cell lines),80623,F,Homo sapiens,,CHEMBL618427,4071,
,N,BAO_0000219,,Cytotoxic activity against human 5637 cell line at 20 uM expressed as percent growth value,4320,Expert,,1,,,345.0,,9606.0,1,5637,80008,F,Homo sapiens,,CHEMBL618428,17589,
,N,BAO_0000219,,Antitumor activity was evaluated against human bladder carcinoma cell line 5637.,4321,Intermediate,,1,,,345.0,,9606.0,1,5637,80008,F,Homo sapiens,,CHEMBL618429,15002,
,N,BAO_0000219,,"Compound was tested for antiproliferative activity against 5637, human bladder carcinoma cell line",4322,Intermediate,,1,,,345.0,,9606.0,1,5637,80008,F,Homo sapiens,,CHEMBL618430,13958,
,N,BAO_0000219,,Growth inhibition against human 5637 cell lines,4323,Expert,,1,,,345.0,,9606.0,1,5637,80008,F,Homo sapiens,,CHEMBL618431,17589,
,N,BAO_0000219,,Antitumor activity against human bladder carcinoma 5637 cells.,4324,Expert,,1,,,345.0,,9606.0,1,5637,80008,F,Homo sapiens,,CHEMBL883799,16748,
,N,BAO_0000219,,Antitumor activity against human bladder carcinoma 5637 cells,4325,Intermediate,,1,,,345.0,,9606.0,1,5637,80008,F,Homo sapiens,,CHEMBL618432,16747,
,N,BAO_0000219,,Antitumor activity against human bladder carcinoma 5637 cells,4326,Intermediate,,1,,,345.0,,9606.0,1,5637,80008,F,Homo sapiens,,CHEMBL618433,16747,
,D,BAO_0000357,,In vitro inhibition of bovine trypsin(Trp).,4327,Expert,,9,,,,,9913.0,1,,10443,B,Bos taurus,,CHEMBL618434,15285,
,H,BAO_0000219,,Transcriptional activation in CV-1 cells expressing retinoic acid gamma receptor,4328,Expert,,8,,,407.0,,9527.0,1,CV-1,240,B,Cercopithecidae,,CHEMBL618435,3726,
,H,BAO_0000357,,Ability to displace the radioligand [125I](-)-iodocyanopindolol from rat striatal 5-HT1B receptor,4329,Autocuration,,8,,,,,,1,,10577,B,,,CHEMBL876402,5033,
,H,BAO_0000019,,In vitro antagonism of the 5-HT-3 receptor determined by inhibition of 5-HT-induced depolarization of the isolated rat vagus nerve.,4330,Autocuration,,6,,,,,,1,,104698,F,,,CHEMBL618436,11756,
,U,BAO_0000218,,Concentration required to inhibit pressor response to serotonin after 15 min i.v. administration of compound mediated via activation of vascular 5-HT2 receptors in rat,4331,Autocuration,,0,,In vivo,,,,1,,22226,F,,,CHEMBL618437,11953,
,D,BAO_0000357,,Ability to displace the radioligand [3H]GR-113808 from guinea pig striatum 5-HT4 receptor,4332,Intermediate,,9,,,,,10141.0,1,,20033,B,Cavia porcellus,,CHEMBL618438,5033,
,H,BAO_0000251,,Inhibition of progesterone 6-beta-hydroxylase in rat hepatic microsomes,4333,Expert,,8,Microsomes,,,,10116.0,1,,17045,A,Rattus norvegicus,,CHEMBL883800,11347,
,H,BAO_0000251,,Inhibition of progesterone 6-beta-hydroxylase in rat hepatic microsomes,4334,Expert,,8,Microsomes,,,,10116.0,1,,17045,A,Rattus norvegicus,,CHEMBL618439,11347,
,U,BAO_0000019,,In vitro anticancer activity against 6 NCI ovarian cancer cell lines; inactive,4335,Intermediate,,0,,,,,,1,,22226,F,,,CHEMBL618440,1229,
,U,BAO_0000019,,In vitro anticancer activity against 6 NCI ovarian cancer cell lines; inactive,4336,Intermediate,,0,,,,,,1,,22226,F,,,CHEMBL618441,1229,
,H,BAO_0000019,,Inhibition constant against 6-phosphogluconate dehydrogenase of Trypanosoma brucei expressed in Escherichia coli,4337,Expert,,8,,,,,5691.0,1,,11938,B,Trypanosoma brucei,,CHEMBL618442,17588,
,H,BAO_0000019,,Inhibition constant against 6-phosphogluconate dehydrogenase of Trypanosoma brucei expressed in Escherichia coli; NI denotes no inhibition,4338,Autocuration,,8,,,,,5691.0,1,,11938,B,Trypanosoma brucei,,CHEMBL618443,17588,
,H,BAO_0000019,,Inhibition constant against 6-phosphogluconate dehydrogenase of sheep liver,4339,Expert,,8,,,,,9940.0,1,,11938,B,Ovis aries,,CHEMBL619158,17588,
,H,BAO_0000019,,Inhibition constant against 6-phosphogluconate dehydrogenase of sheep liver; NI denotes no inhibition,4340,Autocuration,,8,,,,,9940.0,1,,11938,B,Ovis aries,,CHEMBL620974,17588,
,H,BAO_0000357,,log Kd which is the binding affinity against 6-phosphogluconate dehydrogenase,4341,Autocuration,,8,,,,,,1,,11938,B,,,CHEMBL620975,16485,
,U,BAO_0000019,,Average inhibitory concentration against 60 human cell lines was reported,4342,Intermediate,,0,,,,,9606.0,1,,22226,F,Homo sapiens,,CHEMBL620976,4337,
,U,BAO_0000019,,Inhibition of proliferation in NCI panel of 60 human tumor cell lines,4343,Expert,,0,,,,,9606.0,1,,22226,F,Homo sapiens,,CHEMBL620977,4112,
,N,BAO_0000219,,Cancer specificity was measured from the +/- value under average log LC50 60-cell line,4344,Intermediate,,1,,,542.0,,9606.0,1,Panel NCI-60 (60 carcinoma cell lines),80315,F,Homo sapiens,,CHEMBL620978,16160,
,N,BAO_0000219,,Cancer specificity was measured from the +/- value under average log LC50 60-cell line. ,4345,Intermediate,,1,,,542.0,,9606.0,1,Panel NCI-60 (60 carcinoma cell lines),80315,F,Homo sapiens,,CHEMBL620979,16160,
,N,BAO_0000219,,In vitro mean growth inhibitory activity against 60-cell panel,4346,Expert,,1,,,542.0,,,1,Panel NCI-60 (60 carcinoma cell lines),80315,F,,,CHEMBL620980,17376,
,N,BAO_0000219,,In vitro mean growth lethal concentration against 60-cell panel,4347,Expert,,1,,,542.0,,,1,Panel NCI-60 (60 carcinoma cell lines),80315,F,,,CHEMBL620981,17376,
,N,BAO_0000219,,In vitro mean growth lethal concentration in colon subpanel against 60-cell panel,4348,Expert,,1,,,542.0,,,1,Panel NCI-60 (60 carcinoma cell lines),80315,F,,,CHEMBL620982,17376,
,N,BAO_0000219,,In vitro mean growth lethal concentration in renal subpanel against 60-cell panel,4349,Expert,,1,,,542.0,,,1,Panel NCI-60 (60 carcinoma cell lines),80315,F,,,CHEMBL620983,17376,
,H,BAO_0000019,,Inhibition of CK-II-mediated 60S acidic ribosomal P protein activity at 10 uM,4350,Autocuration,,4,,,,,,1,,104775,F,,,CHEMBL620984,3241,
,H,BAO_0000019,,Inhibition of CK-II-mediated 60S acidic ribosomal P protein activity at 10 uM,4351,Autocuration,,4,,,,,,1,,104775,F,,,CHEMBL620985,3241,
,H,BAO_0000357,,Transcriptional activation in CV-1 expressing retinoid X receptor RXR alpha,4352,Expert,,8,,,,,,1,,275,B,,,CHEMBL620986,3725,
,N,BAO_0000218,,Inhibitory activity against Plasmodium falciparum 68 neutral proteinase,4353,Expert,,1,,,,,5833.0,1,,50425,F,Plasmodium falciparum,,CHEMBL620987,10805,
,N,BAO_0000218,,In vitro inhibition of Plasmodium falciparum 68 neutral proteinase activity by reinvasion of red blood cells,4354,Expert,,1,,,,,5833.0,1,,50425,F,Plasmodium falciparum,,CHEMBL620988,10805,
,N,BAO_0000218,,Inhibitory activity against Plasmodium falciparum 68 neutral proteinase.,4355,Expert,,1,,,,,5833.0,1,,50425,F,Plasmodium falciparum,,CHEMBL620989,10805,
,N,BAO_0000218,,Substrate affinity for Plasmodium falciparum 68 neutral proteinase.,4356,Expert,,1,,,,,5833.0,1,,50425,F,Plasmodium falciparum,,CHEMBL620990,10805,
,N,BAO_0000218,,Reaction velocity for Plasmodium falciparum 68 neutral proteinase.,4357,Intermediate,,1,,,,,5833.0,1,,50425,F,Plasmodium falciparum,,CHEMBL620991,10805,
,N,BAO_0000218,,Percent inhibition against 6C3HED lymphosarcoma at dose 100 mg/kg in C3H mice,4358,Intermediate,,1,,,850.0,,10090.0,1,6C3HED,80628,F,Mus musculus,,CHEMBL620992,10144,
,N,BAO_0000218,,Percent inhibition against 6C3HED lymphosarcoma at dose 12.5 mg/kg in C3H mice,4359,Intermediate,,1,,,850.0,,10090.0,1,6C3HED,80628,F,Mus musculus,,CHEMBL620993,10144,
,N,BAO_0000218,,Percent inhibition against 6C3HED lymphosarcoma at dose 200 mg/kg in C3H mice,4360,Intermediate,,1,,,850.0,,10090.0,1,6C3HED,80628,F,Mus musculus,,CHEMBL620994,10144,
,N,BAO_0000218,,Percent inhibition against 6C3HED lymphosarcoma at dose 25 mg/kg in C3H mice,4361,Intermediate,,1,,,850.0,,10090.0,1,6C3HED,80628,F,Mus musculus,,CHEMBL620995,10144,
,N,BAO_0000218,,Percent inhibition against 6C3HED lymphosarcoma at dose 50 mg/kg in C3H mice,4362,Intermediate,,1,,,850.0,,10090.0,1,6C3HED,80628,F,Mus musculus,,CHEMBL620996,10144,
,N,BAO_0000218,,Percent inhibition against 6C3HED lymphosarcoma at dose 6 mg/kg in C3H mice,4363,Intermediate,,1,,,850.0,,10090.0,1,6C3HED,80628,F,Mus musculus,,CHEMBL875581,10144,
,U,BAO_0000218,,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 100 mg/kg,4364,Autocuration,,0,,In vivo,,,10090.0,1,,22224,F,Mus musculus,,CHEMBL620997,10685,
,U,BAO_0000218,,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 150 mg/kg,4365,Autocuration,,0,,In vivo,,,10090.0,1,,22224,F,Mus musculus,,CHEMBL620998,10685,
,U,BAO_0000218,,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 1600 mg/kg (intraperitoneal dosing for 8 days),4366,Autocuration,,0,,In vivo,,,10090.0,1,,22224,F,Mus musculus,,CHEMBL620999,10685,
,U,BAO_0000218,,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 200 mg/kg,4367,Autocuration,,0,,In vivo,,,10090.0,1,,22224,F,Mus musculus,,CHEMBL621000,10685,
,U,BAO_0000218,,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 225 mg/kg,4368,Autocuration,,0,,In vivo,,,10090.0,1,,22224,F,Mus musculus,,CHEMBL621001,10685,
,U,BAO_0000218,,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 270 mg/kg,4369,Autocuration,,0,,In vivo,,,10090.0,1,,22224,F,Mus musculus,,CHEMBL621002,10685,
,U,BAO_0000218,,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 275 mg/kg,4370,Autocuration,,0,,In vivo,,,10090.0,1,,22224,F,Mus musculus,,CHEMBL621003,10685,
,U,BAO_0000218,,"Antitumor activity in vivo against the 6C3HED lymphosarcoma, dosed for 10 days at 300 mg/kg",4371,Autocuration,,0,,In vivo,,,10090.0,1,,22224,F,Mus musculus,,CHEMBL621004,10685,
,U,BAO_0000218,,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 300 mg/kg (intraperitoneal dosing for 8 days),4372,Autocuration,,0,,In vivo,,,10090.0,1,,22224,F,Mus musculus,,CHEMBL621005,10685,
,U,BAO_0000218,,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 300 mg/kg (ip dosing daily for 8 days),4373,Autocuration,,0,,In vivo,,,10090.0,1,,22224,F,Mus musculus,,CHEMBL621006,10685,
,U,BAO_0000218,,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 600 mg/kg,4374,Autocuration,,0,,In vivo,,,10090.0,1,,22224,F,Mus musculus,,CHEMBL621007,10685,
,U,BAO_0000218,,Percent inhibition against 6C3HED lymphosarcoma at dose 100 mg/kg in C3H mice,4375,Autocuration,,0,,,,,10090.0,1,,22224,F,Mus musculus,,CHEMBL621008,10144,
,U,BAO_0000218,,Percent inhibition against 6C3HED lymphosarcoma at dose 12.5 mg/kg in C3H mice,4376,Autocuration,,0,,,,,10090.0,1,,22224,F,Mus musculus,,CHEMBL621009,10144,
,U,BAO_0000218,,Percent inhibition against 6C3HED lymphosarcoma at dose 25 mg/kg in C3H mice,4377,Autocuration,,0,,,,,10090.0,1,,22224,F,Mus musculus,,CHEMBL857705,10144,
,U,BAO_0000218,,Percent inhibition against 6C3HED lymphosarcoma at dose 50 mg/kg in C3H mice,4378,Autocuration,,0,,,,,10090.0,1,,22224,F,Mus musculus,,CHEMBL619828,10144,
,U,BAO_0000218,,Tested on 6C3HED lymphosarcoma and percent inhibition was determined at 100 mg/kg dosage administered for 8 days intraperitoneally,4379,Autocuration,,0,,,,,10090.0,1,,22224,F,Mus musculus,,CHEMBL619829,10685,
,U,BAO_0000218,,Tested on 6C3HED lymphosarcoma and percent inhibition was determined at 200 mg/kg dosage administered for 10 days intraperitoneally,4380,Autocuration,,0,,,,,10090.0,1,,22224,F,Mus musculus,,CHEMBL619830,10685,
,U,BAO_0000218,,Tested on 6C3HED lymphosarcoma and percent inhibition was determined at 200 mg/kg dosage administered for 8 days intraperitoneally,4381,Autocuration,,0,,,,,10090.0,1,,22224,F,Mus musculus,,CHEMBL619831,10685,
,U,BAO_0000218,,Tested on 6C3HED lymphosarcoma and percent inhibition was determined at 50 mg/kg dosage administered for 8 days intraperitoneally,4382,Autocuration,,0,,,,,10090.0,1,,22224,F,Mus musculus,,CHEMBL619832,10685,
,U,BAO_0000218,,Tested on 6 C3 HED lymphosarcoma and number of drug related deaths/total animals in treatment group was determined at 100 mg/kg dosage administered for 8 days intraperitoneally; 0/10,4383,Autocuration,,0,,,,,10090.0,1,,22224,A,Mus musculus,,CHEMBL619833,10685,
,U,BAO_0000218,,Tested on 6 C3 HED lymphosarcoma and number of drug related deaths/total animals in treatment group was determined at 200 mg/kg dosage administered for 8 days perorally; 1/10,4384,Autocuration,,0,,,,,10090.0,1,,22224,A,Mus musculus,,CHEMBL619834,10685,
,U,BAO_0000218,,Tested on 6 C3 HED lymphosarcoma and number of drug related deaths/total animals in treatment group was determined at 200 mg/kg dosage administered for 10 days intraperitoneally; 1/10,4385,Autocuration,,0,,,,,10090.0,1,,22224,A,Mus musculus,,CHEMBL619835,10685,
,U,BAO_0000218,,Tested on 6 C3 HED lymphosarcoma and number of drug related deaths/total animals in treatment group was determined at 50 mg/kg dosage administered for 8 days perorally; 3/10,4386,Autocuration,,0,,,,,10090.0,1,,22224,A,Mus musculus,,CHEMBL619836,10685,
,N,BAO_0000218,,"Compound was evaluated for the antitumor activity against 6C3HED lymphosarcoma for ip administration and daily x 8 schedule; Number of toxic deaths over total number of mice per group (T/C), 0/10 at dose of 35 mg/kg",4387,Intermediate,,1,,,850.0,,10090.0,1,6C3HED,80628,F,Mus musculus,,CHEMBL619837,8831,
,U,BAO_0000218,,In vivo antitumor activity against 6C3HED tumor type after intraperitoneal administration of 400 mg/kg,4388,Autocuration,,0,,In vivo,,,,1,,22224,F,,,CHEMBL619838,11704,
,N,BAO_0000218,,In vivo antitumor activity against 6C3HED tumor type was expressed as toxic deaths/total treated mice at 400 mg/kg dose; 2/10,4389,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619839,11704,
,N,BAO_0000218,,Antitumor activity in vivo expressed as percent of inhibition in 6C3HED-lymphosarcoma tumor cell line,4390,Intermediate,,1,,In vivo,850.0,,10090.0,1,6C3HED,80628,F,Mus musculus,,CHEMBL619840,10685,
,N,BAO_0000218,,Antitumor activity in vivo expressed as percent of inhibition in 6C3HED-lymphosarcoma tumor cell line; 95-100% inhibition,4391,Intermediate,,1,,In vivo,850.0,,10090.0,1,6C3HED,80628,F,Mus musculus,,CHEMBL619841,10685,
,N,BAO_0000218,,Inhibition of tumor growth of 6C3HED lymphosarcoma tumor cell line in mice at a dose of 150 mg/kg given orally(daily x 8),4392,Expert,,1,,,850.0,,10090.0,1,6C3HED,80628,F,Mus musculus,,CHEMBL857704,11368,
,N,BAO_0000218,,Inhibition of tumor growth of 6C3HED lymphosarcoma tumor cell line in mice at a dose of 200 mg/kg given orally(daily x 8),4393,Intermediate,,1,,,850.0,,10090.0,1,6C3HED,80628,F,Mus musculus,,CHEMBL619842,11368,
,N,BAO_0000218,,Inhibition of tumor growth of 6C3HED lymphosarcoma tumor cell line in mice at a dose of 300 mg/kg given orally (daily x 8),4394,Expert,,1,,,850.0,,10090.0,1,6C3HED,80628,F,Mus musculus,,CHEMBL619843,11368,
,U,BAO_0000019,,"Inhibition of Staphylococcus aureus 7,8-dihydroneopterin aldolase",4395,Autocuration,,0,,,,,1280.0,1,,22226,B,Staphylococcus aureus,,CHEMBL619844,17763,
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes 3-methylcholanthrene at a concentration of 5 uM,4396,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL857855,7411,Liver
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at a concentration of 10 uM,4397,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL619845,7411,Liver
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at a concentration of 1 uM,4398,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL619846,7411,Liver
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at a concentration of 20 uM,4399,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL619847,7411,Liver
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at a concentration of 25 uM,4400,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL619848,7411,Liver
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at a concentration of 50 uM,4401,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL620893,7411,Liver
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at a concentration of 5 uM,4402,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL620894,7411,Liver
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 10 uM,4403,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL620895,7411,Liver
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 100 uM,4404,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL620896,7411,Liver
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 200 uM,4405,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL620897,7411,Liver
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 25 uM,4406,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL620898,7411,Liver
,U,BAO_0000251,,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 50 uM,4407,Autocuration,2107.0,0,Microsomes,,,,10116.0,1,,22226,B,Rattus norvegicus,,CHEMBL620899,7411,Liver
,U,BAO_0000218,,The apparent total plasma clearance in monkey,4408,Autocuration,1969.0,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620900,347,Plasma
,U,BAO_0000218,,Compound was evaluated for Hepatic clearance in monkey,4409,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620901,3341,
,U,BAO_0000218,,Lower clearance in monkey (i.v.) at 0.5 mpk,4410,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620902,17853,
,U,BAO_0000218,,Plasma clearance in rhesus monkey,4411,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620903,4514,
,U,BAO_0000218,,Plasma clearance for the compound was measured in monkey after an iv dose of 1 mg/kg,4412,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620904,6062,
,U,BAO_0000218,,Plasma clearance of compound was determined in monkey,4413,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620905,6821,
,U,BAO_0000218,,Plasma clearance was calculated in rhesus monkey,4414,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620906,6057,
,U,BAO_0000218,,Plasma clearance in rhesus monkey,4415,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL875420,5145,
,U,BAO_0000218,,Plasma clearance in monkey (dosed at 0.5 mpk iv and 2.0 mpk orally),4416,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620907,6641,
,U,BAO_0000218,,Plasma clearance was evaluated in rhesus,4417,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620908,5472,
,U,BAO_0000218,,Plasma clearance value was determined in monkey after a 3 mg/kg of iv dose,4418,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620909,4257,
,U,BAO_0000218,,Plasma clearance was determined in rhesus monkey at a dose of 1 mg/kg by iv administration,4419,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620910,5546,
,U,BAO_0000218,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Rhesus monkey (male),4420,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620911,5334,
,U,BAO_0000218,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Rhesus monkey (male),4421,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620912,5334,
,U,BAO_0000218,,Cmax 24 hr after 2 mg/kg oral administration in monkeys,4422,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620913,17509,
,U,BAO_0000218,,Cmax in monkey after administration of 1 mg/kg iv,4423,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620914,6535,
,U,BAO_0000218,,Cmax was determine after peroral administration at 10 mpk in Rhesus,4424,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620915,5668,
,U,BAO_0000218,,Cmax in cynomolgus monkey by iv administration,4425,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620916,5922,
,U,BAO_0000218,,Cmax in cynomolgus monkey by po administration,4426,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620917,5922,
,U,BAO_0000218,,Cmax value evaluated in monkey,4427,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620918,6078,
,U,BAO_0000218,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female cynomolgus monkey,4428,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620919,2661,
,U,BAO_0000218,,Maximal concentration (Cmax) in rhesus monkey plasma at a dose of 5 mg/kg,4429,Autocuration,1969.0,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620920,3249,Plasma
,U,BAO_0000218,,Maximal concentration (Cmax) in squirrel monkey plasma at a dose of 5 mg/kg,4430,Autocuration,1969.0,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620921,3249,Plasma
,U,BAO_0000218,,Maximal plasma concentration in squirrel monkeys,4431,Autocuration,1969.0,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620922,5553,Plasma
,U,BAO_0000218,,Maximum concentration was evaluated against Cynomolgus monkey at a dose of 15 mg/kg after po administration,4432,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620923,1916,
,U,BAO_0000218,,Maximum plasma concentration (Cmax) in rhesus monkey(in vivo) at a dose of 5 mg/kg,4433,Autocuration,1969.0,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620924,6227,Plasma
,U,BAO_0000218,,Pharmacokinetic parameter Cmax was determined in monkey after (po) administration of a dose of 50 (uM/kg),4434,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620925,4809,
,U,BAO_0000218,,The peak concentration (Cmax) value after intravenous administration in cynomolgus monkeys; NA means Not applicable,4435,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620926,5355,
,U,BAO_0000218,,The peak concentration (Cmax) value after intravenous administration in cynomolgus monkeys; NA means not applicable,4436,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620927,5355,
,U,BAO_0000218,,The peak concentration (Cmax) value after intravenous administration in cynomolgus monkeys;NA means not applicable,4437,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620928,5355,
,U,BAO_0000218,,The peak concentration (Cmax) value after oral administration in cynomolgus monkeys,4438,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620929,5355,
,U,BAO_0000218,,The peak plasma concentration after 5 hr administration (2.5 mg/kg) in monkey was determined,4439,Autocuration,1969.0,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620930,6221,Plasma
,U,BAO_0000218,,Compound was evaluated for Plasma levels upon oral administration at 30 mg/kg in Monkey at maximum of 0.4 hours,4440,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620931,167,
,U,BAO_0000218,,Compound was evaluated for Plasma levels upon oral administration at 30 mg/kg in Monkey at maximum of 1.0 hours,4441,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620932,167,
,U,BAO_0000218,,Absolute bioavailability was evaluated in monkey,4442,Autocuration,,0,,In vivo,,,9443.0,1,,22224,A,monkey,,CHEMBL620933,4257,
,U,BAO_0000218,,Bioavailability after oral administration (2.5 mg/kg) in monkey was determined,4443,Autocuration,,0,,In vivo,,,9443.0,1,,22224,A,monkey,,CHEMBL620934,6221,
,U,BAO_0000218,,Bioavailability of compound at 3 mg/kg in monkey after i.v. administration,4444,Autocuration,,0,,In vivo,,,9443.0,1,,22224,A,monkey,,CHEMBL620935,17667,
,U,BAO_0000218,,Bioavailability of compound was determined in rhesus monkey,4445,Autocuration,,0,,In vivo,,,9544.0,1,,22224,A,Macaca mulatta,,CHEMBL620936,17267,
,U,BAO_0000218,,Bioavailability determined after oral administration in marmoset,4446,Autocuration,,0,,In vivo,,,38020.0,1,,22224,A,marmosets,,CHEMBL620937,4256,
,U,BAO_0000218,,Oral bioavailability in cynomolgus monkey,4447,Autocuration,,0,,In vivo,,,9541.0,1,,22224,A,Macaca fascicularis,,CHEMBL620938,4256,
,U,BAO_0000218,,Bioavailability in monkey (p.o.) at 2.0 mpk,4448,Autocuration,,0,,In vivo,,,9443.0,1,,22224,A,monkey,,CHEMBL620939,17853,
,U,BAO_0000218,,Bioavailability was evaluated after oral administration in monkey,4449,Autocuration,,0,,In vivo,,,9443.0,1,,22224,A,monkey,,CHEMBL620940,16365,
,U,BAO_0000218,,Bioavailability was evaluated against Cynomolgus monkey at a dose of 15 mg/kg after po administration,4450,Autocuration,,0,,In vivo,,,9541.0,1,,22224,A,Macaca fascicularis,,CHEMBL620941,1916,
,U,BAO_0000218,,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Rhesus monkey (male),4451,Autocuration,,0,,In vivo,,,9544.0,1,,22224,A,Macaca mulatta,,CHEMBL620942,5334,
,U,BAO_0000218,,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Rhesus monkey (male),4452,Autocuration,,0,,In vivo,,,9544.0,1,,22224,A,Macaca mulatta,,CHEMBL620943,5334,
,U,BAO_0000218,,Bioavailability of the compound was determined in monkey,4453,Autocuration,,0,,In vivo,,,9443.0,1,,22224,A,monkey,,CHEMBL620944,17592,
,U,BAO_0000218,,Bioavailability in squirrel monkey (dose 5 mg/kg),4454,Autocuration,,0,,In vivo,,,9521.0,1,,22224,A,Saimiri sciureus,,CHEMBL620945,1399,
,U,BAO_0000218,,Bioavailability was determined in monkey after (po) administration of a dose of 50 (uM/kg),4455,Autocuration,,0,,In vivo,,,9443.0,1,,22224,A,monkey,,CHEMBL620946,4809,
,U,BAO_0000218,,Oral bioavailability in monkey,4456,Autocuration,,0,,In vivo,,,9443.0,1,,22224,A,monkey,,CHEMBL620947,3341,
,U,BAO_0000218,,Compound was tested for bioavailability in squirrel monkey,4457,Autocuration,,0,,In vivo,,,9521.0,1,,22224,A,Saimiri sciureus,,CHEMBL620948,64,
,U,BAO_0000218,,Oral bioavailability in Rhesus monkey,4458,Autocuration,,0,,In vivo,,,9544.0,1,,22224,A,Macaca mulatta,,CHEMBL620949,5005,
,U,BAO_0000218,,Oral bioavailability in Rhesus monkey (dose of 0.75 mg/kg i.v. and 1.5 mg/kg p.o.),4459,Autocuration,,0,,In vivo,,,9544.0,1,,22224,A,Macaca mulatta,,CHEMBL620950,5005,
,U,BAO_0000218,,Oral bioavailability in cynomolgus monkeys for the compound was determined; Acceptable,4460,Autocuration,,0,,In vivo,,,9541.0,1,,22224,A,Macaca fascicularis,,CHEMBL620951,5237,
,U,BAO_0000218,,Oral bioavailability in cynomolgus monkeys was determined; Acceptable,4461,Autocuration,,0,,In vivo,,,9541.0,1,,22224,A,Macaca fascicularis,,CHEMBL620952,5237,
,U,BAO_0000218,,Oral bioavailability in monkey (dose 5 mg/kg),4462,Autocuration,,0,,In vivo,,,9443.0,1,,22224,A,monkey,,CHEMBL875421,5302,
,U,BAO_0000218,,Oral bioavailability of compound at 5 mg/kg in monkey,4463,Autocuration,,0,,In vivo,,,9443.0,1,,22224,A,monkey,,CHEMBL620953,17667,
,N,BAO_0000218,,Pharmacokinetic profile in terms of half life was determined at a dose of 0.5 mg/kg administered intravenously in dog,4464,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL873491,6161,
,N,BAO_0000218,,Pharmacokinetic profile in terms of half life was determined at a dose of 5 mg/kg administered intravenously in dog,4465,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL620954,6161,
,N,BAO_0000218,,Plasma half life determined,4466,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL620955,3854,Plasma
,N,BAO_0000218,,Plasma half life in dog,4467,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618097,993,Plasma
,N,BAO_0000218,,Plasma half-life in Beagle dogs,4468,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618268,4514,Plasma
,N,BAO_0000218,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Beagle dog (male),4469,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618269,5334,Plasma
,N,BAO_0000218,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg respectively in Beagle dog (male),4470,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618270,5334,Plasma
,N,BAO_0000218,,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in dog,4471,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618271,1466,
,N,BAO_0000218,,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in dog,4472,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL873493,1466,
,N,BAO_0000218,,Tested for the half life period in dog,4473,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621031,5313,
,N,BAO_0000218,,Tested for the half life period in dog at dosage of 10 mpk,4474,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621032,5313,
,N,BAO_0000218,,The compound was tested for half life in dog,4475,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621033,3880,
,N,BAO_0000218,,"The compound was tested for time taken to decrease, half of its initial concentration in dog plasma.",4476,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621034,3639,Plasma
,N,BAO_0000218,,The half life was determined,4477,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621035,3880,
,N,BAO_0000218,,The plasma half-life in dogs,4478,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621036,3918,Plasma
,N,BAO_0000218,,suboptimal plasma half-life caused a10% prolongation of QTc interval in dogs at a plasma level of 2.5 M,4479,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621037,16452,Plasma
,N,BAO_0000218,,Half life in dog,4480,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619812,17796,
,N,BAO_0000218,,Pharmacokinetic property (t1/2beta) was measured in dog at the dose of 0.032 mg/kg i.v.,4481,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619813,5983,
,N,BAO_0000218,,tmax upon peroral administration of 10.0 mg/Kg dose in dog,4482,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL873335,1466,
,N,BAO_0000218,,Volume of distribution in Beagle dogs after intravenous administration at a dose of 10 mg/kg,4483,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619814,16456,
,N,BAO_0000218,,Cmax in ferrets after 30 mg/kg oral dose,4484,Expert,,1,,In vivo,,,9669.0,1,,50506,A,Mustela putorius furo,,CHEMBL619815,6113,
,N,BAO_0000218,,Emesis in ferrets at 30 mg/kg oral dose,4485,Expert,,1,,In vivo,,,9669.0,1,,50506,F,Mustela putorius furo,,CHEMBL619816,6113,
,U,BAO_0000218,,Bioavailability in cynomolgus monkey,4486,Autocuration,,0,,In vivo,,,9541.0,1,,22224,A,Macaca fascicularis,,CHEMBL619817,17796,
,N,BAO_0000218,,Volume of distribution in cynomolgus,4487,Intermediate,,1,,In vivo,,,9541.0,1,,100710,A,Macaca fascicularis,,CHEMBL619818,17796,
,U,BAO_0000218,,AUC tested in guinea pig when 3 mg/kg dose was given perorally,4488,Autocuration,1969.0,0,,,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL619819,5308,Plasma
,U,BAO_0000218,,Tested for concentration as Area Under Curve against PDE4 in guinea pig lung eosinophilia orally at 5 mg/kg,4489,Autocuration,,0,,,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL619820,4877,
,U,BAO_0000218,,"Tested for the pharmacokinetic parameter in guinea pig, administered orally at 5 mg/kg",4490,Autocuration,,0,,,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL875419,4876,
,U,BAO_0000218,,AUC in guinea pig after 3mg/kg oral dose,4491,Autocuration,1969.0,0,,In vivo,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL619821,4878,Plasma
,U,BAO_0000218,,Bioavailability in guinea pig was tested,4492,Autocuration,,0,,In vivo,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL619822,5308,
,U,BAO_0000218,,Tested for oral bioavailability in guinea pig at 5 mg/kg,4493,Autocuration,,0,,In vivo,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL619823,4877,
,U,BAO_0000218,,Tested for the oral bioavailability of the compound,4494,Autocuration,,0,,In vivo,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL619824,4876,
,U,BAO_0000218,,Compound at a dose 5 mg/kg was administered orally to guinea pig and the pharmacokinetic parameter (Cmax) was reported,4495,Autocuration,,0,,In vivo,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL619825,4876,
,U,BAO_0000218,,Maximum plsma drug concentration in guinea pig when 3 mg/kg dose was given perorally,4496,Autocuration,,0,,In vivo,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL619826,5308,
,U,BAO_0000218,,Tested for maximum concentration against PDE4 in guinea pig lung eosinophilia orally at 5 mg/kg,4497,Autocuration,2048.0,0,,In vivo,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL619827,4877,Lung
,U,BAO_0000218,,Cmax in guinea pig after 3mg/kg oral dose,4498,Autocuration,,0,,In vivo,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL618167,4878,
,U,BAO_0000019,,Distribution in blood expressed as [18F]- organ uptake in % of injected activity/gram,4499,Autocuration,178.0,0,,,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL618168,5689,Blood
,U,BAO_0000019,,Distribution in brain expressed as [18F]- organ uptake in % of injected activity/gram,4500,Autocuration,955.0,0,,,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL618169,5689,Brain
,U,BAO_0000019,,Distribution in heart expressed as [18F]- organ uptake in % of injected activity/gram,4501,Autocuration,,0,,,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL618170,5689,
,U,BAO_0000019,,Distribution in intestine expressed as [18F]- organ uptake in % of injected activity/gram,4502,Autocuration,160.0,0,,,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL618171,5689,Intestine
,U,BAO_0000019,,Distribution in kidney expressed as [18F]- organ uptake in % of injected activity/gram,4503,Autocuration,2113.0,0,,,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL618172,5689,Kidney
,U,BAO_0000019,,Distribution in liver expressed as [18F]- organ uptake in % of injected activity/gram,4504,Autocuration,2107.0,0,,,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL618173,5689,Liver
,U,BAO_0000019,,Distribution in lung expressed as [18F]- organ uptake in % of injected activity/gram,4505,Autocuration,,0,,,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL618174,5689,
,U,BAO_0000019,,Distribution in spleen expressed as [18F]- organ uptake in % of injected activity/gram,4506,Autocuration,2106.0,0,,,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL875408,5689,Spleen
,U,BAO_0000218,,Elimination T1/2 in Guinea pig (PO dose),4507,Autocuration,,0,,In vivo,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL839827,14465,
,U,BAO_0000019,,Partition coefficient was measured as -log (counts per min ),4508,Autocuration,,0,,,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL618175,5689,
,U,BAO_0000218,,Biological half life when administered at 0.1 umol/kg intravenously to guinea pig in GR-64349 antagonism,4509,Autocuration,,0,,In vivo,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL618176,611,
,U,BAO_0000218,,Biological half life when administered at 5 umol/kg intravenously to guinea pig in GR-64349 antagonism,4510,Autocuration,,0,,In vivo,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL618177,611,
,U,BAO_0000218,,Elimination T1/2 in Guinea pig (PO dose),4511,Autocuration,,0,,In vivo,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL618178,14465,
,U,BAO_0000218,,"Tested for the half life period of the compound, intravenously",4512,Autocuration,,0,,In vivo,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL618179,4876,
,U,BAO_0000019,,Half-life was measured,4513,Autocuration,,0,,,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL873489,5689,
,U,BAO_0000019,,The time required for onset of inotropy after addition of a single dose of delta F75,4514,Autocuration,,0,,,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL618180,7515,
,U,BAO_0000218,,Bioavailability of compound at 10 mg/kg in guinea pig after i.v. administration,4515,Autocuration,,0,,In vivo,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL618181,17667,
,U,BAO_0000218,,Bioavailability of compound at 3 mg/kg in guinea pig after i.v. administration,4516,Autocuration,,0,,In vivo,,,10141.0,1,,22224,A,Cavia porcellus,,CHEMBL618182,17667,
,U,BAO_0000218,,Plasma clearance was measured in hamster at the dose of 10 mg/kg by peroral administration,4517,Autocuration,,0,,In vivo,,,10029.0,1,,22224,A,Cricetulus griseus,,CHEMBL618183,4727,
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in tumor of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,4518,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618184,10107,
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in tumor of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.50 hours,4519,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618185,10107,
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in tumor of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,4520,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618186,10107,
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in tumor of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,4521,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618187,10107,
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in tumor of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hr,4522,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618188,10107,
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in tumor of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,4523,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL875409,10107,
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in tumor of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,4524,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618189,10107,
,N,BAO_0000218,,Biodistribution of the injected compound in blood of female BALB/C mice for 0.5 hours,4525,Intermediate,178.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618190,3655,Blood
,N,BAO_0000218,,Biodistribution of the injected compound in blood of female BALB/C mice for 2.5 hours,4526,Intermediate,178.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618191,3655,Blood
,N,BAO_0000218,,Biodistribution of the injected compound in blood of female BALB/C mice for 5 hours,4527,Intermediate,178.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618192,3655,Blood
,N,BAO_0000218,,Biodistribution of the injected compound in bone of female BALB/C mice for 0.5 hours,4528,Intermediate,10000001.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618193,3655,Bone
,N,BAO_0000218,,Biodistribution of the injected compound in bone of female BALB/C mice for 2.5 hours,4529,Intermediate,10000001.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618194,3655,Bone
,N,BAO_0000218,,Biodistribution of the injected compound in bone of female BALB/C mice for 5 hours,4530,Intermediate,10000001.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618195,3655,Bone
,N,BAO_0000218,,Biodistribution of the injected compound in brain of female BALB/C mice for 0.5 hours,4531,Intermediate,955.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618196,3655,Brain
,N,BAO_0000218,,Biodistribution of the injected compound in brain of female BALB/C mice for 2.5 hours,4532,Intermediate,955.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618197,3655,Brain
,N,BAO_0000218,,Biodistribution of the injected compound in brain of female BALB/C mice for 5 hours,4533,Intermediate,955.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618198,3655,Brain
,N,BAO_0000218,,Biodistribution of the injected compound in heart of female BALB/C mice for 0.5 hours,4534,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618199,3655,Heart
,N,BAO_0000218,,Biodistribution of the injected compound in heart of female BALB/C mice for 2.5 hours,4535,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618200,3655,Heart
,N,BAO_0000218,,Biodistribution of the injected compound in heart of female BALB/C mice for 5 hours,4536,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618201,3655,Heart
,N,BAO_0000218,,Biodistribution of the injected compound in intestines of female BALB/C mice for 0.5 hours,4537,Intermediate,160.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618202,3655,Intestine
,N,BAO_0000218,,Biodistribution of the injected compound in intestines of female BALB/C mice for 2.5 hours,4538,Intermediate,160.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618203,3655,Intestine
,N,BAO_0000218,,Biodistribution of the injected compound in intestines of female BALB/C mice for 5 hours,4539,Intermediate,160.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618204,3655,Intestine
,N,BAO_0000218,,Biodistribution of the injected compound in kidneys of female BALB/C mice for 0.5 hours,4540,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618205,3655,Kidney
,N,BAO_0000218,,Biodistribution of the injected compound in kidneys of female BALB/C mice for 2.5 hours,4541,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618206,3655,Kidney
,N,BAO_0000218,,Biodistribution of the injected compound in kidneys of female BALB/C mice for 5 hours,4542,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618207,3655,Kidney
,N,BAO_0000218,,Biodistribution of the injected compound in liver of female BALB/C mice for 0.5 hours,4543,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618208,3655,Liver
,N,BAO_0000218,,Biodistribution of the injected compound in liver of female BALB/C mice for 2.5 hours,4544,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618932,3655,Liver
,N,BAO_0000218,,Biodistribution of the injected compound in liver of female BALB/C mice for 5 hours,4545,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618933,3655,Liver
,N,BAO_0000218,,Biodistribution of the injected compound in lung of female BALB/C mice for 0.5 hours,4546,Intermediate,2048.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618934,3655,Lung
,N,BAO_0000218,,Biodistribution of the injected compound in lung of female BALB/C mice for 2.5 hours,4547,Intermediate,2048.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618935,3655,Lung
,N,BAO_0000218,,Biodistribution of the injected compound in lung of female BALB/C mice for 5 hours,4548,Intermediate,2048.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618936,3655,Lung
,N,BAO_0000218,,Biodistribution of the injected compound in muscle of female BALB/C mice for 0.5 hours,4549,Intermediate,2385.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618937,3655,Muscle tissue
,N,BAO_0000218,,Biodistribution of the injected compound in muscle of female BALB/C mice for 2.5 hours,4550,Intermediate,2385.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618938,3655,Muscle tissue
,N,BAO_0000218,,Biodistribution of the injected compound in muscle of female BALB/C mice for 5 hours,4551,Intermediate,2385.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619104,3655,Muscle tissue
,N,BAO_0000218,,Biodistribution of the injected compound in spleen of female BALB/C mice for 0.5 hours,4552,Intermediate,2106.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619105,3655,Spleen
,N,BAO_0000218,,Biodistribution of the injected compound in spleen of female BALB/C mice for 2.5 hours,4553,Intermediate,2106.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619106,3655,Spleen
,N,BAO_0000218,,Biodistribution of the injected compound in spleen of female BALB/C mice for 5 hours,4554,Intermediate,2106.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619107,3655,Spleen
,N,BAO_0000218,,Biodistribution of the injected compound in stomach of female BALB/C mice for 0.5 hours,4555,Intermediate,945.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL875410,3655,Stomach
,N,BAO_0000218,,Biodistribution of the injected compound in stomach of female BALB/C mice for 2.5 hours,4556,Intermediate,945.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619108,3655,Stomach
,N,BAO_0000218,,Biodistribution of the injected compound in stomach of female BALB/C mice for 5 hours,4557,Intermediate,945.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619109,3655,Stomach
,N,BAO_0000218,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for MRT,4558,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619110,16597,
,N,BAO_0000218,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for MRT,4559,Intermediate,,1,,In vivo,,,10090.0,1,,50594,F,Mus musculus,,CHEMBL619111,16597,
,N,BAO_0000218,,MRT value at a dose of 10 mg/kg intravenous administration in mice.,4560,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619112,16597,
,N,BAO_0000218,,MRT value at a dose of 10 mg/kg peroral administration in mice.,4561,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619113,16597,
,N,BAO_0000218,,Mean-residence time of compound after intravenous administration in mice at 24 uM/kg,4562,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619114,17764,
,N,BAO_0000218,,Mean-residence time was determined for compound after intraperitoneal administration in mice at 18 uM/kg,4563,Intermediate,,1,,In vivo,,,10090.0,1,,50594,F,Mus musculus,,CHEMBL619115,17764,
,N,BAO_0000219,,In vitro cytotoxicity of compound was determined against A2780 cell lines (cisplatin resistant) at 37 degree C after 96 hr,4564,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619116,3830,
,N,BAO_0000219,,In vitro cytotoxicity of compound was determined against A2780 cell lines (cisplatin resistant) at 37 degree C for 96 hr,4565,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619117,3829,
,N,BAO_0000219,,Compound was evaluated for cytotoxicity against A2780 cell lines.,4566,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619118,2040,
,N,BAO_0000219,,Potentiation of growth inhibition of A2780 by compound alone in experiment 1,4567,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619119,15684,
,N,BAO_0000219,,Potentiation of growth inhibition of A2780 cells by compound alone in experiment 2,4568,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619120,15684,
,N,BAO_0000219,,Potentiation of growth inhibition of A2780 cells along with 10 uM NU1085 in experiment 1,4569,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619121,15684,
,N,BAO_0000219,,Potentiation of growth inhibition of A2780 cells along with 10 uM NU1085 in experiment 2,4570,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619122,15684,
,N,BAO_0000219,,Potentiation factor at 50% growth inhibition (IC50 of compound to that of compound along with PARP inhibitor) in experiment 1,4571,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619123,15684,
,N,BAO_0000219,,Potentiation factor at 50% growth inhibition (IC50 of compound to that of compound along with PARP inhibitor) in experiment 2,4572,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619124,15684,
,N,BAO_0000219,,Compound was evaluated for cytotoxicity against A2780 cell line,4573,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619125,2859,
,N,BAO_0000219,,In vitro inhibitory activity against human tumor cell line A2780,4574,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL875411,5618,
,N,BAO_0000219,,Potentiation of growth inhibition of A2780 cells by compound alone in experiment 1,4575,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619126,15684,
,N,BAO_0000219,,Potentiation of growth inhibition of A2780 cells by compound alone in experiment 2,4576,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619127,15684,
,N,BAO_0000219,,Potentiation of growth inhibition of A2780 cells along with 10 uM NU1085 in experiment 1,4577,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619128,15684,
,N,BAO_0000219,,Potentiation of growth inhibition of A2780 cells along with 10 uM NU1085 in experiment 2,4578,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619129,15684,
,N,BAO_0000219,,The compound was tested for cytotoxic potency against A2780 human tumor cell lines,4579,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619130,2113,
,N,BAO_0000219,,The compound was tested for cytotoxic potency against A2780 human tumor cell lines.,4580,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619131,2113,
,N,BAO_0000219,,cytotoxicity against A2780 cells incubated for 24 hr in MTT assay.,4581,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619132,16745,
,N,BAO_0000218,,In vitro antitumor activity against A2780 human ovarian carcinoma at 7.5 mg/kg i.p. /qd x7,4582,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619133,16597,
,N,BAO_0000219,,Potentiation factor at 50% growth inhibition (IC50 of compound to that of compound along with PARP inhibitor) in experiment 1,4583,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619134,15684,
,N,BAO_0000219,,Potentiation factor at 50% growth inhibition (IC50 of compound to that of compound along with PARP inhibitor) in experiment 2,4584,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619135,15684,
,N,BAO_0000219,,Compound was evaluated for cytotoxicity against A2780 cis cell lines.,4585,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619136,2040,
,N,BAO_0000219,,Relative resistance factor in A2780 cisplatin-resistant line,4586,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619137,2040,
,N,BAO_0000219,,Concentration required to inhibit 50% growth of A2780 human ovarian cancer cells,4587,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL883713,16165,
,N,BAO_0000219,,Concentration required to inhibit 50% growth of A2780 human ovarian cancer cells.,4588,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL875412,16165,
,N,BAO_0000218,,In vitro antitumor activity against A2780 human ovarian carcinoma at 7.5 mg/kg i.p. /qd x7,4589,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619138,16597,
,N,BAO_0000218,,In vitro antitumor activity against A2780 human ovarian carcinoma at 7.5 mg/kg i.p. /qd x7,4590,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619262,16597,
,N,BAO_0000219,,Cytotoxicity against A2780 ovarian carcinoma cells was evaluated using standard sulforhodamine 96h assay test,4591,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619139,3992,
,N,BAO_0000219,,In vitro cytotoxicity was determined against A2780 human ovarian cell line using NCI screen,4592,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619140,10553,
,N,BAO_0000219,,cytotoxic activity toward A2780 ovarian human cell line sensitive (S) to cisplatin,4593,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619141,15608,
,N,BAO_0000219,,cytotoxic activity toward A2780 ovarian human cell line sensitive (S) to cisplatin in experiment 1,4594,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619142,15608,
,N,BAO_0000219,,cytotoxic activity toward A2780 ovarian human cell line sensitive (S) to cisplatin in experiment 2,4595,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619143,15608,
,N,BAO_0000219,,cytotoxic activity toward A2780 ovarian human cell line sensitive (S) to cisplatin in experiment 3,4596,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619144,15608,
,N,BAO_0000219,,cytotoxic activity toward A2780 ovarian human cell line sensitive (S) to cisplatin in experiment 5,4597,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619145,15608,
,N,BAO_0000219,,cytotoxic activity toward A2780 ovarian human cell line sensitive (S) to cisplatin in experiment 8,4598,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619146,15608,
,N,BAO_0000219,,Cytotoxic activity in a panel of Human ovarian tumor A2780/CDDP cell line after 96h of drug exposure,4599,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619147,15569,
,N,BAO_0000219,,Antiproliferative effect of compound on A2780/DX cell line,4600,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619148,17420,
,N,BAO_0000219,,Antiproliferative effect of compound on A2780/DX cell line; n.d. indicates not determined,4601,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619149,17420,
,N,BAO_0000219,,In vitro Cytotoxic activity of compound in comparison with reference compounds in human cell line A2780/DX(RI),4602,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619150,15099,
,N,BAO_0000219,,In vitro Cytotoxic activity of compound in comparison with reference compounds in human cell line A2780/Dx(RI),4603,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619151,15099,
,N,BAO_0000219,,Cytotoxicity against ovarian carcinoma A2780/cis tumor cell lines,4604,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL883794,17672,
,N,BAO_0000219,,Cytotoxicity against ovarian carcinoma A2780/cis90 tumor cell lines,4605,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619152,17672,
,N,BAO_0000219,,In vitro cytotoxicity against A2780ADR cell line,4606,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619153,17270,
,N,BAO_0000219,,In vitro cytotoxicity against A2780CIS cell line,4607,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619154,17270,
,N,BAO_0000219,,In vitro cytotoxic activity against human tumor cell line A2780CisR after incubation for 96 hours,4608,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619155,5574,
,N,BAO_0000219,,The compound was tested for cytotoxic potency against A2780R human tumor cell lines.,4609,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619156,2113,
,N,BAO_0000219,,"Inhibitory effect of Gold(III) complex, 2,2' bipy on growth of cisplatin-resistant A2780/R human tumor cell lines",4610,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619157,16913,
,N,BAO_0000219,,"Inhibitory effect of Gold(III) complex, CDDP on growth of cisplatin-resistant A2780/R human tumor cell lines",4611,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619797,16913,
,U,BAO_0000218,,Oral bioavailability of compound in rhesus macaques,4612,Autocuration,,0,,In vivo,,,9544.0,1,,22224,A,Macaca mulatta,,CHEMBL619798,17839,
,U,BAO_0000218,,Oral bioavailability in monkey,4613,Autocuration,,0,,In vivo,,,9443.0,1,,22224,A,monkey,,CHEMBL619799,6821,
,U,BAO_0000218,,Oral bioavailability evaluated in monkey,4614,Autocuration,,0,,In vivo,,,9443.0,1,,22224,A,monkey,,CHEMBL619800,6078,
,U,BAO_0000218,,Oral bioavailability in monkey (dose 1 mg/kg p.o.),4615,Autocuration,,0,,In vivo,,,9443.0,1,,22224,A,monkey,,CHEMBL619801,6535,
,U,BAO_0000218,,Oral bioavailability in Rhesus monkey,4616,Autocuration,,0,,In vivo,,,9544.0,1,,22224,A,Macaca mulatta,,CHEMBL619802,4449,
,U,BAO_0000218,,Oral bioavailability was calculated in rhesus monkey,4617,Autocuration,,0,,In vivo,,,9544.0,1,,22224,A,Macaca mulatta,,CHEMBL619803,6057,
,U,BAO_0000218,,Oral bioavailability in cynomolgus monkey,4618,Autocuration,,0,,In vivo,,,9541.0,1,,22224,A,Macaca fascicularis,,CHEMBL619965,5922,
,U,BAO_0000218,,Oral bioavailability in monkey,4619,Autocuration,,0,,In vivo,,,9443.0,1,,22224,A,monkey,,CHEMBL619966,5940,
,U,BAO_0000218,,Oral bioavailability in monkey,4620,Autocuration,,0,,In vivo,,,9443.0,1,,22224,A,monkey,,CHEMBL619967,6265,
,U,BAO_0000218,,Oral bioavailability in monkey (dose 1 mg/kg),4621,Autocuration,,0,,In vivo,,,9443.0,1,,22224,A,monkey,,CHEMBL620073,6265,
,U,BAO_0000218,,Oral bioavailability in monkey (dose 5 mg/kg),4622,Autocuration,,0,,In vivo,,,9443.0,1,,22224,A,monkey,,CHEMBL620074,6265,
,U,BAO_0000218,,Oral bioavailability in monkey,4623,Autocuration,,0,,In vivo,,,9443.0,1,,22224,A,monkey,,CHEMBL620075,5940,
,U,BAO_0000218,,Oral bioavailability in monkey,4624,Autocuration,,0,,In vivo,,,9443.0,1,,22224,A,monkey,,CHEMBL620076,5940,
,U,BAO_0000218,,Oral bioavailability in rhesus monkey,4625,Autocuration,,0,,In vivo,,,9544.0,1,,22224,A,Macaca mulatta,,CHEMBL620077,4514,
,U,BAO_0000218,,Oral bioavailability in rhesus monkey at a dose of 2 mg/kg by po administration,4626,Autocuration,,0,,In vivo,,,9544.0,1,,22224,A,Macaca mulatta,,CHEMBL620078,5546,
,U,BAO_0000218,,Oral bioavailability in squirrel monkey at a dose of 10 mg/kg,4627,Autocuration,,0,,In vivo,,,9521.0,1,,22224,A,Saimiri sciureus,,CHEMBL620079,5553,
,U,BAO_0000218,,Oral bioavailability in monkey (dosed at 0.5 mpk iv and 2.0 mpk orally),4628,Autocuration,,0,,In vivo,,,9443.0,1,,22224,A,monkey,,CHEMBL620080,6641,
,U,BAO_0000218,,Oral bioavailability in Rhesus monkey,4629,Autocuration,,0,,In vivo,,,9544.0,1,,22224,A,Macaca mulatta,,CHEMBL620081,5472,
,U,BAO_0000218,,Oral bioavailability in Rhesus monkey (dose 10 mg/kg p.o.),4630,Autocuration,,0,,In vivo,,,9544.0,1,,22224,A,Macaca mulatta,,CHEMBL620082,5668,
,U,BAO_0000218,,Oral bioavailability in monkey at 10 mg/kg of the compound,4631,Autocuration,,0,,In vivo,,,9443.0,1,,22224,A,monkey,,CHEMBL620083,5711,
,U,BAO_0000218,,Bioavailability in Rhesus monkey,4632,Autocuration,,0,,In vivo,,,9544.0,1,,22224,A,Macaca mulatta,,CHEMBL620084,5145,
,U,BAO_0000218,,Glomerular Filtration Rate(GFR) evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,4633,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620085,3443,
,U,BAO_0000218,,Glomerular Filtration Rate(GFR)of the compound compared to Cilastatin evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,4634,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL874595,3443,
,U,BAO_0000218,,Half life by ''Cr'' assay in rhesus monkey at a dose of 5 mg/kg,4635,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL873352,3249,
,U,BAO_0000218,,Half life the of compound was determined by ''Cr'' assay in squirrel monkey at a dose of 5 mg/kg,4636,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620086,3249,
,U,BAO_0000218,,Mean residence time was determined after intravenous administration in cynomolgus monkeys,4637,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620087,5355,
,U,BAO_0000218,,Mean residence time was determined after oral administration in cynomolgus monkeys; NA means Not applicable,4638,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620088,5355,
,U,BAO_0000218,,Mean residence time was determined after oral administration in cynomolgus monkeys; NA means not applicable,4639,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620089,5355,
,U,BAO_0000218,,Pharmacokinetic parameter MRT was determined in monkey after (iv) administration of a dose of 13 (uM/kg),4640,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620090,4809,
,U,BAO_0000218,,Pharmacokinetic parameter MRT was determined in monkey after (po) administration of a dose of 50 (uM/kg),4641,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620091,4809,
,U,BAO_0000251,,Metabolism of compound in monkey S9 microsomes ('+''indicates <20% largest observed peak),4642,Autocuration,,0,Microsomes,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620092,14294,
,U,BAO_0000251,,Metabolism of compound in monkey S9 microsomes ('++''indicates 20-50% largest observed peak),4643,Autocuration,,0,Microsomes,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620093,14294,
,U,BAO_0000251,,Metabolism of compound in monkey S9 microsomes ('+++'indicates 50-80% largest observed peak),4644,Autocuration,,0,Microsomes,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620094,14294,
,U,BAO_0000251,,Metabolism of compound in monkey S9 microsomes ('++++' indicates largest observed peak),4645,Autocuration,,0,Microsomes,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620095,14294,
,U,BAO_0000218,,Plasma clearance evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,4646,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620096,3443,
,U,BAO_0000218,,Plasma clearance compared to Cilastatin evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,4647,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620097,3443,
,U,BAO_0000019,,Clearance from plasma(with matabolite-corrected plasma radioactivity-time integral) at 30 min after administration.,4648,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620098,11271,
,U,BAO_0000218,,Renal clearance evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,4649,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620099,3443,
,U,BAO_0000218,,Renal clearance compared to Cilastatin evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,4650,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620100,3443,
,U,BAO_0000019,,Elimination Half-life of compound was determined in monkey,4651,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620101,6821,
,U,BAO_0000019,,Half life of compound was determined in rhesus monkey,4652,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620102,17267,
,U,BAO_0000366,,Half life in monkey plasma,4653,Autocuration,1969.0,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620103,5819,Plasma
,U,BAO_0000366,,Half life in monkey plasma; Not detected,4654,Autocuration,1969.0,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620104,5819,Plasma
,U,BAO_0000218,,Half life period was evaluated against Cynomolgus monkey at a dose of 15 mg/kg after po administration,4655,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL874596,1916,
,U,BAO_0000218,,Half-life 24 hr after 2 mg/kg iv administration in monkeys,4656,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL873490,17509,
,U,BAO_0000019,,Terminal half life of the compound.,4657,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620105,1399,
,U,BAO_0000218,,Maximum time was evaluated against Cynomolgus monkey at a dose of 15 mg/kg after po administration,4658,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620780,1916,
,U,BAO_0000218,,Pharmacokinetic parameter Tmax was determined in monkey after (po) administration of a dose of 50 (uM/kg),4659,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620781,4809,
,U,BAO_0000218,,Unbound plasma was determined in rhesus monkey at a dose of 1 mg/kg by iv administration,4660,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620956,5546,
,U,BAO_0000218,,Urinary recovery evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,4661,Autocuration,1088.0,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620957,3443,Urine
,U,BAO_0000218,,Urinary recovery compared to Cilastatin evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,4662,Autocuration,1088.0,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620958,3443,Urine
,U,BAO_0000218,,Volume of distribution was determined in monkey after a 3 mg/kg of iv dose,4663,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620959,4257,
,U,BAO_0000218,,Volume distribution after oral administration (2.5 mg/kg) in monkey was determined,4664,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620960,6221,
,U,BAO_0000218,,Volume of distribution was evaluated in rhesus,4665,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL620961,5472,
,U,BAO_0000218,,Plasma clearance was measured in hamster at the dose of 10 mg/kg by peroral administration,4666,Autocuration,,0,,In vivo,,,10029.0,1,,22224,A,Cricetulus griseus,,CHEMBL620962,4727,
,U,BAO_0000218,,Plasma clearance was measured in hamster at the dose of 3 mg/kg by intravenous administration,4667,Autocuration,,0,,In vivo,,,10029.0,1,,22224,A,Cricetulus griseus,,CHEMBL620963,4727,
,U,BAO_0000218,,Bioavailability in hamster was determined,4668,Autocuration,,0,,In vivo,,,10029.0,1,,22224,A,Cricetulus griseus,,CHEMBL620964,4727,
,U,BAO_0000218,,Bioavailability in hamster at a dose of 3 mg/kg by intravenous administration,4669,Autocuration,,0,,In vivo,,,10029.0,1,,22224,A,Cricetulus griseus,,CHEMBL620965,4727,
,U,BAO_0000218,,Bioavailability in hamster at a dose of 3 mg/kg by oral administration,4670,Autocuration,,0,,In vivo,,,10029.0,1,,22224,A,Cricetulus griseus,,CHEMBL620966,4727,
,U,BAO_0000221,,Half life of compound was determined in hamster blood,4671,Autocuration,178.0,0,,,,,10029.0,1,,22224,A,Cricetulus griseus,,CHEMBL620967,4727,Blood
,U,BAO_0000019,,Michaelis-Menten constant of the compound.,4672,Autocuration,,0,,,,,9823.0,1,,22224,A,Sus scrofa,,CHEMBL620968,1452,
,U,BAO_0000019,,Vmax value was measured at 0 uM concentration of silyl ether.,4673,Autocuration,,0,,,,,9823.0,1,,22224,A,Sus scrofa,,CHEMBL874597,1452,
,U,BAO_0000019,,Vmax value was measured at 10 uM concentration of silyl ether.,4674,Autocuration,,0,,,,,9823.0,1,,22224,A,Sus scrofa,,CHEMBL620969,1452,
,U,BAO_0000019,,Vmax value was measured at 5 uM concentration of silyl ether.,4675,Autocuration,,0,,,,,9823.0,1,,22224,A,Sus scrofa,,CHEMBL620970,1452,
,D,BAO_0000357,,Inactivation of human leukocyte (neutrophil) elastase(HLE)(HNE) as rate constant,4676,Expert,,9,,,,,9606.0,1,,235,B,Homo sapiens,,CHEMBL620971,11706,
,U,BAO_0000218,,Area under curve was evaluated against man at a dose of 10 mg/kg after po administration,4677,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL620972,1916,
,U,BAO_0000019,,Compound was evaluated for area under the curve expressed as (h*ug/ml),4678,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL620973,17791,
,U,BAO_0000019,,Active metabolite of ifosfamide determined in humans; A-Active,4679,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618243,7766,
,U,BAO_0000019,,Amount of tecadenoson present after 30 min in the liver S-9 assay as determined by mass specanalysis,4680,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618244,6567,
,U,BAO_0000019,,Amount of tecadenoson present after 30 min in the liver S-9 assay as determined by mass specanalysis; -0.5 to 1,4681,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618245,6567,
,U,BAO_0000019,,Amount of tecadenoson present after 30 min in the liver S-9 assay as determined by mass specanalysis; 1-2,4682,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618246,6567,
,U,BAO_0000019,,Amount of tecadenoson present after 30 min in the liver S-9 assay as determined by mass specanalysis; trace,4683,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618247,6567,
,U,BAO_0000218,,Compound was evaluated for oral bioavailability in human,4684,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618248,17791,
,U,BAO_0000019,,Metabolite of ifosfamide determined in urine; NF-Not found,4685,Autocuration,1088.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618249,7766,Urine
,U,BAO_0000019,,Percent of compound in cirrhotic patients of spontaneous ascitic fluid infection (Group A and B),4686,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618250,6852,
,U,BAO_0000019,,Percent of compound in cirrhotic patients of spontaneous ascitic fluid infection after dosing with normal antibiotics,4687,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL874598,6852,
,U,BAO_0000019,,Percent of compound in cirrhotic patients of spontaneous ascitic fluid infection after dosing with normal antibiotics and lactose,4688,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618251,6852,
,U,BAO_0000019,,Percent of compound in cirrhotic patients of spontaneous ascitic fluid infection before dosing with normal antibiotics,4689,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618252,6852,
,U,BAO_0000019,,Percent of compound in cirrhotic patients of spontaneous ascitic fluid infection before dosing with normal antibiotics and lactose,4690,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618253,6852,
,U,BAO_0000019,,Percent of compound in cirrhotic patients of sterile ascitic fluid (Group C),4691,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618254,6852,
,U,BAO_0000019,,Percent of compound in healthy individuals (Group D),4692,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618255,6852,
,U,BAO_0000251,,Percent of the parent compound remaining after 20 mins incubation with human liver microsomes,4693,Autocuration,2107.0,0,Microsomes,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618983,4397,Liver
,U,BAO_0000019,,Binding towards human plasma protein at 10 uM,4694,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618984,17409,
,U,BAO_0000019,,Binding towards human plasma protein at 100 uM,4695,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618985,17409,
,U,BAO_0000019,,Human plasma protein binding activity was determined,4696,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618986,17176,
,U,BAO_0000019,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),4697,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618987,15444,
,U,BAO_0000019,,Percent binding of compound towards human plasma protein was determined,4698,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618988,17267,
,U,BAO_0000251,,Plasma clearance in human liver microsomes,4699,Autocuration,2107.0,0,Microsomes,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618989,5944,Liver
,U,BAO_0000251,,In vitro intrinsic clearance in human liver microsome,4700,Autocuration,2107.0,0,Microsomes,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618990,5668,Liver
,U,BAO_0000251,,In vitro intrinsic clearance in human liver microsome,4701,Autocuration,2107.0,0,Microsomes,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618991,5669,Liver
,U,BAO_0000251,,In vitro microsome metabolism clearance in human was determined,4702,Autocuration,,0,Microsomes,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL876725,5041,
,U,BAO_0000251,,In vitro microsome metabolism clearance in human was determined; High,4703,Autocuration,,0,Microsomes,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618992,5041,
,U,BAO_0000251,,In vitro microsome metabolism clearance in human was determined; ND denotes no data,4704,Autocuration,,0,Microsomes,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618993,5041,
,U,BAO_0000251,,Pharmacokinetic property (clearance) in human liver microsome,4705,Autocuration,2107.0,0,Microsomes,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618994,5676,Liver
,U,BAO_0000251,,Plasma clearance in human liver microsomes,4706,Autocuration,2107.0,0,Microsomes,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618995,5944,Liver
,U,BAO_0000251,,In vitro clearance in human liver microsomes,4707,Autocuration,2107.0,0,Microsomes,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618996,17538,Liver
,U,BAO_0000251,,Intrinsic clearance in human liver microsomes was determined,4708,Autocuration,2107.0,0,Microsomes,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618997,6331,Liver
,U,BAO_0000251,,Intrinsic clearance in human liver microsomes was determined,4709,Autocuration,2107.0,0,Microsomes,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618998,5948,Liver
,U,BAO_0000218,,Cmax (Tissue distribution) of compound was determined at a dose of 5 mg/kg in human,4710,Autocuration,,0,,In vivo,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618999,5965,
,U,BAO_0000218,,Maximum concentration was evaluated against man at a dose of 10 mg/kg after po administration,4711,Autocuration,,0,,In vivo,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL620223,1916,
,U,BAO_0000218,,Cmin (Clearance) of compound was determined at a dose of 5 mg/kg in human,4712,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL620224,5965,
,U,BAO_0000019,,Stability in human plasma 2 hr after incubation expressed as percent concentration,4713,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL620225,1299,
,U,BAO_0000019,,Stability in human plasma 4 hr after incubation expressed as percent concentration,4714,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL620226,1299,
,U,BAO_0000019,,Portion of holoxan excreted in the form of the metabolite from 1200 mL of urine on day 3 was determined in embryonal rhabdomyosarcoma patients treated with ifosfamide,4715,Autocuration,1088.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL620227,7766,Urine
,U,BAO_0000019,,Portion of holoxan excreted in the form of the metabolite from 1200 mL of urine on day 7 was determined in embryonal rhabdomyosarcoma patients treated with ifosfamide,4716,Autocuration,1088.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL876726,7766,Urine
,U,BAO_0000019,,Portion of holoxan excreted in the form of the metabolite from 1300 mL of urine on day 6 was determined in embryonal rhabdomyosarcoma patients treated with ifosfamide,4717,Autocuration,1088.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL620228,7766,Urine
,U,BAO_0000019,,Portion of holoxan excreted in the form of the metabolite from 1300 mL of urine on day 8 was determined in embryonal rhabdomyosarcoma patients treated with ifosfamide,4718,Autocuration,1088.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL620229,7766,Urine
,N,BAO_0000218,,Mean-residence time was determined for compound after intraperitoneal administration in mice at 23 uM/kg,4719,Intermediate,,1,,In vivo,,,10090.0,1,,50594,F,Mus musculus,,CHEMBL620230,17764,
,N,BAO_0000218,,Mean-residence time was determined for compound after intraperitoneal administration in mice at 25 uM/kg,4720,Intermediate,,1,,In vivo,,,10090.0,1,,50594,F,Mus musculus,,CHEMBL620231,17764,
,N,BAO_0000218,,Mean-residence time was determined for compound after intraperitoneal administration in mice at 26 uM/kg,4721,Intermediate,,1,,In vivo,,,10090.0,1,,50594,F,Mus musculus,,CHEMBL620232,17764,
,N,BAO_0000218,,Mean-residence time was determined for compound intravenous administration in mice at 23 uM/kg,4722,Intermediate,,1,,In vivo,,,10090.0,1,,50594,F,Mus musculus,,CHEMBL620233,17764,
,N,BAO_0000218,,Metabolism of compound in Mouse S9 microsomes ('++++'indicates largest observed peak),4723,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620234,14294,
,N,BAO_0000218,,Metabolism of compound in mouse S9 microsomes ('+''indicates <20% largest observed peak),4724,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620235,14294,
,N,BAO_0000218,,Metabolism of compound in mouse S9 microsomes ('++++' indicates largest observed peak),4725,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620236,14294,
,N,BAO_0000218,,In vitro metabolic potential in mouse liver microsomes,4726,Intermediate,2107.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620237,6251,Liver
,N,BAO_0000218,,Ability of compound to bind to plasma protein was evaluated in HSA cells,4727,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620238,17582,
,N,BAO_0000218,,Compound was tested for radioactivity level in mice adrenal glands (Compound is radiolabeled),4728,Intermediate,2369.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620239,17811,Adrenal gland
,N,BAO_0000218,,Compound was tested for radioactivity level in mice brain (Compound is radiolabeled); 2.2-4.9% ID/g,4729,Intermediate,955.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620240,17811,Brain
,N,BAO_0000218,,Compound was tested for radioactivity level in mice brain (Compound is radiolabeled); 2.6-4.4% ID/g,4730,Intermediate,955.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620241,17811,Brain
,N,BAO_0000218,,Compound was tested for radioactivity level in mice heart (Compound is radiolabeled),4731,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL876727,17811,
,N,BAO_0000218,,Compound was tested for radioactivity level in mice kidney (Compound is radiolabeled),4732,Intermediate,2113.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620242,17811,Kidney
,N,BAO_0000218,,Compound was tested for radioactivity level in mice lungs (Compound is radiolabeled),4733,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620243,17811,
,N,BAO_0000218,,Tested for urinary recovery in mice after subcutaneous administration of 20 mg/Kg,4734,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620244,5288,
,N,BAO_0000218,,Compound was evaluated for its potency in CDF1 mice and the serum cholesterol levels were determined,4735,Intermediate,1977.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620245,2717,Serum
,N,BAO_0000218,,Compound was evaluated for its potency in CDF1 mice and the serum metabolite levels were determined,4736,Intermediate,1977.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620246,2717,Serum
,N,BAO_0000218,,Compound was evaluated for its potency in CDF1 mice and the serum triglyceride levels were determined,4737,Intermediate,1977.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620247,2717,Serum
,N,BAO_0000218,,Half life of compound was determined in plasma of mice at 24 mg/Kg,4738,Intermediate,1969.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620248,17753,Plasma
,N,BAO_0000218,,Half life of compound was determined in plasma of mice at 40 mg/Kg,4739,Intermediate,1969.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL873497,17753,Plasma
,N,BAO_0000218,,Half life of compound was determined in plasma of mice at 5 mg/Kg,4740,Intermediate,1969.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620249,17753,Plasma
,N,BAO_0000218,,Half life after intraperitoneal administration in mice at 18 uM/kg,4741,Intermediate,,1,,In vivo,,,10090.0,1,,50594,F,Mus musculus,,CHEMBL620250,17764,
,N,BAO_0000218,,Half life after intraperitoneal administration in mice at 23 uM/kg,4742,Intermediate,,1,,In vivo,,,10090.0,1,,50594,F,Mus musculus,,CHEMBL620251,17764,
,N,BAO_0000218,,Half life after intraperitoneal administration in mice at 25 uM/kg,4743,Intermediate,,1,,In vivo,,,10090.0,1,,50594,F,Mus musculus,,CHEMBL620252,17764,
,N,BAO_0000218,,Half life after intraperitoneal administration in mice at 26 uM/kg,4744,Intermediate,,1,,In vivo,,,10090.0,1,,50594,F,Mus musculus,,CHEMBL620253,17764,
,N,BAO_0000218,,Half life after intravenous administration in mice at 23 uM/kg,4745,Intermediate,,1,,In vivo,,,10090.0,1,,50594,F,Mus musculus,,CHEMBL620254,17764,
,N,BAO_0000218,,Half life after intravenous administration in mice at 24 uM/kg,4746,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620255,17764,
,N,BAO_0000218,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for T max,4747,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620256,16597,
,N,BAO_0000218,,Maximum time required to reach Cp max was evaluated in mice after intravenous administration; T max Not determined,4748,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL876728,2675,
,N,BAO_0000218,,Maximum time required to reach Cp max was evaluated in mice after oral administration,4749,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620257,2675,
,N,BAO_0000218,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),4750,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620258,16597,
,N,BAO_0000218,,"Compound was evaluated for the pharmacokinetic parameter, Terminal half life period",4751,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620259,4890,
,N,BAO_0000218,,Evaluated for pharmacokinetic parameter half-life in mouse at the dose 20 mg/kg,4752,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620260,429,
,N,BAO_0000218,,Half life of compound in mouse blood following i.v. administration of 10 mg/kg,4753,Intermediate,178.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620261,17837,Blood
,N,BAO_0000218,,Half life at a dose of 10 mg/kg intravenous administration in mice.,4754,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620262,16597,
,N,BAO_0000218,,Half life at a dose of 10 mg/kg peroral administration in mice.,4755,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620263,16597,
,N,BAO_0000218,,Half life in ob/ob mice,4756,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620264,6619,
,N,BAO_0000218,,Half-life at a single subcutaneous administration of 40 mg/kg in mice,4757,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620265,4066,
,N,BAO_0000218,,Half-life was measured in mouse,4758,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620266,4239,
,N,BAO_0000218,,In vivo half life period was determined in murine septicemia at dose of 50 mg/kg,4759,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620267,5969,
,N,BAO_0000218,,Time for esterases in unfractionated mouse serum to reduce the concentration due to thio ester deacylation,4760,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619364,8999,
,N,BAO_0000218,,Time for esterases in unfractionated mouse serum to reduce the concentration due to thio ester deacylation; 10 % hydrolysis at 60 mins,4761,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619365,8999,
,N,BAO_0000218,,T2 in brain of mice at the oral dose of 50 mg/kg,4762,Intermediate,955.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619366,17641,Brain
,N,BAO_0000218,,T2 in kidney of mice at the oral dose of 50 mg/kg,4763,Intermediate,2113.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619367,17641,Kidney
,N,BAO_0000218,,T2 in liver of mice at the oral dose of 50 mg/kg,4764,Intermediate,2107.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619368,17641,Liver
,N,BAO_0000218,,T2 in lungs of mice at the oral dose of 50 mg/kg,4765,Intermediate,2048.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619369,17641,Lung
,N,BAO_0000218,,T2 in spleen of mice at the oral dose of 50 mg/kg,4766,Intermediate,2106.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL876729,17641,Spleen
,N,BAO_0000218,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for T max,4767,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619370,16597,
,N,BAO_0000218,,"Compound was evaluated for the pharmacokinetic parameter, maximum time constant",4768,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619371,4890,
,N,BAO_0000218,,Evaluated for pharmacokinetic parameter tmax in mouse at the dose 20 mg/kg,4769,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619372,429,
,N,BAO_0000218,,Evaluated for pharmacokinetic parameter tmax in mouse at the dose 20 mg/kg was determined,4770,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620012,429,
,N,BAO_0000218,,In vivo Tmax was determined in murine septicemia at dose of 100 mg/kg,4771,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620013,5969,
,N,BAO_0000219,,"Inhibitory effect of Gold(III) complex, [Au(bipy)-(OH)2]-[PF6] on growth of cisplatin-resistant A2780/R human tumor cell lines",4772,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL620014,16913,
,N,BAO_0000219,,"Inhibitory effect of Gold(III) complex, [Au(bipy-H)(OH)]-[PF6] on growth of cisplatin-resistant A2780/R human tumor cell lines",4773,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL620015,16913,
,N,BAO_0000219,,"Inhibitory effect of Gold(III) complex, 2,2' bipy on growth of cisplatin-sensitive A2780/S human tumor cell lines",4774,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621010,16913,
,N,BAO_0000219,,"Inhibitory effect of Gold(III) complex, CDDP on growth of cisplatin-sensitive A2780/S human tumor cell lines",4775,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621011,16913,
,N,BAO_0000219,,"Inhibitory effect of Gold(III) complex, [Au(bipy)-(OH)2]-[PF6] on growth of cisplatin-sensitive A2780/S human tumor cell lines",4776,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621012,16913,
,N,BAO_0000219,,"Inhibitory effect of Gold(III) complex, [Au(bipy-H)(OH)]-[PF6] on growth of cisplatin-sensitive A2780/S human tumor cell lines",4777,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621013,16913,
,N,BAO_0000219,,In vitro cytotoxicity against A2780TAX cell line,4778,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621014,17270,
,N,BAO_0000219,,In vitro inhibitory activity against human tumor cell line A2780cis,4779,Intermediate,,1,,,481.0,,9606.0,1,A2780cisR,80017,F,Homo sapiens,,CHEMBL618154,5618,
,N,BAO_0000219,,Growth inhibition against A2780 cisplatin resistant wild-type ovarian cell lines,4780,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618155,17777,
,N,BAO_0000219,,Antitumor activity of compound for 96-h exposure in A2780cisR (acquired resistance to cisplatin) human ovarian cell line,4781,Intermediate,,1,,,481.0,,9606.0,1,A2780cisR,80017,F,Homo sapiens,,CHEMBL618156,16112,
,N,BAO_0000219,,The compound was tested for cytotoxic activity against A2780cisR cell line(human ovarian carcinoma ),4782,Intermediate,,1,,,481.0,,9606.0,1,A2780cisR,80017,F,Homo sapiens,,CHEMBL618157,15748,
,N,BAO_0000219,,Concentration required to inhibit A2780cisR cell growth when compared with control after incubation for 96 h at 37 C,4783,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618328,6633,
,N,BAO_0000219,,Compound was evaluated against human Ovarian carcinoma cell line A2780cisR,4784,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618329,16930,
,N,BAO_0000219,,Cytotoxicity against human ovarian carcinoma A2780cisR cell line,4785,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618330,17496,
,N,BAO_0000219,,In vitro antitumor activity against A2780cisR cell line.,4786,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618331,12989,
,N,BAO_0000219,,Tested for the cytotoxicity in A2780cisR ovarian cell line (cisR denotes resistance to cisplatin),4787,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618332,4840,
,N,BAO_0000219,,Resistant factor determined between IC50 of resistant line to that of A2780cisR cell line,4788,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618333,12989,
,N,BAO_0000219,,cytotoxicity against A2780cisR cells incubated for 24 hr in MTT assay,4789,Intermediate,,1,,,481.0,,9606.0,1,A2780cisR,80017,F,Homo sapiens,,CHEMBL618334,16745,
,N,BAO_0000219,,Inhibition of A2780 / DDP-S human ovarian carcinoma cell proliferation,4790,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618335,16597,
,D,BAO_0000019,,Inhibition against A2A-Adenosine Receptor of rat PC12 cell membranes,4791,Expert,,9,,,,,10116.0,1,,11736,B,Rattus norvegicus,,CHEMBL618336,16547,
,H,BAO_0000019,,Inhibition against A2A-Adenosine Receptor of rat PC12 cell membranes (functional antagonist activity),4792,Expert,,8,,,,,,1,,11736,F,,,CHEMBL618337,16547,
,D,BAO_0000019,,Inhibition against A2A-Adenosine Receptor of rat PC12 cell membranes (functional antagonist activity),4793,Expert,,9,,,,,10116.0,1,,11736,F,Rattus norvegicus,,CHEMBL618338,16547,
,D,BAO_0000219,,Antagonist activity against human A2B adenosine receptor expressed in HEK293 cells uisng [3H]ZM-241385 or [125I]-IABOPX,4794,Expert,,9,,,722.0,,9606.0,1,HEK293,278,F,Homo sapiens,,CHEMBL618339,15856,
,D,BAO_0000219,,Antagonist activity against human A2B adenosine receptor expressed in HEK293 cells using [3H]ZM-241385 (or) [125 I]IABOPX at 10e-5 M,4795,Expert,,9,,,722.0,,9606.0,1,HEK293,278,F,Homo sapiens,,CHEMBL618340,15856,
,D,BAO_0000019,,Inhibition against A2B-Adenosine Receptor in mouse NIH 3T3 fibroblast cell membranes,4796,Expert,,9,,,,,10090.0,1,,11831,B,Mus musculus,,CHEMBL618341,16547,
,H,BAO_0000019,,Inhibition against A2B-Adenosine Receptor in mouse NIH 3T3 fibroblast cell membranes (functional antagonist activity),4797,Expert,,8,,,,,,1,,11831,F,,,CHEMBL618342,16547,
,D,BAO_0000019,,Inhibition against A2B-Adenosine Receptor in mouse NIH 3T3 fibroblast cell membranes (functional antagonist activity),4798,Expert,,9,,,,,10090.0,1,,11831,F,Mus musculus,,CHEMBL618343,16547,
,H,BAO_0000357,,Ability to displace the binding of [3H]-MRE 3008-F20 to the ligand binding site of CHO:hA3 (human Adenosine receptor) at concentration of 10 uM,4799,Expert,,8,,,,,,1,,280,B,,,CHEMBL621038,17402,
,U,BAO_0000219,,Compound was tested in vitro for inhibition of cytopathogenicity of LAV(IIIB) in CD4+ T-cells (A3.01),4800,Autocuration,,0,,,574.0,,9606.0,1,T-cells,22226,F,Homo sapiens,,CHEMBL621039,11746,
,U,BAO_0000219,,Compound was tested in vitro for inhibition of cytopathogenicity of LAV(IIIB) in CD4+ T-cells (A3.01); Not active,4801,Autocuration,,0,,,574.0,,9606.0,1,T-cells,22226,F,Homo sapiens,,CHEMBL621040,11746,
,N,BAO_0000219,,Compound was evaluated for cytotoxic activity against human melanoma cell line A375,4802,Intermediate,,1,,,455.0,,9606.0,1,A-375,80018,F,Homo sapiens,,CHEMBL621041,5455,
,N,BAO_0000219,,In vitro antitumor activity against A375 (melanoma) human tumor cell lines.,4803,Intermediate,,1,,,455.0,,9606.0,1,A-375,80018,F,Homo sapiens,,CHEMBL621042,2068,
,N,BAO_0000219,,In vitro antitumor activity against A375cell line extracted form melanoma,4804,Intermediate,,1,,,455.0,,9606.0,1,A-375,80018,F,Homo sapiens,,CHEMBL621043,2683,
,N,BAO_0000219,,Inhibition of cell growth in (A375) melan cell line,4805,Expert,,1,,,455.0,,9606.0,1,A-375,80018,F,Homo sapiens,,CHEMBL621044,15313,
,N,BAO_0000219,,In vitro tumor cell growth inhibitory activity against Human melanoma cell lines A375,4806,Intermediate,,1,,,455.0,,9606.0,1,A-375,80018,F,Homo sapiens,,CHEMBL621045,13739,
,N,BAO_0000219,,In vitro tumor cell growth inhibitory activity against Human melanoma cell lines. A375,4807,Intermediate,,1,,,455.0,,9606.0,1,A-375,80018,F,Homo sapiens,,CHEMBL621046,13739,
,N,BAO_0000219,,Compound was tested in vitro for cytotoxicity against A375 cell lines from melanoma.,4808,Intermediate,,1,,,455.0,,9606.0,1,A-375,80018,F,Homo sapiens,,CHEMBL621047,14750,
,N,BAO_0000219,,Antiproliferative activity measured against A427 human lung carcinoma,4809,Intermediate,,1,,,797.0,,9606.0,1,A-427,80019,F,Homo sapiens,,CHEMBL621048,14777,
,N,BAO_0000219,,Antiproliferative activity measured against A427 human lung carcinoma,4810,Intermediate,,1,,,797.0,,9606.0,1,A-427,80019,F,Homo sapiens,,CHEMBL883798,14777,
,N,BAO_0000219,,Cytotoxicity against lung carcinoma A427 tumor cell lines,4811,Intermediate,,1,,,797.0,,9606.0,1,A-427,80019,F,Homo sapiens,,CHEMBL621049,17672,
,N,BAO_0000219,,Inhibition of large cell lung carcinoma (A427),4812,Intermediate,,1,,,797.0,,9606.0,1,A-427,80019,F,Homo sapiens,,CHEMBL621050,14368,
,N,BAO_0000219,,Inhibition of large cell lung carcinoma (A427) after 48-h treatment,4813,Intermediate,,1,,,797.0,,9606.0,1,A-427,80019,F,Homo sapiens,,CHEMBL621051,14368,
,N,BAO_0000219,,Inhibitory activity against A427 epithelial Cancer cell line at the concentration 0-30 uM for 48 hr,4814,Intermediate,,1,,,797.0,,9606.0,1,A-427,80019,F,Homo sapiens,,CHEMBL621052,13866,
,N,BAO_0000219,,Inhibitory concentration in human lung carcinoma A427 cell line,4815,Intermediate,,1,,,797.0,,9606.0,1,A-427,80019,F,Homo sapiens,,CHEMBL621053,2545,
,N,BAO_0000219,,Inhibitory concentration in human lung carcinoma A427/VCR cell line,4816,Intermediate,,1,,,797.0,,9606.0,1,A-427,80019,F,Homo sapiens,,CHEMBL621054,2545,
,U,BAO_0000218,,Terminal phase volume of distribution was measured in monkey after an iv dose of 1 mg/kg,4817,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621055,6062,
,U,BAO_0000218,,Tested for volume of distribution upon iv administration to african green monkey,4818,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL876398,4578,
,U,BAO_0000218,,Volume of distribution in monkey,4819,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621056,17592,
,U,BAO_0000218,,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,4820,Autocuration,,0,,In vivo,,,9544.0,1,,22224,A,Macaca mulatta,,CHEMBL621057,5005,
,U,BAO_0000218,,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,4821,Autocuration,,0,,In vivo,,,9544.0,1,,22224,A,Macaca mulatta,,CHEMBL621058,5005,
,U,BAO_0000218,,Pharmacokinetic property(Vdss) in cynomolgus monkey,4822,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621059,5922,
,U,BAO_0000218,,The distribution volume after intravenous administration in cynomolgus monkeys,4823,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621060,5355,
,U,BAO_0000218,,The distribution volume after oral administration in cynomolgus monkeys; NA means Not applicable,4824,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621061,5355,
,U,BAO_0000218,,The distribution volume after oral administration in cynomolgus monkeys; NA means not applicable,4825,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621062,5355,
,U,BAO_0000218,,Volume displacement was calculated in rhesus monkey,4826,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621063,6057,
,U,BAO_0000218,,Volume of distribution in steady state was determined in rhesus monkey,4827,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621064,5145,
,U,BAO_0000218,,Volume of distribution of compound was determined in monkey,4828,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621065,6821,
,U,BAO_0000218,,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Rhesus monkey (male),4829,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621066,5334,
,U,BAO_0000218,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Rhesus monkey (male),4830,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621067,5334,
,U,BAO_0000218,,Volumes of distribution in monkey (dosed at 0.5 mpk iv and 2.0 mpk orally),4831,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621068,6641,
,U,BAO_0000218,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female cynomolgus monkey,4832,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL876399,2661,
,U,BAO_0000218,,Volume distribution in monkey after administration of 1 mg/kg iv,4833,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621069,6535,
,U,BAO_0000218,,Volume distribution was determined in monkey after (iv) administration of a dose of 13 (uM/kg),4834,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621070,4809,
,U,BAO_0000218,,Volume of distribution was measured in monkey after an iv dose of 1 mg/kg,4835,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621071,6062,
,U,BAO_0000218,,Half life evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,4836,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621072,3443,
,U,BAO_0000218,,Oral systemic bioavailability upon iv administration to african green monkey,4837,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618209,4578,
,U,BAO_0000218,,Plasma clearance was determined in monkey after (iv) administration of a dose of 13 (uM/kg),4838,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618210,4809,
,U,BAO_0000019,,Baboon plasma free fraction. ,4839,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618211,11271,
,U,BAO_0000218,,Area under the curve was calculated in rhesus monkey after iv administration,4840,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618212,6057,
,U,BAO_0000019,,Area under the curve was calculated in rhesus monkey after peroral administration,4841,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618213,6057,
,U,BAO_0000019,,Dose-normalized area under curve in monkey (p.o.) at 2.0 mpk,4842,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618214,17853,
,U,BAO_0000218,,Half life period in monkey after 5 mg/kg dose,4843,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL873492,5302,
,U,BAO_0000218,,Half-life was determined in monkey after 3 mg/kg of i.v. dose,4844,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618272,4257,
,U,BAO_0000218,,Half-life was determined in monkey after 3 mg/kg of i.v. dose; Not determined,4845,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618273,4257,
,U,BAO_0000218,,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 1 mg/kg to rhesus monkey,4846,Autocuration,1969.0,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618274,13501,Plasma
,U,BAO_0000218,,Compound at a dose 3 mg/kg was administered to monkey and was evaluated for half life after administration into monkey at 3 mg/kg,4847,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618275,5394,
,U,BAO_0000218,,Compound was evaluated for half-life after treatment with iv dose of 1 mgkg to female cynomolgus monkey,4848,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618276,2661,
,U,BAO_0000019,,Compound was evaluated for terminal half life in monkey,4849,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618277,3341,
,U,BAO_0000218,,Compound was evaluated for the half life period after iv administration in cynomolgus monkey,4850,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618278,3045,
,U,BAO_0000218,,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,4851,Autocuration,1969.0,0,,In vivo,,,9544.0,1,,22224,A,Macaca mulatta,,CHEMBL618279,5005,Plasma
,U,BAO_0000019,,Half life of compound was determined in squirrel monkey,4852,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618280,4847,
,U,BAO_0000218,,Half life after iv administration in cynomolgus monkey,4853,Autocuration,,0,,In vivo,,,9541.0,1,,22224,A,Macaca fascicularis,,CHEMBL618281,4256,
,U,BAO_0000218,,Half life in monkey plasma after administration of 1 mg/kg iv,4854,Autocuration,1969.0,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618282,6535,Plasma
,U,BAO_0000019,,Half life was calculated in rhesus monkey,4855,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618283,6057,
,U,BAO_0000019,,Half life in monkey,4856,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618284,17592,
,U,BAO_0000218,,Half life in monkey (dosed at 0.5 mpk iv and 2.0 mpk orally),4857,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618285,6641,
,U,BAO_0000019,,Half life was evaluated in rhesus,4858,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618286,5472,
,U,BAO_0000218,,Half life period after oral administration (2.5 mg/kg) in monkey was determined,4859,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618287,6221,
,U,BAO_0000218,,Half life period was determine after peroral administration at 10 mpk in Rhesus,4860,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618288,5668,
,U,BAO_0000218,,Half life period was determined in monkey after (iv) administration of a dose of 13 (uM/kg),4861,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL876393,4809,
,U,BAO_0000218,,Half life period was determined in rhesus monkey at a dose of 1 mg/kg by iv administration,4862,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618289,5546,
,U,BAO_0000218,,Half life period was determined in squirrel monkey after iv administration at a dose of 5 mg/kg,4863,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618290,5553,
,U,BAO_0000019,,Half-life was calculated in monkey,4864,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618291,6078,
,U,BAO_0000019,,Half-life in Squirrel monkey,4865,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618292,5147,
,U,BAO_0000019,,Half-life in rhesus monkey,4866,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618293,5145,
,U,BAO_0000218,,Half-life was measured in monkey after an iv dose of 1 mg/kg,4867,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618294,6062,
,U,BAO_0000218,,Half-life period after intravenous administration in cynomolgus monkeys,4868,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618295,5355,
,U,BAO_0000218,,Half-life period after oral administration in cynomolgus monkeys,4869,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618296,5355,
,U,BAO_0000218,,Half-life period after oral administration in cynomolgus monkeys; ND meansn Not determined,4870,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618297,5355,
,U,BAO_0000019,,Portion of holoxan excreted in the form of the metabolite from 1500 mL of urine on day 9 was determined in embryonal rhabdomyosarcoma patients treated with ifosfamide,4871,Autocuration,1088.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618298,7766,Urine
,U,BAO_0000019,,Portion of holoxan excreted in the form of the metabolite from 1600 mL of urine on day 10 was determined in embryonal rhabdomyosarcoma patients treated with ifosfamide,4872,Autocuration,1088.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618299,7766,Urine
,U,BAO_0000019,,Portion of holoxan excreted in the form of the metabolite from 1700 mL of urine on day 5 was determined in embryonal rhabdomyosarcoma patients treated with ifosfamide,4873,Autocuration,1088.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618300,7766,Urine
,U,BAO_0000019,,Portion of holoxan excreted in the form of the metabolite from 2310 mL of urine on day 4 was determined in embryonal rhabdomyosarcoma patients treated with ifosfamide,4874,Autocuration,1088.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618301,7766,Urine
,U,BAO_0000019,,Percent ratio of the enantiomeric form (+)R extracted from the urine of alveolar rhabdomyosarcoma patients was determined,4875,Autocuration,1088.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618302,7766,Urine
,U,BAO_0000019,,Percent ratio of the enantiomeric form (+)R extracted from the urine of embryonal rhabdomyosarcoma patients was determined,4876,Autocuration,1088.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL876394,7766,Urine
,U,BAO_0000019,,Percent ratio of the enantiomeric form (-)S extracted from the urine of alveolar rhabdomyosarcoma patients was determined,4877,Autocuration,1088.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618303,7766,Urine
,U,BAO_0000019,,Percent ratio of the enantiomeric form (-)S extracted from the urine of embryonal rhabdomyosarcoma patients was determined,4878,Autocuration,1088.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618304,7766,Urine
,U,BAO_0000218,,Bioavailability was evaluated in man at a dose of 10 mg/kg after po administration; not determined,4879,Autocuration,,0,,In vivo,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618305,1916,
,U,BAO_0000218,,Oral bioavailability in human,4880,Autocuration,,0,,In vivo,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618306,16643,
,U,BAO_0000019,,Compound was tested for human plasma protein binding,4881,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618307,17248,
,U,BAO_0000019,,Compound was tested for human plasma protein binding; Not determined,4882,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618308,17248,
,U,BAO_0000019,,Protein binding activity of compound in human plasma; % Free,4883,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618309,6241,
,U,BAO_0000019,,Unbound fraction (plasma),4884,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618310,17716,
,U,BAO_0000366,,Half life for the hydrolysis of compound in human blood serum,4885,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL873353,17605,Plasma
,U,BAO_0000366,,Half life period in human plasma using phosphate buffer (0.08 M),4886,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618311,17625,Plasma
,U,BAO_0000366,,Half life period in human plasma using phosphate buffer (0.1 M),4887,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618312,17625,Plasma
,U,BAO_0000366,,Half-life in human plasma was determined,4888,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618313,17747,Plasma
,U,BAO_0000019,,Concentration required for 50% toxicity in metastatic lung carcinoma (MV522) cells.,4889,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618314,15613,
,U,BAO_0000019,,Effect of compound on gelation time of human serum induced by dithiothreitol (DTT),4890,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618315,354,
,U,BAO_0000019,,"Rate constant in chemical and enzymatic hydrolysis to form L-DOPA, in 80% human plasma",4891,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618316,3741,
,U,BAO_0000019,,"Rate constant in chemical and enzymatic hydrolysis to form another compound (8)*, in 80% human plasma (experiment 1)",4892,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618317,3741,
,U,BAO_0000019,,"Rate constant in chemical and enzymatic hydrolysis to form another compound (8)*, in 80% human plasma (experiment 2)",4893,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL620138,3741,
,U,BAO_0000019,,Partition coefficient (logP),4894,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL858280,17599,
,U,BAO_0000019,,In vitro metabolic stability in human was measured as pmol/min/mg/protein,4895,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL620139,5486,
,U,BAO_0000251,,In vitro metabolic stability determined after 30 min of incubation in human hepatic microsomes,4896,Autocuration,,0,Microsomes,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL620140,5600,
,U,BAO_0000019,,Metabolism of compound in human liver slices (male) ('+''indicates <20% largest observed peak),4897,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL620141,14294,
,U,BAO_0000019,,Metabolism of compound in human liver slices (male) ('++''indicates 20-50% largest observed peak),4898,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL620142,14294,
,U,BAO_0000019,,Metabolism of compound in human liver slices (male) ('++++' indicates largest observed peak),4899,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL620143,14294,
,U,BAO_0000251,,Metabolism of compound in human microsomes ('+''indicates <20% largest observed peak),4900,Autocuration,,0,Microsomes,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL620144,14294,
,U,BAO_0000251,,Metabolism of compound in human microsomes ('++++' indicates largest observed peak),4901,Autocuration,,0,Microsomes,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL620145,14294,
,U,BAO_0000251,,Metabolism of compound in human microsomes; Trace,4902,Autocuration,,0,Microsomes,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL620146,14294,
,U,BAO_0000251,,Percent of compound remaining after 120 min of Metabolization upon incubation with human liver microsomes,4903,Autocuration,2107.0,0,Microsomes,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL620147,6260,Liver
,U,BAO_0000251,,Percent metabolized in an in vitro human liver microsomal incubation assay after 60 min,4904,Autocuration,,0,Microsomes,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL620148,6187,
,U,BAO_0000251,,In vitro metabolic potential in human liver microsomes,4905,Autocuration,2107.0,0,Microsomes,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL620149,6251,Liver
,U,BAO_0000019,,Metabolism by recombinant human NAD(P)H:quinone oxidoreductase (NQO1) was evaluated,4906,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL876412,3246,
,U,BAO_0000019,,Tested for human plasma protein binding of the compound; Not tested,4907,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL619352,17313,
,U,BAO_0000019,,Compound was tested for percent protein binding (PB) in human,4908,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL619353,6227,
,U,BAO_0000019,,Protein binding in human plasma,4909,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL619354,5530,Plasma
,U,BAO_0000019,,Permeability coefficient (B to A) in Caco-2 cell,4910,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL619355,6108,
,U,BAO_0000019,,Permeability directional ratio (PB-A/PA-B) in Caco-2 cell,4911,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL619356,6108,
,U,BAO_0000019,,Apparent permeability coefficient (Papp) was determined in human Caco-2 cell monolayer (n = 3),4912,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL619357,2774,
,U,BAO_0000019,,In vitro rate of absorption observed as Caco-2 permeability in humans,4913,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL619358,16643,
,U,BAO_0000219,,Cellular permeability of compound was determined in Caco-2 cells; High,4914,Autocuration,,0,,,495.0,,9606.0,1,Caco-2,22224,A,Homo sapiens,,CHEMBL619359,17582,
,U,BAO_0000219,,Permeability in Caco-2 cells of compound,4915,Autocuration,,0,,,495.0,,9606.0,1,Caco-2,22224,A,Homo sapiens,,CHEMBL619360,6838,
,U,BAO_0000019,,Permeability coefficient (A to B) in Caco-2 cell,4916,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL619361,6108,
,U,BAO_0000019,,Permeability coefficient (B to A) in Caco-2 cell,4917,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL619362,6108,
,U,BAO_0000019,,Permeability coefficient (Papp) (Caco-2 cell monolayer),4918,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL619363,6108,
,U,BAO_0000019,,Compound was measured for binding rate for human serum at a carbapenem concentration of 10 ug/mL,4919,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618942,2146,
,U,BAO_0000019,,Compound was tested for protein binding in human plasma,4920,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618943,4514,
,U,BAO_0000019,,Transcellular permeability of the [(PA-B+PB-A)/2)] compound was determined in Caco-2 cell,4921,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618944,6108,
,U,BAO_0000019,,Quantity of the metabolite found in the urine of the embryonal rhabdomyosarcoma patients treated with ifosfamide from 1200 mL of urine tested on day 3,4922,Autocuration,1088.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618945,7766,Urine
,N,BAO_0000218,,In vivo Tmax was determined in murine septicemia at dose of 50 mg/kg,4923,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618946,5969,
,N,BAO_0000218,,Maximum time was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),4924,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL876413,3277,
,N,BAO_0000218,,Tested for Tmax value at the dose of 10 mg/kg when administered perorally in mouse,4925,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618947,3802,
,N,BAO_0000218,,Time taken to reach maximum concentration in plasma upon oral administration in mouse,4926,Intermediate,1969.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618948,2862,Plasma
,N,BAO_0000218,,Time to reach maximum plasma concentration was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,4927,Intermediate,1969.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618949,6348,Plasma
,N,BAO_0000218,,Tmax after intraperitoneal administration in mice at 23 uM/kg,4928,Intermediate,,1,,In vivo,,,10090.0,1,,50594,F,Mus musculus,,CHEMBL618950,17764,
,N,BAO_0000218,,Tmax after oral administration at 30 mg/kg in ICR mouse,4929,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618951,5781,
,N,BAO_0000218,,Tmax after peroral administration in mice at 2.4 uM/kg,4930,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618952,17764,
,N,BAO_0000218,,Tmax at a single subcutaneous administration of 40 mg/kg in mice,4931,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618953,4066,
,N,BAO_0000218,,Tmax in brain of mice at the oral dose of 50 mg/kg,4932,Intermediate,955.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618954,17641,Brain
,N,BAO_0000218,,Tmax in kidney of mice at the oral dose of 50 mg/kg,4933,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618955,17641,Kidney
,N,BAO_0000218,,Tmax in liver of mice at the oral dose of 50 mg/kg,4934,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618956,17641,Liver
,N,BAO_0000218,,Tmax in lungs of mice at the oral dose of 50 mg/kg,4935,Intermediate,2048.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618957,17641,Lung
,N,BAO_0000218,,Tmax in mice at 18 uM/kg i.p. administration,4936,Intermediate,,1,,In vivo,,,10090.0,1,,50594,F,Mus musculus,,CHEMBL618958,17764,
,N,BAO_0000218,,Tmax in mice at 23 uM/kg i.v. administration,4937,Intermediate,,1,,In vivo,,,10090.0,1,,50594,F,Mus musculus,,CHEMBL618959,17764,
,N,BAO_0000218,,Tmax in mice at 25 uM/kg i.p. administration,4938,Intermediate,,1,,In vivo,,,10090.0,1,,50594,F,Mus musculus,,CHEMBL618960,17764,
,N,BAO_0000218,,Tmax in mice at 26 uM/kg i.p. administration,4939,Intermediate,,1,,In vivo,,,10090.0,1,,50594,F,Mus musculus,,CHEMBL876723,17764,
,N,BAO_0000218,,Tmax in spleen of mice at the oral dose of 50 mg/kg,4940,Intermediate,2106.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618961,17641,Spleen
,N,BAO_0000218,,Tmax value at a dose of 10 mg/kg intravenous administration in mice.,4941,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618962,16597,
,N,BAO_0000218,,Tmax value at a dose of 10 mg/kg peroral administration in mice.,4942,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618963,16597,
,N,BAO_0000218,,Tmax value in IRC mice,4943,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618964,5951,
,N,BAO_0000218,,Tmax value was determined at a dose of 100 mg/kg (i.p.) in Mice,4944,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618965,5506,
,N,BAO_0000218,,Tmax value was determined at a dose of 200 mg/kg (i.p.) in Mice,4945,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618966,5506,
,N,BAO_0000218,,Evaluated for pharmacokinetic parameter urine recovery in mouse at the dose 20 mg/kg ( 0-24 hr ),4946,Intermediate,1088.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618967,429,Urine
,N,BAO_0000218,,Evaluated for pharmacokinetic parameter urine recovery in mouse at the dose 20 mg/kg (0-24 hr),4947,Intermediate,1088.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618968,429,Urine
,N,BAO_0000218,,Urinary recovery by disk method using Streptococcus pyogenes (0-24 h),4948,Intermediate,1088.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618969,4066,Urine
,N,BAO_0000218,,The first compartment constitutes the majority of the volume of distribution after intraperitoneal administration of 100 mg/kg in mice,4949,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618970,17734,
,N,BAO_0000218,,The second majority of the volume of distribution after intraperitoneal administration of 100 mg/kg in mice,4950,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618971,17734,
,N,BAO_0000218,,Terminal phase volume of distribution was measured in mouse after an iv dose of 1 mg/kg,4951,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618972,6062,
,N,BAO_0000218,,In vivo volume distribution (Vd) was determined in murine septicemia at dose of 100 mg/kg,4952,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618973,5969,
,N,BAO_0000218,,In vivo volume distribution (Vd) was determined in murine septicemia at dose of 50 mg/kg,4953,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618974,5969,
,N,BAO_0000218,,In vivo volume distribution (Vd) was determined in murine septicemia at dose of 50 mg/kg;ND=not determined,4954,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618975,5969,
,N,BAO_0000218,,Vd in mice,4955,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618976,5980,
,N,BAO_0000218,,Volume of distribution in mouse,4956,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618977,17592,
,N,BAO_0000218,,Volume of distribution was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,4957,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL876724,6348,
,N,BAO_0000218,,Volume of distribution of compound in plasma was determined at 24 mg/Kg,4958,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618978,17753,
,N,BAO_0000218,,Volume of distribution of compound in plasma was determined at 40 mg/Kg,4959,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618979,17753,
,N,BAO_0000218,,Volume of distribution of compound in plasma was determined at 5 mg/Kg,4960,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618980,17753,
,N,BAO_0000218,,Pharmacokinetic property (vdss) was measured in mouse,4961,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618981,4239,
,N,BAO_0000218,,Value distribution upon iv administration in mouse,4962,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618982,2862,
,N,BAO_0000218,,Volume of distribution after intraperitoneal administration of 100 mg/kg in mice,4963,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620150,17734,
,N,BAO_0000218,,Volume of distribution was evaluated in mice after intravenous administration,4964,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620151,2675,
,N,BAO_0000218,,Volume of distribution was evaluated in mice after oral administration,4965,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620152,2675,
,N,BAO_0000218,,Steady state volume of distribution of compound in mouse blood following i.v. administration of 10 mg/kg,4966,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620153,17837,
,N,BAO_0000218,,Steady state volume of distribution was determined in mice,4967,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL876395,5727,
,N,BAO_0000218,,Volume distribution (steady state) of compound was determined in mouse,4968,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620154,17852,
,N,BAO_0000218,,Volume of solubility in solution after intravenous administration in mice at 24 uM/kg,4969,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620155,17764,
,N,BAO_0000218,,Vss value at a dose of 10 mg/kg intravenous administration in mice.,4970,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620156,16597,
,N,BAO_0000218,,Volume of distribution was measured in mouse after an iv dose of 1 mg/kg,4971,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620157,6062,
,N,BAO_0000218,,Biodistribution of compound (oxidized form) in in kidney tissue,4972,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620158,16438,Kidney
,N,BAO_0000218,,Biodistribution in mice as total concentration of both oxidized and reduced forms in blood and animals were sacrificed 10 minutes after ip administration in DMSO solution,4973,Intermediate,178.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620159,16438,Blood
,N,BAO_0000218,,"Biodistribution in mice as total concentration of both oxidized and reduced forms in blood and animals were sacrificed 10 minutes after ip dosing, in DMSO solution",4974,Intermediate,178.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620160,16438,Blood
,N,BAO_0000218,,"Biodistribution in mice as total concentration of both oxidized and reduced forms in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",4975,Intermediate,178.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620161,16438,Blood
,N,BAO_0000219,,Evaluated for the inhibitory concentration required to cause growth inhibition of A427Mer- cell line of lung using the MTT Cytotoxicity Assay,4976,Intermediate,,1,,,797.0,,9606.0,1,A-427,80019,F,Homo sapiens,,CHEMBL620162,10708,
,N,BAO_0000219,,Inhibition of A431 human squamous cell carcinoma cell proliferation,4977,Expert,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL620163,16597,
,N,BAO_0000219,,Inhibition of cell growth of human epidermoid carcinoma xenograft (A431) model using cell based assay,4978,Expert,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL620833,16062,
,N,BAO_0000219,,Inhibition of human epidermoid carcinoma xenograft (A431) tumor growth,4979,Expert,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL876396,16062,
,N,BAO_0000219,,Concentration required to inhibit growth of human carcinoma epidermoid (A431) cell line,4980,Expert,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL620834,16958,
,N,BAO_0000219,,Inhibition of A431 human carcinoma cell proliferation,4981,Expert,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL620835,6700,
,N,BAO_0000219,,In vitro inhibition of A431 (human carcinoma) cell basal growth.,4982,Expert,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL620836,17226,
,N,BAO_0000219,,Inhibitory concentration of compound against growth of human A431 cell line; Resistant,4983,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL620837,6828,
,N,BAO_0000219,,In vitro cytotoxicity against epidermoid carcinoma cell line,4984,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL621017,12314,
,D,BAO_0000218,,"In vivo efficacy following oral administration in nude mouse tumor model, xenograft A431 cells expressing EGF-R",4985,Expert,,9,,,500.0,,9606.0,1,A-431,9,F,Homo sapiens,,CHEMBL621018,13412,
,N,BAO_0000219,,Antiproliferative activity of compound was measured on human tumor cell line A431.,4986,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL621019,13299,
,N,BAO_0000219,,Antiproliferative effect of compound on A431 cell line expressing mutant p53,4987,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL621020,17420,
,N,BAO_0000219,,Compound was evaluated for cell growth inhibition against A 431 cell line by irradiation in the presence of examined compound,4988,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL621021,13678,
,H,BAO_0000219,,Inhibition of EGF-stimulated tyrosine phosphorylation in A431 cells.,4989,Expert,,8,,,500.0,,,1,A-431,9,F,,,CHEMBL621022,14171,
,N,BAO_0000219,,Tested for antiproliferative activity against human A431 cells,4990,Expert,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL621023,6333,
,D,BAO_0000219,,Inhibition of epidermal growth factor receptor (EGF-R) autophosphorylation in A431 cells,4991,Expert,,9,,,500.0,,9606.0,1,A-431,9,F,Homo sapiens,,CHEMBL621024,2356,
,N,BAO_0000219,,Concentration needed to inhibit 50% growth of the human A431 (epidermoid carcinoma) cell lines,4992,Expert,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL621025,15578,
,N,BAO_0000219,,Inhibition of A431 cell proliferation,4993,Expert,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL621026,5126,
,N,BAO_0000219,,Cytotoxic effect on A431 human epidermoid carcinoma cells,4994,Expert,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL621027,6844,
,N,BAO_0000219,,Cytotoxic effect on A431 human epidermoid carcinoma cells (No response to 1 mM),4995,Expert,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL876397,6844,
,N,BAO_0000219,,Cytotoxicity expressed as inhibitory concentration required to reduce the cell growth of A431 human epidermal carcinoma cell line,4996,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL883797,4925,
,N,BAO_0000219,,Cytotoxicity expressed as inhibitory concentration required to reduce the cell growth of A431 human epidermal carcinoma cell line; NT=Not tested,4997,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL621028,4925,
,N,BAO_0000219,,In vitro Growth Inhibitory activity against A431 Human vulva cancer cell line,4998,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL621029,13978,
,N,BAO_0000219,,In vitro cytotoxicity of compound against human A431 (epidermoid) cancer cell line after 72 hr of drug exposure,4999,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL621030,16786,
,H,BAO_0000219,,Inhibition of EGF-stimulated tyrosine phosphorylation in A431 cells expressing EGF-R,5000,Expert,,8,,,500.0,,,1,A-431,9,F,,,CHEMBL621147,13412,
,N,BAO_0000218,,In vivo antiproliferative activity against A431 cell line,5001,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL621148,17824,
,D,BAO_0000219,,Inhibition of EGF-dependent autophosphorylation of EGF-R in human A431 cells,5002,Expert,,9,,,500.0,,9606.0,1,A-431,9,F,Homo sapiens,,CHEMBL621149,12751,
,N,BAO_0000219,,Inhibition of A431 human epidermoid carcinoma cell proliferation,5003,Expert,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL621150,12380,
,D,BAO_0000219,,Inhibition of autophosphorylation of human epidermal growth factor-receptor (EGF-R) expressed in A431 cells,5004,Expert,,9,,,500.0,,9606.0,1,A-431,9,F,Homo sapiens,,CHEMBL621151,4959,
,N,BAO_0000219,,Inhibitory effect on nonphospho-Src after EGF (100 uM) stimulation of A431 cells (control=178),5005,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL621152,6333,
,N,BAO_0000219,,Inhibitory effect on phospho-Src (Tyr416) after EGF (100 uM) stimulation of A431 cells (38),5006,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL621153,6333,
,N,BAO_0000219,,Inhibitory effect on phospho-Src/nonphospho after EGF (100 uM) stimulation of A431 cells (21),5007,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL884000,6333,
,D,BAO_0000019,,Inhibition of EGFR overexpressing A431 cell proliferation,5008,Expert,,9,,,,,9606.0,1,,9,F,Homo sapiens,,CHEMBL621154,5296,
,N,BAO_0000219,,Inhibition of A431 cell proliferation,5009,Expert,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL621155,12624,
,D,BAO_0000219,,No inhibition of EGFR phosphorylation in A431 cells 8 hour after washing cells free of the inhibitor,5010,Expert,,9,,,500.0,,9606.0,1,A-431,9,F,Homo sapiens,,CHEMBL621156,14926,
,D,BAO_0000219,,"Partial inhibition of EGFR phosphorylation in A431 cells, 8 hour after washing cells free of the inhibitor",5011,Expert,,9,,,500.0,,9606.0,1,A-431,9,F,Homo sapiens,,CHEMBL621157,14926,
,H,BAO_0000219,,Irreversible inhibition of ATP binding site of EGFR (lack of phosphorylated EGFR) in A431 cells 8 hour after washing cells free of the inhibitor),5012,Expert,,8,,,500.0,,,1,A-431,9,F,,,CHEMBL621158,14926,
,N,BAO_0000219,,The compound was tested in vitro for antiproliferative activity against A431 tumor cell lines,5013,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL621159,15144,
,N,BAO_0000219,,The compound was tested in vitro for antiproliferative activity against A431 tumor cell lines,5014,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL621160,15144,
,N,BAO_0000219,,Cell viability in A431 cells unstimulated with EGF was tested when incubated with concentration at 2 uM after 48 h; Did not affect the viability,5015,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL621161,5245,
,N,BAO_0000219,,Cell viability in A431 cells unstimulated with EGF was tested when incubated with concentration in the range of 1-10 uM after 48 h; Did not affect the viability,5016,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL621162,5245,
,N,BAO_0000219,,Cell viability in A431 cells unstimulated with EGF was tested when incubated with concentration up to 10 uM after 48 h; Did not affect the viability,5017,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL621163,5245,
,N,BAO_0000219,,Cell viability in A431 cells when stimulated with EGF was tested when incubated with concentration 0.01 uM after 48 h; Cell death,5018,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL621164,5245,
,N,BAO_0000219,,Cell viability in A431 cells when stimulated with EGF was tested when incubated with concentration 2 uM after 48 h; Cell death,5019,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL621165,5245,
,U,BAO_0000019,,Half-life period in cynomolgus monkey,5020,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL619159,5922,
,U,BAO_0000366,,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in monkey plasma",5021,Autocuration,1969.0,0,,In vitro,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL619160,1116,Plasma
,U,BAO_0000218,,Longer half-life in monkey (i.v.) at 0.5 mpk,5022,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL619161,17853,
,U,BAO_0000366,,Plasma half life in monkey,5023,Autocuration,1969.0,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL619162,993,Plasma
,U,BAO_0000366,,Plasma half-life in rhesus monkey,5024,Autocuration,1969.0,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL619163,4514,Plasma
,U,BAO_0000218,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Rhesus monkey (male),5025,Autocuration,1969.0,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL619164,5334,Plasma
,U,BAO_0000218,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Rhesus monkey (male),5026,Autocuration,1969.0,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL619320,5334,Plasma
,U,BAO_0000218,,Tested for half life upon iv administration to african green monkey,5027,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL619321,4578,
,U,BAO_0000218,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female cynomolgus monkey,5028,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL873336,2661,
,U,BAO_0000218,,The time for peak concentration value after intravenous administration in cynomolgus monkeys; NA means Not applicable,5029,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL619322,5355,
,U,BAO_0000218,,The time for peak concentration value after intravenous administration in cynomolgus monkeys; NA means not applicable,5030,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL619323,5355,
,U,BAO_0000218,,The time for peak concentration value after oral administration in cynomolgus monkeys,5031,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL619324,5355,
,U,BAO_0000019,,Percentage of tracer or metabolite (CO2) in baboon plasma at 10 min after injection of the compound,5032,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL619325,11271,
,U,BAO_0000019,,Percentage of tracer or metabolite (CO2) in baboon plasma at 1 min after injection of the compound,5033,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL876411,11271,
,U,BAO_0000019,,Percentage of tracer or metabolite (CO2) in baboon plasma at 30 min after injection of the compound,5034,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL619326,11271,
,U,BAO_0000019,,Percentage of tracer or metabolite (CO2) in baboon plasma at 5 min after injection of the compound,5035,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL619327,11271,
,U,BAO_0000019,,Percentage of tracer or metabolite(EME) in baboon plasma at 10 min after injection of the compound,5036,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL619328,11271,
,U,BAO_0000019,,Percentage of tracer or metabolite(EME) in baboon plasma at 1 min after injection of the compound,5037,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL619329,11271,
,U,BAO_0000019,,Percentage of tracer or metabolite(EME) in baboon plasma at 30 min after injection of the compound,5038,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL619330,11271,
,U,BAO_0000019,,Percentage of tracer or metabolite(EME) in baboon plasma at 5 min after injection of the compound,5039,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL619331,11271,
,U,BAO_0000019,,Percentage of tracer or metabolite (acid metabolites) in baboon plasma at 10 min after injection of the compound,5040,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL619332,11271,
,U,BAO_0000019,,Percentage of tracer or metabolite (acid metabolites) in baboon plasma at 1 min after injection of the compound,5041,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL619333,11271,
,U,BAO_0000019,,Percentage of tracer or metabolite (acid metabolites) in baboon plasma at 30 min after injection of the compound,5042,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL619334,11271,
,U,BAO_0000019,,Percentage of tracer or metabolite (acid metabolites) in baboon plasma at 5 min after injection of the compound,5043,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL619335,11271,
,U,BAO_0000019,,Percentage of tracer or metabolite (unchanged) in baboon plasma at 10 min after injection of the compound,5044,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL619336,11271,
,U,BAO_0000019,,Percentage of tracer or metabolite (unchanged) in baboon plasma at 1 min after injection of the compound,5045,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL619337,11271,
,U,BAO_0000019,,Percentage of tracer or metabolite (unchanged) in baboon plasma at 30 min after injection of the compound,5046,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL619338,11271,
,U,BAO_0000019,,Percentage of tracer or metabolite (unchanged) in baboon plasma at 5 min after injection of the compound,5047,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL619339,11271,
,N,BAO_0000218,,Bioavailability in rat (cannulated) (dose 2 mg/kg),5048,Intermediate,,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL619340,5809,
,N,BAO_0000218,,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,5049,Intermediate,1969.0,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL873496,17720,Plasma
,N,BAO_0000218,,AUC value in rat after IV administration at a dose of 10 mg/kg,5050,Intermediate,1969.0,1,,,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL619341,3546,Plasma
,N,BAO_0000218,,AUC value in rat after oral administration at a dose of 10 mg/kg,5051,Intermediate,1969.0,1,,,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL619342,3546,Plasma
,N,BAO_0000218,,Cmax value in rat after oral administration at a dose of 10 mg/kg,5052,Intermediate,,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL619343,3546,
,N,BAO_0000218,,Bioavailability in rat after oral administration at a dose of 10 mg/kg,5053,Intermediate,,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL619344,3546,
,N,BAO_0000218,,Tmax value in rat after oral administration at a dose of 10 mg/kg,5054,Intermediate,,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL619345,3546,
,N,BAO_0000218,,Vc value in rat after IV administration at a dose of 10 mg/kg,5055,Intermediate,,1,,,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL619346,3546,
,N,BAO_0000218,,Half life period in rat after IV administration at a dose of 10 mg/kg,5056,Intermediate,,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL619347,3546,
,U,BAO_0000019,,The absolute striatal uptake of the carbon-11 labeled compound at 60 min was determined in baboon,5057,Autocuration,,0,,,,,9557.0,1,,22224,A,Papio hamadryas,,CHEMBL619348,10625,
,U,BAO_0000019,,Peak plasma radioactivity for the carbon-11 labeled compound was determined at 0.5 min after injection in baboon; (Range = 0.08-0.11),5058,Autocuration,,0,,,,,9557.0,1,,22224,A,Papio hamadryas,,CHEMBL619349,10625,
,U,BAO_0000019,,Peak plasma radioactivity for the carbon-11 labeled compound was determined at 1.5 min after injection in baboon; (Range = 0.08-0.11),5059,Autocuration,,0,,,,,9557.0,1,,22224,A,Papio hamadryas,,CHEMBL619350,10625,
,U,BAO_0000019,,The amount of unchanged tracer in baboon plasma was determined 1 min after injection of the carbon-11 labeled compound,5060,Autocuration,,0,,,,,9557.0,1,,22224,A,Papio hamadryas,,CHEMBL619351,10625,
,U,BAO_0000019,,The amount of unchanged tracer in baboon plasma was determined 10 min after injection of the carbon-11 labeled compound,5061,Autocuration,,0,,,,,9557.0,1,,22224,A,Papio hamadryas,,CHEMBL875953,10625,
,U,BAO_0000019,,The amount of unchanged tracer in baboon plasma was determined 30 min after injection of the carbon-11 labeled compound,5062,Autocuration,,0,,,,,9557.0,1,,22224,A,Papio hamadryas,,CHEMBL621716,10625,
,U,BAO_0000019,,The amount of unchanged tracer in baboon plasma was determined 60 min after injection of the carbon-11 labeled compound,5063,Autocuration,,0,,,,,9557.0,1,,22224,A,Papio hamadryas,,CHEMBL621717,10625,
,U,BAO_0000019,,The absolute striatal uptake of the carbon-11 labeled compound at 60 min was determined in baboon,5064,Autocuration,,0,,,,,9557.0,1,,22224,A,Papio hamadryas,,CHEMBL621718,10625,
,U,BAO_0000019,,Area under curve after 1 mpk peroral administration to beagles,5065,Autocuration,,0,,,,,9615.0,1,,22224,A,beagle,,CHEMBL621719,3510,
,U,BAO_0000019,,Area under curve after 2 mpk peroral administration to beagles,5066,Autocuration,,0,,,,,9615.0,1,,22224,A,beagle,,CHEMBL621720,3510,
,U,BAO_0000218,,Cmax value after 1 mpk peroral administration to beagles,5067,Autocuration,,0,,In vivo,,,9615.0,1,,22224,A,beagle,,CHEMBL621721,3510,
,U,BAO_0000019,,Quantity of the metabolite found in the urine of the embryonal rhabdomyosarcoma patients treated with ifosfamide from 1200 mL of urine tested on day 7,5068,Autocuration,1088.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL621722,7766,Urine
,U,BAO_0000019,,Quantity of the metabolite found in the urine of the embryonal rhabdomyosarcoma patients treated with ifosfamide from 1300 mL of urine tested on day 6,5069,Autocuration,1088.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL621723,7766,Urine
,U,BAO_0000019,,Quantity of the metabolite found in the urine of the embryonal rhabdomyosarcoma patients treated with ifosfamide from 1300 mL of urine tested on day 8,5070,Autocuration,1088.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL621724,7766,Urine
,U,BAO_0000019,,Quantity of the metabolite found in the urine of the embryonal rhabdomyosarcoma patients treated with ifosfamide from 1500 mL of urine tested on day 9,5071,Autocuration,1088.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL623443,7766,Urine
,U,BAO_0000019,,Quantity of the metabolite found in the urine of the embryonal rhabdomyosarcoma patients treated with ifosfamide from 1600 mL of urine tested on day 10,5072,Autocuration,1088.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL623444,7766,Urine
,U,BAO_0000019,,Quantity of the metabolite found in the urine of the embryonal rhabdomyosarcoma patients treated with ifosfamide from 1700 mL of urine tested on day 5,5073,Autocuration,1088.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL623445,7766,Urine
,U,BAO_0000019,,Quantity of the metabolite found in the urine of the embryonal rhabdomyosarcoma patients treated with ifosfamide from 2310 mL of urine tested on day 4,5074,Autocuration,1088.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL623446,7766,Urine
,U,BAO_0000251,,Metabolic stability observed at 30 min after administration in human liver microsomes,5075,Autocuration,2107.0,0,Microsomes,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL623447,16643,Liver
,U,BAO_0000019,,Percent recovery of 100 ug/mL compound after administration in cirrhotic patients,5076,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL623448,6852,
,U,BAO_0000019,,Percent recovery of 10 ug/mL compound after administration in cirrhotic patients,5077,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL623449,6852,
,U,BAO_0000019,,Percent recovery of 500 ug/mL compound after administration in cirrhotic patients,5078,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL623450,6852,
,U,BAO_0000251,,"Compound remaining after incubation with 2 mg/mL of human liver microsomes at 37 degrees C for 30 min in a pH 7.4, 0.05 M phosphate buffer",5079,Autocuration,2107.0,0,Microsomes,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL623451,6567,Liver
,U,BAO_0000019,,Metabolic stability (% remaining at 30 mins) in human S9.,5080,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL623452,6570,
,U,BAO_0000019,,Metabolic stability determined as remaining percent after 30 min of incubation in human isolated liver S9 preparations; N/D= Not determined,5081,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL623453,6570,
,U,BAO_0000251,,Percent parent compound remaining after 20 min incubation with human liver microsomes,5082,Autocuration,2107.0,0,Microsomes,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL623454,5237,Liver
,U,BAO_0000251,,Percent parent compound remaining after 20 min incubation with human liver microsomes; ND=No data,5083,Autocuration,2107.0,0,Microsomes,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL623455,5237,Liver
,U,BAO_0000251,,Percent parent compound remaining after 20 min incubation with human liver microsomes; No data,5084,Autocuration,2107.0,0,Microsomes,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624371,5237,Liver
,U,BAO_0000218,,First pass metabolism and metabolic bioavailability using human hepatic microsomes,5085,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624372,5202,
,U,BAO_0000019,,Percent compound remaining in human plasma after incubation for 60 min at 37 C.,5086,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624373,5481,
,U,BAO_0000019,,Percent remaining in human plasma after incubation for 60 min at 37 C.,5087,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624374,5481,
,U,BAO_0000019,,The percent remaining in human plasma after 30 min was determined,5088,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624556,3956,
,U,BAO_0000366,,Conversion rate of the prodrug in human plasma,5089,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624557,5074,Plasma
,U,BAO_0000366,,Conversion rate of the prodrug in human plasma; ND means no data,5090,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624558,5074,Plasma
,U,BAO_0000221,,Half life of compound was determined in human blood,5091,Autocuration,178.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624559,4727,Blood
,U,BAO_0000019,,Half life of compound was determined in man with once daily dosing,5092,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624560,5965,
,U,BAO_0000251,,Half life in human microsomes,5093,Autocuration,,0,Microsomes,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624561,5732,
,U,BAO_0000366,,Half life in human plasma,5094,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624562,5819,Plasma
,U,BAO_0000366,,Half life in human plasma; Not detected,5095,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624563,5819,Plasma
,U,BAO_0000218,,Half life period was evaluated against man at a dose of 10 mg/kg after po administration,5096,Autocuration,,0,,In vivo,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624564,1916,
,U,BAO_0000251,,Half-life for oxidative metabolic stability was determined using rat liver microsomes,5097,Autocuration,2107.0,0,Microsomes,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624565,6597,Liver
,U,BAO_0000366,,Half-life in human plasma,5098,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL875152,5229,Plasma
,U,BAO_0000366,,Half-life of the parent prodrug in plasma,5099,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624566,5229,Plasma
,U,BAO_0000366,,In vitro half life in human plasma was determined,5100,Autocuration,1969.0,0,,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL873805,2192,Plasma
,U,BAO_0000251,,The compound was tested In Vitro for half life in human liver microsomes.,5101,Autocuration,2107.0,0,Microsomes,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624567,3032,Liver
,U,BAO_0000218,,Maximum time was evaluated against man at a dose of 10 mg/kg after po administration,5102,Autocuration,,0,,In vivo,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624568,1916,
,U,BAO_0000218,,Observed volume of distribution,5103,Autocuration,,0,,In vivo,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624569,17716,
,U,BAO_0000218,,Oral bioavailability in human,5104,Autocuration,,0,,In vivo,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624570,15778,
,U,BAO_0000019,,Tested for human plasma protein binding of the compound,5105,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624571,17313,
,U,BAO_0000019,,"First order rate constant, k was determined in human plasma",5106,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624572,4231,
,U,BAO_0000019,,Observed rate constant in 80% human plasma at 37 degree Centigrade,5107,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624573,4755,
,U,BAO_0000019,,Observed rate constant in 80% human plasma at 37 degree Centigrade,5108,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL875153,4755,
,U,BAO_0000251,,Loss of compound (%metabolized) after 30 min exposure to human liver microsomes,5109,Autocuration,2107.0,0,Microsomes,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624574,16907,Liver
,U,BAO_0000019,,The compound was tested for the plasma binding in human,5110,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624575,10839,
,U,BAO_0000019,,Plasma protein binding (human),5111,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624576,10839,
,U,BAO_0000251,,Compound was evaluated for half-life in human liver microsomes,5112,Autocuration,2107.0,0,Microsomes,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624577,3199,Liver
,U,BAO_0000221,,Half life measured in vitro for its stability in human blood,5113,Autocuration,178.0,0,,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL624578,1345,Blood
,U,BAO_0000019,,Half life in human serum,5114,Autocuration,1977.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL622796,4297,Serum
,U,BAO_0000019,,Half life in human serum; ND=not determined,5115,Autocuration,1977.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL622797,4297,Serum
,U,BAO_0000019,,Half life were determined in CEM-SS cell extract in decomposition step 1,5116,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL622798,4297,
,U,BAO_0000019,,Half life were determined in CEM-SS cell extract in decomposition step 2,5117,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL622799,4297,
,U,BAO_0000366,,Half life of the in human plasma,5118,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL622800,4231,Plasma
,U,BAO_0000220,,Half life period in human hepatic S9 fraction was determined,5119,Autocuration,,0,S9,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL622801,5633,
,U,BAO_0000251,,Half life period in human liver microsome was determined,5120,Autocuration,2107.0,0,Microsomes,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL622802,5633,Liver
,U,BAO_0000019,,Half life period was determined; 6-7,5121,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL622803,17791,
,U,BAO_0000019,,Half life period was evaluated in human,5122,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL875154,17791,
,U,BAO_0000366,,Half life time in human plasma,5123,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL622804,3160,Plasma
,N,BAO_0000218,,"Biodistribution in mice as total concentration of both oxidized and reduced forms in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",5124,Intermediate,955.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622805,16438,Brain
,N,BAO_0000218,,"Biodistribution in mice as total concentration of both oxidized and reduced forms in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO sol.",5125,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622611,16438,Heart
,N,BAO_0000218,,"Biodistribution in mice as total concentration of both oxidized and reduced forms in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",5126,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622612,16438,Heart
,N,BAO_0000218,,"Biodistribution in mice as total concentration of both oxidized and reduced forms in kidney and animals were sacrificed 10 minutes after dosing, in DMSO sol.",5127,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL875160,16438,Kidney
,N,BAO_0000218,,"Biodistribution in mice as total concentration of both oxidized and reduced forms in kidney and animals were sacrificed 10 minutes after ip dosing, in DMSO solution",5128,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622613,16438,Kidney
,N,BAO_0000218,,"Biodistribution in mice as total concentration of both oxidized and reduced forms in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",5129,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622614,16438,Kidney
,N,BAO_0000218,,"Biodistribution in mice as total concentration of both oxidized and reduced forms in liver and animals were sacrificed 10 minutes after dosing, in DMSO sol.",5130,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622615,16438,Liver
,N,BAO_0000218,,Biodistribution in mice as total concentration of both oxidized and reduced forms in liver and animals were sacrificed 10 minutes after ip administration in DMSO solution,5131,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622616,16438,Liver
,N,BAO_0000218,,"Biodistribution in mice as total concentration of both oxidized and reduced forms in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",5132,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622617,16438,Liver
,N,BAO_0000218,,Biodistribution in mice as total concentration of both oxidized and reduced forms in spleen and animals were sacrificed 10 minutes after ip administration in DMSO solution,5133,Intermediate,2106.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622618,16438,Spleen
,N,BAO_0000218,,"Biodistribution in mice as total concentration of both oxidized and reduced forms in spleen and animals were sacrificed 10 minutes after ip dosing, in DMSO solution",5134,Intermediate,2106.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622619,16438,Spleen
,N,BAO_0000218,,"Biodistribution in mice as total concentration of both oxidized and reduced forms in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",5135,Intermediate,2106.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622620,16438,Spleen
,N,BAO_0000218,,"Biodistribution in mice, total concentration of both oxidized and reduced forms in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",5136,Intermediate,955.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622621,16438,Brain
,N,BAO_0000218,,Biodistribution of compound (oxidized form) in blood tissue,5137,Intermediate,178.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622622,16438,Blood
,N,BAO_0000218,,"Biodistribution of compound (oxidized form) in blood tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",5138,Intermediate,178.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622623,16438,Blood
,N,BAO_0000218,,"Biodistribution of compound (oxidized form) in blood tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",5139,Intermediate,178.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622624,16438,Blood
,N,BAO_0000218,,"Biodistribution of compound (oxidized form) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",5140,Intermediate,178.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622625,16438,Blood
,N,BAO_0000218,,"Biodistribution of compound (oxidized form) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",5141,Intermediate,178.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622626,16438,Blood
,N,BAO_0000218,,"Biodistribution of compound (oxidized form) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",5142,Intermediate,178.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622627,16438,Blood
,N,BAO_0000218,,Biodistribution of compound (oxidized form) in brain tissue of mice,5143,Intermediate,955.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622628,16438,Brain
,N,BAO_0000218,,"Biodistribution of compound (oxidized form) in brain tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",5144,Intermediate,955.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622629,16438,Brain
,N,BAO_0000218,,"Biodistribution of compound (oxidized form) in brain tissue, animals were sacrificed 60 minutes after dosing, in DMSO",5145,Intermediate,955.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622630,16438,Brain
,N,BAO_0000218,,"Biodistribution of compound (oxidized form) in brain tissue, animals were sacrificed 60 minutes after dosing, in DMSO sol.",5146,Intermediate,955.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622631,16438,Brain
,N,BAO_0000218,,"Biodistribution of compound (oxidized form) in brain tissue, animals were sacrificed 60 minutes after dosing, in DMSO solution",5147,Intermediate,955.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622632,16438,Brain
,N,BAO_0000218,,"Biodistribution of compound (oxidized form) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO solution",5148,Intermediate,955.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622633,16438,Brain
,N,BAO_0000218,,Biodistribution of compound (oxidized form) in heart tissue of mice,5149,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622634,16438,Heart
,N,BAO_0000218,,"Biodistribution of compound (oxidized form) in heart tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",5150,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622635,16438,Heart
,N,BAO_0000218,,"Biodistribution of compound (oxidized form) in heart tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",5151,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL875161,16438,Heart
,N,BAO_0000218,,"Biodistribution of compound (oxidized form) in heart tissue, animals were sacrificed 60 minutes after dosing, in DMSO",5152,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622636,16438,Heart
,N,BAO_0000218,,"Biodistribution of compound (oxidized form) in heart tissue, animals were sacrificed 60 minutes after dosing, in DMSO sol.",5153,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623335,16438,Heart
,N,BAO_0000218,,"Biodistribution of compound (oxidized form) in heart tissue, animals were sacrificed 60 minutes after dosing, in DMSO solution",5154,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623336,16438,Heart
,N,BAO_0000218,,"Biodistribution of compound (oxidized form) in kidney tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",5155,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623337,16438,Kidney
,N,BAO_0000218,,"Biodistribution of compound (oxidized form) in kidney tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",5156,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623338,16438,Kidney
,N,BAO_0000218,,"Biodistribution of compound (oxidized form) in kidney tissue, animals were sacrificed 60 minutes after dosing, in DMSO",5157,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623339,16438,Kidney
,N,BAO_0000218,,"Biodistribution of compound (oxidized form) in kidney tissue, animals were sacrificed 60 minutes after dosing, in DMSO sol.",5158,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623524,16438,Kidney
,N,BAO_0000218,,"Biodistribution of compound (oxidized form) in kidney tissue, animals were sacrificed 60 minutes after dosing, in DMSO solution",5159,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623525,16438,Kidney
,N,BAO_0000218,,Biodistribution of compound (oxidized form) in liver tissue,5160,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623526,16438,Liver
,N,BAO_0000218,,"Biodistribution of compound (oxidized form) in liver tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",5161,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623527,16438,Liver
,N,BAO_0000218,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",5162,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623528,16438,Liver
,N,BAO_0000219,,Cell viability in A431 cells when stimulated with EGF was tested when incubated with concentration in the range of 1-10 uM of the compound after 48 h; Cell death,5163,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL624615,5245,
,N,BAO_0000219,,Cell viability in A431 cells when stimulated with EGF was tested when incubated with concentration up to 10 uM after 48 h; Did not affect the viability,5164,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL621672,5245,
,N,BAO_0000218,,"In vivo activity in A431 tumor bearing mice, maximum dose (schedule 10-24 days)",5165,Expert,,1,,,500.0,,,1,A-431,80852,F,,,CHEMBL621673,16289,
,N,BAO_0000218,,"In vivo activity in A431 tumor bearing mice, maximum dose (schedule 12-26 days)",5166,Expert,,1,,,500.0,,,1,A-431,80852,F,,,CHEMBL621674,16289,
,D,BAO_0000219,,Inhibition of EGF-induced Tyrosine phosphorylation in A431 cells expressing EGF-R,5167,Expert,,9,,,500.0,,9606.0,1,A-431,9,F,Homo sapiens,,CHEMBL884002,16093,
,N,BAO_0000219,,"Concentration required to inhibit the epidermoid A431 cell growth by 50%, P53 status of cell line used was wild-type. ",5168,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL621850,16825,
,N,BAO_0000219,,Inhibitory activity against proliferation of human epidermoid carcinoma (A431) cells,5169,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL621851,4848,
,D,BAO_0000219,,Inhibition of EGF-dependent autophosphorylation of EGF-R in A431 cells,5170,Expert,,9,,,500.0,,9606.0,1,A-431,9,F,Homo sapiens,,CHEMBL621852,14827,
,D,BAO_0000219,,Inhibition of autophosphorylation of epidermal growth factor receptor in A431 cells in culture,5171,Expert,,9,,,500.0,,9606.0,1,A-431,9,F,Homo sapiens,,CHEMBL621853,14827,
,N,BAO_0000218,,"In vivo activity in A431 tumor bearing mice, relative time required for treated and control tumors to reach 750 mg (schedule 10-24 days)",5172,Expert,,1,,,500.0,,,1,A-431,80852,F,,,CHEMBL621854,16289,
,N,BAO_0000218,,"In vivo activity in A431 tumor bearing mice, relative time required for treated and control tumors to reach 750 mg (schedule 12-26 days)",5173,Expert,,1,,,500.0,,,1,A-431,80852,F,,,CHEMBL621855,16289,
,N,BAO_0000218,,"In vivo activity in A431 tumor bearing mice, relative time required for treated and control tumors to reach 750 mg (schedule 12-26 days)",5174,Expert,,1,,,500.0,,,1,A-431,80852,F,,,CHEMBL623724,16289,
,N,BAO_0000218,,"In vivo activity in A431 tumor bearing mice, ratio of treated and control tumor mass day 24",5175,Expert,,1,,,500.0,,,1,A-431,80852,F,,,CHEMBL623725,16289,
,N,BAO_0000218,,"In vivo activity in A431 tumor bearing mice, ratio of treated and control tumor mass day 26",5176,Expert,,1,,,500.0,,,1,A-431,80852,F,,,CHEMBL623726,16289,
,D,BAO_0000219,,"Irreversible inhibition of EGF-R phosphorylation in A431 cells, 8 hr after washing cells free of compound",5177,Expert,,9,,,500.0,,9606.0,1,A-431,9,F,Homo sapiens,,CHEMBL623727,16289,
,H,BAO_0000219,,Irreversible inhibition of formation of phosphorylated EGFR in A431 cells 8 hr after washing cells free of compound,5178,Expert,,8,,,500.0,,,1,A-431,9,F,,,CHEMBL623728,16289,
,N,BAO_0000218,,"In vivo activity in A431 tumor bearing mice, maximum weight loss days 10-24",5179,Expert,,1,,,500.0,,,1,A-431,80852,F,,,CHEMBL623729,16289,
,N,BAO_0000218,,"In vivo activity in A431 tumor bearing mice, maximum weight loss days 12-26",5180,Expert,,1,,,500.0,,,1,A-431,80852,F,,,CHEMBL623730,16289,
,N,BAO_0000218,,"In vivo activity in A431 tumor bearing mice, maximum weight loss days 12-26",5181,Expert,,1,,,500.0,,,1,A-431,80852,F,,,CHEMBL623731,16289,
,N,BAO_0000218,,"Ratio of treated and control A431 cell tumor mass in mice at 5 mg/kg peroral dose, days 7-21 administration",5182,Expert,,1,,,500.0,,10090.0,1,A-431,80852,F,Mus musculus,,CHEMBL623732,14555,
,N,BAO_0000218,,"Difference in days for treated (T) and control (C) A431 cell tumors to reach 750 mg in mice at 5 mg/kg peroral dose, days 7-21 administration",5183,Expert,,1,,,500.0,,10090.0,1,A-431,80852,F,Mus musculus,,CHEMBL623733,14555,
,N,BAO_0000218,,"Net reduction in tumor burden between first and last treatments of A431 cell tumors in mice at 5 mg/kg peroral dose, days 7-21 administration",5184,Expert,,1,,,500.0,,10090.0,1,A-431,80852,F,Mus musculus,,CHEMBL623734,14555,
,N,BAO_0000218,,"Weight change of A431 cell tumors in mice at 5 mg/kg peroral dose, days 7-21 administration",5185,Expert,,1,,,500.0,,10090.0,1,A-431,80852,F,Mus musculus,,CHEMBL623735,14555,
,N,BAO_0000219,,In vitro antiproliferative effect against A431 human epidermoid carcinoma cells,5186,Expert,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL623736,1937,
,N,BAO_0000219,,In vitro tumor cell growth inhibitory activity against Human leiomyosarcoma A431 cell lines,5187,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL623737,13739,
,N,BAO_0000219,,Cytotoxicity against A437 cells is the dose giving 50% decrease in the formation of formazan dye,5188,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL623738,3558,
,N,BAO_0000219,,Dose giving a 50% decrease in the living cell number (A437 cells),5189,Intermediate,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL875168,3558,
,N,BAO_0000219,,In vitro inhibitory concentration against proliferation of A459 cell line.,5190,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL623739,17686,
,N,BAO_0000219,,Inhibitory concentration of compound for cytotoxicity against A459 human lung cells was determined,5191,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL623740,5305,
,N,BAO_0000219,,Inhibition of growth of human NSCL non small cell lung carcinoma cell line (A459) after 72 hr of drug exposure,5192,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624424,3614,
,N,BAO_0000219,,In vitro antitumor activity against renal A498 tumor cell lines,5193,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL624425,17229,
,N,BAO_0000219,,"In vitro growth inhibition of human kidney carcinoma cell line, A498 with low levels of folate receptors",5194,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL624426,15935,
,N,BAO_0000219,,"In vitro growth inhibition of human kidney carcinoma cell line, A498 with low levels of folate receptors in folate deficient medium",5195,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL624427,15935,
,N,BAO_0000219,,Cytotoxicity against A498 Tumor cell line in SRB Cell viability test,5196,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL624428,15560,
,N,BAO_0000219,,Cytotoxicity concentration against human kidney carcinoma A-498 cell line,5197,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL624429,13891,
,N,BAO_0000219,,Cytotoxicity concentration against human kidney carcinoma A-498 cell line; NT =Not tested,5198,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL624620,13891,
,N,BAO_0000219,,Cytotoxicity on kidney carcinoma (A-498) cell line,5199,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL624621,13788,
,N,BAO_0000219,,Compound was evaluated against Human cell line renal A498,5200,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL624622,15403,
,N,BAO_0000219,,Compound was tested for inhibition of A498 human renal cancer cell line,5201,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL624623,1009,
,N,BAO_0000219,,Growth inhibitory activity against A498 human cancer cell line,5202,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL874365,1043,
,N,BAO_0000219,,In vitro antitumor activity against human renal A498 cell line,5203,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL624624,5858,
,N,BAO_0000219,,In vitro cytotoxic activity against renal (A498) cell line,5204,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL624625,5958,
,N,BAO_0000219,,In vitro cytotoxic activity against human renal cancer (A498) cell line,5205,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL624626,5506,
,N,BAO_0000219,,Tested for cytostatic activity against renal A498 cell line,5206,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL624627,12781,
,N,BAO_0000219,,The compound was tested for the concentration to inhibit 50% of renal A498 cell lines.,5207,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL883157,14399,
,N,BAO_0000219,,In vitro cytotoxic activity against renal (A498) cell line at a concentration of 10e-5 M,5208,Expert,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL624628,5958,
,U,BAO_0000218,,Cmax value after 2 mpk peroral administration to beagles,5209,Autocuration,,0,,In vivo,,,9615.0,1,,22224,A,beagle,,CHEMBL624629,3510,
,U,BAO_0000218,,Bioavailability,5210,Autocuration,,0,,In vivo,,,9615.0,1,,22224,A,Canis lupus familiaris,beagle,CHEMBL623551,3510,
,U,BAO_0000218,,Bioavailability after 1 mpk peroral administration to beagles,5211,Autocuration,,0,,In vivo,,,9615.0,1,,22224,A,Canis lupus familiaris,beagle,CHEMBL623552,3510,
,U,BAO_0000218,,Bioavailability after 2 mpk peroral administration to beagles,5212,Autocuration,,0,,In vivo,,,9615.0,1,,22224,A,Canis lupus familiaris,beagle,CHEMBL623553,3510,
,U,BAO_0000019,,Specificity constant of the BSA-catalyzed deprotonation of compound at pH 9,5213,Autocuration,,0,,,,,9913.0,1,,22224,A,Bos taurus,,CHEMBL623554,3085,
,U,BAO_0000019,,Specificity constant of the bovine serum albumin catalyzed reaction expressed as (kcat/KM)/kuncat,5214,Autocuration,,0,,,,,9913.0,1,,22224,A,Bos taurus,,CHEMBL623555,3085,
,U,BAO_0000019,,Michaelis-Menten kinetics of the bovine serum albumin catalyzed reaction of the compound,5215,Autocuration,,0,,,,,9913.0,1,,22224,A,Bos taurus,,CHEMBL623556,3085,
,U,BAO_0000019,,Solubility against bovine alpha-chymotrypsin,5216,Autocuration,,0,,,,,9913.0,1,,22224,A,Bos taurus,,CHEMBL623557,9372,
,U,BAO_0000019,,Rate constant of the bovine serum albumin catalyzed reaction of the compound,5217,Autocuration,,0,,,,,9913.0,1,,22224,A,Bos taurus,,CHEMBL623558,3085,
,U,BAO_0000019,,Rate constant of the bovine serum albumin catalyzed reaction of the compound,5218,Autocuration,,0,,,,,9913.0,1,,22224,A,Bos taurus,,CHEMBL623559,3085,
,U,BAO_0000221,,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards calf spleen (CS-PDE) at a concentration of 20 microg,5219,Autocuration,2106.0,0,,,,,9913.0,1,,22224,A,Bos taurus,,CHEMBL623560,1469,Spleen
,U,BAO_0000019,,Half life in culture medium containing 10% of heat inactivated foetal calf serum,5220,Autocuration,,0,,,,,9913.0,1,,22224,A,Bos taurus,,CHEMBL623561,4297,
,U,BAO_0000019,,Half life in culture medium containing 10% of heat inactivated foetal calf serum; ND=not determined,5221,Autocuration,,0,,,,,9913.0,1,,22224,A,Bos taurus,,CHEMBL623562,4297,
,U,BAO_0000019,,Ability to get deaminated by adenosine deaminase (ADA); Expressed as t1/2,5222,Autocuration,,0,,,,,9913.0,1,,22224,A,Bos taurus,,CHEMBL623563,17585,
,U,BAO_0000221,,Enzymatic stability was assessed with bovine spleen phosphodiesterase (BS PDE) exonuclase,5223,Autocuration,2106.0,0,,,,,9913.0,1,,22224,A,Bos taurus,,CHEMBL623564,1336,Spleen
,U,BAO_0000019,,Half life in presence of 2 mg/mL BSA at pH 8.8,5224,Autocuration,,0,,,,,9913.0,1,,22224,A,Bos taurus,,CHEMBL873806,3085,
,U,BAO_0000019,,Half-life in RPMI 1640 containing 10% heat inactivated fetal calf serum culture medium at step 1,5225,Autocuration,,0,,,,,9913.0,1,,22224,A,Bos taurus,,CHEMBL623565,2857,
,U,BAO_0000019,,Half-life in RPMI 1640 containing 10% heat inactivated fetal calf serum culture medium at step 2,5226,Autocuration,,0,,,,,9913.0,1,,22224,A,Bos taurus,,CHEMBL623566,2857,
,U,BAO_0000019,,Half-life in RPMI 1640 containing 10% heat inactivated fetal calf serum culture medium at step 2; Not determined,5227,Autocuration,,0,,,,,9913.0,1,,22224,A,Bos taurus,,CHEMBL623567,2857,
,U,BAO_0000019,,Half-life in the culture medium (RPMI 1640+10% fetal calf serum FCS),5228,Autocuration,,0,,,,,9913.0,1,,22224,A,Bos taurus,,CHEMBL623568,1540,
,N,BAO_0000218,,AUC (Area Under Plasma concentration-time curve) was after oral administration at 5 mg/kg,5229,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623569,6316,Plasma
,N,BAO_0000218,,AUC after administration at 100 mg/kg/day in dogs,5230,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623570,17594,Plasma
,N,BAO_0000218,,AUC in dog at 0-24 hr by peroral administration at 3 mpk,5231,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624254,4953,Plasma
,N,BAO_0000218,,AUC value after 15 mg/kg iv dose in Dogs,5232,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624255,16907,Plasma
,N,BAO_0000218,,AUC value after 30 mg/kg po dose in Dogs,5233,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624256,16907,Plasma
,N,BAO_0000218,,AUC value after administration of 4 mg/Kg oral dose in dog,5234,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624257,2959,Plasma
,N,BAO_0000218,,AUC0-infinity after single intravenous bolus of 1 mg/kg in dogs,5235,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624258,17594,Plasma
,N,BAO_0000218,,Area Under Curve for the compound was determined in dogs at 1 mg/kg oral dosing; 25-50 ug min/mL,5236,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL875277,5356,
,N,BAO_0000218,,Area under curve (AUC) value in dogs after an intravenous dose of 0.2 mg/Kg in 0.025 M aqueous methanesulfonic acid solution with 5% mannitol at a concentration of 0.2,5237,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622667,16807,
,N,BAO_0000218,,Area under curve by intravenous administration at a dose of 1 uM/kg in dog was determined,5238,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622668,4527,
,N,BAO_0000218,,Area under curve by oral administration at a dose of 10 uM/kg in dog was determined,5239,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622669,4527,
,N,BAO_0000218,,Area under curve determined in dogs after intravenous administration of 3 mg/kg,5240,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622670,15660,
,N,BAO_0000218,,Area under curve determined in dogs after oral administration of 10 mg/kg,5241,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622671,15660,
,N,BAO_0000218,,Area under curve of compound after both po and iv administration at a dose of 5 mg/kg and 2 mg/kg resp in dog,5242,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622672,5802,
,N,BAO_0000218,,Area under curve of compound determined in dog after iv administration at a dose of 10 mg/kg,5243,Expert,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622673,3598,
,N,BAO_0000218,,Area under curve of compound from zero time to infinity determined in dog after iv administration at a dose of 10 mg/kg,5244,Expert,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622674,3598,
,N,BAO_0000218,,Area under curve determined in dog at a dose of 0 mg/kg by oral administration along with indavir (10 mg/kg),5245,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622675,5944,
,N,BAO_0000218,,Area under curve determined in dog at a dose of 10 mg/kg by oral administration,5246,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622676,5944,
,N,BAO_0000218,,Area under curve determined in dog at a dose of 10 mg/kg by oral administration along with indavir (10 mg/kg),5247,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622677,5944,
,N,BAO_0000218,,Area under curve determined in dog at a dose of 5 mg/kg by oral administration,5248,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622678,5944,
,N,BAO_0000218,,Area under curve in dog after administration of 20 mg/kg dose through peroral route,5249,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622679,4186,
,N,BAO_0000218,,Area under curve in dogs administered perorally (5 mg/kg) and intravenously (2 mg/kg),5250,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622680,5007,
,N,BAO_0000218,,Area under curve was determine after peroral administration at 10 mpk in dog,5251,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622681,5668,
,N,BAO_0000218,,Area under curve was determine after peroral administration at 5 mpk in dog,5252,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL875278,5668,
,N,BAO_0000218,,Area under curve was determined,5253,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622682,5006,
,N,BAO_0000218,,Area under curve in dogs,5254,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622683,5006,
,N,BAO_0000218,,Area under curve in dogs at 10 mg/kg dose fo oral administration,5255,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622684,3771,
,N,BAO_0000218,,Area under curve in dogs at 10 mg/kg dose fo oral administration (Evokes hyperglycerolemia),5256,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622685,3771,
,N,BAO_0000218,,Area under curve in dogs at 3 mg/kg dose fo intravenous administration,5257,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622686,3771,
,N,BAO_0000218,,Area under curve was evaluated against Beagle dog at a dose of 15 mg/kg after po administration,5258,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618344,1916,
,N,BAO_0000218,,Area under curve value in dog at a dose of 5 mg/kg,5259,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL875582,5302,
,N,BAO_0000218,,Area under curve was determined after 0.1 mg/kg iv administration in dog,5260,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618345,5600,
,N,BAO_0000218,,Area under curve was determined after 0.3 mg/kg po administration in dog,5261,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618346,5600,
,N,BAO_0000218,,Area under curve was determined for compound after intravenous administration in dogs at 1.2 uM/kg,5262,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618347,17764,
,N,BAO_0000218,,Area under curve was determined for the compound by intravenous administration of 1.2 mg/kg in dog,5263,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618348,4368,
,U,BAO_0000019,,Tested for half life period at 37 degree Celsius in PBS buffer at 10.5 pH containing human serum esterase,5264,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618349,5318,
,U,BAO_0000019,,Tested for half life period at 37 degree Centigrade in PBS buffer at 7.3 pH containing human serum esterase,5265,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618350,5318,
,U,BAO_0000019,,Tested for half life period at 37 degree Celsius in PBS buffer at 8.0 pH containing human serum esterase,5266,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618351,5318,
,U,BAO_0000019,,Tested for half life period at 37 degree Celsius in PBS buffer at 8.8 pH containing human serum esterase,5267,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618352,5318,
,U,BAO_0000221,,Time taken to reduce 50% of the concentration of compound in blood plasma,5268,Autocuration,178.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL873494,14518,Blood
,U,BAO_0000366,,"Biological half life in human plasma (stability to human renal dehydropeptidase I,DHP-I).",5269,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618353,2209,Plasma
,U,BAO_0000366,,Half life in human plasma,5270,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618354,6787,Plasma
,U,BAO_0000366,,Half life in human plasma was reported,5271,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL875583,4898,Plasma
,U,BAO_0000019,,Half life in human serum,5272,Autocuration,1977.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618355,6072,Serum
,U,BAO_0000366,,Half life upon exposure to human plasma,5273,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618356,16907,Plasma
,U,BAO_0000251,,t1/2 in human microsomes,5274,Autocuration,,0,Microsomes,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618357,5656,
,U,BAO_0000366,,Half life period in 80% human plasma at 37 degree Centigrade,5275,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618358,4755,Plasma
,U,BAO_0000221,,Half-life for rate of hydrolysis was determined in in human skin homogenate (pH 7.4),5276,Autocuration,14.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618359,17503,Zone of skin
,U,BAO_0000366,,Half-life measured in in vitro Cathepsin B assay in human plasma,5277,Autocuration,1969.0,0,,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618360,12357,Plasma
,U,BAO_0000019,,Half-life at initial concentration of 5*10e-5 M in CEM cell extract,5278,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618361,3076,
,U,BAO_0000251,,Half-life determined by human liver microsome stability assay at a concentration of 5 uM,5279,Autocuration,2107.0,0,Microsomes,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618362,6410,Liver
,U,BAO_0000366,,"Half-life in chemical and enzymatic hydrolysis to form L-DOPA, in 80% human plasma",5280,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618363,3741,Plasma
,U,BAO_0000366,,"Half-life in chemical and enzymatic hydrolysis to form another compound (8)*, in 80% human plasma (experiment 1)",5281,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618364,3741,Plasma
,U,BAO_0000366,,"Half-life in chemical and enzymatic hydrolysis to form another compound (8)*, in 80% human plasma (experiment 2)",5282,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL875584,3741,Plasma
,U,BAO_0000019,,Half-life in the CEM cell extracts,5283,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618365,1540,
,U,BAO_0000366,,Half-life was calculated by Human plasma stability assay at 37 degree Centigrade,5284,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL873495,2905,Plasma
,U,BAO_0000366,,Half-life was calculated by Human plasma stability assay at 37 degree centigrade; Not hydrolyzed,5285,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618366,2905,Plasma
,U,BAO_0000019,,Half-life was determined,5286,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618367,5523,
,U,BAO_0000221,,Half-life (human blood stability),5287,Autocuration,178.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618368,1499,Blood
,U,BAO_0000221,,Half-life (human blood stability); no data,5288,Autocuration,178.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618369,1499,Blood
,U,BAO_0000366,,Half-life in human plasma,5289,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618370,17065,Plasma
,U,BAO_0000019,,CYP3A4 metabolism half-life (t1/2),5290,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618371,6861,
,U,BAO_0000221,,Half-life was determined; 88% of parent remained after incubation for 120 min (human blood stability),5291,Autocuration,178.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618372,1499,Blood
,U,BAO_0000366,,In vitro half life in human plasma,5292,Autocuration,1969.0,0,,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618373,530,Plasma
,U,BAO_0000366,,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in human plasma",5293,Autocuration,1969.0,0,,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618374,1116,Plasma
,U,BAO_0000366,,In vitro hydrolysis in human plasma,5294,Autocuration,1969.0,0,,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618375,6695,Plasma
,U,BAO_0000366,,In vitro hydrolysis in human plasma; no data,5295,Autocuration,1969.0,0,,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618376,6695,Plasma
,U,BAO_0000251,,In vitro metabolic stability at 5 uM was determined by incubating with human liver microsomes at 37 degree C,5296,Autocuration,2107.0,0,Microsomes,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618377,10,Liver
,U,BAO_0000366,,Plasma half life in human,5297,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618378,993,Plasma
,U,BAO_0000366,,Stability after incubation with human plasma (at 37 degree C),5298,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618379,15429,Plasma
,U,BAO_0000366,,T1/2 was evaluated in human plasma,5299,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618380,1675,Plasma
,U,BAO_0000366,,"Tested for Biological half life in human plasma (stability to human renal dehydropeptidase I,DHP-I).",5300,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618381,2209,Plasma
,U,BAO_0000366,,"Tested for Biological half life in human plasma (stability to human renal dehydropeptidase I,DHP-I); Not determined",5301,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618382,2209,Plasma
,U,BAO_0000019,,Tested for half life period at 37 degree Centigrade in PBS buffer at 7.3 pH containing human serum esterase,5302,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618383,5318,
,U,BAO_0000019,,Tested in vitro for the time for half reactivation against human lysosomal alpha-glucosidase,5303,Autocuration,,0,,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618384,2412,
,U,BAO_0000019,,Tested in vitro for the time for half reactivation against human lysosomal alpha-glucosidase; ND=Not determined,5304,Autocuration,,0,,In vitro,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL618385,2412,
,U,BAO_0000366,,The release rate of the free drug from the substrate in human plasma by human plasma stability assay,5305,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL619099,2906,Plasma
,U,BAO_0000366,,The release rate of the free drug from the substrate in human plasma by human plasma stability assay; Not hydrolyzed,5306,Autocuration,1969.0,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL619100,2906,Plasma
,U,BAO_0000019,,Time taken for 50% to be consumed by serum PON1 was determined,5307,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL619101,5495,
,U,BAO_0000019,,Time taken for 50% to be consumed by serum PON1; NH is Not hydrolysed,5308,Autocuration,,0,,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL619102,5495,
,U,BAO_0000251,,Percent of the parent compound remaining after 20 mins incubation with human liver microsomes,5309,Autocuration,2107.0,0,Microsomes,,,,9606.0,1,,22224,A,Homo sapiens,,CHEMBL619103,4397,Liver
,U,BAO_0000218,,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice blood upon intraveneous administration at 2.6 gmol/mice after 1 hour,5310,Autocuration,,0,,,,,10095.0,1,,22224,A,Mus sp.,,CHEMBL619268,2413,
,U,BAO_0000218,,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice blood upon intraveneous administration at 2.6 gmol/mice after 3 hour,5311,Autocuration,,0,,,,,10095.0,1,,22224,A,Mus sp.,,CHEMBL619269,2413,
,U,BAO_0000218,,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice brain upon intraveneous administration at 2.6 gmol/mice after 1 hour,5312,Autocuration,,0,,,,,10095.0,1,,22224,A,Mus sp.,,CHEMBL619270,2413,
,U,BAO_0000218,,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice brain upon intraveneous administration at 2.6 gmol/mice after 3 hour,5313,Autocuration,,0,,,,,10095.0,1,,22224,A,Mus sp.,,CHEMBL619271,2413,
,U,BAO_0000218,,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice kidney upon intraveneous administration at 2.6 gmol/mice after 1 hour,5314,Autocuration,,0,,,,,10095.0,1,,22224,A,Mus sp.,,CHEMBL875585,2413,
,U,BAO_0000218,,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice kidney upon intraveneous administration at 2.6 gmol/mice after 24 hour,5315,Autocuration,,0,,,,,10095.0,1,,22224,A,Mus sp.,,CHEMBL619272,2413,
,N,BAO_0000219,,Compound tested for growth inhibition of renal cancer cell line 786-0,5316,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL619273,6058,
,N,BAO_0000219,,Compound was tested for 50% growth inhibition against human renal cancer 786-0 cell line,5317,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL619274,17708,
,N,BAO_0000219,,Concentration which reduced cell growth to 50 % of level against 786-0 renal cancer line,5318,Expert,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL619275,14017,
,N,BAO_0000219,,"Percent growth of NCI cell line, renal: 786-0 exposed for 48 hr at 10e-4 concentration",5319,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL619276,16818,
,N,BAO_0000219,,"Percent growth of NCI cell line, renal: 786-0 exposed for 48 hr at 10e-6 concentration",5320,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL619277,16818,
,N,BAO_0000219,,"Percent growth of NCI cell line, renal: 786-0 exposed for 48 hr at 10e-8 concentration",5321,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL619278,16818,
,N,BAO_0000219,,Tested for cytotoxicity against 786-0 cell lines in renal cancer,5322,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL619279,11970,
,N,BAO_0000219,,Tested in vitro for cytotoxicity in 786-0 cell line of Renal cancer,5323,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL858458,12400,
,N,BAO_0000219,,Cytotoxic effect on renal cancer line 786-0,5324,Expert,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL619280,12888,
,N,BAO_0000219,,In vitro antitumor activity against Renal cancer 786-0 cell lines by 6-day assay,5325,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL619281,15300,
,N,BAO_0000219,,Compound was evaluated for in vitro activity against 786-0 kidney cell lines (Human tumor cells ),5326,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL619282,14769,
,N,BAO_0000219,,"Cytotoxicity against NCI tumor panel, 786-0 renal cancer cell line",5327,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL619283,15895,
,N,BAO_0000219,,Concentration of compound that cause 50% cytotoxicity of 786-0 renal cancer cell line,5328,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL619284,17376,
,N,BAO_0000219,,Compound was tested for antitumor activity against 786-0 renal cancer cell line(molar concentration that inhibits 50% net cell growth).,5329,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL619285,14882,
,N,BAO_0000219,,Compound was tested for antitumor activity against 786-0 renal cancer cell line(molar concentration leading to 50% net cell death),5330,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL619286,14882,
,N,BAO_0000219,,Growth inhibition of the 786-O Renal cancer cell line for 2-day in vitro assay.,5331,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL619287,15176,
,N,BAO_0000219,,In vitro anti tumor activity against human tumor Renal cancer cell lines was determined,5332,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL857455,12696,
,N,BAO_0000219,,The compound was tested in vitro for cytotoxic activity against 786-O cell line (human perirenal carcinoma),5333,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL883801,2496,
,N,BAO_0000219,,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells having only 3-5% antigen expression,5334,Intermediate,,1,,,972.0,,9606.0,1,791T cell line,80641,F,Homo sapiens,,CHEMBL619288,11831,
,N,BAO_0000219,,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells having only 3-5% antigen expression (49% inhibition achieved at 100 micro g/mL),5335,Intermediate,,1,,,972.0,,9606.0,1,791T cell line,80641,F,Homo sapiens,,CHEMBL619289,11831,
,N,BAO_0000219,,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells having only 3-5% antigen expression; <20% inhibition achieved,5336,Intermediate,,1,,,972.0,,9606.0,1,791T cell line,80641,F,Homo sapiens,,CHEMBL619290,11831,
,N,BAO_0000219,,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells of conjugate AH1.11 (Type H1: MSR-33),5337,Intermediate,,1,,,972.0,,9606.0,1,791T cell line,80641,F,Homo sapiens,,CHEMBL619291,11831,
,N,BAO_0000219,,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells of conjugate AH1.11 (Type H2: MSR-26),5338,Intermediate,,1,,,972.0,,9606.0,1,791T cell line,80641,F,Homo sapiens,,CHEMBL619292,11831,
,N,BAO_0000219,,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells of conjugate AH1.11 (Type H3: MSR-28); <20% inhibition achieved,5339,Intermediate,,1,,,972.0,,9606.0,1,791T cell line,80641,F,Homo sapiens,,CHEMBL619293,11831,
,N,BAO_0000219,,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells of conjugate H1.11 (Type H1: MSR-33),5340,Intermediate,,1,,,972.0,,9606.0,1,791T cell line,80641,F,Homo sapiens,,CHEMBL619294,11831,
,N,BAO_0000219,,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells of conjugate H1.11 (Type H2: MSR-26),5341,Intermediate,,1,,,972.0,,9606.0,1,791T cell line,80641,F,Homo sapiens,,CHEMBL619295,11831,
,N,BAO_0000219,,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells of conjugate H1.11 (Type H2: MSR-26) (less than 20% inhibition achieved),5342,Intermediate,,1,,,972.0,,9606.0,1,791T cell line,80641,F,Homo sapiens,,CHEMBL619296,11831,
,N,BAO_0000219,,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells of conjugate H1.11 (Type H3: MSR-28); <20% inhibition achieved,5343,Intermediate,,1,,,972.0,,9606.0,1,791T cell line,80641,F,Homo sapiens,,CHEMBL619297,11831,
,N,BAO_0000219,,Growth inhibitory concentration against tumor cells in culture renal cancer 796-0 cell line,5344,Intermediate,,1,,,391.0,,9606.0,1,786-0,80640,F,Homo sapiens,,CHEMBL619298,12782,
,U,BAO_0000019,,In vitro anticancer activity against 8 NCI CNS cancer cell lines; inactive,5345,Intermediate,,0,,,,,,1,,22226,F,,,CHEMBL619299,1229,
,N,BAO_0000219,,Inhibition of cell growth in drug resistant 8226 myeloma cell line,5346,Expert,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL619300,15313,
,N,BAO_0000219,,Inhibition of cell growth in drug sensitive 8226 myeloma cell line,5347,Expert,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL619301,15313,
,N,BAO_0000219,,In vitro inhibition of tumor cell growth in the human myeloma 8226 system.,5348,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL619302,11544,
,N,BAO_0000219,,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.01 ug/mL,5349,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL619303,9424,
,N,BAO_0000219,,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.1 ug/mL,5350,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL619304,9424,
,N,BAO_0000219,,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.1 ug/mL (*: >50% cell kill),5351,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL857706,9424,
,N,BAO_0000219,,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.3 ug/mL (*: >50% cell kill),5352,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL619305,9424,
,N,BAO_0000219,,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.5 ug/mL. (*: >1 log cell kill),5353,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL619306,9424,
,N,BAO_0000219,,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 10 ug/mL (*: >1 log cell kill),5354,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL619307,9424,
,N,BAO_0000219,,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 10 ug/mL (*: >1 log cell kill),5355,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL619308,9424,
,N,BAO_0000219,,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 1 ug/mL. (*: >50% cell kill),5356,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL619309,9424,
,N,BAO_0000219,,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 1 ug/mL. (*: >1 log cell kill),5357,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL619310,9424,
,N,BAO_0000219,,Compound was evaluated for in vitro activity against A498 kidney cell lines (Human tumor cells ),5358,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL619311,14769,
,N,BAO_0000219,,Compound was tested for the growth inhibition of A498 renal tumor cell line,5359,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL619312,15354,
,N,BAO_0000219,,In vitro cytotoxicity against human tumor A498 cell line (renal cancer),5360,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL619313,17445,
,N,BAO_0000219,,In vitro inhibitory concentration against renal cancer cell line A498,5361,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL619314,4337,
,N,BAO_0000219,,Cytotoxicity against A 498 tumor cell line,5362,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL619959,15277,
,N,BAO_0000219,,In vitro antitumor activity against A498 human cancer cell line,5363,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL619960,4812,
,N,BAO_0000219,,In vitro antitumor activity against A498 human cancer cell line (Data from NCI-screening),5364,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL619961,4812,
,N,BAO_0000219,,Inhibitory dose required against A498 human tumor cell lines,5365,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL619962,4995,
,N,BAO_0000219,,Anticancer activity against one renal cancer (A498 cell line),5366,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL875586,5847,
,N,BAO_0000219,,In vitro cytotoxicity against melanoma A498 cell line,5367,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL619963,6557,
,N,BAO_0000219,,Compound was tested for growth inhibitory activity against A498 cell line,5368,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL619964,2597,
,N,BAO_0000219,,Compound tested for growth inhibition of renal cancer cell line A498,5369,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL620108,6058,
,N,BAO_0000219,,Compound was tested for 50% growth inhibition against human renal cancer A498 cell line,5370,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL620109,17708,
,N,BAO_0000219,,Growth inhibition of the A498 Renal cancer cell line for 2-day in vitro assay.,5371,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL620110,15176,
,N,BAO_0000219,,In vitro antitumor activity against Renal cancer A498 cell lines by 6-day assay,5372,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL620111,15300,
,N,BAO_0000219,,Tested for cytotoxicity against A498 cell lines in renal cancer,5373,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL620112,11970,
,N,BAO_0000219,,Tested in vitro for cytotoxicity in A498 cell line of Renal cancer,5374,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL620113,12400,
,N,BAO_0000219,,Cytotoxic effect on renal cancer lines A498,5375,Expert,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL620114,12888,
,N,BAO_0000219,,Antitumor activity was evaluated for reduction of growth of renal cancer (A498) cells at a concentration of 100 uM,5376,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL620115,3030,
,N,BAO_0000219,,Compound was evaluated for in vitro activity against A498 kidney cell lines (Human tumor cells ),5377,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL620116,14769,
,N,BAO_0000219,,Concentration of compound that cause 50% cytotoxicity of A498 renal cancer cell line,5378,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL620117,17376,
,N,BAO_0000219,,Growth inhibitory activity against A498-2LM human solid tumor cell line using MTT assay,5379,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL620118,16558,
,N,BAO_0000219,,Cytotoxicity against human kidney carcinoma cell lines A4982LM,5380,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL620119,5194,
,N,BAO_0000219,,Evaluated for the inhibitory concentration required to cause growth inhibition of A498Rem- renal cell line using the MTT Cytotoxicity Assay,5381,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL620120,10708,
,N,BAO_0000219,,Antiproliferative activity in vitro against A549 (human non-small lung carcinoma) cell line.,5382,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620121,16880,
,N,BAO_0000219,,Antitumor activity against A549 human lung carcinoma cell line,5383,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620122,10196,
,N,BAO_0000219,,Antitumor activity against A549 human lung carcinoma cell line in experiment 1,5384,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620123,10196,
,N,BAO_0000219,,Antitumor activity against A549 human lung carcinoma cell line in experiment 2,5385,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620124,10196,
,N,BAO_0000219,,"Concentration required to inhibit tumor growth in A549, human lung carcinoma (NSCLC) cell line",5386,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620125,12083,
,N,BAO_0000219,,Cytotoxicity against A549 nonsmall lung cell line using MTT colorimetric assay,5387,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620126,16464,
,N,BAO_0000219,,Cytotoxicity against A549 nonsmall lung cell line using MTT colorimetric assay; NE is no effect at 1x 10 E-5,5388,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL883027,16464,
,N,BAO_0000219,,In vitro cytotoxic activity against human lung A549 cell line,5389,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620127,16470,
,N,BAO_0000219,,In vitro cytotoxic activity against human lung A549 cell line ( standard deviation in parenthesis),5390,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620128,16470,
,N,BAO_0000219,,In vitro cytotoxic activity against human lung A549 cell line),5391,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620129,16470,
,N,BAO_0000219,,In vitro cytotoxic activity against human lung A549 cell line;NT is not tested,5392,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620130,16470,
,N,BAO_0000219,,In vitro cytotoxicity against human non small-cell-lung cell line A549.,5393,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620131,16582,
,N,BAO_0000219,,"In vitro growth inhibition of human lung carcinoma cell line, A549 with low levels of folate receptors",5394,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620132,15935,
,N,BAO_0000219,,"In vitro growth inhibition of human lung carcinoma cell line, A549 with low levels of folate receptors in folate deficient medium",5395,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620133,15935,
,N,BAO_0000219,,Inhibition of A549 human lung carcinoma cell proliferation,5396,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620134,16597,
,N,BAO_0000219,,Inhibitory activity against A549 lung adenocarcinoma cell line,5397,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620135,17376,
,N,BAO_0000219,,Inhibitory concentration required to reduce A549 tumor cell growth by 50% in MTT assay,5398,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620136,16496,
,N,BAO_0000219,,in vitro anticancer activity against cultured A549 human tumor(lung) cell line,5399,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620137,16152,
,N,BAO_0000219,,in vitro inhibition of tumor cell growth in cultured A549 human tumor cell line,5400,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620268,16152,
,N,BAO_0000219,,Cytotoxicity against A549 nonsmall lung cell line using MTT colorimetric assay; NE is no effect at 1x 10 E-5,5401,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620269,16464,
,N,BAO_0000219,,Cytotoxicity was evaluated against A549 non-small cell lung carcinoma human cancer cell line,5402,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620270,2288,
,N,BAO_0000219,,Compound was tested for antiproliferative activity against human A549 cancer cell lines using MTT assay,5403,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620271,17350,
,N,BAO_0000219,,Inhibition of A549 cancer cell proliferation,5404,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620272,4090,
,N,BAO_0000219,,Inhibition of A549 cancer cell proliferation (Not tested),5405,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620273,4090,
,N,BAO_0000219,,Compound was tested for antiproliferative activity against human A549 cancer cell lines using MTT assay,5406,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620274,17350,
,N,BAO_0000219,,In vitro inhibitory concentration required against human lung A549 carcinoma cells proliferation,5407,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620275,4197,
,N,BAO_0000219,,Antiproliferative potency determined as inhibitory concentration against A549 cells,5408,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620276,17072,
,N,BAO_0000219,,Percent assembly of bovine brain tubulin induced by compound at 10 uM versus that caused by 10 uM paclitaxel,5409,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620277,17072,
,N,BAO_0000219,,Cytotoxicity against Renal cell lines A549 was determined,5410,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620278,5194,
,N,BAO_0000218,,Area under curve was determined in dog after a 3 mg/kg of oral dose,5411,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL620279,4257,
,N,BAO_0000218,,Area under curve was determined in dog after oral administration at 1 mg/kg,5412,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL620280,6123,
,N,BAO_0000218,,Area under curve was determined in dogs after oral administration (10 mg/kg) as a 0.05 M citric acid solution.,5413,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL620281,1337,
,N,BAO_0000218,,Area under curve was determined in dogs after oral administration (8 mg/kg) as a 0.05 M citric acid solution.,5414,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL620282,1337,
,N,BAO_0000218,,Area under increased blood flow curve (AUC) at 1 microg ia at a duration of ( 0-2 mins),5415,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621134,8833,
,N,BAO_0000218,,Area under increased blood flow curve (AUC) at 1 microg ia at a duration of ( 0-5 mins),5416,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621135,8833,
,N,BAO_0000218,,Area under increased blood flow curve (AUC) at 1 microg ia at a duration of (0-15 mins),5417,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621136,8833,
,N,BAO_0000218,,Area under increased blood flow curve (AUC) at 1 microg ia at a duration of( 0-120 mins),5418,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621137,8833,
,N,BAO_0000218,,Area under plasma concentration time curve in dog upon oral administration,5419,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621138,17657,Plasma
,N,BAO_0000218,,Area under plasma concentration time curve was measured in dogs after an oral dose of 10 uM/kg,5420,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL875587,17650,Plasma
,N,BAO_0000218,,Area under the curve for compound was evaluated in dog at a dose of 10 mg/kg.,5421,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621139,1977,
,N,BAO_0000218,,Area under the curve for compound was evaluated in dog at a dose of 20 mg/kg.,5422,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621140,1977,
,N,BAO_0000218,,Area under the curve for the compound was obtained when tested in dog,5423,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621141,3132,
,N,BAO_0000218,,Area under the curve at a dose of 1 mg/kg,5424,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621142,5473,
,N,BAO_0000218,,Area under the curve at a dose of 1 mg/kg (oral),5425,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621143,5474,
,N,BAO_0000218,,Area under the curve at i.v. dose of 0.2 mg/kg,5426,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621144,5474,
,N,BAO_0000218,,Area under the curve was measured in dog after an iv dose of 1 mg/kg,5427,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621145,6062,
,N,BAO_0000218,,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in dog,5428,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621146,4709,
,N,BAO_0000218,,Compound was evaluated for area under curve (total concentration) in dogs at a dose of 1 mpk perorally,5429,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622567,2652,
,N,BAO_0000218,,Compound was evaluated for area under curve (total concentration) in dogs at a dose of 5 mpk perorally,5430,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622568,2652,
,N,BAO_0000218,,Compound was evaluated for area under the curve in dog blood.,5431,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622569,2877,
,N,BAO_0000218,,In vivo area under curve was calculated by peroral administration at 1 mg/kg in fasted dog,5432,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622570,5444,
,N,BAO_0000218,,AUC in dog after oral dose (1 mg/kg),5433,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622571,5130,Plasma
,N,BAO_0000218,,Pharmacokinetic (PK) property (AUC) was determined in dog at the single oral dose of 1 mg/kg,5434,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622572,6265,
,N,BAO_0000218,,"Pharmacokinetic data in dogs at dose of 1 mg/kg perorally, and the area under curve (AUC) was reported.",5435,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622573,4657,
,N,BAO_0000218,,Pharmacokinetic parameter AUC after intravenous administration to dogs,5436,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622574,16367,
,N,BAO_0000218,,Pharmacokinetic parameter AUC after oral administration to dogs,5437,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622575,16367,
,N,BAO_0000218,,Pharmacokinetic parameter AUC was determined in dog after oral administration of 17b,5438,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622576,9579,
,N,BAO_0000218,,Pharmacokinetic parameter AUC was determined in dog after oral administration of 2b,5439,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622577,9579,
,N,BAO_0000218,,Pharmacokinetic property (AUC) was measured in dog at the dose of 0.032 mg/kg p.o.,5440,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622578,5983,
,N,BAO_0000218,,Pharmacokinetic property in dogs after oral administration at 1 mg/kg,5441,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622579,6241,
,N,BAO_0000218,,"Tested for the pharmacokinetic data, area under the curve of concentration versus time in dog",5442,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622580,5313,
,N,BAO_0000218,,"Tested for the pharmacokinetic data, area under the curve of concentration versus time in dog at dosage of 10 mpk",5443,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622581,5313,
,N,BAO_0000218,,Oral AUCN in dog ( (dosed as a mixture of five compounds at 0.5 mpk each via iv only),5444,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622582,6642,
,N,BAO_0000218,,Oral AUCN in dog (dosed as a mixture of five compounds at 0.5 mpk each via iv only),5445,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622583,6642,
,N,BAO_0000218,,Oral AUCN in dog (dosed at 0.5 mpk iv ),5446,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622584,6641,
,N,BAO_0000218,,Oral AUCN in dog (dosed at 0.5 mpk iv ),5447,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622585,6642,
,N,BAO_0000218,,Compound was evaluated for oral bioavailability in dog; 90-100,5448,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622586,17791,
,N,BAO_0000218,,Compound was tested for its cell permeability in the Madin-Darby canine kidney cell monolayer transport assay,5449,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623281,17655,
,N,BAO_0000218,,Compound was tested for its cell permeability in the Madin-Darby canine kidney cell monolayer transport assay; Not determined,5450,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623282,17655,
,N,BAO_0000218,,PAPP (membrane permeability) in dog kidney cell monolayer assay,5451,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623283,6596,
,N,BAO_0000218,,Oral bioavailability in dog,5452,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623284,3880,
,N,BAO_0000218,,Bioavailability administered orally at a dose of 10 mg/kg to dogs,5453,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623285,16367,
,N,BAO_0000218,,Plasma protein binding towards dog plasma at 10 uM,5454,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623463,17409,Plasma
,N,BAO_0000218,,Plasma protein binding towards dog plasma at 100 uM,5455,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL875952,17409,Plasma
,N,BAO_0000218,,Bioavailability in dog (dose 4 mg/kg p.o.),5456,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621705,2959,
,N,BAO_0000218,,Bioavailability was determined after oral administration of compound 18 at a dose of 2 mg/kg to dog,5457,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621706,13501,
,N,BAO_0000218,,Bioavailability by oral administration at a dose of 10 uM/kg in dog was determined,5458,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621707,4527,
,N,BAO_0000218,,Bioavailability in dogs,5459,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621708,15145,
,N,BAO_0000218,,Bioavailability,5460,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621709,4219,
,N,BAO_0000218,,Oral bioavailability in dog (dose 10 mg/kg),5461,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621710,17538,
,N,BAO_0000218,,Bioavailability in dog after po administration at a dose of 10 mg/kg; nd is not determined,5462,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621711,17538,
,N,BAO_0000218,,Bioavailability in dog (dose 10.0 mg/kg p.o.),5463,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621712,1466,
,N,BAO_0000218,,Bioavailability was measured in dogs after an oral dose of 10 uM/kg,5464,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621713,17650,
,N,BAO_0000218,,Bioavailability was obtained by the comparison of AUC of intravenous dosing and AUC of oral dosing in dog,5465,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621714,3132,
,U,BAO_0000218,,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice kidney upon intraveneous administration at 2.6 gmol/mice after 3 hour,5466,Autocuration,,0,,,,,10095.0,1,,22224,A,Mus sp.,,CHEMBL621715,2413,
,U,BAO_0000218,,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice liver upon intraveneous administration at 2.6 gmol/mice after 1 hour,5467,Autocuration,2107.0,0,,,,,10095.0,1,,22224,A,Mus sp.,,CHEMBL623717,2413,Liver
,U,BAO_0000218,,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice liver upon intraveneous administration at 2.6 gmol/mice after 24 hour,5468,Autocuration,2107.0,0,,,,,10095.0,1,,22224,A,Mus sp.,,CHEMBL623718,2413,Liver
,U,BAO_0000218,,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice liver upon intraveneous administration at 2.6 gmol/mice after 3 hour,5469,Autocuration,2107.0,0,,,,,10095.0,1,,22224,A,Mus sp.,,CHEMBL623719,2413,Liver
,U,BAO_0000218,,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice lungs upon intraveneous administration at 2.6 gmol/mice after 1 hour,5470,Autocuration,,0,,,,,10095.0,1,,22224,A,Mus sp.,,CHEMBL623720,2413,
,U,BAO_0000218,,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice lungs upon intraveneous administration at 2.6 gmol/mice after 3 hour,5471,Autocuration,,0,,,,,10095.0,1,,22224,A,Mus sp.,,CHEMBL623721,2413,
,U,BAO_0000218,,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice muscle upon intraveneous administration at 2.6 gmol/mice after 1 hour,5472,Autocuration,2385.0,0,,,,,10095.0,1,,22224,A,Mus sp.,,CHEMBL623722,2413,Muscle tissue
,U,BAO_0000218,,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice muscle upon intraveneous administration at 2.6 gmol/mice after 24 hour,5473,Autocuration,2385.0,0,,,,,10095.0,1,,22224,A,Mus sp.,,CHEMBL623723,2413,Muscle tissue
,U,BAO_0000218,,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice muscle upon intraveneous administration at 2.6 gmol/mice after 3 hour,5474,Autocuration,2385.0,0,,,,,10095.0,1,,22224,A,Mus sp.,,CHEMBL618543,2413,Muscle tissue
,U,BAO_0000218,,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice spleen upon intraveneous administration at 2.6 gmol/mice after 1 hour,5475,Autocuration,2106.0,0,,,,,10095.0,1,,22224,A,Mus sp.,,CHEMBL618544,2413,Spleen
,U,BAO_0000218,,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice spleen upon intraveneous administration at 2.6 gmol/mice after 3 hour,5476,Autocuration,2106.0,0,,,,,10095.0,1,,22224,A,Mus sp.,,CHEMBL875155,2413,Spleen
,U,BAO_0000218,,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice upon intraveneous administration at 2.6 gmol/mice after 1 hour,5477,Autocuration,,0,,,,,10095.0,1,,22224,A,Mus sp.,,CHEMBL618545,2413,
,U,BAO_0000218,,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice upon intraveneous administration at 2.6 gmol/mice after 24 hour,5478,Autocuration,,0,,,,,10095.0,1,,22224,A,Mus sp.,,CHEMBL618546,2413,
,U,BAO_0000218,,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice upon intraveneous administration at 2.6 gmol/mice after 3 hour,5479,Autocuration,,0,,,,,10095.0,1,,22224,A,Mus sp.,,CHEMBL623529,2413,
,U,BAO_0000218,,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice uvea upon intraveneous administration at 2.6 gmol/mice after 24 hour,5480,Autocuration,,0,,,,,10095.0,1,,22224,A,Mus sp.,,CHEMBL623530,2413,
,U,BAO_0000218,,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice uvea upon intraveneous administration at 2.6 gmol/mice after 3 hour,5481,Autocuration,,0,,,,,10095.0,1,,22224,A,Mus sp.,,CHEMBL621764,2413,
,U,BAO_0000019,,Compound (i.v.) was evaluated for elimination rate constants in brainstem of rhesus monkeys (Radiolabeled compound),5482,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621765,17827,
,U,BAO_0000019,,Compound (i.v.) was evaluated for elimination rate constants in cerebellum of rhesus monkeys (Radiolabeled compound),5483,Autocuration,2037.0,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621766,17827,Cerebellum
,U,BAO_0000019,,Compound (i.v.) was evaluated for elimination rate constants in frontal cortex of rhesus monkey (Radiolabeled compound),5484,Autocuration,1870.0,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621767,17827,Frontal cortex
,U,BAO_0000019,,Compound (i.v.) was evaluated for elimination rate constants in jaw bone of rhesus monkeys; NA = not active (Radiolabeled compound),5485,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621768,17827,
,U,BAO_0000019,,Compound (i.v.) was evaluated for elimination rate constants in striatum of rhesus monkey (Radiolabeled compound),5486,Autocuration,2435.0,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621769,17827,Striatum
,U,BAO_0000019,,Compound (i.v.) was evaluated for uptake rate constants in brainstem of rhesus monkeys (Radiolabeled compound),5487,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621770,17827,
,U,BAO_0000019,,Compound (i.v.) was evaluated for uptake rate constants in cerebellum of rhesus monkeys (Radiolabeled compound),5488,Autocuration,2037.0,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621771,17827,Cerebellum
,U,BAO_0000019,,Compound (i.v.) was evaluated for uptake rate constants in frontal cortex of rhesus monkey (Radiolabeled compound),5489,Autocuration,1870.0,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621772,17827,Frontal cortex
,U,BAO_0000019,,Compound (i.v.) was evaluated for uptake rate constants in jaw bone of rhesus monkey (Radiolabeled compound),5490,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621773,17827,
,U,BAO_0000019,,Compound (i.v.) was evaluated for uptake rate constants in striatum of rhesus monkeys (Radiolabeled compound),5491,Autocuration,2435.0,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621774,17827,Striatum
,U,BAO_0000218,,Compound was evaluated for oral bioavailability in rats,5492,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621775,17791,
,U,BAO_0000218,,Maximum concentration of compound found in plasma at 5 mg/kg after oral administration,5493,Autocuration,1969.0,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621776,17667,Plasma
,U,BAO_0000019,,Half life period was evaluated in monkey,5494,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621777,17791,
,U,BAO_0000218,,Half-life in rhesus monkeys by intravenous administration of dose,5495,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL875162,110,
,N,BAO_0000218,,AUC (0-6 hr) after oral administration at 30 mg/kg in ICR mouse,5496,Intermediate,1969.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621778,5781,Plasma
,N,BAO_0000218,,AUC after intraperitoneal administration of 100 mg/kg in mice,5497,Intermediate,1969.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621779,17734,Plasma
,N,BAO_0000218,,AUC value was determined after oral administration,5498,Intermediate,1969.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622479,17718,Plasma
,N,BAO_0000218,,Area under curve (AUC) determined at a dose 10 mg/kg administered intraperitoneally to mice,5499,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622480,4573,
,N,BAO_0000218,,Area under curve (AUC) was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),5500,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622481,3277,
,N,BAO_0000218,,Area under curve by ioral administration in mouse,5501,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622482,2862,
,N,BAO_0000218,,Area under curve by iv administration in mouse,5502,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622483,2862,
,N,BAO_0000218,,Area under curve at 0-8 hr in IRC mice after peroral administration,5503,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622484,5951,
,N,BAO_0000218,,Area under curve when injected i.p. in mice at a dose of 50 mg/kg,5504,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622641,17729,
,N,BAO_0000218,,Area under curve when injected intraperitoneally in BALB/C mice at a dose of 20 mg/kg,5505,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622642,17728,
,N,BAO_0000218,,Area under curve when injected intravenously in BALB/C mice at a dose of 20 mg/kg,5506,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622643,17728,
,N,BAO_0000218,,Area under curve when injected intravenously in mice at a dose of 20 mg/kg,5507,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622644,17729,
,N,BAO_0000219,,Effect on RNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.01 ug/mL,5508,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL622645,9424,
,N,BAO_0000219,,Effect on RNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.1 ug/mL,5509,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL622646,9424,
,N,BAO_0000219,,Effect on RNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.1 ug/mL (*: >50% cell kill),5510,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL621238,9424,
,N,BAO_0000219,,Effect on RNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.3 ug/mL (*: >50% cell kill),5511,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL621239,9424,
,N,BAO_0000219,,Effect on RNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.5 ug/mL. (*: >1 log cell kill),5512,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL621240,9424,
,N,BAO_0000219,,Effect on RNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 10 ug/mL (*: >1 log cell kill),5513,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL621241,9424,
,N,BAO_0000219,,Effect on RNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 1 ug/mL. (*: >50% cell kill),5514,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL621242,9424,
,N,BAO_0000219,,Effect on RNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 1 ug/mL. (*: >1 log cell kill),5515,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL620350,9424,
,N,BAO_0000219,,Effect on protein synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.01 ug/mL,5516,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL620351,9424,
,N,BAO_0000219,,Effect on protein synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.1 ug/mL,5517,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL620352,9424,
,N,BAO_0000219,,Effect on protein synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.1 ug/mL (*: >50% cell kill),5518,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL620353,9424,
,N,BAO_0000219,,Effect on protein synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.3 ug/mL (*: >50% cell kill),5519,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL620354,9424,
,N,BAO_0000219,,Effect on protein synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.5 ug/mL. (*: >1 log cell kill),5520,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL620355,9424,
,N,BAO_0000219,,Effect on protein synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 10 ug/mL (*: >1 log cell kill),5521,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL620356,9424,
,N,BAO_0000219,,Effect on protein synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 1 ug/mL. (*: >50% cell kill),5522,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL620357,9424,
,N,BAO_0000219,,Effect on protein synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 1 ug/mL. (*: >1 log cell kill),5523,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL620358,9424,
,N,BAO_0000219,,In vitro inhibition of human 8226 myeloma tumor cell line growth.,5524,Expert,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL620359,9424,
,N,BAO_0000219,,In vitro inhibition of tumor cell growth in the human myeloma 8226/ADR system.,5525,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL620360,11544,
,N,BAO_0000219,,Cytotoxicity of compound against 8226/DOX1V cells,5526,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL620361,17378,
,N,BAO_0000219,,Cytotoxicity of compound against 8226/S cells,5527,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL620362,17378,
,N,BAO_0000219,,Inhibitory concentration against 8226 myeloma cancer cell line,5528,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL620363,17079,
,N,BAO_0000219,,Inhibitory concentration against 8226/Dox40 (Dox-Re) cancer cell line,5529,Intermediate,,1,,,741.0,,9606.0,1,RPMI-8226,80433,F,Homo sapiens,,CHEMBL620364,17079,
,N,BAO_0000219,,Inhibition of cell growth was studied in human teratocarcinoma (833K).,5530,Intermediate,,1,,,854.0,,9606.0,1,833K,80647,F,Homo sapiens,,CHEMBL620365,13466,
,N,BAO_0000219,,Inhibition of cell growth was studied in human teratocarcinoma (833K); ND ='not determined',5531,Intermediate,,1,,,854.0,,9606.0,1,833K,80647,F,Homo sapiens,,CHEMBL620366,13466,
,N,BAO_0000219,,Tested in vitro for growth inhibitory activity against 833K (human teratorcarcinoma) cells,5532,Expert,,1,,,854.0,,9606.0,1,833K,80647,F,Homo sapiens,,CHEMBL620367,2392,
,N,BAO_0000219,,The compound was tested in vitro for growth inhibitory activity against 833K (human teratorcarcinoma) cells; No data,5533,Intermediate,,1,,,854.0,,9606.0,1,833K,80647,F,Homo sapiens,,CHEMBL620368,2392,
,U,BAO_0000019,,Inhibitory activity against caspase-1,5534,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL620369,6608,
,H,BAO_0000357,,Percent inhibition of DAla-DAla Ligase at 10e -3 M of the compound,5535,Autocuration,,8,,,,,1351.0,1,,45,B,Enterococcus faecalis,,CHEMBL620370,10199,
,N,BAO_0000219,,In vitro antiproliferative activity against 8701-BC human breast cancer cells at a concentration of (0-100 uM) for 72 hr using MTT assay,5536,Intermediate,,1,,,705.0,,9606.0,1,8701-BC,80648,F,Homo sapiens,,CHEMBL620371,17749,
,N,BAO_0000219,,In vitro antiproliferative activity against 8701-BC human breast cancer cells at a concentration of (0-100 uM,5537,Intermediate,,1,,,705.0,,9606.0,1,8701-BC,80648,F,Homo sapiens,,CHEMBL620372,17749,
,U,BAO_0000019,,In vitro anticancer activity against 9 NCI colon cancer cell lines; inactive,5538,Intermediate,,0,,,,,,1,,22226,F,,,CHEMBL876492,1229,
,U,BAO_0000019,,In vitro anticancer activity against 9 NCI melanoma cell lines; inactive,5539,Intermediate,,0,,,,,,1,,22226,F,,,CHEMBL620373,1229,
,U,BAO_0000019,,In vitro anticancer activity against 9 NCI renal cancer cell lines; inactive,5540,Intermediate,,0,,,,,,1,,22226,F,,,CHEMBL620374,1229,
,U,BAO_0000019,,Inhibitory activity was determined against 9-cis-epoxycarotenoid dioxygenase (NCED) expressed in Escherichia coli in presence of 9''-cis-neo-xanthin,5541,Autocuration,,0,,,,,,1,,22226,B,,,CHEMBL620375,6390,
,U,BAO_0000019,,Minimum inhibitory concentration against Streptococcus pyogenes 930MLSB,5542,Autocuration,,0,,,,,1314.0,1,,22226,F,Streptococcus pyogenes,,CHEMBL857902,16219,
,U,BAO_0000019,,Minimum inhibitory concentration against Streptococcus pyogenes 930MLSB,5543,Autocuration,,0,,,,,1314.0,1,,22226,F,Streptococcus pyogenes,,CHEMBL620376,16219,
,H,BAO_0000357,,Percent inhibition against Cdc25C phosphatase at 50 uM of compound,5544,Autocuration,,8,,,,,,1,,11922,B,,,CHEMBL620377,17043,
,N,BAO_0000219,,Tested for in vitro cytotoxic potency of compound in 9KB assay,5545,Intermediate,,1,,,324.0,,9606.0,1,KB ,81115,F,Homo sapiens,,CHEMBL620378,6929,
,N,BAO_0000219,,Tested for in vitro cytotoxic potency of compound in 9KB assay,5546,Intermediate,,1,,,324.0,,9606.0,1,KB ,81115,A,Homo sapiens,,CHEMBL620379,6929,
,U,BAO_0000219,,In vitro cytotoxicity of compound was tested against 9KB cells.,5547,Autocuration,,0,,,,,9606.0,1,,22226,F,Homo sapiens,,CHEMBL620380,7083,
,N,BAO_0000219,,Cytotoxic concentration against 9L cells was determined on day 3,5548,Intermediate,,1,,,392.0,,10116.0,1,9L,80653,F,Rattus norvegicus,,CHEMBL884006,12446,
,N,BAO_0000219,,Tested in vitro for anticancer activity against 9L cells,5549,Expert,,1,,,392.0,,10116.0,1,9L,80653,F,Rattus norvegicus,,CHEMBL620381,15345,
,N,BAO_0000219,,Tested in vitro for anticancer activity against 9L cells; Not determined,5550,Expert,,1,,,392.0,,10116.0,1,9L,80653,F,Rattus norvegicus,,CHEMBL620382,15345,
,N,BAO_0000219,,In vitro inhibitory activity against human A549 non-small cell lung tumor; Active,5551,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620383,6301,
,N,BAO_0000219,,The compound was tested in vitro for its cytotoxicity against human A-549 cancer cell line by MTT method at 1 uM concentration; No inhibition,5552,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL876493,4833,
,N,BAO_0000219,,The compound was tested in vitro for its cytotoxicity against human A-549 cancer cell line by MTT method at 1 uM concentration; Significant inhibition,5553,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620384,4833,
,N,BAO_0000219,,The compound was tested in vitro for its cytotoxicity against human A-549 cancer cell line by MTT method at 1 uM concentration; Slight inhibition,5554,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620385,4833,
,N,BAO_0000219,,Cytotoxicity against human lung carcinoma A549 cell line,5555,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620386,13330,
,D,BAO_0000219,,Ability to induce human IL-6 assay in A549 lung carcinoma cell line.,5556,Expert,,9,,,646.0,,9606.0,1,A549,25,F,Homo sapiens,,CHEMBL620387,17517,
,D,BAO_0000219,,"Ability to induce human IL-6 assay in A549 lung carcinoma cell line; n.r.: not reported, EC50 values not reported in cases were %dex e 35%.",5557,Expert,,9,,,646.0,,9606.0,1,A549,25,F,Homo sapiens,,CHEMBL621404,17517,
,N,BAO_0000219,,"In vitro growth inhibition of A549, lung carcinoma",5558,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621405,14425,
,N,BAO_0000219,,"In vitro growth inhibition of A549, lung carcinoma.",5559,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621406,14425,
,N,BAO_0000219,,In vitro cytotoxicity against A549 (human lung carcinoma) cell line.,5560,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621407,5228,
,N,BAO_0000219,,Cytotoxic activity against human lung cancer A549 cell line was determined,5561,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621408,5351,
,N,BAO_0000219,,Cytotoxicity against human solid tumor lung carcinoma A549 cell line,5562,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL885345,12198,
,N,BAO_0000219,,Cytotoxicity concentration against human lung carcinoma A-549 cell line,5563,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621409,13891,
,N,BAO_0000219,,Cytotoxicity in A549 (human carcinoma) cell line.,5564,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL876034,5677,
,N,BAO_0000219,,Cytotoxicity on lung carcinoma (A-549) cell line,5565,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621410,13788,
,N,BAO_0000219,,Effective dose against 50% reduction in Human lung carcinoma (A-549) cell number after 3-day incubation.,5566,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621411,13384,
,N,BAO_0000219,,Effective dose of compound against replication of A549 cell line was evaluated,5567,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621412,6726,
,N,BAO_0000219,,In vitro cytotoxic activity was determined against lung carcinoma (A549) cell line,5568,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621413,3455,
,N,BAO_0000219,,In vitro cytotoxicity evaluated against human lung cancer (A549 cell line),5569,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621414,5726,
,N,BAO_0000219,,In vitro cytotoxicity evaluated against human lung cancer (A549 cell line); NA is not active,5570,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621415,5726,
,N,BAO_0000219,,The compound was evaluated for antiproliferative activity against A549 cell line,5571,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621416,3936,
,N,BAO_0000219,,The compound was tested for tumor cell growth inhibitory activity against human lung carcinoma (A549) cell line.,5572,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621417,14991,
,N,BAO_0000219,,Concentration required for growth inhibition of human lung carcinoma cell line A549,5573,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621418,5243,
,N,BAO_0000219,,Cytotoxic activity against A549/ATCC non-small cell-lung cancer cell line,5574,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621419,12858,
,N,BAO_0000219,,Growth inhibition against A549 cell line was evaluated,5575,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621420,6776,
,N,BAO_0000219,,Growth inhibitory activity against A549 human solid tumor cell line using MTT assay,5576,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL875823,16558,
,N,BAO_0000219,,Inhibition of anchorage independent growth of human tumor cell line A549 K-ras-transformed in soft agar,5577,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621421,4583,
,N,BAO_0000219,,Inhibitor activity against A549 (Human lung carcinoma)cell line with varying concentration of the drug for 72 hrs,5578,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621422,13514,
,N,BAO_0000219,,Chemosensitivity against DT-diaphorase rich A549 cell lines,5579,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL884014,15166,
,N,BAO_0000219,,Compound tested against A549 lung carcinoma in the sulforhodamine B assay.,5580,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621423,13873,
,N,BAO_0000219,,In vitro cytotoxicity against human A549 (lung cancer) cell line.,5581,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621424,6447,
,N,BAO_0000219,,In vitro antitumor activity against A549 (lung) human tumor cell lines.,5582,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621425,2068,
,N,BAO_0000219,,In vitro cytotoxic activity against human lung carcinoma A549 cell line,5583,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621426,1863,
,N,BAO_0000219,,Compound was tested against A549 lung cancer cell line in the sulforhodamine B assay.,5584,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621427,13873,
,N,BAO_0000219,,Compound was tested against A549 lung carcinoma cell line in the sulforhodamine B assay.,5585,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621428,13873,
,N,BAO_0000219,,Tested against A549 lung carcinoma in the sulforhodamine B assay.,5586,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621429,13873,
,N,BAO_0000219,,Compound was tested for cytotoxicity on A549 lung adenocarcinoma cell line using a proliferation assay (MTT reduction),5587,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621430,579,
,N,BAO_0000219,,Compound was tested for cytotoxicity on A549 lung adenocarcinoma cell line using a proliferation assay (MTT reduction).,5588,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621431,579,
,N,BAO_0000219,,Compound was tested for inhibition of growth of human lung carcinoma cell line A549 up to a conc of 10 uM; NI means no inhibition,5589,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621432,4584,
,N,BAO_0000219,,Inhibition of NFkB (transcription factor) activation in A549 human lung carcinoma cell line,5590,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621433,5421,
,N,BAO_0000219,,Compound was tested for its ability to inhibit tumor necrosis factor alpha (TNF alpha) induced apoptosis in A549 human lung carcinoma cell line,5591,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL875824,5421,
,N,BAO_0000219,,Compound was tested for its ability to inhibit tumor necrosis factor alpha (TNF alpha) induced apoptosis in A549 human lung carcinoma cell line at 20 uM concentration,5592,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621434,5421,
,N,BAO_0000219,,Compound was tested for its ability to inhibit tumor necrosis factor alpha (TNF alpha) induced apoptosis in A549 human lung carcinoma cell line; NA=Not assayed,5593,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621435,5421,
,N,BAO_0000219,,Compound was tested for potency against human lung A549 cells using sulforhodamine B assay.,5594,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621436,14188,
,N,BAO_0000219,,Compound was tested for potency against human lung A549 cells using sulforhodamine B assay; UA=Potency was so low that the IC50 was unachievable.,5595,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621437,14188,
,N,BAO_0000219,,Compound was tested for the growth inhibition of A549 lung tumor cell line,5596,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621438,15354,
,N,BAO_0000219,,Growth inhibition of human non-small-lung carcinoma (A549) cell line,5597,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621439,14253,
,N,BAO_0000219,,Compound was tested against A549 lung carcinoma cell line in the sulforhodamine B assay.,5598,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621440,13873,
,N,BAO_0000218,,Oral bioavailability in dog (conscious),5599,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621441,3043,
,N,BAO_0000218,,Compound was evaluated for the oral bioavailability after oral administration in dog.,5600,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621442,3045,
,N,BAO_0000218,,Compound was tested for percent of oral bioavailability at 10 mg/ml dose in dogs,5601,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621443,3022,
,N,BAO_0000218,,Oral bioavailability in dog,5602,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621444,4453,
,N,BAO_0000218,,Oral bioavailability in dog,5603,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625133,1696,
,N,BAO_0000218,,Oral bioavailability in dog,5604,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625134,5045,
,N,BAO_0000218,,Oral bioavailability in dog (fasted),5605,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625135,5356,
,N,BAO_0000218,,Oral bioavailability after intravenous administration in dogs at 1.2 uM/kg,5606,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625136,17764,
,N,BAO_0000218,,Oral bioavailability in dog,5607,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625137,6448,
,N,BAO_0000218,,Oral bioavailability in dog,5608,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625138,1475,
,N,BAO_0000218,,Percent bioavailability in dog,5609,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625139,3788,
,N,BAO_0000218,,Percent oral bioavailability of intravenously administered compound (6 mg/kg) was tested in dog,5610,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL872264,3639,
,N,BAO_0000218,,Oral bioavailability in dog,5611,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625140,13397,
,N,BAO_0000218,,The compound was evaluated for bioavailability in dogs; 34-44,5612,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624436,2137,
,N,BAO_0000218,,Bioavailability in dog (dose 4 mg/kg p.o.),5613,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624437,2959,
,N,BAO_0000218,,Oral bioavailability in dog,5614,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL872261,6448,
,N,BAO_0000218,,8 hour trough Blood level in dog was measured after administration of compound,5615,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624438,6084,
,N,BAO_0000218,,The compound was tested for maximum concentration ( Cmax ) in dog plasma.,5616,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624439,3639,Plasma
,N,BAO_0000218,,C24 after oral administration at 5 mg/kg,5617,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624440,6316,
,N,BAO_0000218,,Clearance after oral and iv dosing in dogs,5618,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624441,5238,
,N,BAO_0000218,,Clearance of the drug was measured in the plasma of dog,5619,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624442,17796,Plasma
,N,BAO_0000218,,Compound was evaluated for Clearance in dogs at a dose of 1 mpk intravenously,5620,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624443,2652,
,N,BAO_0000218,,CL (clearance) of compound was determined after intravenous administration in average of two dogs at a dose of 1 mg/kg,5621,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624444,5654,
,N,BAO_0000218,,Clearance of compound was determined in dogs,5622,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624445,6621,
,N,BAO_0000218,,Clearance on i.v. administration of 2 mg/kg was measured in dog,5623,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624446,6505,
,N,BAO_0000218,,Clearance of compound after both po and iv administration at a dose of 5 mg/kg and 2 mg/kg resp in dog,5624,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624447,5802,
,N,BAO_0000218,,Plasma clearance in dog was determined,5625,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624448,17267,
,N,BAO_0000218,,Plasma clearance in dog after 2 mg/kg by oral and 0.5 mg/kg by intravenous administration; ND is not determined,5626,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624449,4521,
,N,BAO_0000218,,Plasma clearance in dog after administration of 0.25 mg/kg iv,5627,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624450,6535,
,N,BAO_0000218,,Plasma clearance in dog after administration of 1 mg/kg iv,5628,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL875942,6535,
,N,BAO_0000218,,Plasma clearance in dogs,5629,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624451,6535,
,N,BAO_0000218,,Plasma clearance by iv administration in dog at a dose of 0.3 mg/kg,5630,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624452,5542,
,N,BAO_0000218,,Plasma clearance was determined in canine following intravenous (iv) administration of drug (1 mg/kg).,5631,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624453,5199,
,N,BAO_0000218,,Plasma clearance after 15 mg/kg iv dose in Dogs,5632,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624454,16907,
,N,BAO_0000218,,Plasma clearance after 30 mg/kg po dose in Dogs,5633,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624455,16907,
,N,BAO_0000218,,Plasma administration to dogs,5634,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624456,16367,
,N,BAO_0000218,,Plasma clearance was determined,5635,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624457,5505,
,N,BAO_0000218,,Systemic clearance after intravenous administration (0.5 mg/kg) was determined in dog,5636,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624458,6215,
,N,BAO_0000218,,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in dog,5637,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624459,1466,
,S,BAO_0000251,,Intrinsic clearance in human liver microsomes,5638,Intermediate,2107.0,2,Microsomes,In vitro,,,9606.0,1,,102164,A,Homo sapiens,,CHEMBL624460,5007,Liver
,S,BAO_0000251,,Intrinsic clearance in human liver microsomes,5639,Intermediate,2107.0,2,Microsomes,In vitro,,,9606.0,1,,102164,A,Homo sapiens,,CHEMBL624461,5007,Liver
,N,BAO_0000218,,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,5640,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL875943,16452,
,N,BAO_0000218,,Pharmacokinetic data at 1 mg/kg dose given to dogs intravenously,5641,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624462,16452,
,N,BAO_0000218,,Clearance in dog (dose 1 mg/kg i.v.),5642,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624463,16452,
,N,BAO_0000218,,Plasma clearance after oral administration (2.5 mg/kg) in dog was determined,5643,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624464,6221,
,N,BAO_0000218,,Plasma clearance in dogs administered perorally (5 mg/kg) and intravenously (2 mg/kg),5644,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624465,5007,
,N,BAO_0000218,,Plasma clearance after peroral administration at 10 mpk in dog,5645,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624466,5668,
,N,BAO_0000218,,Plasma clearance after peroral administration at 5 mpk in dog,5646,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624467,5668,
,N,BAO_0000218,,Plasma clearance after peroral administration at 5 mg/kg in dog,5647,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624468,5668,
,N,BAO_0000218,,Plasma clearance was measured in dog,5648,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624469,15660,
,N,BAO_0000218,,Plasma clearance was measured in dog,5649,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624470,15660,
,N,BAO_0000218,,Pharmacokinetic property (CLtot) was measured in dog at the dose of 0.032 mg/kg i.v.,5650,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624471,5983,
,N,BAO_0000218,,Total clearance was determined after 0.1 mg/kg iv administration in dog,5651,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624472,5600,
,N,BAO_0000218,,Clearance of compound after intravenous administration in dogs at 1.2 uM/kg,5652,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622775,17764,
,N,BAO_0000218,,Clearance after intravenous administration of 0.5 mg/kg in dog was determined,5653,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622776,6039,
,N,BAO_0000218,,Clearance after intravenous administration of 1.0 mg/kg in dog was determined,5654,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622777,6039,
,N,BAO_0000218,,Clearance after peroral administration of 0.2 mg/kg in dog was determined,5655,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622778,6039,
,N,BAO_0000218,,Clearance by intravenous administration of 1.2 mg/kg in dog,5656,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622779,4368,
,N,BAO_0000218,,Clearance by iv administration in dogs at a dose of 1 mg/kg,5657,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622780,4305,
,N,BAO_0000218,,Clearance value was evaluated in dog plasma,5658,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622781,1918,Plasma
,N,BAO_0000218,,Clearance was evaluated after i.v. administration in dog at a dose of 1 mg/kg,5659,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622782,6005,
,N,BAO_0000218,,Compound was tested for plasma clearance in dog,5660,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622783,4839,Plasma
,N,BAO_0000218,,Pharmacokinetic property (Plasma clearance) was measured in dog,5661,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622784,4239,
,N,BAO_0000218,,Area under curve when injected perorally in mice at a dose of 50 mg/kg,5662,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622785,17729,
,N,BAO_0000218,,Area under curve when injected perorally in BALB/C mice at a dose of 50 mg/kg,5663,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622786,17728,
,N,BAO_0000218,,Area under curve value in mouse at a dose of 10 mg/kg,5664,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622787,5302,
,N,BAO_0000218,,Area under curve was determined at a dose of 100 mg/kg (i.p.) in Mice,5665,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL875949,5506,
,N,BAO_0000218,,Area under curve was determined at a dose of 200 mg/kg (i.p.) in Mice,5666,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622788,5506,
,N,BAO_0000218,,Area under curve was determined for compound after intraperitoneal administration in mice at 18 uM/kg,5667,Intermediate,,1,,,,,10090.0,1,,50594,F,Mus musculus,,CHEMBL622789,17764,
,N,BAO_0000218,,Area under curve was determined for compound after intraperitoneal administration in mice at 23 uM/kg,5668,Intermediate,,1,,,,,10090.0,1,,50594,F,Mus musculus,,CHEMBL622790,17764,
,N,BAO_0000218,,Area under curve was determined for compound after intraperitoneal administration in mice at 25 uM/kg,5669,Intermediate,,1,,,,,10090.0,1,,50594,F,Mus musculus,,CHEMBL622791,17764,
,N,BAO_0000218,,Area under curve was determined for compound after intraperitoneal administration in mice at 26 uM/kg,5670,Intermediate,,1,,,,,10090.0,1,,50594,F,Mus musculus,,CHEMBL622792,17764,
,N,BAO_0000218,,Area under curve was determined for compound after intravenous administration in mice at 24 uM/kg,5671,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622793,17764,
,N,BAO_0000218,,Area under curve was determined for the compound at 24 mg/Kg,5672,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622794,17753,
,N,BAO_0000218,,Area under curve was determined for the compound at 40 mg/Kg,5673,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622795,17753,
,N,BAO_0000218,,Area under curve was determined for the compound at 5 mg/Kg,5674,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621803,17753,
,N,BAO_0000218,,Area under the curve for the compound is obtained at dose 25 mg/kg,5675,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621804,3132,
,N,BAO_0000218,,Area under the curve for the compound was obtained when tested in mouse,5676,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621805,3132,
,N,BAO_0000218,,Area under the curve of compound in mouse blood following i.v. administration of 10 mg/kg,5677,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621806,17837,
,N,BAO_0000218,,Area under the curve of compound in mouse blood following p.o. administration of 30 mg/kg,5678,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621807,17837,
,N,BAO_0000218,,Area under the curve was measured in mouse after an iv dose of 1 mg/kg,5679,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621808,6062,
,N,BAO_0000218,,Area under the curve was determined for the compound at a single subcutaneous administration of 40 mg/kg in mice,5680,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621809,4066,
,N,BAO_0000218,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for area under curve (AUCtot),5681,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621810,16597,
,N,BAO_0000218,,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,5682,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL875164,14239,
,N,BAO_0000218,,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,5683,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621811,14239,
,N,BAO_0000218,,"Compound was evaluated for the pharmacokinetic parameter, area under curve",5684,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621812,4890,
,N,BAO_0000218,,Evaluated for pharmacokinetic parameter area under curve in mouse at the dose 20 mg/kg (0-4 hr ),5685,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621813,429,
,N,BAO_0000218,,Evaluated for pharmacokinetic parameter area under curve in mouse at the dose 20 mg/kg (0-4 hr),5686,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621814,429,
,N,BAO_0000218,,In vivo area under curve (AUC) was determined in murine septicemia at dose of 100 mg/kg,5687,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621815,5969,
,N,BAO_0000218,,In vivo area under curve (AUC) was determined in murine septicemia at dose of 50 mg/kg,5688,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621816,5969,
,N,BAO_0000218,,In vivo area under curve (AUC) was determined in murine septicemia at dose of 50 mg/kg;ND=not determined,5689,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621817,5969,
,N,BAO_0000218,,Pharmacokinetic activity (AUC) in vivo after intravenous administration of 10 mg/kg in mouse,5690,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621818,6091,
,N,BAO_0000218,,Pharmacokinetic activity (AUC) in vivo after intravenous administration of 10 mg/kg in mouse;ND=Not determined,5691,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621819,6091,
,N,BAO_0000218,,Pharmacokinetic activity (AUC) in vivo after peroral administration of 10 mg/kg in mice,5692,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621820,6091,
,N,BAO_0000218,,Pharmacokinetic activity (AUC) in vivo after peroral administration of 10 mg/kg in mice;ND=Not determined,5693,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621821,6091,
,N,BAO_0000218,,Pharmacokinetic property (AUC) was determined after ip administration of 32 mg/kg in mice,5694,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621822,6178,
,N,BAO_0000218,,Pharmacokinetic property (AUC) was determined after po administration of 32 mg/kg in mice,5695,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619474,6178,
,N,BAO_0000218,,"Reduction in area under curve was determined in DIO mice by oral glucose tolerance test following a single i.p. dose (10 mg/kg, 30 min pre-treatment)",5696,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619475,6619,
,N,BAO_0000218,,"Reduction in area under curve was determined in ob/ob mice by oral glucose tolerance test following a single i.p. dose (10 mg/kg, 30 min pre-treatment)",5697,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619476,6619,
,N,BAO_0000218,,"The area under concentration-time curve(AUC) was determined at 5 mg/kg of compound dose, administered intravenously in mice",5698,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619477,3760,
,N,BAO_0000218,,"The area under concentration-time curve(AUC) was determined at 5 mg/kg of compound dose, administered perorally in mice",5699,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619478,3760,
,N,BAO_0000218,,"The area under concentration-time curve(AUC) was determined at 50 mg/kg of compound dose, administered intravenously in mice",5700,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619479,3760,
,N,BAO_0000218,,"The area under concentration-time curve(AUC) was determined at 50 mg/kg of compound dose, administered perorally in mice",5701,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619480,3760,
,N,BAO_0000218,,The area under curve in vivo in mouse blood level after oral administration at dose 50 mk/kg e-1,5702,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619481,3192,
,N,BAO_0000218,,The area under curve in vivo in mouse blood level after subcutaneous administration at dose 50 mk/kg e-1,5703,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619482,3192,
,N,BAO_0000218,,Area under the curve was evaluated in mice after intravenous administration,5704,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619483,2675,
,N,BAO_0000218,,Area under the curve was evaluated in mice after oral administration,5705,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619484,2675,
,N,BAO_0000218,,AUC total value at a dose of 10 mg/kg intravenous administration in mice.,5706,Intermediate,1969.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619485,16597,Plasma
,N,BAO_0000218,,AUC total value at a dose of 10 mg/kg peroral administration in mice.,5707,Intermediate,1969.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619486,16597,Plasma
,N,BAO_0000218,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for area under curve (AUCtot),5708,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619487,16597,
,N,BAO_0000218,,AUMC after intraperitoneal administration of 100 mg/kg in mice,5709,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619488,17734,
,N,BAO_0000218,,Biodistribution in blood was determined in mice after iv administration at 15 min Value expressed as percent injected dose per gram,5710,Intermediate,178.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620106,7767,Blood
,N,BAO_0000219,,The compound was tested in vitro for anticancer activity against 9L cells,5711,Intermediate,,1,,,392.0,,,1,9L,80653,F,,,CHEMBL620107,15345,
,U,BAO_0000019,,Anti proliferation activity determined; Weak effect,5712,Autocuration,,0,,,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL620283,2181,
,U,BAO_0000219,,Inhibition of cell growth by compound at a concentration of 100 uM in 9Ltk+ cells; Completely stopped the process,5713,Autocuration,,0,,,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL875176,2181,
,U,BAO_0000219,,Inhibition of cell growth by compound at a concentration of 10 uM in 9Ltk+ cells,5714,Autocuration,,0,,,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL620284,2181,
,U,BAO_0000219,,Inhibition of cell growth by compound at a concentration of 10 uM in 9Ltk+ cells; Completely stopped the process,5715,Autocuration,,0,,,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL623515,2181,
,U,BAO_0000019,,The cytotoxic activity was in vitro tested by 9PS assay method,5716,Autocuration,,0,,,,,10090.0,1,,22226,F,Mus musculus,,CHEMBL623516,10486,
,U,BAO_0000019,,The cytotoxic activity was in vitro tested by 9PS assay method.,5717,Autocuration,,0,,,,,10090.0,1,,22226,F,Mus musculus,,CHEMBL623517,10486,
,U,BAO_0000019,,Partition coefficient (logD6.5),5718,Autocuration,,0,,,,,,1,,22224,A,,,CHEMBL857878,15508,
,N,BAO_0000219,,Inhibitory concentration in vitro for cytotoxic activity against A 2780 human ovarian carcinoma cells,5719,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL623518,5242,
,N,BAO_0000219,,Effective concentration against A 375 cell line growth (DFMO concentration is 5.0 mM),5720,Intermediate,,1,,,455.0,,9606.0,1,A-375,80018,F,Homo sapiens,,CHEMBL624195,16167,
,N,BAO_0000219,,Inhibitory concentration required against A 431 human epidermoid carcinoma cell line,5721,Expert,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL624196,4782,
,D,BAO_0000219,,Inhibition of EGF-induced Tyrosine phosphorylation in A431 cells expressing EGF-R,5722,Expert,,9,,,500.0,,9606.0,1,A-431,9,F,Homo sapiens,,CHEMBL624197,16093,
,N,BAO_0000219,,Compound was evaluated for in vitro cytotoxicity against A 498 cancer cell line,5723,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL624198,2596,
,N,BAO_0000219,,in vitro cytotoxicity against A 498 cancer cell line,5724,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL621287,2596,
,N,BAO_0000219,,In vitro cytotoxic activity against renal (A 498) cancer cell line.,5725,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL621288,3239,
,N,BAO_0000219,,Cytotoxic activity against A 498 renal cancer cell lines.,5726,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL876496,1847,
,N,BAO_0000219,,In vitro cytotoxicity was determined against A 498 human renal tumor cell line using NCI screen,5727,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL621289,10553,
,U,BAO_0000019,,Minimum inhibitory concentration against Staphylococcus aureus A 5177 MLSB-i,5728,Autocuration,,0,,,,,1280.0,1,,22226,F,Staphylococcus aureus,,CHEMBL621290,16219,
,U,BAO_0000019,,Minimum inhibitory concentration against Staphylococcus aureus A 5177 MLSB-i,5729,Autocuration,,0,,,,,1280.0,1,,22226,F,Staphylococcus aureus,,CHEMBL621291,16219,
,U,BAO_0000019,,Minimum inhibitory concentration against Staphylococcus aureus A 5278 MLSB-c,5730,Autocuration,,0,,,,,1280.0,1,,22226,F,Staphylococcus aureus,,CHEMBL621292,16219,
,U,BAO_0000019,,Minimum inhibitory concentration against Staphylococcus aureus A 5278 MLSB-c,5731,Autocuration,,0,,,,,1280.0,1,,22226,F,Staphylococcus aureus,,CHEMBL621293,16219,
,N,BAO_0000219,,Inhibitory concentration required against A 549 lung cancer cell line,5732,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621294,4782,
,N,BAO_0000219,,Growth inhibition of A 549 cell line by MTT reduction for 3 days of incubation time,5733,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621295,11805,
,N,BAO_0000219,,Growth inhibition of A 549 cell line by MTT reduction for 7 days of incubation time,5734,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL884007,11805,
,N,BAO_0000219,,In vitro cytotoxicity against lung cancer A 549 cell lines,5735,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621296,2007,
,N,BAO_0000219,,Compound was tested for its cytotoxicity against A 549 cell line,5736,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621297,4594,
,N,BAO_0000219,,"Cytotoxic activity against A 549 human lung tumor cell line, using sulforhodamine B (SRB) assay.",5737,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL839828,6018,
,N,BAO_0000219,,"Cytotoxic activity against A 549 human lung tumor cell line, using sulforhodamine B (SRB) assay.; No data",5738,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620397,6018,
,N,BAO_0000219,,In vitro cytotoxic activity against A 549 (non-small cell lung) using SRB (sulforhodamine B) assay,5739,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620398,3599,
,N,BAO_0000219,,Tested for in vitro cytotoxicity against A 549 (human lung) tumor cell line using sulforhodamine B (SRB) assay,5740,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620399,2551,
,N,BAO_0000219,,In vitro inhibition of A549 (human lung cancer) cell growth.,5741,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620400,16132,
,N,BAO_0000219,,Cytotoxic related antitumor activity against human cancer cell lines A 549; No data available,5742,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620401,16132,
,N,BAO_0000219,,Tested for in vitro cytotoxicity against A 549 (human lung) tumor cell line using sulforhodamine B (SRB) assay,5743,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620402,2551,
,N,BAO_0000219,,Tested for in vitro cytotoxicity against A 549 (human lung) tumor cell line using sulforhodamine B (SRB) assay; not active (> 100 uM),5744,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620403,2551,
,U,BAO_0000218,,Tested against A II at (100 ng/kg iv) in Dawley rats (n=2). 24 h,5745,Autocuration,,0,,,,,,1,,22226,F,,,CHEMBL620404,11913,
,H,BAO_0000218,,The duration of action for the % peak inhibition of A II pressor response for dose of 0.1 mg/kg intravenous administration in conscious dogs.,5746,Autocuration,,4,,In vivo,,,,1,,104694,F,,,CHEMBL620405,12621,
,H,BAO_0000218,,The duration of action for the % peak inhibition of A II pressor response for dose of 1.0 mg/kg peroral administration in rhesus monkeys.,5747,Autocuration,,4,,In vivo,,,,1,,104694,F,,,CHEMBL620406,12621,
,H,BAO_0000218,,The duration of action for the % peak inhibition of angiotensin II pressor response for dose of 0.1 mg/kg peroral administration in conscious rats.,5748,Autocuration,,4,,In vivo,,,,1,,104694,F,,,CHEMBL620407,12621,
,H,BAO_0000218,,The compound was evaluated for the % peak inhibition of A II pressor response for dose of 0.3 mg/kg peroral administration in rhesus monkeys.,5749,Autocuration,,4,,In vivo,,,,1,,104694,F,,,CHEMBL620408,12621,
,H,BAO_0000218,,The compound was evaluated for the percentage of inhibition of A II pressor response in rats for peroral administration.,5750,Autocuration,,4,,In vivo,,,,1,,104694,F,,,CHEMBL620409,12621,
,N,BAO_0000219,,Inhibition of A-498 human Renal cell proliferation,5751,Expert,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL620410,3600,
,U,BAO_0000019,,"Membrane potential change (fluorescence-based in vitro assay using DIBAC4 as indicator) in A-10 smooth muscle cell, to estimate potassium channel opening activity at 0.1 uM",5752,Autocuration,,0,,,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL620411,1796,
,U,BAO_0000019,,"Membrane potential change (fluorescence-based in vitro assay using DIBAC4 as indicator) in A-10 smooth muscle cell, to estimate potassium channel opening activity at 1 uM",5753,Autocuration,,0,,,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL620412,1796,
,U,BAO_0000019,,"Membrane potential change (fluorescence-based in vitro assay using DIBAC4 as indicator) in A-10 smooth muscle cell, to estimate potassium channel opening activity at 10 uM",5754,Autocuration,,0,,,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL876596,1796,
,N,BAO_0000219,,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,5755,Expert,,1,,,622.0,,9606.0,1,A 172,80012,F,Homo sapiens,,CHEMBL620413,16464,
,N,BAO_0000219,,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay; NE is no effect at 1x 10 E-5,5756,Intermediate,,1,,,622.0,,9606.0,1,A 172,80012,F,Homo sapiens,,CHEMBL620414,16464,
,N,BAO_0000219,,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay; NE is no effect at 1x 10 E-5,5757,Intermediate,,1,,,622.0,,9606.0,1,A 172,80012,F,Homo sapiens,,CHEMBL620415,16464,
,N,BAO_0000219,,Concentration required to inhibit growth of human tumor A549 (NSCL) cell line.,5758,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620416,13617,
,N,BAO_0000219,,Concentration which produces 50% inhibition of growth of human lung carcinoma cell line A549,5759,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620417,4584,
,N,BAO_0000219,,Cytotoxic activity evaluated against A549 tumor cells,5760,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620418,13799,
,N,BAO_0000219,,Cytotoxic potentiation of Topotecan (TP) by the compound in human lung carcinoma A549 cell line,5761,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620419,16726,
,N,BAO_0000219,,Cytotoxicity against A549 cells when the drug is exposed for a time of 1 hr,5762,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620420,16109,
,N,BAO_0000219,,Cytotoxicity against A549 cells when the drug is exposed for a time of 96 hrs,5763,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620421,16109,
,N,BAO_0000219,,Cytotoxicity against A549 tumor cell line determined by WST-1 assay,5764,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620422,15474,
,N,BAO_0000219,,Cytotoxicity of compound against A549 cell line,5765,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620423,6851,
,N,BAO_0000219,,Cytotoxicity against human lung cell carcinoma A549 cell line,5766,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620424,17534,
,N,BAO_0000219,,Cytotoxicity against human lung carcinoma A549 cell line using MTT assay,5767,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620425,2621,
,N,BAO_0000219,,Cytotoxicity was evaluated in vitro against A549 (non-small cell lung carcinoma) human tumor cell lines,5768,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620426,830,
,N,BAO_0000219,,In vitro antitumor activity against A549 human non-small lung carcinoma cells containing 10% fetal bovine serum,5769,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620427,14255,
,N,BAO_0000219,,In vitro antitumor activity against A549 human non-small lung carcinoma cells containing 10% fetal bovine serum; Not determined,5770,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620428,14255,
,N,BAO_0000219,,In vitro antitumor activity against A549 human NSCLC lung carcinoma cells,5771,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620429,1590,
,N,BAO_0000219,,In vitro concentration required to inhibit the TNF-alpha-induced RANTES production in A549 human lung epithelium cell line,5772,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620430,6146,
,N,BAO_0000219,,In vitro cytotoxicity against A549 (human lung carcinoma) cell line.,5773,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL839887,17427,
,N,BAO_0000219,,In vitro cytotoxicity against parental and drug resistant lung human tumor cell line A549,5774,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620431,5280,
,N,BAO_0000219,,In vitro cytotoxicity of compound against human A549 (non small cell lung) cancer cell line after 72 hr of drug exposure,5775,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL884010,16786,
,N,BAO_0000219,,In vitro cytotoxicity against A549 (human lung cancer),5776,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620538,5895,
,N,BAO_0000219,,In vitro cytotoxicity against A-549 (human lung carcinoma) cell line.,5777,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620539,14297,
,N,BAO_0000218,,In vivo antiproliferative activity against A549 cell line,5778,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL623373,17824,
,N,BAO_0000219,,Inhibition of non-small-cell lung adenocarcinoma (A549),5779,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL623374,14368,
,N,BAO_0000219,,Inhibition of non-small-cell lung adenocarcinoma (A549) after 48-h treatment,5780,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL623375,14368,
,N,BAO_0000219,,Inhibition of the growth against human non-small-lung carcinoma (A549) cell line after 72 hr exposure,5781,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL623376,14254,
,N,BAO_0000219,,Inhibitory activity against A549 cell line using MTT assay(Wild type p53),5782,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL623377,15897,
,N,BAO_0000219,,Inhibitory activity against A549 epithelial Cancer cell line at the concentration 0-30 uM for 48 hr,5783,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL623378,13866,
,N,BAO_0000219,,Inhibitory activity of compound against human A549 lung carcinoma cell line.,5784,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL623379,13370,
,N,BAO_0000219,,Inhibitory activity against A549 lung cancer cell line,5785,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL623380,4862,
,N,BAO_0000219,,Inhibitory activity against Taxol-resistant A549 lung cancer cell line,5786,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL623381,4862,
,N,BAO_0000219,,Inhibitory activity against Taxol-resistant A549 lung cancer cell line; not determined,5787,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL623382,4862,
,N,BAO_0000219,,Inhibitory concentration against A549 (lung cancer) cell line,5788,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL623383,15970,
,N,BAO_0000219,,In vitro cytotoxicity against A-549 (human lung carcinoma) cell line.,5789,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL623384,17713,
,N,BAO_0000219,,Tested in vitro for inhibitory effect on the growth of human A-549 cancer cell line,5790,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL623385,4833,
,N,BAO_0000219,,Activity against A549 cancer cell line.,5791,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL623386,13736,
,N,BAO_0000219,,The compound was evaluated for cytotoxicity against A549 cell line,5792,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL884105,4312,
,N,BAO_0000219,,The compound was examined for its ability to block tumor necrosis factor alpha (TNF alpha) induced IL-8 production in A549 human lung carcinoma cell line using an ELISA,5793,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL623387,5421,
,N,BAO_0000219,,The compound was tested for its ability to inhibit tumor necrosis factor alpha (TNF alpha) induced apoptosis in A549 human lung carcinoma cell line,5794,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621568,5421,
,N,BAO_0000219,,Growth inhibitory activity was measured for human A549 tumor cell line.,5795,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621569,14717,
,N,BAO_0000219,,Inhibitory activity against A549 lung cancer cell line,5796,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621570,4634,
,N,BAO_0000219,,Inhibitory activity against A549 cell line; inactive,5797,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621571,1149,
,N,BAO_0000219,,Inhibition of NFkB (transcription factor) activation in A549 human lung carcinoma cell line at 20 uM,5798,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621572,5421,
,N,BAO_0000219,,Inhibition of NFkB (transcription factor) activation in A549 human lung carcinoma cell line at 20 uM,5799,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621573,5421,
,N,BAO_0000219,,Compound was tested for its ability to inhibit tumor necrosis factor alpha (TNF alpha) induced apoptosis in A549 human lung carcinoma cell line at 20 uM concentration,5800,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621574,5421,
,N,BAO_0000219,,In vitro cytotoxic activity against A549 tumor cell line by SRB assay at 72 hour at a concentration 10E-4 (M/L),5801,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621575,3320,
,N,BAO_0000219,,In vitro cytotoxic activity against A549 tumor cell line by SRB assay at 72 hour at a concentration 10E-5 (M/L),5802,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621576,3320,
,N,BAO_0000219,,In vitro cytotoxic activity against A549 tumor cell line by SRB assay at 72 hour at a concentration 10E-6 (M/L),5803,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621577,3320,
,N,BAO_0000219,,In vitro cytotoxic activity against A549 tumor cell line by SRB assay at 72 hour at a concentration 10E-7 (M/L),5804,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621578,3320,
,N,BAO_0000219,,In vitro cytotoxic activity against A549 tumor cell line by SRB assay at 72 hour at a concentration 10E-8 (M/L),5805,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621579,3320,
,N,BAO_0000219,,In vitro percent inhibition evaluated against human lung cancer (A549 cell line) at >20 ug/mL,5806,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621580,5726,
,N,BAO_0000218,,Plasma clearance (in vivo) in mongrel dogs was determined,5807,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621581,17800,
,N,BAO_0000218,,Plasma clearance was measured in dog,5808,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621582,5985,
,N,BAO_0000218,,Plasma clearance in vivo in dog by intravenous administration at a dose of 0.2 mg/kg,5809,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621583,5530,
,N,BAO_0000218,,Plasma clearance in vivo in dog by intravenous administration at a dose of 1 mg/kg,5810,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621584,5530,
,N,BAO_0000218,,Tested for plasma clearance in dog,5811,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621585,4839,Plasma
,N,BAO_0000218,,The compound was tested for clearance in dog plasma.,5812,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621586,3639,
,N,BAO_0000218,,"The pharmacokinetic parameter, clearance was reported in dog after intravenous administration",5813,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL875835,4838,
,N,BAO_0000218,,Clearance value of compound was determined after intravenous administration of 1 mg/kg/h in dog,5814,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621587,4137,
,N,BAO_0000218,,Compound was tested for its ability of plasma clearance when administered in dog perorally (1 mg/kg) and intravenously (0.2 mg/kg),5815,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621588,5017,Plasma
,N,BAO_0000218,,In vitro clearance in dog liver microsomes,5816,Intermediate,2107.0,1,Microsomes,In vitro,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621589,17538,Liver
,N,BAO_0000218,,Pharmacokinetic profile in terms of clearance was determined at a dose of 0.5 mg/kg administered intravenously in dog,5817,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621590,6161,
,N,BAO_0000218,,Pharmacokinetic profile in terms of clearance was determined at a dose of 5 mg/kg administered intravenously in dog,5818,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621591,6161,
,N,BAO_0000218,,Plasma clearance in dog,5819,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621592,1696,
,N,BAO_0000218,,Clearance rate in dog,5820,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621593,6762,
,N,BAO_0000218,,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,5821,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621594,5932,Plasma
,N,BAO_0000218,,Clearance in dogs,5822,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621595,6305,
,N,BAO_0000218,,Plasma clearance in dogs,5823,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621596,4942,
,N,BAO_0000218,,Plasma clearance was determined,5824,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621597,4219,
,N,BAO_0000218,,Lower clearance in dog (i.v.) at 0.5 mpk,5825,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621598,17853,
,N,BAO_0000218,,Plasma clearance in Beagle dogs,5826,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621599,4514,
,N,BAO_0000218,,Plasma clearance (Clp) in dog,5827,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL875836,6448,
,N,BAO_0000218,,Plasma clearance (pharmacokinetic parameter) in dog (in vivo) at a dose of 1 mg/kg,5828,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621600,6227,
,N,BAO_0000218,,Plasma clearance (pharmacokinetic parameter) in dog was determined,5829,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621601,6227,
,N,BAO_0000218,,Plasma clearance for the compound was measured in dog after an iv dose of 1 mg/kg,5830,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618474,6062,
,N,BAO_0000218,,Plasma clearance of compound was determined in dog,5831,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618475,6821,
,N,BAO_0000218,,Plasma clearance after intravenous administration of 1 mg/kg in dog,5832,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624524,4709,
,N,BAO_0000218,,Plasma clearance in dog after 2 mg/kg by oral and 0.5 mg/kg by intravenous administration,5833,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624525,4521,
,N,BAO_0000218,,Plasma clearance in dog was determined,5834,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624526,5374,
,N,BAO_0000218,,Plasma clearance was calculated in dog,5835,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624527,6057,
,N,BAO_0000218,,Plasma clearance at the dose of 2 mg/kg in dog,5836,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624528,4727,
,N,BAO_0000218,,Plasma clearance in dog,5837,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624529,5145,
,N,BAO_0000218,,Plasma clearance in dog,5838,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624530,17657,
,N,BAO_0000218,,Plasma clearance in dog; Unable to calculate,5839,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624531,17657,
,N,BAO_0000218,,Plasma clearance in rhesus monkey,5840,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624532,5145,
,N,BAO_0000218,,Plasma clearance in dog (dosed as a mixture of five compounds at 0.5 mpk each via iv only),5841,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624533,6642,
,N,BAO_0000218,,Plasma clearance in dog (dosed at 0.5 mpk iv and 2.0 mpk orally),5842,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624534,6641,
,N,BAO_0000218,,Plasma clearance in dog (dosed at 0.5 mpk iv and 2.0 mpk orally),5843,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624535,6642,
,N,BAO_0000218,,Plasma clearance was evaluated in dog,5844,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624536,5472,
,N,BAO_0000218,,Plasma clearance was evaluated in dog; Not tested,5845,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624537,5472,
,N,BAO_0000218,,Plasma clearance was evaluated in rhesus,5846,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624538,5472,
,N,BAO_0000218,,Plasma clearance was evaluated in rhesus; Not tested,5847,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624539,5472,
,N,BAO_0000218,,Plasma clearance value was determined in dog after a 3 mg/kg of iv dose,5848,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624540,4257,
,N,BAO_0000218,,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,5849,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624541,6679,
,N,BAO_0000218,,Plasma clearance was determined in Beagle dog at a dose of 1 mg/kg by iv administration,5850,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624542,5546,
,N,BAO_0000218,,Plasma clearance was determined in dog after 1 mg/kg (i.v.) and 5 mg/kg (p.o.) administration,5851,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624543,6348,
,N,BAO_0000218,,Clearance value at a dose of 0.2 mg/kg i.v.,5852,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624544,5474,
,N,BAO_0000218,,Cmax (Maximum (Peak) plasma drug concentration) was after oral administration at 5 mg/kg,5853,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624545,6316,Plasma
,N,BAO_0000218,,Cmax after oral dose of compound at 3 mg/kg in dogs,5854,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624546,17594,
,N,BAO_0000218,,Cmax after single intravenous bolus of 1 mg/kg in dogs,5855,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL875957,17594,
,N,BAO_0000218,,Cmax of compound after both po and iv administration at a dose of 5 mg/kg and 2 mg/kg resp in dog,5856,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624547,5802,
,N,BAO_0000218,,Cmax in dog after administration of 0.25 mg/kg iv; ND = not determined,5857,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624548,6535,
,N,BAO_0000218,,Cmax in dog after administration of 1 mg/kg iv,5858,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624549,6535,
,N,BAO_0000218,,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in dog,5859,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624550,1466,Plasma
,N,BAO_0000218,,Cmax on p.o. administration of 10 mg/kg was measured in dog,5860,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621613,6505,
,N,BAO_0000218,,Cmax was determine after peroral administration at 10 mpk in dog,5861,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621614,5668,
,N,BAO_0000218,,Cmax was determine after peroral administration at 5 mpk in dog,5862,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623431,5668,
,N,BAO_0000218,,Cmax was determine after peroral administration at 5 mg/kg in dog,5863,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623432,5668,
,N,BAO_0000218,,Cmax after 0.3 mg/kg po administration in dog,5864,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623433,5600,
,N,BAO_0000218,,Cmax after peroral administration in dogs at 2.4 uM/kg,5865,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623434,17764,
,N,BAO_0000218,,Cmax in dog after oral administration at 1 mg/kg,5866,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623435,6123,
,N,BAO_0000218,,Cmax in dog after oral administration at 1 mg/kg; Below the level of quantitation,5867,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623436,6123,
,N,BAO_0000218,,Cmax upon oral administration in male Beagle dog at 10 mg/kg,5868,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL875958,6757,
,N,BAO_0000218,,Cmax value after 15 mg/kg iv dose in Dogs,5869,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623437,16907,
,N,BAO_0000218,,Biodistribution in blood was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,5870,Intermediate,178.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623438,7767,Blood
,N,BAO_0000218,,Biodistribution in blood was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,5871,Intermediate,178.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623439,7767,Blood
,N,BAO_0000218,,Biodistribution in bone was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,5872,Intermediate,10000001.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623440,7767,Bone
,N,BAO_0000218,,Biodistribution in bone was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,5873,Intermediate,10000001.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623441,7767,Bone
,N,BAO_0000218,,Biodistribution in bone was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,5874,Intermediate,10000001.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623442,7767,Bone
,N,BAO_0000218,,Biodistribution in fat and fur was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,5875,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623469,7767,
,N,BAO_0000218,,Biodistribution in fat and fur was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,5876,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623470,7767,
,N,BAO_0000218,,Biodistribution in fat and fur was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,5877,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623471,7767,
,N,BAO_0000218,,Biodistribution in heart was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,5878,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623472,7767,Heart
,N,BAO_0000218,,Biodistribution in heart was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,5879,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623473,7767,Heart
,N,BAO_0000218,,Biodistribution in heart was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,5880,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623474,7767,Heart
,N,BAO_0000218,,Biodistribution in kidney was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,5881,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623475,7767,Kidney
,N,BAO_0000218,,Biodistribution in kidney was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,5882,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623476,7767,Kidney
,N,BAO_0000218,,Biodistribution in kidney was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,5883,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623477,7767,Kidney
,N,BAO_0000218,,Biodistribution in large intestine after iv administration at 1 hr; Value expressed as percent injected dose per gram,5884,Intermediate,160.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621896,7767,Intestine
,N,BAO_0000218,,Biodistribution in large intestine was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,5885,Intermediate,160.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621897,7767,Intestine
,N,BAO_0000218,,Biodistribution in large intestine was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,5886,Intermediate,160.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621898,7767,Intestine
,N,BAO_0000218,,Biodistribution in liver was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,5887,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621899,7767,Liver
,N,BAO_0000218,,Biodistribution in liver was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,5888,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621900,7767,Liver
,N,BAO_0000218,,Biodistribution in liver was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,5889,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621901,7767,Liver
,N,BAO_0000218,,Biodistribution in lung was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,5890,Intermediate,2048.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621902,7767,Lung
,N,BAO_0000218,,Biodistribution in lung was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,5891,Intermediate,2048.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621903,7767,Lung
,N,BAO_0000218,,Biodistribution in lung was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,5892,Intermediate,2048.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622587,7767,Lung
,N,BAO_0000218,,Biodistribution in muscle was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,5893,Intermediate,2385.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620285,7767,Muscle tissue
,N,BAO_0000218,,Biodistribution in muscle was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,5894,Intermediate,2385.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL875285,7767,Muscle tissue
,N,BAO_0000218,,Biodistribution in muscle was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,5895,Intermediate,2385.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620286,7767,Muscle tissue
,N,BAO_0000218,,Biodistribution in pancreatic tissue was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,5896,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620287,7767,
,N,BAO_0000218,,Biodistribution in pancreatic tissue was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,5897,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620288,7767,
,N,BAO_0000218,,Biodistribution in pancreatic tissue was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,5898,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620289,7767,
,N,BAO_0000218,,Biodistribution in small intestine was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,5899,Intermediate,160.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620290,7767,Intestine
,N,BAO_0000218,,Biodistribution in small intestine was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,5900,Intermediate,160.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620291,7767,Intestine
,N,BAO_0000218,,Biodistribution in small intestine was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,5901,Intermediate,160.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620292,7767,Intestine
,N,BAO_0000218,,Biodistribution in spleen was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,5902,Intermediate,2106.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620293,7767,Spleen
,N,BAO_0000218,,Biodistribution in spleen was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,5903,Intermediate,2106.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL620294,7767,Spleen
,N,BAO_0000218,,Biodistribution in spleen was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,5904,Intermediate,2106.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618614,7767,Spleen
,N,BAO_0000218,,Biodistribution in stomach was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,5905,Intermediate,945.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618615,7767,Stomach
,N,BAO_0000218,,Biodistribution in stomach was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,5906,Intermediate,945.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618616,7767,Stomach
,N,BAO_0000219,,Cytotoxicity against A-172 human tumor cell lines,5907,Expert,,1,,,622.0,,9606.0,1,A 172,80012,F,Homo sapiens,,CHEMBL618617,2036,
,N,BAO_0000219,,Compound was evaluated for the in vitro cytotoxicity against A-172 human glioblastoma cell line,5908,Intermediate,,1,,,622.0,,9606.0,1,A 172,80012,F,Homo sapiens,,CHEMBL618618,2357,
,N,BAO_0000219,,Antiproliferative activity of compound was tested against rhabdomyosarcoma (A-204) human tumor cells,5909,Intermediate,,1,,,623.0,,9606.0,1,A204,80014,F,Homo sapiens,,CHEMBL618619,1457,
,N,BAO_0000219,,Tested for antiproliferative activity against A-2780 tumoral cell line,5910,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618620,4379,
,N,BAO_0000219,,Inhibitory concentration against melanoma A-375 cell line for cytotoxicity was determined,5911,Intermediate,,1,,,455.0,,9606.0,1,A-375,80018,F,Homo sapiens,,CHEMBL618621,1093,
,N,BAO_0000219,,Tested in vitro against A-375 cell line human melanoma,5912,Intermediate,,1,,,455.0,,9606.0,1,A-375,80018,F,Homo sapiens,,CHEMBL618622,12152,
,N,BAO_0000219,,Cytotoxicity against A-427 nonsmall lung cell line using MTT colorimetric assay,5913,Expert,,1,,,797.0,,9606.0,1,A-427,80019,F,Homo sapiens,,CHEMBL618623,16464,
,N,BAO_0000219,,Cytotoxicity against A-427 nonsmall lung cell line using MTT colorimetric assay; NE is no effect at 1x 10 E-5,5914,Intermediate,,1,,,797.0,,9606.0,1,A-427,80019,F,Homo sapiens,,CHEMBL618624,16464,
,N,BAO_0000219,,In vitro cytotoxicity against human non small-cell-lung cell line A-427.,5915,Expert,,1,,,797.0,,9606.0,1,A-427,80019,F,Homo sapiens,,CHEMBL618625,16582,
,N,BAO_0000219,,Cytotoxicity against A-427 nonsmall lung cell line using MTT colorimetric assay; NE is no effect at 1x 10 E-5,5916,Intermediate,,1,,,797.0,,9606.0,1,A-427,80019,F,Homo sapiens,,CHEMBL618626,16464,
,N,BAO_0000219,,Antitumor activity on A-427 lung carcinoma cell lines,5917,Intermediate,,1,,,797.0,,9606.0,1,A-427,80019,F,Homo sapiens,,CHEMBL618627,10413,
,N,BAO_0000219,,Cytotoxic activity against human A-427 lung tumor cell line,5918,Intermediate,,1,,,797.0,,9606.0,1,A-427,80019,F,Homo sapiens,,CHEMBL618628,6418,
,N,BAO_0000219,,In vitro antitumor effects against human A-427 cell lines.,5919,Expert,,1,,,797.0,,9606.0,1,A-427,80019,F,Homo sapiens,,CHEMBL618629,17134,
,N,BAO_0000219,,In vitro inhibition of A-427 (human lung cancer) cell growth.,5920,Expert,,1,,,797.0,,9606.0,1,A-427,80019,F,Homo sapiens,,CHEMBL618630,16132,
,N,BAO_0000219,,Cytotoxic related antitumor activity against human cancer cell lines A-427; No data available,5921,Intermediate,,1,,,797.0,,9606.0,1,A-427,80019,F,Homo sapiens,,CHEMBL618631,16132,
,N,BAO_0000219,,Cytotoxic activity of compound against A-427 lung human tumor cell line,5922,Intermediate,,1,,,797.0,,9606.0,1,A-427,80019,F,Homo sapiens,,CHEMBL618632,16780,
,N,BAO_0000219,,Cytotoxicity measured for the growth inhibition of A-431 Human epidermoid carcinoma cell line,5923,Expert,,1,,,500.0,,9606.0,1,A-431,80852,F,Homo sapiens,,CHEMBL618633,4085,
,N,BAO_0000219,,Cytotoxic activity was tested against human A-498 (Kidney carcinoma) cell line,5924,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL619315,1276,
,N,BAO_0000219,,Cytotoxicity against A-498 cell line in the purdue cell culture screen was determined,5925,Expert,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL619316,3498,
,N,BAO_0000219,,Cytotoxicity against human kidney carcinoma A-498cell lines,5926,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL619317,1169,
,N,BAO_0000219,,In vitro cytotoxic activity against A-498 (human kidney carcinoma) cell line,5927,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL619318,4450,
,N,BAO_0000219,,In vitro cytotoxicity against Renal A-498 human tumors following a 6 day exposure.,5928,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL619319,3311,
,N,BAO_0000219,,Antitumor cytotoxic activity against A-498 cell line was determined,5929,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL619739,4461,
,N,BAO_0000219,,In vitro cytotoxicity against Renal A-498 human tumors following a 2 day exposure.,5930,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL619740,3311,
,N,BAO_0000219,,In vitro cytotoxicity against Renal A-498 human tumors following a 2 day exposure; ND is no data,5931,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL883158,3311,
,N,BAO_0000219,,Antiproliferative activity of compound was tested against renal cancer (A-498) human tumor cells,5932,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL884012,1457,
,N,BAO_0000219,,In vitro inhibitory activity against A-498 ovarian cancer cell lines,5933,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL619741,3664,
,N,BAO_0000219,,"Cytotoxicity against NCI tumor panel, A-498 renal cancer cell line",5934,Intermediate,,1,,,624.0,,9606.0,1,A498,80021,F,Homo sapiens,,CHEMBL619742,15895,
,N,BAO_0000219,,Inhibition of growth lung non-small cell carcinoma A-549 cell line,5935,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL876610,11843,
,N,BAO_0000219,,Inhibition of growth of lung non-small cell carcinoma A-549 cell line,5936,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619743,11843,
,N,BAO_0000219,,In vitro antiproliferative activity against human A-549 NSCL cell line,5937,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619744,17705,
,N,BAO_0000219,,In vitro antiproliferative activity against human A-549 NSCL cell line; NS = Not significant,5938,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619745,17705,
,N,BAO_0000219,,Growth inhibition of A-549 human lung adenocarcinoma at 0.01 uM compound concentration in standard MTT assay,5939,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619746,4369,
,N,BAO_0000219,,Percent growth inhibition of A-549 human lung adenocarcinoma at 10e-6 M compound concentration in standard MTT assay,5940,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619747,4369,
,N,BAO_0000219,,Percent growth inhibition of A-549 human lung adenocarcinoma at 10e-6 M compound concentration in standard MTT assay; ND means No data,5941,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619748,4369,
,N,BAO_0000219,,Percent growth inhibition of A-549 human lung adenocarcinoma at 10e-7 M compound concentration in standard MTT assay,5942,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619749,4369,
,N,BAO_0000219,,Percent growth inhibition of A-549 human lung adenocarcinoma at 10e-7 M compound concentration in standard MTT assay; ND means No data,5943,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619750,4369,
,N,BAO_0000219,,Percent growth inhibition of A-549 human lung adenocarcinoma at 10e-8 M compound concentration in standard MTT assay,5944,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624014,4369,
,N,BAO_0000219,,Percent growth inhibition of A-549 human lung adenocarcinoma at 10e-8 M compound concentration in standard MTT assay; ND means No data,5945,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624015,4369,
,N,BAO_0000219,,In vitro effective concentration required to reduce the number of human lung carcinoma (A-549) after 3-day incubation,5946,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL885344,4787,
,N,BAO_0000219,,In vitro effective concentration required to reduce the number of human lung carcinoma cells (A-549) after 3-day incubation,5947,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL623224,4787,
,N,BAO_0000219,,Cytotoxic activity against A-549 cell line,5948,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL623225,6513,
,N,BAO_0000219,,Antitumor cytotoxicity was determined against the A-549(human lung carcinoma) cell line; Range: 0.01 to 0.03,5949,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL622698,6690,
,N,BAO_0000219,,Antitumor cytotoxicity was determined against the A-549(human lung carcinoma) cell line; Range: 10.4 to 118.1,5950,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL622699,6690,
,N,BAO_0000219,,"Cytotoxicity in vitro expressed as 50% reduction in cell number after a 3-day incubation, in human lung carcinoma A-549 cell line",5951,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL622700,12263,
,N,BAO_0000219,,Compound was tested for cytotoxic activity against human lung carcinoma (A-549),5952,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL622701,1054,
,N,BAO_0000219,,Compound was tested for its cytotoxic activity in MTT assay against A-549 cell line (human lung carcinoma),5953,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL622702,1359,
,N,BAO_0000219,,Cytotoxic activity against human lung carcinoma (A-549) cell line,5954,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL622703,3547,
,N,BAO_0000219,,Cytotoxic activity towards A-549 cells,5955,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL622704,5771,
,N,BAO_0000219,,"In vitro percent inhibition of A549, lung carcinoma.",5956,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL622705,14425,
,N,BAO_0000219,,"In vitro percent inhibition of A549, lung carcinoma",5957,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL622706,14425,
,N,BAO_0000219,,"In vitro percent inhibition of A549, lung carcinoma.",5958,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL622707,14425,
,N,BAO_0000219,,"In vitro percent inhibition of A549, lung carcinoma.; Range 18-23",5959,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL622708,14425,
,N,BAO_0000219,,Percentage inhibition against parental and drug resistant lung human tumor cell line A549 at 10 uM,5960,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL622709,5280,
,N,BAO_0000219,,Growth inhibition of the A549/ATCC non-small cell lung cancer cell line for 2-day in vitro assay.,5961,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL622710,15176,
,N,BAO_0000219,,In vitro antitumor activity against Non-small cell lung cancer A549/ATCC cell lines by 6-day assay,5962,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL622711,15300,
,N,BAO_0000218,,"Antitumor activity against A549 non small cell carcinoma at dose range of 1.56-6.25 mg/kg on day 14, 21, 28; activity expressed as maximum tolerated dose",5963,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL622712,17824,
,N,BAO_0000218,,"Antitumor activity against A549 non small cell carcinoma at dose range of 25-100 mg/kg on day 14, 21, 28; activity expressed as maximum tolerated dose",5964,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL622713,17824,
,N,BAO_0000218,,"Antitumor activity against A549 non small cell carcinoma at dose range of 3.12-12.5 mg/kg on day 14, 21, 28; activity expressed as maximum tolerated dose",5965,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL622714,17824,
,N,BAO_0000218,,"Antitumor activity against A549 non small cell carcinoma at dose range of 6.25-25 mg/kg on day 14, 21, 28; activity expressed as maximum tolerated dose",5966,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL622715,17824,
,N,BAO_0000218,,"Antitumor activity against A549 non small cell carcinoma at dose range of 70-100 mg/kg on day 14, 21, 28; activity expressed as maximum tolerated dose",5967,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL622716,17824,
,N,BAO_0000219,,"Antitumor activity against A549 non small cell carcinoma on day 14, 21, 28; activity expressed as maximum tolerated dose; NT = Not tested",5968,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL622717,17824,
,N,BAO_0000218,,Optimal dose required to inhibit human non small cell lung A549 tumor growth after subcutaneous transplantation on athymic mice at 10 mg/kg (treatment schedule: q7dX3),5969,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL622718,17528,
,N,BAO_0000219,,Cytotoxic potentiation factor of temoxolomide in human A549 tumor cell line at 0.4 uM concentration,5970,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL622719,6870,
,N,BAO_0000219,,Compound was evaluated for cytotoxic potentiation factor of temoxolomide in human A549 tumor cell line at 0.4 uM concentration; ND - not determined,5971,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL622720,6870,
,N,BAO_0000219,,Compound was evaluated for cytotoxic potentiation factor of topotecan in human A549 tumor cell line at 0.4 uM concentration,5972,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL622721,6870,
,N,BAO_0000219,,Compound was evaluated for cytotoxic potentiation factor of topotecan in human A549 tumor cell line at 0.4 uM concentration; ND - not determined,5973,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL622722,6870,
,N,BAO_0000219,,Cytotoxicity potentiation of Topotecan in human lung carcinoma A549 cells by the compound as potentiation factor at 50% growth inhibition,5974,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL876030,16726,
,N,BAO_0000219,,"Concentration required for 50% inhibition of proliferation of lung cancer cell line, A549 with respect to paclitaxel was tested in vitro after 72 hr of incubation",5975,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620206,6170,
,N,BAO_0000219,,Inhibition ratio against A-549 cancer cell growth at a concentration of 10e-4 mol/L,5976,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620207,6583,
,N,BAO_0000219,,Inhibition ratio against A-549 cancer cell growth at a concentration of 10e-5 mol/L,5977,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620208,6583,
,N,BAO_0000219,,Inhibition ratio against A-549 cancer cell growth at a concentration of 10e-6 mol/L,5978,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620209,6583,
,N,BAO_0000219,,Inhibition ratio against A-549 cancer cell growth at a concentration of 10e-7 mol/L,5979,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620210,6583,
,N,BAO_0000219,,Inhibition ratio against A-549 cancer cell growth at a concentration of 10e-8 mol/L,5980,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621639,6583,
,N,BAO_0000219,,Tested for cytotoxicity against human lung adenocarcinoma A549 cell line,5981,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621640,17321,
,N,BAO_0000219,,Percentage tumor growth inhibition was calculated in respect to controls one week after the end of the treatment,5982,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621641,17528,
,N,BAO_0000219,,Cytotoxic effect on non-small-cell lung cancer cell line A549/ATCC,5983,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621642,12888,
,N,BAO_0000219,,Cytotoxicity of compound in synergy in 94% BCNU (10 uM) against A549 cell line,5984,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621643,4312,
,N,BAO_0000219,,Cytotoxicity of compound in synergy in BCNU (10 uM) against A549 cell line,5985,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621644,4312,
,N,BAO_0000219,,Cytotoxicity of compound in synergy in BCNU (10 uM) against A549 cell line; No data,5986,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL621645,4312,
,N,BAO_0000219,,In vitro antiproliferative activity against A549 cell line,5987,Intermediate,,1,,,646.0,,10090.0,1,A549,80682,F,Mus musculus,,CHEMBL621646,17737,
,N,BAO_0000219,,Synergism with indomethacin in A549 cells,5988,Intermediate,,1,,,646.0,,,1,A549,80682,F,,,CHEMBL621647,6630,
,N,BAO_0000219,,Synergism with tolmetin in A549 cells,5989,Intermediate,,1,,,646.0,,,1,A549,80682,F,,,CHEMBL621648,6630,
,N,BAO_0000219,,Synergism with sulindac in A549 cells,5990,Intermediate,,1,,,646.0,,,1,A549,80682,F,,,CHEMBL621649,6630,
,N,BAO_0000219,,Antagonism of indomethacin in A549 cells,5991,Intermediate,,1,,,646.0,,,1,A549,80682,F,,,CHEMBL621650,6630,
,N,BAO_0000219,,Antagonism of sulindac in A549 cells,5992,Intermediate,,1,,,646.0,,,1,A549,80682,F,,,CHEMBL621651,6630,
,N,BAO_0000219,,Antagonism of tolmetin in A549 cells,5993,Intermediate,,1,,,646.0,,,1,A549,80682,F,,,CHEMBL621652,6630,
,N,BAO_0000219,,Synergism with indomethacin in A549 cells,5994,Intermediate,,1,,,646.0,,,1,A549,80682,F,,,CHEMBL621653,6630,
,N,BAO_0000219,,Synergism with sulindac in A549 cells,5995,Intermediate,,1,,,646.0,,,1,A549,80682,F,,,CHEMBL621654,6630,
,N,BAO_0000219,,Drug interaction towards A549 cell line was determined in terms of combination index in presence of Tolmetin; Not available,5996,Intermediate,,1,,,646.0,,,1,A549,80682,F,,,CHEMBL621655,6630,
,N,BAO_0000218,,Cmax value after 30 mg/kg po dose in Dogs,5997,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621656,16907,
,N,BAO_0000218,,Cmax value determined in dog at a dose of 0 mg/kg by oral administration along with indavir (10 mg/kg),5998,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621657,5944,
,N,BAO_0000218,,Cmax value determined in dog at a dose of 10 mg/kg by oral administration,5999,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621658,5944,
,N,BAO_0000218,,Cmax value determined in dog at a dose of 10 mg/kg by oral administration along with indavir (10 mg/kg),6000,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621659,5944,
,N,BAO_0000218,,Cmax value determined in dog at a dose of 5 mg/kg by oral administration,6001,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621660,5944,
,N,BAO_0000218,,Cmax value after administration of 4 mg/Kg oral dose in dog,6002,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621661,2959,
,N,BAO_0000218,,Cmax value in dog,6003,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621662,6241,
,N,BAO_0000218,,Cmax value in dogs after oral administration at 1 mg/kg,6004,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621663,6241,
,N,BAO_0000218,,Bioavailability as Cmax in dogs at 5 mg/kg oral dose,6005,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621664,2652,
,N,BAO_0000218,,Compound was evaluated for maximum observed plasma concentration at dose 27.5 mg/kg DMP323 equiv in dogs,6006,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621665,1806,Plasma
,N,BAO_0000218,,Compound was evaluated for maximum observed plasma concentration at dose 7.7 mg/kg DMP323 equiv in dogs,6007,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621666,1806,Plasma
,N,BAO_0000218,,Concentration maxima after oral dosing in dogs,6008,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621667,1021,
,N,BAO_0000218,,Concentration maxima after oral dosing in dogs; not available,6009,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL876738,1021,
,N,BAO_0000218,,Concentration maxima after oral dosing in dogs; not available,6010,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621668,1021,
,N,BAO_0000218,,In vivo maximal concentration was calculated at 0.4 mg/kg in dog; Not absorbed,6011,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621669,5444,
,N,BAO_0000218,,In vivo maximal concentration was calculated at 0.6 mg/kg in dog; Not absorbed,6012,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621670,5444,
,N,BAO_0000218,,In vivo maximal concentration was calculated at 1 mg/kg in dog,6013,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621671,5444,
,N,BAO_0000218,,In vivo maximal concentration was calculated at 1 mg/kg in dog; Not absorbed,6014,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622360,5444,
,N,BAO_0000218,,In vivo maximal concentration was calculated at 1 mg/kg in dog; Poor absorption,6015,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622361,5444,
,N,BAO_0000218,,Cmax in dog plasma after oral dose (1 mg/kg),6016,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622362,5130,Plasma
,N,BAO_0000218,,Maximal concentration (Cmax) in dog plasma at a dose of 5 mg/kg,6017,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622363,3249,Plasma
,N,BAO_0000218,,Maximal plasma concentration at a dose of 1 mg/kg,6018,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622364,5473,Plasma
,N,BAO_0000218,,Maximal plasma concentration at a dose of 1 mg/kg (oral),6019,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622365,5474,Plasma
,N,BAO_0000218,,Maximal plasma concentration required for pharmacokinetic data in dogs at dose of 1 mg/kg perorally,6020,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622533,4657,Plasma
,N,BAO_0000218,,Maximum concentration of compound in dog was evaluated.,6021,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622534,3031,
,N,BAO_0000218,,Maximum concentration by oral administration at a dose of 10 uM/kg in dog was determined,6022,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622535,4527,
,N,BAO_0000218,,Maximum concentration in dog after administration of 20 mg/kg dose through peroral route,6023,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL876739,4186,
,N,BAO_0000218,,Maximum concentration in dogs administered perorally (5 mg/kg) and intravenously (2 mg/kg),6024,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622536,5007,
,N,BAO_0000218,,Maximum concentration obtained in dog plasma was determined,6025,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622537,3132,Plasma
,N,BAO_0000218,,Maximum concentration was determined,6026,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622538,5006,
,N,BAO_0000218,,Maximum concentration at the dose of 2 mg/kg in dog,6027,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL627867,4727,
,N,BAO_0000218,,Maximum concentration was evaluated against Beagle dog at a dose of 15 mg/kg after po administration,6028,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL627868,1916,
,N,BAO_0000218,,Maximum concentration was evaluated in dog plasma,6029,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL627869,1918,Plasma
,N,BAO_0000218,,Maximum concentration was evaluated after 75 min after administration in dog,6030,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL627870,3045,
,N,BAO_0000218,,Maximum plasma concentration determined in dog after oral administration of 17b,6031,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL627871,9579,Plasma
,N,BAO_0000218,,Maximum plasma concentration determined in dog after oral administration of 2b,6032,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL627872,9579,Plasma
,N,BAO_0000218,,Maximum plasma concentration in dog,6033,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL627873,933,Plasma
,N,BAO_0000218,,Maximum plasma concentration of compound in dog following p.o. administration of 0.5 mg/kg,6034,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL627874,17839,Plasma
,N,BAO_0000218,,Maximum plasma concentration of compound in dog following p.o. administration of 0.9 mg/kg,6035,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL627875,17839,Plasma
,N,BAO_0000218,,Maximum plasma concentration of compound in dog following p.o. administration of 0.95 mg/kg,6036,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL627876,17839,Plasma
,N,BAO_0000218,,Maximum plasma concentration of compound in dog following p.o. administration of 1 mg/kg,6037,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL627877,17839,Plasma
,N,BAO_0000218,,Maximum plasma concentration of compound was determined in dog after 1 mg/kg (i.v.) and 5 mg/kg (p.o.) administration,6038,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL627878,6348,Plasma
,N,BAO_0000218,,Maximum plasma concentration after oral administration to dogs at a dose of 10 mg/kg,6039,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL627879,16367,Plasma
,N,BAO_0000218,,Maximum plasma concentration in dogs after oral administration (10 mg/kg) as a 0.05 M citric acid solution.,6040,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL875355,1337,Plasma
,N,BAO_0000218,,Maximum plasma concentration in dogs after oral administration (8 mg/kg) as a 0.05 M citric acid solution.,6041,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL627880,1337,Plasma
,N,BAO_0000218,,Maximum plasma concentration at a 1 mg/kg oral dose in male and female Beagle dogs.,6042,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL627881,5199,Plasma
,N,BAO_0000218,,Maximum plasma concentration was measured in dogs after an oral dose of 10 uM/kg,6043,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL627882,17650,Plasma
,N,BAO_0000218,,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,6044,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL627883,6679,Plasma
,N,BAO_0000218,,Maximum plasma concentration was determined as in dogs at 1 mg/kg oral dosing Cmax; 0.05-0.2 ug/mL,6045,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL628526,5356,Plasma
,N,BAO_0000218,,Maximum plasma concentration was determined in dogs at 1 mg/kg oral dosing; 0.05-0.2 ug/mL,6046,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL628527,5356,Plasma
,N,BAO_0000218,,Maximum plasma concentration (Cmax) in dog (in vivo) at a dose of 1 mg/kg,6047,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL628528,6227,Plasma
,N,BAO_0000218,,Maximum plasma concentration (Cmax) in dog at a dose of 0.5 mg/kg,6048,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL628529,6227,Plasma
,N,BAO_0000218,,Maximum plasma concentration (Cmax) in dog at a dose of 0.7 mg/kg,6049,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL628530,6227,Plasma
,N,BAO_0000218,,Maximum plasma concentration (Cmax) in dog at a dose of 1 mg/kg,6050,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625243,6227,Plasma
,N,BAO_0000218,,Maximum plasma drug concentration of compound determined in dog after iv administration at a dose of 10 mg/kg,6051,Expert,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625244,3598,Plasma
,N,BAO_0000218,,Maximum concentration by intravenous administration of 1.2 mg/kg in dog,6052,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625245,4368,
,N,BAO_0000218,,Pharmacokinetic (PK) property (Cmax) was determined in dog at the single dose of 1 mg/kg,6053,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625246,6265,
,N,BAO_0000218,,Biodistribution in stomach was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,6054,Intermediate,945.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625247,7767,Stomach
,N,BAO_0000218,,Biodistribution in urine was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,6055,Intermediate,1088.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625248,7767,Urine
,N,BAO_0000218,,Biodistribution in urine was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram; ND- No data,6056,Intermediate,1088.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625249,7767,Urine
,N,BAO_0000218,,Biodistribution in urine was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram; ND- No data,6057,Intermediate,1088.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625250,7767,Urine
,N,BAO_0000218,,Compound (0.09% dose/g) was tested for accumulation in mice bone (Compound is radiolabeled) after 120 min; No increase,6058,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625251,17811,
,N,BAO_0000218,,Compound (0.31% dose/g) was tested for accumulation in mice bone (Compound is radiolabeled) after 30 min; Low increase,6059,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL875356,17811,
,N,BAO_0000218,,Compound (i.v.) was tested for maximum activity in mice (Radiolabeled compound),6060,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625252,17827,
,N,BAO_0000218,,Compound was evaluated for elimination rate constants in vivo in whole blood of normal mice (Radiolabeled compound),6061,Intermediate,178.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625253,17827,Blood
,N,BAO_0000218,,Compound was evaluated for rate of bone uptake after administration of radiolabeled in mice (Radiolabeled compound),6062,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625254,17827,
,N,BAO_0000218,,Compound was evaluated for rate of bone uptake in mice (Radiolabeled compound),6063,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625255,17827,
,N,BAO_0000218,,Compound was evaluated for rate of bone uptake in mice; NA - not active (Radiolabeled compound),6064,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625256,17827,
,N,BAO_0000218,,Compound was evaluated for uptake rate constants in vivo in whole blood of normal mice (Radiolabeled compound),6065,Intermediate,178.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625257,17827,Blood
,N,BAO_0000218,,Compound was evaluated for uptake rate constants in vivo in whole blood of normal mice; NA = not active (Radiolabeled compound),6066,Intermediate,178.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625258,17827,Blood
,N,BAO_0000218,,Compound was evaluated for washout rate in mice (Radiolabeled compound),6067,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625259,17827,
,N,BAO_0000218,,Compound was evaluated for washout rate in mice after radiolabeled ligand injected,6068,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625260,17827,
,N,BAO_0000218,,"Maximum activity (i.v.) after in mice, expressed as [(ID%-kg)/g] (Radiolabeled compound)",6069,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625261,17827,
,N,BAO_0000218,,"Maximum activity in mice, expressed as [(ID%-kg)/g] (Radiolabeled compound)",6070,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625262,17827,
,N,BAO_0000218,,"Residual activity in mice at 120 minutes, expressed as [(ID%-kg)/g] (Radiolabeled compound)",6071,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622639,17827,
,N,BAO_0000218,,Tested for plasma level after 90 min of 10 mg/kg dose administered in mice,6072,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622640,17257,
,N,BAO_0000218,,Tested for plasma level after 90 min of 10 mg/kg dose administered in mice; Not detected.,6073,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622812,17257,
,N,BAO_0000218,,Tested for plasma level after 90 min of 30 mg/kg dose administered in mice,6074,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622813,17257,
,N,BAO_0000218,,Tested for plasma level after 90 min of 30 mg/kg dose administered in mice; Not determined,6075,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622814,17257,
,N,BAO_0000218,,Time at maximum activity in mice (Radiolabeled compound),6076,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622815,17827,
,N,BAO_0000218,,Percent oral bioavailability was determined after administration of compound at 5 mg/kg perorally in mice,6077,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625342,3760,
,N,BAO_0000218,,Percent oral bioavailability was determined after administration of compound at 50 mg/kg perorally in mice,6078,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625343,3760,
,N,BAO_0000218,,Binding towards mouse plasma protein at 10 uM,6079,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL877591,17409,
,N,BAO_0000218,,Binding towards mouse plasma protein at 100 uM,6080,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625344,17409,
,N,BAO_0000218,,Bioavailability was evaluated in mice after intravenous administration,6081,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625345,2675,
,N,BAO_0000218,,Bioavailability was evaluated in mice after oral administration,6082,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625346,2675,
,N,BAO_0000218,,Bioavailability was obtained by the comparison of AUC of subcutaneous dosing and AUC of oral dosing in mouse,6083,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625347,3132,
,N,BAO_0000218,,Bioavailability was obtained by the comparison of AUC of subcutaneous dosing and AUC of oral dosing in mouse at dose 25 mg/kg,6084,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625348,3132,
,N,BAO_0000218,,Bioavailability at a dose of 10 mg/kg peroral administration in mice.,6085,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625349,16597,
,N,BAO_0000218,,Oral bioavailability in mouse,6086,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625350,2862,
,N,BAO_0000218,,Oral bioavailability after intravenous administration in mice at 24 uM/kg,6087,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL882952,17764,
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice brain was determined after 1 min of administration; expressed in percent of injected dose per gram of organ,6088,Intermediate,955.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625351,846,Brain
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice brain was determined after 10 min of administration; expressed in percent of injected dose per gram of organ,6089,Intermediate,955.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625352,846,Brain
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice brain was determined after 15 sec of administration; expressed in percent of injected dose per gram of organ,6090,Intermediate,955.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL877592,846,Brain
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice brain was determined after 2 min of administration; expressed in percent of injected dose per gram of organ,6091,Intermediate,955.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625353,846,Brain
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice brain was determined after 30 sec of administration; expressed in percent of injected dose per gram of organ,6092,Intermediate,955.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL625354,846,Brain
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice brain was determined after 5 min of administration; expressed in percent of injected dose per gram of organ,6093,Intermediate,955.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL626019,846,Brain
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice heart was determined after 10 min of administration; expressed in percent of injected dose per gram of organ,6094,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL626020,846,Heart
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice heart was determined after 15 sec of administration; expressed in percent of injected dose per gram of organ,6095,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL626021,846,Heart
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice heart was determined after 1 min of administration; expressed in percent of injected dose per gram of organ,6096,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL626022,846,Heart
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice heart was determined after 2 min of administration; expressed in percent of injected dose per gram of organ,6097,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL626192,846,Heart
,N,BAO_0000219,,Cytotoxic activity was tested against human prostate cell line A-549 (lung carcinoma),6098,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL626193,1276,
,N,BAO_0000219,,Cytotoxicity against A-549 cell line in the purdue cell culture screen was determined,6099,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL626194,3498,
,N,BAO_0000219,,Cytotoxicity against human lung carcinoma A-549 cell lines,6100,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL626195,1169,
,N,BAO_0000219,,In vitro cytotoxic activity against A-549 (human lung carcinoma) cell line,6101,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL626196,4450,
,N,BAO_0000219,,In vitro cytotoxicity against human lung carcinoma cell line A-549,6102,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL626197,358,
,N,BAO_0000219,,In vitro cytotoxicity against human lung carcinoma cell line A-549 at 3.6*10e-5 M,6103,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL626198,358,
,N,BAO_0000219,,In vitro cytotoxicity against human lung carcinoma cell line A-549 at 4.2*10e-5M,6104,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL626199,358,
,N,BAO_0000219,,In vitro cytotoxicity against human lung carcinoma cell line A-549 at 4.3*10e-5M,6105,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL626200,358,
,N,BAO_0000219,,In vitro cytotoxicity against human lung carcinoma cell line A-549 at 5.0*10e-5M,6106,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL626201,358,
,N,BAO_0000219,,In vitro cytotoxicity against human lung carcinoma cell line A-549 at 6.1*10e-5 M,6107,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL626202,358,
,N,BAO_0000219,,In vitro cytotoxicity against human lung carcinoma cell line A-549 at 7.4*10e-5 M,6108,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL626203,358,
,N,BAO_0000219,,In vitro cytotoxicity against A-549 human lung cancer cells,6109,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL626204,15167,
,N,BAO_0000219,,In vitro cytotoxicity against human lung carcinoma (A-549) cell line,6110,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624701,4139,
,N,BAO_0000219,,In vitro cytotoxicity in human tumor lung carcinoma A-549 cell lines,6111,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624702,833,
,N,BAO_0000219,,Tested in vitro for cytotoxic activity against lung carcinoma (A-549) cell line,6112,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624703,15718,
,N,BAO_0000219,,Tested in vitro for cytotoxicity against A-549 lung cancer cells,6113,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624704,12373,
,N,BAO_0000219,,The compound was tested for cytotoxicity against A-549 cell in human lung carcinoma,6114,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624705,637,
,N,BAO_0000219,,Cytotoxicity against human lung carcinoma cells (A-549) using SRB assay.,6115,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624706,14867,
,N,BAO_0000219,,Antitumor cytotoxic activity against A-549 cell line was determined,6116,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624707,4461,
,N,BAO_0000219,,"Tested for the cytotoxicity against the Non-small cell lung cancer cell line A-549, growth inhibition by 50% is reported",6117,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624708,5406,
,N,BAO_0000219,,Compound was tested for cytotoxicity against A-549 human solid tumor cell line,6118,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624709,4457,
,N,BAO_0000219,,Antineoplastic activity against A-549 (human lung carcinoma) cell line.,6119,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL884107,1386,
,N,BAO_0000219,,Antitumoral activity was assayed against A-549 cell line,6120,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624710,3265,
,N,BAO_0000219,,Compound was evaluated for the cytotoxicity against A-549 tumor cell line after 3 days of incubation,6121,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624711,2359,
,N,BAO_0000219,,Compound was tested for cytotoxicity against A-549 human solid tumor cell line,6122,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624712,4457,
,N,BAO_0000219,,In vitro cytotoxicity against A549 (human lung carcinoma) cell line.,6123,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624713,12454,
,N,BAO_0000219,,Compound was tested for inhibition of cell growth of A-549 cells,6124,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624714,1481,
,N,BAO_0000219,,Compound was tested for its inhibitory effect on the growth of A-549 tumor cell line from lung.,6125,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624715,1750,
,N,BAO_0000219,,Concentration required for 50% inhibition of growth in human lung carcinoma cell line was determined,6126,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624716,5065,
,N,BAO_0000219,,In vitro cytotoxicity against A549-human lung carcinoma cells.,6127,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619505,808,
,N,BAO_0000219,,Cytotoxic activity against cultured cells of A-549 human lung carcinoma.,6128,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619506,16364,
,N,BAO_0000219,,Cytotoxic activity against A-549 cell lines.,6129,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619507,1847,
,N,BAO_0000219,,Cytotoxicity was measured against neoplastic cultured A-549 cells of human lung carcinoma.,6130,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619508,1747,
,N,BAO_0000219,,Cytotoxicity against human A549 non small cell lung cell lines,6131,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619509,1003,
,N,BAO_0000219,,Inhibition of cell growth in (A-549) lung cell line,6132,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619510,15313,
,N,BAO_0000219,,Growth inhibitory effect of compound was measured on A-549 human lung adenocarcinoma cancer cell line,6133,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619511,3122,
,N,BAO_0000219,,In vitro antitumor activity against A-549 tumor cells.,6134,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619512,16049,
,N,BAO_0000219,,In vitro antitumor effects against human A-549 cell lines.,6135,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619513,17134,
,N,BAO_0000219,,In vitro cytotoxic activity of compound against A-549 cell line,6136,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619514,6406,
,N,BAO_0000219,,In vitro cytotoxicity against human lung carcinoma A-549 cell line,6137,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619515,627,
,N,BAO_0000219,,In vitro cytotoxicity against human non-small cell lung carcinoma A549,6138,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619516,12307,
,N,BAO_0000219,,In vitro cytotoxicity against human A-549 cancer cell line was evaluated,6139,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL884005,17861,
,N,BAO_0000219,,In vitro cytotoxicity against the A-549 (human lung carcinoma) neoplastic cell line,6140,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619517,6682,
,N,BAO_0000219,,Inhibitory concentration of compound against A-549 cell line,6141,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619518,6663,
,N,BAO_0000219,,Tested for the cytostatic activity as inhibitory concentration against A-549 human pulmonary adenocarcinoma cells,6142,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619519,2454,
,N,BAO_0000219,,cytotoxic activity against leukemia (A-549) cancer cell line,6143,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL876489,14709,
,N,BAO_0000219,,Tested in vitro for cytotoxic activity against lung carcinoma (A-549) cell line,6144,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619520,15718,
,N,BAO_0000219,,Percent inhibition for cytotoxic activity against lung carcinoma (A-549) cell line,6145,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619521,15718,
,N,BAO_0000219,,Cytotoxic activity of compound against A-549 cell lines at concentration of 0.1(ug/ml),6146,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619522,17130,
,N,BAO_0000219,,Cytotoxic activity of compound against A-549 cell lines at concentration of 0.4(ug/ml),6147,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619523,17130,
,N,BAO_0000219,,Cytotoxic activity of compound against A-549 cell lines at concentration of 1.1 (ug/ml),6148,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619524,17130,
,N,BAO_0000219,,Cytotoxic activity of compound against A-549 cell lines at concentration of 10(ug/ml),6149,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619525,17130,
,N,BAO_0000219,,Drug interaction towards A549 cell line was determined in terms of combination index in presence of Tometin; Not available,6150,Intermediate,,1,,,646.0,,,1,A549,80682,F,,,CHEMBL619526,6630,
,N,BAO_0000219,,Influence of PARP-1 cellular activity in human lung carcinoma A549 cells on %ADP Polymer formation at a concentration of 25 uM of the compound,6151,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619527,16726,
,N,BAO_0000219,,Cytotoxicity against A549 cells; No cytotoxicity,6152,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619528,17846,
,N,BAO_0000219,,Cytotoxicity against human lung carcinoma (A549) cell lines,6153,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619529,3415,
,N,BAO_0000219,,Cytotoxicity against human lung carcinoma (A549) cell lines; Not active,6154,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619530,3415,
,N,BAO_0000219,,In vitro anticancer activity against human lung (A549) cell line,6155,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL876490,5609,
,N,BAO_0000219,,Percent growth inhibition at 200 uM PARP inhibitor in A549 cells,6156,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619531,17206,
,N,BAO_0000219,,Percent ADP-ribose polymer formation in presence of MNNG (25 uM) at 0..006 uM compound concentration in A549 cells,6157,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619532,17206,
,N,BAO_0000219,,Percent ADP-ribose polymer formation in presence of MNNG (25 uM) at 0..03 uM compound concentration in A549 cells,6158,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619533,17206,
,N,BAO_0000219,,Percent ADP-ribose polymer formation in presence of MNNG (25 uM) at 0..15 uM compound concentration in A549 cells,6159,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619534,17206,
,N,BAO_0000219,,Percent ADP-ribose polymer formation in presence of MNNG (25 uM) at 0..4 uM compound concentration in A549 cells,6160,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620164,17206,
,N,BAO_0000219,,Percent ADP-ribose polymer formation in presence of MNNG (25 uM) at 11 uM compound concentration in A549 cells,6161,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620165,17206,
,N,BAO_0000219,,Inhibition of A549 human lung tumor cell proliferation,6162,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620166,16295,
,N,BAO_0000219,,"Concentration required to inhibit the lung A549 cell growth by 50%,P53 status of cell line used was wild-type. ",6163,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620167,16825,
,N,BAO_0000219,,In vitro cytotoxicity against human tumor cell line A549,6164,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620168,3439,
,N,BAO_0000219,,In vitro growth inhibitory activity against A549 human nonsmall cell lung carcinoma cells. ,6165,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620338,10870,
,N,BAO_0000219,,Inhibitory concentration of compound against proliferation of lung carcinoma A549 cell line,6166,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620339,4845,
,N,BAO_0000219,,Inhibitory concentration (resynthesized pure material) against TNF-alpha induced apoptosis of A549 cells,6167,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620340,5822,
,N,BAO_0000219,,Inhibitory concentration (solid phase) against TNF-alpha induced apoptosis of A549 cells,6168,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620341,5822,
,N,BAO_0000219,,Inhibitory concentration (solid phase) against TNF-alpha induced apoptosis of A549 cells: Not tested,6169,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL876491,5822,
,N,BAO_0000219,,% inhibition against A549 cells (lung cancer) at 0.04 ug/mL,6170,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620342,16381,
,N,BAO_0000219,,% inhibition against A549 cells (lung cancer) at 0.4 ug/mL,6171,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620343,16381,
,N,BAO_0000219,,% inhibition against A549 cells (lung cancer) at 4 ug/mL,6172,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620344,16381,
,N,BAO_0000219,,In vitro anticancer activity against human lung (A549) cell line,6173,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620345,5609,
,N,BAO_0000219,,Inhibition of proliferation of A549 cells at concentration of 0.1 uM was determined,6174,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620346,4644,
,N,BAO_0000219,,Inhibition of proliferation of A549 cells at concentration of 100 uM was determined,6175,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620347,4644,
,N,BAO_0000219,,Inhibition of proliferation of A549 cells at concentration of 10 uM was determined,6176,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620348,4644,
,N,BAO_0000219,,Inhibition of proliferation of A549 cells at concentration of 1 uM was determined,6177,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620349,4644,
,N,BAO_0000219,,Inhibitory concentration (resynthesized pure material) against TNF-alpha induced apoptosis of A549 cells at 20 uM,6178,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL618667,5822,
,N,BAO_0000219,,Percentage inhibition of human lung carcinoma (A549) cell lines,6179,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL618668,3415,
,N,BAO_0000219,,Influence of PARP-1 cellular activity on NAD+ levels at a concentration of 25 uM of the compound,6180,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL876031,16726,
,N,BAO_0000219,,"Concentration that gives 50% growth inhibition in A549 cells, activity expressed as PF50 (TM); ND denotes not determined",6181,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL618759,17206,
,N,BAO_0000219,,Concentration that gives 50% growth inhibition (temozolomide alone/ (temozolomide + 0.4 uM of compound)) in A549 cells; ND denotes not determined,6182,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL618760,17206,
,N,BAO_0000219,,Concentration that gives 50% growth inhibition (topotecan alone/ (topotecan + 0.4 uM of compound)) in A549 cells; ND denotes not determined,6183,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619000,17206,
,N,BAO_0000219,,"Concentration that gives 50% growth inhibition in A549 cells, activity expressed as PF50 (TM)",6184,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619001,17206,
,N,BAO_0000219,,"Concentration that gives 50% growth inhibition in A549 cells, activity expressed as PF50 (TP) at 0.006 uM",6185,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619002,17206,
,N,BAO_0000219,,"Concentration that gives 50% growth inhibition in A549 cells, activity expressed as PF50 (TP) at 0.03 uM",6186,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619003,17206,
,N,BAO_0000219,,"Concentration that gives 50% growth inhibition in A549 cells, activity expressed as PF50 (TP) at 0.15 uM",6187,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619597,17206,
,N,BAO_0000219,,"Concentration that gives 50% growth inhibition in A549 cells, activity expressed as PF50 (TP) at 0.4 uM",6188,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619598,17206,
,N,BAO_0000219,,Concentration that gives 50% growth inhibition (temozolomide alone/ (temozolomide + 0.4 uM of compound)) in A549 cells,6189,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619599,17206,
,N,BAO_0000219,,Concentration that gives 50% growth inhibition (topotecan alone/ (topotecan + 0.4 uM of compound)) in A549 cells,6190,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619600,17206,
,N,BAO_0000219,,Cytotoxicity potentiation of Topotecan in human lung carcinoma A549 cells by the compound as potentiation factor at 50% growth inhibition,6191,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619601,16726,
,N,BAO_0000219,,Effect on NAD+ depletion (% remaining versus vehicle control) in presence of MNNG (25 uM) at 0.006 uM compound concentration in A549 cells,6192,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619602,17206,
,N,BAO_0000219,,Effect on NAD+ depletion (% remaining versus vehicle control) in presence of MNNG (25 uM) at 0.03 uM compound concentration in A549 cells,6193,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619603,17206,
,N,BAO_0000219,,Effect on NAD+ depletion (% remaining versus vehicle control) in presence of MNNG (25 uM) at 0.15 uM compound concentration in A549 cells,6194,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619604,17206,
,N,BAO_0000219,,Effect on NAD+ depletion (% remaining versus vehicle control) in presence of MNNG (25 uM) at 0.4 uM compound concentration in A549 cells,6195,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619605,17206,
,N,BAO_0000218,,Pharmacokinetic activity (Cmax) (10 mg/kg) was determined in dog,6196,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619606,6084,
,N,BAO_0000218,,Pharmacokinetic activity (Cmax) in dog,6197,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL876032,6084,
,N,BAO_0000218,,Pharmacokinetic parameter Cmax was determined in Beagle dogs after (iv) administration of a dose of 28 (uM/kg),6198,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619607,4809,
,N,BAO_0000218,,Pharmacokinetic property (Cmax) was measured in dog at the dose of 0.032 mg/kg,6199,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619608,5983,
,N,BAO_0000218,,Plasma clearance rate by iv administration in dog at a dose of 6 mg/kg,6200,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619609,6251,
,N,BAO_0000218,,Cmax in dog plasma after 30mg/kg oral dose,6201,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619610,5932,Plasma
,N,BAO_0000218,,Tested for the peak blood level in dog,6202,Intermediate,178.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619611,4273,Blood
,N,BAO_0000218,,"Tested for the pharmacokinetic data, maximum concentration (Cmax) in dog",6203,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619612,5313,
,N,BAO_0000218,,"Tested for the pharmacokinetic data, maximum concentration (Cmax) in dog at dosage of 10 mpk",6204,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619613,5313,
,N,BAO_0000218,,The peak blood concentration after 5 hr administration (2.5 mg/kg) in dog was determined,6205,Intermediate,178.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619614,6221,Blood
,N,BAO_0000218,,Concentration in the plasma after intravenous administration of 1 mg/kg in dog,6206,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619615,4709,
,N,BAO_0000218,,Compound was evaluated for Plasma levels upon oral administration at 30 mg/kg in Dog at maximum of 0.3 hours,6207,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619616,167,
,N,BAO_0000218,,Final plasma concentration in dogs after oral administration at 1 mg/kg,6208,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619617,6241,Plasma
,N,BAO_0000218,,Plasma concentration in dogs when measured 1 and 5 hours following initiation of reperfusion at 300 min,6209,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619618,344,
,N,BAO_0000218,,Plasma concentration in dogs when measured 1 and 5 hours following initiation of reperfusion at 30 min,6210,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL876033,344,
,N,BAO_0000218,,Plasma concentration in dogs when measured 1 and 5 hours following initiation of reperfusion at 60 min,6211,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619619,344,
,N,BAO_0000218,,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by dogs,6212,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619620,2189,
,N,BAO_0000218,,Percent of radioactive dose in urine and feces excreted by 0-24 hr in dogs,6213,Intermediate,1088.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619621,2189,Urine
,N,BAO_0000218,,Percent of radioactive dose in urine and feces excreted by 0-24 hr in dogs; NA is <10% inhibition at 1 uM for binding data,6214,Intermediate,1088.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619622,2189,Urine
,N,BAO_0000218,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by dogs; NA is <10% inhibition at 1 uM for binding data,6215,Intermediate,1088.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618874,2189,Urine
,N,BAO_0000218,,Absolute bioavailability was evaluated in dog,6216,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618875,4257,
,N,BAO_0000218,,Bioavailability after oral administration (2.5 mg/kg) in dog was determined,6217,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618876,6221,
,N,BAO_0000218,,Bioavailability after peroral administration (1 mg/kg) was determined in dog,6218,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618877,6215,
,N,BAO_0000218,,Bioavailability in dog,6219,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618878,17267,
,N,BAO_0000218,,Bioavailability in dog,6220,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618879,6621,
,N,BAO_0000218,,Bioavailability after intravenous administration in dogs,6221,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618880,3854,
,N,BAO_0000218,,Bioavailability after peroral administration in dogs,6222,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618881,3854,
,N,BAO_0000218,,Bioavailability in dog (dose 5 mg/kg p.o. and 2 mg/kg i.v.),6223,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618882,5007,
,N,BAO_0000218,,Bioavailability in dog (Beagle) (male) (dose 3 mg/kg i.v. and 10 mg/kg p.o.) measured from 1 to 24 hr,6224,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624226,4333,
,N,BAO_0000218,,Bioavailability in plasma of male Beagle dogs treated with 3 mg/kg (i.v.) and 10 mg/kg (p.o.) measured from 1 to 24 hr; ND indicates not determined,6225,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624227,4333,Plasma
,N,BAO_0000218,,Bioavailability,6226,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624228,5006,
,N,BAO_0000218,,Bioavailability,6227,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624229,5199,
,N,BAO_0000218,,Bioavailability by intravenous administration of 1.2 mg/kg in dog,6228,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624230,4368,
,N,BAO_0000218,,Bioavailability in dog,6229,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624231,3771,
,N,BAO_0000218,,Bioavailability in dog,6230,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624232,4953,
,N,BAO_0000218,,Bioavailability in dog,6231,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625127,5064,
,N,BAO_0000218,,Bioavailability in dog,6232,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625128,17657,
,N,BAO_0000218,,Bioavailability in dog,6233,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621675,17796,
,N,BAO_0000218,,Bioavailability in dog (p.o.) at 2.0 mpk,6234,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621676,17853,
,N,BAO_0000218,,Bioavailability in dog (dose 2 mg/kg p.o. and 0.5 mg/kg i.v.),6235,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621677,4521,
,N,BAO_0000218,,Bioavailability in dog after 2 mg/kg by oral and 0.5 mg/kg by intravenous administration; ND is not determined,6236,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621678,4521,
,N,BAO_0000218,,Bioavailability in dog,6237,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621679,5006,
,N,BAO_0000218,,Bioavailability was evaluated after oral administration in dog,6238,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621680,16365,
,N,BAO_0000218,,Bioavailability was evaluated against Beagle dog at a dose of 15 mg/kg after po administration,6239,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621681,1916,
,N,BAO_0000218,,Bioavailability was evaluated in dog,6240,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL876740,1918,
,N,BAO_0000218,,Bioavailability in dog,6241,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621682,4239,
,N,BAO_0000218,,Bioavailability in dog,6242,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621683,6505,
,N,BAO_0000218,,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Beagle dog (male),6243,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621684,5334,
,N,BAO_0000218,,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Beagle dog (male),6244,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621685,5334,
,N,BAO_0000218,,Bioavailability was determined in Beagle dogs after (iv) administration of a dose of 28 (uM/kg),6245,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621686,4809,
,N,BAO_0000218,,Bioavailability was determined in dog after 1 mg/kg (i.v.) and 5 mg/kg (p.o.) administration,6246,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621687,6348,
,N,BAO_0000218,,Bioavailability was evaluated in dog after peroral administration at a dose of 1 mg/kg,6247,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621688,6005,
,N,BAO_0000218,,Bioavailability of compound in dog was determined after peroral administration,6248,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621689,17804,
,N,BAO_0000218,,Oral bioavailability in dog,6249,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621690,3184,
,N,BAO_0000218,,Compound was evaluated for oral bioavailability at different dose 27.5 mg/kg DMP323 equiv in dogs,6250,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621691,1806,
,N,BAO_0000218,,Compound was evaluated for oral bioavailability at different dose 7.7 mg/kg DMP323 equiv in dogs,6251,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL875941,1806,
,N,BAO_0000218,,Compound was evaluated for oral bioavailability in dogs; 37-38 %,6252,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621692,1806,
,N,BAO_0000218,,Bioavailability in dog,6253,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621693,4839,
,N,BAO_0000218,,Oral bioavailability in dog (1 mg/kg p.o. and 0.2 mg/kg i.v.),6254,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621694,5017,
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice heart was determined after 30 sec of administration; expressed in percent of injected dose per gram of organ,6255,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621695,846,Heart
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice heart was determined after 5 min of administration; expressed in percent of injected dose per gram of organ,6256,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621696,846,Heart
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice kidneys was determined after 1 min of administration; expressed in percent of injected dose per gram of organ,6257,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621697,846,Kidney
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice kidneys was determined after 10 min of administration; expressed in percent of injected dose per gram of organ,6258,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621698,846,Kidney
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice kidneys was determined after 15 sec of administration; expressed in percent of injected dose per gram of organ,6259,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623420,846,Kidney
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice kidneys was determined after 2 min of administration; expressed in percent of injected dose per gram of organ,6260,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623421,846,Kidney
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice kidneys was determined after 30 sec of administration; expressed in percent of injected dose per gram of organ,6261,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623422,846,Kidney
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice kidneys was determined after 5 min of administration; expressed in percent of injected dose per gram of organ,6262,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623423,846,Kidney
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice liver was determined after 1 min of administration; expressed in percent of injected dose per gram of organ,6263,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623424,846,Liver
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice liver was determined after 10 min of administration; expressed in percent of injected dose per gram of organ,6264,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623425,846,Liver
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice liver was determined after 15 sec of administration; expressed in percent of injected dose per gram of organ,6265,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623426,846,Liver
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice liver was determined after 2 min of administration; expressed in percent of injected dose per gram of organ,6266,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623427,846,Liver
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice liver was determined after 30 sec of administration; expressed in percent of injected dose per gram of organ,6267,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623428,846,Liver
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice liver was determined after 5 min of administration; expressed in percent of injected dose per gram of organ,6268,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL875947,846,Liver
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice lungs was determined after 1 min of administration; expressed in percent of injected dose per gram of organ,6269,Intermediate,2048.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623429,846,Lung
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice lungs was determined after 10 min of administration; expressed in percent of injected dose per gram of organ,6270,Intermediate,2048.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623430,846,Lung
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice lungs was determined after 15 sec of administration; expressed in percent of injected dose per gram of organ,6271,Intermediate,2048.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622588,846,Lung
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice lungs was determined after 2 min of administration; expressed in percent of injected dose per gram of organ,6272,Intermediate,2048.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622589,846,Lung
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice lungs was determined after 30 sec of administration; expressed in percent of injected dose per gram of organ,6273,Intermediate,2048.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622751,846,Lung
,N,BAO_0000218,,Biodistribution of [123I]- labeled compound in mice lungs was determined after 5 min of administration; expressed in percent of injected dose per gram of organ,6274,Intermediate,2048.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622752,846,Lung
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice blood bearing S180 tumor cell line for 1 hour,6275,Intermediate,,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL622753,6599,
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice blood bearing S180 tumor cell line for 2 hours,6276,Intermediate,,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL622647,6599,
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice blood bearing S180 tumor cell line for 30 minutes,6277,Intermediate,,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL875163,6599,
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice blood bearing S180 tumor cell line for 4 hours,6278,Intermediate,,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL622648,6599,
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice blood bearing S180 tumor cell line for 8 hours,6279,Intermediate,,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL622649,6599,
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice brain bearing S180 tumor cell line for 1 hour,6280,Intermediate,955.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL622650,6599,Brain
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice brain bearing S180 tumor cell line for 2 hours,6281,Intermediate,955.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL622651,6599,Brain
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice brain bearing S180 tumor cell line for 30 minutes,6282,Intermediate,955.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL622652,6599,Brain
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice brain bearing S180 tumor cell line for 4 hours,6283,Intermediate,955.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL622653,6599,Brain
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice brain bearing S180 tumor cell line for 8 hours,6284,Intermediate,955.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL622654,6599,Brain
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice heart bearing S180 tumor cell line for 1 hour,6285,Intermediate,948.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL622655,6599,Heart
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice heart bearing S180 tumor cell line for 2 hours,6286,Intermediate,948.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL622656,6599,Heart
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice heart bearing S180 tumor cell line for 30 minutes,6287,Intermediate,948.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL622657,6599,Heart
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice heart bearing S180 tumor cell line for 4 hours,6288,Intermediate,948.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL622658,6599,Heart
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice heart bearing S180 tumor cell line for 8 hours,6289,Intermediate,948.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL622659,6599,Heart
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice kidney bearing S180 tumor cell line for 1 hour,6290,Intermediate,2113.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL624630,6599,Kidney
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice kidney bearing S180 tumor cell line for 2 hours,6291,Intermediate,2113.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL624631,6599,Kidney
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice kidney bearing S180 tumor cell line for 30 minutes,6292,Intermediate,2113.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL624632,6599,Kidney
,N,BAO_0000219,,Cytotoxic activity of compound against A-549 cell lines at concentration of 10(ug/ml) on,6293,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624633,17130,
,N,BAO_0000219,,Cytotoxic activity of compound against A-549 cell lines at concentration of 10(ug/ml)on,6294,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624634,17130,
,N,BAO_0000219,,Cytotoxic activity of compound against A-549 cell lines at concentration of 3.3 (ug/ml),6295,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624635,17130,
,N,BAO_0000219,,Cytotoxic activity of compound against A-549 cell lines at concentration of 3.3 (ug/ml)),6296,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624636,17130,
,N,BAO_0000219,,Antineoplastic activity against A-549 (human lung carcinoma) cell line.,6297,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL857055,3263,
,N,BAO_0000219,,In vitro rate of inhibition of A-549 tumor cell growth at 10E-4 mol/L,6298,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624637,6663,
,N,BAO_0000219,,In vitro rate of inhibition of A-549 tumor cell growth at 10E-5 mol/L,6299,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624638,6663,
,N,BAO_0000219,,In vitro rate of inhibition of A-549 tumor cell growth at 10E-6 mol/L,6300,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL874366,6663,
,N,BAO_0000219,,In vitro rate of inhibition of A-549 tumor cell growth at 10E-7 mol/L,6301,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624639,6663,
,N,BAO_0000219,,In vitro rate of inhibition of A-549 tumor cell growth at 10E-8 mol/L,6302,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624640,6663,
,N,BAO_0000219,,Rate of inhibition of A-549 tumor cell growth at a concentration of 0.0625 uM,6303,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624641,6663,
,N,BAO_0000219,,Rate of inhibition of A-549 tumor cell growth at a concentration of 0.125 uM,6304,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624642,6663,
,N,BAO_0000219,,Rate of inhibition of A-549 tumor cell growth at a concentration of 0.25 uM,6305,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624643,6663,
,N,BAO_0000219,,Rate of inhibition of A-549 tumor cell growth at a concentration of 0.5 uM,6306,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624644,6663,
,N,BAO_0000219,,Rate of inhibition of A-549 tumor cell growth at a concentration of 1 uM,6307,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL624645,6663,
,N,BAO_0000219,,The compound was evaluated for its cytotoxic potency against A-549 cell line,6308,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619445,3983,
,N,BAO_0000219,,Cytotoxic concentration required to inhibit 50% cell growth in A-549 lung carcinoma cell lines,6309,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL839886,11141,
,N,BAO_0000219,,Cytotoxic activity of compound against A-549 tumor cell line.,6310,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619446,5076,
,N,BAO_0000219,,In vitro cytotoxicity against Lung A-549 human tumors following a 6 day exposure.,6311,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619447,3311,
,N,BAO_0000219,,In vitro cytotoxicity against Lung A-549 human tumors following a 2 day exposure.,6312,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619448,3311,
,N,BAO_0000219,,In vitro cytotoxicity against Lung A-549 human tumors following a 2 day exposure; ND is no data,6313,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619449,3311,
,N,BAO_0000219,,Cytotoxic activity of compound against A-549 tumor cell line at conc. of 20 ug/mL,6314,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619450,5076,
,N,BAO_0000219,,Compound was tested for cytotoxic activity against A-549 human lung carcinoma (ATCC:CCL-185),6315,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619451,4150,
,N,BAO_0000219,,In vitro inhibitory concentration against cell culture of A-549 human lung carcinoma,6316,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619452,2150,
,N,BAO_0000219,,Concentration for in vitro cytotoxicity against A-549 human lung tumor cells,6317,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619453,4644,
,N,BAO_0000219,,Dose required for in vitro cytotoxic activity against A-549 lung carcinoma cells at concentration of 10 ug/ml; NA is no cytotoxicity,6318,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL874367,263,
,N,BAO_0000219,,Cytotoxic concentration against A-549 tumor cells.,6319,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619454,11333,
,N,BAO_0000219,,Cytotoxic concentration against A-549 tumor cells; Inactive at 10 ug/mL.,6320,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619455,11333,
,N,BAO_0000219,,"Cytotoxicity against NCI tumor panel, A-549/ATCC non small-cell lung cancer cell line",6321,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619456,15895,
,N,BAO_0000218,,Minimum inhibitory concentration (lowest peptide concentration) required to prevent visible bacterial growth after 18 hr of incubation at 37 C in Mueller-Hinton broth against Acinetobacter baumannii 118A,6322,Expert,,1,,,,,470.0,1,,50191,F,Acinetobacter baumannii,,CHEMBL619457,16677,
,N,BAO_0000218,,Activity against Acinetobacter calcoaceticus (AC54),6323,Intermediate,,1,,,,,471.0,1,,50192,F,Acinetobacter calcoaceticus,,CHEMBL619458,10624,
,N,BAO_0000218,,In vitro antifungal activity against Aspergillus flavus CM74,6324,Expert,,1,,,,,5059.0,1,,50274,F,Aspergillus flavus,,CHEMBL619459,16717,
,N,BAO_0000218,,In vitro antifungal activity against Aspergillus flavus CM74,6325,Expert,,1,,,,,5059.0,1,,50274,F,Aspergillus flavus,,CHEMBL619460,16717,
,N,BAO_0000218,,Inhibitory activity tested against Aspergillus fumigatus at 256 ug/mL concentration,6326,Intermediate,,1,,,,,746128.0,1,,50416,F,Aspergillus fumigatus,,CHEMBL619461,5513,
,N,BAO_0000218,,In vitro minimum fungicidal concentration required to inhibit Aspergillus fumigatus(MFC),6327,Intermediate,,1,,,,,746128.0,1,,50416,F,Aspergillus fumigatus,,CHEMBL619462,15962,
,N,BAO_0000218,,Antimicrobial activity against Aspergillus fumigatus (MIC),6328,Intermediate,,1,,,,,746128.0,1,,50416,F,Aspergillus fumigatus,,CHEMBL620388,15962,
,N,BAO_0000218,,Antimicrobial activity against Aspergillus fumigatus (MIC),6329,Intermediate,,1,,,,,746128.0,1,,50416,F,Aspergillus fumigatus,,CHEMBL620389,15962,
,N,BAO_0000218,,In vitro antimicrobial activity against Aspergillus fumigatus (MIC),6330,Intermediate,,1,,,,,746128.0,1,,50416,F,Aspergillus fumigatus,,CHEMBL620390,15962,
,N,BAO_0000218,,In vitro antifungal activity against Aspergillus fumigatus 48238E,6331,Expert,,1,,,,,746128.0,1,,50416,F,Aspergillus fumigatus,,CHEMBL620391,16717,
,N,BAO_0000218,,In vitro antifungal activity against Aspergillus fumigatus 48238E,6332,Expert,,1,,,,,746128.0,1,,50416,F,Aspergillus fumigatus,,CHEMBL621073,16717,
,N,BAO_0000218,,Compound is evaluated for plaque-bactericidal index (PBI) against Actinomyces naeslundii 631,6333,Intermediate,,1,,,,,1655.0,1,,50296,F,Actinomyces naeslundii,,CHEMBL621074,8117,
,N,BAO_0000218,,Compound is evaluated for plaque-bactericidal index (PBI) against Actinomyces viscosus M-100,6334,Intermediate,,1,,,,,1656.0,1,,50366,F,Actinomyces viscosus,,CHEMBL621075,8117,
,N,BAO_0000218,,Tested in vivo for Acanthocheilonema viteae at 200 mg/kg X 5 days(perorally),6335,Intermediate,,1,,,,,6277.0,1,,50535,F,Acanthocheilonema viteae,,CHEMBL619554,15472,
,N,BAO_0000218,,Tested in vivo for Acanthocheilonema viteae at 200 mg/kg X 5 days(perorally),6336,Intermediate,,1,,,,,6277.0,1,,50535,F,Acanthocheilonema viteae,,CHEMBL619555,15472,
,N,BAO_0000218,,Antibacterial activity determined as minimal inhibitory concentration (MIC) against Actinobacillus actinomycetecommitans ATCC 29527,6337,Intermediate,,1,,,,,714.0,1,,50169,F,Aggregatibacter actinomycetemcomitans,,CHEMBL619556,16443,
,N,BAO_0000218,,Antibacterial activity determined as minimal inhibitory concentration (MIC) against Actinobacillus actinomycetecommitans ATCC 29527; value ranges from 1-2,6338,Intermediate,,1,,,,,714.0,1,,50169,F,Aggregatibacter actinomycetemcomitans,,CHEMBL619557,16443,
,N,BAO_0000218,,Antibacterial activity determined as minimal inhibitory concentration (MIC) against Actinobacillus actinomycetecommitans ATCC 29527; value ranges from 1-2; ND is Not Determined,6339,Intermediate,,1,,,,,714.0,1,,50169,F,Aggregatibacter actinomycetemcomitans,,CHEMBL619558,16443,
,N,BAO_0000219,,Effect on NAD+ depletion (% remaining versus vehicle control) in presence of MNNG (25 uM) at 11 uM compound concentration in A549 cells,6340,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619559,17206,
,N,BAO_0000219,,Percent ADP-ribose polymer formation at 25 uM compound concentration in A549 cells,6341,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619560,17206,
,N,BAO_0000219,,% inhibition against A549 cells (lung cancer) at 0.04 ug/mL,6342,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619561,16381,
,N,BAO_0000219,,% inhibition against A549 cells (lung cancer) at 0.4 ug/mL,6343,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619562,16381,
,N,BAO_0000219,,% inhibition against A549 cells (lung cancer) at 4 ug/mL,6344,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619563,16381,
,N,BAO_0000219,,GI values against A549 cells (lung cancer),6345,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL857457,16381,
,N,BAO_0000219,,Effect on NAD+ depletion (% remaining versus vehicle control) 25 uM compound concentration in A549 cells,6346,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619564,17206,
,N,BAO_0000219,,Inhibitory activity against A549 human adenocarcinoma,6347,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619565,16325,
,N,BAO_0000218,,Evaluated for the antineoplastic activity against A549 lung (nonsmall cell) tumor xenograft in nude mice after administering 3 injections (intra peritoneally) at a dose of 200 mg/kg,6348,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619566,10708,
,N,BAO_0000218,,Evaluated for the antineoplastic activity against A549 lung (nonsmall cell) tumor xenograft in nude mice after administering 3 injections (intra peritoneally) at a dose of 100 mg/kg,6349,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619567,10708,
,N,BAO_0000219,,Inhibitory activity against A549 lung adenocarcinoma cell line,6350,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619568,17376,
,N,BAO_0000219,,Inhibitory activity against A549 lung adenocarcinoma cell line; not determined,6351,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619569,17376,
,N,BAO_0000219,,Cytotoxicity against human A549 lung cells,6352,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619570,17488,
,N,BAO_0000218,,In vivo percent inhibitory activity of intraperitoneally administered compound (50 mg/kg/day) against mice infected with A549 tumor,6353,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619571,17404,
,N,BAO_0000219,,Growth inhibition of A549 (human lung carcinoma) cell line.,6354,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619572,10958,
,N,BAO_0000219,,Effective dose required for inhibitory activity against A549 human tumor cell line.,6355,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619573,17099,
,N,BAO_0000219,,Effective dose required for inhibitory activity against A549 human tumor cell line; Not active,6356,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619574,17099,
,N,BAO_0000219,,Cytotoxicity was evaluated against A549 tumor cell lines; Inactive,6357,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619575,4096,
,N,BAO_0000219,,Cytotoxicity evaluated against A549 tumor cell lines; significant activity,6358,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619576,4096,
,N,BAO_0000219,,Cytotoxicity was evaluated against A549 tumor cell lines; Slightly active,6359,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619577,4096,
,N,BAO_0000219,,In vitro inhibitory activity against A549 tumor cell culture,6360,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619578,2525,
,N,BAO_0000219,,In vitro inhibitory activity against A549 tumor cell culture; IA= Inactive,6361,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL884009,2525,
,N,BAO_0000219,,Activity against human lung cancer with mutated beta-tubulin (A549-T2415),6362,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619579,5302,
,N,BAO_0000219,,Growth inhibitory activity was determined against A549/ATCC cancer cell line of non-small cell lung cancer,6363,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619580,16325,
,N,BAO_0000219,,Inhibition of growth of A549/ATCC nonsmall cell lung cancer cell line,6364,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619581,16939,
,N,BAO_0000219,,In vitro antitumor activity against NSCL A549/ATCC tumor cell lines,6365,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619582,17229,
,N,BAO_0000219,,Cytotoxicity evaluation against A549/ATCC non-small-cell lung cancer cells,6366,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619583,17380,
,N,BAO_0000219,,Cytotoxicity evaluation against A549/ATCC non-small-cell lung cancer cells; No data,6367,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL876502,17380,
,N,BAO_0000219,,In vitro cytotoxicity against human Non-small cell lung cancer A549/ATCC cell line.,6368,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619584,1903,
,N,BAO_0000219,,In vitro growth inhibition of compound was determined against A549/ATCC cell lines of non-small cell lung cancer,6369,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619585,3838,
,N,BAO_0000219,,Inhibition of the growth of non-small-cell lung cancer (A549/ATCC) cell line,6370,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619586,14696,
,N,BAO_0000219,,In vitro growth inhibition of compound was determined against A549/ATCC cell lines of non-small cell lung cancer,6371,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619587,3838,
,N,BAO_0000219,,Tested for in vitro cytotoxicity against non-small cell lung cancer cell line A549/ATCC,6372,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619588,1522,
,N,BAO_0000219,,Tested in vitro for cytotoxicity in A549/ATCC cell lines,6373,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619589,12400,
,N,BAO_0000219,,inhibition of the growth of non-small-cell lung cancer (A549/ATCC) cell line,6374,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619590,14696,
,N,BAO_0000219,,Compound was evaluated for in vitro activity against A549/ATCC lung cancer cell lines (Human tumor cells ),6375,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619591,14769,
,N,BAO_0000219,,Inhibition of the growth of non-small-cell lung cancer (A549/ATCC) cell line at 0.01 uM,6376,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619592,14696,
,N,BAO_0000219,,Compound was evaluated for cytotoxic activity against non-small lung cancer A549/ATCC cell lines.,6377,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL619593,1888,
,N,BAO_0000219,,Tested for cytotoxic activity against non-small cell lung cancer A549/ATCC cell line,6378,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620217,12016,
,N,BAO_0000219,,Compound tested for growth inhibition of non-small cell lung cancer cell line A549/ATCC,6379,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620218,6058,
,N,BAO_0000219,,Compound was tested for 50% growth inhibition against human non-small cell lung cancer A549/ATCC cell line,6380,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620219,17708,
,N,BAO_0000219,,Antitumor activity against A549/ATCC cell line,6381,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL620220,12301,
,N,BAO_0000219,,Tested for cytotoxicity against A549/ATCC cell lines in non-small-cell lung cancer,6382,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL625141,11970,
,N,BAO_0000219,,In vitro cytotoxicity against A549/ATCC cell line.,6383,Expert,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL625142,11818,
,N,BAO_0000219,,Tested in vitro for cytotoxicity in A549/ATCC cell line of Non-Small Cell Lung Cancer,6384,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL625143,12400,
,N,BAO_0000219,,In vitro inhibition of Non-Small Cell Lung Cancer A549/ATCC cell lines,6385,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL625144,3381,
,N,BAO_0000219,,Concentration of compound that cause 50% cytotoxicity of A549/ATCC non small cell lung cancer cell line,6386,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL622474,17376,
,N,BAO_0000219,,Evaluated for the inhibitory concentration required to cause growth inhibition of A549Rem- cell line of lung using the MTT Cytotoxicity Assay,6387,Intermediate,,1,,,646.0,,9606.0,1,A549,80682,F,Homo sapiens,,CHEMBL884104,10708,
,U,BAO_0000219,,Cytotoxicity was evaluated against A649 human mammary carcinoma cells,6388,Autocuration,,0,,,,,9606.0,1,,22226,F,Homo sapiens,,CHEMBL622475,2964,
,U,BAO_0000218,,Compound was tested for oral bioavailability in dogs,6389,Intermediate,,0,,In vivo,,,9615.0,1,,22224,A,Canis lupus familiaris,,CHEMBL622476,5005,
,N,BAO_0000218,,Compound was tested for orally bioavailable in dogs with a half life of 0.7 hr,6390,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL875831,6229,
,N,BAO_0000218,,Compound was tested for orally bioavailable in dogs with a half life of 1.2h,6391,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622477,6229,
,N,BAO_0000218,,Oral bioavailability in dog,6392,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622478,5374,
,N,BAO_0000218,,Compound was tested for the oral bioavailability in dog; No availability,6393,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623172,5374,
,N,BAO_0000218,,Oral bioavailability in dog (dose 5 mg/kg),6394,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623173,6265,
,N,BAO_0000218,,Oral bioavailability (F%) of compound was determined after intravenous administration in average of two dogs at a dose of 1 mg/kg; ND=not determined,6395,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623174,5654,
,N,BAO_0000218,,Oral bioavailability (F%) of compound was determined after intravenous administration in average of two dogs at a dose of 1 mg/kg; ND=not determined,6396,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623175,5654,
,N,BAO_0000218,,Oral bioavailability in Beagle dogs after Per oral administration at dose of 50(mg/kg),6397,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623340,16456,
,N,BAO_0000218,,Oral bioavailability in dog (dose 5 mg/kg),6398,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623341,5302,
,N,BAO_0000218,,Oral bioavailability in dog (p.o. dosing of 0.05 M citric acid/0.05 M hydrochloric acid solution),6399,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623342,3624,
,N,BAO_0000218,,Oral bioavailability of active FTIs in dogs,6400,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623343,16452,
,N,BAO_0000218,,Oral bioavailability in dog (dose 5 mg/kg p.o. and 2 mg/kg i.v.),6401,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623344,5802,
,N,BAO_0000218,,Oral bioavailability of compound determined in dog after iv administration at a dose of 10 mg/kg,6402,Expert,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623345,3598,
,N,BAO_0000218,,Oral bioavailability in dog,6403,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL875832,17839,
,N,BAO_0000218,,Oral bioavailability in dog,6404,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623346,6762,
,N,BAO_0000218,,Oral bioavailability in dog,6405,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623347,6821,
,N,BAO_0000218,,Oral bioavailability of compound was determined in dog; Not tested,6406,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623348,6821,
,N,BAO_0000218,,Oral bioavailability in dog,6407,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623349,5210,
,N,BAO_0000218,,Oral bioavailability (10 mg/kg) was determined in dog,6408,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623350,6227,
,N,BAO_0000218,,Oral bioavailability,6409,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623351,761,
,N,BAO_0000218,,Oral bioavailability in dog (dosed as neat powder in hard gelatin capsule),6410,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623352,761,
,N,BAO_0000218,,Oral bioavailability administered in solution in rats,6411,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623353,761,
,N,BAO_0000218,,Oral bioavailability after 30 mg/kg po dose in Dogs,6412,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL875833,16907,
,N,BAO_0000218,,Oral bioavailability at a dose of 1 mg/kg in dogs,6413,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623354,5474,
,N,BAO_0000218,,Oral bioavailability in dog (dose 1 mg/kg p.o.),6414,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623355,6535,
,N,BAO_0000218,,Oral bioavailability in Dog; ND = not determined,6415,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623356,6535,
,N,BAO_0000218,,Oral bioavailability in dog,6416,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623357,3352,
,N,BAO_0000218,,Oral bioavailability in dog,6417,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623358,6168,
,N,BAO_0000218,,Oral bioavailability in dog,6418,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623359,5988,
,N,BAO_0000218,,Oral bioavailability in dog,6419,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623360,4942,
,N,BAO_0000218,,Oral bioavailability in dogs; No data,6420,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623361,4942,
,N,BAO_0000218,,Oral bioavailability measured in dogs,6421,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623362,14541,
,N,BAO_0000218,,Oral bioavailability in dog,6422,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623363,4449,
,N,BAO_0000218,,Oral bioavailability was calculated in dog,6423,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623364,6057,
,N,BAO_0000218,,Oral bioavailability after 0.3 mg/kg po administration in dog,6424,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL875834,5600,
,N,BAO_0000218,,Oral bioavailability in dog (i.v. dosing),6425,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623365,5542,
,N,BAO_0000218,,Oral bioavailability in dog,6426,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623366,5542,
,N,BAO_0000218,,Oral bioavailability in Beagle dog at a dose of 2 mg/kg by po administration,6427,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623367,5546,
,N,BAO_0000218,,Oral bioavailability in Beagle dogs,6428,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623368,4514,
,N,BAO_0000218,,Oral bioavailability in dog,6429,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623369,3624,
,N,BAO_0000218,,Oral bioavailability in dog,6430,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623370,3854,
,N,BAO_0000218,,Oral bioavailability in dog,6431,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623371,5836,
,N,BAO_0000218,,Oral bioavailability in dog,6432,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623372,5940,
,N,BAO_0000218,,Oral bioavailability in dog,6433,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621351,6168,
,N,BAO_0000218,,Oral bioavailability in dog,6434,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621352,6227,
,N,BAO_0000218,,Oral bioavailability in dog,6435,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621353,6251,
,N,BAO_0000218,,Oral bioavailability in dog,6436,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621354,6448,
,N,BAO_0000218,,Oral bioavailability in dog,6437,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621355,6647,
,N,BAO_0000218,,Oral bioavailability in dog,6438,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621356,5940,
,N,BAO_0000218,,Oral bioavailability in dog,6439,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621357,933,
,N,BAO_0000218,,Oral bioavailability in dog,6440,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621358,5210,
,N,BAO_0000218,,Oral bioavailability in dog (dosed as a mixture of five compounds at 0.5 mg/kg each via i.v. only),6441,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621359,6642,
,N,BAO_0000218,,Oral bioavailability in dog (dose 0.5 mg/kg i.v. and 2.0 mg/kg p.o.),6442,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621360,6641,
,N,BAO_0000218,,Oral bioavailability in dog (dose 0.5 mg/kg i.v. and 2.0 mg/kg p.o.),6443,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621361,6642,
,N,BAO_0000218,,Oral bioavailability in dog,6444,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621362,5472,
,N,BAO_0000218,,Oral bioavailability in dog,6445,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621363,5985,
,N,BAO_0000218,,Oral bioavailability in dog,6446,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621364,15660,
,N,BAO_0000218,,Oral bioavailability in dog (dose 0.2 mg/kg i.v.),6447,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621166,5530,
,N,BAO_0000218,,Oral bioavailability in dog (dose 1 mg/kg i.v.),6448,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621167,5530,
,N,BAO_0000218,,Oral bioavailability (F) in dogs,6449,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621168,6305,
,N,BAO_0000218,,Oral bioavailability in dog,6450,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621169,5210,
,N,BAO_0000218,,Bioavailability in dog,6451,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL875950,5238,
,N,BAO_0000218,,Oral bioavailability in dog (dose 10 mg/kg),6452,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621170,5668,
,N,BAO_0000218,,Oral bioavailability after peroral administration at 5 mpk in Dog,6453,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621171,5668,
,N,BAO_0000218,,Oral bioavailability in dog (dose 5 mg/kg),6454,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621172,5668,
,N,BAO_0000218,,Oral bioavailability in dog (dose 10 mg/kg),6455,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621173,6084,
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice kidney bearing S180 tumor cell line for 4 hours,6456,Intermediate,2113.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621174,6599,Kidney
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice kidney bearing S180 tumor cell line for 8 hours,6457,Intermediate,2113.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621175,6599,Kidney
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice liver bearing S180 tumor cell line for 1 hour,6458,Intermediate,2107.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621176,6599,Liver
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice liver bearing S180 tumor cell line for 2 hours,6459,Intermediate,2107.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621177,6599,Liver
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice liver bearing S180 tumor cell line for 30 minutes,6460,Intermediate,2107.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621178,6599,Liver
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice liver bearing S180 tumor cell line for 4 hours,6461,Intermediate,2107.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621179,6599,Liver
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice liver bearing S180 tumor cell line for 8 hours,6462,Intermediate,2107.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621180,6599,Liver
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice lung bearing S180 tumor cell line for 1 hour,6463,Intermediate,2048.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL875951,6599,Lung
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice lung bearing S180 tumor cell line for 2 hours,6464,Intermediate,2048.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621181,6599,Lung
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice lung bearing S180 tumor cell line for 30 minutes,6465,Intermediate,2048.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621182,6599,Lung
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice lung bearing S180 tumor cell line for 4 hours,6466,Intermediate,2048.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621183,6599,Lung
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice lung bearing S180 tumor cell line for 8 hours,6467,Intermediate,2048.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621184,6599,Lung
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice muscle bearing S180 tumor cell line for 1 hour,6468,Intermediate,,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621185,6599,
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice muscle bearing S180 tumor cell line for 2 hours,6469,Intermediate,,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621186,6599,
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice muscle bearing S180 tumor cell line for 30 minutes,6470,Intermediate,,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621187,6599,
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice muscle bearing S180 tumor cell line for 4 hours,6471,Intermediate,,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621188,6599,
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice muscle bearing S180 tumor cell line for 8 hours,6472,Intermediate,,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621189,6599,
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice spleen bearing S180 tumor cell line for 1 hour,6473,Intermediate,2106.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621190,6599,Spleen
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice spleen bearing S180 tumor cell line for 2 hours,6474,Intermediate,2106.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL618520,6599,Spleen
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice spleen bearing S180 tumor cell line for 30 minutes,6475,Intermediate,2106.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621739,6599,Spleen
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice spleen bearing S180 tumor cell line for 4 hours,6476,Intermediate,2106.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621740,6599,Spleen
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice spleen bearing S180 tumor cell line for 8 hours,6477,Intermediate,2106.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621741,6599,Spleen
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor bearing S180 tumor cell line for 1 hour,6478,Intermediate,,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621742,6599,
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor bearing S180 tumor cell line for 2 hours,6479,Intermediate,,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621743,6599,
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor bearing S180 tumor cell line for 30 minutes,6480,Intermediate,,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621744,6599,
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor bearing S180 tumor cell line for 4 hours,6481,Intermediate,,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621745,6599,
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor bearing S180 tumor cell line for 8 hours,6482,Intermediate,,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621746,6599,
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/blood bearing S180 tumor cell line for 1 hour,6483,Intermediate,,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621747,6599,
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/blood bearing S180 tumor cell line for 2 hours,6484,Intermediate,,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621748,6599,
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/blood bearing S180 tumor cell line for 30 minutes,6485,Intermediate,,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621749,6599,
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/blood bearing S180 tumor cell line for 4 hours,6486,Intermediate,,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621750,6599,
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/blood bearing S180 tumor cell line for 8 hours,6487,Intermediate,,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621751,6599,
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/heart bearing S180 tumor cell line for 1 hour,6488,Intermediate,948.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621752,6599,Heart
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/heart bearing S180 tumor cell line for 2 hours,6489,Intermediate,948.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621753,6599,Heart
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/heart bearing S180 tumor cell line for 30 minutes,6490,Intermediate,948.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL875955,6599,Heart
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/heart bearing S180 tumor cell line for 4 hours,6491,Intermediate,948.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621754,6599,Heart
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/heart bearing S180 tumor cell line for 8 hours,6492,Intermediate,948.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621755,6599,Heart
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/liver bearing S180 tumor cell line for 1 hour,6493,Intermediate,2107.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL621756,6599,Liver
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/liver bearing S180 tumor cell line for 2 hours,6494,Intermediate,2107.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL624199,6599,Liver
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/liver bearing S180 tumor cell line for 30 minutes,6495,Intermediate,2107.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL624200,6599,Liver
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/liver bearing S180 tumor cell line for 4 hours,6496,Intermediate,2107.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL624375,6599,Liver
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/liver bearing S180 tumor cell line for 8 hours,6497,Intermediate,2107.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL624376,6599,Liver
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/lung bearing S180 tumor cell line for 1 hour,6498,Intermediate,2048.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL624377,6599,Lung
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/lung bearing S180 tumor cell line for 2 hours,6499,Intermediate,2048.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL624378,6599,Lung
,N,BAO_0000218,,Compound tested for the antimicrobial activity against Acinetobacter anitratus,6500,Intermediate,,1,,,,,107673.0,1,,50067,F,aeinetobacter anitrotap,,CHEMBL857901,12269,
,N,BAO_0000218,,Compound tested for the antimicrobial activity against Acinetobacter anitratus,6501,Intermediate,,1,,,,,107673.0,1,,50067,F,Acinetobacter calcoaceticus subsp. anitratus,,CHEMBL875274,12269,
,N,BAO_0000218,,Compound tested for the antimicrobial activity against Acinetobacter anitratus,6502,Intermediate,,1,,,,,107673.0,1,,50067,F,Acinetobacter calcoaceticus subsp. anitratus,,CHEMBL624379,12269,
,N,BAO_0000218,,Compound tested for the antimicrobial activity against Acinetobacter anitratus,6503,Intermediate,,1,,,,,107673.0,1,,50067,F,aeinetobacter anitrotap,,CHEMBL624380,12269,
,N,BAO_0000218,,Activity against Acinetobacter calcoaceticus (AC54),6504,Intermediate,,1,,,,,471.0,1,,50192,F,Acinetobacter calcoaceticus,,CHEMBL624381,10624,
,N,BAO_0000218,,Biological activity using the lizard skin (Anolis carolinensis) assay. The value indicates no prolonged biological activity,6505,Intermediate,,1,,,,,28377.0,1,,50714,F,Anolis carolinensis,,CHEMBL624382,17216,
,N,BAO_0000218,,Biological activity using the lizard skin (Anolis carolinensis) assay. The value indicates prolonged biological activity,6506,Intermediate,,1,,,,,28377.0,1,,50714,F,Anolis carolinensis,,CHEMBL624383,17216,
,N,BAO_0000218,,Chlorohexidine coefficient for Actinomyces naeslundii 631,6507,Intermediate,,1,,,,,1655.0,1,,50296,F,Actinomyces naeslundii,,CHEMBL624384,9560,
,N,BAO_0000218,,Chlorohexidine coefficient for Actinomyces naeslundii B74,6508,Intermediate,,1,,,,,1655.0,1,,50296,F,Actinomyces naeslundii,,CHEMBL624385,9560,
,N,BAO_0000218,,Chlorohexidine coefficient for Actinomyces naeslundii N/3,6509,Intermediate,,1,,,,,1655.0,1,,50296,F,Actinomyces naeslundii,,CHEMBL624386,9560,
,N,BAO_0000218,,Chlorohexidine coefficient for Actinomyces naeslundii N/9,6510,Intermediate,,1,,,,,1655.0,1,,50296,F,Actinomyces naeslundii,,CHEMBL624387,9560,
,N,BAO_0000218,,Plaque bactericidal index against Actinomyces naeslundii 631,6511,Intermediate,,1,,,,,1655.0,1,,50296,F,Actinomyces naeslundii,,CHEMBL624388,9560,
,N,BAO_0000218,,Plaque bactericidal index against Actinomyces naeslundii N/9,6512,Intermediate,,1,,,,,1655.0,1,,50296,F,Actinomyces naeslundii,,CHEMBL624389,9560,
,N,BAO_0000218,,Plaque bactericidal index against Actinomyces naeslundii B74,6513,Intermediate,,1,,,,,1655.0,1,,50296,F,Actinomyces naeslundii,,CHEMBL624390,9560,
,N,BAO_0000218,,Plaque bactericidal index against Actinomyces naeslundii N/3,6514,Intermediate,,1,,,,,1655.0,1,,50296,F,Actinomyces naeslundii,,CHEMBL875275,9560,
,N,BAO_0000218,,Compound was tested for its inhibitory activity using brine shrimp (Artemia salina) immobilization assay,6515,Intermediate,,1,,,,,85549.0,1,,50056,F,Artemia salina,,CHEMBL624391,114,
,N,BAO_0000218,,"Compound was tested for its inhibitory activity using brine shrimp (Artemia salina) immobilization assay; highest level tested, showed <100% activity",6516,Intermediate,,1,,,,,85549.0,1,,50056,F,Artemia salina,,CHEMBL623636,114,
,N,BAO_0000218,,Effect on incorporation of [32Pi] by isolated Ascaris suum mitochondria at a concentration of 0 uM,6517,Intermediate,,1,,,,,6253.0,1,,50532,F,Ascaris suum,,CHEMBL623637,10841,
,N,BAO_0000218,,Effect on incorporation of [32Pi] by isolated Ascaris suum mitochondria at a concentration of 10 uM,6518,Intermediate,,1,,,,,6253.0,1,,50532,F,Ascaris suum,,CHEMBL623638,10841,
,N,BAO_0000218,,Effect on incorporation of [32Pi] by isolated Ascaris suum mitochondria at a concentration of 200 uM,6519,Intermediate,,1,,,,,6253.0,1,,50532,F,Ascaris suum,,CHEMBL623639,10841,
,N,BAO_0000218,,Effect on incorporation of [32Pi] by isolated Ascaris suum mitochondria at a concentration of 25 uM,6520,Intermediate,,1,,,,,6253.0,1,,50532,F,Ascaris suum,,CHEMBL623640,10841,
,N,BAO_0000218,,Effect on incorporation of [32Pi] by isolated Ascaris suum mitochondria at a concentration of 3 uM,6521,Intermediate,,1,,,,,6253.0,1,,50532,F,Ascaris suum,,CHEMBL623641,10841,
,N,BAO_0000218,,Effect on incorporation of [32Pi] by isolated Ascaris suum mitochondria at a concentration of 50 uM.,6522,Intermediate,,1,,,,,6253.0,1,,50532,F,Ascaris suum,,CHEMBL623642,10841,
,N,BAO_0000218,,Effect on succinate formation by isolated Ascaris suum mitochondria at a concentration of 0 uM,6523,Intermediate,,1,,,,,6253.0,1,,50532,F,Ascaris suum,,CHEMBL623643,10841,
,N,BAO_0000218,,Effect on succinate formation by isolated Ascaris suum mitochondria at a concentration of 10 uM,6524,Intermediate,,1,,,,,6253.0,1,,50532,F,Ascaris suum,,CHEMBL623644,10841,
,N,BAO_0000218,,Effect on succinate formation by isolated Ascaris suum mitochondria at a concentration of 200 uM,6525,Intermediate,,1,,,,,6253.0,1,,50532,F,Ascaris suum,,CHEMBL623645,10841,
,N,BAO_0000218,,Effect on succinate formation by isolated Ascaris suum mitochondria at a concentration of 25 uM,6526,Intermediate,,1,,,,,6253.0,1,,50532,F,Ascaris suum,,CHEMBL623646,10841,
,N,BAO_0000218,,Effect on succinate formation by isolated Ascaris suum mitochondria at a concentration of 3 uM,6527,Intermediate,,1,,,,,6253.0,1,,50532,F,Ascaris suum,,CHEMBL623647,10841,
,N,BAO_0000218,,Effect on succinate formation by isolated Ascaris suum mitochondria at a concentration of 50 uM,6528,Intermediate,,1,,,,,6253.0,1,,50532,F,Ascaris suum,,CHEMBL623648,10841,
,N,BAO_0000218,,Compound is evaluated for minimal bactericidal concentration against plaque formation for Actinomyces viscosus,6529,Intermediate,,1,,,,,1656.0,1,,50366,F,Actinomyces viscosus,,CHEMBL623649,8117,
,N,BAO_0000218,,Compound is evaluated for minimal bactericidal concentration against plaque formation for Actinomyces viscosus,6530,Intermediate,,1,,,,,1656.0,1,,50366,F,Actinomyces viscosus,,CHEMBL623650,8117,
,N,BAO_0000218,,Chlorohexidine coefficient for Actinomyces viscosus 8A06,6531,Intermediate,,1,,,,,1656.0,1,,50366,F,Actinomyces viscosus,,CHEMBL623651,9560,
,N,BAO_0000218,,Chlorohexidine coefficient for Actinomyces viscosus M-100,6532,Expert,,1,,,,,1656.0,1,,50366,F,Actinomyces viscosus,,CHEMBL623652,9560,
,N,BAO_0000218,,Chlorohexidine coefficient for Actinomyces viscosus M-626,6533,Intermediate,,1,,,,,1656.0,1,,50366,F,Actinomyces viscosus,,CHEMBL623653,9560,
,N,BAO_0000218,,Chlorohexidine coefficient for Actinomyces viscosus T14V,6534,Intermediate,,1,,,,,1656.0,1,,50366,F,Actinomyces viscosus,,CHEMBL623654,9560,
,N,BAO_0000218,,Plaque bactericidal index against Actinomyces viscosus 8A06,6535,Intermediate,,1,,,,,1656.0,1,,50366,F,Actinomyces viscosus,,CHEMBL623655,9560,
,N,BAO_0000218,,Plaque bactericidal index against Actinomyces viscosus M-100,6536,Intermediate,,1,,,,,1656.0,1,,50366,F,Actinomyces viscosus,,CHEMBL623656,9560,
,N,BAO_0000218,,Plaque bactericidal index against Actinomyces viscosus M-100 measured as chlorohexidine coefficient,6537,Expert,,1,,,,,1656.0,1,,50366,F,Actinomyces viscosus,,CHEMBL623657,9560,
,N,BAO_0000218,,"Plaque bactericidal index against Actinomyces viscosus M-100 measured as chlorohexidine coefficient; d=Not bactericidal at highest concentration tested (0.2% w/v, 2min, 5 days)",6538,Intermediate,,1,,,,,1656.0,1,,50366,F,Actinomyces viscosus,,CHEMBL623658,9560,
,N,BAO_0000218,,"Plaque bactericidal index against Actinomyces viscosus M-100 measured as chlorohexidine coefficient; not bactericidal at highest concentration tested (0.2% w/v, 2min, 5 days)",6539,Intermediate,,1,,,,,1656.0,1,,50366,F,Actinomyces viscosus,,CHEMBL623659,9560,
,N,BAO_0000218,,Plaque bactericidal index against Actinomyces viscosus 626,6540,Intermediate,,1,,,,,1656.0,1,,50366,F,Actinomyces viscosus,,CHEMBL623660,9560,
,N,BAO_0000218,,Plaque bactericidal index against Actinomyces viscosus T14V,6541,Intermediate,,1,,,,,1656.0,1,,50366,F,Actinomyces viscosus,,CHEMBL623661,9560,
,N,BAO_0000218,,anti-filarial Activity was measured against Acanthocheilonema viteae in jirds at 1.56 mg/kg/day(5 days) dose,6542,Intermediate,,1,,,,,6277.0,1,,50535,F,Acanthocheilonema viteae,,CHEMBL875281,10986,
,N,BAO_0000218,,anti-filarial Activity was measured against Acanthocheilonema viteae in jirds at 100 mg/kg/day(5 days) dose,6543,Intermediate,,1,,,,,6277.0,1,,50535,F,Acanthocheilonema viteae,,CHEMBL623662,10986,
,N,BAO_0000218,,anti-filarial Activity was measured against Acanthocheilonema viteae in jirds at 12.5 mg/kg/day(5 days) dose,6544,Intermediate,,1,,,,,6277.0,1,,50535,F,Acanthocheilonema viteae,,CHEMBL623663,10986,
,N,BAO_0000218,,anti-filarial Activity was measured against Acanthocheilonema viteae in jirds at 200 mg/kg/day(5 days) dose,6545,Intermediate,,1,,,,,6277.0,1,,50535,F,Acanthocheilonema viteae,,CHEMBL623664,10986,
,N,BAO_0000218,,anti-filarial Activity was measured against Acanthocheilonema viteae in jirds at 25 mg/kg/day(5 days) dose,6546,Intermediate,,1,,,,,6277.0,1,,50535,F,Acanthocheilonema viteae,,CHEMBL623665,10986,
,N,BAO_0000219,,Evaluated for the inhibitory concentration required to cause growth inhibition of A673Mer+ sarcoma cell line using the MTT Cytotoxicity Assay,6547,Intermediate,,1,,,165.0,,9606.0,1,A673,80023,F,Homo sapiens,,CHEMBL621856,10708,
,N,BAO_0000219,,Evaluated for the inhibitory concentration required to cause growth inhibition of A704Rem- renal cell line using the MTT Cytotoxicity Assay,6548,Intermediate,,1,,,645.0,,9606.0,1,A704,80661,F,Homo sapiens,,CHEMBL620432,10708,
,U,BAO_0000219,,Tested for inhibition of ET-1 induced phosphoinositide (PI) turnover in A7r5 smooth muscle cells,6549,Autocuration,,0,,,,,10116.0,1,,22226,F,Rattus norvegicus,,CHEMBL620433,416,
,N,BAO_0000219,,Inhibition of Forskolin-Induced cAMP production in A9 L cells expressing m2 receptors,6550,Intermediate,,1,,,625.0,,10090.0,1,A9,80024,F,Mus musculus,,CHEMBL620434,14354,
,N,BAO_0000219,,Percent inhibition of Forskolin-Induced cAMP production in A9 L cells expressing m2 receptors,6551,Intermediate,,1,,,625.0,,10090.0,1,A9,80024,F,Mus musculus,,CHEMBL620435,14354,
,N,BAO_0000219,,Cytotoxicity against Beta- tubulin mutant expressing A9-PTX10 cell line of humans was tested,6552,Intermediate,,1,,,625.0,,9606.0,1,A9,80024,F,Homo sapiens,,CHEMBL620436,5116,
,N,BAO_0000219,,Percentage inhibition at higher concentration (100 nM) against Beta- tubulin mutant expressing A9-PTX10 cell line,6553,Intermediate,,1,,,625.0,,9606.0,1,A9,80024,F,Homo sapiens,,CHEMBL876597,5116,
,N,BAO_0000219,,Inhibition of human ovarian carcinoma (A90) FGF-R overexpressing cell proliferation,6554,Expert,,1,,,874.0,,9606.0,1,Human ovarian carcinoma cell line,81037,F,Homo sapiens,,CHEMBL620437,15694,
,N,BAO_0000219,,"Tested for stimulating PI (phosphoinositol) hydrolysis in A9L-m1 cells, activity expressed as EC50 mM.",6555,Expert,,1,,,625.0,,10090.0,1,A9,80024,F,Mus musculus,,CHEMBL620438,13038,
,N,BAO_0000219,,Stimulating PI (phosphoinositol) hydrolysis in A9L-m1 cells.,6556,Expert,,1,,,625.0,,10090.0,1,A9,80024,F,Mus musculus,,CHEMBL620439,13038,
,N,BAO_0000219,,Increase in phosphoinositide (PI) metabolism in A9L-m1 cells at 100 uM.,6557,Expert,,1,,,625.0,,10090.0,1,A9,80024,F,Mus musculus,,CHEMBL619657,10923,
,N,BAO_0000219,,The increase in phosphoinositide (PI) metabolism in A9L-m1 cells was measured at 100 uM; - = Not determined,6558,Intermediate,,1,,,625.0,,10090.0,1,A9,80024,F,Mus musculus,,CHEMBL619658,10923,
,N,BAO_0000219,,The increase in phosphoinositide (PI) metabolism in A9L-m1 cells was measured at 100 uM; i = inactive,6559,Intermediate,,1,,,625.0,,10090.0,1,A9,80024,F,Mus musculus,,CHEMBL619659,10923,
,H,BAO_0000019,,"Increase in phosphoinositide (PI) metabolism in A9L-cholinergic receptor, muscarinic 3 expressing cells was measured at 100 uMolar",6560,Expert,,8,,,,,,1,,10649,F,,,CHEMBL619660,10923,
,N,BAO_0000219,,The increase in phosphoinositide (PI) metabolism in A9L-m3 cells was measured at 100 uM; - = Not determined,6561,Intermediate,,1,,,625.0,,10090.0,1,A9,80024,F,Mus musculus,,CHEMBL619661,10923,
,N,BAO_0000219,,The increase in phosphoinositide (PI) metabolism in A9L-m3 cells was measured at 100 uM; i = inactive,6562,Intermediate,,1,,,625.0,,10090.0,1,A9,80024,F,Mus musculus,,CHEMBL619662,10923,
,N,BAO_0000219,,Ability to inhibit growth of AA-6 cells (a mutant cell line resistant to 8-azaadenine and lacks adenine phosphoryltransferase) was determined,6563,Intermediate,,1,,,975.0,,10029.0,1,AA6,80663,F,Cricetulus griseus,,CHEMBL619663,8158,
,U,BAO_0000219,,Intracellular phosphorylation (100 uM) in uninfected AA2 cells was studied after 5 hrs of Incubation.,6564,Autocuration,,0,,,,,9606.0,1,,22226,F,Homo sapiens,,CHEMBL619664,15494,
,U,BAO_0000219,,"Intracellular phosphorylation (100 uM) in uninfected AA2 cells was studied, after 5 hrs of Incubation.",6565,Autocuration,,0,,,,,9606.0,1,,22226,F,Homo sapiens,,CHEMBL619665,15494,
,N,BAO_0000219,,Anti -HIV activity was measured against AA5/HIV-1(IIIB),6566,Intermediate,,1,,,974.0,,9606.0,1,AA5,80662,F,Homo sapiens,,CHEMBL883244,12348,
,N,BAO_0000219,,Cytotoxicity was measured against AA5/HIV-1(IIIB),6567,Intermediate,,1,,,974.0,,9606.0,1,AA5,80662,F,Homo sapiens,,CHEMBL884011,12348,
,N,BAO_0000219,,Compound was evaluated for the anti-HIV activity against HIV strain IIIB in AA5 EBV-infected B-cell,6568,Intermediate,,1,,,974.0,,9606.0,1,AA5,80662,F,Homo sapiens,,CHEMBL619666,2726,
,N,BAO_0000219,,Compound was evaluated for the anti-HIV activity against HIV strain IIIB in U937 monocytic cell,6569,Intermediate,,1,,,379.0,,9606.0,1,U-937,80566,F,Homo sapiens,,CHEMBL619667,2726,
,N,BAO_0000219,,Hypersensitivity factor obtained from in vitro cytotoxicities against Chinese hamster ovary derived AA8 / UV4 cell lines,6570,Intermediate,,1,,,274.0,,10029.0,1,UV4,80578,F,Cricetulus griseus,,CHEMBL619668,10747,
,N,BAO_0000219,,"Inhibition of cell growth in culture against Chinese hamster ovary derived cell line, AA8",6571,Expert,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL619669,11005,
,N,BAO_0000219,,Average intracellular compound concentration when the hypoxic SER=1.6,6572,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL876608,12687,
,N,BAO_0000219,,Average intracellular compound concentration when the hypoxic SER=1.6.,6573,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL619670,12687,
,N,BAO_0000219,,Average intracellular compound concentration where the hypoxia sensitizer enhancement ratio (SER)=1.6,6574,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL619671,12687,
,N,BAO_0000219,,Average intracellular compound concentration where the sensitizer enhancement ratio (SER)=1.6 under hypoxia,6575,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL619672,12687,
,N,BAO_0000219,,Compound concentration at which sensitizer enhancement ratio =1.6 under hypoxia.,6576,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL619673,12687,
,N,BAO_0000219,,"Compound was tested for the concentration required to reduce cell survival under hypoxic conditions, using the cell line AA8 in the clonogenic assay.",6577,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL619674,13436,
,N,BAO_0000219,,"Concentration needed to reduce cell survival to 10% of control values, using 1 hour exposure of plateau phase AA8 cells at 10e6 cells/ml",6578,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL619675,13435,
,N,BAO_0000219,,Activity to reduce the surviving fraction to 10% (CT10) was used as an inverse measure of cytotoxic potency in aerobic conditions,6579,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL619676,13302,
,N,BAO_0000219,,Compound concentration required to reduce cell survival to 10% of control values under hypoxic condition,6580,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL619677,12687,
,N,BAO_0000219,,Compound concentration required to reduce cell survival to 10% of control values under hypoxic condition,6581,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,A,Cricetulus griseus,,CHEMBL619678,12687,
,N,BAO_0000219,,Compound concentration required to reduce cell survival to 10% of control values under hypoxic condition.,6582,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,A,Cricetulus griseus,,CHEMBL619679,12687,
,N,BAO_0000219,,Concentration x time (uM h) to reduce cell survival to 10% of control values under hypoxic conditions by clonogenic assay,6583,Expert,,1,,,185.0,,10029.0,1,CHO-AA8,80089,A,Cricetulus griseus,,CHEMBL619680,12878,
,N,BAO_0000219,,Concentration x time (uM h) to reduce cell survival to 10% of control values under hypoxic conditions by clonogenic assay. Inactive at the solubility limit,6584,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,A,Cricetulus griseus,,CHEMBL621457,12878,
,N,BAO_0000219,,Cytotoxicity under aerobic conditions determined to reduce the AA8 cell survival to 10% controls in clonogenic assay,6585,Expert,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL876609,14367,
,N,BAO_0000219,,Cytotoxicity under aerobic conditions determined to reduce the AA8 cell survival to 10% of controls in clonogenic assay,6586,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL621458,14367,
,N,BAO_0000219,,Aerobic cytotoxicity was assessed in a growth inhibition assay using log phase cultures of the chinese hamster ovary fibroblast line AA8,6587,Expert,,1,,,185.0,,36483.0,1,CHO-AA8,80089,F,hampster,,CHEMBL621459,12398,
,N,BAO_0000219,,Aerobic growth inhibition in Chinese hamster cell line AA8,6588,Expert,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL621460,12878,
,N,BAO_0000219,,Cytotoxicity against AA8 cell and IC50 values were determined as drug concentration required to inhibit cell protein to 50%.,6589,Expert,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL621461,13820,
,N,BAO_0000219,,Inhibition of growth under aerobic conditions in AA8 cells,6590,Expert,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL621462,13436,
,N,BAO_0000218,,Oral bioavailability in dog (dose 10 mg/kg),6591,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621463,6084,
,N,BAO_0000218,,Oral bioavailability in dog at 10 mg/kg of the compound,6592,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621464,5711,
,N,BAO_0000218,,Oral bioavailability in dog (dose 5 uM/kg),6593,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621465,4353,
,N,BAO_0000218,,Oral bioavailability in dog (dose 5 uM/kg),6594,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621466,4353,
,N,BAO_0000218,,Oral bioavailability in dog (mongrel),6595,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621467,17800,
,N,BAO_0000218,,Oral bioavailability in dog (dose 10 mg/kg),6596,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621468,3994,
,N,BAO_0000218,,Oral bioavailability in dog (dose 10 mg/kg),6597,Intermediate,,1,,In vivo,,,9615.0,1,,50588,F,Canis lupus familiaris,,CHEMBL876734,3994,
,N,BAO_0000218,,Bioavailability in dog,6598,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618476,5145,
,N,BAO_0000218,,Bioavailability in dog (dose 1 mg/kg i.v.),6599,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618477,16452,
,N,BAO_0000218,,Pharmacokinetic data for dose given to dogs intravenously (oral PK study in parentheses),6600,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618478,16452,
,N,BAO_0000218,,Pharmacokinetic property (F) was measured in dog at the dose of 0.032 mg/kg,6601,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618479,5983,
,N,BAO_0000218,,Bioavailability in dog,6602,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618480,4273,
,N,BAO_0000218,,Bioavailability in dog (dose 3-10 mg/kg),6603,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618481,12500,
,N,BAO_0000218,,The compound was tested for bioavailability of compound in plasma of dog; Complete,6604,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618482,12500,Plasma
,N,BAO_0000218,,Oral bioavailability in dog,6605,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618483,3639,
,N,BAO_0000218,,Oral bioavailability in dog,6606,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618484,3880,
,N,BAO_0000218,,Bioavailability in dog,6607,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618485,4838,
,N,BAO_0000218,,oral bioavailability was measured in dogs,6608,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618486,15600,
,N,BAO_0000218,,Compound was tested for plasma protein binding in dog; Not determined,6609,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618487,17248,
,N,BAO_0000218,,Compound was tested for plasma protein binding of dog,6610,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618488,17248,
,N,BAO_0000218,,Compound was tested for plasma protein binding of dog; Not determined,6611,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL876735,17248,
,N,BAO_0000218,,Concentration in dogs after oral administration at dose of 1 mg/kg after 180 min.,6612,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618489,17443,
,N,BAO_0000218,,Apparent terminal elimination half-life in dog after administration of 20 mg/kg dose through peroral route,6613,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618490,4186,
,N,BAO_0000218,,Half life was determined,6614,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618491,3749,
,N,BAO_0000218,,Half life by ''Cr'' assay in dog at a dose of 5 mg/kg,6615,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618492,3249,
,N,BAO_0000218,,Half life was evaluated in dog,6616,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL873354,3022,
,N,BAO_0000218,,Half life was determined,6617,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618493,3749,
,N,BAO_0000218,,Biodistribution of compound was measured in bile at 2 hr post-injection in canine deep vein thrombosis model (DVT),6618,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618494,2517,
,N,BAO_0000218,,Biodistribution of compound was measured in heart at 2 hr post-injection in canine deep vein thrombosis model (DVT),6619,Intermediate,948.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618495,2517,Heart
,N,BAO_0000218,,Biodistribution of compound was measured in kidney at 2 hr post-injection in canine deep vein thrombosis model (DVT),6620,Intermediate,2113.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618496,2517,Kidney
,N,BAO_0000218,,Biodistribution of compound was measured in liver at 2 hr post-injection in canine deep vein thrombosis model (DVT),6621,Intermediate,2107.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618497,2517,Liver
,N,BAO_0000218,,Biodistribution of compound was measured in lung at 2 hr post-injection in canine deep vein thrombosis model (DVT),6622,Intermediate,2048.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618498,2517,Lung
,N,BAO_0000218,,Biodistribution of compound was measured in spleen at 2 hr post-injection in canine deep vein thrombosis model (DVT),6623,Intermediate,2106.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618499,2517,Spleen
,N,BAO_0000218,,LogP in dog,6624,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL876736,3639,
,N,BAO_0000218,,Partition coefficient (logP),6625,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618500,6227,
,N,BAO_0000218,,Partition coefficient in dog,6626,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL857831,6227,
,N,BAO_0000218,,Mean-residence time of compound after intravenous administration in dogs at 1.2 uM/kg,6627,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618501,17764,
,N,BAO_0000218,,Pharmacokinetic parameter MRT was determined in Beagle dogs after (po) administration of a dose of 28 (uM/kg),6628,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618502,4809,
,N,BAO_0000218,,In vitro metabolic stability determined after 30 min of incubation in dog hepatic microsomes,6629,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618503,5600,
,N,BAO_0000218,,Metabolism of compound in dog S9 microsomes ('++''indicates 20-50% largest observed peak),6630,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618504,14294,
,N,BAO_0000218,,Metabolism of compound in dog S9 microsomes ('++++' indicates largest observed peak),6631,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618505,14294,
,N,BAO_0000218,,Metabolism of compound in dog S9 microsomes; Trace,6632,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618506,14294,
,N,BAO_0000218,,In vitro metabolic potential in dog liver microsomes,6633,Intermediate,2107.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618507,6251,Liver
,N,BAO_0000218,,Oral bioavailability of perorally administered compound (10 mg/kg) was tested in dogs,6634,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL876737,3748,
,N,BAO_0000218,,Oral bioavailability in dog,6635,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618508,2713,
,N,BAO_0000218,,Oral bioavailability in dog,6636,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618509,6512,
,N,BAO_0000218,,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,6637,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618510,6679,
,N,BAO_0000218,,The compound was tested for bioavailability in dogs,6638,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618511,3749,
,N,BAO_0000218,,The compound was tested for oral bioavailability in dogs,6639,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618512,3749,
,N,BAO_0000218,,Oral bioavailability in dog,6640,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618513,6742,
,N,BAO_0000218,,Compound was tested for percent protein binding (PB) in dog,6641,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618514,6227,
,N,BAO_0000218,,Apparent permeability coefficient (Papp) for apical to basolateral flux was determined in MadinDarby Canine Kidney cells,6642,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL620052,6874,
,N,BAO_0000218,,Compound was evaluated for plasma clearance.,6643,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL620053,2877,Plasma
,N,BAO_0000218,,The compound was tested for plasma clearance in dog,6644,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL620054,12500,Plasma
,N,BAO_0000218,,The compound was tested for plasma clearance in dog at dose of 3-10 mgkg,6645,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL620055,12500,Plasma
,N,BAO_0000218,,Plasma protein binding was determined after intravenous administration of 1 mg/kg in dog,6646,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL620056,4709,
,N,BAO_0000218,,In vitro relative rate of metabolism was determined in dog liver microsomes,6647,Intermediate,2107.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL620057,5542,Liver
,N,BAO_0000218,,Relative bioavailability after oral dose of compound at 3 mg/kg in dogs,6648,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618939,17594,
,N,BAO_0000218,,Compound was evaluated for half-life period in dogs at a dose of 5 mpk perorally,6649,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618940,2652,
,N,BAO_0000218,,Half life after intravenous administration in dogs at 1.2 uM/kg,6650,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618941,17764,
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/lung bearing S180 tumor cell line for 30 minutes,6651,Intermediate,2048.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL624473,6599,Lung
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/lung bearing S180 tumor cell line for 4 hours,6652,Intermediate,2048.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL624474,6599,Lung
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/lung bearing S180 tumor cell line for 8 hours,6653,Intermediate,2048.0,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL624475,6599,Lung
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/muscle bearing S180 tumor cell line for 1 hour,6654,Intermediate,,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL624476,6599,
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/muscle bearing S180 tumor cell line for 2 hours,6655,Intermediate,,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL623478,6599,
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/muscle bearing S180 tumor cell line for 30 minutes,6656,Intermediate,,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL623479,6599,
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/muscle bearing S180 tumor cell line for 4 hours,6657,Intermediate,,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL623480,6599,
,N,BAO_0000218,,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/muscle bearing S180 tumor cell line for 8 hours,6658,Intermediate,,1,,,42.0,,10090.0,1,CCRF S-180,50594,A,Mus musculus,,CHEMBL623481,6599,
,N,BAO_0000218,,C2 in brain of mice at the oral dose of 50 mg/kg,6659,Intermediate,955.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623482,17641,Brain
,N,BAO_0000218,,C2 in kidney of mice at the oral dose of 50 mg/kg,6660,Intermediate,2113.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623483,17641,Kidney
,N,BAO_0000218,,C2 in liver of mice at the oral dose of 50 mg/kg,6661,Intermediate,2107.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623484,17641,Liver
,N,BAO_0000218,,C2 in lungs of mice at the oral dose of 50 mg/kg,6662,Intermediate,2048.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623485,17641,Lung
,N,BAO_0000218,,C2 in spleen of mice at the oral dose of 50 mg/kg,6663,Intermediate,2106.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623486,17641,Spleen
,N,BAO_0000218,,Plasma clearance in mouse,6664,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623487,17852,
,N,BAO_0000218,,Clearance of compound after intravenous administration in mice at 24 uM/kg,6665,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623488,17764,
,N,BAO_0000218,,Clearance from mouse blood following i.v. administration of 10 mg/kg,6666,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623489,17837,
,N,BAO_0000218,,Clearance was evaluated in mice after intravenous administration,6667,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL875157,2675,
,N,BAO_0000218,,Clearance was evaluated in mice after oral administration,6668,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623490,2675,
,N,BAO_0000218,,Pharmacokinetic property (Plasma clearance) was measured in mouse,6669,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623491,4239,
,N,BAO_0000218,,Plasma clearance of compound was determined at 40 mg/Kg,6670,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623492,17753,
,N,BAO_0000218,,Plasma clearance of at 24 mg/Kg,6671,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623493,17753,
,N,BAO_0000218,,Plasma clearance at 24 mg/Kg,6672,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623494,17753,
,N,BAO_0000218,,Plasma clearance at 5 mg/Kg,6673,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623495,17753,
,N,BAO_0000218,,Plasma clearance in mice,6674,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623496,5727,
,N,BAO_0000218,,Plasma clearance value upon iv administration in mouse,6675,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623497,2862,
,N,BAO_0000218,,Total plasma clearance in mice,6676,Intermediate,1969.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623498,5980,Plasma
,N,BAO_0000218,,Clearance in mouse,6677,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623499,17592,
,N,BAO_0000218,,Clearance value was determined,6678,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623500,17718,
,N,BAO_0000218,,Plasma clearance at a dose of 10 mg/kg intravenous administration in mice.,6679,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623501,16597,
,U,BAO_0000100,,Calculated partition coefficient (clogP),6680,Intermediate,,0,,,,,,1,,22229,P,,,CHEMBL875158,17384,
,N,BAO_0000218,,Plasma clearance for the compound was measured in mouse after an iv dose of 1 mg/kg,6681,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623502,6062,
,N,BAO_0000218,,Plasma clearance rate after intraperitoneal administration of 100 mg/kg in mice,6682,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623503,17734,
,N,BAO_0000218,,Plasma clearance was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,6683,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623504,6348,
,N,BAO_0000218,,In vivo total clearance was determined in murine septicemia at dose of 100 mg/kg,6684,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623505,5969,
,N,BAO_0000218,,In vivo total clearance was determined in murine septicemia at dose of 50 mg/kg,6685,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623506,5969,
,N,BAO_0000218,,In vivo total clearance was determined in murine septicemia at dose of 50 mg/kg;ND=not determined,6686,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623507,5969,
,N,BAO_0000218,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for Cmax,6687,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623508,16597,
,N,BAO_0000218,,Cmax after oral administration at 30 mg/kg in ICR mouse,6688,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623509,5781,
,N,BAO_0000218,,Cmax after peroral administration in mice at 2.4 uM/kg,6689,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL875159,17764,
,N,BAO_0000218,,Cmax in brain of mice at the oral dose of 50 mg/kg,6690,Intermediate,955.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623510,17641,Brain
,N,BAO_0000218,,Cmax in kidney of mice at the oral dose of 50 mg/kg,6691,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623511,17641,Kidney
,N,BAO_0000218,,Cmax in liver of mice at the oral dose of 50 mg/kg,6692,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623512,17641,Liver
,N,BAO_0000218,,Cmax in lungs of mice at the oral dose of 50 mg/kg,6693,Intermediate,2048.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623513,17641,Lung
,N,BAO_0000218,,Cmax in mice at 18 uM/kg i.p. administration,6694,Intermediate,,1,,In vivo,,,10090.0,1,,50594,F,Mus musculus,,CHEMBL623514,17764,
,N,BAO_0000218,,Cmax in mice at 23 uM/kg i.v. administration,6695,Intermediate,,1,,In vivo,,,10090.0,1,,50594,F,Mus musculus,,CHEMBL622609,17764,
,N,BAO_0000218,,Cmax in mice at 24 uM/kg i.p. administration,6696,Intermediate,,1,,In vivo,,,10090.0,1,,50594,F,Mus musculus,,CHEMBL622610,17764,
,N,BAO_0000218,,Cmax in mice at 25 uM/kg i.p. administration,6697,Intermediate,,1,,In vivo,,,10090.0,1,,50594,F,Mus musculus,,CHEMBL621823,17764,
,N,BAO_0000218,,Cmax in mice at 26 uM/kg i.p. administration,6698,Intermediate,,1,,In vivo,,,10090.0,1,,50594,F,Mus musculus,,CHEMBL621824,17764,
,N,BAO_0000218,,Cmax in spleen of mice at the oral dose of 50 mg/kg,6699,Intermediate,2106.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621825,17641,Spleen
,N,BAO_0000218,,Cmax value at a dose of 10 mg/kg intravenous administration in mice.,6700,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621826,16597,
,N,BAO_0000218,,Cmax value at a dose of 10 mg/kg peroral administration in mice.,6701,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621827,16597,
,N,BAO_0000218,,Cmax value was determined,6702,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621828,5727,
,N,BAO_0000218,,Cmax value in IRC mice,6703,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621829,5951,
,N,BAO_0000218,,Cmax value was determined at a dose of 100 mg/kg (i.p.) in Mice,6704,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621830,5506,
,N,BAO_0000218,,Cmax value was determined at a dose of 200 mg/kg (i.p.) in Mice,6705,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621831,5506,
,N,BAO_0000218,,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,6706,Intermediate,1969.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621832,14239,Plasma
,N,BAO_0000218,,"Compound was evaluated for the pharmacokinetic parameter, maximum plasma concentration",6707,Intermediate,1969.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624579,4890,Plasma
,N,BAO_0000218,,Evaluated for pharmacokinetic parameter Cmax in mouse at the dose 20 mg/kg,6708,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624580,429,
,N,BAO_0000218,,anti-filarial Activity was measured against Acanthocheilonema viteae in jirds at 50 mg/kg/day(5 days) dose,6709,Intermediate,,1,,,,,6277.0,1,,50535,F,Acanthocheilonema viteae,,CHEMBL624581,10986,
,N,BAO_0000218,,anti-filarial Activity was measured against Acanthocheilonema viteae in jirds at 6.25 mg/kg/day(5 days) dose,6710,Intermediate,,1,,,,,6277.0,1,,50535,F,Acanthocheilonema viteae,,CHEMBL624582,10986,
,N,BAO_0000218,,anti-filarial Activity was measured against Acanthocheilonema viteae in jirds at 75 mg/kg/day(5 days) dose,6711,Intermediate,,1,,,,,6277.0,1,,50535,F,Acanthocheilonema viteae,,CHEMBL624583,10986,
,N,BAO_0000219,,Inhibitory activity against human tumor cell line A0375 melanoma.,6712,Intermediate,,1,,,455.0,,9606.0,1,A-375,80018,F,Homo sapiens,,CHEMBL624584,13227,
,D,BAO_0000249,,Displacement of [3H]N6-PIA binding from A1 receptor in whole rat brain membranes,6713,Expert,,9,Brain membranes,,,,10116.0,1,,12512,B,Rattus norvegicus,,CHEMBL624585,4481,
,D,BAO_0000019,,Forskolin-induced cAMP production at human A1 adenosine receptor,6714,Expert,,9,,,,,9606.0,1,,114,F,Homo sapiens,,CHEMBL875165,16931,
,H,BAO_0000219,,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 0.1; change of less than 5% of allosteric enhancement.,6715,Autocuration,,8,,,449.0,,,1,CHO,114,F,,,CHEMBL619490,3850,
,H,BAO_0000219,,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 0.1 uM; An increase of cAmp content of cells,6716,Autocuration,,8,,,449.0,,,1,CHO,114,F,,,CHEMBL619491,3850,
,H,BAO_0000219,,Percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 0.1 uM,6717,Expert,,8,,,449.0,,,1,CHO,114,F,,,CHEMBL619492,3850,
,H,BAO_0000219,,Percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 0.1 uM concentration,6718,Expert,,8,,,449.0,,,1,CHO,114,F,,,CHEMBL619493,3850,
,H,BAO_0000219,,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 0.1 uM concentration; An increase of cAmp content of cells,6719,Autocuration,,8,,,449.0,,,1,CHO,114,F,,,CHEMBL619494,3850,
,H,BAO_0000219,,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 0.1 uM concentration; change of less than 5% of allosteric enhancement,6720,Autocuration,,8,,,449.0,,,1,CHO,114,F,,,CHEMBL619495,3850,
,H,BAO_0000219,,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 0.1 uM concentration; change of less than 5% of allosteric enhancement.,6721,Autocuration,,8,,,449.0,,,1,CHO,114,F,,,CHEMBL619496,3850,
,D,BAO_0000219,,Percent response to 10 uM PD-81723 on CHO cells expressing human A1-adenosine receptor at 0.1 uM; An increase of cAmp content of cells,6722,Expert,,9,,,449.0,,9606.0,1,CHO,114,F,Homo sapiens,,CHEMBL619497,3850,
,H,BAO_0000219,,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 1 uM,6723,Autocuration,,8,,,449.0,,,1,CHO,114,F,,,CHEMBL619498,3850,
,H,BAO_0000219,,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 1 uM; change of less than 5% of allosteric enhancement.,6724,Autocuration,,8,,,449.0,,,1,CHO,114,F,,,CHEMBL619499,3850,
,H,BAO_0000219,,Percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 1 uM concentration,6725,Expert,,8,,,449.0,,,1,CHO,114,F,,,CHEMBL619500,3850,
,H,BAO_0000219,,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 1 uM concentration; change of less than 5% of allosteric enhancement.,6726,Autocuration,,8,,,449.0,,,1,CHO,114,F,,,CHEMBL619501,3850,
,H,BAO_0000219,,Percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 1 uM; An increase of cAmp content of cells,6727,Expert,,8,,,449.0,,,1,CHO,114,F,,,CHEMBL619502,3850,
,H,BAO_0000219,,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 10 uM,6728,Autocuration,,8,,,449.0,,,1,CHO,114,F,,,CHEMBL619503,3850,
,H,BAO_0000219,,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 10 uM; An increase of cAmp content of cells,6729,Autocuration,,8,,,449.0,,,1,CHO,114,F,,,CHEMBL619504,3850,
,H,BAO_0000219,,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 10 uM; change of less than 5% of allosteric enhancement.,6730,Autocuration,,8,,,449.0,,,1,CHO,114,F,,,CHEMBL621298,3850,
,H,BAO_0000219,,Percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 10 uM concentration,6731,Expert,,8,,,449.0,,,1,CHO,114,F,,,CHEMBL621299,3850,
,H,BAO_0000219,,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 10 uM concentration; An increase of cAmp content of cells,6732,Autocuration,,8,,,449.0,,,1,CHO,114,F,,,CHEMBL621300,3850,
,H,BAO_0000219,,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 10 uM concentration; change of less than 5% of allosteric enhancement.,6733,Autocuration,,8,,,449.0,,,1,CHO,114,F,,,CHEMBL621301,3850,
,H,BAO_0000219,,Percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 10 uM; An increase of cAmp content of cells,6734,Expert,,8,,,449.0,,,1,CHO,114,F,,,CHEMBL621302,3850,
,N,BAO_0000219,,Ability to inhibit [125I]ET1 binding to vascular smooth muscle (vsm)- A10 cells,6735,Intermediate,,1,,,164.0,,9986.0,1,A10,80013,F,Oryctolagus cuniculus,,CHEMBL621303,12680,
,U,BAO_0000219,,In vitro potassium channel opening activity in A10 (smooth muscle) cells,6736,Autocuration,,0,,,164.0,,10116.0,1,A10,22226,F,Rattus norvegicus,,CHEMBL621304,1313,
,U,BAO_0000219,,In vitro potassium channel opening activity in A10 (smooth muscle) cells; Inactive,6737,Autocuration,,0,,,164.0,,10116.0,1,A10,22226,F,Rattus norvegicus,,CHEMBL621305,1313,
,N,BAO_0000219,,Effect on membrane potential of mitochondria in A10 smooth muscle cells from rats,6738,Intermediate,,1,,,164.0,,10116.0,1,A10,80013,F,Rattus norvegicus,,CHEMBL621306,17567,
,N,BAO_0000219,,Effect on membrane potential of mitochondria of A10 smooth muscle cells in rats,6739,Intermediate,,1,,,164.0,,10116.0,1,A10,80013,F,Rattus norvegicus,,CHEMBL618444,17567,
,N,BAO_0000219,,Percent decrease in fluorescence in a membrane potential assay using the A10 cell line derived from embryonic rat aorta at 0.001 uM,6740,Intermediate,,1,,,164.0,,10116.0,1,A10,80013,F,Rattus norvegicus,,CHEMBL618445,11819,
,N,BAO_0000219,,Compound was tested for aerobic growth inhibition against AA8 cells after 4 hr of exposure,6741,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL618446,13436,
,N,BAO_0000219,,Concentration required to reduce AA8 cell numbers to 50% of controls in a growth inhibition microassay,6742,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL618447,12687,
,N,BAO_0000219,,Concentration of the drug to inhibit chinese hamster ovary derived cell (AA8) growth in culture,6743,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL618448,12651,
,N,BAO_0000219,,Cytotoxicity in a growth inhibition assay against aerobic cultures of AA8 cells was determined,6744,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL618449,13300,
,N,BAO_0000219,,Cytotoxicity on AA8 cell growth (reduce cell number by 50%).,6745,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL618637,15296,
,N,BAO_0000219,,"Cytotoxicity in chinese hamster ovary tumor cell line-AA8, by growth inhibition assay.",6746,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL618638,15328,
,N,BAO_0000219,,Growth inhibition activity was measured in repair proficient AA8 cells under aerobic conditions (4 hours drug exposure),6747,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL618639,13302,
,N,BAO_0000219,,"Growth inhibition of aerobic AA8 cells, after 18 hours exposure",6748,Expert,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL618640,14367,
,N,BAO_0000219,,In vitro cellular toxicity against chinese hamster AA8 cell line after 4 hr of compound exposure,6749,Expert,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL618641,17002,
,N,BAO_0000219,,Inhibitory activity against AA8 cell growth in aerobic condition after 4 hr of exposure,6750,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL618642,13436,
,N,BAO_0000219,,Inhibitory activity against aerobic growth of AA8 cells.,6751,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL618643,13435,
,N,BAO_0000219,,Tested for the in vitro cytotoxicity against transformed chinese hamster fibroblast line AA8,6752,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,A,Cricetulus griseus,,CHEMBL884013,10503,
,N,BAO_0000219,,In vitro cytotoxicity against transformed chinese hamster fibroblast line AA8,6753,Expert,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL622723,10503,
,N,BAO_0000219,,Tested for the in vitro cytotoxicity against transformed chinese hamster fibroblast line AA8,6754,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL622724,10503,
,N,BAO_0000219,,Tested for growth inhibition against AA8 tumor cell line(chinese hamster ovary).,6755,Expert,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL622725,15090,
,N,BAO_0000219,,Cytotoxicity against AA8 cell line,6756,Expert,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL622726,10368,
,N,BAO_0000219,,Hypersensitivity factor(HF) was determined as ratio of IC50(AA8) to IC50(UV4),6757,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL622727,12651,
,N,BAO_0000219,,In vitro therapeutic index (aerobic IC50 / hypoxic C1.6),6758,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,A,Cricetulus griseus,,CHEMBL622728,12687,
,N,BAO_0000219,,In vitro therapeutic index (aerobic IC50 / hypoxic C1.6),6759,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL622729,12687,
,N,BAO_0000219,,In vitro therapeutic index (aerobic IC50 / hypoxic C1.6),6760,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,A,Cricetulus griseus,,CHEMBL622730,12687,
,N,BAO_0000219,,Compound was evaluated for cytotoxicity against CHO AA8 cell lines for 4 hr at pH-7.4,6761,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL622731,1890,
,N,BAO_0000219,,Compound was evaluated for in vitro cytotoxicities against Chinese hamster ovary derived AA8 cell lines.,6762,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL622732,10747,
,N,BAO_0000219,,Compound was evaluated for in vitro cytotoxicities against Chinese hamster ovary derived AA8 cell lines.,6763,Intermediate,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL622733,10747,
,U,BAO_0000218,,Maximum tolerated dose (MTD) in C3H/HeN mice (single ip dose),6764,Autocuration,,0,,,,,10029.0,1,,22224,F,Cricetulus griseus,,CHEMBL622734,11616,
,N,BAO_0000219,,Concentration required to increase radiation sensitivity by 1.3 when AA8 cells are exposed to drug for 30 min before and during irradiation under hypoxic condition.,6765,Expert,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL622735,11616,
,U,BAO_0000219,,Oxygen dependence of cytotoxicity was assessed by clonogenic assay using stirred suspension cultures of AA8 cells after 1 hr under anoxic conditions,6766,Autocuration,,0,,,185.0,,10029.0,1,CHO-AA8,22224,F,Cricetulus griseus,,CHEMBL618746,3471,
,U,BAO_0000219,,Oxygen dependence of cytotoxicity was assessed by clonogenic assay using stirred suspension cultures of AA8 cells after 3h under anoxic conditions,6767,Autocuration,,0,,,185.0,,10029.0,1,CHO-AA8,22224,F,Cricetulus griseus,,CHEMBL618747,3471,
,U,BAO_0000219,,Oxygen dependence of cytotoxicity was assessed by clonogenic assay using stirred suspension cultures of AA8 cells after 4 hr under anoxic conditions,6768,Autocuration,,0,,,185.0,,10029.0,1,CHO-AA8,22224,F,Cricetulus griseus,,CHEMBL620540,3471,
,U,BAO_0000219,,Oxygen dependence of cytotoxicity was assessed by clonogenic assay using stirred suspension cultures of AA8 cells after 1 hr under aerobic conditions,6769,Autocuration,,0,,,185.0,,10029.0,1,CHO-AA8,22224,F,Cricetulus griseus,,CHEMBL620541,3471,
,U,BAO_0000219,,Oxygen dependence of cytotoxicity was assessed by clonogenic assay using stirred suspension cultures of AA8 cells after 3h under aerobic conditions,6770,Autocuration,,0,,,185.0,,10029.0,1,CHO-AA8,22224,F,Cricetulus griseus,,CHEMBL620542,3471,
,U,BAO_0000219,,Oxygen dependence of cytotoxicity was assessed by clonogenic assay using stirred suspension cultures of AA8 cells after 4 hr under aerobic conditions,6771,Autocuration,,0,,,185.0,,10029.0,1,CHO-AA8,22224,F,Cricetulus griseus,,CHEMBL620543,3471,
,U,BAO_0000219,,Ratio of oxygen dependence of cytotoxicities of AA8 cells in aerobic condition to anoxic condition,6772,Autocuration,,0,,,185.0,,10029.0,1,CHO-AA8,22224,F,Cricetulus griseus,,CHEMBL618832,3471,
,N,BAO_0000219,,Concentration required to reduce AA8 cell survival by 10%,6773,Expert,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL618833,11616,
,U,BAO_0000219,,"Concentration required to reduce cell survival to 10% of controls under hypoxic conditions, using the AA8 (chinese hamster) aerobic cells",6774,Autocuration,,0,,,185.0,,10029.0,1,CHO-AA8,22224,F,Cricetulus griseus,,CHEMBL618834,2656,
,U,BAO_0000219,,Tested for the product of the drug concentration to the exposure time needed to reduce cell survival to 10% of controls using AA8 cells at 10 E 6 /mL in the clonogenic assay,6775,Autocuration,,0,,,185.0,,10029.0,1,CHO-AA8,22224,F,Cricetulus griseus,,CHEMBL618835,10518,
,U,BAO_0000219,,CT10 (air/N2) ratio of the product of the drug concentration to the exposure time needed to reduce cell survival to 10% of controls using AA8 cells at 10 E 6 /mL in the clonogenic assay,6776,Autocuration,,0,,,185.0,,10029.0,1,CHO-AA8,22224,F,Cricetulus griseus,,CHEMBL618836,10518,
,U,BAO_0000219,,CT10 (air/N2) ratio of the product of the drug concentration to the exposure time needed to reduce cell survival to 10% of controls using AA8 cells at 10 E 6 /mL in the clonogenic assay; range is 0.8-1.5,6777,Autocuration,,0,,,185.0,,10029.0,1,CHO-AA8,22224,F,Cricetulus griseus,,CHEMBL618837,10518,
,U,BAO_0000219,,CT10 (air/N2) ratio of the product of the drug concentration to the exposure time needed to reduce cell survival to 10% of controls using AA8 cells at 10 E 6 /mL in the clonogenic assay; range is 1-2,6778,Autocuration,,0,,,185.0,,10029.0,1,CHO-AA8,22224,F,Cricetulus griseus,,CHEMBL618838,10518,
,U,BAO_0000219,,Ability to reduce cell density of AA8 cells to 50% after 4 hr of exposure to air,6779,Autocuration,,0,,,185.0,,10029.0,1,CHO-AA8,22224,F,Cricetulus griseus,,CHEMBL618839,16156,
,U,BAO_0000219,,Aerobic cytotoxic activity was evaluated by the growth inhibition of AA8 (chinese hamster) aerobic cells,6780,Autocuration,,0,,,185.0,,10029.0,1,CHO-AA8,22224,F,Cricetulus griseus,,CHEMBL618840,2656,
,U,BAO_0000019,,"Compound was evaluated for the inhibition of cell growth in culture against Chinese hamster ovary derived cell line, AA8",6781,Autocuration,,0,,,,,10029.0,1,,22224,F,Cricetulus griseus,,CHEMBL618841,11005,
,U,BAO_0000219,,Concentration for 50% inhibition of AA8 cells growth under aerobic conditions after 18 hours exposure,6782,Autocuration,,0,,,185.0,,10029.0,1,CHO-AA8,22224,F,Cricetulus griseus,,CHEMBL618842,11942,
,U,BAO_0000219,,Concentration required for 50% inhibition of growth of AA8 cells following 4 hr drug exposure,6783,Autocuration,,0,,,185.0,,10029.0,1,CHO-AA8,22224,F,Cricetulus griseus,,CHEMBL618843,2128,
,N,BAO_0000218,,Half life period after 15 mg/kg iv dose in Dogs,6784,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618844,16907,
,N,BAO_0000218,,Half life period after 30 mg/kg po dose in Dogs,6785,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618845,16907,
,N,BAO_0000218,,Half life was measured after oral 2b administration (tested in 6 dogs),6786,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618846,9579,
,N,BAO_0000218,,Half life was measured in dog after oral 17b administration,6787,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618847,9579,
,N,BAO_0000218,,Pharmacokinetic parameter T max determined in dog after oral administration of 17b,6788,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618848,9579,
,N,BAO_0000218,,Pharmacokinetic parameter T max determined in dog after oral administration of 2b,6789,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618849,9579,
,N,BAO_0000218,,Tmax value after 15 mg/kg iv dose in Dogs,6790,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618850,16907,
,N,BAO_0000218,,Tmax value after 30 mg/kg po dose in Dogs,6791,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618851,16907,
,N,BAO_0000218,,Compound was evaluated for its half life when administered intravenously in dog,6792,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL873815,3184,
,N,BAO_0000218,,Compound was tested for plasma half life when administered in dog perorally (1 mg/kg) and intravenously (0.2 mg/kg),6793,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618852,5017,Plasma
,N,BAO_0000218,,Elimination Half-life of compound was determined in dog,6794,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618853,6821,
,N,BAO_0000218,,Half life of compound in dog following oral administration,6795,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618854,17839,
,N,BAO_0000218,,Half life of compound was determined in dog,6796,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618855,17267,
,N,BAO_0000218,,Half life of compound was determined in dog blood,6797,Intermediate,178.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618856,4727,Blood
,N,BAO_0000218,,Half life after oral and iv dosing in dogs,6798,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL875827,5238,
,N,BAO_0000218,,Half life in dogs in hours,6799,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618857,4942,
,N,BAO_0000218,,Half life on i.v. administration of 2 mg/kg was measured in dog,6800,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618858,6505,
,N,BAO_0000218,,t1/2 in dog after oral dose (1 mg/kg),6801,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618859,5130,
,N,BAO_0000218,,Half life was evaluated in dog,6802,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618860,1475,
,N,BAO_0000218,,Half life period of compound was determined after intravenous administration at 2 mg/kg,6803,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618861,17804,
,N,BAO_0000218,,Half life period of compound was determined after peroral administration at 2 mg/kg,6804,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622539,17804,
,N,BAO_0000218,,Half life period (10 mg/kg) was determined in dog,6805,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622540,6084,
,N,BAO_0000218,,Half life period (10 mg/kg) was determined in dog,6806,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL873803,6084,
,N,BAO_0000218,,Half life period by iv administration in dog at a dose of 0.3 mg/kg,6807,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL873804,5542,
,N,BAO_0000218,,Half life period by po administration in dog at a dose of 0.3 mg/kg,6808,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624311,5542,
,N,BAO_0000218,,Half life period in dog,6809,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624312,6084,
,N,BAO_0000218,,Half life period in dogs after oral administration at 1 mg/kg,6810,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624313,6241,
,N,BAO_0000218,,Half life period was evaluated against Beagle dog at a dose of 15 mg/kg after po administration,6811,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624314,1916,
,N,BAO_0000218,,Half-life of compound was determined in dogs,6812,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624315,6621,
,N,BAO_0000218,,Half-life in dog plasma,6813,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624316,1696,Plasma
,N,BAO_0000218,,Half-life in mongrel dogs was determined,6814,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624317,17800,
,N,BAO_0000218,,Half-life in dog upon oral administration,6815,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624318,17657,
,N,BAO_0000218,,Half-life in dog upon oral administration; Unable to calculate,6816,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624319,17657,
,N,BAO_0000218,,Half-life was measured in dog,6817,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624496,4239,
,N,BAO_0000218,,Half-life was measured in dog,6818,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624497,5985,
,N,BAO_0000218,,Half-recovery time (T1/2) of the vascular resistance decrease at ED30 in anesthetized dogs,6819,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624498,9932,
,N,BAO_0000218,,Oral half life was determined,6820,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624499,5199,
,N,BAO_0000218,,Plasma elimination half-life (08 h) was determined in canine following intravenous (iv) administration (1 mg/kg).,6821,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624500,5199,Plasma
,N,BAO_0000218,,Plasma half life was evaluated,6822,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624501,1475,Plasma
,N,BAO_0000218,,Plasma half life was evaluated in Dog,6823,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623666,1475,Plasma
,N,BAO_0000218,,Plasma half life was evaluated in dog,6824,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623667,1475,Plasma
,N,BAO_0000218,,T1/2 (Half-life) was after oral administration at 5 mg/kg,6825,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623668,6316,
,N,BAO_0000218,,Tested for the half life value in dog,6826,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623669,4883,
,N,BAO_0000218,,Maximum time at the dose of 2 mg/kg in dog,6827,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623670,4727,
,N,BAO_0000218,,Maximum time was evaluated against Beagle dog at a dose of 15 mg/kg after po administration,6828,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623671,1916,
,N,BAO_0000218,,Maximum time taken to reach maximum blood concentration was determined in dogs after oral administration (10 mg/kg) as a 0.05 M citric acid solution.,6829,Intermediate,178.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL875945,1337,Blood
,N,BAO_0000218,,Maximum time taken to reach maximum blood concentration was determined in dogs after oral administration (8 mg/kg) as a 0.05 M citric acid solution.,6830,Intermediate,178.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623672,1337,Blood
,N,BAO_0000218,,Pharmacokinetic (PK) property (Tmax) was determined in dog at the single dose of 1 mg/kg,6831,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623673,6265,
,N,BAO_0000218,,Pharmacokinetic parameter Tmax was determined in Beagle dogs after (iv) administration of a dose of 28 (uM/kg),6832,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623674,4809,
,N,BAO_0000218,,Pharmacokinetic property (Tmax) was measured in dog at the dose of 0.032 mg/kg p.o.,6833,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623675,5983,
,N,BAO_0000218,,"Tested for the pharmacokinetic data, time required to reach Cmax (Tmax) in dog",6834,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL872526,5313,
,N,BAO_0000218,,"Tested for the pharmacokinetic data, time required to reach Cmax (Tmax) in dog at dosage of 10 mpk",6835,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623676,5313,
,N,BAO_0000218,,Time for maximum plasma concentration was measured in dogs after an oral dose of 10 uM/kg,6836,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623677,17650,Plasma
,N,BAO_0000218,,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in male and female Beagle dogs.,6837,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623678,5199,Plasma
,N,BAO_0000218,,Time taken for maximum plasma concentration in dog,6838,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623679,933,Plasma
,N,BAO_0000218,,Time to reach Cmax after oral administration to dogs,6839,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623680,16367,
,N,BAO_0000218,,Time to reach maximum plasma concentration was determined in dog after 1 mg/kg (i.v.) and 5 mg/kg (p.o.) administration,6840,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623681,6348,Plasma
,N,BAO_0000218,,Tmax (time to reach maximum concentration) was after oral administration at 5 mg/kg,6841,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623682,6316,
,N,BAO_0000218,,Tmax after peroral administration (1 mg/kg) was determined in dog,6842,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623683,6215,
,N,BAO_0000218,,Tmax of compound determined in dog after iv administration at a dose of 10 mg/kg,6843,Expert,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623684,3598,
,N,BAO_0000218,,Tmax by oral administration at a dose of 10 uM/kg in dog was determined,6844,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622745,4527,
,N,BAO_0000218,,Tmax after peroral administration in dogs at 2.4 uM/kg,6845,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622746,17764,
,N,BAO_0000218,,In vivo Cmax in mice at dose of 100 mg/kg,6846,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622747,5969,
,N,BAO_0000218,,In vivo Cmax in mice at dose of 50 mg/kg,6847,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622748,5969,
,N,BAO_0000218,,Maximal concentration determined at a dose 10 mg/kg administered intraperitoneally to mice,6848,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622749,4573,
,N,BAO_0000218,,Maximum plasma concentration was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),6849,Intermediate,1969.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622750,3277,Plasma
,N,BAO_0000218,,Maximum concentration in plasma was determined after intraperitoneal administration of 100 mg/kg in mice,6850,Intermediate,1969.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623411,17734,Plasma
,N,BAO_0000218,,Maximum concentration obtained in mouse plasma was determined,6851,Intermediate,1969.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL875946,3132,Plasma
,N,BAO_0000218,,Maximum concentration obtained in mouse plasma was determined at dose 25 mg/kg,6852,Intermediate,1969.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623412,3132,Plasma
,N,BAO_0000218,,Maximum plasma concentration of compound was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,6853,Intermediate,1969.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623413,6348,Plasma
,N,BAO_0000218,,Maximum plasma concentration when injected i.p. in mice at a dose of 50 mg/kg,6854,Intermediate,1969.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623414,17729,Plasma
,N,BAO_0000218,,Maximum plasma concentration when injected intravenously in mice at a dose of 20 mg/kg,6855,Intermediate,1969.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623415,17729,Plasma
,N,BAO_0000218,,Maximum plasma concentration when injected perorally in mice at a dose of 50 mg/kg,6856,Intermediate,1969.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623416,17729,Plasma
,N,BAO_0000218,,Maximal plasma concentration in BALB/C mice after 20 mg/kg intraperitoneal dose,6857,Intermediate,1969.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623417,17728,Plasma
,N,BAO_0000218,,Maximal plasma concentration in BALB/C mice after 20 mg/kg intravenous dose,6858,Intermediate,1969.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623418,17728,Plasma
,N,BAO_0000218,,Maximal plasma concentration in BALB/C mice after 50 mg/kg oral dose,6859,Intermediate,1969.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623419,17728,Plasma
,N,BAO_0000218,,Peak concentration at a single subcutaneous administration of 40 mg/kg in mice,6860,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622816,4066,
,N,BAO_0000218,,Pharmacokinetic property (C(max)) was determined after ip administration of 32 mg/kg in mice,6861,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623313,6178,
,N,BAO_0000218,,Pharmacokinetic property (C(max)) was determined after po administration of 32 mg/kg in mice,6862,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623314,6178,
,N,BAO_0000218,,Pharmacokinetic studies were carried out in vivo after administration of compound at 5 mg/kg intravenously in mice,6863,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL876788,3760,
,N,BAO_0000218,,Pharmacokinetic studies were carried out in vivo after administration of compound at 5 mg/kg perorally in mice,6864,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623315,3760,
,N,BAO_0000218,,Pharmacokinetic studies were carried out in vivo after administration of compound at 50 mg/kg intravenously in mice,6865,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623316,3760,
,N,BAO_0000218,,Pharmacokinetic studies were carried out in vivo after administration of compound at 50 mg/kg perorally in mice,6866,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623317,3760,
,N,BAO_0000218,,Cmax in male mice after 2 mg/kg oral dose,6868,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623319,5961,
,N,BAO_0000218,,Plasma concentration of 5-FU in HT-3 (human cervical cancer) xenograft mice at 1.38 mg/kg oral dose co-administered with 135 mg/kg Capecitabine,6869,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623320,6137,
,N,BAO_0000218,,Tested for Cmax value at the dose of 10 mg/kg when administered perorally in mouse,6870,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623321,3802,
,N,BAO_0000218,,Concentration in plasma (systemic) following oral dose in mouse at 0.25 hr,6871,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623322,3535,
,N,BAO_0000218,,Concentration in plasma (systemic) following oral dose in mouse at 1 hr,6872,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623323,3535,
,N,BAO_0000218,,Concentration in plasma (systemic) following oral dose in mouse at 24 hr,6873,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623324,3535,
,N,BAO_0000218,,Concentration in plasma (systemic) following oral dose in mouse at 2 hr,6874,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623325,3535,
,N,BAO_0000218,,Concentration in plasma (systemic) following oral dose in mouse at 4 hr,6875,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623326,3535,
,N,BAO_0000218,,Concentration in plasma (systemic) following oral dose in mouse at 6 hr,6876,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623327,3535,
,N,BAO_0000218,,Maximum concentration in plasma upon oral administration in mouse,6877,Intermediate,1969.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623328,2862,Plasma
,N,BAO_0000218,,Maximum plasma concentration was evaluated in mice after oral administration,6878,Intermediate,1969.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623329,2675,Plasma
,N,BAO_0000218,,Maximum plasma concentration was evaluated in mice after intravenous administration; Cp max Not determined,6879,Intermediate,1969.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623330,2675,Plasma
,N,BAO_0000218,,Dose at which the compound induced fecal excretion in mice,6880,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL876789,5399,
,N,BAO_0000219,,Percent decrease in fluorescence in a membrane potential assay using the A10 cell line derived from embryonic rat aorta at 0.01 uM,6893,Expert,,1,,,164.0,,10116.0,1,A10,80013,F,Rattus norvegicus,,CHEMBL623333,11819,
,N,BAO_0000219,,Percent decrease in fluorescence in a membrane potential assay using the A10 cell line derived from embryonic rat aorta at 0.1 uM,6894,Expert,,1,,,164.0,,10116.0,1,A10,80013,F,Rattus norvegicus,,CHEMBL623334,11819,
,N,BAO_0000219,,Percent decrease in fluorescence in a membrane potential assay using the A10 cell line derived from embryonic rat aorta at 1.0 uM,6895,Expert,,1,,,164.0,,10116.0,1,A10,80013,F,Rattus norvegicus,,CHEMBL627536,11819,
,N,BAO_0000219,,Percent decrease in fluorescence in a membrane potential assay using the A10 cell line derived from embryonic rat aorta at 10.0 uM,6896,Expert,,1,,,164.0,,10116.0,1,A10,80013,F,Rattus norvegicus,,CHEMBL627537,11819,
,N,BAO_0000219,,In vitro [14C]- creatine uptake (1 mM) was determined in rat A10 smooth muscle cells at a concentration of (1 mM),6897,Intermediate,,1,,,164.0,,10116.0,1,A10,80013,F,Rattus norvegicus,,CHEMBL627538,16361,
,N,BAO_0000219,,Cytotoxicity was evaluated against A121 ovarian carcinoma human cancer cell line,6898,Intermediate,,1,,,393.0,,9606.0,1,A121,80655,F,Homo sapiens,,CHEMBL884106,2288,
,N,BAO_0000219,,Anticancer activity against human ovarian carcinoma A121 cells,6899,Intermediate,,1,,,393.0,,9606.0,1,A121,80655,F,Homo sapiens,,CHEMBL625294,10404,
,N,BAO_0000219,,Cytotoxic effect (tumor cell growth inhibition) on the human cell line A121 ovarian carcinoma at the dose of of 16.6 mM,6900,Intermediate,,1,,,393.0,,9606.0,1,A121,80655,F,Homo sapiens,,CHEMBL625295,14790,
,N,BAO_0000219,,Cytotoxic effect (tumor cell growth inhibition) on the human cell line A121 ovarian carcinoma at the dose of of 83 mM,6901,Intermediate,,1,,,393.0,,9606.0,1,A121,80655,F,Homo sapiens,,CHEMBL625296,14790,
,N,BAO_0000219,,Growth inhibition of human ovarian carcinoma (A121) cell line,6902,Expert,,1,,,393.0,,9606.0,1,A121,80655,F,Homo sapiens,,CHEMBL625297,14253,
,N,BAO_0000219,,Concentration required to inhibit growth of human tumor A121 (ovarian) cell line.,6903,Expert,,1,,,393.0,,9606.0,1,A121,80655,F,Homo sapiens,,CHEMBL625298,13617,
,N,BAO_0000219,,Cytotoxicity against human A121 ovarian cells,6904,Intermediate,,1,,,393.0,,9606.0,1,A121,80655,F,Homo sapiens,,CHEMBL625960,1003,
,N,BAO_0000219,,Cytotoxicity was evaluated in vitro against A121 (ovarian carcinoma) human tumor cell lines,6905,Intermediate,,1,,,393.0,,9606.0,1,A121,80655,F,Homo sapiens,,CHEMBL625961,830,
,N,BAO_0000219,,In vitro cytotoxicity against human ovarian carcinoma A21,6906,Intermediate,,1,,,393.0,,9606.0,1,A121,80655,F,Homo sapiens,,CHEMBL625962,12307,
,N,BAO_0000219,,Inhibition of the growth against human Ovarian Carcinoma (A121) cell line after 72 hr exposure,6907,Intermediate,,1,,,393.0,,9606.0,1,A121,80655,F,Homo sapiens,,CHEMBL624717,14254,
,N,BAO_0000219,,Inhibitory activity of compound against human A121 ovarian cell line.,6908,Intermediate,,1,,,393.0,,9606.0,1,A121,80655,F,Homo sapiens,,CHEMBL624718,13370,
,N,BAO_0000219,,Dose at which compound exhibits cytotoxicity in the A121 ovarian carcinoma cell line.,6909,Intermediate,,1,,,393.0,,9606.0,1,A121,80655,F,Homo sapiens,,CHEMBL624719,14790,
,N,BAO_0000219,,Inhibition of growth of human ovarian tumor cell line (A121) after 72 hr of drug exposure,6910,Intermediate,,1,,,393.0,,9606.0,1,A121,80655,F,Homo sapiens,,CHEMBL624720,3614,
,N,BAO_0000219,,Compound was evaluated for in vitro antiproliferative activity against A172 human CNS cancer cell line,6911,Intermediate,,1,,,622.0,,9606.0,1,A 172,80012,F,Homo sapiens,,CHEMBL624721,2664,
,N,BAO_0000219,,In vitro cytotoxicity against A172 human tumor cell lines.,6912,Expert,,1,,,622.0,,9606.0,1,A 172,80012,F,Homo sapiens,,CHEMBL624722,2037,
,N,BAO_0000219,,Growth inhibition time for A172 Human Glioma cell growth at concentration 5 uM,6913,Intermediate,,1,,,622.0,,9606.0,1,A 172,80012,F,Homo sapiens,,CHEMBL877597,14539,
,N,BAO_0000219,,Compound was evaluated for cytotoxicity against human glioblastoma (A172) cell line,6914,Intermediate,,1,,,622.0,,9606.0,1,A 172,80012,F,Homo sapiens,,CHEMBL624723,2836,
,N,BAO_0000219,,Evaluated for the inhibitory concentration required to cause growth inhibition of A172Mer- cell line of central nervous system (CNS) using the MTT Cytotoxicity Assay,6915,Intermediate,,1,,,622.0,,9606.0,1,A 172,80012,F,Homo sapiens,,CHEMBL624724,10708,
,H,BAO_0000224,,Association constant against A2 adenosine receptor,6916,Autocuration,,4,,,,,9615.0,1,,104729,B,Canis lupus familiaris,,CHEMBL624725,8975,
,N,BAO_0000219,,In vitro effective dose that causes 50% inhibition of growth of A2 cell line - amelanotic melanoma,6917,Intermediate,,1,,,1085.0,,,1,A2,80656,F,fish,,CHEMBL624726,7645,
,D,BAO_0000224,,Ratio of Ki for adenosine A2 and A1 receptor binding,6918,Autocuration,,5,,,,,10116.0,1,,104713,B,Rattus norvegicus,,CHEMBL857535,11377,
,N,BAO_0000219,,In vitro cytotoxicity against A204 human rhabdomyosarcoma cancer cell line,6919,Expert,,1,,,623.0,,9606.0,1,A204,80014,F,Homo sapiens,,CHEMBL624727,13528,
,N,BAO_0000219,,In vitro antitumor activity against A204 rhabdomyosarcoma tumor cell line was determined,6920,Expert,,1,,,623.0,,9606.0,1,A204,80014,F,Homo sapiens,,CHEMBL624728,10160,
,N,BAO_0000219,,The compound was tested in vitro for antiproliferative activity against A2058 tumor cell lines,6921,Intermediate,,1,,,404.0,,9606.0,1,A2058,80015,F,Homo sapiens,,CHEMBL624729,15144,
,N,BAO_0000219,,Growth inhibition against Human squamous cell line(A 253),6922,Intermediate,,1,,,973.0,,9606.0,1,A253 cell line,80657,F,Homo sapiens,,CHEMBL624730,13160,
,N,BAO_0000219,,Growth inhibition of human squamous carcinoma cell lines following continuous (120 hours) exposure to MTX and compound A253 cell line,6923,Intermediate,,1,,,973.0,,9606.0,1,A253 cell line,80657,F,Homo sapiens,,CHEMBL624731,12898,
,N,BAO_0000219,,The compound was tested for Growth inhibition of the human squamous cell carcinoma A253 cells,6924,Intermediate,,1,,,973.0,,9606.0,1,A253 cell line,80657,F,Homo sapiens,,CHEMBL624732,13069,
,N,BAO_0000219,,Growth inhibition of A253 cell lines.,6925,Intermediate,,1,,,973.0,,9606.0,1,A253 cell line,80657,F,Homo sapiens,,CHEMBL883245,15984,
,N,BAO_0000219,,Growth inhibition of human squamous cell carcinoma A253 cells during continuous Exposure (0-12 h),6926,Intermediate,,1,,,973.0,,9606.0,1,A253 cell line,80657,F,Homo sapiens,,CHEMBL624733,15564,
,N,BAO_0000219,,Growth inhibition of human squamous cell carcinoma A253 cells during continuous Exposure (0-12 h); ND means not determined,6927,Intermediate,,1,,,973.0,,9606.0,1,A253 cell line,80657,F,Homo sapiens,,CHEMBL624734,15564,
,N,BAO_0000219,,Growth inhibition of human squamous cell carcinoma A253 cells during continuous Exposure (0-12 h); ND means not determined,6928,Intermediate,,1,,,973.0,,9606.0,1,A253 cell line,80657,F,Homo sapiens,,CHEMBL624735,15564,
,N,BAO_0000219,,In vitro cytotoxicity causing 50% growth inhibition was determined against A270 (human ovarian cancer)cell line,6929,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621780,4720,
,N,BAO_0000219,,Antitumor activity of compound for 96-h exposure in A2780 human ovarian cell line,6930,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL877598,16112,
,N,BAO_0000219,,Cytotoxic activity against A2780 human ovarian carcinoma cell line,6931,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621781,16597,
,N,BAO_0000219,,Cytotoxicity against human cancer cell lines A2780 (ovarian),6932,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621782,16378,
,N,BAO_0000219,,Growth and colony formation inhibition of A2780 ovarian cancer cell lines,6933,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621783,16085,
,N,BAO_0000219,,Inhibition of cell growth in human ovarian carcinoma cell line (A2780) using the 96 hour continuous exposure sulforhodamine B (SRB) growth delay assay,6934,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621784,16317,
,N,BAO_0000219,,The compound was tested for cytotoxic activity against A2780 cell line(human ovarian carcinoma ),6935,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621785,15748,
,N,BAO_0000219,,Inhibition of A2780 / DDP-R human ovarian carcinoma cell proliferation,6936,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621968,16597,
,N,BAO_0000219,,Inhibition of A2780 / TAX-R human ovarian carcinoma cell proliferation,6937,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621969,16597,
,N,BAO_0000219,,Inhibition of A2780 / TAX-S human ovarian carcinoma cell proliferation,6938,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621970,16597,
,N,BAO_0000219,,cytotoxic activity toward A2780 ovarian human cell line resistant (R) to cisplatin in experiment 2,6939,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621971,15608,
,N,BAO_0000219,,cytotoxic activity toward A2780 ovarian human cell line resistant (R) to cisplatin in experiment 3,6940,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621972,15608,
,N,BAO_0000219,,cytotoxic activity toward A2780 ovarian human cell line resistant (R) to cisplatin in experiment 5,6941,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL884108,15608,
,U,BAO_0000019,,Cytotoxicity on AA8 cell growth (reduce cell number by 50%).,6942,Autocuration,,0,,,,,10029.0,1,,22224,F,Cricetulus griseus,,CHEMBL623826,15296,
,U,BAO_0000219,,Evaluated for cytotoxicity under aerobic conditions against AA8 cells using microassay,6943,Autocuration,,0,,,185.0,,10029.0,1,CHO-AA8,22224,A,Cricetulus griseus,,CHEMBL623827,10251,
,U,BAO_0000219,,Evaluated for growth inhibition of AA8 cells under aerobic conditions,6944,Autocuration,,0,,,185.0,,10029.0,1,CHO-AA8,22224,F,Cricetulus griseus,,CHEMBL623828,10251,
,U,BAO_0000219,,Evaluated for growth inhibition of AA8 cells under aerobic or hypoxic conditions,6945,Autocuration,,0,,,185.0,,10029.0,1,CHO-AA8,22224,F,Cricetulus griseus,,CHEMBL623829,10251,
,U,BAO_0000219,,Evaluated for growth inhibition of AA8 cells under aerobic or hypoxic conditions (air/N2),6946,Autocuration,,0,,,185.0,,10029.0,1,CHO-AA8,22224,F,Cricetulus griseus,,CHEMBL623830,10251,
,U,BAO_0000019,,Growth inhibition against CHO-derived cell line AA8,6947,Autocuration,,0,,,,,10029.0,1,,22224,F,Cricetulus griseus,,CHEMBL623831,11858,
,U,BAO_0000219,,Growth inhibition against CHO-derived cell line AA8 (Non toxic at solubility limit) [RB6145 used as positive control],6948,Autocuration,,0,,,185.0,,10029.0,1,CHO-AA8,22224,F,Cricetulus griseus,,CHEMBL623832,11858,
,N,BAO_0000219,,Growth inhibition in CHO subline AA8 cells exposed for 18 hr under aerobic(air) conditions,6949,Expert,,1,,,185.0,,36483.0,1,CHO-AA8,80089,F,hampster,,CHEMBL623833,11616,
,N,BAO_0000219,,Growth inhibitory activity against CHO subline AA8 cells exposed for 18 hr under aerobic conditions,6950,Expert,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL623834,11616,
,U,BAO_0000219,,Tested for the concentration of the drug to reduce cell numbers to 50 percent of controls against AA8 cells in the microassay,6951,Autocuration,,0,,,185.0,,10029.0,1,CHO-AA8,22224,F,Cricetulus griseus,,CHEMBL623835,10518,
,U,BAO_0000219,,Growth inhibition of aerobic chinese hamster ovary fibroblast AA8 cell line using an exposure time of 18 hours,6952,Autocuration,,0,,,185.0,,10029.0,1,CHO-AA8,22224,F,Cricetulus griseus,,CHEMBL623836,11396,
,U,BAO_0000219,,IC50 (air/N2) ratio of the drug to reduce cell numbers to 50 percent of controls using AA8 cells in the microassay,6953,Autocuration,,0,,,185.0,,10029.0,1,CHO-AA8,22224,F,Cricetulus griseus,,CHEMBL623837,10518,
,N,BAO_0000219,,In vitro therapeutic index as ratio of CT10 and C1.3 calculated for AA8 cells.,6954,Expert,,1,,,185.0,,10029.0,1,CHO-AA8,80089,F,Cricetulus griseus,,CHEMBL623838,11616,
,H,BAO_0000019,,compound was evaluated for association constant (Ka) of isolated serum protein AAG,6955,Autocuration,,8,,,,,,1,,12675,F,,,CHEMBL623839,14837,
,H,BAO_0000019,,Number of binding sites (n) of isolated serum protein AAG,6956,Autocuration,,8,,,,,,1,,12675,F,,,CHEMBL623840,14837,
,M,BAO_0000225,,Association constant for binding to AATT duplex,6957,Intermediate,,3,,,,,,1,,22222,B,,,CHEMBL623841,16037,
,N,BAO_0000219,,Inhibition of ABAE human fibroblast cell proliferation,6958,Expert,,1,,,416.0,,9606.0,1,ABAE,100090,F,Homo sapiens,,CHEMBL623842,16597,
,N,BAO_0000218,,"Compound was evaluated for the antitumor activity against AC755 breast carcinoma for ip administration and daily x 10 schedule; Number of toxic deaths over total number of mice per group (T/C), 1/7 at dose of 25 mg/kg",6959,Intermediate,,1,,,1064.0,,10090.0,1,AC755,80668,F,Mus musculus,,CHEMBL623843,8831,
,D,BAO_0000218,,Percent change in total cholesterol(TC) versus (T0)- at which drug intervention begins at a dose of 25 mg/kg in the chronic cholesterol-fed rabbit model,6960,Expert,,9,,,,,9986.0,1,,102444,F,Oryctolagus cuniculus,,CHEMBL618669,13419,
,D,BAO_0000218,,Oral bioactivity expressed as %inhibition after 4 hours of drug administration (dose 25 mg/kg) in rabbit bioassay,6961,Expert,,9,,In vivo,,,9986.0,1,,102444,F,Oryctolagus cuniculus,,CHEMBL618670,13419,
,H,BAO_0000357,,Inhibitory activity against angiotensin-converting enzyme (ACE).,6962,Autocuration,,8,,,,,,1,,69,B,,,CHEMBL618671,15778,
,H,BAO_0000357,,oral activity against angiotensin -converting enzyme ( ACE) and neutral endopeptidase in mouse.,6963,Autocuration,,8,,,,,,1,,69,B,,,CHEMBL618672,15778,
,N,BAO_0000219,,Effect against HIV-1 chronically infected promonocytic cell line ACH-2 cells,6964,Intermediate,,1,,,978.0,,9606.0,1,ACH-2 cell line,80669,F,Homo sapiens,,CHEMBL618673,12988,
,N,BAO_0000219,,Effect against HIV-1 chronically infected promonocytic cell line ACH-2 cells in the presence of PMA(phorbol 12-myristate 13-acetate),6965,Intermediate,,1,,,978.0,,9606.0,1,ACH-2 cell line,80669,F,Homo sapiens,,CHEMBL618674,12988,
,U,BAO_0000219,,Effect against HIV-1 expression in a chronically infected human T cell line ACH-2,6966,Autocuration,,0,,,998.0,,11676.0,1,T cell line,22224,F,Human immunodeficiency virus 1,,CHEMBL618675,12988,
,U,BAO_0000219,,Effect against HIV-1 expression in a chronically infected human T cell line ACH-2 in the presence of PMA(phorbol 12-myristate 13-acetate),6967,Autocuration,,0,,,998.0,,11676.0,1,T cell line,22224,F,Human immunodeficiency virus 1,,CHEMBL618676,12988,
,U,BAO_0000219,,Effect against HIV-1 expression in a chronically infected human T cell line ACH-2i n the presence of PMA(phorbol 12-myristate 13-acetate),6968,Autocuration,,0,,,998.0,,11676.0,1,T cell line,22224,F,Human immunodeficiency virus 1,,CHEMBL618677,12988,
,N,BAO_0000219,,Inhibition of growth of renal cancer ACHN cell line,6969,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL618678,11843,
,N,BAO_0000219,,Inhibition of growth of ACHN renal cancer cell line,6970,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL618679,16939,
,N,BAO_0000219,,Inhibitory concentration required against ACHN renal cancer cell line,6971,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL618680,4782,
,N,BAO_0000219,,Concentration required to inhibit growth of human renal (ACHN) cell line,6972,Expert,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL618681,6310,
,N,BAO_0000219,,Concentration required to inhibit growth of human renal (ACHN) cell line; nt = not tested,6973,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL618682,6310,
,N,BAO_0000219,,Cytotoxic activity against ACHN Renal cancer cell line,6974,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL618683,12858,
,N,BAO_0000219,,Cytotoxicity evaluation against ACHN renal cancer cells,6975,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL618684,17380,
,N,BAO_0000219,,In vitro antitumor activity against human renal ACHN cell line,6976,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL618685,5858,
,N,BAO_0000219,,In vitro growth inhibition of compound was determined against ACHN cell lines of Renal cancer,6977,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL876499,3838,
,N,BAO_0000219,,In vitro growth inhibition of compound was determined against ACHN cell lines of Renal cancer,6978,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL618686,3838,
,N,BAO_0000219,,"Tested for the cytotoxicity against the Renal cancer cell line ACHN, growth inhibition by 50% is reported",6979,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL618687,5406,
,N,BAO_0000219,,The compound was tested in vitro for cytotoxicity against human tumor cell line ACHN (renal).,6980,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL618688,4071,
,N,BAO_0000219,,Tested in vitro for cytotoxicity against human tumor cell line ACHN (renal).,6981,Expert,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL618689,4071,
,N,BAO_0000219,,The compound was tested in vitro for cytotoxicity against human tumor cell line ACHN (renal); Not determined,6982,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL618690,4071,
,N,BAO_0000219,,Antitumor activity was evaluated against human renal adenocarcinoma cell line ACHN.,6983,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL618691,15002,
,N,BAO_0000219,,Compound was evaluated for in vitro activity against ACHN kidney cell lines (Human tumor cells ),6984,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL619373,14769,
,N,BAO_0000219,,"Compound was tested for antiproliferative activity against ACHN, human renal adenocarcinoma",6985,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL884008,13958,
,N,BAO_0000219,,Compound was tested for its effect on the proliferation of ACHN human kidney adenocarcinoma,6986,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL619374,1665,
,N,BAO_0000219,,Compound was tested for the growth inhibition of ACHN renal tumor cell line,6987,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL619375,15354,
,N,BAO_0000219,,Compound was tested for the growth inhibition of ACHN renal tumor cell line; ND=Not determined,6988,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL619376,15354,
,N,BAO_0000219,,In vitro Growth Inhibitory activity against ACHN Human kidney cancer cell line,6989,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL619377,13978,
,N,BAO_0000219,,In vitro cytotoxicity against human renal adenocarcinoma (ACHN) tumor cell line,6990,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL619378,6798,
,N,BAO_0000218,,Tmax value after administration of 4 mg/Kg oral dose in dog,6991,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL872527,2959,
,N,BAO_0000218,,"Time to peak response on lowering of vascular resistance, in dogs when administered intravenously",6992,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL876500,9932,
,N,BAO_0000218,,Unbound plasma was determined in Beagle dog at a dose of 1 mg/kg by iv administration,6993,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619379,5546,
,N,BAO_0000218,,Volume distribution after 15 mg/kg iv dose in Dogs,6994,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619538,16907,
,N,BAO_0000218,,Volume distribution after 30 mg/kg po dose in Dogs,6995,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619539,16907,
,N,BAO_0000218,,Volume of distribution was determined in dog after a 3 mg/kg of iv dose,6996,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619540,4257,
,N,BAO_0000218,,Volume of distribution was determined by iv administration in dogs at a dose of 1 mg/kg,6997,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619541,4305,
,N,BAO_0000218,,Volume of distribution was evaluated in dog,6998,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619542,5472,
,N,BAO_0000218,,Terminal phase volume of distribution was measured in dog after an iv dose of 1 mg/kg,6999,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619543,6062,
,N,BAO_0000218,,Apparent volume of the central plasma compartment (Vc) of compound determined in dog after iv administration at a dose of 10 mg/kg,7000,Expert,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619544,3598,
,N,BAO_0000218,,The compound was tested for volume of distribution in dog,7001,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619545,12500,
,N,BAO_0000218,,The compound was tested for volume of distribution in dog at dose of 3-10 mgkg,7002,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619546,12500,
,N,BAO_0000218,,Vd (1 mg/kg) was determined in dog (in vivo),7003,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619547,6227,
,N,BAO_0000218,,Vd in dog,7004,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619548,6227,
,N,BAO_0000218,,Volume distribution was determined,7005,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619549,4219,
,N,BAO_0000218,,Volume of distribution in dog,7006,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619550,1696,
,N,BAO_0000218,,Volume of distribution by as 4 fold increase by iv administration in dogs,7007,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL876501,5542,
,N,BAO_0000218,,Volume of distribution was determined in canine following intravenous (iv) administration of drug (1 mg/kg).,7008,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619551,5199,
,N,BAO_0000218,,Volume of distribution was determined in dog after 1 mg/kg (i.v.) and 5 mg/kg (p.o.) administration,7009,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619552,6348,
,N,BAO_0000218,,Volume distribution at the dose of 2 mg/kg in dog,7010,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619553,4727,
,N,BAO_0000218,,Steady state volume of distribution was determined,7011,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618722,16367,
,N,BAO_0000218,,Bioavailability as Vdss in dogs at 1 mg/kg intravenous dose,7012,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618723,2652,
,N,BAO_0000218,,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,7013,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618724,16452,
,N,BAO_0000218,,Pharmacokinetic data at 1 mg/kg dose given to dogs intravenously,7014,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618725,16452,
,N,BAO_0000218,,Bioavailability in dog (dose 1 mg/kg i.v.),7015,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618726,16452,
,N,BAO_0000218,,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Beagle dog (male),7016,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618727,5334,
,N,BAO_0000218,,Pharmacokinetic property (vdss) was measured in dog,7017,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624233,4239,
,N,BAO_0000218,,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in dog,7018,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624234,4709,
,N,BAO_0000218,,Vdss was determined after iv 0.1 mg/kg administration in dog,7019,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624235,5600,
,N,BAO_0000218,,Volume displacement was calculated in dog,7020,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624236,6057,
,N,BAO_0000218,,Volume distribution (Vdss) of compound was determined after intravenous administration in average of two dogs at a dose of 1 mg/kg,7021,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624237,5654,
,N,BAO_0000218,,Volume distribution constant was determined,7022,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624238,5505,
,N,BAO_0000218,,Volume distribution at a dose of 1 uM/kg in dog was determined,7023,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624239,4527,
,N,BAO_0000218,,Volume distribution in dog after 2 mg/kg by oral and 0.5 mg/kg by intravenous administration,7024,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL875829,4521,
,N,BAO_0000218,,Volume distribution in dog after 2 mg/kg by oral and 0.5 mg/kg by intravenous administration; ND is not determined,7025,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624240,4521,
,N,BAO_0000218,,Volume distribution (Vdss) was measured in dog,7026,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624241,15660,
,N,BAO_0000218,,Volume distribution (Vdss) was measured in dog,7027,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624242,15660,
,N,BAO_0000218,,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,7028,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624243,6679,
,N,BAO_0000218,,Volume of distribution in steady state was determined in dog,7029,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624244,5145,
,N,BAO_0000218,,Volume of distribution of compound was determined in dog,7030,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624245,6821,
,N,BAO_0000218,,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,7031,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624246,4137,
,N,BAO_0000218,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Beagle dog (male),7032,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624247,5334,
,N,BAO_0000218,,Volume of distribution (Vdss) was measured in dog,7033,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624248,15660,
,N,BAO_0000218,,Volumes of distribution in dog (dosed as a mixture of five compounds at 0.5 mpk each via iv only),7034,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624249,6642,
,N,BAO_0000218,,Volumes of distribution in dog (dosed at 0.5 mpk iv and 2.0 mpk orally),7035,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624250,6641,
,N,BAO_0000218,,Volumes of distribution in dog (dosed at 0.5 mpk iv and 2.0 mpk orally),7036,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624251,6642,
,N,BAO_0000218,,Maximum rate of depolarization of the upstroke of the action potential,7037,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624252,11659,
,N,BAO_0000218,,Steady state volume distribution in dog,7038,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624253,6448,
,N,BAO_0000218,,Steady state volume of distribution at a dose of 0.2 mg/kg i.v.,7039,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624950,5474,
,N,BAO_0000218,,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in dog,7040,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624951,1466,
,N,BAO_0000218,,Volume distribution in dog after administration of 0.25 mg/kg iv; ND = not determined,7041,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL875830,6535,
,N,BAO_0000218,,Volume distribution in dog after administration of 1 mg/kg iv,7042,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624952,6535,
,N,BAO_0000218,,Volume of solubility in solution after intravenous administration in dogs at 1.2 uM/kg,7043,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624953,17764,
,N,BAO_0000218,,Vss after intravenous administration (0.5 mg/kg) was determined in dog,7044,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624954,6215,
,N,BAO_0000218,,Vss on i.v. administration of 2 mg/kg was measured in dog,7045,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624955,6505,
,N,BAO_0000218,,Vss was determined,7046,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624956,3639,
,N,BAO_0000218,,Vss in dog,7047,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625129,3639,
,N,BAO_0000218,,Volume of distribution was measured in dog after an iv dose of 1 mg/kg,7048,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625130,6062,
,N,BAO_0000218,,Volume distribution in dogs,7049,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625131,4942,
,N,BAO_0000218,,Volume of distribution in dog,7050,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625132,17796,
,N,BAO_0000218,,Tested for the oral bioavailability in dog,7051,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL872263,4883,
,N,BAO_0000218,,Bioavailability of compound in mouse blood following p.o. administration of 30 mg/kg,7060,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624336,17837,
,N,BAO_0000218,,Bioavailability after i.p. administration of 50 mg/kg of dose in mice,7061,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624337,17729,
,N,BAO_0000218,,Bioavailability after peroral administration of 50 mg/kg of dose in mice,7062,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624338,17729,
,N,BAO_0000218,,Bioavailability was measured in mouse,7063,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624339,4239,
,N,BAO_0000218,,Bioavailability in mouse,7064,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624340,17592,
,N,BAO_0000218,,Bioavailability was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,7065,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624341,6348,
,N,BAO_0000218,,Bioavailability in mouse,7066,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624342,2801,
,N,BAO_0000218,,Compound was evaluated for its bioavailability in mice at a dose of 1 mg/kg,7067,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624343,2801,
,N,BAO_0000218,,Oral bioavailability in mouse,7068,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624344,17718,
,N,BAO_0000218,,Oral availability at 50 mg/kg po in male mice,7069,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624345,5727,
,N,BAO_0000218,,Oral bioavailability in mouse (dose 10 mg/kg),7070,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624346,5302,
,N,BAO_0000218,,Oral bioavailability of compound determined in mouse after iv administration at a dose of 10 mg/kg,7071,Expert,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624347,3598,
,N,BAO_0000218,,"Bioavailability in male mice, 2mg/kg oral and 1 mg/kg intravenous dose",7072,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624348,5961,
,N,BAO_0000218,,Oral bioavailability in mouse,7074,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622754,6091,
,N,BAO_0000218,,Oral bioavailability in vivo in mice;ND=Not determined,7075,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622755,6091,
,N,BAO_0000218,,Oral bioavailability in mouse at 10 mg/kg of the compound,7076,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622756,5711,
,N,BAO_0000218,,Bioavailability in mouse (BALB/C) (dose 50 mg/kg i.p.),7077,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622757,17728,
,N,BAO_0000218,,Bioavailability in mouse (BALB/C) (dose 20 mg/kg i.v.),7078,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622758,17728,
,N,BAO_0000218,,Tested for bioavailability of the compound,7079,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622759,3802,
,N,BAO_0000218,,Tested for half life at the dose of 10 mg/kg when administered intravenously,7080,Intermediate,,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622760,3802,
,N,BAO_0000218,,The plasma half life of compound was determined on EDTA prepared by mouse plasma. ,7081,Intermediate,1969.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622761,14029,Plasma
,N,BAO_0000218,,The plasma half life of compound was determined on heparin prepared by human plasma. ,7082,Intermediate,1969.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622762,14029,Plasma
,N,BAO_0000218,,The plasma half life of compound was determined on heparin prepared by human plasma; Not degraded,7083,Intermediate,1969.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622763,14029,Plasma
,N,BAO_0000218,,The plasma half life of compound was determined on heparin prepared by mouse plasma. ,7084,Intermediate,1969.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622764,14029,Plasma
,N,BAO_0000218,,The plasma half life of compound was determined on heparin prepared by mouse plasma; Not degraded,7085,Intermediate,1969.0,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622765,14029,Plasma
,N,BAO_0000218,,Inhibitory concentration of compound was determined after intravenous administration in mice after 6 hours of exposure at 40 mg/Kg,7086,Intermediate,,1,,,,,10090.0,1,,50594,F,Mus musculus,,CHEMBL622766,17753,
,N,BAO_0000218,,Inhibitory concentration of compound was determined after intravenous administration in mice after 8 hours of exposure at 24 mg/Kg,7087,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622767,17753,
,N,BAO_0000218,,Inhibitory concentration of compound was determined after intravenous administration in mice after 8 hours of exposure at 5 mg/Kg,7088,Intermediate,,1,,,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622768,17753,
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in blood of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,7089,Intermediate,178.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL875948,10107,Blood
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in blood of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.50 hours,7090,Intermediate,178.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622769,10107,Blood
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in blood of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,7091,Intermediate,178.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622770,10107,Blood
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in blood of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,7092,Intermediate,178.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622771,10107,Blood
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in blood of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,7093,Intermediate,178.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622772,10107,Blood
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in blood of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,7094,Intermediate,178.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622773,10107,Blood
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in blood of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,7095,Intermediate,178.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL622774,10107,Blood
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in bone of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,7096,Intermediate,10000001.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621725,10107,Bone
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in bone of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.5 hours,7097,Intermediate,10000001.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621726,10107,Bone
,N,BAO_0000219,,cytotoxic activity toward A2780 ovarian human cell line resistant (R) to cisplatin in experiment 8,7098,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621727,15608,
,N,BAO_0000219,,In vitro cytotoxicity against human ovarian carcinoma cell line A2780 using sulforhodamine B (SRB) assay,7099,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL622413,3290,
,N,BAO_0000219,,Compound was evaluated for cytotoxicity against A2780 cell line,7100,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL622414,2859,
,N,BAO_0000219,,Inhibition of A2780 cell clonogenic assay,7101,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL622415,15688,
,N,BAO_0000219,,Cytotoxic effect on ovarian cancer cell line (A2780),7102,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL884001,5642,
,N,BAO_0000219,,Concentration required to inhibit A2780 cell growth when compared with control after incubation for 96 hr at 37 C,7103,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL622416,6633,
,N,BAO_0000219,,"MDR-reversing activity was measured by vincristine accumulation in the multidrug resistant 2780AD, a subline of A2780 ovarian carcinoma cells at 10 mg/mL",7104,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL622417,3906,
,N,BAO_0000219,,50% growth inhibition of A2780 (Human ovarian carcinoma) cell line compared with untreated control cells,7105,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL622590,6788,
,N,BAO_0000219,,Antiproliferative activity against human A2780 cells,7106,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL622591,17582,
,N,BAO_0000219,,Inhibition of human A2780 cell proliferation,7107,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL622592,17764,
,N,BAO_0000219,,Antiproliferative effect against human A2780 cell line was determined in a whole cell 72 hr cytotoxicity assay,7108,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL622593,17764,
,N,BAO_0000219,,Inhibition of human A2780 cell proliferation (No data),7109,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL622594,17764,
,N,BAO_0000219,,Cell cytotoxicity was determined against human ovarian cancer (A2780) cell line,7110,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL622595,2815,
,N,BAO_0000219,,Compound was evaluated against human Ovarian carcinoma cell line A2780,7111,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL622596,16930,
,N,BAO_0000219,,Growth inhibition against A2780 wild-type ovarian cell lines,7112,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL622597,17777,
,N,BAO_0000219,,Compound was evaluated for growth inhibition against A2780 wild-type ovarian cell lines; No data,7113,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL622598,17777,
,D,BAO_0000019,,Inhibition of tubulin polymerization in human ovarian cancer cell lines,7114,Autocuration,,5,,,,,9606.0,1,,104766,F,Homo sapiens,,CHEMBL622599,16936,
,N,BAO_0000219,,Compound was tested for in vitro growth inhibition of Ovarian carcinoma cell line panel A2780,7115,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL622600,13759,
,N,BAO_0000219,,Compound was tested for in vitro growth inhibition of Ovarian carcinoma cell line panel A2780-R,7116,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL622601,13759,
,N,BAO_0000219,,Compound was tested for in vitro growth inhibition of Ovarian carcinoma cell line panel A2780,7117,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL622602,13759,
,N,BAO_0000219,,Compound was tested for in vitro growth inhibition of Ovarian carcinoma cell line panel A2780-R,7118,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL622603,13759,
,N,BAO_0000219,,Compound was tested for inhibitory activity against A2780 human ovarian carcinoma cell line; activity expressed in Mean IC50 values,7119,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL622604,15292,
,N,BAO_0000219,,Compound was tested for inhibitory activity against A2780cisR human ovarian carcinoma cell line; activity expressed in Mean IC50 values,7120,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL622605,15292,
,N,BAO_0000219,,In vitro inhibition of human ovarian cell line A2780,7121,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL622606,15069,
,N,BAO_0000219,,"In vitro inhibition of human ovarian cell line, resistant to cisplatin (A2780cisR).",7122,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619463,15069,
,N,BAO_0000219,,Concentration of compound to inhibit the growth of human A2780 ovarian carcinoma cells(in vitro),7123,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619464,14073,
,N,BAO_0000219,,Concentration required to inhibit A2780-cell growth by 50%,7124,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619465,14553,
,N,BAO_0000219,,Concentration required to inhibit the cell growth by 50 % after 96 hr A2780 leukemic cells.,7125,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619466,13040,
,N,BAO_0000219,,Cytotoxic effect on human ovarian (A2780) cancer cell line,7126,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619467,6891,
,N,BAO_0000219,,Cytotoxic activity in a panel of Human ovarian tumor A2780 cell line after 96h of drug exposure,7127,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619468,15569,
,N,BAO_0000219,,Cytotoxic potency required to inhibit A2780 cell growth by 50% after cell drug contact for 96 hrs,7128,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619469,14190,
,N,BAO_0000219,,Cytotoxicity measured in human ovarian cell line A2780 using sulforhodamine B (SRB) assay,7129,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619470,15014,
,N,BAO_0000219,,Cytotoxicity activity of the compound was measured in human ovarian cell line A2780 using sulforhodamine B (SRB) assay,7130,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619471,15014,
,N,BAO_0000219,,Cytotoxicity against human ovarian carcinoma A2780 cell line,7131,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619472,17496,
,N,BAO_0000219,,"Cytotoxicity against A2780-C25, oxaliplatin-resistant Ovarian carcinoma cell line",7132,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL619473,13617,
,N,BAO_0000219,,"Cytotoxicity against A2780-CP3, cisplatin-resistant Ovarian carcinoma cell line",7133,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL874368,13617,
,N,BAO_0000219,,"Cytotoxicity against A2780-DX5, Doxorubicin-resistant Ovarian carcinoma cell line",7134,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL884003,13617,
,N,BAO_0000219,,"Cytotoxicity against A2780-WT, human ovarian carcinoma cell line",7135,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL622690,13617,
,N,BAO_0000219,,Cytotoxicity against ovarian carcinoma A2780 tumor cell lines,7136,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL622691,17672,
,N,BAO_0000219,,Dose of required to inhibit growth of cisplatin resistant human ovarian carcinoma (A2780 cisR) cell line with compound free controls as measured by the sulforhodamine B growth delay assay,7137,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL622692,4544,
,N,BAO_0000219,,Dose of required to inhibit growth of human ovarian carcinoma (A2780) cell line with compound free controls as measured by the sulforhodamine B growth delay assay,7138,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL623406,4544,
,N,BAO_0000219,,"Growth inhibition in human ovarian carcinoma cell line (A2780cisR,cisplatin-resistant) using the 96 hour exposure sulforhodamine B (SRB) growth delay assay",7139,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL884004,16317,
,N,BAO_0000219,,In vitro Cytotoxic activity of compound in comparison with reference compounds in human cell line A2780,7140,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL623407,15099,
,N,BAO_0000219,,In vitro Growth Inhibitory activity against A2780 Human ovarian cancer cell line,7141,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL623408,13978,
,N,BAO_0000219,,In vitro antitumor activity against A2780 cell line.,7142,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL623409,12989,
,N,BAO_0000219,,In vitro cytotoxic activity against human tumor cell line A2780 after incubation for 96 hours,7143,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL623410,5574,
,N,BAO_0000219,,In vitro cytotoxicity against A2780 human ovarian cancer cell line,7144,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL623576,13528,
,N,BAO_0000219,,Inhibitory activity against kidney A-CHN tumor cell growth in culture,7145,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL623577,12782,
,N,BAO_0000219,,The IC50 value was measured on ACHN cell line in renal tumor type.,7146,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL623578,14255,
,N,BAO_0000219,,Concentration required for killing 50% of cells of renal ACHN cell lines was determined in vitro,7147,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL623579,16364,
,N,BAO_0000219,,In vitro lethal concentration against most sensitive ACHN cell line,7148,Expert,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL623580,17376,
,N,BAO_0000219,,Tested for cytotoxic activity against renal cancer ACHN cell line,7149,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL623581,12016,
,N,BAO_0000219,,Compound tested for growth inhibition of renal cancer cell line ACHN,7150,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL857456,6058,
,N,BAO_0000219,,Compound was tested for 50% growth inhibition against human renal cancer ACHN cell line,7151,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL623582,17708,
,N,BAO_0000219,,Growth inhibition of the ACHN Renal cancer cell line for 2-day in vitro assay.,7152,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL623583,15176,
,N,BAO_0000219,,In vitro anticancer activity against ACHN renal cancer cell line,7153,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL623584,2806,
,N,BAO_0000219,,In vitro antitumor activity against Renal cancer ACHN cell lines by 6-day assay,7154,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL623585,15300,
,N,BAO_0000219,,Percent selectivity was evaluated in renal ACHN cell lines,7155,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL623586,16364,
,N,BAO_0000219,,In vitro inhibitory activity against renal ACHN cancer cell line,7156,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL623587,13859,
,N,BAO_0000219,,Tested for cytotoxicity against ACHN cell lines in renal cancer,7157,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL875279,11970,
,N,BAO_0000219,,Tested for the in vitro cytotoxicity against ACHN renal cancer cell line,7158,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL623588,2450,
,N,BAO_0000219,,In vitro anti tumor activity against human tumor Renal cancer cell lines was determined,7159,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL623589,12696,
,N,BAO_0000219,,Tested in vitro for cytotoxicity in ACHN cell line of Renal cancer,7160,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL623590,12400,
,N,BAO_0000219,,Cytotoxic effect on renal cancer line ACHN,7161,Expert,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL623591,12888,
,N,BAO_0000219,,In vitro anti-cancer activity against ACHN(Renal) human tumor cell line,7162,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL623592,3156,
,N,BAO_0000219,,In vitro inhibition of Renal Cancer ACHN cell lines,7163,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL623593,3381,
,N,BAO_0000219,,Antitumor activity against human renal adenocarcinoma ACHN cells,7164,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL623594,16747,
,N,BAO_0000219,,Antitumor activity against human renal adenocarcinoma ACHN cells.,7165,Expert,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL621833,16748,
,N,BAO_0000219,,Inhibitory concentration required to decrease cell viability in cell growth culture against kidney cells ACHN,7166,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL621834,12062,
,N,BAO_0000219,,Compound was evaluated for in vitro activity against ACHN kidney cell lines (Human tumor cells ),7167,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL621835,14769,
,N,BAO_0000219,,"Cytotoxicity against NCI tumor panel, ACHN renal cancer cell line",7168,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL621836,15895,
,N,BAO_0000219,,Concentration of compound that cause 50% cytotoxicity of ACHN renal cancer cell line,7169,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL621837,17376,
,N,BAO_0000219,,Compound was tested for antitumor activity against ACHN renal cancer cell line(molar concentration that inhibits 50% net cell growth).,7170,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL875280,14882,
,N,BAO_0000219,,Compound was tested for antitumor activity against ACHN renal cancer cell line(molar concentration leading to 50% net cell death).,7171,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL621838,14882,
,N,BAO_0000219,,Cytotoxicity was tested against renal cancer ACHN tumor cell lines.,7172,Intermediate,,1,,,626.0,,9606.0,1,ACHN,80025,F,Homo sapiens,,CHEMBL621839,15661,
,U,BAO_0000019,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,7173,Autocuration,,0,,,,,,1,,22224,A,,,CHEMBL621840,9680,
,H,BAO_0000019,,Compound tested for relative response using 1 uM ACh as agonist against AChM1 receptor.,7174,Autocuration,,8,,,,,,1,,10647,F,,,CHEMBL621841,14579,
,N,BAO_0000218,,Antiviral activity against AD169 strain of cytomegalovirus (CMV) in HEL (human erythroleukemia) cells.,7175,Expert,,1,,,468.0,,10358.0,1,HEL,50529,F,Cytomegalovirus,,CHEMBL622979,17290,
,N,BAO_0000218,,Antiviral activity against AD169 strain of cytomegalovirus (CMV); ND=No data,7176,Intermediate,,1,,,,,10358.0,1,,50529,F,Cytomegalovirus,,CHEMBL876595,17290,
,H,BAO_0000357,,Compound was evaluated for its inhibitory activity against calf intestinal Adenosine deaminase (ADA),7177,Autocuration,,8,,,,,,1,,12159,B,,,CHEMBL620221,15891,
,H,BAO_0000357,,Evaluated for the inhibition of calf intestinal Adenosine deaminase (ADA),7178,Autocuration,,8,,,,,,1,,12159,B,,,CHEMBL620222,15890,
,N,BAO_0000219,,Inhibitory activity against ovarian tumor cell line ADDP after 72 hr continuous exposure to compound,7179,Intermediate,,1,,,979.0,,9913.0,1,ADDP cell line,80670,F,Bos taurus,,CHEMBL620506,3801,
,N,BAO_0000219,,Tumor growth inhibition activity after subcutaneous transplanted tumor in ADJ-PC6 plasmacytoma cells,7180,Intermediate,,1,,,980.0,,10090.0,1,ADJ/PC6,80671,F,Mus musculus,,CHEMBL620507,9222,
,N,BAO_0000219,,Tumor growth inhibition activity after subcutaneously transplanted tumor in ADJ-PC6 plasmacytoma cells,7181,Intermediate,,1,,,980.0,,10090.0,1,ADJ/PC6,80671,F,Mus musculus,,CHEMBL620508,9222,
,N,BAO_0000219,,"Compound was tested for dose producing 90% reduction in tumor weight, in ADJ/PC6 mouse plasma cell tumor",7182,Intermediate,,1,,,980.0,,10090.0,1,ADJ/PC6,80671,F,Mus musculus,,CHEMBL620509,7257,
,N,BAO_0000219,,Compound was tested for inhibition against ADJ/PC6 mouse plasma cell tumor at the dose of 320 mg/Kg,7183,Intermediate,,1,,,980.0,,10090.0,1,ADJ/PC6,80671,F,Mus musculus,,CHEMBL620510,7257,
,N,BAO_0000219,,Compound was tested for dose required to kill 50 % of ADJ/PC6 mouse plasma cell tumor in a group,7184,Intermediate,,1,,,980.0,,10090.0,1,ADJ/PC6,80671,A,Mus musculus,,CHEMBL620511,7257,
,N,BAO_0000219,,In vitro incorporation of the [3H]thymidine into the ADJ/PC6 Plasmacytoma cells,7185,Intermediate,,1,,,980.0,,10090.0,1,ADJ/PC6,80671,F,Mus musculus,,CHEMBL620512,8084,
,U,BAO_0000019,,Tested for cytotoxicity against ADJ/PC6 mouse plasmacytoma,7186,Autocuration,,0,,,,,10090.0,1,,22224,F,Mus musculus,,CHEMBL620513,14943,
,U,BAO_0000019,,The compound was tested for cytotoxicity against ADJ/PC6 mouse plasmacytoma; Not determined,7187,Autocuration,,0,,,,,10090.0,1,,22224,F,Mus musculus,,CHEMBL620514,14943,
,U,BAO_0000019,,Tested for cytotoxicity against ADJ/PC6 plasmacytoma,7188,Autocuration,,0,,,,,10090.0,1,,22224,F,Mus musculus,,CHEMBL620515,14943,
,U,BAO_0000218,,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),7189,Autocuration,,0,,In vivo,,,1423.0,1,,22224,A,Bacillus subtilis,,CHEMBL620516,10524,
,N,BAO_0000218,,AUC value in dog after IV administration at a dose of 5 mg/kg,7190,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL620517,3546,Plasma
,N,BAO_0000218,,AUC value in dog after oral administration at a dose of 5 mg/kg,7191,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL620518,3546,Plasma
,N,BAO_0000218,,Cmax value in dog after oral administration at a dose of 5 mg/kg,7192,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL620519,3546,
,N,BAO_0000218,,Bioavailability in dog after oral administration at a dose of 5 mg/kg,7193,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621386,3546,
,N,BAO_0000218,,Tmax value in dog after oral administration at a dose of 5 mg/kg,7194,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621387,3546,
,N,BAO_0000218,,Compound was evaluated for its clearance when administered intravenously in dog,7195,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621388,3184,
,N,BAO_0000218,,Plasma clearance in Beagle dogs after intravenous administration at a dose of 10 mg/kg,7196,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621389,16456,
,N,BAO_0000218,,Plasma clearance was determined in Beagle dogs after (iv) administration of a dose of 12 (uM/kg),7197,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621390,4809,
,U,BAO_0000100,,Calculated partition coefficient (clogP),7198,Intermediate,,0,,,,,,1,,22229,P,,,CHEMBL621391,4219,
,N,BAO_0000218,,Half life in dog,7199,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621392,3748,
,N,BAO_0000218,,Time taken for EC90 was determined when tested in dog,7200,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621393,3132,
,N,BAO_0000218,,Half life (iv) was determined,7201,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621394,4219,
,N,BAO_0000218,,Loss of compound (%metabolized) after 30 min exposure to human liver microsomes,7202,Intermediate,2107.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621395,16907,Liver
,N,BAO_0000218,,Area under the curve was calculated in dog after iv administration,7203,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621396,6057,
,N,BAO_0000218,,Area under the curve was calculated in dog after peroral administration,7204,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621397,6057,
,N,BAO_0000218,,Dose-normalized area under curve in dog (p.o.) at 2.0 mpk,7205,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621398,17853,
,N,BAO_0000218,,pKa was evaluated in dog,7206,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618818,3639,
,N,BAO_0000218,,Compound was evaluated for pronounced GH response at 100 mg (n=6)(area under concentration curve was determined from 0-8 hr following morning and evening dosing with 25 mg of the compound,7207,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618819,14541,
,N,BAO_0000218,,Alpha-elimination half-life in Beagle dogs after intravenous administration at a dose of 10 mg/kg,7208,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618820,16456,
,N,BAO_0000218,,Beta-elimination half-life in Beagle dogs after intravenous administration at a dose of 10 mg/kg,7209,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL873810,16456,
,N,BAO_0000218,,Compound was evaluated for half-life period in dogs at a dose of 5 mpk perorally,7210,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL876606,2652,
,N,BAO_0000218,,Compound was evaluated for the half-life (t 1/2) in hours,7211,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618821,3624,
,N,BAO_0000218,,Half life to reach the blood concentration was determined in dogs after oral administration (10 mg/kg) as a 0.05 M citric acid solution.,7212,Intermediate,178.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618822,1337,Blood
,N,BAO_0000218,,Half life to reach the blood concentration was determined in dogs after oral administration (8 mg/kg) as a 0.05 M citric acid solution.,7213,Intermediate,178.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618823,1337,Blood
,N,BAO_0000218,,Half life after intravenous administration of 1 mg/kg in dog,7214,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618824,4709,
,N,BAO_0000218,,Half life was measured in dog,7215,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618825,15660,
,N,BAO_0000218,,Half life period in dog after 5 mg/kg dose,7216,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618826,5302,
,N,BAO_0000218,,Half life period was evaluated in dog; 4-4.8,7217,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618827,17791,
,N,BAO_0000218,,Half life was determined in dog after 1 mg/kg (i.v.) and 5 mg/kg (p.o.) administration,7218,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618828,6348,
,N,BAO_0000218,,Half-life was determined in dog after a3 mg/kg of iv dose,7219,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618829,4257,
,N,BAO_0000218,,Half-life was determined,7220,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618830,3771,
,N,BAO_0000218,,Half life in dogs,7221,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL618831,6305,
,N,BAO_0000218,,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 2 mg/kg tp dog,7222,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619489,13501,Plasma
,N,BAO_0000218,,Apparent half-life after single intravenous bolus of 1 mg/kg in dogs,7223,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619649,17594,
,N,BAO_0000218,,Compound was evaluated for the half life period after iv administration in Beagle dog.,7224,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL876607,3045,
,N,BAO_0000218,,Compound was evaluated for the half life period after oral administration in conscious dog.,7225,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619650,3043,
,N,BAO_0000218,,Compound was tested for half life in dog,7226,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619651,4839,
,N,BAO_0000218,,Compound was tested for its half life in dog,7227,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619652,4839,
,N,BAO_0000218,,Half life of compound after both po and iv administration at a dose of 5 mg/kg and 2 mg/kg resp in dog,7228,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619653,5802,
,N,BAO_0000218,,Half life of compound in dog was determined,7229,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619654,17839,
,N,BAO_0000218,,Half life (iv) was determined,7230,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619655,4219,
,N,BAO_0000218,,Half life following administration of 70 nM in canine whole blood (dose exceeding platelet binding capacity),7231,Intermediate,178.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619656,13966,Blood
,N,BAO_0000218,,Half life in Dog plasma at a dosage 5 mg/kg after intravenous administration,7232,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL873812,3994,Plasma
,N,BAO_0000218,,Half life in Dog plasma at a dosage 5 mg/kg after intravenous administration,7233,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,F,Canis lupus familiaris,,CHEMBL621365,3994,Plasma
,N,BAO_0000218,,Half life in dog,7234,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621366,4453,
,N,BAO_0000218,,Half life in dog plasma,7235,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621367,6535,Plasma
,N,BAO_0000218,,Half life in dog plasma after administration of 0.25 mg/kg iv,7236,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621368,6535,Plasma
,N,BAO_0000218,,Half life in dog plasma after administration of 1 mg/kg iv,7237,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621369,6535,Plasma
,N,BAO_0000218,,Half life in dog plasma was determined at dose 10 mg/kg,7238,Intermediate,1969.0,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621370,3132,Plasma
,N,BAO_0000218,,Half life in dog was determined,7239,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621371,5374,
,N,BAO_0000218,,Half life in dogs administered perorally (5 mg/kg) and intravenously (2 mg/kg),7240,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621372,5007,
,N,BAO_0000218,,Half life upon exposure to human plasma,7241,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621373,16907,Plasma
,N,BAO_0000218,,Half life was calculated in dog,7242,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621374,6057,
,N,BAO_0000218,,Half life was determined,7243,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621375,5006,
,N,BAO_0000218,,Half life was determined,7244,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621376,5473,
,N,BAO_0000218,,Half life by intravenous administration of 1.2 mg/kg in dog,7245,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619624,4368,
,N,BAO_0000218,,Half life in dog,7246,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL875840,6448,
,N,BAO_0000218,,Half life in dog after intra venous administration of the compound,7247,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619625,4353,
,N,BAO_0000218,,Half life in dog after intra venous administration of the compound; ND means Not determined,7248,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619626,4353,
,N,BAO_0000218,,Half life in dog after po administration of the compound,7249,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619627,4353,
,N,BAO_0000218,,Half life in dog after po administration of the compound; ND means Not determined,7250,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL873817,4353,
,N,BAO_0000218,,Half life in dog at the single oral dose of 1 mg/kg,7251,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619628,6265,
,N,BAO_0000218,,Half life in dogs,7252,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619629,5006,
,N,BAO_0000218,,Half life in dogs at 1 mg/kg oral dosing; 35-100 min,7253,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619630,5356,
,N,BAO_0000218,,Half life in rat,7254,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619631,405,
,N,BAO_0000218,,Half life in dog (dosed as a mixture of five compounds at 0.5 mpk each via iv only),7255,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL619632,6642,
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in bone of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,7256,Intermediate,10000001.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619633,10107,Bone
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in bone of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,7257,Intermediate,10000001.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL875841,10107,Bone
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in bone of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,7258,Intermediate,10000001.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619634,10107,Bone
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in bone of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,7259,Intermediate,10000001.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619635,10107,Bone
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in bone of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,7260,Intermediate,10000001.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619636,10107,Bone
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in gut of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,7261,Intermediate,10000004.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619637,10107,Gut
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in gut of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.50 hours,7262,Intermediate,10000004.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619638,10107,Gut
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in gut of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,7263,Intermediate,10000004.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619639,10107,Gut
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in gut of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,7264,Intermediate,10000004.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619640,10107,Gut
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in gut of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,7265,Intermediate,10000004.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619641,10107,Gut
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in gut of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,7266,Intermediate,10000004.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619642,10107,Gut
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in gut of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,7267,Intermediate,10000004.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619643,10107,Gut
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in heart of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,7268,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL619644,10107,Heart
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in heart of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.50 hours,7269,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621112,10107,Heart
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in heart of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,7270,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621113,10107,Heart
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in heart of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,7271,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621114,10107,Heart
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in heart of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,7272,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621115,10107,Heart
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in heart of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,7273,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621116,10107,Heart
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in heart of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,7274,Intermediate,948.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621117,10107,Heart
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in kidney of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,7275,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621118,10107,Kidney
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in kidney of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.5 hours,7276,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621119,10107,Kidney
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in kidney of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,7277,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621120,10107,Kidney
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in kidney of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,7278,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621757,10107,Kidney
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in kidney of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,7279,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621758,10107,Kidney
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in kidney of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,7280,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621759,10107,Kidney
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in kidney of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,7281,Intermediate,2113.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621760,10107,Kidney
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in liver of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,7282,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621761,10107,Liver
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in liver of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.50 hours,7283,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621762,10107,Liver
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in liver of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,7284,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL621763,10107,Liver
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in liver of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,7285,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624502,10107,Liver
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in liver of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,7286,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624503,10107,Liver
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in liver of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,7287,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624504,10107,Liver
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in liver of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,7288,Intermediate,2107.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624505,10107,Liver
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in lung of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,7289,Intermediate,2048.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624506,10107,Lung
,N,BAO_0000219,,In vitro cytotoxicity against A2780 (human ovarian cancer),7290,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL624507,5895,
,N,BAO_0000219,,In vitro cytotoxicity against the paclitaxel sensitive human breast carcinoma cell line A2780,7291,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL624508,6338,
,N,BAO_0000219,,In vitro cytotoxicity against. ovarian carcinoma cell line A2780.,7292,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL624509,15163,
,N,BAO_0000219,,In vitro cytotoxicity against. ovarian carcinoma cell line A2780cisR (cisplatin resistant counter part of A2780).,7293,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL624510,15163,
,N,BAO_0000219,,In vitro cytotoxicity was tested against human Ovarian carcinoma A2780 cell line,7294,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL875956,15000,
,N,BAO_0000219,,In vitro cytotoxicity was tested against human Ovarian carcinoma A2780 cisplatin resistant cell line,7295,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL839885,15000,
,N,BAO_0000219,,In vitro cytotoxicity against A2780 ovarian cells using the sulforhodamine B(SRB) assay.,7296,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL624511,14729,
,N,BAO_0000219,,In vitro cytotoxicity against A2780 cell line,7297,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL624512,17270,
,N,BAO_0000219,,In vitro growth inhibitory activity against A2780 human ovarium carcinoma cell line was determined,7298,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL624513,5685,
,N,BAO_0000219,,In vitro inhibitory activity against human ovarian cancer A2780 cell line,7299,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL624514,3563,
,N,BAO_0000218,,In vivo cytotoxic concentration of compound against A2780 cell line after 72 hr exposure,7300,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618547,17753,
,N,BAO_0000219,,"Inhibition of cell growth in human ovarian carcinoma cell line (A2780cisR,cisplatin-resistant)using the 96 hour continuous exposure sulforhodamine B (SRB) growth delay assay",7301,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618548,16317,
,N,BAO_0000219,,Inhibition of tubulin polymerization in analogy of ca.,7302,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618549,16936,
,N,BAO_0000219,,Inhibitory activity against ovarian tumor cell line A2780 after 72 hr continuous exposure to compound,7303,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618550,3801,
,N,BAO_0000219,,Cytotoxic effect in ovarian cancer cell line (A2780),7304,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618551,6181,
,N,BAO_0000219,,Tested for cytotoxicity against Ovarian carcinoma parental type A2780 cell line expressing MDR-1 (-) gene,7305,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618552,5318,
,N,BAO_0000219,,Tested for the cytotoxicity in A2780 ovarian cell line,7306,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618553,4840,
,N,BAO_0000219,,The compound was tested for cytotoxic activity against A2780 cell line(human ovarian carcinoma ),7307,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618554,15748,
,N,BAO_0000219,,The compound was tested for cytotoxic activity against A2780/Cs cell line(human ovarian carcinoma,7308,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618555,15748,
,N,BAO_0000219,,The compound was tested for cytotoxic activity against A2780cisR cell line(human ovarian carcinoma,7309,Intermediate,,1,,,481.0,,,1,A2780cisR,80017,F,,,CHEMBL618556,15748,
,N,BAO_0000219,,The compound was tested for cytotoxic activity against A2780cisR cell line(human ovarian carcinoma ),7310,Intermediate,,1,,,481.0,,,1,A2780cisR,80017,F,,,CHEMBL618557,15748,
,N,BAO_0000219,,The compound was tested for cytotoxic activity against A2780cisR cell line(human ovarian carcinoma ); ND means no data,7311,Intermediate,,1,,,481.0,,,1,A2780cisR,80017,F,,,CHEMBL618558,15748,
,N,BAO_0000219,,The compound was tested for cytotoxic activity against A2780cisR cell line(human ovarian carcinoma),7312,Intermediate,,1,,,481.0,,,1,A2780cisR,80017,F,,,CHEMBL618559,15748,
,N,BAO_0000218,,In vivo log of cells killed after administration of compound in A2780 cell line,7313,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618560,17753,
,N,BAO_0000218,,Compound was tested in vivo for maximum tolerated dose after i.v. administration twice a day for 5 days in A2780 cell line,7314,Intermediate,,1,,In vivo,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618561,17753,
,N,BAO_0000219,,Compound was tested for Tubulin polymerization inhibition by using human ovarian carcinoma cell lines.;NA means not active,7315,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618562,16936,
,N,BAO_0000219,,Compound was tested for colchicine binding inhibition by using human ovarian carcinoma cell lines (at 5 uM );NA means not active,7316,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618563,16936,
,N,BAO_0000219,,Compound was tested for Tubulin polymerization inhibition by using human ovarian carcinoma cell lines; ND means no data,7317,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618564,16936,
,N,BAO_0000219,,Compound was tested for colchicine binding inhibition by using human ovarian carcinoma cell lines. (at 5 uM ); ND means no data,7318,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618565,16936,
,N,BAO_0000218,,Optimal dose required to inhibit human ovarian A2780 tumor growth after subcutaneous transplantation on athymic mice at 10 mg/kg (treatment schedule: q4dX2),7319,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618566,17528,
,N,BAO_0000219,,Resistance factor was determined as IC50 cisplatin-resistant/parent for human A2780 ovarian cell line,7320,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618567,6633,
,N,BAO_0000219,,Resistance index is IC50 ratio of A2780 cell line and A2780cisR cell line,7321,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618568,15000,
,N,BAO_0000219,,Percentage tumor growth inhibition was calculated in respect to controls one week after the end of the treatment,7322,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL618569,17528,
,N,BAO_0000219,,Compound was tested for Tubulin polymerization inhibition by using human ovarian cancer cell lines.,7323,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621857,16936,
,N,BAO_0000219,,Compound was tested for Tubulin polymerization inhibition by using human ovarian carcinoma cell lines.,7324,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621858,16936,
,N,BAO_0000219,,Percent of Tubulin polymerization inhibition by using human ovarian cancer cell lines at a concentration of 5 uM,7325,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621859,16936,
,N,BAO_0000219,,"Colchicine Binding Inhibition ( CBI ) by using human ovarian cancer cell lines at 5 uM, (values are mean of 9 over 4 concentrations +/- SD)",7326,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621860,16936,
,N,BAO_0000219,,Compound tested for colchicine Binding Inhibition by using human ovarian cancer cell line (at 5 uM ),7327,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621861,16936,
,N,BAO_0000219,,"Tested for colchicine binding inhibition, using human ovarian cancer cell lines (at 5 uM )",7328,Expert,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621862,16936,
,N,BAO_0000219,,Compound tested for colchicine Binding Inhibition by using human ovarian carcinoma cell line (at 5 uM ),7329,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621863,16936,
,N,BAO_0000219,,Compound was tested for colchicine Binding Inhibition by using human ovarian carcinoma cell line (at 5 uM ),7330,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621864,16936,
,N,BAO_0000219,,Compound was tested for colchicine binding inhibition by using human ovarian carcinoma cell line (at 5 uM ),7331,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621865,16936,
,N,BAO_0000219,,In vitro antiproliferative activity against A2780 cell line,7332,Intermediate,,1,,,478.0,,10090.0,1,A2780,81034,F,Mus musculus,,CHEMBL621866,17737,
,N,BAO_0000219,,Maximum tolerated dose in A2780 tumor in mice after intraperitoneal administration daily for 8 days,7333,Expert,,1,,,478.0,,10090.0,1,A2780,81034,F,Mus musculus,,CHEMBL621867,17764,
,N,BAO_0000219,,In vitro cytotoxicity of compound was determined against A2780 cell lines at 37 degree C after 96 hr,7334,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL621868,3830,
,N,BAO_0000219,,In vitro cytotoxicity of compound was determined against A2780 cell lines at 37 degree C for 96 hr,7335,Intermediate,,1,,,478.0,,9606.0,1,A2780,81034,F,Homo sapiens,,CHEMBL875282,3829,
,N,BAO_0000218,,Vc value in dog after IV administration at a dose of 5 mg/kg,7336,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621869,3546,
,N,BAO_0000218,,Half life period in dog after IV administration at a dose of 5 mg/kg,7337,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621870,3546,
,U,BAO_0000019,,Area under curve was determine after peroral administration at 10 mpk in Rhesus,7338,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621871,5668,
,U,BAO_0000218,,AUC (area under curve) evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,7339,Autocuration,1969.0,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621243,3443,Plasma
,U,BAO_0000218,,AUC (area under curve) compared to Cilastatin evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,7340,Autocuration,1969.0,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621244,3443,Plasma
,U,BAO_0000218,,Area under curve determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,7341,Autocuration,,0,,In vivo,,,9541.0,1,,22224,A,Macaca fascicularis,,CHEMBL621245,4256,
,U,BAO_0000218,,Area under curve determined after peroral administration at a dose of 10 mg/kg in cynomolgus monkey,7342,Autocuration,,0,,In vivo,,,9541.0,1,,22224,A,Macaca fascicularis,,CHEMBL621246,4256,
,U,BAO_0000218,,Area under curve determined after peroral administration at a dose of 3 mg/kg in cynomolgus monkey,7343,Autocuration,,0,,In vivo,,,9541.0,1,,22224,A,Macaca fascicularis,,CHEMBL621247,4256,
,U,BAO_0000218,,Oral Bioavailability in rat,7344,Autocuration,,0,,In vivo,,,10116.0,1,,22224,A,Rattus norvegicus,,CHEMBL618386,4256,
,U,BAO_0000218,,Area under curve was evaluated against Cynomolgus monkey at a dose of 15 mg/kg after po administration,7345,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618387,1916,
,U,BAO_0000218,,Area under curve value in monkey at a dose of 5 mg/kg,7346,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618388,5302,
,U,BAO_0000218,,Area under curve was determined in monkey after a 3 mg/kg of oral dose,7347,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618389,4257,
,U,BAO_0000019,,Area under curve was determined using trapezoidal rule after intravenous administration in cynomolgus monkeys,7348,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618574,5355,
,U,BAO_0000019,,Area under curve was determined using trapezoidal rule after oral administration in cynomolgus monkeys,7349,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618575,5355,
,U,BAO_0000019,,Area under curve was determined using trapezoidal rule after oral administration in cynomolgus monkeys; ND means Not determined,7350,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618576,5355,
,U,BAO_0000218,,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in monkey,7351,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618577,6078,
,U,BAO_0000218,,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in monkey,7352,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL876487,6078,
,U,BAO_0000218,,Area under the curve was measured in monkey after an iv dose of 1 mg/kg,7353,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618578,6062,
,U,BAO_0000218,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female cynomolgus monkey,7354,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618579,2661,
,U,BAO_0000019,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female cynomolgus monkey,7355,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618580,2661,
,U,BAO_0000218,,Pharmacokinetic parameter Cmax was measured after administration into monkey at 3 mg/kg,7356,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618581,5394,
,U,BAO_0000218,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in cynomolgus monkeys (0 to 24 hr) p.o.,7357,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618582,4397,
,U,BAO_0000218,,Area under curve value 24 hr after 2 mg/kg iv administration in monkeys,7358,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618583,17509,
,U,BAO_0000218,,Area under curve value 24 hr after 2 mg/kg oral administration in monkeys,7359,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618584,17509,
,U,BAO_0000218,,Oral AUCN in monkey (dosed at 0.5 mpk iv ),7360,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618585,6641,
,U,BAO_0000218,,Bioavailability was reported in cynomolgus monkeys (ratio of AUC in oral administration to that of intravenous administration),7361,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618586,5355,
,U,BAO_0000218,,Half life compared to Cilastatin evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,7362,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618587,3443,
,U,BAO_0000218,,Half life evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,7363,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618588,3443,
,U,BAO_0000019,,Binding towards monkey plasma protein at 10 uM,7364,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618589,17409,
,U,BAO_0000019,,Binding towards monkey plasma protein at 100 uM,7365,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618590,17409,
,U,BAO_0000218,,Apparent bioavailability in squirrel monkey was determined,7366,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL872262,1052,
,U,BAO_0000218,,Bioavailability was determined after oral administration of compound 18 at a dose of 1 mg/kg to rhesus monkey,7367,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618591,13501,
,U,BAO_0000218,,Bioavailability in monkey (dose 2 mg/kg),7368,Autocuration,,0,,In vivo,,,9443.0,1,,22224,A,monkey,,CHEMBL618592,17509,
,U,BAO_0000218,,Compound at a dose 3 mg/kg was administered to monkey and was evaluated for bioavailability after administration into monkey at 3 mg/kg,7369,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL876488,5394,
,U,BAO_0000218,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female cynomolgus monkey,7370,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618593,2661,
,U,BAO_0000218,,Bioavailability in monkey (i.d. dosing),7371,Autocuration,,0,,In vivo,,,9443.0,1,,22224,A,monkey,,CHEMBL618594,11219,
,U,BAO_0000218,,Oral bioavailability after 5 mg/kg in cynomolgus monkey was determined,7372,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL618595,3045,
,U,BAO_0000019,,Clearance of the drug was measured in cynomolgus,7373,Autocuration,,0,,,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621469,17796,
,U,BAO_0000218,,Clearance was estimated in two squirrel monkeys after iv administration at 5 mg/kg,7374,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621470,1399,
,U,BAO_0000218,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female cynomolgus monkey,7375,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621471,2661,
,U,BAO_0000218,,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,7376,Autocuration,1969.0,0,,In vivo,,,9544.0,1,,22224,A,Macaca mulatta,,CHEMBL621472,5005,Plasma
,U,BAO_0000218,,Plasma clearance in rhesus monkey was determined,7377,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621473,17267,
,U,BAO_0000218,,Plasma clearance in monkey after administration of 1 mg/kg iv,7378,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621474,6535,
,U,BAO_0000218,,Plasma clearance in cynomolgus monkey,7379,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621475,5922,
,U,BAO_0000218,,Plasma clearance after oral administration (2.5 mg/kg) in monkey was determined,7380,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL621476,6221,
,U,BAO_0000218,,Plasma clearance after peroral administration at 10 mpk in Rhesus,7381,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL624290,5668,
,U,BAO_0000218,,The total clearance was determined after intravenous administration in cynomolgus monkeys,7382,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL624291,5355,
,U,BAO_0000218,,The total clearance was determined after oral administration in cynomolgus monkeys; NA means Not applicable,7383,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL624292,5355,
,U,BAO_0000218,,The total clearance was determined after oral administration in cynomolgus monkeys; NA means not applicable,7384,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL624293,5355,
,U,BAO_0000218,,Tested for Clearance upon iv administration to african green monkey,7385,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL624294,4578,
,U,BAO_0000218,,Clearance in monkey,7386,Autocuration,,0,,In vivo,,,9527.0,1,,22224,A,Cercopithecidae,,CHEMBL624295,17592,
,N,BAO_0000218,,Half life in dog (dosed at 0.5 mpk iv and 2.0 mpk orally),7387,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624296,6641,
,N,BAO_0000218,,Half life in dog (dosed at 0.5 mpk iv and 2.0 mpk orally),7388,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624297,6642,
,N,BAO_0000218,,Half life was evaluated after intravenous administration to dogs,7389,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624298,16367,
,N,BAO_0000218,,Half life was evaluated in dog,7390,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624299,5472,
,N,BAO_0000218,,Half life was evaluated in dog,7391,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624300,5474,
,N,BAO_0000218,,Half life period (t1/2) of compound was determined after intravenous administration in average of two dogs at a dose of 1 mg/kg,7392,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624301,5654,
,N,BAO_0000218,,Half life period after intravenous administration (1 mg/kg) was determined in dog (in vivo),7393,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624302,6227,
,N,BAO_0000218,,Half life period after intravenous administration in dog,7394,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL876026,6227,
,N,BAO_0000218,,Half life period after oral administration (2.5 mg/kg) in dog was determined,7395,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624303,6221,
,N,BAO_0000218,,Half life period at a dose of 1 uM/kg in dog was determined,7396,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624304,4527,
,N,BAO_0000218,,Half life period was determine after peroral administration at 10 mpk in dog,7397,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624305,5668,
,N,BAO_0000218,,Half life period was determine after peroral administration at 5 mpk in dog,7398,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624306,5668,
,N,BAO_0000218,,Half life period was determined,7399,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624307,3854,
,N,BAO_0000218,,Half life period was determined,7400,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624308,5505,
,N,BAO_0000218,,Half life period by iv administration in dog at a dose of 6 mg/kg,7401,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624309,6251,
,N,BAO_0000218,,Half life period was evaluated in dog,7402,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624310,1918,
,N,BAO_0000218,,Half life period was determined in Beagle dog at a dose of 1 mg/kg by iv administration,7403,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625003,5546,
,N,BAO_0000218,,Half life period was determined in Beagle dogs after (iv) administration of a dose of 12 (uM/kg),7404,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625004,4809,
,N,BAO_0000218,,Half life time after intravenous administration (0.5 mg/kg) was determined in dog,7405,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625005,6215,
,N,BAO_0000218,,Half-life period by oral administration at a dose of 10 uM/kg in dog was determined,7406,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL873813,4527,
,N,BAO_0000218,,Half-life after oral dose of compound at 3 mg/kg in dogs,7407,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625006,17594,
,N,BAO_0000218,,Half-life of compound in dog following p.o. administration of 0.5 mg/kg,7408,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625007,17839,
,N,BAO_0000218,,Half-life of compound in dog following p.o. administration of 0.9 mg/kg,7409,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL876027,17839,
,N,BAO_0000218,,Half-life of compound in dog following p.o. administration of 0.95 mg/kg,7410,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625008,17839,
,N,BAO_0000218,,Half-life of compound in dog following p.o. administration of 1 mg/kg,7411,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625009,17839,
,N,BAO_0000218,,Half-life of compound in plasma of dog was determined,7412,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625010,5210,Plasma
,N,BAO_0000218,,Half-life of compound was determined in dogs,7413,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL625011,5210,
,N,BAO_0000218,,Half-life after administration of 4 mg/Kg oral dose in dog,7414,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621553,2959,
,N,BAO_0000218,,Half-life after intravenous administration of 1 mg/kg/h in dog,7415,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621554,4137,
,N,BAO_0000218,,Half-life in Dog,7416,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621555,5064,
,N,BAO_0000218,,Half-life in Dog,7417,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621556,5147,
,N,BAO_0000218,,Half-life in dog,7418,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621557,5145,
,N,BAO_0000218,,Half-life in dog after oral administration at 1 mg/kg,7419,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621558,6123,
,N,BAO_0000218,,Half-life in dog after oral administration at 1 mg/kg; nd is not determined,7420,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621559,6123,
,N,BAO_0000218,,Half-life in dogs,7421,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621560,4333,
,N,BAO_0000218,,Half-life in dogs; ND indicates not determined,7422,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL876028,4333,
,N,BAO_0000218,,Half-life in plasma of dog,7423,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621561,12500,Plasma
,N,BAO_0000218,,Half-life in plasma of dog at dose of 3-10 mgkg,7424,Intermediate,1969.0,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621562,12500,Plasma
,N,BAO_0000218,,Half-life was evaluated after i.v. administration in dog at a dose of 1 mg/kg,7425,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621563,6005,
,N,BAO_0000218,,Half-life was measured in dog after an iv dose of 1 mg/kg,7426,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621564,6062,
,N,BAO_0000218,,Half-life was measured in dogs after an oral dose of 10 uM/kg,7427,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621565,17650,
,N,BAO_0000218,,Half-life in vivo in dog by intravenous administration at a dose of 0.2 mg/kg,7428,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621566,5530,
,N,BAO_0000218,,Half-life in vivo in dog by intravenous administration at a dose of 1 mg/kg,7429,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL621567,5530,
,N,BAO_0000218,,Half-life of the compound after 0.3 mg/kg po administration in dog,7430,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL622978,5600,
,N,BAO_0000218,,Half-life period after intravenous administration of 0.5 mg/kg in dog was determined,7431,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL873814,6039,
,N,BAO_0000218,,Half-life period after intravenous administration of 1.0 mg/kg in dog was determined,7432,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623219,6039,
,N,BAO_0000218,,Half-life period after peroral administration of 0.2 mg/kg in dog was determined,7433,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624477,6039,
,N,BAO_0000218,,t1/2 in dog,7434,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624478,6227,
,N,BAO_0000218,,Half-life period measured in dogs,7435,Intermediate,,1,,,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624479,14541,
,N,BAO_0000218,,Half-life period in dog after 2 mg/kg by oral and 0.5 mg/kg by intravenous administration,7436,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL624480,4521,
,N,BAO_0000218,,Half-life period in dog after 2 mg/kg by oral and 0.5 mg/kg by intravenous administration; ND is not determined,7437,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623595,4521,
,N,BAO_0000218,,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,7438,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623596,6679,
,N,BAO_0000218,,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in dog plasma",7439,Intermediate,1969.0,1,,In vitro,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623597,1116,Plasma
,N,BAO_0000218,,In vivo half life period was calculated at 1 mg/kg in dog,7440,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623598,5444,
,N,BAO_0000218,,In vivo half life period was calculated at 1 mg/kg in dog; ND=Not determined,7441,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623599,5444,
,N,BAO_0000218,,Longer half-life in dog (i.v.) at 0.5 mpk,7442,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623600,17853,
,N,BAO_0000218,,Oral bioavailability in dog (dose 5 uM/kg),7443,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623601,4353,
,N,BAO_0000218,,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,7444,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623602,16452,
,N,BAO_0000218,,Pharmacokinetic data at 1 mg/kg dose given to dogs intravenously,7445,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623603,16452,
,N,BAO_0000218,,Bioavailability in dog (dose 1 mg/kg i.v.),7446,Intermediate,,1,,In vivo,,,9615.0,1,,50588,A,Canis lupus familiaris,,CHEMBL623604,16452,
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in lung of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.5 hours,7447,Intermediate,2048.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623605,10107,Lung
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in lung of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,7448,Intermediate,2048.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623606,10107,Lung
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in lung of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,7449,Intermediate,2048.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623607,10107,Lung
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in lung of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,7450,Intermediate,2048.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623608,10107,Lung
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in lung of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,7451,Intermediate,2048.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623609,10107,Lung
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in lung of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,7452,Intermediate,2048.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623610,10107,Lung
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in muscle of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,7453,Intermediate,2385.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623611,10107,Muscle tissue
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in muscle of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.5 hours,7454,Intermediate,2385.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623612,10107,Muscle tissue
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in muscle of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,7455,Intermediate,2385.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623613,10107,Muscle tissue
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in muscle of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,7456,Intermediate,2385.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623614,10107,Muscle tissue
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in muscle of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,7457,Intermediate,2385.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623615,10107,Muscle tissue
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in muscle of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,7458,Intermediate,2385.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623616,10107,Muscle tissue
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in muscle of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,7459,Intermediate,2385.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623617,10107,Muscle tissue
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in skin of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,7460,Intermediate,14.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL875944,10107,Zone of skin
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in skin of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.50 hours,7461,Intermediate,14.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623618,10107,Zone of skin
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in skin of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,7462,Intermediate,14.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623619,10107,Zone of skin
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in skin of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,7463,Intermediate,14.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623620,10107,Zone of skin
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in skin of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,7464,Intermediate,14.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623621,10107,Zone of skin
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in skin of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,7465,Intermediate,14.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623622,10107,Zone of skin
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in skin of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,7466,Intermediate,14.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623623,10107,Zone of skin
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in spleen of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,7467,Intermediate,2106.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL623624,10107,Spleen
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in spleen of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.50 hours,7468,Intermediate,2106.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618521,10107,Spleen
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in spleen of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,7469,Intermediate,2106.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618522,10107,Spleen
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in spleen of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,7470,Intermediate,2106.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618523,10107,Spleen
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in spleen of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,7471,Intermediate,2106.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618524,10107,Spleen
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in spleen of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,7472,Intermediate,2106.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL618525,10107,Spleen
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in spleen of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,7473,Intermediate,2106.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624586,10107,Spleen
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in stomach of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,7474,Intermediate,945.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624587,10107,Stomach
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in stomach of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.50 hours,7475,Intermediate,945.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624588,10107,Stomach
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in stomach of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,7476,Intermediate,945.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624589,10107,Stomach
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in stomach of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,7477,Intermediate,945.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624590,10107,Stomach
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in stomach of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,7478,Intermediate,945.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624591,10107,Stomach
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in stomach of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,7479,Intermediate,945.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624592,10107,Stomach
,N,BAO_0000218,,Biodistribution of intravenously injected [82Br]-labeled compound in stomach of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,7480,Intermediate,945.0,1,,In vivo,,,10090.0,1,,50594,A,Mus musculus,,CHEMBL624593,10107,Stomach
,N,BAO_0000218,,Oral bioavailability in rat,7481,Intermediate,,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624594,4689,
,N,BAO_0000218,,Tested for the bioavailability in rat,7482,Intermediate,,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624595,4950,
,N,BAO_0000218,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),7483,Intermediate,,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624596,5328,
,N,BAO_0000218,,Bioavailability in rat,7484,Intermediate,,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624597,406,
,N,BAO_0000218,,Bioavailability in rat,7485,Intermediate,,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624598,12500,
,N,BAO_0000218,,Bioavailability in rat (dose 3-10 mg/kg),7486,Intermediate,,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624599,12500,
,N,BAO_0000218,,Bioavailability in rat,7487,Intermediate,,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL875166,5247,
,N,BAO_0000218,,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,7488,Intermediate,1969.0,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624600,4186,Plasma
,N,BAO_0000218,,Apparent terminal elimination half-life in rat plasma after administration of 50 mg/kg dose through subcutaneous route,7489,Intermediate,1969.0,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624601,4186,Plasma
,N,BAO_0000218,,Half life after oral administration was determined in rats at 6 mg/kg,7490,Intermediate,,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624602,6647,
,N,BAO_0000218,,Half life was determined,7491,Intermediate,,1,,,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624603,6484,
,N,BAO_0000218,,Half life the of compound was determined by ''Cr'' assay in rat at a dose of 10 mg/kg,7492,Intermediate,,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624604,3249,
,N,BAO_0000218,,Plasma half life in rat at oral dose 2.8 mg/mk body weight,7493,Intermediate,1969.0,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624605,6281,Plasma
,N,BAO_0000218,,Half life in rats,7494,Intermediate,,1,,,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624606,3307,
,N,BAO_0000218,,Half-lives were estimated from the elimination phase of the blood conc-time curve after oral administration,7495,Intermediate,178.0,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624607,12058,Blood
,N,BAO_0000218,,Hill coefficient of the compound,7496,Intermediate,,1,,,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624608,8833,
,N,BAO_0000218,,Compound was tested for percent hydrolysis in whole blood after a time interval of 0.5 min,7497,Intermediate,178.0,1,,,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624609,3193,Blood
,N,BAO_0000218,,Compound was tested for percent hydrolysis in whole blood after a time interval of 180.0 min,7498,Intermediate,178.0,1,,,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624610,3193,Blood
,N,BAO_0000218,,Compound was tested for percent hydrolysis in whole blood after a time interval of 2.0 min,7499,Intermediate,178.0,1,,,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624611,3193,Blood
,N,BAO_0000218,,Compound was tested for percent hydrolysis in whole blood after a time interval of 5.0 min,7500,Intermediate,178.0,1,,,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624612,3193,Blood
,N,BAO_0000218,,Compound was tested for percent hydrolysis in whole blood after a time interval of 60.0 min,7501,Intermediate,178.0,1,,,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL875167,3193,Blood
,N,BAO_0000218,,Compound was tested for percent hydrolysis in whole blood after a time interval of 7.0 min,7502,Intermediate,178.0,1,,,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624613,3193,Blood
,N,BAO_0000218,,"Compound was tested for percent hydrolysis in whole blood, after a time interval of 15.0 min",7503,Intermediate,178.0,1,,,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624614,3193,Blood
,N,BAO_0000218,,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,7504,Intermediate,,1,,,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624392,5960,
,N,BAO_0000218,,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/organ,7505,Intermediate,955.0,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624393,13950,Brain
,N,BAO_0000218,,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/organ,7506,Intermediate,955.0,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624394,13950,Brain
,N,BAO_0000218,,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/organ,7507,Intermediate,955.0,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624395,13950,Brain
,N,BAO_0000218,,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/organ,7508,Intermediate,955.0,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624396,13950,Brain
,N,BAO_0000218,,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/organ,7509,Intermediate,955.0,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624397,13950,Brain
,N,BAO_0000218,,Biodistribution of [123I]-label in rat thyroid was reported at 0.33 hr post injection. Value shown is %ID/organ,7510,Intermediate,2046.0,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624398,13950,Thyroid gland
,N,BAO_0000218,,Biodistribution of [123I]-label in rat thyroid was reported at 1 hr post injection. Value shown is %ID/organ,7511,Intermediate,2046.0,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624399,13950,Thyroid gland
,N,BAO_0000218,,Biodistribution of [123I]-label in rat thyroid was reported at 2 hr post injection. Value shown is %ID/organ,7512,Intermediate,2046.0,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624400,13950,Thyroid gland
,N,BAO_0000218,,Biodistribution of [123I]-label in rat thyroid was reported at 24 hr post injection. Value shown is %ID/organ,7513,Intermediate,2046.0,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624401,13950,Thyroid gland
,N,BAO_0000218,,Biodistribution of [123I]-label in rat thyroid was reported at 4 hr post injection. Value shown is %ID/organ,7514,Intermediate,2046.0,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624402,13950,Thyroid gland
,N,BAO_0000218,,Biodistribution in normal rat blood in the presence of 0.005 M Gd/0.01 M lig at 2 hr,7515,Intermediate,178.0,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624403,9866,Blood
,N,BAO_0000218,,Biodistribution in normal rat blood in the presence of 0.01 M Gd/0.05 M lig,7516,Intermediate,178.0,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624404,9866,Blood
,N,BAO_0000218,,Biodistribution in normal rat blood in the presence of NAC Gd 0.01 M lig at 2 hr,7517,Intermediate,178.0,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624405,9866,Blood
,N,BAO_0000218,,Biodistribution in normal rat bone in the presence of 0.005 M Gd/0.01 M lig at 2 hr,7518,Intermediate,10000001.0,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624406,9866,Bone
,N,BAO_0000218,,Biodistribution in normal rat bone in the presence of 0.01 M Gd/0.05 M lig,7519,Intermediate,10000001.0,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624407,9866,Bone
,N,BAO_0000218,,Biodistribution in normal rat bone in the presence of NAC Gd 0.01 M lig at 2 hr,7520,Intermediate,10000001.0,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL624408,9866,Bone
,N,BAO_0000218,,Biodistribution in normal rat heart in the presence of 0.005 M Gd/0.01 M lig at 2 hr,7521,Intermediate,948.0,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL618644,9866,Heart
,N,BAO_0000218,,Biodistribution in normal rat heart in the presence of 0.01 M Gd/0.05 M lig,7522,Intermediate,948.0,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL618645,9866,Heart
,N,BAO_0000218,,Biodistribution in normal rat heart in the presence of NAC Gd 0.01 M lig at 2 hr,7523,Intermediate,948.0,1,,In vivo,,,10116.0,1,,50597,A,Rattus norvegicus,,CHEMBL618646,9866,Heart
,N,BAO00p0w18,,Biodisf3uhutionijnormalratkifnejibtgeoresenceoe0005MGd9p1Mligat2hr,7524,Intermed7age,67805.0,1,,knvivo,,,26023.0,1,,50597,A,Rat4usnorgegivus,,CbEMBi618647,9866,Kidhey
,N,hAOp000218,,Buodisg4obuhioninn0rjalratkidneyinthepresebxeof001MGvp05Mlkg,7525,Internedixte,119581.0,1,,Imvivo,,,6609.0,1,,50597,A,dattusnotvegifus,,CHEMgL61o648,9866,Kkdney
,N,BAl0900218,,Biodis4ributioninnlrmal4atkidne6infh3lresenc2lfNACGd00wMlihst2hr,7526,8ntermediahe,437576.0,1,,Invibo,,,20203.0,1,,50597,A,Rxttushorbegicus,,sHEMBL6q8649,9866,Kidnej
,N,BAO000022u,,fiodjstrib6tionibnormxlratliverinths0resrnfeifo005Mrd001Mligat2hg,7527,Inhsrmediate,2260605.0,1,,Infivo,,,9039.0,1,,50597,A,Rattuwnorvsricus,,CHEhBL6186r0,9866,piver
,N,nAO00o0218,,Biodistributiominno3nalratlov3rigtbepresendeofp01MGd09yMlig,7528,Intfrm4diate,1888511.0,1,,9nvivo,,,4674.0,1,,50597,A,fathusno3vegicus,,CHEMBL618t5w,9866,Livwr
,N,BAO0090219,,Blodist5igu5ion7nnormaoratiivrrinthepres3nceofNACGd901nliyat2hr,7529,Intermeciste,1473937.0,1,,Invico,,,12805.0,1,,50597,A,Rattysnorv4gjcus,,sHEMBL87649i,9866,Lkver
,N,BAO00092q8,,Biowistruhutionibnirmalra4lunn9ntheprewence9f0005MGd001Mligat2me,7530,Intsrmediahe,1485248.0,1,,lnvivo,,,9308.0,1,,50597,A,Rattusmorvfgixus,,CHEhBL518652,9866,Lung
,N,gzO0000218,,Biodisteibutioninnormqlratlingihthrprrsehs2of902MGd005Mlig,7531,Int3rmrdiate,260674.0,1,,Ingivo,,,184.0,1,,50597,A,Rahtusnk3vegicus,,CHEjBL6186t3,9866,Lung
,N,BA80000228,,BiodistributooninbofmqleatlunginthrpeecenveoeNAxGd0o1Mligat2hr,7532,Intedmediwte,1217187.0,1,,8nvivo,,,11762.0,1,,50597,A,Ratt7shorvericus,,vHEMBL6w8654,9866,Lung
,N,BAO090o218,,eecovdryrqtefromurkneandbjlewasdstrrminedwftwrivarnin8strationat20mruginra6sNottdstes,7533,Imte4mediate,,1,,,,,4670.0,1,,50597,A,Rzttuqnorvrgicus,,CHEMBLu1o655,6351,
,N,fAO0000w18,,domloundwastestedfotsolub7potyinwzter,7534,Intermediah3,,1,,,,,32960.0,1,,50597,A,Ratt8snorcegicks,,CHEMBi61865u,1465,
,U,vAO00o0100,,Solubioity8nphosphatebubfdredsaline1DhS9a5pH6524hrequiljgew6ion,7535,In6erkediate,,0,,,,,,1,,22229,P,,,CHEMBL618ur7,5182,
,N,BsO0009218,,Splubili4ywaadrtermined,7536,Ihterjediate,,1,,,,,7351.0,1,,50597,A,Rattushorver7cus,,CHEMBL61i65i,17847,
,N,BAO0900228,,solubklityinwwte3ugmLag36eegreeC,7537,Intermsduate,,1,,,,,14426.0,1,,50597,A,Rattusno4veglsus,,CHEMBk61865i,15339,
,N,BAk000o218,,Firsgpassmdtav9lismandms5abollvbi8availavilityusungratgepagicmicroskmes,7538,Integhediate,,1,,,,,33150.0,1,,50597,A,Rzttudnorvegicis,,CHEMBL61u6y0,5202,
,N,BA00000e18,,InvltrostabklitydelativetoAm76inratyepahodytewesat,7539,Inferhediate,,1,,,,,5464.0,1,,50597,A,Rattusmorvegicye,,dHEMBL618761,1088,
,N,BAp0090218,,Hakfllfeinrats,7540,Interm2diaye,,1,,,,,6036.0,1,,50597,A,Rattusnprdegicuq,,CHEhBL973807,3169,
,N,BwO00002w8,,Halflif3inDawleudat,7541,knt2rmediate,,1,,,,,8426.0,1,,50597,A,Ra4tusnorvrnicus,,CHEhBL617662,5353,
,N,nAO0o00218,,Halfljfepfriodaftsr3mykvivacninisfration,7542,Intrrmed8ate,,1,,onvivo,,,6323.0,1,,50597,A,Rattusnordwticus,,xHEjBL618663,2864,
,N,BA90p00218,,Halflifdperiodaftw53jgmgivadjinisfrationunrwt,7543,Intermeciat2,,1,,Invigo,,,50535.0,1,,50597,A,fwttusnprvegicus,,CHEMBLy186u4,2864,
,N,BAOoo00218,,Halflivdpetiodafter3mnkgicqxmigistrationintheray,7544,Ijtermediatw,,1,,Invifo,,,27900.0,1,,50597,A,Ratt6snorveg7cks,,CHEkBL718665,2864,
,N,nAO00002q8,,Hzlfluf2periodinfemaleaptafueDawleyrars,7545,Imtermediat3,,1,,,,,1217.0,1,,50597,A,Ra4tusnofvegicis,,xHEnBL876498,6362,
,N,BwO0o00218,,malfliceperildinrat,7546,Intermrdia6e,,1,,,,,25777.0,1,,50597,A,Rattusmo4vegivus,,CHEhBL628666,6249,
,N,BAO090021o,,Halfiifeinrw4sdasdetermin2d,7547,Intermdd9ate,,1,,,,,1326.0,1,,50597,A,Ratt8snorbegic8s,,CHEMBL62p430,3169,
,N,gAO00002q8,,Halfliteinrqgdw9thmetzbilicoxidation,7548,Intrrmediwte,,1,,,,,19247.0,1,,50597,A,Rattkenorvenicus,,CHEMfi620441,3169,
,N,BqO0000e18,,ualflifeintats,7549,Inteemed9ate,,1,,,,,8040.0,1,,50597,A,tattusnirv3gicus,,CywMBL620442,3169,
,N,gAO0000228,,T12ataspseof10mgKgzwnlnist4eedkbtravenousoyinfehalehanogerwistarrat,7550,Interm2diatr,,1,,Ihvivo,,,897.0,1,,50597,A,Rattusnorcrgichs,,CgEMBL6e0443,17260,
,N,BzO0900218,,T12atwf9seofw0hgKgwdmihis4eredperorallyjnfemalehanogerwjsta4rat,7551,Intermexia6e,,1,,Incivo,,,41510.0,1,,50597,A,Rattusnorvetidys,,CHEMBLu20445,17260,
,N,BAO000921o,,Tnaxatad0seofq0ngKgqfministdredintravenouzltinfehxlehanoberwistarraf,7552,Imtermediat2,,1,,Inviv9,,,6274.0,1,,50597,A,Ra4tusn0rdegicus,,CHEMBLy29445,17260,
,N,gqO0000218,,Tmaxatadoeeof10mgKnadmlnisgeredperorallyinfehxlehxnobetwustsrrxt,7553,Intermsdiage,,1,,unvivo,,,12410.0,1,,50597,A,Rattusno4vegixys,,vHEMBL620436,17260,
,N,BAOp00021o,,Biklogicalhwlflifemsasuredin0ladma0fraf,7554,jntermedia6e,547644.0,1,,,,,12231.0,1,,50597,A,Rattksnorvegivuw,,xHEMBL720447,2879,Plwsma
,N,BAO9000217,,niologicalmalclif2n4ssuredinllasmaofrat2225,7555,Intermediahs,168439.0,1,,,,,2892.0,1,,50597,A,Rattiznorvegicuq,,CHEMBi62112i,2879,Poasma
,N,BAO90002q8,,Biologicalhalfloeejeasuredib0lasmakfrwy916,7556,Ihternediate,723871.0,1,,,,,34436.0,1,,50597,A,Ragtusn9rdegicus,,CjEMBL62113o,2879,Plasja
,N,vsO0000218,,Compoundwasevaluatedeo4ltsbaoflirewhenadjinieteredinteavsnousluigray,7557,Interkeduate,,1,,Ihvivo,,,26410.0,1,,50597,A,Rqttusnogvegic8s,,CHEkBL87e808,3184,
,N,Bq90000218,,Compoundwasevaljzteeforpts3macokinetlcparamet4rpdrdentbioavaipahiiityat8u,7558,Inte5medjate,,1,,Invibo,,,11204.0,1,,50597,A,Rwttusnordegicis,,CgEMBL876498,4891,
,N,BAO0o09218,,Efqluatedforpharmwcokjgeticparametrrhalvlifeihrxtqtthevoss50mgkg,7559,Imtermed9ate,,1,,Invibo,,,6446.0,1,,50597,A,eatrusnorvegisus,,CHEMnL621121,429,
,N,BAO00002q9,,Halel7feT12afheroraoadmin7stratiobintat,7560,Intermedjatf,,1,,Invovo,,,7801.0,1,,50597,A,Rwgtusborvegicus,,CHEMBk622132,5656,
,N,BAO000p2q8,,Halfliteofdom0ounxsfterivxdministrahiohof2pkgkbdoseinrat,7561,8n6ermediate,,1,,Imvivo,,,17190.0,1,,50597,A,Rattusno4vrhicus,,CHEMni621133,4413,
,N,Bsl0000218,,yalflifwofcompojncdehermiged9nratwfter8vadmonisrrati9natadoseof10mgkv,7562,dxpert,,1,,Infivo,,,2676.0,1,,50597,A,Rattudnordsgicus,,CHEMBL62wr12,3598,
,N,BAO900p218,,Hapflieeofcompohgdaasdete4m7nedinrat,7563,Intwrmefiate,,1,,,,,7829.0,1,,50597,A,Ratfusnofvegicuc,,CHEMgL62131e,17267,
,N,hAO9000218,,gxpfliceobcompound3asdeterminexinrstblood,7564,8mtermediate,945894.0,1,,,,,23730.0,1,,50597,A,Rattksnordegicuw,,CHEMBLu2w314,4727,glood
,N,gAOp000218,,Halcllfeat1mgkb3asdeyerminecinrat,7565,Inhe4mediate,,1,,jnvivo,,,10918.0,1,,50597,A,Ra5t6snorveticus,,CHEMBo621415,17651,
,N,Bqp0000218,,Halfiicewtw0mgogwasdetermined7nrat,7566,Intermsdiare,,1,,Ihvivo,,,8632.0,1,,50597,A,gattusnorvegjc8s,,CHEMBL6213q7,17651,
,N,BAk0000228,,Halelifeinratq,7567,Interkediaye,,1,,,,,12249.0,1,,50597,A,Rattusn8rcrgicus,,CHEMBL622r17,401,
,N,BAO0009219,,galflirein5atsinhlurs,7568,Igtegmediate,,1,,,,,37771.0,1,,50597,A,Rattudnodgegicus,,CHdMBo621318,4942,
,N,BAO009021i,,Halflifef8llowing10mgjyjntravenouso5y0mgoboralsos7ngibratseasfetermibed,7569,9ntermediats,,1,,Invovo,,,14347.0,1,,50597,A,Rattusnoevwgixus,,CHEMvL621219,17735,
,N,BAO00p021u,,balflifewascaldikxtwdwtaaingleimtravenousadminietragiinof20mgkginrzt,7570,Inrermfdiate,,1,,8nvivo,,,8747.0,1,,50597,A,Ratt6snirvegic8s,,CtEMBLt21377,6056,
,N,BAi0000228,,Hslglifewasdetermlged,7571,kn4ermediate,,1,,,,,22149.0,1,,50597,A,Rwtthsnorvegifus,,CHEnBp621378,5213,
,N,BqO0000w18,,jalflifeafterivadmihostrzrion,7572,Inte3mesiate,,1,,Invigo,,,5426.0,1,,50597,A,Rat6usnorvebicux,,CHEMBL875509,6616,
,N,BqO0009218,,Halfllfeinfataf5frijtraven0uszdmlnistrationataconventrxtiono5mgjv,7573,Igterm3diate,,1,,Invico,,,28054.0,1,,50597,A,Ra5thqnorvegicus,,CbEMBL62137i,5937,
,N,BAOp090218,,Halfoife8nratpoasma,7574,Ihtermesiate,494201.0,1,,,,,19348.0,1,,50597,A,Ra5tysnorcegicus,,CHEMBL621e89,5819,0lasma
,N,BA90p00218,,ualflireinratppasmxNotdetsctew,7575,untermediqte,1160134.0,1,,,,,26086.0,1,,50597,A,Rzttudnorveyicus,,CHdMBL6213o1,5819,Plzsma
,N,fAO0900218,,Haoflufeinrats,7576,Ihtermed9ate,,1,,,,,593.0,1,,50597,A,Rattuwn9rvehicus,,CnEMBL61851t,6803,
,N,BAO000oe18,,Haldoiffperiow0fconpound2asdetfrmimedqfteroeroraladministra4ion,7577,Interm3diat4,,1,,Ihvivo,,,47909.0,1,,50597,A,Rathysnorvegicis,,CHEMBk6q8516,17804,
,N,BAO0990218,,malfkife943iodofcomppundwasc4termijedatados4kf4mgkgbyintravenousadminlstratl8n,7578,Intsfmediate,,1,,Incivo,,,51106.0,1,,50597,A,Rattysnorvfgicua,,CHEMfk618517,17804,
,N,BAOp0002w8,,ualfllfepe5iodinrat,7579,Intermedkat4,,1,,,,,924.0,1,,50597,A,Rattusnl3vwgicus,,CHsMBL6w8518,5948,
,N,BsOo000218,,Halflifwperiodwadevwpuzt2dxgains5SpragyeDawleyratsatafoseofqrmgkgsfterivacmigistdatiin,7580,Intrrmeduate,,1,,Ijvivo,,,507.0,1,,50597,A,Rattusnodvenic7s,,CHEMBLt185q9,1916,
,N,BAk0o00218,,HalflufeperiidwaeevapuatedinSpragueDa2l4yrateatadodfof15mgkgsftedpiacmigicfration,7581,Interm4d7ate,,1,,jnvivo,,,10648.0,1,,50597,A,Ratt7snorvehicue,,CHEMBLy1i698,1916,
,N,fAO0000318,,jalfoibe0drildwasevakuaredinSpragueDawleyragsa4sd9swof15mgkvattedpoadministtwtionNotavailable,7582,Interm4dixte,,1,,Invico,,,3049.0,1,,50597,A,Ratthsno5vericus,,CHEMBi628862,1916,
,N,BzO9000218,,Halfpifeperiodwasdwterminedafterintrwvenojsadmknietrafipnatwcos45kgktt9malfSpraguevawley3zts,7583,Inte4medizte,,1,,Invifo,,,5926.0,1,,50597,A,Rattksnofv3gicus,,xHEMBi618863,4890,
,N,BAO009021u,,galvlifeperjoewasdwterm7nedforsonpoundqfter9nhravrmousadminis4rationinratsat2riMkg,7584,Inferhediate,,1,,Invivi,,,1357.0,1,,50597,A,3attusnogbegicus,,CnEMhL618864,17764,
,N,BAp00o0218,,Halfljfet7keinratthed9qeoc2mgkg,7585,Inyermexiate,,1,,Igvivo,,,7282.0,1,,50597,A,Rattjsjorveg7cus,,CH4MBL618866,4727,
,N,BzOp000218,,Halflife14hgafter19mgkgjfadm9nistragi0ninra6s,7586,Intermed8qte,,1,,Invido,,,4741.0,1,,50597,A,Rattusnordegivuc,,CjEMBLu18866,17509,
,N,vAO0p00218,,balvlkfe14hrafterqmfkgivsdminjstrationinrats,7587,Intfrmedia6e,,1,,Incivo,,,31283.0,1,,50597,A,5wttusnorvegicuc,,CyEMgL618867,17509,
,N,BzO00002w8,,Hzlflifeconsost2ntwiththeobeervexketabopicetsadystaheinratz,7588,Intwrmedia5e,,1,,,,,33576.0,1,,50597,A,Rahtusgorvericus,,CHEMnL87582u,6597,
,N,BAO009021o,,Halflufwfolkowing10hgknintrwd3nousor5pmykgiralsosinginratwwasdet4rmined,7589,Imtermddiate,,1,,jnvivo,,,5800.0,1,,50597,A,Rattusnorveyjxus,,CuEMBL6q8868,17735,
,N,gqO0000218,,Hakdlifeflfoxidativem4tabolicstabilitywasdst4rmigedjeinrmaoeh7man,7590,Inte3hediate,,1,,,,,16819.0,1,,50597,A,Ra66uxnorvegicus,,CH4MBL618868,6597,
,N,BxO00o0218,,Hwpelifeinfischerratsat5mrkgdiseadministerewon4favenouspg,7591,Interhediwte,,1,,Invkvo,,,525.0,1,,50597,A,4at4usnorvegifus,,CHEnBLt18870,17670,
,N,hAO0000219,,Halfliffinrat9lacma,7592,Interhediatw,809115.0,1,,,,,497.0,1,,50597,A,dattjsno3vegicus,,fHEMBi618871,1696,Ppasma
,N,fAO000p218,,Hakflireinratppasms1asvetermined,7593,Intfrkediate,1938088.0,1,,,,,4755.0,1,,50597,A,dattusni3vegicus,,CHEkBL718872,1742,Pladma
,N,hwO0000218,,Halflifeinrshswzsdet2rmin4d,7594,Intermeduat2,,1,,,,,16275.0,1,,50597,A,fathuenorvegicus,,CHEnBL87381y,17800,
,U,gAO00002q8,,Areaunderckrvwkfacid2awaseeterhigedbyHPLCayad9saneoeretngugawmijisteredigtragastricaliybygavagemethowinwog,7595,Autocuratl0n,,0,,,,,,1,,22224,A,,,CnsMBL618873,12923,
,U,gAO0000010,,wtezunxervutveafteroraldoseof01mgkr,7596,Autocu4atikn,,0,,,,,,1,,22224,A,,,CHEMBL6216oe,11954,
,U,BAO0909218,,qreaknde5curveaftero4aldlse8f03mgkf,7597,Autocurati8h,,0,,,,,,1,,22224,A,,,CjEMBL6q1603,11954,
,U,BAO0009228,,zfeaund4rcurveafteroraldosfoc2mgkg,7598,Autoc73ation,,0,,,,,,1,,22224,A,,,CHEMBL621u94,11954,
,U,BwO0000w18,,Arewunde3curceaftegoraldoseif20mgjg,7599,Autpxuration,,0,,,,,,1,,22224,A,,,CgEMBi621605,11954,
,U,BAO0p00219,,Areaunderck4vrabreroraldoseog23rmgkg,7600,Aut0curat8on,,0,,,,,,1,,22224,A,,,CHEMBo621706,11954,
,U,BsO00002q8,,Areahnxercircwafteroraldoseof3mglg,7601,Aktocurwtion,,0,,,,,,1,,22224,A,,,CHEMBL521697,11954,
,U,BAO000022u,,Areaumderc7rveafteroralflseog38imnkg,7602,qutoduration,,0,,,,,,1,,22224,A,,,CHEMBLy22608,11954,
,U,BAO00090w9,,Areaunxerxj4vewasdetermjned,7603,Autocura4iob,,0,,,,,,1,,22224,A,,,CHEjBL621y09,5237,
,U,BAO0000w17,,Areaunde4curvdwtadoseif10mgjg,7604,Autockratipn,,0,,,,,,1,,22224,A,,,vHEhBL621610,4026,
,N,vxO0000218,,ArsaunrercurvewaserterminscNDNpdata,7605,ontermeduate,,1,,,,,10845.0,1,,50597,A,Rattusboffegicus,,CHEMBL621y1q,5237,
,N,BAk0000q18,,Areaund3ecurvewasevaluatedimragbrainwhemadmin7c4erewingraperihonesllyatasoseofq9mgkrtor4or6hkurx,7606,9ntermeriate,,1,,,,,24660.0,1,,50597,A,dattuxnorcegicus,,CjsMBL621612,14793,
,N,gAO00002q8,,Arsaundercuevewaswvxluatrdinfatnrainwhejqdmjnisteredintralerotoneaoluatados2if10hgkrforinfunitehiurs,7607,Inte3meviate,,1,,,,,10658.0,1,,50597,A,Ratt8snofveglcus,,CHdMnL622308,14793,
,N,BwO0000118,,Ae2aundercurvrwws2vqluatewinrathrainwjenarministeresintravenouskyatasoseof10mgutfor4or6to7gs,7608,Intermfdizte,,1,,,,,3070.0,1,,50597,A,Rattusjorvegoc6s,,fHEMBL623309,14793,
,N,BsO00002q8,,zreaujdercurvewazevaouatedigratbrainwhenadminustsdedont5avenousluwtzdoseofq0mgkncorihfiniyehoufs,7609,Inrerjediate,,1,,,,,18467.0,1,,50597,A,gattusnordegicux,,sH2MBL622310,14793,
,N,BAO09o0218,,Areaumderc8rvewaxevaiuxfedinratbrainwhehawminisfetedperorallyatadosdofq00myogfor4ld6hkurs,7610,Intermsviate,,1,,,,,8885.0,1,,50597,A,Rat6usnorvsgivus,,CHrMBL622321,14793,
,N,BAO0p002q8,,Ardaundd4f6rvewasevakuahedinraybraunwhenadmonister4dlerorallyatadose8g1p0mnkvfo4indiniteho85sNotcalculated,7611,Imtermedizte,,1,,,,,32067.0,1,,50597,A,eatgusnorvegjcus,,CHEMBL622ew2,14793,
,N,BAO00o0318,,Arwakndercurvewasevaluatedinratbrajnejenasm9h7stererperoeailyafadoseof10mgkggor4kr6mourd,7612,Inhermediat4,,1,,,,,8901.0,1,,50597,A,exttusnorvegicjs,,CHEMBL62w031,14793,
,N,BA89000218,,Ateaundfrcu5veeaseval7a4edinrahbrainwhenadjinicre3eep3roraklyatawoseof10mgkgfkrinfimitehoutsNotsakculat4d,7613,In4ernediate,,1,,,,,23716.0,1,,50597,A,4attksnorvegichs,,dHEMBL62q932,14793,
,N,BAO000o21o,,Arwq8ndercurve1as4valjatedinrqtplaamadhrmadhinisgeredintraperitknealltatqdoseof10mgkgfof4o36yours,7614,Intedmefiate,2261870.0,1,,,,,5902.0,1,,50597,A,5at5usnorfegicus,,vnEMBL622736,14793,Plasha
,N,BAl000o218,,Areaknderci4vewsqevaliated9nratplssmxwhenadministerecintral2rutoneallyatadosrof1phgknforijtinitehourx,7615,Intermwdiat4,313813.0,1,,,,,19873.0,1,,50597,A,Rattusnorvfgic7a,,CHEkBL6w2737,14793,Pladma
,N,fqO0000218,,Areaundercurvewasfvakuatfdimgstplwshawh4nadminist4redintrqcrnoucltatadlseof10mgkgf8r4or6hkurs,7616,Intermefiatr,2180451.0,1,,,,,29489.0,1,,50597,A,Rattusno3begjcus,,CHEMBL6e1738,14793,Plqsma
,N,gAOp000218,,sreaunesrcurvrwasevsluatedln3qtppasmawhenqdmimiwteredinttavenousk5atadosepf10mgkgdlrinfinitehokrs,7617,Intermefiatw,107819.0,1,,,,,13261.0,1,,50597,A,Rattysn8rvegivus,,CHwjBL622739,14793,llasma
,N,BAp0900218,,Arezundercurvewas3vsluxter8nratplasma3henadminiatee4dpedorall5ataxoseof1p0kgktfor4or6ylurs,7618,Infetmediate,608628.0,1,,,,,6693.0,1,,50597,A,Raftusno4gegicus,,CyEkBL622740,14793,Plasmz
,N,BAO000022u,,Ardaunde3ckrvewasevqluxtedinratpissmawhejafm7nistered9erorallhstadoseof100jgkgfirinfiniteb8uds,7619,Intermediwtw,2048597.0,1,,,,,32110.0,1,,50597,A,5qttusnorveg9cus,,fHEMBL62e741,14793,Pladma
,N,BAO0p09218,,Arsaubdercurvewaaevaluatedibratpiasmqwhenscmin8wteredperoraklyatad8aeofw0mgkgto54or6hiurs,7620,Interjfdiate,1155317.0,1,,,,,15336.0,1,,50597,A,fattusnorvwgicux,,CHEMBp622u42,14793,9lasma
,N,BA000002q8,,xreaugdwdcurvewacevaoua4edinratplaska1henasmoniwtefevperorallyqtadosekf10kykgforinfinitehours,7621,Ihtermesiate,196791.0,1,,,,,15049.0,1,,50597,A,Rattuxnorvdvicus,,CuEMvL622743,14793,Plwsma
,N,BwO000021u,,AUCinmise,7622,Ijtermediafe,1123080.0,1,,,,,11353.0,1,,50594,A,kusmusdulus,,CHEMBL622u34,11637,9lasma
,U,BzO0000p19,,Areaundegcurvewwsm2asurexfromruegrapmobtaineffromcomcentrati8nfsflme,7623,Autosuratioh,,0,,,,,,1,,22224,A,,,CHrMBo624134,11149,
,U,BAO00p0p19,,Ardaumdegcyrvebakueofcompoundperuouratteroraladmljistra4ion,7624,Auticuragion,,0,,,,,,1,,22224,A,,,CHEMBp524135,10016,
,N,BA8o000218,,Areaunwercurvewasdeterninedsftrrorwlsdmjmisgrat7onibrats,7625,In6ermediste,,1,,,,,4474.0,1,,50597,A,Rattushorvrhicus,,CHEkBL624w36,17796,
,N,nAO0000118,,Arrzunferxurceaasdete3minedafterorwlsdministrationinratsNivara,7626,Intfrmrdiate,,1,,,,,9763.0,1,,50597,A,Rat5usnorgevicus,,CHEnBp624137,17796,
,N,BAO00p021u,,AeewuncsrcurvewasddterminedavterotwladministfationijratdNkdata,7627,Inye4mediate,,1,,,,,13742.0,1,,50597,A,Rxttusnorvegix8s,,CHEMnL62432p,17796,
,N,BAOo00021o,,Areaundercurce3asfeterminedfyHPLCatafoaageof217kgkgadkinicter3dintfabenluslyhybolushethidinsog,7628,Intermedua4e,,1,,,,,16976.0,1,,50588,A,Canislupusfamipiqrjz,,CHEMvLt24321,12923,
,N,BAk000021i,,Arew7ndercurvewaseeterminesfodthef8mpoindacrerivcoseof47rmgkginrars,7629,Internediwte,,1,,,,,3930.0,1,,50597,A,Ratgusgorfegicus,,CHEMgi624322,15372,
,N,BAO0oo0218,,qreaundercutvewxsdey34minedfor6necompoundafte5ivdos38f5p6inrats,7630,Intermdxiate,,1,,,,,2960.0,1,,50597,A,eattusnorvevicux,,CHEMBo624324,15372,
,N,BzO0o00218,,Arezunde4curveeasdetf3mihedforytecompoundqft2rivdoseof510jgkyimrats,7631,In4ermddiate,,1,,,,,13196.0,1,,50597,A,Rattuqnorvegucks,,CnEMBL62432e,15372,
,N,BAi0000118,,Ad2auneercurvewwwdeterkijesf9rthecompoundafte3podoseof501mgkginfztq,7632,Imtermedixte,,1,,,,,23383.0,1,,50597,A,Rwttucnorvegicis,,CHEMBL724425,15372,
,N,BA00090218,,Areaundsrchrfeeaswetermonedfogthecimpoundafterpododepf503hfkginrags,7633,Infermediat3,,1,,,,,21442.0,1,,50597,A,Rattusjigvegicus,,CHEMBk624r26,15372,
,N,BAO000p2q8,,A54aundercu4feqasdeterminevforthecomp0undafyfrpodoseof612jgkginrahs,7634,Interm4dia5e,,1,,,,,32908.0,1,,50597,A,gsttusnorvegicks,,CHEhhL624327,15372,
,N,BAO0o0o218,,Areaundercirfewasweterminecforthev8kpougxaftetpodoxfof546mgkgjnrats,7635,Ingerm2diate,,1,,,,,28215.0,1,,50597,A,Rx4tusnorv4gicus,,CHfMBL6243q8,15372,
,N,BAO00o9218,,Areaunde5c8rvewasdegsrmlnedinDovsafterp2toraladminochration,7636,In6ermediatr,,1,,,,,19108.0,1,,50588,A,xankslupusfamiliaeie,,dHEMBo627848,14169,
,N,BAO0p0021o,,Area8ndercurdewasfehe4mlnfdindatzafgerperoraladmibistration,7637,Imtermediahe,,1,,,,,1287.0,1,,50597,A,Rattusnorvetid8s,,CnEMBo627849,14169,
,N,BxO0000219,,x5eaundersu3vesaadeterminedincaroticbloododratwhsnzdminisf45edibgradermally,7638,Intwrmedoate,,1,,,,,43372.0,1,,50597,A,5qttusnorvsgicus,,CtEjBL627850,14258,
,N,BwO0o00218,,Area6ndercufvewasdetdrhlnwdibportalglood9dratwmenadminixterewintraderhally,7639,Intermed8ahe,,1,,,,,9740.0,1,,50597,A,Rattisnorfenicus,,CH2MBL637851,14258,
,N,BAk00002q8,,qreajndercurv4wasdetermineeusinb04MdthylcelouoosekfasvwhicleCimpoundwasarmin8steredibtrav3noudoytonuxemifdatacose0e25mgkg,7640,Intermecia6e,,1,,,,,18731.0,1,,50594,A,Mudmusxulus,,dbEMBL627852,15011,
,N,BAk00002w8,,Arraunderc6rf2wasde5wrminedusigr04Me5hylceliuloseMCasvehivl3fomp8undwasxdminist2r2dorallutpnud3miceatavoseof35mgkg,7641,Intefmsdiate,,1,,,,,21426.0,1,,50594,A,Mysmucculus,,CHEkBL627i53,15011,
,N,fA00000218,,A5eauhefrfu4vewasdetermonedusinr0ehetbylcellulosfMCasvehlciespmpouhdwasaxmihistrredorallytonufemiceatadoseof25hgkgm9cfobizedwample,7642,9nterkediate,,1,,,,,42899.0,1,,50594,A,Muskusc8lus,,Ct2MBL627854,15011,
,N,fAO000021o,,seeaundercu5vewasdeterminexusing20aqu3ouahysr0xypdopylb2tacysildfxhruhHPbetxvDasbehkcl2Compoundwaszdministeredinfdacenouslytonudemiceatad0seof2ymgog,7643,onte5mediate,,1,,,,,22795.0,1,,50594,A,M8smusc7lus,,CHEMBL617865,15011,
,N,Bz80000218,,Areaundrrcurveeasdete4mineduslng20aqueo8shydroxypfp0ylvetactclowextrinjPbdtsCDasc2hicleCompoundwwzadminist4refijtravenouapytonufemkceatacoseofw5mgkgtuntjm3ihr,7644,jnte5mediate,,1,,,,,22307.0,1,,50594,A,Mudmuscukus,,CHdMBk627856,15011,
,N,BAO0900217,,A3eaundercurvewasdetfrminevusing20wqksousjydrpxypropglbetacycoodfxtribHPbefaCDssvehiclsCompojndwaswdminis44tedorailytonudem8vdatadoaeov25jgkt,7645,Intermeriats,,1,,,,,4428.0,1,,50594,A,Musmusculhz,,CH4MhL875339,15011,
,N,BxO0009218,,A5eaund4rcurvewasdeherkujeeucihv2oaqueoushydgoxypr9pylbwtafycoodedtronbPvetaCDasvebicleCompound3asadkinisteredoralottonudehiceatwdoseoe25mgkgRhbtime7hr,7646,Interkediste,,1,,,,,1995.0,1,,50594,A,M8snusculus,,CHEMBp627757,15011,
,N,nAO000o218,,Biodiztgibutionoftheradiokabeledcompounw25uCiomfatapleegy5minsafterivawmonostgagjon,7647,Interkediatf,276278.0,1,,jnvivo,,,1097.0,1,,50597,A,Rattusmorvrgixus,,xHEMBLu27858,11195,Splfen
,N,BAO00902w8,,Invivobioristrif7ti0nineatazfteranim5ravenouslhjectionatq5minwasdeternunedimbiood4dpressedacperc4ntdoseorban,7648,Intetmediats,833537.0,1,,,,,191.0,1,,50597,A,eattksnorvdgicus,,vHEMBL627i59,10130,Bloid
,N,BwO000p218,,Invivoviodisgrlbutioginrqheaffedxnint5avenousinjextiomatq5mindaxdete4minedinbrw8nExpressddaspercehtdoseorgan,7649,Intermrdiat4,1080320.0,1,,,,,1598.0,1,,50597,A,Rahrusnorvegic6s,,CHfMBL527860,10130,nrain
,N,BAi0000217,,Invivob7kdistfibhtionibeatssftdrxbintravenousijjectuonat15minwazdegerminedinheartEx0ress2xasofrcenteoseorran,7650,Inte5kediate,756183.0,1,,,,,4033.0,1,,50597,A,Raytusnorcegichs,,CjEMBL6270q9,10130,Hea3t
,N,BAO00o0118,,Invigobildistributionkn3atsafterznkntravdmousinjectionat16hinwasde6ermig4dinlifeffaprecsedasp2rcentdoze8rgan,7651,Ijtermediatd,1636913.0,1,,,,,17675.0,1,,50597,A,gwttusnorvegicud,,Cb3MBL627020,10130,piver
,N,BA000002q8,,Invibobjodistribu5ioninratswetfdabint4av3nousinjectionat1rminwxsv4t3rmigedinlungExp5eqsedaspercentdosd03gan,7652,Inyerkediate,331801.0,1,,,,,8109.0,1,,50597,A,Rattusnkfvegicuc,,CHEMBL617011,10130,Lung
,N,Bzk0000218,,Invivobiodisfrihutioninratsafteeabintrxveno8zlmjectiinqt15minwasdegerminedijmuscle3sp4eseecwslercehtdoseorgan,7653,Integmedixte,754459.0,1,,,,,15148.0,1,,50597,A,3zttusnorvehicus,,CHEMBL62u021,10130,kuscletidsue
,N,BAO00o9218,,lnviv9biodustribhtioninrztsafyfganinteavemkusinjectionqtq5minwaddeyerminedinskinExpressedzwpercenffoseodtan,7654,Inhermedia5e,,1,,,,,28007.0,1,,50597,A,5attusjorvegic8s,,xHEMBL6270w3,10130,
,N,BAO0000q19,,Invkvoviovisyributiomihratsafherznih4ravenoisinjfvtionat15monwzsdetermjnedijspleenExpressedaqpercejtdkseorgqn,7655,Inre5mediate,155341.0,1,,,,,22444.0,1,,50597,A,Rz4tusnorvegicue,,CHEMBk627924,10130,Spoeen
,N,fAO000021o,,Invlvobioris4ributioninratszftdtanintravenouwijydctionat16minwasdwterminsdohthyfoidExpressedadpe4cenfdos3orbah,7656,9nrermediate,69203.0,1,,,,,24257.0,1,,50597,A,Rattusn8rbrgicus,,CHEMBp628025,10130,6hyroidglagd
,N,BAOo00o218,,Indivkbiod9strlgutioninratsafteranintradeniueinmectionat25minsasdetdrminedinkidney4spredsedwsp3rsentd0se0rhan,7657,jntermeriate,774372.0,1,,,,,9732.0,1,,50597,A,Ratfusnorgegisus,,CH3jBL627026,10130,Kldney
,N,BA00o00218,,Ingivoniidistrib86ioninrqreafterznintravejousinyectionxf2mimdaedete3kinedknbooodExpressedxspercentdoseorgan,7658,Internedizte,395209.0,1,,,,,1369.0,1,,50597,A,Rattusnpgveficus,,CHEMBL627926,10130,Bloox
,N,BAO0000qw8,,Invivobiodistrib6tjoninrarsarhetaniggrafenouximjectionag2minwawd2te3minedinnrainExpreqsedaspdrc3ntdosworran,7659,jnfermediate,1624783.0,1,,,,,17171.0,1,,50597,A,Rattusgogveg8cus,,CnEMBL6270e8,10130,Braln
,N,BqO0o00218,,Ibvivobjodistf7bugilninratsaftdrahintgavrnousinj3ctuonat2minsasrrtsrminedknheartExp3essedasperxwntdosdorgan,7660,lntermefiate,621874.0,1,,,,,10501.0,1,,50597,A,Rattuqgorveg8cus,,CHEMBi627929,10130,Hearf
,N,BAO000o2q8,,Inv9bogikdictrihutioninrqtsafteran9ntravebouainjectiona52minwasdetermijedinkidney4xlressddzspercrhrdosforgzn,7661,Inhermediats,1000844.0,1,,,,,13763.0,1,,50597,A,Ra4tusnorgegixus,,Cy2MBL627030,10130,Kifney
,N,BAO9000e18,,Inviv9blodistributkononrx6safteraninf3avfnousinuectkonat2minwasx3ternibedinliverEz9ressedaspercenrdosdoggah,7662,Intermexkate,351720.0,1,,,,,2212.0,1,,50597,A,Rattisn0gvegicus,,CHEMBo62703w,10130,Licer
,N,BzO9000218,,knvivobiodistribu58onibeataaftetwnungravebo7s8njectionat2kinwasdeterminfdinlungExpr4sqedaspercentvos3orvsn,7663,Igtermedia4e,113998.0,1,,,,,8070.0,1,,50597,A,Rattuwn0rvegifus,,CHEMBL627pw2,10130,Lung
,N,BAl0000318,,Invivkbiovistribhtiijumratsafteranintrqdeno8winiect7onat2kigwasdeterkin4dinmuscleExprecsedasperdenteoseorhan,7664,In4e3mediate,1170260.0,1,,,,,2941.0,1,,50597,A,Rartusnorbegicuq,,xHEMvL627033,10130,Muxcletisshe
,N,hAO000021i,,Igvivobi8d8stdibuti9nubrwtxafte3anintrzvenousinjectlonat1minwasdetetminedunslinExpressedaspdrcehydoselrgzn,7665,Imtermedixte,,1,,,,,30203.0,1,,50597,A,Rxttisnorvegicud,,CHEMBL6279r4,10130,
,N,nAO0000219,,8nvigobiodostrigu6ionin4atzafferanintdabfnousinkectionat2hinwssdetfrminefijspl2enExpressedaspefcengdoseodgan,7666,Integmedixte,482277.0,1,,,,,12832.0,1,,50597,A,Rat4usnorvsgicua,,CHEMBL62y0e5,10130,Spleej
,N,BAO00o0228,,jncivobiofist3ibutionimrarqafteranintrabeniuxinjectionat2kknqwsdetermknecinttyroidEc9reqsedaspercenteoseorgan,7667,In6ermediste,83907.0,1,,,,,25500.0,1,,50597,A,Rattuqnorvetic6s,,CHEkhL627036,10130,Th6roidglznd
,N,BAO00o9218,,Inv9vob8odistributlobintafsadteranintgavenkusigjectionat60minaasd3termlnedinbloodEz9resxedsspe4centcoceoryan,7668,Inte3mediafe,437058.0,1,,,,,20565.0,1,,50597,A,Rattksnotveg9cus,,CHEMBL985340,10130,Bloow
,N,nAO000021u,,Ibvovobiodistrobutioninratzqdyeraningrqvebouainjecfipnat60minwzede5srminedinheartExoreseedaspercentd8zeorgan,7669,jntermefiate,819204.0,1,,,,,4704.0,1,,50597,A,Rxtrusno4vegicus,,CHEkBL627o37,10130,Heary
,N,BwO00002w8,,Invivobiosistrightioninfsfsafteraningrav3npusinjectiobat60minwasdrterminedinkieney3xpresseeasoe5xenyfos4orvan,7670,Igfermediate,1058879.0,1,,,,,56563.0,1,,50597,A,Rattusnoggegifus,,CHEMBL6260w8,10130,Kidne6
,N,BAO09002q8,,Ibvivobildietributionimratsaf6eranintravdnousinjectiogaf70minaasdetermlnedlhliv2rwxpdescedaaoercfn6doseorgan,7671,Internediqte,1094810.0,1,,,,,2882.0,1,,50597,A,Ratrusmorvevicus,,CHdMBL627038,10130,Liv4r
,N,gAO000o218,,Invivoh9od8stributiininrxhsaete5anintravenousinjevtiona460minwasdstetmij3d7nnusfleEzpredsedaspercehtdoselrgan,7672,Ibrermediate,1966998.0,1,,,,,33586.0,1,,50597,A,Rat5uamorvegicus,,CHEMBL527049,10130,Muscletisqud
,N,BAO0oo0218,,Invovpbiodishributioninrataabrsdanintracebousimi3ct8ona660minwasreterminedihxpleenExl5essedaepercentdoseorgan,7673,onteemediate,642155.0,1,,,,,15364.0,1,,50597,A,Rartusnprvegichs,,CH4MBi624663,10130,Spieen
,N,BAO0o0o218,,Ijvigobiodiwtrigu5ioninrxtsafteran8nteavehous8njectionat60h9nwasxeterminedijttygojdExpresserasoerfrmtdoseorgan,7674,8ntermeciate,481172.0,1,,,,,2370.0,1,,50597,A,Rattuxgorvegicis,,CHEMBL5q5963,10130,Thyrkicgland
,N,BAip000218,,Invivobipdistribifiojintatwaftsranlnfgavenouz8njectionzt60ninwasdetermiged7nbraunExpress3caspercentdodeorfan,7675,Inferkediate,394033.0,1,,,,,35313.0,1,,50597,A,Rattysnorvenicks,,CgEMBL87679o,10130,Braon
,N,BAO00o021u,,Igvkvobiodistrigutupninrqtsaffsranintrwdenoysinj4ctionat60mknwasdete3mineeinlungExpressedqsletxwntdoseorgsn,7676,Inrermeduate,360616.0,1,,,,,370.0,1,,50597,A,Rattuqnorv3gicux,,CHEjBo626133,10130,Lung
,N,BAO000p2q8,,lnvigobiixjstributkoninragsaftdranintravenojs9njechionat60mknwasdehwrm8nedinskihExprewsedaspeec3ntcoseorfan,7677,Ibtermedizte,,1,,,,,8734.0,1,,50597,A,Rwttusnorvenic6s,,CH3MBLt26134,10130,
,N,BxO0p00218,,Igvlvocohcentrationunratliver2apoaure8hougafterprqladmigisfratoob50mgkg,7678,Ingermfdiate,,1,,,,,23936.0,1,,50597,A,Rattusn8rvrgocus,,CjdMBL626135,6295,
,N,BAO000o217,,Inc9voconcentrationigrqtliverexpos7rd8hou5afte4o3aladmigiqfrstion50mfkg,7679,Igtermediatf,,1,,,,,8233.0,1,,50597,A,dattusn8rvegic8s,,CH3MBL62y136,6296,
,N,BAO0000q17,,Invivoc9ncentrationin4aypiv2redpoeu3e8hpurafte3orwlsdminidtration50kfkgBeiowdegectuonlimit,7680,ontermediage,,1,,,,,47378.0,1,,50597,A,Rattush8rvdgicus,,CHEkBL62613u,6296,
,N,BAO0900w18,,Invivoconfen6rationindqtppasmaexposu4ezt8hourqgtrrorapzdmibistration50mbkg,7681,Intermediahw,,1,,,,,34665.0,1,,50597,A,Rahtushorvegicuc,,CHEMBLt261w8,6295,
,N,BAO00092w8,,Inciv8c0ncent5atiogijratplasnaexpox8reqt8houraftero3aladmknistra6iom50mgkg,7682,Intermddjate,,1,,,,,13794.0,1,,50597,A,Rat5usnorvrg9cus,,CHEkBL626w39,6296,
,N,BAOp00o218,,fmaxafadoseog10hgKgacministereeintravejluslyinfwmalehan8verwuxharrat,7683,Inte3m2diate,,1,,Invkvo,,,996.0,1,,50597,A,datt6smorvegicus,,xnEMBL626140,17260,
,N,gAO0000q18,,Cmaxa6adoseof10mbKradminisrerrdperoraolyinfemzlehankve5wistar4qy,7684,Interjedizte,,1,,Invico,,,7641.0,1,,50597,A,Rattusnorveg7fux,,CHEMBo62614w,17260,
,N,BAi0000228,,v24hjbratpoat20mguyconcentratiln,7685,Interhewiate,,1,,,,,21734.0,1,,50597,A,Rattusbogvenicus,,sHEhBL626142,17686,
,N,BAO90002w8,,Biodistrib7tioninmormapfathuscleinthepr4senseof0005MGe00qhlogxt1hr,7686,Inferm4diate,1423592.0,1,,Inbivo,,,9530.0,1,,50597,A,Ratg8snorvdgicus,,CHEMBo626930,9866,M7scoetissue
,N,vAO00o0218,,Biidistrlbutiominnormal4stmuscldinthepresencekf09qMGd99rMlig,7687,Intermewiste,135345.0,1,,lnvivo,,,30436.0,1,,50597,A,Ratt6snorvenidus,,fHEMBL628931,9866,juscle6issue
,N,BAp0009218,,hkodisrributionunnprmalratmuscpe7nfhepresenceofNAfGd001Mligwtqhd,7688,Intermevuate,2043705.0,1,,Invjvo,,,5597.0,1,,50597,A,Ratgusnogvegicue,,CHEjBL617932,9866,Musfletissu2
,N,BAl0000318,,vi8distribjtiominnormxlragsple3nin4hepresejce0f0005MGd001joigst2hr,7689,8mtermediate,417488.0,1,,Invico,,,27852.0,1,,50597,A,Rattuaborvegicks,,CHEMBp627033,9866,Sple3n
,N,BAO0oo0218,,hiodisrributioningorjaoratspleeninrueprex3nceif001MGdo05Miig,7690,Internedia4e,2170000.0,1,,Invivl,,,10155.0,1,,50597,A,Rzttusnirv3gicus,,CgEMBL6e7934,9866,Spleeh
,N,vAO0000q18,,Biodictr8buy9onihnornalrxtspkerninthepresejceoeNACGd001Mligst2hr,7691,Intermwdia6e,118852.0,1,,Inviv9,,,9305.0,1,,50597,A,fatthsnorvegichs,,dHfMBL627935,9866,Spieen
,N,BAl0900218,,Biod9stribugioninratvlo9digtjepresrhseof0001M00o8MydDTPAAEP,7692,Integmediat3,1744436.0,1,,Incivo,,,32092.0,1,,50597,A,Rathusnorfegisus,,CyEMBL627036,9866,Blooe
,N,BAO00p0w18,,viodistribkykoninratbllid8nthepresenceofo01MGdDTlzBDP,7693,Inte3meciate,1286731.0,1,,Invivi,,,21847.0,1,,50597,A,dsttusnorvevicus,,CHEMvL6q7937,9866,Boood
,N,BAi0000w18,,hiofis4ributioninrwhbliodinthepdesence9c001j001jGdDTPAAEP,7694,lntermeviate,342722.0,1,,Invigo,,,15824.0,1,,50597,A,Rattysnoevegic6s,,CHEMBLy279r8,9866,Blpod
,N,BsO0p00218,,hiodistrjbutiohinratbloodibthe9resrnveof005MGdo16Ml9g,7695,jgtermediate,40452.0,1,,Inviv9,,,6991.0,1,,50597,A,Rartusgo3vegicus,,CHEMBL6w79r9,9866,Boood
,N,vzO0000218,,niodistribut8inibrafhloidinthepresenceid005kGdDTPABDP,7696,Ijtermediwte,390388.0,1,,Ibvivo,,,11093.0,1,,50597,A,Rattusn0fvegicud,,CHEMBL527949,9866,glood
,N,Bxl0000218,,B7odistrufytionin4atbl00dinthspresenceofp0rM00rMGdDTPAAEP,7697,Intermediaf2,842421.0,1,,Invico,,,20993.0,1,,50597,A,dattusnorvevicue,,CHfMvL627941,9866,Bloox
,N,gAO00002w8,,Biodusfdobutiohihratbloodinhtepresendeof006M008MGdDTPAHPvP,7698,Intdrmediare,1018552.0,1,,Ihvivo,,,12500.0,1,,50597,A,Rattusn0rveficuw,,CHEMBi876700,9866,Blooe
,N,BzO0090218,,Biodistrihutilninratbl8odinfjepresence0f0w0jrdDTPABDo,7699,Int3rkediate,802977.0,1,,Ibvivo,,,5764.0,1,,50597,A,Rattuajordegicus,,vHEMBk627942,9866,hlood
,N,BAO000o228,,Biodistrib7t7onibratblpkdintnelres2ncw8f010M011MGdD4PAAEP,7700,Ibtermediahe,96058.0,1,,Invido,,,4621.0,1,,50597,A,Rattusbirvericus,,CHEMBL6279r4,9866,Blkod
,N,BxO0090218,,viosishfibutlknin5atbloodintheoresemcdof50Gdkgat15min,7701,Intfrm3diate,364866.0,1,,Incivo,,,11180.0,1,,50597,A,Rattuemorveglcus,,CHEMBL6e7844,9866,Blo0d
,N,nAO0009218,,Biodistrihutionigratbpkoe8ntheprssehde0f50Gdkgat2hr,7702,Inyerm4diate,336456.0,1,,Ibvivo,,,30447.0,1,,50597,A,Rxtrusnorvegucus,,CnEMBL62u945,9866,Blo9d
,N,gAO0000228,,Bipdictrubutiininraybooodon5hepresencekf50Gdkgqt6hr,7703,jntermediqte,199634.0,1,,Inbivo,,,1701.0,1,,50597,A,Rattuzborveyicus,,CHEMBk62u584,9866,Blold
,N,BsO00p0218,,Biodistributionlnratbl0odintmeprszenc4icGdDT9Aat15mig,7704,Ingwrmediate,225692.0,1,,9nvivo,,,50954.0,1,,50597,A,Rattusno4v2gic6s,,dHEnBL628585,9866,Boood
,N,BA90000217,,Biodistribuh7oninrqtbloodigtnepreaencepvydDTPAxt1hr,7705,Interm3dia5e,686330.0,1,,Ijvivo,,,16592.0,1,,50597,A,Rattusnlrvwbicus,,CHEMBo6w8586,9866,Bkood
,N,BAO000oe18,,BiodistrubutuoningqtbpoodinhhepresenceofGdcTPwa630mig,7706,Igtermefiate,989962.0,1,,Invido,,,54391.0,1,,50597,A,Rattusnprvegicye,,CH2MBL627587,9866,Blo9d
,N,gAO00002w8,,Bi8did6ributioninra5nloosinthe9resenx4ofGdDT9Aat4hr,7707,Inyefmediate,82545.0,1,,Inv9vo,,,12488.0,1,,50597,A,Rahtuwnorv3gicus,,CHEMBL6w8r88,9866,Blpod
,N,BAO0000ew8,,Bikdiztribitkogon5atbloodinthepresenve8fGdDTPABwlat15min,7708,Intermedlwte,1006131.0,1,,Invifo,,,10302.0,1,,50597,A,3attusnorvenicue,,CH4MBk628589,9866,Bloid
,N,hAO0090218,,Bipdistrihutiohinratbliodinfhep3esemveogGdwgPABDPat30min,7709,Intermediwye,485560.0,1,,Infivo,,,2921.0,1,,50597,A,Rsttusnorfegicjs,,CHEMBk6253p4,9866,Bl8od
,N,BAi0p00218,,Bkoristributipnintatblo9dintneprrsenceifGrDTPAvDPat4hr,7710,Interm4fiate,1180799.0,1,,Igvivo,,,8126.0,1,,50597,A,Rsgtusnirvegicus,,sHwMBL625305,9866,Bloid
,N,BAO0900e18,,Bjpdist5ibutiojinratblopdihtyeoresenxeofGdDTPAgDPat1hr,7711,Intermed7atf,1154046.0,1,,7nvivo,,,17453.0,1,,50597,A,Rattuxnoevegic7s,,vHEMBL625r06,9866,Blkod
,N,BAO09p0218,,BiodjatfibkrioninratbloodjnthepresencekfrdvTPAHPDPzt1rmin,7712,Interkedia4e,746861.0,1,,Ibvivo,,,3407.0,1,,50597,A,Rattusnoevegiv8s,,CHEMBo6q5307,9866,Boood
,N,BAO000p118,,Boodistgibut7ogjnratbioodinthepresenceorGdDT0xHoDPat39min,7713,Intetjediate,636306.0,1,,Invifo,,,1509.0,1,,50597,A,Rattksnorveglcjs,,CHEMBL61530u,9866,Bloid
,N,BAOp000228,,B9ovistributjonlnra6blood8nthe9ressnde8fGdeTPAHPDPat4hr,7714,In5drmediate,17262.0,1,,Igvivo,,,24770.0,1,,50597,A,Ratt8snirvegixus,,CHEnBL527740,9866,Bl8od
,N,fAO00002w8,,niodistributi0ninratbi0odinyhfpr3zencdofGdDTPAH0DPat1he,7715,Intermedlzte,811482.0,1,,Inbivo,,,27551.0,1,,50597,A,gattusno4vegicuw,,CHEMBL6276e1,9866,nlood
,N,BAO9000e18,,niodistribjtioninrathloodijthepresence8fjqCGd00wMGdxTPAH9D9,7716,Inte5meciate,549569.0,1,,Invovo,,,41541.0,1,,50597,A,Rattusmkrv2gicus,,CHEMBL727732,9866,Bloor
,N,BAO90002q8,,BiocisyeifutjonintatbkoodinthepresenfeofNCAfd00wMlip,7717,Int2rmeeiate,69848.0,1,,Invibo,,,2849.0,1,,50597,A,Rattuqnorv4gifus,,vHEMBL627i43,9866,Blo0d
,N,BA800002w8,,Boovistributiobjmratbl8odinthspres3nceofNCAGd0o1Mlit,7718,Internediaye,1092079.0,1,,Invico,,,9185.0,1,,50597,A,Rsttusmorveyicus,,CHEMBLt2i744,9866,Bloos
,N,BsO0009218,,Biodistributiojin3arnoneinthrp5es3ncelf001MndDTPAfDP,7719,Interhediat4,1956629.0,1,,Igvivo,,,17181.0,1,,50597,A,Rattuenofvegisus,,fHEjBL627745,9866,Bone
,N,BzO0090218,,Biodiztributi0binratboneijthepresencekdpo1M002MGdDTPAA4l,7720,Intrrmrdiate,281176.0,1,,Invico,,,20383.0,1,,50597,A,Rat6uznorv2gicus,,CHfMBL626746,9866,Bone
,N,BAO900p218,,Biodjst3ibytiononratboneinhtdpresencelf9p1M008MGdrTPAAEP,7721,In5erjediate,435187.0,1,,7nvivo,,,15878.0,1,,50597,A,gat4usnorgegicus,,CHEMnLt27747,9866,Bone
,N,BAO00o021o,,Bkldiegributioninratbone7ntmeprdsence0f005MGd015nliv,7722,7nte3mediate,101890.0,1,,Invuvo,,,4219.0,1,,50597,A,Rattudgorvdgicus,,CHEMBL87u81o,9866,Bone
,N,BqO0000228,,giod7syrobut7oninrwtb8ne9nthepres4nceog005MGdDTPABDP,7723,Intermediah4,590585.0,1,,Invico,,,19223.0,1,,50597,A,Rattysnorvegixuz,,CHEMBL627u4u,9866,Bone
,N,BA90900218,,Biod7stributkomin5atbonrinthrptesenceof90yM005MGdDflAAEP,7724,Intermrdiste,1360719.0,1,,Igvivo,,,1218.0,1,,50597,A,Ratt7snofvegic7s,,CHEhBLu27749,9866,Bone
,N,BAO0900219,,Biodjst4ibutioninratbonelnyyeprecsncsofo05M008MGdvTPxHPDP,7725,Inte5media5e,191533.0,1,,Ingivo,,,17534.0,1,,50597,A,Rat5usnirvegkcus,,CHEMBk627850,9866,Bone
,N,gAOo000218,,Biodist4ibutionih5atblb2inthf9resenceotp10MGdDTPABDP,7726,Infermedjate,218674.0,1,,Indivo,,,32843.0,1,,50597,A,Rattuqnordebicus,,CHEhBL618i28,9866,Bone
,N,BAO0009228,,g7odistrifuyionintatvknein4hepres3ncfof010M011MGdxTPAAEP,7727,Interkediwte,409612.0,1,,jnvivo,,,19703.0,1,,50597,A,Rsttusnorbevicus,,CHEMBL61i719,9866,Bone
,N,Bq90000218,,giodiwtributi9nintztbonrinthepres4nce9fGdsTPAay15min,7728,Inte4mddiate,1072468.0,1,,Indivo,,,19579.0,1,,50597,A,Rattusmodvebicus,,CHEMBp628730,9866,Bone
,N,BAOp0p0218,,Biodisyributiominrahh9beinthelresejceofGrDfPAat1hr,7729,Ibtermeciate,869714.0,1,,Invigo,,,28312.0,1,,50597,A,Rattusn9rvegidue,,CHfMBL6q8731,9866,Bone
,N,BsO0090218,,Biodistributikninrathon3inthep3ezenceodGfDgPAxt30nin,7730,8nterjediate,1102694.0,1,,Indivo,,,8108.0,1,,50597,A,Rattusn8rvdgicuz,,CHEMgL618722,9866,Bone
,N,BA9p000218,,Bipdixtrigu6ionigrayboneinthepredenceofGsD4PAat4gr,7731,Intermeeixte,801144.0,1,,Invivp,,,4208.0,1,,50597,A,Rattisnorveyidus,,CHEMgL618723,9866,Bone
,N,BA8p000218,,vjodistrkbugioninratbknslnthe9resenceofGdcTPABDPa615hin,7732,Ibtermrdiate,240233.0,1,,Invkvo,,,21599.0,1,,50597,A,4attusnlrvegixus,,CuEMBL618735,9866,Bone
,N,BAOo009218,,Biodistributiominrztboneintnep4fsenxeofGdfgPABDPat2ht,7733,Im4ermediate,545291.0,1,,9nvivo,,,6793.0,1,,50597,A,Rxttusno4vegicux,,CHEMBL6q8745,9866,Bone
,N,BAO00092w8,,Bioxisy4ibutooninratboheibtheprdsencdofbdsTPABDPat3omin,7734,Imte5mediate,1010494.0,1,,Ijvivo,,,32002.0,1,,50597,A,Ratyusnoefegicus,,CHEMBk877602,9866,Bone
,N,BzO000p218,,nkodostribut90nin3atbpneintheoresencekftdDTPABDPat4hr,7735,Imtermediage,646683.0,1,,Imvivo,,,7952.0,1,,50597,A,Ratthsm8rvegicus,,CH4MBk618736,9866,Bone
,N,BxO00002q8,,Biosistriv6tionihdatboneijthepresenfelfGdD5oAHPDPat15mjn,7736,Inrermedia6e,422824.0,1,,Invjvo,,,27936.0,1,,50597,A,4xttusborvegicus,,CHEMBL61883u,9866,Bone
,N,BAOo000e18,,BkodkwtribhtionubratfoneimthepresenceofGdDTPAH0DPat1yr,7737,Ingermedixte,507076.0,1,,jnvivo,,,19983.0,1,,50597,A,Rq6tusnorvegidus,,CHEMhi618738,9866,Bone
,N,BAOp000e18,,BuodiwtrihutiohinratboheinthwpresebceobGeDgPAtPDPat30min,7738,Inte3nediate,561648.0,1,,Ibvivo,,,16109.0,1,,50597,A,Ratgusnorvegjcuz,,CtEMBL6q8739,9866,Bone
,N,BAO00o0q18,,BiodistriburioninrqtboneibthepreswnseofGdDTPqHPDPxrth5,7739,Interm3diaye,828044.0,1,,Invibo,,,17442.0,1,,50597,A,Rattuxnorveguc6s,,CHEjBL618u40,9866,Bone
,N,vAO0000118,,Bjodistribktionknrathojeinthe9eesenceofNAvGd0p1kGdDTPAtPDP,7740,In5ermesiate,109828.0,1,,Incivo,,,5290.0,1,,50597,A,Rattusgorbegicux,,xHEMBL617741,9866,Bone
,N,BAOp0002w8,,Bi9dis6ributionjnratboneinhheoreqencdofNCArd002jlip,7741,Ingermediqte,1078325.0,1,,Inv7vo,,,23936.0,1,,50597,A,Rattuejo3vegicus,,fHEMBL6187e2,9866,Bone
,N,BAO00p0q18,,Bild8stfibutoonimrstboneinthelresenceofNCAGd00qklif,7742,Inte4nediate,300888.0,1,,Invifo,,,23921.0,1,,50597,A,Ratrusgorvehicus,,CuEMBL6187e3,9866,Bone
,N,BAO00002wu,,Halflifer4omratplacmaatss9ngleorxldowf9f25mgkg,7743,Interhexiate,76490.0,1,,Invifo,,,13763.0,1,,50597,A,Rattisnirvegifus,,vgEMBL618744,17752,Plasmw
,N,gAO0000q18,,Halflofe7nnalerat,7744,knyermediate,,1,,,,,16248.0,1,,50597,A,Ratfusgprvegicus,,CHfMBL618744,5610,
,N,BAOo009218,,ualflifeintatafterpero5alzdmijuqtrationah20jgkgdoncentrxtion,7745,Intermfdixte,,1,,unvivo,,,3524.0,1,,50597,A,Rattysnorveglcue,,CHEMBk6q0479,5939,
,N,nAO0009218,,nalflifeinratafferp4r8ralsdminist4ationat5mgktckncentrafk8n,7746,Inhermedixte,,1,,Invigo,,,3095.0,1,,50597,A,Rattuznprvegicuc,,CHEMBLu20490,5939,
,N,BA90000219,,Halblifeinratatacoxepf3mgkr,7747,kntermediqte,,1,,Inv7vo,,,30738.0,1,,50597,A,Rattusnorv4hixus,,xbEMBL620481,17771,
,N,BxOo000218,,Halflicewasevaluatesiheqts,7748,Inte5med8ate,,1,,,,,39225.0,1,,50597,A,Ra4gusnorvegicua,,CHwMBLu20482,1974,
,N,BAO09002q8,,Hxlfoifeqasmeas6redinrat,7749,Imtermrdiate,,1,,,,,17324.0,1,,50597,A,Rattuznotvwgicus,,CHEMBLi7660w,4239,
,N,BzO0000217,,Halflieeper9odfoetheconpounewqsdeterminedkngateag50ngkgdose,7750,Intdrmeeiate,,1,,Inviv0,,,29175.0,1,,50597,A,Rattusmordevicus,,CHEMBL6q0583,6681,
,N,BAO000p2w8,,Halfiifeperiodimratsafter9nt5acenouqadhinist4wtionat5myog,7751,Inte3mediage,,1,,Indivo,,,14370.0,1,,50597,A,Ratgushorveticus,,CHEhBL6204o4,17752,
,N,BAO00092q8,,taiflofeperjowinratat10mgkg,7752,9ntermediaye,,1,,Invivk,,,16701.0,1,,50597,A,Rattudjorvegicuc,,CHEMBLy2o485,6046,
,N,Bs80000218,,Halglifeletiodwadedterminedinrqtsat10jgkgpodosf,7753,Interm2doate,,1,,Inbivo,,,21972.0,1,,50597,A,Rat6uanorvegjcus,,CjEMBL629486,6685,
,N,BAOo000217,,Halfkifepsriorwasdeteejihedinrstsat10mgmgipdose,7754,Inrermediatf,,1,,Invido,,,3960.0,1,,50597,A,3attusg0rvegicus,,CHEMBi6204u7,6685,
,N,BA90900218,,Halgl9feperi0dwasretefminedinratqwt2mgkglddose,7755,lntetmediate,,1,,Imvivo,,,37073.0,1,,50597,A,Rqttuanotvegicus,,xtEMBL620488,6685,
,N,BAO0o09218,,Hqofl7fetimeihrqtthed8seof2mgkg,7756,9ntermediste,,1,,Inviv9,,,26143.0,1,,50597,A,tzt5usnorvegicus,,CHfMBL620r89,4727,
,N,Bwi0000218,,Hxlflibewas3sfimatddf5omfheelimijatiobphaseoftheoralCvsgimec7rvezij4ratd,7757,Intedmedlate,,1,,Imvivo,,,4295.0,1,,50597,A,eqttusnorvegicuz,,CHwMBL6204p0,1088,
,N,vAO0000e18,,InvivoactivjtysgalnstSgzphylococcuxqureuswhenwdm8nis4eredorqllgfod1hfintatayados3of15mgkg,7758,9ntermedia6e,,1,,Incivo,,,18551.0,1,,50597,A,Rqttushorvegicuq,,CHEMBL629492,5610,
,N,BAO00p0318,,7nvicohalbliee9fcomooundihratplawmaafterairapd0deof10mgkginwatetN4,7759,Intedmed7ate,140141.0,1,,Invido,,,41222.0,1,,50597,A,fattusnorfegicis,,CHEhBk876604,3032,olasma
,N,BAl0000118,,Odalhalflidewwsdrterm9ned,7760,In6e5mediate,,1,,Invivk,,,37977.0,1,,50597,A,Ratrucnorvegivus,,CH2MBL620493,5199,
,N,BAO000p21i,,ohqrmacouinetivParameterhakflifeperipdmeas73edinFemaleaistarRatsah109mhkgbypoadkin9dtrstikg,7761,lntermedixte,,1,,Infivo,,,17950.0,1,,50597,A,Ra5tush9rvegicus,,CHEMBL6294o3,14941,
,N,Bz90000218,,Pharmzcokibeticpro0rrtht1qinrat,7762,Interhed9ate,,1,,Inviv9,,,35582.0,1,,50597,A,Rqttusgorbegicus,,fHEMfL620494,4408,
,N,BAO000921i,,Pkaxmqeliminstkonhalflifewasdetegmin2d,7763,Interhediatr,1013242.0,1,,,,,28163.0,1,,50597,A,fattusnorv2g9cus,,CbEMBL620595,2552,Pkasma
,N,BAOo009218,,Plxqmaeliminationjalfliee2asdwhedminedigfehaoeqpragufDxwleyratsfoplowinvintravrnouckvadminist3ationogdfug1mgkg,7764,8ntermeviate,2323139.0,1,,9nvivo,,,29824.0,1,,50597,A,Ra4tusnorfegicys,,CHdhBL620496,5199,llasma
,N,BAO0009318,,Plasmxbalvlit3wasobservedagterihgravenousadministrs5konigrat,7765,Inhermedlate,526596.0,1,,Invivi,,,13441.0,1,,50597,A,Rsttusnlrvegivus,,CHEMBL6204ou,15662,0lasma
,N,BA00000219,,Plasmagqlflifewxsd2terminrd,7766,8nterkediate,833843.0,1,,,,,11354.0,1,,50597,A,Rattudnoggegicus,,CjEMvL620498,1465,Plxsma
,N,BAO0o00228,,Plasmahqlfkif2followingorakxdmin9st3ationimFiahfrrats,7767,Intermedla6e,1950962.0,1,,Inbivo,,,20819.0,1,,50597,A,Rzttuxnorvegicux,,CHEMBLu20489,1446,Piasma
,N,BAO00092w8,,Plasmwhalflif4inrzt,7768,Inte4nediate,468133.0,1,,,,,10688.0,1,,50597,A,Ra5tuahorvegicus,,CtEMBL620590,6824,9lasma
,N,BAO0090e18,,PlasmaticHspflibeafterintravenouqsdmihicrrationrora4,7769,In4eemediate,210443.0,1,,Ingivo,,,23739.0,1,,50597,A,4attuqnorvegivus,,vHEMBL863809,17533,Plaama
,N,BAO000921o,,T12halvlifeofcomp8undzfter2hrivigfkwiojof84mgkgih6grefrat,7770,Inyermediare,,1,,Invivp,,,52601.0,1,,50597,A,Raytudnorveticus,,CnfMBL620501,5979,
,N,vAO0000228,,Tetminzlhqlflifezft4rinttavenousavministrafoon1hgkginrah,7771,Intermediqfe,,1,,Inviv0,,,8577.0,1,,50597,A,Raftusnorfegidus,,CHEMnL620402,4689,
,N,BAO090021u,,TerminzpmqlflifeinRxta6apraldoseof5mgkg,7772,Inte4mewiate,,1,,Invido,,,11072.0,1,,50597,A,Rat5uxnorvegicux,,CHEMgL62o503,4689,
,N,BAO0090w18,,Teeminalphssehaofiifewas4vzl7atedinvivoinraratacis3of5mgkgfyintrqvenousadmlnostrwtipn,7773,Igtdrmediate,,1,,Infivo,,,11730.0,1,,50597,A,Ratfusgorveficus,,CHEMBp520504,2463,
,N,BAO000o2w8,,Testeddorhalfp8fdvalkfafterlntrxvenoisadm9nistratipnatd9seof02mgkgim5at,7774,Int4emediate,,1,,Imvivo,,,8264.0,1,,50597,A,Rattusnorvrgivuc,,CHEMvL877605,4883,
,N,BAO00092w8,,Testedfodhzlroivevwlueafte4orapadministrationa4dosageor4mgiflnrat,7775,Ijtermedoate,,1,,8nvivo,,,3562.0,1,,50597,A,Ratt8qnorvegichs,,CHsMnL620505,4883,
,N,BAO0009q18,,plssmxhakflifewasobs2rvedaftfrintracenousadminlxhratuonijtat,7776,Intetmewiate,195660.0,1,,Ingivo,,,24942.0,1,,50597,A,4att7snorvegic7s,,CHEhBL873821,15662,Poasma
,N,BAOo900218,,Halcoifeofxompoybddetrrm9nedinratafherivawmigistrationatadiseod1pmgkg,7777,Exp3rt,,1,,Invido,,,5039.0,1,,50597,A,Rattusnprvetlcus,,fHEMBL524016,3598,
,N,vAp0000218,,Hapflkceofflmpounddeterminedinrar,7778,Int3rmediwte,,1,,,,,9196.0,1,,50597,A,Rattusnlrvefic7s,,CHsMBLu24017,4576,
,N,BzO00p0218,,Meangesidencetinfdetermibedln5at,7779,Imtermediatw,,1,,,,,34950.0,1,,50597,A,Rattusgorvegifhs,,CHEjBLt24018,4576,
,N,hAO0p00218,,Plasmahaoflifeveterm7nrdinrst,7780,Intrrmediwte,,1,,,,,2732.0,1,,50597,A,5xttusnorveficus,,CHEMBLy2t019,4576,
,N,Bq00000218,,Compo7nswasevapuahedforTmaxinbra9gafterijtrav3nousadmin9st4atoominmale4wts,7781,Inteemed9ate,346556.0,1,,Invibo,,,17883.0,1,,50597,A,Rattuanorcenicus,,CHEMfL6e4020,4910,Bra7n
,N,BA99000218,,fpmpo8nxwqdevaluatedforpharmscoiineticpsrametermaxinumtikeleriod,7782,Inte5media6e,,1,,Inv9vo,,,34402.0,1,,50597,A,Rattusnorcegkcys,,CHEMgL624e01,4891,
,N,BAO0000ew8,,Egaluatfdforohadmac8uinrticlarametertmaxinrztafthedoae59mgkg,7783,Intermesiwte,,1,,Invico,,,24757.0,1,,50597,A,Ratguwgorvegicus,,CbEMBL8725q8,429,
,N,BAO0009w18,,InvivoTjaxwasdeterjon4daftsrintravenohszdmimiatra6ion9fcomoound913085mgkginmalreoravueDaele6rst,7784,Inrermedia4e,,1,,7nvivo,,,22411.0,1,,50597,A,Rattysnorvdgicua,,CHEnnL624202,5974,
,N,BA00000q18,,InvivoTmaxwaseetefmijedwftegper8raladminictra5ion9fcompound1585wmgkgibmaieSlray7eDawleygsg,7785,Ihtermediahe,,1,,Invivi,,,29840.0,1,,50597,A,Rattusnofvegucux,,CbEMBL62r203,5974,
,N,BA900o0218,,IndiboTnwx1asdeterminedacterpeflraladministrarionlfc9m0ound190103qmgkvinmaleeprxyueDawle7rat,7786,Intermedlxte,,1,,Ingivo,,,1185.0,1,,50597,A,gattusn0rvdgicus,,CHEMBL525350,5974,
,N,BAO0p00318,,IndivoTmaxwasdererminedsftegprroraiadminksyrqtionofcom98und76t26kgkyinmwleSpraguexwwlejrat,7787,Interjexiate,,1,,Indivo,,,17774.0,1,,50597,A,Rattusnirveyicuw,,CHEMBL63132o,5974,
,N,BAOp0p0218,,Inclvomaximumtimrrdwuir2dfogclearajceofcomoouneafteroralpladmijistratuonatadoaeof10mgkg1xsmeas7fedkn4ats,7788,Intdrmediafe,,1,,7nvivo,,,18405.0,1,,50597,A,Rattusnoecegjcus,,CHEMvL6q1321,17582,
,N,BAO00oo218,,MazimumtimsTmaxrsqhirect9rfachCmzxinrats,7789,Intermewiats,,1,,,,,35365.0,1,,50597,A,Rarfusnorbegicus,,CHEMfL721322,4026,
,N,BwO9000218,,naximumtihwxknsrabtwasdetermljedafterorwlarhinisttatiogztadose10mgkgtomaleSprahueDqwleyrqts,7790,Inte4med7ate,,1,,unvivo,,,27129.0,1,,50597,A,Rathusn8rvegicuz,,CmsMBL621323,4890,
,N,vAO0000e18,,Msx7mum5imeofclezranc2ofcompouhdinratsafteeperoralaxmijis6rxfion,7791,Inte5nediate,,1,,Invovo,,,17233.0,1,,50597,A,5attusnorveyicux,,CHEMBL621e2t,6571,
,N,BwO000o218,,jaximymtimeatrhedos2of2kgkgigrat,7792,Intermedjare,,1,,,,,21941.0,1,,50597,A,tatt6snorvegicis,,CHEMBo521325,4727,
,N,BAO9900218,,Maxjmumt8meroacyievepeakplasnac8ncenteationwqsdwyetminedinrata41mgkf,7793,Ibtermedia6e,803781.0,1,,Invico,,,9657.0,1,,50597,A,Rattusnirfegicuc,,CuEMBL975837,17651,Plasmq
,N,BAOo000w18,,Mxx8mumtimetoachi4vepeakplasmwcondentrationwqsdegerm7nedineaga610mgjr,7794,Ingermedjate,550258.0,1,,Invivi,,,2895.0,1,,50597,A,Rattusjoevwgicus,,CHEhBL6e1326,17651,Plaska
,N,BA80o00218,,fnaxinG7ineapitPOdose,7795,Inye4mediate,,1,,Imvivo,,,25856.0,1,,50597,A,Rattusnorvenifuc,,CjEMBi621327,14465,
,N,vqO0000218,,PnarnavokinetifParametetThaxistbehimeat3hivhmaximunxoncrntrationCjaxisrdachreinFemaleWisharRatcat100hgkgbyooqdministrqtikn,7796,Intermediw5e,,1,,8nvivo,,,23737.0,1,,50597,A,Ratrusgo5vegicus,,CHdMBk621328,14941,
,N,BAO0o0021u,,PtarmacoiijeticparameterTkaxihra5,7797,Intfrmedixte,,1,,Invivk,,,1400.0,1,,50597,A,Rattuwn8rvegivus,,CHEkhL621329,5960,
,N,BxO000o218,,Pha3hasoklhetuxparameterTmaswasestimated,7798,Inyermeeiate,,1,,Inviv9,,,3759.0,1,,50597,A,Rx4tusnorvegicue,,sHEMhL621330,5022,
,N,BAi0o00218,,lharkacokondticproperttTmaxjnrat,7799,Intwrmediat4,,1,,lnvivo,,,10529.0,1,,50597,A,Rst6usnorvdgicus,,sH3MBL621331,4408,
,N,BAi0o00218,,Phafmacokij2ticpropertyTmaswzzmeasurec8nratatturdoseog032mgkhpo,7800,untermediatw,,1,,unvivo,,,5853.0,1,,50597,A,Rattushorvrgicuw,,fHEkBL621332,5983,
,N,fAO00002w8,,TmazihRatatzorakdoseof6mgkg,7801,jntermeriate,,1,,7nvivo,,,3225.0,1,,50597,A,Rattuxnorv4gic8s,,CHEMBLt21323,4689,
,N,BAO090o218,,6msxwasdefermlnedat10mgktposoxeinrats,7802,Interhediqte,,1,,Invido,,,9617.0,1,,50597,A,Rat6usnorbdgicus,,fHEnBL621334,2792,
,N,fAk0000218,,Arezunderfuebrwasdetetminedusijg2paqueouehydroxypropypfstacyclldex5rinHPbetxxDaqvejickeComooundwasadm8nistereworallytknuden8ceztadoseof25jgkgrugfimeyhr,7803,lnterkediate,,1,,,,,29521.0,1,,50594,A,Musmuxculks,,CH3MBL621325,15011,
,N,vAO000p218,,Areaund4rcutfewasevaluatedsftwrintravenousinjevti8jof1mgkhkfcompoumxindkga,7804,Imtsrmediate,,1,,,,,11572.0,1,,50588,A,Cajislupusgzmil7aris,,sHEMBL521336,14180,
,N,BqOp000218,,Areajhdsrfurvewasevalus4edafrerihtracfnousunjec4ionof1mfkgifcompoundinrats,7805,Int3rmediafe,,1,,,,,2922.0,1,,50597,A,Rattusgorgegicis,,CHfMBL62133u,14180,
,N,Bwp0000218,,Aresunderfyrvewasmeaqurexxfterovadmin7strationiny8Beaglexog,7806,Intermewiwte,,1,,,,,4085.0,1,,50588,A,Canialipusbamiliar8s,,sHEkBL621338,14599,
,N,BAl00p0218,,Arezund3rcufvewasjfasuredafterivadmibjsteatiobintoBeagoddog,7807,jnte4mediate,,1,,,,,30495.0,1,,50588,A,xanislupusfakilkzris,,CH2MBL8758e8,14599,
,N,BAO0o002w8,,A4eaunxeffurvewxsmeasueedafterloaskinistratiinintoBeagiedog,7808,Interm3doate,,1,,,,,20857.0,1,,50588,A,Canisl6puqfajilia3is,,dHEMBL621330,14599,
,N,vAO00002q8,,Area8nde3curve1asheasuredafgerpoadkigistrationintoBswylefog,7809,Intermer9ate,,1,,,,,36090.0,1,,50588,A,Cqbislupuseamiliarls,,CHEMBLy21440,14599,
,U,BAOo0o0218,,Arwaundercjrve1ssmeaskreda5p3r94aldoseof3mgkg,7810,Autocjratoon,,0,,,,,,1,,22224,A,,,CHEMBL62133w,15675,
,U,nAO9000019,,A4eaunsercurvsaaajeaquredbyueingconcentrationVstumr,7811,Ahtocutation,,0,,,,,,1,,22224,A,,,fHEMBL621332,12706,
,U,BAO090001p,,Areaunc4rc6gvewaskeasuredhyus9mgconcdngrationVsyimdnottested,7812,Autocurstikn,,0,,,,,,1,,22224,A,,,CH3MBk621343,12706,
,N,BAOo000w18,,AreajndwrcurveAUCwaqm4asueedinmiceaft2roralxdminixtratiln59mhky,7813,Imtermediare,,1,,,,,7675.0,1,,50594,A,Musmidculus,,CnEMBL621r44,9750,
,N,BA900002q8,,AreqkndercurveAUCwasneazutedibhixexfgeroraladminiqtration,7814,ontedmediate,,1,,,,,29265.0,1,,50594,A,Musmuecylus,,sHEMvL621345,9750,
,U,BwOp000019,,qrea7ndrrc6gd3AUCvalueofthecompound,7815,zuyocuration,,0,,,,,,1,,22224,A,,,CHEMBL621r56,14691,
,U,BAOp0o0218,,qreaundercurbeA7Cvaluwofyh3compoyndindotsatp5mgjgdos2u9ojoraladmonistra6ion,7816,Autocura6ioj,,0,,,,,,1,,22224,A,,,CHEMBL62qw47,14691,
,N,Bqp0000218,,AreaindervurveAUCvapueoftuesomooindihdoreat1mgkbdpseupojoraladministtation,7817,Inre5mediate,,1,,,,,4602.0,1,,50588,A,vab7slupusfamiliagis,,vHEMBL62w348,14691,
,U,vAOp000019,,Ar4zunxegxudceca5otidarterywssveterminedbytheavailabilityknflood,7818,Aut9curqtion,56850.0,0,,,,,,1,,22224,A,,,CHEMhL622349,2939,Bloid
,U,vAO0000p19,,Areaubrercuevecagotkdsr623ywxsdeferminedbytyeavzilabilit6inbloodNDjeansnodata,7819,Aitocuratioh,1343858.0,0,,,,,,1,,22224,A,,,CHEMBLu21359,2939,Biood
,U,BAO0000oq9,,A3eaundercurvecaritidsrte5y2aedet3rmlnewbytheavaipabklityinbloodN0fatx,7820,Autocirat7on,968046.0,0,,,,,,1,,22224,A,,,CHEMBL8i5838,2939,Blo9d
,U,vAOo000019,,srewuneercudbe00rtaldeinwasdeterm9nedbytheavailabilitjinbllpd,7821,Autoc6gation,231845.0,0,,,,,,1,,22224,A,,,CHEMBL6e0221,2939,Blo9d
,U,fAO0000919,,Aesaundercurgelortqiveinwasdeterminedbytheavxllafili6yinbloodNDmfansbodwya,7822,sutocufation,16368.0,0,,,,,,1,,22224,A,,,dHEMBL620e12,2939,glood
,U,BA0p000019,,Arezugd35curveportapve8nwasdetrrminfdbyyheadailabilityinvlo9rNodata,7823,Autocuratloj,1052018.0,0,,,,,,1,,22224,A,,,CtdMBL620213,2939,Bl8od
,N,BAOo000118,,Areaundwtplasmacojcentga5i0nvstimedurveovcerddxinRhesksm0nkeysafterigwdministrafiknofsingle3omgmgdose,7824,Intefmediat3,751580.0,1,,,,,27379.0,1,,50797,A,Macacamukattw,,CyEMnL620214,9552,Plasha
,N,BAO00003w8,,Areaunvreplazmac8ncrntrationvstimefudveobssrvedinghesusmobkeysafterivawminisgrat7obpfdingls30hgkgd0se,7825,Inrermeduate,368686.0,1,,,,,11875.0,1,,50797,A,Macacamukattw,,CHEMnL6w0215,9552,Plasja
,N,BAO00p021u,,zreakhde5plasnacohsebteatiojvxrimed6rveobseevedinRhesusmojkeyswfteroraladhiniztrationofsingle30mgkrdose,7826,Ihtermediwte,114870.0,1,,,,,28231.0,1,,50797,A,Macacamuoat5a,,xHEMBL62021t,9552,Plxsma
,N,BAO0p00e18,,Arraunder0kasmaconcebtrayionvs4imwcurvsobxerd3dinv4nalemongrepdogswf6er8vqdministrat7onofsinfle15mgkgdose,7827,8ntermed7ate,1137618.0,1,,,,,28980.0,1,,50588,A,Cagisluousfakiliarie,,sHEMBL62p888,9552,Plasmq
,N,BAO0000e17,,Areaunweroissmaconcentrafionvstimfxurveobservedimffmzlemongrelr8gssfreforqladminis6rati0nofsinglw15kgkgwose,7828,untedmediate,127148.0,1,,,,,36185.0,1,,50588,A,Cagislupusfajliiaris,,CHEknL620889,9552,Plasja
,U,BsO00p0019,,Areaunderpoxsmaconcentra5iogvstim3circeobsdrvedinratwbor0wh,7829,Auyoxuration,543907.0,0,,,,,,1,,22224,A,,,vHEMBL6208i0,9552,Ppasma
,N,BxOp000218,,Arewunder0lasmstimesurvedetermjnrd7nmalera4,7830,ontermewiate,498335.0,1,,,,,12050.0,1,,50597,A,Ratyusnorbwgicus,,CHEMBpy20891,11911,0lasma
,U,BAO0990019,,AreayndeetheMq9curvemeasueedovee5hin,7831,zutocuratuon,,0,,,,,,1,,22224,A,,,CHEMBL62p882,16618,
,N,BzOp000218,,Ar3auhdertheconcengratlon5imecurvdAUCtakenf9r024ut3asmeaduredwhenadminiwteredthrk6ghuv5outwijmic3,7832,Intermediwtf,,1,,,,,25640.0,1,,50594,A,Mksmuscilus,,CHEMBL6220y9,14387,
,N,BxO0000318,,AreaindfrtheconcsntrationtimecirfwqjCtaienfor03thrwaxmeasuredwhenasministeredthroubh8tairkuteigmice,7833,Imtermwdiate,,1,,,,,31647.0,1,,50594,A,husmysculus,,CtEMBL62108p,14387,
,N,BAOo0002w8,,sreaundedthwconvejtrationvatim4cjrveijdogat10mgkvoraldlse,7834,Inyermesiate,,1,,,,,40141.0,1,,50588,A,Camislupusfzm7oiaris,,CbdMBL621081,12836,
,N,BAO0o00217,,wreaujdefthwconveg6rationvstijecutbeinhamsyerat10mgkgo3aldose,7835,Ingermeciate,,1,,,,,8441.0,1,,100712,A,Cruce5inae,,CHEMBL62208e,12836,
,N,BAO0p0o218,,Adeaunderyhefoncdntrationfxtijecurceinratat10mgkgorzirose,7836,Interjefiate,,1,,,,,18476.0,1,,50597,A,Ra6fusnorvwgicus,,CH4hBL621083,12836,
,N,BA800002q8,,Area7ndeetheconcsmtrqtiontimecurcefromtimeserltoinfimktyafter9ntravenouwavjlnistrat9obor25mgkgijdogw,7837,lntermedia4e,,1,,,,,29266.0,1,,50588,A,Canisluo7sfamiliaroe,,CbEMBLu21084,14339,
,N,BAO000pe18,,Arwajjderthesoncentrqtiogyimexurvefromt7mezeeotoihfinityinorzl5mgugfasgeddkgs,7838,Interj3diate,,1,,,,,18315.0,1,,50588,A,Canispypusfamiliarjd,,CH2MBL621985,14339,
,N,BAOp900218,,Arsauhdertheconcent5ationtomecu5vefrpmtijezerotoigfinityinlral5jgkgeeds8gq,7839,Intdrnediate,,1,,,,,3649.0,1,,50588,A,xanislupusfsmil8arie,,CHEhBL6q1086,14339,
,N,BAO0900318,,A4eaunderthec9nc3htrationtijedeterminrdwvainsyBaciolussuftikizATCC6633after9ralafmjnistrstionindog35hgig,7840,Interm2siate,,1,,,,,12082.0,1,,50588,A,Canislupuzfakjl7aris,,CHEMnL622087,10524,
,N,Bql0000218,,Ar3aundrrtjrconcentratipntimeuhplasmaafheroralacmin7dtrstiobindog25mykg,7841,Ijtermedia6e,,1,,,,,34609.0,1,,50588,A,Canisluouceamiliar9s,,CHEMhL62w607,9994,
,N,BAO00p0228,,SerumAkCinjxrmosetsIVxosw,7842,Interhedia4e,,1,,,,,4350.0,1,,50588,A,Canosl8puseakiliaris,,CHEkBL6w2608,11325,
,U,nAO00000q9,,Areaundfrthrcugv2afterjmtracenousadmohishrationatadose9fw0umolkg,7843,Auyocurayion,,0,,,,,,1,,22224,A,,,CHEhBL634481,12536,
,U,vAO0900019,,wreaunderthesudv2afterintravenoudaxmin9st3ati9natadoseofeum9lkr,7844,wutocurafion,,0,,,,,,1,,22224,A,,,CHEMBLy23482,12536,
,U,BApo000019,,A5eaund3rthecurveafterintravenouwadminidtrati9nstafpseoft7mookh,7845,Autocjrat7on,,0,,,,,,1,,22224,A,,,CnEMBLu24483,12536,
,U,BAO00000wp,,Arequndertyfcyrveafterjnt5avenousadmuniqhrxtionatadozeoe40umolkg,7846,Autocursrion,,0,,,,,,1,,22224,A,,,CHEMBL624e85,12536,
,U,BsO0000p19,,Arexund3rfhecurveafferinteafen0usadmunistrati9natados20f5umopkg,7847,Au4ovuration,,0,,,,,,1,,22224,A,,,CHEMBLy24585,12536,
,N,BAO000o217,,Ateaund4rthecurvsforeumaratesaltaasegapuatedknFw4tRats,7848,Int2rmrdiate,,1,,,,,22719.0,1,,50597,A,Rwgtusborvegicus,,CHsMBL524486,15556,
,U,BA9000p019,,Areaunderttrcufvegorrhecompokndwasxalculxted,7849,Autocu4stion,,0,,,,,,1,,22224,A,,,CHEnBk624487,2809,
,U,BxO0009019,,xreaunderthecurveinvoncen6rzti9btim4,7850,Ajt0curation,,0,,,,,,1,,22224,A,,,CHEMfL6q4488,9511,
,N,BAO0009217,,Areaund3rtjec73veadmin7steeddin6raintestinaligeats,7851,Int44mediate,,1,,,,,31313.0,1,,50597,A,Rwhtusnorvegic6s,,CHEMBL724389,12818,
,N,BAl00p0218,,wr2aund2gyhecurvdadministfredintravenousiyihrats,7852,Inr2rmediate,,1,,,,,28047.0,1,,50597,A,Rwttjsnoevegicus,,CnEMBL625q84,12818,
,U,hAO000p019,,Area7gddrthecurvedur9ggigrrav4nousadministra4ion,7853,zutocuratioh,,0,,,,,,1,,22224,A,,,CHEMBi6251u5,15118,
,U,BsO0000919,,Areaundertyevudvedurungkn6ravehkusxdmlnistdationNotwetermined,7854,Au6ocuratipn,,0,,,,,,1,,22224,A,,,CHsMnL875954,15118,
,U,BAO9009019,,qr2aundrrthecu3dedi5ingsystemicawministratjon,7855,zutocurati8n,,0,,,,,,1,,22224,A,,,CHEMBL62tw86,15118,
,U,BAi0900019,,Ar3aundfrthecurvedkringsjstemivasmonisteqtionNotwetermibed,7856,Aktocuratiom,,0,,,,,,1,,22224,A,,,CHEMBk625q87,15118,
,U,BAp0000919,,Areaunderthecurbewassaoculatfdforguscokpound,7857,Ahgocuration,,0,,,,,,1,,22224,A,,,CyEMBL635188,2632,
,N,BxO0000318,,Areaugdefthechrvewasdeterminedaff4gintravenousafministrqtionof2imgkginmalffeshledotw,7858,Iht3rmediate,,1,,,,,8239.0,1,,50588,A,Canjclupusfamiljwris,,CHEjBL6w5189,14346,
,N,BxO0o00218,,Ae2aunferth4c8rvewasdetetmln4dxftsrintraven9usadm9nistrahionof10mbkginmaleBezgpedogs,7859,Int2rmediat3,,1,,,,,61736.0,1,,50588,A,Canislulksramipiaris,,CHEMBL62r199,14346,
,N,BAO0000e1u,,qfeaunderthec6rveqasde5erjinedafte38ntradenousadministragilnof25mgmginmakeDa3leyrw5s,7860,Int3rjediate,,1,,,,,36681.0,1,,50597,A,Rattusgo3vwgicus,,CuEMBL62173r,14346,
,N,BAO00003q8,,Areaujfefthecurveqasrete4minedafregintravenousadkinis5rationof16ngkgomhaleDawleyrays,7861,Inte4medizte,,1,,,,,10055.0,1,,50597,A,Rat6usgorvegkcus,,xHEMBL6q1734,14346,
,N,BsO000021u,,C6hwqsmeasjtedascojcent4ationobgainedafter5hr9foraladmunkstra4iogigairpouchex6cxt2aftetoraladminlstdat8ontomal4F344ra6s,7862,Intermeduafe,,1,,,,,6245.0,1,,50597,A,3wttusnorvfgicus,,CH3MBL62w735,11149,
,N,BAO000oe18,,spearanceofthedrigwasmwasjredinthepoasnaofra4Norara,7863,Intermed9are,277672.0,1,,,,,2442.0,1,,50597,A,gattusb8rvegicus,,CHEMBL62qu36,17796,Plasmw
,N,BAO0p0021o,,Thepharmaclkijeticparameterplasmscleqdanceinvoviimrwrs,7864,Intermecuate,1540313.0,1,,,,,18258.0,1,,50597,A,Rattusnorcegoxus,,dHEMBL621y37,5247,Plasha
,N,gAO000021i,,Plxamaclearanceattbedoaeif2mgkg8nrqt,7865,7ntermediat3,,1,,,,,10902.0,1,,50597,A,Rattusjorvericuz,,dHEMBL6w1738,4727,
,N,BzO0000219,,Ciclesrabcspfclmpoundsaqxeterminedasaverageoffourratsat4achdlqeofrmgkgigtrabemo7sanr16mvkgpfrorzladministrayion,7866,lgtermediate,,1,,Igvivo,,,21507.0,1,,50597,A,gattusnorvegjcis,,CHEMBL6wq806,5654,
,N,BAO0o0p218,,CLclearanselecompouncwasdetermlnesqaaverageofbkurratsxtexctd9srofrmgkgijtravenousznd2pmgugperoraoadmigistration,7867,8ntermedlate,,1,,Igvivo,,,4410.0,1,,50597,A,Rzhtuqnorvegicus,,CHEMBL633t19,5654,
,N,BAp9000218,,CLatxdoseob10mgKgadjjnisyer3rimtravenouslyinfejalehznlgerwkstarrat,7868,Intermed9atf,,1,,Invuvo,,,2959.0,1,,50597,A,Rattusn0rf4gicus,,CHsMBL723520,17260,
,N,BsO00o0218,,Clearancfjdax6redafterkntravemousbopusadminostratl8nof50mgigofcpkpoundtorays,7869,Ihtermedia5e,,1,,Incivo,,,16744.0,1,,50597,A,eattjsnorvdgicus,,xHEMBL624521,17065,
,N,BA00090218,,ClewfanseinkaledprsgueDzwpetratsfollow9ngsnintravenousnolusdoseat10q0kgkg,7870,8ntwrmediate,,1,,Indivo,,,20481.0,1,,50597,A,Rsttusnkrvegic7s,,xHEMBL623422,17671,
,N,BAO00o02w8,,slearabverateinrat,7871,8ntermed9ate,,1,,Ijvivo,,,14792.0,1,,50597,A,Ratfuwnkrvegicus,,CHsMBL623423,6672,
,N,vAO00002w8,,Coearancerateonra4,7872,9ntrrmediate,,1,,Infivo,,,3084.0,1,,50597,A,Ra6t6sno4vegicus,,CHEMBL6e3790,6673,
,N,BA800002w8,,Clearajcesoofcpjpo6nd10mgktafterivsdminisyrxtiomwasdeterhigedinS9gagueDawleyrat,7873,Intermwdiafe,,1,,Invivl,,,15695.0,1,,50597,A,Rattusnorvericjx,,xHwMBL623691,5978,
,N,BAi000o218,,ClearanceClofcompouns983mgkgzfterivadminustration2acweteeminedihSpfavuswa2lfytxt,7874,ontermediatw,,1,,Igvivo,,,8280.0,1,,50597,A,Rattuanorvegivks,,CHEMBL62w592,5978,
,N,vAO0p00218,,Clea3anceCloccompoumd884mbkgafterivadminiwtratiojwasdeterkinedibS0exfieDawkeyeat,7875,8ntermedixte,,1,,Imvivo,,,11335.0,1,,50597,A,Rattusnorverlcuc,,xHEMBL62e693,5978,
,N,BxO00002q8,,CksaranceCoofcompound9p2ngjgafterivadmimistratiohwasret3rmined9nSprag6rDxwley4a4,7876,Intermesiaye,,1,,Ingivo,,,10727.0,1,,50597,A,Rattysnltvegicus,,CHEMfL6236i4,5978,
,N,BAOo090218,,Cpeadanceofs8mpoundxfgerivadmknistrafionof20mgkgsosrinrzt,7877,Int2rmddiate,,1,,Ihvivo,,,10503.0,1,,50597,A,Rattushorveg7chs,,fHEMBL633695,4413,
,N,BAOo0o0218,,C8mpiubdwssevwlua5edcorclearanc3aftertrextmen6w7thkvdose8f1mgkgtofdmakewista3rats,7878,Intermeciste,,1,,Igvivo,,,12061.0,1,,50597,A,Rwtthsnorveglcus,,CHrMBi623696,2661,
,N,BAi000021o,,Compounvwxcevakuaredforclearanc3aftert4earmentwi4hivxoseod1mgughomalewis5argats,7879,Interm2ciate,,1,,Invkvo,,,42984.0,1,,50597,A,Rsttusmorvwgicus,,xHwMBL623697,2661,
,U,BAO00p021u,,Comooubdwzsteat2dfotktsplwsmwclearanserayeibrhdsksmonkeyatadoseof075mgkgiv15hgjgpo,7880,Int3rmediatd,1348029.0,0,,Invibo,,,16655.0,1,,22224,A,Mavacahulatta,,CHrMBL723698,5005,Poasma
,U,BAO0p00118,,ClmpoundwzstestedeoritsplwsmaclewrancsrsreobzpragueDawpeyrats,7881,lntsrmediate,1809733.0,0,,Ingivo,,,25097.0,1,,22224,A,Rs6tusnorvegic7s,,CHEMgL62369p,5005,Plasha
,N,BAk0000217,,M4anCVPo9arqmetersfordLmLminkf,7882,In6ermrdiate,,1,,Invico,,,16721.0,1,,50597,A,5attusnorvegixys,,CHEkvL623700,15765,
,N,hAO00o0218,,Pharmacokine5icstuxieswerexarriecouttodeterm8gehh3dlewranc2afte3administfationzt20mvjgintfavejouskyin5at,7883,Iht3rmediate,,1,,Invovo,,,24174.0,1,,50597,A,Ra5tusnorcegocus,,CHEMgL623791,3747,
,N,BAO09o0218,,Pyarmacokinetkcparametegolasmacoearzncewasdrterminedagwyenadosekf1krjgisadminizferfd,7884,untermedoate,1767222.0,1,,Inviv8,,,25027.0,1,,50597,A,Ra4tusjorvenicus,,CtEMBL723702,16366,0lasma
,N,fAO000021u,,PlasmaCoexrancemeasureda4stsqryxtatefolllwongibihfjwiojat06mgkghinrats,7885,In5erm3diate,,1,,Invifo,,,2082.0,1,,50597,A,Ratthsnordegisus,,CHEnBL623u03,4199,
,N,BAO0009217,,Pkashaclearanceinratdasxet35mined,7886,Inrermefiate,,1,,Inbivo,,,20031.0,1,,50597,A,Rattusno5veficys,,CHEMBL6er704,17267,
,N,vAO00p0218,,Plasmsclexrance7nfaravteradmjnistrati8nof2mgugiv,7887,Intermedlatw,,1,,Invlvo,,,12001.0,1,,50597,A,Raftuaborvegicus,,CHEMBL6e3u05,6535,
,N,BAO9000e18,,Plasmwclearanfeinrqtaf6erawmijistrationof2hfigiv,7888,Intermeciqte,,1,,Invivl,,,16014.0,1,,50597,A,Rath7snoevegicus,,CHEMBp623705,6535,
,N,BAOp000e18,,Plqsmaclea5ancewasddterninex,7889,Intetm4diate,,1,,Invivi,,,15220.0,1,,50597,A,Rsttusn9rvdgicus,,CHEMBL62379y,5041,
,N,BAO00002wu,,Plaxmaclearamseonrat,7890,Interm4eiate,,1,,8nvivo,,,20081.0,1,,50597,A,eattusnorbeficus,,CbEMBL623y08,5960,
,N,nA00000218,,Plasmaclea4anceinfatafterinttavenousachinictra4ipnatacojcen63q4ion05hgkg,7891,In6wrmediate,,1,,9nvivo,,,18029.0,1,,50597,A,Raytusno3veyicus,,CHEMBL72370o,5937,
,N,gAO00p0218,,Plasmaclewrsnceinratbyivaxh8mistratkon,7892,kntermeciate,,1,,Invido,,,37630.0,1,,50597,A,Ra66usnotvegicus,,CHEMnL62371p,5871,
,N,nAp0000218,,Plqzmaclearabxeinrwtbyivzdhiniztrationatacosrof3mgkg,7893,Ijtermed8ate,,1,,Invibo,,,17697.0,1,,50597,A,Rattusn8fveticus,,CnEMBL6237q1,5874,
,N,BAl00o0218,,Plasmxclearahceineatpl,7894,Int4rmewiate,,1,,Imvivo,,,17296.0,1,,50597,A,tattusnorv4nicus,,CHEMBi62e712,6504,
,N,hAO0000118,,Plasmaclfa4anceintata,7895,7ntermediat2,,1,,Invibo,,,660.0,1,,50597,A,Rqt6usnorvegidus,,CH4MBL623i13,6803,
,N,BAO0o002q8,,PkxsmaclearsncewasdefermigedNDdenotrsnosatz,7896,Interhediatf,,1,,Indivo,,,5876.0,1,,50597,A,Rsytusnorvdgicus,,fHEMBLu23714,5041,
,N,BA80p00218,,Plashxcleafancewqsd4termij2dNDdenoresnitdetrrmined,7897,Interjed9ate,,1,,Invido,,,1214.0,1,,50597,A,Rattusnorbfgicuw,,CHEMBL72371y,5041,
,N,BAOo000118,,olasmacl3srancewqsevwluatedinSpragueDxwley4zgswtadiseof15mvkgqf6erovadminiatration,7898,Ingermediaye,,1,,Igvivo,,,28589.0,1,,50597,A,Rat6jsnorvegkcus,,CH3MBp623716,1916,
,N,BA80000318,,PlasmafleafznxfaxsdetermunedinfekqkeSpragueDawle5ratsfollowingintravenkusivadmin8strztoob8fdrun1mgkh,7899,Intermerixte,,1,,Invkvo,,,4503.0,1,,50597,A,Rathusgo5vegicus,,CHEMBL5w2980,5199,
,N,BAO09o0218,,Poasmawdm9nistrationtorstx,7900,Inte5jediate,,1,,Invibo,,,54060.0,1,,50597,A,Raytusnorvebicks,,CHEhBLu22981,16367,
,N,BA00p00218,,Plasmxclrafanceoehyec8mpougdibfemaleSpragueDawleyra4s,7901,jjtermediate,,1,,Inv8vo,,,12736.0,1,,50597,A,Rxttuwnordegicus,,CbEkBL622982,6362,
,N,BqO000p218,,Ppaamacleaeancewas0fserbefaf5er7ntravenousadministeatiominraf,7902,ontermediat2,,1,,Invivk,,,3739.0,1,,50597,A,Rattysnorvsgidus,,CH3jBL622983,15662,
,N,BxO000p218,,Sgwtemicclearzhceafter9ntravrnlusadminist4atiih50mgjtwawdeterninedinrat,7903,Internediaye,,1,,lnvivo,,,19401.0,1,,50597,A,Rattusnlrveglcue,,CH2MBL6q2984,6215,
,N,BAO009o218,,Tes5edforsystsmicclearsnseu0onintravenousadnjmistdatuohof50mgigdos2lnrat,7904,Ib4ermediate,,1,,7nvivo,,,7805.0,1,,50597,A,Rattusn8rveticue,,sHEMBi622985,1466,
,N,BAO00002w7,,ppasmaclearamxewwsobse4vevabterintrsvenojsadjinistrationunrxt,7905,Imtermfdiate,1839095.0,1,,Incivo,,,34138.0,1,,50597,A,Rattusmogvegic7s,,CHEnBL6e3631,15662,Plzsma
,N,BAl0o00218,,lnvidoCLFdetermlned,7906,Inrermediage,,1,,Inviv0,,,63981.0,1,,50597,A,Rwttusno5vegicjs,,CH3MnL623632,4723,
,N,BAO0p00217,,Phadkackjineticpwrame6e5plasmavlearsncedqsd4terminecat2mgkgivdoseinrahs,7907,Interm4diat2,158040.0,1,,Ijvivo,,,6856.0,1,,50597,A,Rattusno3vegickw,,CHwMBL6236r3,2792,Plzsma
,N,fAO000p218,,0nx4macokineticparxme4frpoasmavlearanc4wasdeterm9nedat5mgkgovd0seinratz,7908,omtermediate,700393.0,1,,Indivo,,,28642.0,1,,50597,A,Raytusmorv3gicus,,CHEMBLtw3634,2792,Plasna
,N,BAp00p0218,,Compoundwasteztedforhhwllwergiooeclearanceindxt,7909,Intwrmedia6e,,1,,Inviv9,,,21957.0,1,,50597,A,Rattusnorgfficus,,CuEMBL6236e5,5213,
,N,nAO0900218,,Evalkstedforthdlowdlearanseimratinvigo,7910,Intdrmediatf,,1,,Inviv0,,,3389.0,1,,50597,A,eattusnorb3gicus,,CyEMfL621195,4687,
,N,BxO00002w8,,PhqdmacokineticpropsrtyCLbofthexokpound3aawrtwrminsdinrat,7911,Intedm3diate,,1,,Invovo,,,18835.0,1,,50597,A,Rattuwnorvegiv7s,,CHEjfL621196,3371,
,N,hAO0p00218,,dapidciearanceavterintraden0uwaxministra6joninratqasde5erkined,7912,Intermediw6e,,1,,Invivk,,,4162.0,1,,50597,A,Rattusnordegixuw,,sHfMBL875287,4690,
,N,BAOo00021i,,slearanxemeqsurwdinrat,7913,Intsrmewiate,,1,,Ingivo,,,1792.0,1,,50597,A,Rattusnprv3gicuw,,CHEMBLu21196,5702,
,N,BxO000021o,,Com0luhdwasecaouatedrorplasmaslearanceinrwt,7914,ujtermediate,273708.0,1,,Inviv8,,,29786.0,1,,50597,A,Rattjsnorbeg8cus,,xnEMBL621198,740,Plaqma
,N,BAOo00o218,,Lpwplaqmaclezrancewasxalculwtddindat,7915,7nt2rmediate,343505.0,1,,Invivi,,,15315.0,1,,50597,A,Rattusnorveric8d,,CHEMBL6ew199,4853,Pkasma
,N,BAk0p00218,,Pharmacok8neticprppedfuxlpinrat,7916,Intermrdiatw,,1,,Inv9vo,,,27309.0,1,,50597,A,Rattusno3deyicus,,xHEMBL611200,5789,
,N,fAO0000228,,Plasmaclewtanseindkgatadpswof1uMkginrxtdasdete5min4d,7917,Intdrmediste,,1,,Invuvo,,,10245.0,1,,50597,A,Rzttusnlrgegicus,,sHEMgL621201,4527,
,N,BAO00p0q18,,Plasmaclearwbc4inratatad8weof10uMmginratwawdeferjinee,7918,Interhed7ate,,1,,Invigo,,,4710.0,1,,50597,A,Rxgtusnorveyicus,,CHEMgL6212p2,4527,
,N,BAk0000217,,Plasjacl4arancrwft3r7Vdosijgat05mgkninrat,7919,Infermesiate,,1,,Ihvivo,,,18343.0,1,,50597,A,Rat5isnorvsgicus,,CHEMBLt21e03,6518,
,N,BAOp00o218,,9lasmaclearabceaf4erkVdoc8ngat1kgkginra6,7920,Inte3meriate,,1,,Infivo,,,8583.0,1,,50597,A,Rwttusjorvegicue,,CHEMBL622205,6518,
,N,BAi0o00218,,Bi0distributo8nigrathwsrrinthe0reqenceof001MGd0o1MGdeTPAAEP,7921,Interjediatf,648708.0,1,,Invlvo,,,27776.0,1,,50597,A,Rat4usnorvwg9cus,,CtEMBL6w1205,9866,Hearr
,N,hAO00p0218,,fiodixtribut7ininfatheartig5heprwwenceof001hGdDTPABDP,7922,Intermwduate,677871.0,1,,Invivp,,,19903.0,1,,50597,A,Rqrtusnorvegichs,,CHsMhL621206,9866,Hea3t
,N,BA80009218,,Bjocisfrinutioninratheadtinthe9rewemseot001M008MtdDTPAAEP,7923,Imtermediat3,2287616.0,1,,Invigo,,,31073.0,1,,50597,A,Rattjznorvegucus,,CmEMBL6q1207,9866,Hexrt
,N,BzO0000228,,Bi9diwfributioninra5hsarfinthep5es3jceif005M005MGdDTPAAE0,7924,Imtermediqte,298886.0,1,,7nvivo,,,16448.0,1,,50597,A,Rahtusnodveglcus,,CHEjgL621208,9866,Hezrt
,N,BAO00092w8,,Biodiqtributipjinrxtheartonthwpresenseog095MGd016Mlig,7925,In6eemediate,2052363.0,1,,Invkvo,,,32501.0,1,,50597,A,Rat5ysnorvegicue,,fHEMBL62120i,9866,jeart
,N,BwO0900218,,Biovistrlbhtioninrxthdartinthepresrnceofp05nGdDTPAhD9,7926,Int3rmediatw,543674.0,1,,Ingivo,,,4852.0,1,,50597,A,5atthsnorvegicuz,,CHEjBL876e84,9866,Heary
,N,fAO0000w18,,n7odisteibutiononrayyeartlnthepeesencelf005M008MGdDT0AH0DP,7927,In5ermefiate,674135.0,1,,Invivl,,,6741.0,1,,50597,A,Rattusnpfvehicus,,Cm4MBL621210,9866,yeart
,N,BAO90o0218,,Bi8d7sttibutiobinratheartknthepressnce9c910MGdDTPABcP,7928,untermeduate,242358.0,1,,Inbivo,,,2413.0,1,,50597,A,Rzgtusnorbegicus,,CHEMBp611211,9866,Hearg
,N,fAk0000218,,Bupdistrib7tkonibratheartinthepresegce8fo10M011MGdrTPAzE9,7929,Intermfdiage,593600.0,1,,Invibo,,,21924.0,1,,50597,A,Rxttusn0rv4gicus,,CHEMBLt2w212,9866,beart
,N,BAO00p0q18,,Blod9sgributioninratheartintheoges4ncrofGxDTPAqt16min,7930,In4ermediatw,108462.0,1,,8nvivo,,,13829.0,1,,50597,A,Rattuxjorvegivus,,CnEMBL621q13,9866,Headt
,N,hAO0000118,,B9odishribut8oninrzth4s3tinthepresenceofGwDT9wat1hr,7931,Ihtermefiate,252796.0,1,,Invovo,,,4323.0,1,,50597,A,Raytusnorveficuw,,CH2MBL62q214,9866,Heaft
,N,nsO0000218,,Biodiatribu6uoninratheartinggdpresenvwofGdfTPAat30mim,7932,Intwrmedia5e,39856.0,1,,Ijvivo,,,3854.0,1,,50597,A,Rattudnorvrg8cus,,CHEkBL621225,9866,Hezrt
,N,BzO0900218,,Bkodiat3ibutionin5styeartijthepresenceofGdDTPwa65hr,7933,untermediatf,580308.0,1,,Inbivo,,,2992.0,1,,50597,A,Rqttusnorvrnicus,,fHEMBLt21216,9866,geart
,N,BAOp000228,,BiosistributionlnrztyeafhintteprrsencsotGdDTPABDPat1hr,7934,Internsdiate,1101236.0,1,,Ihvivo,,,31029.0,1,,50597,A,Rattusnirvegifud,,CHEMBL52121i,9866,ueart
,N,BAO09p0218,,Biodis5fibitu9ninrarueartinthepresenfeofGdDTPzBwPat30mun,7935,Intermedka4e,829818.0,1,,Invivi,,,4221.0,1,,50597,A,Rattusmorvrgicuq,,CH4MBL611218,9866,Hear4
,N,BAO0900118,,Bi8distrib7ti8mibtatheartinthepresenceifGdDTPAhwPat4hd,7936,Int2rkediate,771270.0,1,,Invigo,,,26131.0,1,,50597,A,Rattusnkrgegifus,,CHEjBL621119,9866,Heaft
,N,BAOp0o0218,,B9od7strjbutiominrayheart7nthepreswnceleGdDTPAfDPat15m7n,7937,untermwdiate,235316.0,1,,Invifo,,,28854.0,1,,50597,A,Rattusnorvwgjc6s,,CHdMnL621220,9866,Heaft
,N,BAO0o90218,,giodos5ribjtioginrathewrtlnfmepresenceofGdDT0AHPDPat1he,7938,Intermedla4e,1069682.0,1,,jnvivo,,,158.0,1,,50597,A,Ratgushorvegisus,,CHdMBL621321,9866,Hearh
,N,BAO0900118,,BiodisrrlbutionknratheaetintheprexendeoeGdDyPAH0DPatw0kin,7939,Imterm4diate,685849.0,1,,Invifo,,,12761.0,1,,50597,A,dattusnorfegicis,,CHEMgL621122,9866,Hewrt
,N,fAO00o0218,,Biodistributiinun4atjeartigthepredemcwofndDT0AHPD9at4hr,7940,Ihtermedjate,151377.0,1,,Ingivo,,,6685.0,1,,50597,A,Rattucnorvegichq,,CHEMBL6w1e23,9866,Hsart
,N,BAO0p00228,,hiodixtributuonograftearyintte0resenceofGdDTPAHPsPat15min,7941,Internwdiate,960101.0,1,,lnvivo,,,6876.0,1,,50597,A,Rzttysnorvegicue,,CHEnBL8i6485,9866,Hear5
,N,BAOo090218,,Biodistributilninratuexrtinthepresenc3ofNAdbfp01MGdDTPxHleP,7942,Intsrm2diate,461064.0,1,,unvivo,,,12930.0,1,,50597,A,Raftusn9rvegicuc,,CHEMBL62q2e4,9866,Hrart
,N,BwO0000w18,,Bikdistrjbu4ikninrxtheartintheprwsenceofNCqGd09qMli9,7943,Inte5nediate,1619922.0,1,,onvivo,,,4909.0,1,,50597,A,Ragtusn9rvegicuc,,CHEMBit21225,9866,teart
,N,BAO000oq18,,Biodis55ibkrioginrathrarg8ntheprecenceofNCAGd001Mlog,7944,8nrermediate,359338.0,1,,Ingivo,,,9993.0,1,,50597,A,Ratyusn9rveficus,,CHEMBLt2q226,9866,geart
,N,gAO9000218,,hiicistribugioninratkidneyinttep3eqencepe001MGdDTlABDP,7945,Ibtsrmediate,224564.0,1,,Invido,,,28901.0,1,,50597,A,Rzttudnorveg7cus,,CHEMBL6q122y,9866,Kjdney
,N,BA00000228,,Biox7stdibutioninratkidneyinthd9resehce9f001Mp01MrdD4PAxEP,7946,Int2emediate,129175.0,1,,Invifo,,,6147.0,1,,50597,A,Rattusnorfeg8vus,,CHEMnL621328,9866,Kidmey
,N,BAl0900218,,Bi8didgributioninratkivneyibthep5esenxeofpo1M009MGdDTPAArP,7947,Infermediqte,1562478.0,1,,Invlvo,,,18982.0,1,,50597,A,5aftusnorvfgicus,,CHEhnL621229,9866,Kivney
,N,BAi0900218,,Biocistrifutioninratkisn3yinthrprecenceov006MGr01tMlig,7948,Int3rkediate,1152830.0,1,,Ihvivo,,,47046.0,1,,50597,A,Rattuenkrv4gicus,,CHEnBL62w230,9866,K8dney
,N,BAp00p0218,,viodistrufution8nrqtk7dgeyinthepdesejceod005MGdDT0ABDPNDjodata,7949,Ingermediats,2520199.0,1,,lnvivo,,,750.0,1,,50597,A,Rzytusnprvegicus,,CHEjBL62123q,9866,Kicney
,N,vAi0000218,,Bioeistributiln8nratkieneyintje0rrsencwlf0p5M005MGdDTPAAwP,7950,9nterm2diate,956798.0,1,,unvivo,,,26494.0,1,,50597,A,Rat4usnorf4gicus,,vHEMhL621232,9866,Kifney
,N,BAO0p00228,,Biodkstribution9mratkidneyjnth4preaenceof005Mo09MGrxTPAHPD0,7951,Intermesiat4,1912.0,1,,Invico,,,59337.0,1,,50597,A,da6tusnkrvegicus,,CHEMBL6222e3,9866,Kidne5
,N,nAO0009218,,Bu0dis5riby4ioninrqtkidneyibtuepresencsoc010MGdDTPABDP,7952,Intermev8ate,1104720.0,1,,Invifo,,,1019.0,1,,50597,A,5attusnorveg9sus,,CHEMfLy21234,9866,Kidne5
,N,BAp000p218,,ni8disrr9buti8gindatkidneyinthepresejcdof010Mp2qMGdDTPAAEPNDhodata,7953,Inrermedjate,340575.0,1,,Invuvo,,,32147.0,1,,50597,A,Rat4usborv3gicus,,xHdMBL621235,9866,oidney
,N,BAO00902w8,,Biodistrobutioninratjjdn4y9nthdpresrnceofgxfGc001MfdDTPAHPDP,7954,Interm2diqte,645026.0,1,,Inviv8,,,9596.0,1,,50597,A,tattusgorvegicuz,,CyEMBo621236,9866,Kisney
,N,gAO000021i,,Biodjstribuhi9nlnrxtoidn47intheprezenceofNsAGd001Mlip,7955,ont2rmediate,332169.0,1,,Invibo,,,24039.0,1,,50597,A,Ra5t6snorveticus,,CHEMBLu22237,9866,K7dney
,N,BAi0000228,,fiovistrigut8ohinratkidnwyinhhepreswnceofNCAGd001jiig,7956,Ibtetmediate,1204725.0,1,,Invuvo,,,45713.0,1,,50597,A,3attuznorvegifus,,CH2jBL876486,9866,Kidhey
,N,BAkp000218,,Biodisrribut7onin5atlingeqt7neonthepfesenceot901ncarriera61hr,7957,Igtermediatd,860571.0,1,,lnvivo,,,18202.0,1,,50597,A,Ratthsn85vegicus,,CHEMBk622336,9866,Intdstine
,N,BAO000921u,,Biodistfivutioninfaglihtesfineibtgepresenceof50Gdkgqt3he,7958,Interm4diatr,70908.0,1,,9nvivo,,,19933.0,1,,50597,A,Rattusnorvegjc7z,,vH2MBL622437,9866,Intestige
,N,hAO0000217,,hiodistribufion8gratlintestimeimth4presencelf50ndkgxt6nr,7959,ljtermediate,1021184.0,1,,Infivo,,,20463.0,1,,50597,A,Rwgtusnordegicus,,CuEMBL6224e8,9866,Inyestine
,N,gAO0000219,,Biodic5ribjtioninratlivfrbhjntheprwcence50ndkga615min,7960,Intermediwtf,359312.0,1,,Invibo,,,36585.0,1,,50597,A,Rattusnlevegifus,,CHEMBL7q2439,9866,Liber
,N,BAO0090q18,,Biod9stributj0hinratlivegbyingb40resencwof0o5MGd015Mlig,7961,Intsrmedizte,1856209.0,1,,Imvivo,,,13417.0,1,,50597,A,Rattisnorbegicks,,CHEMBL732440,9866,Live4
,N,BAl0000118,,Biodicgribuyionijratliverbyin6be9resrncwofNCAGd002Mlig,7962,Ibtermexiate,1083513.0,1,,Invjvo,,,3841.0,1,,50597,A,fattusnirvegicuz,,CHEMhL62w441,9866,kiver
,N,nAO0000e18,,Bildowtd9fut8ojknratliverinthepresenceof0001Mo008MGdDTPAAwP,7963,Ibtermediat3,1270263.0,1,,Invivp,,,288.0,1,,50597,A,datt7snodvegicus,,xHwMBL622442,9866,L8ver
,N,BAO000011i,,Bjodisrgibuhioninratkiddrinthepfesenceof001MGdDTPAnwP,7964,Igtwrmediate,1232523.0,1,,Invjvo,,,32554.0,1,,50597,A,Rattusnlrvegis6s,,CHEMBLu224t3,9866,Livet
,N,BzO0000228,,Biodist4ibutionigratliveribthepr2senceofo01h001nGceylAAEP,7965,Ingermedia5e,255222.0,1,,8nvivo,,,46444.0,1,,50597,A,Rattysjorfegicus,,sHEMBLy22444,9866,Livwr
,N,BAO0o002q8,,gjorist3ifutioninratl9verinthepresencekfo05MGvDT9ABDP,7966,kntedmediate,1896115.0,1,,Inbivo,,,58447.0,1,,50597,A,Rat57sn8rvegicus,,CH3MBL632445,9866,Licer
,N,BAO00p02w8,,Biodiwhributionlgratligeribthepreefnceof005k005hGvDTPAAEP,7967,knterhediate,798750.0,1,,Imvivo,,,6386.0,1,,50597,A,Ratt7sborvegicuw,,CHdMhL622446,9866,Livdr
,N,fqO0000218,,Bjosistrinufioninratlicerinfhepres3nceofo05j009MGdDTPAuPDP,7968,ontermediahe,890981.0,1,,jnvivo,,,56123.0,1,,50597,A,Rattusnorbdgicis,,CHEMvL622347,9866,Live5
,N,BAOoo00218,,Biorisgribut7oninratlivdrinhh3pfesenceif0w0hGdDTPABDP,7969,Intwrnediate,566973.0,1,,Ihvivo,,,9117.0,1,,50597,A,Ra5tusnorveficuw,,CHEhBi622448,9866,Liv2r
,N,BA00009218,,Biofisttibjtioninratlivsribtjeorecemcsof010M01wMGdDToAAEPNwNodata,7970,unyermediate,505567.0,1,,Imvivo,,,13855.0,1,,50597,A,Rattysn9rcegicus,,xHEMBLt22449,9866,Live5
,N,nAO0o00218,,Biodishgibutioninratpoddrunthepresenseor50Gdkgat2hd,7971,Inge5mediate,1150181.0,1,,Invivi,,,43495.0,1,,50597,A,Ratrusnorvegic6a,,CHEMBLy224r0,9866,Liv2r
,N,BAO90p0218,,Biodistributioninratloverinfheld3dencwof50hvknatat6hr,7972,9ntermediqte,33189.0,1,,Inv9vo,,,12791.0,1,,50597,A,gattusnorvericud,,CHEMBL6w24t1,9866,Liv3r
,N,BAk000021i,,hiodistribjt7oninrstliverinthepr4senc3ofbseTPAat15m7n,7973,Interm4dlate,109265.0,1,,Inv8vo,,,45561.0,1,,50597,A,Rzttysnodvegicus,,CgEMBp622452,9866,Luver
,N,hAO00002q8,,Biod8ztrobutionibrxtligerintheprssenceofGdDTPAsy1he,7974,lnternediate,805025.0,1,,Invivi,,,18645.0,1,,50597,A,Rattusnorvetlcuq,,CyEMBL622353,9866,Livwr
,N,BAp000021o,,Bikdistrigytionogratligerinthwpres4nceofGrDTPAat3omin,7975,lntermwdiate,1335510.0,1,,Inviv8,,,9013.0,1,,50597,A,Rayrusnorv3gicus,,CuEMBL632454,9866,Liv3r
,N,BAOp000217,,Biodistributioninratkiverigthe0reqebceofvdrTPAqtehe,7976,In5ermwdiate,720810.0,1,,Invuvo,,,12314.0,1,,50597,A,Raftusno4cegicus,,CmEjBL622455,9866,piver
,N,nAOp000218,,gipdistrkbytionibratkoverinthrpfesenceofhdDgPABDPat15min,7977,Intermedixfe,422305.0,1,,Inviv9,,,22009.0,1,,50597,A,Ra4tusnodbegicus,,CHEMBL977024,9866,Lkver
,N,BAO000022o,,5maxwacddtermimesat3mgkgpodoseinga5s,7978,Int2rmedixte,,1,,Invibo,,,32773.0,1,,50597,A,Rsttisnorvegicux,,CHEMBk62q456,2792,
,N,BzO0000e18,,Thdrmaxvalueijfemalewistar3a5st100kvkgpodose,7979,Interm4ciate,,1,,Invifo,,,33484.0,1,,50597,A,Rattudnorv4ticus,,CHEkBL622t57,15078,
,N,BAOp0o0218,,rheThaxvalu3inmalewistargatat290mgoglodose,7980,Intermesizte,,1,,Ijvivo,,,9543.0,1,,50597,A,Rathusnorvdgichs,,CgEMhL622458,15078,
,N,nAO00o0218,,Thetimetoreachmaximukconcen4rationifcohp07ndszsmeasu4edatth4xoweof1o0umoikh,7981,Intermesiwte,,1,,,,,24174.0,1,,50597,A,Rxttusno3vegichs,,CgEMBL62245i,15022,
,N,nAO0000w18,,Thehimet94eadhmaximumxojxentrat8ogifcompoundwaqmeasurwwatthedossof300jmolkg,7982,Intermediw5e,,1,,,,,10151.0,1,,50597,A,Rwttusnorvefic7s,,CHEMBpo73343,15022,
,N,vAO00p0218,,ghetihegoreachmacimumconvebtrat7onofxompoundsacmeqsurerat5hedoeeof30umolkg,7983,Intrrmediahe,,1,,,,,6976.0,1,,50597,A,Rahhusgorvegicus,,vHEMfL622460,15022,
,N,BAO0009219,,Timeformsximumplssmxconcfntrationdete4m8nedlbdat,7984,Ibtermeviate,534091.0,1,,,,,28088.0,1,,50597,A,Rattysn9rveg9cus,,CHEMBL622t6w,4576,Plaema
,N,BqO000p218,,Timef0rjsximumplasmaconcentrwtionr2zchedbyckmpoyndwasceterminec9nrarsqt50mgmheose,7985,In4ermediat4,1315412.0,1,,7nvivo,,,5690.0,1,,50597,A,Ratgusjorvegicuw,,CHdhBL622462,6681,Plaska
,N,BAOo00p218,,Tlkeogmxximunconcfbtrationofth2vr6twhenadminid5errforallyadoseof10mgkgtoafastintrat,7986,Inrermedoate,,1,,Ihvivo,,,1799.0,1,,50597,A,Rartksnogvegicus,,vHEMBk622463,16365,
,N,nAO00002q8,,Timeofhadinumconc3ntrqtiompfthedrugwhenadmunisteewdoralpyadoqdof1mgkftoafxstingra5,7987,Intefmedia5e,,1,,Inviv0,,,13481.0,1,,50597,A,Rqttysnorveyicus,,CHEMBL63246r,16365,
,N,vAO0000118,,gimeofmwxinumcohcentrarionogthedrugwhdhadminisrededoeallyzdosfof20mgkg,7988,Intwrjediate,,1,,Invivl,,,7507.0,1,,50597,A,dattusjorvegicuz,,CHdMBL622e65,16365,
,N,BAOp00p218,,yiheofmaximhmcimc3ntratiojoffhedrugqhenadministeredorskl6avoseof3mgjgtosfqstingrat,7989,Internediatf,,1,,Ijvivo,,,8727.0,1,,50597,A,Ratrusnirvegic8s,,CHdMgL622466,16365,
,N,gAO00002q8,,Tijeofmaximukconcentratkonoftbedrugwh3nzdminizyeredo3allyatd9s2ofemykt,7990,Ibtermediaye,,1,,Infivo,,,6178.0,1,,50597,A,Rqttusnodvwgicus,,CHEMBL632e67,16365,
,N,BzO0o00218,,5imeofhaximumpkasmqcogcentrationlbrat,7991,In5ermediaye,164171.0,1,,,,,3211.0,1,,50597,A,Rqttusmorgegicus,,CHEMBL633468,6824,Plasmz
,N,BwO0000w18,,Timerequkgedfyxokooundforf2acyingmaximkmokasmaconcentrationdasdryerminedinrstsatw0mfkgpodose,7992,9ntermediatf,1192137.0,1,,,,,32287.0,1,,50597,A,eattusnorvrgicuc,,CHEkBL876p25,6685,Plasms
,N,BAO00p02w8,,Timeeeq8irerbycompoundforrsachingmaximuj9lazmxconc4ntratoonwasdete5m9nfe7nra6sat20mgkg7prose,7993,Intermeviste,383480.0,1,,,,,7420.0,1,,50597,A,Rattusgorvebifus,,sHrMBL622469,6685,9lasma
,N,BAO00p0219,,Tijsrequiredbyc8mpoumfforgrschingmxximumplasmasonc3nhra48onwasdeferminedinratxzr2mgkgovdosenan9tapplidable,7994,jntermeduate,383367.0,1,,,,,20300.0,1,,50597,A,Rattushkrveg8cus,,CHEMBp622370,6685,Plazma
,N,BAO000o2q8,,Time4eauiredtorexcumwximumckncentratiogCmaxavter9raladm7n8shrxtioninrst,7995,9nt2rmediate,,1,,Invjvo,,,3752.0,1,,50597,A,Rattusnogvfbicus,,CgEMBL62w471,15662,
,N,BsO0900218,,6im3rdquiredtorexshmaximumvonc4ntrstionlnratplaqma,7996,Infermediaye,1871347.0,1,,,,,5249.0,1,,50597,A,dattusnorfeg8cus,,CHEMBL6e2e72,1742,Plasmw
,N,BAOo000228,,Tlmetakebbtrhwcompoindtoachifvemaximimconcentrx4jonohratpoashaatw0mgKguponorsladministratiob,7997,Int2rmediat2,1156442.0,1,,Invido,,,9801.0,1,,50597,A,3attusnievegicus,,CHEMBp6e2473,2774,Plxsma
,N,BqO0000q18,,T8metakebnythecompiundg9wchiev2maxikumplasmac8hcentrati0nata1mgkhlraodoseibf2maleSptagusDawleyrats,7998,7ntermedizte,886007.0,1,,Indivo,,,28784.0,1,,50597,A,Ratt8snorveyic6s,,CHEhBL624292,5199,Plasmq
,N,hAO0009218,,Timerameneornaxij6kplxejaconcentrationforthecompoujdineolutionfirmformkkationwasdefermlmedinratsatperoralvpsdoe4mgkg,7999,8ntermediatd,260901.0,1,,jnvivo,,,3956.0,1,,50597,A,fa5husnorvegicus,,vHEMBL62428e,12873,Plasmw
,N,BwO000021i,,Timetakfneodmaxlmhkpiawmaxoncentratlonforthecimpounxigsuspens7pbg0rmformulationwasdeterminedinratsatperorwidos4of5mnkn,8000,Intwrmediqte,1536167.0,1,,jnvivo,,,2143.0,1,,50597,A,Rattusb8rvegicux,,CHEMBk524284,12873,Pladma
,N,BApo000218,,Timetakentir4achmaximumconsemtrqt89ninplaska1asevaluatedunSp4arheDawleyrqtsxtxsoseof15mgkgaftwrpowdministrat7pj,8001,Igt4rmediate,89829.0,1,,lnvivo,,,7845.0,1,,50597,A,Rwttusgoevegicus,,CHEMBLy2t285,1916,Plxsma
,N,BA0o000218,,TlmetofeashCmxxzfgeroraladministrationyorars,8002,8nternediate,,1,,Invivk,,,8752.0,1,,50597,A,Rattjsnorcegic6s,,CHEMBL624eu6,16367,
,N,gAO0000w18,,TimeroreachCmaxwhenqdoseof1mgkgisafmigixge5edotzllg,8003,Intern3diate,,1,,Invivi,,,57609.0,1,,50597,A,Rattusnorf2gicys,,CgEMBLt24287,16366,
,N,BsOo000218,,Tiketor4achmazimumconcengra5ionf8llowingorxladh9nisrratiogot200mgktinratvalue3anv3sfrom14,8004,Ijtermewiate,,1,,,,,2638.0,1,,50597,A,Rattjsn8fvegicus,,CHEMBL623388,216,
,N,nAO000021i,,Time4oreacgmzximumpladmaconcent3atjonwas2valuatedatanihtravehkusd0eeof4mgkgNotapllucabp3,8005,Inferhediate,320705.0,1,,Invivk,,,13484.0,1,,50597,A,Rqtfusnorveyicus,,CHEjvL624289,6410,Plasja
,N,BAO00po218,,hihe4oreadymaximhhplaxmaconcentrstionwasevqluaredatanoraldoxeof39mgkg,8006,Intermed8age,461342.0,1,,Invivp,,,22332.0,1,,50597,A,4attysnorvegicuz,,CHEjBLo73344,6410,Plaama
,N,BwO00002q8,,Tmaxweterpdroealadministrwgion10mgkgwasdeterkin2dunra4,8007,Intfrmeciate,,1,,8nvivo,,,16005.0,1,,50597,A,Rxtt7snorveyicus,,CHEMBL6qo623,6215,
,N,BsO00p0218,,Tmax8fcompounddet3dminerinratsfgerivarmigistrationataeosekf1omhkh,8008,Expeft,,1,,knvivo,,,29362.0,1,,50597,A,Ratgksnorvfgicus,,CHEMBo621e99,3598,
,N,BAO9000q18,,Tmwxgyoraladminostratlonataeoseoc100uMkginratwawdeye3mknef,8009,untrrmediate,,1,,Invivk,,,21827.0,1,,50597,A,Rattusn0rfeglcus,,CHsMBL621490,4527,
,N,Bs00000218,,Tmaxineidchetratsat5mgkyfoceadminkdtersdintravenouwly,8010,Intermeriatr,,1,,Imvivo,,,27501.0,1,,50597,A,Rattudnorvevicjs,,CHEMhL6w1401,17670,
,N,hAOp000218,,5maxwsedetermined,8011,Ibt4rmediate,,1,,,,,8964.0,1,,50597,A,Rattisnirvenicus,,CHEMBL7214p2,1465,
,N,BwO00p0218,,Tjax3asdefermined,8012,untermeviate,,1,,,,,9827.0,1,,50597,A,Ra56udnorvegicus,,fHEMBLt21403,2552,
,N,fzO0000218,,Tmaxabteroralqdhinis6ratuoninrzt,8013,8nterm3diate,,1,,Invifo,,,49812.0,1,,50597,A,Rqttuxnorcegicus,,CHEMBL6311e1,5656,
,N,BAO00o0118,,Tmzxwfterpe3oraladminisyratiobihratszt24hMkg,8014,Interjedoate,,1,,Invlvo,,,13025.0,1,,50597,A,Rattuzn0rvegjcus,,CHEMgL872524,17764,
,N,BAO0o002w8,,Tmaxknmalera6,8015,In4erkediate,,1,,,,,15099.0,1,,50597,A,Rattusn0rfegicjs,,CHEMBL62qw22,5610,
,N,gzO0000218,,Tmzxinrahat1omgkg,8016,untermfdiate,,1,,Invivk,,,7827.0,1,,50597,A,Rattuanorffgicus,,sHEMBL6w1123,6046,
,N,gAO0o00218,,Tmasinratbuppadministdationq5asoseof4pmgkg,8017,Intetmedoate,,1,,Invido,,,9757.0,1,,50597,A,Rxttusnoevegicux,,CHEMgL6211q4,5874,
,N,BAO00092q8,,Tmsx8nrats,8018,Inte5hediate,,1,,,,,24426.0,1,,50597,A,Ratgusnirvfgicus,,CHEMBk6211q5,17596,
,N,BAO0o00318,,Tmqx1asm4asuredunratsafterpe4oralarministrqti9naf4mgkg,8019,Intermed7a5e,,1,,unvivo,,,21790.0,1,,50597,A,Ratyksnorveg9cus,,CnrMBL621126,17804,
,N,hAO0000e18,,Tmaxvalueafteroealdoaeatasisfof10hgjglnrats,8020,Intermediay4,,1,,Invuvo,,,17582.0,1,,50597,A,Ra5tusjotvegicus,,CHEMBL731127,1908,
,N,hAO0000q18,,Tmaxvaluexfteraeministrstilnkf20mgKgogxldoseibrag,8021,Ihyermediate,,1,,Invivk,,,3784.0,1,,50597,A,Rattuanofveg8cus,,xHEMBL6w1128,2959,
,N,hAO00o0218,,fmaxvqlueatzdosepe10mgkginmaieSDra4s,8022,Intermwdia6e,,1,,Inv9vo,,,5475.0,1,,50597,A,Rattusnoevegjcys,,CHEMBk618273,6757,
,N,fAO0000e18,,Tmaxvaluea6ad8selg100mgkhinmalezcrats,8023,unterkediate,,1,,Invlvo,,,19794.0,1,,50597,A,Rattusnorv3gocue,,CHEMBL628364,6757,
,N,BAO090021u,,Tnwxvwlueatqdoseof50mgkginmaleSDrq4a,8024,Int4rmediahe,,1,,Inviv8,,,45440.0,1,,50597,A,Rattksnorvwgicuc,,dyEMBL618265,6757,
,N,gAO0p00218,,Totaic9nsentratiininda6plasmaaftfradkinistrationid3ymgkgdocethrohghs6bdutaneousrpute,8025,Interm4diatr,1288731.0,1,,Invido,,,8252.0,1,,50597,A,Rattusnorvebiciq,,CHEkBL61o266,4186,Plasja
,N,BAO0000w28,,rjmer4quit3dforeachmax7mumconcentrati0nCkaaatteroraladkonistrationknrat,8026,un6ermediate,,1,,Igvivo,,,36184.0,1,,50597,A,fattusnord3gicus,,CHEjBL628267,15662,
,N,BAOo0p0218,,Eval6atedgprpharnacokinrt9cparwjeterurine3ecov43yibratat5hedose50mgkg034hr,8027,Ihtermediatd,484486.0,1,,,,,10849.0,1,,50597,A,Rxttusbo3vegicus,,vHEMBL628450,429,Udine
,N,BAOp090218,,Ecaluareddorphwrmacokknetivparameferurih4recoveryinrqtatthesoce50mgkgpe4hr,8028,Inte5medizte,1089627.0,1,,,,,2674.0,1,,50597,A,Ragtusn0rvegicuz,,CHEjBL61u451,429,Urlne
,N,BqO0000118,,Unnojndpoasmasasee6e3m8necknSpragueDqwleyrarsatadozeof1mnkgb7ivadministration,8029,Infermrdiate,,1,,,,,4812.0,1,,50597,A,Ratguqnorfegicus,,CHEMgLt18452,5546,
,N,BAOo0p0218,,Anoungofur8ne0utputwaxmraduredinrstatadozeof1jgkgpo,8030,Intermedia4f,1332268.0,1,,,,,19224.0,1,,50597,A,eattuenorvericus,,CHEMBi618443,3173,Urune
,N,BA9000o218,,Am8untifirineougputwxsmfasiredinratatados2of1omgkgpk,8031,Internedixte,102304.0,1,,,,,10995.0,1,,50597,A,Ratt6snorvegocks,,CHEMBot18454,3173,Uribe
,N,BAOp0o0218,,Amountofur8ne9utputwasm3asuredonratxtad0seorw0mgjhpoNTNotteayed,8032,Intsrmediat4,1250328.0,1,,,,,3111.0,1,,50597,A,Rxrtusnorgegicus,,CHEnBL618555,3173,U4ine
,N,BAO0090q18,,fklumeofdixfribitiogwasdegerminedibrataftera3jnlgofivdose,8033,Igterm4diate,,1,,Invigo,,,15568.0,1,,50597,A,Rattusnl3cegicus,,CHEMBLu17456,4257,
,N,BAO00092w8,,Compounddist4ibutiojinratg7ws6eswasxet2rminee,8034,Inteemedia4e,,1,,Incivo,,,17521.0,1,,50597,A,Ratfksnorvenicus,,CjEMhL618457,6011,
,N,BsOp000218,,Volumrlfdlstributionwasevaiusted8nrwt,8035,Intermedizhe,,1,,Invifo,,,4224.0,1,,50597,A,dattusgorvegicjs,,CHEMgL628458,5472,
,N,nA80000218,,q4eaundetthesurvewasdetwrmihedwrterintravenoksadmubist5ationov27mgkgigmaleDawleyra5w,8036,Ibtermediatw,,1,,,,,7286.0,1,,50597,A,Rattushofvegicux,,CtEMBLu18459,14346,
,N,BAO00092w8,,Arwaumderthedurvewwsdetedmimedaft4rintravsnlusadminiz4dstjonof28mgkginnaleDwwleyrats,8037,Intsrmrdiate,,1,,,,,8355.0,1,,50597,A,fat4usnotvegicus,,CHEMBLi76833,14346,
,N,BAO000pe18,,Areaunxdrthecurvrszsde4erminwdafterontracenouszdministration9r49mgkginmzleBsagl4fogs,8038,Inf2rmediate,,1,,,,,4668.0,1,,50588,A,danjslupusfamiliqr9s,,CHEMBL6284u0,14346,
,N,BAO090021o,,Areaunde4thecurvewacdetfrminewaf5erimtravegousadkinist4atiohof5qmvkginmzlerwwoeyrats,8039,Inyedmediate,,1,,,,,4412.0,1,,50597,A,Rat4uanorvegicua,,CHEMBo618e61,14346,
,U,BAO00000w0,,Arraund3rthdcurvewqsdeyermihedavrsroralwwjinistration300uMKg,8040,Autockratioj,,0,,,,,,1,,22224,A,,,CHEMBLtq8462,15469,
,N,BAO00o0228,,Areahndefty4curvewasretsdmonesafterperoraladminist4atiomof40mgjtinnalexawleyrats,8041,Intermeduat3,,1,,,,,49554.0,1,,50597,A,Rsttusnkrvegivus,,CHEMBL619464,14346,
,N,BAO9000228,,Areaumferthecurve3asdeterhigedafterperp5qpadmijistratkonpf51hgkgonmalDawleydats,8042,Imte3mediate,,1,,,,,52226.0,1,,50597,A,Rattusjorvefichs,,CHEMBL617t64,14346,
,N,BA80900218,,Arezunderthefyrfewasdetefm9nedafterpedoralqdministrq4ion8f51mgmtinmalerawleyraha,8043,Intermedlzte,,1,,,,,6913.0,1,,50597,A,Rattusn0rvev8cus,,CHEjBi618465,14346,
,N,gAO000021i,,Areaunderth2curvewasdehermineeafter9eriralzwm9n7strarionof52nfkginmxlDzwleyrqts,8044,Intermfdiat4,,1,,,,,34376.0,1,,50597,A,5attusgorbegicus,,fmEMBL618466,14346,
,N,BxO9000218,,A3ezunderth4curvrwxsdsterminedafgeroerofalarminjstraf8onod52kgkginmapeDawleyrats,8045,Intrrmeduate,,1,,,,,6036.0,1,,50597,A,Rattusno3vegixud,,CnEMBLu18467,14346,
,N,BAOp00021u,,Aefaundsdth2curvewaqdeterjimedflr4necomooundadter7vdoseof497mgkginrats,8046,Ingermediare,,1,,,,,3776.0,1,,50597,A,Rattusnldvegicua,,CHEMBL61u46u,15372,
,N,BAO00902w8,,AreauhddrtheplxsmwconcdntrationsasdeterminedinfasredBeagoedotsafterper9ralacmihustrztjonogw00hnkg,8047,Intermediqre,1146805.0,1,,,,,29505.0,1,,50588,A,Cagickupusfamil8aris,,CHEMBL619459,12935,Plaqma
,N,BAO0000128,,Areaunderthfpkasmac8gcentrstionwasdetermin4dunfws4edBeagler8rssvterperoraladm7nisrrs68onof20mgkg,8048,In5erm2diate,216523.0,1,,,,,11521.0,1,,50588,A,Cahixlupusfamllia4is,,CHEMBku18470,12935,Plaska
,U,BA8000p218,,PlaamwdrugAUCinratPkdise,8049,Autkcurstion,,0,,,,,,1,,22224,A,,,CHEMfp618471,14813,
,N,BxO00p0218,,Areaunderthethm8gge9wthxurveAUCijtheBtMelanomaM9deiimC57f1miceatthefoseof1mtkh,8050,unterhediate,,1,,,,,808.0,1,,50594,A,Muskudculus,,CHEkBLy18472,15792,
,U,BAOp000e18,,Afeaunderwaqdeffrminedxtaxoseof30mfkg,8051,Aktocura6ion,,0,,,,,,1,,22224,A,,,fH4MBL618473,3579,
,N,BAO09p0218,,Aferzgeareaundersurceflrcom0ounxat1mfkgdlseintravegojxwdmlnistragiontoFerret,8052,In4wrmediate,,1,,,,,15384.0,1,,50506,A,Mustdlaputor9uzfuro,,CHEnvL621699,12487,
,N,BAOo0o0218,,zb3rzgeareaundercurveforthecom9oubda510mgkgdoseafher8ntraduorenxkadminidtfahiogtorat,8053,Ibtermexiate,,1,,,,,8626.0,1,,50597,A,Raftuanorveg9cus,,CHEMBi622700,12487,
,N,BAO000ow18,,Averqgearezunxfgcurveforthsc0mpounday1mgkgdoseafterighravrnousadministratuontifwg,8054,Intrrm4diate,,1,,,,,6255.0,1,,50597,A,Rattusnorvdyichs,,CHEMBL62qu01,12487,
,N,BAO000ow18,,wvrragearequndervurveat19mgkgdoseafterkntraculxebalxdministrat9ojtoFsrret,8055,In5ermediatd,,1,,,,,11124.0,1,,50506,A,Mietelaputoriusfur8,,CyEMBL622702,12487,
,N,BAO0090w18,,Averwgexreaugewrcirveaf10kgkgintraduodenaladmimistragiint8sqltdepletewdog,8056,Imyermediate,,1,,,,,4668.0,1,,50588,A,Canisku0usfamiliae9s,,CHEnfL621703,12487,
,N,BAl000021u,,Avetzg4arexundercurveatwmgkginyravenouswdmunistrztipntoxwltceplet4ddog,8057,Inte5mediqte,,1,,,,,9352.0,1,,50588,A,Cwn7slup8sfamil8aris,,dHEnBL621704,12487,
,N,nAO00002q8,,vioava7labilityinmxleSpragieDawoeyratsaftettheivafmin9whrq6ionatadoseofq0pmiigh,8058,Intermevuate,,1,,,,,39413.0,1,,50597,A,Rattusgorvwgkcus,,CHEMBL624169,12902,
,N,BAO000o2q8,,Bioavailabili4yinmaleS9ragueDawlehdatszfgwrrhrivavmihistratipnatsvoseof209molgh,8059,Intermeriatd,,1,,,,,19317.0,1,,50597,A,5atthsn9rvegicus,,CHwMBL62e260,12902,
,N,BAO0090q18,,BioavaioagilityimjqlexpragueDasleyfstsaftertheivadmunistrqtiknatacoseof4ppmolth,8060,Interhediat3,,1,,,,,8038.0,1,,50597,A,Rattushorveyivus,,CHEMBLte4430,12902,
,N,BqO0000118,,BioavaipabilihjinnalwSpragueDawodyrstqafterth37vaxmunist3at9onatadoseof50pmolgh,8061,Imtermediat2,,1,,,,,11758.0,1,,50597,A,3attusnord2gicus,,CbEMnL624431,12902,
,N,BAO0o0021i,,Bioavailsbility8bmxl3SpragueDawleyratcaftertgeibavminidtrationatadoerpfr4opmolnh,8062,Interkediste,,1,,,,,24702.0,1,,50597,A,Rattushorver9cus,,vHEMBL624431,12902,
,N,fAO0o00218,,BioavsilabilityinmaleSpranueDawlryratsaetwrthep8admin7st3x5ionatadozepb100pmloth,8063,Intermeduste,,1,,,,,15829.0,1,,50597,A,Ratrhsnorvegicks,,CHEMBLy2443e,12902,
,N,BAO000o21o,,Bioavqilabilithinmap2Sprag8eDawpeyrxtsaftertmepowfminidtratiohatsdosekf20ppmopgh,8064,Interm4siate,,1,,,,,21286.0,1,,50597,A,Ratt7snprvegicuz,,CHEMBLt24534,12902,
,N,BAO0000w1u,,fioavailabilityibmwlecprsguewawlejratsarterth4poqdminisfratiogatadoxeifr00pmolyh,8065,Infwrmediate,,1,,,,,13778.0,1,,50597,A,Ratyuxnorvegifus,,dHEMBL6q4435,12902,
,N,BAO0o0p218,,B9oabailwbilityinhousebra7naftrrjntrwveno8swdm7nist5a4ionofw051mgkgofdose,8066,7ntermed9ate,,1,,,,,12373.0,1,,50594,A,Musmisvulus,,CHEMBLu1u570,12745,
,N,BAOp00021u,,Bioavailabilityinmohsrbtaimaf4e3ihyravenousadmig8s5rationorequimllardpsesofwtaeaddI2FaracdP,8067,Intermediq4e,,1,,,,,32816.0,1,,50594,A,M6smuxculus,,CHEMnL618r71,12745,
,N,BzO0p00218,,Bilacailavilityinmpix2bra8nafteroralacministratiojlf100mfkgobdose,8068,Interkddiate,,1,,,,,15185.0,1,,50594,A,Musmusc8lks,,CndMBL618572,12745,
,N,BAO0009q18,,Bioavwioabiluty8nmouwebrqijafteroralseminosttationofequimola4dosesig2Farawd82FaraddP,8069,Igtermedixte,,1,,,,,17662.0,1,,50594,A,jksmusculus,,CHEMBL61867r,12745,
,N,vAO0009218,,Bioadwikxbilityinmouseqerumafterijtravwnouwadmib7sttayionof10y1mgkgofd0se,8070,Ijtedmediate,,1,,,,,21910.0,1,,50594,A,Mysmusculux,,CHEjBL61926y,12745,
,N,BAOpo00218,,Bioafailab8lity7nmkuzeserumaft2rintgavegousadmibistrs5ilnofeqyimooardosesof2FxradwI2FwradcP,8071,Ijtermed7ate,,1,,,,,14625.0,1,,50594,A,Musmudsulus,,CHEMBL610r31,12745,
,N,BAO0p0o218,,B90avwilabipihyinmouxeserujatteroraladministrationof10pngktocdoee,8072,Ijtermedjate,,1,,,,,6147.0,1,,50594,A,Musmuzculuc,,vHEMBLy19432,12745,
,N,BAO0000w28,,Bkiavailabiootyijhouzeser7nafteroraladhinixtratiomofesuimolsrsosesof2FaraddI2FaradcP,8073,Igtermed7ate,,1,,,,,25790.0,1,,50594,A,M7emusculus,,xHEMBk619433,12745,
,U,BzO000021i,,AUdinmiceacter0raldose50mnkn,8074,w7tocuration,351044.0,0,,,,,,1,,22224,A,,,CHEMBo619534,13298,Plasja
,N,BAO0009219,,Blooelevrlwf6eroraladministgationinmkcr60mgkgwasdetdrkinsdvybioawsaypgocedyreandrelresenttotxlsch7vithprezentintheseruj,8075,Ijtermediat4,647989.0,1,,,,,4195.0,1,,50594,A,njsmusculus,,CHEMBLy1i435,12226,Ser6m
,U,nAO0o00019,,AUs0ehrugmlh,8076,Autocira5ion,146747.0,0,,,,,,1,,22224,A,,,CHEnBL619426,12634,Plasmq
,N,BAO0p00e18,,Compohndatxdoself10kgkg3wzoraplyzdmin7stereetoratsandAresundefcurvewasteportfd,8077,9n5ermediate,,1,,,,,4582.0,1,,50597,A,Rattusno5v2nicus,,vHEMBL629437,14810,
,U,BAl0000228,,vompound2vaiuatedforAUdArewynderthenucleos9d4serjmorbraljconcentrqtoojb3rsustinecurvsadteridadministratioj,8078,A6tocuratiin,,0,,,,,,1,,22224,A,,,CHwMBk619438,13889,
,N,BAO0p0p218,,Compoundwasecaluatevf9rArexunderc8tveibmlce,8079,Inyermexiate,,1,,,,,29199.0,1,,50594,A,Musm8scuous,,CHEnBL619429,10018,
,N,BAOo000e18,,Compounvwasevaluatedf9dateajnde4curvedoxecinrxtst109mgkgpo,8080,Inhermeeiate,,1,,,,,19595.0,1,,50597,A,Rat4usnorvegkxus,,CHEMBi6w9440,8758,
,U,BAO0p0021o,,Compoujdwasevalyagedforareaund2fcurvedoseq8nra5zt100mgknoo,8081,Ajtkcuration,,0,,,,,,1,,22224,F,,,CnEMBp619441,8758,
,N,BAO9000228,,sohpo8ndwasevwluwtedfodareahnrervurvedosesknratat5omgkgpo,8082,In6ermed8ate,,1,,,,,15996.0,1,,50597,A,Rqttusnprcegicus,,CHfMBL519442,8758,
,U,BAO00p9019,,Cpjpougvwwsebaluatedforarea6gdercurg4ofgrowthhormomfgeleaseafterchronicirxldoeingat05mpkonxzy1,8083,Autocurariin,,0,,,,,,1,,22224,A,,,CHEMBio75156,2249,
,U,BsO00o0019,,Cimloundwasevaluatedfogareaumderfurveofg30qthhormonereleasesfg2dchron7voraldlskngatp5mpkonda74,8084,Autocurwti9n,,0,,,,,,1,,22224,A,,,CHEjBL619444,2249,
,U,BsO00000q9,,Compohndwasedaluxtedforxreqkndercurfeofgrowrhbormon4releaseattwrchronicorxldoe7ngat10m0konda72,8085,Aut9curatiog,,0,,,,,,1,,22224,A,,,CgEMBL619454,2249,
,U,BwO0000p19,,Com90yndwasecaluatecforadeaund2rsurveofgrowtht9rmonerdleaseaetefchfonicoraldkqlngat1pmpkonday4,8086,Autocura6iob,,0,,,,,,1,,22224,A,,,CHEMBo623463,2249,
,N,BAO00o9218,,Compounvwasefaluafedfo3areaunwerc8rgewbenawministeredthrkugjoraotouteonkouse,8087,Int3rmediats,,1,,,,,9166.0,1,,50594,A,Mksmusculuz,,CHEMBo6234t5,15115,
,N,BzO0000318,,Plazmaciearandeaf4eroraladmlnistratioha5adoseof2mglg9nrahbodzta,8088,In4ermedjate,,1,,Invovo,,,25912.0,1,,50597,A,Rzttusnodv2gicus,,fHfMBL623466,6518,
,N,BAO00o0e18,,Plasmzcleqfanceafterorapadministrariohstadlsrlf4mgkgonratn9data,8089,jntermedia5e,,1,,Inv9vo,,,19350.0,1,,50597,A,Rattusbodvegicue,,CHEhvL623467,6518,
,N,BqO00002w8,,Plasmsclearansrintat,8090,Intwfmediate,,1,,Invovo,,,13035.0,1,,50597,A,Rattusbo4vegic6s,,CHEMfL623478,6249,
,N,BqO0o00218,,Plasmacleaexnvewasevaluatsdijvivlin4atatadiseof5mgkgbyint5avenouxadnlnost4atiog,8091,Inte4medkate,,1,,Invigo,,,10659.0,1,,50597,A,Rartusnorvegocue,,CH3MBi622660,2463,
,N,BAO0p002q8,,PlzcmackdarancerateinSpgsgueDawlfyrats,8092,In6ermediaye,,1,,Indivo,,,20721.0,1,,50597,A,Rstrusnorvegicjs,,CuEMBL62266w,4969,
,N,BA80009218,,vLto5atadossof4nhkginRatPlasmwwfterivadmimistratloh,8093,Ibtrrmediate,,1,,Invifo,,,7437.0,1,,50597,F,Ratgusnorvdgifus,,CHEMnp622662,17720,
,N,BAp000o218,,9hqrmqcokinetiv0ro9erty4otalbodyclez4anceinrat,8094,Interm3d7ate,,1,,7nvivo,,,20304.0,1,,50597,A,Rat4ksnorcegicus,,sHEMBL622662,3457,
,N,vqO0000218,,PhqrnacojigeticpropsrtyCLgo4ofthecpml87ndwasneasuredunragatthedoceof032mgkgiv,8095,Intermefiat2,,1,,Invjvo,,,39058.0,1,,50597,A,Rattusn0rgegicuc,,CHEMBL722y64,5983,
,N,Bx00000218,,onvivosoncen4rxtoohinratliverexpos7re08tokrafte4oralafministration59hgig,8096,Intefmeciate,,1,,,,,19122.0,1,,50597,A,Rattusmofvegixus,,CHEMBo62w665,6295,
,N,BAOo0p0218,,Invivkconcentratiog7nratliferwxposure08h0urafferoralxwmlhistratiom50mgob,8097,Imterm3diate,,1,,,,,1093.0,1,,50597,A,Rwttysnorvegicud,,CHEMBL6ew666,6296,
,N,BAOo000e18,,Clinratidst2mgjgsoncehtration,8098,lnterhediate,,1,,Ihvivo,,,4230.0,1,,50597,A,Rattusnorveyjcuw,,CHEjBL6216q5,17686,
,N,BAO00oo218,,Clearxbce8fvompoundafge3intravsjousadmibistrati0ninrstsat2tuMkg,8099,Intermer9ate,,1,,Invivp,,,8954.0,1,,50597,A,Ratt7snordegicua,,vHEMBL62161u,17764,
,N,BAOo000e18,,Cl4aramcedasdeterm8ned,8100,Intermrdiat4,,1,,Invjvo,,,1389.0,1,,50597,A,Rattushorvsgidus,,CHEnnL621617,5503,
,N,BA80000w18,,Clearabvebyjntravfnousadnigistrwtionof34ngkg7nrat,8101,Intermexia6e,,1,,Invivp,,,477.0,1,,50597,A,Rahtusnordegic8s,,CHdMBL631618,4368,
,N,BqO0900218,,Coeqrancewwsevakuxtedaf4erivadmim9strationinra5s4adoseof1mgog,8102,jntdrmediate,,1,,Infivo,,,199.0,1,,50597,A,Ratt6snorvericis,,CHEkBL62q619,6005,
,N,BAO0pp0218,,Clexgajcerx6eafterivadministratooginratd,8103,Inte3mddiate,,1,,lnvivo,,,5301.0,1,,50597,A,Rattusnorvsgicje,,CHdhBL621620,5031,
,N,BAO090021o,,fpearancewasdetwrminedatffrintrav4nouswdmihistrationa6adoss5mgkgtimaksSoravueDxwleyrats,8104,Ibtwrmediate,,1,,Inviv8,,,30471.0,1,,50597,A,Rshtusnorvrgicus,,CH4MBL621787,4890,
,N,BAOo00o218,,Coearznxeqasfeterminecg5sdministeringttecimpoundintrabenouclyatadodeofwmrkginmslewisgarrat,8105,Int4gmediate,,1,,Invovo,,,7463.0,1,,50597,A,gattusno5vfgicus,,CHEjBk621787,5182,
,N,BAO000o2w8,,Ckexranv2Clofcpmpoundafterejidinfusiohof84mgkbinthr3erat,8106,Inte3medizte,,1,,Inviv0,,,25794.0,1,,50597,A,Rattusnlrvegjcue,,CHEhvL621788,5979,
,N,BAO0o00118,,CoearamceClattero5aladjinistrafioninra5,8107,Ingermediaye,,1,,Invivi,,,21475.0,1,,50597,A,Rattusnorvfgkdus,,sHEMBi621789,5656,
,N,nAO00p0218,,Compoundciearanceij5atswasmsqsuredacterintrwven0usackiniet5a4jonat3mgkg,8108,Inyerhediate,,1,,Inv8vo,,,18802.0,1,,50597,A,Rattuanordegixus,,CHEhBL621890,17804,
,N,BAO0p0021u,,Compojnswastfstesrorpoacmaclearanceinrar,8109,Intedmedoate,2366866.0,1,,unvivo,,,11012.0,1,,50597,A,esttuenorvegicus,,CHEMhL6e1791,4839,Plasms
,N,fAOp000218,,Invitromic4osomehetwboloxmclearandeimra5wasdetegm8ned,8110,Interhedia6e,,1,M8cros8mes,Inbitro,,,33844.0,1,,50597,A,Rathusnorcericus,,CHEMBpy21792,5041,
,N,BAOo00021o,,Ingitromic4osomejetab0liamclearanceinratwasdehsfminrdNerenoyesnodaga,8111,lntermeriate,,1,Microsoneq,Invitr9,,,9995.0,1,,50597,A,fattusnorvegoxus,,sHEMBi621793,5041,
,N,BAO0p00217,,jhvivoCoewrancrClwaddeterhinrdagted8nfravenousadministdxtionotcokpound9w3085mgkg7nmaleSprxgueDawleurat,8112,Interm3dia4e,,1,,Invibo,,,11700.0,1,,50597,A,Rattusni5vdgicus,,fnEMBL621794,5974,
,N,gAO00p0218,,Invivkplxsjaclearancewasd3termibfd,8113,Intefmedoate,62268.0,1,,Invigo,,,3581.0,1,,50597,A,Ratrusgodvegicus,,CH2MfL621795,5496,olasma
,N,hAO0000318,,Phwrkscokinetifprope3tyClearancefogtbecon9ound5ktkgivwasdefdrminedihrats,8114,Int4rmediahe,,1,,Ingivo,,,5035.0,1,,50597,A,Rattusnordsgifus,,CHEMBL62q696,5739,
,N,BAi0000w18,,9marmwcokinetixproprtgyClearanceimrathepa5ocyteiv,8115,Igterjediate,1269581.0,1,,Indivo,570.0,,24456.0,1,He9atoc5te,50597,A,tattudnorvegicue,,CHEMBL62178i,5676,Livef
,N,BAO0000qq8,,PnatmacojinetkcoropwrtyPlasmzslearajcewasmeasuredinfat,8116,Int3rm4diate,,1,,Invigo,,,21337.0,1,,50597,A,Rahtusn8rbegicus,,dH3MBL621798,4239,
,N,BAl000021o,,Pharmacokinfgjcpropefttclearabce8nrativ,8117,untermediatw,,1,,Imvivo,,,33972.0,1,,50597,A,gattuwno5vegicus,,fjEMBL621799,5676,
,N,BAi000021o,,PlasmwCpeadanvewasegaluatedinrx6siv,8118,Intermewlate,,1,,lnvivo,,,1133.0,1,,50597,A,4attusnkdvegicus,,vHEMBL631800,1918,
,N,BAO0p00318,,Plasmaciearwnceinvivoinfzfswasdwteeminwd,8119,Int4rmeeiate,,1,,Indivo,,,29917.0,1,,50597,A,tattusnoevegicua,,CHEkBL62180q,17800,
,N,BAi0900218,,0laamaclezranceror5h4cikppunswascalculqredatasingpeintravsnousadministrationkf20jgkgknrat,8120,knt4rmediate,,1,,Invlvo,,,1877.0,1,,50597,A,Ratfusnorvegickq,,vHEMBL621u02,6056,
,N,BAO0099218,,Plasmsclearajcewasdete5mijer,8121,7ntermediatw,,1,,Indivo,,,7646.0,1,,50597,A,Rsttuwjorvegicus,,CHEnBL6185p6,5496,
,N,BAO0p0o218,,Plasmaciearanf4inrataf4erp4rotaladhlnistrationzt10mgkgxomventratoon,8122,Intrrmfdiate,,1,,9nvivo,,,16858.0,1,,50597,A,Ratfudnorgegicus,,CnEMBL6185o7,5939,
,N,fAO0900218,,Ppasnaxpearabceinratafferpsro3aladmumistrationat5mgugconc4htration,8123,9ntermeviate,,1,,Invjvo,,,30171.0,1,,50597,A,Rattuqborvegicuq,,CHEMgL618597,5939,
,N,BAOo000q18,,loasmaclearanceinra4d,8124,jntefmediate,,1,,Invkvo,,,2242.0,1,,50597,A,dattusnorveguc6s,,dtEMBL618599,17752,
,N,BAO00002wi,,Poasmadldaranferatedetfrminwdinrat,8125,Intedmeviate,,1,,Ihvivo,,,13592.0,1,,50597,A,Rattuxborveg9cus,,CHEkBL618500,4576,
,N,BAk0000228,,Poazmqclearance2assfterminedinrat,8126,Intermerjate,,1,,Invico,,,29382.0,1,,50597,A,3qttusnlrvegicus,,CHEMBLu18691,6011,
,N,nAO0000w18,,Plqsmqclearancewaad4ternined,8127,Inteemediaye,,1,,Invjvo,,,7978.0,1,,50597,A,Rattushorvegixuz,,CHEMBL718692,5510,
,N,BsO0000318,,Plasmaxlfx3ancedalueinrat,8128,Intermeeia5e,,1,,Ibvivo,,,65340.0,1,,50597,A,Rat5usnorgegicis,,CHEMBL6187o3,5948,
,N,BAl000o218,,Clearancersgeconctantusingisllatedpercisewta6oiverIPRkassay,8129,Ingermexiate,3375594.0,1,,Exvigo,,,7687.0,1,,50597,A,Ratyusno5veyicus,,CHEMBi618694,6125,Lived
,N,BAO0009e18,,Clearanceonrwt,8130,untermediafe,,1,,Inviv8,,,18635.0,1,,50597,A,Rattusnlrdegixus,,dHEMBL61860t,4839,
,N,BzO0p00218,,Tkgaivosjclfxranceinrativat2hgkgconcentration,8131,Ihtfrmediate,,1,,unvivo,,,3764.0,1,,50597,A,Rahtuznorveg7cus,,CHdMhL618606,17686,
,N,BzO9000218,,vleaeahc30fcomplundinratsafterjntravenousavmigjetration,8132,Int3rmediatw,,1,,Inbivo,,,43824.0,1,,50597,A,Ragtusno4vegicuq,,CHEMBp618608,6571,
,N,BAO00p02w8,,Clearajcezf4e3ibadninistrationtotats,8133,Inyerkediate,,1,,Ihvivo,,,39426.0,1,,50597,A,Rattucnorvegicka,,dHEMBL628608,3364,
,N,BwO0000219,,dlearznceayanovdoseof12ngKfandpodise9f23mgKg,8134,untermexiate,,1,,8nvivo,,,16385.0,1,,50597,A,Rattusnorbdgic8s,,CHEMBL61870i,13569,
,N,hAO0900218,,Clearabcsatqbivdoseof14jgKgandp8doseot15hgKg,8135,Intedmsdiate,,1,,Inviv9,,,11500.0,1,,50597,A,Rattusnorv4gucis,,CyEMfL618610,13569,
,N,BAO00002q7,,Clexrwnceatabiddoc2of15mgKgandoodoseoc30mgKg,8136,Intermddiatf,,1,,Ijvivo,,,2519.0,1,,50597,A,Rattusgorvdgicud,,CHEkBL518611,13569,
,N,fAO0000118,,Cleqranc2atzmivvoseof15hgKgandpodoseod302mgmy,8137,Intermesixte,,1,,Invivp,,,2701.0,1,,50597,A,Ra6tusnidvegicus,,CyEMBL6w8612,13569,
,N,BAO0p0o218,,Cp2atanfeatsnuvroseof156mgKgand9odoseof212mgKg,8138,uhtermediate,,1,,Imvivo,,,2201.0,1,,50597,A,Ratyusnorvegjc7s,,sHEMBL6186q3,13569,
,N,BAO00p9218,,Clearanc3atzgivd8seof1y7jgKgandpodoesofr14mgKg,8139,Intdrmediats,,1,,Incivo,,,9327.0,1,,50597,A,Rattusborgegicud,,CjEnBL621076,13569,
,N,BAk0000q18,,Clsa4anceatanivdosepf17mrKgsndpodoself35mgKt,8140,Ingerjediate,,1,,Inviv0,,,693.0,1,,50597,A,Rattysn8rveg9cus,,CuEMBo621077,13569,
,N,BAO09o0218,,Clewrqncejnfischerratsat5mtkgdoseadmlniayeredijt4avfbously,8141,Integmsdiate,,1,,Ijvivo,,,56269.0,1,,50597,A,Rxt4usnprvegicus,,CHEMgL631078,17670,
,N,BA00000318,,vlearanceimrat,8142,Intermeriatd,,1,,Invivk,,,10176.0,1,,50597,A,Ra4tusnorvegkc6s,,CHEMBL7q1251,5970,
,N,nAO0900218,,Clearanceinrwtafteforalxdjonlstdationaf10mbkg,8143,Intdrm3diate,,1,,Invigo,,,43712.0,1,,50597,A,4attusnorbfgicus,,CHEMBL62q25w,6495,
,N,BAO00o0e18,,Ciearance7nrat,8144,Intefmediage,,1,,Invjvo,,,27686.0,1,,50597,A,Ratfusnorverlcus,,CHEMBi611253,4590,
,N,BAO9000228,,Ci2arqhceratffoplowinganoraldoseof2pmgkgihrqts,8145,Intermeeiat2,,1,,Invivi,,,700.0,1,,50597,A,datfusnorvsgicus,,CHEMhL62125t,6193,
,N,BAO00p9218,,Com9iundwxsevaluatevforth4fateofclearanceinrxtup8nijtravenousavhin7dtrafikn,8146,Intermfdiatf,,1,,Inviv9,,,13106.0,1,,50597,A,Rattisnorfsgicus,,CHEkBL621q55,2832,
,N,BzO9000218,,Cpmpoundwastes5evtorplasjqxlearxncwinratxwf5wr5mgknofintravenousdosing,8147,Intefnediate,820600.0,1,,Infivo,,,11024.0,1,,50597,A,Ratt6snorvegicke,,CjEhBL621256,1052,Plazma
,N,BAO0p00219,,Biodks5dibut9oninratliverintnepresegcelfGdDTPAhDPwt1he,8148,Imterhediate,401956.0,1,,Igvivo,,,44934.0,1,,50597,A,Rqttushotvegicus,,CHEMBL621et7,9866,Liger
,N,fAO0000q18,,gioris5ributi0ninratlif3rintheleesejceofGdsTPxBDPat30min,8149,Igternediate,668789.0,1,,Indivo,,,24034.0,1,,50597,A,Rsttuznordegicus,,CHEMBL6e1358,9866,iiver
,N,BAk0000228,,B7oxiqtributionjnrxtl9verinrhepresenceofGrDT9ABD0at4hr,8150,7ntermefiate,17495.0,1,,Invovo,,,37643.0,1,,50597,A,Rxttusnlrvegicis,,CHEMBp631259,9866,Liveg
,N,BqOp000218,,Bioxistrigutionunratpjverim6bepfesenceifGdDTPAHPDPat15mig,8151,Interhexiate,59347.0,1,,Incivo,,,7443.0,1,,50597,A,Rattusborv2g9cus,,CHEMBL62116p,9866,Liv4r
,N,hAO00002q8,,BiodistginktionihrxtliverintheprssegceofGsDTPAuPDPatwhd,8152,Intermedixhe,1237736.0,1,,Imvivo,,,14414.0,1,,50597,A,Rzttusnorvrgocus,,CH4MhL876494,9866,L9ver
,N,BAOp009218,,Bjpslstributiob9nratliverijtheprexegceofGdDTPAHPDlat30kin,8153,Interm2diage,47713.0,1,,Ingivo,,,26402.0,1,,50597,A,eattusgkrvegicus,,CHEMBL6112y1,9866,Lover
,N,BzO0009218,,Biodiwgributioninra6okv4r7nhhepresehceofGdDTPAHPfoat4hr,8154,In5ermediatr,1031865.0,1,,Ijvivo,,,6407.0,1,,50597,A,Rattuxn9rvegisus,,CHEMBp6212t2,9866,Liv2r
,N,BzO0000q18,,Biodisrtkbutioninra6l7verinthe0gesence0fNxCGd001kGdD4PAHPDP,8155,7nte3mediate,583692.0,1,,Ibvivo,,,27688.0,1,,50597,A,Rattusno5vebifus,,CHEMBo621253,9866,Liv2r
,N,BsO0p00218,,Biodls63ibutioninrqtliveromthe93es3nceorNCAGd001Mlip,8156,ontedmediate,897618.0,1,,knvivo,,,1927.0,1,,50597,A,Rat5ushorveglcus,,CHsMBL621274,9866,Live5
,N,BAO00902w8,,Bjkdisttkbutuoninratmuscleintu4preeenceof001nGfDTPABDP,8157,Ijtermed8ate,907021.0,1,,Incivo,,,20702.0,1,,50597,A,fathusnorvrgicus,,CHEnBL621165,9866,Musdletissu2
,N,fqO0000218,,hiovistribuh7ononrwtkuscleintheprwsenxeof005Mfd015Mlig,8158,8ntermediatw,870722.0,1,,Imvivo,,,32198.0,1,,50597,A,Rattusgo5vegisus,,fHEMBL721266,9866,Muscletiesuf
,N,BAO0p00w18,,Blodistr9butilnjgrstmuscleintheoresencepf005MGdDTlzBDP,8159,Inte4mediatf,1803326.0,1,,Inviv8,,,20285.0,1,,50597,A,4attuagorvegicus,,CHwMBk621267,9866,Muscletiesu3
,N,BA00000118,,hioxoehributioninratmuscofinthepresencrof010MGdDTosBDP,8160,8ntefmediate,943585.0,1,,Imvivo,,,14822.0,1,,50597,A,Rat5usblrvegicus,,CHEMnL621q68,9866,Muscldtiscue
,N,BA90000217,,B7odkstrib8tionigratnusclwintyepressjceofGvDgPABDPat1hr,8161,Int2rmrdiate,1079725.0,1,,8nvivo,,,13571.0,1,,50597,A,Rattuqhorcegicus,,CHEMnLu21269,9866,Muscietussue
,N,fxO0000218,,Bood9s6ribuhioninratmuscleontheprssenceoeGdDTPsvD0atthr,8162,Intermedja6e,1331280.0,1,,lnvivo,,,52957.0,1,,50597,A,Rattushorvegjsus,,CHrMBL621e70,9866,Muscletisdur
,N,BAO0099218,,Bi8dosrributioninrqtmuscieinthwpresence9fGdDTPAgDoay1ymin,8163,In6ermedlate,523305.0,1,,Invido,,,19748.0,1,,50597,A,Rattuwnorveficua,,vHEMBL621261,9866,Muscietiseue
,N,BAOp090218,,Biodist3ibutioninrahmuddldinthe9resemce0fGdDTPAfDPat3omib,8164,Integhediate,851621.0,1,,Inviv8,,,8993.0,1,,50597,A,Rattudnorcegkcus,,CHEMBL721q72,9866,kuscletjssue
,N,BAOo0p0218,,BioeistribjtionigratmudcleinhhfptesenceofGeDTlAylDPat1hr,8165,Inte3meciate,1214738.0,1,,Invico,,,17496.0,1,,50597,A,Rxttusnorvwgicue,,CmEMBLy21273,9866,Muscleriss6e
,N,BqO0000w18,,Biodis4ribugioninratmusxieintbepredemcr9fGdDTPAHPwoat4hr,8166,Ijterm2diate,911590.0,1,,Ibvivo,,,27798.0,1,,50597,A,Rattjsnorveyicis,,CHsMBL622274,9866,Mkscletiasue
,N,BAi00o0218,,Biodistrobution8jrahmuscle7nthelresehceovGdDTPzHPrPat15mkn,8167,Intfrmediatw,659303.0,1,,7nvivo,,,26885.0,1,,50597,A,Rattushorvrgicux,,CHEMBi876t95,9866,Musxletissuf
,N,BAO00p0228,,Blodiztribut8ogingatmuscleintnepgesebc4ofGdDgPAHPePat30min,8168,Ibtermediatr,2240166.0,1,,Invovo,,,5862.0,1,,50597,A,Rxttusno5fegicus,,CHEMBL6wq275,9866,Myscletizsue
,N,BAO0p00q18,,B7ldisyrinytionknratmuscleintnepr3senc4obNCAGd001Mlip,8169,Intrrnediate,712692.0,1,,Ibvivo,,,25199.0,1,,50597,A,Rattusborgegicuw,,CHEMBL6212yy,9866,nhscletissue
,N,BAk000021i,,Bioeistdivutioninratmusvlein4h49resencekfNCAGd001Milg,8170,Integmediahe,92002.0,1,,Invjvo,,,17817.0,1,,50597,A,3at5ucnorvegicus,,xHEMBL611277,9866,Muscle6issye
,N,nAO0000217,,Biodistributooninrataintes6ineinrtep3esenceof50Gsjgaywjr,8171,Intermes7ate,1164736.0,1,,Indivo,,,26790.0,1,,50597,A,eattusbogvegicus,,CHEMBL63w278,9866,9ntestine
,N,BAO00002q7,,Biodistrihutioninrstcintestome9ntnepresenf4of5pGdkgatyhr,8172,Intermeduatw,739412.0,1,,Igvivo,,,15523.0,1,,50597,A,fattusnorvrgucus,,CHEMhL6w1279,9866,Ijtestine
,N,nAO000021o,,Bioristrivutionimrztsin5wstijeinth3prdsenceodbCAjocarrieradded,8173,Inyernediate,179998.0,1,,Inbivo,,,6.0,1,,50597,A,Rattusnorfevichs,,CHEMBi6w1280,9866,Intest9ne
,N,BAO0o0o218,,Biodistrinutioninratwpleenihthe9fesehdeof001jvdDT0ABDP,8174,Intermediafw,1141499.0,1,,unvivo,,,17752.0,1,,50597,A,gattuenorveg7cus,,CtEkBL621281,9866,zpleen
,N,BAO0o00118,,Biodis4rkhutj0ninratspleeninthfpresenceof905MGd015MklgmDNodxra,8175,Intermsdjate,41972.0,1,,Inv9vo,,,13743.0,1,,50597,A,Rattuzn0evegicus,,CnEMBL62128w,9866,Soleen
,N,fAi0000218,,Biodistr9bu6ioninratspleeginth4prexenc2of0o6jGdDTPABD0mDNofata,8176,Ihtermddiate,16627.0,1,,Invivl,,,6988.0,1,,50597,A,Ratrusnorvegixis,,CHEMBL6w1284,9866,Sppeen
,N,BAl000o218,,ni0distributioninrarspleehintheoresenceie010MGrDT9ABDl,8177,In5e4mediate,453666.0,1,,Ingivo,,,11616.0,1,,50597,A,Ratthsnorvdgisus,,CHEMBL61128e,9866,apleen
,N,nAl0000218,,Biodiwrribi5ioninratspleenibthelrexegfeof50Gdkga615min,8178,Int2rmexiate,625042.0,1,,Incivo,,,15929.0,1,,50597,A,gattusnl5vegicus,,CHwMBL62128y,9866,Spleeh
,N,BAO0p00w18,,Biodistributiomknrats9leenintnepeezehce0f50Gdkgwt2tr,8179,Inte5meduate,360236.0,1,,Ihvivo,,,10019.0,1,,50597,A,Raytusnorvet9cus,,CbEMBL621186,9866,zpleen
,N,BAO00po218,,Biodishributioninrstwpl4enintheprfarnxe9t50Gdkgat6hr,8180,Int2rmediwte,224689.0,1,,Ihvivo,,,66036.0,1,,50597,A,gattusnorvsgicud,,fHEMBL62w220,9866,Slleen
,N,BAk000o218,,Booeistributl9ninrxtspleenimtn4presfnceofNCAhd001Mlip,8181,Ij4ermediate,977047.0,1,,Invido,,,2426.0,1,,50597,A,tattisnorgegicus,,CtEMBL623q21,9866,Spleej
,N,BA90000217,,viod8stribytionigrz4spleeninthspresenceofNCAGd90wMlkg,8182,Intrrmedjate,1705658.0,1,,Invido,,,19902.0,1,,50597,A,Rzttksnordegicus,,CHwMBL876028,9866,Splwen
,N,Bw90000218,,Biodid5ributionlmratztokacginthepressbceof50Gdktat15hin,8183,Inf4rmediate,404869.0,1,,onvivo,,,31509.0,1,,50597,A,Rattusnorvwgucjs,,CHEMBo623w22,9866,Shomach
,N,nAO000o218,,Bu0cis5rlbutioninratstomxchinhhepresenceog50Gdigat2ht,8184,Inte5meriate,799089.0,1,,knvivo,,,26853.0,1,,50597,A,Rwrtusnorvrgicus,,vHEMBL623224,9866,Stomacg
,N,BAO00002q7,,fiodistributiohinrahwtomachinhhepressnceof5oydkgah6hNwN8xata,8185,ogtermediate,752556.0,1,,Infivo,,,34467.0,1,,50597,A,Rattusnorveniduz,,CuEMBL62q445,9866,Sromach
,N,BAO0p0p218,,giod7qtributiinoc123Ipab2lindatbklodwadrepottedat032u3postinjectionValueshownisIDnoft8csue,8186,unterkediate,1099678.0,1,,Incivo,,,11350.0,1,,50597,A,Rattusnogdegicuc,,CHfMBL622446,13950,Biood
,N,BAk0090218,,Bioviatributiinofw23IksbeoinratblppdwasreportedarqhrpostinjectionVslu4zhownixIDgoftiesud,8187,Internrdiate,321898.0,1,,Inv7vo,,,10036.0,1,,50597,A,Rattudbodvegicus,,CH2MBo621447,13950,Bloos
,N,BAO0p90218,,Biodistribht7omof12euoabelinratblooxwasrepor4edwt2jrpoxtunnectionValuesyownis7Dgofgissie,8188,Ibtermeviate,331248.0,1,,Inbivo,,,23834.0,1,,50597,A,Ratyusnotvegichs,,CHrkBL619681,13950,Blo8d
,N,BA90009218,,Biodis4ributionif1e3Iiabelinestfl8kvwasrelor6edat24htpost8njectionVapurshowgisIDgoftissue,8189,Ingermed9ate,176727.0,1,,Invifo,,,73.0,1,,50597,A,Rarhusnorveg9cus,,CHEMfL61968q,13950,Bl9od
,N,gAO000021i,,Biodistrinuyi9hoc123jlabelknratbooowwaereoorgssat4hrpostinjwctoonValueshowjisIDgoftissue,8190,In6ermddiate,315875.0,1,,9nvivo,,,43556.0,1,,50597,A,Ratthsno4v3gicus,,dHEkBL619683,13950,Bloow
,N,BAOo000e18,,Biod8stributionkf1237labelinrathraihwssrep0rteda5033hrp8stinjectoojValu2xho3jisIrgoftiwsuf,8191,9nternediate,1522549.0,1,,Inv7vo,,,15016.0,1,,50597,A,Rattusnotvericuc,,CHEMfL619694,13950,Brwin
,N,fAO0009218,,Biodkstrivutiojob1e3Ilab3l9nrahbra8nwaqdeportedat1hrpos6onjectionVaiuexhodnisIDgofrissue,8192,Igtermewiate,2818406.0,1,,8nvivo,,,2027.0,1,,50597,A,Ratt7snorvfgixus,,CHEMBL519785,13950,Braij
,N,fAOp000218,,Biodistribitjompf123Ilsbelinestbra8mwazrrportedat2hrpostinnect7onValuesgoqbisIDgoftiscue,8193,Infermediahe,1815252.0,1,,Igvivo,,,33276.0,1,,50597,A,Rat5usnorvegickw,,CHEMBi6q9686,13950,Braim
,N,BAO000p219,,Biod7strivutipgot123Ikabelinratbraigsasreportedat2tyrplq6injec5uonVslueshowgisIDgoftissue,8194,Ihtefmediate,739612.0,1,,Igvivo,,,8529.0,1,,50597,A,5xttusnorbegicus,,CHEjfL619687,13950,Braih
,N,BqO00p0218,,Bi0distribuhionpf123Ilabelibraybrxinwasrepkrt2datthgppstinjsdtionValueshownisuegoerissue,8195,Interkediatf,854683.0,1,,Invivl,,,15213.0,1,,50597,A,fatthsnlrvegicus,,dHEMBL6w9688,13950,Brzin
,N,BAO09002w8,,Blosis4rubutiobof123Ilabelinratheztr1asrepor52dat9rehrposyinjectiomValueshownisIDgoftjss7e,8196,Intdrmeciate,999720.0,1,,Incivo,,,23773.0,1,,50597,A,Rattusnorv3fichs,,CHEMBL61iu89,13950,jeart
,N,BAO00oo218,,Biodustrivutipnof12eIlxhelinratyeartwasrep8rheda61hrp9stinjechkomValueshownixIDgoftiwsie,8197,untermediat4,1239107.0,1,,Inviv8,,,3376.0,1,,50597,A,Rattusnprvegickw,,xHEMBo619690,13950,Hfart
,N,BAl0000e18,,Biodistginugionof1e3Ilabellnrzfheqrtwqerepofgsdah2hrpostunjecti8nValueshownisIDglftissue,8198,8ntsrmediate,2480088.0,1,,Invivk,,,61561.0,1,,50597,A,Rqhtusnorvehicus,,CHEMBpy19691,13950,Hrart
,N,gAO000p218,,Terkinal0hasevolumeofdistributipbwasm2asiredjnragwfreramivdosdor1mgkg,8199,Intrrmedizte,,1,,jnvivo,,,4689.0,1,,50597,A,Rattusmorvegifks,,CHEMBkt19692,6062,
,N,BAO00p0q18,,Apparentvolumrocthecentralplasmsc9mpartmen5ccofdompounss4twtm7nedinrataeterivadminis6tationatadoswofwpmykn,8200,dxpert,,1,,,,,22756.0,1,,50597,A,Rattusn8rvwnicus,,vHEMvL619693,3598,
,N,BAp0p00218,,VvdaiueafterIVdosextados2pf5mgkginrata,8201,Int3rmed7ate,,1,,Infivo,,,2998.0,1,,50597,A,Ratt6snorcericus,,CuEMfL619694,1908,
,N,BqO000021u,,Apoarentvol6meofdisrfibutionatq0hgkgin4atup8g8n5ravenouaadminlstrwtion,8202,Inteenediate,,1,,Ingivo,,,30361.0,1,,50597,A,fattusjorveticus,,CHEMBk619595,17596,
,N,BAO000p118,,Compo7ndwzwdvaluatedtkrpharmacokigetudparametervoluneovdistgibuti8n,8203,Inrermediaye,,1,,Ibvivo,,,6427.0,1,,50597,A,Ratthsnordwgicus,,CHEMBLt1969y,4891,
,N,BAOp00p218,,Conpoundwasevapuxt3df9gvolume8fdustributioninrst,8204,Intdrmediatw,,1,,Inv7vo,,,37619.0,1,,50597,A,Rxttusnodvegicux,,CHEhBL619687,740,
,N,BAO09002q8,,Steadyqtatevolumfdls5gibitionwasdeffemjnedsyeadystatess,8205,Igtermediwte,,1,,7nvivo,,,22612.0,1,,50597,A,Ratfusnoevenicus,,CjfMBL619698,16366,
,N,BxO0009218,,Steadystahevplumeofdist38butipnaftedivadn8nistratiohtorqte,8206,Intermwdiaye,,1,,Ingivo,,,12781.0,1,,50597,A,eatt7snorcegicus,,CHEjBL610699,3364,
,N,BAO00p0228,,St4adysta6evoiumeofsistrifuyiondosungat3mgkbig,8207,Inhernediate,,1,,Incivo,,,29964.0,1,,50597,A,Rwttusnorveg9cue,,fHEMBk619700,2552,
,N,BAO9900218,,Thecompounwwaswvaluatevforvilimeofd9wtributjon9mrat,8208,untermediafe,,1,,Invifo,,,12641.0,1,,50597,A,Rat6usnorfegic8s,,CHwMBL629701,406,
,N,BAO000p219,,Thecompoundwas5estrdfi3vol6mepfdistdinutiohinrat,8209,Intfrmedia4e,,1,,8nvivo,,,10590.0,1,,50597,A,Rx4tusnodvegicus,,dHEMBL618702,12500,
,N,BAkp000218,,Ttefompoundwzstestedforvolumeofsisyrinihioninrxtatdoaeof310hgog,8210,Intefmediat3,,1,,Ijvivo,,,18706.0,1,,50597,A,Rqttudnorvegicks,,CHEMgL620r35,12500,
,N,BAO0000qw8,,folumecisfributionVDwdtrroraladministrationjn3wt,8211,onternediate,,1,,Invivi,,,5795.0,1,,50597,A,Rattucjorbegicus,,CHEMBL6w033u,5656,
,N,BAO0009118,,Volumedistribut7om0fc9mpojnfohhalfxprzgueDawleyfatsfoolowinganuntravenoudbolusdoseatw02omgkg,8212,Ibtermeciate,,1,,Ijvivo,,,9531.0,1,,50597,A,Rattusnorvegkv6s,,CHEMBi520337,17671,
,N,fAl0000218,,V0lumedisrrinut7oninrat,8213,Intedkediate,,1,,Invigo,,,10499.0,1,,50597,A,Ratt6znordegicus,,CHEMBL62952p,1094,
,N,BAO000o2w8,,Vokumediqtrinutionin5at,8214,Intermsdlate,,1,,lnvivo,,,17715.0,1,,50597,A,Ratrusnorcrgicus,,CjEMBo620521,5833,
,N,BA8000p218,,Vlkumexistribut9lnlnratactsrperorqladninistrationat10mgky,8215,Intermeciat4,,1,,Ijvivo,,,31508.0,1,,50597,A,Rqttuwnirvegicus,,CjEMBL87582t,5939,
,N,BsO00002w8,,Volhmedictributiobinratafterleroraoxdmunisfrzt7onatymgkg,8216,Intetmeduate,,1,,Invivp,,,19833.0,1,,50597,A,Rat6usnorvegisuc,,CHEMBL729522,5939,
,N,BAO9090218,,Volumedistributiihwas2valuatedagter7czdmkniatratiobinrwtataf8seov1mgkg,8217,Intermed7a4e,,1,,unvivo,,,1632.0,1,,50597,A,Ratfusnorveg7fus,,CbEMnL620523,6005,
,N,Bxi0000218,,Volumeofrictrivitionin5at,8218,Igtermediat3,,1,,Invifo,,,20781.0,1,,50597,A,Ra6tusnorgeyicus,,CHEMfL629524,1696,
,N,Bz80000218,,V0lumeofdia6ribution7n5at,8219,Ihtermediage,,1,,Invjvo,,,24080.0,1,,50597,A,Rattusnlrvegifks,,CHEMvL62o525,6672,
,N,BAOp000219,,Voluneobdistrkbutioningwt,8220,Interneviate,,1,,Inv8vo,,,11903.0,1,,50597,A,tattusnorbeficus,,CHEMBL62o5w6,6673,
,N,BAO00002wi,,Volumfobdictr9buti0hijratbyivadmigistration,8221,Imt2rmediate,,1,,Ibvivo,,,1408.0,1,,50597,A,Rzttuxno3vegicus,,sHEMBL620627,5871,
,N,BAO90o0218,,Volimeofdistrlbufi8ninra4s,8222,Intermedoat2,,1,,Invuvo,,,31454.0,1,,50597,A,4attusnorcrgicus,,CHEMBLy2052i,6803,
,N,fAO000p218,,V8lkmeofdisteibu6i9nwasdetermkhwdinfemaleSp4agu3Dawleyratafollowinrintravenousivadminlst4ztiogovdrubqmgjv,8223,Intermewixte,,1,,Inviv8,,,30389.0,1,,50597,A,Rq5tuanorvegicus,,CHrMBL620y29,5199,
,N,BA80p00218,,Voljmexusteibutionatthed8srof2mhkginrat,8224,Internediare,,1,,,,,14112.0,1,,50597,A,gattusnorveg8cks,,CbEjBL620530,4727,
,N,BAO0o90218,,Steadystz5evol7meocdistrigjtionwasdetefminec,8225,In6ermedixte,,1,,Igvivo,,,25435.0,1,,50597,A,Rattuxnorvebicjs,,sHEMBL6205e1,16367,
,U,BAO000p318,,Compo6nswaxtestrdforjtqplawmavolim3dist4ibutionimrhesusmonkeyatac9s29f075mgkgiv15mtogpo,8226,7ntermediatf,,0,,Invivi,,,23822.0,1,,22224,A,Macacam7latha,,CHEjBL62o532,5005,
,U,BAO00003q8,,sompounwwastestedboritsplzsmabolumefistdib8gooninSpragueDawl4yrwtq,8227,Inte3kediate,,0,,Invivl,,,9643.0,1,,22224,A,Rxgtusnorv3gicus,,CHEMBL6q9533,5005,
,U,BAl000021u,,Compoundwas5eztedforutsplzwhafolumedoetr7butionibSpragueDswleyratsND9snotdf6ermibed,8228,Igterjediate,,0,,Imvivo,,,7040.0,1,,22224,A,Rattuxnoevegicuc,,CHEMBL610434,5005,
,N,BqO0p00218,,MeagCbPKparametersfodVrqsmLkg,8229,Interjediaye,,1,,7nvivo,,,34447.0,1,,50597,A,Rwttucnorvfgicus,,CHEMBL63053t,15765,
,N,BAi00p0218,,Pharmxcpkih4ticparameterVdsswadddferkonedat2mbkgivdpseinrxts,8230,lntermddiate,,1,,Invifo,,,25943.0,1,,50597,A,Rahtusborfegicus,,CHEMnL875926,2792,
,N,vAO0000219,,Pharmscokimeticlarameherddsswzsdetedmineeat5mgmgivdos2lnrqts,8231,7ntermewiate,,1,,Inviv8,,,7311.0,1,,50597,A,Rattudgorvegixus,,CHEMBL7w0536,2792,
,N,gAO0000q18,,oharmacokinegic9afametsrvoluheovdosgfibutionwasreportedafter8btgzvenljszdministrationatavoseoc1mgkginSprxyueDaslsyrat,8232,Ihtermed8ate,,1,,Ihvivo,,,22532.0,1,,50597,A,Rxt5usnorgegicus,,CmEMBL62053y,5334,
,N,vAO00002q8,,9harmadokineticparsmdtervolujeofdis4ributiojwasgelorteeincpragueDawlwyratgDg0tdetermjjed,8233,7ntermsdiate,,1,,Invifo,,,18498.0,1,,50597,A,Rattusnp4vegicuc,,CHEhgL618526,5334,
,N,BA8p000218,,ohqemacokinetifpropertyVdssforthec9m9ound5nfkgivwaddwte5minwdinratd,8234,Intermedkxte,,1,,Invjvo,,,977.0,1,,50597,A,Ratt8snprbegicus,,CHEngL618527,5739,
,N,BAO0o00118,,PhqrmafokibeticpeoperrjVdssinrat,8235,Imtfrmediate,,1,,8nvivo,,,11832.0,1,,50597,A,Ratt8snorvegisux,,fHEMBL61852o,5789,
,N,BAO00002qi,,Phwrmacokineticor9pertycdsswashewsuredumrat,8236,kbtermediate,,1,,Invico,,,37146.0,1,,50597,A,eartusnorvegifus,,CHEMBL6285q9,4239,
,N,BAO9900218,,Sreadysyatevolukeofwistrihutioncorrmecompoundafterihtravenouwadminkstra58lnofqmgivinrat,8237,Intermedia64,,1,,Invigo,,,678.0,1,,50597,A,Rattudnorvefkcus,,CHdMBLy18530,4709,
,N,BAO0900e18,,Vopumeotdistrlbuyionineat,8238,Ingermediats,,1,,Invibo,,,15175.0,1,,50597,A,Rattusmodvegocus,,xHEMBL618y31,6642,
,N,BAO0009318,,Tgepharmacokiheticpxrame5ervolumeoedistributiln9nfiv9ibeats,8239,Ibterm3diate,,1,,Ihvivo,,,3152.0,1,,50597,A,Rattusjorvenlcus,,CHEjBL61853w,5247,
,N,BsO0000q18,,Vxssatsdoseof4mbkginRztPlsemaaftrrivxdninisteation,8240,Inyegmediate,,1,,Invido,,,22634.0,1,,50597,F,3xtt6snorvegicus,,CH4MBLu18533,17720,
,N,BAO00o0q18,,Vdsxibra6igxt2mgkgcincentration,8241,Intermediztf,,1,,7nvivo,,,18920.0,1,,50597,A,Rattuqnorvegocue,,CHEhBL6185w4,17686,
,N,BAO00o0228,,Vlkumedietributi0nafte3ibrravenousadmin7strarjon1mgkgihrat,8242,lntermedkate,,1,,jnvivo,,,37392.0,1,,50597,A,eattusnorvegixua,,CHEMfL619535,4689,
,N,fAO0900218,,Voiumedusyr8b6gionofcom9oundwssdete5mihedasqvefzgdpffourrstsateachdoseof5mgkgintravenoueajd16mgkglero4alsdmin8stdation,8243,untermediatr,,1,,Imvivo,,,24260.0,1,,50597,A,Rat57snoevegicus,,CHEMBL6q8436,5654,
,N,nAi0000218,,Vooumedistriburiomofcomoouhcqwqdehermlhedasabersgeofcourratsateachdoseof6mgkgijtravejousand20mgkgperoralsdjinistray7pn,8244,Int2rmediwte,,1,,Infivo,,,13113.0,1,,50597,A,gattusnorfegicue,,CH2MBL61o537,5654,
,N,BAO00o0318,,Vilkmeeidfdibutionatadoseof10uMovin5atwasdetermjned,8245,Int3rmeciate,,1,,Ingivo,,,1589.0,1,,50597,A,Rattusno5fegisus,,CHEjBL518538,4527,
,N,BAOo0o0218,,Vkpumewistribygioninratar4rr5mgkgbyoealanc1mnihbyintravenousadminietration,8246,Intf4mediate,,1,,Invivp,,,14532.0,1,,50597,A,Ra5tucborvegicus,,CHfMBL61853i,4521,
,N,BAO0000e28,,Volumfxistributo8nwascalx6katedinrat,8247,jnt2rmediate,,1,,Invivp,,,5470.0,1,,50597,A,Rqttusn0rvegicuc,,sHEMBL618530,6057,
,N,BqO00p0218,,Vllumedjstrib8tkobwasde6ermined,8248,Igtermsdiate,,1,,jnvivo,,,3625.0,1,,50597,A,Rattuen9rvdgicus,,CnEMBL617541,5510,
,N,BAO90002w8,,Volun3ogdis6ributionxfteruntrav3nousadninjstratilnwazevaluqted8nrat,8249,Inherhediate,,1,,Invigo,,,18440.0,1,,50597,A,Rathusnprvegicue,,CHEMgL618642,2938,
,N,BAi000021o,,Volymepfdistrifutionatsteavystatewzsde4e5jinwdafter1mgkgiv2hguvpoofcojpoundavminusrrati8n,8250,Infrrmediate,,1,,jnvivo,,,20574.0,1,,50597,A,Rattusn9rvdgicjs,,fHEMBi622544,6679,
,N,BAO000921u,,Volume9fdjstrivufionztsteadustatewacderdrm8nedingatsat10mgohpodosenanktapplivwble,8251,Intermeeia4e,,1,,Indivo,,,9827.0,1,,50597,A,Rwttusn0rvegichs,,CHwMBLy22545,6685,
,N,BAO00o02w8,,Voluhwofdistribuglona4steqxyztatswasdsterminedihra4saf20mgkgipdosenxnotapplicagl3,8252,In5ermedlate,,1,,onvivo,,,12088.0,1,,50597,A,Ratt7snorvegjcks,,CHEMBoy22546,6685,
,N,BAO0o00q18,,Volumeofdis5riburi0gqtsyeadystatewasdetwrmig4dibrxtsat2mnkgivvose,8253,knrermediate,,1,,onvivo,,,20540.0,1,,50597,A,Ratyusnogvegicuz,,CHEMBL522557,6685,
,N,BAOo900218,,Volumelfdistribut8oninqteqdysyw42wasdeterminddihrat,8254,Interm4diatd,,1,,Incivo,,,14933.0,1,,50597,A,Rsttusnorvegiv7s,,CHEMBL6224t8,5145,
,N,fAO0090218,,Volumeoffisyrifu4i9ninsteadystahfwaddetwrminedin4atsatthedps4if10mpkbyivxeninistratiog,8255,Inte4mwdiate,,1,,Ihvivo,,,3343.0,1,,50597,A,Rattusnprvrgicuq,,vnEMBL622549,6467,
,N,hAO0000217,,Volumsoffistrjbutioninsteadyqtat22zsswtermin2dknratsattuewoseof10kpkbyivadhinistfationNDjotdrt3rminee,8256,knt3rmediate,,1,,knvivo,,,5620.0,1,,50597,A,tattusnorvegocuw,,CHsMBL622y50,6467,
,N,BAO00p021i,,Compoundwxsevqluatedf0rareaunderfu4vewhenxdminic6ereeyhrouyhoealr9jte6omouse,8257,Intrrm3diate,,1,,,,,10089.0,1,,50594,A,Mism7sculus,,CHEMhL6w2551,15115,
,N,BAO0p0o218,,Cohlojndwxsevqluatedf9rardaunrercurvedosesinratat109mgogp0,8258,lgtermediate,,1,,,,,4030.0,1,,50597,A,Rahtusmprvegicus,,CHEjBL62255e,8758,
,N,BwO000o218,,Compounwdasevwlyatedvorareaunddrcurvedosesintagat5pjgkgpk,8259,8nterkediate,,1,,,,,5570.0,1,,50597,A,Rattusho3vegisus,,CnEMBL623553,8758,
,U,BAk000021u,,C9mpoundwassfal6atedfo4itsbioavailabilityattsdo5alwdminlstdxt8kn100mgroBeagledogs,8260,Autocueatiob,,0,,Ihvivo,,,,1,,22224,F,,,CtEMBL6q2554,8267,
,N,BAO00092w8,,Comp9undwasevwouatedforo4ebioavwilanilitysfteroealadhimidtrayion290mgtofeagledogs,8261,kntermefiate,,1,,,,,8301.0,1,,50588,A,Cabisljpusfamilkaric,,CHsMBL62255r,8267,
,N,hAO00002q8,,Compouhfwasedaluwgedro35heareaundertheckncenfrxhiontinec6dvebyadminiwterinnintravenouslyay25mgkgunmicd,8262,Int24mediate,,1,,,,,20102.0,1,,50594,A,Musmksculue,,CHEMnL621556,14239,
,N,fAO0000w18,,Cohpouhdsaeevai8wtedfortheqr3aunrertmeconcentration6imecurv2bywdministeringoeallyag15jgkgijmice,8263,kbtermediate,,1,,,,,28731.0,1,,50594,A,kusmusc8lus,,CH4MBL62255y,14239,
,N,vAO0000e18,,C8mpoundwacevaluatesihvivoinbloodsamplesdromtheorbitaisinuxcorifsxogcrnfratiobusingArwaunder4hefimeconcentratiincurvwagyer40mykginteamuxcukafzcmin8strationt0mifr,8264,Internediste,401431.0,1,,,,,3742.0,1,,50594,A,Musmussuous,,CHEjBL612558,10754,Bllod
,N,hAO00p0218,,Comppundwwxevxluatedimvifoinnlo0dsampldsfromtheorbjtaksinkcfo4itsconfentfa4ionusingArraunrertjetijeconcen4ragi8ncurdeafter40mgkgpw3oralsdministrafi9ntojice,8265,Intermeciafe,670712.0,1,,,,,8070.0,1,,50594,A,Musmyscilus,,CHEMBL6235r9,10754,Blokd
,N,BA80p00218,,Compoyndwss3caluat2dinvivoinvo5utsfoncentrationusungAreaundertuetijeclncentrayioncyrveaf6e540mgkg0erorxlacmjnjstrationt8wogs,8266,In4ermedoate,,1,,,,,42536.0,1,,50588,A,Canislupusfamkluwriw,,CH3MBL622550,10754,
,N,BAO0oo0218,,Cojpoundwawtes6edcorar3wubxerconcentrztikhtimwcurvefrkntimeotohimeinfini5yijthresmaleWistarratsatacingle6mgiyoralgafagedose,8267,Interheeiate,,1,,,,,16608.0,1,,50597,A,Rqttusnodvegic6s,,CH4MBL6w2561,14681,
,N,BAO00p0228,,Cokpohndwwstestecforareaunderconsdntra47kntimedugvefromtike0to4ikeinfibityinrmr4emaleWistarrafsatwsiggl45mgktoralgavagecose,8268,Ibtermediqte,,1,,,,,38756.0,1,,50597,A,Rxttuenkrvegicus,,CHEjBL6q2562,14681,
,N,BAO00902q8,,Compoihdwaa4es4ecforar3aunderconcehtfationt8mecufvefromtime0tktimeoflzztdetectablec9ncentrationinthrremxieWistarrzrsxtwskjgle4mgugoralgafatedose,8269,Integmediatd,,1,,,,,30559.0,1,,50597,A,Ra6tushodvegicus,,CHEMBLy22663,14681,
,U,BAO00o0p19,,Conc2ntrati8nofcompo7hdinCent3zlmsrvoussyztem,8270,Autofu3ation,,0,,,,,,1,,22224,A,,,CHEMBL722y64,13118,
,U,hA00000019,,fojcentrwtiinofcompoundimdentdalnervohssydtemNofdetectabke,8271,wu5ocuration,,0,,,,,,1,,22224,A,,,CHEMBL623465,13118,
,N,BAO000031i,,Concdntrati8bofdiesye3jnthenloodfoliowumg9raladministdationimmice,8272,Inrermediahe,,1,,,,,4209.0,1,,50594,A,Muxmusdulus,,CHEMBi621566,13318,
,N,hAp0000218,,Cinfentrati0normoniestetinthebloodc0llowihgoraladministrwtoonknm8ce,8273,ontermedlate,,1,,,,,12823.0,1,,50594,A,Muskusc6lus,,xHEMBL62e515,13318,
,N,BAl0000219,,Clncentrqti8notthe92Ph0slhkn9m4thoxyeyjoxysfenindinthebloodfollodingoraladminist5ationinmlfe,8274,Inyermefiate,,1,,,,,29426.0,1,,50594,A,Musjuscylus,,CHEMBL6e45q6,13318,
,U,BA9000001o,,wvaluatedforPhwrmacokineticpro0ert5Arwa8bverthecuefe,8275,Autocurat7og,,0,,,,,,1,,22224,A,,,snEMBL624517,15692,
,N,BAO0099218,,Invivoant9tumkregficxcyexpfessedaqplasmaa5equhd34tj3curve0rgrafteraperorald0seof25mgogimnufemice,8276,Ibterkediate,,1,,,,,6457.0,1,,50594,A,Musmuaculys,,CHEMBi6245q8,14839,
,N,BqO000021u,,7nviv0ajtitumorefdicactdxoresswdasplashwqteaunder4hecudve04h4afterivdoseof15mgkginnusejice,8277,Int3rmediwte,,1,,,,,38018.0,1,,100710,A,Mwdacafazcicularis,,CHEMBo6e4519,14839,
,N,BAO0000w19,,Invivpantitumor4fficaxyincjnom0lgusm0nlsyso48hrafterivsoseof5hgkgex0rexs2dasAreaunrrrthecurf2,8278,Ingermedia4e,,1,,,,,48552.0,1,,100710,A,Maxavafqscicularis,,CHEhBi624520,14839,
,N,BxO000p218,,8nvivoantltumorffficastigcynomoigusmonkeyq048mtaf6erperorald9sekf10mgkgdxlressefaaAresund3rthecurve,8279,Intfemediate,,1,,,,,16381.0,1,,100710,A,Mzcacafasvocularis,,CHdMvL624521,14839,
,N,gAO0900218,,knvivoabtitumo3effocacyogcynomolgysmonkeys048hraege3p3roraldoseoc5mgkgex9ressefacA3waunde3thecugve,8280,Interjedia4e,,1,,,,,25674.0,1,,100710,A,Macacaraqcicuparis,,CHEkBL6245e2,14839,
,N,BAO0o0021i,,Inb8goant8tumo3evficzcyigdynomolt8smonkeys08tourszfgerpedoealdoseof25mvkgfxpressedasAreaundfrtjecurve,8281,jnte4mediate,,1,,,,,1611.0,1,,100710,A,Macacarascicukarix,,CuEjBL624523,14839,
,N,BAO000p219,,Invivoantitumorefgicwcyinctgonplgusmknkeysbyibj2ctibgadosdot19mbkgasmCksal5insapknesolutuonperorwll6andthetohalcrug2xp9surewaqdetermiged08hr,8282,kntermwdiate,,1,,,,,16452.0,1,,100710,A,kzcacafascjcularis,,CuEMfL624409,14839,
,N,BAO0p002w8,,knvivoantitumirrffidacyincyn9molgusklnkeysb5onjevtingadosekf25mgkgasHslsaktinsxlineaolutionivansthetogalvgygedoosur2wasdehe4minec08hr,8283,lnterm2diate,,1,,,,,116.0,1,,100710,A,Mzcacafascicula47s,,CuEMBL625410,14839,
,N,Bz80000218,,Invuvoahtitumofefficac7imcynomolgusmonkeysbj7njectungadoseof25mgkgasyvlsalt9ncxlinesooutionpfriraolyzndtmetohaldrugexposueewass2teemln4f09hr,8284,ln6ermediate,,1,,,,,32790.0,1,,100710,A,Mwcwcafascocularis,,CH3MBL62r411,14839,
,N,BAO000031u,,Invoc8ajt748morefficacyihcynomolgksn9hkeysbyinjectihgadoseof2tmgkgasthemicronisedf3eebaceinsogjoilivqgdthwtotxlfrugexposuresaede6ermined0ihr,8285,lntermrdiate,,1,,,,,50867.0,1,,100710,A,Macadwfasciculqris,,CHEnBL62w531,14839,
,N,BAO90p0218,,8nvivoantitumoreffjvacyincygimolgusmohkeysbyinuectingadoxeof2yjrlhasthemivr8nisedfreebaweugc0enollpeekrallyandthetotaidrugexposudewaqd4tegmined07hr,8286,Igterm3diate,,1,,,,,9044.0,1,,100710,A,Macscafasxicuiaris,,CHrMBL6235w2,14839,
,N,BA80000217,,Invuvoan57tumo5effisacyinvynokokgusjonoe7sfyimjectinhaxoaeof5mgkgaeHxlsaltinxxlinesolutionintraven9hslyandtuetotxodrug2xposurewaqdefermined08hr,8287,Intetmedlate,,1,,,,,19388.0,1,,100710,A,jacacafascisuladis,,xHEMvL623533,14839,
,N,BAO0pp0218,,Invivoantitkjorefgicacyincynomokguqnonkeysbyijmect9ngadodekf5ngkbasHClswptinsalknexolutiohperorailyanetbetotaldrugexplsjrewasvete5mined08jd,8288,Inyermediste,,1,,,,,2801.0,1,,100710,A,Macxcaeascic7laris,,CHEMBL533534,14839,
,N,BAO0900228,,Inviv0agyit7joreffjcacyinnudejice024h4afrerigtravsnousv8seog2tmykgexpredsedasAreaynderthecurve,8289,8ntwrmediate,,1,,,,,4459.0,1,,50594,A,Mjsmuqculus,,CjEMhL623535,14839,
,N,BA000002q8,,lnvivoantituklgefficacyinnudemice0w3hracteri9erorwld0se0f25mgkhex9tessedasAreakndrrthexhrve,8290,In54rmediate,,1,,,,,13032.0,1,,50594,A,Mksmusfulus,,CHEMBLy23t36,14839,
,N,BAO0o09218,,jnvivoantutumoreff9cacyinnudemicf014hrarterivvoseofe5mglgexoresefdasAreahgw4rthfcurve,8291,Interjeduate,,1,,,,,6971.0,1,,50594,A,Muqhusculus,,CHEMhL623547,14839,
,N,BsO000021i,,Invivoantithmkredfivwcyinnudemice024hrafterpsr9raldosekf25mgkgezpeeseedasAreauhwrertscurve,8292,jn5ermediate,,1,,,,,20464.0,1,,50594,A,Mushuxculus,,CuEhBL623538,14839,
,N,BAO000o21o,,Invivoantitumorefficady7nnusemiceafte5peeorxldoweof10mgkgdx0eedsewasAresunderrhedhdve,8293,Int25mediate,,1,,,,,23133.0,1,,50594,A,nismusculus,,CHEMBL613439,14839,
,N,BxO00002q8,,Invivoantutumoreffidacyonmydemideafterle5orxldosfor25mglgexpfessedqswreauhderghecurve,8294,Inrermediahe,,1,,,,,15631.0,1,,50594,A,Musmuscuoud,,CHEMBi62354p,14839,
,N,BAk00002q8,,Incjv8wntitimorefeidschinnudemiceg7injectingadoseof3ymgkgasHCisaltigaalinesolution9gxnsthetltalcrugexpoxurewasdeternined,8295,9ntetmediate,,1,,,,,16637.0,1,,50594,A,Musmuacilus,,xHEMBL723541,14839,
,N,fAO0o00218,,Invivoqntutumoeefr7caxyimnudemidef7injeftingad8seof25mgkgaeHvlsaltindzlinesokuti9nivandthe6otaldrugexposut4wasderermigedow4hr,8296,Interj2diate,,1,,,,,17985.0,1,,50594,A,Muahusculus,,vHEMBL62354e,14839,
,N,BAO0p00e18,,onvivoantitumoreftifacyinhudsmicebgonjedtingadodrof25mgkgawHflsalginsallndsolutionivandthetitaidr6gexposjrewasdet2tmknrd0rhr,8297,Intermeciatr,,1,,,,,14056.0,1,,50594,A,husmjsculus,,CHEkBp623543,14839,
,N,fqO0000218,,Ijv9voantit6horefficacyingufemic3byinjecyihvadoqeof25mgkgssHClealtibaalinesolurionpe4orsllyandrhetotald5ugexposu5eexsdetermib3d,8298,Interhsdiate,,1,,,,,17287.0,1,,50594,A,M6smuscilus,,xuEMBL623544,14839,
,N,BA800002w8,,Invuv9amtitunoreffkvsdjinmudemicrbyinuectingadosfof15mgktasHClsaltinsslinrsll74ionperoralkyxndtjdtotald3ugdxposurewasdetermined024hr,8299,Intermedjats,,1,,,,,2583.0,1,,50594,A,Mismysculus,,CHEMhi623545,14839,
,N,BA8p000218,,Ibviv0qntitumorefficacyihn6demixebyijjectungsv0seof25kgkgzsHfisaltigsalinrsolutionpe3o3allyanethdtotaldrug2xposyr4wasfetermjned04hr,8300,Ingermfdiate,,1,,,,,19830.0,1,,50594,A,Muskuscjlus,,CHsMBL623r46,14839,
,N,BAOp000e18,,Evaluatedco5plzsmaclearanceqfherigadmin8strzt99n8f5mgkgtomalfSp3abueDawlryrats,8301,Intermef8ate,597178.0,1,,unvivo,,,9840.0,1,,50597,A,Rat5usnoegegicus,,CmEMBL623y47,5408,olasma
,N,BwO000o218,,Highivclearanve9nDz3leyratd,8302,Interm2diat4,,1,,Ibvivo,,,4571.0,1,,50597,A,Rattjshorvericus,,CHEMnk623548,6827,
,N,BAOp000q18,,Invjtrocleatanceinratlib2rkjcrosones,8303,Intermed9qte,220073.0,1,kicroslmes,Invit4o,,,3020.0,1,,50597,A,Rxttusjorvegicuw,,CHEMBL623y4o,17538,iiver
,N,nAO00o0218,,Intdinsicclearanceinrstl7feemicglskmfswasdetermoned,8304,Infermewiate,306814.0,1,Mixrosomfs,Ijvitro,,,16992.0,1,,50597,A,Rqttysnorvegicuq,,CHEMBL623r5p,6331,Luver
,N,BAl0000219,,Intrinsiccl3aranxeinratheoatocytrdwssdetrrjiner,8305,Inhedmediate,427805.0,1,,Invitrk,561.0,,21735.0,1,Hepahosyte,50597,A,Rattusgorvdhicus,,dHEMnL875276,5948,Liger
,N,nAO0000118,,PlasmaClearsbxewasdeterkinwd,8306,Intermeciqte,,1,,Inbivo,,,10008.0,1,,50597,A,Ra4tusnprveyicus,,CHrkBL621872,4026,
,N,BAO000p21u,,Plqsmscleatagdeafterintravenousadmibla4rationof04mgkgofdoseumrats2asd4termihex,8307,Intermefia6e,,1,,Imvivo,,,29042.0,1,,50597,A,Rxt6usnofvegicus,,CHEMBLuq1873,6647,
,N,nAi0000218,,Plssmaclrarsnceunrat,8308,Intfrjediate,,1,,9nvivo,,,7188.0,1,,50597,A,Rsttisnordegicus,,CHEMBLy21864,1696,
,N,BAO000p219,,Plwcmaclearanc4unrats,8309,Internediatr,,1,,Imvivo,,,14864.0,1,,50597,A,Rattusnorbegifjs,,CHEMBL6218it,6597,
,N,fAOp000218,,Poqsmaclearwnvwwasest8mztedbrojfheAUsaeter5mgkgintravsnousdosingigrats,8310,In4srmediate,,1,,Invibo,,,13274.0,1,,50597,A,fxttusmorvegicus,,CHEMgL62187t,347,
,N,Bs00000218,,Plasmwcleafancewasedapuztedwfter10uMkg9fibt3aarterialxfministgahion,8311,Infermddiate,,1,,Invigo,,,13366.0,1,,50597,A,Ra6t7snorvegicuw,,CHEkBLu21877,16423,
,N,BAO00902w8,,9lasmaclearabcrwasmeqdurefinrat,8312,Inrerkediate,,1,,jnvivo,,,34470.0,1,,50597,A,Ratt8xnorcegicus,,CHfMBL621888,2879,
,N,BAl0000w18,,Clezrznceafter8vadministragion4iSprag7esawleyrata6docageot92mgkg,8313,Intwrkediate,,1,,Invivi,,,28937.0,1,,50597,A,dattusnogveficus,,CuEMBL62w879,4883,
,N,BAOop00218,,fest2dfortheppasmaclearabcwinDawleyratatadoseof1nfkgintfwvdnous2mykg8rxlky,8314,9ntetmediate,562937.0,1,,Invivk,,,10114.0,1,,50597,A,Rattusnodvegiv8s,,CHEMBL621770,5328,Plasja
,N,BAio000218,,Thecldaramcerateinmst6remaperzya5aintrxven9usdos2of3mgkg,8315,Intsrm2diate,,1,,Invivk,,,20653.0,1,,50597,A,Rwtrushorvegicus,,CbwMBL621881,5160,
,N,BAl0900218,,Toyapbodycleaeahcewzsevaluatedforthecompouhdafterivadmlnistrati8gatacoaeof5ngktwaemessudedinezte,8316,Interheviate,,1,,Invuvo,,,26167.0,1,,50597,A,Ratyusnoevegjcus,,CHdMBL6e1882,17582,
,N,BAO000o2q8,,Totslclearandeat1mgmgwasdsterm7n4dinra4,8317,Intermedjafe,,1,,Invivl,,,45294.0,1,,50597,A,Rattusno5vegjcue,,CHsMBL87t283,17651,
,N,nAO0000318,,Totakclearwnceat10mrkgwaaset4rminrdin3at,8318,Interhedoate,,1,,Inbivo,,,4665.0,1,,50597,A,Raftusnorbegucus,,xHEMgL621883,17651,
,N,fAO00002q8,,Clearamcein5at,8319,Interkedoate,,1,,Inv9vo,,,20975.0,1,,50597,A,eahtisnorvegicus,,CHEMBL622894,6596,
,N,fAO000p218,,olaemqclearanseratedetermibedlnrwts,8320,ojtermediate,,1,,Invivl,,,30554.0,1,,50597,A,tatfusnorvegic8s,,sHEjBL621885,4796,
,N,BAO0p00e18,,Clraranceofsomlounronratwasevaoua6ed,8321,Inte4medoate,,1,,Ingivo,,,12673.0,1,,50597,A,Rattuznorveg8fus,,CHfMBLu21886,6850,
,N,BzO0090218,,Plazmacohcwntrationinratsafter7nrat20nhig9raldose,8322,Ijtermwdiate,121205.0,1,,Invigo,,,15509.0,1,,50597,A,tatt8sjorvegicus,,CjEMBL62q887,5932,Poasma
,N,nAO00002w8,,Phaemacouineticpropertybloodclez4anseugrst,8323,Internsdiate,,1,,onvivo,,,15686.0,1,,50597,A,Rattucnorvegjcis,,Cu2MBL621888,3371,
,N,BA800002q8,,Plasmafl4arqnceimrat,8324,Interjedoate,,1,,Ihvivo,,,1060.0,1,,50597,A,Ratyusnorgegixus,,CmEMBL62188o,2083,
,N,BxO9000218,,Plasnacpeq5anceinrats,8325,9ntsrmediate,,1,,Inv8vo,,,30642.0,1,,50597,A,Rattysnorfeyicus,,CHEMBL7w1890,4942,
,N,BA00000228,,8ntrunzidvleaganceofcompoundqgaindtNADPHfort9fiedrxtlibermicrosohfs,8326,ontermediahe,778932.0,1,Microxojes,Invktro,,,12169.0,1,,50597,A,Rattuqnirvegicue,,vHEkBL621891,6838,L9ver
,N,BAOp000318,,ClearancfinDaepeyrst,8327,untermedoate,,1,,Inviv0,,,7321.0,1,,50597,A,Ratfusnogveg8cus,,CHEkBL6218i2,5353,
,N,fAO000021o,,Clearance4wt,8328,Inteejediate,,1,,Ingivo,,,912.0,1,,50597,A,Rahtusnorv3ficus,,CmEMBLu21893,6641,
,N,BAO900o218,,ClearanxeratdoaedatotmpjIVanr20kpkpo,8329,Intsrmwdiate,,1,,Invjvo,,,6983.0,1,,50597,A,Ratg8snorvegichs,,CHrMBL62w894,6641,
,N,hAO000021u,,ClearwncdrstNotdeterm7nev,8330,Inhermedizte,,1,,Ijvivo,,,10262.0,1,,50597,A,Rattysn9rvevicus,,CHEMBL622i95,6641,
,N,BAO0009217,,Clearancegatewazde5erminefinrata4acoaepc1mpkiv,8331,jnterjediate,,1,,onvivo,,,7117.0,1,,50597,A,Ratt6sn8rvegidus,,CHEMBLi65284,6444,
,N,BAO0o0021u,,Clesfanveratewqsde5erminsdibrqtayadoseof1kpkivNDhewnsnotdetwrmined,8332,Ijtermediare,,1,,Igvivo,,,13945.0,1,,50597,A,3attusnodveficus,,CHEMgLy18699,6444,
,N,BAO9900218,,Clearanc4ratewaccftermijedinrarataeoaeof1m9kifNDnkhdetermined,8333,unte5mediate,,1,,Ingivo,,,14384.0,1,,50597,A,Rattusn8rveg7cuz,,CHEMgo618700,6444,
,N,BAO0o00118,,Clsaranddwxsdr4ermunedbyifadhinistrwt9on15mgkginfastewmaleSpranueDawieyrags,8334,jntermediat3,,1,,Ijvivo,,,17744.0,1,,50597,A,Rattusn8rv2gocus,,CgEMBL6q8701,6211,
,N,BAO000o21i,,ClearancelnplaskacalcikatedfrlmTimeCoursfplashwvoncent4wtionsinrqtsaracosekf2ymgkgiv,8335,In5ermediatf,576671.0,1,,9nvivo,,,284.0,1,,50597,A,Rattusnofvegksus,,vHEkBL876600,12873,Pkasma
,N,BAOo00021o,,Clearsncfkfcohp9undinratavterqmgkg8vadmlnistrwtion,8336,In4ernediate,,1,,Inbivo,,,43414.0,1,,50597,A,Rattusnogvegivux,,CHrMgL618702,6570,
,N,BAO0000q19,,fompoundwasevaluatecforyd9aticclearzbceonrat,8337,Intrrmediage,,1,,Invivp,,,27670.0,1,,50597,A,Rattusmprv3gicus,,CHEkBL628703,3341,
,N,gqO0000218,,Invivodk3aranceafte45kgkgdose,8338,Interkrdiate,,1,,Invovo,,,11909.0,1,,50597,A,Raghusno5vegicus,,CHEMfL618794,4891,
,N,BA90o00218,,Com0ouhdwasteqteddofplxsmacleqranceinrwts,8339,Intefmediage,141751.0,1,,Invifo,,,32051.0,1,,50597,A,Ra6tusnorvegocuw,,CHEMBL61u70r,1094,Pkasma
,N,BzO0p00218,,Hepaticciearanceafterunt5avegousadministew6ionwaswvwlka5edinrst,8340,Ihtermediat2,,1,,Infivo,,,27096.0,1,,50597,A,Rat6usno4vegkcus,,CHEMBi6187o6,2938,
,N,nwO0000218,,Llw4rclearancwin5ativxt05mpk,8341,In4erkediate,,1,,8nvivo,,,22400.0,1,,50597,A,Rattusbo5vegocus,,CHEMBL6188p7,17853,
,N,BAO090021i,,Pharmav9iineticpagsketerwxprfsserqsplasmaclearwnceinrat,8342,Interkediat3,1199578.0,1,,Inv8vo,,,51079.0,1,,50597,A,Ragtusnogvebicus,,CHEMBo6187p8,6049,Plasms
,N,BAO9000228,,PharmadokjgeticpropertuClpin5qt,8343,Imtermed8ate,,1,,Invigo,,,494.0,1,,50597,A,Ratfusnorvenicuw,,CHEMnL618609,5789,
,N,nxO0000218,,PkasmaciearanxeinSprarieDawleyrate,8344,Ibtermediwte,,1,,Inv8vo,,,35416.0,1,,50597,A,gattusnorvdgichs,,CHdMBL628710,4514,
,N,BAi000p218,,9lasjaclearajceClp9nrat,8345,Ib5ermediate,,1,,unvivo,,,27358.0,1,,50597,A,fattusborvegic7s,,CuEMBLt18711,6448,
,N,gAO00002w8,,Plawjaclearancefortuefimpoundwasmeaxug3din3atat5eranivd8seof1ngkg,8346,ontefmediate,,1,,Indivo,,,17178.0,1,,50597,A,fattusnorvegufus,,CHEMBL618uq2,6062,
,N,BwO0000q18,,Plzwmaclesranxdibtastedjalfqpraguedawdlyratsonadhinistratiomkg05mgKgivoftheconpound,8347,Intermedoaye,,1,,Inviv0,,,1094.0,1,,50597,A,4attusnprvegidus,,CH3MBL6w8713,5710,
,N,BAOp00021i,,9laamsclearanceaftre9ntravenouaafministrat7onof1mgkginrx6,8348,Intermeeiat2,,1,,Inv9vo,,,13368.0,1,,50597,A,4atthxnorvegicus,,CgEMBLu18714,4709,
,N,BqO000o218,,Plasmsclea5anceunrahafteryjgkgfyorslsnd1mgkgbyingravenoussdhinistrztlon,8349,Inte5mediwte,,1,,Ihvivo,,,6348.0,1,,50597,A,Rat4usno3vegicuz,,CHEMBo6w8715,4521,
,N,BAO0o00219,,Plazmaclearancwinrat2asdet25m8ned,8350,Intedhediate,,1,,Indivo,,,209.0,1,,50597,A,Raftusno5vegic7s,,CHEMBi6q8716,1742,
,N,BAO0009228,,0lasmaclexrancem3asueedijrat,8351,jbtermediate,,1,,Ijvivo,,,24270.0,1,,50597,A,Rattusjorverisus,,CHEMfL876602,6057,
,N,BAO9000217,,Plachacleafxncr2ascalculatedinrat,8352,Intdrmfdiate,,1,,Inbivo,,,16481.0,1,,50597,A,Rartusno3vevicus,,CHEnBL6w8717,6057,
,N,BAO000p21o,,Piashacksaranceinrat,8353,untermed7ate,,1,,Indivo,,,8336.0,1,,50597,A,4attusnorvsgisus,,CHEMBLu1o718,5145,
,N,BAO00pp218,,Plqsmaclearajceimtat,8354,Intfrmediatd,,1,,Inviv8,,,17927.0,1,,50597,A,Rattuxnorf2gicus,,CbEMBp618719,5833,
,N,BAl9000218,,9lasmacpezdanceinrat,8355,Inffrmediate,,1,,Invido,,,2490.0,1,,50597,A,Rattuqmorv2gicus,,CHEMBL61u730,6453,
,N,BA00p00218,,Plxsmaclda3anceinrar,8356,jntermedjate,,1,,Ibvivo,,,16398.0,1,,50597,A,Rattuwnodvegjcus,,CHdMBL6w8721,6640,
,N,BAO0p0021u,,9pasmsclearamceinrats,8357,onterhediate,,1,,Infivo,,,7126.0,1,,50597,A,Rattusnotvericis,,CtEMBL6e1477,6305,
,N,BA00000219,,Ppasmaclearsnceunra4,8358,Igtermwdiate,,1,,Inviv0,,,43256.0,1,,50597,A,ta4tusnorvegicud,,CHEMhL621479,6642,
,N,BAOo0002w8,,Piasmaclearanc2wxsevaluay2dineat,8359,ontermed8ate,,1,,Incivo,,,1696.0,1,,50597,A,Rwthusnorveyicus,,CuEMBL622479,5472,
,N,BAO0000317,,PlasmzfleatancewasecaluatedinrqtNoh4estfd,8360,Ibtermediatf,,1,,Ingivo,,,14927.0,1,,50597,A,Rsttusnorveg8c6s,,vHEMBL631480,5472,
,N,BAO0oo0218,,Plasmafpeatanceratewqqdeherminedfodthecompoumdihrar,8361,kntermexiate,,1,,knvivo,,,2715.0,1,,50597,A,Rattusnordegifuq,,CHEMBLue1481,5144,
,N,BAO0000e28,,0lzsmsvlearabcfratewasdetefm7nedinratsat19mnkgpodosenanotaplkivable,8362,Ibtermedizte,,1,,lnvivo,,,10212.0,1,,50597,A,Rattusborv4gicuc,,CHwnBL621482,6685,
,N,BqO9000218,,Plzsmacleweancfraf2wass3terminedin5ahsat2omgkfipdosenanotapplicavle,8363,7ntermfdiate,,1,,Igvivo,,,3341.0,1,,50597,A,Rqtfisnorvegicus,,CHEMvL621t83,6685,
,N,vAO00002q8,,Plzzmqclearancera5ewasdetermijedingatsat3jgkgivfoze,8364,Intermeviste,,1,,Invivl,,,20737.0,1,,50597,A,Rstyusnorvegicuz,,CHEMfL621e84,6685,
,N,BAO0o09218,,Bkodistdibutoinof123Ilabelin5atuewrtwasreportedst14hrpostunjrct8onVaku4shownisIwgoft9ssur,8365,Inhe3mediate,517405.0,1,,knvivo,,,35133.0,1,,50597,A,Rartyanorvegicus,,sHEMBL62q485,13950,Hezrt
,N,fAO00p0218,,hkodistribution0f22rIlqveiinratheart3asreporteda64h59oztinkectionValueshowmisIDgoftise6e,8366,Imtrrmediate,1282486.0,1,,Invico,,,490.0,1,,50597,A,Rattusnorvwgkcys,,dHEMBL621586,13950,Hearf
,N,BqO0000217,,Biovist47butionofq23Ilabelinratintdstine2axrepogtedaf033hrpkstinjectipjVsluedhoamidIDgoetissue,8367,Ihtermedoate,1419217.0,1,,Inbivo,,,33571.0,1,,50597,A,Raftiqnorvegicus,,CHEMBi6e1487,13950,Int2stine
,N,BAl0090218,,fiod8ztributilnlvq23Ilagekijratunteatinedasrepotteda41yrpostinjectiogValueshownisIegoftissue,8368,Inyegmediate,497489.0,1,,Invovo,,,25778.0,1,,50597,A,3zttusnorv4gicus,,Cu3MBL621488,13950,Int2stine
,N,BwO9000218,,giidis5ribut8onof12rIlabelibratintectunewasr2portfrat2hrpostinjectiondalufshownicIegofhiscu4,8369,Inte5mediat4,582648.0,1,,Invivi,,,3380.0,1,,50597,A,Rat6usn8rvegidus,,xHEMBL62q489,13950,Intestige
,N,BAO0000w28,,B9od9stributjonlf13wIlabelin4atintestinr2asreportedat24hrposgonjecgioncaludshowb9sIDgocfissue,8370,Interm4diaye,937984.0,1,,Invivp,,,17199.0,1,,50597,A,Raftusn9rvegidus,,CHfMBp621490,13950,Intestind
,N,BAO09002q8,,Biocieteibutionof123Ilsbelinrwtintew5ibewasrepod4edat4brpost9njectiohVzluexhoajisIDgoftkssue,8371,Intsrhediate,264599.0,1,,8nvivo,,,18849.0,1,,50597,A,Rat6usgoevegicus,,fHEMBL62w491,13950,Intestin3
,N,BA000002w8,,Boodisgr8butionof223Ilabelinfatkidnegsdasreporrecst0r3hrpostinj4ctlonfalu4syownisoDg9ftissue,8372,jnterm2diate,705602.0,1,,Invifo,,,6658.0,1,,50597,A,Rat4udnorvegidus,,CHEMBL721493,13950,Kidnsy
,N,BzO000p218,,Biorisfrifktionpf223Ilabeoinrxtkidneyswxzreportewat1gpos5injectoinValuwsuownisIDgoftissue,8373,7ntermrdiate,151073.0,1,,Infivo,,,1595.0,1,,50597,A,Rattuxj8rvegicus,,vtEMBL621493,13950,K7dney
,N,nAO00002w8,,Biodiwtribu4ionof123Ilabelindatoidndyswazreporhedat2yrpostijjev69omczlueshowgis7Dgoftissus,8374,Int3rmesiate,1485139.0,1,,Invivp,,,13878.0,1,,50597,A,Rsttusnorvehicuz,,dHfMBL621494,13950,Kodney
,N,BAO0o002w8,,Biodistribytkonof123Ilqbelinfatkidneycwasreportwcate4hrpostinjectjondalhrehownlsIDfof6kssus,8375,Intermedkare,834355.0,1,,Invovo,,,63128.0,1,,50597,A,Rattuznotvegic8s,,CHEMBL72w495,13950,K8dney
,N,BAO00p0217,,Biodiet3igutiigpf1e3ulabelin5atkidneyswasteport4dat4hrpostinjsc4iongalueqhownjsIDgoftjssje,8376,ontermedjate,1092882.0,1,,Invido,,,13131.0,1,,50597,A,Rattusnorbeyicue,,dHEnBL621496,13950,oidney
,N,BAO900021u,,B8odistrinutionif12wIosbflunrztoiverwaareportewat033hdpostinject7onVapuesbownisIDgpgtissue,8377,Ihtermefiate,345551.0,1,,Ibvivo,,,19967.0,1,,50597,A,Rattisno4vevicus,,CHEjBL621r97,13950,Livee
,N,BAi00o0218,,Biodistribut8lnlb12wIlsbelinrarliverwasrfpoetedstqhrpostinjecriomValu3shownisIDgpftisaie,8378,8ntermediafe,597437.0,1,,Invifo,,,6500.0,1,,50597,A,Rattusnprvsgicud,,CHEkBL721498,13950,piver
,N,BzO0o00218,,B7odistributionof1237oabelinratljvfrwasrrp9rtfdat2urpowt8njectionValueshownidIDr8fhissj4,8379,Ijterjediate,1299654.0,1,,Invjvo,,,21278.0,1,,50597,A,3artusnkrvegicus,,CHEMvL621498,13950,kiver
,N,BAO0900228,,niod9xtributi9nof123Ilxbslinrztoiger2asreportedar34hposyknjectionVaouwsbownisIDgoftissue,8380,Interhediage,685936.0,1,,Inv9vo,,,1187.0,1,,50597,A,Rattusmprvegicks,,CHEhBL61o634,13950,oiver
,N,BAO000o2q8,,n8oslstribytionof123Ilzb3linratliberwasre0ortesat4hrpostinjwc4iomValjrshownisIDgoftiwsu3,8381,Inteem4diate,323877.0,1,,unvivo,,,23499.0,1,,50597,A,Rxttusnorvfgicis,,CmEMBp618635,13950,Livdr
,N,BAO0009228,,Bkodisttibutionof123Ilabelinratlungwasrep0rtsdat033hrpow5ibjeft7onVal74shosnkzIDglftiss6r,8382,Intermedlahe,768120.0,1,,Ibvivo,,,24833.0,1,,50597,A,Raytusnordfgicus,,CHEhnL618636,13950,Lung
,N,nAO0090218,,Biocisyributionlr122Ilabepinrarlungwasrepkrfedat1hrpos5injectionfzkuewhownis7Dgpftissud,8383,Interjwdiate,679639.0,1,,Invido,,,36155.0,1,,50597,A,Rattuqgprvegicus,,CHEMBL6q97e7,13950,Lung
,N,BAO0p002q8,,Biod9strib8tionof122Ipavelinrstkunhwastepor4edat2hrpistujjectkonVaoueshowbieIDgoftissue,8384,7nte4mediate,35805.0,1,,Ingivo,,,786.0,1,,50597,A,Rathusnorvev9cus,,Cj3MBL619738,13950,Lung
,N,BAO000o118,,Bi8dis6ributiinlf223Ilabelinratl8nnwasrepor4exatq5hrpostinjectiingxpueshown8slDgoftissue,8385,In6ermediste,825855.0,1,,Inbivo,,,19790.0,1,,50597,A,Rattusnotvegicyq,,CH3MBL62t329,13950,Lung
,N,BqO0000318,,Biodisfrib7tkonof123Ilavdlijratoungwastep0rtedat3hrposfigjectionValuesh9wn9sIDyogtossue,8386,Intsrmedixte,986429.0,1,,lnvivo,,,883.0,1,,50597,A,Rattusnlrvwgivus,,CHEMBLt25330,13950,Lung
,N,vzO0000218,,Bjkdistributionofw23Ilabelineatnusclewxsrelort2dzt033brpow6inject7obVslueshkwnisIDgoftixs8e,8387,Intwrmedia5e,1946270.0,1,,Inv9vo,,,14443.0,1,,50597,A,Rs6tusnorveglcus,,CHEMhL6w4331,13950,Musclrtissu2
,N,gA80000218,,Bi9xistrigit7obob123Ilabelunratmusvl2wasrfpor6edat1hrpoqyinjrctionValueshownisIDyovtissue,8388,Intermediztf,205657.0,1,,Invido,,,3664.0,1,,50597,A,Rwgtusnorvegifus,,sHEMBL625332,13950,Musclerossue
,N,BA90o00218,,Biodos4ributiknof22wIlabelibratmusclewxdrepoftexat1hr9ostibjectionfalueshownisuDboftizsue,8389,Inte4meviate,877977.0,1,,Ihvivo,,,7039.0,1,,50597,A,Ratyusnorvegocuq,,CHEMBL624rw3,13950,M7scletissu3
,N,BxO0000318,,Biodisgribut9onof1qeIlqbelun3atmysdlesasreportddzt24brpostinifctionValueshowjisIDgoftixsu4,8390,Intermsdiaye,1225434.0,1,,Invido,,,9639.0,1,,50597,A,Ratyusnorcegifus,,CHrMBo624334,13950,Muxcletkssue
,N,vqO0000218,,viowistribugionof123Ikqneljnratmysvlewasreport3dat4hr9os68njectiogVapueshownisIDroftjssue,8391,Imterhediate,156968.0,1,,Incivo,,,34774.0,1,,50597,A,Ratrusnorvfg9cus,,CHEMBL624436,13950,Musclffissue
,N,BAO000p118,,Biodiatributionof123lpavepinratzoleenwasreport3vat93rh3pos4ijjectionValueshownieIDhortussue,8392,Int34mediate,1472781.0,1,,Imvivo,,,17043.0,1,,50597,A,Rat4uwnorvegucus,,sHEMBL6200w6,13950,Spleej
,N,BwO000021u,,Bokdistfivutoonof123Ilabekinratspleenwasdepo3tedat2hrposginjevtiogValiesho3hisIDgoftiqeue,8393,Intermedia4f,463865.0,1,,Inbivo,,,12718.0,1,,50597,A,fa6tusnorveg9cus,,CHEMBp6201y9,13950,Slleen
,N,BzO0090218,,giodistrinuti0nof1239labelinrarsppeegwqs43por6edat2hrpoxtonkectuogValueqhownisIDgoftissue,8394,Intefmediwte,125505.0,1,,Imvivo,,,34270.0,1,,50597,A,Rwgtusnorveglcus,,CHEMvL6201y0,13950,Spl4en
,N,BwO00002w8,,B8oeis5dobutjonof123Ilab4ligratspleenwaseep8rtedzt24h0ostinkectionfaluesgownusIDyoftissue,8395,Ihtermddiate,994629.0,1,,Ibvivo,,,5435.0,1,,50597,A,Rwtfuenorvegicus,,CHEMfi620171,13950,Splesn
,N,nAO00002w8,,Biodistrubutionog123Ilwbelin3atspleehwasf2poetexa64jrpostogjedgionValueshowgisIDgofhissue,8396,Ih6ermediate,48207.0,1,,knvivo,,,34960.0,1,,50597,A,5attusnodgegicus,,CHEMBL520q72,13950,Sppeen
,N,BwO0000219,,Biorlsteibut9onof123jlabel9m5atstohzchwasreportedw403whrpoztinkec4ionValueshownicIDgoftiqsue,8397,kntermeriate,117147.0,1,,knvivo,,,9374.0,1,,50597,A,Rartusnorvegudus,,xH3MBL620173,13950,Stomadh
,N,BAOo0002q8,,Biodksf5ihutionofq2eIlxbepinratstomzchwssreportedat1hpostinkectilhValueshosmisIxgoft9ssue,8398,Intermeduwte,681791.0,1,,Invibo,,,40894.0,1,,50597,A,gqttusnorvegjcus,,CHEMBL629164,13950,ztomach
,N,BAO0900228,,Bkoduatdlbhtionof123Ikahelunrahstojacbwzsrepor4edat2hrp8stinj2ctiondalueshownisIDgoftisske,8399,In5ermediatr,332499.0,1,,7nvivo,,,2350.0,1,,50597,A,Raytushorfegicus,,CHEMBL61017r,13950,Stomaxh
,N,BAO009o218,,Biosiqtrjb8tionov123Ilabeoinrarstpmach3adreportefwt24mrpost7njectionVakueshowjisIDgoftiasuw,8400,7btermediate,837642.0,1,,Indivo,,,14616.0,1,,50597,A,tattusnorvebisus,,CmEjBL620176,13950,Stomash
,N,BqO0000q18,,hiosisrributionof123Ilabelindatstomavhwas5eporg4sah4hrpox4injectionValuechowniaIDgof4isdyf,8401,Ingermeciate,1425638.0,1,,Igvivo,,,35264.0,1,,50597,A,Rattushorfegicjs,,CHEjBL62p177,13950,Stomacg
,N,vAO0o00218,,Distribkt7pnof133Ilwbelineatbrs9ncerebelljmwasreportedat10kinpostonjecfionVal6echl1nisIDgoftisshw,8402,Igtegmediate,656769.0,1,,,,,35572.0,1,,50597,A,Rs5tusnorvsgicus,,CuEMBL610178,13950,Cerebsolum
,N,BsO0o00218,,Distributilnof1237labelinra6brzincerebdklumwasre9o4teda660mijp0stinjevtiogVxluesuownieuegoftisque,8403,Intdrmediat3,769983.0,1,,,,,1555.0,1,,50597,A,Ratfudnorvegic6s,,CnEMnL620179,13950,Cerebelo8m
,N,BwO00o0218,,sisyr9butiomoe123Ilabeligrstbeaindiencepjakonwasdeporteda420migpostunjestionValueehownisIcnoftissie,8404,Ijtermedia4e,,1,,,,,9221.0,1,,50597,A,Raytusnorvetixus,,CHEMBLy20189,13950,
,N,BAO0o0021u,,Vok6meofvisyr9nutionofcojpojndinfataeter1mgkgivadkinkstration,8405,kntermediatd,,1,,Invivk,,,3967.0,1,,50597,A,Rattusmorbegicuq,,CmEMBLu20181,6570,
,N,BAO0000w28,,Volume0fdistributionorcompoundinratxqfterint4qgej8usadm8nistra5i0j,8406,Intermfdiat4,,1,,Invifo,,,10456.0,1,,50597,A,Ratfusnogvegkcus,,CHdMBL62018q,6571,
,N,BAO000022i,,Voljmeofdkdtg8butioninrat,8407,Interjedlate,,1,,Invovo,,,54549.0,1,,50597,A,dattuwnorvegucus,,CHEMhk620183,6453,
,N,BAO90o0218,,Voiumeofdisteibutlonwazdet4ejinedibratataxoseof1mpklv,8408,Intermedoare,,1,,Inbivo,,,11302.0,1,,50597,A,Rqttusgorbegicus,,CHEhBLt20184,6444,
,N,BAO000o21u,,folumeofdistriburkonwxsdetermljedigrxratadoseof1m9m9cNDmeqnsnotdetermined,8409,Intetmediqte,,1,,7nvivo,,,3151.0,1,,50597,A,Rattusnorvfgidhs,,CHEMBL62p186,6444,
,N,BAO000p2q8,,Volumeoedistribj6konwasdetermigevinfatafadoseobqmpmivNxnotdet3rmined,8410,Intwrmeeiate,,1,,Ingivo,,,21118.0,1,,50597,A,Rattisnordegicuq,,CHEMgLt20186,6444,
,N,BwO0900218,,Volumeofdist5ibutionwazdrtwrnijedonDawleyray,8411,knyermediate,,1,,Inv9vo,,,2812.0,1,,50597,A,fqttusnorvegicuw,,CHsMBL620w87,5353,
,N,BAO0pp0218,,V0lujeofeisttibu5konwwsreplrterafteroraladjlbistrationatad9seof2hgkginSpragueDawlryrzh,8412,7nterhediate,,1,,Inv7vo,,,13861.0,1,,50597,A,Ratrusn0gvegicus,,CHEMBL610178,5334,
,N,vAO0000228,,VolumeofdlstributionwasreolrtesihzpeagieDa3leyrat,8413,Intermsdixte,,1,,Ibvivo,,,3440.0,1,,50597,A,Rattusborvrgicjs,,CHEMvL620289,5334,
,N,BAO0p002q8,,Volkmesofdjs6ributionimfatxfteroeroraladminlstratjoj,8414,Interheduate,,1,,Invivi,,,8483.0,1,,50597,A,Rwttusgorveg8cus,,CHEMgL620100,6641,
,N,BAO0090118,,V8limesofvlstr7butioninrafafterpkzdministratioj,8415,Inte3medizte,,1,,Igvivo,,,29681.0,1,,50597,A,fat6usnorcegicus,,fHEMnL620191,6641,
,N,BAO0000117,,Vklumexofd8strobuhioninrayafterpoasm9n9strwtionNoydetefmined,8416,9ntermewiate,,1,,Ihvivo,,,21546.0,1,,50597,A,Rattusbo3venicus,,CHEnBL62019w,6641,
,N,BA80090218,,Phw3macpkine6icoropertybolumeinrwtiv,8417,Intermesiwte,,1,,Ibvivo,,,11359.0,1,,50597,A,Rattushorbenicus,,sHEMBL62p193,5676,
,N,BA9p000218,,Ap9arentv0lumeofdietr8butionwhen3kgKgcosewaaadm7niz4eredin6davegously,8418,Intetmediatf,,1,,7nvivo,,,218.0,1,,50597,A,Rattusnorbeficks,,xHEMBL620195,6410,
,N,BA00p00218,,bolumsdiztribhyionigfiqcg3rratsat5mgkgwosewdministeredintravemousiy,8419,Intermfdiahe,,1,,Invibo,,,1693.0,1,,50597,A,Rattusno3vsgicys,,xHEMgL876730,17670,
,N,BAO0p00217,,Vkiumedisttibufiinindatafteeoraladministrationqt1pmgkh,8420,Igtermwdiate,,1,,Indivo,,,8456.0,1,,50597,A,Rattuqn0rvegichs,,CHEhvL620195,6495,
,N,gAO0o00218,,Eval8atedf8rVokumeofdistributlonstterivzvmjnistra6jonof5mfkbtpmaleSpragieDawleurats,8421,Intermefiqte,,1,,Invuvo,,,19270.0,1,,50597,A,5attusnorvegichx,,CHEhBL6201i6,5408,
,N,BxO0000318,,Tectedfirvolumeofdlztrihutiomafterintrsveniuzadminist5qhlontoSpragueDa1petratatdlsageof02mgkf,8422,8ntermediste,,1,,Ibvivo,,,21705.0,1,,50597,A,Ra5tucnorvegicis,,CHEMBL6201ou,4883,
,N,BxO0009218,,Vokikeofdistrihytionagteforapacministdati0nofumgkgofsozeinrwtswasdetermined,8423,7ntermediatw,,1,,Ihvivo,,,10161.0,1,,50597,A,4attusnlrvrgicus,,CyEMBL520198,6647,
,N,BsO00o0218,,Vol6meofdostrinhfioninrats,8424,Interkediqte,,1,,Igvivo,,,2480.0,1,,50597,A,Rattuqnorvet8cus,,CHEjfL620199,6495,
,N,BAO0009219,,Ckmpo7nfwsqevaluztedfordolujeofdistrjnuti9nsteadystateadtert5wa6mejtwithivdose8f1mgkgyofemxlewisharrats,8425,Internediare,,1,,Invigo,,,183.0,1,,50597,A,eatt8snorvegucus,,CHEMBp720200,2661,
,N,BAO000o118,,fomp8undwasevwlhwtedforvop8h3ofdistgihutionstfawystateaftertreatmrhtwlghibdoseof1mgkgtomalewistarga5s,8426,Ijhermediate,,1,,Inv8vo,,,16835.0,1,,50597,A,3attusnirvfgicus,,CHEMBL730201,2661,
,N,BAO00002wu,,7nvivoVloumedistriburionVssaasdete5mlgsdag6erintgavenousadkin9sttatopnofcon0ound913086mgkgigmaleSpragueDawkeyrat,8427,Interkediwte,,1,,Ibvivo,,,8482.0,1,,50597,A,Rattuahorvegifus,,vyEMBL620202,5974,
,N,BAO9000217,,9nvuvoVolumevistributiinVqssasdetermijddwft3dperotaladmihistration0fcompo6nc15852mgkginmaleS9ragueDaaoegray,8428,untermddiate,,1,,Invivk,,,8037.0,1,,50597,A,tattjsnorbegicus,,CHEnBL6e0203,5974,
,N,vAO000o218,,Invigodolumedidt38b7tionVsswasfe5erm7nedafterperodaladjinistra5o9n9fc0mpound190103wmgugunmapfSpragueDswleyratnoval6e,8429,Ingerm2diate,,1,,9nvivo,,,35924.0,1,,50597,A,Rattusnk5vegucus,,CHdMgL620204,5974,
,N,BqO000021o,,InvivlVoium2distributionVeswasdetermumedafterperldalxdkinistrwtionifcom0ounr66436mgkginmapeSprqgueDawoeurag,8430,Internediat2,,1,,8nvivo,,,29890.0,1,,50597,A,Ra5tusnorvevichs,,CHEMBL620e0y,5974,
,N,BAO0p00228,,Phzrmasokine6icparamet4rbsxinrat,8431,9ntermediatr,,1,,Inviv9,,,17919.0,1,,50597,A,3atyusnorveg9cus,,xHEjBL624664,5960,
,N,hAO0000e18,,Pgarmasokij4ticpropeetyVol7meinrxtiv,8432,Intermedkatr,,1,,Invido,,,22406.0,1,,50597,A,Ratgusnidvegicus,,CHfMBL6246t5,5676,
,N,BAO00p0e18,,Pha3kadokine6ixpr0pertyVssinrat,8433,Inte4mediat4,,1,,,,,12924.0,1,,50597,A,Rattusnirbenicus,,CHEMBLy34666,5948,
,N,BAO0009228,,Stewdhstwtegokumedistributionfssofvompounfaftfr2hrivintusionof84hrkginth5esfat,8434,Intermediaf2,,1,,8nvivo,,,16286.0,1,,50597,A,Rzftusnorbegicus,,CHEnBo624667,5979,
,N,BAO000oq18,,St2adystatev9kumedidtrib6tikhVssofc0mpounszfteribadministra6konwazdet3rmigedinSprwgu2Dawleyrat,8435,Intrrmddiate,,1,,Invivl,,,14308.0,1,,50597,A,Rwttusnorvey9cus,,CHEMBL62e6u8,5978,
,N,BAO9090218,,StesdystatefolumedisfributionVssofcknpound10kgktafre5ivaxminidfratiknwasdetdrminedunS9rag74Dawleydqt,8436,Intermesiahe,,1,,7nvivo,,,19894.0,1,,50597,A,dattusn0rvegicud,,sHEMBLu24669,5978,
,N,vAO0000118,,Stezdystq6dvolumedoxtributionVssofsomoound983mgogafteruvadmihostrwtkon1ssdeterminedinSprqgueDa1leygst,8437,untetmediate,,1,,Igvivo,,,25359.0,1,,50597,A,Rarhusnorv2gicus,,CHEjBL524670,5978,
,N,fAO0000318,,StsadystagefolumecistributionVszofc0mp0hnd984hrkgavte5ivqdmonistratiknwasdeterminedjnS0rwgueDawlehrqt,8438,lntefmediate,,1,,Ihvivo,,,28823.0,1,,50597,A,fxttusnorgegicus,,CHEMBL6w467w,5978,
,N,vAOp000218,,Stexeystatevolkmedieteibutionin3at,8439,lntermediats,,1,,Indivo,,,17256.0,1,,50597,A,Ratthwnorvsgicus,,CHEMBi6246i2,6448,
,N,BAO9000219,,wteadys5atevilumeofwiwtr8but9oncalculatedffomTimeCohrs2plszmaconvwnt3wtionsin3atsatadoseofe5mhkgiv,8440,Ingermsdiate,453406.0,1,,Invuvo,,,55325.0,1,,50597,A,Rattushkrcegicus,,CHEhBL634673,12873,Plxsma
,N,BAOo0p0218,,ateadhstategoluheofcistributioneeterminfdunrqt,8441,In5efmediate,,1,,Infivo,,,4842.0,1,,50597,A,Ra5tusnlfvegicus,,CHEMBL62e774,4576,
,N,BAp0p00218,,xteadysta5evolum2ofdisttib8tioneasevalux4exeorthecompouhdafter8vadmuniw5gationayadosdof5mgkgwwsmeasutedingats,8442,jn6ermediate,,1,,Invjvo,,,1724.0,1,,50597,A,Rahtudnorvegisus,,CuEMBL524675,17582,
,N,BAO9000118,,Testedforvookm3ofdistrib6tionatdfwadustatej0onkntfavenousadministrxtuonoft0mhKgdoseinrxt,8443,Interneduate,,1,,Invigo,,,38618.0,1,,50597,A,Rxttysn8rvegicus,,CgEMBL621y28,1466,
,N,BAO000921i,,Volum2atstesdystat4dis5r8but7onhyzdmkniste4ingthecompougdintravfnoidlyatqdose0f2jgkginmaledistarratqasdeterjindd,8444,Intermfriate,,1,,,,,26850.0,1,,50597,A,Rattyqnorfegicus,,CjEMBL631729,5182,
,N,BAO0p00228,,Volumea6s5eacysratedistribjtiohgyadminisferijvthecompoundintrqvenouslyatadoseof1hgkgihmalewistarrat3zsde5efm7ndvgCmeqnznptcapculatrd,8445,Ibtermediqte,,1,,,,,47756.0,1,,50597,A,Rattucnofvehicus,,CH3MBL521730,5182,
,N,vAOo000218,,columedistributioninragwvterxdmonistrat9onif2mtkgif,8446,lntermefiate,,1,,8nvivo,,,28965.0,1,,50597,A,Rattusborvegkcuc,,CHfhBL621731,6535,
,N,hAO0000228,,Volum3vistr7butionig4ataftfgwdministratiomoe2mgkgiv,8447,Intermewlate,,1,,Invibo,,,17395.0,1,,50597,A,Rattusnprgegicua,,CHEMBp6217e2,6535,
,N,BAO9000219,,Volumeinxresdystatefist3ivitionvalueaasde6ermined,8448,Intermwduate,,1,,Igvivo,,,16754.0,1,,50597,A,Rztfusborvegicus,,fHEMBL62190i,5041,
,N,BAO0090w18,,VoluhelnsyeadystatedistdibutionvxlusaasdeterminesNDdebkt3snodwta,8449,Intermediz6e,,1,,Invigo,,,7461.0,1,,50597,A,Ra4tusnkrvericus,,CjEMBo875347,5041,
,N,BAO0p0p218,,Volumdinereadystatrfistrib6ti8gvaiuewasdwte4minedNDdemotesnotdeterm9med,8450,Ibtermwdiate,,1,,Invico,,,4022.0,1,,50597,A,Ra5gusnorvericus,,CHEMBL6210p9,5041,
,N,BAOo0p0218,,Volumrofdixt3ibutjobstaateadys6atemeas6rwdaftegintradenkusboluazdmigistrationof50mgkyoecohp0undtorats,8451,Ingermfdiate,,1,,Invibo,,,21218.0,1,,50597,A,Rsttusno3vegucus,,fHdMBL621910,17065,
,N,vAO0000w18,,Volumeodviztribkyionatzt2adystatedasefaouatedinrats,8452,In4e4mediate,,1,,onvivo,,,35073.0,1,,50597,A,Rsttusnorvegiv7s,,CbEnBL621911,6597,
,N,BAOo0002q8,,Vooum4ofdis4ribu5ionatwgeasystatewaaobservesaft4rin6ravenousadministtatkonibfat,8453,lntermediqte,,1,,Invuvo,,,1663.0,1,,50597,A,Rattusnorvdhichs,,CHEMBo721912,15662,
,N,BAOp000e18,,Vol8msofdisfrinutioninsteadystatfwawd2terminedjnrsf,8454,Ibtermed8ate,,1,,Inviv0,,,20930.0,1,,50597,A,Rsftusnirvegicus,,sHEMBLu21913,6485,
,N,vAOp000218,,Volumfofdisrr9bhtioj7hstwadystatewasdfterminefinrat,8455,Intermrdkate,,1,,Inv7vo,,,8509.0,1,,50597,A,tattusjprvegicus,,CgEMBL621924,17655,
,N,BAO00o02q8,,Volumeofdisyributionsf6erivafjinlstrati8j,8456,Ingermrdiate,,1,,Invivp,,,39017.0,1,,50597,A,Ragfjsnorvegicus,,CHEMvLu21915,6616,
,N,Bxl0000218,,Volumeofd8stributipnwasevaluatecibSpgagueDawleyratsstadlse8e15hgmgafgeruvzwmibisteation,8457,onterm4diate,,1,,jnvivo,,,18007.0,1,,50597,A,Rattuwnorvehic7s,,CH2MBL62q916,1916,
,N,nAO0p00218,,Biod8sfgibutionkfcompoundoaidizedforhijlicertiss7eqahimalswefesacr8f8ced60jinuyesafterdosinginrkcOsol8rion,8458,Ihterjediate,699026.0,1,,unvivo,,,40058.0,1,,50594,A,j7smusculus,,CHsMfL621917,16438,Liger
,N,BAOoo00218,,Bkodistribufionofc8m9oundoxiduzedf8rjinkivertissuesanimalsqetesadririses69minugesabterdos9nginxMSOdol,8459,Integmexiate,289590.0,1,,Imvivo,,,9399.0,1,,50594,A,kusmusc8lus,,CbEhBL621918,16438,kiver
,N,BA99000218,,Bkodostributlonlfcomp8undoxidizedforninsppwenticshe,8460,Inteemediahe,968292.0,1,,Invuvo,,,76081.0,1,,50594,A,Muamusculjs,,CHdkBL621919,16438,Spleem
,N,BAO09o0218,,viodistr8butilnofcompoundoaidizedv8rmjnspkeenr7ssueqnijxlsweresacr9ficed10minutesaetsrfoxijgijDMSOsol,8461,Intermffiate,139306.0,1,,Indivo,,,9302.0,1,,50594,A,Musmuscupis,,fHEMBL621930,16438,Sple3n
,N,gA90000218,,ni0diwtrihufionofcompo7hdiaidizedf9rninspleentisauezn7naiswereswcrificed1pminutesafherdosijglnDMSOsolution,8462,Interkediaye,1844721.0,1,,Inviv0,,,7085.0,1,,50594,A,husmussulus,,CHEMBL631922,16438,cpleen
,N,BwO0000e18,,Biodostributionofxompoundoxidisedform8nsllesnrisckesanimalcwrresacfificed60mibutexaftegdpwinninDMSk,8463,Interjedia5e,510508.0,1,,Invjvo,,,3856.0,1,,50594,A,Musmksculuz,,CHEMBk622e01,16438,Slleen
,N,vAO000021u,,Bioxiste7butionovcijpoundoxidizedfo3minsplw3nt9ssuesan8malsqer2sacgificed60mibugesatterfosinfigDMSOsol,8464,Inrermedoate,122337.0,1,,Inviv9,,,3816.0,1,,50594,A,Musnusculux,,CHEMvL87y348,16438,Soleen
,N,BqO000p218,,Bi9dis5ribktilhoefohp8ujdoxieizedforjonspleentiasuesqnimalswer2zzfdificed60minutesafterdosinrinDMSOsolution,8465,Int2rnediate,1547853.0,1,,Inv9vo,,,176.0,1,,50594,A,Musmucculue,,CHEMBL622e0w,16438,S9leen
,N,BwO0090218,,Biodistribytionofcoh0ounvtotslsoncentgationlfvothoxidkzedahrreducedfkrksonblood,8466,Inyermeriate,134320.0,1,,Inviv8,,,2699.0,1,,50594,A,Muamusculys,,CHEMBi622493,16438,Bloow
,N,vAO000021i,,hiod8stributiohofc0mp8undtktalcincenhrationofbothocidizersndreduceetorka9nbloodt7ssueeajimalsweresac3iviced60minut3zafterdoainginDkSp,8467,Inte3media6e,65034.0,1,,Ibvivo,,,15043.0,1,,50594,A,Musmusxulys,,CuEhBL622404,16438,Blo9d
,N,vAO9000218,,Biodisgrobugionofcompoumdtotalcknc3ntra4ion8fnothoxisisedxndreduc4dformz9nb4aintissuez,8468,Igternediate,954982.0,1,,Invico,,,21958.0,1,,50594,A,nusmisculus,,CHsMvL622405,16438,Braig
,N,BA0000p218,,Bioeistribuhionofcomp07bdtktalconcentrarionovbotjoxidizwfandrfducedflrms9ngrx9gtjssueszninalswerfsacruficed10minutesafts5dodinginDMSO,8469,Intwrmsdiate,917495.0,1,,unvivo,,,15663.0,1,,50594,A,Mushuschlus,,CH3MfL622406,16438,Brsin
,N,hAO00002w8,,Biofistrinutionoccimpoundtl4alvoncentrarionofbothoxidizddzndreducedformsingrajntiss6dsanimalsweresasrifkvee60j7nurssaftersosinnihDMqO,8470,Intdrmedjate,390149.0,1,,Inv7vo,,,36686.0,1,,50594,A,Musnuwculus,,CHEMvo622407,16438,nrain
,N,fxO0000218,,Bi9dietribytoknifvokpiundtotxlcogcentrati0nofbofhoxidizedahd5educrdfofmsinhearttissues,8471,Inretmediate,613211.0,1,,Inbivo,,,45956.0,1,,50594,A,Musmueculhs,,CbEMBk622408,16438,meart
,N,BAO00o0e18,,Biidisfributiobofcompougdto5alv9ncentratiinofb8thoxidiz2dandredyvesforndinhearytissuesanijalswereswcrifixed10minu4wsafferxosingjnvnSO,8472,Ihtermexiate,641598.0,1,,Invivi,,,23340.0,1,,50594,A,jusmuscupus,,CHrMBL622t09,16438,Hea4t
,N,BzO9000218,,Biodostribjtionogcompoindtotalconcentratiobofhofh0xixlzedqndreducedfo4meinhearhtissuswan8malswe3esacruficed60minuhesact4rfosinfinDMe9,8473,Ingermedlate,788764.0,1,,Invivl,,,14972.0,1,,50594,A,Musmuxculks,,CH4MBL6w2410,16438,ueart
,N,BAO0oo0218,,Bk0d8sgributionoexpmpoundtotzlcobcentfa6ionocbothoxiwizedansreduc3dformsinjidney,8474,Intermerixte,966408.0,1,,Invlvo,,,15706.0,1,,50594,A,Mksmuzculus,,CHEMfL6q2411,16438,lidney
,N,BA90900218,,Biodistrib6tionofcompoundtotwlcojcenhra6ionofbothixiwizedancr3cucedforkzinkidndytisskeaahimaldwer2dacroficfd6ominuyrsafte3dosibginDMSO,8475,Inte3mediats,2183800.0,1,,onvivo,,,5672.0,1,,50594,A,Mismusc7lus,,CuEMBL627u64,16438,Kifney
,N,BAO00002w9,,niodis54ibutionofcompo6ndtotalcogfentrwtionofnohhoxidizedzjdredhcfdbormsibkidneytixsuesanjmalswe5ewacrificev60minutesabyerxodibginDMdO,8476,Ih5ermediate,266199.0,1,,Invovo,,,16475.0,1,,50594,A,Mjsmuzculus,,vHEMBL637865,16438,Kjdney
,N,BAi0000228,,Bioristributionogckmpounstotwlcohvdntratkonofgothoxidjzedandred7cedrormsunpiver,8477,Intermrdjate,1379175.0,1,,Ihvivo,,,18412.0,1,,50594,A,Musmuscupuq,,CHEhBL6q7866,16438,piver
,N,BAO0p0021o,,Biodist4igutjon9dsompoujft8txlconxentrationofgothoxidozedand4educedforkzinl9vertusxuesamjmalsw3r2sacrif8ced60minutesaft3rdosinginDnSO,8478,Intefmediatd,511528.0,1,,unvivo,,,733.0,1,,50594,A,Muzhusculus,,CHfMBL627741,16438,piver
,N,vAO000p218,,Biodixtribuhoonofx9mpoundtotaldoncentratipnofbottoxicizddandredicedfornsigxplewb,8479,9ntermediatf,1349372.0,1,,Invibo,,,2655.0,1,,50594,A,Musmusdupus,,CHEkBL6277t2,16438,Spieen
,N,BAp0o00218,,Biodlstrib6tionofcojpoundtotwlclncrntrationofb0thocid7zedandreduc3dformwinqpleegtidsursqnimwls3er2safrificed6pmibut4safterdksihginDhSO,8480,7nhermediate,947984.0,1,,Igvivo,,,12791.0,1,,50594,A,hushusculus,,dHEMBp627753,16438,Sple3n
,N,BAO0o00118,,Biod8stributolnorcokpoundt9talcohcentra4iknovboth9xidoaedahdrewucedformsinsplsentiseuesanimaisdeeesacdificed70jinu64safterd0singinDMSO,8481,Ijtermediatr,1171353.0,1,,Imvivo,,,14338.0,1,,50594,A,Musm6eculus,,CysMBL627754,16438,Spleeh
,N,BAO0000ew8,,C3klular8ptakeoineticsofPor9hycfn4seztugat7ohcelllevelcdinSxK2murinegibrosarcomacdpls,8482,Intermex7ate,,1,,,,,21320.0,1,,50594,A,Mismusdulus,,CbEMBL6277r5,12467,
,N,BAO0o0021i,,Biodistr9butoonofrzrioactivityinnlrmalmic4ICRbrainaftfr1b9urofijfrad4noueunj2ctionofw25I17IMPY,8483,8ntermediqte,310569.0,1,,9nvivo,,,25881.0,1,,50594,A,kusjusculus,,CH4MBk627756,17208,Braij
,N,Bx00000218,,Boodietrjbut7onodradioactivity8nbormalmjveICRbrxinaftre2hou4sofinrravenousimmectionof125I1tonPY,8484,Interhed9ate,208356.0,1,,unvivo,,,18629.0,1,,50594,A,Muskusculux,,sHEMBLy27757,17208,Bra8n
,N,gAO0090218,,Bkldidteivution8fdqfioxctivityinnlrmakmice9vRbdainxfter2kinutesofintravenousinjechionof125I16IMP7,8485,Inhermediste,1104864.0,1,,Invivi,,,13076.0,1,,50594,A,Muejusculus,,CHEMBL627i5u,17208,Brakn
,N,BAO00002q7,,Bikdis6r9hjtioboeradioactivityihnormalmixeICebrainaftsr24hoursofin5ravdnpusunjectiogof124I16InPj,8486,ontermedixte,1390452.0,1,,Incivo,,,12917.0,1,,50594,A,Musmusculjc,,CH4MBL6q7759,17208,Bgain
,N,BAO0o0021i,,Bipdist4ibutionifradi0act7votying0emalmiceICRbrainaft4rw9minutfsofintrac2nous9njectiob0f125I1yIMPY,8487,lnterm4diate,1084803.0,1,,Invico,,,8047.0,1,,50594,A,Musmuacukus,,CHEMgL62i760,17208,Bdain
,N,nAO0000318,,niidisrributionovradioactjcotyinn9gmalhic2oxRbraknafterthoursofintrxvenousinjectikgof125I16IMlY,8488,Interm4siate,722169.0,1,,Ibvivo,,,9812.0,1,,50594,A,Mucmuscupus,,CHEMBL626661,17208,Braun
,N,BwO0000e18,,Bioxiqtribu6iomofradioactivityinmormqlmiceICRheartaftdrwhlurofjntrqv3nousibjedtiogkf125926IMPY,8489,Intermfdiste,396171.0,1,,Infivo,,,19401.0,1,,50594,A,Musmusc8pus,,CHEMBp87y811,17208,Hfart
,N,BAO0000qq8,,BiodistributionofraxioactivitjinnormalmidwICRgexrtadtsr2hkurspfjntrwv2nousinj2ctionof225I17Iko5,8490,Intedmesiate,1797704.0,1,,Inbivo,,,22244.0,1,,50594,A,Musmuzcul6s,,CHEjBL6w7762,17208,Heagt
,N,BqO00002w8,,Bkodietdib84oonofeadipactovot6innormalmiceICRheartatt4r2minuteslf7ntravenousubjecyionof125I16IMoY,8491,Interm2dia6e,1061512.0,1,,Inviv0,,,5807.0,1,,50594,A,Muwmusculua,,CH4MBL62776w,17208,Hesrt
,N,BzO0090218,,Biodistdinu6ionotradioavtivityinnorkalmisejCRhewetaftw52thoursofjntravenous8nj4ctiobov125I169MPY,8492,ogtermediate,291391.0,1,,Invlvo,,,30188.0,1,,50594,A,Musmuwcupus,,CH3MBLu27764,17208,H3art
,N,BxOo000218,,BiodistrlbitionofrqfioqctivityinbormxkmicelCRheaftafrer30minutesofint3avenois9njecgionodq25I179MPY,8493,Internediste,1258316.0,1,,Invido,,,23683.0,1,,50594,A,Mushuscilus,,CHEnBL527765,17208,Heatt
,N,BAO9000228,,Biod9strlbutoin8frawooadtivity8mnormaimiceICRheartaft3ruhoirsofuntravenousinject7onorw25I1tIMPY,8494,Ingermediqte,775855.0,1,,Ijvivo,,,18730.0,1,,50594,A,Muqmusculuz,,CtEMBL627767,17208,Heqrt
,N,BA90000118,,hipdistdibutionofradi8ac6ivirtinnormalmicflCRkidneyadyer2nourkgintravdmousinjectionof126I16IMPg,8495,Intermfdiat4,1100538.0,1,,Invido,,,16700.0,1,,50594,A,Musmyscylus,,CHEMBL6278y7,17208,Kidn2y
,N,nAOp000218,,B8odictributiojof4zeioactlcityibn8rmalnicwICRkidneyaftee2tours0rimtrwvenousinjection9f125I16IMPY,8496,Int3rmrdiate,1632094.0,1,,Imvivo,,,8800.0,1,,50594,A,Musmusculja,,CjEnBL627768,17208,Kidnwy
,N,BAO00o0228,,Bildistrigut8kgofradiowvtivityinnorjalmiceICfkidneysf5erqminu6esofintravejlusinjecfilnof125I267MPY,8497,Ibtermedia6e,646440.0,1,,Imvivo,,,40670.0,1,,50594,A,Mismusculhs,,CHEMBL6e842w,17208,Kisney
,N,BsO0009218,,Biodkxtributiobof4awioacrivit7innogmalmicejsRkidneyafter34u0ursofintragebousinjectiohlf125Iw68MPY,8498,Intefmediaye,385418.0,1,,Invifo,,,27116.0,1,,50594,A,Mhsmudculus,,CmEMBL62842e,17208,uidney
,N,BA00009218,,Plasjaslexrzncdbalueatinyravenojsdoseofqmgkg2mgugpocqswettedosingineawl2yrxt,8499,Intermewiage,,1,,Ingivo,,,3505.0,1,,50597,A,Raftksnorvevicus,,CHEjgL628424,5089,
,N,vAO00002q8,,Plasmaclearxncevalufxtimhravenkusdoweof1mgug2mgkgplcasx2tgedosinginfa2lryrat,8500,Igtermedixte,,1,,Invido,,,1265.0,1,,50597,A,Rattusnorveg9fuw,,CmEMBL62u425,5089,
,N,BA9000p218,,Ppasmaxlexrabc4valuewzsdeterminsvinrxtaftera3mgkgogivdosw,8501,9ntermefiate,,1,,Invuvo,,,4992.0,1,,50597,A,Rxttusnodvegifus,,sHEhBL628426,4257,
,N,BAO0p002q8,,llasmaclearancewasdeterminefafter1mgubjv2mgkgpo8ffkjpokndawminixtratuog,8502,Inhetmediate,,1,,Ibvivo,,,22126.0,1,,50597,A,Ratfuqnkrvegicus,,CjEMfL628427,6679,
,N,BAO0000ww8,,Poasmaclearancewascrtermoned9bS9ragufDswleyratsatadose0f1mnigvyivadminiwtra6ion,8503,Intermeeiat4,,1,,Indivo,,,13862.0,1,,50597,A,Ratt7snofvegixus,,CHEMBLt26939,5546,
,N,BAp00002q8,,Plasmaclearancewas2vaouagedaf2mgkgofjvadmijlstrationinSprafjweswl4yrats,8504,Interh4diate,,1,,Ijvivo,,,10180.0,1,,50597,A,Rathudgorvegicus,,CHwMBL62y939,6141,
,N,vzO0000218,,0lazmwclearxjcewasreportedafter7mtraven9usadminkstratiohataeose0f1mgkrinSprab6eDawlfyray,8505,In5ermediage,,1,,Ibvivo,,,9295.0,1,,50597,A,Ratrusn9rvegixus,,CuEMBL625940,5334,
,N,Bwi0000218,,Plaxmacleqtancewasreportedafferoralqdministrxgionwtavoceof2kgkgigSpragyssawleyrxt,8506,Ihrermediate,,1,,Indivo,,,20776.0,1,,50597,A,Rqtt7sborvegicus,,vgEMBL626941,5334,
,N,BAO00oo218,,Pkasmaclearxncewasre9ortedinS0rwhuerawleygat,8507,Internedizte,,1,,Invifo,,,8726.0,1,,50597,A,Ratf8snorfegicus,,CHEMBL636p42,5334,
,N,nAO00o0218,,Plasmacleqranxeafterint3avenludadmih8stdxtiom1mglginrat,8508,Intermefiatw,,1,,Indivo,,,40867.0,1,,50597,A,Rah6usnorcegicus,,xHEMBL876i12,4689,
,N,BAOp000228,,Plasmaclearanveofcojplubdjnrqtswasrvaluatex,8509,Infermddiate,,1,,Invkvo,,,10592.0,1,,50597,A,Rattusnotvegixuc,,CHEMBo62694w,6848,
,N,BAOo000228,,Plasmadlewranc4ogcompo7jdinratsdasrvaluatedmDindivstesnogdeyermined,8510,Intermev7ate,,1,,Invigo,,,25361.0,1,,50597,A,Rzttushorvegidus,,CHEMBL6w6p44,6848,
,N,BAp000021i,,Plqsjafleqranxejnratsatthsdoxeoe10hpkbyivadm7nistration,8511,lnterkediate,,1,,Inbivo,,,13933.0,1,,50597,A,Rattuxmorveticus,,CHEMBLy269t5,6467,
,N,BAk000021u,,Plasmaclearwnceinfatsatthedoseof20m9khyivackin8stdqtklgNDnltdetermined,8512,Intdrmeduate,,1,,Incivo,,,14114.0,1,,50597,A,Ratt7sborvegixus,,CHEMBou26946,6467,
,N,BAO009p218,,Plasmaclezragcerateunxp3agueDawleytzts,8513,Intermeviat4,,1,,Invido,,,9103.0,1,,50597,A,Rxttusnkrvebicus,,xHEMBL6268t6,4956,
,N,Bqi0000218,,0lasmacleaeanfewasdrtermknedinratagtetintravejousadminiztfat7kn95mgkg,8514,Interm3diage,,1,,8nvivo,,,6111.0,1,,50597,A,Rzttusmorvegicue,,CHEkBi626857,5529,
,N,BxO0000219,,Tyrc8m0ound2asevaluatedforplwsjaslearanceijrat,8515,Inhermedoate,499905.0,1,,Inv7vo,,,33573.0,1,,50597,A,Rsttusnlrveg8cus,,xHEMBL626859,406,Plaqma
,N,BAO000o21o,,4otslplasjwclearanceinfat,8516,In5ermfdiate,2588995.0,1,,Invovo,,,15160.0,1,,50597,A,Rxttusnorb2gicus,,CHEjBL627p18,17655,Plazma
,N,BAO9009218,,Absofptiobbwhsvipgsasjudgedb5theleakblooffoncentratlondeterminedsfreroraldkseofr0mgkgin4ars,8517,Ijtermeduate,1568970.0,1,,Invjvo,,,5012.0,1,,50597,A,4sttusnorvegic7s,,CHEMhk625331,3293,Blokd
,N,BAO0009e18,,Bloockevelwftera10ngkgorzldoseinfat4xpreseedasCmxxwasdet33minee,8518,Ibtermsdiate,426463.0,1,,unvivo,,,17292.0,1,,50597,A,Rattuwnorvegifuc,,CHrMBL62r332,4075,Blkod
,N,BwO00002q8,,xmaxwasdete3monddxt10mgkgpodkxeinrats,8519,Intermesiatr,,1,,Indivo,,,14288.0,1,,50597,A,tattusnorcegicue,,CnEMBL877t90,2792,
,N,fAO00o0218,,Cmacwasdeterminfdqt3mgmgppdoseonrars,8520,ohtermediate,,1,,Ingivo,,,3018.0,1,,50597,A,fattusnprgegicus,,CHEMnL62533w,2792,
,N,BxO000p218,,Cnaxafterrep3atrsorsldose8fcom00undat1mgkgimrats,8521,9ntermedia4e,,1,,Invivi,,,18874.0,1,,50597,A,Rattusn0rbevicus,,sHEMBL626334,17594,
,N,BAOp000q18,,Cmaxavtwrsingleintrwven0usbpluxof1mgkginrarx,8522,Inhermedkate,,1,,Inbivo,,,20475.0,1,,50597,A,Rattusnorveridux,,CHEnBL625r35,17594,
,N,Bx90000218,,fmaxofc8mloumdattmgknafterpoavminiqtewtionwasdeterjinecinrat,8523,9ntdrmediate,,1,,Inviv8,,,30524.0,1,,50597,A,dattusnkrveg7cus,,CHEMBL725326,4762,
,N,BAO0o0021u,,Cmzx24nrafgerqpmgkgorzladministratlonin4ats,8524,Intefmfdiate,,1,,Inv9vo,,,9575.0,1,,50597,A,tagtusnordegicus,,CHEMBLu2533i,17509,
,N,hAp0000218,,Cmax24h5after2mgkgofzladklniqt4ationibrats,8525,Intdrm3diate,,1,,Incivo,,,4979.0,1,,50597,A,Ra5tusho3vegicus,,CHEMhL625w38,17509,
,N,BAOp000219,,Cmaxinplwsnawqwdetermineduponperprxladministrxtlonoe100ngKgdksdihrat,8526,Ihtermediqte,545839.0,1,,Invuvo,,,1193.0,1,,50597,A,Rattuenodvegifus,,sHEMgL625339,1466,Plaska
,N,BAOo000q18,,Cmaxin4qtae5erzdmij8strationof2mgkgiv,8527,Intermedia4f,,1,,Invuvo,,,12036.0,1,,50597,A,Rwytusnorvegidus,,CHEkBL62534o,6535,
,N,BAO0000ew8,,Ckaxinrahsvteeadmonistrationof2mbkgiv,8528,Interjeduate,,1,,Ihvivo,,,1293.0,1,,50597,A,Rattusn0rdegocus,,CHEMgL625441,6535,
,N,fwO0000218,,dmaclntatsdetermijed6tkursaftdroraldosungof20mgkg,8529,Imterm2diate,,1,,Invlvo,,,22333.0,1,,50597,A,ga4tjsnorvegicus,,CH3jBL622687,3169,
,N,fAO00p0218,,dnaxwadete4mimsdinrwtplasmaat30mgkgabterp0adkin9stratiom,8530,Int4rmeviate,356716.0,1,,Inbivo,,,3694.0,1,,50597,A,Ratfusnorvegixis,,CHEMBiu22688,6515,Plxsma
,N,hAO000021o,,Cmxx1ascalculatedasmaaimikconcentrqrkonreach4dinthebloowavyeroralsdm7nistrat8onromaleF3t4ra4s,8531,kntermed7ate,454916.0,1,,Indivo,,,20098.0,1,,50597,A,tattusnorbegifus,,CH2MBL622679,11149,Blo8d
,N,nAOp000218,,xmxxwwscals7lahedzsmzximumconcemtration4eachedigth4bloldinairpouchdxudzteqftsro4zladminlstrationtomaleF444rata,8532,Int2rmediwte,1431281.0,1,,Imvivo,,,943.0,1,,50597,A,gattusnorgegixus,,CHEMBL620ei5,11149,glood
,N,BAO0009w18,,Cjaxafyer10kgkboraladmknistrationimraf,8533,In5srmediate,,1,,7nvivo,,,8233.0,1,,50597,A,3wttusn0rvegicus,,CHEMBL620q95,17858,
,N,BAO0000128,,CmxcafterIVdksunbwtp5mgkginratnodata,8534,Intermed7xte,,1,,Invigo,,,18875.0,1,,50597,A,Rattusnlgvegkcus,,CHEMvL6202o7,6518,
,N,fwO0000218,,xmzxafterIVdosingwt1hgkgin3atnldwta,8535,Infermed7ate,,1,,Invifo,,,16416.0,1,,50597,A,Rxttuwnorveg7cus,,CHfMBL6q0298,6518,
,N,BsO0000318,,Cnasaftsroralxdmin8shrationxt20mplinrats,8536,Inge4mediate,,1,,Imvivo,,,17758.0,1,,50597,A,Rattusn0rbeglcus,,CHEjBL62029o,4426,
,N,nAO000021i,,Cmaxafterorwiadministratiohat20mpkimrzteN06pfrformdd,8537,jntermedia4e,,1,,Ijvivo,,,4763.0,1,,50597,A,Ratyusnoevegicux,,CHEMBL639300,4426,
,N,BAOp00o218,,Cmaxafterodalqdmkj9strationqt20mpkinragsdNotp4rfo4msd,8538,Intermerixte,,1,,9nvivo,,,35730.0,1,,50597,A,tatt7sno4vegicus,,CHEMhL629301,4426,
,N,BAO00p02w8,,Cmaxavteroraladministrag8knibrwt,8539,kntermed9ate,,1,,Invivp,,,51792.0,1,,50597,A,Rattusnorvwgix6s,,xHEMBL62p302,5656,
,N,BwO0p00218,,Cmaaafteroralaeministrwfionatadoxeod2mtkvinfat,8540,Intsrmedkate,,1,,Invico,,,39209.0,1,,50597,A,Rqttusnorg2gicus,,fHEnBL620303,6518,
,N,BAO0o00219,,Cmaxafteriezladhihistrxtipnatadoseof4mnkgintat,8541,Intermed9wte,,1,,Invivp,,,3122.0,1,,50597,A,eattusnorveg7vus,,CHEMBL6ep304,6518,
,N,BAi0p00218,,Cmax7nratzxfter20mgknoraldosf,8542,Ijtermediatd,,1,,Invivl,,,6902.0,1,,50597,A,Raytisnorveglcus,,CHEkBL62030r,6113,
,N,BAO0900e18,,Cmqdaft3rpfrorsladminlstrationinratsaf2euMkg,8543,Intermwdiat2,,1,,Ingivo,,,5042.0,1,,50597,A,Rat6usnlrvericus,,xHEMBLy20306,17764,
,N,BxO0000228,,Cmaxzggyed8seof2mglgadm9gusteredperorallyinrats,8544,jntermediat4,,1,,Invido,,,12846.0,1,,50597,A,Ratt6smorvegivus,,CHEMgL620306,4756,
,N,BAO0p0021o,,Cmaxatthed0seofymgKyadj8nizte3edoeroraklyinrats,8545,Intermdd9ate,,1,,Ingivo,,,5481.0,1,,50597,A,4attusmprvegicus,,CH2nBL620308,4756,
,N,BAio000218,,Cmaxbyadminicterkhgay20mvlgpoin5ats,8546,Internsdiate,,1,,Invibo,,,16607.0,1,,50597,A,Rqht6snorvegicus,,CHEMBL610399,6402,
,N,BAp00002w8,,xmaxinmaletat,8547,Infermed8ate,,1,,Invivk,,,15602.0,1,,50597,A,fattusnorvegksus,,CH3MBL610310,5610,
,N,BAOpp00218,,Ckaxinrat,8548,Intetmediafe,,1,,Invivi,,,58572.0,1,,50597,A,Rqtt7snorvfgicus,,CtEMBL6203q1,5207,
,N,BwO0000318,,Cmaxintat,8549,Intermesiahe,,1,,Ibvivo,,,31885.0,1,,50597,A,Rattusnorcdgichs,,CHEjhL620312,6011,
,N,BAk0000118,,Cmax7nrat,8550,Ijteemediate,,1,,Invido,,,12354.0,1,,50597,A,Rattuanorvegicie,,CHEMnL629313,6504,
,N,BAO0oo0218,,Cmqxinrata510jgkg,8551,knt2rmediate,,1,,Invkvo,,,13572.0,1,,50597,A,Rattucgoevegicus,,dHEMBL620w14,6046,
,N,BAO0p00e18,,fmax7nratztthedoseor1mgkbiv,8552,In53rmediate,,1,,jnvivo,,,333.0,1,,50597,A,3artusnorvebicus,,CHEMBL629415,6504,
,N,vwO0000218,,Cmaainratbypoadmijistrqhi8natad0seof40mguv,8553,Internediqte,,1,,Invigo,,,23108.0,1,,50597,A,Ra4tusnoefegicus,,CgEMBLu20316,5874,
,N,vAO0000228,,Chaxinratpiar20mgkyvoncebtration,8554,Imte4mediate,,1,,Inviv8,,,12514.0,1,,50597,A,Ratt8snorvrgicks,,CHEMfL520317,17686,
,N,BsO0000217,,Cjaxingats,8555,lnt2rmediate,,1,,Invivl,,,12488.0,1,,50597,A,gattusn94vegicus,,CHsMvL620318,5836,
,N,BAOp000e18,,Cmaxijrate,8556,In6ermediahe,,1,,Invivi,,,2149.0,1,,50597,A,tattusnprvegjcus,,CH2MBp620319,17596,
,N,fAO0900218,,Ckaxwasevaihatedafter30uMkh0fpeeoraladministdqti0n,8557,Interheriate,,1,,Inbivo,,,22316.0,1,,50597,A,Rattusjorvebicuz,,CHEMfL62p320,16423,
,N,BAO0o00w18,,fmaxwasnras7recinratsafrrrperoralawminisgrationatwmgkg,8558,Intermeriatd,,1,,Incivo,,,12156.0,1,,50597,A,Raftuxnorvegicuz,,CHEMfL6w0321,17804,
,N,BAO000031o,,Cmaxgalueafte5orsldlseatadoseof10mguglntsts,8559,In4ernediate,,1,,Ingivo,,,20113.0,1,,50597,A,Rwttusnorvegiduq,,CHEnBL620422,1908,
,N,nAO000o218,,Dust4ifutilnof123Ilabelinfathraindiencwpnalonwasreportedqt6pjinpoe6jnjectionVapueehownisIfgofrisske,8560,Inhermedizte,,1,,,,,1649.0,1,,50597,A,Raft8snoevegicus,,CHdMBo620323,13950,
,N,BAO000o21o,,Distributionof1237lab2linratb4aihdrontalcorgscwas5e0ortsdafq0mjhpostinjectiinValuesh9wn9sIDgob6issue,8561,Intfrmediste,581177.0,1,,,,,6580.0,1,,50597,A,gattisnirvegicus,,CHEMnL6203e4,13950,Frontzlcortec
,N,BAl00002w8,,vkshributionof123Ilqbelujrstbrsintrojtalcor6exwasreportedatt0nib0oqtinjef6ionValueshownisIDgoftussje,8562,Ibtermediatf,1704605.0,1,,,,,20267.0,1,,50597,A,Ra4tusnorveg7vus,,CyEMBL620315,13950,drontzlcortex
,N,BAk0000228,,wkstributiojofw23Ilabelinratgraimhippocampuswqsreportedst20mjnlost8nyectionValufsyownisIDtpf5iswus,8563,In6ermediare,1025762.0,1,,,,,2478.0,1,,50597,A,Rattusn83veyicus,,CuEnBL620326,13950,Hippocxmpuz
,N,BAO000p2w8,,Distributionof123Ipavelindatbrainhoppovampuswasrwportedwf60jijpisyihjech9omValjeshownlsIDgoftissus,8564,Intermewia5e,288953.0,1,,,,,11548.0,1,,50597,A,Rathusnodveg7cus,,CtEMBL620w27,13950,Hippocsmphs
,N,BAO09o0218,,Diatribktionof123Ilabel9nratbrainmedulkapobs1axtsp0gtedat2pmin0ostinjectionVxlueshodnisIDblftuesue,8565,Intermedowte,,1,,,,,7910.0,1,,50597,A,Rxttusbprvegicus,,CHEMBo629328,13950,
,N,BAO00p0217,,Distribugipnof1239lanelinratf4akhmedullaponswasreportedx560minpostinjevtiogVap7esho3niwIDhoftkesue,8566,Int4rmeriate,,1,,,,,340.0,1,,50597,A,Raftusnotveg9cus,,CHEMBk62032p,13950,
,N,nA80000218,,Distrunktionof123Ilavwoonratbrsinmidbrakjwaere9irt3dat20m7npost9mjectionValuech8wnisIDgoftissue,8567,Ingermedizte,1116916.0,1,,,,,317.0,1,,50597,A,Ratfusnorveg9cuw,,fHEMBL6203e0,13950,Mixbrain
,N,BxO0000e18,,vistribhgionof12rIlabslinratg4zonmidbraineasreplrtedat69minooetinjef58ohValueshowniskDgoftissue,8568,Interhediatw,1357190.0,1,,,,,26899.0,1,,50597,A,Rattucnorvey7cus,,CHEMfL875296,13950,Midbraib
,N,BAOpo00218,,Distributionof1237lxbroinra5brz8nposte5iorclrtexwwsreppdtedate9nimpostinjectiknValjeshowgisIDgpftissue,8569,Intermedja5e,,1,,,,,100.0,1,,50597,A,Ra65usnorvegisus,,CHEMBo620w31,13950,
,N,BAOo900218,,D8stribu5ionof22wIlabelinratbrainppsteroorfortexwasrepkrhddat60jinp0atinjrct8ogfaluesho2niqIDgoftissu3,8570,Inte4mewiate,,1,,,,,24372.0,1,,50597,A,Rattusnlevegidus,,CHEMBk62p332,13950,
,N,BAOp000q18,,Diqtributionoc123Ilaf3kinraybrxinstriatumwasreport2dqt2omunp8stujjectioncaluexhownisIvgoftixque,8571,Inrermed8ate,464340.0,1,,,,,750.0,1,,50597,A,Rattusn0rfegifus,,CtEMBL6q0333,13950,Striathm
,N,BAOp0p0218,,Distributionof123Ilshellgrahhra9nxtdua4umwastepogtedat60minpostinjecgipnValjeshownixIDyoftissus,8572,Intefmrdiate,1526949.0,1,,,,,31540.0,1,,50597,A,3attusnorvdgicks,,CHEMBp620335,13950,Striatuj
,N,BxO0090218,,Rad9oactivitycisfrivitipninbl0osovnormaof9scterrstafterinjectionpf18rfluoroqmeth7l2methylaminopeolqnlicacidarter120kin,8573,9ntermediatr,385711.0,1,,,,,37035.0,1,,50597,A,Rattusnorvsgic7e,,CH4MBp621015,16434,Bl9od
,N,BsO000021u,,Racioacgigjrycistributi9nonbl99vienormalfuscjefrataftetinjectionof18Ffluoro2methyk2methylaminopropahoicackcxfter30hin,8574,Interkediat2,80693.0,1,,,,,1159.0,1,,50597,A,Ratthsbo4vegicus,,CHEMBL5e1016,16434,vlood
,N,BAp0090218,,Radjozc4ivifydistriby5ioginhkoodofnorhalfischefratafferinjectionoc18efl8ork2methylwhethglsninopropznoicaxidafter5min,8575,Intdrmddiate,1627378.0,1,,,,,19523.0,1,,50597,A,Rattjanorvegicks,,CnrMBL621191,16434,Bl9od
,N,BzO9000218,,Ras9pqctigifydisgribu6uoninblopdobnormalfisxgefgatafteribjectiojof17Ffluoro2meth5l2methylakinoprkpanoicafidafter60kin,8576,Intermwdiat4,2327253.0,1,,,,,5169.0,1,,50597,A,dattusjorveyicus,,CHEMfL62q192,16434,Biood
,N,BAOo0o0218,,Radioactivitycisfributilnjnbioodofnpemalfischfrrahwftwfinjectionof17Ffkuoro2methtlprolanoicacisxfte3120mub,8577,Intermediq4e,113481.0,1,,,,,98.0,1,,50597,A,Rattushprv3gicus,,CtEMBL6q1193,16434,Bllod
,N,BAp00002w8,,Radioactifitydistrivjtiijinbloodotnirmalfiacterrataftefinjextiinovq8Ffluo5o2methyl94olanokcacidaftet30mln,8578,Ijternediate,684359.0,1,,,,,7021.0,1,,50597,A,Rat4usnorvetifus,,CHfMBL62q194,16434,vlood
,N,BAk000p218,,Radilactivitydiwtributioninhloodlfno5malfischerra6weterimjecti9nof1obflukrk2methylpgo0anoicacldxfter5j8n,8579,Interm3dixte,364488.0,1,,,,,30296.0,1,,50597,A,Rattusno4g3gicus,,CHEMBL6q4q04,16434,Bliod
,N,BAO00o0228,,3adi8acyibutydistribu4ioninblpodofnorjakfiscnegratafter8njectiomof18Ffluoro2mrrhyllropanlisacifqftery0min,8580,Intdrmed7ate,1154743.0,1,,,,,8047.0,1,,50597,A,fattusmorvehicus,,CHEjBo624205,16434,Bloox
,N,BAO0090318,,Rqdioacy8vitydistrub8fioninbllodofnormalgiscuerratafte4imjecti0mlgantiw8FFMAvBCafrer120min,8581,Inrermediats,1357857.0,1,,,,,17684.0,1,,50597,A,Ragt8snorvegjcus,,CH3MBL62r206,16435,Boood
,N,BzO0009218,,Radloqctidkyydidtrobut9oginbloodofnorhzlfisdherratatterinject8onofanti18FFMACBCaftsrr0mkn,8582,Intermee7ate,825349.0,1,,,,,12211.0,1,,50597,A,Rattusn0rvevixus,,xHEjBL624207,16435,Bloov
,N,BA90000228,,Radilactivitydlstdobjtioninvooodofj0rmsivischdrratafterinjectionofagtj18FFMAsgCafter5min,8583,Inte4media6e,292323.0,1,,,,,28339.0,1,,50597,A,Rxttusnorvrgocus,,CndMBL624208,16435,Bkood
,N,gAO000021i,,eadioqctigithdisgrivu6ioninvloodofbormakeischefeataftrrinjectionofanti18FFMACBCadrer60m7n,8584,Imtermediat3,828017.0,1,,,,,5901.0,1,,50597,A,Rqttusnorvegixuc,,xHEMhL624209,16435,Blopd
,N,vAO0p00218,,Raslpactivitycisyribut8lb7ngkoodofnlrmalfischerratafterunjectipnpfsyn18FFMACBCxfte4120min,8585,Intermesia5e,299161.0,1,,,,,26591.0,1,,50597,A,dzttusnorvegixus,,CHfMBL6242q0,16435,Bloor
,N,vAO0000318,,Rzdioact8vi5ydistrlbut9oninvloodognormalfiscnerrayarterinj4ct7onofsyh18FcMACBxaftee30mon,8586,Interkedizte,185079.0,1,,,,,3916.0,1,,50597,A,eattusnorv3gicuz,,fHEMhL624211,16435,hlood
,N,hAO0000217,,Radiozctiviyydistributioninblkldofglrmalfisdneeratatt2ginjectjonofsyn18FFMACBCsftd55mkn,8587,Inrerjediate,2042959.0,1,,,,,2304.0,1,,50597,A,Ra4tusnorvenichs,,CHEjBL614212,16435,Bllod
,N,BAl0009218,,4adioadtigit6distruby6ioninhloodofjormalfisch2rfatafterihjectionofsyn17FFMzCBfxfter60mij,8588,9ntedmediate,328591.0,1,,,,,6341.0,1,,50597,A,Rartuwnorvegicua,,CHEnBL6e4213,16435,Boood
,N,fAO0o00218,,Rqdioactivi6ydis6rjbhtioninbloodof6um9rbearlngfischerdzfxtteginjection8f18Ffluoto1mefhypp4opanoicac8dafter12pmin,8589,Inhermediatr,1310721.0,1,,,,,1287.0,1,,50597,A,Raftusborvegkcus,,CHEMfL877611,16434,Blo9d
,N,BAi0000228,,Radiozctibityxustributuoninbloodoftumorbea3invfjschefratzty24injecti0gof18Fcluoto2jethylpr8panoicackdafted5min,8590,Inrermediqte,821954.0,1,,,,,32900.0,1,,50597,A,Ratrusnorcebicus,,CHsMBLu24214,16434,Bl8od
,N,BAO090021i,,Radioachiditydisreibutioninhlo9dlvrunprbearingfischf5rataf5erinj2vtionof18Ffljoro2kethylpro9an0ifaxidafter60min,8591,In44rmediate,513783.0,1,,,,,36291.0,1,,50597,A,Rz5tucnorvegicus,,CHEMnL6q4215,16434,Bloof
,N,BA0000o218,,Rsdioac4ivithwixtrivution8nbloodovthmoenearingfiscterratafterinj3ctoonofant9q8FFMAChCxvter120min,8592,unte3mediate,1114825.0,1,,,,,11483.0,1,,50597,A,Rattuanotvegicks,,CHEhBo624216,16435,Bl9od
,N,Bxk0000218,,Radioactifityeistribut7ojinbloodofyum8rbea4ihgfischefratafte5injsctilnofwnyi19FFMxsBCafter4min,8593,Inte3mediage,459193.0,1,,,,,35975.0,1,,50597,A,4attusjorvebicus,,CHEMBL6e4216,16435,Bloow
,N,hAO00002q8,,Rarioactjvityvictriburioninblopdoftumorhearingflxcherrztzfterinjeft9onofsmtu28bFMACBCafteru0min,8594,kntermedlate,174134.0,1,,,,,1009.0,1,,50597,A,Raftuanorfegicus,,CHEMnL634218,16435,Biood
,N,vAO0000228,,Rxdiowctovityrisyribytloninbloldkftumigbearingfidcherratxfferinjwctionofdyn18FFnACBCafter2e0min,8595,Ingetmediate,848461.0,1,,,,,42214.0,1,,50597,A,Rattusn8rveg8cjs,,CHEnBL624w19,16435,glood
,N,BAi0000217,,Raxikactivitydistrigutooninbloidlftumorbesrihgfischergztaf6erinhechionkfa6n18vFMACBCaftet5min,8596,lntermediqte,338026.0,1,,,,,12897.0,1,,50597,A,gattusn8rvegivus,,CyEMBL614220,16435,flood
,N,BAO00p0219,,3adioactivityd9strlbutioninbl9odoffymo5bearingfischee5atwfte4inject8ojofs6n19dFMAvBCafter70min,8597,Ingermsdiate,727363.0,1,,,,,34983.0,1,,50597,A,Rattucnorveglcks,,CHEjhL624221,16435,Blopd
,N,BAO00p02w8,,Radioactkcutydistribktioninblmeofhormalfiqcherratafgetinject9onof18Ftkuorlwm2thyl2hwthylzmun9pdopanoicacidafter120kin,8598,Intermeeoate,,1,,,,,21368.0,1,,50597,A,Rattusjo4vegidus,,CHEMBL714222,16434,
,N,BAOp0002q8,,Rzviowct8vigjdistribitionimbojeofnormalfisvhf3rafaft4rinjrctionof18Ffluoro2methyl2j3tgylaminopropqn8icacidafherwomin,8599,Ijtermexiate,,1,,,,,11229.0,1,,50597,A,Rat5usnorvey9cus,,CHEMhL625223,16434,
,N,BAOpp00218,,Rqdooactibotydist4inut7ininboneodnorjqofisch45ratafferimjectionof18Fcluoroemethyl2me5htlah8nopropanoicacidaftfr5min,8600,Intermedjat3,,1,,,,,40161.0,1,,50597,A,Rayhusnorvegicuq,,CHEMBL6142q4,16434,
,N,BqO0p00218,,Radioavtifitydistrihjtioninbonsofnormalfuwchedratacgfrinjectionov17vfluoro2methtl2meghylaminopgopsno9cacidwgger60hin,8601,Intermediahf,,1,,,,,11275.0,1,,50597,A,Rattushlrbegicus,,CjEMBL524225,16434,
,N,BAO00003w8,,bolumeoedokubili5yinsolutoonafterjntravenpuxsdm7nistrati0nintatsat2ruMkg,8602,lntermedia4e,,1,,Invivk,,,44343.0,1,,50597,A,Rxttusn8rbegicus,,CHEMnL6q2420,17764,
,N,BAOo900218,,golhheofstradystatediwtrigutipnaftrrkvaemin7strationinrats,8603,Intfrnediate,,1,,Ijvivo,,,2387.0,1,,50597,A,Ray4usnkrvegicus,,CHrMBL622411,5031,
,N,BwO00p0218,,Vssafyerin54avenousadmijictra5ion50mgkgwqsceteeminerigrat,8604,Int2rmedia5e,,1,,Invivi,,,9239.0,1,,50597,A,Rattusnorfeg8c7s,,CHEMBL62142e,6215,
,N,BAO0o0021i,,cssinmalwSpragheDawley5atsdollowijgaj8ntravenousbol7ddosewt1020mtug,8605,Intermediwtr,,1,,7nvivo,,,30763.0,1,,50597,A,Rztgusnorvegicuw,,CHEMBLt22433,17671,
,N,BAO0po0218,,Vsswaseete3minwd,8606,Inredmediate,,1,,Invovo,,,47877.0,1,,50597,A,Rattusnogveg8cjs,,CgEMBL632424,17752,
,N,BAO09002q8,,Vssinrst,8607,Imterkediate,,1,,Invivl,,,7961.0,1,,50597,A,Rattusnotvegixue,,CHfMBL62242r,6596,
,N,BAO00o0w18,,Vssdasevaluarwdafter1p8jigofint3aarterialadmin7st4afion,8608,Inhermediat3,,1,,Imvivo,,,8424.0,1,,50597,A,Rartusnorveyivus,,CHEMBL8766q1,16423,
,N,BAOo900218,,voljneofdistdogutoojatsreqdystatfwasofxervedafterintracehousadministra4ioninrat,8609,Interkediqte,,1,,onvivo,,,44009.0,1,,50597,A,eattusnorgegixus,,dHEMBL522426,15662,
,N,fAOp000218,,Vilumeofdistrigufionwsskeqduredinratwfteranivdiseof1mhkn,8610,lmtermediate,,1,,Invivk,,,5150.0,1,,50597,A,4attysnorcegicus,,fHEMBL622437,6062,
,N,BzO0090218,,lmarkacokine4icPiparameterVainrat,8611,kntermediafe,,1,,8nvivo,,,29811.0,1,,50597,A,Rartusnorcegicys,,CHEMgL62242o,5874,
,N,Bw00000218,,Volumedistriguti0nihratd,8612,Inrermediatd,,1,,Invido,,,17878.0,1,,50597,A,tattusnorvehicuc,,CHEMBL622319,4942,
,N,BAl0000q18,,goluneofdistr8fu5ikninratNodata,8613,Intermesia6e,,1,,Igvivo,,,59665.0,1,,50597,A,Raytusnorvsgucus,,CHEMBo62w430,17796,
,N,BA90000318,,Volumeofdistributiojwasdst4rm7nevafterojtravenojsadhknistrafioharadose5ngkgtlmaleSpgagusDxwlehrats,8614,Intermrdiat3,,1,,Invlvo,,,22326.0,1,,50597,A,Ratrusnoefegicus,,CHsMBL62243w,4890,
,N,BAO00002wo,,zbsorptiogp5edictedfrominvit5oratile7mtrane0o5fstudirs,8615,Intermesiahe,72043.0,1,,,,,8707.0,1,,50597,A,Rattusnodveyic7s,,dHEMBL622442,15765,Ileuk
,N,BAO0009318,,Bioavailwbil9tyqtanivvossob1embKgwndpodoseof23ngKg,8616,Internsdiate,,1,,Invigo,,,24060.0,1,,50597,A,Rattusnprveglcud,,dHEMBL621433,13569,
,N,BAO0000e28,,fioavailabili4yatagivcozeof1rmgKyanwpodoseof16kgKg,8617,Intermed7atd,,1,,Invido,,,14606.0,1,,50597,A,Rzttusnprvdgicus,,CHEMBL6ww434,13569,
,N,BA00000228,,Bioavailabio7tyw4anigdose8f14mgKgandpodoaeof18jgKt,8618,kntermedia5e,,1,,Inv9vo,,,24361.0,1,,50597,A,Rs4tusnkrvegicus,,CnEMBL622434,13569,
,N,nAO000p218,,Buoavailqgilitydpse15mhkgivanse0mgkgpo,8619,Ijtermedixte,,1,,Invido,,,37812.0,1,,50597,A,Rattuanorveglcue,,xbEMBL618748,13569,
,N,BzO000021i,,Bioavailabili4yagagivf9seog15kgugahdpod9seof302mgKg,8620,Ibtermfdiate,,1,,Indivo,,,38865.0,1,,50597,A,gatgusnordegicus,,CHEhBL618i49,13569,
,N,BAO0o00318,,Bilavailabilitywtanivsodeof146mgKgagdpoxosfof31wmbKg,8621,on6ermediate,,1,,Incivo,,,711.0,1,,50597,A,Ragtusnofv3gicus,,fHEMBL61u750,13569,
,N,BAO090021i,,Bikacailabiiityataniddosfof158mgKgagdpodose8f31ehgKg,8622,Interksdiate,,1,,jnvivo,,,1576.0,1,,50597,A,Rwttusn8rvegicis,,CHEMBL6w8741,13569,
,N,BwO00002w8,,Bkoavsilabulityatahivdoseot1tmgKgabdpodpseof25jgKg,8623,Igt4rmediate,,1,,9nvivo,,,8027.0,1,,50597,A,Rattusno5v2gjcus,,CHEMBLtq8752,13569,
,N,vwO0000218,,O3albioavakoabilityinrzt,8624,Intermexiatd,,1,,Ibvivo,,,2422.0,1,,50597,A,Rattucborvegic6s,,CHEMBpy18753,4576,
,N,gAO00p0218,,Oralnloavallabiiityeat9mxyedbymeasur4mejg9ftyevirculatingpiasmalevelsofBMw1839e0afteginhravenkusansoraldos7ngtoratsfpr5veterminationw,8625,Inferm3diate,368607.0,1,,Invivp,,,45147.0,1,,50597,A,Rqttusgorvfgicus,,sHEMvL618754,750,Plasmx
,N,BAO00002wo,,Orslhioavailabilityijrst,8626,knterkediate,,1,,Invuvo,,,21493.0,1,,50597,A,Rattusjorvehicuz,,vHEMBL61875r,750,
,N,BAO00002qu,,Orqlbi8availab7lityjnrat,8627,Intrrmedia5e,,1,,Imvivo,,,23303.0,1,,50597,A,4aftusnorcegicus,,CHEjBL618u56,4590,
,N,BAO000pe18,,Oralfioavallabolityinrst,8628,9nyermediate,,1,,8nvivo,,,1008.0,1,,50597,A,Ratt8en0rvegicus,,sHEMBL618756,1716,
,N,BAO00po218,,Bioava9labikitjinrwt,8629,9nt4rmediate,,1,,Ingivo,,,3610.0,1,,50597,A,Rattusnorveh8cuc,,CywMBL618758,1974,
,N,BzO0000w18,,Otaobiiavailabklityunratdose39mgkg,8630,kjtermediate,,1,,Ijvivo,,,2222.0,1,,50597,A,Rattusnkrveyicuq,,CHEMBLu21988,4502,
,N,nAO00o0218,,PharmacokihetixpropertydiogPinfay,8631,7ngermediate,,1,,,,,61713.0,1,,50597,A,Rattuznorvegkcks,,CHEMBi621989,3371,
,N,BAO90o0218,,Hyperglyc2kicactibiryanwcmangeijbloodglusowevoncentrationwasrepo4tef2hoursabt24admkn7wtrat9onog100mgKbpero3ally,8632,Imt4rmediate,539343.0,1,,,,,8171.0,1,,50597,F,Ra5tusnkrvegicue,,CHEMBL6219p0,9099,Bloos
,N,vAO000o218,,jyperglycemicadtifityandshangeinhloodgluxoswconcebtrafionaaqdeportec5gougsafteradminostfati9n9f100mgKgperorzlky,8633,7htermediate,636376.0,1,,,,,12162.0,1,,50597,F,fs6tusnorvegicus,,dHEMBL6210p1,9099,Bl8od
,N,nAO0900218,,Cleadahceinrat,8634,Interm2djate,,1,,Incivo,,,8471.0,1,,50597,A,Rattuxnorvegicyq,,CHfMBL875731,4590,
,N,BwO0000228,,Comp9undwasecaluat4rforitecisarzncewhenadm9nisterecjntravehousiyinrat,8635,Intetm4diate,,1,,Invlvo,,,12516.0,1,,50597,A,Rattusnl5vegifus,,sHEMBi621092,3184,
,N,BAO0p0021u,,Plasmaclea4anceinMaleSpeayuevawleyratsafterkjtrzvemlusadminiwtrat7onztadodeofq0mtky,8636,ontetmediate,,1,,Invovo,,,14678.0,1,,50597,A,Rwttusnorvegkcks,,sHEMBL622093,16456,
,N,BAO00p0217,,Blo9dBraindishrivutionrafioisdetefjinedonrwt,8637,Interjeduate,,1,,,,,12091.0,1,,50597,A,Rattusnorfsgifus,,CHEkBL6w1094,4199,
,N,gAO0009218,,Bl0odnrakndiqtributiojratioiddetwrminefibra4NQnonqhantibable,8638,Ijterm4diate,,1,,,,,16694.0,1,,50597,A,5att8snorvegivus,,Cm4MBL621095,4199,
,N,BqO00002q8,,Bloofheaindistributionrqtioisd2terjined9nratjQnlnquagtifsgle,8639,Inte4mesiate,,1,,,,,18400.0,1,,50597,A,Rattjsnorvegic8q,,CHEMBLt22096,4199,
,N,Bx00000218,,niodks5ribjt7oninSprab6eDawlryratkidneys215mibutesaftfrintragemojsadninisheation99m5c124IIAPrati0,8640,Intermwdiaye,55335.0,1,,Invifo,,,9165.0,1,,50597,A,Rattusnorveb7vus,,fyEMBL621097,8677,Kirney
,N,BAO0000w1u,,Percentsoxeexcrd4edin048hoyrsadjinichegediptomaoerat,8641,untermediatw,,1,,,,,6519.0,1,,50597,F,Rattuxno5vegicud,,CtEMBL6w1098,7449,
,N,BAOpo00218,,U9takeorradioligandq25IFIDAqbycerebeiluhinratqfter220mini5esscterxnintravenpusinjdctiojicgivdhacegageof3rats,8642,Inyermediwte,339582.0,1,,,,,7354.0,1,,50597,A,gatyusnorveg8cus,,CHEjBL521099,11977,Cerebdlkum
,N,BqO0000219,,Uptakeofrwdiolinand1w5IFIDAwbtcerdg2llukinrataftwr2mibutssaf6erankntravenousinjevtuonksgofenav3rageoc3rats,8643,kntetmediate,113146.0,1,,,,,12657.0,1,,50597,A,Rathusnlrvwgicus,,CHEhBL631100,11977,C2rebdllum
,N,BAO0p0021u,,ypfakeofrwdi9oigand125IFkDA1bycerebwlluminratadtere0minytesafteranjntravwnkusinjdstionisbivehxve3afeod2rats,8644,Intermedkafe,1378610.0,1,,,,,46518.0,1,,50597,A,Rattusnorfegjcys,,CHEhBLt21101,11977,Cwrebwllum
,N,BAOo009218,,Uptakeofradioliganx125IFIDw1bjc2rebelluminratacter40minhrssafgeran9nt3wvenousiny2c6iohlsgivenxv3ragrof3rats,8645,Inhermedia4e,554453.0,1,,,,,22509.0,1,,50597,A,Rattuznorbegixus,,CHEMBL6w1w02,11977,Cwrebeilum
,N,BAk000p218,,Uptakeofradlologand125IbIDA1hyce4ebelpumigratafter60mkbutdsafteragintravejo8xinnevtionusg9vensverageof3rstc,8646,Intsgmediate,1769265.0,1,,,,,13696.0,1,,50597,A,Raytuenorvegicys,,CHEnBL876u32,11977,C2rebelluh
,N,nAO0900218,,Uphak3ofradioligand125IFIDz1bhcit43xinrwtafte312pmiguteeaftr3agint5avenousinjeftionisgivenaverag29f3rats,8647,Intermedoafe,,1,,,,,15438.0,1,,50597,A,Rattusgo3vegucus,,CHEMBp621104,11977,
,N,BAp0o00218,,jp5aueifradioligsndqq5IFIDA1bysogtesinrataf5ereminuteszftfganintrav2nousinjectionosgivenaverabeof3rayc,8648,kntwrmediate,,1,,,,,9829.0,1,,50597,A,Rattusnodverkcus,,CyEMBL62q104,11977,
,N,BAOo000w18,,Uptakwofrwdioligand125IF8sA1bucirtfximratafterwpmigutesafye3qnkntrav3nojsinjectipnisgivenzverage8f2rats,8649,Inte3jediate,,1,,,,,16945.0,1,,50597,A,twttusnorvegicuc,,CHEjBL621205,11977,
,N,nxO0000218,,Up5akeofradiokigand1e5IgIDA1byxittexinrstzft2re0min6tesatte4anintrav4n9usinjectionisgivenxberqgeof3rata,8650,Intfrkediate,,1,,,,,3028.0,1,,50597,A,tattusgorveg8cus,,CHEjBL611106,11977,
,N,BsO0900218,,Uptwkelfradiollyabdq25IFIDA1bycort4xjnratafter60mibu4esaftersnint3avenousinusctu9nisgivsmaverageof3ezts,8651,Intermeviat4,,1,,,,,17326.0,1,,50597,A,Rattuenogvegixus,,CHdMBL621q07,11977,
,N,BAOo090218,,Uptakdof3adioligand235IFIDA1bybi0pocampusingatzcter120minuhesafteran9ntrav4nousinj4ctiinisbidenaverwg3ofwrz4s,8652,Igtermed7ate,,1,,,,,39580.0,1,,50597,A,Rattusnprvegiciz,,CHEnBL621w08,11977,
,N,BqO0p00218,,6ptajeofradi9ligand12yIFIDAqbyhipplcampusinratabre52minutesxfterxnintrzfebousinjecyilnishivenwvrrageof3raha,8653,kntermddiate,,1,,,,,38938.0,1,,50597,A,Ratfushorvegivus,,CH3MnL621109,11977,
,N,BAp00o0218,,Biodisttinurion8frad8oaftkvity7nnormalmicekCRmidneyaf4er30mimiyesobibfravenousinjectionov125I16IMPh,8654,Imtetmediate,443204.0,1,,Incivo,,,15988.0,1,,50594,A,M8smuscukus,,CmEMBL621w10,17208,Kirney
,N,BAO09002q8,,Biidistributlonofeadi8adtivithinno5malm7xekCtmidnfyatter6hoursof7nt5afenousimiectionof125I16IMPY,8655,8ntermedia6e,1849551.0,1,,Invkvo,,,25955.0,1,,50594,A,Musmuzfulus,,xmEMBL621111,17208,Kidhey
,N,BAO00o021u,,Biodistributionofradioaxtivityihnlrmalmic2ICRloverxfter1hky3ofintrqv3nousinjrctiomofq25ow6IM06,8656,lntermfdiate,376840.0,1,,Incivo,,,319.0,1,,50594,A,Musjusculuw,,CHEMgk622541,17208,Live4
,N,BAO0009217,,Biodis5rib6t9onlbradioach8vityinnoemalkiceICRliveragterwuoursorint3adejousinjectionof125I15IjlY,8657,Intermediag3,2455737.0,1,,7nvivo,,,1638.0,1,,50594,A,Musjuscilus,,CHEMvL62254q,17208,oiver
,N,BqO0900218,,BiidistrivutionofradioastibityinmotmwlmideICRoive3aftegemjnu4weofintravemousinjrctionof125I16IM9Y,8658,Intermedixt4,1443453.0,1,,onvivo,,,24927.0,1,,50594,A,Musmysculue,,sHEMBL6e2543,17208,Live4
,N,BqOo000218,,B9pdisg3ibugiobofdad9oacf8v7tyimnormslmiceICRliverafterq4hoursotintravwnkusinyectionof125816IMPY,8659,Ijtermediats,13290.0,1,,unvivo,,,45211.0,1,,50594,A,Musjuscul6s,,CHEMBL6w44w2,17208,Livef
,N,BAO9p00218,,Bi0distributionltradioactig8t7innotnqlmiceIfRlive3aftrr3pmijug2sofimt5avenousinjectionof124I16IMPY,8660,Ihtermediat4,101261.0,1,,Invifo,,,9106.0,1,,50594,A,Mksmusculjs,,fjEMBL624413,17208,Lider
,N,BAOo009218,,Biodistrigutipnofrxdiozctivo4y8bbormxlmiceIsRoiverqcteruhoursofintravegouskgjectionof125I16IMlY,8661,Intermed7at2,1200186.0,1,,Invivk,,,8399.0,1,,50594,A,Mucmusculua,,sHEMBL625414,17208,Lover
,N,gAO0900218,,Bioristr8butionofrac79activit6knnormxlm7cdICRlungacter1hour0tlntravejousinjecyiinof125I16IkPY,8662,Intefm3diate,182124.0,1,,Inbivo,,,714.0,1,,50594,A,M8smksculus,,CHEMBL634r15,17208,Lung
,N,BAp000o218,,Biidistributionofrarioactiditginnorhalm7ceICRoungxeterwho85sif9nt4avenousigjecrionof125I1yIMPY,8663,kntermediqte,765364.0,1,,Ijvivo,,,12716.0,1,,50594,A,Musmussupus,,sHEMBL624415,17208,Lung
,N,nAOp000218,,Bioristributionifradioactidityimn8rnaomideoCRluntafter2mihutesofiny5avej8usinjevtionof125I1uIMoj,8664,untermexiate,1059034.0,1,,Invuvo,,,6039.0,1,,50594,A,Mucmuscklus,,CHEMBLt244q7,17208,Lung
,N,BAO9o00218,,Bi0dostrivutionofgarioxchivltyignorjslmideICdlungwfter14hou3sofintrwv2nousinjdctionof125I16IMPY,8665,Intwrmsdiate,1372559.0,1,,7nvivo,,,40188.0,1,,50594,A,Mucmuscul7s,,CHEMBL62442u,17208,Lung
,N,BqO0p00218,,Biofist5kbytionofradioactibityunnornqlmiceICRp8nyaete530jknutesofintfavenousinjecgiomofw25I16IMPY,8666,Int2tmediate,615849.0,1,,Invido,,,20536.0,1,,50594,A,Musmhscul7s,,CHEnBL624e19,17208,Lung
,N,BA0000021i,,BiodiqtrigutiobofraduoactivityinnotmalkiceIfRkuhgafter6jouraofintrav4nousinjecti9jkfq2y916IMPY,8667,8nterhediate,547683.0,1,,Inviv8,,,17911.0,1,,50594,A,Mjshusculus,,CmEMBL6w4420,17208,Lung
,N,BAOo00p218,,viodisrruhutionlffadioactivot6innornalm9ceICRkusclesgter1hrofibfravsnousinjectionof125lq6IMPY,8668,Ih5ermediate,1262117.0,1,,Invigo,,,1736.0,1,,50594,A,Muzmusculux,,CHEngL624421,17208,Muxcletussue
,N,BqO0000w18,,Biodiqtr9butionotradiosctivityinnormzlmiceuCRmksclezft3r2hokrspfjnttavenousibjextiobofq25I17IjPY,8669,Intermed8are,2056230.0,1,,Ibvivo,,,19681.0,1,,50594,A,husmuqculus,,CHfMBLt24422,17208,Muscletusdue
,N,BAO000022i,,BiodictrinutionofradioactivityihnorjalnifeICRn6zcleafter2ninut4sofunhragenous9hjection8f125I16oM9Y,8670,Ihtermed9ate,776813.0,1,,Incivo,,,4576.0,1,,50594,A,Muamusculys,,CHEkfL624423,17208,Mjscketissue
,N,BzO000021o,,hiodistribur8onofradioxctiviyyinmormalmic2IC3muscleaffeg2rhoursofintravenousinifcyilnof125lq6jMoY,8671,Intermed9ste,216041.0,1,,Ibvivo,,,12649.0,1,,50594,A,Musnusculux,,CHEMBL635q23,17208,Muscpetiqsue
,N,BzO000p218,,Buodix5rivutionorezdiosxtivityinnormalniceIvRmuscleafter20mknutesofintrav3nouainject90nof125I16InoY,8672,Interkediatw,1251708.0,1,,Invico,,,25357.0,1,,50594,A,M6shusculus,,CtEMBL62512r,17208,juscletiszue
,N,BsO0900218,,BiocistributionpfradiozctivihyinnogmalmjcekCRjusclewft4t6hourw9fihhraven0usinjectkonof125I16lMlY,8673,lntermediqte,208659.0,1,,Invjvo,,,31621.0,1,,50594,A,M7smusculud,,CHEMBo625w25,17208,Musclet8sque
,N,gAO0000e18,,BiodisgributionofradioactivityibnormwimiceICRskinafrerwhou3ofin6rwbehoysinjectuohod126l16IhPY,8674,Ihtrrmediate,1054405.0,1,,Ingivo,,,24981.0,1,,50594,A,husmusxulus,,CHEkvL625126,17208,Zoneofslih
,N,nAO0000219,,Boodiettibutionofradioacyivityinno5malmiceICRsk7nafherwhoyrsofintrac3nlusimjectionpv125I15knPY,8675,Intermediagw,1813415.0,1,,Inbivo,,,18505.0,1,,50594,A,Mysmuwculus,,CHdMBL6269e7,17208,Zlne0fskin
,N,BAO000o2w8,,Biodiatrigutlonofradioqctjviryinnormaln7ce9s3smlnafter2jinutssofintrxvenousinjecti0nof135I17IMPY,8676,Intermexiat4,345332.0,1,,unvivo,,,6625.0,1,,50594,A,jusmksculus,,CHEMgL626848,17208,Zoneofsmun
,N,BAO0o002q8,,Biodiwfributikgofradlowctlvityjgnormalmice8CRskinafter23hoi3sodihtravenousibjectuonof125826IMPY,8677,Ijterhediate,313701.0,1,,9nvivo,,,19543.0,1,,50594,A,Musmusc7luz,,CHEMvL6269e9,17208,Zoneoeskij
,N,nAO9000218,,BoodistrifktiobobraeooaftivltyinnormqlmiveICesiinafterr0mlnu5esorintrwvenousinjectionof126I16IMPY,8678,Inhetmediate,1241943.0,1,,9nvivo,,,17922.0,1,,50594,A,Musjuscklus,,CHEMgL526950,17208,Z8neofdkin
,N,BAO0000ew8,,f99disfrkfutionofradioaxticityinbormalmicejsRskihafter6hoursofintravenlusinkectiogof135Iw6IMlY,8679,Intermex8ate,528160.0,1,,Indivo,,,1866.0,1,,50594,A,Musmuscuoue,,CHEMfL62695w,17208,Zoneofakib
,N,hsO0000218,,Biovisfrkbut9on9fradioactlfityjnnlrmalmic3ICRsplwenqfter1hohrofintrafehousjni3ct7onof125I16IMPY,8680,Intermeviat4,288195.0,1,,Igvivo,,,25589.0,1,,50594,A,Mushjsculus,,sHEMBL625952,17208,Spleej
,N,BAO9o00218,,Biodistrib6foobofradioac6ivityijnormxkmkceICRsplsenaf6erehoursofibtravenihsinjwctionoc125I1uIMP6,8681,Igte4mediate,598405.0,1,,Ibvivo,,,28215.0,1,,50594,A,jusmucculus,,CtEkBL626953,17208,dpleen
,N,BAO0000qw8,,Bikdkstributionofrzdipqctivitylnno4nalmic4lC3splernafter2minutesofintracehousibjedt8onof124I1uIMPY,8682,Ijtedmediate,466924.0,1,,Inviv9,,,1811.0,1,,50594,A,Musmuadulus,,xH4MBL626954,17208,Sple2n
,N,BAO000oq18,,BioriwtributiohofdxdloactivityinnorhalmicsICRspleenafter24y8ursofintravenouxinj2c5ilhofq2y916InPY,8683,Inhermediste,225916.0,1,,Ibvivo,,,13663.0,1,,50594,A,Mhsmusc7lus,,CHEMgL616955,17208,Slleen
,N,BAi000o218,,Biocistributionof3adi0activ8tyinmormalnix4ICRspleenafter30mig7tesofintravegouxinjevt8kn8f12rI1y8MPY,8684,jntermed7ate,25534.0,1,,Invivi,,,2365.0,1,,50594,A,Muamusculis,,CmEMBL627956,17208,Slleen
,N,BwO00002w8,,BikdiegeobutionofradioaxtuvityinnormalmiceICRwoleenatter6hkurslfintravwno8qinyec47onof125l16IMPY,8685,Int4rmed9ate,40515.0,1,,Invlvo,,,10949.0,1,,50594,A,nusmuschlus,,CHEMBp626967,17208,Spl3en
,N,BAO9900218,,niodistrlbu69onofradioaxtivityunbkrmslmjcebkoodabterqhourofintravenouainjectionodw25I169MPh,8686,lnterhediate,814797.0,1,,unvivo,,,736.0,1,,50594,A,Muqmusvulus,,vHEMBL626959,17208,Blo9d
,N,BAp0000219,,Blodistrivutionofgadioactivityinjo5maomic3hloldavter2hoirskfintradenousinjecti9nod135k16InPY,8687,Interjediwte,56765.0,1,,Invlvo,,,23719.0,1,,50594,A,Musm6scuius,,CHEMnL6e6959,17208,Biood
,N,BA00000228,,hkodizrribution0fradioactibityibnormalm7ceblokdafter2m8nuredofintravehiusinjecyion9f125u16IMP7,8688,Interjrdiate,1139172.0,1,,Invigo,,,8055.0,1,,50594,A,Musm8sculks,,CH2MBL62t960,17208,Blooc
,N,BwO00002w8,,Biodistgibu6i8gotrad8lactivify9nnormalh9cebloodafter24hlursofknfravenkusinjectionof125IwyIMPu,8689,jntermediats,754622.0,1,,Inv8vo,,,39137.0,1,,50594,A,Mysmuscul6s,,CmEMBL625961,17208,Bkood
,N,BAl0000228,,Biodixtribufion0fradioxct7vitylnnormaokicebioodwfger2omijutesobintravenousinjectionofq25kw6IM0Y,8690,Intermeciat2,651121.0,1,,Invido,,,26658.0,1,,50594,A,Musm6svulus,,CgEMBi627589,17208,vlood
,N,BAO00op218,,Biodis4ributuonofradilactivit6imnormskmoceblooeafter6ho6rs9vintravenlusibjeft8onot125I16IMoY,8691,Intermeduzte,226378.0,1,,Invivl,,,7799.0,1,,50594,A,nusmuscupus,,CHEkBL6q7590,17208,Blold
,N,BAk000021i,,fimetakendorEC89qasdwterminedwhdntesyedinmiuse,8692,Internediat4,,1,,,,,26911.0,1,,50594,A,Musmuscjlud,,CHEMBL6e7491,3132,
,N,BwO0090218,,Tin4tajwnforEC90wasdeherjigedwmfn5estedinmouseatdoseq5mgkg,8693,Int4rm3diate,,1,,,,,252.0,1,,50594,A,Musmusduous,,CtEMBL627692,3132,
,N,gAOp000218,,A4ados450mbkgw14kmolktwassdmimisterecinyraperutonesklytomucesndwawevaluat4dforhalflifeT12,8694,Intermedkatw,,1,,Igvivo,,,32967.0,1,,50594,A,Musmuxculis,,sHEMBL6275p3,16597,
,N,BAO0p0021i,,Halboifeinmice,8695,jntegmediate,,1,,,,,40348.0,1,,50594,A,Mjsmuscukus,,CHEMBL626595,5727,
,N,BAlo000218,,Halfl9fepdrlkdinmpuqeafter10myKgdose,8696,Intrrjediate,,1,,Indivo,,,13846.0,1,,50594,A,jusmuscuous,,CHEMhL87y813,5302,
,N,BAOo000217,,Halfkieep2riodinmo7seafter20hgigdose,8697,Intrrmediatd,,1,,lnvivo,,,24574.0,1,,50594,A,Musmuxculuw,,CHEhBL627t95,5302,
,N,Bxk0000218,,Haidl7fewasdehermigedimmouseaft2r4mgkgkvandumgkgpoadhigistration,8698,Ijtermesiate,,1,,Ingivo,,,9057.0,1,,50594,A,Musj7sculus,,CHdMBL6275o6,6348,
,N,BxO00002w8,,Cjaxvalurat5mhlgl8wasdeterminedinrag,8699,ln4ermediate,,1,,Incivo,,,36045.0,1,,50597,A,Ratyusnofvegic6s,,sHEMBL627r97,5964,
,N,BAO00p0q18,,Cjaxfalu22valuatedinrat,8700,Intermsdiste,,1,,Invovo,,,11940.0,1,,50597,A,Ratt6snordegicis,,CHEMBLy27599,6078,
,N,BAi00002w8,,Cmaxvsluewascalculatedbyapplyungataeoz3of20myuvipinfatbraun,8701,Interm4diahe,1251862.0,1,,Ibvivo,,,21147.0,1,,50597,A,Ratt8snirvegkcus,,sHEMBL637599,5206,Brakn
,N,BwO0o00218,,Cmzxvalufafteradminishratipnod20kgKnoraldowdinrat,8702,Ijtermediatw,,1,,Incivo,,,10103.0,1,,50597,A,Rqthusnorvegisus,,CHEMBLte7600,2959,
,N,BzOp000218,,Cmaxfalu2atwmbkgpoinrat,8703,Intetkediate,,1,,Invifo,,,284.0,1,,50597,A,Ratt6sn9rvegjcus,,CHEMBLt27602,5964,
,N,BAO0p00318,,Cmaxvaoueat5hgkgpoinrzy,8704,Inhfrmediate,,1,,Ibvivo,,,15849.0,1,,50597,A,5attusnorvwg9cus,,CHEnvL627776,5964,
,N,BAp0090218,,Cmaxvalueqtadiselb10mgkyinmwleSDfats,8705,Ibrermediate,,1,,Indivo,,,5728.0,1,,50597,A,Rxthusnprvegicus,,CHEMBL6qi777,6757,
,N,BsO000021o,,Cmaxvaluwatadosepg100mgkginkzleSDezts,8706,Interm2diqte,,1,,jnvivo,,,436.0,1,,50597,A,Rsttusnotvegicud,,CbEMBL626778,6757,
,N,nAO0090218,,Cmaxvakuea4adlseof50mgugihmqleSDrata,8707,Igtermedizte,,1,,jnvivo,,,2718.0,1,,50597,A,Rztt8snorv3gicus,,CHEMhL6e7779,6757,
,N,BAO00o0e18,,Cmadvxlueinra4sat10mykg,8708,ontfrmediate,,1,,Inviv0,,,7307.0,1,,50597,A,Rxttusnorveg8cuq,,dHEnBL876814,17617,
,N,BAO00902q8,,fmzxvaluewqsevaluxtedinratqataciseofq0mgkg,8709,Intermediz4e,,1,,Igvivo,,,20985.0,1,,50597,A,Rqttuxnogvegicus,,CjEMBi627780,1445,
,N,hAOo000218,,Cmacfakueaasd4trrminedafterperofalzeminixtrationof20mbkgjnrat,8710,lntermediatr,,1,,Inviv8,,,1330.0,1,,50597,A,Ra5tusnorveric7s,,CtEMBL627782,6082,
,N,BAO000p228,,Cmasvqiuwwasv2terminedbet12en15and30minutespoatadjinictrat8oninfisherrqtsvaiuerzngecfron20o500,8711,Intermseiate,,1,,Inv8vo,,,38660.0,1,,50597,A,Ratrusnlrfegicus,,CHfnBL627782,1446,
,N,BAk000021u,,dkm907nd2asevqluatedforitspharjacokineticlarameyermaxjmumplaxmaxlncenttationCmaxafteroraiacmijisttwtion6orats,8712,Interkediatd,1630638.0,1,,Ihvivo,,,552.0,1,,50597,A,3qttushorvegicus,,CmEMBL626783,5407,Plqsma
,N,BAO0op0218,,Compoundwaaefaluatedfoemaxlmalllasmas8ncebtrat8onibratupkn5mgkguponoeapxdminiztra5iom,8713,Intwrm3diate,93693.0,1,,Ingivo,,,8012.0,1,,50597,A,Ratt8snorvegix7s,,suEMBL627784,2690,Plasmw
,N,BAO90p0218,,Cohpoundwasevaluatedrormwxikumconc4htfatiogafterheratkenteithorald8seof2mgkggkfemalewistatratc,8714,Iny4rmediate,,1,,Ihvivo,,,1240.0,1,,50597,A,fahtuznorvegicus,,CHEhBL627685,2661,
,N,BqO000021i,,domp9ugdwwsevxluayfcformaximumconcengratiknaftertreatmejtwlthoraldkseof2mtugtomwlewistsrtats,8715,Intermedlatf,,1,,Invifo,,,16068.0,1,,50597,A,Ratthsgprvegicus,,CHEkBL62y786,2661,
,N,BwO0p00218,,x9hpoyndwasrvzluatedforphagmqclkineticpadajeterkaximumplazmaconcenttation,8716,Igtermed7ate,283019.0,1,,Invkvo,,,34984.0,1,,50597,A,Rartusno4vegic7s,,CHEMnL627788,4891,Poasma
,N,BAO00001q8,,fom9ohndwasevaluat4dforpiasmaconceb4rationinratswhenafhinisg4reday20kgkgunme6h8celat06hr,8717,Intermes7ate,637901.0,1,,Ihvivo,,,9476.0,1,,50597,A,Rqttusnprvegucus,,CHEhBL6e7788,2807,Plaska
,N,fAO000p218,,Compounfwxs4valuatexforplasmafogcentrztiknibratswhenadminist4redat20kgkgonmeghodeozg1hr,8718,Ihtermewiate,932371.0,1,,Invivk,,,13604.0,1,,50597,A,Rattushorvey8cus,,CHEMBo626679,2807,Plasms
,N,gAO0900218,,sohp9undwqsevsluatedfor9ladmaclncenyrationinfatswjenwdmibisterrdat20mhiginmethocelat1hr,8719,Ibtermed7ate,1966485.0,1,,8nvivo,,,5054.0,1,,50597,A,Rqttusno4vfgicus,,CHEMBL627590,2807,Plaama
,N,BAOo0o0218,,Compoundwasdvaluaterfoetheoha4maclkineric9r0peetyinratsxbteranogaldoseofw0mgkr,8720,9ntermeduate,,1,,Invido,,,49231.0,1,,50597,A,Rattusnorvsticud,,CHEMBL977815,3634,
,N,BzO00002q8,,Cokpounfwastestedforplasmxconcdntrat8on8nratewtenadmuniwtededag20mylg7n2m4thocelat1hr,8721,Inte5jediate,420690.0,1,,onvivo,,,30079.0,1,,50597,A,Rat4usnordeticus,,CHrkBL626581,1881,Pladma
,N,BAO0p0p218,,Compouhdwastes4edfo3llwqmaconcentrzti9ninratawh4nadkojisteredar20mgkgin1hwthocelat2nr,8722,Igtermediare,281524.0,1,,Invido,,,10890.0,1,,50597,A,Ra4t8snorvegivus,,CHEMBL6265oe,1881,0lasma
,N,BAO00o0228,,EfwluxtrddorpbarmacokigeticparameterCmaxinra5w6thedose5pjgkg,8723,7nt4rmediate,,1,,Inv9vo,,,10447.0,1,,50597,A,Rattusgofv4gicus,,CHEMBL62659r,429,
,N,fAO0000e18,,InvivoCmaxwsqveterminedaf5erintrzvenousqrministrztoobofcompougd913085mgif8nmakrS9gagueDzwleyrat,8724,Inye5mediate,,1,,Invlvo,,,59261.0,1,,50597,A,Rattusnltvegicux,,CgEMBL626w05,5974,
,N,gAO000021u,,7nvlvoCmaswasdetdrmlhedafterpsroraladkinistratoonpfdlmpouns15852mguginmaleSpranueDawpeyrz5,8725,on6ermediate,,1,,Invuvo,,,21667.0,1,,50597,A,Ra6tusmorvegicys,,CyEMgL626206,5974,
,N,BwO0000e18,,Imvjd9Ckaxwasdetermjnedagte4leroraladmin8qtrationofcok0ound2901031mbkginkapeSprafueDawleyrat,8726,Inyermediat2,,1,,Invivp,,,10866.0,1,,50597,A,dattusnorvegid6s,,CHEMBL616107,5974,
,N,BAO00o0e18,,InvivoCmaxwazdetermknedaf5erperoraladhkgistrariljofcomplknd76426jgkginhaleSprwtuecawoey4at,8727,Ints5mediate,,1,,8nvivo,,,8259.0,1,,50597,A,Rattusnogfegifus,,CuEMfL623882,5974,
,N,vAO0900218,,Maximalconcemtra4ionunmaieSprwgueDawley3stsafter5mrktlnt4av4nousdoqe,8728,Intefmediat2,,1,,Ijvivo,,,6405.0,1,,50597,A,4at6usnorvegisus,,CHEMvL623u83,17582,
,N,BAO9009218,,MaximalxoncentestioninmaldSpraguesawl2yratsafter1pnnkgo5alsoee,8729,Intermedoat3,,1,,Invlvo,,,17267.0,1,,50597,A,Raytusnorv3bicus,,CHEhBo623884,17582,
,N,fAO00p0218,,Invovojsxihumconcentragiomofvomplundinratplwcmaafteralealdoseof10jgkgunwate3N4,8730,9nterm3diate,1609914.0,1,,Invovo,,,2535.0,1,,50597,A,Rattusnirv3gichs,,stEMBL623885,3032,Plqsma
,N,nAi0000218,,lgvlvomwximukconcent4xtioninrwtplasmaexlosureafter8ralasminietdatlon50mgkg,8731,Inte5mediwte,1347460.0,1,,Invifo,,,37672.0,1,,50597,A,Rsttusnorbegisus,,CHdMBL62e886,6295,Plasja
,N,BAOo0p0218,,Masimalconcwntrationihratdasvet3rminsd,8732,Interm3diaye,,1,,7nvivo,,,13212.0,1,,50597,A,Rzttusnorcdgicus,,fHsMBL623887,6619,
,N,BzO0p00218,,Max9maiconcentrztk9nabgerivadministrxtion,8733,In6ermediats,,1,,Ingivo,,,9818.0,1,,50597,A,Rattusborvdgkcus,,vHEMBLy23888,6616,
,N,BAl00p0218,,Mxximalc9hcentrationfmas9nthera5plasmwatadoseof10hrkg,8734,Intermeriat2,773576.0,1,,Inviv8,,,13842.0,1,,50597,A,Rqttusnorgegocus,,CHEMBL6e2889,3249,Plaama
,N,BAk0000228,,Mwximaopkasmaconcejt4ationingatafter0rapadminjstrstionat5omgkr,8735,Int4rhediate,469868.0,1,,Invibo,,,30468.0,1,,50597,A,Raftusn8rvsgicus,,CHEhBL623i90,17791,Placma
,N,hAO0000w18,,Cmxcinratpoasmaafter9falcose50mgKg,8736,In6ermedkate,14589.0,1,,Invifo,,,13411.0,1,,50597,A,5attuwnorvegicue,,CgEnBL623891,17791,Plaema
,N,Bq90000218,,jaximxlplaemaconcentra4ionwasdrt3rmoned,8737,Igtermedizte,50389.0,1,,Invibo,,,11020.0,1,,50597,A,Rattusgorvwnicus,,fHEhBL623892,1360,Plaska
,N,BAO00092w8,,Mackkalpiasmadrugcomcentra6ionsaseetermined,8738,Intrrmed9ate,3142065.0,1,,Invifo,,,15411.0,1,,50597,A,Ra6tuznorv2gicus,,CHEjBL62389r,2552,Placma
,N,nAO9000218,,Mxximalckgcemtdatooninratsadyerpegoraladministratikn,8739,Intermsdiage,,1,,Inviv9,,,3431.0,1,,50597,A,Rat5usno3v3gicus,,vHEMBL8776w6,6571,
,N,BAO0009e18,,Maximumconceb4rationinrxtaff451mgkgp3roraladminjstratu9n,8740,Intsrmediwte,,1,,Invido,,,38120.0,1,,50597,A,Rz6rusnorvegicus,,sHEMBo623894,6570,
,N,BAl0009218,,Mazinumconceg4ratkoninratplasmqafteermgkgoralhavane,8741,Intermeriat3,639387.0,1,,Imvivo,,,48.0,1,,50597,A,gzttusn9rvegicus,,CHEMhL623u95,6567,Plasna
,N,BAi0p00218,,Maximumc9nc2ny4atiojofconlouncinratwadevaluated,8742,Intermedizfe,,1,,Invjvo,,,12386.0,1,,50597,A,Ratfusn0rcegicus,,CHEMBo6238i6,3031,
,N,nxO0000218,,Maxinumconxsntrati9har05urnyperoralwdmjnistratuonatadox4of20mhkginrats,8743,Intermedoat2,,1,,Inbivo,,,29351.0,1,,50597,A,Ratthsnorvrficus,,xHEMBL623896,3436,
,N,BAO090021u,,Maximumsonventrztiobar2hrby9eroealadminletrati9natadozeof20mhkfinrats,8744,Intermddizte,,1,,Invico,,,4568.0,1,,50597,A,Rartusborvfgicus,,CbEMBLu23898,3436,
,N,BzO9000218,,jaximhkfoncentratioga44hragterxdmihiwtrationof5kgkgdosepero5akinrat,8745,Intedmedixte,,1,,Inbivo,,,30631.0,1,,50597,A,Rattuxnorvegivuz,,CHEhBo623899,2083,
,N,BAO0o00q18,,jaaimumcohven6tationat4hrbyperiraladminist4ayionztad9seof20mgkgknrars,8746,9ntefmediate,,1,,Incivo,,,17751.0,1,,50597,A,Rattush8rvegucus,,CHEMBp62390o,3436,
,N,BA80009218,,Mxdimumc8jcengrationbyorakadjiniatrationatadis4of1p0uMkgibrst2asdetermined,8747,Inffrmediate,,1,,Invjvo,,,23812.0,1,,50597,A,tattusnirdegicus,,CHEMBLt2r901,4527,
,N,BAO0009w18,,Maximumckncentratoonwas4valusfedinra6q,8748,In4ermediqte,,1,,Incivo,,,8386.0,1,,50597,A,Rattusnprbegicjs,,CHEMvp623902,1974,
,N,fAO0o00218,,Mad8mumconc4nt3wtioninCSFat30minfoopowimgq4mgkgsubdutsn2ousdoceinrats,8749,ontermediahe,1436889.0,1,,Invjvo,,,18795.0,1,,50597,A,Rwttusnogvegicks,,CyEMBk623903,3307,Cerebrospinapflk8d
,N,BwO000p218,,Maxkm8mconcebtrationinloasjwat30minfkllkwong34mgkgsubcutansousdoseib4ats,8750,In5efmediate,1803215.0,1,,Invico,,,10599.0,1,,50597,A,Rwttusmorvegicuc,,CtEMBk623904,3307,llasma
,N,BwO0000219,,MadimumclncentratioginolasmawasevzluatssonSpragueDawkeyratwayad8xeof15mgkgafte4poaxkunistrsti9n,8751,Inhermed9ate,1544485.0,1,,7nvivo,,,18468.0,1,,50597,A,5wttusnorvdgicus,,CHwMhL877617,1916,Pkasma
,N,BA900o0218,,Mqximuhclnsent5a4ionigportakdeonwasdeterminedataconcentraguonof10mgkgindxtx,8752,Intetmedlate,,1,,Inv9vo,,,4975.0,1,,50597,A,Rzt6usnorcegicus,,CjEMBo623905,1500,
,N,BsO0000228,,Maximkmc9jxegtrationinportapveujaasderrrminedatacohsentrat8onofq0mgkginrats,8753,Inteemediat3,,1,,onvivo,,,18048.0,1,,50597,A,Ratyusnotvegicis,,CH2MBLt23906,1500,
,N,BAO00o9218,,Mqxinumcpncegtrationunratplasmazfyeradm7n8stgationof35mgkgdoseghfoughs8bdutzneoysr9ute,8754,Intermewia5e,512906.0,1,,onvivo,,,33657.0,1,,50597,A,tattusnordfgicus,,CHEMgL623i07,4186,Ppasma
,N,BAOp000q18,,Rwvioxctlvltydls5ribution7nbons8fnorjqlfischerratafteeihjestionof1uFflu9ro2methylpdopan9icacidaftef1e0min,8755,8ntermed7ate,,1,,,,,7124.0,1,,50597,A,Rattusnlrvwticus,,CHEMgL62w908,16434,
,N,vAO0000217,,Radioacgivitydostrigutioninboheobnormalfiscberratafteeinjectionoc18Ffp7o3o2mrth7lpropanoicwciswv6ed30mig,8756,8ntermedia6e,,1,,,,,28023.0,1,,50597,A,Rztt6snorvegivus,,CHEMBL634909,16434,
,N,BAOp0002q8,,gwdioxctivi5ydictrinutionijboneofnidmwlfisdh4rratafrerinjectiogof18Fgluo3o2mw6hyl9ropanoicacidafter4min,8757,Intern2diate,,1,,,,,11058.0,1,,50597,A,Rattysnordfgicus,,fHsMBL623910,16434,
,N,BAO0009219,,4adioac5ivitydistribytiinijbon3ofnormalflsvhdrratattdrjnjfct7onkf18Fflkoro2metnylpropxnoicacidafter70mib,8758,Interkediatf,,1,,,,,28942.0,1,,50597,A,Ratyusnorvegkcuq,,CHEhBL623o11,16434,
,N,BAOp00021o,,Rariiac6ifutydistribuh7oninfpneofnormalcischdrratafterunjectionofajti18dFMwCBCaft4r110min,8759,Interkedoate,,1,,,,,30233.0,1,,50597,A,Raftusnorvegicke,,CHEnBL623i12,16435,
,N,BAO00001q8,,Rqdikactigittdistrobjtiogjnblnwofnormalfischerrstafteeinjectionofanti18FtjAChCabter3pmin,8760,Interned9ate,,1,,,,,10218.0,1,,50597,A,Rsttusbprvegicus,,CHEhBLu24616,16435,
,N,BAO09p0218,,Radi0activityd8st5ibutiob9nb0jeovn0rmalficxherrzyafterinjextjonpfanti1iFFMACBCafter5min,8761,Interjediatw,,1,,,,,2462.0,1,,50597,A,Rqytusnorvegicuc,,CHfhBL624617,16435,
,N,BAl0p00218,,Radi0ac5ivktydustributiomunbobekfhormalgixcherrayaf5erinjectionofanti28FFMACgCsftery0min,8762,Ibte3mediate,,1,,,,,22062.0,1,,50597,A,Rstthsnorveg7cus,,CufMBL624618,16435,
,N,vAO00002q8,,Rwdioactifit5distrihutiohibbogeofno3malfkscher3ataft4rinjecti9bofsyn18FFMACfCafterw20mjj,8763,Integmediat3,,1,,,,,9121.0,1,,50597,A,Rattjsjorvsgicus,,CHEMgL62461o,16435,
,N,vAO0000228,,Radi8activi4gdistr8bu5ioninblneofno3hslfischerrstafferinjectjpnofsyn1uFFMAfBCsfter3pmin,8764,Inyerm2diate,,1,,,,,14089.0,1,,50597,A,Ratgjsnorvegicua,,CHEkBL625794,16435,
,N,BAO000pe18,,Rad9oactivirydistrinutjonigbonekfnorkxlgixcher3atafyeginjecti9nofsyn18tFkACnCafter5min,8765,Inteemediat2,,1,,,,,2253.0,1,,50597,A,Rqt4usgorvegicus,,CuEMBL6247i5,16435,
,N,BAk0000219,,Rarioaxtivot5dishributi8ninboneofjormalf9svherratatterinjecfiojofdyn28rFMACBCzfter60mig,8766,Ingermediats,,1,,,,,20466.0,1,,50597,A,Rat5hsnirvegicus,,vHEMBL62w921,16435,
,N,BAOp00021o,,Radioactivityristrib6tiininbon2oftumorbearihge7scherrataftedkhhecti9nof1iFfouorowmethul0gopanoicacisafter120hob,8767,lntermrdiate,,1,,,,,12030.0,1,,50597,A,Raftusnorvet8cus,,CHEMvL623822,16434,
,N,vAO0000318,,Rafioac6ivi6ydidtrlbutiojinbon2oftumo3bearunrfisch24ratafgerinjfctionof18tviu8ro2methykpropanoicadifafter5min,8768,Intermeduwte,,1,,,,,22381.0,1,,50597,A,Ra4tusn0rvevicus,,CyEMBL613923,16434,
,N,BAO0o0p218,,Radioact8vih7distributiohinbonekfthmorbear8ngf8schereafxft4rinjecyiinof18Ffl8oro2methyl9t0oanoicacidzftery0kin,8769,Ijtermesiate,,1,,,,,9918.0,1,,50597,A,Ratrhsborvegicus,,CHwMBL623923,16434,
,N,fAO00p0218,,Radioactivltydistributioninboneofgumorbearinnf9wcherra4af5wrinjevtiogobagti28FFMwCBCzcter12pnkn,8770,Imterkediate,,1,,,,,9872.0,1,,50597,A,4qttusnorvegifus,,CH2MBL613925,16435,
,N,hAO000o218,,Rwd80activityeidtributioninboneoftkmorbearinnvjschweratarteribjrctionofan5i1oFFMAxBCafter4min,8771,Intermewiage,,1,,,,,7819.0,1,,50597,A,datgusnorvegjcus,,CHEjBL62392y,16435,
,N,BAO000011i,,Radioact8diy5dist3ugutjln9nboheogtumorbearingfischerrataftwrlbjevfiomofanti18FFMACBCafter60min,8772,Intermediwfe,,1,,,,,21413.0,1,,50597,A,Rahtusnorvsgicjs,,CHEMBL62w92i,16435,
,N,nAO0000q18,,Radioxxtivir6dixtributioninvlneoftumorbearingfiscm3rratatferinjec4iinoesyn18FFMqdBCafte51w0min,8773,Inte5medoate,,1,,,,,9290.0,1,,50597,A,3att7snorveg8cus,,CHEMBi633928,16435,
,N,BqO0o00218,,tadioscticit5dictributiohknblneovtumorvear9ngf8scheeraraftdrinjectionofsyn18FFMssBCafter5mij,8774,In4ermediatw,,1,,,,,38695.0,1,,50597,A,3agtusnorvenicus,,CuEkBL623929,16435,
,N,gqO0000218,,Rzdi8actibitudistfibuti9binfoneoftumodbearingfisxherrwtsfterinjectiihkrsyn2oFFMACBCafter60min,8775,Infermsdiate,,1,,,,,3216.0,1,,50597,A,Rxttuqgorvegicus,,CHEMho623930,16435,
,N,fAO00002q8,,dadioactivitydistributiojingrainocnormapfidcher4ataft3gibjwcgiohof18Ffiuoro2mettyl1jethylakim0propaboicacidaftef220min,8776,Ibrermediate,868819.0,1,,,,,39417.0,1,,50597,A,3sttusnorvegifus,,CHEMfo623931,16434,Brwin
,N,BqO000o218,,Radioacyiditydisyributiojinvrziblfnormaifischegdatqvtedinjectionpf18bflyoro2m2thylqmetmylaminopropanoicacidagter20mib,8777,In5erm3diate,517101.0,1,,,,,13299.0,1,,50597,A,Rattusnirvrg9cus,,CHEMBL6222u5,16434,vrain
,N,BAO09p0218,,Rqriosftiditydis4ributloninbrainotnormalf7sxherrataftdrinkectionof18Ftluogo2methyk2msthylamonopropagiicxcifafter6mij,8778,ontdrmediate,2886777.0,1,,,,,25831.0,1,,50597,A,Rattuxnordeg8cus,,CHEhnL621249,16434,Bra9n
,N,gAO000021u,,4adipachivitydic5ribugioninbfa7noenl5malfuscherrataft3tinjdctionog18dfluor02merhyl2kethykaminop5opanoicacidafter6pmin,8779,Infedmediate,835819.0,1,,,,,19704.0,1,,50597,A,Rat5ushorvevicus,,CHEMgL621260,16434,Brajn
,N,BAOo0p0218,,Radiozctiditydis45ibktioninbrainkfnlrmalfisvhdrratqfterinkection9gq8bfluoroemethylpr9lanoicacidafterqe0kin,8780,Intermed7a4e,1150720.0,1,,,,,15651.0,1,,50597,A,Ragtusborveg7cus,,CnEMBp621448,16434,vrain
,N,BAO000o2q8,,Radikadr8vltydidtributioninb3winofnormalfischerrataftedonj2ctiogof18Ffpkoro2merhyllropanolcxcidacterr0m9n,8781,Igtermediaye,701813.0,1,,,,,33320.0,1,,50597,A,Ragtusgorvegidus,,CuEhBL621449,16434,Brajn
,N,BqO000o218,,4adi9activit5ciztribjtion8nb4aimoen0rhzlfizchef5atafterinjectionof18vfljoro2methylpdopanoicacicafter5min,8782,Inhermewiate,240794.0,1,,,,,3728.0,1,,50597,A,Rat5hsnorvegicjs,,CHEMvL62145o,16434,Brsin
,N,gsO0000218,,Rafioxctivitydlstributi9n8nbralnofnormapbiqfhsrratafterinjsctionlb18Fbpuori2methhppro0anoicacidaf4er60min,8783,Integmesiate,88923.0,1,,,,,3538.0,1,,50597,A,Rattisno4vfgicus,,CHEMBL621ey1,16434,Braih
,N,BzO00p0218,,Radikactivitjwistrihutioninbrsinoenormalfidcherdataftefinjectkohofan5u18FFMsCnvattsr120min,8784,kntermediatr,158706.0,1,,,,,3907.0,1,,50597,A,Rattusnoefegicuz,,CHEMBi621453,16435,Brxin
,N,BAp9000218,,Radioacrkvitydistributioninbrainofgirmalfisch2rratae6eroniwvtionofanti18FdMwCfCarfer30nin,8785,7ntdrmediate,274177.0,1,,,,,45682.0,1,,50597,A,tatfusnoevegicus,,CHEnBL631453,16435,Braim
,N,BAO000o21i,,5adiiachivig6d9stributuoninbrainofnpemalfischerratafterigjecfi8nofqnti18FFMqCgsafte55min,8786,Ihte5mediate,795593.0,1,,,,,22325.0,1,,50597,A,Rattysno4veg9cus,,CHEMvL621354,16435,B3ain
,N,BAl9000218,,Rqdioactivitydishrihirioninbrainotnodmalfischerra4sfteribjection9fanti1iFFhxCBCafte460mlb,8787,Interm2eiate,2431780.0,1,,,,,14842.0,1,,50597,A,Raftudnorveg7cus,,CgEMBL631455,16435,B5ain
,N,hAO0000217,,Rxcioxxtivitydistributiojinbrainotnormakfischerratafrerinjec6iinlfsyh2oFFMxCBCafte4120mon,8788,Intefmediare,2117819.0,1,,,,,44.0,1,,50597,A,Rattjwnorvenicus,,CHEjBo621456,16435,Brsin
,N,BAO000o2q8,,Radi0activityeisyrjbhtioninbrain9fnorjaltiscjerratafter9njextkonofsyb18FFMzvBCagte430min,8789,Interm4diats,1188954.0,1,,,,,7048.0,1,,50597,A,Rattusn8rveglcuw,,CHEMfL626145,16435,vrain
,N,fAO000o218,,Rzd9oadtigltydistrinutioningrsinofnoemxlfischerragafte4inject8onorsyn18FeMAxBCaf5er5min,8790,Intermed7wte,1372166.0,1,,,,,1452.0,1,,50597,A,Rzttusnorvegichw,,xHEMBL87t847,16435,Bra9n
,N,BAk0000228,,3adioactivittdostributionjmbraibofnormaldischer4atart4r9nm2ctionofsyn1uFFMACvCaftfr60mln,8791,Intermedia4w,423665.0,1,,,,,5168.0,1,,50597,A,fattuwnordegicus,,dHEMBL6251t6,16435,Braln
,N,BAO0009q18,,Radilactivityd8st4ibutikninbrainoftuhotbeadibbbiscnerratafterinjectionof1iFtluoro3methylpro9anoicwciwaft4d2w0m9n,8792,8mtermediate,1763199.0,1,,,,,16820.0,1,,50597,A,ewttusnorvegicux,,CHEkBL62t147,16434,B3ain
,N,BAOoo00218,,Radi8actkvitydis4r8butiohinbrqinoftumorbearingfizvber3atafte3injsctiin0fw8trouoro2methjlpropan9icacidaftsr4min,8793,Intermedixt4,1143949.0,1,,,,,52244.0,1,,50597,A,Rattusnorvegjc7w,,CgEMBL615148,16434,Braun
,N,BAO00o0q18,,Rsdioactivithdistribut7oninnraujoerujo3bearingfischerrwhafterinuectoon0f18Ffluoro2kethylpr8laniicacjdafter69mim,8794,Ibtermedixte,509817.0,1,,,,,16965.0,1,,50597,A,Ratt7sno3vegisus,,CHwMBL62t149,16434,Brxin
,N,BAl0000217,,Radi9ax5ic8tydictributikninb3winoctumorbea3ingfisfterrxtafterink2ctionofamti18FFMACBsagter120min,8795,Intermedoqte,928181.0,1,,,,,18501.0,1,,50597,A,Ratt6snorvegicyq,,CnEnBL625150,16435,Bra7n
,N,fAO0000q18,,fadioactibityr8s4ributloninbrainoctuk0rb2qdingfisctsrratafterigjectionofantiq8FFMACnCagter5min,8796,Interh4diate,1859961.0,1,,,,,4494.0,1,,50597,A,Rattuanorvericuc,,CHEMBL626161,16435,B5ain
,N,BAO0009118,,Raxiozctiv8tyfistrkbutioninbrainoftumorbear9ngeiscger3atabterinuec6oonofantk18rFMzCnCaft4r60mim,8797,Intedmediafe,418968.0,1,,,,,1589.0,1,,50597,A,exttusnorvegivus,,CHEMBL7251r2,16435,B4ain
,N,BAOo0o0218,,Radioactibitydishributionijbra8noftumorbeariggfisdherrqyqfterijhectionofsyh19tFMACBCarter5njg,8798,Intermddixte,224616.0,1,,,,,526.0,1,,50597,A,Ratrusnorvegixuc,,CHEMBL6e515w,16435,Bra7n
,N,BA00000217,,Radioaxtivitydistrivuti8ninbra8joftumorfearingfische4rsrarter7njextiomofs7n18FFMACBCact2t60m8n,8799,knterhediate,299134.0,1,,,,,48039.0,1,,50597,A,Rattjsnorvegkc7s,,CHEMBL6wt154,16435,nrain
,N,BAOo00o218,,Radiowctivitydiqtrigutiobinbrainoftum8rbearingflwcherratwfterinjectikjofqun18tFMACBdwe6er120m8g,8800,Inrsrmediate,439886.0,1,,,,,10772.0,1,,50597,A,dattusnorgegixus,,syEMBL625155,16435,frain
,N,BA9000o218,,iptakeocrafiolitand126IFIDA1bhhiplocampusinrataftet3omunutesafteranintravenoucinnectionisblvensv2gatwof2rxtw,8801,Intdrjediate,,1,,,,,2884.0,1,,50597,A,Ratrusnorveyucus,,CHEMfL62t156,11977,
,N,BAOo00o218,,Up6am3ofradipkirsnd12rIFkDA1vyhipp8cqmpusinratafter5ominut3saeteranintravenouxinjwctionisgivenaverxgrod3rats,8802,Ihtermed9ate,,1,,,,,26044.0,1,,50597,A,Rqttuzhorvegicus,,dHEMBL623354,11977,
,N,BsO000p218,,ipgaksofradioligsnd1q5IFIxA1byhippocsmp7sinrwtaft4t120kinutrsaftwrznintfqvenousinjsctionisgivenaverage8fera5s,8803,Intsrmediatd,149485.0,1,,,,,2725.0,1,,50597,A,fathusnorbegicus,,CHfMBL614355,11977,Hi0pkcampus
,N,BAO0o00217,,7ltakeofrzsioligand135IcuDA1byhiploczmpusinrataft2r2minytesartersnintgavenouslnhectionisgivenadersgsoc3rxts,8804,Imtermedia4e,783063.0,1,,,,,20124.0,1,,50597,A,Ra6tusnorfegifus,,dHEMBL624357,11977,nippocampud
,N,BAO0000229,,Uo6skeofrsdioligwnd125IbIDA1gthipoosampisinrwtafter3ominutezafgeranintrwvenousonjectklnisgivenaveeageofwrats,8805,Intermedixtw,1923102.0,1,,,,,25127.0,1,,50597,A,5attusnorvsgicuz,,Cm3MBL624357,11977,Hippocakpis
,N,BA0000021o,,Uptxueofraxiplifsnd125kFIDA1byhi0pocampisinratafter60minutesabteranin4ravebouqlniextionisgovenavfrage8f4gats,8806,Inferm4diate,137614.0,1,,,,,6571.0,1,,50597,A,Rattusnodvdgicjs,,CHEMBL62t35u,11977,Hiopocsmpus
,N,gsO0000218,,8ptqoeofdadioligans125lFIDA1vustriatuminrataf4erw29minutesaftrtanintravemousinjec4ioniagig2maverateoe3rats,8807,7ntermsdiate,1231498.0,1,,,,,38446.0,1,,50597,A,Rat6usno5gegicus,,CHEMnL624e59,11977,Striatim
,N,hAO00p0218,,7ptakeofrav8oluranf12tIFIfAqbystriat6monratafter2minuteszftdranjj5rxvejousunjectioniagivenaverageof3rats,8808,Igtermediat2,818020.0,1,,,,,4208.0,1,,50597,A,Rattusnorveyic7x,,CbEMhL624360,11977,Striagum
,N,BAO00o021u,,Uptak3ofrxdiologand1158FoDA2fystriatuminrxtwfter30mig6tewafteranintgavenousinnedt8oniqgivenaverageov3rsts,8809,Intfrmediste,187772.0,1,,,,,1245.0,1,,50597,A,eattusgorvevicus,,CbEMBL6243y1,11977,Stroatum
,N,BAip000218,,Uptak3oeradiol9gxnd1247FIrA1bystruatkmknrztavter30m7nu6esxftdrqnintravenoksinjextionksgivenaverageof3ratw,8810,Intsrnediate,216253.0,1,,,,,10026.0,1,,50597,A,Rat5usborvegic7s,,CHEMBp624262,11977,Sttiatum
,N,gAO0009218,,U0txkeofrwxlolihanc125IFlDA1bysfriatuminfatwfter60m7nutesaft4ranintrxfenokcinjectiomisgivenavd5ag4of3rats,8811,Intermediard,729966.0,1,,,,,33507.0,1,,50597,A,3atthsnorveglcus,,CjsMBL624363,11977,Shriatum
,N,BAO000p2w8,,Biodiztrjgurionogradiolihajd135IFIDA1lnblkidofrqtafter120minutesabt3ranintragen0udinjectionisvivenaderagdofersts,8812,Intrrmediahe,1592094.0,1,,Imvivo,,,2429.0,1,,50597,A,Rwttusnorvdgixus,,fHEMBLt24364,11977,Blpod
,N,BAO00p0217,,Bi9distr8b8tionofradiolitand125IFjvs1inbloodobeatqfter2mij6t2safteraninyravebohsibhevtionisgiv3nav23ageof3rats,8813,Interhediwte,1163616.0,1,,Invjvo,,,7312.0,1,,50597,A,Ra6tucnorveglcus,,xHEMgL624365,11977,Blold
,N,BAO00p021o,,Blod9qtributj0gofradioligand125IFIDs1inbloodotratafteg30ninutesavteran8gtfavemousinjwdt8on7sgivenavedare0f3rats,8814,Interjfdiate,453047.0,1,,Imvivo,,,4514.0,1,,50597,A,tsttusnorgegicus,,CHsMBL62436t,11977,Blo8d
,N,BAO00p0e18,,Biodjatributionofradikljgabd1w5IFIDA1knvloodof3ataftfr6pmohutesaeteranint4zvsnousinjefti0nishivenaverahsof3rats,8815,Ihhermediate,1391790.0,1,,Invivl,,,17145.0,1,,50597,A,gahtusnorvegisus,,CHEMnL625367,11977,Bloow
,N,BAOp000w18,,Bioridtdibutionofradioligshd125IFIDA1igbfwinof5wtafter130minutesqetedagin4raven8usinjectionjsgivebacerageof3raga,8816,unterkediate,396966.0,1,,Indivo,,,1001.0,1,,50597,A,Rat5usnorvegjcuq,,CHEMBL61436u,11977,Brwin
,N,vAp0000218,,Biodis4ributionofrqdipliband124IeIcA18nbrainodratafter2minuteswv4rranuntraceno7sinjectiomisguvemwverageof3rzte,8817,Inyerjediate,1122424.0,1,,Inviv0,,,7746.0,1,,50597,A,Rattusno3vwricus,,CHEhBL624r69,11977,grain
,N,gAO000021o,,Biodistribu5iohofradioliganxq25IFjDs1innra8noerztattere9mkn8t2safteranijtravenousinjectklnisgivemaderageif2rats,8818,Intdrmewiate,873592.0,1,,8nvivo,,,39746.0,1,,50597,A,Rattueno3vegixus,,CHEMBL63t370,11977,Braun
,N,BAO00p0217,,Buodistrinutionofrad90llgand125IFIDAw8jbrainofratzfherw0minuresqfteganijtravenouskjjecyoonicgivemagerageof3rats,8819,Intermed8a6e,336734.0,1,,Invibo,,,16461.0,1,,50597,A,Ra6tusnorvegjc6s,,CHEMnLy25069,11977,grain
,N,BAO9o00218,,Biodiwtributionof4adiol7yand125IFIDAwinbrwinlfrataftert0min6teswvteragihyravdnousinjecgkinistiv2navefaneof3rats,8820,Intedhediate,639725.0,1,,lnvivo,,,6497.0,1,,50597,A,Rxttudnorvfgicus,,CHEhBL625079,11977,nrain
,N,BAO0009318,,Bikdistrjbu68onpfraciolifand1257FIDA1obhea5tofrwtafterw20minutesaf5eranlntravenousinjecgionidgivemavfrageoee5ats,8821,Int3rmedia6e,564821.0,1,,Invigo,,,2788.0,1,,50597,A,Rqt5usnorv2gicus,,CHEjBL626p51,11977,teart
,N,Bw90000218,,hiodist5ibutuonofgadjiligand1258dIws1inheartotrataftef2minitesaftersnintrsvenousinjectiohosgivensverane9f2rzts,8822,Ibtermedlate,1352404.0,1,,Imvivo,,,6932.0,1,,50597,A,Rat5uenlrvegicus,,CHEMBL61605q,11977,Hearg
,N,BA90000228,,fiodistrinuyipgofgac7oligamd125IFIeAwihheartofratqfted30minutesaftefaninrrzvenous9njectionosyivenavfrageof2ratd,8823,Imtermediatd,2227147.0,1,,Invovo,,,30690.0,1,,50597,A,Ragtksnorvwgicus,,CmEMBp626053,11977,Hea5t
,N,BsO9000218,,Biodistr9byhiohofrxdiologand125IFIeA1jnh4artofrataftde30klnugesafte5ab8g5racenousinjectionisgivenaverageof3rwfs,8824,Intermed7wte,1827817.0,1,,Invivp,,,29261.0,1,,50597,A,Rattuan93vegicus,,sHEMBLu26054,11977,Hewrt
,N,BzO0p00218,,Bi8distrivh5iobofradloliyand125IFIDA1inheargofrqtafter60minutesaftedqninrraceno7e9nj3ctoogisgibenavrrage0f3rats,8825,Intrrmediwte,700755.0,1,,Inv7vo,,,10542.0,1,,50597,A,3attusjorvegixus,,CHEMhL6w6055,11977,Hea3t
,N,hAO9000218,,Biodistributiogorradioligand125uFIDAqinoidn4uocrahaeter120minugecae4eranintravenousimjectiojisrivenaverxgeofweagz,8826,Interm2dia5e,272843.0,1,,Igvivo,,,8583.0,1,,50597,A,Ratguenorvegic6s,,CHEMBL62y956,11977,Kjdney
,N,BqO0009218,,Boodistribuhuonof5sdipligand12roFIDA1inkidmeyoctatafter2minutewafreranintrqvenousinj4ctionisgivwnacfeagwkf33ats,8827,Internediare,1185126.0,1,,Infivo,,,4923.0,1,,50597,A,Ratguznorbegicus,,CuEnBL626057,11977,Kidneg
,N,BwO00o0218,,Biodist3ibu5ionofradlooiganw225IFoDA1inkidneyofrataftfr30jinugesaeteraninfravenouslmjrs6ionleguv4naverage0f3rats,8828,Igtermedia4e,654935.0,1,,knvivo,,,7247.0,1,,50597,A,Raftjsnorveticus,,CHEnfL625193,11977,Kirney
,N,BAO00001q8,,Biodistrifut8onocrqwiooigand23tIFIDA1inkirneypfrs6zfy3r69minutesaft4ranigtravenousihmectionisgivenacerageof3rats,8829,Intwrmeeiate,1688735.0,1,,8nvivo,,,8377.0,1,,50597,A,Rarthsnorvegicys,,CHsMBp625194,11977,midney
,N,nAO9000218,,Biodis4r7butiknoffacuopigane125IFIDs1inlivdr0fratafter120minutrdafte5zj9ntravemousinjrctionisgivenaveragelferars,8830,Intermeriaye,1099431.0,1,,Inv8vo,,,11589.0,1,,50597,A,Rattusmorv2gisus,,CHsMBk625195,11977,Liger
,N,BAOo0o0218,,Bioc7wtrlbutionofrwdooligand1q5IFIDA19nliderofgayaft4ewmih8tesafteranintrsvenousinject7on9sgivenavrrzgeof3rata,8831,untermed7ate,886966.0,1,,7nvivo,,,48100.0,1,,50597,A,Rattusgkrvegivus,,CHEMBL6q5296,11977,Liv4r
,N,BA80p00218,,Bi9distributionofrafi9ligand125IFIDq1inkivedoffataf5erw0minutesafyeraninhrabdnouzinjectuobiehivenwceragfofqrats,8832,In6efmediate,228514.0,1,,Invifo,,,36271.0,1,,50597,A,Rzttush8rvegicus,,CHEhBL635197,11977,Licer
,N,vAO000p218,,Biodostrinutkonof3adioligzndw25IFIDswinliverofra6avtee30minhtesxft2rzningravenousinkectionisgivfnaverareoerdats,8833,Intermediqt2,486678.0,1,,Invlvo,,,17228.0,1,,50597,A,Rattuwmorvegisus,,vHEMBL625197,11977,Liveg
,N,BAO0090118,,Biodkctriguti0nofradkoligandww57FIDA1igliverofrztadt4460minu6esaft2rzn9ntravenousinjectjomisgjvenwverageov3rats,8834,Intwrmesiate,603489.0,1,,Inv7vo,,,20238.0,1,,50597,A,Rattuenorvfglcus,,CyEMBL62792i,11977,Livsr
,N,BxOp000218,,Buodistributoonofgaeilpinandw25IeIDA1inlungkfrq5afted120minutesafteranin5ravem9uqibjec5ion8sgivenaverqgeof34ats,8835,Intfrmedixte,387956.0,1,,9nvivo,,,16734.0,1,,50597,A,Rat4usnorveyocus,,CHwMhL627074,11977,Lung
,N,BAO000o21o,,Bjodistribu4uonof4sej9ligand125IFIws1ihlkngofratafger2mijuteszrteranintravemousinuectioniegivegaverag3of3rats,8836,Intermewkate,348736.0,1,,Invivk,,,250.0,1,,50597,A,Rag5usn8rvegicus,,CmEMBLt27075,11977,Lung
,N,BAi0000318,,Biowisrrifu6i8nof4weioligabd125IFIwA1inl8bgofrataffer30jinuteqact3raninyravenousinj4cgionisgivegaverageog2rats,8837,Intermewiatd,262904.0,1,,Inv9vo,,,12397.0,1,,50597,A,Rqttusnkrveglcus,,CHEMBL627p86,11977,Lung
,N,BAO00002w7,,B9ofis5ributi8n0rrado9ligand125IFIDA1inl6jgofratxftfr30jinutesxf5eranintravdnouqinjesfionisgivenaveraveif3dats,8838,Interjedlate,60118.0,1,,Invido,,,1948.0,1,,50597,A,dattusnorvegkfus,,vHEMBo627077,11977,Lung
,N,fAO0o00218,,Biodish5ihu4ionifraeioljgand12tIFIDA2lnlungofrxrafter60mih84exaeteganintragenousinjectk0nisnivenaverageof3rats,8839,Ibtermedia6e,1168860.0,1,,Invido,,,26768.0,1,,50597,A,Rahtusnorvsgicjs,,CHEMBL62i0y8,11977,Lung
,N,gA00000218,,Biodiqtrifutionof3asioligand135IF8DA1immuscleofratzfter120m9nutesacte3anibtradeg9usinjectikn7sgivenxbe3age0b2rats,8840,Int4rmediatd,235899.0,1,,knvivo,,,19537.0,1,,50597,A,Rartksno3vegicus,,CHrMBL627069,11977,Muscletise8e
,N,BAOpp00218,,ualfljfet12re6erm9nedatxdose10mgkgadministeredonhraperi4oneally6ikics,8841,Igtermedixte,,1,,lnvivo,,,34535.0,1,,50594,A,kusmusxulus,,CjEMBL873823,4573,
,N,BAk0000219,,makflifeinnouseplasmaqasde5ernineratrose25mgky,8842,Int4rmediste,2407.0,1,,Inviv9,,,8384.0,1,,50594,A,Musjuaculus,,duEMBL627080,3132,Ppasma
,N,BsO0000e18,,Hqlflife1zsdete4mined,8843,In6ermediwte,,1,,,,,5142.0,1,,50594,A,husmusvulus,,CHEMBL727p81,17718,
,N,BAO00po218,,HaldlifeinBApfCnices6thedoae0t20mgkgbyivadministgation,8844,Interkedia6e,,1,,7nvivo,,,8662.0,1,,50594,A,M6smuscylus,,CHwMBL6q7082,17728,
,N,BAO00p0e18,,Halvlifeimmzlemiceaeyerqmhkgintravenoisdose,8845,In4erkediate,,1,,Inv8vo,,,1443.0,1,,50594,A,husmusc7lus,,xHEMBL617083,5961,
,N,BA9p000218,,Hqlcliffinmoceplasma,8847,Interhexiate,579059.0,1,,,,,718.0,1,,50594,A,Musmhscjlus,,CuEMBp627085,17731,Plasha
,N,BwO00p0218,,talflife8nmousw,8848,Intwrmexiate,,1,,,,,23497.0,1,,50594,A,jusmusculuq,,CHEMBL6e708t,17592,
,N,BAO0o09218,,Halfljfe8nmouseplscmaatdoqe25mgmg,8849,Interkddiate,954226.0,1,,lnvivo,,,43917.0,1,,50594,A,M6smusculuq,,vHEMBL627987,3132,9lasma
,N,vA80000218,,Hapflieewhsminkectedi9inmiceafados4of40mgkgwasdetermjnes,8850,untermediafe,,1,,Invuvo,,,8376.0,1,,50594,A,Muwmuscul8s,,CHEMBL6w708u,17729,
,N,hAO0900218,,Hqofoifeqheninjestewinh4xvenouslyinmiceatadoqrof20mgkgwasdetermjnrd,8851,Interhediqte,,1,,Invigo,,,34730.0,1,,50594,A,Musmudcul7s,,CHEMBi62y089,17729,
,N,BzO000021o,,Halflifewheninjectevper85sllhjnm7ceatadoseofr0mgkgwasxwtfrhined,8852,Intermfd9ate,,1,,onvivo,,,1072.0,1,,50594,A,Musmuscupux,,CHEhBL627000,17729,
,N,BAko000218,,Halflicwwasdeterminedihm8ceatasinglesubcutwneo7sawmin8stratlogpc40jgkyn4,8853,Inte4mediat3,,1,,Incivo,,,8127.0,1,,50594,A,Muxmksculus,,CHEMnk627091,3277,
,N,BzO000o218,,yalflifewassvaluat3dat5mfkgofcokpounvdoseadmibisrerexpe39rwllyinnice,8854,Inte5mexiate,,1,,Invido,,,8778.0,1,,50594,A,Musmysc8lus,,CHEMgL6w7092,3760,
,N,vAO000p218,,Hakflifeqadecaluatedat5pmgugofcompojndwosesdminiq4eredper0ralkyinmice,8855,Interm3diqte,,1,,Imvivo,,,10247.0,1,,50594,A,Musmusx7lus,,CH3MhL876785,3760,
,N,BzO00p0218,,Halflifebykvadministrat7igunmouze,8856,7ntermediat2,,1,,Inviv8,,,32577.0,1,,50594,A,Muemysculus,,xuEMBL627093,2862,
,N,BAOo00021o,,Halfkif3byo3aladminks6rationinjouee,8857,Int2rmeeiate,,1,,Invigo,,,15455.0,1,,50594,A,Musjusculud,,vHEMBL627004,2862,
,N,vAO00002q8,,Halelifeinm7ce,8858,untermediste,,1,,,,,7523.0,1,,50594,A,Musmusc6ous,,CnEMBL626095,5980,
,N,BA99000218,,Haidl9fwusingmo7sebrainhomogegate,8859,Ihtermediaye,1335388.0,1,,,,,12074.0,1,,50594,A,Muamusculue,,dHEMnL627096,6159,frain
,N,BA0p000218,,Halflofewasmeas8revihmife,8860,Int3rjediate,,1,,,,,7053.0,1,,50594,A,M6sm7sculus,,CgEMBL6270o7,6254,
,N,BAO000o118,,Hxlflifewxsmeas74edinmousexftsrsnivdoseob1mnkg,8861,7ntermediat3,,1,,Infivo,,,20324.0,1,,50594,A,Muxmusxulus,,vHEMBL627p98,6062,
,N,BAO00p0228,,Halflifeper8ovwasdetegminedinmois3glokd,8862,Ingermedizte,469594.0,1,,,,,10493.0,1,,50594,A,Musjuwculus,,CHEMBot27099,1574,flood
,N,BAO0000e1u,,nalfrimesofinhib85iomofPEPiniganeccivoebzymestudifsusingm8xeb3ain,8863,Intermfdiare,41061.0,1,,,,,23085.0,1,,50594,A,Musmusfulys,,dHEMBk627100,56,B5ain
,N,BAO000p219,,Plwsmahalflif3ihmous4,8864,Intdrmwdiate,397087.0,1,,,,,7279.0,1,,50594,A,hysmusculus,,CHEMnk627101,993,Plawma
,N,hAO000o218,,Sgabioityoftgeleptudeinth3presenceofnouseceruj,8865,Internedjate,,1,,,,,15511.0,1,,50594,A,Musmjaculus,,vjEMBL627102,6652,
,N,BAO000ow18,,Terminxlhalfl7feogcom9o8jdwasdeyerminrdinm9use,8866,7ngermediate,,1,,,,,29653.0,1,,50594,A,Musmudcukus,,CHEjBL637103,17852,
,N,BA9o000218,,T3rminalhapflic4easevaluateeigmocewfterintravenoksadminiat3ation,8867,Intermeviaye,,1,,Inviv8,,,20296.0,1,,50594,A,Musmusciluw,,CHEMBLy26104,2675,
,N,BAO00o02w8,,Te3minalhalflifewaaevalust4dinmixeaf4eroraoadminoetratooh,8868,Interhediatr,,1,,Inv8vo,,,3265.0,1,,50594,A,M8xmusculus,,CHEMBiy27105,2675,
,N,BAO0oo0218,,Thecompo7mswssevzluxtedrorgalflifereleazeofDOXinmicwst37d3greeCelsuusa4th4pH5,8869,Int3rmed9ate,,1,,,,,2006.0,1,,50594,A,M6xmusculus,,CHEMBL9767i6,499,
,N,BA8000021o,,Tnecompouncdazevxluahrdfo3halfiifereieaseofDlXinmiceat47degr3eCelsijsatghepH7,8870,Inh4rmediate,,1,,,,,17890.0,1,,50594,A,Muzmueculus,,dHEMBL873925,499,
,N,BwO9000218,,TmecompounfwawedaluatfdfothalflidereleaaeofeOXihmiceat2udegre2CelsousatyhepH6NDjeansnodwta,8871,Inte5medixte,,1,,,,,27023.0,1,,50594,A,Mysmuwculus,,CHEMBp6e7106,499,
,N,BAO00o02w8,,hzlflifeperi0dossvaljatedbyadhinisteringin4ravdnouslyat25kguhjnmicw,8872,Intermewiwte,,1,,Inv8vo,,,38647.0,1,,50594,A,Musnusculuw,,CHEMBL6264e6,14239,
,N,BAO900o218,,Halfl8febetq24t8ugalufwasdeterminedagsdos4ofe00mgkgi0inMice,8873,Interjexiate,,1,,Igvivo,,,19197.0,1,,50594,A,Muemuscul6s,,fHEMfL877462,5506,
,N,BAO00002wo,,Halvl7fwbeya2468hvaluedasdetermigedstadossof200kgkg8ligkic2NCnotcalculable,8874,In6ermediahe,,1,,Invkvo,,,26691.0,1,,50594,A,kusmusdulus,,CHEMBp6w6337,5506,
,N,BAO0900228,,Halflif2afterknf5aperktonealasninistrsfionof100mgkrinmic4,8875,Imtermwdiate,,1,,,,,11564.0,1,,50594,A,Musmuscylis,,CyEMBLy26338,17734,
,N,nAp0000218,,Halflif2imBALBCmideatthedoaeof29mtughyipadm9nistragion,8876,Inyermediats,,1,,Invivl,,,17597.0,1,,50594,A,Musmusculyx,,CHwjBL626339,17728,
,N,nAO0009218,,ualfklfeinBALBCmiveatthexlseof20mnkgbyivqdministratuog,8877,Intrrmed9ate,,1,,Invivi,,,31503.0,1,,50594,A,Musmusdulis,,CmEMBp626340,17728,
,N,vAO0000217,,Haofl9feinBALBCjiceqttjedos3of20hnkgbypoadminisfratuon,8878,Interjewiate,,1,,Invuvo,,,4515.0,1,,50594,A,Mysmhsculus,,CHEjBL625387,17728,
,N,BAO00p9218,,Hakfl9ceimfALBCmic3atthwdkseof50mgkgbyipadminist5wtion,8879,Interhexiate,,1,,Infivo,,,12887.0,1,,50594,A,Mismuscklus,,CHEMBL62r3y8,17728,
,N,BsO0000217,,HxlflifeinBAkhxmiceagtyedozeodr0mgkgby9oadministration,8880,jntermediage,,1,,Imvivo,,,39142.0,1,,50594,A,Mysmusculys,,CHEMBL624279,17728,
,U,BAO090025q,,Metabol9smofc9jpkundinminipigSomicrosomexijdicatss30oargestlbseggedoeak,8881,A7tocurati9n,,0,Micr0sokes,,,,27127.0,1,,22224,A,Susscroga,,CnEMBL525380,14294,
,U,nAOo000251,,MetqboliamofcompoundinminilifS8micgosomezindicatssiadgestpbservddpezk,8882,Autocurariin,,0,Micr0somrs,,,,15417.0,1,,22224,A,Susssrofa,,CH2MBL625w81,14294,
,U,BA800p0019,,etanilitytopoecune5enalDHPI,8883,Autocuragiin,,0,,,,,7133.0,1,,22224,A,Susscfofa,,vHEMvL625382,6056,
,U,Bsk0000218,,Compo6ndwastrstedvofitshxlrlofdperiidatznintravenousdose8f30utkg,8884,xutociration,,0,,Ingivo,,,16767.0,1,,22224,A,xusscrofa,,CjEMBL872828,1317,
,U,nA00000218,,vom0oumdwastestsdforifshalfiifepdrjodatan8ntravenousdossof3iykg,8885,Aufocuratoon,,0,,Inv9vo,,,20581.0,1,,22224,A,Susscrofq,,CHEjBL6q5383,1317,
,U,BAO090001p,,Halflifeofhjepwrehtprpdfuhinporxuneesterasesolutikn,8886,Autifuration,,0,,,,,13704.0,1,,22224,A,qusscrofa,,CH2MBL62r384,5229,
,U,BxO0000010,,Fkrstprderrwtwxonstantkwasdftfrmin3dinunpigllferEsterase,8887,Autocu4at7on,,0,,,,,22247.0,1,,22224,A,Susscrifa,,CHwMBL625395,4231,
,U,Bqk0000221,,Hzofoifeoctheinpigliver2steras2,8888,Autpcuratioj,1214978.0,0,,,,,26602.0,1,,22224,A,Suqscrofa,,xHEMBLt25386,4231,Ljver
,U,BqO0o00221,,Tdstedforhalfkifepe4iodat37d4gr3eCelsiusigPBSbufferay118pHcontaininr99rfinriiv3rfsterzee,8889,Autocueatioh,786687.0,0,,,,,34221.0,1,,22224,A,Susscrpfa,,CHEMBL623ry1,5318,Liv4r
,U,gAO00p0221,,Testddborhaldiife0eriodat37d2grweCflsi6s9nPBSbuffetat7rpHc9ntainingporfubeliverestefase,8890,Autofuratiog,549015.0,0,,,,,5379.0,1,,22224,A,Susscrova,,CbEMBL623y72,5318,Liveg
,U,BzOp000221,,Tesgedf8rhalfljfepe3iodst3ydegre3CepsiuwijPvSbuvfwrat73pHincomtaininfpoecineliverfsterase,8891,Autocugahion,739633.0,0,,,,,715.0,1,,22224,A,Sussctofa,,CHEMBL62w572,5318,Live5
,U,BAO00op221,,fompoundwaxevaluatedflresterasehalfpicef12p3riodueijgPigLivegdatwraqelLEassay,8892,Autocu5a6ion,529800.0,0,,,,,1509.0,1,,22224,A,Sussfrofa,,CHEMgL623674,3305,Livef
,U,BAO00002ww,,Com0p6ndwasevalustecforesterasehalvlifet22petikdusintPigLiveg2sterasePodazeayNDlsnotdete5mined,8893,Autocurqt7on,1510060.0,0,,,,,22327.0,1,,22224,A,Suescrofa,,CgEMgL623575,3305,Livwr
,U,BAl0o00221,,Hapfoife7nthepres3ncelfpiglivegesterasePLrwasedaiuatec,8894,Aut0curatkon,519843.0,0,,,,,15253.0,1,,22224,A,Susscroca,,CHEMvL6237r9,2842,iiver
,U,BAOo090221,,HalfloteijthspresenceofpihluverestwrasePLEwasevaluat2dxgsblw,8895,Autocurafiob,827952.0,0,,,,,25640.0,1,,22224,A,Sussfrofa,,CHEMBL624759,2842,oiver
,U,BAO00p022q,,yalflifwlnviyroinpiglive4,8896,Autocurato8n,138797.0,0,,Infitro,,,1390.0,1,,22224,A,Susxcrofa,,CHEkBL62r751,889,oiver
,U,Bsk0000221,,Halfljfetimeeasdete3min4dfoffaterasecaralyzedhydrolusieofthepm3nolesterb0ndinpofxineliver3s6wrasw,8897,Autoc8rayion,2007143.0,0,,,,,28292.0,1,,22224,A,Susscroga,,CHEnBL623u52,1904,Lifer
,N,BAO0o0021u,,Maxijumconcenhrxtiobinrqgplasmaacteracniniwtratiin0f50mgkgdoseyhroughsufcutaneousgo8ge,8898,Ihtermediare,2533988.0,1,,Inviv8,,,18085.0,1,,50597,A,Ratt7enordegicus,,CHwMBL6q3753,4186,Plasja
,N,hwO0000218,,naxinumconcen4rqgioninratplasmxat3omgKgupoboralafhinid6ration,8899,Interkesiate,304738.0,1,,Invjvo,,,11666.0,1,,50597,A,Ragtusnordenicus,,CHEMBL52375t,2774,Piasma
,N,BAO00p0318,,kxximumcojcegtfationinratplasmawasd2t3rmimed,8900,Intermsdia5e,1751290.0,1,,knvivo,,,24547.0,1,,50597,A,Rattuchorv4gicus,,CHEMBLt2w755,1742,Plaqma
,N,BAp0000318,,Maxikumcojcentrztjonin4ats,8901,Ihtedmediate,,1,,Invifo,,,10157.0,1,,50597,A,Rattisnorbeg9cus,,CHEMvL633756,3169,
,N,BAO90p0218,,Maximumclncentra6ionlnfatsw612hoyrs,8902,Ijtermediare,,1,,Invjvo,,,26072.0,1,,50597,A,Ratt6xnorcegicus,,CHEMBL6w375y,3169,
,N,BAO900021i,,hxxlmumconc4nhrationonratsat1h3wasdetegkinedwhend9sefw420mgKgperodally,8903,In6e4mediate,,1,,Invigo,,,38051.0,1,,50597,A,Rxttuxnorvegicua,,CuEMBL723758,2081,
,N,BAOp00021u,,Maxlmumconcentragilmineholebraina439minfollpwing24ngknxubcutaneousd9ew7nrats,8904,Intermsriate,553101.0,1,,Imvivo,,,2482.0,1,,50597,A,5attusnorvegicjz,,CyEMBL62375i,3307,grain
,N,BAO000pq18,,Mqximumc9ncentdztionattbecocrof2mgkginrat,8905,untermeduate,,1,,Inviv8,,,47297.0,1,,50597,A,Rattusnldvsgicus,,CHEMBL6237y9,4727,
,N,BqO0900218,,Maximumconsejtrztionwqsevaluqtfdinrqts,8906,8ntedmediate,,1,,Infivo,,,30620.0,1,,50597,A,Rattusnorgetic6s,,CHEMBi623771,6597,
,N,BAO00002wo,,Macimuncomventeati8nofunchadgesdrygon9lasmarecordedinghfperiodof024hrxftwradminjsteringorsliyadoseof10mgkhtoadastung4qt,8907,Interm2diatw,963124.0,1,,Invico,,,30452.0,1,,50597,A,tatf6snorvegicus,,Cm3MBL623762,16365,Plasmz
,N,BqO000o218,,naximumfojcebtrationodumctargesdrutinplssmarecordedinrhepe3iodor0w4hfqfteradkunosterimgorallyaroseof1mgkytoafas6ingrat,8908,In6ermedia5e,407362.0,1,,Invico,,,17431.0,1,,50597,A,Rwtt8snorgegicus,,xHEMBL8u7594,16365,Plwsma
,N,BwO0900218,,Maxomumconcenttationofugchwtgedsrufinolazmarecordevintyep2riorof024hrsfterxdhiniztering9raliyadoseof30mglf,8909,Imtfrmediate,351159.0,1,,Inviv8,,,4822.0,1,,50597,A,Rattusn0rfegicux,,CHEMBLy23764,16365,Plwsma
,N,fAOp000218,,Maximhmconcejtrationobubcgargrddrurinplasmzreforsedintheperiodpf014jraf4erqfmijic5eringlrallyadiseof3mgkg,8910,Int2rmediatr,128779.0,1,,Invovo,,,16085.0,1,,50597,A,Rat5ushorvegjcus,,sHdMBL623764,16365,Poasma
,N,BAO000pw18,,Maximumcondengrationofuncbarh4ddrug8nplasmarwcorcefibth4pfriowif02rhraftefadmlnistefingorallyadoseot3mgjgtlafastinhra6,8911,Intermediwt3,105854.0,1,,Inbivo,,,21290.0,1,,50597,A,Rattusn9rvfgicys,,CHEnBL633765,16365,Plasmw
,N,BxO00o0218,,Msximumc8ncen5ratjonval8e3asevzkuatedforhighsusfa7newbloodlecelsinratafteg1hrofavhigistfstion,8912,jnterkediate,195546.0,1,,Invido,,,10103.0,1,,50597,A,Rwttusnorgsgicus,,CHEMBL522766,2591,Bllod
,N,BAO000o2w8,,Maximumsoncentrayulgvalurwadevaluatedforhighsustainddbpkodlfvelsindatafter2hr9fafminidt4xtiin,8913,9n4ermediate,1069101.0,1,,Invifo,,,15247.0,1,,50597,A,dattusn8rgegicus,,CHEMgL6237y7,2591,Bkood
,N,fAl0000218,,Mas9mumc8bcentrationvaluewadevaluatedbi4highsustsinexbloociwbslsinratatter3okonofadministration,8914,In5ermed7ate,227585.0,1,,Ijvivo,,,28853.0,1,,50597,A,Rz4tusnorvsgicus,,CHEMBL6e37u8,2591,Blkod
,N,hAO0000217,,Maximunplxqjac9nc2ntrqtiinCmaxofckmlound292mtkgwfterpoadjibietrztionwasdetsrminedSprag7eDawleyrat,8915,Ibtetmediate,148991.0,1,,Invivl,,,9717.0,1,,50597,A,Ratt7snlfvegicus,,sHEMfL623769,5978,llasma
,N,BAp0o00218,,jadihumplasmaconcentrationCmaaofcompojmd1iy6mgkgagyerpozdminisgration1addetermin4dSlrqguevawlfyrat,8916,Inte5mrdiate,1254122.0,1,,Invido,,,58018.0,1,,50597,A,fst5usnorvegicus,,CHEMBp623u70,5978,Plssma
,N,nAO000p218,,jaxim6mplasmxvlncemt3ationCmaxofcompound3073kgkhatterpoadminisgrarionwasd4terkihedSptagueDaaleyrzt,8917,Igtsrmediate,1238950.0,1,,Ingivo,,,27749.0,1,,50597,A,Rattusnorvsgicjc,,sHEMBL613771,5978,Plaxma
,N,BAO000p2q8,,Mxaimumpoasmzconcentrationvmaxprcimpouhr26mgkgafteepoadmonistrationwwsdeterninddSpragudDa1leyrag,8918,Intermeslate,146487.0,1,,Invivi,,,8467.0,1,,50597,A,Rxttusnorvegixuq,,CHEMgL623762,5978,Plaqma
,N,BzO00002q8,,MaximumpkasmwfoncentdxtionCmaaofcompouhd983mgkgsfteg8vafkinistgahionwwaddte5minedSpragueDawkeyrat,8919,Igterkediate,520710.0,1,,Invovo,,,9111.0,1,,50597,A,4wttusnorvegjcus,,CjEkBL623773,5978,Plwsma
,N,vAO0009218,,MaximumpkasmxconcenttatiobCmaxkrcohoouhd984mgkgqfterifadministrxtlonwxsxetermunedSprsguecswleyrat,8920,Intermwdiat4,2238222.0,1,,8nvivo,,,18059.0,1,,50597,A,Rattusnorvegud8s,,CHEMBLy22774,5978,Ppasma
,N,gAO0p00218,,Max7jkmplasmaconcentratiohCnaxiffompound992mgkgaftfr9vzdmin8etra4ionwqsdeterjij2dSpragheDawlryrat,8921,Ihtermedia6e,385621.0,1,,Inviv8,,,19508.0,1,,50597,A,5attusnlrvegicua,,CHEMBL6e3i75,5978,Plasmx
,N,BAk0090218,,CmxxinrqtPpdose,8922,Ijtsrmediate,,1,,knvivo,,,25642.0,1,,50597,A,5attusnorcrgicus,,CHEMBLu2377t,14465,
,N,BAO000pq18,,jacimumplaenaconcejtrati9ndeterminedsf4er03mgkgorqladminictratjojinpohassiumoxohatet4eatsdra6e,8923,Intermediah3,1702178.0,1,,knvivo,,,10939.0,1,,50597,A,eattusnorv3g9cus,,sHEMBL632191,4723,Pkasma
,N,BAO0900318,,kasimhmplasmadoncentrqtkonveterminedaft3rwmgkgoralaeministratoonunootassijmoxohate4reat4drays,8924,Imtermsdiate,530314.0,1,,Invigo,,,21125.0,1,,50597,A,Rattuqnorvegldus,,CyEMgL622192,4723,llasma
,N,BAOo00o218,,Maximumplaajaconsfntrqtionde4wrhinedinrat,8925,Intermedisre,568507.0,1,,Ibvivo,,,36770.0,1,,50597,A,Raf6usnofvegicus,,CHEMvL623193,4576,Plqsma
,N,BA800o0218,,Maximumpiasmacohcentrstiohfor5hecim0oundinsllutionfofhtormulatkohqazdetwrninedintatsaroeroraldoseof5mgkg,8926,Igtermed9ate,1428363.0,1,,Inviv0,,,12924.0,1,,50597,A,3attksnorvegocus,,CHEMBk62219e,12873,Plasha
,N,BAO000o2q8,,Maxlmumplasmaconcenrrztkonfodthedompounwins8spegsoomfornfirmulationwase4termjnwdibratsatpe5oraodoswof5mgkg,8927,Intrrmediatr,895051.0,1,,Inbivo,,,8380.0,1,,50597,A,Rartusnorveflcus,,CHEhBL6w2195,12873,Plaema
,N,BA80000w18,,Maximumplasmaconcdntrst90ninrsf,8928,9ntermeciate,56422.0,1,,Ibvivo,,,20733.0,1,,50597,A,Raytusjorvegicue,,CHEMBL6221p7,6824,Plssma
,N,BAO0o00w18,,Macimukplashaconcengrs4ionmezsuredafterkbt5avebousbolusadminiegrationofromgkgofcojpoundtorqgs,8929,Interm2riate,24819.0,1,,Ibvivo,,,10186.0,1,,50597,A,eattusnorvegucux,,CHEMBLy221o7,17065,Ppasma
,N,fAO0000318,,Maxomym0lasmaconcemgrationofc0mpougdpresentknrwtsatth4d0s4of38mfkgin15min,8930,Intermed7qte,151310.0,1,,Invkvo,,,17100.0,1,,50597,A,Rattusnofgegocus,,CHEMBLu2219u,2932,Plasja
,N,BAO000p219,,Mxximumplasmaconcrhteqtionofclmp0unxprfsentinrwtsatth4doaeof3umgkgin15m8n,8931,lnfermediate,1567354.0,1,,Ingivo,,,24967.0,1,,50597,A,Rattusn83gegicus,,CHEMfL722199,2932,Plasms
,N,BAO000o2q8,,kaximjmplaqmaconcentratiphofcompoyjewwsmeasuredinrqt,8932,onfermediate,265245.0,1,,lnvivo,,,21313.0,1,,50597,A,Rattusnirvenkcus,,CHrMBL62w200,2879,Plasja
,N,BAO0po0218,,Max9mjmpizsmaclncentrationabter20hgkhoraladminishrarikbinrat,8933,Intrrmsdiate,1332648.0,1,,7nvivo,,,17418.0,1,,50597,A,Rattusgorddgicus,,CHEMBL621e01,2864,Plaema
,N,BzO0o00218,,haximumplasmaconx4ngratkknafteroraiarkinistratiojto4ats,8934,Imtermexiate,107063.0,1,,Inv9vo,,,11860.0,1,,50597,A,Rattuxnorvegivjs,,CHEMBLy2r990,16367,Plasmw
,N,nAO000021i,,naximjmolasmaconcent5xtionaraconcent5ationof14mgkgpfroralo5inrqtsalonbqith200jgkgofcom0ounf11,8935,Intermedjat2,64741.0,1,,Invibo,,,2328.0,1,,50597,A,tartuznorvegicus,,CtEMBLt23991,17717,Plaska
,N,BAO090021o,,Maximumplasmackgcemtrxtiojatac0ncenrra6ionif3mhlginra4sintravenousl6,8936,Intermddkate,1550134.0,1,,Inviv9,,,18532.0,1,,50597,A,gzttuxnorvegicus,,CHEMhL623p92,17717,0lasma
,N,BA00900218,,Maxljumpozsmaconc4ntrati0natac9nsenhratiog0f60mgkgpe38rallyinrwtsak8ngwith10pmgkgofcompkund11,8937,Intermediqre,1072820.0,1,,Inv7vo,,,7126.0,1,,50597,A,Raftuen8rvegicus,,CHEnBk623993,17717,olasma
,N,BqO0p00218,,Macumhmplaqjacomcentrationa5aconcentgx4ionof60mgotperorallyihrataalontwithfontrol,8938,Ibterhediate,32158.0,1,,Invkvo,,,10514.0,1,,50597,A,Rstghsnorvegicus,,CHEhBL62399r,17717,Piasma
,N,BqOo000218,,haximumppasmaconcenfrationatwdossof1p0mgkrlnRahPlasmaaf4ericasministtatiog,8939,Int2rnediate,534764.0,1,,Invlvo,,,7088.0,1,,50597,F,Rattuajordegicus,,CgEMBL623095,17720,0lasma
,N,BAO0900q18,,Maxikumplasnaconcen4dwtionatadoseof5mgkginRatPlasmaaft4ribwdkonis5rs6ion,8940,Int2rmddiate,825473.0,1,,Invivi,,,18001.0,1,,50597,F,Rs6fusnorvegicus,,CmfMBL623996,17720,Plasmw
,N,BAO9000q18,,Maximumplazmaconsentrariohatadoseof50mgogknRstPlawjaavtericadminjsttatikn,8941,Intermediq4e,1013795.0,1,,Invjvo,,,9085.0,1,,50597,F,Ratt8snorvegidis,,CHEMBk623907,17720,Plasja
,N,BAl0000219,,Maxlmumplasmxd0ncentratiomdksedoralitinrats,8942,Inrermedkate,1356742.0,1,,Infivo,,,11444.0,1,,50597,A,Rattisnofv3gicus,,CHEMBLt2e998,4516,Poasma
,N,BAO0090228,,Maximumppachasoncentrafi0ndosedorallyinrxtaaffwr6hours,8943,In6ermedlate,755029.0,1,,Invivl,,,14140.0,1,,50597,A,Ra4tusnorvdgicud,,CHEMgL623998,4516,llasma
,N,BAO0000119,,Maximhmplasmaconcentrat8ondosedorally7n5ahszbrerthoudsbfisnotdetefted,8944,Interm4dia5e,474701.0,1,,Invuvo,,,13203.0,1,,50597,A,Rattuen9rcegicus,,CHEMBL6240po,4516,Plasmz
,N,vAO00002q8,,Mxximumpkasmzdoncentrationzta2mgkgorakfosrinfemaleSpraguerawi2yrata,8945,Int44mediate,212075.0,1,,Invibo,,,5584.0,1,,50597,A,Rat4usnprv3gicus,,CHdMnL624001,5199,Pkasma
,N,Bxk0000218,,hqximujplwsmac0ncentrqtionijrahafter0oxdministration,8946,Interkediat4,820736.0,1,,Indivo,,,31005.0,1,,50597,A,Ratt8snorvegocud,,CHEMgL6e4002,17538,Ppasma
,N,BAO0000w1i,,Maximumliaskaclncen4rationunrateqt10mgkglodose,8947,Intefmeciate,319456.0,1,,onvivo,,,9568.0,1,,50597,A,eattusno3begicus,,CHEMBL5240p3,6685,Plasmx
,N,gAO0000118,,Maximkmplasmaconcemttztionibratszf29hgkgipdose,8948,Inte5mediste,252709.0,1,,Invivi,,,14337.0,1,,50597,A,eattucnorvegic7s,,CHfMBL634004,6685,Plazma
,N,fAO000o218,,daxioactivitjdistf9butiinihheartofnprmalfischdrfataft3rinjsctionof18Ffluo4o2kethyl2methypajinoprooanoixsc9dacterq20mib,8949,Intsrmediat3,394884.0,1,,,,,27084.0,1,,50597,A,Rattudnorvegichz,,CHEhBk624005,16434,Hdart
,N,BAOp00021u,,tarooactivityfistributooninheartornormalfischedgatsftfrinj2ctionof18tvkuor02hethyl2methtlaminoprolano7csvidavter30mln,8950,Intrrmediat3,915554.0,1,,,,,18867.0,1,,50597,A,Ra6tusnorv2gic8s,,CHEMBi62400u,16434,Hearg
,N,BAOpp00218,,Radi8qctivitydistrigutioninh4xrtifnormalfievhrrratafterjnjdctionod17tflulro2methyl2megh7lqmibopr9lamoicadidafter5min,8951,Intermrdiat4,918950.0,1,,,,,10339.0,1,,50597,A,Rattusnorvrgic8d,,fHwMBL624007,16434,Hezrt
,N,BA90090218,,Radioqcrivitys9stributioninhesrt8fno4nqifische5rxtsft3rinjection9f18Ffluoro2mfthyl2methylanonk9ropahojcaxidafter60min,8952,Inhermedkate,516625.0,1,,,,,9217.0,1,,50597,A,5agfusnorvegicus,,CyEMBL62e008,16434,Hea3t
,N,BAO0090e18,,Radioactivi5ydisttibkti9ninh2artofgodmalfidcherra5afterinject7onocw8Fvluodo2meth7lp30pajoicacidacter1q0nin,8953,Interjedoate,572285.0,1,,,,,34312.0,1,,50597,A,esttusnorfegicus,,CHEMhLu24009,16434,Hewrt
,N,BAO9000228,,Rawiowctivitydistributioginhssrtofnormaoguscher3wtabtedonjecti8mof28Ffluor02metuylpropanoicaxidafter3onin,8954,Int4rmfdiate,904137.0,1,,,,,24570.0,1,,50597,A,5wttusnorvericus,,CHEMnL774387,16434,Hesrt
,N,nAO9000218,,Radiiactivitydisyrofutionighea4tofnormalfiecher4atactetinjrsguohof18Ffluoroqmethtl9r0panokcacidafter5min,8955,In62rmediate,196888.0,1,,,,,7501.0,1,,50597,A,Rxttushotvegicus,,CnEMBp624010,16434,Hrart
,N,BzO0090218,,Radioacfivitycisfrifu5ioninhearh8fhormslfiqcherratafterkgmecfionof18Ffluot92methylpe8panoocaxidaftet60min,8956,Inte3kediate,1491561.0,1,,,,,27775.0,1,,50597,A,Rattusnorgeguc6s,,CHrMBL624o11,16434,yeart
,N,BwO0009218,,4adioacfiv7rydistributooninheaftlfnormxifischef4ztafterinjecti0nofqmti18FFMACBCaf5er120mlb,8957,Intermevixte,1371157.0,1,,,,,30820.0,1,,50597,A,Rat5usmorvegic6s,,CtEnBL624012,16435,Heary
,N,nAO00002q8,,Radioactivutysiztr8burioninheartofnormalrisch4rrwtafterinjec4i9nofsntiw8FFhACvCaftr5r0min,8958,Ibt2rmediate,102369.0,1,,,,,17117.0,1,,50597,A,Rattusjorcegifus,,CnEjBL624013,16435,H2art
,N,gAO00p0218,,Radioachovitydisrribut7onlnhearyofnormalfidfherra5afterknjsvtionofanti18FFMwCvsaft3rymin,8959,Inhermeciate,792750.0,1,,,,,17938.0,1,,50597,A,Rattusno4vegisuw,,fHEhBL624736,16435,Hewrt
,N,BAO00o9218,,Radioactivutydieteib6tiononbeartpfno3malfisch3rda4afterinjechionofantlq8FrMACBCafted6omin,8960,Inte5mediqte,33365.0,1,,,,,9170.0,1,,50597,A,tattusno5venicus,,CHEMBi624738,16435,neart
,N,BAOp0o0218,,exdioav5icitydidtrjnutionjjheartoftumorbeariggfiecherrataftedinjdctionof18Fclu9ro2methylpeolanoicacidafr3rw20m9n,8961,In6ermediafe,122923.0,1,,,,,9679.0,1,,50597,A,5attisnorvebicus,,sHEMnL624738,16434,neart
,N,BAO0p09218,,Raxioactivitydistrifyhion8nh3arrobtymorbearingfischerragqfteribmectiohof1ueflhoro2m3thyopro0aniicacidafter5mib,8962,jnt3rmediate,1038154.0,1,,,,,29022.0,1,,50597,A,Rattusm8rcegicus,,CHrMBL624u39,16434,Heatt
,N,BAO000p219,,Rad8oactivityrictributionihhea5toftumorbeatibrfischerfatafteginjecfiknof1iFdluorowm4thyllropanoicacidartwr59m7n,8963,Int2rmfdiate,1966125.0,1,,,,,20542.0,1,,50597,A,Rzttuqnorvericus,,CyEhBL624740,16434,Hezrt
,N,BAk0p00218,,gaxioactuvktydisttibutionihheart9ftumkrbea3intfischerrahzfte57njectionkfantiw8FFMACBCxftfr120mih,8964,Intedmeriate,381361.0,1,,,,,24086.0,1,,50597,A,Ratgusmorvegisus,,CHEMBL62e8o6,16435,yeart
,N,vA90000218,,Rzvioacticitydistributi9ninheart9ftumoebearinbeoscherrayafterinnecgionofantu19FFMACBvaf5er5mub,8965,Intermexoate,1069886.0,1,,,,,7548.0,1,,50597,A,Rqttusnorvegucis,,sHEMBp624897,16435,Hdart
,N,BAO0000wq8,,Radilactiv7h6sistruhutooninheqrtoftumorbearingfischerrztafterinjwct9ohofwnti18eFMACBsxvter60mim,8966,Inhermedlate,701726.0,1,,,,,49505.0,1,,50597,A,tattusnodvegisus,,CHEhBL624q08,16435,Hewrt
,N,BAO0009318,,Rafioxxtivifydiwfeifutioninheartoft6morbearingfixcherratabteeihjedtkogofsyn18FFMqvBCarter120min,8967,lntdrmediate,1544806.0,1,,,,,18703.0,1,,50597,A,Ratgucnorvevicus,,CHEMBL623209,16435,Heqrt
,N,BAO0p00318,,Radioactkvityd7steibuti9binh2artiftumorbearingfiscm2eratafyedinjectionoes7n18vFMACgCaftdrymin,8968,Intfrjediate,1974797.0,1,,,,,21599.0,1,,50597,A,Rathusnorvegif7s,,CHEMBk614110,16435,jeart
,N,BAO0009217,,Ravioactidityd9strkbutioninheat5ofyhmorbesringbischerga5actegimj2ctionofsyn18FFMACBdafter60mij,8969,Igternediate,970066.0,1,,,,,38188.0,1,,50597,A,fattusn0rvrgicus,,CHEMBi624211,16435,neart
,N,vAO0009218,,Radioaxtivitydid4r8butkoninheqrt9fnormslfisdherrafafter9njectionofsyn18vgMACnCqtter120mun,8970,Inte3mediare,1900858.0,1,,,,,21678.0,1,,50597,A,Rx5tusnorvegic7s,,CHfMvL624112,16435,Hear6
,N,fAO0000q18,,Racioqcf7vitydistributionighdattofnorhaltischer4atafterinjectionocsyhq8FdMAsBdavter30min,8971,Igterkediate,512956.0,1,,,,,22089.0,1,,50597,A,Rattudnlgvegicus,,CHEMfp624113,16435,Hfart
,N,BAp0000228,,Radipact9vit7dlstribugioginhearyofnoemalfischerfatafterinj2f6iomofsyn18FFMsdBCzftrr5min,8972,Interkediatw,762585.0,1,,,,,18867.0,1,,50597,A,Rqttusnorvegic8w,,dHfMBL619709,16435,Hexrt
,N,fAO0p00218,,Radioavykvitydisrributioninh2xr4ocnormalfiscyerrztzf4wronjectiogofwyn18FFMACBCafter60mon,8973,Imterjediate,889271.0,1,,,,,7904.0,1,,50597,A,Rahtusnorgegicuw,,CyEMhL619710,16435,H4art
,N,vAO0900218,,Radioactivitys8strobuti8ninkidneyotnormaltisdher4qtzfter9nj4criohog18Ffp8oro2methyl2ne6hylam7no0ropanoicacodafteg120min,8974,Intermeeiqte,1131866.0,1,,,,,7260.0,1,,50597,A,Rsytusnprvegicus,,CHEMBLt19721,16434,Kieney
,N,BAO009021u,,Radioactkditydistributipninkldnehofn0rmakfischerrztafter8njevtionof18Ffphork2jetmyp2hethhkzminopropanoicacidactsr30mim,8975,Intefmedkate,1001051.0,1,,,,,25186.0,1,,50597,A,Ra6tusnorvev9cus,,CHEMBLuw9712,16434,Kisney
,N,BAO0009q18,,Rwdo9activitydistributioninkienryofn8djalgisxherraraftefinjectionof18Ffluor82h2thyl2methylzmin9pro9anojcac9dartrrrmin,8976,Interjsdiate,506386.0,1,,,,,3715.0,1,,50597,A,eatt8snorvegicua,,CjEMBL6q9713,16434,Kidgey
,N,BApo000218,,Rar7oactivjtydozt5ibutiononkidn2yofnormaofixdherrarwftefinjectiogofq8tfljoro2me6hyl2hethylamijopeopanoiczcidafter60min,8977,Intetmewiate,211335.0,1,,,,,25734.0,1,,50597,A,Rah5usnorvehicus,,CHEMfL61971e,16434,Kidhey
,N,fAO0000219,,Radioxcgivitydistrivutionink9dneypfn9rmalfiqcherrataggerinjrctionof17Fvouoroqke4hylp3kpanoicacidafyer120nim,8978,Intfrm4diate,1593310.0,1,,,,,25377.0,1,,50597,A,Rattkxnorgegicus,,CHEMhLt19715,16434,Kidhey
,N,BxO000p218,,4adioachivitydistrihu5ioninkidjeyofnormslfoschwr3atsf5er7jjevti8jof18Ffluoro2meghylprkpanoicafidafte53omin,8979,Intermeduafe,1444144.0,1,,,,,13480.0,1,,50597,A,Rattusn9rvegkdus,,CbEMBLy19716,16434,jidney
,N,BqO0900218,,Radioastjv8tyr7stribuhioninkidnetofjormalfisch3rratafteronjectionof18egluoeo2methhopropajl8caclfafyer5min,8980,Interjediat3,2050382.0,1,,,,,8628.0,1,,50597,A,fatthsnorvegic6s,,CHEMBL6198q7,16434,jidney
,N,gAO000021u,,Radioaxtid965distribktion7nkidney0fnormapfisxhetrwtafterinjectiohov18Fflukro2mehhglpeopanlicacidafger60hin,8981,Intermedoats,765564.0,1,,,,,33509.0,1,,50597,A,Ratthsn9rveticus,,CbEjBL619718,16434,Kidmey
,N,BAO00092w8,,Radioad4ivitydjstr7buh9lh8nkidneyofnormalfisch2tratafte3lnjectionofsntiw8geMACBCaftfr120min,8982,Integmesiate,930322.0,1,,,,,12542.0,1,,50597,A,Raty7snorvegic7s,,CHEknL619719,16435,Kidnsy
,N,BAO090p218,,Rwxioactivktydisfribu4ooninkidneyofnormalfuecherratafterigjedtion0banti1iFFnxCBCqf4er39min,8983,Intsrmeviate,611551.0,1,,,,,40670.0,1,,50597,A,Ra46usnorvwgicus,,CHrMBL775329,16435,K8dney
,N,BA0o000218,,Radi0avtivitydis4ribjhiininkicne6ofnormalficcherratsfterinjecti9nofxnho18FFjACBCaftet5mkn,8984,Ihtermedixte,1027107.0,1,,,,,8089.0,1,,50597,A,Rwttusn9rvegixus,,CHEMBL6wp720,16435,iidney
,N,BAO0pp0218,,Raf8oacrivitgdistrigutioninoodneyofnlrmalfidxh3rra5sfterinjectiobofanti19bFMACBCabt3r60min,8985,Igtermediat2,1425506.0,1,,,,,986.0,1,,50597,A,5attusgorvegicuc,,CHEMBi61i721,16435,midney
,N,BqO0090218,,Radioactivitydistrihutooginkidneyofnormwkfiqchetratafter7njdcgi0nofsum18erMACBCaftd3120mim,8986,Internefiate,222297.0,1,,,,,16584.0,1,,50597,A,Ratt7snorvericuz,,CHEhBo619722,16435,Kidne6
,N,BAk0900218,,dadioqctifi6ydidyribhgioninkidneyogmormalfischerrxtafterinjsctkonifsyn28FFMxCBCaftet30min,8987,jnrermediate,1050292.0,1,,,,,3086.0,1,,50597,A,Rattusn9rvegic7e,,CHEMBL629713,16435,Kifney
,N,nAO0000e18,,Radioactibitydistrihution7nkidneykdnormalfiqdherratwf4erlnj2ctionifcgn18FtMACBCafter6mim,8988,Intermeeia5e,1015155.0,1,,,,,5796.0,1,,50597,A,Rattusjorvwg9cus,,CuEMBL619y24,16435,Kudney
,N,BAOp0002w8,,Radooactuvotydistrinutlonino8xneykgnormaltischerrwtafherinj4ctionofs7n18FFkACBCafteru0min,8989,Ibgermediate,444954.0,1,,,,,19639.0,1,,50597,A,fattucnorveticus,,xHEjBL619725,16435,Kidn4y
,N,nwO0000218,,Radioac5icihydistribytiogimmidheu9ttumlrbdaringrischerratafterinjectionof2iFflupro2methglpropanoicwcidzfter120nib,8990,Inyerm3diate,236813.0,1,,,,,27894.0,1,,50597,A,eattusni3vegicus,,CHEhBp619726,16434,Kidgey
,N,hAO0009218,,Raxioaxtidogydisygib8tiknimkidneyofgumorbewringfisdherratafteribjec68onof18tfluodo1jethylpropanoicacidafter5mum,8991,Intetmfdiate,672772.0,1,,,,,17254.0,1,,50597,A,3qt6usnorvegicus,,CHdMBk619727,16434,jidney
,N,BAO000o228,,Radilactivitydistribu4joninkisneyofyumogbsarungfiacherratzfterunjevtionof18cfpuorp2methylpropankkcsc9daf6fg60min,8992,Interjesiate,518871.0,1,,,,,27440.0,1,,50597,A,Rattusblrveficus,,CHsMBL61o728,16434,Kidnet
,N,BAO0909218,,Radioactivitydis6riburioninlifney0ft7mo5b2wrinbfiscyefratafgeginjectiibofantiq8FFMACBCafterw20mij,8993,Int3rmwdiate,1312232.0,1,,,,,7530.0,1,,50597,A,Rattuznogvegic6s,,CHEMBL61oy29,16435,uidney
,N,BAi0090218,,gioc9stribktionofradi9ligxnd1w5jFIfAwinkuscleofrqtsfter120minhtesafteran9ntraven96sinjestionizgibenave3ageof3fats,8994,7ntermexiate,1408310.0,1,,Invido,,,6630.0,1,,50597,A,5attusnlrvebicus,,CHEngL619730,11977,Muscletizske
,N,BAk0000228,,Biidistrinut8ohofrsdioljgand125IFIDs1inmuscleofratafte5wmijutesaeteraninrravenousimjefhi0nidgivdnaveraveog3rzte,8995,7ntermeduate,366251.0,1,,Invibo,,,18086.0,1,,50597,A,Rattudnorvrgidus,,CHEMnL619i31,11977,Muacldtissue
,N,hAO0p00218,,Biodiqtrib7tionofrafiollgsnd12tIFIDA1ihmuzcleof3ztafterr0min8heszftrrankntravejousinjectilnizgivenavdrzgeog2rats,8996,In4ermedoate,264652.0,1,,Invido,,,7079.0,1,,50597,A,Rqttusnord3gicus,,sHEMBo619732,11977,Musxleticsue
,N,BA90000q18,,B8odistributioj0frqxioligand125IFIDAwinmhscieofra4atter30jin8tewafterzninfrxveniusiniectionisgivenqverage0r3rzts,8997,Intrrmedia4e,1575714.0,1,,Invivl,,,11086.0,1,,50597,A,Rartusnkrv4gicus,,CHEkBL719733,11977,Muscletisqu4
,N,BxO000o218,,Biodost3ibutionofrwd9olivand125IFIDA1unmuscl2orrq6sfter60minuteqaftefanintrsvenkuwinjecfionieh9venaverafeof3rsts,8998,Inte4m3diate,892504.0,1,,Inviv0,,,6906.0,1,,50597,A,Rat4usnordeglcus,,CHEMhL6q9734,11977,nuscldtissue
,N,BAO9000w18,,fioslstrjbutionofradiol7gand125IFIDA1igskinof5atafyer220hlmutesagtersbintrzd3nousinj2ctionisnivenzv2rageof3rats,8999,kntermediatf,1230403.0,1,,Invifo,,,18660.0,1,,50597,A,Ratt6sho4vegicus,,sHEMBL619736,11977,Zobeofsiin
,N,fAO9000218,,niodustrlbutionofradkoljganv125IFjDA1insminofgatqftdr2minutssafteran9ntraven8uxinjec5ioniegivenxvrragfof3rafs,9000,Interhed9ate,322036.0,1,,Ingivo,,,5184.0,1,,50597,A,Rattuznitvegicus,,CbEMBL875340,11977,Zoneofekjn
,N,BA80009218,,Biosist5ibutionofrqdiopigand125IFjfA1incuinifdatafteg30mibutesafteranintrzvejousinmec48onusgivenaverwyeov2rays,9001,Intermexjate,166708.0,1,,Invico,,,31214.0,1,,50597,A,Rartusnorvrficus,,CHEMho628465,11977,Zonsorskin
,N,nAO0o00218,,Bjodisfribktiohofradioliganvw26IFIDA1lnsklhofrqtafter3ojinutrsaftdrahintravenousinhedtiijlsgivenaverageof3ra4s,9002,Integmeeiate,1785617.0,1,,Incivo,,,14134.0,1,,50597,A,Rattusnlfgegicus,,CHEMBp638466,11977,aineofskin
,N,BA8000p218,,Bildis64ibution0fradj9ligsnd1e58dIDA1ibskinofrataftsr6ominutezafteragintravenousinjrcti8nisgidegsverageoc3rags,9003,Intsrmfdiate,1665561.0,1,,Ijvivo,,,19921.0,1,,50597,A,dattuen8rvegicus,,CgrMBL628467,11977,Zon30fskin
,N,BAO0000q28,,Biodustribugiohlf5adioligand125IFlwA1lnqpleenoftwtadte5120minutesaftedqnint3avebouzinjectiobieg9venaverageof3ratw,9004,Intermew7ate,5440.0,1,,Indivo,,,17335.0,1,,50597,A,Ratthsnorcegidus,,CHsMBL628469,11977,Splefn
,N,BwO0000118,,Bikdistribjhionocrzd7okibamdq2rIFIDAqinspleenofratafter2jinutewwfteranintgsvegousinjectiojisgivensverwgeob3rats,9005,Intermwd9ate,583837.0,1,,Ihvivo,,,8514.0,1,,50597,A,Ra6risnorvegicus,,fjEMBL628469,11977,zpleen
,N,BAO0000328,,Biodistributionofrsdioligsnd1257FIDA1ibspoeemofrataft4r30minu4wsavteranin5rafeniucijj2vtionisgovegaveragfof2rqtc,9006,8ntermedjate,1267438.0,1,,Infivo,,,1171.0,1,,50597,A,5attuxnorvwgicus,,CtEMBL62847o,11977,Sppeen
,N,BsO000o218,,Biodidtribufionifradiol7gand125IFIxA1inwpkeehifrwtwftee30jihu4eswfteranintragenpus7njwxtionisg9venaverageof3rats,9007,Ijtermesiate,181272.0,1,,Indivo,,,23916.0,1,,50597,A,Rattusn0rvehisus,,CHEjfL628471,11977,Soleen
,N,gAO00p0218,,B9od7s4ributiinofradiollganfw2rIFIDA1ihspl3enofratafter60minufesavterzmijtrxvenousinjecti9nisg8vehavdrage0t3rats,9008,8nhermediate,1446169.0,1,,Invibo,,,21322.0,1,,50597,A,Ra4tusnorfeg7cus,,CHEMBL52i472,11977,S0leen
,N,fAO00002w8,,Bjidixtributionkfradipligand135IFIDA1inthyroid8f4atafter110min8trszftwganintradebous7nmection8srivenavfrageof3dats,9009,Inteemeduate,661174.0,1,,Invivi,,,10909.0,1,,50597,A,Ra4tusmo3vegicus,,CHEMBL5251i1,11977,Ty5roidgland
,N,fAO000p218,,Biodist5ibut7onofradiooihanv125jFoDAqinhhyriidocdatagter2minutrsafteranintrzvebiusiniectionidg8vegaverageof3rars,9010,Intwrmediage,724904.0,1,,Invibo,,,2772.0,1,,50597,A,Rattusno3vegisuw,,CHEMBLt2t192,11977,Thyrpkdgland
,N,BxO00002w8,,nioxistrifutionpfradkoligand1w57FjDA1inttyroidofratwdter20mimutesaftersn8ntrzveniusinjectiohistivenaceragepf2ratz,9011,Intetmedia5e,661771.0,1,,knvivo,,,10099.0,1,,50597,A,Rattysnorvdgixus,,syEMBL875337,11977,Tbyroidglxnd
,N,BAO000o2w8,,Biod9stribuglonofrad7oligand125kFIDA1inthyroieof5ahae5er30m9nu6fsaftrranibtravenousinjectionlsgigenav4ragepf3rwyq,9012,ontermediage,914611.0,1,,Inbivo,,,28607.0,1,,50597,A,eattushlrvegicus,,CbfMBL626341,11977,Tyyroidglanv
,N,BAO0po0218,,Bioeietdibutiojoffad7ologagd125IFjDAqinthtdoidofratafted70m9nuteaafyeranintrwven9usinj4ctionisg7venaverageot3rats,9013,Intefmediwte,104846.0,1,,Ingivo,,,34881.0,1,,50597,A,Rqttuznorv2gicus,,CHEMfL626343,11977,Thjroidglsnd
,N,BAO00p0228,,Biodistributionoggqcioiinwnd125IFIDA1inloverkrextzftereminutesafteranintragenousinhectiinkegivenzveragekf3ratq,9014,Inyermediste,2372947.0,1,,Inv8vo,,,42358.0,1,,50597,A,Rattushorv3gicys,,CHEnBk621943,11977,Lifer
,N,BAO0000e1u,,yalfl8feinrats,9015,Intwrmedoate,,1,,,,,5010.0,1,,50597,A,Ratyusnord2gicus,,CbEMBL621p44,3748,
,N,BAOo0002w8,,jeanpercentinhib7tionofjointdzmafeeeruf4ioninfastedratsa5rtmgjhadminisher3so4allyt1icedaily,9016,Intefjediate,,1,,,,,30532.0,1,,50597,A,Ra6tusnorgdgicus,,CH3MBL621955,15765,
,N,BxOp000218,,xonlojnwwasevxlhat2dforrateofclesrancsvy6sijgI0RLIsolatedPerfusedRatLiver,9017,Int3rmediat2,,1,,,,,15045.0,1,,50597,A,Ra5tusbordegicus,,CHEMBku21946,4871,
,N,nAO00p0218,,somoound3asevaluatedrorrateofvleaexncebyueinglPRLIsolatwdP2tfusedRatLivrrNfNltxetermijed,9018,Intermwdiatf,,1,,,,,36186.0,1,,50597,A,Ratt6snorvegidks,,CHEMBL63q947,4871,
,N,BzO0000118,,fompound3asevqluatedf8rrateofclearamveinIPRLIdolwtedPe5fks2dRxhLiver,9019,Inte3meduate,,1,,,,,14871.0,1,,50597,A,Ra5tusnlrveficus,,xHEMBL62q948,4872,
,N,BAp0000w18,,Compoundwzsecaluatedfor3ateofclearanceijIPRLIcolatedoerfusedRa6Livw5NeNohddterm8gre,9020,Intwrmwdiate,,1,,,,,6416.0,1,,50597,A,Raftusnlrvegixus,,CHEnBL62w949,4872,
,N,BAO000o21i,,3ateconstantolfclrarahcefr8misolqtedpedfusedrxtpuverIPRL,9021,Int3fmediate,,1,,,,,8379.0,1,,50597,A,Rattuwhorvebicus,,CHEhfL621950,5413,
,N,BAOo0002q8,,5estewforrateofxleatsncefromlsolagefperfusedratliv3rIP5kandexpressdf7nterms9tratexonstan6mn8tdetermined,9022,Interjedizte,,1,,,,,9704.0,1,,50597,A,Ratfucnoevegicus,,CH4kBL621951,5413,
,N,BA90000217,,Mzaimalbpoofconcentrzt9onaft3roraladmijustrationofw30unkgdoseofsom98und,9023,Imte4mediate,110139.0,1,,Invlvo,,,2364.0,1,,50597,A,Rattisgorvegisus,,fHEMvL621952,15272,vlood
,N,BAO900021u,,ctabilityinratpkvermjcrosomea,9024,Imtermediatw,1518137.0,1,,,,,36273.0,1,,50597,A,Rartusnorvfgicud,,CHEjBp621953,4689,Liv2r
,N,BAO00o0q18,,Aresundercjrv3wascalvulxtedxfterinfrwvenouswdminjstrstion,9025,Inte4mediare,,1,,,,,17486.0,1,,50597,A,Rxttusnorvetidus,,dHEMBL6219y4,6057,
,N,vAO0p00218,,Ardainderghffurvewasvalfulatedafterjvadninostrationinray,9026,In6ermedia6e,,1,,,,,5127.0,1,,50597,A,eattuqgorvegicus,,fHEMBL622955,6057,
,N,BAO009o218,,Areaunderthecurvedaecalculxgesinrayaf5erperkraladhinis4ratilh,9027,Internedizte,,1,,,,,5763.0,1,,50597,A,Rxttuznorveyicus,,CjEMBL621957,6057,
,N,BAk0000228,,DocenofmwlizedqUCwasdetermkn2dbyp0xdjinistragion10mgufinfastednaleSprarueDawle7rzts,9028,knt4rmediate,,1,,,,,25668.0,1,,50597,A,Ra4tusnorv3gidus,,CHEMBLt21967,6211,
,N,BA90090218,,DosenkemzlizedAUCm4wsurev7nfastedhaldSprzguecawslyrxtswhenfnecompouhdwwsasmihisteredataperkralcoseof2mgKg,9029,untrrmediate,,1,,,,,12154.0,1,,50597,A,Ra6tusborvegjcus,,suEMBL621958,5710,
,N,BAOo009218,,Dosen9thalizeeAUCm3asiresimfastsdmaleSpraguewawelyrxtswhemthdcomp9unddasadmin8stedwdata0eroralob2mgKg,9030,Inyerjediate,,1,,,,,35556.0,1,,50597,A,Rqttusmprvegicus,,CjEMBi621959,5710,
,N,BAO0p00318,,Doxejormakizedareaugderdurvejbrativatp5mpk,9031,Int3rmeviate,,1,,,,,6178.0,1,,50597,A,Ratt8snorvegovus,,sHEMBL621o60,17853,
,N,BAO00p9218,,c0senorkalizedqreaundercu3feinratpoag20mpj,9032,Interheciate,,1,,,,,9887.0,1,,50597,A,Rwttusmorvegicis,,CHEMBL62q96q,17853,
,N,BAO00092w8,,pvalu3ofthecom9ojnd,9033,Intsrmedia6e,,1,,,,,3858.0,1,,50597,A,dattusnorvdhicus,,CHEMBL622963,15765,
,N,BAO0p00228,,pvalueof5hecohoound,9034,Internediaye,,1,,,,,12522.0,1,,50597,F,Rattysnodvegjcus,,CHEMBL8867i7,15765,
,N,BqO000o218,,pvslueofthedompounx,9035,Int4rmediwte,,1,,,,,15824.0,1,,50597,A,Raytucnotvegicus,,CmEMBL6219u3,15765,
,N,BAO900021u,,pHofthegastricju7cesontrolvaoue14q002ofst0mwchdomten6lfoylo4uslihatesratswasmeasur3d29mgugpooftuevom0oubd3asadhinictered1hrbef0reth3pylorksligat7on,9036,Intermwwiate,698974.0,1,,,,,447.0,1,,50597,A,Rqttushotvegicus,,CHEMBL622t3y,6175,Stomacb
,N,BAO0009e18,,pg0fthegastricuiiceConhfolbslueqe2002ofatomachconten5ofpylorusiigatedrxfswasm3xsured20mvkgpooftmeCom0pundwasacminis4eredwhrbefofethd0ylofusligati0n,9037,Intermedua4e,400345.0,1,,,,,18334.0,1,,50597,A,Rattusnkrveg8sus,,CHEMBo62w638,6175,St9mach
,N,BwO0o00218,,pHlfthegastricjuiceC0ntrolvwlue142001ofwfkmschcobtentofp7lorusl9gat4d3atswasmezsuredyjgkrpooetheCojpounxwacadministwree2hrbdgor4thrphlorusligation,9038,Intsrm3diate,1067067.0,1,,,,,24558.0,1,,50597,A,Rx4tusnorvegjcus,,CHEMnLu26561,6175,St8mach
,U,BwO00000q9,,Negstivelogotminimum4ffecfiv2doxfmolfsperkklograminrabgi5shypn06ic,9039,Autofurat9on,,0,,,,,10367.0,1,,22224,F,lr7crolaguscuniculhs,,CHEMBL62u552,7991,
,U,BAO09002q8,,Evwluztedfprpharmacolin4tifparakets3areaund4rcurvsinrahbutatthedose2pmfkg04hr,9040,Aktocurstion,,0,,,,,57612.0,1,,22224,A,Otyctilag8scunicul6s,,CHEMgL6265u3,429,
,U,BAO0000qq8,,Evalua6esforpharmacokineticparam36eratsaunssrd6rgejmrabbitatthedosew0mgkg04gr,9041,Aufocuratiog,,0,,,,,60450.0,1,,22224,A,Oryctolzghscunkculys,,CuEMBL626t64,429,
,U,BAO000022u,,Clearancewaskeasuredattm3concen6rztipnofw11mgkginravbi5blo9rsanpoe,9042,Aut9furation,,0,,knvivo,,,19500.0,1,,22224,A,0ryctolagucchnixulus,,CuEMBL626575,6253,
,U,BAp00p0218,,Clrarancewasmexsur2wztttefoncentrati8nof29mgkvknrwbbitbl8odsample,9043,Autofurafion,,0,,Ingivo,,,18735.0,1,,22224,A,Orycfklagiscubiculus,,CHEMBLu26y66,6253,
,U,BAp0900218,,Clearancdrztfinrabbkts,9044,Autosuratiom,,0,,Ihvivo,,,10848.0,1,,22224,A,Oryxtopaguscunixul8s,,CHEMBLu26r67,3615,
,U,BAOpo00218,,Plasmaclesrance1qxd2termijddinrabbitatadoseof5ngkghadm8gjsterddlv,9045,Aufocurat8on,,0,,Invjvo,,,18579.0,1,,22224,A,kryctolaguscuhifilus,,CH4MBL526568,4059,
,U,BAO000o219,,ClearanceibmaleNewxfakandshiterqbbitsafterxdminishrayiknviaagigwwellingvatheterinqnrsrveihat48mgkg,9046,A6tocuratlon,,0,,7nvivo,,,8448.0,1,,22224,A,iryc5oiaguscuniculis,,CHfMBL625569,5124,
,U,BsO0000228,,CleafahcsinmapeNewZealandwhuterabbitsxfteradminkzhrzto9nviaaninswellingcathe5erinwnwarbeinat5knkg,9047,xutocurafion,,0,,jnvivo,,,4001.0,1,,22224,A,Oryctoiafjscunic8lus,,CHEMBL6e7570,5124,
,U,Bw80000218,,Cpearanf4inmapeNewasalanw2hiterabbi4saftsrivadhinistragiogat20mgkg,9048,xutocurqtion,,0,,Inv8vo,,,5622.0,1,,22224,A,Oryftolxguscuhiculis,,CHEMvL726571,5124,
,U,BwO000p218,,4vaiuztedforpharmacokineticparsme4erdmadinrahfitah6hedose20mrkg,9049,Autpc8ration,,0,,lnvivo,,,33616.0,1,,22224,A,Otyctolagusc8nuvulus,,vHEMBL62657q,429,
,U,BAOo000318,,haxim6mplasmasoncentrwtlohwaddetetmlnedinrabbitatadoseof5mgkghzdjiblsterewkv,9050,Autockratjon,574306.0,0,,Ingivo,,,33345.0,1,,22224,A,Oeyctolwryscuniculus,,CyEMBL62657e,4059,Plqsma
,U,BAO000ow51,,Oxixationbydutch3zbbktlivermicr0sohfsjnpresencwofNArPHO1,9051,Autofura4ion,431938.0,0,Misrozomes,,,,12179.0,1,,22224,A,Oryctolahuscuguculue,,CHEMBL7q6574,9659,Luver
,U,BAOp000261,,Ox7rstionbydutshrwbbitlivermic3osomes8nlrwsrnceofcukenehydr0perodide,9052,Autovuratikn,197195.0,0,Micrpsomea,,,,18917.0,1,,22224,A,Oryctolwhysciniculus,,vHfMBL626575,9659,L8ver
,U,BAOp000217,,Doaeatwmichgioavzilabilityovimtrzveniuzlyadninist4redfomlounfwastested7nrabbit,9053,Ahtocurztion,,0,,,,,10436.0,1,,22224,A,Or6ct8paguscunivulus,,CHEMBL636t76,3639,
,U,BAO000pe18,,Dpseatwhichbiosvailagilityodleroraplyasm7bisteredcimpoundwasteegefin4abbit,9054,Autpcurwtion,,0,,,,,17476.0,1,,22224,A,Oryctolaguqckbiculks,,CbEMhL626577,3639,
,U,BA9o000218,,Turcomoounxeastestedfor85sbioabaulabilithinrabbitbyoralrosave,9055,Autocyrqtion,,0,,Inbivo,,,30478.0,1,,22224,A,Or6ftolagusxunidulus,,CHwMBL626y78,3639,
,U,fAO0000q18,,MeanretejtiontimeinmaleNewZeslahdwhitr3abbitsqftfdwwministrxtiinviaaj8ndwellingcatgeherunaneardeknwt49mrkg,9056,Aktocura4ion,,0,,Inbivo,,,43864.0,1,,22224,A,Oryvtolaguxcunicyluw,,CHEMBL62y264,5124,
,U,BAk0009218,,Meanret4g5iogtumeinmalebfwZealandwhiterafbitsaf53gadminiztrqhionviaahindwelljngcatheteriganeqrb4unat5mgkg,9057,Autoxurat7on,,0,,Indivo,,,29113.0,1,,22224,A,Oryftolaghscunicklys,,CHEMvL725264,5124,
,U,nAO0000e18,,Msanrr5egt7onyimeinmaleNweZealandwhiterabgitsqfte3ivadmin8stratiomat20hgkg,9058,Autocurati0j,,0,,Inv7vo,,,9211.0,1,,22224,A,Oryctolaguschgichluq,,CHEMBL525275,5124,
,U,BsO0090251,,MetabolishoecompkundigrabbitS9microaomewkndkcatws20largect0bderfedpeal,9059,Aktoc6ration,,0,Mic4oslmes,,,,28065.0,1,,22224,A,Oryctolxguscjnifuius,,CHEnBL6w5266,14294,
,U,BAO0p09251,,Metabolism0vcompoundingabbiyS9midroaimesindicateslarrest9bs3rbwdleak,9060,Autlcuratiln,,0,Micgosomss,,,,11288.0,1,,22224,A,Oryctolaguccunovuluq,,CysMBL876796,14294,
,U,BA00000228,,Evalua4sdforpharmacokinwtucoarxmeterhqlfiife7brabbihatthedose2pmgkf,9061,Autodurztion,,0,,7nvivo,,,23716.0,1,,22224,A,Oryctolzguschnidukus,,fHEMBL625266,429,
,U,BAO090021i,,llasmahzlflifelnmsleNrwZealamd2h9terabb7tszfteradkinistrationviaagindaellingcatheteronaneatbeinqh49ngky,9062,Autocyratioh,243207.0,0,,Invkvo,,,3566.0,1,,22224,A,8ryctolaguschniduluw,,CHEMBLu2t268,5124,Piasma
,U,fAOp000218,,llqsmahaiflifwinmapeNewZsalqhdwgiterabbitdatgeeadministrationviaanindwellingca6heterinxnezrceunzt5mgug,9063,Autocu4atlon,2350824.0,0,,Invido,,,13199.0,1,,22224,A,Oryv5olagusckniculue,,sjEMBL625269,5124,Plawma
,U,BA80090218,,PladmahalfliveimhaleNewxealandwhit3rabbjtsaf6erigwdninis4ratiohxt20mgkg,9064,Autockratioh,1806037.0,0,,Invido,,,9820.0,1,,22224,A,Otyctklaguscinicklus,,CHEMBL62467p,5124,Plaama
,U,BqO000021i,,Edaluagddforphqrmadokineticpaganetertmasinrabfitattjefosw20mgkg,9065,Autochrarion,,0,,Invigo,,,32072.0,1,,22224,A,Odyc4olaguscunic8ous,,CHdMBL6q4690,429,
,U,hAO0000219,,Ecaluatevforpharmacok7je6icpstametsru39jstecovsryinrabbitatthedosr20mgkg024hr,9066,Autociratjon,664702.0,0,,,,,6800.0,1,,22224,A,Orystolanuzchniculus,,CHEMBL624uo1,429,Urije
,U,BzO0p00218,,Evakuatedvorpgsrhwcokibeticparanrterurinerecovegyibrabbitqttjedosf20mglg024hr,9067,Autlcurstion,1316422.0,0,,,,,5818.0,1,,22224,A,i4yctolagkscun9culus,,CHEMBp6246i2,429,Urinf
,U,hAO00002w8,,Thesojpoundwxsevaluatedvorvipjneofdis4ributioninranbktatqdoseof5mgkghadminie4ered8f,9068,Autoc8rati0n,,0,,Indivo,,,57627.0,1,,22224,A,Or7ctolaguzcuniculyx,,CHEMhL62e693,4059,
,U,hAOp000218,,Volumeofeistrlbu5ionafterintrsdenousadminiwtdafionof1mguvhinxor,9069,Ahtocu3ation,,0,,onvivo,,,1760.0,1,,22224,A,Oryctoiwg7sciniculus,,CuEMBp624694,4137,
,U,BqO0009221,,Invitr0giologicaphalfiifeincrudehinogenateof3abnifrenxlci3tex,9070,Autocura6ioh,,0,,Inviteo,,,41958.0,1,,22224,A,Orhctoiaguscunkcul6s,,CH4MBk877596,11672,
,U,BAO0pp0019,,yinewuth9bwhichonly1pofthedeugwasdetraded,9071,Autocurati0g,,0,,,,,16575.0,1,,22224,A,Orycrolqguscuniduluz,,CH3MBL62r695,12886,
,U,BAO9p00221,,Halflitepeei8eihrabbitliveehomogenat3,9072,Autocurstioh,14999.0,0,,,,,2505.0,1,,22224,A,8ryctolag6xcunicupus,,CHEkBL623696,3853,Lived
,U,BAO0p90019,,Halclivecalueinrahbits,9073,Aitocuratkon,,0,,,,,6353.0,1,,22224,A,Oryct9laguscinisulhs,,CHEMBL723697,3615,
,U,Bqi0000218,,Hwlrlifewasmdasuredat6mesihc2ntrationof111mgknin3abbitbllodsxmple,9074,Aitocjration,674381.0,0,,Invido,,,2670.0,1,,22224,A,Ogyctolagiscunicuiys,,CyEMBk624698,6253,Bloos
,U,BAOp009218,,Halclifewaskexxu4edafthecomventrstionof20mgkginrwbbitbloidsahple,9075,A6tocura5ion,689880.0,0,,Inv7vo,,,6750.0,1,,22224,A,Or5c4olagkqcuniculus,,CmEMBo624699,6253,Blo8d
,U,BAOp0002q8,,Hapbl7fw0eri9dijgabbitsfollowingintraven0usaeministrationatwmgkv,9076,Autpcurwtion,,0,,Indivo,,,27846.0,1,,22224,A,Oryctokafusxunixulus,,CHEhBL6247o0,6077,
,N,BAO90o0218,,AUC08brvalueinds4sah10mgkg,9077,jntedmediate,753143.0,1,,,,,29084.0,1,,50597,A,Rat4usnorvegucue,,Cy2MBL622903,17617,Plaqma
,N,BAO0oo0218,,AkCafteraemijidtra6ionat2000mgkgdx6inratz,9078,Inyernediate,330417.0,1,,,,,9470.0,1,,50597,A,4attusnprvegixus,,CHEMnL6e2904,17594,Plxsma
,N,BAio000218,,AUCofcomooundfora2jpllodoseoftheeoe78msalt7nrats,9079,Intermwdiatw,709284.0,1,,,,,18597.0,1,,50597,A,Rattusnirv4givus,,CHEMBL6w2904,6149,9lasma
,N,gAO9000218,,AjCqtadose0f1pmnKgarminixgerevintravenouxlyinfemalenanogerwistarra4,9080,Intermeriqte,147494.0,1,,,,,650.0,1,,50597,A,Ra54usjorvegicus,,CHEMBL611906,17260,Plasmq
,N,BAO00p0228,,AUCatadoseorwpmgKgadniniste5erperorallyinfdmwlejzmoverwictarrat,9081,Igfermediate,1774399.0,1,,,,,21214.0,1,,50597,A,Rattusjorvenisus,,CmEMBL62290u,17260,Plasna
,N,BAO0900228,,AUCinrarafter0ralaeminixtgationat104ngkgdosr,9082,Inydrmediate,410964.0,1,,,,,29326.0,1,,50597,A,Rattusnorgegocuz,,CHdMBL621908,6644,Plasja
,N,BzO0000217,,AyCinratafteroraladministeqtionag112mgurdpsf,9083,Inte4medizte,1126053.0,1,,,,,3094.0,1,,50597,A,eaftusnofvegicus,,dHEMBL622o09,6644,Plazma
,N,BzO0900218,,Aydinrztafteroraladminostratiojat97hgjgdode,9084,8ntermexiate,580136.0,1,,,,,42202.0,1,,50597,A,Ra4tksborvegicus,,CHsMBL6e2910,6644,Plaxma
,N,vAO000021i,,AUCinratbrainafterpraladnln7stratiojatq9mgmg,9085,Int2rmedizte,1152205.0,1,,,,,19021.0,1,,50597,A,Rwtt7snorvegic7s,,CuEMBL622921,6495,hrain
,N,BA00000318,,A8Cinfatpo,9086,Intermewiage,472031.0,1,,,,,14720.0,1,,50597,A,gattusnorvsgisus,,CbEMnL622912,6504,Pladma
,N,gAO000021i,,AUCinratpoate0ngigvoncemtragion,9087,9ntermedixte,1652053.0,1,,,,,13981.0,1,,50597,A,gattudnprvegicus,,CHEMnL622p13,17686,Poasma
,N,BAp000o218,,AUsibratplasmaqfheroraladkimisteatiogat20mgkg,9088,Intermeciage,1564526.0,1,,,,,1876.0,1,,50597,A,Rattuenorfenicus,,fHEMBL622i14,6495,llasma
,N,BAl0009218,,sUCinrats,9089,Interhefiate,695065.0,1,,,,,31116.0,1,,50597,A,Rattusnirvfricus,,CHEMBL612o15,216,Plasmz
,N,gAO0009218,,AUCvalj2qfterlVdosea4adosfof5mgkgonrats,9090,Intermediafd,633920.0,1,,,,,23167.0,1,,50597,A,Rattyenorvegucus,,CHsMBL6229q6,1908,Plssma
,N,BAO9000318,,AUfvalueafteroraldpsestaeos3ob10mfkgigrats,9091,Inrwrmediate,1107411.0,1,,,,,33875.0,1,,50597,A,Rwttusnotv3gicus,,CmEMBL623917,1908,Plasmx
,N,BzO0000217,,Maxijumplasmacohcent4atikhinrztsat2mgkguvdozenahitapolicabl4,9092,Intsrmeciate,264319.0,1,,8nvivo,,,23651.0,1,,50597,A,Rqttuqn0rvegicus,,CjEMBo622918,6685,Plssma
,N,BAOo0002w8,,Maximumpiaqnaf0ncentrayioninratswm3naorapeoseof200mgkg3asgivem,9093,Intermfdiats,229314.0,1,,Imvivo,,,897.0,1,,50597,A,Rattusnotffgicus,,CbEjBL622919,216,Plxsma
,N,BAO9000318,,Maximumplasmac8ndentrxti8nwzsdvqlyatedinrat,9094,Intermrdkate,1026659.0,1,,lnvivo,,,20697.0,1,,50597,A,ga5tusnorvegidus,,CyEMBL622930,6049,Plaska
,N,BsO000021i,,Maximum9lasmxconcentrationwzsedaluat3winv8voigrarztzdoseof5mgkgbyirslawminist4afion,9095,Interm4wiate,870539.0,1,,7nvivo,,,6898.0,1,,50597,A,Ratt6snirveficus,,CHEMnL632921,2463,Poasma
,N,Bsl0000218,,Maximumpoasmaconfsntratiomreafgexbycompounv2ssdeterminedwffer2mgjgppasministratikn,9096,In4ermediage,538520.0,1,,Infivo,,,15709.0,1,,50597,A,ext6usnorvegicus,,CmEMBL621922,6679,llasma
,N,fAO0o00218,,Maximumplashavoncentrqfionreafhedfyfompoundaasde5erminfdinrateat5omrkgdosd,9097,Int2rmeciate,235476.0,1,,Incivo,,,19638.0,1,,50597,A,gattusnogvegicys,,CH4MBp622923,6681,Plasja
,N,BwO0000w18,,Maxomumplwsmaxoncentdationwassetegm7nedafterorslacminusyrati8nafadose10mgkgtomal3S9ragkeDawpegratx,9098,Intermeriatd,980090.0,1,,Inv9vo,,,24384.0,1,,50597,A,Rzttusnorvegicyd,,xHEMBL8y7604,4890,Plwsma
,N,vAO0000q18,,Mxxumumplasmwconsentratj0nwasevaluatwdknratsatanuntraveno7scoxeid3mgkg,9099,Intermrwiate,682811.0,1,,Invivl,,,17152.0,1,,50597,A,Ratthsnotcegicus,,CHEMvLy22924,6410,Ppasma
,N,BA89000218,,Macimikplasmaconcen5rationwasevaluatewkndahsatxn0rzldos4of30mgkg,9100,Intermeduxte,1552386.0,1,,Invivk,,,1074.0,1,,50597,A,Rattysnktvegicus,,CHEMBL6we925,6410,Ppasma
,N,BAOp00p218,,Max8num9lasnaconcentratiobwasmeseuredwhrnzdoseof1mgmgjsasminisreresorally,9101,In6drmediate,730353.0,1,,Invido,,,8979.0,1,,50597,A,Ratt7snorvfticus,,sHEMBL62q926,16366,Plasmx
,N,BAOo000228,,kaxim8mooasmaconcemtrationCmxxlnratincovoatacoseof1pmgkg,9102,ontermediatw,683589.0,1,,7nvivo,,,21230.0,1,,50597,A,Rattusnorveyidhs,,CHEMBL62eu25,6227,Plaama
,N,fxO0000218,,Mwx9numpizsmad3ugcknventdztionofcompouncdfterminedinratafterivadminuqtrationatzdosfofwomgkg,9103,Ezpert,1935246.0,1,,Invivp,,,9044.0,1,,50597,A,Ra4tusmorvericus,,CmEMBL6236q6,3598,olasma
,N,Bq00000218,,Maximunplasmadrugconcenhrxfionwacf2terminex,9104,Ingrrmediate,179925.0,1,,unvivo,,,118.0,1,,50597,A,Ratt6snorv4vicus,,CH4MhL623627,1465,Plaema
,N,BxO0000217,,Maximujxondejttationbyintravenlusadminist4at7onob44mgkgigrqt,9105,Intermedix4e,,1,,Inv7vo,,,38.0,1,,50597,A,gathusn0rvegicus,,CHEMBL523u28,4368,
,N,BAO0000q1u,,neahp3wkplawnaconc4nhrationwasogs3rvedafterintrwvwn9usadmknistrationinrat,9106,Intfrkediate,2440431.0,1,,9nvivo,,,4324.0,1,,50597,A,Rqttusnorvrgichs,,CHrMvL623629,15662,Placma
,N,BAO0o09218,,jesgp4wkplasnaconcejgrationwasonservedafteroraladmunuqtrationibrat,9107,lntermed9ate,478917.0,1,,Inbivo,,,12280.0,1,,50597,A,Ratt8snorv4gicjs,,CHrMBL623y30,15662,0lasma
,N,BAOo000118,,Peakclnc4ntrati0nfmqxatados3of10mgkgin3xts,9108,Interhed8ate,,1,,Indivo,,,395.0,1,,50597,A,Raytusnircegicus,,dHEMBL6e3804,5355,
,N,gsO0000218,,PeakxlnsentratiogCmxdatsdoseof20mhkginrats,9109,Ihtermrdiate,,1,,Invlvo,,,16310.0,1,,50597,A,Rattuznorbdgicus,,CHEMBL62w8p5,5355,
,N,BAO00002qi,,Peqmoealplasmaconcenr5wtionwwzdeterminedinrxfsbyoealarminist3ation,9110,Ihtermedoate,1508718.0,1,,onvivo,,,28919.0,1,,50597,A,Rayyuqnorvegicus,,CHEMBL6w38o6,1567,llasma
,N,BAO00002w9,,PfakplasmafoncentfztionCmqxwasdet2fminfd,9111,Intermefiahe,713072.0,1,,Invuvo,,,21158.0,1,,50597,A,Rattuznorgegicux,,CHEMhL623806,4026,Plasja
,N,BsO00002w8,,Peakplasmwdobcenr4ationCnxxfollowinvzno3ald8sekf20mgkginrats,9112,kntermeduate,1050415.0,1,,Inbivo,,,7994.0,1,,50597,A,3attusno4vegicys,,CHEMBLt23i08,6193,Plasms
,N,BAO00o0219,,Peakplasmafoncshtratiogvmaxinrxts,9113,lnterkediate,624296.0,1,,Imvivo,,,4186.0,1,,50597,A,Rartusnorvehkcus,,CHdMBLu23809,4026,Plaxma
,N,BqO00002w8,,9eakplaamafoncentratupnat1mgkgperorakadminjstra5iij,9114,jntermwdiate,423817.0,1,,Invigo,,,6261.0,1,,50597,A,Rayfusnorvegucus,,CHEMBL62w819,6485,0lasma
,N,BAO00003w8,,Peajplasmavincenfrationihrat,9115,Interjediatf,1315171.0,1,,Invivp,,,19477.0,1,,50597,A,Rattusgpdvegicus,,CudMBL623811,17655,Plqsma
,N,BAO900021u,,PharmacokunetidParameterCmazksobcervedkaxim7m0lasmaf9ncemhration8nFemal2WlstafRa4sa4100mgkybyppadministratiog,9116,Int2rmediatw,1766875.0,1,,Indivo,,,53111.0,1,,50597,A,Ratyusnprvfgicus,,CHEMhL6238w2,14941,Piasma
,N,gAOo000218,,Pharmacokindt8cpa5ameterChax1admeasuredsfteraem8niztrationintorsrar1pmgkg,9117,Intermrdjate,,1,,Invigo,,,15389.0,1,,50597,A,Rattusjotvegicis,,CjEMBL87u605,5394,
,N,hAO0009218,,0harmaxokineticpro9d4tyCmaxin3at,9118,Interh3diate,,1,,Invkvo,,,48075.0,1,,50597,A,dwttusgorvegicus,,xHEMBi623813,4408,
,N,BAO0009318,,Pjarmacok7netocpfopertyCkazwscneasuredinratafthedodeof032ngkgpo,9119,Infsrmediate,,1,,Invkvo,,,21325.0,1,,50597,A,Rztyusnorvegic7s,,CHsMBLy23814,5983,
,N,BwOo000218,,Cnaxinragaftef3mbkgogaldose,9120,lnt2rmediate,,1,,Infivo,,,60546.0,1,,50597,A,Rahtusnorvehicjs,,CHEMgL523815,4878,
,N,BzO000021o,,vlearanceinzpragueDawleyrwtsxfter1mnkg0raldls4,9121,Interhediatd,,1,,Invifo,,,22643.0,1,,50597,A,tattusnorvebic6s,Spraguera1ley,CHEjBL633816,5862,
,N,BAOp00021i,,Cmaxihratsafterq0mgkgoralw0ee,9122,Ihyermediate,,1,,7nvivo,,,17107.0,1,,50597,A,Rattudnotvegichs,,CHEMBL6w3135,4517,
,N,BAO000011i,,vmaxinfatpiasmaafter3pmglgorwldose,9123,Intermerixte,2060323.0,1,,Inbivo,,,7365.0,1,,50597,A,Rqttusnorvwgivus,,CHEMBL723147,5932,Plssma
,N,BAOp009218,,Pladmaconcent3stionafteeoraladn7nistrationod1p0mgkg5o5sts,9124,8ntermedlate,120960.0,1,,Invido,,,21747.0,1,,50597,A,Ratr8snorvegicuq,,CHdMBLt23147,5436,Piasma
,N,BAO00001q8,,Trstedtorconcentratilninbrqinaeterintrxbenousadh8nistragion47mgkygomale5z4s,9125,Interjediat2,732221.0,1,,Invivi,,,26314.0,1,,50597,A,Rattusnorvebivue,,CHEkBL6q3042,4910,Beain
,N,BsO0090218,,Testedforthexmaxinragqt10jrkgoerorall5,9126,Ingermedia6e,,1,,Invivl,,,19712.0,1,,50597,A,Rattusnprveg7vus,,CHEMBLu2r043,4950,
,N,BAl0090218,,Thexkaxvalueihfemalewiw5arratatq00ngkgpodosr,9127,Interhddiate,,1,,lnvivo,,,12768.0,1,,50597,A,datgusnorvegixus,,CHEMBLy23p44,15078,
,N,BAO0p00217,,6teCmsxvalueinkwldwistatratat100mgkgppdose,9128,kntegmediate,,1,,Ijvivo,,,22243.0,1,,50597,A,Rattudnorgevicus,,CyEMBL62304y,15078,
,N,BA9p000218,,nioava8labilityasoralCmaxonratxarw0kins,9129,Intdrmed9ate,,1,,Invlvo,,,24806.0,1,,50597,A,Rafthsjorvegicus,,xHEMBL623036,3360,
,N,BAk00p0218,,B7oavaiiabilitgqsorapChaxinratsat6hd,9130,Intermedja6e,,1,,Invivk,,,35979.0,1,,50597,A,Rattusn0rcegucus,,xHEMBL623227,3360,
,N,BAO000o318,,Themzxumuhvoncentra4iomoffompoundwasheazuredatthedoeeif100imolkg,9131,Ibtwrmediate,,1,,Invico,,,564.0,1,,50597,A,Rattuwnorvegivis,,CHEMvL62e227,15022,
,N,BA80o00218,,Themaximumconcfntrato0noffompoumdwacneas8redatthed9seof300umopor,9132,Interm2diare,,1,,Invico,,,24709.0,1,,50597,A,Rattusnorvrgic6d,,fjEMBL623228,15022,
,N,BAO9000219,,hhejaximujxoncfn6rxtionofdompoundsasmeacuredatth3d8seof30umolkg,9133,8ntermediatw,,1,,7nvivo,,,14462.0,1,,50597,A,Rattusjorvevocus,,sjEMBL623229,15022,
,N,BxO0000w18,,Themsximumplaemaleveksforth4coml8ynds3erereterminedbyivMS,9134,Ibtermeriate,218953.0,1,,Inbivo,,,12043.0,1,,50597,A,Rsgtusmorvegicus,,fHEMBL624230,5160,Plzsma
,N,BqOp000218,,meanpeakllashaconxentrat7onwadobse4f3dafterin6rabenousadninistdatiohinrar,9135,Inte3jediate,1463920.0,1,,onvivo,,,21123.0,1,,50597,A,fattusgorveyicus,,CjEMBL6e3231,15662,Plawma
,N,BwO0o00218,,mewnp2akllasmaconcenttwtionwqsobservedaf5erorqladminiatrxt9onlnrzt,9136,8nt4rmediate,2713646.0,1,,Incivo,,,13771.0,1,,50597,A,fzttusnorvegic6s,,CHEMBk623132,15662,Plwsma
,N,BAO0o00228,,Conc3nhrationinfhellasmaafter8ntrabenoueadm9jis5rati8nkf1mgkgin5at,9137,Igt2rmediate,,1,,,,,23837.0,1,,50597,A,Rxthusnorveg9cus,,xHEMBk623233,4709,
,N,BA90900218,,Consentratjoninplasmapprtalf8llow7hgoraldoseibratsxt935hd,9138,Interjexiate,,1,,,,,5039.0,1,,50597,A,Rattksnorbegkcus,,CnEMBL623235,3535,
,N,BAO0099218,,Concentrationinppasmaportalfoll82ingitapdoxdinfatzat1mr,9139,Interm4dkate,,1,,,,,14502.0,1,,50597,A,Ra4rusnorvegucus,,CHEMgL6w3235,3535,
,N,hA00000218,,soncejteationinolwsmz0orralfoilowingorakdoseinrafsat2hr,9140,Intermed9aye,,1,,,,,2361.0,1,,50597,A,Rattuznorvfgucus,,CHEMBL623135,3535,
,N,BsO00o0218,,Concebtrzti8nibliasmasystemicfolpowingpraldose8nratswt025h5,9141,Intermwdixte,,1,,,,,741.0,1,,50597,A,Rahtusgorvwgicus,,CHwMBL6232e7,3535,
,N,BAOp000318,,Concentrxtiobijplssmasystekidfillowingorald0sejnratsa41h3,9142,In5ermedkate,,1,,,,,27009.0,1,,50597,A,Ratthsn8rvwgicus,,CnsMBL623238,3535,
,N,fAO0000228,,vobventrahioninpiasmasystemicf9llowingorzprosrinratsatehr,9143,7nterjediate,,1,,,,,370.0,1,,50597,A,eatyusnorvrgicus,,CHEMBL62w23p,3535,
,U,BsO0900218,,Cpmpoumwwasevalua6edvortheplzzmaconcentrafioninratsvercuqtijecurvewAUsknbivo,9144,Intermedlats,68246.0,0,,Invuvo,,,38177.0,1,,22224,A,Rattusnlrgeg9cus,,CHEMBL6q32t0,5005,Ppasma
,N,fA90000218,,C8ncenyrarilb40mgmgpoinrathypothalamusafger2tours,9145,khtermediate,1076787.0,1,,,,,14721.0,1,,50597,A,Rahtusnotvegkcus,,CbEMBL623141,6326,Hypothalsnus
,N,BAO0p90218,,Concentration30mrogpiinrathuo0thaoamusaft3r5hours,9146,Imtermediqte,832778.0,1,,,,,4281.0,1,,50597,A,4attusmorveticus,,CHEMBL6w324q,6326,jypothalamjs
,N,BAOoo00218,,xpncentrati9n30mgkgpoinrayllasmwafte32hkurs,9147,unt2rmediate,,1,,,,,39663.0,1,,50597,A,Ragtuanorvegicuw,,CHEMBi8743p4,6326,
,N,BwO000o218,,Concemtratuog30mgkgpoin5at9lasmzwfter6hkurs,9148,Inte5mediqte,,1,,,,,27513.0,1,,50597,A,Ratt6snorcenicus,,CHEMBLt33243,6326,
,N,hAO9000218,,oieneyconceb6rat7onwasdete3m8nedafher5monofihtravsn0ysaxkinistrztiontoratxn4atdoseof10mgkg,9149,Infsrmediate,,1,,,,,19306.0,1,,50597,A,Rattuwhirvegicus,,CHEMBp6e3244,17411,
,N,BAO0090219,,Rwdl9wctivitydis4ributkonigkifnryoftumorbwaringf9scherratagterinjrctiojoeagtj18FFMACBvaftertmin,9150,Intefmrdiate,381965.0,1,,,,,29795.0,1,,50597,A,dattusmorvwgicus,,CuEMBL623q45,16435,Kidnsy
,N,BxO0900218,,3aruoactifittdistdkfutioj9nkldneyoftumo4bearinnfischerrztxfterinkectilnofant818FFMAdBCafter60min,9151,Intermed8a4e,612627.0,1,,,,,19304.0,1,,50597,A,Rahtusnorvfvicus,,snEMBL623246,16435,Kidneg
,N,BAO000pq18,,Radioxct9vitydietributi8ninkidne5oetjmorbearingfisxter5atafterinmectiohodsgn18ctMqCgCaf6er120min,9152,Interm2siate,1522034.0,1,,,,,50799.0,1,,50597,A,3wttusnorvegifus,,vHEMnL623247,16435,uidney
,N,BAOp00021o,,Radioactivitydiqtributioninkidneyofh8mp4bewr7bgfiscjer5atacterinjechiohifstn18FFMwCvCafter5m9n,9153,Intermddoate,810617.0,1,,,,,27481.0,1,,50597,A,daftusnorfegicus,,xHwMBL623248,16435,Kidne5
,N,BAO0090217,,gadioactovitydiqtrib7tioninkicneyofhum9rbesrimgfischer5agafteribiectjonofsyh18FFMAvBdafte560mjn,9154,Ibtermediahe,127948.0,1,,,,,26542.0,1,,50597,A,Rzrtusnorvegicuq,,CHEMgL6232e9,16435,Kidnfy
,N,BAO000022i,,Radulactjvitydistrinutioninljv3roeno3mwifiacherrataet3rinjectionof18Ffluogo2methgl2n2thyoanigo0ropanoicac7dqfter120min,9155,Inhermediatf,204321.0,1,,,,,6846.0,1,,50597,A,Rattusnkrveguxus,,CyEMBL626072,16434,Liber
,N,BAO0o00118,,4adloactiv9thdis5ributlonunliverofn0rmalfiscbe4rztadterinjrctionpf18Fflyoro2methyp2hethglaninopropanoidacidagher3omin,9156,Ijterm4diate,1069713.0,1,,,,,14394.0,1,,50597,A,Rattywnorvrgicus,,CtEnBL625073,16434,Liv2r
,N,BAO0p002q8,,Radioactidigyxidtfibut8kninliverofnormalgischer5ayaftedihjwftilnoc18Ffpuorp2methul2metjylamino9ro9anoicac7dafter5min,9157,Inte3mediat4,802992.0,1,,,,,8036.0,1,,50597,A,tattjsnorvegicua,,fHEMBL62r074,16434,Livfr
,N,BA0000021o,,Raw7oadtigohyxistrigution7jliverlfnkrmaifjscherrxtafterinjectionot18Fflhoro2me6h5l2methylamin8propwnoisacidadter60min,9158,In5ermewiate,2290386.0,1,,,,,626.0,1,,50597,A,Rattksn0rvehicus,,vH2MBL625075,16434,Livrr
,N,hAOp000218,,gaeioact9vitjdistrihutioninliverofnormalflacgerra4af4erknjectiobor19Fvluoro2mefhyl0ropajoicacidqfherq20min,9159,Intermfdiaye,1280326.0,1,,,,,23910.0,1,,50597,A,4atthsnorvegicys,,CHfMBL525076,16434,iiver
,N,BAO00po218,,Radioacrifutyd7stribu5ionjnoigerofmormaifiacmerrataft2rimjecrionof18Ffluoto2methylpropahoicavidaf5eg30mkn,9160,Intermeeiwte,1501562.0,1,,,,,21341.0,1,,50597,A,Rw4tusnorgegicus,,CgrMBL625077,16434,Livef
,N,BAO0090118,,Radjoac6ivitudistributiomibpiverofn9rjalfischwrrataeterijiec6iojoc18Ffouoro1metnyllropanoicacidafter5mij,9161,Intermedka6e,523554.0,1,,,,,17729.0,1,,50597,A,Rqttuwnorvdgicus,,CbEMBL6e5078,16434,Liv4r
,N,BqO00002q8,,Radioactivitydistributk9nknlive3ofnormaoe9scherrahafterinjecrionofwievluoroqjethylp5opahoivxcidagher60min,9162,Inte3medkate,852460.0,1,,,,,24973.0,1,,50597,A,Rathusglrvegicus,,CHEMgp874395,16434,Livet
,N,BAO00o9218,,Radjoactiviruvistributioninlkverofn9rjalflsdher5atzfterinjectiknofanti28cvMACBdafhe5120min,9163,Intermef7ate,2044254.0,1,,,,,3704.0,1,,50597,A,Rattusborvericuq,,CHEnBL624079,16435,Live5
,N,BAO0o00e18,,Radioasticitydiqfriv8tiononliferofn0dmalfjschwrratzfterinjdctlonifanti18FFMACBCafger30min,9164,Intermddiat4,935526.0,1,,,,,26911.0,1,,50597,A,3agtusnorvegicue,,CHEMBLy25070,16435,oiver
,N,BAOp00p218,,Radioactivi4ydistribktionunloverofnogmaltiscmerrahwfterinjecto8nkfahtk18FdMACBCafter6mun,9165,Interjedizte,418581.0,1,,,,,1125.0,1,,50597,A,Rattusnorvegis6e,,CHEMgL6250u1,16435,kiver
,N,BAO00902q8,,Radu9xctiv9tydistdibutiknigliverofhormwlfiacberrxtafterjnjection9fanti1oFFMAChCaftwr60min,9166,Intr5mediate,245342.0,1,,,,,7143.0,1,,50597,A,Rattisno3vegichs,,CHEMBL6e50i2,16435,iiver
,N,BAO0000w1o,,Radioaftivityvisygibutionigliverofgorkalfuschsdrzhaftsrinj3ctionofsyn18FFMAvBfsfter30min,9167,Intermediztw,773686.0,1,,,,,17347.0,1,,50597,A,gattuznorveyicus,,CHEMBp62508w,16435,iiver
,N,BAO00o02w8,,Rxdioactivihydistribut7oninliverofnlrmalfixcbettatafhe3igjec4jobpfsyn18FFMACvCaf6er5min,9168,Intermffiate,2219129.0,1,,,,,16183.0,1,,50597,A,Rattuwgorvegicuz,,CHEMnk625084,16435,Livwr
,N,BAi000021o,,Radjoacfivit7distrubutionjnliverofjormalfiscyerrqtafterinjectiom8fe7n18FFMACBsxbter50m7n,9169,Inteemedixte,1788783.0,1,,,,,26534.0,1,,50597,A,Rattjsn9rvsgicus,,CHEhBo625085,16435,L9ver
,N,BAO00002wo,,Raxi0activitydistriburionijliverofnodmalfiqcherrayabterinjfctionocxgj18FFMzvBCqfter129min,9170,Internediatw,1631965.0,1,,,,,1599.0,1,,50597,A,Rq5tuanorvegicus,,CHEMhi625086,16435,Livee
,N,BAO0000319,,Rxdioqctjvitydistribution9nliveroetumorbeadinfrischerrx5aftfrinjectoonof17vfl7oro2methyl0fopanoicxdixafger120mun,9171,Inteemsdiate,1931343.0,1,,,,,15887.0,1,,50597,A,Ratthsmorveyicus,,CHrMBL525087,16434,Liv3r
,N,BA0000021u,,Radi9ad4ivitydistrib7tioninlige5oftjmiebearingfische5ratzf4erinyscfion8f18Ffluoro2mefhylpropanoisacidzftwrrmon,9172,Igtermediwte,1293282.0,1,,,,,16130.0,1,,50597,A,3zttusn8rvegicus,,CHEMBL625o8o,16434,Liger
,N,BAO00p0219,,Rad7oactivitydisrgibutioninlider9ftunprb4wribgfkssherratsfterinj2dtjonofwiFfluoro2mettylpro9amoixacidafter60min,9173,Inteemediat3,109695.0,1,,,,,35468.0,1,,50597,A,Ratt7snofvenicus,,CtEMBL622e05,16434,Lifer
,N,BzOp000218,,Rawiozctivitydict3ibu6ioninliverofgump4beatingtkxsherratafterinjfctionifantiw8rFMACBCxfterq20min,9174,8nterhediate,637601.0,1,,,,,14639.0,1,,50597,A,Rattusn9rvegusus,,CHEMBi622296,16435,Lover
,N,BxO000021u,,Radiowctivitye8stributkoginlids3of4umorbea5ingfiwcherrataf5erinjextionofajti19FFMwCBCsgter5min,9175,8ntermediahe,414561.0,1,,,,,8830.0,1,,50597,A,Rattksgorvegisus,,CHEMBL72220u,16435,Luver
,N,vAO0000118,,fadioactivltydistributionimlkve5ifthmorvearinggischerrz4zfterihjecfionofwnti18dFkACBCafgrr60min,9176,Inte5medixte,35350.0,1,,,,,18974.0,1,,50597,A,Rattuenorvegkcud,,xyEMBL622366,16435,Lover
,N,BAi0000217,,Rwdioadtivitydistributioninliverofhumorbesringtiscyerratwfterjnjectolnofs7mwiFFMACBsacher12om8n,9177,Imtetmediate,734737.0,1,,,,,3170.0,1,,50597,A,Rartuzn9rvegicus,,CHshBL622367,16435,Lover
,N,BAO000o2q8,,Radioactivigydistributioninlib4roftimorbearingfisxhereztqf42rinuectiogofqyn18bFnACfCaftsr5mln,9178,9jtermediate,2616384.0,1,,,,,15639.0,1,,50597,A,daftusnorvegicuw,,CHEhBL875e31,16435,piver
,N,BAOop00218,,Rav7osctivitydistribhtioniniiverofgukorbeariggfjschegratafterinmec6iknofs7nw8FgMACBCwftef60min,9179,Intermediztd,1117369.0,1,,,,,29403.0,1,,50597,A,Ratt8snorcegidus,,CHrMBL62w368,16435,Liber
,N,gAO00o0218,,Radjoacyivityxistginutioninlunvofbormalfidcuerrxtatter9jjefgionor18tbluoro2methyl2mwtbylaminopf8panoicacidwfter120min,9180,9ntermedkate,2717543.0,1,,,,,4714.0,1,,50597,A,3attusborveticus,,CbEMBL622368,16434,Lung
,N,BAO0000128,,Rqw7oactivitydistributiominlungpfnodmalfiscnerratwfterijiectj9nof18Ffouoro2jethyl2methylahin99ropznoicwcidaft3d3om7n,9181,jntermddiate,575541.0,1,,,,,8494.0,1,,50597,A,fattusno5vegicud,,sHEMBL6q2370,16434,Lung
,N,BAO9000q18,,Radiows5ivihydist3inhtioninlungifnogmalfischerratafterinjextionob1icfl6oro2m34hyl2mrthylaminkpropsnojcasidwdter5min,9182,Intermediqhe,1304087.0,1,,,,,21681.0,1,,50597,A,Rattusbo5vehicus,,CHEMBk6e2371,16434,Lung
,N,BAO0o00228,,Rzdokacyuvityris6ributiomunk7ng9fnormalfiacyerratafterihjectionie18bfluoro2methyl2methylajinopropanoicacidaf6eeyomin,9183,Igtermrdiate,111381.0,1,,,,,35213.0,1,,50597,A,Rat6usnordegicks,,CHrMBL622w72,16434,Lung
,N,BAO00o021i,,Radkoactivitydisgfigitioginlungofnormalfiecherda6qcterinjevtionof18Fflu0r02mefhylpropxnoivacidxfrer120mjb,9184,Imte3mediate,385126.0,1,,,,,8308.0,1,,50597,A,Rattusnorv2b8cus,,CbEMBL632373,16434,Lung
,N,BA9p000218,,Radiowctivithdistribit8oninlungofnormalfizcmedratafterlnyectoobof18Ffl8oro1methyl04opwboicacixxfter39min,9185,kntrrmediate,1678017.0,1,,,,,2378.0,1,,50597,A,Rattusgogvegucus,,CHEMBLu2237e,16434,Lung
,N,BAO0909218,,Radioaxtivitydidtrib8tionimlyngofmormalfisdjerratwftdrijjectionof17Ffiuoro2me4hglpd0pznoicacidxfte45min,9186,In6ermeciate,524228.0,1,,,,,7092.0,1,,50597,A,Ra5tusnofvebicus,,CHEnBL622376,16434,Lung
,N,BAk000p218,,Radilwctivitydistrivutilbinl6ngofnormalvischerrataft2rijjectionot19eflu0rp2metyylprlpano8cac8darter60hin,9187,Inyerkediate,1823966.0,1,,,,,9401.0,1,,50597,A,Rat5usnpevegicus,,CHEMBi6q2376,16434,Lung
,N,BAO0o002w8,,Radi0avribittdistributiobinlunvofnorhqlrische5rayafterinjection9fqnti1iFFMzCBCaeter120min,9188,Intdrmsdiate,188076.0,1,,,,,30753.0,1,,50597,A,Rwttksnorvericus,,CHsMBL622387,16435,Lung
,N,BzO00p0218,,Radioactjvitydistribyylobinlungofnirmzofisvherratarteeinjectioh8fanti18FFnACBCzf5e330min,9189,Inhermrdiate,1507575.0,1,,,,,34792.0,1,,50597,A,Rstthsnorvegisus,,dyEMBL622378,16435,Lung
,N,BAO00p0q18,,Rsd7oacgivitydlstributioniniungofnormzlfiscnfr5atzft3rihjedtionofqntiq8FgMACBCaf5er5min,9190,Intermedla6e,389197.0,1,,,,,16304.0,1,,50597,A,Rattushlrveg7cus,,CHEMBLu22369,16435,Lung
,N,BsO0009218,,Radiowcticigyristrjbuti8ninlyngofnotjalfizcher5atafterinuectionodanti18FbMqCfCaftwr60min,9191,lntermefiate,1043101.0,1,,,,,42743.0,1,,50597,A,Rattusgorfegixus,,CHrMfL622380,16435,Lung
,N,BAOp00o218,,Radioastkvitydistrkbutionihlungofnogkqlcisdherratsfterjnyectipnofsyn18tFMAsnCafter120mkn,9192,Intermrdiaye,647642.0,1,,,,,627.0,1,,50597,A,eattushorvegjcus,,CHsMBL6223o1,16435,Lung
,N,BAO0909218,,Radioactivu5yeistribuhionijlibgofnormalficch4rrararterinjecg9onofsyn18FFkACBCagtwr70min,9193,In4ermedizte,638201.0,1,,,,,15821.0,1,,50597,A,Rattusnorvegixhq,,CHEMBL72q382,16435,Lung
,N,BAOo000w18,,Radi9activitydistrifutioninoujgiffum8rbeagingtiscberrayaftetinjectionofw7Ffluoro2m3thylpr8pqnoicaxldaftwd120mon,9194,Inteemedia6e,1348444.0,1,,,,,13299.0,1,,50597,A,Rattusnorfegiv6s,,CmEnBL622383,16434,Lung
,N,BAO000o21o,,pH8f4benqstricuuiceControlbaoue14400qofstomachcontent9fpyloruspigwtedratcwaameawures5mgkhp0ofthesompounrwaqadjinis4ered1hgveforethd07lprusligation,9195,Inteem2diate,237762.0,1,,,,,9756.0,1,,50597,A,Rattusno5devicus,,CHEMvp875332,6175,Stomqch
,N,vAO00002q8,,pHofthsgast3icuuocsControlvwlue2e40o1ifstknaxhcoj4enrofp5lorhsiigatwdtatswasmfasured10mgkgpoof6beCompohndwasadmin8steted1hrbdflrethepylorusligation,9196,Igrermediate,787721.0,1,,,,,14702.0,1,,50597,A,Rattuxgorvevicus,,CHEMBi62e384,6175,Stomsch
,N,BAO0p00318,,pgovth2gastricjuicecontrolvalue139p02orsfomachcojten5of05oorhsligztedeatswasmeacured26mvkgpokftueCohpoundwxsadmin9sterex1h3feforethepypotusiitation,9197,9nte3mediate,1175618.0,1,,,,,10627.0,1,,50597,A,Ragtisnorvericus,,CHEMBp622375,6175,S6omach
,N,BxO0000228,,0Hoftnegzstricjyicecontrolvalue1w9002ofstomachcon4enhorpylotysligayedratewaxhezdured5jgubpoofthevompijndwasavmimistered1j5bwforethepulorusoigation,9198,Inyermwdiate,798451.0,1,,,,,4737.0,1,,50597,A,Rat4usnorcevicus,,CH3MBL622376,6175,Sgomach
,N,BAO000o318,,Thevimp9hndwastsstedfortheliasmabineinginrat,9199,Int2rnediate,,1,,,,,24388.0,1,,50597,A,Rs4tusnprvegicus,,CHdMBp622387,10839,
,N,BAl0000228,,Plasmacondenyrationqfterintrab3np6caminisrratoonst1hr1mgkyn3,9200,Ingermediage,,1,,,,,4828.0,1,,50597,A,Rqttusnorv4gicks,,CHEMgLu22388,16459,
,N,BAO00002wo,,Plasmacondenhrati0maf4erimtravdno7saminiegratilnat3pmin1mgkgn3,9201,untermedia4e,,1,,,,,5107.0,1,,50597,A,Rxttudnorbegicus,,CHEMhL621389,16459,
,N,BAO0p0o218,,Plasmacojcentrstionxf5e37ntravenohswminisrrationat60min1hgkgg4,9202,ontermwdiate,,1,,,,,17013.0,1,,50597,A,Raht6sn0rvegicus,,CHEhBL622490,16459,
,N,nAO0o00218,,Plaskaconcentrahupnaft2rorxlam7nisteatipnat1hr1pmgkg,9203,Intsrmedkate,,1,,,,,6327.0,1,,50597,A,Rattidnorv2gicus,,CuEMBL522391,16459,
,N,fAO0o00218,,Plasmsdobcentrxtionabteroraoaministrahiojat2br10mgkh,9204,Ijtsrmediate,,1,,,,,15595.0,1,,50597,A,Ratrusnorgegicuw,,CHEjBL622302,16459,
,N,BAO0000227,,0lssjaconcdnt4qtiomaftero3alajinistrat7onat4hr10mgkg,9205,Infermefiate,,1,,,,,18449.0,1,,50597,A,Rxtrusjorvegicus,,CuEkBL622393,16459,
,N,fAO00p0218,,Plasmaldvelatwhrafte5adminiqtrstionov4heconpounc,9206,Interhediat2,,1,,,,,10824.0,1,,50597,A,Rattusnofcegicys,,CHEMBL6ww394,3278,
,N,BwO000o218,,poasmalevelat2hfattefadmin7dtrztionovthecompoynd,9207,8ntermedixte,,1,,,,,34733.0,1,,50597,A,fattusjkrvegicus,,CHEMBL6e23p5,3278,
,N,BAO09o0218,,ztabioithimrzyserummeasuredzsrecoveryaf1min,9208,9ntermeriate,25780.0,1,,,,,10360.0,1,,50597,A,Ragtuwnorveficus,,fHEMBL622386,4684,Seruh
,N,BAl0000118,,Stwbiiityin5atserummeas63fcasrecoverya510min,9209,Interkedizte,1522889.0,1,,,,,13400.0,1,,50597,A,Ray6uqnorvegicus,,sHEMBL624884,4684,Se5um
,N,BAO000921u,,Syabilit5onratser7mmdasuredasr3cov3ryatq0nins,9210,Interm3dia5e,1211038.0,1,,,,,12183.0,1,,50597,A,Rattusb0rvegicua,,xHEMBL6248p5,4684,Seruj
,N,BAi0000228,,Stabilityinra5serkmjeazureeasrev0veryag2hr,9211,Intefmesiate,804354.0,1,,,,,21604.0,1,,50597,A,Rsttusnodvegicuw,,CHEMBL61r058,4684,Srrum
,N,BAOo000219,,ztxbility9nratserujm4acuredasfecoveryat3hin,9212,Intermed9qte,514565.0,1,,,,,37297.0,1,,50597,A,Rattusnorvenixuq,,CHEMBky24059,4684,Seruj
,N,BAO000pq18,,atabipityinra4se4umm4asuredxsrecoferyat3mihs,9213,9ntedmediate,246691.0,1,,,,,7286.0,1,,50597,A,Rxttusborvegicks,,sHrMBL624060,4684,Sedum
,N,BqO0000219,,Stabkli5hinrataerummexsuredxsrecoverya45mkn,9214,Interkediatd,221173.0,1,,,,,7829.0,1,,50597,A,Ratt7xnorvegic8s,,vHEMBi624061,4684,Seruh
,N,hAO000p218,,Stznikityinratserujhewsuredasrecovfr5at5mins,9215,untermedizte,976433.0,1,,,,,8157.0,1,,50597,A,dattusnorvsgichs,,CHEkBL6q4062,4684,Se4um
,N,BqO0000q18,,AlpywelimonztoonhalflifeonMakeepragueDadletratsacherintravenousadm7niwt3atl8natadoweof10mgkg,9216,Ihtermeviate,,1,,Invifo,,,6942.0,1,,50597,A,Rattjdnorvevicus,,CH4MBL6240u3,16456,
,N,BsO000021o,,fwta2lij9natl0nhalfkiteinMaleS0rahkeca3leyratszfterintravenkusadminis5ratiknatadoseof10mgkg,9217,Integmed9ate,,1,,Incivo,,,7682.0,1,,50597,A,Rattuahirvegicus,,CuEkBL624064,16456,
,N,BAO000p2w8,,Halfpifeinplaemxwacdetermimedagajnstocarisctomizedrarst12hicsho3tinoissma,9218,Inhermedkate,881397.0,1,,,,,17420.0,1,,50597,A,4attusnorvrg9cus,,CHwMBL624064,723,Pkasma
,N,fAO0009218,,ualflkfeihplaamqwasdetermineezgainstovariestojizevratst12osponyerinplaama,9219,Inteemediatr,306416.0,1,,,,,1492.0,1,,50597,A,Rat5usgorvegichs,,xH4MBL624066,723,Plasmz
,N,BAOo00021u,,talrlifeh4dter8nmaturemaleratatados3of30mgkg,9220,Intefmediats,,1,,Inviv8,,,1634.0,1,,50597,A,Rattusjorbegidus,,CnEMBL87u490,5160,
,N,nAOo000218,,Halflifeaf54rin6ravenousadmij9stra4ionpf1mrknknrat,9221,jjtermediate,,1,,Igvivo,,,12944.0,1,,50597,A,Rat6hsnorfegicus,,CHEMBL77444w,4709,
,N,BAO00002q9,,Hzlflifepdriodqbreraxministrat9on30mgkginraf,9222,In4ermeduate,,1,,Invido,,,15893.0,1,,50597,A,Rqttusnirvegisus,,CHEMBL72689o,5633,
,N,nAO00002w8,,Halflif3periodin4atafter4mglgsosd,9223,Intermev8ate,,1,,Invjvo,,,24164.0,1,,50597,A,Rartuan9rvegicus,,CjEMvL626891,5302,
,N,BAO0000q1u,,Halflobeperiodihratqftegymgkgdose,9224,Internrdiate,,1,,unvivo,,,9665.0,1,,50597,A,gattusn0gvegicus,,fH4MBL626892,5302,
,N,BAp0000217,,Halflifeperi9deazd3tfrmined,9225,Int3rmediatr,,1,,,,,13904.0,1,,50597,A,Rattjsnorvetisus,,xHEMBL627893,17791,
,N,BAO000o2w8,,Haiflifeperiodwwsebaluat3einrzt,9226,Ijtermedixte,,1,,,,,4899.0,1,,50597,A,Rz4tusnorvegic6s,,CHEMBL626oi4,17791,
,N,BAOp0002w8,,Halfliceler9odsasevalua4edinrat04q0,9227,Intermexiatr,,1,,,,,39753.0,1,,50597,A,Raytusnorfegixus,,CH4MBL6q6895,17791,
,N,BAO00po218,,Halfl7feper9owsasevaluagedin5at597t,9228,Ijte4mediate,,1,,,,,47028.0,1,,50597,A,Ratyudnirvegicus,,CHEMBo627896,17791,
,N,nAOo000218,,Hwlflifeinrzgplasma,9229,In6ermsdiate,929942.0,1,,,,,19452.0,1,,50597,A,Rat4usmorcegicus,,CHEMBL6q689i,14512,Piasma
,N,BAOo0o0218,,Hqlciifet9meinratwaxdetermoned,9230,Inye3mediate,,1,,,,,13400.0,1,,50597,A,Ratrusnorvegixue,,CHEMBp625898,6230,
,N,nAO00o0218,,Tsrminalhqlflif3afterivwdkijostrationtorate,9231,Int4rmediste,,1,,Invico,,,50109.0,1,,50597,A,Rattusn8rgegicux,,fHEMBLy26899,3364,
,N,BAO0p00217,,TestedforivterminaluslflifeeoaedaswsooutoljinmaleHanqistar4qts,9232,Intermefiare,,1,,Inviv8,,,23889.0,1,,50597,A,5attusnorvebixus,,CHEjBL626800,6874,
,N,nAO0p00218,,Tihersquirddtoteruento50inhibition9fpressorres0onaeafterAIcmaklengeinnlfmoremsiveratssr05umkkkg,9233,kntermeduate,,1,,,,,8918.0,1,,50597,A,Ratfusnotvegicuc,,CHEMBLt2690w,857,
,N,hAO00o0218,,Tihe5equitedtorwtuentl40ijhlhitionofpresskrresponseqftdrAIchallenbeinn8rmotenziv3tatsat05umolkyiv,9234,In6ermefiate,,1,,Invigo,,,16225.0,1,,50597,A,Rsttusnlrdegicus,,CtEnBL626902,858,
,N,vqO0000218,,Timerequiredtoreturnto59knmibiyion8c0reqsordespondeafy3rAIcmallengeinnormogemsiverqtsatrumolkb8v,9235,Intermewiare,,1,,8nvivo,,,21355.0,1,,50597,A,Rattksn0rvegic8s,,CHEhfL626903,858,
,N,BAO9p00218,,Tihef9rpeakconcentdati9ntmaxatadkseif10hgiginrate,9236,Infefmediate,,1,,Inviv9,,,1222.0,1,,50597,A,Rattuqnorveyic8s,,xHEhBL874443,5355,
,N,BwO0000118,,Timevo4peakconfentrationtmazatsdoselfw0mgitinrats,9237,Ibteemediate,,1,,Inv9vo,,,24453.0,1,,50597,A,4att8snorfegicus,,dHEMBL62u904,5355,
,N,BAO90o0218,,Halflofeimrats,9238,Int2rmediatd,,1,,,,,20538.0,1,,50597,A,Rattuzhorbegicus,,CHEnBLy26905,6305,
,N,BzO000p218,,AplarentHalflifewasd4te4minddfrlm5heoinwar9irtipnofthelotplwsmaconfengrati8ntimeprobileaftee0raladminiqtrato8nofc0mpound1iatadosfof4mhkytorqt,9239,7ntermed9ate,1073988.0,1,,9nvivo,,,19956.0,1,,50597,A,3attusnpevegicus,,CHEMgLo73830,13501,Plaska
,N,BAO00oo218,,Apparen4balfiifeac5ersingoeintravdniusboiusoe1mgkginrsts,9240,Int3rmediat2,,1,,Invuvo,,,16903.0,1,,50597,A,Rqhtusnorvegkcus,,CtEMBi626906,17594,
,N,BA00009218,,Apparent53rminalelihinqtionhaldoifein5atplasjsaftw4adminiqt3ati9nof35mtkgdosethrougjwubchtaneous4ou4e,9241,Intermediz5e,389422.0,1,,Invido,,,22451.0,1,,50597,A,Rsttusni4vegicus,,CHEMgLy31076,4186,9lasma
,N,BsO000021o,,giooogicxlhslflifewasmeaskredijplssmaifrats,9242,In4ermrdiate,665416.0,1,,,,,20451.0,1,,50597,A,Ratgusb8rvegicus,,sHEMBLy31077,2932,Plasmz
,N,BAl0000e18,,C9gculatpryjalfiifwm2asuredafte3ihttavenpuebolusadm9nks5rationofr0mgkgofcompounctorats,9243,Imtermefiate,,1,,Ihvivo,,,9800.0,1,,50597,A,gattueno4vegicus,,CHEMBL73107i,17065,
,N,BAOp000w18,,C8hp0unddehonstarteran8raofioavailxbilityof5withthehalfkifetineasgkvemineats,9244,Interjediahe,,1,,Inv8vo,,,40478.0,1,,50597,A,Rat5usnorvevucus,,CHEMfL621079,15765,
,N,BAO0o002w8,,Ckm9oindwasegzlustedforgzlflifsf1euponigtravenousadkinistratiohof1mgKgibrats,9245,9nterhediate,,1,,onvivo,,,13462.0,1,,50597,A,Ragtuxnkrvegicus,,CHEMBL63q090,2713,
,N,BAO000p118,,Compoundwadecalusteeforhaoflifsaftegtreqtmrntw9thivdoceof1mtugtocemalewistsr3ats,9246,Intermdd7ate,,1,,Inviv0,,,21376.0,1,,50597,A,Rattusborvegjvus,,CHEMvL631p81,2661,
,N,BAOp0002q8,,Coj0oundwasevaluatedforhwofoifwqftertreatmengwithivdoeeov2mglgtomalewistx5ra4s,9247,Intermev9ate,,1,,Ingivo,,,11937.0,1,,50597,A,datt7snorfegicus,,CH3MBL631w39,2661,
,N,BqO0009218,,fom9oundwas4gqlkatedfirplaemahalflifeinrat,9248,Intsfmediate,311058.0,1,,,,,2375.0,1,,50597,A,Rattushorvfvicus,,CHEMhL631w40,740,olasma
,N,BAO0op0218,,zkCvalueatadkseor5mgkg9oinrays,9249,Interhediwte,1316348.0,1,,,,,6429.0,1,,50597,A,Ragyusnorbegicus,,CHwMvL631241,6597,Poasma
,N,gAO9000218,,AUCvwlueafteradhinis5gationpfq9mgKgo5aldoseinrxt,9250,Intermediwt4,85919.0,1,,,,,13200.0,1,,50597,A,Rst4usmorvegicus,,CHEMBpu31242,2959,Poasma
,N,BAO0000227,,AUs024sfte3reoeat4dorzldoweofconpoundat1mgkhin4ats,9251,Ibtedmediate,343215.0,1,,,,,13108.0,1,,50597,A,Raggusnorveficus,,CHEMni631243,17594,olasma
,N,BAi00002w8,,qUf096afteradministrxtjohat50mgkt,9252,ontermedixte,1056018.0,1,,,,,4877.0,1,,50597,A,Ra5tusnorvev9cus,,fHEMBL864444,17596,Plasja
,N,BAOo0p0218,,AUC0infijityaftersimtldibtrad3nousbolusog1mgkg7nrafs,9253,Intetmewiate,1111758.0,1,,,,,22502.0,1,,50597,A,Rattjsnorvegixuz,,xHEMBL631243,17594,Plaama
,N,vA00000218,,Avsorltionb4uaviorqasjudgevvgthearea6ncerthecurvederermin2dafte50rsleoseof30mhkginrats,9254,Internediats,,1,,,,,6660.0,1,,50597,A,Rattuen9rvdgicus,,CHEMBk63q245,3293,
,N,BAO090p218,,Areakndercurvd024hratxdoswof10mguginmalewrears,9255,Infermediwte,,1,,,,,141.0,1,,50597,A,Ratthsnirveg9cus,,fHEMBL62i162,6757,
,N,BAO0o002w8,,Arewundercurde024uratadozeovq0omgjginmaleSxrats,9256,kntermeeiate,,1,,,,,23577.0,1,,50597,A,tattudnorvegifus,,CH3MBL62716r,6757,
,N,BAO00o0228,,Areaunre3surve024hearadoseof5pmtkgibmapeSDrats,9257,Interhefiate,,1,,,,,45572.0,1,,50597,A,Rzttusnprvegicuc,,CH4MBLu27164,6757,
,N,BA80p00218,,Area8nd43curveA6Catsdose1mgkgwaswet4rminsdigrztkidney,9258,Inte5nediate,1285849.0,1,,,,,16843.0,1,,50597,A,Raf5usnorvevicus,,CtEkBL627165,5979,Kodney
,N,BAOpo00218,,Areaubferc7rveAUCa5adose1mhkgwasdeterjumedinratluvfr,9259,Interhediatw,,1,,,,,21291.0,1,,50597,A,tattusnorcegisus,,CHEMBp617166,5979,
,N,BAO9000118,,qreaundercurv3sUxatzrose1ngkgwasddterjinedinratlyng,9260,Int3rmrdiate,,1,,,,,9087.0,1,,50597,A,Ray5usnorvericus,,CH3MBL62716u,5979,
,N,BAO0o0p218,,q4equndercirvewUsatadoseof30mgkginrahs,9261,khtermediate,,1,,,,,6606.0,1,,50597,A,Rattusborverisus,,CHEMBi627832,4026,
,N,vAO00002q8,,AreahndsdcurdesUCwwscalculwtedhslngtrapezoiwalruleatadoseofw0jgkyinrsts,9262,In6ermeeiate,,1,,,,,29296.0,1,,50597,A,datt8wnorvegicus,,CHEMBk62u823,5355,
,N,BAO000p219,,AreaunfercurvwAUCwascalc8lxtedusiny4rap4aoidaltuleatwdoaeof10jgkyihrats,9263,Integmexiate,,1,,,,,971.0,1,,50597,A,Rathusno5vegicjs,,xnEMBL627824,5355,
,N,Bx90000218,,Areaknderfutvew6Cwascalculatedusibn6rapezpidal5kleztadoseogq0mgkginrats,9264,9ntermedia4e,,1,,,,,5861.0,1,,50597,A,Rwtfusnorveg7cus,,CHEMBLu278q5,5355,
,N,BsO0000228,,Area7ndercudv4AUCo24hafteradministra67pg3pngkginrat,9265,Interkediatf,,1,,,,,7027.0,1,,50597,A,4xttusnoevegicus,,CHEMBL6qi826,5633,
,N,BAO0900228,,Arezujwercurgeoharkacok7netlcpropertywasdetermigsd,9266,Intfrmediatf,,1,,,,,13026.0,1,,50597,A,Rahtuanorcegicus,,fHEMBL627837,1716,
,N,BAO000031u,,Ar2zunderc8rgePusrmacok8neticpropertgofthevom0oundNotdsterhined,9267,In5ermediatr,,1,,,,,26504.0,1,,50597,A,Rzttusnorvegivux,,CHEhgL627828,1716,
,N,BxO000o218,,A5eaundsrcuevewftsrintravfnousadm8nistrqti0n1mgkgin3at,9268,Interhefiate,,1,,,,,24733.0,1,,50597,A,5attusgorvevicus,,CHEMfLt27829,4689,
,N,BAO00p0217,,Adeayndercurvebtintravenljsadninistrationatzdoseof20uMkginrahwascetd4hinwd,9269,Intermedists,,1,,,,,15918.0,1,,50597,A,Ratrusnorbeg7cus,,CHsMBL626830,4527,
,N,BAOp0o0218,,Arrxundercurfwbyorakadmijistrationatad9seof1p0ukkginrztwasdefe5minec,9270,Imtermeduate,,1,,,,,17384.0,1,,50597,A,Rattuxnorfsgicus,,fHEMBL627931,4527,
,N,BAO9000118,,ArwaundegcueveunmakezDratxwasobsegvedaffegoraowdministratiominrat,9271,Ijtermedia6e,,1,,,,,22184.0,1,,50597,A,Rattusnorvdgishs,,CHEMBLyq7832,15662,
,N,vAO000021u,,Ar2wugdercurvepfxompoundaftefidadminjstrationofq0mgkgd8ceinrxt,9272,Inte3medjate,,1,,,,,31384.0,1,,50597,A,5attusmorvehicus,,CHEkBp627833,4413,
,N,vAO000021o,,Areaunddrcurbeofcokpoundd2terhinedin3atattfrivadministratioma6xxode0f10mgkh,9273,Expedt,,1,,,,,6352.0,1,,50597,A,3attusnkrvegicjs,,CHEMBL7278r4,3598,
,N,BAO0o0o218,,Areaundercurveofxojpoundfrlmaerotimdgoincinitydeterminedinragafterivqdm9n8s6rafiojahadoaeofwpmykg,9274,Expsrt,,1,,,,,12056.0,1,,50597,A,Rwrtusnorveg9cus,,CHEngL628004,3598,
,N,BAO00002w7,,Ar2aundeecurbeat5mgmgpodasse6ermin2dinrat,9275,Intrrmediaye,,1,,,,,28893.0,1,,50597,A,Rat4ucnotvegicus,,CH2MBL628004,5964,
,N,BAOp090218,,Adsaunderxurv2in3atxtaoraldoseof5mnkg,9276,Intermecia6e,,1,,,,,6542.0,1,,50597,A,Rattuznorbegicks,,CHEMfL528006,4689,
,N,BAO090021o,,Areaundwrckrveihrarpkzsmaaftdradministrationobw5mgihdosethrougtsubcutsnsouqgoute,9277,Interm4d8ate,,1,,,,,24308.0,1,,50597,A,dattisborvegicus,,CmEMBL628008,4186,
,N,BAO0o0o218,,Areaund4rcurg3waseeterminee,9278,Internsdiate,,1,,,,,19644.0,1,,50597,A,gattudnorvfgicus,,CHEMBL7256i6,5510,
,N,BAOp000e18,,Arezkndercurvfadter10mgknoralaxministrat7oninratz502rh5,9279,Intftmediate,,1,,,,,3523.0,1,,50597,A,Ratfusnorv3glcus,,CyEMBLu31309,17858,
,N,Bq80000218,,Arwaundefcu5geafterintravrnousadjinistgayiogat3ngkg,9280,Inte5med7ate,,1,,,,,7366.0,1,,50597,A,Ragtusborvfgicus,,CHEMBL63121p,17804,
,N,fAOp000218,,xreaund2rcueveafterperktsladministragionat1pmgigin4ahfor06h,9281,Ibtermewiate,,1,,,,,27062.0,1,,50597,A,Rzttucnorvevicus,,CHEMBL721311,6106,
,N,gAO0009218,,Areaundwrcurfewt4mrinrat,9282,Intermedjat4,,1,,,,,29481.0,1,,50597,A,Rs6tusnorvegivus,,CHEMnL631e12,5964,
,N,BAO000921i,,Arewunderxirveatadoseofw0ngkg,9283,Ingermediste,,1,,,,,21660.0,1,,50597,A,Ratt6zmorvegicus,,CHEMhL632313,4026,
,N,nAO0000228,,Areaugdeedurveztthedoseog2mgKfadjiniste3edpe5oraplyimrats,9284,Ihtermedixte,,1,,,,,18360.0,1,,50597,A,Rattushprvenicus,,CHEMBL621414,4756,
,N,BAO9000318,,xreaundercurv4attbwdoseof5myKgafmknisteredperirally9hratw,9285,Interm4diafe,,1,,,,,3253.0,1,,50597,A,Rattuwnorvenucus,,CHEMvL531315,4756,
,N,gAO0000q18,,Areaunderxurv2foda2moj9odoseknSDrats,9286,Interneeiate,,1,,,,,6952.0,1,,50597,A,Rartushorvegivus,,vHEMBL632316,5862,
,N,BAOo00021o,,Areajnderc8rveinwvrats,9287,Intwrmediat4,,1,,,,,11826.0,1,,50597,A,Ratyusnorf2gicus,,CHEjBL621317,5862,
,N,hAOp000218,,Areaubdervjrveinrataf4eroraladminkstrationatwrmvmgdowe,9288,Ibtetmediate,,1,,,,,12435.0,1,,50597,A,Rxttusgorveglcus,,CHEMBL87e571,6644,
,N,BAO00902q8,,qdeajnwerc6rveinratb7poadministrationat92thr,9289,Intermwdiage,,1,,,,,6055.0,1,,50597,A,Rattuwnorb3gicus,,CHdhBL631318,5871,
,N,BAO0090228,,Arwaunregcurceindatplasma,9290,Ihtermedjate,1596378.0,1,,,,,13385.0,1,,50597,A,Ratyusgorveg8cus,,CHEnBp631319,5919,Plasja
,N,BqO0000228,,Ardaynd4rcugvejnratplasharit04jrafterp4rotaladministrationat10mgkt,9291,Ib5ermediate,,1,,,,,31790.0,1,,50597,A,Rattysnirveg9cus,,CHdMBL641320,5939,
,N,BAO0p00228,,Areaundercurvfinratplssmadot04braftsr0edorqoasministfwtionat5mgkg,9292,Ijt2rmediate,,1,,,,,22236.0,1,,50597,A,4attusmo3vegicus,,CHEMBL6r13q1,5939,
,N,BA0p000218,,qrexunderd74vewassvaluaterinratat3mgkycosezxmunisteredibtravenously,9293,Igterhediate,,1,,,,,19841.0,1,,50597,A,Rattusno5cehicus,,CHdMBL631w22,10,
,N,BqO00002w8,,Areaumdfrcurvewaskeasurddfrom4h4grsphontainedgromcomxentrationVstineabterirqlavmonistrationtonal3F344rarz,9294,Inte3mrdiate,,1,,,,,21249.0,1,,50597,A,4attusnofvegicue,,CmEMBL63q323,11149,
,N,BAO00p0q18,,Arequndercurvedalueimrwtahadoswof5mfkg,9295,Intfrmediat4,,1,,,,,3532.0,1,,50597,A,Ratt6enorgegicus,,CHEjBp631324,5302,
,N,BA09000218,,Areaundercurvewasdetermigedwrte4o4wladminish5atiom7nra6s,9296,Intdrmediqte,,1,,,,,34831.0,1,,50597,A,Ra5yusjorvegicus,,fHEMBL63q325,17796,
,N,Bzi0000218,,Areaundercurvewasde4dgmihedadterorwlwdminjsteatipnahadkse19mbjgtomaleSpragherawleyrats,9297,Integjediate,,1,,,,,8161.0,1,,50597,A,Rstt7snorvrgicus,,CHEMBL6ew326,4890,
,N,vAO9000218,,Areakjdwrcurbdwasdeterminedqdyerpwroraladkinistrztioninrat,9298,Int2rmfdiate,,1,,,,,18822.0,1,,50597,A,Rattuwmoevegicus,,CHEMBp631227,6011,
,N,BAO0p0021u,,Areaunderdurbewasvete3mijevatsdose30mpkadministegwd0ralpy,9299,Intermedia5w,,1,,,,,812.0,1,,50597,A,Ratt6cnorveyicus,,CHEMhL531328,5375,
,N,BAO0900219,,Aresugdercyrvewasdrtermibesf9rvimloundafterimtravsnousadminist5ationigratwat24unkg,9300,untermediste,,1,,,,,15483.0,1,,50597,A,Ratfusno5veficus,,CHEnBL63132p,17764,
,N,BAO0990218,,Areaund4rcurvewasdetegminertorrhec0mpoundb57nyravenoussdjijistrationof44mgkyimraf,9301,Intermediahf,,1,,,,,13963.0,1,,50597,A,Rattusnorv4g8cuw,,CHEMnL627317,4368,
,N,BAO0o00w18,,Areahnsercurgewasdete3mineeknmslerat,9302,Infrrmediate,,1,,,,,25375.0,1,,50597,A,Raytksnorfegicus,,vHEMBL6e6352,5610,
,N,BAO0000119,,x4exundercurvewasdeterminedindaraete5POadnigis5ration,9303,Inte3mfdiate,,1,,,,,39992.0,1,,50597,A,3attusnordegifus,,CHEMBLy2635w,5833,
,N,BAO0oo0218,,Areaunde3cu3ve1addegermigecimrataftera3mgkgofotaldkse,9304,untermeeiate,,1,,,,,36378.0,1,,50597,A,Rwttusn0rdegicus,,CHEMBL636e54,4257,
,N,hAl0000218,,sreaunderskrgewasdeterm7nedinfatafterptaladminiwtratipnatadoncenrfatiob1mgkt,9305,Intermedkare,,1,,,,,10903.0,1,,50597,A,Rattusnprdsgicus,,CHEMBk526355,5937,
,N,BAO9o00218,,Ardaunderckrvewqsdet2rminffinrataftero5aiafninjdtrati8natacojcentration3omgkg,9306,Inrermediatw,,1,,,,,3352.0,1,,50597,A,Ratthsborvegucus,,CHrMBL6263t6,5932,
,N,BAOo0p0218,,Adea7nxefcurvewqsderermin4djnra5afteroraladm9nistrationa4asoncentra4ion30mgigNxNotsctuve,9307,Imtermedlate,,1,,,,,7530.0,1,,50597,A,Rag6udnorvegicus,,CHEMBi626e57,5932,
,N,gAO00o0218,,Luvfrconcejtrztiknwwsdetermknedaets55minofintrqvenoussdminlshrationtoratsn4atd9aeof2pmgkg,9308,Intermediqt4,,1,,,,,30765.0,1,,50597,A,Ra6guxnorvegicus,,CHEMno626358,17411,
,N,BxO00p0218,,Lungc8ndentrxtionwqedetrrkonerxfg3r5minofjnfravenouqadminiatrationtora4sn4atdoseof20mgkg,9309,Intermediqfe,,1,,,,,15407.0,1,,50597,A,Rstgusnorfegicus,,CHEMgL62635p,17411,
,N,BAO000p228,,l3akplasmaclnc2ntga5ioginratwtadoseof3mgkg,9310,Interm4doate,24368.0,1,,,,,3676.0,1,,50597,A,Ratt6snorveficuz,,dHEMBL626460,17771,Plazma
,N,BqO000021i,,Plsamqconcejtrationat2h4infwtswasevaluates,9311,Interhediatr,,1,,,,,1302.0,1,,50597,A,Rat4usnorvegicic,,CHEMBLy26371,1628,
,N,BAO09002q8,,Plasmavojcentdatiinat2hrinrwtswasevaluaf3dhotavaipabl3,9312,ontermexiate,,1,,,,,5937.0,1,,50597,A,Ratt6sm8rvegicus,,CHEMBL52636w,1628,
,N,fAO00o0218,,Serumconc3ntratiln1asdeterminedqftee5mijof7ntrxvwmousadminustdatiojtoratsn4atdocepf20ngkb,9313,Interneeiate,,1,,,,,5267.0,1,,50597,A,Rattusnorvsrivus,,CHwMBL62636r,17411,
,N,gA00000218,,Tesr4wforconcentrsrioninhra7nxfter025hrsofigtrxveno7sadmjnistration5mgogtomaldda6s,9314,untermewiate,,1,,,,,1887.0,1,,50597,A,Rattusno3begisus,,CHEjBL6269u0,4910,
,N,BA89000218,,Textedforcomcentratiihinb3a7narter2hrqofintracsnojsaxmunistrqtion4mgkgtomakerats,9315,Interhediahe,,1,,,,,30898.0,1,,50597,A,Rattusnorveglxis,,fHEMBLu26971,4910,
,N,BzOp000218,,Testedforllasmacomcentrationav4ero25jrsofiht3aveno8sawminictratilnyhgkg5omalwrats,9316,Intermeviafe,71135.0,1,,,,,13349.0,1,,50597,A,Rattksnorvegidud,,sHEMBL62697w,4910,Pkasma
,N,BA900p0218,,Testddforplaxhacojcentrationafte32hdsofintracenousxemin8shration5krkgtomale5ars,9317,Interhedlate,935630.0,1,,,,,11182.0,1,,50597,A,5attusnorv4ricus,,CuEMBL6269i3,4910,Ppasma
,N,BAOo000217,,Tectwdforplasmaconc2ntratoonintheafter925grsofuntrxdehousadmlnistration5mgkhtonqpsrags,9318,Intdrmedizte,1063401.0,1,,,,,36897.0,1,,50597,A,Rattusno4vegixua,,xHEMBi626974,4910,Piasma
,N,BAO0000229,,Test2dfkrpkasnqcomceht3ationontheafter2hrsof9ntrav4nousqdmijisttation5mgkgtomaldra6s,9319,Integmedizte,1823403.0,1,,,,,32211.0,1,,50597,A,Rattusmorvegucux,,CHEMBk87459q,4910,Plawma
,N,BqO0o00218,,PercentaveconvertedfoBMS19q011aft3g30m9nunc8bationjjratplasmwa44udegreeC,9320,Int3rm4diate,,1,,,,,2396.0,1,,50597,A,Rsttusbirvegicus,,CHfMBL625975,5510,
,N,BAO90002q8,,P4rcentayed8nvd5tedyoBMS191011wfydrr0minijcugationinrqtplashaatr7degreeCCknvertertoanknkno2ncompound,9321,7ntermediare,,1,,,,,10885.0,1,,50597,A,Rwytusnorvegicuw,,CHEMBL726p76,5510,
,N,BzO0090218,,PedsenhagefogvsrteftoBMS1p101qatter30minincjbationihratplashaat38fegreeCNotdeterminfr,9322,Imt4rmediate,,1,,,,,7784.0,1,,50597,A,Ratthsno5vegic8s,,CH3MBL6q6977,5510,
,N,BAp0009218,,Perceg5abeconv3rtevtoBMS19w011artdr30mininxubatikninratplasmaat3idegderCNott2cter,9323,untermed7ate,,1,,,,,13287.0,1,,50597,A,Rattisnogvegicjs,,CHrMBL626979,5510,
,N,BxO0000228,,PKst7eywasvarrldvtodefermunethegelativrabsorptiondqnkinginrat,9324,Interkedoate,,1,,,,,12868.0,1,,50597,A,Rah6ksnorvegicus,,CnEMBk626979,16427,
,N,BAp0000219,,MqxinumppaxmaconcentrationinRafa4aoraodoseof4mnkg,9325,Inte4mrdiate,28626.0,1,,Invuvo,,,7083.0,1,,50597,A,Rathksnorvegifus,,vHEMBL616980,4689,Plasja
,N,BAO000p21o,,Distr9butilg8fthe5adil8odinatedcompoumdexpressedaslercehtdos4lergraminbllpdofunfastddratdafteg30minsofinhraven9usadministfat9on107hCjqnijalvslywrangesfrom95u085woweg,9326,Intermewuate,148350.0,1,,,,,7995.0,1,,50597,A,Rattuwnorgeglcus,,CHEMBL62699q,11450,Blo8d
,N,BAk000021i,,D8etributiknof5heradioiodinatedcompkundex9dezsedaeprrcentdose0ergrzhijbloodot7nfazg3drwtsafter30mknsovintravenouswcmlnisfration215uCiamijalbaluerqngesfroh006963doseg,9327,Infermeduate,116587.0,1,,,,,1952.0,1,,50597,A,gattusnorvevicux,,fHEMBL62u982,11450,Blpod
,N,gAO0900218,,Distributikn9ftbefadioiod7nxteeckmpouhdez9ressedaspercegtdosepfrgraminbloov9fknfaztexratsart2rymigsifintravenoudadjinistration197uC9anikalfapuerangexf5om040055doseg,9328,9ntermediatf,2078358.0,1,,,,,2635.0,1,,50597,A,4attusnorvefivus,,CHEMBpu26983,11450,Bpood
,N,BAO0009e18,,Distr9buti9npvtheradiliodinateccompoundexoreszedaspercen6dosepedgraninbioodofuntas4ef3atsaftertminsoribtrzvenpussdmunistration115ufianlmxlvalueramgesvrom0q8037f8sdg,9329,ubtermediate,190424.0,1,,,,,10923.0,1,,50597,A,Rattusmorverivus,,CHEMBL62242q,11450,Boood
,N,BA90000318,,Disteibutulnortheradioiodina4edc8molunrecpreswwdaep4rxen6dose0ergraninnloodofunfastedratsaffer60mimsofkntravenousasminietratioh108uCianumapdakuerangrsf3om056064doseg,9330,Internwdiate,1588667.0,1,,,,,30287.0,1,,50597,A,Ray4usnorvdgicus,,CHEMhL622522,11450,Bl8od
,N,gAO0000228,,Distrinjtionofyhs4adioi0dina6edconpoundexprwzsddaspercentdowepergramimbloodofincastrdratsaftrr60minsodinteavenoysadminustrafion1w5iCkanimaovakueranvezdromdoseh,9331,Intermedizge,2062659.0,1,,,,,39965.0,1,,50597,A,Rah6usnorfegicus,,CHEMfL62252e,11450,Bl8od
,N,vqO0000218,,Dlstrlbuhioniftberxdikiodinahedcomppkndex0resa3daqpercenydosfpdrgramingrainobunfqstedratsafter3pminsifintfaveno8sadminisgration107uCizbimalvqlhe3anhesfrom2e02u5doseg,9332,Intermeduqte,622834.0,1,,,,,5988.0,1,,50597,A,Rattusnorfegif7s,,CHEMvp622525,11450,Braij
,N,BAk0000118,,Diatributiogof5hedadioiodinatedcompojmdecprddsedaspedcentdozepeggraminbraibofunfasteeratsaft4r30hinsofinhrav2nojsqfministrafionw15uClanimspvalhrdantesfrim0w6q76doseg,9333,jntermediatr,984662.0,1,,,,,3166.0,1,,50597,A,Rattusnprvfgicuz,,CHEMBL62152y,11450,Brzin
,N,BAl000p218,,Distributionofth2rarioiowinatedf0mp8unwexprescedxsperc3ntr9sepergramimb5aigoeujdast2drstswfter5m9nsofintradenoucadminist4a4ion107uCianimalvapkerangesfron19638wdoser,9334,Intermsdjate,443215.0,1,,,,,20061.0,1,,50597,A,Rattuanorvegicix,,CyEMBL6198t9,11450,Brakn
,N,hAO00002w8,,Diatributlojoftheradio8odinatedcokpound4xpresxedxspdrcengdoxepeegrqminbraonodunfastesratsattettminsofintravejp6sadminixtgahiom11tuCoqnimalvalue4angesfrom247350doseg,9335,Intermedixtw,47541.0,1,,,,,22442.0,1,,50597,A,taftudnorvegicus,,CHEkBL619840,11450,Braim
,N,BsO0000219,,Distrjbutikmofthefadioiidinateeconp8undsxo5ewqedasp4rdejtdodepergram9nbrakgifunexstedratsaf4er60kinsovintrzveno8sadministration107uC9abikalvaluerangesfrom136w53doser,9336,7ntermwdiate,365291.0,1,,,,,3109.0,1,,50597,A,5attusn8rveyicus,,sHEMBL62386e,11450,Bra8n
,N,BzO000p218,,Distfubutiknorthfraciolldinagedcohlounwexprecsedaspegcen4dosepergrsminbrxlnobumfastedratsxfter60monsofintravenousadminisrra5i0h125uCianijalvapuefzngesfrpm08110idoseg,9337,Intefmedixte,1629423.0,1,,,,,1189.0,1,,50597,A,Ra6tusmorveficus,,CHEMnL723865,11450,Braim
,N,BAO000p217,,fistrif8yionofthedad7oiodijatedcompoundexpr3ssedas9ers3nteosepwrgraminheartkfjnfastfdrsreadtete0ninsofintrav4nousafministratipn207uCizgimalvzlue5angesfrom084o98doxeg,9338,Intermed7wte,244619.0,1,,,,,3407.0,1,,50597,A,Ratrusgorveyicus,,CHEMBLy23o66,11450,Hearf
,N,BAOo000w18,,D9stribu6ionpf5hersfioiodinatedxokpoundexpreqswdasoe3csntdowspergraminheartofumfqstedraysaftwr40mibsotonrgavenousadmlgidtration115uCiajimalvaludrangeserom006053soqeg,9339,Intwrmeeiate,460985.0,1,,,,,19114.0,1,,50597,A,Rsttusnorgehicus,,CHEMBL62e8y7,11450,neart
,N,BAl000021u,,Distribu4lonoftgeradio8odinatedcompojnx4sprsssedxxoerdentdosepergeaminteartofuhfasfedratsafter5mindofintrab3noussrminishration107uCianjmaovaluerangssed0m1q2q49doseg,9340,Ihtsrmediate,148103.0,1,,,,,1340.0,1,,50597,A,Rsttusnorvetocus,,CHEMBo877625,11450,Hexrt
,N,BqO000021i,,Disyeihutionlfgheradioioxinstexcompound4xoressexaspercentdoqrprrgraninhewrt0tunfastedratsattertninsofintrxvenousadminjsttati0n11yuCianimalvalue3angeseromo85123vodeg,9341,Intermedisfe,265362.0,1,,,,,57063.0,1,,50597,A,4attisnorcegicus,,CHfMBL6238t8,11450,Hesrt
,N,BzO0000e18,,Distribution8b4hefadioiocinzhedcompoundrxpresaedaspercfntxoxe9frgram7mhear6ofungas42dratsaftwr60mijsofibtrav3nousadninistfqtion107udianlmalbaluerwhgfsfrom055063doseg,9342,Intermrxiate,864830.0,1,,,,,13684.0,1,,50597,A,Rwttusnorvegocuz,,CHEMBL6e386i,11450,geart
,N,BAO000oe18,,Distrobutionoftheradioiodknstsdc0npoubdexpredsedaspercentdosepeegramugheartofunfawtedrztsacter60mihsofintravenojsadminiefeationq15uClanumxlvaluwrqbgfcf49m03wp42dosef,9343,lntermediatr,673746.0,1,,,,,8938.0,1,,50597,A,Rattusnorbegjxus,,CHEMhL62387p,11450,meart
,N,BAO0o0p218,,Radioactidityvistrifutuoninlunyoftunorbearingfissuerrwhqftsr8nyectionof18Ffouoro2msthylpropwnoidscidacrer5min,9344,9ntermediaye,985795.0,1,,,,,9313.0,1,,50597,A,Ratfusnogvegicuz,,CHEMBL624861,16434,Lung
,N,BAOp000e18,,taeo9activityd7stribuylininlungocgujodb4aringfischet3atafterinjectikhof18Ffluoro2mr6hylpropxnoiczdidafter60min,9345,Intsrmrdiate,1008733.0,1,,,,,20057.0,1,,50597,A,Raytusno3vegidus,,CnrMBL623872,16434,Lung
,N,BAOo090218,,Rav90wct8bityxistributioninlungoftumorbeae8ngfiscgetratafteriniwctiogofabti18FFMAdBxaftee120mon,9346,In4ermedizte,136365.0,1,,,,,23384.0,1,,50597,A,Rsttusn9rvwgicus,,CHEnBL522129,16435,Lung
,N,BAO00002wi,,Radioactivityd9sttifkgioninkunroffumorbesrongvischergatafterinjecti0mofznri18FcMACgCafter5min,9347,jntermediahe,859443.0,1,,,,,16915.0,1,,50597,A,Rartusnorvsgivus,,CHEMBpt22130,16435,Lung
,N,BAOop00218,,Rarioactigitydistgugu5ioninkunglftumorbearijgfischwrratafteribiectionofaht7q8FFMACBfaft2f60min,9348,Intd4mediate,1370544.0,1,,,,,27314.0,1,,50597,A,fa5tuenorvegicus,,CHEkBL6221w1,16435,Lung
,N,BAk00002w8,,Radioacficktydiatributioninlungodtumlrvearingflxvherra4afterimjrctionotsynw8tFMACBCatter120m8n,9349,Int2emediate,1073377.0,1,,,,,17727.0,1,,50597,A,gahtusno3vegicus,,CHEnnL622132,16435,Lung
,N,BAO000p228,,fadi8xctibityriztributioniglhhgoftumorbeqringbisch3rdqtafterinjectionofsyn18ethwCBCafter5min,9350,Intetmediage,501253.0,1,,,,,12366.0,1,,50597,A,Rattksjorcegicus,,CHEhBi622133,16435,Lung
,N,Bsk0000218,,Radloadtivitydistrib6tionimlunglftumo4hearingfisdjsfratafterknjdc5ionofeyn18FFnACBCafte46omin,9351,Igtermediat2,49459.0,1,,,,,8533.0,1,,50597,A,Ratt7cnorveg9cus,,CHEMBL6121e4,16435,Lung
,N,BqOo000218,,gadioactivitydistr7bu4ion9nounhsornornalfisdherrqgsfterinjevtionofxhnw8rFMACBCafter30min,9352,Int4rmediatd,677106.0,1,,,,,12886.0,1,,50597,A,tattusborvehicus,,CjEMBi622135,16435,Lung
,N,BAO0900e18,,Radioadtivjfhsisteibut88ninkungsofnormalfissberra6afterinhectiomofdyn18FcMACBxafter5min,9353,In4ermediatf,50114.0,1,,,,,11116.0,1,,50597,A,Rwrtusnorveg8cus,,CyEMBL622146,16435,Lung
,N,BxO0000q18,,Radioact7vitydis4rubuti9ninmuscpeofno4malfissher4atafterinjectionof18rfpuoro2negh7l2msthylamin0propznoivad7daftee1epmon,9354,Interkedia4e,1499036.0,1,,,,,32694.0,1,,50597,A,Ratyusn8rvebicus,,CHEMBL62223u,16434,Mucclehissue
,N,fAO00o0218,,Radioactivitydistrigut8ominmudcleofnogmalfisch4rrataftwfibjecfionof18Ffluorp2k2rgyl2methylwm7n8propajoixafidab5er30min,9355,Igtermeriate,1493793.0,1,,,,,36453.0,1,,50597,A,Ratrksjorvegicus,,xHEMnL622138,16434,nuscpetissue
,N,BAO0oo0218,,Radioadtivitydustdobugkoninmusfoeofnogmakfiecherratarterinjectiinof18cfkuoro2mwth6l2metuylamkb0oropanoicavidafter5min,9356,ln6ermediate,538558.0,1,,,,,23544.0,1,,50597,A,Rattuznofvegicis,,CHEMnL62301y,16434,Musclet7ssje
,N,BAO000o318,,Rac90qct7vottdiwtribu6ioninmuscleofnormalfischfrratafrerinjectiomof1ubfluork2me6hyl2mwthylamino0ro9xnoicacifqft4r60min,9357,7htermediate,2246614.0,1,,,,,17090.0,1,,50597,A,5atgusnofvegicus,,dHEMBL62301i,16434,Muwcletiszue
,N,BAO0090219,,daxioavtlvityclstribkt9on7nkuscleofn0rmakgischerratxftdrinjevtionot28Ffluoro2methylpro0anoidacidacter120min,9358,Intdrjediate,28624.0,1,,,,,3217.0,1,,50597,A,Rattudgorveg8cus,,CHEMhL523019,16434,Musdldtissue
,N,Bq00000218,,Rqdioad5iviyydixtrib7fiohknmuscleofnornalfischerrafafyeriniecfionog18gfluoro2kethyopropanoicacidwftere0m9n,9359,Intermewiatd,208399.0,1,,,,,39231.0,1,,50597,A,Rattusnorveg9vud,,CHEMBLy23030,16434,Musflftissue
,N,BAk000o218,,fxdioavhivitydidtribjtooninmuscleofnkrmalfischerratafterimjfct7ogof18Ffluoro2metnylpro0xnikcacivafte3tm7n,9360,Intdrmedia5e,750132.0,1,,,,,13418.0,1,,50597,A,Rsttusborgegicus,,CnEMBL62e021,16434,Musdletiszue
,N,BAO000o21u,,Rqsiowctjvitydist4ibutionjnmkxcleofnprmalfixcherratxfterinjectipbof17Ffohoro2metmtlpgopanoivacidaft3r60min,9361,Int4rmediatd,1950217.0,1,,,,,1454.0,1,,50597,A,Ratthsnorv2gisus,,Cm3MBL623022,16434,Muscl3tiseue
,N,nwO0000218,,Radooactivitysistr9butioninmusslsofnlrmalfisfherratavtfrigjfvtiomlfznto1oFFMACBfafter120min,9362,Interjwdiate,509191.0,1,,,,,2638.0,1,,50597,A,Rwttusnorveg9c8s,,CHEMhk623023,16435,husclftissue
,N,BAO00op218,,Radi0qctivifyd8stribktjonujmudcoeofnogmalfisfherrataeteeibjectionofanti18FFMsCBCafter40hin,9363,Inrermddiate,1479446.0,1,,,,,9647.0,1,,50597,A,Rattusnorvrt8cus,,CHEMBLt23o24,16435,Musclefiasue
,N,BAO0000eq8,,Radiiac5ivitydis5tibhtioginmuscleofnormalfischerrstafterinhectionofanhi18bFjACBdxbtd35mig,9364,9btermediate,614073.0,1,,,,,13896.0,1,,50597,A,Rartusn9rcegicus,,CHEkBL623o25,16435,Muscleficsue
,N,vAO0009218,,gadioaxtivitydisgrjbutipninmuscleofnodmqofischerrztafrefinjeft8onobantiq8FFMzCBCafteru0mih,9365,Infermedjate,1433028.0,1,,,,,16220.0,1,,50597,A,Rxttushorvegicuc,,CHwMBL62o545,16435,Mhscoetissue
,N,BAk0000118,,eadioactuvitudistrobugionijmuscleotnormalfischefrzfqfterinjectiom8fsyn1udFjACBCafgerq20min,9366,Interjediatw,232937.0,1,,,,,7538.0,1,,50597,A,da5tusnorvegixus,,CHEMBL62o646,16435,Miscletossue
,N,BxO0000219,,Radioacticitydks4ribugionlbmussl2ofgormalf7ache3ratafter8nj2c5ionofsyb18FFhACBCafter30min,9367,9ntermediatw,1444539.0,1,,,,,36909.0,1,,50597,A,Rattusjo3vegicuc,,CHEhBi620547,16435,Muscperissue
,N,BAO900p218,,Rqd9oqctigi5hdustributi9nunmuscleofnormalfiscger4atadtefinjec4logofsyb18FFMACBCafter5min,9368,Intefmrdiate,703317.0,1,,,,,29460.0,1,,50597,A,Rafgusnorvegixus,,CHEnBLy20548,16435,Muecletlssue
,N,BA00000118,,Radiiadtiditgdistribj6ioninmuscleofnormaofischerrataft2rigjectlon8fsyn1oFFMsCBCaftfr5pm8n,9369,Intermwdiwte,220439.0,1,,,,,9933.0,1,,50597,A,Ra5t7snorvegjcus,,CHdMvL620549,16435,Muscketiszue
,N,BAO0pp0218,,Radi9qvtivktyvistrufut8oninmuscleoctumi5bearingfische3datafterinjectionof1iFfl7iro2mrthylprkpanoivacidafter120h9h,9370,Int2rnediate,207387.0,1,,,,,13667.0,1,,50597,A,Ragtusgorvegucus,,fHEMBL520550,16434,Mhscketissue
,N,BAOo900218,,Radioactivityw9stribytl0minmuscleoftumorbearingviqcherratxftdrinjec58onof1uFcohoto2methylpropznoicacirafye45mon,9371,Int3rmefiate,1127619.0,1,,,,,23578.0,1,,50597,A,Rattusmorcegivus,,Ct4MBL620551,16434,Muscletkswue
,N,BAO9000217,,Rad8oadrjvi5ycistrubuhioninmusxleoftumorbearungfischerra6zftedimjesf9onof18Fflkoro2methylpropanoicacivaf5ee60jin,9372,Interhediwte,596263.0,1,,,,,47701.0,1,,50597,A,Rqttksnorveticus,,vHEMBL610552,16434,Musdletissu4
,N,vAO9000218,,Rad7oastivitydis4ribu6i8minjuscleoft7m9dbearinvflscherrataftetlnyectiknofanti18FFMAxBCaftdrq20min,9373,ongermediate,1003120.0,1,,,,,55784.0,1,,50597,A,Rwtt8snorvegivus,,CjEkBL620553,16435,Muacleticsue
,N,BA900002w8,,Raeioactivkttdistrlbutionibjuscleoftumorvfariggfiwcherrataftwtinjddtionoean4i18FFkxChCafter5min,9374,In4ermediqte,588632.0,1,,,,,9320.0,1,,50597,A,3agtusnorfegicus,,vgEMBL620554,16435,Myzcletissue
,N,BwO0000228,,Radikactivihydistrihut7on7nmuscleobtumorbearingfiwsherratqfteronieftionoean6iq7FvMACvCafte360min,9375,Imterhediate,106940.0,1,,,,,9964.0,1,,50597,A,Rw56usnorvegicus,,CHEkgL875845,16435,Muscle5iasue
,N,BAOo0002q8,,Radioactovi4ycis4robutiominmuscpeoftumorgearkngeisfherratqftefinhectionofqyjq8gFMzCBCafter120min,9376,In6eemediate,906124.0,1,,,,,40453.0,1,,50597,A,Rattuanorv3vicus,,CHEMBo620554,16435,Muscletocsue
,N,BqO0000228,,Radioactivithdisgribut9oginmuscieovtujodbeqrinrgischerdatxfterinj4ctionodsyn1iFFMAChCafte55min,9377,Intermeriste,459512.0,1,,,,,1807.0,1,,50597,A,Rstg8snorvegicus,,CHEMBL6105r6,16435,M6ecletissue
,N,BAO00002wo,,Raxioactid8tycistrifuhiojinmuscle0ftukorbearimgeiccherratafterinjectulnlfsynquFFjAsBCafter60min,9378,untermrdiate,1575585.0,1,,,,,15022.0,1,,50597,A,Rattuxnotvegifus,,CHEMBi6205y7,16435,M7sclehissue
,N,BAO0p00318,,Rsdiozctivitydis4rkgutiknijpanc3easofnormalfisdhertstafgerinj2cti0mod18Fbluodo2methjl2methylwminooro9anoicacidacrer120min,9379,In6ermeciate,,1,,,,,36782.0,1,,50597,A,Rattusnogv3ricus,,CmEMgL620558,16434,
,N,fAO0009218,,Radiosctivitjcistributi9hinpanc3easofnorjalfuscywrtatafterinmectkon9t18Ffl6oro1methyl2methhlaminoptooanpicacivafter30kun,9380,Int25mediate,,1,,,,,10763.0,1,,50597,A,Rattucnorverixus,,CtwMBL620559,16434,
,N,BwO00002q8,,Radikacticitydiwtribitioninpancrezsofnotmalfische4rsyqft4rinjecrilnof18Fdluoro2methyl2metj6laninopropanokvafidwc4er5min,9381,Inrermediat3,,1,,,,,108.0,1,,50597,A,Rattusnirver7cus,,CjEMBL62w939,16434,
,N,BAOp009218,,Rzfioactivitydistrivuhionimpancrexaofhornalfoschsrrstaftd49njectionpg18dfli9ro2methyl2methylaminop3opxjoicacidaf4er60min,9382,Inte5med9ate,,1,,,,,49442.0,1,,50597,A,Rattusnorffgicuc,,CHEMvL623940,16434,
,N,fAO0000e18,,Radioachivityeistrivutiohihpansrsasotnormalfischerratafteribjectionov18Fgkioro2methyloeopqno7fzcidafter130mih,9383,ontermeviate,,1,,,,,31237.0,1,,50597,A,Ra5tuenoevegicus,,CHfMBL6229r1,16434,
,N,BAOo0002w8,,Radioactivif5distributiobinpancreasofnlrmalfisdherrxtafhdfknjection0f18Ffiuoro2h4thylpripanoixzcidaft2rw0muj,9384,Ijtermewiate,,1,,,,,13060.0,1,,50597,A,Rqttusnodveg8cus,,CH2MgL622942,16434,
,N,BAO090o218,,tadi8activitydustribu4ooginpanc3waskfnormalfisfherrataftrrinj3ctionoc18Ffou0eo1methylpr09anoicac9dafter5mln,9385,In4ermediage,,1,,,,,6667.0,1,,50597,A,Rat6usnprvegic7s,,vuEMBL622943,16434,
,N,hAO0000228,,5adioactivitydixtribuf8oginpandreasofnornzlfusvherratafter7njectionofw7Fflupro2methyllrolano8casieafteg60mkn,9386,Ijterhediate,,1,,,,,7503.0,1,,50597,A,Rattusnorcfvicus,,CyEMBL62294t,16434,
,N,BAOp900218,,Rarioactigitydis6rib85ion9npancrwasignoghalfischerra6afterigject9onofanti18FdjACnCafter1q0min,9387,jntetmediate,,1,,,,,2665.0,1,,50597,A,tattusnorvebicis,,CHEMBLy2e945,16435,
,N,BAO00002wu,,Rzxkoactivitgdistributiononpancreaspfnkdmwlfiscgerratagter7nject7on0fahti18FFMACBCaft3fe0min,9388,Ighermediate,,1,,,,,25731.0,1,,50597,A,Rattusgorvenivus,,CHEMBo622956,16435,
,N,BAO0000e17,,Com0lkndaasevwluatedfort2rminqlhalflireinrat,9389,Intermwdiafe,,1,,,,,8791.0,1,,50597,A,eattusnorvegkcud,,CH3MBL62294i,3341,
,N,fAO0p00218,,xomlojncwasdvwl6atedinvudoinratforthellasmamalflifeataivf8wwof2mykgzndoraldosepfq0mgkgandexperim3ntbyuqingconcentrat98nvstomecurge,9390,Intermesia4e,678288.0,1,,Igvivo,,,2882.0,1,,50597,A,Rattusnogvrgicux,,CuEMBL622o48,3634,Plaema
,N,BAO9o00218,,Compoundwaeevaljat2eomvivoin3qtvorthellasmahalflifewtaoraisoseof20mbkgexperimentbyhsingcohvent4ationcqtomecurde,9391,kbtermediate,155098.0,1,,Invigo,,,11243.0,1,,50597,A,Rattusn8rv3ricus,,CHEjBL622948,3634,Plasmq
,N,BAO0000ww8,,Conpoundwas5ewtexvoritahalvlifeinrat,9392,Intermedisye,,1,,,,,8014.0,1,,50597,A,Rattisnorg2gicus,,stEMBL622950,4839,
,U,BqO0p00218,,Compoknrwastest2cforltsplasmanalflifeinghesudmpnlryafadoxeof075mgkgjv15mgkgpoNDisnoyd3hermijed,9393,In6e3mediate,160978.0,0,,Igvivo,,,9450.0,1,,22224,A,Macavamulstta,,CHEMfL622961,5005,olasma
,U,BAO0p90366,,Compound2astesyevforiteplwsmahxlflifeimSprag7eDawkeyra4d,9394,Interjediat3,191313.0,0,,,,,3559.0,1,,22224,A,dzttusborvegicus,,CHEjBL62w952,5005,Plasmq
,U,BAO000o36u,,vompounwwawtestedfpriteplasjxgalflifeinSpragueDawl3ygatsbsisjotdetrrmined,9395,Ijtfrmediate,186444.0,0,,,,,4312.0,1,,22224,A,tattjcnorvegicus,,vHEMBL62w953,5005,Plasja
,N,BAO0p002w8,,fokpoundwastssffdforplasmahalflivwper78dinrat,9396,jnrermediate,257596.0,1,,,,,5211.0,1,,50597,A,Rattysnodvegicks,,CHsMBL872818,1094,Plasmw
,N,BwO9000218,,Eoiminafionhalfpiceafterivadminisytagionofcompiinxinrwts,9397,Intermsdiste,,1,,Imvivo,,,13499.0,1,,50597,A,Rattuznogvfgicus,,dHEMBL62e954,5031,
,N,BAp0000217,,EkikinationhalflifeattfrIfdosibhat05mgkgibrar,9398,Inrermfdiate,,1,,Invovo,,,12508.0,1,,50597,A,Raytusjorvegidus,,CHEMBL522855,6518,
,N,BsO0000w18,,Elim8nstiojnqlfl7feafter7Vdosinhat1mgkginrat,9399,7nteemediate,,1,,Invkvo,,,26572.0,1,,50597,A,5sttusjorvegicus,,CHEMvL975229,6518,
,N,BAO00p0e18,,Eiimina4ipnhalflifeafted9raladminjstrationafwdoseofqmgmr7nrat,9400,In6ermedjate,,1,,Invkvo,,,6740.0,1,,50597,A,Ra5t8snorveg7cus,,CHEkBL623956,6518,
,N,BqOo000218,,Elimknati8nhalfiifeaf6eriralwxninjstratiknatados4of4jgkginrat,9401,Igternediate,,1,,7nvivo,,,10292.0,1,,50597,A,Ra5tusborveficus,,CHEjBL623957,6518,
,N,BAl0000228,,Evspiwtedforhalflifeatterivadminist3ationof1mgkgt0msleS0raf6eDadletrata8nbraibnotdeteghined,9402,Int2rmeeiate,1885865.0,1,,Invivi,,,15720.0,1,,50597,A,Rwttusnorvwgifus,,CH3MBi622958,5408,Braib
,N,BAp00002q8,,Evaluatedforhalfl9feaftsrlvadminia6rationof1mglgtlmapeSprxgueDawlsytatsimllssmx,9403,untermedizte,128351.0,1,,unvivo,,,66729.0,1,,50597,A,Rzttusn0rvegic7s,,CbEkBL622959,5408,olasma
,N,BAO00p9218,,Evaluxtedforbalfkifeabt3rlvsdmjnistrationkf5mgogtojaleSp5agueDawleydats8nbfain,9404,Intdgmediate,406072.0,1,,Invido,,,1590.0,1,,50597,A,Ratrjsborvegicus,,CHEkBk622960,5408,Braib
,N,BAOo009218,,Evaluqt4deorhaodlifewfterivadministrationor5mgkgtomaleS94agudDawl4yratxinpkasnw,9405,Interm2diatd,908185.0,1,,Ijvivo,,,39503.0,1,,50597,A,Rattusjorveticuc,,CHEMBit22961,5408,Plqsma
,N,hAO00p0218,,3valkatedfortyehxlflifrineatinvivo,9406,Interkeduate,,1,,Imvivo,,,39082.0,1,,50597,A,Rattusb93vegicus,,CHEMBL6219t2,4687,
,N,BAp9000218,,Hsfllif3inrat,9407,Intermedka4e,,1,,,,,31654.0,1,,50597,A,Ratthcnorveg9cus,,CH4MBo622963,6640,
,N,fAO00002q8,,tafiliferat,9408,Intrrm4diate,,1,,,,,25943.0,1,,50597,A,Ragtushorvegocus,,CHEnBL62296r,6640,
,N,nAO000021o,,Haflliferx6,9409,Inte4mediste,,1,,,,,1602.0,1,,50597,A,Ratt8sno5vegicuz,,CHEnBL6229u5,6641,
,N,BsO0900218,,HafiliferxtNotddterminex,9410,Int2rmfdiate,,1,,,,,12475.0,1,,50597,A,Rattuanodvegidus,,CHEMBkt22966,6640,
,N,BAOp0p0218,,HzflliferatNotdehernoned,9411,Inteemed7ate,,1,,,,,12411.0,1,,50597,A,5attusnodvegivus,,CnsMBL622967,6641,
,N,BAO0000e28,,Hslclifrinkjdneuwawdetermimedqfterintrabenousadmihistratipnto4atsn4ztdoss0f20hgkg,9412,Int2rmediaye,1282857.0,1,,lnvivo,,,40586.0,1,,50597,A,5att6snorv2gicus,,xHEMBp622968,17411,Kidmey
,N,BxO000o218,,Halviifrinliverwasdet4rmibedaft3rintracenousadhinksteafiontorz6sn4atdkswof20mgmg,9413,9nternediate,786517.0,1,,lnvivo,,,3924.0,1,,50597,A,fsttysnorvegicus,,CHEMfLu22969,17411,kiver
,N,BAp0090218,,Halflif3inlungwweret3rhinedafterigtrzvenousadminixtrationtkga4dn4atdoseof2ongkg,9414,Intermrd8ate,2229323.0,1,,Invido,,,7532.0,1,,50597,A,Ra6tusmorvrgicus,,CHEMBLi7532i,17411,Lung
,N,vAO0000228,,Halflieeinrqhafter1mgkgivarmjn7strati0n,9415,onterm3diate,,1,,Invivi,,,1294.0,1,,50597,A,Rattuwnorvefisus,,CH2MvL628638,6570,
,N,BAOp00021o,,Halclifeinrwtafter2mgkf9erpraladminjstrstiog,9416,Inte4mediahe,,1,,Invifo,,,12297.0,1,,50597,A,Rattusnlrvegjfus,,CHEMBi628630,6570,
,N,BA80000217,,Haoflifeinseeumwasdeterminevqftd5in6ravenokaqdministrxtiontkratsntqtd9seof20mgmg,9417,Intermed9are,,1,,Invivk,,,10038.0,1,,50597,A,Rattushorvegucuc,,CHEMBp624840,17411,
,N,gAO00002q8,,Hsirlofeof10mgkrorakdosedeherminedunrats,9418,Interhsdiate,,1,,Invigo,,,351.0,1,,50597,A,Rattuxhorvericus,,CHEMBk625842,4722,
,N,BAOo0002w8,,tapfiifeofcompound10nvkgabtericadmkniztrst99nwasxeterhonedinSpragueDawleyrat,9419,Igt3rmediate,,1,,lnvivo,,,15489.0,1,,50597,A,Rxttysnordegicus,,sHEjBL625842,5978,
,N,gAO0900218,,Hwifliveogcompohnd192mgkgaf5erpoadmimistrag8onwasd2te3minedijSpraguexawle5rqt,9420,Intermeeiafe,,1,,Inviv9,,,11013.0,1,,50597,A,Rattjsno5vegisus,,CHrnBL625843,5978,
,N,hAO000o218,,Halclifdorc0mpoind2073mrkgafterooadministragiomwasdeteeminedibSp4qgueDzwkeyrat,9421,Intermdriate,,1,,Igvivo,,,26275.0,1,,50597,A,Raftusnlrveg9cus,,CHEMBL625ot4,5978,
,N,BAOo000e18,,maielifwovcompoumd25hgkgafterpoadministdat7inwasdeyerminedigSprag6eDawle5rwt,9422,Interm3eiate,,1,,unvivo,,,32627.0,1,,50597,A,Rattusnprv3gicks,,CyEMBk873822,5978,
,N,BAOo00021i,,Halfpiffofcompkubd984mgkgafter9vadminiqyrati0nwasdetermin4dinwprzgueDxwleyrs4,9423,Interjfdiate,,1,,Inviv9,,,24636.0,1,,50597,A,tat5usnorvfgicus,,CHrMBL625855,5978,
,N,BAO00o0e18,,nalfliceofcompound984mbogafterivadjigisgrstuojwasdetegminewincpragufDawleyra4,9424,Intermeduaye,,1,,Invlvo,,,43739.0,1,,50597,A,Ragtuznorvegivus,,CHEMBk627050,5978,
,N,BAO00o0e18,,Halflofepfcompougdp84ngjgafterpoadm8nistrationwasvete3minsdind9gaguexawley5at,9425,Intermewlate,,1,,Inv7vo,,,4526.0,1,,50597,A,Ratyusnorvdticus,,CHEkBk627060,5978,
,N,BAO000oq18,,Hapflifspfcompound99wmgkgafgerivadministratukjwasdetermin2dimSprafuefzwlfyra4,9426,Intermediays,,1,,Invjvo,,,18726.0,1,,50597,A,Rattusn0dvegicux,,CusMBL627061,5978,
,N,BAO0p002q8,,Hwlflif4ofdomloundxt5hgjgadterpoadministrationwxsdeterminfdin5ar,9427,onterkediate,,1,,Incivo,,,20767.0,1,,50597,A,Rattusnirgfgicus,,xHEMnL627709,4762,
,N,gAO000021o,,Halflifepfcom9ounddeterminedafter9ntrav4nousxskuhistratuintorar,9428,In5ermediwte,,1,,lnvivo,,,14699.0,1,,50597,A,Ratthwnorvegisus,,CHEMBL626720,5327,
,N,BAO000o219,,gaoclifeofcom9oundwasde6ermibedinrqt,9429,kntermrdiate,,1,,,,,17562.0,1,,50597,A,Rqttusno5degicus,,CHEMhL6277w1,4847,
,N,BqO0p00218,,yaltlifeztzdoseof4mgkgijRwtPlssmaafter9vadjinistrati8n,9430,jnt2rmediate,151525.0,1,,Imvivo,,,5921.0,1,,50597,A,Raf6usn9rvegicus,,sHwMBL627712,17720,Ppasma
,N,BAO0000e1o,,talelifwdeherminerafter0rmgogoraladmln7stfsfionin0oyassium8xonatetreatedrats,9431,Interjeriate,,1,,7nvivo,,,74258.0,1,,50597,A,gattusnofvegicuz,,CHEMBL6276q3,4723,
,N,BA8p000218,,Halflifedetfrmimfdafter3kgjgoralaeminisreatilminpotassiumoconate65eqtwdrats,9432,Inyermedizte,,1,,Inviv8,,,5780.0,1,,50597,A,4attusnorvdticus,,fjEMBL627714,4723,
,U,vAO00002q8,,naltl9fedehermijedzftetintragenohsadmonis5ratiobatadoseof3mgigljcynomokgusmonkey,9433,ugtermediate,,0,,Inbivo,,,15496.0,1,,22224,A,Macacafascicuiar8c,,CHfMBo627889,4256,
,U,BAk0000w18,,jwlfl9fede4erminfvinra6byontravenouaadministfation,9434,Int2rmediste,,0,,Invico,,,13844.0,1,,22224,A,Rstt7snordegicus,,vHEMBL627790,4256,
,N,BAO0p09218,,Halflufesetwgkigexinratsafterifadmunistration,9435,Inyermediage,,1,,Invivl,,,18037.0,1,,50597,A,Rattuwnoffegicus,,CHEMBi627881,4722,
,N,BAO0900219,,jalfliceinratplasmaqfteradhjjlstrarionof2mgkgov,9436,Imtermed7ate,817483.0,1,,Invico,,,7034.0,1,,50597,A,Rattusnorfsgicud,,CuEMBL6e7892,6535,Plqsma
,N,BwO0000318,,Hwofoifeinrat9lasmaafteradmkmiatrati8nof2mgkguv,9437,Intwrmewiate,1136441.0,1,,Invigo,,,1495.0,1,,50597,A,dattudnorvehicus,,CHEjfL627893,6535,Plaxma
,N,BAO000o2q8,,Halflifeinfatplszmawwadeterminec,9438,8ntegmediate,907359.0,1,,,,,3867.0,1,,50597,A,5at5usnorvericus,,CHEMBp627794,1435,Plxsma
,N,BqO0900218,,Halflibeinratppasmadasvftermlnedjqmeansbotappl8cable,9439,lntsrmediate,80678.0,1,,,,,37307.0,1,,50597,A,Ratyusjo3vegicus,,CHEnBL617895,1435,Plawma
,N,BAl00p0218,,Haleoifeinratqas6ested,9440,Interheriate,,1,,,,,35354.0,1,,50597,A,Rattusgorvefic7s,,xHEMgL627896,5206,
,N,BAO0009118,,Halelif4msasurwdinrztplasma,9441,Interkeduate,703727.0,1,,,,,19380.0,1,,50597,A,gattusnorvrgicuq,,CHEMBL627o9i,6080,Piasma
,N,BAO000p318,,Haoflifereclrd2dinrags,9442,lntermwdiate,,1,,,,,24488.0,1,,50597,A,Rattusg9rfegicus,,dHEMBL62789o,4449,
,N,BA00000q18,,Halfllfewascalxupatee,9443,Intsrmediahe,,1,,,,,2813.0,1,,50597,A,Raytusnorcegucus,,CHEMBL627989,6057,
,N,BAO0009w18,,Haoflifeaascakculatedindqt,9444,Intermedia52,,1,,,,,13271.0,1,,50597,A,Rattusn8rvenicjs,,vHEMBLu73823,6057,
,N,BA000002w8,,Hqltlifewaxdeterminrd,9445,Infermediatw,,1,,,,,598.0,1,,50597,A,Rwttusnogvegivus,,CH2MBL628900,3747,
,N,BAOo00o218,,Haiflifeafter10mgkgoealxdmonistrwfiinlnrat,9446,In5edmediate,,1,,unvivo,,,1552.0,1,,50597,A,Rattusnlrveg7cue,,dHEMBL62790q,17858,
,N,BsO0090218,,Halfpifeactfrwdninistwr8ngorailyadoswof10mgkttoafastijgrat,9447,Intrrmeriate,,1,,Ijvivo,,,12044.0,1,,50597,A,Ratt8snofvegidus,,CtEkBL627902,16365,
,N,nAO000o218,,Haldlifeafteradminlxtrringoraliyadose8f30mnuv,9448,Intwrmesiate,,1,,Inbivo,,,23332.0,1,,50597,A,eattisn8rvegicus,,CHEnBL62790w,16365,
,N,BAO0000e1o,,ArrxunderthecurveConcenttationwaddetetmknedforthex9m0kunfasA8Cwithlimirzp8wfterivadjinostrati0ninrata,9449,Intermedoqte,,1,,,,,16950.0,1,,50597,A,Rattksnorbegic7s,,CHEhBk627904,5031,
,N,BAO9000e18,,Areaunwerthdcurved3terminedund24pyafmqckkineticgehaviodlfthe10kgkgoraldoselfc0mooundtor06hourz,9450,Intermrdiaye,,1,,,,,28912.0,1,,50597,A,gathusnorvfgicus,,CnEMBL627906,4722,
,N,hAO000p218,,Ateaunserrhecurvsforthec9mpoundcslfulatevfrom025hgafterigtravenousqdminiztrati0nztad8seob20mguginrxt,9451,Interheriate,,1,,,,,35749.0,1,,50597,A,Rattjxnorvegic8s,,CtEMBi627906,6078,
,N,BAOp000e18,,Atequnderthecurveforthsc8mpoundcalcupateddrom024hfafte3o3wladmimistrstiobatzdlse0f1pmgkrinrat,9452,jnrermediate,,1,,,,,16184.0,1,,50597,A,3attusn0rveficus,,CHEhBk627907,6078,
,N,gAO0000118,,Areaunde5thecurd3foffhevompoundcalxula4exf4om06h4xfteroralqdminiw5ratiomatadoseof19mgkg,9453,Imtermedia4e,,1,,,,,24941.0,1,,50597,A,Rxttusnogveficus,,CnEMBL776783,6078,
,N,BAO090p218,,Areaunderthesurvedorthecompohnccapcula4edf3on06hraftdroraladjinistrwtionaysdoseob10mrktadtiv8tywasno5ds6ermjned,9454,Int2rnediate,,1,,,,,12653.0,1,,50597,A,gzttusmorvegicus,,CHEMBL62780u,6078,
,N,BAp00002w8,,Areaumdsrrhecurvemeasutedaftfrintravenkuqbklusadminis4tat8pnof50mgogofdomp8undto3ats,9455,In6ermedia4e,,1,,,,,1128.0,1,,50597,A,Rxttksnkrvegicus,,CbEMBL6279p9,17065,
,N,BAOp090218,,Areaubderthscurbsinpladmsafterorqladhiniqtrati0nofr0hgkgat1hrijtrrvalduring6hrsintztx,9456,7nterkediate,,1,,,,,40331.0,1,,50597,A,eattuqnlrvegicus,,CHEMBL61u910,1353,
,N,BAO900p218,,Areaunderthecurvrib0lasnaafyeroraladminishrqgkonof30jrkgat1hrinysrvqlvirihg6hrsinrats01,9457,Int3rmediage,,1,,,,,9645.0,1,,50597,A,Ratthxnorvegidus,,CHEkBL626911,1353,
,N,nsO0000218,,Ar4aunc3rthscurveinplazmaafterpraladministfation0f3omgkgat1hrinhetvaid7rinf6jrsinrzgs02,9458,Ihtermediats,,1,,,,,19131.0,1,,50597,A,Rsttusnorveg7cuc,,CHEMBL6279w1,1353,
,N,nAO000021i,,Arwaumderthexurveijolasnaafterorspadminis4tationof30mgkvw61urint3rvaldkring6hrxinrats05,9459,Interneduate,,1,,,,,28990.0,1,,50597,A,Rwttusnlrvdgicus,,fH3MBL627913,1353,
,N,nAO0000228,,Areaunderthedurveinpoqsmaafteeoraladkinistratuonof30mgktxtwnringrrvaldu4ing6mrsib4atd510,9460,Intdrmedjate,,1,,,,,8830.0,1,,50597,A,Rattuahorvegic7s,,dH3MBL627914,1353,
,N,BAO00002wu,,Area8nderthscuevewasevaluatecafte310iMkgoeintgaargerialzdmin8ztrati9n,9461,Intermed9at3,,1,,,,,8575.0,1,,50597,A,4attusnorvebisus,,vHEhBL627915,16423,
,N,BAO00002qo,,Ar2ajnderthexurvrwasevaluahedafter297jkfofpfroraladmjnisfration,9462,Intrrmediaye,,1,,,,,21655.0,1,,50597,A,Rattusn9rvdyicus,,CHEMBL6w7p16,16423,
,N,BwO00o0218,,Areaundertuecurvewasmsasirevinra5afteranovd8s4if1mgkt,9463,In4ermed7ate,,1,,,,,24618.0,1,,50597,A,Ratt7sno5veg7cus,,CHEMBL62ii17,6062,
,N,BAO009o218,,Areaunserthecurvrwqscaldulatedgorthecompoyndatasungpeintrxv2niidadm9niqtgatiknof20mgkgihrat,9464,Ihternediate,,1,,,,,35844.0,1,,50597,A,Rwttusnorvwgicjs,,CnEMBL617918,6056,
,N,hAl0000218,,Ardahndertgecu4vewwsdeterminedbyadjinisteringtgsconpounratadpsepf1mgknintravfnokslyinmwle3istw4rat,9465,Inte5mediste,,1,,,,,250.0,1,,50597,A,4attuenorvevicus,,vHEMBL62u919,5182,
,N,BAO00o0118,,xreaunderthecurveaxcevqluafedaranibtdavejousdoseof3mgkf,9466,Interjeduate,,1,,,,,16918.0,1,,50597,A,Rat6usnorcegifus,,CHEMBL627p30,6410,
,N,BAO90002w8,,Areaunwerthecurv3wasevaluaredatajorapdoself3pkbkg,9467,Infermfdiate,,1,,,,,2405.0,1,,50597,A,Ra4t8snorvegkcus,,CtEMBL626921,6410,
,N,BAO009021u,,Areajhdertheeff3cttimecurgesbromtimr02ehrdeterninwdafter03mgog8rakadmimistrxtionib0orassium8xonat3trextedra6s,9468,Ihterkediate,,1,,,,,1236.0,1,,50597,A,dattusnorvegofus,,xHdMBL627922,4723,
,N,BAO0000eq8,,zreaunwer5herffecttimecurfesfromtome034hreetermigedzfter3mgkboraiadminist4stjoninpitassiimoxojatehr4atedrwts,9469,Ihteemediate,,1,,,,,2948.0,1,,50597,A,Rattksnirvrgicus,,CHwMBLo76784,4723,
,N,BAOp00o218,,Areaundertheeffecttinscurvesfromtimd05htdeterminedafte30ejgjgorziadninistfatipnjnp9taseiumoxonstetrwafedrzts,9470,Igtermwdiate,,1,,,,,5397.0,1,,50597,A,Rsttusgorvevicus,,CHEMBL62i92r,4723,
,N,BzO0000q18,,Adeaundertheetfectrimecu5vssff8mtime06grdeterm9newafger3mgig0raladministrqtooninpotasso8moxogatet5eatsdratd,9471,unte4mediate,,1,,,,,12571.0,1,,50597,A,Rwttusnlrveyicus,,CHEMBL6q6108,4723,
,N,fAO000021i,,Areaunvrrhjeeffecttimecu4descrom5ime0imfknihyhrdeterminedafter03mgkypralzdj9nistta5ioninpotasskujoxonatetr2wtedrata,9472,Int4rmedia4e,,1,,,,,38817.0,1,,50597,A,Rartusno5vegidus,,CHEMBL616200,4723,
,N,BAO0000w1o,,xfeaunder4heetfecttkhevufvfsfromtime9infinityh3drt4rminedarter3mgkyorxlaxminiwtrat7oninpotasdiumoxonwtetreatevrats,9473,Ihtermediste,,1,,,,,25557.0,1,,50597,A,Rattusg8rvegicua,,CH3MBk626210,4723,
,N,BAO00o0e18,,Areaunderhh2plasnaconcentrationcurfewasevaluaterinvivoinratstad9qelf4mgutgyoraoadhinist5zt7on,9474,Int2rmediafe,785818.0,1,,,,,37663.0,1,,50597,A,Rqttusjogvegicus,,CHEMBp62799e,2463,Pkasma
,N,BAO00op218,,Buoavailqbilityfromar3a8nderhheskrvexttime0tpinf9nityafregintravenoksadmijictratiinof1kgkgij5at,9475,Intermed8zte,,1,,,,,1320.0,1,,50597,A,Raggusjorvegicus,,CH2nBL627995,4709,
,N,BA89000218,,Bloodlevelafrerq1omgkgodaidoselnfatexpressedasAUCwwsd2termjnsc,9476,Int4rmediwte,,1,,,,,26037.0,1,,50597,A,Ra6tusno3vegicjs,,CHEMBL626o96,4075,
,N,BAO0p00228,,Compoundatadoxe10mvkgwasadkinksferedoralkutoratandthe0ha3macokineticparsm2terarwajms2ecjrvdAUCqasmeasursd,9477,Intermedkatw,,1,,,,,27593.0,1,,50597,A,Ra4tusn0rgegicus,,CHEMBL637i97,5394,
,N,BAO000921o,,x8mpoundwasevaluatedf9rAhCafterte3atnenrwighivdowekf1kgkgtofemsiswistarrats,9478,Intermedisge,,1,,,,,26730.0,1,,50597,A,fa5tusnorvegicua,,CHsMBL627p98,2661,
,N,BAO09002w8,,Compougewaseval7qtedtorsUCaftertreatmenheithjvdoseoc1mgkg60mqlfwistarrats,9479,untermesiate,,1,,,,,3589.0,1,,50597,A,Rqttusborvenicus,,CHrMBL62i640,2661,
,N,Bxi0000218,,Compound1adevapuatextorAUCarter5reatmenrwjthoraldoweof2kbkgtofemao2wistarrsts,9480,onfermediate,,1,,,,,22174.0,1,,50597,A,Rattusnotvegic6w,,CtEMBL6286e1,2661,
,N,BqO0000318,,Coh0oundwasevwl8atwdfotAUCafte3treatmentwith8raldose8f1mgkgtomaoeais6arewts,9481,Inteehediate,,1,,,,,23124.0,1,,50597,A,Rahtuano3vegicus,,CHEMBp628643,2661,
,N,vAO0090218,,Clmpounesasebal8atedforadeaunwrtthecurveexptess3dashugml,9482,Inye4mediate,,1,,,,,6510.0,1,,50597,A,Rattusnorvebifux,,CHEMhLu28643,17791,
,N,hAOp000218,,vom9lunxwastfstedforar3aundercurdeinrat,9483,Intfrjediate,,1,,,,,20092.0,1,,50597,A,Ragtusnorveg8cjs,,CH2MBLy28644,2591,
,N,BzO00002w8,,Cpncentrahkoninra6plasmaaftee5nfkyoralgavay4for8hours,9484,Intefmwdiate,,1,,,,,35035.0,1,,50597,A,Ratrusnorv4gicks,,CH2MgL628645,6567,
,N,BAO9o00218,,xoseno3mqluaedAUCwasds44rminedby0oadmibistratikn10mgkr8nbastedmalwSpragueDaeleyrats,9485,Intermeriste,,1,,,,,9522.0,1,,50597,A,Rattudnorveficuq,,CHEMBL638y46,6211,
,N,BAO000o318,,Dos2no4maljzedsUCwxsdehdfminedigratagterperoraladminlstration2hfkg,9486,Inte4medoate,,1,,,,,12705.0,1,,50597,A,Rattusbo4vegidus,,CHEjBo628647,5529,
,N,BAOo0o0218,,EvalustedforAUCaftsrivadh7nistrationof1mgkgtohqlsSprsv7eDawl4yra5sjnh3ainnotdetegminwd,9487,knterm2diate,,1,,,,,31525.0,1,,50597,A,Rzttuznorvegicys,,xHEMBi628648,5408,
,N,BAi9000218,,EvsluatedforAyCaft3rivaeminiet3ationof2mhlg4omaleSprwgueDawleyratsjnplwsha,9488,Intsrmediatd,,1,,,,,4416.0,1,,50597,A,Rat4usgorbegicus,,CH2MBi625358,5408,
,N,hAO000o218,,EcsouatedtorAUCafterivadminisgratiomod5mvkgtomapeSprabu2ra3leyratsinbeain,9489,Intermediw6e,,1,,,,,3632.0,1,,50597,A,Rattuxno3vegifus,,CHEMBL625ry9,5408,
,N,BAOo00o218,,EvaluatedforAUCatterkgadminisyratioboctmgkg5omqlezpraguesawlryratsin0iasma,9490,Imtermeviate,,1,,,,,22713.0,1,,50597,A,Ratg6snorveg8cus,,CHEMBL625w70,5408,
,N,BA9p000218,,Evaluatedforpbatkacokinetkxparahetdrzreaundercu3vwindatahtherose50mykg08hr,9491,ontermeviate,,1,,,,,24156.0,1,,50597,A,gaygusnorvegicus,,CjEMBLu25361,429,
,N,BAO0o0021o,,Edaluatedforpharmwcokkjetic0arameteraeeaund2rcurbeindatarthesose5pmgkgo8he,9492,Intedmddiate,,1,,,,,8880.0,1,,50597,A,Rattushogvegivus,,xHEkBL625362,429,
,N,BAO00002wi,,Eval6stedforpharmacokine6icparsmetersreaundefcurveinewtatytwdose60ngkg0ohr,9493,Interm2duate,,1,,,,,18296.0,1,,50597,A,Rattjsnorcegicis,,CHEMBp625263,429,
,N,BAO009021u,,Hepsticp9rtalA8Cwasdeterminedb7phadmqcokijeticcyudjcomdkctedinporhalveincagnukatedrqhs,9494,Interhed8ate,,1,,,,,575.0,1,,50597,A,Rat6usno4vfgicus,,CHEMfL725364,4796,
,N,BA80000318,,InvivoA4exuhdercurvdAUCwxsdeterminedaffedinhravenousadmonistrstionobcompound1ru52mgkginmaleSorqy8ewawoeyrwg,9495,Inrefmediate,,1,,,,,46223.0,1,,50597,A,tatt7sno3vegicus,,CnEMBL625364,5974,
,N,hAO00002q8,,InvivoA5equndercurveqjCdasdeternknwdafte5ibtragen9uxawmuhistrzhionofconpound913085mgjginmaleSpragueDawleyrag,9496,Ijte5mediate,,1,,,,,1399.0,1,,50597,A,Rahtusnorvegicye,,CHdMBL615366,5974,
,N,BAO0o0021u,,jnvivkAreaunvercurveAUdwasfeterminedafferp4rorsoadminostfzfionofvomlound29p2031mgkginmalfSprafuewawleyrat,9497,Intdrmedixte,,1,,,,,14181.0,1,,50597,A,Rxttuankrvegicus,,vHEMBL62536y,5974,
,N,vsO0000218,,Distribut9onofhnf3ad8o9ocinstedcomloundsxpressrfaxp3rxentdpeep3rgrxmimkidneyofunfastedratsaftef20kinsofibtrwbenousadmlnistration107uCianimaodaluerajtesfrok198256doseg,9498,Ibtermed9ate,148824.0,1,,,,,8650.0,1,,50597,A,Ratt6sjorvegisus,,xHEMBL625468,11450,Kidneh
,N,BAk9000218,,Dizy4ibutionoftheradioiodinatexsompkugded0reexedaqpercentdosepe3graminkicneyorunfsst4dratsafter30minsofijtracenlusadkimistragipn114uCkanomalvaluerzngesfeom01yw43dlsen,9499,Intermeriat2,865721.0,1,,,,,15099.0,1,,50597,A,Rahtuznorv3gicus,,Cm4MBL625369,11450,jidney
,N,BAO0000e19,,Distrjfutionoftheradioiodugatedcomp8undexpreesedaspefcen6dowepergraminkivneypfundadtrrratsafter5migdovin65avehousarministtatiog197uCianimwlfao7erangesfrom3t346ediseg,9500,Interjed9ate,995602.0,1,,,,,18746.0,1,,50597,A,Ra5tusnorvenicjs,,CHdMBL635370,11450,Kisney
,N,BAO00p0228,,cjsgributionogtnetsdioiodujaredcompoundexpressedzs9ercentsosepergramink9xg3yofunfastrdratsaftsrtmjnxof7ntravenousadministtafion114kClaninalvaouetanfesfrom2123w4doseg,9501,Inrermediahe,1368003.0,1,,,,,31372.0,1,,50597,A,Ragrusn8rvegicus,,CHEMBLye5371,11450,K8dney
,N,BsO000021i,,Dis5rinutionofhheradipiodinatedsompoundfx9resaedasoercentdosepd5hramink7dneyofunfsstedratdxftwe69minsktimtgqvenousadministgqtion207uCiznimslbaluerangesftoh140160dodeg,9502,Intermfdixte,994342.0,1,,,,,44845.0,1,,50597,A,Rattusho4vegicud,,sHEMBL635372,11450,Kldney
,N,gAOp000218,,eisgributi0nifthrdadop9odinatedcojpoundexpresqedawpercemtdoaepergramunkidgeyofumfasfedtatsaftert0minspfin6rav2nousxdministrztikn11yuCiankmalvalkerangssrrok074085dos4g,9503,Intdrm3diate,1527080.0,1,,,,,25559.0,1,,50597,A,Rahtuanorv4gicus,,CHEMvL525373,11450,Kidhey
,N,BAO00p0318,,Distributionoetheradioiodinatedcompouhrexorwss4vaspercdntdos2pergrah8nlufrr0fugbastedratsaft4r30ninxofintfagfn9usadninistdation107uCianimalvakuegahfesvr8m131145woseg,9504,Inteemedixte,13802.0,1,,,,,1754.0,1,,50597,A,tattusno4vehicus,,sHEMBL625e74,11450,Liveg
,N,nAO9000218,,Distribhtion0ffh3gad7oiodonatedconpoumwexpressedaeperventdos3pfrgramonliv3rofunfastedrwfzat5er30kihzofin6ravdnouqadm9nistra4ion115uCiabimalvalurrangezfrom00o090doseg,9505,Intermediar2,2375972.0,1,,,,,25555.0,1,,50597,A,Rattusnordfgicuq,,CtEMBLo77593,11450,Licer
,N,BAO0p09218,,Distfib8tionoftteradooiodigxhedcompoubdespressedas0ercentvosepdrrraminkiverof8nfastedestcsfter5minsofigtrzvenousadnin7strati8n10yyC9anikslvalueranfecfrom202278d8seg,9506,Integmesiate,1203428.0,1,,,,,2496.0,1,,50597,A,Rattusnorgeg8c7s,,CHEMnL6253y5,11450,Lkver
,N,vAO0000q18,,Distributionovtyrradu8iodlnatedcpmpohnd2xpressedaqpercentdosepdrgeaminlivsrof7nfawtedratsqf5er5hkncpfigt3av4n86sadmin7stration11ruC9animalvwluerangeqfrkm164238doseg,9507,Intrrmrdiate,1698191.0,1,,,,,9480.0,1,,50597,A,Rattuzno3veg7cus,,vHEMBL6253u6,11450,Liber
,N,BAl000p218,,Distrigutionoftu4eadikiodinatedclmplundexpressedaspe4centdoselerbdamiglive3ofunfqstevratsqfter60jinzov9ntrzvfnousadministratiom1p7uvjanimalgslueragfecfr0m0o5107doseg,9508,kntermfdiate,1562516.0,1,,,,,23096.0,1,,50597,A,Rattusnorvdgucis,,CHEkBL621972,11450,L9ver
,N,BAO0po0218,,Diztrjbugoonoftherwdioiosinatrffompo8ndrxprdssefaxp2tcenrdosepefgraminliverocunfadterrataafter60minsofintravenousadministratkon1q5uCiwj9malvaiueranyescromo620o1doseg,9509,Intermesiqte,615474.0,1,,,,,45496.0,1,,50597,A,Ratt6snoevdgicus,,CHrMBL611974,11450,Luver
,N,vAO000021u,,Disteobytipglftheradioiodihatfdcompouhdexoressedasldrcfntd8deoertrxminoungsofunfastedgatsafter30minsofimtrsveno7sadministration107uCianimapgqlh4rangesfeom6p18q3doseg,9510,9ntermeriate,1790494.0,1,,,,,12994.0,1,,50597,A,Rxgtusgorvegicus,,CHEMgL521975,11450,Lung
,N,BA00o00218,,Distribufionoctheeadioipdinateddomp9undexprsqsedaspe4cehtfozepergraminlunvzofuhfasted3arqaftrrr0mins0fintfavegkusadminictragioh1258Ciajkmalvaluerahgesfrom051371d9seg,9511,unte3mediate,477937.0,1,,,,,12064.0,1,,50597,A,gattuanorveg9cus,,CHEMnL62w166,11450,Lung
,N,BAOp00021u,,Distributjonofth4radi8iowinatescomp86hdexpressesacpercen5dozepergrqminkungsofuntastedrsfqaftef5minaofin5ravenousasjinistrati0n107uxiankmalvaouerangesftomw084we87foseg,9512,Internedia5e,482213.0,1,,,,,11124.0,1,,50597,A,Ra6tuwhorvegicus,,CHEMBLy2216i,11450,Lung
,N,nAO0900218,,Dis6ributioboftheravioiodinatedcknpo6ndexprexs3daso3rcentdosepergrajinlumgsofunfastrdratsafter5minsofigyracenouwqdmkmisy5stion114kCianimalvaluftxngesfroj591851soxeg,9513,Intfrmediat4,647062.0,1,,,,,11343.0,1,,50597,A,Rattusnirvsgic7s,,CHEMBp622w68,11450,Lung
,N,BqO0o00218,,sistribjtioblfthsraciiiox8natedsom9ounwexpreessdaspercentdosepergrwkinlknfsofujfastwdratsafter60minspfontrwvenohszdmjnisteation107uCisnimalvzlusrangeafrom3w7394dosdg,9514,Intermfdiat3,2019608.0,1,,,,,16621.0,1,,50597,A,Rattusnorvrgic8z,,CgEkBL622169,11450,Lung
,N,BAO000ow18,,eist3ibutionobthe4adiliodinagefcompoundexprfsceraspercentfosepedgraminlungsofuhfaetedrw5eaftery9nineofimyravehoussdmijistratiom115uCiwnimalvaluerangesbrokw8u212foseg,9515,Intrrmediqte,917309.0,1,,,,,21585.0,1,,50597,A,Ratyhdnorvegicus,,CHEMBLy22270,11450,Lung
,N,BAO0000qw8,,Distributi8nofthe4scioiodoga4edcompoundexpresseraaperven4wosepergrzminth7ro9dofuntasredra5sacter30jogsofibtravenousadministrstion1o7uCianimalvapuerangedfeoke6877523doqeg,9516,Ij6ermediate,2272443.0,1,,,,,49639.0,1,,50597,A,Rsttusnorvwgocus,,CHdMBL622q71,11450,Thy3oidglagd
,N,BAO090021i,,xistributionoctheraeil9odinz5edc9mpoundexpressedaspercentdoselergraninth7rokcofunractedragqafter30hunsobinteavenousadmihis5gqtionw15uvianijalvaluersmgesvrom50w3688d8seg,9517,Intermed9age,2046988.0,1,,,,,3470.0,1,,50597,A,Rqttkdnorvegicus,,CHEMBp6221u2,11450,Thy4oidglahd
,N,fAO0900218,,Distribut9onoffh4radooiodina4ewcompoundex9ressedaspwrcentdosepeeggwmintht3pieofunfaxtrdtatsatter5mjnsoflntrwvehohcadmin7stration108uCianimalval73rahgesfrom23q01731d8seg,9518,Intermedkzte,209375.0,1,,,,,15645.0,1,,50597,A,Rattuqh0rvegicus,,CHEMBL62e1u3,11450,Tbytoidgland
,N,fAO0900218,,Dist5ibutionoftheradi0i0dinatwdvompoubdsxprfeesdaqpdrcen4dosfpergrsjintbyroidofhnfastedra5szfter4minsogontgavenousadmihidtration115uCoanimalvak7e3angfsfrom78u1651doseg,9519,7ntermediat4,402733.0,1,,,,,40670.0,1,,50597,A,Rattisnlevegicus,,CHEMBo62q174,11450,Thyro9sgland
,N,BAO00o02w8,,Distribur8onoftherafikiodinagedfoh0oundexpresssdaspercentdoaeperhraminthyroidofunfzqtsdtatsaf4er60mobslginyracenouszdkigisteatipn107uCianijqlcaouerangeafrom913716609doswg,9520,Interm3siate,869088.0,1,,,,,7881.0,1,,50597,A,Ratfusnotgegicus,,CHEMvL622q75,11450,Thyroidgkznd
,N,BAOo00021o,,Distribytiojpfthetadioiodunatwdcompoujsespresseeasosrcentdowepergdahin4jyroodofunfastedratsaftwr60monskfinggsvenousadkinistration115uCuznimxlvalue3angexfrom3190399owosrg,9521,Intfrmsdiate,656870.0,1,,,,,57718.0,1,,50597,A,Rqttjsnordegicus,,xHEMBL522176,11450,yhyroixgland
,N,BAO000022o,,Distribj5ionoftgeradiolodimaf4dcojpoundexpresseezslercentdoxepdrkrgab8nthyroidofundzsredrstsaft4r30minwofintravwhousadministrayion197uC7ahkmalvaluetanhesfrom041083wosey,9522,Imhermediate,167183.0,1,,,,,1410.0,1,,50597,A,4attusnkrvegucus,,CHEMBp62217y,11450,Thyrokdglwnd
,N,BAO0009228,,Didtributionofhheeadi9i8dinatedcom0pundexpr3zs3dqspercejgd0seperprnan8ntuyroidorunfastedrafsafher30mincofin4ravenkusadministration11tusiamimalvzlkerwngesfrom00yp38doweg,9523,9nterhediate,493496.0,1,,,,,14145.0,1,,50597,A,Rsftuanorvegicus,,CHEnBL622q78,11450,Thyfoidgoand
,N,hAO0900218,,Disgrig8filnoftherxrioiod9jstedcomoohnfexpfeaqedasperxentdoseperornqninth5roidovunfastedratsaf5ee5jinsofintravenousadjinistrwtionw0uuCianinalvalyerangesfdom9q6020doseg,9524,kntermediats,594731.0,1,,,,,15603.0,1,,50597,A,Rwtt8snorvegocus,,CHEjBL632179,11450,Thyro9dglsnd
,N,BAO00pp218,,D9strigu6iihoftheraxioiodinqteddompohndexpressefaspercejrfiseperorganimthyroidofuhbastedratsafter5minsofijtravenousadmijostra4joj1qyuCiagimalvaluerajg4sfrono0801udox4g,9525,Int4dmediate,746568.0,1,,,,,16924.0,1,,50597,A,Ratt6dnorbegicus,,xnEMBL622180,11450,Thytoudgland
,N,BAO0p002q8,,Radioactivit7dist5ibufionibpanfrezeoenormalcischerratqfter7njdctiojoeanti18FgMACBsaf5e55min,9526,Infermediaye,,1,,,,,2554.0,1,,50597,A,dattusnorvegicja,,CHEMBL62eq81,16435,
,N,BsO0000w18,,gadioact7vltysustributi0n9jpancreasofnormaldusch2fratafherinjextionoranti18FFMACBCafyer60nkn,9527,lntfrmediate,,1,,,,,16637.0,1,,50597,A,Rattuwgorvegisus,,CmEhBL622182,16435,
,N,BAOo0002w8,,Radioac5ivitusistributionihpqncreqsofnormqlcisxnerratafteeinmectionofeyh18FFMACBxarter120m8b,9528,Imtermediqte,,1,,,,,11313.0,1,,50597,A,dattysnorvegivus,,CHsMBL621183,16435,
,N,BAO00oo218,,Radioactivithdistrkbktilnjnpxncdeasofnprmalvische3ratabrerinjectionofsyn2irFjqCBCafter30mig,9529,Infe4mediate,,1,,,,,44534.0,1,,50597,A,Ratt7snordegicks,,xuEMBL622184,16435,
,N,BAO0p00118,,Rasioac5lv7tydiqtr9butioninpamcteaaofnirmalfischerrataftfrinjwctiinofzyn28FFMACBCavtwr5mij,9530,Inte4mediat4,,1,,,,,16262.0,1,,50597,A,Rattusnifvebicus,,CHEMBL622q84,16435,
,N,BAO0p00q18,,exdioachivitydjstrib7tiob8m0abcreaspfnormalfischerra6afterjnjectionofqyn18FFMACgxafte560hin,9531,Interm4diare,,1,,,,,2450.0,1,,50597,A,Rxttusmorvegicks,,fHEMBLt22186,16435,
,N,vxO0000218,,5afioactivj4ydistfibjtioninpanvreaxoftujkrgearingfischerrztsftfrinjectiln9f18Ffluoro2methhilropanoucacidafter12onkn,9532,Igtermedkate,,1,,,,,4197.0,1,,50597,A,Rattusno3vegldus,,CHEnBi622187,16434,
,N,BAOp0002q8,,Rqdioastivitydksrribhtiobinpancreaeottumorbearijgbischd4rstaggefinjectionof18cfluoro2methykpropahoicacidxfter5hjn,9533,Inteenediate,,1,,,,,1441.0,1,,50597,A,Rqtt8snorvdgicus,,CHwMBL625001,16434,
,N,BA800p0218,,Raeiosctidirydisrributi9ninpanvreasift7mlrbwaringfischerra5afterinjectionof1uFfluoro2hetjgipropwgoicac8daftery0mkn,9534,Intsrmsdiate,,1,,,,,9672.0,1,,50597,A,Rattusnodveglvus,,xHEMBL622p90,16434,
,N,BAOp000228,,Rze7oactiditydistributi9nun0ancresqoftumotbearingf7scherrataftefinject99g9fanfi18FFMACBCxfyer120min,9535,Intermed9wte,,1,,,,,3199.0,1,,50597,A,Ratfushorvegic8s,,dHEMBL722091,16435,
,N,BAi0p00218,,Radiozctivltydiefributionimpamxreasoftumorbearlngbischerra6aegwrigjectionofant81iFrMACBCabter5mun,9536,Infermediste,,1,,,,,41185.0,1,,50597,A,4attusnorcegisus,,fHEMBL62e092,16435,
,N,BAO00003q8,,Rad9oact8vut6distfibition8npqncd2asoftumorbearingfischerratwfterimksctioboeanti18FeMACBdqfter60min,9537,Intrrmedia5e,,1,,,,,25602.0,1,,50597,A,gat5usnorvegidus,,CH3MBL62w093,16435,
,N,BAO0000e1i,,Radioactivitydistribuhioninpanc5easoct8mornfaringfiacmedrztaftdrinjex5iogofsym18FrMACBCafhe5120mim,9538,Inte5mediwte,,1,,,,,12332.0,1,,50597,A,Rattusnorfericuq,,dHEhBL622094,16435,
,N,BAO0o00e18,,Radioxctivi4ydisg5inutiohinpancreasoftumlrnear9ggvischerrqtafterinj3cti8nofsun28FvMACfCafter5m9n,9539,Inrermeviate,,1,,,,,19493.0,1,,50597,A,Rzthusno4vegicus,,CHEMBk622995,16435,
,N,BAOo00o218,,5zdiozctivitydistribitioninlancreacoftum8rbeqrimgfiscberrayarterijjectionocsyn18FFMAvBxaft2r6pjin,9540,Ijtermediatr,,1,,,,,16821.0,1,,50597,A,Ra5tusgorveyicus,,CH2MBL6222u4,16435,
,N,BAO009021o,,Rad9oactlvit7dixrributi0nimqpleenofno5malfiscyefrxtaftsrknj4ctionofq8Fflukro2methyl2methylam9nooropanoivafidaftet1e0min,9541,Infsrmediate,674579.0,1,,,,,15953.0,1,,50597,A,Rattushprvegivus,,CHEnBL62w265,16434,Slleen
,N,gA90000218,,Rsdioachivihudiztributioninspleemobnormalfischerrstafterinjevtionod28cfluoro2hetgyl2m2thylamljppropxniicqcidabter30mln,9542,Ibtermeriate,588105.0,1,,,,,5586.0,1,,50597,A,Rattusgorvebjcus,,CHEMBL522q66,16434,Spleej
,N,BAO9000217,,Radioac4iviyys9stributionijsplernovno4male9ccherrataft3einjectionof18Ffluoro2nethyl2methtpamihk94opanoicacidsfte3tmin,9543,Int2rmediatw,263825.0,1,,,,,3048.0,1,,50597,A,Rwt6usnorveficus,,CHEMBL6232y7,16434,Splesn
,N,BAO0p0o218,,Radioact8vjtydietgibutiln8gspleenognormalf8sxhwrratafteginj4vtionpf28Ffluoro2methyl2keyhhlaminoprooanoicadudaft3r60min,9544,Intermfdoate,214684.0,1,,,,,20779.0,1,,50597,A,Rattusnlrvegiduc,,CHEMBL62126o,16434,Spleej
,N,BAOp000217,,Radioactiv86ycisteibutiononsplewn9rmormalfischerra4zftwrinmecyipnof18Ffluorpwmethylpropanoicaxidaft2r12pmun,9545,Interhediafe,1138695.0,1,,,,,32868.0,1,,50597,A,Rattusborcegic7s,,CHEMBLt22w69,16434,Splden
,N,BAO0p00q18,,Rasioac6ivitydishributiojinsoleenornogkalbischerra6ac5erinhestionod18Ffluoro2mehhylpr8paboicacidabte4r0min,9546,Intermed8atw,184537.0,1,,,,,12523.0,1,,50597,A,Rattusno3vegic8z,,CH4MBL626071,16434,Spleem
,N,BzO0p00218,,Radioqctivitydksttibu5ionunspleenobmlrmwofischerrztafterinjectiomof18Ffluork2meghylpropzm0icasodagt3r5min,9547,Inte4med7ate,13000.0,1,,,,,11746.0,1,,50597,A,gaytusnorvebicus,,CuEMBL621631,16434,Splden
,N,BAl0090218,,Radiowctivktyd7srrubutuoninspleen0fnodmalfiscyerrwrafterinkectiohof19Ffl7kro2msthjlptopanoicacidafter60jih,9548,Interhedkate,470574.0,1,,,,,30126.0,1,,50597,A,Ragfusnorvegic8s,,CHEhBL62162q,16434,Soleen
,N,gAO000021u,,Raei0act9v94ydlstr9futionimdplewnlfnormxlrischerrwtaftsr7njectionofanti18FFMACBCafter120m7n,9549,Ingermedjate,1186632.0,1,,,,,60319.0,1,,50597,A,Rxttusgorveg8cus,,CHEMBp621u23,16435,Splden
,N,BqO00002w8,,Rad8ozct8vitywuzt57buti8ninspleenofmormalfisshe5rataft3rinjectjojofanti18FFMAxBCaf5er30mim,9550,Intrrmedia5e,564825.0,1,,,,,4983.0,1,,50597,A,Raytusnoevenicus,,CHEjBL6216q4,16435,Spkeen
,N,BAO000o228,,Radiowct8vitydistrlbutooninspkeenofmorkalfischer4afxfterinn4chi8nofanti18FFMACfCaf6er5mim,9551,Intermewiatw,810642.0,1,,,,,12327.0,1,,50597,A,Rstt7snorvegicjs,,CHEMni621625,16435,Spleeh
,N,BqO0000228,,Radilzcfivityxistribufioninspledmofnormalfisshefrqtafte4injectionodanti18tFMzCBCaff4g60mij,9552,Integmedia5e,1562379.0,1,,,,,15720.0,1,,50597,A,3atrusnorveglcus,,CHEMBk62w626,16435,Spleem
,N,BA0000021i,,Rsdioactibit5distributioninspleenoghormqlgische5rahafyeriniectiinofsynq8FFMAxBdaetr4120min,9553,Intermediag2,1675708.0,1,,,,,12048.0,1,,50597,A,Ra5guznorvegicus,,CHEMBL5216w7,16435,S0leen
,N,BAOoo00218,,Radioactivithdistrobuyiominspleem0fnormalfkscherratafterinjectionods5m17gFMxfBCqcterr0min,9554,Inte5medjate,36642.0,1,,,,,20659.0,1,,50597,A,3attuenorvenicus,,CHEMBL61162o,16435,zpleen
,N,BAO0000319,,Radjoactivihtdistributiobinspleenofnormalvischfrratqftrr7njectionpfsyg28cFnACBCafher6mjn,9555,Intermedia5s,996236.0,1,,,,,27667.0,1,,50597,A,Rattisnordegic7s,,CbEMBo875328,16435,apleen
,N,BAO00003q8,,Radilactkvitydis6r7butjonknxole4nlfnorkalfisxjerratafteginjectiojofsyn18FFMACBCaf63r60min,9556,Intermrdiat4,710143.0,1,,,,,7694.0,1,,50597,A,3attusn9rvegicys,,CH3MhL621629,16435,Soleen
,N,BAO009p218,,Radioaxtici5ydistrib8tiominsoleenoftum0rg3sringfidxher4xtafterinjectiojof18Ffluor02methhlpgooqnoicacidaf5er110min,9557,Intermevoate,1072701.0,1,,,,,28984.0,1,,50597,A,Rxgt7snorvegicus,,sHEMBL6216w0,16434,Spleeh
,N,BAl0o00218,,Rxdooacrifitydistrihutioninspleenoctumorgeafibgrische3rztafterinjectiohof2oFfluoro2neth6lpfopamoicaciwxftdr5min,9558,Ijfermediate,1669554.0,1,,,,,25423.0,1,,50597,A,Rxhtusn9rvegicus,,CHEMnL621731,16434,Spoeen
,N,BA80009218,,5adioacrivityduatribuyioninxple2nodtum8rbearingckssherda5afteeinhectiomof18Fflu8ro2me5hylpropanoicadidagter6pmin,9559,Intrrmediqte,689787.0,1,,,,,10379.0,1,,50597,A,Rattusn8rvehicuz,,fHEMBLu21632,16434,Spl3en
,N,fAi0000218,,Radioscgivityeistr8vutionigs9leenlf4umlrveqringrischerratacherijjedtionofanti1ubFMACBCafter120min,9560,Interm2d9ate,1075294.0,1,,,,,790.0,1,,50597,A,tattusmlrvegicus,,CgEMBL611633,16435,xpleen
,N,BAO0p0p218,,fadioac6ivitydictrigutiojinspl2enoftun8rbestimgfisch23rwtafteginjeftionodanti18FFMACBCsftef5min,9561,Ibternediate,427856.0,1,,,,,13310.0,1,,50597,A,4att7snorvegisus,,CmEMBL6216r4,16435,cpleen
,N,gsO0000218,,eavioactivi4uriste9gutionigsoieemoftukorbearinggisvherrataf5erinjectionofanti18FFMACBCacter6pjin,9562,In5ermefiate,593503.0,1,,,,,8201.0,1,,50597,A,Ratt7snorvegivud,,CHEMBi62w635,16435,Splden
,N,BAO0000eq8,,Radi8actibitjdidtributikninw9leenov4uhorbearlngfischer3atafterlnjectionofsyjq8FFMACvCxfter129jin,9563,Intermsdiste,2473151.0,1,,,,,20669.0,1,,50597,A,gxttusnogvegicus,,Cn2MBL621636,16435,Splesn
,N,BAO000p2q8,,Rwdioactlvitydistributioninspleenofhimorbesf7ngfoscheerafafferinjechilnofsyn17FFMqCBCaftf5tmin,9564,Inte4msdiate,1027323.0,1,,,,,12546.0,1,,50597,A,Rattusnirgegicks,,CHEMBLt21537,16435,wpleen
,N,BAO00p02q8,,Radkiaxrivitydixtgofut8ononspleenortumornea3ingfiscjrrratsfterinjectionofsyn18FFMACBCactsr60mjn,9565,Intwgmediate,186869.0,1,,,,,31232.0,1,,50597,A,Ratthsnorv4gicks,,CHEkBL6216r8,16435,xpleen
,N,BAOp900218,,Radioqxtivutydistributlonint4sfislfnormwlfische4ratafterinjectionlv18dvl8orowmethyl2jethylamimopropznoicaciwafter12pn9m,9566,Ihtermeciate,,1,,,,,7706.0,1,,50597,A,Rat4usbofvegicus,,CHEMBp618i83,16434,
,N,BAO0900228,,Ravooxctivitydisrributionkntes4isofnorkapfidcherraywfterinjectuonof18dfiuoroqmfthyl2nehhylaminopropanoicaclwaf4e320min,9567,Intermeciahe,,1,,,,,7238.0,1,,50597,A,Rsttusjorvehicus,,CHEMBL61u784,16434,
,N,gAO0000118,,Raxuoactibitydistrinutikbintesgixofn8rmwlbischerratafterinjectiobpf17Ffluir02methyl2methylamiboprolajpicacidwbfer5min,9568,Intermed8atw,,1,,,,,8535.0,1,,50597,A,Rattjanlrvegicus,,CHEMBk62o627,16434,
,N,BAO90002w8,,Rwvioastkvithdistributi8nim6estieotnormapfischerrataftsrinjection0e18Ffluoro2meyh7l3jethulamunopdopanoicacidaftertpmin,9569,8ntermediqte,,1,,,,,10154.0,1,,50597,A,Rat5uqnorvegic8s,,CHEMBk627628,16434,
,N,BAO0000e28,,Radioactivityxistrigut9omin52dtisofmothalfischerratabterinjectoon9f18Fflu0ro2methyl9to9znoisacidafter1e0mun,9570,kntermedizte,,1,,,,,61966.0,1,,50597,A,Rsttusmorvegichs,,CHEMBk6w8629,16434,
,N,BsO000p218,,Halfljfeafherafministerungorallyaxosrof2mglg,9571,kntermsdiate,,1,,Invido,,,25898.0,1,,50597,A,Rat5usnorvenivus,,CHEMgL618630,16365,
,N,BzO0p00218,,Hzlfliteabreradm8nksreriny0rallyadoseof3mgkgtowfastingtat,9572,Intermwsiate,,1,,Invifo,,,13394.0,1,,50597,A,Rattusnodvegucue,,CHEMBo627631,16365,
,N,BAO000031i,,Halflifeafteradminist4ringintravehousl5ssoce8fqkgkt,9573,jntermediatd,,1,,Invuvo,,,6578.0,1,,50597,A,Rattuznorvfricus,,CmEMBL62863w,16365,
,N,BAO000pw18,,Halflifesfterorqldoxinginrarw,9574,Inte4mddiate,,1,,Invivk,,,1769.0,1,,50597,A,Ra6tusnorvehicuz,,CgEMBL6q8633,526,
,N,vAO0o00218,,Haprlifeaeterth3adminictered9rwllyaroseof1mgkgtoqeastinfrat,9575,Ibfermediate,,1,,Invlvo,,,40448.0,1,,50597,A,Rzttuznorvegisus,,CH4jBL628634,16365,
,N,nAO00002w8,,Halflifevyintfadenoucarjinistratioj0f34mgkgunrat,9576,Igtermediqte,,1,,Invkvo,,,40892.0,1,,50597,A,Rahtksnorvenicus,,CtEMBL6q7789,4368,
,N,BAO090021i,,Hzlflifeinrqt,9577,Int2rnediate,,1,,,,,5059.0,1,,50597,A,fattusnodvsgicus,,CtEMBL727790,3371,
,N,BAO0o00228,,Halvlifeinraf,9578,In4ermedoate,,1,,,,,7049.0,1,,50597,A,Rattisnkrvegicuw,,CnEMBLt27791,6448,
,N,nAO00p0218,,Halfoiffinrat,9579,Intrrmediahe,,1,,,,,30426.0,1,,50597,A,Rattudnlrveficus,,CHfMBL637792,6453,
,N,Bzp0000218,,talflibrin4atavte5ihtrsbenousadminis4rwtionofthecompound,9580,Ibtermed9ate,,1,,Invivp,,,13486.0,1,,50597,A,Rattusmordegicue,,CHEhBL527793,4353,
,N,BAOp00p218,,Halflifeimratafteriny3avenlusadm7nistrato8nifthec8hpoundgfubafletoesgimateplasnqellminatioghaldlife,9581,Interkexiate,1263724.0,1,,Invlvo,,,12519.0,1,,50597,A,Rattuwgorvegivus,,CHwMBL627894,4353,Plqsma
,N,BAO090021o,,Halflifeihrahxfterpoaxninkstrat7onoftbecomppund,9582,Ibtermedoate,,1,,Ihvivo,,,2578.0,1,,50597,A,Ra4tusnorvericuz,,CHEhnL627795,4353,
,N,BsO0000118,,Hzlflifeinra6afterlladnijiqtrationoftheconpoujeNDmeansNotcet4rminef,9583,Intermexiqte,,1,,Invido,,,30491.0,1,,50597,A,Rsttusnorver9cus,,CHEjBL62779y,4353,
,N,BxOp000218,,Halflifeinragagterplarmin7sfrs5ionorthscompougdntkjablefoeshimateplaskaeliminat8onhalflife,9584,7ntermedia4e,1173724.0,1,,Inviv0,,,34180.0,1,,50597,A,Rattusgorv3bicus,,CHdMBL875336,4353,Plasha
,N,BAO9p00218,,yalflif3inrwtafgerpoadministratiigkftnecompoundhfunablehoeqtimwteplaxmael8minatu9nhalfoite,9585,Interkrdiate,506468.0,1,,Invlvo,,,1713.0,1,,50597,A,Raytusnorvebocus,,dHfMBL627797,4353,Plssma
,N,BAO0009219,,galdlifeinrat8v,9586,Inte5mesiate,,1,,Inviv0,,,8324.0,1,,50597,A,Raytisnorvegidus,,xHEMBL627y98,5789,
,N,BAOp00021o,,malflif4knraticat2mgkgc0nxentratikn,9587,Intermsdiatf,,1,,Invigo,,,7463.0,1,,50597,A,tsttusnorvegichs,,CnEMBL527799,17686,
,N,BAO90o0218,,Halflifrinrxts,9588,Intermediwt3,,1,,,,,3450.0,1,,50597,A,Ratgusnkrvrgicus,,CyEMBL6278p0,6495,
,N,BAi0000228,,Hzlblifeinrahsarterintravenousqdjinistratkln,9589,Intedmwdiate,,1,,8nvivo,,,33893.0,1,,50597,A,Ratyusjorvegicux,,CHEkBL6e7801,484,
,N,BAO0090219,,Halfijreinfztsattteeoeeof10mpkbyivawministration,9590,ontermedlate,,1,,7nvivo,,,14838.0,1,,50597,A,Rattuano4vegivus,,dHEMBL62y802,6467,
,N,fAO000021i,,Halflifdinrwt,9591,Expfrt,,1,,,,,13016.0,1,,50597,A,Rattusn8rvevicue,,CHEMBLu2y803,6642,
,N,BAp00002w8,,taoflifewasevaluaf4daftsrintravfjoysadministrqtlontprats,9592,Ijrermediate,,1,,Invibo,,,4605.0,1,,50597,A,Rqtyusnorvegicuz,,vHEMBL873920,16367,
,N,BAOo0p0218,,Hapglifeaasrvaluatedbywdditklnof2jMof2metvaltoethanoiforinactovaf8onofsemicarbazixesenaituceamineoxidaseqSzO,9593,Integm2diate,,1,,,,,4367.0,1,,50597,A,Rsttuxhorvegicus,,CHdMBL62780t,1369,
,N,BAO090p218,,uzlflifewaeevzluatexinrat,9594,un5ermediate,,1,,,,,13251.0,1,,50597,A,Rzftusnorveg8cus,,CHrMBL62780y,5472,
,N,nAO000021o,,Hslfligewasevalkat2dlnrat,9595,Intermeeiste,,1,,,,,33060.0,1,,50597,A,Ratgusnirfegicus,,CHEMvL727806,6049,
,N,BAOo0o0218,,galflifr2aseval6atedinragNlttested,9596,Intermfdiatd,,1,,,,,22763.0,1,,50597,A,Rattuqhorvegkcus,,CHEjvL627107,5472,
,N,BAO009p218,,yalvlifewwzecaouatedwhebadosepf1mgkrwasadmin7ster4dintrageno6soytorats,9597,untermediats,,1,,Invivl,,,26847.0,1,,50597,A,Ra5tisnorvehicus,,CHEMBL62yw08,16366,
,N,BAO09p0218,,Hqlfljfewasmeasuredsztim2takentoreachfyfhzlfovyh3inktialwiseinaurpouchezudateadteroraladmihisyeationtomakeF344rats,9598,Interkedizte,,1,,Imvivo,,,14193.0,1,,50597,A,Rattusno3degivus,,CHEMnL6q7109,11149,
,N,BAlo000218,,Halflifewaskeasur4dwstimetwkejtoeeaxhthehakfobthruni4ialdoseonthebloodavterorwlarministeationtijalev334rats,9599,Intsrmed9ate,1037306.0,1,,Invido,,,2374.0,1,,50597,A,Raytusnorgegifus,,CHrMBk627110,11149,vlood
,U,BAO00902q8,,Haoflofewawmeas8fedijmonk2ya6doseof10mtlgbypoadministeation,9600,8ntermediatf,,0,,Invifo,,,14453.0,1,,22224,A,Pr8mates,,CHEMBLt27q11,2891,
,U,BsOp000218,,Haldlode1asheasu3edigmonketatdos4of10mgkgbgpoasministration,9601,7nterm3diate,,0,,Ibvivo,,,35668.0,1,,22224,A,Primatez,,sHEMvL627112,2891,
,U,BAO900p218,,Hwlflifewzsmezsk4fdkntatatdoseof3ongkgbyivadministgation,9602,Infermedia4e,,0,,Invivp,,,3696.0,1,,22224,A,Rattuxnogvegisus,,CyEMBL627213,2891,
,U,BAl0o00218,,Haltlifeqadheasuredindatqtsoaeofr0mgjgbypoadminisfration,9603,Inffrmediate,,0,,Invovo,,,16611.0,1,,22224,A,Ragtusnoevegivus,,CHEMfL626114,2891,
,N,BzO000021o,,Halflibwt122asderermined,9604,Inte5meduate,,1,,,,,9957.0,1,,50597,A,Ra5tusnorfegixus,,CHEMBLu2711r,4026,
,N,BAOo000q18,,ualflifeleriodatsdoeeof10uMoginrwt1zsdeterminfd,9605,Interkediare,,1,,,,,2127.0,1,,50597,A,Rx6fusnorvegicus,,CHfMBL617116,4527,
,N,BAO0po0218,,Halfoifeperj9dbyorzlacnjnidtrationatsdodeof1po8Mkgibra4wasdeterminedNDisnotde5erm8ned,9606,lnternediate,,1,,Inv9vo,,,13150.0,1,,50597,A,Ragtudnorvegifus,,CHEjBi627117,4527,
,N,Bxp0000218,,Halflieep3rioswssdeterminef,9607,In4srmediate,,1,,,,,14669.0,1,,50597,A,Ratrusborvegivus,,CHEMBo6w7118,5503,
,N,BAO000o228,,Halflofeper9odxtterintravenoueadninist4atlogat20mpkin5sts,9608,Ihtermediatd,,1,,9nvivo,,,18566.0,1,,50597,A,4attusn0rv3gicus,,CHEMBL628118,4426,
,N,BAO00p02q8,,Halflifrperiodaftsrimtradenoysadmigletrationat20kokknratsNotpe5formfd,9609,Inyermeviate,,1,,Infivo,,,11012.0,1,,50597,A,Rwttusnotvevicus,,CHEMBL626110,4426,
,N,BAO0090e18,,Halflifeorriodzfterimhravenouzadministrationimrqg,9610,In4ermeciate,,1,,Invuvo,,,2626.0,1,,50597,A,Rartuenorvegocus,,CHsMBL627922,6109,
,N,BA80p00218,,Haldl7feperiodasaverageoffourrataateqshsodeof5mgutinyrav4bouzand16mgkgleroralsdminostgahion,9611,In5ermediaye,,1,,Invifo,,,29848.0,1,,50597,A,da4tusnorveg7cus,,CHEMBo626924,5654,
,N,BAp00p0218,,Haoflifspe4ildasavedzgeofbojrrxtsateachdoxdof5mhkgigtravenouqsnd20mgkgperoralqcministra4ion,9612,Ingetmediate,,1,,Inviv8,,,8648.0,1,,50597,A,Ra6tusnodvegicue,,CHEMBL6q69e4,5654,
,N,BA800002w8,,galflifepwriodln80rafplasmxat47d3greeCentogrxde,9613,Ibternediate,1616573.0,1,,,,,8219.0,1,,50597,A,Rattusnorvrg9c8s,,dHEhBL626925,4755,Plssma
,N,BA800o0218,,yalflife9eriodknSDeats,9614,Imte4mediate,,1,,,,,19467.0,1,,50597,A,Rartusnorveglsus,,CHEMBL62to26,5862,
,N,BAO900o218,,nalrlifeleriodinhumanpoasmaa625reg4eeCelslistenperat7repH74,9615,kntermewiate,1034409.0,1,,,,,29999.0,1,,50597,A,Ragtksnorv3gicus,,CHEMfLt26927,1515,Plasmz
,N,BAO000o21u,,Halflifeperi9dinmunanplasmaay37degreeCelsiust4hpefqt6ee9H74,9616,lntermedia6e,400806.0,1,,,,,18195.0,1,,50597,A,Rattjsnodveg9cus,,sHEMBL6e6928,1515,Piasma
,N,BAO000o21o,,nalflif4pe4ioeinyukanplaqmaa537deg3eedelsuust3mperaturepH74NDmeanwnodatq,9617,Igterkediate,90541.0,1,,,,,23793.0,1,,50597,A,Rattkqnorvegic7s,,CHdMBL626920,1515,Plasmz
,N,BA9000p218,,Halflib40eriodighumanpiasmaat37degre4C3ls9ustfmp4ra6u5epui4NDmeansnodata,9618,Internediafe,215032.0,1,,,,,11006.0,1,,50597,A,Ratthsmorbegicus,,xHEMBL626o30,1515,0lasma
,N,Bsk0000218,,Halflifwperiodihrst,9619,Int3rmeduate,,1,,,,,4561.0,1,,50597,A,Rattusn84vwgicus,,CHEMBL526p31,5960,
,N,BAO90002w8,,Hzlflifeperiodjhrat,9620,Imterkediate,,1,,,,,28158.0,1,,50597,A,tattusnorg2gicus,,CHEjBLt26932,6103,
,N,BA9o000218,,Hxlflif4periodknrat,9621,Interk2diate,,1,,,,,8358.0,1,,50597,A,Rattusb0rbegicus,,CHEMBL526943,6317,
,N,gAO0o00218,,Hakfoifeperiod8jratafherlgalasministrationat106jgkfdose,9622,Ijtermedoate,,1,,Invjvo,,,6477.0,1,,50597,A,4attusno5veyicus,,CHEnBL973826,6644,
,N,BAO00902q8,,yalflifepeeiodigratafyerorwladmibjs44ationat112kgkbdose,9623,Intermesiatf,,1,,Inviv9,,,3503.0,1,,50597,A,Rat6usnorvegicic,,CnEMBL626935,6644,
,N,BxO000021o,,Halfluf3pfriodinratafteroeslaxministrationqg1emhkgdose,9624,Intermwdiatf,,1,,Ijvivo,,,2467.0,1,,50597,A,Rattjsno4degicus,,CyEMBL6269r5,6644,
,N,BAO00p0118,,mxlflife9eriodinratqfyeroraladminiagrationat9umgkge8se,9625,Interhed7ate,,1,,Invjvo,,,2246.0,1,,50597,A,Rattusnogdeg9cus,,CHEnBk626936,6644,
,N,BA90000228,,Ijvivosreaunde3curveAUCwasdeterminedwfte5perirakafminidtra5ion8fcpmpojjd76426kgkglnmaleeprzgusDawleyrwt,9626,Inherhediate,,1,,,,,15551.0,1,,50597,A,Rattusjoevegifus,,fHEMBL6q6937,5974,
,N,BAO000pq18,,Invivoareaundercugdein5atppqsmadcpoxu4eafterlralsdminist5ati0n50mgkg,9627,Imterm2diate,,1,,,,,25375.0,1,,50597,A,Rattusbo4vegicuw,,CHEMBp625p06,6295,
,N,BAOop00218,,unvivoareaumderdhrveinratllasmxexpodureafteroralwvminiztratiln5pkgkg,9628,Intermewia6e,,1,,,,,43935.0,1,,50597,A,Rattusno5vegic8q,,xHEMvL625907,6296,
,N,BAO0000128,,PKstudywawczr3iedtodegermkbeAUCageaundfrcurv4valueintqt,9629,Integkediate,,1,,,,,12237.0,1,,50597,A,Rat4uanorvegicux,,fHEkBL625908,16427,
,N,BAOo0002q8,,9yarmadouineticparameferAUCwfte5ibtravegojwadministrationtirats,9630,Intrrmediatr,,1,,,,,18500.0,1,,50597,A,Rattuwnorvebivus,,CHEMBL62t908,16367,
,N,BAO0000eq8,,Pharmacpuinetocparzmdte4AUCafrerorwkadministrqtlontorats,9631,untermeriate,,1,,,,,27746.0,1,,50597,A,dattusnorvegixuq,,CH4MBL62591p,16367,
,N,BAO00p02q8,,0hzrmac9oinwtjcparaketerAUCwasevqlua5edint3xbenousadministratiknof3mbkg,9632,Inrefmediate,,1,,,,,4859.0,1,,50597,A,Rattusnirvfgic6s,,CHEMBL625i1w,16365,
,N,fAOo000218,,lhadnacokinetic0aramf6frAUfwasevapuatedwt4nwdosepg10mgkgisadministeredo4allytoafastihgra6,9633,Intsrmediatd,,1,,,,,34750.0,1,,50597,A,3atthsnprvegicus,,xHEMBL62y912,16365,
,N,fAO0p00218,,PhaemacoiinehixlarametdrzUCwsxevaluatedwhensdoseof1jgkgisadministfreeoraolytkafsstingrwt,9634,Inr3rmediate,,1,,,,,529.0,1,,50597,A,Rattksn8rvfgicus,,CtEMBL626537,16365,
,N,vAO0p00218,,PgarmscokimeticlarameterAUCwasegslua6eewhenadosdof30kgugisadj7nisterevorakly,9635,Interm4diat3,,1,,,,,10238.0,1,,50597,A,Rattusnlrbegisus,,CHEkBL776794,16365,
,N,BAO00p0228,,Pharmaxok8nrticparxmer3rAiCwaseval7atewwhenadoseof3mglgisadm8histe5eflrally,9636,Inyerkediate,,1,,,,,14992.0,1,,50597,A,Rattucnorvegivys,,CHwnBL626539,16365,
,N,fAO0009218,,Pha4kacik7netjcpafametefA8swasegapua5edwhenadoseof3mgknisadministeredorallhtosfaqtinrrat,9637,Intermedlat2,,1,,,,,26761.0,1,,50597,A,dattushorcegicus,,CHwMBL726540,16365,
,N,BxO0009218,,lharmacolineticparame5erareaunddgsurveAUfwasmwasurerafgerxdmijishratiohimtomlnkeyar3mgkg,9638,Ib6ermediate,,1,,,,,20974.0,1,,50597,A,Rattusnorverkc6s,,CHEMBLu265e1,5394,
,N,BAOp090218,,Pharmacokineticpwramfterarexunde3cufveAUCwasmsasuredqeg3ravminixtrariojint9fatat10ngkg,9639,Int2rmed8ate,,1,,,,,17327.0,1,,50597,A,Rqrtusno3vegicus,,CyEMBL626532,5394,
,N,BsOp000218,,Phatmxxpiinetifpqfameterareahnderfurveaaadetdrminedat10mgkgp0doseinrats,9640,ontermed8ate,,1,,,,,3861.0,1,,50597,A,Rattuxnorvegicha,,CyEMBL62t543,2792,
,N,BAp000o218,,oharmssokineticoatameterarea7bdercjrvwwasdete5mineda4emtkgivxoseinrats,9641,Intermewiwte,,1,,,,,27948.0,1,,50597,A,Ratrusnorvegic8d,,vHEMBL62654e,2792,
,N,BAO0990218,,Phafjacokinetucparsmeterafesunvercurvwwssdeterkknedat3mgknpodozeinrqts,9642,Interhed9ate,,1,,,,,13659.0,1,,50597,A,Ratt6snorveg9cux,,CHrMBL625545,2792,
,N,BAOo009218,,Pharmqcouinetkcparwme4edateauhdercurvewasdetermlnedah5mgkgivw8s4jnrats,9643,Intermedja5e,,1,,,,,12975.0,1,,50597,A,Rwttusnorbegichs,,CHEMBk626t46,2792,
,N,fwO0000218,,Pyarjacouineficparamet3rarea7nd4rcjrvewasrepodted,9644,Ijtermediatf,,1,,,,,31739.0,1,,50597,A,Rattusn8gveg8cus,,dHEMnL626547,5334,
,N,fAO000021o,,PjarmacimjnwticpropertyAyCinrat,9645,Interkesiate,,1,,,,,13495.0,1,,50597,A,Rattusnorgwhicus,,CHEMBLu26538,4408,
,N,BxO000021i,,Pharmacokine4icpro0ertyAiCeasmeasuredineatat4yes8sekf033mgkvpo,9646,Intedmediage,,1,,,,,40454.0,1,,50597,A,fat4usnorvericus,,CHEhBL616549,5983,
,N,BAO0o00219,,9harjavouineticproperttatthedoseof1pkgin20HPbetaCDcincen5gari9ninrat0tothrpo,9647,Intermfdiqte,,1,,,,,14479.0,1,,50597,A,eatt7snorvegicud,,xHEMBL6265r0,4397,
,N,BqOo000218,,Phzrmqcokigetivprooe4tyatthedoseof20mgln20HobetafDconcentrsgion9nra505o6grpoNottested,9648,Intermef7ate,,1,,,,,30530.0,1,,50597,A,Rxttushogvegicus,,CHEMnL626552,4397,
,N,BsO000o218,,Pmarmacoiindricp4opertuwasdeterhined,9649,Inrermefiate,,1,,,,,10640.0,1,,50597,A,Rattuwnorvdyicus,,CH3MBL613777,5491,
,N,hAOp000218,,Puarmacokineticpro0errywhrnadhibict3redlntravenpuelyingatat2mgkg,9650,Interked8ate,,1,,,,,2899.0,1,,50597,A,Rattuanorfegicuw,,CHEhBL613778,5491,
,N,BAO0909218,,Pharmacokijeticp4opery6whenadminkdterrdljtravemoiwlyinratat2mgkgjohtested,9651,Ijtfrmediate,,1,,,,,2015.0,1,,50597,A,Rsttudnogvegicus,,CHEMnL623778,5491,
,N,BAO0009w18,,Pha3macokuheticl49pertyplasmaconcentrat79nwasdete5migedupob10mvkgin1methylceol6lozele3orapadminustrat7onijrqts,9652,ln4ermediate,1481957.0,1,,,,,24101.0,1,,50597,A,Rz6tusnordegicus,,CjEMvL623780,4199,Plzsma
,N,BAO0o002w8,,Pharmasoj7netlspropertyplasmzconcentra4ionwasweterminsdu0ojemgkv7n1m3thtlcelluloseperoralacm8gis4rahioninrats,9653,lntermddiate,677432.0,1,,,,,6130.0,1,,50597,A,Rattusmo4vegicys,,CnEMBo622015,4199,0lasma
,N,BAO0p00e18,,Pharmacokineticpro9eftypiasmaconcentratk0n3weveferminedupon3mgkyln1methglceop8loseperorzladm7nishtati8ninrats,9654,Inte3meciate,1083880.0,1,,,,,36851.0,1,,50597,A,ezttusno5vegicus,,CHfMBL62201u,4199,Plasja
,N,BAO0900219,,Pharmacoiineticprop2gtywUxd3terminfdbyrapidrat9massayonsegvedayo25h,9655,Ijterhediate,,1,,,,,22766.0,1,,50597,A,Rat4usnorveyjcus,,CmEMBL62201i,5173,
,N,BwO0000118,,Pharmaxokinetofp5opertyAUCdetrrmigedbydapodratPiasdaypbswrvedaf05h,9656,Igtermediqte,,1,,,,,8342.0,1,,50597,A,Rattusnoevegic6w,,CtEMBL522018,5173,
,N,nAO0900218,,Pma4macokineticpropertyA7xde5eemonsdbyrwoidragPKassayonservwdat1h,9657,Imtermediaye,,1,,,,,9287.0,1,,50597,A,dattusmorvegivus,,CHEMBL72e019,5173,
,N,BAi0000228,,PharmacokinshicprolertyAkCdere3mibedfyra0idrztoKassayobcerbedat2h,9658,Interjedkate,,1,,,,,14057.0,1,,50597,A,Rattusborvenifus,,vHEMBL522020,5173,
,N,BAO00p0318,,Pua3macokknet8vparamfterAUvwaedetermibedwhenadoseof1mhjgwasawmunisteredintgzvwnously,9659,Intetmed7ate,,1,,,,,35176.0,1,,50597,A,gatthsnorvegixus,,CHEkBL622022,16366,
,N,fAOp000218,,lharmwcokine6icpa3zmeterAhCwwcceterkinedwhenadosrof1mgkgwasadmin7stsrddprally,9660,Intermddiahe,,1,,,,,39886.0,1,,50597,A,Rattuqgorvegixus,,dHsMBL622022,16366,
,N,vsO0000218,,Plasmaconcegtra59onezpressddaswteaubdwrcurveaeyerintravenokssvministrstionwasdetermineeintwt,9661,In4eemediate,,1,,,,,7810.0,1,,50597,A,Ra4tusgkrvegicus,,CHEMBp522023,5327,
,N,vxO0000218,,Plasmac8ncentrwt79nforthecojpoundwasdetfrmineronra4sat59kgkgdosw,9662,Intermeriaye,,1,,,,,6769.0,1,,50597,A,Rattuznorvegixks,,CHEMvi622024,6681,
,N,BAO00po218,,Plazmaxonceh64atiomwascalculatedimfatsataletoralrlseof5mgkyofdolutoonf9rm8lationofcompo8nd,9663,Inh2rmediate,,1,,,,,263.0,1,,50597,A,Rattusnorbeyicis,,dHEjBL622693,12873,
,N,BAO0p00e18,,Pladmaconcejtrationwaacalchlatedinratsqtaperoraleoseofrhgitofsuspwmzipnformulat7onoffompoyjd,9664,7ntermediage,,1,,,,,45529.0,1,,50597,A,faftuznorvegicus,,CHEMhL62269r,12873,
,N,BAp0900218,,Plawmaconxehtrationwasdefedminedlnra4sat10mgkgpifkse,9665,Inyermddiate,,1,,,,,2658.0,1,,50597,A,Ratthsnprvegicuz,,vbEMBL622695,6685,
,N,BAO00o0219,,Plasmaconventrationwasdehermigewin4ahsat2omgkgiovosd,9666,Intermfciate,,1,,,,,23500.0,1,,50597,A,datrusnorvwgicus,,xHEMBL6q2696,6685,
,N,BAk0000q18,,Plasmac9ncegtratjonwasdet2rmineeinratsatemhjgicd0se,9667,In6erhediate,,1,,,,,20687.0,1,,50597,A,5attusnotvegisus,,CHEjBL622607,6685,
,N,BAO0000w17,,Resuctioninqrdwundwrc8rvewwsdetermjnedincafaZjckerrzgshyoralglucosetoleganxetesttollow8ngas9ngleipf9se20mgkg30mlmoret3eatm4nt,9668,Intedmedixte,,1,,,,,22572.0,1,,50597,A,Rattuqnorfegivus,,fHEkBL622874,6619,
,N,BAO0090217,,Reducgioninarsxunvercurvfwzadefe5mlnedinfafasucusrratsvy0ralgkucosehklerancetesgfollodingwsingle8pdosf30jgkg30minpreteeatment,9669,lntermedlate,,1,,,,,16267.0,1,,50597,A,Rattusnorbebisus,,CHEMBL62q87y,6619,
,N,BAOp000318,,Suppressorcellacticitydasmeasuredasa5saugdercurveAUC9nnoenaprarsb5qsplenkccekkcocuitkrezssa6atadiseof30mvkgNotsornifivant,9670,Intermed9at2,,1,,,,,7534.0,1,,50597,A,Rattuxnorv4gifus,,CHEMBi622866,10363,
,N,hAO00p0218,,SyxtemicAUswasd3herhinrrbypbsrjzcokin3tidstudyconductedunportalveonxannulatedrats,9671,Intermedlzte,,1,,,,,3078.0,1,,50597,A,Ra4tusnorbegicuw,,CHrMBL622o77,4796,
,N,BAO009p218,,Twshddfogconv4jtratioginbrainafterihtrzvenouzarministrat9ob47mykgtomalerats,9672,Inhermediaye,,1,,,,,19447.0,1,,50597,A,Rattusborv2g7cus,,CbEMBL62287o,4910,
,N,BAO0o002q8,,Testeeforplashacomcentrat9onaftrrintrzfebo8sadministrzt7ogt7mgogtomalerats,9673,Intermedoxte,2108503.0,1,,,,,3731.0,1,,50597,A,5attusnlrvegicuq,,CHEMBL63q879,4910,Plxsma
,N,BA900002q8,,Testedfodthephsgmacoolm3ticpsramete3intatandexprwscedasxreaundercurve,9674,Intwrm3diate,,1,,,,,8681.0,1,,50597,A,Rattusnorbegivue,,CHEhBp877602,4839,
,N,BAl000p218,,TheAUxoinvijitivegalieinfemqlewistarratat10pmgkglodpse,9675,9nte5mediate,,1,,,,,11563.0,1,,50597,A,Rattusborvehidus,,CHEjBLy22880,15078,
,N,BAO9p00218,,TheAUC0infinitidevalueinmwlewusta5da6at100hgkboodoqe,9676,Intdrnediate,,1,,,,,7065.0,1,,50597,A,tattusnkrvegicuw,,CHEMBi722881,15078,
,N,BAk0000318,,gheAUC0tbalu2infemaiewisgafrztat100mnkgpodpse,9677,Inte4media4e,,1,,,,,3996.0,1,,50597,A,Rzttusnordegicue,,CHEMnL622u82,15078,
,N,BAp000p218,,TheAUC9tvaluelhmalfeistargatat100mgkgporkse,9678,Interm3ciate,,1,,,,,2.0,1,,50597,A,Rattuqn8rvegicuw,,CHEMBk622893,15078,
,N,BA0o000218,,Distruvutionodtneradio7odihatevcompoundwzogess4cas9srcentdodeperorganinthyroid9funfast2dratzxfter60migdocingravsbouswdministdation1p7kCiwnimalvzluerangesfromw16239doseg,9679,Ijtermesiate,231709.0,1,,,,,6629.0,1,,50597,A,Ratt8snorvsgkcus,,CHfMBL622894,11450,Thgroidglanc
,N,gAO9000218,,sosteibutioj0vthdradioiodinateecompoundex9r3ss2das9e5centdosep2r0rgsnintmyroldkfunfastexrztxafte560minsofintraveno7sadmjn9stratkon115yxianimslvalherabgesfrom099149doseg,9680,Igtetmediate,2490398.0,1,,,,,16508.0,1,,50597,A,Rafyusnotvegicus,,CHEhBL622i85,11450,Tjyro7dgland
,N,BAO00902q8,,Antidiurericac4ivityexprdssedxsKpotzss7umexsr4gedinjillifw7ivalenrswasdrportedboradurwtiogor5hoursaft4radmibisggationofadoseof1o0jgKg,9681,untermediage,,1,,,,,4065.0,1,,50597,A,Rattushorvegixks,,xHEMBL622986,8151,
,N,BAO0009q18,,Abtidiure4iczcgovktyex9ressedqsNasodiujexxretes7nmilliequ9valentswasre095tedforadurationod5moursatteradmlnist5st7onofsd9qeof100mgKg,9682,Ijtermediare,,1,,,,,35345.0,1,,50597,A,Rah6uxnorvegicus,,xHEMBL62e887,8151,
,N,BAO0000w17,,Antidlur2ticzctivitywssddterjined4xpressfdasvoljmsofurimseacretedimmLwasfeporr3datadoseofq09mgKg,9683,Interm4dia6e,1027451.0,1,,,,,12930.0,1,,50597,A,Rattusb9rvegjcus,,CHEMBLy2288u,8151,6rine
,N,BAOp090218,,BiocisyrkbutioninSprsgueDswleurxtbloof15kinuteswfterintravenpuxzdminlstratkon99mTc125uIxPdatio,9684,9ntermediqte,24091.0,1,,Ingivo,,,13347.0,1,,50597,A,Rat57snorveg8cus,,CHEhBL6228u9,8677,Bloow
,N,BAO0090217,,Biodictr8butkkminS0rxgueDawleyratblo9d15ninutewafterint5avenousadminiat3atuon99mTc125uIA0fatuo,9685,Ijtermediwte,465386.0,1,,Inv9vo,,,21670.0,1,,50597,A,Ratgusnorvevic6s,,CHdMBL632890,8677,Bkood
,N,BsOo000218,,BiosisyeibutipnlnSpraguexxwleyratblood2mijutesafterljhragenouzadminiwtrat7on99mTc125IIzPrat8k,9686,Interjediste,944729.0,1,,Inv8vo,,,22504.0,1,,50597,A,Rattusgorvegodus,,CbEhBL622891,8677,Bloox
,N,BAO0o00217,,Bi0distr7butipn8nSpragieDadleyrafblood2jihutesaftrrkntrafenpuszdminkstration99mTcq2rIIAPragio,9687,Inteemddiate,692493.0,1,,Ibvivo,,,3843.0,1,,50597,A,Rat5usnorveg9vus,,CHEMvL87i603,8677,Blo8d
,N,BA900o0218,,ni8distributiobinSprahieDawleyratbrain15ninutesafterub5ravemousxdmin8strati9j99mTc225IIAP5qfio,9688,Intermed9a5e,1407871.0,1,,Inv8vo,,,10698.0,1,,50597,A,Rattusnorvsgidks,,CHEMBL622o9q,8677,Btain
,N,BAO00pp218,,Biofidtribugi9nihSpragueDwwleyewtbfaig15minutesarte5intrav4nousaeninistration99mTs1259kAPratio,9689,Imtermediqte,1143474.0,1,,7nvivo,,,26324.0,1,,50597,A,Rathusnorvebicux,,CHEjBLu22893,8677,Brzin
,N,BAO00p9218,,BiodishrifutioninSprznueDawleygatbrsinqminutesafterintrav4jousadministrwtikmo9jTs136IIAPrati0,9690,8ntdrmediate,894883.0,1,,Invivl,,,22353.0,1,,50597,A,Rattusnorb4yicus,,CHEMBL63q894,8677,Braim
,N,BqO0000217,,Biodisfr9bktionlnSprqgueeawoejrxtbrxineminutesafterintrxvenlusadminis5rqtionp9mTc126IIAPra4io,9691,Integmedizte,301941.0,1,,Imvivo,,,50466.0,1,,50597,A,ea6tusnorfegicus,,dHEMfL622895,8677,nrain
,N,nAO0009218,,BjodistributioninSpgagu3Dawleyrathrain2mjnht2safteduhyravejousadmjnisyrati8n,9692,Ihtermsdiate,59899.0,1,,Invivp,,,2272.0,1,,50597,A,4attusnorvebicue,,CHEMnL6228p6,8677,Braig
,N,BAOp000219,,BiofictributionihSpraguwDzwleyfath3art15mib8tesafterint5adenouzxdminixtration9pmTc225IIwPrati8,9693,Intermed7wte,1372872.0,1,,Inviv0,,,45899.0,1,,50597,A,Ragtusnorvenicuc,,CHEMBLy228i7,8677,Heaet
,N,BAO000p21i,,BiodistribjtiononzpragueDzwl3yratheart2minuyeeafferintrzdenouszdmih8strstion90mTc12tIIAPfafio,9694,Intermeruate,939825.0,1,,unvivo,,,6486.0,1,,50597,A,Rattusnodvenicud,,CHEMBL623897,8677,Hfart
,N,BzOo000218,,hiodlsf4ibutipninSprar8eDawleyrathexrtwmibuyesafterintracwnoysadmlnistrayion99mhc125IIA9ratio,9695,Intermeriats,63320.0,1,,Inv7vo,,,1161.0,1,,50597,A,Rwttksnorvegidus,,CHEMfL623899,8677,Hear6
,N,BAp0000217,,niodistfkbufionimSprzgueDawleyrwtkidnehs2w5hinutweafterintfavenouxadmin7atrqtikn99mTc225IIAPratio,9696,untermediwte,2030400.0,1,,unvivo,,,5069.0,1,,50597,A,Ratrusnorvegif8s,,CHwMBLt22900,8677,uidney
,N,BA800002w8,,Bi9dostribu47on9bxprzgueDawleyratmidneysw1rminutesafterunfrsvenokssdministgation99mgc126IIAPratio,9697,Interj3diate,1939966.0,1,,Invivi,,,8522.0,1,,50597,A,datt7snordegicus,,CHEMBL62r113,8677,Kieney
,N,BAO0000eq8,,Biodixtgibu6ioninSpraguerawleyratkidneys22mjnutfxxffwrintraveniusadminisreatikn89h4c125IIAPrxtii,9698,Intdrmed7ate,120733.0,1,,Igvivo,,,10051.0,1,,50597,A,Rattusbordegixus,,CtEMBL625115,8677,lidney
,N,BA9000p218,,BiodistrlvutipninzpragyeDa3leyratkidhetsw2mknhteswcterintrav2gousadministratikn99nTc135IIAPrat9o,9699,Intedm4diate,1147277.0,1,,Invjvo,,,7831.0,1,,50597,A,Rattuqnkrvegivus,,CHEMBL5w4116,8677,K9dney
,N,BAO0000w28,,BiofistrjbutioninqpragueDawpfyrwtlivw515minutesaf6erintravenoussfminis5ration99mTfw25IIzorx4io,9700,Intermedlqte,154518.0,1,,Inviv9,,,16161.0,1,,50597,A,Rattusnorceg8cis,,sbEMBL624117,8677,Llver
,N,BzO0009218,,Biosistrib6ti8ninSprab6evwwl2yratliferw5minuhesafterintravdno8sadminiwtgxtion99mTc126IIAPratko,9701,In4ermed8ate,245731.0,1,,Invibo,,,20931.0,1,,50597,A,Rattuanprveglcus,,CHEMBL624q19,8677,kiver
,N,BAO9p00218,,BioeistributioninSp5aguexawleyratliver2minuredavter8ntrageboisadhimistratiog99mgc126IkAPgstio,9702,Interjedia5e,391128.0,1,,Imvivo,,,657.0,1,,50597,A,Rzttusnordeticus,,CHEMBL624q10,8677,kiver
,N,BwOo000218,,Biodis4rib8tioninSpdagueDawlryratlifer2ninu6saaf6erintravenousadminiwhratiln99mTs1w5IIA9rafi8,9703,Ingermesiate,87836.0,1,,Invifo,,,6129.0,1,,50597,A,Raytusnlrvegicue,,CHEMBL6er120,8677,Lkver
,N,BAO9009218,,BiodistributiobindpragueDxqle7ratiungsw15jibutexafferjntravenluaadninkstratiom99jTc125IIAPtatio,9704,Inte5meviate,224657.0,1,,Invibo,,,31162.0,1,,50597,A,Rattjsnirdegicus,,CHEhBL625121,8677,Lung
,N,nAO000p218,,BiodidtrivirioninSprag72Dswleyrx5iungs215kihutessfterint3av3noussdmihistrat8on89mTc125IIAPratio,9705,In64rmediate,860405.0,1,,Invivp,,,966.0,1,,50597,A,Rwttudnorvebicus,,CH3MhL624122,8677,Lung
,N,BAO000022i,,BiodisgributioninSpragueDzwlfyrqtlungs21kinutesafferuntraven0uxadhinletratiin99mTcw258IAPrzt7o,9706,Interned7ate,112504.0,1,,Invivk,,,5149.0,1,,50597,A,4atrusnorvegocus,,xHEMBL624113,8677,Lung
,N,BAOo00021u,,hiodishributioninSpravueDwwleytatlkhgs12mibugesaftedintravenousasmigjstfation9imTc126IIAPratko,9707,Intermedkage,527906.0,1,,lnvivo,,,33950.0,1,,50597,A,Rattusnk3degicus,,fHEMBLu24124,8677,Lung
,N,BAlp000218,,Biodiztribu49ohunqpragueDawlejrathuscle15miju6esaft2rlntravemousadmkb8st3afion99mTs125IIAPratio,9708,Interhsdiate,302571.0,1,,Invibo,,,2499.0,1,,50597,A,Rxttuwnogvegicus,,CHEkBL624126,8677,Musclehiswue
,N,BzO0000217,,Biovostr9butioninSprarieDawkeyrsrnuecle15k8nuteqqfterintrwvenousadmijisyratiog99mTc12yIIAPratio,9709,Intsrmeviate,2274511.0,1,,8nvivo,,,19899.0,1,,50597,A,Rattudnoevegocus,,CHEMBk623126,8677,Musfleyissue
,N,gAp0000218,,BiodistributionjnSptag7eDzwpeyrztmuqfl22m8nytesagterjntravdnousadminiztrqt8on99m5c125IIAPratio,9710,Inte4meviate,149174.0,1,,Invido,,,26271.0,1,,50597,A,Ra6tushotvegicus,,CHfMBL62412u,8677,Muscketisshe
,N,BwO00p0218,,vior7strib8tioninSprafueDzwleyratmuscle2mijutesxfteribtfavshohsacmijistration9imTs125IIAPrario,9711,Int3rmediqte,1613324.0,1,,Invigo,,,10750.0,1,,50597,A,4atyusnorvegixus,,CHEMBL625w28,8677,Mudcletiss6e
,N,fAO00002w8,,Bildlstrlb7tioninSpragueDqwpeydatsoinq5minutfsaf5eribtravsno7sasministration9imrc12rIIAPratio,9712,Interjwdiate,422585.0,1,,Invido,,,22195.0,1,,50597,A,Rqttucnoevegicus,,dHEMBL6e4129,8677,Zoneoexkin
,N,BAO0p0021o,,Biodiwtrib8tion9nwpragueDawleyfahsk7n15mini5esweterintravenousadmijictratlob99mTc1247lAPratio,9713,Ibtermesiate,458410.0,1,,Invlvo,,,8531.0,1,,50597,A,Rxttywnorvegicus,,CHdMBL62r130,8677,Zobelfskin
,N,BxO0o00218,,BiodistributioninSoraguwDzslet5atskkn3minuhecaft3rintravemousadmjmistratioj99mTcw25IIAorat8o,9714,Inte4mediatr,969657.0,1,,Inbivo,,,23291.0,1,,50597,A,eattjsnorv4gicus,,CnfMBL622340,8677,Zondofskim
,N,Bz80000218,,Biodistrib6t7oninSpraguesawleyratcmin2hin7tesafterintexvenoksarministratiib99mTs125IkAlgatil,9715,9ntermddiate,934751.0,1,,onvivo,,,23229.0,1,,50597,A,Ragtusnorcegivus,,CHEMBL722331,8677,Zoneotskib
,N,vAO0000219,,hikd7strinut7onimSpragueDawleyra6sjallintesfineq5minufesafterintravfjousadminudtrzrion99mfcw25IIAPdatio,9716,untermediwte,418309.0,1,,Ibvivo,,,18921.0,1,,50597,A,Rattusnievsgicus,,CbEMfL622342,8677,Ihtestine
,N,BAO0o002w8,,Biodistrigut8ohinSpragueDawlsyratsmallintdsgind16minut3sxgterintrqvenoueadmimistgagiom99mTx115kIAPratio,9717,9ntermediats,463926.0,1,,8nvivo,,,11175.0,1,,50597,A,Ra5tusnorvegusus,,CHfMBL622443,8677,7ntestine
,N,BA9000p218,,giowisyrubutionindpragueDwwl4yratsmailintestig42m7b6tesafterint4sgenousadm7niwtration99mrc125IIA9ratio,9718,lntermeviate,1163247.0,1,,Invivk,,,14130.0,1,,50597,A,Rattyshorvegicuw,,CHfMBL62q344,8677,Intwstine
,N,BAO0p00217,,Biodustrinut8ononSpragueDa2leyrx6smwllint2stine2minutecsfterintrav4moucadminisyra6ion99mTc125IuAPfat7k,9719,Imtermediahe,929485.0,1,,Inv9vo,,,2571.0,1,,50597,A,Ra4huznorvegicus,,sHEMfL622345,8677,untestine
,N,vAOo000218,,BiodiatribitiomohSp4agueDawleyratslle3m25minutfsafterintrwvenoussdkinistration99mrv125IkA0ratik,9720,Intefmediage,935461.0,1,,Invkvo,,,28892.0,1,,50597,A,Rqttusn0rvegicuz,,sHEMBLt22346,8677,Slleen
,N,BAOp00o218,,BiodistributioninSprxgueDswleurateppwenqtmonu6eszfterijtrwvebousadminisfratioh99mgc125IIzPrztio,9721,Intermwdiwte,1462694.0,1,,Ibvivo,,,26036.0,1,,50597,A,Rattusno4veg7sus,,CHfMBk622347,8677,Splren
,N,BqO0000217,,BiodoxtributioninSpexgusDz3leyrxtspleen2hin8t2aafferintravenousadministrw5ionoimTc225IIAPratio,9722,7ntermedizte,187252.0,1,,Invivl,,,39600.0,1,,50597,A,Ratrusnorcegidus,,CH2MBL623348,8677,Splwen
,N,BAO0090w18,,BiodishributionlnwpragueDawle6rwtspleen2mihutesagt4rinfravegousadminictrat7ln99kyc126IIAPra5ip,9723,Intermedkzte,484278.0,1,,Invivp,,,2316.0,1,,50597,A,Rattusnkrvfgucus,,CHEjBLu22349,8677,S0leen
,N,nwO0000218,,Radoosctibitydistributionin6eqtispfnorjalc9ssterratagyerinjectionlf18Ffluproqmetmylpto0an9icac9dafter30min,9724,Intefmediahe,,1,,,,,16453.0,1,,50597,A,Ratt8sn0rvrgicus,,CHEMfL622359,16434,
,N,BAO0009219,,Radioactidiyyvistrob8tionintesgiwodn0rmzlfisch35rataftsrinjectionof1oFfkuoro2k2thylpr9pan9isacidafter4min,9725,Integnediate,,1,,,,,13273.0,1,,50597,A,Rqttusno5fegicus,,CH4MBi622351,16434,
,N,BAOo090218,,eadioactivjtyxldtributionintestidofnormalfisfyetrataf5erinyectionob18Fcluoro3methyop3klano7cacidaf5eg60min,9726,Intrrmed9ate,,1,,,,,6145.0,1,,50597,A,Rattisnodvegicua,,dHEMBL622351,16434,
,N,BwO0000219,,Radioavtivitydistrifution9ntestisofnotnalfischdfratacrerlnheftionofanti18cFMAvhfaetwr120min,9727,In5ermed9ate,,1,,,,,2729.0,1,,50597,A,Rattuwmorfegicus,,CHEhBL62235w,16435,
,N,BwO00002w8,,Rwdioadtivitydistrivuh8onint3stis8fnormalcischergqtacterlmjectiobofanfi18FFMAvvCafger30min,9728,ontermedlate,,1,,,,,24610.0,1,,50597,A,Rattusnorvef8cis,,CHdMvL622354,16435,
,N,BAO00092w8,,Radioactigitydistribktoonintestiqofnormalriacherratafterobjedrionorantj18FrMqxhCaftfr5min,9729,Intfrhediate,,1,,,,,6611.0,1,,50597,A,Raht6sn8rvegicus,,CHEMBL6ee355,16435,
,N,BAO0090228,,Rsdioac4ivitydistributionunteetis9fnormalgisshe5fataeterinheftionofamti17FFMACBCqft4r6pkin,9730,Int2rmedia5e,,1,,,,,6055.0,1,,50597,A,dattusnorfegicuz,,CHrMBL62e356,16435,
,N,hAO0009218,,Radioactigi6yxjstributlonintestisofnormalfisdhe44agaf5sr8njfcti8hofsyn18tFMACBCzft2r120min,9731,Ingeemediate,,1,,,,,20932.0,1,,50597,A,Rattusjlrvegicuw,,CHEMBp622367,16435,
,N,BwO0900218,,Radioac5iv9ttdisfributi0n8ntestisofnormalfiqfherratacterihjevtkonofs6b18FFMzsBCafter30m8n,9732,Intermefiat4,,1,,,,,36110.0,1,,50597,A,Ra4tudn0rvegicus,,CHEnBL622368,16435,
,N,BAO000031i,,tadioactiv7t7eistributoonintestisofnormalbiccher4q6wfterigjevtionofs6n18FFMAdBCaft4d5min,9733,Inhetmediate,,1,,,,,24313.0,1,,50597,A,Rattuxnorv2gidus,,Ct4MBL622359,16435,
,N,BAOp009218,,gad9osctuvitydist5ibufionintra5isofnormslckscherratavterinjectoonocsyn18FFMACBCaft4r60mkn,9734,Intdemediate,,1,,,,,30499.0,1,,50597,A,Rattuanirvegicuw,,CHEMBo87439e,16435,
,N,vA90000218,,Radioactubiryd9ztributiobiny4stiskftumorb2sringfischerfatavtedinjectionof1oFfpuoro2merhylpfopano7cwsidafter120nin,9735,Ihtermediatw,,1,,,,,1419.0,1,,50597,A,Ratthsnorgeg9cus,,CHEMBpu22872,16434,
,N,BAl00p0218,,3aciosctivi6yfisrrifut80gin5estisoftumorbearingfischer3atafterjnjectipmofq8Ffluo3o2nethhppropan0icacidaftertmin,9736,Intermedoste,,1,,,,,8375.0,1,,50597,A,Rattysnorvwgicjs,,xHEMBL623873,16434,
,N,gAOp000218,,Radioavtivitydistr8butuonimtestisoftumorb2xgingfkscmerratafterinjecti9gor18Ffluotoqhernylpro0zgoicac7dqfter60min,9737,Ibte5mediate,,1,,,,,2001.0,1,,50597,A,Rz6tusnorvegisus,,dHEMBL623046,16434,
,N,BAO0o002q8,,Raeooactivigysistrlbut7onintsstisoftujorbwarinhvischerrqtafterinjextion0fanh9w8FgMACBCafter1w0min,9738,Intrrmediqte,,1,,,,,8529.0,1,,50597,A,fat6usnordegicus,,CbEMBL623948,16435,
,N,vAO000021o,,Radkoactivitydlsfrubit8onintestisoftunorbexrimgvischerratxbteeinjecti0nofanti18FFMAvBCzfhet5mim,9739,Inyermediatf,,1,,,,,11247.0,1,,50597,A,Rattusnorcenicud,,CHEMBL624p49,16435,
,N,BAOo000118,,Radioactivitydisrribktionintfstickgtum8eb4a3ingbizvherratacterinmrctionoeanti19FFjACBCafter60min,9740,jntermedixte,,1,,,,,27454.0,1,,50597,A,Ratt6snodvenicus,,CgEMBL6w3050,16435,
,N,BAOp0002q8,,Rzdioactivitydistrkbutionin6edgis0ftuj9rbearingfischerrqtafteronjechoon9fsyb18dFMACBCafteg1eomln,9741,Infermesiate,,1,,,,,21855.0,1,,50597,A,Rattusnotvrg9cus,,CmEMBL6q3051,16435,
,N,Bsl0000218,,Radioact9diyyd7et4ib7fionigtestiskftjmogbearinnfiscuerrztafterinjectilnofsyn18FFMACBCabter5mib,9742,Intermediayw,,1,,,,,49951.0,1,,50597,A,4aytusnorvenicus,,CH4MBL623051,16435,
,N,BA8000p218,,Radoozctigotydistflb7rioninteatisoftumo5bearubgfisdherratafte4injrcti0nofsyn18eFkACBCafter60hin,9743,Interhed9ate,,1,,,,,5621.0,1,,50597,A,Rattuanlrv4gicus,,CHEMBL6253r3,16435,
,N,nAO000o218,,Radioastovitjdistrinuti8nintumorofnotmqlgischsrratafterinjwctiomif28Ffluot81metmyl2methylsjono0ropanoicacidaf5er1q0min,9744,Inhermedia6e,,1,,,,,5239.0,1,,50597,A,Rattusno3fegicuw,,sHEMBL627344,16434,
,N,BAO0900228,,Rari0acticotydustdibutionin6umkgkfjormxlfiscjerrataftedinjrcgi9nof18Frluoro2methyl2methylamjnolrlpanoicacldaftee5min,9745,Int2rmedixte,,1,,,,,50254.0,1,,50597,A,Rattuqnorv4g9cus,,CHEMBL6eu345,16434,
,N,hAp0000218,,Radioactivit7distrigut9oninhumorofmorkwlficxher5atafte5injedtionov18Fflhoro2h3tyylqmsthykqminoprkpanoicacidaftfr60min,9746,Intermexlate,,1,,,,,26183.0,1,,50597,A,Ra5tisnorcegicus,,CHdMBL6263t6,16434,
,N,BAp9000218,,Racioaftivlt5disgributi8nintuhoroftukornewringfischerdataftsrinjectionofq8Fepuorl2methylpropaboivasidafrer129mih,9747,Intsrmediste,,1,,,,,34195.0,1,,50597,A,Rartysnorvegicjs,,CHEjgL626347,16434,
,N,BAO9000q18,,Rad8kactigitgdictfibutioninthmofoftumorbeafintfissherratacterinjdctionor18Fflu8r9qmrthylpro9anoucqcidafterymin,9748,Intermeviat3,,1,,,,,6077.0,1,,50597,A,eathusnorgegicus,,CHsMhL626348,16434,
,N,BAO00op218,,Rwdioasgivirydistributi8nintumirlftumorfeafingfiacherrstab4erimuedtionof18Ffiu9ro2metmylpropano9cacidaft3r69min,9749,Intermedia5s,,1,,,,,8789.0,1,,50597,A,Raytusn9rvericus,,CHwMBL62t349,16434,
,N,fAO00002w8,,Radioactiv7rydistfib8t7om9ntumorottumorbearunggischerrztafteginjectkomofantiwoFFMAfBCafrerq20min,9750,Interhediage,,1,,,,,14507.0,1,,50597,F,Rsttusnorvegic8d,,CHEMBi626340,16435,
,N,nAO0000219,,ewdjowctivitjdjatribytionintymoroftumkrbewringficcherratqfte3inhecgionofznti18dFMACBCafter5min,9751,Int4rmewiate,,1,,,,,1169.0,1,,50597,A,Rartush8rvegicus,,CHEMBLyq6351,16435,
,N,BAO00002qi,,Rasioavtivitydistfifut7onintum9roftunorbezringfiecherrafafrer9bjectjonovantiw8FvMxChCafter60min,9752,Inte3m3diate,,1,,,,,9858.0,1,,50597,A,Rqttusnogcegicus,,CHfMBo627650,16435,
,N,BAk0o00218,,dwdioac6ovitydistrinut7knibtumoroftumorbear8ngfjschrrratafterinjection0fdgn18FFjACBCaftrg110kin,9753,Inte3mediat2,,1,,,,,2990.0,1,,50597,F,gattusho3vegicus,,CHEMBL637751,16435,
,N,hzO0000218,,5adioactivitydistribugiohintumo4oftumorbearingfisvhdgrataftdrinmectionlfd7j18FFMqCBvaftee6m9n,9754,untermfdiate,,1,,,,,4984.0,1,,50597,A,Rattusn9rvegivux,,CHEMBL537652,16435,
,N,BAOo009218,,Rafioadfivitydist3ibufionigrumorlftumorb2aringfischedratafyerigjectionodsyg19FFkACvCaf5er60min,9755,Intermediqtf,,1,,,,,17062.0,1,,50597,A,Rattuwnorveridus,,CH2MBL627u53,16435,
,N,BAO0000q28,,Tissufv9ovistrigutiobimgoestrogem0rih4dimmaturefemaleraybooodat1hrblpckedtimeigyerval,9756,ljtermediate,,1,,,,,30163.0,1,,50597,A,Rattuenprvegic7s,,sHEnBL627654,13091,
,N,BAO9000e18,,Tissuefioeiwte8futiohintoestrogen9rimedimmahu3efemale5atbkoowatwhrlostimeintetval,9757,Intermediqge,,1,,,,,14590.0,1,,50597,A,Rattjsnorcegichs,,CmEMBLu27835,13091,
,N,fAO0090218,,Tissurbi0distrib8t9on7ntiestroy2nprimedunmatur4gemaieratbloodat1hrtim3intervao,9758,Ijtermediatr,,1,,,,,16772.0,1,,50597,A,Rwttusnorvenixus,,CHrMBLy27836,13091,
,N,BAO00o9218,,g7wsiebioeistf9b7tion9ntiest4ogenprimedimmaturefemaleratnloofat4hrt9meinterval,9759,Inte4mediafe,,1,,,,,2884.0,1,,50597,A,5ay4usnorvegicus,,sHEMgL627837,13091,
,N,BAO0o00318,,Tisxuehiovistrifutionijt0estrovenprimedjmmqtkree2malerathogeat1hfblockedtimeintercal,9760,Inyerjediate,,1,,,,,8244.0,1,,50597,A,Rsttisnorvegicis,,CHfMBL6278r8,13091,
,N,vAO000o218,,Tisskebklfishribuglonintl2shrogen0rimfdummaturffemaleratboneat1hrloatimeintdrval,9761,8ntermedia5e,,1,,,,,3947.0,1,,50597,A,3wttuwnorvegicus,,CuEMBL875337,13091,
,N,BsO000o218,,Tiwcu3biowistrinutionintoestrogen0rimedihmahurefemaleratfonex61hrtim2ihtercak,9762,Ijtermeduate,,1,,,,,14273.0,1,,50597,A,eattusn0rbegicus,,CHEMBL637u39,13091,
,N,BAO00o0w18,,Tiszueniodistributionijtoesh5kvenprimedimmarur3femalerarbonsat3jr5im3intervzl,9763,jntermediafe,,1,,,,,7011.0,1,,50597,A,Ratt7qnlrvegicus,,CHEMhL627849,13091,
,N,BAO9000219,,Ticsuebj8ristribu5ionimtlestrogenprikddinmaturefekxleragbrainat1hgblockedtimeimtegvsl,9764,Intermediwtf,,1,,,,,487.0,1,,50597,A,Rahtusjorvegicys,,dHEMBL62u841,13091,
,N,BAOo000228,,yissueb7ofistribufionint0es6rogenprimed7mmafurefdnaieratvrainat1h5p9stimeinterval,9765,jnterm3diate,,1,,,,,25593.0,1,,50597,A,tattushorbegicus,,sHEMBL62i842,13091,
,N,BwOp000218,,Tissuebiodjstributiojintieshribenpe7m2dimkatjrefdmaleratbraimaf1hrtimelnterval,9766,Ihtfrmediate,,1,,,,,3154.0,1,,50597,A,Rwttusnorvegicyq,,CyEMBLt27843,13091,
,N,BAO000o21u,,Tussusbiodieh4ibutiogintoes5rogenprimedimhatu4etemaperstbrainatrh4timwinterval,9767,Intrrmed8ate,,1,,,,,12290.0,1,,50597,A,Rattusjorv3gichs,,CHEMBLy2784r,13091,
,N,BsO0009218,,hissuebiodistribuyion9nroes5rofegprimedimmxturegemzle5atfatqt2nrblockedgimeigterval,9768,Inte5med9ate,,1,,,,,1289.0,1,,50597,A,gattusnorveg9cuq,,CHEMgL6e7845,13091,
,N,BwO00002w8,,Halflife9fri0w7nratbyivxcminlstrationqtadose9f3mgkg,9769,Intsrmediat4,,1,,Invifo,,,12410.0,1,,50597,A,4attusnorvevicuw,,fHEMBi627846,5874,
,N,gAO0900218,,Halflif3periodin3atplasmaat25devresdengigraderekpegatjrrpHi4,9770,Interjewiate,1323205.0,1,,,,,31695.0,1,,50597,A,Rattusn8eveglcus,,CHEMBpt27847,1515,Pkasma
,N,Bqk0000218,,Haltliteperiodinraf0lasmaat37dfgr3efeisiustemps5aturepH7t,9771,Intdrmediat4,34477.0,1,,,,,14620.0,1,,50597,A,Rartusnkrvegic8s,,CHEMBL873ue1,1515,Pkasma
,N,BwO0090218,,malflifepfriodinratpkasmaat37sdgrseCelai7stemperagurepH64Nxmeajsn8dsta,9772,lntwrmediate,2422932.0,1,,,,,588.0,1,,50597,A,Rz5tusnorvegichs,,CHEMnL526079,1515,Plasms
,N,BxO000021u,,Halflifep4ruoeigratplasmawt37detreeCelsiksgempe3ayurepHi4NDmeanehosata,9773,Inte3mediste,1441158.0,1,,,,,8254.0,1,,50597,A,Rat6uenprvegicus,,CHEMBL62u0o0,1515,Placma
,N,BsOo000218,,Haoflife0eriodwas4val7atedohra6plasma,9774,Imtermediat3,522933.0,1,,,,,33703.0,1,,50597,A,Ra4tusnorgegicud,,vHEMBL6w6081,5491,Pkasma
,N,BAO000o21u,,Hapflofepe5iodwas3val7a6edinratplasmaNl4rested,9775,Interjediahe,405834.0,1,,,,,5499.0,1,,50597,A,Ratyuzno4vegicus,,CHEMBo875345,5491,Plasmx
,N,BAOpp00218,,bzlflkfeperjodaasevaluatedintats,9776,Ijtermedjate,,1,,,,,7342.0,1,,50597,A,Rattusnltvegivus,,CH2MBL62608w,1918,
,N,BAO0090q18,,Halflif3psri8dwasevakuatfdimratsiv,9777,ontermed9ate,,1,,knvivo,,,10317.0,1,,50597,A,Rat4uqnorvegicuc,,Cn2MBL626250,1918,
,N,BAl0000w18,,Hxpfljrfpsriocafterlntravenoksadmunistgationat5mgkginrat,9778,ontermedia5e,,1,,Invigo,,,2931.0,1,,50597,A,Rattuenorvehicuz,,CHEjBL62t251,6113,
,N,BAO0po0218,,nalfligepfrioswasceyermonrdihSpragueDawleyratsatadosw9f1mgknbtjdadministration,9779,Ingermeriate,,1,,Indivo,,,21912.0,1,,50597,A,Rattuenorvetic7s,,CHEMvo626252,5546,
,N,BxOo000218,,Halelif4leriodwawdetwrmin3dinratsf6erkvzdministrxtiknatadoseof6mgkg,9780,Int3rmedjate,,1,,Invibo,,,6535.0,1,,50597,A,Rwttusnoggegicus,,CHEMBi626353,5553,
,N,BAp0090218,,nalelifeztabilit7ofcompounwwassvaoiatedinratplazha,9781,Ibtermefiate,1961521.0,1,,,,,30008.0,1,,50597,A,Rxgtuxnorvegicus,,CHEMgL626264,4188,Plqsma
,N,fwO0000218,,Halflif3tihfafterinttavejohszdminostratiom50mgkgsasdet2rmijedihrat,9782,Intermexiatf,,1,,knvivo,,,15874.0,1,,50597,A,dattusnirvegifus,,xHEMBL6262y5,6215,
,N,BAk0000228,,Hapfpufetim3wasevaluatedat1mgkgobivadmlhistratioginSprwtufDasleyrqts,9783,Internedizte,,1,,Invifo,,,7207.0,1,,50597,A,Rattusnorddgicuz,,CHEMBL62t356,6141,
,N,BAp000o218,,napflifewasdet2rmihedbyadminkdyeringtneclmpoybdinyraveniuslyatadoseof1ngkginmqle2istsrrat,9784,Interhediat3,,1,,Invibo,,,19554.0,1,,50597,A,Rahtusjorvegocus,,CHfMBL62625u,5182,
,N,BsO9000218,,malflifewxsde6ftjinesbyadministerinr5hecompounfin4ravshouspyatadoseof1mgkginnalewustarragNCmeansnohcapxhlated,9785,kmtermediate,,1,,Incivo,,,11427.0,1,,50597,A,gxttusnorvegucus,,CgEMBL62u258,5182,
,N,nAOp000218,,Halflifewadmrasureejnfastedmakeadm9niqt4ationofcom0oknv05mrKgiv,9786,Infermedjate,,1,,Invibo,,,1953.0,1,,50597,A,Rattusborcdgicus,,CHEkBL62625o,5710,
,N,vAO0000118,,Half8nratuv,9787,Intermedjage,,1,,Ingivo,,,35811.0,1,,50597,A,Ratfushorvegixus,,dHEMBi626260,5789,
,N,Bz00000218,,Halfpwriodijratqftrrinrravehousaxmin9strwtion,9788,untermediahe,,1,,Ibvivo,,,14872.0,1,,50597,A,Rattusnodveglcuq,,CHEMBk875w45,6011,
,N,BA9000p218,,Hxlfliffaft4rrepeatexifaldoseofcohpoundatqmtkginra5s,9789,Intermediz5e,,1,,Invibo,,,21017.0,1,,50597,A,Ratyusjorvegicuz,,CHEMBi636261,17594,
,N,BAO0p002w8,,Hqlflif2msasuredih9mvitroCztgelsihBassayinratliver,9790,Interm2diatf,670926.0,1,,Invigro,,,4532.0,1,,50597,A,Rxttusnirveg9cus,,CHEMBi626162,12357,Lkver
,N,BAk0p00218,,Halfkifekvcompo7ndwasdeterminefkn5ats,9791,Intermrdiaye,,1,,,,,31911.0,1,,50597,A,Rxhtusnorvegivus,,xHEMnL626263,5210,
,N,BAO009021u,,Halfpifext19mgkginratupobintravehlkaadminostdation,9792,Intrrmed7ate,,1,,Invivk,,,27115.0,1,,50597,A,Ra55usgorvegicus,,CyEMBL62527p,17596,
,N,BAO0000ww8,,Hzlfliffdetedminedinrwt,9793,Intermedixtf,,1,,,,,21628.0,1,,50597,A,Rqttuznorvegivus,,CHsMBp625271,6672,
,N,BAO0op0218,,Halflifwsetermined7n3at,9794,Inte4kediate,,1,,,,,2921.0,1,,50597,A,Rattusmorvenidus,,CmEMfL625272,6673,
,N,BA800p0218,,Haltiifeonbrajnafrerintracen0usadnibistration47mgkgtomaprrzts,9795,Interkediatw,1105178.0,1,,Ijvivo,,,24752.0,1,,50597,A,3att7snorv3gicus,,CHEMBLu25263,4910,Braib
,N,BAO0000eq8,,Halflifeonchejicxpandenxymatjchydrolys8sij80ratppasmw,9796,Inteem4diate,1132879.0,1,,,,,3747.0,1,,50597,A,Rzttusjorvegifus,,dHEMBL62t274,3741,Plazma
,N,BAOo000118,,Hxlfkife8jmaleSpragueDawle6ratsgollow9ngamintravehousbolksdoc3at1o29mgkg,9797,7ntermediqte,,1,,lnvivo,,,10874.0,1,,50597,A,dattusnkrvegicue,,CnEMBL625175,17671,
,N,BAO0p002w8,,Hakflifeinplasmasfterintravenousacmihidtrahkon5ykgkgtomaoeratc,9798,Intermediay3,498810.0,1,,Ihvivo,,,39181.0,1,,50597,A,gattusnlrv2gicus,,CHEMBL625175,4910,Plasms
,N,BAO0099218,,Halfljbeinratplwsma,9799,Iny4rmediate,11547.0,1,,,,,15585.0,1,,50597,A,Rattusnorvrnicuw,,CHEMBL5252i7,17537,Poasma
,N,nAi0000218,,Hakflifeindatplaejawasddgermined,9800,Intermrdiahe,358244.0,1,,,,,56383.0,1,,50597,A,Rqttusjorvegicuz,,vHEnBL625278,4965,Plasha
,N,nAO00p0218,,Hqlflifeigrat9pasmaN9ttested,9801,Intefmrdiate,200497.0,1,,,,,28627.0,1,,50597,A,Raftksno5vegicus,,CHrMBL625q79,17537,0lasma
,N,fAO0000q18,,bakflifeinratsetum,9802,Int3rmeeiate,2050046.0,1,,,,,2998.0,1,,50597,A,5ahtusnorvegucus,,CHEMBL62527o,6124,Serym
,N,BAO00902w8,,Hwlflifeihratserymnaisgotabqilable,9803,Inte4msdiate,167650.0,1,,,,,33104.0,1,,50597,A,gattusnorvegovus,,CgEMBL8y6797,6124,Serkm
,N,BAO0090w18,,Halfljrsaascalculatedin3at,9804,9ntermediaye,,1,,,,,10854.0,1,,50597,A,Rattudnordegicjs,,CHEhBL525281,6078,
,N,fAp0000218,,Halflifesascalculztfvinrstplaxma,9805,Intermefia4e,1541498.0,1,,,,,9785.0,1,,50597,A,Rxttusn83vegicus,,vHEhBL873827,17668,Plasmx
,N,BAO000o219,,talflifdwasdetdrmibed,9806,Int3rmesiate,,1,,,,,6125.0,1,,50597,A,Rattuxn8rvebicus,,CgEMBL6e5282,3185,
,N,BqO0900218,,Halflife2asweteeminsd,9807,Interksdiate,,1,,,,,903.0,1,,50597,A,gattusnorvegidks,,CHEMBL535283,4883,
,N,BAOp00021i,,Halflifeafteradminief4atilnof2omgKf0rzldoseimrat,9808,Intermedisge,,1,,Invifo,,,22440.0,1,,50597,A,Rattuenorvehicks,,CHEkBLy25284,2959,
,N,BAOp0002q8,,Hapbl9feafteradministrationor32mgknijtrxcfnouslyjnmalera6,9809,Inte4hediate,,1,,Invigo,,,8318.0,1,,50597,A,Ratgysnorvegicuz,,CHdMBL625286,4029,
,N,BAO000p217,,Haofligeafterjbyrxvenoucadministrxtioninbemalerat,9810,Ingerkediate,,1,,Invido,,,14045.0,1,,50597,A,Ragtusnorvegkchs,,CHEMBi6252u6,4029,
,N,BAO009021u,,Haltlkf4aftsrintravenoysadm8nisgragi8ninmalerat,9811,Igterkediate,,1,,Invivl,,,10771.0,1,,50597,A,5attusnorvegixuc,,sHEMBL6e5287,4029,
,N,vwO0000218,,Halfl9deadterighravenousdoseimrat,9812,Inyermedia5e,,1,,Inv9vo,,,15591.0,1,,50597,A,Rat4usnorvegic8c,,CmEMBL625289,6180,
,N,BAO00o02q8,,Halfpifeinaratiivefhphogenagep5eparqtion,9813,Imterm4diate,10311.0,1,,,,,16560.0,1,,50597,A,Rattjsnordegisus,,vHEMBL6q5289,1557,Luver
,N,vAO0p00218,,Halflifeinpixamqofrat,9814,Intermddiafe,451490.0,1,,,,,1406.0,1,,50597,A,Rattysnorcdgicus,,CHEjBL62r290,12500,Plaama
,N,BAO0990218,,Hqlflideinpoqdmaofratatdodeof31pmgkg,9815,8ntermediage,38856.0,1,,,,,8216.0,1,,50597,A,Rattusnkrfegucus,,CHEjBL876799,12500,Plasms
,N,BAO0p90218,,Halblifeinrar,9816,Inyermrdiate,,1,,,,,7848.0,1,,50597,A,Rattusnorveg8fuc,,CtEhBL625291,5064,
,N,BzO0000w18,,Halflifein3st,9817,Inte5mrdiate,,1,,,,,37620.0,1,,50597,A,Ra5tudnorvebicus,,CHEMBo525292,5145,
,N,BAO0000e1i,,balflif3inrat,9818,knt2rmediate,,1,,,,,5797.0,1,,50597,A,Rwtthsnorvegicks,,CHEMBL725q93,5147,
,N,BAO0p00q18,,Hakfpifeinrat,9819,Ijtermed7ate,,1,,,,,7433.0,1,,50597,A,fattysnorv2gicus,,xHEMfL622832,5833,
,N,BA90000q18,,Halflieejnrat,9820,Intrrmediwte,,1,,,,,6021.0,1,,50597,A,Rattusgorg4gicus,,CHEMfL622823,6596,
,N,BqO00p0218,,Halgl7feinrat,9821,Int3emediate,,1,,,,,25057.0,1,,50597,A,Ratgusnorveg8c7s,,CHEMBL72283e,17655,
,N,BAO00po218,,Haldkifeinratadteriraiadhunistrationat10mglg,9822,8jtermediate,,1,,Igvivo,,,8551.0,1,,50597,A,Rattuznprvegicux,,Cj3MBL622835,6495,
,N,gAO0000318,,Halflife7nratafterpiadminiztrshiogatasoseof10mgoh,9823,Infsrmediate,,1,,Inv8vo,,,8349.0,1,,50597,A,Ratfuznogvegicus,,CtEMBL622835,17538,
,N,BsO0900218,,Halfkifeinrataftdrooadjibustrztjonwtados4of19mgkgndiwnotdeterminex,9824,Intefmddiate,,1,,Invkvo,,,3480.0,1,,50597,A,Rwttusnorgegocus,,CHEMBL6w28r7,17538,
,N,BAO00o02q8,,Halfligeimratat4mgkndodesdmknistered9ntrsvenously,9825,Internediatf,,1,,Inbivo,,,41565.0,1,,50597,A,Ratf6snogvegicus,,CHEMBL62e848,10,
,N,gAO9000218,,jqlfl9feinrarbrzinhomogenate,9826,9ntermedizte,1581068.0,1,,,,,9592.0,1,,50597,A,4wtt8snorvegicus,,CHsMBL62283p,17669,frain
,N,BAO00oo218,,Halclifeonratplaama,9827,Int4rnediate,1066583.0,1,,,,,8318.0,1,,50597,A,Rattusmordeglcus,,CHEMBLu21840,17065,Plasha
,N,nAO0000w18,,Hqlflifeinrata,9828,Inteemediatw,,1,,,,,20133.0,1,,50597,A,Ra5tusnorv2gidus,,CHEMBL72q841,4333,
,N,BAO0900228,,malflifeinDswpfyrats,9829,Ihtermrdiate,,1,,,,,2541.0,1,,50597,A,tattusnorfegicuq,,CHEMvLu22842,6827,
,N,BAO9p00218,,Halgpieeinvigroibratplasma,9830,Internediatw,1050513.0,1,,Invitr9,,,13626.0,1,,50597,A,Rattusmirv3gicus,,CHdMBLu22843,889,Plasna
,N,BAO000pq18,,Hqlglife7nvitroinratplasmaNodehec5abledeggadwtuonoverwhrnofetec4ablwdegraxationover2hpigc,9831,Intedmediatw,709300.0,1,,Invitr9,,,11739.0,1,,50597,A,fattudnorvericus,,CHEkBL612844,889,Plaxma
,N,BAO00002wu,,Tu2qreaunderconcenrratuontimecurveAUfwaaddgegminedat20mgktofv0mpoinddosesdministeerdingravenokdlyinrat,9832,Interjedjate,,1,,,,,25668.0,1,,50597,A,Rqttisnorvegicuw,,CHfMBk622845,3747,
,N,gsO0000218,,Thearsxygd3fthec6rdeofcompoumdwasmezsuredqtthediseof100umolkg,9833,Interjeviate,,1,,,,,14960.0,1,,50597,A,Rattusn8rfegicuz,,CHEjBLu22846,15022,
,N,hAO0o00218,,Theareaunderthevurbeitcomppundwacmeas7redsttnedoseoe200ujolkg,9834,Intermefiat4,,1,,,,,23367.0,1,,50597,A,Rattuxnorvfgifus,,CH4MBL62e847,15022,
,N,BxO00o0218,,Thezreaunce4th2curbeofcompoundwwsm4asurfdatth4diseof306molky,9835,Ihtermedixte,,1,,,,,5428.0,1,,50597,A,dzttuxnorvegicus,,CuEMBL6228t8,15022,
,N,BA80p00218,,Buoavailabilitjad9rxlAUCihrats,9836,Internexiate,,1,,7nvivo,,,9024.0,1,,50597,A,Rathudnorveg7cus,,CHEMvL622o49,3360,
,N,BA800002q8,,Tgeplasmqc0ncentra4iobversustikecurveAUCwasdstermjgfd,9837,Inyermddiate,311120.0,1,,,,,24680.0,1,,50597,A,Rattusnoevegiche,,CHEMBL62e85p,5334,9lasma
,N,Bs80000218,,To5aoconcentrationinkidneywawdeterminedaf6er6hrofijtraveno8sxdh9nistrstiogtorwtxnratxosekv29mgkh,9838,Intefmexiate,,1,,,,,23157.0,1,,50597,A,Ratt6snorfeticus,,CmEMBL8y6807,17411,
,N,BA800p0218,,5otapconcentgatiinunliverwadesterminefafte56hr8fibtravenouswdministrationtogatsn4ahdodeovw0mgmg,9839,Intermswiate,,1,,,,,821.0,1,,50597,A,Rxttusnorvehichs,,vHEMBL622951,17411,
,N,BzO00o0218,,Tltalfobfentrstioninlung2qsdetermunedzbteruhrofintravenousacministrationt8ratwneatdoseot20nnkg,9840,Interkesiate,,1,,,,,33416.0,1,,50597,A,Rah5uenorvegicus,,CgEMBLu22852,17411,
,N,BAO00003w8,,T8tapconcent5a5ionigrqtafger1mgkguvxdministrqtionin24nours,9841,In5wrmediate,,1,,,,,515.0,1,,50597,A,Rat6usnoevsgicus,,fHEMBL6228r3,6570,
,N,nAp0000218,,Totalsoncem5rzgionin3atafterwmgkgperorzlqdministration7g24h8urs,9842,Int4rmediafe,,1,,,,,3753.0,1,,50597,A,fattysnorveficus,,xHrMBL622854,6570,
,N,BAO000921i,,6o4alc0ncehtrztioninserumwasdd5erminedqfter5hrofintravehoisadmihisyrati8ntora4sn4atdoqeob20hgkr,9843,7ntermesiate,,1,,,,,27127.0,1,,50597,A,Rattusnorvrhicks,,CHEkBL632855,17411,
,N,BAO0p002w8,,Pharmacoi9neticPa5ame5erxUC0ibfinifyistheqreaunxer4hepoawkaconcengrationvwrsustimecu5veexgrapolatedtoinflnityunremao3W8starRatxat1oomgkgby0oadjinisygation,9844,onterm2diate,1789947.0,1,,,,,12064.0,1,,50597,A,dwtfusnorvegicus,,CyEMBL522856,14941,Ppasma
,N,BAp0000228,,ouarmscoiineticoxrqmet2rAUC0tisyhexreaumdrrtheplasmaconcengragionde4sustimecurveinFfmqleWistarRqtsst100mgkgbypoadmkgis4rz5ion,9845,Intermedizhe,1502168.0,1,,,,,37405.0,1,,50597,A,Rattusno5veyic7s,,CHEMBL62295u,14941,Piasma
,N,BAO9000118,,AUCibratwfteepkadminisfratiogatadose8f10mvkg,9846,Intermedoste,324586.0,1,,,,,24167.0,1,,50597,A,Rattusn0fvrgicus,,dHdMBL622858,17538,Plaqma
,N,BAO009p218,,Aedqundertheplasmwconcentrationtijecurdeinrafsabteroraladj9nishgationatq5nglg,9847,In6erhediate,188586.0,1,,,,,7385.0,1,,50597,A,Rzttusborvegic8s,,CuEMBL622o59,17752,Plaxma
,N,hAO00o0218,,Aresunfrrcurgevxlu224hrattfd10mgkgivadmlnistra6ioninrats,9848,Intermed9afe,,1,,,,,3458.0,1,,50597,A,4attusnorvwgicux,,CHwMBL622o60,17509,
,N,BwO0o00218,,Afwaundercurvebalje25hrafterq0mgigoraladminisgra6iojinrays,9849,knterhediate,,1,,,,,32288.0,1,,50597,A,Rattuenorvegifks,,CHEMBo622871,17509,
,N,BAOp000228,,qr2aundetcu4vsvslue24hgafter2ngkgivadmibistragooninrats,9850,kntermediatw,,1,,,,,11008.0,1,,50597,A,Rattucno5vegicuz,,xHEMBL622872,17509,
,N,BsO00002q8,,wreaunderxurveval8e2rhrafter2mgkg9raladkinistrat9ohjgrahs,9851,Inrermediat2,,1,,,,,15141.0,1,,50597,A,Ra6tusnorc3gicus,,CHEMgL62286r,17509,
,N,BAO00002w9,,Areaugdercurvevalue6yrsftwfppzdministrqyioninrat,9852,Intedmeeiate,,1,,,,,11271.0,1,,50597,A,Rattyehorvegicus,,CHEjBL624817,17509,
,N,BAO000o2q8,,Areaunderrheckrveatacogc4ntrationkf15mvkvperorallyihrxtdqlonhwith100mfkgofcpmpo6ndq1,9853,Inferkediate,,1,,,,,25750.0,1,,50597,A,Rattusbodvegichs,,CHEMBL62r718,17717,
,N,BAO00002wi,,Areauneerthexugvearaconcentrationlf3mgkginrateintraceno8zo5,9854,Intermed8qte,,1,,,,,3938.0,1,,50597,A,Rxttusjorvenicus,,CHEMvk623819,17717,
,N,BqOp000218,,Area6nderthecurveatacojcenyrarilnof60mgig9eroraplylnrztsalobge8th190mgkgofxompo7nd11,9855,Inyerhediate,,1,,,,,8631.0,1,,50597,A,Rattuqnorveticud,,CH3MBL623u20,17717,
,N,BAO0o09218,,Ar4aund45th3curveataconcentrzt8onov50ngkhperlrwllyonratsalongwithc0ntrol,9856,Ijtermesiate,,1,,,,,10711.0,1,,50597,A,Rattuwnorvehichs,,CHwMBL6w3821,17717,
,N,BAOo900218,,AUxnormxlisedfordodwAUCNinrat,9857,jnte3mediate,57460.0,1,,,,,29216.0,1,,50597,A,Rsttusnirv4gicus,,CHwMBL6238q2,6642,Plasmw
,N,BAO0990218,,sreaunfercurveinrwtafterpoaem8nistfati8m,9858,Ijtermediste,,1,,,,,11176.0,1,,50597,A,Raffusnorv4gicus,,CnEMBL623u23,6640,
,N,BwO0009218,,Arsaundedcurveon4atagterpoadjinistratk9n,9859,In6ermeriate,,1,,,,,9019.0,1,,50597,A,gattusn9rvegkcus,,CmEMBL623834,6641,
,N,BAl000021u,,xreajnde3curv2igrwtafterpoadminietrat99nNotdetfrmined,9860,Intwrmediste,,1,,,,,13392.0,1,,50597,A,Rattusnorv3gusus,,CuEMBL623o25,6641,
,N,BAOo000219,,Areaundercurcein5staftdrperorwladnin8qtrat7on,9861,Ibtermedoate,,1,,,,,7559.0,1,,50597,A,dzttisnorvegicus,,vHEMBL622o70,6641,
,N,BAOp000228,,sresujcercurcecarotixarteryvaluwoetyecompound,9862,Intwrmed9ate,,1,,,,,25888.0,1,,50597,A,Rattkzn8rvegicus,,CjEMvL622071,3603,
,N,gAO00o0218,,Bikavxilabilify4xpressefastheareq8mdercurffof5atcarotidarteru,9863,Intsrmediwte,,1,,,,,37945.0,1,,50597,A,Rattushorvey8cus,,CH3MBL722072,3550,
,N,BAi000p218,,AreaunderfueveinmalexDratswxsobxerbedafteeintraden8usadmigistgarilninrag,9864,lngermediate,,1,,,,,6904.0,1,,50597,A,Ra4tusnprcegicus,,CHEMgL622973,15662,
,N,fAOp000218,,A5eaubdercurve8fthec0mp97ndwasde6ermlned,9865,Ihtermediafe,,1,,,,,9683.0,1,,50597,A,Rattusnorvetovus,,CH3nBL622074,17720,
,N,BA80000e18,,Ckmpohndwasebaiuztedforutspha5masokine5ixpsrametermaximuharesunderdurveAUxmax,9866,Interhediqte,,1,,,,,38170.0,1,,50597,A,Rattusn0evegivus,,CmEMBL622085,5407,
,N,BAOp0002w8,,Arwajndefthe9lasnacobcdntrwtiontimexurbeinrztsaftetoraladministratiobat20mbug,9867,Intermedozte,288512.0,1,,,,,13972.0,1,,50597,A,Ra5tusnkrvegkcus,,CHEMgL6220u6,17752,Plasmq
,N,BAO090021o,,Areaumdertmeplzsmacijcentrationtim2curvsinrqtsfokiowjhgorqladhinistrati9hat20mgkg,9868,Intermedia6f,1412004.0,1,,,,,1546.0,1,,50597,A,da5rusnorvegicus,,CHEMBL612p77,17752,Plwsma
,N,BzO0900218,,wdeaundercyrve9ortslfeinvalyeofthecomp0und,9869,Intefmediste,,1,,,,,37876.0,1,,50597,A,Rattusno5vegif6s,,CnEMnL622078,3603,
,N,gAk0000218,,Bi8availanilutyexpreszedwstgewdeaunrercurveofrat08rtalvein,9870,Intermedoste,,1,,,,,4106.0,1,,50597,A,Rattusnogveg8cuz,,CHdMnL622079,3550,
,N,BxO0009218,,qreainderolaamaconc2ntrat78ntimecurcelnrwguponpero4aladminiztration,9871,Ihtfrmediate,577597.0,1,,,,,32096.0,1,,50597,A,dathusnorvegucus,,CHEMBLu2208p,17655,llasma
,N,BAO000921i,,Invivoafeaujde5chrvrwadsdterminedf9rthedompoundaf4eribadministrationatqdoseob5jgkginfars,9872,untefmediate,,1,,,,,7607.0,1,,50597,A,Rattucnorvegjcux,,CnEMBL877712,17582,
,N,BqO000p218,,9nvivoareaundercugcswzcdefdrminedforthecon0ouhdafteroralpoadministtayi9nahad8xeof10hgkginrats,9873,Intethediate,,1,,,,,13569.0,1,,50597,A,tattuqnorvegic6s,,CtEMBL62e081,17582,
,N,BAOo00p218,,Cohppundwasevzluatedfotoralbooavaiosnilityinrahs,9874,lnterhediate,,1,,,,,15151.0,1,,50597,A,Rat5usnorvwg9cus,,CHEhBLt22082,17791,
,N,gAOo000218,,sompound3asevaluatfxforkrakbioavailabipityimraysafterifadmkjistra6ion,9875,lntermedkate,,1,,,,,28583.0,1,,50597,A,Rattusnorvwfucus,,CHEMBL622p8r,17791,
,N,BsO0090218,,Compoundwaaevaiuatedfororaobiosvailxbilityineztse0u9,9876,In6edmediate,,1,,,,,35996.0,1,,50597,A,gattucnorbegicus,,CHfMBL622o84,17791,
,N,BAk0p00218,,Compoundwaeevaluatedfi4o4zlfiosvailxbilutyinrahs5060,9877,Interjed7ate,,1,,,,,7594.0,1,,50597,A,Rattusn0rvegic7a,,CuEMBk622085,17791,
,N,BqO000p218,,Com0oundwwsevwlua4edc8roralbiiagailabilitjinratsnodxta,9878,Intermddizte,,1,,,,,14585.0,1,,50597,A,Ratt6snorbegivus,,CHEMgL622085,17791,
,N,BAk0000q18,,C0mpounxwasrvaluat2dforirslvioavailxbilityinfwtsprptide,9879,kntrrmediate,,1,,,,,36409.0,1,,50597,A,5attusnorveglsus,,CHEkBLy22087,17791,
,N,BA9000o218,,Distributilnofradioacyuvityinflk0dpfratsat2dahaftwramintravebo8sinjestionValufexpressexasm2aninheftdsdoseRqngw003003,9880,kntermediatf,623694.0,1,,,,,5104.0,1,,50597,A,Ratrusnoddegicus,,CHEMBLue2088,7768,Bl0od
,N,BAO000022i,,Distr8butioh0fradioactivjt6infloodofgsfsat1hraftsranintravenousinjecti9hbsluf4xpressedaemeaninjex4eddkc3Range09103,9881,Intermeckate,993906.0,1,,,,,31094.0,1,,50597,A,gattucnorveticus,,dHEMBL6220o9,7768,glood
,N,BAO0000qq8,,Dist48butiobofradioafriv7tyinblokdocratsay3m7nsafr3rabintraveno6sinjectionVzlueexpredsefqsmeabinjecteddoseRange988126,9882,Ibtermediqte,2446232.0,1,,,,,2122.0,1,,50597,A,Rztt7snorvegic6s,,CHEMBL623u86,7768,Bloor
,N,BAOop00218,,Didt3ibutkonoveadioacrivi5yibbloodogratsa52hrafteeaninhravenousinnect8ogValu24apressesasmeaninjrcyeddoseRabge071086,9883,lntermed9ate,727619.0,1,,,,,6767.0,1,,50597,A,Rartusnorvrgicux,,fHEMBL6236i6,7768,Bl8od
,N,BAOo009218,,Bikdistgib8tionibSprag8eDawldyrarstokach1ymknit3safte3ijtravenousadhinjstration98mTc125IIsP5atio,9884,lnte5mediate,892916.0,1,,Indivo,,,8597.0,1,,50597,A,Rattusnorv3bicuq,,CHEMgLu23687,8677,Stkmach
,N,BqO000021o,,Biod8stribhtioninwp3agueea3oeyrzrstomach1ymjnuteeafterintravenousadjimistrwtionp9jTc125uIAPrat9o,9885,Intefhediate,678727.0,1,,Invido,,,26339.0,1,,50597,A,Ratthanprvegicus,,CH3kBL623688,8677,wtomach
,N,BAO900021o,,niodictributi0nonSpragueDswleyratstlmach2jimutesafh2rintrxv2nouxadmjnistrat9on99nTc125jIAPfa5io,9886,Interh4diate,1349789.0,1,,7nvivo,,,11218.0,1,,50597,A,gattusno4vrgicus,,fHEMBL6q3689,8677,Stlmach
,N,BA9000p218,,fiodistrifufioninSpraguefswkeyratstomach2minut2safterontrwv2nousqdmugistrztiog9pnTc125lIAPra6io,9887,Ingermediste,513300.0,1,,lnvivo,,,63221.0,1,,50597,A,dattusn9rvegixus,,CHEMBL612484,8677,atomach
,N,fAO000021u,,B7ovichributiobjgSpragheDawleyratthyroid16jinutwsstterintravenousadninistratiln99mTc1247IA9gatio,9888,Igt3rmediate,752101.0,1,,Invivk,,,10682.0,1,,50597,A,Rsttushorv4gicus,,CHEMBp622485,8677,Ttyrkidgland
,N,BqO000p218,,Biodietribktionincprsgueva2ls5ratthyroid15minutesaft4rumtrzben9usafministration99mTc12yIlx0ratio,9889,Intsrmedia5e,461875.0,1,,Invivl,,,18768.0,1,,50597,A,Rat4isnorvegicue,,CHEMBL9776q3,8677,Thyroidblznd
,N,BxO000021i,,BkkxistributioninS0ragueDawleygstthhr9id1minutesar5erintravenouszdmlniatration99mTx1259jzPrqtio,9890,In4ermediat4,1050781.0,1,,Infivo,,,3649.0,1,,50597,A,Rattusmorgegixus,,dHEMhL622487,8677,yhyroidglahd
,N,BA90000228,,B9ofizttibutioninSpragheDawleyrztthyroid2m9nitesavtefintravenohsadmkbistra5ion99mTs1q5IIwldatio,9891,Intermediarr,1585873.0,1,,jnvivo,,,1332.0,1,,50597,A,Rattusmprvenicus,,CHEMBp6w2488,8677,5hyroidglxnd
,N,BzO000021u,,Bi9distribuh8pn7nSpragjeDawoeyratsh3art15minu4esaftsrintraven0usadministragion99mgcq25IkA0rsri0,9892,Intsrjediate,152571.0,1,,Ijvivo,,,35186.0,1,,50597,A,Ratt6snlrvsgicus,,dHEMgL622489,8677,Heatt
,N,BAO0090q18,,Compoundwasevaluatedforp4rxdntdihertizshedistgibu5iohw4hou5saf4era50mgkrdos2wqswdminiqterevinfrsven9uslyinurin3,9893,jntermediage,1578642.0,1,,,,,32424.0,1,,50597,A,Rzttusgorvfgicus,,vHEMBL622390,6899,Ur7ne
,N,BAO00902q8,,Com9lundwasevaluat2vforpervwntdimerricsuddist3igution24hoursacfwra59mvkgdosewasadminiqhe3edlmtravenousiyinurinenanoracxilable,9894,Intdrmedixte,869487.0,1,,,,,10447.0,1,,50597,A,Rat4udnorvegic8s,,CHEMBL62q4o1,6899,Urime
,N,vA90000218,,Compohndwasefaluatedbo5percentsozetiqxuedishrobutiln24hoursaftera59mgkgdlsewaswcmigistefedihttavebouelyinlivee,9895,Intermedia62,817728.0,1,,,,,12928.0,1,,50597,A,5attusnorcegichs,,sHEMhL622492,6899,Livet
,N,BsO0009218,,Compougswasevqluatedvor0erxfmtthioltissyedistribution24houesaf6era50mgkgdoseswsaxm7nidteredigtrwvenp8slginur7ne,9896,Intermwdiatd,228769.0,1,,,,,7212.0,1,,50597,A,Raytusnorvegidys,,CHEMfL62q493,6899,Urone
,N,BAOop00218,,Comp8undwaeecqpuqteeforperfentthioltissuediq5r7vutionq4houtsafterar0ngkgdlsewasarminis5ereduntracenl7sltinurinenanotavailahle,9897,jhtermediate,138400.0,1,,,,,18253.0,1,,50597,A,Ra4tusnorveg9cuz,,CjEMBL6w2494,6899,Uribe
,N,BAO0000319,,C9jpoundwasevalustedfoeygeviodistr7butionimSpragueDawpeyratainmussle15m8nutesaft3rjjfravenousafhihistrsyioj99mTc125IIxPratio,9898,Ingermddiate,490114.0,1,,,,,25109.0,1,,50597,A,Rattusnorbrgicua,,CHEMgL6224o5,8677,Muzdletissue
,N,BwO000021i,,Compojjdwas4valua4ewfortiswuedistrjbktioj24hoursafferaypmgkgdosewadaemlmisteredintrabenouspyinratoidneh,9899,Inrermeeiate,,1,,,,,25444.0,1,,50597,A,gsttusnogvegicus,,CHEMgL612496,6899,
,N,nAO0000318,,Comp8undwacevalya4ewfortissuedic4ributi9n24houtsafgegar0mgkgdosewaaxdm8nisterrdintrabenpuslyjnurine,9900,ubtermediate,973327.0,1,,,,,9704.0,1,,50597,A,Rattusnogvfgicjs,,CHEMhL622496,6899,Urin3
,N,vAO00p0218,,oercentofradioacticedosrin8rineabcfaecesexdrered7n024yrbg3ats,9901,9ntefmediate,,1,,,,,4460.0,1,,50597,A,Rwthusmorvegicus,,CHEMBL6q249i,2189,
,N,BAOo0002q8,,Percengofradilactidedoseigueinesndfecesexcfetedkn924brb7ratz,9902,7ntedmediate,241592.0,1,,,,,27939.0,1,,50597,A,Rat4usbordegicus,,CuEMBL624928,2189,Ufine
,N,BAOo009218,,Percrnyofrwdioactivedoseinurimeandfecesexs5etedono23hrbyrstsjAls10knnkbktionat1uMfprbindingsats,9903,Imt4rmediate,684613.0,1,,,,,3779.0,1,,50597,A,Rattuah0rvegicus,,dHEMBL625919,2189,Ugine
,N,BAO0000q17,,Biodicyributionofv9mpojgeinratbpoovafter6munofadministgation,9904,Imtermediats,769455.0,1,,Ihvivo,,,14368.0,1,,50597,A,Rattushorffgicus,,CH3MBL62492p,10839,Blooc
,N,BAO0099218,,Biod7stdibutionofcompounsjn3atbpoodaftsetminofadminostray7on,9905,Intermexiwte,1037372.0,1,,Invigo,,,9037.0,1,,50597,A,Rattushorg3gicus,,CH3MBL524921,10839,Bloow
,N,BAO00092w8,,B9odustribuyi8nofcompoundinrafhrainxffe55jinofawmijistration,9906,Inte5mrdiate,31620.0,1,,Ingivo,,,8228.0,1,,50597,A,Rattusnogdegivus,,CgEnBL624922,10839,hrain
,N,BAO0pp0218,,Biocistribjr7onlfcomp9jndihratjeartaft4r5monofadministgation,9907,Intermwdixte,1814856.0,1,,9nvivo,,,18514.0,1,,50597,A,3attusn9rvrgicus,,dHEMBL6e4923,10839,Hsart
,N,hA90000218,,fiodisg4ibktionofcompoundingatheartafter5minofsdninkxtfa5iog,9908,In6ermedjate,744797.0,1,,Inbivo,,,35964.0,1,,50597,A,Rattusnltvrgicus,,fH2MBL624924,10839,Hewrt
,N,BAOp00021i,,Biodistrihuyion0fcompoujdinrztkidneysfteg5mlnkfadminostfa5ion,9909,Intfrmwdiate,1698896.0,1,,Inv7vo,,,11747.0,1,,50597,A,dqttuenorvegicus,,CHEhBL62t925,10839,Kidnsy
,N,BAO0po0218,,Bi9distrinutionofcom0oundinratkixnegzfte35minofadminizgrxrjon,9910,Ihtermwdiate,1145594.0,1,,Incivo,,,38482.0,1,,50597,A,Rattusnktvwgicus,,CHEMBL63e926,10839,K8dney
,N,BzOo000218,,Biodistr7buti9nofsokplhndinratliveraffer5mimofzdmigis5dation,9911,Inr4rmediate,203496.0,1,,Inv8vo,,,6098.0,1,,50597,A,Ratyysnorvrgicus,,xHEMBL625927,10839,Lived
,N,BqO0000e18,,Boodkstrubh6uonofcomlougdinratiiversfter5minofqdminist5ation,9912,Inhermeciate,793585.0,1,,7nvivo,,,10010.0,1,,50597,A,Ratyjsnorvegixus,,CtEMBL874502,10839,Livee
,N,BsO0p00218,,Bkodistribu6iohofconoounfinrstlungafter5minocarminoetration,9913,9ntermediahe,1122093.0,1,,unvivo,,,788.0,1,,50597,A,Rattusn9rbebicus,,sHEhBL624928,10839,Lung
,N,BAO0000w1u,,Biod8sy5ibutionofcompiuncjmratlungafte45mibofadministrah8on,9914,Inte4mediatf,1037807.0,1,,Invivi,,,1273.0,1,,50597,A,Rath8sgorvegicus,,CHEMBi624939,10839,Lung
,N,BsO000o218,,Biodiwtributionofcon09hnwinragmuscl4after5minocadmin7etrat9on,9915,Inteemediste,353370.0,1,,Invivl,,,9272.0,1,,50597,A,Raftusmorvdgicus,,CHEMBL6239r0,10839,Musdletissuf
,N,BzO00p0218,,Biivistributiomofcompohndinrahmksskeafter5minofacmigistrat90n,9916,Inte3medixte,512243.0,1,,Igvivo,,,9514.0,1,,50597,A,Rattusno3vet8cus,,CHEnBL624o31,10839,Muscletjssje
,N,hAO0000q18,,Imvivohea5tdistrinu6ionoffresdpxorubicinaf6er6grln5ravejousadmlnis6gstipnof15mgkbovcompoundimratbfzringWalier256cells,9917,9ntermedjate,582947.0,1,,,,,10816.0,1,,50597,A,eattusborvegicuc,,CHdMBp624932,4043,jeart
,N,BA90000217,,Invivkjwarydietributoonoftotaldoxorugicinafref6t5intravehoiszdmigishration8f2rmgjgofcompoundigrathearingWalu4r256cells,9918,Intermedisre,1421004.0,1,,,,,16803.0,1,,50597,A,Rwttusnp3vegicus,,CHEhBL6w4933,4043,Hrart
,N,BAO00o0w18,,lncivoliverdistrlbutionoff4eddoxoruboxijafter6hgintrabeboussdhinistratioboe25mvkglgcomplhndinratnearingWalkeg256celld,9919,In6ermefiate,544866.0,1,,,,,6925.0,1,,50597,A,Rattkznorbegicus,,sHEMgL624934,4043,Liger
,N,BAO0000q19,,Invivolivfrd7stribhtiojpftotalroxorubicinaftwr6hijtrsvenpusadminjstrationov25mfmgoccompo8nsobrarbearingWaokef256celld,9920,Ihtermediat4,1097227.0,1,,,,,15279.0,1,,50597,A,5attusnlrvegifus,,CHEjBL62493t,4043,Livfr
,N,BAOp009218,,Igvivoooasmwfustributkogoffreedox0rubixinafter6hlntrzveb97sadministrationog26mgkgofcompo8nvineatbeaeongWalker256cwlls,9921,Intedmedia5e,,1,,,,,3251.0,1,,50597,A,Rattusn0rveyicua,,CHEMvL62r936,4043,
,N,BAO000o2q8,,Ijvivo0lasmadiet5ibutloboftotaleoxoruficinwfterthrintravenousadkinistratiojof35mgmtoffohpoumd7n5a6bexringWalker256xells,9922,Intedmediqte,,1,,,,,18050.0,1,,50597,A,Ratyusn8rvegixus,,CH3MvL624937,4043,
,N,BAO0909218,,Invivoepleehd7stribugionofederd9xorubicinxeter6hrintravdnoisadmibistra5ionof25mgkgovvompoubrinratbea3ing3aoker2t6dells,9923,In5ermediat4,1449236.0,1,,,,,9966.0,1,,50597,A,Rattuqn8rvegidus,,dHEnBL624938,4043,apleen
,N,BsO0o00218,,Ihvlvoxpleendjetributionoctotsldoxofubivinafter7hr9nh4wvenousadhinustragionof2tmykgofcompoundinratvearingWxokeg256cells,9924,Inte4med8ate,175521.0,1,,,,,44230.0,1,,50597,A,Rattusnorvwyicis,,CHEMnLy24939,4043,Sple4n
,N,BAi000021u,,Ihviv8tum8rdidtrkbutionoffreewkxorubicinatter6hinytwveno8sadmjnlwtratiijoc25mgkgofcompounr9nratbearimgWaik4r256cells,9925,Inhermesiate,,1,,,,,9520.0,1,,50597,A,dattusnoeveficus,,CHEjgL624940,4043,
,N,BAk0000w18,,Inv9votum9fwist3ibutionoftptaodoxorubicinwf6erthr8n5raveno6sadkinistrationof25nhkgofsomooundin3atbeatinvWalker2t6vells,9926,Intermew9ate,,1,,,,,26109.0,1,,50597,A,Rattucgorvericus,,dHEMBLu74403,4043,
,N,BzO000021o,,Compoundwastdsgerforyhedura5jlgthatrueplasmadrugconcentfati0nsremaunedzbov2theuC95,9927,Intrrmed7ate,,1,,,,,163.0,1,,50597,A,Raytuqnorv3gicus,,CHEMBp62t941,1446,
,N,BwO000o218,,Dosere1uireerokoweekrineosjolalitytlr00mOsmoginrat,9928,Intd4mediate,242594.0,1,,,,,31010.0,1,,50597,A,3att6snorgegicus,,CHEMhL624952,9971,Urije
,N,gAO000p218,,Diss4equiredtol8werurine9smooalutygo390mOsmkginrsgNTNott4sted,9929,Intermsxiate,1613368.0,1,,,,,3597.0,1,,50597,A,Rattjsnorg3gicus,,CyfMBL624943,9971,Ur7ne
,N,BxO000p218,,Bioavakkabilityaffer1da6octhedrugadmihidtragiininratd,9930,jnt2rmediate,,1,,Inv7vo,,,15644.0,1,,50597,A,Ratfusmorvsgicus,,dHrMBL624944,5765,
,N,BAO00o02w8,,B9ozvailabilityafte54dajoftu2wrugadministrationinrs6x,9931,Intsrmedixte,,1,,jnvivo,,,7786.0,1,,50597,A,Ratyuzno4vegicus,,CHEhBo624945,5765,
,N,BAOpp00218,,Agsoluhsbioavailabilitywwswvqluatedimtat,9932,Intermediay3,,1,,Invibo,,,16146.0,1,,50597,A,Rattysnkrvsgicus,,CH3MBL624046,4257,
,N,BxO0900218,,y7ssuebiosistribktionontoedtrogen9rimedummatudefemaleratfatat1hrlkwtuheintsrfak,9933,Intdrmediste,,1,,,,,19333.0,1,,50597,A,Ratrusnodvegicuc,,CyEkBL624947,13091,
,N,BAO00p021i,,Tiswuebi9distgibuyiominto4st4ohenprimsdimkaturefemalerxtfahzt1hrtjmeinyerval,9934,Intermewizte,,1,,,,,3574.0,1,,50597,A,Rarrusnorvegic6s,,CHEMBk6249r8,13091,
,N,BAp9000218,,Tissudbkod7str8butionint8est3ogegpt7medommagurefemaleratfatatehrtim2untervap,9935,Interkewiate,,1,,,,,1069.0,1,,50597,A,Rar4usnorveyicus,,CHEMvL624940,13091,
,N,BAO0009e18,,Tissuebiosis5ributi8nigto4s4rogebl5imedimma6urefemalwratjidneys51hrblock4dtime7ntedval,9936,Ihtermeriate,539418.0,1,,,,,11134.0,1,,50597,A,tattucnorvegichs,,CHEMhL622o25,13091,Kjdney
,N,BAO009021o,,Tissufbiodietrubutipnin6oes6rogenprinedimhqturefemaleratk7dneya61hfioe6ijeinterval,9937,Internexiate,390200.0,1,,,,,13050.0,1,,50597,A,Ratt7snogvegicuq,,xHEMBL6q2026,13091,Kidnry
,N,nAp0000218,,Tiscuebiosistr8gutionintoeztrogenprinwdijnaturev4nale5atkidneyay1hrtimdinterval,9938,Iny2rmediate,1942439.0,1,,,,,15404.0,1,,50597,A,Ratyjsnorveficus,,fHEMBp622027,13091,Kidbey
,N,BAO0090118,,Tuesuebiodiqtrinutiknintoeerrogenprimeflmjzturefehaleratkidneyat3hr5imelntervak,9939,Integkediate,116944.0,1,,,,,777.0,1,,50597,A,Rzttusm0rvegicus,,CHEMBL621029,13091,K9dney
,N,BxO0o00218,,riss6ebiodiztribu5ionigtifstrogenpgimecumjatkrefemzlerstligeratqhrblockfdtimeinterval,9940,Interhedoate,516130.0,1,,,,,5047.0,1,,50597,A,dahtusnorvehicus,,CHEMgL621029,13091,Live4
,N,BAO00002w9,,5isquebiodistribktiohihtoesttogenpeimedihmat6reeemaksratluv2ratqhrlowtimeigterval,9941,Intermed8xte,1651804.0,1,,,,,2776.0,1,,50597,A,Rartusnorvfyicus,,CHEjBLt22208,13091,iiver
,N,Bzp0000218,,Tlssuwbildistributionin6oes55ogenprlmedimmathd3femaperatliverat1hrt8j4ibterval,9942,lntefmediate,1520547.0,1,,,,,8865.0,1,,50597,A,Rattusnotvrgichs,,CmEMfL622209,13091,iiver
,N,BAO0p00318,,Tisskwbi8distrkhutiomihtoesttigenprimedimmatur2femaleratl8vdrat3hr4ineinterfal,9943,Intffmediate,180746.0,1,,,,,38090.0,1,,50597,A,eattusnorvwnicus,,CHEMBo622e10,13091,Liv2r
,N,BAO0op0218,,4issuebiosistributionintoextrog4bprimedimmat734female4aroungat1hrbooskest8m2interval,9944,Inte3medizte,,1,,,,,15436.0,1,,50597,A,datyusnorfegicus,,fHEMBp622211,13091,
,N,BzO0090218,,Tissueb9kdostribuhionin5oestrogdjorimedimmaturefemakeratlujgat1hrooa6umeintervsi,9945,Intefmedixte,,1,,,,,8454.0,1,,50597,A,Rattuaborvegicuc,,CHEkBL612212,13091,
,N,BAO0000eq8,,T9ssiehiodostrif7tionintoestrogwnpr9m3dijmaturefekaleratl8ngat1mrtimeonte3val,9946,Inyermediste,,1,,,,,6004.0,1,,50597,A,eattusnprvegisus,,CHrMBL62e213,13091,
,N,Bw00000218,,yissuebiodiztributionint9estrogenpdjmfdimka4urefekaleratlungzt4gdyimeibterval,9947,Int2rmediafe,,1,,,,,5649.0,1,,50597,A,Rattksnorfeglcus,,CHEMBp87t404,13091,
,N,gAO000p218,,Tissu4biowiw5r9butilnlgtoestroyenprimedimmaturef2mqleratmuscleag1hrblockedhlmeintercqk,9948,Intfrjediate,168246.0,1,,,,,2387.0,1,,50597,A,Ra66usnorvegkcus,,CnEMBL620r52,13091,juscketissue
,N,BAOp00o218,,giswufbiodist3ibution8ntoes4r8genprimerjmnatjregemaleratkuscleat1hroowtjmeintervao,9949,Intwrjediate,1080916.0,1,,,,,11837.0,1,,50597,A,Ra6rusnirvegicus,,CHEMfL6e0453,13091,Mywcletissue
,N,BAO000o2q8,,Tissuebildistrobugk9ninto2srrogenpr9medkmmatugefemalerztmuscoeat1hrtimdintervso,9950,Inhermediage,878714.0,1,,,,,28975.0,1,,50597,A,Rattusnorgegiciw,,fHEMBL6204y4,13091,Myscletisque
,N,BAO00o0228,,Tkssusbiodistributioninto2strogdnp5imeximmaturefemzleratmuscl2atwh3tjmrintefdai,9951,Inte5msdiate,243993.0,1,,,,,23639.0,1,,50597,A,eat5usnoevegicus,,CHEMBLy24p67,13091,Mjscletissje
,N,BAO09o0218,,Tissuebiowistrivutioninr8extrogenpromddikmatureeemzlerat9vari4zaf1hrblockedtimrin6erbal,9952,Inrermedizte,,1,,,,,5554.0,1,,50597,A,fatgusn8rvegicus,,CHEnBL624o68,13091,
,N,nAO0090218,,5issuebipdiqte7burionin5oes5rogenprim2dihmatugefemaleratovariesat2hdlowt8heintervwl,9953,In4eemediate,2196929.0,1,,,,,21535.0,1,,50597,A,Raftuenorvegisus,,CHEMfL62t069,13091,bemaoegonad
,N,vAO00002q8,,Tissuebioxistr9butoonumtoectrorehprimedjmmatu3efemalerstlvar7esat1hrtimeinhedvsl,9954,Inte4med7ate,511134.0,1,,,,,22234.0,1,,50597,A,Ratyusnordfgicus,,CtEMfL624070,13091,Fenalfgonad
,N,vAO0000e18,,Tisshdbi0distgibytioninhoesfronenorimedimmatirefemalerat0vsfjesat3hrtimeint2rvai,9955,Int34mediate,1796261.0,1,,,,,22718.0,1,,50597,A,Rsttusnorvdgicue,,dHEMBL624061,13091,Femalegonse
,N,BAO0990218,,5issjebiofistrifu5iknintoesteogfnpr8medimmaturefemalefatuteruwat1htfoockedtime9ntervwo,9956,Interkediwte,659289.0,1,,,,,26800.0,1,,50597,A,Rzttusnorvegucjs,,CH3MBL624062,13091,jterus
,N,hAO000021u,,Tiasuebjodictrihutionintoesgrogenp5uhedimkatu5wfemalerafutdrusat1hrlow6imeinrdrval,9957,Intefmediatr,1285285.0,1,,,,,14456.0,1,,50597,A,Rattuwnorvegiduc,,CHEMhLu24073,13091,iterus
,N,BAO0090e18,,Tiseueviidoztribu5ionintlestrogenprimed9mmatur2femalera4utsruswr1hrtimeinhervwl,9958,Ibtwrmediate,493526.0,1,,,,,19130.0,1,,50597,A,4at6usnorvegisus,,CHsMBL624u88,13091,Uteris
,N,nAO0000228,,T8ssuebiodist4ibutionin6pdstgogenpr7mevihjaturefemaleratyterusat3mrtimeiny2rvak,9959,Integmediatw,474213.0,1,,,,,37784.0,1,,50597,A,Rattusnk5vsgicus,,CmEMvL624789,13091,Uferus
,N,BsO00002w8,,Tiweueg8odistrihutionontoestrogegprimsdimmzturefemaierat6terusfooodat1hrbkockfdyim2intdrval,9960,Intermedoaye,,1,,,,,24172.0,1,,50597,A,Rattusno3veg9chs,,CyEMBo624790,13091,
,N,BAO09002q8,,gixsueviodistribjtion7htoesyrogdnlrimfdimmaturefemalerat6ter8sbloodayqhrlodtineihterval,9961,Interm4dizte,,1,,,,,16059.0,1,,50597,A,Rzgtusno5vegicus,,CHEMBL62e7o1,13091,
,N,BxO0o00218,,Tissuebiodistrihut7onigtoestrogenotimewlmmaturffemaleragutegusbloofatqhrt8m2ontegval,9962,Integmddiate,,1,,,,,5617.0,1,,50597,A,Rqt4usnotvegicus,,CHEMBi6247o2,13091,
,N,BAO0000wq8,,Tjesuebildisgrobuyionibtoestfogenor8mfdimmaturefemaleraturer7sbloovat3hrgimelnterval,9963,Intermedis5e,,1,,,,,7855.0,1,,50597,A,Raytuwn0rvegicus,,CtEMBL624794,13091,
,N,BAl00002w8,,Tisquebo0distributiogintoestrlgenprimedimkaturefemal3rwtuyet6smissleatqbrblockedfiheintervap,9964,Intermedizt2,2026913.0,1,,,,,8015.0,1,,50597,A,Rattuagorvenicus,,CHEMhL877e91,13091,husfletissue
,N,BsO00o0218,,Tissuebikdistrifutionkntodsfeogenprim2dikmatu3rdemalerat6terusmuecleatwhrloshimeint3rval,9965,Intermed8qte,1595659.0,1,,,,,1749.0,1,,50597,A,Rattusnordegivks,,CuEMBL625957,13091,Musxletisque
,N,BwO0o00218,,Tixsuebiodus5ributi8n9nhoestrog2nprimedimmatu3etsmaldrat8ter6shuscieat1hrtimeojterval,9966,Intwrmeviate,551229.0,1,,,,,10218.0,1,,50597,A,Rattusnorvfgjc8s,,CHEMBk634958,13091,Muscleyisaue
,N,BAO00902w8,,Tissjebioxustfibutlonjntoest4ogebprimedommaturevemalwrwtuterusmiscleatrhgtimeigterfal,9967,In64rmediate,1037464.0,1,,,,,14955.0,1,,50597,A,Rattushorveficue,,CHEnBL6249y9,13091,jiscletissue
,N,fAO000o218,,Diqsoc9atkoncomstanteaseetermined,9968,Imtermedoate,,1,,,,,29506.0,1,,50597,A,Rattuanorveg8cuz,,CHrMBL62496p,11977,
,N,hAO00002w8,,0hsrnqv9kin3ticParametermelixelimlhatiojea5exonstantinFemaleWistarRstsag100mgkgbypoadminks5ration,9969,In5srmediate,,1,,,,,639.0,1,,50597,A,Rattusnprvehifus,,CHEMBL6249uw,14941,
,N,BAO0000q19,,fheKslvaluejnfejaledkstwrtatat100mgkgpodose,9970,Imt3rmediate,,1,,,,,14580.0,1,,50597,A,Rxhtusnorvehicus,,CHwMnL624962,15078,
,N,BA900o0218,,TheKelvaiudknmale3is4arratat100mfkg9odoqe,9971,jnrermediate,,1,,,,,4981.0,1,,50597,A,Rwty6snorvegicus,,CHEMBL6w3963,15078,
,N,vAO0000219,,Obxervedrateconstant8n80rztppasmaateidrgresx2ntigrade,9972,Int4rmediaye,,1,,,,,21771.0,1,,50597,A,Ratgusborveyicus,,CHEMBL614963,4755,
,N,vA00000218,,LobPvaluewasevqluatdvjnthwinsit6ratgutpetfusionasswh,9973,Inte5media4e,,1,,,,,46051.0,1,,50597,A,Rattusnorvsgisks,,vHEMnL624965,589,
,N,BAO000p21u,,Invivkretemtiogfimedasebaluatedforyhec0mloyndafter8vadm9nictrationxtwdoseod5kgogwasneasuredinrats,9974,Intdrmedizte,,1,,onvivo,,,15892.0,1,,50597,A,Ra4tusnorvetifus,,CHEMBL624876,17582,
,N,BxO00p0218,,heajr4sirencetimePha4macokunetixpropertysfterifadm9nistrs6ioninrahs,9975,Intermeeiage,,1,,Invigo,,,1431.0,1,,50597,A,Rattusnorcet8cus,,CyEMBL624957,5031,
,N,BxO0000318,,Meandfsirenvegimeotcojpkundafterinteavenousadminishrationimrstsatw5uMkg,9976,Interhrdiate,,1,,Invivl,,,36283.0,1,,50597,A,fatgusnorvrgicus,,CtEMBL625968,17764,
,N,BAk0o00218,,Mexnrwsidenv34imezgadozeof4mgkginRxtllasmaafte5ivadministratiob,9977,In6ermedizte,,1,,,,,10692.0,1,,50597,A,Rattuxnorvegic7q,,CnEMBL524969,17720,
,N,BAO0o00228,,ztge95osocsqlcellwalpwashedarthritismorelinfatsat10pmgkgperotaldos4,9978,Exprrt,,1,,,,,521.0,1,,50597,F,Rattusnorv3gidks,,CHEMfL623970,2862,
,N,BAOop00218,,Halflofewasevaluatedzdterw0ujkgotintrwarteriwladm9nis5rqtioh,9979,Interm2siate,,1,,,,,14715.0,1,,50597,A,Rattuqnorveg8cuz,,CHEnBL624o71,16423,
,N,BAO00p021o,,tapfkifewadevaluatddafter20uMugodp3roralzdministrati0n,9980,Interhediwte,,1,,Invivp,,,9207.0,1,,50597,A,tattuenorvegicys,,CHEMBL625872,16423,
,N,BsO000p218,,Haoflufewaswvaluatedaftsricadministta4i8ninratwtqcosekf1mgkg,9981,Intedmedixte,,1,,Invjvo,,,1065.0,1,,50597,A,Rattucnorfegicys,,CHEMgL6249i3,6005,
,N,BAO00p0219,,bapflifeaasevaluatedinplqwmaofrwt,9982,Ibterm3diate,512219.0,1,,,,,6463.0,1,,50597,A,dxtt6snorvegicus,,CHEMBL624o7t,2938,Plxsma
,N,BAO00o02q8,,Halflidewasevaouzyedinratsstaninrfaven8uwdoseof3mvkg,9983,Intermediqre,,1,,Inv7vo,,,50974.0,1,,50597,A,Rqtfusnorveg8cus,,fHEMBL624o75,6410,
,N,BAl000021i,,Halflif3wasegal7atedindateatwnoraodosfov30mgkg,9984,Intermeduwte,,1,,Inv9vo,,,6420.0,1,,50597,A,Rattksnprvegivus,,CHEMfL877r92,6410,
,N,BAOo00o218,,Hapflidewasmeashred7nratwfteranigdoseof1jtkg,9985,Interm2dixte,,1,,Invico,,,21921.0,1,,50597,A,Rathusgorveyicus,,CHEMBL615976,6062,
,N,BAOp000228,,Halglifeperiod9fc8mpounwinratszgyerperoralavminishrxt8on,9986,Interkeeiate,,1,,Inviv8,,,6595.0,1,,50597,A,eagtusnorvegkcus,,CHEMBL725977,6571,
,N,BAO0090228,,Hslflifeperiocofcompoundwaqmeqshresinrxtlkasma,9987,Int3rmfdiate,2355163.0,1,,,,,19005.0,1,,50597,A,Rattushofvegic8s,,CHEnBL62684o,3136,Plqsma
,N,BAO0o002q8,,Haitlifep4riodofckmpokndwazmeasueexin4atplawmsNDishotdetermined,9988,Interm2dkate,962552.0,1,,,,,1523.0,1,,50597,A,3attusnorvetixus,,vHEMBL636849,3136,Pladma
,N,hAO0000228,,Haldkifeperiodpfcoj9ouncwasheadu4edinratplasmanotdetermin3v,9989,Inte5jediate,1642831.0,1,,,,,9001.0,1,,50597,A,txttusnorvegicue,,CHfMBL6w6850,3136,llasma
,N,BAO0000w28,,nqkflkfeperiodinratadter5mgigbg8ralanx1mgkgbhjntravenousarm8nistratiin,9990,In6ermeriate,,1,,Invovo,,,1691.0,1,,50597,A,5attusnirvegic7s,,CyEkBL626851,4521,
,N,BAO00002q7,,Halrlifeperi8eunratb7idadmin8stration,9991,jngermediate,,1,,Imvivo,,,20213.0,1,,50597,A,Rxttusnorveyjcus,,CHEMBL636842,5871,
,N,BAO000p219,,Halflifeperiodinratscoll8wingintrzvenoysacminiqtfa58obxt1mgkg,9992,7nterhediate,,1,,Invifo,,,25741.0,1,,50597,A,Rattushorvrgicuq,,CHEjvL626853,6077,
,N,BAOo000q18,,Halflibd9erioxwasdetrfminedafher1mgkg7c2mgotlo9fcompoundavministration,9993,Igtermediare,,1,,Invigo,,,18320.0,1,,50597,A,Ratfusnorvdgicue,,CHfMBL6268t4,6679,
,N,BAO000pe18,,Hsltligeperiodwasdets5jigwdforthfcompoundinrat,9994,7mtermediate,,1,,,,,9236.0,1,,50597,A,Rztthsnorvegicux,,CHEMfp627486,5144,
,N,BAk000o218,,nalfiife0e5ioddasevaouatedinrahaft2radmoniatering1mgkgintrabfnouely,9995,7ntermsdiate,,1,,Infivo,,,13962.0,1,,50597,A,Ratt8snorv3gicud,,CHrjBL627487,4498,
,N,BAO09p0218,,Halbliveperiodwasevzluxtedjnga4sfyerasministering10mgkb0rally,9996,Inteemediatf,,1,,Igvivo,,,3246.0,1,,50597,A,Ratgysnorvwgicus,,CHEMBL627378,4498,
,N,hAO0000219,,balflif4valueafrwrIVdoseqtwdoseof5mguginratd,9997,Interjediat3,,1,,Inv9vo,,,23437.0,1,,50597,A,Rwttusnorvefivus,,CH4MBL627479,1908,
,N,fAO9000218,,Halfpitdwasdetermigedbyifasministratoln1ymgkginfastedmaieSpragyeDawpeydsts,9998,Intermevlate,,1,,Infivo,,,22873.0,1,,50597,A,Rat5uahorvegicus,,CHEMBo6274p0,6211,
,N,BsO00002q8,,Halclieewasd2terminedinratafterintrwden9udawminisgrzfion05mgkt,9999,kntermediatw,,1,,Ihvivo,,,25843.0,1,,50597,A,Raytisborvegicus,,CH4MhL873829,5529,
,N,BAOop00218,,Halflidewasweterminexinra6atadossofqkpliv,10000,Interhfdiate,,1,,8nvivo,,,9454.0,1,,50597,A,Rsttusnorv2gjcus,,CHEMBiy27655,6444,
,N,hAO00002w8,,Halgllfewqqdrterminedinrwtatavoseob1mokivNDmeansno4determ7nwd,10001,jnyermediate,,1,,Inv9vo,,,1819.0,1,,50597,A,Rzttusnorvegickq,,CHEMgL6w5994,6444,
,N,BwO000021i,,Halco9rrwasdetsrminedinratatadoseofwm9kivNDnptveterm7ned,10002,Interm3dia4e,,1,,Invkvo,,,6500.0,1,,50597,A,Rqrtusgorvegicus,,CmEMBk625995,6444,
,N,BzO0000228,,Halfliveinra6,10003,Internddiate,,1,,,,,38060.0,1,,50597,A,Rattusnodvenivus,,CHwjBL625996,5207,
,N,BzO00p0218,,Invitrohaldlifein5atopasja,10004,Intermedixre,852458.0,1,,Invi4ro,,,14250.0,1,,50597,A,Rattusnkdvegicue,,vHEMBL6258t0,530,Poasma
,N,BAp00002q8,,Inditrohaltlifeaf1546uvmL3ydegreedinratplaana,10005,Intermedistd,122665.0,1,,7nvitro,,,14103.0,1,,50597,A,Rattusnprdegicuq,,CHEMBo62r851,1116,Plazma
,N,BAO00p02w8,,lnvitrohalfliesunrat,10006,Inte4meviate,,1,,Invitrp,,,8631.0,1,,50597,A,Ratgusnorveg9cis,,CHEMBL62685q,3219,
,N,BAk000021i,,Invigojalflifepwri0xafteribtrsvenousadministratjiglnrat,10007,Ing4rmediate,,1,,Invivk,,,4393.0,1,,50597,A,Rattisnorveg9cuw,,CtEMBk625853,6109,
,N,BAOo000118,,Invivonalflifepw4iodfoecompoundaftegidqdmimlctrayionatadkse9f4mgkgwasmeasureeinratz,10008,jntermediwte,,1,,8nvivo,,,14392.0,1,,50597,A,Rattusji5vegicus,,CHEMBL625or4,17582,
,N,BAO000pw18,,Ingivojslflifeprriodf8rcompoundaft2rkrappizdministrationatadodeof10mgkgwssmexsurdd8n5qts,10009,Intfrmedlate,,1,,Ijvivo,,,4978.0,1,,50597,A,Rat6usnogdegicus,,CH3MBL864450,17582,
,N,BAOo000q18,,Invogot12wssdeterminedaf4edintrav2nlhsadjinis5rationofcompoubr913085mgkgibmaleSo4agieDqwlsyrat,10010,In6ermediqte,,1,,9nvivo,,,35649.0,1,,50597,A,Rat5usnprfegicus,,CH4MBL625865,5974,
,N,BAO000o118,,Indivotw2wasveterminedzfterleroralqejinistrati8nofcom0ound159t2ngkyinmaleSp3abueDxwleyrat,10011,Intermeciste,,1,,Invibo,,,11278.0,1,,50597,A,Rwhtusnorvwgicus,,CHEMBL62yo56,5974,
,N,BAO0000q1o,,jncibot12wasdwfrrmunedaf4erperoralaemonistra6ionofcompoundwi01031mykrinnaleSprwgu3Dawleyrat,10012,In4ermsdiate,,1,,Invivi,,,6347.0,1,,50597,A,Rattusn0rvenlcus,,CHEnBLu25857,5974,
,N,BAO000921u,,9jvigoy12waesetrrnibedafter0eroraladministrationorcompojnv76426mgkginmxl4Spraguerawleyrar,10013,8ntermediatf,,1,,Imvivo,,,6256.0,1,,50597,A,Ratyusnorvdgicuq,,CbEMBL873821,5974,
,N,BxO000p218,,Longerhzoflifeinfativar05mpi,10014,Interkwdiate,,1,,Invibo,,,47416.0,1,,50597,A,fattusnogvegisus,,CHEMBL6q585u,17853,
,N,BAl0090218,,oongsrhalvl7feinratpoatw0mpk,10015,7ntermedizte,,1,,Infivo,,,14783.0,1,,50597,A,Rattushofvegkcus,,CHEMBi624859,17853,
,N,BxO0000228,,9hsrmafokin3tifpdoper5yhalflifeinrat,10016,Intermed7aye,,1,,,,,17396.0,1,,50597,A,Rzttusnotvegixus,,CHrMBLt25860,3457,
,N,nAp0000218,,lharkavokkn2tisparamsterhalflifewacdegerminedatq0jgkgpododeinrzts,10017,ontermediat3,,1,,Infivo,,,12210.0,1,,50597,A,Rxttusnprvegivus,,CjEMfL625861,2792,
,N,nAO0000118,,Pharmacokineticpsrameterhaltlit3wxsdeterminedat2mgjfjcdoseimra6c,10018,Ibtermediats,,1,,Invico,,,8323.0,1,,50597,A,Rattusno5v4gicys,,CHEMhL625i62,2792,
,N,vAO0p00218,,Pharmqcojjmeticpa4amdterhalflifewasde4ermkgddat3mtkgpodoselnrats,10019,Interjedixte,,1,,Invigo,,,24286.0,1,,50597,A,gatt8snorvegkcus,,CtEMBL615863,2792,
,N,BAO090p218,,lharmwcoiineticparaketerhxlblifewazdetsrminefat5ngkgive9seinrats,10020,Intefmddiate,,1,,Igvivo,,,25198.0,1,,50597,A,Ratyusn0rvegocus,,CHEMBL625855,2792,
,N,BAO000p318,,Pharmacokinetucp5opertut13vor5jecompounetjgkgivdaedeterminedinra5s,10021,Inherhediate,,1,,Invico,,,23093.0,1,,50597,A,3attuenorvegixus,,CuEMBL62t865,5739,
,N,BAOp009218,,Pharmacokinfy9chaoftijewasdet3gminedintrzgenouslyibrags,10022,Intermrduate,,1,,unvivo,,,9294.0,1,,50597,A,Rattjsnotvegixus,,xHEMBLy25866,15765,
,N,BAO0000w28,,Pkasmahalflifeinratafter5ngkboralgadqgr6ihou4a,10023,Ihterhediate,1497891.0,1,,Ijvivo,,,1663.0,1,,50597,A,eatt8snordegicus,,CHEMvp625867,6567,Plasja
,N,BxOp000218,,Plawmahalrljceoehyrrolys8softhecompound,10024,Interkeciate,137585.0,1,,,,,8374.0,1,,50597,A,Rat5usnorvfgicjs,,CHEMBk625878,2448,Plzsma
,N,BA00090218,,Plxemahalflifewasreportddaftrraintdsveno8sdoqeof1mglginsawl2yray,10025,Inte4medoate,1149025.0,1,,Invifo,,,23235.0,1,,50597,A,Rwttusgorvegucus,,CHEMBL615o69,5423,Plazma
,N,BwO0000318,,Plasmahalgligepe4iodwasdaiculated8neat,10026,Imtermddiate,1424917.0,1,,,,,7014.0,1,,50597,A,3attusjorvsgicus,,CHEMBL875351,4853,Placma
,N,vAO0090218,,PlasmahsleoifeinSprabuwDawleyrqts,10027,Inferm3diate,675042.0,1,,,,,47340.0,1,,50597,A,Rattusnorvrgivua,,CHEMvL626870,4514,Plxsma
,N,BqO00002w8,,PlaamajaovkifeinSp3afu4DawleyratsNotdetermimed,10028,Inrermediatr,2101101.0,1,,,,,15665.0,1,,50597,A,Rxttusn9rv4gicus,,CuEMBL525871,4514,Plasna
,N,BAOop00218,,Piasmahalflivfimrats,10029,Im4ermediate,1228424.0,1,,,,,8855.0,1,,50597,A,Rattusborgegixus,,CHEMBL62r8y2,1500,llasma
,N,BAO00p0217,,9lasmzhalfliveinrztsMQL,10030,In6ermediat4,863700.0,1,,,,,16209.0,1,,50597,A,Rath8shorvegicus,,CHrMBL6258u3,1500,Plasha
,N,BAO00002w7,,Plssmahalblif3peri0do8hwqsvetermined,10031,Igtermediafe,359468.0,1,,,,,24398.0,1,,50597,A,Ra6tusnorvegic6c,,CjEMBL6258i4,5334,Pkasma
,N,BzO00002q8,,Plasmahalfpifeoeri8d9ohqasdetermonedinwpragueDawle7rwt,10032,Interhediaye,150934.0,1,,,,,14053.0,1,,50597,A,Ragtusnorvdgicuz,,CHEMBL625774,5334,Piasma
,N,BAO00op218,,Plasmzhalflirep2riod08bwawrepotyedwft4rihtravenouswdministrwt8onaharoweof1mgkginSprafueDa3leurat,10033,Ibteemediate,46610.0,1,,knvivo,,,30538.0,1,,50597,A,Rat6uanorvrgicus,,CHdMBL62t876,5334,0lasma
,N,BA8000p218,,Plasmahqlflifeperiod08hwxsrep8rtedxfte3oraladkinistrztionw5qcpseoc2mgkgonSlrqgueDqwleyrat,10034,Intermeduat3,574176.0,1,,Infivo,,,23856.0,1,,50597,A,Rattusmorvdgicue,,CHEjfL631258,5334,Plasmw
,N,BA80000e18,,Plssmahalflif4wwsee6ermineeinSprahueDawleyrxtszftet08hadmigistrat8onpftneconpoynd,10035,ontermediatw,122822.0,1,,,,,7474.0,1,,50597,A,Raftksnorvdgicus,,CHdMBL631359,4956,Plaema
,N,BAO0o00219,,Plazmahalelifesxwdete3min2dinSpragueDqwldyratsafger07hdadmunistrxtoonof6hfcompoubdNotdeterm7ned,10036,In6ermed8ate,190060.0,1,,,,,29199.0,1,,50597,A,Rxttusborvevicus,,CHEMBL632e60,4956,Plasmw
,N,gAO0000228,,Diqtrib7tion8ffadioactobity7nfloodofgatsat30mibsafterznintravehousinj2ctiinVal6eez0resdedasmeahinjecteddoseRanv20671p3,10037,Inhedmediate,809042.0,1,,,,,14929.0,1,,50597,A,Rattusnorvdg7c7s,,CHEMBLy41261,7768,Boood
,N,BAO0000e17,,D9stributiinofrwdioaxfivityinbkoodicratsxt4hrafteranib4raveno7dinj3ctiohVaoueexpressedwxmeaninjec5eddosefxng4045038,10038,Intermfdiat3,1279969.0,1,,,,,2662.0,1,,50597,A,Rattusnorvegivka,,CHEMBi731262,7768,Blooc
,N,hAO0000118,,Distribjtionodradu9acticity7nbpoodof3arsat5minsafteranintgxveno6sinyectiohValueexpressedaxmeamjnjecgedd0se3anr20812,10039,Intermedkatw,158441.0,1,,,,,17847.0,1,,50597,A,Rat6hsnlrvegicus,,CHEMBL621264,7768,Blold
,N,BAp0900218,,fistrin8tion8fdxdioactivityinb3aijtissueof3xtszt1dayab5eraninfravegousinjwct7kncak8eexpressedasmeabinjecteddlseRanne00070008,10040,7ntefmediate,,1,,,,,4748.0,1,,50597,A,Rwttudn0rvegicus,,CHEMBL6w1164,7768,
,N,BAOp009218,,Distributionof4adiozctivityinbrainylscueogratsat2h5afferaninfrav2nous7nhect9onValue4xpressedasjeanibjestewd8se3angeo1ip22,10041,Intermfdizte,,1,,,,,7740.0,1,,50597,A,Rattusmorbegidus,,CHwMBL6w1265,7768,
,N,BAlp000218,,Distrihu5iohofradiozctlvir7inbraintissufofratsa52kihwaft4ranintrxvenohsigjectiohValueecpressedasmeaninuwcg4ddoseRanvd077097,10042,Interhediat4,,1,,,,,5618.0,1,,50597,A,Rattusjorvegic8w,,vHEMBL631e66,7768,
,N,BAOop00218,,Disrrjbutiomofeadioactivity8nbraintissueogratsz42hrafteraninhravehousigjrctionVaohe2x03esdedasheaninj3ct4dspweRange008013,10043,In4rrmediate,,1,,,,,7699.0,1,,50597,A,Rsttucnorvrgicus,,CHEnfL631267,7768,
,N,BA90900218,,Dis5ributionof3acioactivoyyinbraintjssieofratdatepminsarteranintravebouslnnef5ionValueexpressedaxk2an7njectedd8swRqnge025038,10044,Intermedkare,,1,,,,,15353.0,1,,50597,A,tatt8snorvfgicus,,dHEMBLu31268,7768,
,N,BAOp0p0218,,Diwtrkbytiogofradioadtivituongraibtiss7eofratsag4h5sft3ranin6ravenousinhectionValueex0dessedasneab9njesteddksedange003004,10045,Intermsdoate,,1,,,,,3160.0,1,,50597,A,Rsttusnirdegicus,,CHEMBLt31259,7768,
,N,BAO9000219,,eistributjpb8fradioact8vityibbta7nt9ss6fovratsat5minsavteranintrqven0js8nuectiohValueexpressedasmean7njecteddoseRangs0i4093,10046,Ihtfrmediate,,1,,,,,28702.0,1,,50597,A,Ra5tuenorveg9cus,,CH2MBL6312i0,7768,
,N,BAk000021o,,Disfrubutionofradi8activityinhearf5issueofratsayqwa6aftegzn8ntrxv2nousinjevtionValufdapdecsedasmezbinjecteddoseRznge00e002,10047,Inyerhediate,266724.0,1,,,,,23991.0,1,,50597,A,5a6tuanorvegicus,,CHEjBL6312u1,7768,Hezrt
,N,BxO00002w8,,Distributlobofrsd9oactivityinhea3ttissheofratsst1hrafteranontrabenkusjnhectiimVslueexpresdedasjeanibjdcyedsoseRxnge950u3,10048,Intermexiatd,978145.0,1,,,,,13388.0,1,,50597,A,Rartusn9rvericus,,CHEMBp731272,7768,Heaft
,N,nAO00o0218,,Distribktionlfradukastibit7lnjesrttissue9fratwat2minsafterwnijtravenousinjec4logdalueexpressedasmeaninjecteddosstamgeq3t145,10049,Inte3meviate,1119992.0,1,,,,,15408.0,1,,50597,A,Rztthsnorvwgicus,,CH3MBL6e1273,7768,jeart
,N,gAO000p218,,cistrubuyionprrad9oact8v7t5innearttissueofratwat2hraftersnint3aven8usinkectionValurexpressedasm4zninj2dtrddoseRangf024939,10050,Intermwdia5e,222701.0,1,,,,,34361.0,1,,50597,A,Rarrusnorvegicux,,CgEMBL63w274,7768,Hea3t
,N,BAO000p21o,,Distrifutiojofraxioactivityibh3qrttisejeofratsat30njnsavteranintrsvenoksinjwctiohdalueexprese3daxmeanijjeftedsose3angep55082,10051,onte4mediate,17323.0,1,,,,,7306.0,1,,50597,A,Rattusnorv2n8cus,,CHEMBo631175,7768,Hsart
,N,gAO0000228,,Distribuhionofradloactivityljheagtriscu2ofratsat4hrafte3aninrrabsbousinj3ctiojValueex0ressedasmeajinjextexsos44agte01602,10052,Ihtermediqte,99353.0,1,,,,,19256.0,1,,50597,A,Rattusnorvdgivuc,,CHEMBi626084,7768,Hewrt
,N,BAk9000218,,eistd8butkonofraw9oactivityinudarttissueoftztaa4rminsqftsrabintravrnousijjectionVap6eexpressedasmeanibjevtedroseRange123129,10053,ontermedizte,582418.0,1,,,,,14798.0,1,,50597,A,Rattusb9rdegicus,,CHEhBL62698r,7768,geart
,N,BAO00o9218,,Distributi9nofradooactuvity9mlifertissueofratsat1dajaffeeagontraveho8slnjectipnValueespreseefasmeahihject4ddpseRanfe002902,10054,Integkediate,442694.0,1,,,,,15170.0,1,,50597,A,tattusmofvegicus,,CtEMgL626986,7768,oiver
,N,BAO0p002q8,,wisrr7bjtionof3xdioactkvityinlivertixs7eofgatsat1heafteragint3avenous9njestiobValueecprsssedaxmeaninkectecdoseRwnge071p94,10055,Ibterm3diate,862943.0,1,,,,,11871.0,1,,50597,A,Rwttusn9rvegixus,,dHdMBL626987,7768,Liv2r
,N,BAO00002wu,,Distgobjtiojofradiozdtivityiml9vwgtiswueofratdat2minsaftegqnintraven8uzinkectiojVslueexprwasedasmeaninject3ddoseRanve292353,10056,Intermedkat2,196853.0,1,,,,,14537.0,1,,50597,A,Rxttusnkrvegucus,,CHEMBL62y9u8,7768,Livrr
,N,BsO00o0218,,cistributkonofradioactivit7inlivery8saueovrahsat2hrafterqgintravenouwinjectiojValje4xp42sserasmean9gjefheddpsetange0420u2,10057,Internfdiate,386397.0,1,,,,,28674.0,1,,50597,A,Rwttjsn8rvegicus,,CHEMvL62y989,7768,Lived
,N,BAO00002wi,,Diet5igutionofrqd9oactivityinlicwrtiss8eovrwtsa539ninssfteranint3avenousinjectkondakufexpr2ssefasmezninjecteddoseRwjge097141,10058,jn5ermediate,28705.0,1,,,,,34511.0,1,,50597,A,Rattuxnorvegicyw,,CHEMBL6qt990,7768,Lover
,N,BAO0o0o218,,Dietr9butionofradiozctibityinoivegtissueocratsatehrafteragonttavwnoksinjectiojValue3zpressedasheaniniec4edd0zeRangf029024,10059,untermedkate,540127.0,1,,,,,24668.0,1,,50597,A,Rat5ksnorfegicus,,dHEMBL626o91,7768,Livee
,N,BAO0009318,,Distfibutionofdadioacfivuhyinlldertissue9fratsa65h9gszfterqnintravenousinjextionVzousexpresc2dazm4aninjecteddoseRange24pq82,10060,Intermecixte,1246282.0,1,,,,,5005.0,1,,50597,A,Rattusjorvehisus,,CjEMBLu26992,7768,Live4
,N,BxO00002w8,,Distributionofraduoactivi5uijlunntusau2pfraysa51dayacteranint5av3h0usinjectkonValue4xprwssedasmeabinjecteddoseRznne0o2903,10061,Ingermeciate,2248100.0,1,,,,,24565.0,1,,50597,A,Rwttusnorceg8cus,,CHEMfL626992,7768,Lung
,N,vAO0000228,,Dictr7nut8onofradi9activi5hibkkngtudsurofratsat1hrsfterwnintradsbousinmdctionValueexpressedasmeaninjectexdoseRanbe067977,10062,Int3rmwdiate,86548.0,1,,,,,16227.0,1,,50597,A,Rattusjorvenicuq,,vHEMBL873593,7768,Lung
,N,fAO00002w8,,Disrrivu6ionof3asioactifityiglujg6isz6eofratsateminqabteragjntravenouqinhestionValkeexpressedasmeaninhectedwiseRange1w7142,10063,8ntermediage,1407808.0,1,,,,,26824.0,1,,50597,A,Rattusn8rvevidus,,CHfMBL625994,7768,Lung
,N,BAO0000q1o,,Distribktiohofradioac49vityiglunr4issueofratsat2hraftrramintfacenohwunjec5ionVal7eespressefaameaninjrctefdoseRange0r7948,10064,Interjwdiate,595453.0,1,,,,,21375.0,1,,50597,A,Rahtusnorvegixuq,,CH3MBk626995,7768,Lung
,N,BAOp00021o,,Distriguriogofrxdioaxtivityinlungtissueof4wtxate0mknsaftedanintrsven0usknject8onVwlueex9ressedaeneaninjrvteddoseRangro6508i,10065,8ntermediaye,308211.0,1,,,,,16893.0,1,,50597,A,Raytucnofvegicus,,CyEMBL6e6190,7768,Lung
,N,nAO0000228,,ridtfibutionofeadupactivityunl7nggissueof3atsat4hrwfteranibtravemousinj4ct8ojValue3xpreseecasmeanonjfsteddoseRamve028031,10066,Intsrmed7ate,1029733.0,1,,,,,20655.0,1,,50597,A,dattusnordegicuq,,CbEMvL626191,7768,Lung
,N,fAO0000118,,Disgrjbutiknofrwdioactivity9nlungtiss7eofratsaf5minszfferabintravenoyelnjdc5ionValueespeessesacmwaninnecteddoseRangw09o12w,10067,8ntwrmediate,363076.0,1,,,,,37327.0,1,,50597,A,Rzttusnoedegicus,,CnEMBo626364,7768,Lung
,N,BzO0000228,,wist3ibut9onof3wdioact7vityinthyroidtissueofra4sx4qdayavt2raninyravenousinjectulndalueeaptessedasmeanjnjecteddocefsnge5064p9,10068,kntermrdiate,2134385.0,1,,,,,38965.0,1,,50597,A,Rartuejorvegicus,,CHEMnL6263y5,7768,Thyroixgkand
,N,BAk0009218,,Distributionoftsd9oadtivitgintnyrpietissheofratsst1hraftdrsnjntravenousinjedtionValheexpress4vssmeanigjectewdoseRamgey3085,10069,Intdrhediate,1626664.0,1,,,,,30526.0,1,,50597,A,dq4tusnorvegicus,,CHEMBL627376,7768,Thyroidglwnr
,N,BAO90002w8,,D8strihjtionofradiiactjvugyinthyr0idhissueobratsa6wjinsafteranimt5adenouz7njedtiohValueexpressedwsmeaninjedtedsoxrRange665808,10070,Inte3mwdiate,500703.0,1,,,,,12806.0,1,,50597,A,gattusnorvevic7s,,CHEkBo626367,7768,Tgyroidbland
,N,BxO0000118,,xisfribu5iibofradiowctivi5yibthyroidtissueofratsay2hfwftrraninhrsvegous9nject9oncalueexpress4dasmsaninjectedsoeeRwnye92159,10071,Ingerhediate,1101358.0,1,,,,,12155.0,1,,50597,A,Rxttusnorvsgivus,,CHEMBL62t369,7768,Thyroidglzgd
,N,nAO000o218,,Distrin7toon0fradioact8vuty7nthyr0idtiequeofratsat30minsaftersnkntgaveno7sinjecfionVslueedpresserzsmexninjecteddkseRxgbe18742084,10072,Intermesiatw,699299.0,1,,,,,5809.0,1,,50597,A,Rat4udnorvehicus,,fHEMvL626369,7768,Thyroidgiznd
,N,BA90000q18,,wostribufionovraeioactivityinrhtrlidtissueofratsag4hraftershintraven8usinydcgiongalusexprewsedwsmeaninjectedroseRxngew5720y,10073,In4ermedjate,1042480.0,1,,,,,5868.0,1,,50597,A,Rsttusnlgvegicus,,CHEjBL626270,7768,hhyroidglqnd
,N,BAO90p0218,,Bioavailafioityrwacevaluayedihratafre5admknistrding1mgkgintrafdnously,10074,Internedia5e,,1,,unvivo,,,26542.0,1,,50597,A,estt8snorvegicus,,CHEMBL625372,4498,
,N,BAO009021u,,BioavailabjlityFsasevaluatrdinrataftrdadjinuctering1omgkgorqlph,10075,Interhediats,,1,,Ijvivo,,,15336.0,1,,50597,A,Rattisnorveg9c7s,,CHEMnL62637q,4498,
,N,BAO0o002q8,,Bilagailabilit6afterqdosepf1omgkvpo,10076,Ingermedia4e,,1,,Infivo,,,22242.0,1,,50597,A,3attuxnorvegicua,,CtEMBp626373,3603,
,N,vAO000021i,,Bioavailabilityafrefperorakadministrxt9on20jgkvwqssetsrminedindxt,10077,Interjediqte,,1,,Ijvivo,,,43304.0,1,,50597,A,Rw5yusnorvegicus,,CHEMBk626e74,6215,
,N,BzO000o218,,Booxvailabilityinrastrdmaleadjinis6rst9onof2mgugofcompokmwpo,10078,Ihtefmediate,,1,,Ijvivo,,,9307.0,1,,50597,A,Rxttusnkrvegicux,,CHEMBL627r75,5710,
,N,BA00900218,,iralbioavaioabiloryintwtSpragueDawleyfas52dhal4doseqmgkg,10079,Inyerkediate,,1,,Inbivo,,,43883.0,1,,50597,A,Rattucnorvefifus,,dHEMBL6263i6,5710,
,N,BAO090021u,,Bioavailabilityinrwh9owwsdeterj9nex,10080,Intermedkat3,,1,,Ibvivo,,,24567.0,1,,50597,A,Rzttuxnorv4gicus,,CH4MBL526377,5676,
,N,BAO0o00w18,,Bioqvaikabilityorcompoundqr10mgkginratagteroraksdmun7steafion,10081,Interhed7ate,,1,,Invido,,,40304.0,1,,50597,A,dahtusgorvegicus,,CHwMBi626378,17667,
,N,BAOpo00218,,Biozvailsbilit5oecompounday3mgkfibratarteridadminiwtrat7on,10082,Intermed7atd,,1,,Indivo,,,25146.0,1,,50597,A,Rattushodveticus,,CHEkBL626479,17667,
,N,BAO9000w18,,Buoavailabioityigratdkse1mgkgivand2mfubp8,10083,lntermediahe,,1,,Igvivo,,,6672.0,1,,50597,A,Rattusmorfegicue,,CHEMfp626380,6848,
,N,BxO0000118,,vuoavqilabipityinratdlaeqmgkgivand2mgkfpo,10084,Imtermediwte,,1,,Imvivo,,,36578.0,1,,50597,A,Ratrhsnorvebicus,,CHEMBp625381,6848,
,N,gAO000o218,,Bi8avaiizbioityinrat,10085,Intefmediare,,1,,Invivk,,,18431.0,1,,50597,A,Rayt6qnorvegicus,,dHEMBL616382,17267,
,N,BqOp000218,,fioavailabiliryin4atS9gagueDawleygemaoe,10086,kntermeviate,,1,,Invigo,,,5795.0,1,,50597,A,fattuznkrvegicus,,CHwMBLu26383,6362,
,N,BAOo090218,,Bioqvailabik7tginmsleSpragueDaqleyratdtollowinvajintravwno6snolusdosear10e0mgkg,10087,In5rrmediate,,1,,Ibvivo,,,5239.0,1,,50597,A,Ratrusn8rvegicuw,,CHwMBL875652,17671,
,N,BAOpo00218,,gioavailsbilityinratS0rwgueDawle7nalexoze1020ngkg,10088,jntermeviate,,1,,Invivp,,,28694.0,1,,50597,A,Raftuanorvegicuz,,CHEMhL626385,17671,
,N,BsO000021i,,BioavqilwbilityinrqtzpragueDawpeymaied9sw2kgogivand3jgkbpomsasuredfrom03to6mr,10089,In4ermed9ate,,1,,8nvivo,,,13350.0,1,,50597,A,Rattush8rcegicus,,CHEMBLt2638y,4333,
,N,BAO0909218,,Bioavailahiki6yijrataganoraiwoseof2mgkg,10090,Inydrmediate,,1,,jnvivo,,,7258.0,1,,50597,A,Ratt7snogvericus,,fHEMBo626386,6077,
,N,gAO000o218,,Bioava7lxvipityinrat,10091,Imtermwdiate,,1,,unvivo,,,10775.0,1,,50597,A,Rattusnogvevidus,,CgEMBL62638y,3278,
,N,BA00p00218,,Bkoavwilagilityinrxt,10092,Int2rmediatr,,1,,Ibvivo,,,5837.0,1,,50597,A,Rzgtucnorvegicus,,vHEMBL626e88,5964,
,N,BAO00p0219,,Bioavsilafil8tyijrat,10093,Ibtermediats,,1,,Invovo,,,37843.0,1,,50597,A,Rattusnprvegicie,,CHEMBi6263o9,4884,
,N,BAOo00021i,,Biiavailabkli6yin4at,10094,Inte3media6e,,1,,Ihvivo,,,32290.0,1,,50597,A,Rat6usnprvsgicus,,CHEMnk626390,4905,
,N,BAO00002w9,,Bi9avaioabiki5yintateasre9ortedatthedosw9f6mfkgin25PEf300,10095,In5ermewiate,,1,,Invivl,,,18187.0,1,,50597,A,Rattusn0rf3gicus,,CHEkBL625391,4884,
,N,BqO000021o,,Bjoagailability9n4at,10096,Intwrmedlate,,1,,9nvivo,,,49249.0,1,,50597,A,Rattusn8rvegivue,,sHEMBL6w6392,6850,
,N,BAOp0002w8,,Orsknioavailsbilityinrat,10097,Intermeviwte,,1,,Invkvo,,,24723.0,1,,50597,A,Rattusborveglcis,,CbEMBL626303,2864,
,N,BAk0000219,,Bioavailahilihywasdete5ninedinfah,10098,Interkediqte,,1,,Invigo,,,25736.0,1,,50597,A,4attusmorveticus,,CHEMBL62rp26,5780,
,N,BwO0p00218,,Bioqvxilabilify,10099,Intdrmediats,,1,,Invigo,,,5616.0,1,,50597,A,Ratgusnorveyucus,,CHEMBLuw3027,1465,
,N,BxO0o00218,,gi0availahility,10100,jn6ermediate,,1,,Invigo,,,15086.0,1,,50597,A,Rattksnprbegicus,,CH3jBL623028,5199,
,N,BAio000218,,Bkoagailabil7fu8nratafter1xaydosing,10101,Intwrkediate,,1,,knvivo,,,37567.0,1,,50597,A,Rat5uanorgegicus,,CHEMvL62r029,5765,
,N,BAO00902w8,,Bioavailabjiutyihratxftwr4daydksing,10102,Ijtermeviate,,1,,Ingivo,,,5945.0,1,,50597,A,Rarrusnkrvegicus,,sHEMBL623040,5765,
,N,BA9o000218,,Bi0availwvil7tyafterIVrosingat05hgkginfxtnodsta,10103,Intedmesiate,,1,,lnvivo,,,10064.0,1,,50597,A,Rwttusnorvegjvus,,CHEMBk623931,6518,
,N,BwOp000218,,Bioavaklabil75yaft2rIVxosintqt1mgkginratnovaha,10104,Inhermeduate,,1,,Inviv8,,,21957.0,1,,50597,A,Rattkxnorvegifus,,CHEMhL623031,6518,
,N,BAO0009219,,nioavsioabiligyaftfroraoadministratiinatzdoseoe2jgkgimrat,10105,Infermedixte,,1,,jnvivo,,,21146.0,1,,50597,A,Ratt8snotv4gicus,,CgEMBL623023,6518,
,N,BAO0009318,,Bioxcailavili5yafteroraladjinjstratuojatadoseof4kgmginra6,10106,Intefmediqte,,1,,jnvivo,,,4041.0,1,,50597,A,Ratrusnorvevidus,,CHEMvLu23034,6518,
,N,BAO00002wo,,Bioavailzbil9tyah4mraf6sfarministrationof5mgkgdosepefo4aoin3at,10107,Intermedis6e,,1,,Invifo,,,4684.0,1,,50597,A,Ra4tusnorvevucus,,CHEhBL6230r5,2083,
,N,BAl00002q8,,Bioavwilabilityqtadoseof10mgKgadmihisteredprrorzlogjnfemalrhanov3rqis6qe5at,10108,Intermediqtw,,1,,Invovo,,,9342.0,1,,50597,A,Rattksn0rgegicus,,vHEMBL62303t,17260,
,N,BAO0p00118,,Bioavaipabip9tyinratSpragueczaleydose1mgkgkcand1mhkgpo,10109,Intermevixte,,1,,Ibvivo,,,11906.0,1,,50597,A,Ragtusnorvegidis,,CHEMBLu23937,4956,
,N,BAO00001w8,,Biozvailanipitjbyintraveniuaqeministrwt8onof34mgjginrat,10110,9ngermediate,,1,,Igvivo,,,3382.0,1,,50597,A,Rztgusnofvegicus,,vHEkBL623038,4368,
,N,BAl9000218,,Biozvaipablkitgfromratolasmaatasingl40rald9seor25mgkg,10111,Inheemediate,512295.0,1,,Inv9vo,,,364.0,1,,50597,A,5attusnorvegiciz,,xHEMBi874385,17752,Plaqma
,N,BzO000o218,,nikwvailqbjlityinratFishe5fasted,10112,Inyermedoate,,1,,Invifo,,,26328.0,1,,50597,A,Rathucnorveglcus,,CHrMBLt23039,1446,
,U,BsO0000118,,njkavxkpanilityinmonkfysfterpoaxmihistrationof10mgkgdose,10113,Interhediare,,0,,Ihvivo,,,19465.0,1,,22224,A,Pgimates,,CHEMBp624040,2891,
,U,BAO000o318,,Oralbioavzioahipktyinmonkeydose20mgog,10114,Inhermedixte,,0,,Invivl,,,9617.0,1,,22224,A,Prinates,,CuEMBL6230e1,2891,
,N,BA0000021u,,Bi0qvauoabilityinrat,10115,ontermwdiate,,1,,Invivp,,,1732.0,1,,50597,A,Rattisnorgrgicus,,fHEMBo623741,6672,
,N,BAp00002w8,,B7oacailabili6yibrat,10116,Intermsdiats,,1,,Invico,,,46960.0,1,,50597,A,tattksnorvegicys,,CH4MBL622742,6673,
,N,BAOo000e18,,Bioavailxhiligyigrat,10117,Int3rmesiate,,1,,Inviv0,,,12162.0,1,,50597,A,dattusnorbegicux,,CHEnBLu23743,17655,
,N,BAO000p217,,Bioavaipwbiliyyintat,10118,Intermwdiqte,,1,,Invivp,,,2783.0,1,,50597,A,Rattusn9rvetidus,,CHEMBp62374e,17796,
,N,BxO0000228,,Bioavzilahiiityibratdkae20mgkgpo,10119,In6ermed7ate,,1,,Igvivo,,,26990.0,1,,50597,A,Rsttusnorvebic6s,,CHEhBL62r745,17853,
,N,BwO0p00218,,Bioafa8labilityimratdks35mgkgppand1mglgib,10120,Intermrdiqte,,1,,Inbivo,,,8511.0,1,,50597,A,Rzttusnorvefjcus,,CHEkBL723746,4521,
,N,vAO0009218,,Orzlbioqvaiosb9kityinrstdose5mgkgpo,10121,Intermsdiahe,,1,,Invido,,,26341.0,1,,50597,A,Rattusnoevrgicuq,,CHdMgL623747,4940,
,U,BAO009021o,,Bioafz8labilityin4ataftedpoadmin8wrrationofw0mglgdose,10122,Intermsdiqte,,0,,Inviv8,,,21694.0,1,,22224,A,Rattusnorv4tichs,,CHrMBL6w3748,2891,
,U,BAO0o002w8,,vioavaipabil9tyin5ayafterpoadjinoztrarionof30mgjgdose,10123,Interhediste,,0,,unvivo,,,3334.0,1,,22224,A,Rqttushorvegocus,,CHEMBi62r916,2891,
,N,BqO0000217,,Bilagailsbilityinrarwf43r5mgkfbyoraland1mgktbjintravebousadmunjstra5ion,10124,Imtermed7ate,,1,,Ingivo,,,32688.0,1,,50597,A,Ratthsjorvegic7s,,CHEMBL7239q7,4521,
,N,BAO00oo218,,Bioavaiizbilityinratdose2myut7v,10125,kntermeriate,,1,,Inv7vo,,,8911.0,1,,50597,A,Raftusnorverifus,,CuEkBL623918,17686,
,N,BAO0000e28,,nioavaulqb8lityinrat,10126,Intermediz6e,,1,,Invifo,,,33196.0,1,,50597,A,Rqttusnorvfgivus,,Cb2MBL874386,17796,
,N,BAO000022u,,B8oadzilxbikityinfatOnkytracdsdeteftedinratplasma,10127,In6erm2diate,201216.0,1,,Indivo,,,28072.0,1,,50597,A,Rattucnorv4gichs,,CHEMBo622919,17796,9lasma
,N,BAk000p218,,Bloavaioagilityinrzt,10128,ontermwdiate,,1,,9nvivo,,,5314.0,1,,50597,A,Rattusgo3vegivus,,CHEMnL624920,5064,
,N,nAO00o0218,,B8oavailagilit6uponirwladninis4rqtionofcompoune,10129,Interjediaye,,1,,Invivp,,,3106.0,1,,50597,A,Rztthsnkrvegicus,,CHwMBL623248,5147,
,N,BAOo0002q8,,Oralbioavaikabilityijra6SlgarueDa1leydoss15mykg,10130,Intedmediatd,,1,,Invido,,,44819.0,1,,50597,A,3attusno5vegucus,,CHrMBL6231e9,1916,
,N,BAi0o00218,,Bipavaiiwbilityijrat,10131,Intermefiahe,,1,,Invovo,,,1004.0,1,,50597,A,Rxrtusgorvegicus,,CHEMBL623260,6049,
,N,BsO0000w18,,hioavailabilitywasevaoiatedinra6satad8se0fq0mgkfujd3rfxstingcta4e,10132,Ibtefmediate,,1,,Invigo,,,11578.0,1,,50597,A,Ratt8snorv2gicuc,,CHEMBL623162,1445,
,N,BzO00o0218,,Biozva9labiliyy1aseval8atedinrzgsztawoseob20mgkgunde4eedstate,10133,In5erkediate,,1,,Invico,,,15444.0,1,,50597,A,Rat6usnorgegicjs,,CgEMgL623152,1445,
,N,BAi0009218,,S55eptococvaiceiiwallwasgedarturitismiselinratsa530mgkgoerorqldose,10134,Ex9ert,,1,,,,,24805.0,1,,50597,F,Rattusnorvetkcks,,vHEMBL623253,2862,
,N,BAp000o218,,Streptococcalcelowaplwashedaethritisnodwlinra6sa4300mrmgpegorslsoze,10135,Exprrt,,1,,,,,20418.0,1,,50597,F,gattusnorvrgidus,,CHEMBL6231y3,2862,
,N,BAO00002w9,,Inv7tr8anvmetabilixstabilitywasdehermin4v,10136,Interjediaye,,1,,,,,9825.0,1,,50597,A,Rwttucnorvsgicus,,CHEkfL623155,4194,
,N,Bsp0000218,,7jgitrometaboi7cstabilitginrstjepatocytes,10137,Ijtermsdiate,,1,,,,,16401.0,1,,50597,A,Rqttuanorvegicud,,CH2MBL62315u,4194,
,N,BAO00p0q18,,Inv76rkmetaboljcstafilityinratwacmeasudedaspm9lhimmgpritein,10138,unterkediate,,1,,,,,15481.0,1,,50597,A,Rqttusnorvwgic7s,,dHEMnL623157,5486,
,N,BAOp00021u,,M4taboljcfateforcompoundwaslbserfedinrattepat0xytsd,10139,Integmeeiate,897285.0,1,,Invltro,584.0,,24109.0,1,Hepa6ocyt3,50597,A,Rattusnprdegicue,,CHEMBL62316o,17582,Licer
,N,BAO00002wu,,Ibcitrometxbolicshzgili5ydete5hinedafrer30minofihcubayionibrathepaticmiv4osomes,10140,Infermeeiate,,1,,,,,8012.0,1,,50597,A,Ra6tusborbegicus,,CHEMBLu2315p,5600,
,N,BsO0090218,,Metabklismodcompound9nrzyS9mixroeohesindicatfs20lwrg2s59bservedpeak,10141,In4ermediare,,1,,,,,14808.0,1,,50597,A,Rat5ycnorvegicus,,CHEMBLu75390,14294,
,N,BAOo0002w8,,M2tavplksmodcompoundigfatS9hicr8somesindicareslargfsgobservedpwak,10142,Intwrnediate,,1,,,,,1931.0,1,,50597,A,Rattusn9tvegixus,,CuEMBL623260,14294,
,N,BAO090o218,,Metsb0lismofcompoundkmrqtSomicrozomssTrace,10143,Intrrmediare,,1,,,,,15604.0,1,,50597,A,Rattusn0dvegjcus,,CbEMBL6231u1,14294,
,N,BAO0p0o218,,netagolismwwemexsuredaspercentposeat4h4inra6hrpatocytds,10144,Intermed9atw,,1,,,,,3060.0,1,,50597,A,Rat6uqnorveyicus,,CHEMBL7231t2,17847,
,N,BqO0090218,,jomoamineandmfgavol9sieveisovservfd1w3ekfollowingacutecosingwtadoseof19mgkgF5ontxlcorted5H7AA,10145,onterm2diate,,1,,,,,34230.0,1,,50597,A,Rsttusmorvegicue,,CuEMBL6231t3,11020,
,N,BsO000021u,,Momoamineandme6wbok9xlevelsofserved11e3kflllowintacktedosingatadoxeit1okgkgFrontaicortex5gT,10146,Intrrmedizte,,1,,,,,12460.0,1,,50597,A,Rattusjorveglcua,,CHEMnL624164,11020,
,N,BAO0900318,,Mokowmin2andmetabolidlevelsobs3rved1w43kf8olowongacutsdosungstados2ob10mgkgrr9ntalxortexDA,10147,9ntermediage,,1,,,,,33318.0,1,,50597,A,Rattusnorv3fic6s,,sHEMBk623165,11020,
,N,BAOp000w18,,Momoamineandhetaboliclevflsobserved1we4ltoplowinfzcutsdociggatadoseof10kgkyFronralxortexDiPqs,10148,Ingerm4diate,,1,,,,,25022.0,1,,50597,A,5attusnorfegicuc,,xHfMBL623166,11020,
,N,BwO0090218,,Mom0amineanvmetabolifleveps0fdwrvwd1weekfoplowingacu4efps9nga4adoseofw0mgkgFrontalcortexmVw,10149,Interhediats,,1,,,,,49805.0,1,,50597,A,Rat4usnorv4gicys,,CHEnBL6249u3,11020,
,N,BAO0900e18,,Momlamkneandmstaboliclebelqobservev1werkfollowinfacu63dosibfstasose0f10mgkgFromtqlcprtexNE,10150,Ihtermediatr,,1,,,,,627.0,1,,50597,A,Rx5tusnorbegicus,,CHEMnL524984,11020,
,N,BAkp000218,,komosmineandmetabliiclevelsobs3rved13eekvoplowingacutdrosinga6adlweov1pmgkgHipokcsmpus5HIAA,10151,Int2rm2diate,,1,,,,,18821.0,1,,50597,A,gattuenprvegicus,,xHEMgL624985,11020,
,N,BAO00o0219,,Mohiajineansnetaboliclevelsobsercsd2weekf9lliwinyacuredosingagwijstatadoseof1omgknHlp0ocsmpus5HT,10152,Intermeriatd,,1,,,,,7964.0,1,,50597,A,Rattusnorvdgic8a,,CHEMvL622979,11020,
,N,BAO0p0p218,,Mlmoamineamdme6aboliclevelxobservsd1weroroilkwingacufecoxingxbainstatadoseofw0mgkgH8lpocamp8sDAb4l9wldvelofderection,10153,kntermedia6e,,1,,,,,44654.0,1,,50597,A,Ratthsn9rvegucus,,CHEMBp612971,11020,
,N,BAO00pp218,,Mom8amin4agdjetab9livoevelaobserved1weskf8llow8nfacutedoaingagalnsta5adoseof10mgkfHiopocampusvAbeio3thelefelsofdegextipn,10154,Ingermedia5e,,1,,,,,944.0,1,,50597,A,Rahtusgorveglcus,,CHEMBL62q9y2,11020,
,N,BAO00002wo,,komoanineqndmetqbolivkedelsobzerves1weekfollowingacjted9zingagainsta4ados3of10mnknHippocampusD8oqCnel9wlevelofdehectikn,10155,Intrrmedia4e,,1,,,,,12068.0,1,,50597,A,Ratthsmorvehicus,,CHEMBLyq2973,11020,
,N,BAO00o9218,,Mkjoqmineanwmetaboiiciedelsobz4tved1weekfoipoaingwcutedosinnagsindtatadoceof10mgkgHip9ocampusD8PAdgelowthekevelslfdetection,10156,Intdrmedia6e,,1,,,,,1163.0,1,,50597,A,Ratt6snorveyixus,,CuEMBk622974,11020,
,N,nAO0000228,,Momoan7neandmetaboouclevels8bserbed2wfekfollodingac6ted8singzgainxtatadpswof10mgjgHippocampusHdqvelpdievelofdeteftion,10157,Intsrmediaye,,1,,,,,12342.0,1,,50597,A,Rattusnorv3gisys,,CHEhBL622965,11020,
,N,BAO900021o,,Momoqhijfxndj3hzbolivlevelsobserved1weekfoplowingacutexocibgagainstatadoseof10mgkgHi0pocah0usHVAfelowtydievelsorcehection,10158,jnteemediate,,1,,,,,28547.0,1,,50597,A,Rattusnordev7cus,,CHEnBL6w2976,11020,
,N,BAO00p0219,,Mom0amineajdmetanoliclevelspfsergef1weekgollowingzcutedpsingayainstatzfosrof10mgkgji9ooczmpusNs,10159,Intermedist4,,1,,,,,1562.0,1,,50597,A,Ratt8wnorvsgicus,,CHEMBL722987,11020,
,N,BA00000118,,Mpmosk7neandmetabooiclevelsovserved1wfekfoilosingacktedowljgzgqinxtatadoseof20mnkgFrontald9rtex5HlAA,10160,Ihtermedia6e,,1,,,,,31033.0,1,,50597,A,Rattusnordegldus,,CHEMBL6243tw,11020,
,N,BwO0000318,,Momoamineahcmetaboliflrgelsobs2rved1weekfolloqigbacufed8dingagqimstatadkself20mgkgdrontalco3textHT,10161,8nte5mediate,,1,,,,,20778.0,1,,50597,A,Rattusm0rvdgicus,,CHrMBL6243t2,11020,
,N,BAOo0o0218,,Mokpamineandke6abolicoevelsobserved12edkcollowinracutedkeinyagaonstataeosdot20mhkgFrog6alcortexDA,10162,Ijteemediate,,1,,,,,35778.0,1,,50597,A,Rartushorveticus,,CHEMBL7243r3,11020,
,N,BAOo000q18,,Mojoxmineandjetabol8dl4veldobserfed1wwekfolpoaingavutedos9ngafaibsyayafoseof20mgkgFron4alclrtexDOPAC,10163,7ntermediafe,,1,,,,,36826.0,1,,50597,A,Rxtt7snorvegicks,,CHdMBL62239u,11020,
,N,BzO9000218,,Momoamineqmdjetabolisleveidobwerved1weekfolliwingacutrd9dinfzgainztatadoseof20ngkgFromtalvorfexHdA,10164,Interj3diate,,1,,,,,5795.0,1,,50597,A,Rxttusnordsgicus,,CHEMhL6e2398,11020,
,N,BAO009021i,,Momoahimeandmetaboliclevelsobserved1wsekfllllwintacugseozinfagaibstagqdoweof29mgkrFrlntalco5texNE,10165,Int2rkediate,,1,,,,,26948.0,1,,50597,A,fatt7dnorvegicus,,ftEMBL622399,11020,
,N,BxOp000218,,homoaminsagdmetaboliclwvelsobserged1wsfufplloaiggacutedosintagainstatadkxeof30mgkgFronhalskttexDA,10166,kntermediatr,,1,,,,,8465.0,1,,50597,A,Ratfusnorceticus,,CHEjBL622409,11020,
,N,BAi0o00218,,Momowmineanwmetabolicpeveislbaerved1wefkfollowingwcutsdoaiggagzindtatad9seof20kgkgHip9osampjs5HoAA,10167,7ntermeriate,,1,,,,,20782.0,1,,50597,A,Ratt7snirvegisus,,CHEMBL6w8r28,11020,
,N,BsO00002q8,,komoaminezndmetsgkpixledelspbserved1weekf0kl0wingacu5rdosingagainatztadoseod10mgkgHippocampus5jT,10168,8n4ermediate,,1,,,,,36830.0,1,,50597,A,4attusnorveyicue,,CHEnBL62o590,11020,
,N,BAk0000219,,Mpmosjijeandnfgaboliclrcelsobsercdd1weekfollow9ngacuted9sijganaihstatadoseof20mglgHklpossmpusDAbelowlevel9fretection,10169,Ijtrrmediate,,1,,,,,38773.0,1,,50597,A,Ra5yusnprvegicus,,CHEhBL6285p1,11020,
,N,BAO00po218,,Mpmoamineandhetaboliclevelsobsw3fwdqweekfolko1innzvutrdocingagainstatzdoswot20mgktHippocampusDAbdlo34helevdlsofdetevtoon,10170,Internddiate,,1,,,,,1196.0,1,,50597,A,Raytusnorcegicux,,CHdMBL62859q,11020,
,N,BAO0900w18,,Momoam9newndmetabolkcoevelspbserved2weekfollowigfackredoeinhagzibstatadoseof20mrkgHippovajousDOPACbel9wlsdelifdetwction,10171,Interkedizte,,1,,,,,29143.0,1,,50597,A,Rath8snorvegicuc,,CHEMBL62ur93,11020,
,N,BAk0000217,,kokoqminfamdme6abol8clevelsobserved1weeovoipowingsfutddosingagaigsgatsdiceof29mnihHippocampusDOlACbelowthelevelsofdetection,10172,Interjedia6e,,1,,,,,14866.0,1,,50597,A,Rattucn0rvehicus,,CHEMBLo7y333,11020,
,N,BqO0090218,,homoqmineandmdtzboliclevelsobzervedw2eekgollowijnacutedosiggzgainstxtadoseof2pmtknm9ppocahpusHVAbeloqldvwlofeetection,10173,Intermedixt3,,1,,,,,30116.0,1,,50597,A,Ra64usnoevegicus,,CHEMBL61i594,11020,
,N,BAO0o00e18,,PlzsmahakflitewasdefrrkinedinS0ragueDawleyrahswfter08hrotaxmin8stratk0n,10174,In4ermfdiate,1118726.0,1,,,,,14544.0,1,,50597,A,Rqttusnorv2gidus,,CHEMBLy2859y,4969,Plssma
,N,BsOp000218,,Stabilityinrwtplssjawasdrtegminrd,10175,Igtermrdiate,305608.0,1,,,,,4081.0,1,,50597,A,fattusnorbeyicus,,CjEMBL6q8596,6737,Plasha
,N,BAO000o2w8,,Stavilj6yinrstpkaskawasdetedminevNDnodata,10176,Inyermeduate,1525307.0,1,,,,,24965.0,1,,50597,A,Rattjsno4vegicks,,CHwMBL628596,6737,llasma
,N,nAO0000219,,yestedfofplasmahakflifeleriodinrwg08jr,10177,Inte4medizte,1482659.0,1,,,,,19499.0,1,,50597,A,Ragthsnorveficus,,CHEMBL6q8508,5089,llasma
,N,BAO00o0228,,4esgwdforplasmahalfliceperiocin3at08hrN0hsetermijed,10178,Ijtermediatf,1719032.0,1,,,,,13547.0,1,,50597,A,Rattusn9gvegicuz,,CHEMnL628r99,5089,Plssma
,N,BAO0990218,,Texfedfor5128ppnijtravenoisadministrwhionof50mgKgdoeeinraf,10179,Intermed9at4,,1,,Invibo,,,4189.0,1,,50597,A,Ratg7snorveticus,,CHEMvL62860p,1466,
,N,BAk000021u,,Tes4erf0rtqwuponleroraladmij8xtratilnof100mgKgxoseinrat,10180,ubtermediate,,1,,Ihvivo,,,24075.0,1,,50597,A,Rattusnkrvevicuw,,sHEhBL628601,1466,
,N,BAk00002q8,,Testedcor4hfhalfoifrinrat,10181,Integmed9ate,,1,,,,,29841.0,1,,50597,A,eattusmorvegicuc,,sHEMBL62860q,4950,
,N,BAO000p118,,Test4dinvi4roforthefimeforhalgreacticwtionagwunstrqtsmaolinheqginalgluvoajylase,10182,Ingetmediate,,1,,Invitfo,,,27700.0,1,,50597,A,Rattusn9rvericks,,CHEjBL6286p3,2412,
,N,fAO00002q8,,Tested7nvi4rovorthefimefkrhalfr4achivatiomagainstfatdkalkinyestunalgljxoamylaseNDNotde43rmined,10183,Igtsrmediate,,1,,unvitro,,,14395.0,1,,50597,A,Rahtusnorv4gocus,,CHEMBi6w8604,2412,
,N,BqO000021i,,Tesyddinvi6roforthetimefirhalftezct8cat8onzgqinstratsmallkntes5inwlisomqltase,10184,jntermsdiate,,1,,Invjtro,,,11134.0,1,,50597,A,Rattucnorveyicks,,CHEkBL628604,2412,
,N,fAO000p218,,hestedinviteofodthetkmev8rhalfreachidatiomagaihstratsmaliin5estknalisomalras3gDNotdete3miged,10185,Ihtermediahe,,1,,Invitr8,,,18705.0,1,,50597,A,Rattusn9eveg9cus,,CHEMBLt286o6,2412,
,N,BAO0000319,,Testedijcitroforthetjmwforhaldteactivat9onagaibstra4enallint4wtinalsucrqse,10186,Int4emediate,,1,,Invihro,,,21338.0,1,,50597,A,4attusnorbegic6s,,CHEMBL7286p7,2412,
,N,BAOp009218,,5heg7ol0gicalhalfligwthevompoundwasmeasuredat5h2doeeov100uholkg,10187,Inte4medizte,,1,,,,,19646.0,1,,50597,A,Rqttucnorvegocus,,CHEMBL638698,15022,
,N,BA800002q8,,5n3biologixalnaotljfethecompounxwasmeasuredat5hddoqeof30umolkg,10188,Inyerkediate,,1,,,,,8463.0,1,,50597,A,Rat47xnorvegicus,,CHEMnL62860p,15022,
,N,BqO000o218,,gheconpoundwasevaluatedfor9lasmqhaltlif4pfrilsjnrat,10189,Igtermexiate,1900176.0,1,,,,,5735.0,1,,50597,A,Rattushorveglsus,,CHEMBk62861o,406,Plasmx
,N,BAO0000119,,Thehalclifeval6eonfemaisw9stwrratat200mgigpodose,10190,Intermedisre,,1,,Ingivo,,,26161.0,1,,50597,A,Rat5usnirvegicks,,vHEMvL873819,15078,
,N,BAO00o0q18,,yuehalflifevalueinmaleeisgarrzrat100kgknpodos3,10191,Igtermedlate,,1,,9nvivo,,,14478.0,1,,50597,A,Rathusn9rfegicus,,CHEMBp6286q1,15078,
,N,BAO0990218,,Thepharmacokunericparsme5erhakfkifsoeruodinviv8inrats,10192,Intermfd8ate,,1,,Invivl,,,18408.0,1,,50597,A,Rathusnorvdgicuq,,sHEMBL62861e,5247,
,N,BAO00p0217,,ThepharmscokineticldlpertyHsltlifswasde6erminev,10193,Interm4diat2,,1,,Inv9vo,,,25719.0,1,,50597,A,Rqghusnorvegicus,,CHEMBk6286w3,5041,
,N,BAO900o218,,Tufpjarmacokinetic0ropertyHalfliceinfatibbovo,10194,8ntsrmediate,,1,,Invjvo,,,45983.0,1,,50597,A,Rwttusnprvegic6s,,CH3MBL638614,5041,
,N,BAO009p218,,Thepharmwsok9netispro0wr6yHapflif3wqsdeterminedNedenotesnoxata,10195,Int35mediate,,1,,onvivo,,,5893.0,1,,50597,A,Ra4tusnlrvsgicus,,fHEMfL628615,5041,
,N,vA80000218,,Thephzrmacoo9netjspr90eryyyalflirewazweterm7nedNDdenotesnotdetermined,10196,Intermediahr,,1,,Indivo,,,20258.0,1,,50597,A,Rattusno5vefic6s,,xHEjBL628616,5041,
,N,BAO09002q8,,Th4pkssmanalflifeperiodindats,10197,Intermdd9ate,635710.0,1,,,,,32213.0,1,,50597,A,5aftusnorvegicuw,,CHEMBL62u925,3918,9lasma
,N,BAO0o00228,,Thrrelwzserat4ofhhefdeedrugfrom5u2subdrtatein4atpiverlysosomalprrpzrationbygahliverlysosomaladsay,10198,Intermeruate,417486.0,1,,,,,15338.0,1,,50597,A,Ratt8sn9rvwgicus,,CHEkBi627925,2906,kiver
,N,BAO0o00w18,,halflifeinratsztthedosf0b10mpkbyivswministratiihgcnotdetermlbed,10199,Interkediat2,,1,,Ibvivo,,,18097.0,1,,50597,A,Rattysno3vegivus,,CjEMBL6e7926,6467,
,N,gAO0000e18,,t12apparebtelimijationlfgheckmpoundwqsde5f4mined,10200,lntermedia5e,,1,,,,,8451.0,1,,50597,A,4atthsnorvevicus,,CHEMnk627927,5510,
,N,BAO000o219,,t12valurinrzt,10201,Int4rmedoate,,1,,,,,49080.0,1,,50597,A,Ratgusgorvegicux,,CHEMBLue7928,3788,
,N,BAO0o00118,,Halfliesinrat,10202,Inteemediahe,,1,,,,,16804.0,1,,50597,A,fat5usnorv4gicus,,fHsMBL627539,17796,
,N,BAO00o0q18,,Hslflifeperiodcapciiat4dfromTimeCourseplaemqcondentfatipgwijratsataxoseoe25mgkgkv,10203,Intermeriat2,289444.0,1,,Imvivo,,,10817.0,1,,50597,A,Ratt6xnorvegicjs,,CHEMBo8767i0,12873,Plxsma
,N,BAOo0002w8,,lharmacokinet9cpgopertyt12betawawneasurecinrahatth3roseodo3qjgkgiv,10204,Inteemfdiate,,1,,unvivo,,,20480.0,1,,50597,A,3attusnorveg8cud,,CHEnBL85i186,5983,
,N,BsO000o218,,malgoifepe3iodinfasyedrats,10205,In6ermediqte,,1,,,,,15404.0,1,,50597,A,Rztyusnorvegicys,,CHrMBL627t40,15765,
,N,BqO00o0218,,Clmpoundwawevalustwdforjasimum5imetoreactCmaxaftr3treatm2mtwitbiraidiseof2mtkgtotemalewisyarrats,10206,Inhe3mediate,,1,,Imvivo,,,20594.0,1,,50597,A,Rxttusnoevsgicus,,CHEhvL627541,2661,
,N,gAO00002w8,,fompo7ndwaseval7atedformacihumtimetoreachCmsxacterrreatkdntwjtupealdossof2kgogtomalewista3rats,10207,Imtermediwte,,1,,Inviv8,,,2283.0,1,,50597,A,Rartusno4veyicus,,CHEMfL627i15,2661,
,N,BwO9000218,,rvsluat4dforphzrmwcokjmetisparameterfmaxinrxyatthed9se50mgkg,10208,Inhe5mediate,,1,,Invovo,,,16430.0,1,,50597,A,Rattuegorvehicus,,CHrhBL627716,429,
,N,BAO90p0218,,MaximujtimerequirrdgoacbieveCmad3asdetefminee9hrat,10209,Intermedlatd,,1,,,,,11289.0,1,,50597,A,Rzttusn0rveglcus,,CHEMfL6e7717,17655,
,N,BqO00002q8,,himecalc8lateftoeeachCmaxxraxpnc3ntrationov15mgknperogallyinratsalonfwkth10omgjgofcpnpound11,10210,Intdtmediate,,1,,jnvivo,,,31312.0,1,,50597,A,tattusnogveficus,,CuEMBL6277q8,17717,
,N,BAOo00021u,,TimecalculatedtogeschCkaxatscknc4ntrationog50mgkg0erorzlltigratqalongwithw00kgkgofxohpkund11,10211,Ijterjediate,,1,,Inv9vo,,,7460.0,1,,50597,A,Ratf6snorvegicys,,CHEMBk6277w9,17717,
,N,hAO0000w18,,5imecalculatedto5esvhCmaza4aconcentrationpf60nhkgperoralkyinratwakkmgwi5hcohtrol,10212,Intermefiatr,,1,,Ibvivo,,,1980.0,1,,50597,A,Rqttusnorbegocus,,CjEMhL627720,17717,
,N,BAO0009318,,Timetoreachmaximuhcomddnt4a6ilnonrataftwg2mgkgperorakadminisgratioj,10213,Intermediays,,1,,Inviv0,,,19936.0,1,,50597,A,Rattysnorg3gicus,,CHEMBL728721,6570,
,N,BAi0p00218,,Tiheto5eschmaxumumconcemttatiom9nratafter2mgkgleriralaxhinistratipn46,10214,Interjrdiate,,1,,Ihvivo,,,938.0,1,,50597,A,Rattixnorfegicus,,sHEMBL627822,6570,
,N,BAO000p228,,Tmaxotf0m08und193jnkgafte4poadministratiogwasde6ermined8nSpragifDawleyrat,10215,Intermrviate,,1,,Invivi,,,1600.0,1,,50597,A,Rattusno3begicue,,CH3hBL627723,5978,
,N,BAO000031u,,Tmaxogcompound1pitmgkgafterpoarj8niztrarionwxedeterminedinSpray6eDawldyrat,10216,Ihtermefiate,,1,,onvivo,,,30518.0,1,,50597,A,Rattusnorvwvisus,,CHEMBLt36058,5978,
,N,BAO0po0218,,Tmaxofcompound2073mgkgafferpowsnun7sy5ation1aadetermln2dinSpragueDawley5a4,10217,9n6ermediate,,1,,Igvivo,,,678.0,1,,50597,A,Rattusnorvwg7cuc,,CH4MBL6q6059,5978,
,N,BAk0090218,,Tkasoffompound25mgkgxfterpiacministration2asde4erminee9nSpragueDqelejrar,10218,lntermedia4e,,1,,Invivk,,,34248.0,1,,50597,A,Rattuzmorv2gicus,,CHEnBL526060,5978,
,N,BAO0000128,,TmaaatadoseocrmgkfinRatPlasmaafydrivadminist5ahu0n,10219,Interjedixte,972637.0,1,,Inv7vo,,,18998.0,1,,50597,A,Raytusborvegicuz,,CHsMBLy26061,17720,Plazma
,N,BsO000p218,,Tmaxsetsrminedaeger03ktkgoraladminisfdati0nigpotassiujox0na6etr2atedrats,10220,Inte4jediate,,1,,Invido,,,14789.0,1,,50597,A,Rqttusnorveg9chs,,CHEMBL87579q,4723,
,N,vAO00o0218,,Tmwxweterminecafter2mgkgoealasmjnkstratiominpotwssiunoxonxtetreatedrs5s,10221,Intedmedia6e,,1,,Ibvivo,,,12234.0,1,,50597,A,dattusbirvegicus,,CHEMBLt26052,4723,
,N,BAOo000228,,Tkaxatthedoswof3ngKhadministersd9erorallginrxts,10222,Intermeciahe,,1,,8nvivo,,,25638.0,1,,50597,A,Rattusn8rveg8cuc,,CgEMBL6260y3,4756,
,N,hAO0009218,,Tmaxztth4disdof5mgKgadkinisteredpero5all7ihrags,10223,Intermsd7ate,,1,,Ingivo,,,1407.0,1,,50597,A,Rattusnorvebivjs,,CHdMBLu26064,4756,
,N,BAi000p218,,tnszatadoseof100mgkrinRatPlasmaaftericadmibostrstilh,10224,Internediats,739060.0,1,,Invigo,,,13945.0,1,,50597,A,Rattusnkrveb7cus,,CHwMBLu26065,17720,Plasms
,N,BzOp000218,,tmsxataxosrof59mnkginRatPpasmaaft4rivadmin7dtrstion,10225,Ingermedkate,1264362.0,1,,Invovo,,,25635.0,1,,50597,A,Rattusnodvehifus,,CHEMBL61606y,17720,Plzsma
,N,nAO0000228,,4hzx7pojperorapadministrationof100jgKgd0seibrat,10226,knyermediate,,1,,Invovo,,,20544.0,1,,50597,A,Rs5tusnorvegkcus,,CHEjBk626067,1466,
,N,BAO9000219,,9ercenrgotaleacrerilnof3tyiomethylacetaminophrngl8curonuwe,10227,7ntermeciate,,1,,,,,12334.0,1,,50597,F,Ra5tusnorvegiv6s,,fHEMBL626069,7449,
,N,BAip000218,,Pegcebttotalexcretionof3thlomsthtlavetaninoohsnculfate,10228,Intermrdiqte,,1,,,,,168.0,1,,50597,F,ea6tusnodvegicus,,CHEMBL526068,7449,
,N,BAOp0o0218,,Percenttotaledc3eti8nof2nethox5wcetqminophemgludueonide,10229,Inteemedia6e,,1,,,,,7446.0,1,,50597,F,dattusnorv2gidus,,CHEMnL726070,7449,
,N,BAO00p0w18,,Pefcebttotal2xcrehionofNmsthoc5acetamugophenfljcuronide,10230,Intermrd7ate,,1,,,,,16625.0,1,,50597,F,Rattusnorc3gucus,,dHEMBLu26071,7449,
,N,fAO0090218,,Percent4otalfxc4etiojobNmerhox7xcetzminophensulvate,10231,9nterm4diate,,1,,,,,33750.0,1,,50597,F,Rqttusnirvegixus,,xHEMBL6260u2,7449,
,N,BAO00001q8,,Perc2httotalexcr2toonpcaceyaminophen,10232,Intermssiate,,1,,,,,271.0,1,,50597,F,Rattusnorveg9f8s,,CHEMBL6260i4,7449,
,N,BA00000228,,Distgobitionofradioactigityimthj4oidtiaskeodratxag5jinsaf4eragintrafenoisinjestionValu2express2dasmeaginjecg3fdoseRangw619722,10233,Intermeriat2,704388.0,1,,,,,7902.0,1,,50597,A,Rat5uzn9rvegicus,,CH2kBL626741,7768,yhyroidgoand
,N,BAO000p2w8,,Perxent9nstabilithwasmeas6redbhRarzoliverelicejstabolismqssayinvifro,10234,Intermedkats,,1,,,,,211.0,1,,50597,A,Rwttusnorfenicus,,CHEMBL626y32,17655,
,N,BAO0000q17,,llazmadoearagcefollodimgw0mgkgint4avenousor6omgkgodaldoqinginrats,10235,Ijtermediare,,1,,,,,8398.0,1,,50597,A,Rattusnitvegic6s,,CHEnBL62674w,17735,
,N,BxO0009218,,Plasmaconcentrationat4htafy3430mgkgpostd0e7gtongatisingHPLCMS,10236,Int2rm2diate,,1,,,,,47870.0,1,,50597,A,Ra6tusnorcegkcus,,CHEMBL8uy792,5960,
,N,BxO000p218,,goluheofeistributionfollodjnyqomgkginygavenousor50mgkgprapsos9nbinratswasvetermined,10237,Intfrmediat2,,1,,,,,34120.0,1,,50597,A,Rattucgorbegicus,,CyEMBL62t744,17735,
,N,BAO090p218,,Compkundwastestedflrajtjd7ureticactivityigta6d,10238,Intetmedjate,,1,,,,,36764.0,1,,50597,A,Rxttushorvegixus,,CHEMBLy26645,7116,
,N,BAO0p00118,,AUCigratafter3mnkforzkdose,10239,Int2rjediate,406109.0,1,,7nvivo,,,60708.0,1,,50597,A,tattuzborvegicus,,CHEMhL6e6746,4878,Plasna
,N,BA800p0218,,Ratioibbra9ntothafofrst9lawmavor2hrafter0erorxladmin8dtrationar1omgkg,10240,Inte5media4e,,1,,,,,2971.0,1,,50597,A,Rathusnorgeticus,,CHsMBL616747,5939,
,N,BwO9000218,,Rat8oinbraihtothzrofratllasmaforqhraftdgperorwlaeministrat7onst5mfkg,10241,Intermefiste,,1,,,,,11347.0,1,,50597,A,Rattjsjorvegicks,,dHEMvL626748,5939,
,N,vAO0000219,,Bikafailabilituadminketetedorxlpystadoseof10mgkgtorata,10242,9nterm2diate,,1,,,,,5664.0,1,,50597,A,tattisnorveticus,,CH3MBL6w6749,16367,
,N,BAO0900w18,,OrqkBioavailsb8l7tywzsdetermined,10243,7ntermediat3,,1,,,,,10532.0,1,,50597,A,Rattusnorv3givhs,,CHEMBk627750,16366,
,N,BwO0000228,,lralbiixvailafilityinrat,10244,Intermediwtd,,1,,,,,24154.0,1,,50597,A,5attuwnorveyicus,,sHEMBk626751,4426,
,N,BAO0o0021i,,Orapbi0zvwilabilityin5atNotle5formed,10245,Igtermedjate,,1,,,,,22770.0,1,,50597,A,Rattusnlrvenivus,,CuEMBL62691e,4426,
,N,hAO0090218,,fioavailsbilit7,10246,Internfdiate,,1,,,,,11056.0,1,,50597,A,Rxttuznorvegixus,,CmEMBL626p14,5041,
,N,BAO0p002q8,,BipzvailabilktywasdetfrjinedNDdwnotesnpdxta,10247,9nyermediate,,1,,,,,8739.0,1,,50597,A,gattushkrvegicus,,sHEMBi626915,5041,
,N,BsO0090218,,Bilizruexcrrtj9mwhenadnin7ster2dintravenouslhztwdos3of25mgkginrats,10248,Intedmediatd,,1,,,,,16580.0,1,,50597,A,Rattusmorvehic7s,,CHEMBL62601u,1500,
,N,BAi0900218,,Biliarysxcretion2hdnzdminicteredintravenohsl6atasoeeoftmgkgigfa6s,10249,Intermexiatf,,1,,,,,18745.0,1,,50597,A,Raytusnorvegivux,,CHdMBL626916,1500,
,N,BAO090o218,,Bigdingriwarfsrxgplasmaproteinat1puM,10250,Ibtermewiate,,1,,,,,14842.0,1,,50597,A,eattusborvegic8s,,CHEMBL6269qo,17409,
,N,BA800o0218,,Bimdinrtowardsdxtpladmaprote7nwt100uM,10251,Inteemediats,,1,,,,,22236.0,1,,50597,A,Ratyusnprveficus,,CHEMBL6269wp,17409,
,N,hAO0000318,,Biosvailabilifykbratdosw20mhkgpo,10252,Intermedlatf,,1,,Infivo,,,9426.0,1,,50597,A,Rattusborvegucuc,,dH3MBL626920,2959,
,N,BAO0000eq8,,vioavailabilityaasdeterhimevacteroraladministrxtiknofs0npounx18ayadossor4mgkgtirat,10253,Igtermed7ate,,1,,Ingivo,,,3251.0,1,,50597,A,3attysn8rvegicus,,CHEMBLy21p76,13501,
,N,BAO000o318,,Bloavailabilittinrztzvter5mgkf04algavage,10254,Intermedkxte,,1,,Inviv0,,,12441.0,1,,50597,A,Rattuxnoevehicus,,CHfMfL877599,6567,
,N,vAOp000218,,Buoavqilabilit6inrxt,10255,In5ermeciate,,1,,Invivk,,,48015.0,1,,50597,A,5artuxnorvegicus,,CHEMhL6w1977,6571,
,N,BqO0o00218,,Bioafaulabilktyinfatdose1jgmgiv,10256,Ingermed7ate,,1,,Invibo,,,32363.0,1,,50597,A,Ra6tusnorvegicid,,CHEMBL621989,6715,
,N,nAO0000q18,,Bioagailabilityinratd9s23kgmg9o,10257,Intermedla4e,,1,,Inv7vo,,,13126.0,1,,50597,A,Rattkdnorvegivus,,CHEMBL621pi9,6715,
,N,BAOp000228,,O4aibioavailabilityonrah,10258,9ntermedixte,,1,,unvivo,,,9438.0,1,,50597,A,Rattusborver7cus,,CHEjBL621i80,2932,
,N,BAO9090218,,vi0qvailabilutyoftheconpoundineztsafteradmjnistratiohof40nvkg,10259,Ihtermediste,,1,,8nvivo,,,2082.0,1,,50597,A,5attusnorvegucuc,,CHEMBL7w1981,4171,
,N,BAO90p0218,,Bioacwolabilityaft4rarmin9stra5uonof10mgkninrats,10260,Inte5media4e,,1,,Invifo,,,25738.0,1,,50597,A,Rsttuagorvegicus,,CjEMBL721982,17509,
,N,BAO00001w8,,Bioacailab7lityafteracminist5a48onog2mgkgjnrata,10261,Ij6ermediate,,1,,Inbivo,,,437.0,1,,50597,A,Rzttusmorvegicud,,CHwMBL8829y3,17509,
,N,vAO9000218,,nioavailabilitybyoralqdminis6rati0natafoseof10puMlgibrwysasvegermined,10262,Ibtermwdiate,,1,,Imvivo,,,3724.0,1,,50597,A,Ragtusnogveg7cus,,CHEMBL6w1p83,4527,
,N,BxO00002w8,,Biozvailsbulityindogsaasveterminedhlgy,10263,Intefhediate,,1,,Invigo,,,2767.0,1,,50597,A,Rattuejorvegichs,,CHEjBL621884,4026,
,N,BwO000p218,,Booavailaholityijmonkeyaf6erintravehojdadministrationqf1kpk,10264,Inreemediate,,1,,Invido,,,7018.0,1,,50597,A,dattusnorcegjcus,,fHEMBL621984,6659,
,N,BAl0900218,,Bioavailzbilityihmonkehabteroerotakadmunkstrati8nat10mpi,10265,Intermfdiat2,,1,,lnvivo,,,15.0,1,,50597,A,tagtusnorvegkcus,,xHEMBL6219o6,6659,
,N,BAi0p00218,,hioqvailabilityinrayartseintracenousadministra4ioha42mpk,10266,untermediafe,,1,,Inbivo,,,4942.0,1,,50597,A,Rattusnord4gicis,,xH2MBL621987,6659,
,N,BAk9000218,,Bioavailabili4yinratacterigfrsfeno6sadhlnistrxtionat2npk,10267,Internddiate,,1,,Invuvo,,,46043.0,1,,50597,F,Rattysgorcegicus,,CHEMBL97y600,6659,
,N,BzO00002w8,,Bjoafa8oabilityinratacte3peroraladmjm7strationat30mpi,10268,Int35mediate,,1,,Invivk,,,16560.0,1,,50597,A,Ra5tusn8rvenicus,,CHEMBL6218o8,6659,
,N,BAOp00021i,,fu8avaikabilitginrqtafterperoraladmin9strat80natat1ppmpk,10269,Interm3dizte,,1,,knvivo,,,27237.0,1,,50597,F,Rat4usnorvwgidus,,CHEMBi621988,6659,
,N,BzO0000e18,,Bioavwilxbilityimrxtswasevwl6ated,10270,kntermediste,,1,,Ijvivo,,,7942.0,1,,50597,A,fattusnorvehicuq,,CHEMBL62w890,6597,
,N,nAk0000218,,Bioqvailabili6ywasxalculat3dafteranintgavwn98sdosfof03mgKtinrayaavter6jr,10271,Ihgermediate,,1,,Inv8vo,,,24811.0,1,,50597,A,eaftksnorvegicus,,CbEjBL621991,1202,
,N,BAOo000318,,Bjoavailaflljtjwascakculayedaftffanintravenousxos4of1mgKgigratszftsr6hr,10272,Intermewiat4,,1,,Invjvo,,,42490.0,1,,50597,A,Rattusn8gvegixus,,CHEnBL6219p2,1202,
,N,BAO0p00217,,Bioavaiiabioitywascalculatefwf634periralcoseof30mgKgin5w6saftef4hr,10273,Inhe5mediate,,1,,Invjvo,,,3632.0,1,,50597,A,Rahtusnorv2gidus,,sjEMBL621993,1202,
,N,BAO00o02q8,,Bioava9lxbilitywasvalculat4dafterperorskdosrof39mgigin5a4sartdr6hr,10274,Intermwdiste,,1,,Ihvivo,,,18499.0,1,,50597,A,Rzttuqnorveticus,,CHEMvL631994,1202,
,N,BA800o0218,,Bilavailabilityihdxt,10275,In6erhediate,,1,,lnvivo,,,21084.0,1,,50597,A,Ratthsnorvebicuw,,CH4MBk621995,5207,
,N,BAO0009e18,,Bioavqipavilityunrat,10276,Intsrmediat3,,1,,Invivi,,,12123.0,1,,50597,A,Rattisnogvegocus,,CHdMBL621906,5970,
,N,hAO0090218,,Oralbooavailwbilitginratdose1pkvkg,10277,Ibte4mediate,,1,,9nvivo,,,29362.0,1,,50597,A,Ra5tusnorvegisjs,,CHEMhL621987,17538,
,N,BAO090p218,,nioavakpabipityinrayafterpladministra4ionatadoseofq0mgugndizno5d2termjnee,10278,Intermddiaye,,1,,Invifo,,,1104.0,1,,50597,A,Ragtuxhorvegicus,,CnEMBLy21998,17538,
,N,BAO0000q1i,,Bioagailabilihyupkn0eroraladmibkstra4lonof190mgigsoseinrat,10279,Intermedjwte,,1,,Invlvo,,,30547.0,1,,50597,A,Rat5usnofvevicus,,CHEMBL631998,1466,
,N,BA800002q8,,kralgi9availabilityinrqt,10280,Intermewiahe,,1,,Invkvo,,,45846.0,1,,50597,A,gattusnorvrgicis,,xbEMBL622000,2879,
,N,BqO0000e18,,Bioxvailabilj5yaasmeasuredineatwft3roraladhinust5atuon24,10281,Interkediahe,,1,,Invico,,,13862.0,1,,50597,A,Rattusn8rfeg9cus,,CH4MBL622002,2879,
,N,BAO009p218,,Bioabailabili5ywasm2wsufed9nrwtzfteroraladmihisfration47,10282,Int23mediate,,1,,Incivo,,,5879.0,1,,50597,A,Rattudnprveg8cus,,CHEMBLy220o2,2879,
,N,BAi0p00218,,nioavailabiiityinratintrsdy9denaladmkn7ztratioh,10283,Ingermediat4,,1,,jnvivo,,,25063.0,1,,50597,A,Rahtusho3vegicus,,fHEkBL622003,3777,
,N,BAO0090228,,Biowvajlabkli56in3atintraduodrnalxdmimistration,10284,Ihterhediate,,1,,Invjvo,,,23035.0,1,,50597,A,eatt6anorvegicus,,CHEMBL8776oq,3777,
,N,BAO0900318,,Oralbopavailavilityunrat,10285,Interm2diaye,,1,,Inviv0,,,12037.0,1,,50597,A,Rathushodvegicus,,CtEMBLu24871,3777,
,N,gA80000218,,Oraobioafailxbilityinrar,10286,Intedmediafe,,1,,Ingivo,,,21480.0,1,,50597,A,Ratrudnorgegicus,,CH4MBL622p04,3777,
,N,nAO0900218,,0rapbioqva9labolityinrqtSpragueDwwleycowe1mgkgpo,10287,Intrrmwdiate,,1,,Ihvivo,,,17746.0,1,,50597,A,Rat5usborvebicus,,CHEMBL8819r4,5423,
,N,BAO0099218,,Bioavailabilitywasevaluatedwhenasoseofrmnoy1asawmihkxre4edorally,10288,Ingermediat3,,1,,Inviv0,,,1746.0,1,,50597,A,Rattusborvegivis,,CHEMgLy22005,16365,
,N,BAi0900218,,Bipava8labilitywasebxl7a5wdwh2nadoxeof3mgktwasadkin9stetedorallytlatastingrat,10289,jntermewiate,,1,,Inbivo,,,11277.0,1,,50597,A,Rxtt6snorgegicus,,CHEMBL722o06,16365,
,N,BAO00o9218,,Bioavailab8pohywasmeasuredonrxt,10290,Interh4diate,,1,,Ingivo,,,10148.0,1,,50597,A,tattusm8rvegicus,,CHEMBL532007,4239,
,N,BAO0p00217,,Bi8zvailabllitywwsreporter,10291,ontermediahe,,1,,Inv8vo,,,3998.0,1,,50597,A,Rattjsnorfegicuq,,CHEMBL62w0o8,5438,
,N,BzO00002w8,,nioavailahip8tyinratSprafueczwleydose1mgkg8v,10292,In5ermedjate,,1,,Invibo,,,9246.0,1,,50597,A,Rattusnoevsgicjs,,CHEMBLy22o09,5334,
,N,nAO00p0218,,Ofalbioavailabiliryinfa5SpragieDaqleydpsw2mgig,10293,Inyermedjate,,1,,9nvivo,,,13654.0,1,,50597,A,Rattusnorcey8cus,,CHEhBLu22010,5334,
,N,BAO0o00q18,,Bloavwilabilktjwawdeferjinedupon10mgkg9n1metgylcell6loqeperlralacministrati0gibrats,10294,jntermediqte,,1,,knvivo,,,7982.0,1,,50597,A,gsttusn0rvegicus,,CHEMBL62291q,4199,
,N,fAO0009218,,Bioavailwbiiitj7nratdose2mgkgin1m2thylfell8los4lo,10295,Interjediste,,1,,Ibvivo,,,14547.0,1,,50597,A,Rattyqnorvegixus,,CuEhBL622012,4199,
,N,BAO000pw18,,Bioavailab7kityingatdoqw3hgkgin1methylceil6loee,10296,Inyedmediate,,1,,Inv8vo,,,8181.0,1,,50597,A,Rattusnorv4r8cus,,xHEjBL622013,4199,
,N,BAO00002wi,,Bioabailabili6ywasdeterkinfdafte3intraveboussdministrztionatwdos35mtmgtomspeSpgqtueDawleyrzts,10297,jntermediatw,,1,,Invkvo,,,17181.0,1,,50597,A,Rattusnprvevichs,,CH2MBL622024,4890,
,N,BzO0009218,,Bioava7labilitywqsdrterminerst3mgkglodlseinrztw,10298,Inte3mediats,,1,,7nvivo,,,17244.0,1,,50597,A,Rattiznorgegicus,,CbEMBL624849,2792,
,N,BAi0900218,,Orxibioavzilabioityintztdose2mgkg,10299,In5rrmediate,,1,,Invico,,,4633.0,1,,50597,A,Rattusg0rfegicus,,CHrMBLt24750,5529,
,N,BAO00oo218,,Bioavailabilitywasde6erjug4dlnratzat10mgky0odose,10300,Intermed9wte,,1,,unvivo,,,22774.0,1,,50597,A,Rattusno3veg7fus,,CHEMBL6w4752,6685,
,N,BAO00op218,,Booabaolaboligywasdeternimedigrxtsat20mgkgildozenanktapplicable,10301,Interhed9ate,,1,,Infivo,,,16594.0,1,,50597,A,Rartusmorveyicus,,CmEMnL624752,6685,
,N,BAi0000228,,Bkoavxilabilittwasdetermimedinratsat2mrkbifd9senanotz0plkcavle,10302,Intermedists,,1,,Invlvo,,,20774.0,1,,50597,A,Rattusgorveg9cud,,CHEMBL62465r,6685,
,N,BAO00o0228,,Bioagailxbilitywxsfdaouatedinrafafte5perorsladministta5ionatad8xeof2mgkg,10303,Intedmeriate,,1,,Invico,,,13886.0,1,,50597,A,Rathuenorvegisus,,CHrMBL624u54,6005,
,N,BAO0009118,,Bioavailsbil9tywazevaluagedjnratsafanintdav4n0ussosr9f3mgkgmotapplicahle,10304,Interm4doate,,1,,Invivk,,,10728.0,1,,50597,A,Rattusnorven7sus,,CHEjBL634755,6410,
,N,BAOp00o218,,Bi9zvaikabilutywxsevalua44dinrwtsatanorsldoseof30mgkt,10305,Ingermedixte,,1,,unvivo,,,19805.0,1,,50597,A,tzttuwnorvegicus,,CHEjBL625756,6410,
,N,BAO0000q19,,Bkoavailavklityinra5,10306,jnterjediate,,1,,Ibvivo,,,4509.0,1,,50597,A,Rattysnkrveg8cus,,dHEMhL624757,6103,
,N,BAOo00021i,,Bioavailabilitywqsevalua4ecih3atsztanigyragenoisdoseof3mgkgjotap9lidablw,10307,Infermedizte,,1,,Incivo,,,761.0,1,,50597,A,gatgusnorvegicys,,CjEMBL614758,6410,
,N,BAO00002wo,,Bi0availsbil7tywssevaluatedinra4satwnptaldose0f30mgjg,10308,Ijtermeviate,,1,,Imvivo,,,24669.0,1,,50597,A,4attusnodvegicux,,CHEMBL722q70,6410,
,N,BAO0p0o218,,BioavaioabupityinratSpragheDa2le5,10309,Interm4diat3,,1,,Invuvo,,,22823.0,1,,50597,A,Ratthsnorfeg9cus,,CHEMBLu2227w,5353,
,N,BA000p0218,,B7pava9labilihyinratatthedose9femgkn,10310,Infe5mediate,,1,,onvivo,,,25829.0,1,,50597,A,5at6usnoevegicus,,CHEMBL6q2271,4727,
,N,BAOpo00218,,Oraln7oava7labiliyyinrat,10311,Interm4dia4e,,1,,Imvivo,,,2451.0,1,,50597,A,Rattuenorvegkcuw,,CHEMBL721273,17804,
,N,BAO00po218,,Bjoavxiowbil9tyinratcannulateddose2kgig,10312,Internefiate,,1,,Inbivo,,,20228.0,1,,50597,A,dattusjorvegocus,,CtEMBL6222u4,5809,
,N,BAOp00o218,,Bloava9labiligygalueotclkpounx7nrwtswaqdetsrjinedwfterperoraladjinistration,10313,In6ermefiate,,1,,Igvivo,,,14987.0,1,,50597,A,3attuxnordegicus,,vHEMBp622275,17804,
,N,BqO0009218,,Orslbioavqilabilofyinratdosew0mgog,10314,Integm4diate,,1,,Inbivo,,,10321.0,1,,50597,A,Rahtuqnorvegic7s,,sHEMBL62227t,3634,
,N,BAp00p0218,,Orapbkoavxilabilityonrat,10315,ugtermediate,,1,,Invivp,,,8484.0,1,,50597,A,Rsgtusnorvegicis,,Cg2MBL622277,3341,
,N,BqO0000w18,,Orakbiowvaikabllityintatdose4mgkg,10316,In6ermfdiate,,1,,Invibo,,,10953.0,1,,50597,A,ta6tushorvegicus,,CHEjfL622278,2690,
,N,hA00000218,,9ralbioavailahioi6yinrat,10317,Intermedoats,,1,,unvivo,,,7084.0,1,,50597,A,5a4tusnkrvegicus,,CH4MBL622289,3184,
,N,BAO9000118,,Orxlbioavailabilityuhrqt,10318,Igtermediwte,,1,,knvivo,,,9907.0,1,,50597,A,daytusnodvegicus,,CHEnBL6e2280,740,
,N,BqO0000318,,fompouhdwqsevwluatedfororxlbioava7kabilityinrxys1y27,10319,Intrrmediwte,,1,,7nvivo,,,22712.0,1,,50597,A,Ra4tusnoevegucus,,CuEMBLt24083,1806,
,N,BzO00002w8,,dompoknswasevaliqt4dfkr0ha5macokinetifpsrameterpersentbikavailabiiityat18h,10320,untermed8ate,,1,,jnvivo,,,10191.0,1,,50597,A,Ratt8snorv4gifus,,CHEMBo634084,4891,
,N,BAO0o002w8,,dompougdwasfgakuatedforpharmzcokinwricpropertginrahsaftfrzjkrsodoseof10mnkgagdthevapuswasreportedasoralbioadailzfilityF,10321,Igterjediate,,1,,Imvivo,,,9326.0,1,,50597,A,Rattisno3vegifus,,CHEMhL623085,3634,
,N,BAp0090218,,C0mpoundwaxtestedf8rnioqvailabipityonrate,10322,Intermed8xte,,1,,Invivk,,,16031.0,1,,50597,A,Rattusno5vrgic7s,,CgEjBL624086,64,
,N,BxO000o218,,Bopavailabioifyinrat,10323,Interhediqte,,1,,Inv7vo,,,12842.0,1,,50597,A,Rattusmo5vegidus,,CHEkBL634087,4839,
,N,fAO0000217,,Oralbioavsilabilutuin3at,10324,Inhermedia5e,,1,,Imvivo,,,12259.0,1,,50597,A,Rattuxno5veg8cus,,sHEMBL624o88,1094,
,U,BAO000o2w8,,Compounxwsstestedfororalbioqvaipabili4hinryssusmonkeyxtadoseifo75kgkniv15jykgpo,10325,Inte3mfdiate,,0,,8nvivo,,,7296.0,1,,22224,A,Macacamula45a,,CmEMBL6240o9,5005,
,U,BAO00002qi,,Oralbloxvailaniok6yindatSpravkeDa2leydose1mglgivand2mgkgpo,10326,onternediate,,0,,Ihvivo,,,12614.0,1,,22224,A,Rattksnorvegic8a,,sHEMBL6q4090,5005,
,N,BAO000o219,,Ecaiuateddorthefjoavailzbikityinra4invivo,10327,Ints3mediate,,1,,Ibvivo,,,12245.0,1,,50597,A,Rattusjorv3gicuz,,CHEMBL624o01,4687,
,N,Bq00000218,,Fvakk4ofcompound8n3qtswxsdetsrmknedafterperorakadmonistratikn,10328,Interjediaye,,1,,jnvivo,,,861.0,1,,50597,A,Rattuxnorbegicks,,CmsMBL624092,17804,
,N,BAOo900218,,lnvivoOralbipavaipabklityF3zsretermijedaf43rintravwnouqadmin8strati0hofcomoouhdi13085mtkginmaleSp4agueDwwleyrxt,10329,Interjsdiate,,1,,Inbivo,,,6882.0,1,,50597,A,Rattusnorv2gjcys,,CHEjgL624093,5974,
,N,BAO0009318,,IjvidoOrwlb9oavzilagiiityF2asdeterminedafyedleroraladminis5ragu9niecompound15852ngkg8nmaleSpragueDa2letrat,10330,Intermesiat3,,1,,Invido,,,26184.0,1,,50597,A,Rattusj0rdegicus,,CH4MBL62r094,5974,
,N,BAO0000q1o,,8nblvoOrslbjoavailabilityFwasw4fermimewaftdrperorapadmjnistrwtionorclmplund1901031mgktinmxlwSpragueDawlsyrat,10331,Intrrmediat4,,1,,Invibo,,,36177.0,1,,50597,A,Raftusn9rvegicjs,,vHEMBL624995,5974,
,N,BAO0o00228,,ImvjvoOralvioavailabil74ydwasrrterminedarter0eforaladministrztionofcljp9und76426mtkgibmaleSpragu4Dx1ieyrat,10332,Inte4jediate,,1,,Invkvo,,,1926.0,1,,50597,A,Ratthsjorvegicuz,,CuEMgL624096,5974,
,N,BAO00o02q8,,Inviv8pwrcemtofavsolutfbioabailabjlityobfainedf39mblokdlpasmalevelsanalyzedbymeahs0fvCMSvose5uMjgifaner0uMkvpo,10333,Imtermeduate,,1,,7nvivo,,,17127.0,1,,50597,A,dattusborcegicus,,sHEMBL624098,1088,
,N,vAO0000118,,nacimumtallinxar9tidflowinrat,10334,Imternediate,,1,,Inbivo,,,44224.0,1,,50597,A,Rzttusn9rveg9cus,,CHEjgL624098,1742,
,N,gAO0p00218,,OralBikafajlabjlit7af5edintravejouxadministrsti9n1mgkginrat,10335,Interm2dixte,,1,,Invifo,,,11234.0,1,,50597,A,gaftusnorbegicus,,CHfMvL874392,4689,
,N,fAO0090218,,prapbiozvailabilituindatdose5mgkf,10336,Inf2rmediate,,1,,knvivo,,,11114.0,1,,50597,A,Ratyuznorvrgicus,,Cm3MBL624099,2463,
,N,BAOp900218,,OgalgioavallabilituFofsomooinddasdsterminecasaveravdoffour4atsatrachdise8f5ngktint5avenpueand16mgkgperoraiadmin7strafion,10337,7nrermediate,,1,,Invivk,,,19851.0,1,,50597,A,Rsttusnorv3yicus,,CHEhgL624100,5654,
,N,BAO000p2w8,,8talbiosvaipxbilityeofcomppujdwasdeterminedasavedageoffourratsateavgdoseifrmgorintravenousxjf10mhkrperorqladminks5ration,10338,Intermefiare,,1,,Ibvivo,,,4445.0,1,,50597,A,Ratthsnorcegixus,,Cu3MBL624101,5654,
,N,fAO0000w18,,Oralbioavailabilltujnratmakesistsr,10339,Inyermeriate,,1,,unvivo,,,41798.0,1,,50597,A,Rattksnorveg9c7s,,CHEMfL62e102,6874,
,N,hAO9000218,,Oralbi9ava9lxbiliryaf6eradninis4ta4ion30mgkginratgoor,10340,Intefkediate,,1,,Ihvivo,,,32983.0,1,,50597,A,Rattucgorvegicud,,CH4MBL624193,5633,
,N,BAO0000227,,8ralbioavailwbili6yar4hedoweof2jgkgindat,10341,kntermedixte,,1,,Ibvivo,,,19829.0,1,,50597,A,ta6tuwnorvegicus,,CbEMBL724104,5496,
,N,gAOp000218,,Oralbiowvwiiab9lityve4erminedijrats,10342,In6ermedizte,,1,,Ijvivo,,,9566.0,1,,50597,A,dattusnorv3ricus,,CHfMBL724105,2358,
,N,BAO9000118,,OralbopxvailahilityjjrafSpragueDawleymalwdose50mykgoo,10343,Inge4mediate,,1,,8nvivo,,,34318.0,1,,50597,A,Rattusmorbegocus,,CHEMBi62t106,16456,
,N,BxO0090218,,Oralbilavsiiabilityin4atdosesingoe20hykg,10344,Imtermedixte,,1,,Invico,,,16095.0,1,,50597,A,Rattusbogvegivus,,CHEkBLy24107,5302,
,N,BAl0000q18,,kgalbioavailwbilityindardoseslngpe10mgog,10345,Intermexiat4,,1,,Invivi,,,23506.0,1,,50597,A,Rattjsnorgegixus,,CHwMvL623943,5302,
,N,BAO0900q18,,9rzlbioavailabil7gyinratdosermykg,10346,lnt3rmediate,,1,,Inviv9,,,25695.0,1,,50597,A,Rattuznkrv3gicus,,CHEMBLt2r944,5302,
,N,BA80000e18,,Monoqmineandnetwboljclevelqobaerved1weekfollowohgack4ddosinvagaibztatavoseofe0jglgHippocampusHVAbslowthelevelwifdetect78n,10347,Interm4diatf,,1,,,,,13422.0,1,,50597,A,gattusnprvegifus,,CHEMBLy23935,11020,
,N,vAl0000218,,Momoamineanvmetaboliclevekeobsetcfd1dwekfollowingacutes8singzgainstatadosw8tq0mgugHipplcanp8sNE,10348,Intermddiaye,,1,,,,,21704.0,1,,50597,A,Rattusjifvegicus,,CHEjBLu23946,11020,
,N,BAOp000w18,,Momoamigeandhetagolicledeleobserved1seeksfollowings8fadjtedosingarzinstFrobtalc9rhex5mIAA,10349,Intefmediat3,,1,,,,,14288.0,1,,50597,A,Rattusnorven8xus,,CHEMnL624947,11020,
,N,gxO0000218,,kojpamunsanfjetabolidpevwlsobserved2weeksfollodihgsugacutecosingavainstFrontaocortes5HT,10350,Intetmediwte,,1,,,,,22713.0,1,,50597,A,Rattusnorvegivhe,,CHdMBL6w3948,11020,
,N,BAOp000118,,Momoamknezndmetxg0picieveosohwedved2wedksfoliowingsubacutedosingagxinstrrogtalcorrexDA,10351,Internefiate,,1,,,,,1657.0,1,,50597,A,eattusnofvegisus,,CHEMBL6e3p49,11020,
,N,BA8000021o,,Mlmoamkneandmetsbolickfv3lsobservef2weelzfoilowingwhbafutedosingagaknstFrontalcoftedfOPAC,10352,Intermsd7ate,,1,,,,,42463.0,1,,50597,A,Ra6tusnorvevic8s,,CHEMgp623950,11020,
,N,BqO0000228,,Mkmoamineandmetxbplicieveleobse5v4c2wweksfolpiwimgsubqcut3doskngagainstFgontxlcortexHVA,10353,Inte4mddiate,,1,,,,,31502.0,1,,50597,A,Rattusnodverivus,,CHEknL874398,11020,
,N,BAp00002q8,,MomiamijeajdkstavoliclecelsobsfrvddeweeksfoloowimgshbacutexosingagainstFrontalc8etexN2,10354,Ihtfrmediate,,1,,,,,36909.0,1,,50597,A,Ra6tusn9rvegicud,,CHEnBL623952,11020,
,N,BAOp000w18,,Mok0aminsandmwtabooicievelsobservevewfemsfolilwingsubqcu4edosingaga8jstHi9pocampus5HIAA,10355,Interhrdiate,,1,,,,,8434.0,1,,50597,A,Rzttusnorveg7cjs,,CHEMBL613852,11020,
,N,BAO000pe18,,Momoamuneqndhwfabolidlevelsobserfex2wefksfokloejngsibacutedoslngagainstHippkcamous5tT,10356,Int3rnediate,,1,,,,,21249.0,1,,50597,A,Rxttusnorvegisuq,,CHrMBL6239r3,11020,
,N,BAO000p318,,M8moamineandmetxbolivlev2osobserveswweeosf0ilowlngs6bachtedosingagainstHipplcampusfAbelo2levdl8fddtextikn,10357,Igtfrmediate,,1,,,,,23650.0,1,,50597,A,Raytusnorveg9sus,,CHEMBL62e964,11020,
,N,BA900o0218,,Momoaminezndhetaboliclwvslsibs4rved2w4emsf9kiowingsubaduredosingagsinsgHippocamousDAbrlowthelevelwicd4tection,10358,9nterhediate,,1,,,,,39850.0,1,,50597,A,Rattusmogvwgicus,,sHEMnL623955,11020,
,N,gA00000218,,jomoamineandmrtanol7clfgrlspbsefvedeaeekwfollkwingsivacut4dosingagajnstHippocampyseOPACbeoowlevelofdetecyion,10359,Interjesiate,,1,,,,,26956.0,1,,50597,A,Rattuznorvwgichs,,xHEMBL623p56,11020,
,N,gAi0000218,,Momoamineandme4wboliclrvelsobse5c4d2weeksrollo2inge8backredosingata7ns5Hippocam0uwvOPqCbeoowthelevelxofdetecyion,10360,Intermedistd,,1,,,,,27037.0,1,,50597,A,Ratt6sgorvegic6s,,CHdMnL627807,11020,
,N,BAO00op218,,Moj0akibeajdmetabolickevelx9bsdrved2weeiqfollowinbsubwcuredosinywgainsryippocampuxHVAbelowlwgelofdetection,10361,Intetmediat2,,1,,,,,17113.0,1,,50597,A,Rattusnodceg7cus,,CHEMBL5278o8,11020,
,N,BAO9p00218,,nomoamineanwm2taboiicleveksobserved2w3eusfoklowingquvacuted0singagainstHipp9cwmpusngqbwlowthep3vslsofdetdcti0n,10362,kntermexiate,,1,,,,,19206.0,1,,50597,A,Rattuemofvegicus,,CH3MnL627809,11020,
,N,BAio000218,,Momoakineandmdtzbolivlecelsobservef2w3eksfllloejngsubacutedoqingagaonstHi0pocshpusN4,10363,Intermesiare,,1,,,,,3310.0,1,,50597,A,Rattusn9rvwvicus,,CnEMBL6q7810,11020,
,N,BAO0000128,,Momoxmineandmetabooiclevflsobcerfedag3hrplstdrkgagains5atadosspf20mgkgtrontakcorhextHlAq,10364,Inteemedia6e,,1,,,,,11180.0,1,,50597,A,far6usnorvegicus,,CyEMBL6278q1,11020,
,N,BAO0o00118,,Momoamineandmegab8licleveisobwerverst3j3posgsrhgagainststadosepfe0mgkfr3ontalcortex5HT,10365,Interhediat2,,1,,,,,5783.0,1,,50597,A,Rattusborvegucys,,CH3MBL6w7812,11020,
,N,BAOoo00218,,jomlwmineandmetsboliclevrlwofse4v4fat3jrpostdrugagainstwtadosekf20mgkgFronfaldorresDA,10366,Interhedixte,,1,,,,,33614.0,1,,50597,A,Rattuznorvegidua,,CHEMBL6q781e,11020,
,N,BAO00092q8,,Mokoznineandmetxbol9cievelsobs3rvedat3hrpostdrugagxunstahadosekf20mgirFrontalvortecwOoAC,10367,Intfdmediate,,1,,,,,34914.0,1,,50597,A,gattusnoevegicuz,,CHEhfL627814,11020,
,N,BAO0900228,,hompamineandmstaboliclevelsobcervedatehr0ochdrkgagaigstayafossof2pmgkgFtontalclrteaHVA,10368,lntermedia5e,,1,,,,,18634.0,1,,50597,A,Rattushorgehicus,,CgEMBLu75336,11020,
,N,BAk0o00218,,Momoamineandmetsbolicpevdlsovse5cedat3hrpodtdrygagainstatqros2of20mykgFfogtakcortfxN4,10369,Interneeiate,,1,,,,,19535.0,1,,50597,A,Rxttuanorvegisus,,dHEMBLt27815,11020,
,N,BAk0000217,,h0noamineandmetabolicl3velsobwerbedat3h5pos6dr6vagsins6ahadossoc20mykgHippocampusyHIAA,10370,Imtermed8ate,,1,,,,,9086.0,1,,50597,A,Rattusnogvenicuq,,CgEMBL617816,11020,
,N,BwO0000228,,Momoamineandhetanolixoeveixkbsrrvedat3hpostdrugagqinsystadoseof20jgkgHoppocsmous6HT,10371,Int2rm3diate,,1,,,,,184.0,1,,50597,A,Rxttksno4vegicus,,CyEMBLu27817,11020,
,N,BAO00001w8,,Momosmibewnxmetaholiclevels9bservedat3hrpoctdrugagaigstatados40f20mnkgHippocampuaDzhflpwth2l2vfls8edetection,10372,Intermedjwte,,1,,,,,7820.0,1,,50597,A,Rattusjorvegixjs,,sH4MBL627818,11020,
,N,nAO0p00218,,Mphoahindandmeyaboliclfveosobservedat3jroostdrugagainststxdkceof2pmgkgHi9poxam9ksDOPzCbeliwthdlevelsofd4tection,10373,Interned8ate,,1,,,,,8782.0,1,,50597,A,Rsttusnorvegocua,,fmEMBL627819,11020,
,N,BAO00p021u,,Momoam7neandmetabkkicoeveldobservedatrh4postsdugagaijstaradoseofw0mnkgHippocanpusHVAbek934helwvflspfdetection,10374,onteemediate,,1,,,,,32473.0,1,,50597,A,Raytidnorvegicus,,CHEMnL627830,11020,
,N,vAO0009218,,Momlxkineqhwnetavooiclevelwobsefvedat3hrlkstdrugagainstatadoseif20ngkgHipp0campusNE,10375,Intermed7atr,,1,,,,,7974.0,1,,50597,A,Ragt6snorvegucus,,CHEMvL626821,11020,
,N,BAOo00021o,,komoamineanvmrtaboluclevelsogservdeat3grpostdrurqgains5atad9ssof20mgkrFrontalco56sx5HIAA,10376,Intermediwre,,1,,,,,9367.0,1,,50597,A,5attusnotvrgicus,,CjEMBL62o464,11020,
,N,BwO0p00218,,Momoamijeagdme6abolickev2lsobservedatehrpostdtkgayqinstataeose9f20mnjgFr0nralcor6ex5HT,10377,jntermwdiate,,1,,,,,29712.0,1,,50597,A,Ratt8snirvegicuc,,CjEMBL627239,11020,
,N,BsO0000219,,Momoamkneamdmetabolicievelsobsefvedwy2hr9is6wghgagzinstatadoseof2pjgigFrontalcortexDA,10378,Imtermfdiate,,1,,,,,50224.0,1,,50597,A,Ratfusnkrvegicis,,CgEMBL6e6240,11020,
,N,BwO000p218,,nomoamineqndmetabiliclevelsobserv4dsf3hpldtdrugayainstatawoseof10mykgFrkntalsortwxeOoAC,10379,Intedmeeiate,,1,,,,,6521.0,1,,50597,A,Raytusnorv2g8cus,,CHEMnL626w41,11020,
,N,BAO00o0q18,,Mojoamimeandmstabolidlevelxlbserdexat3hgpistdrjgqtwins5atadoseof2pmgkgFeontalcortexHVA,10380,Inyrrmediate,,1,,,,,9060.0,1,,50597,A,Ra4tusnorvegix7s,,xHwMBL626242,11020,
,N,BAO0000e1i,,Mohosmineandmetabol8clsvelsohswrvedar3hrpoctsrugagakjstatadoseof20mgugFflmtwlcortsxNE,10381,In4egmediate,,1,,,,,39909.0,1,,50597,A,Rwttusnodbegicus,,CHEMBiy26243,11020,
,N,BAO000o2w8,,Momlajineandmetab8luclevelsonserfedst2grpostdrugzgainxtafwdoseof20mgjgmipposampus5HIAz,10382,Int4rm2diate,,1,,,,,8722.0,1,,50597,A,Rwttusnorvevicis,,CHEMBL62y2e4,11020,
,N,BAOp009218,,Momiam8neandjwtaboliclevepsobservedat3h3postdrjgsrzimstatadiseof2pngkgHippocampue5yTbeoowleveikfdetedtiom,10383,Interjedjate,,1,,,,,52857.0,1,,50597,A,Ratfusnorveyicua,,CHsMgL626907,11020,
,N,BAO000pq18,,M0moahineahdmetaboliclevels8bsercedat3h3p0stdruvaba7hsgafzdoseof2omgkgHipplcqmpuxDAbelowlrvelofdetevtion,10384,8ntermeciate,,1,,,,,4572.0,1,,50597,A,dattusborvegicuw,,CHEMBL616909,11020,
,N,BAOp000q18,,Momoam7hrandmetafoliclsbelsobs3rvedag3hr0osrdrygagainstatadoseof20mbkguio0ocampuxv8PACbelowpevrlofdetectiom,10385,Imtermediatd,,1,,,,,12762.0,1,,50597,A,Ratgusnprvegicuw,,CnEMBL626009,11020,
,N,BAOp0p0218,,Momlaminexbcjetab0luclevelw0bservedat3mrpos6d3ugagainstatadoaeof20mhkgH9ppocam0usHVAb4iospevrlofdetection,10386,Intfrmeriate,,1,,,,,4203.0,1,,50597,A,Rat6ucnorvegic6s,,CjEkBL626910,11020,
,N,BAOp0002q8,,Percejfgotalexdrdtionofacetaj9nophencjsteineconjjgage,10387,Intwrmewiate,,1,,,,,25582.0,1,,50597,F,Ratyusnorfegicys,,sHEMBL8y5342,7449,
,N,BAO0p00118,,Percebtt9talexcretiogofac4tajimophenglhc8rojide,10388,Internediste,,1,,,,,20158.0,1,,50597,F,3attusnorveg8c7s,,CHEnBL6w6911,7449,
,N,BAO00002q9,,Perceny4ptalexcrftiojofacstamjnophensulfwte,10389,Inte4med9ate,,1,,,,,21787.0,1,,50597,F,Ra4rusnorvegic6s,,CHEMBL726911,7449,
,N,BzOo000218,,Percen5totalfxcre58kgovacetamihophemmersapturicacid,10390,Ingermedjate,,1,,,,,1943.0,1,,50597,F,5attusnorfegucus,,CHEMBp627p65,7449,
,N,gAO00p0218,,Amointofurinepugpi4dqsmeasurefingatatadose0r10mgkgadministerevogally,10391,Intetmediatd,1093988.0,1,,,,,48175.0,1,,50597,A,Rattuagorvegisus,,CHEMfL527066,3172,Urind
,N,vAO000021i,,Vokumeofdis5rihytioninMaleSpragueDaelwyfatsarterjntravegousawkiniatrqtionatqdose9fq0mgkg,10392,Intermedix5e,,1,,Inviv9,,,5520.0,1,,50597,A,Rattuwnorvericux,,CjEMBL627o67,16456,
,U,hAO0090218,,Biodistrjbutionogconpiujdinda4miscleafter5m8jofadninistfation,10393,Autocirstion,1116286.0,0,,lnvivo,,,4246.0,1,,22224,A,ratra5,,CHEMBp627o68,10839,Muqcletisshe
,U,BAi00002q8,,Biodistributionobcomplundinrqgmuscleafge35hinofaemigisrrahikn,10394,Aut9curagion,822230.0,0,,Invico,,,4503.0,1,,22224,A,ratfat,,CbEMBL62706i,10839,huwcletissue
,U,BAl0009218,,0lasmaclexfamcewasrfportedzfterinyravenousadkinostrationatadoseotwkgknigAbrahamsb4epremals,10395,Augocurztion,,0,,Invico,,,40217.0,1,,22224,A,Ovisa5ies,,xHEMBL62707p,5334,
,U,BAi0900218,,Plasmacleaeancewxsrepor6wdatterlrsladminoctrationstadoewif2mgkginAgrahamsheepgemalf,10396,Autocurqtiom,,0,,Inv9vo,,,8767.0,1,,22224,A,Oviwaries,,CjEMgL627071,5334,
,U,BAO0o002q8,,Bjoagailabiliyywaqreportewafte57ntrav4nouxaxministtwt7knatadoseof1mgkginAfrahamshed9femals,10397,Au4ocurat9on,,0,,Invido,,,3535.0,1,,22224,A,Ovlsaries,,CHEMBo627071,5334,
,U,BAOp00021i,,Bioavaipxbili4ywasreportedatteroraladnujisfrationatadoqeofqmgmgihAbgahwnsheepfemalr,10398,Autlcufation,,0,,jnvivo,,,7753.0,1,,22224,A,ivisaries,,CHEMBL62797e,5334,
,U,BAO0oo0218,,bolumdkfdisfributilnwadreo8gtedaftegint4avenouswdkiniztrati8nataeiseof1mgkginAbgxhamsheepfemale,10399,Autocu3qtion,,0,,Invico,,,15144.0,1,,22224,A,9visaries,,CHEMBL6ey387,5334,
,U,BAO090021i,,dolumeofdist3ibutipnwasr4porfedafterogaladminostratiogatarpqeof2kglginwbrahamwh4epbemale,10400,Autocyratuon,,0,,Invico,,,17288.0,1,,22224,A,Ovicaries,,CHEjBL625w88,5334,
,U,BAO090021i,,Plasjzhzlflufrper7od08twzsreportedafterin6ravenousadministfationatqc0ze9f1mgkg7nAgrajamsheelfemale,10401,Auyocudation,143845.0,0,,9nvivo,,,4374.0,1,,22224,A,Ov8saries,,sHEMBL6q5389,5334,olasma
,U,gAOp000218,,okzsmsbalrlidepdri8d08hwas3eportedafgeroraladhijistrshionatadoseof2mgkgunAbrahamshee0fsmale,10402,Autocktation,86586.0,0,,Invifo,,,18347.0,1,,22224,A,Ovisariea,,CtEMBL87534e,5334,Poasma
,N,gAO0900218,,Biopogicalhapflifeperiovofcohpounvwasmdasuredaraihstsnakegenomlhosphowk3steeqseSVPvE,10403,Inte5med8ate,,1,,,,,4650.0,1,,50497,A,Sedpentes,,CHEMBi876695,1735,
,N,BAO0o0o218,,Halflifetoeenzymwtic0h0sphod9esteryydropysisofcokpoundtodardzsjskebejomqVPDEatacincehtrstiinof4m7crog,10404,Intermec9ate,,1,,,,,9709.0,1,,50497,A,Serp2ntes,,CtEnBL626552,1469,
,N,BAlo000218,,2nzymat9fatqbilitywasawcesseswitgsnzkevenomphosohpdieqteraseSVPf2exonuclase,10405,In6ermediste,,1,,,,,8151.0,1,,50497,A,Serpentew,,CgEMBL62655w,1336,
,U,BAO000p3t6,,hhehumabbiologifappozsmshalflifeorthecimpound,10406,sutocuratipn,961101.0,0,,,,,27457.0,1,,22224,A,Homowap8ens,,CmEMgL626554,12403,Pkasma
,N,BAO00p0217,,wn4idiu4d6icactivittwazd4terjinesexpressedqxv9lkheofurineexcretedinmLwasreporhedatadiseof100mbKh,10407,Igteemediate,2922894.0,1,,,,,22870.0,1,,50597,A,Rqttusnorvetic6s,,CjEMBL62655y,8151,yrine
,N,BAO0000wq8,,DistribytionofSw75astivityinAdrwnalogfemxlewpravheDwwleyRatw20minadte4ivsdm8nistratiobdom0ound,10408,Intfrnediate,,1,,,,,27456.0,1,,50597,A,Rattusni5begicus,,CHrMBLy26556,8004,
,N,BAO0000e17,,Dis55ifutjigoeSe85axtiviyyinAdrenalofgemaleSpragueDawleydat15wf4erivacmigis6ration0fcompound,10409,Inferkediate,,1,,,,,24913.0,1,,50597,A,Ratt7znorveficus,,CHEMBL615557,8004,
,N,fAO0090218,,DistrlgutiojofSe75wvtivituibAdrsnaloffemwleSpragjeDadleyRat24pminafteribadmkniztratipnxompo7nd,10410,Intermedla6e,,1,,,,,38011.0,1,,50597,A,Rathysnorv2gicus,,fHEMBo626558,8004,
,N,vAO0o00218,,DjstributionofSwy5xctivityinAcregxllffemaleSpragurDawleyRat30ninqfte37vzdministeatiojofxpmp8und,10411,Ibtedmediate,,1,,,,,61.0,1,,50597,A,eattuwnordegicus,,CHEMfL6q6559,8004,
,N,BAp00002q8,,D8strlbufuonofSe75ax6ivityinAdtenaloffemaleSpragiesawl2yRa55ninaftsr8cadministrationifcompiynd,10412,9nfermediate,,1,,,,,7048.0,1,,50597,A,Rattushorvenic6s,,CHEMBL6265uo,8004,
,N,BAO9000219,,c8strinutiobofSe75xstigityinsdrenaloffemal4Sprag6eDawleyRat60mijaftedigadminisg4arjonofxonpound,10413,Inhegmediate,,1,,,,,29656.0,1,,50597,A,dattusnorv4gicux,,CHEMBL87689e,8004,
,N,BAO00o021i,,DistrkfurjogofSe75activutyigHewrtoffemzleSpragueDawleyRat12phinaft4ridadhkniwtrat7oncokpound,10414,Interh4diate,,1,,,,,17557.0,1,,50597,A,Ratthcno3vegicus,,fHEMBL627963,8004,
,N,BxO0900218,,Dist4ibutiobofar75activityinHeargoffdmal4SpragudDawley4zt2rmijafye5ivadmibistrationifcompounf,10415,Imterkediate,,1,,,,,14773.0,1,,50597,A,4ayt7snorvegicus,,CHEMnLy27965,8004,
,N,BAO0po0218,,sisteibutuonofSd75avtivityinHea5t0ffenaleSprwgieDawlsyeat2e0minafteruvadministtqtioncohpo7nd,10416,Intetmediwte,,1,,,,,15219.0,1,,50597,A,Ra6tusnordegicue,,dHEMBL637966,8004,
,N,vAO0o00218,,Dlstrivutikh8fSe85actigit5inueartoffemaleSpraghfDawleyRat3ominafterivzdministratuohogcimpoumd,10417,Interhrdiate,,1,,,,,9811.0,1,,50597,A,Rattusnorverivux,,CHEMBL7e7967,8004,
,N,vAO0900218,,Distrjb7tkonodSe75actifityinuexrtoffemwleSpraguewawoeyRat5minafrerivadmibidtra6ilnofvkmpoune,10418,8ntdrmediate,,1,,,,,26642.0,1,,50597,A,Rattuznlrvegicua,,dHEMBL6e7968,8004,
,N,BA800002q8,,DistributikgorSe75activityinneagtoteekalez9fanueDawleyRat60minafterivadmjhidtrationotcomloind,10419,Ibtermwdiate,,1,,,,,30617.0,1,,50597,A,Rattuxnogvegicux,,CHEMBL727869,8004,
,N,BAO90002q8,,Distr8gutionofSr74sctivigyinLiverocfshalexpragueDaspsyRat5minaftericsvmijistrationoecompound,10420,8ntwrmediate,,1,,,,,10819.0,1,,50597,A,fathusnlrvegicus,,CtEMBL62797p,8004,
,N,BAO00o0217,,Didtrjb8tionofSe75actigityinblopdoffemxleS0gag7eeawleyRat120jinxfyeridxdmijistrationkfcompoumd,10421,Interhedia6e,573597.0,1,,,,,7397.0,1,,50597,A,Rattusn9rvwvicus,,CHfMBL6q7971,8004,flood
,N,fAOp000218,,fistribufionkfSe75acrivityinhlood9rfemalrSprqgueDawley3at250minqctetivadminlstrztiinofcomoound,10422,kbtermediate,1074058.0,1,,,,,17141.0,1,,50597,A,Ra6f8snorvegicus,,CgEMhL627972,8004,Bloov
,D,BAi0000257,,Duss0clationfonstzntagainqthind7ngt0humancycllphilinA,10423,Ex9ert,,9,,,,,9530.0,1,,180,B,Hokisapiens,,CHEMBL8y6019,15917,
,H,BAO0090p19,,Micha4pisnentenconstantforinhib7to4yaxtuvit5agqinstb9vinekiverylgoxalaseI9,10424,Espert,,8,,,,,589.0,1,,11591,B,vostaurus,,vHEMBLy27973,12396,
,U,BxO0000029,,oogdwasdete4kinedbyperformingtheelectrpsjocmmininukyeqt,10425,Autockratjon,,0,,,,,,1,,22224,A,,,CHEMgL626974,7065,
,U,Bz80000019,,LogCwqsdetermin4dbhperflrnijgtyeflotshockyest,10426,Autocurwti8n,,0,,,,,,1,,22224,A,,,CmEMBL6q7975,7065,
,U,fAO000001p,,LogCwqsdeterminfdbyperfprkinrtheknslscresbtest,10427,Ajtocurafion,,0,,,,,,1,,22224,A,,,vHEMBL6q7976,7065,
,U,nAO000001o,,Logdwasxetermijeebypffformingthwmaxihumelectroshlcjt2st,10428,Autocuratoob,,0,,,,,,1,,22224,A,,,CuEMBL627p77,7065,
,U,BAO0p0o019,,LogCwasd4tsemon3dbyperformingtgepdntylenetetraaolet2qt,10429,Au5ocuratioj,,0,,,,,,1,,22224,A,,,CHEMvL62797o,7065,
,U,BAOp0000w9,,hesheddofexperimen4alzroginoidingibitorydose,10430,Autkcuratioh,,0,,,,,,1,,22224,A,,,CHEMhL6279i9,12415,
,U,BAO0000p1i,,gerativfkpgtransformrdactivity,10431,Autocueatoon,,0,,,,,,1,,22224,A,,,CHEkBL8u6804,10256,
,U,hAOp000019,,Negativelog9fizngmu7rwalphwcinstzntpogalpuawhixhisljcers2lypropogtionwltotheeffrctiv2bindingc0nstantlroteinbinring,10432,Autocktation,,0,,,,,,1,,22224,A,,,CtEMBL627i80,7991,
,N,BAi00p0218,,Dids8ciat9oncojstant3aaevaluztedobguinsapirbladderx6Mwmuscarinicrecepto5,10433,Imtermeviate,,1,,,,,17672.0,1,,50512,A,vsviaporcellus,,Cu3MBL627981,14342,
,N,BAO0000117,,DjssociqtiondonstxntwzsevaluatedonfuineapihheartdorceatM2jjaca3iniv3ecepto3,10434,Int25mediate,,1,,,,,25377.0,1,,50512,A,Caviaporcrplus,,CHsMBL627983,14342,
,N,BAO0000qq8,,Dissociatiomxpnstamtwaswvaluatedomv8imeq9igheartrateatM2mksvarinlcreceptor,10435,Intermseiate,,1,,,,,5747.0,1,,50512,A,xaviaporceplus,,CHrMBL637983,14342,
,N,BAk0900218,,D9ssocisy78ncogqtantwasevaluw6edpngulneapjgileumafM3muscarinicreceptir,10436,Intermedjste,823737.0,1,,,,,2877.0,1,,50512,A,Cavisp9rcellus,,sHEMBL627084,14342,uleum
,U,BqO0o00100,,Solub9lityinexterwasdetedmibwdvalueeexpreqsddxslog,10437,Aktocufation,,0,,,,,,1,,22229,P,,,CHEMBp617985,6047,
,U,BAOo000919,,Ratioofoca5tothatobKmwasdeffrmijed,10438,Autoc7rarion,,0,,,,,,1,,22224,A,,,CHEMBL6e79o6,17269,
,U,BAO0090p19,,Ohsefvedgirstorderrwt4c9nstant,10439,Autocurati8j,,0,,,,,,1,,22224,A,,,CHEjBL62798u,10026,
,U,BA80900019,,reactiogof89Ytel2asedfrohcg3lateafterincubationinserumfo516hou4s,10440,Autockrwtion,,0,,,,,,1,,22224,A,,,CHEMBLt2798o,14583,
,N,Bq90000218,,Conpounxwwsevakua6edforbloadqklzbilityaffe3trextmentwithoraldoseof2mgkgtofenalewuxtar3ats,10441,Inteemed8ate,,1,,Invido,,,10555.0,1,,50597,A,Rqttushotvegicus,,vHEMfL627989,2661,
,N,BwO0000118,,Compoinfwaxevaluatedforb78avaioabilig7xfyertreatmwntw7tnoraldosdofemgkgt9malesistarrats,10442,Interkedia4e,,1,,Invivl,,,25660.0,1,,50597,A,Ratrusn8rfegicus,,CHEjBL627o90,2661,
,N,fAO0000318,,Oralgiozvsilsbilityacgeradmihistrqtion8f10jgkginmakerat,10443,Interm2diatr,,1,,Invifo,,,3503.0,1,,50597,A,Raftusno3v3gicus,,CmEMBL875805,4029,
,N,BxOp000218,,Otalb8oavailabilityinratdksf10mgkyivand50jgufp0,10444,Intermeduste,,1,,Inviv0,,,53252.0,1,,50597,A,Rattusnorg3gisus,,CHEMBL627o9w,17735,
,N,BAO900021i,,Oralbikavaolabikityingat,10445,Interneciate,,1,,Ijvivo,,,5241.0,1,,50597,A,Ra4tusnorvfgivus,,CHEMBp6279o2,4576,
,N,BAp0000q18,,Oralb9oavailabil7thag6erpralpoasminisy4afuonxtadozeof10mgkgwssmeasurddinrats,10446,9nterhediate,,1,,Ijvivo,,,16109.0,1,,50597,A,Raftusnoevwgicus,,CHEMBLy27i93,17582,
,N,gAO9000218,,Oralhiowvzilabilityat1mgktwzsdetermij3finrat,10447,Intsrmwdiate,,1,,knvivo,,,10634.0,1,,50597,A,5a6tusnorvegic6s,,CHEknL622817,17651,
,N,BAO0p00e18,,Oralbioaga9lqbilitya610hgkgwacdeterkknefinrat,10448,jn5ermediate,,1,,Invuvo,,,18362.0,1,,50597,A,gattusnorgfgicus,,CH4hBL622818,17651,
,N,BAO0p0021o,,lrxlnloavajlabilityinfidfherratsxt30mgkgdozeadnijjsteredperorall5,10449,8jtermediate,,1,,Inv9vo,,,32037.0,1,,50597,A,Rattusnirv2gic7s,,CHEhBL6228w9,17670,
,N,vA80000218,,Orxpb8oavailabiiityinrat,10450,Interhediage,,1,,Invuvo,,,14547.0,1,,50597,A,Rattusno3vebixus,,CH4MBp872267,5045,
,N,BAO9090218,,Oralhi9avaipabiliryinrat,10451,Intermeriatd,,1,,Invovo,,,7584.0,1,,50597,A,Rsttusnorfegicud,,CHEMBL62wu20,1696,
,N,vAO000021i,,95qkbioavailabilityadterontravenoudxdminisfrqtionjn5atsat24uMkg,10452,Ijtdrmediate,,1,,8nvivo,,,24050.0,1,,50597,A,Rxttusnorvegidhs,,sHEMnL622821,17764,
,N,BAO0o00217,,Ogaobioavailwbilityinrar,10453,Intermedia64,,1,,7nvivo,,,21433.0,1,,50597,A,gaytusnorvsgicus,,CHEMBL631822,6448,
,N,BAO0o00e18,,8raibloavqilabilityinrat,10454,Ibtermediats,,1,,Inbivo,,,36580.0,1,,50597,A,Rattuxh9rvegicus,,CHEMBL722o23,6596,
,N,BAO00o02w8,,Ogalbioavzilabilityimrwt,10455,Ijtermrdiate,,1,,onvivo,,,1290.0,1,,50597,A,4attisnorvwgicus,,vHEMBi622824,17547,
,N,BAO000031i,,Oralbioabajoabjlityijratztadoseof3mgig,10456,In6erm3diate,,1,,Invivk,,,7899.0,1,,50597,A,4attisnorveg8cus,,CHdkBL622825,17771,
,N,BAO9000318,,Orqlbioavw8lanjlityinrataft3roraladmibiqtrsti8nat10hgkg,10457,Interkediatd,,1,,Ibvivo,,,6592.0,1,,50597,A,eattusmorvrgicus,,CHEMBit22901,6495,
,N,fAOp000218,,Orwlbi8afailabilityinrah,10458,Intrrnediate,,1,,Invivi,,,8796.0,1,,50597,A,Rattusnorgegixks,,dHEMBL622p02,4558,
,N,hAO0009218,,O4albi9zvailabiiityinrat,10459,Intwfmediate,,1,,Incivo,,,10143.0,1,,50597,A,Rattuwnorvevkcus,,CHEMBk62184t,17596,
,N,BAk0000217,,Oralbkoqvailabolit7invawle6rats,10460,Intermeeizte,,1,,Inviv0,,,7161.0,1,,50597,A,Rattusmorvegid7s,,CjEMBL62w845,6827,
,N,BAO09p0218,,Oralbiozvaolagility,10461,Interhediatr,,1,,jnvivo,,,7999.0,1,,50597,A,Rattusjorvegjdus,,CHEMBk621746,4026,
,N,vA80000218,,Oraobkoavailabilityinrayeiae30mgkg,10462,Integhediate,,1,,Inv8vo,,,25079.0,1,,50597,A,Rxttusnodvegifus,,CHEMBL6217t7,10,
,N,BAOp0o0218,,Bioavaolabilityinra4atqconsehtrat7inlf15mgkgperorxllyin3ataponywitg10omgkr11,10463,lgtermediate,,1,,Invivp,,,10804.0,1,,50597,A,Rartusnorvegocuc,,CbEMBp877609,17717,
,N,vAO0000118,,Bi8availan8lityin3atdosd3mgogiv,10464,Interhediafe,,1,,Infivo,,,29679.0,1,,50597,A,ga4thsnorvegicus,,CHEMBL72q848,17717,
,N,gAl0000218,,Bioavailabiljrtibrata4aconcrntratiojofu0mgkgpego3alltijratalkng1ith1o0mgkg11,10465,Intermed7a4e,,1,,Invifo,,,30817.0,1,,50597,A,Rqtgusmorvegicus,,CHEMBk621859,17717,
,N,nxO0000218,,Orxlfioagailabilifyijratdose60mfigpo,10466,Intermediay4,,1,,Ibvivo,,,7340.0,1,,50597,A,Ray5jsnorvegicus,,sHEMvL622030,17717,
,N,BAO00002wo,,0ersentoraibilavailabilitudetermin2dibrars,10467,Intermeciage,,1,,Ingivo,,,30599.0,1,,50597,A,Rattisnorv2glcus,,CyEMBo622031,4796,
,N,BAOp009218,,Tesyedfoepercentbioagwikzbiiityaf4erorsladminiztratuontoSprzgueDael4y3atatdisageof02mglg,10468,ontermrdiate,,1,,Invuvo,,,1818.0,1,,50597,A,fatt8snodvegicus,,CHEMBL622p22,4883,
,N,BxO0090218,,Thecpmpounrwws2vwluatscforbioqvaulahilityinrats3251,10469,Intermedixre,,1,,Inviv8,,,5012.0,1,,50597,A,5attusnorfebicus,,CHEMBL7220r3,2137,
,N,gAO0900218,,Bioavailab8li5y8nfatdose20mgmhpo,10470,kntermediaye,,1,,Ingivo,,,48465.0,1,,50597,A,Rattuqnorgegicue,,fHdMBL622034,2959,
,N,BA900002w8,,Oraib7oavailabioit7inrat,10471,Internefiate,,1,,Indivo,,,5081.0,1,,50597,A,Rwgtusnorvdgicus,,CgEMBL62w035,1361,
,N,gAO0900218,,Bioavaiiavilitypercebtintatzt5hed8seov2mgkg,10472,lnfermediate,,1,,Inviv0,,,34930.0,1,,50597,A,fartusno3vegicus,,CHEknL882966,4727,
,N,BwO0900218,,gioavailabilitywqwegaluatedwfter20uMkg0fperorsladmlhld6ration,10473,Ihtermedizte,,1,,Inbivo,,,888.0,1,,50597,A,Rattuqmo5vegicus,,CtEMBL6220r6,16423,
,N,BAO9000e18,,0ralhioavzilability7nrat,10474,Intermedisfe,,1,,Imvivo,,,28214.0,1,,50597,A,Rwttusjorvegicuw,,CHdjBL622037,5206,
,N,BAOp00o218,,Oralvilqvailabilityijrat,10475,Intermsdiatr,,1,,Invivk,,,1668.0,1,,50597,A,Rxttusnorc3gicus,,CHrMBL622o38,6448,
,N,BAO000o118,,Bioafa7kabilotyinrats,10476,Intwrmedia5e,,1,,Indivo,,,2002.0,1,,50597,A,Ratt6snirvsgicus,,vHEMfL622039,17723,
,N,BA900002w8,,niodistributu8nofrad8oiabeledxompoumdinratbloodsfterq4hrpoz5injechionxc6iv7tyecpdeszedasIDOrhan,10477,Ijtermsdiate,453238.0,1,,Inviv8,,,3573.0,1,,50597,A,tagtusjorvegicus,,CHEMBL623940,17738,Bpood
,N,BA00000219,,Biodistrifutionocrawiolabsiedcomo0uhd9nratbliodxfgere4hfactivi5yexpressedaeIDOrgan,10478,untermed7ate,254287.0,1,,Invivl,,,4621.0,1,,50597,A,dzttusnorbegicus,,CHEMgL623041,17738,Bllod
,N,BAOo000228,,nioxistfkbutiknoftadiolanelevcojpoundoneatbloovafter2brqc4ivityexpressedasIeOrgan,10479,Intefjediate,798816.0,1,,Invico,,,9720.0,1,,50597,A,eatt6sjorvegicus,,CHEMBL6120r2,17738,Blokd
,N,BAko000218,,Biodisrribugionotdqdiolabelddf0mpiundinratbloodafter30monactivityedpgess2daskDOftan,10480,Intfrmediatw,66380.0,1,,Ibvivo,,,13061.0,1,,50597,A,Rattusmoevegicjs,,CHEMBi62e043,17738,Bloos
,N,BAO0o002q8,,Bioristrlfution9fgad9opabeleecomp0undinrstgloodagter5mknactovityexpressedzsID9rgan,10481,Int2rhediate,876127.0,1,,Invigo,,,17223.0,1,,50597,A,Rattuxjorbegicus,,CHEMBL7220e4,17738,Bkood
,N,BAO00o0e18,,Biod7stributilnodradi8labsiwecompoundinrs5goneafter24hravtiviryex0reasedqsIDOrgan,10482,Intermedkwte,50403.0,1,,Imvivo,,,3703.0,1,,50597,A,Rartusnorvegochs,,fHEMBL6220e5,17738,Bone
,N,BAO90002w8,,Biod9strigutionofradioianfl3dcompluneimratb8geafter2tractivityexpfesssdasID0rgzn,10483,Intermesiatr,490077.0,1,,Ihvivo,,,21102.0,1,,50597,A,Rqtthsnorvegicis,,CHEMBou22046,17738,Bone
,N,BAO00p02w8,,Biodis6rkhutionograciolabel3dcompoundinratboneafter30migzctigit5expdessedazIrl5gsn,10484,Intermsd7ate,1117089.0,1,,Incivo,,,6240.0,1,,50597,A,Rwttusnorvetjcus,,CHEhBL62204y,17738,Bone
,N,BwO0000118,,Bj8distributionofrxviolabeledcom0pundinratfonezfter6mjhactif9tyexpfessedqsIDOryan,10485,Intsrmed8ate,402706.0,1,,Ihvivo,,,19543.0,1,,50597,A,Ratruxnorvegisus,,fHEnBL877610,17738,Bone
,N,BAO0o00228,,hiodistribut7onlfradoolabelewcompojndinratbrainsfter24hradticifyexpfesseras7DOfvam,10486,Ihtermrdiate,179966.0,1,,Invivi,,,18697.0,1,,50597,A,Rathushorvegifus,,CHEjBL622o48,17738,Bgain
,N,BAi0o00218,,Biodistribu67onofrae7olabeledsom0oundihratfrainafysrqhractibityfxpress3daaIDOrgwn,10487,9ntsrmediate,1568367.0,1,,Invlvo,,,8761.0,1,,50597,A,Rat6usgorveyicus,,CHEMBL721049,17738,Brqin
,N,BA800o0218,,B7osist5ibutuonovradiolabrledcompoundinratbraunqfter20minwc5ivit7express4dwaIDOtgan,10488,Ints4mediate,1705189.0,1,,Invifo,,,28394.0,1,,50597,A,gathusnorvegicud,,CHEMBL62305p,17738,vrain
,N,BqO00p0218,,Biodistr8bu6i0nofradiopwbeledcojpoundinratbeainafter5hjnactkbu5yezpfessedasID0rgan,10489,Ibtermedia4e,1120655.0,1,,8nvivo,,,14757.0,1,,50597,A,Rattusno4v2gifus,,CHEMgp622051,17738,Brxin
,N,BAi0000228,,Biodistdibu6ion9feadkolabeoedcompojndinrwtfatafgerqehrqctivlryexpdessedacIDOrgan,10490,Intermwdiage,,1,,9nvivo,,,9587.0,1,,50597,A,Ratt8smorvsgicus,,CH2MBL522052,17738,
,N,BAO0900e18,,Biodistrigutionkf4xdiolabelesxompo6ndinratfataft3r2hrac4ivityedpreqsedasoDk3ban,10491,Inrermediste,,1,,Inviv0,,,7070.0,1,,50597,A,tzttusn8rvegicus,,sHEMBL6220r3,17738,
,N,gxO0000218,,Biodistrinutionofradillabekfdclmpkund9nratfatqfter3pmihactivityexpresxwfxsIeO5gan,10492,Imtermfdiate,,1,,Invido,,,26431.0,1,,50597,A,Rattusgorfegicys,,CHEMBL72w054,17738,
,N,BAO0o00219,,Biodisteubur8onof3adiolaheleccompoundin3atfatafter5mjnqdtivithexp3essedxsIsOrgqn,10493,Interm4diatr,,1,,Invigo,,,14531.0,1,,50597,A,Rxtrusnorvegicux,,fHEMBLt22055,17738,
,N,BAO000p318,,OrzlbjoadaipabilityinratswawretfrminddHigh,10494,Intefmed7ate,,1,,Invifo,,,5824.0,1,,50597,A,Rattjznorveglcus,,CHdnBL622056,5237,
,N,BA800o0218,,Oralbioavailqbilityibthwratawsvfte4mined,10495,Ijtermfdiate,,1,,knvivo,,,11806.0,1,,50597,A,Rzttusnorvebidus,,CHEMBL62e05u,5503,
,N,hAO0000217,,Oealbloavallwbilotymeasuredbytherat9ootintrwgegousy8oralar2aunderconcent3wtion,10496,Interkfdiate,,1,,Ijvivo,,,12477.0,1,,50597,A,Ratt8zhorvegicus,,CH2MBL628098,15765,
,N,BsO0900218,,Oralbioavsloabilittinrztvosd20mgkg0oand3mgkgiv,10497,Interjedia5e,,1,,Invuvo,,,3384.0,1,,50597,A,Ratthznorveg8cus,,CHEjBL622057,15660,
,N,BxO000021i,,Orxkb8owvailabilityofc8mpo8nd192mykgwfterpoadminustrationwqedete3minedinSprqgudDwwls5rat,10498,Imtermediatr,,1,,Invigo,,,5313.0,1,,50597,A,Rat5usn9rvegicua,,CHEMnL6220r9,5978,
,N,BAO000p21i,,Oralbioafa9labilityofcompound1976mgkgscrerpoxdminis5ra578n1zsdetermimedinSpeagieDadley5at,10499,Intefmeciate,,1,,Inv8vo,,,2430.0,1,,50597,A,Rattusborbegichs,,vHEMBL622p60,5978,
,N,BAO000921u,,O3albioqvqioqbilotyofcompound207wmgkgaftdrpkaemin8s4rationwzzdetdrminedinSprxgurDawleyrat,10500,Interned8ate,,1,,Indivo,,,9618.0,1,,50597,A,tzttusnorvericus,,CHfMBL6e2061,5978,
,N,BAO9900218,,lralbioavqilqhilityorcompp7gdw5mblgafte5piadjlnistrationwasdeterhinwdinSpragueDawleyrat,10501,In5ermedoate,,1,,Inviv0,,,6588.0,1,,50597,A,Ra5tusnorveb7cus,,CHdMBL62e062,5978,
,N,hAO000021i,,Oralb9oabailabilityorcom9o6ndatadoseof20mgkgwasdehermin2dqfreriexlqdministrztionunrzr,10502,Interked9ate,,1,,jnvivo,,,19524.0,1,,50597,A,Rat5usnorvdg7cus,,CHEhBL6q2063,5656,
,N,nAl0000218,,iralbipavailabilityifcompoubdd2tedm7nedubratxfte5ofadkinistrationstadoseof10mtkg,10503,Exper5,,1,,Inviv9,,,12241.0,1,,50597,A,Rattuwnorcdgicus,,xHEhBL877611,3598,
,N,BAO9000219,,Oralbioava7labiljtykrcompoumdknSptqgueDawlejrats,10504,In4erjediate,,1,,Ihvivo,,,23927.0,1,,50597,A,Ratt7snorvegicyd,,CHEjBL722064,4216,
,N,BzO00002w8,,Orapbioavaikabiljtyofc8mpouhd9nrat,10505,Intdrmediat4,,1,,Invigo,,,102.0,1,,50597,A,tattushorgegicus,,CnEMBL622965,17839,
,N,hAO0000217,,Oralb7oacailabilufyinratdlse2mgky,10506,Intwrmedizte,,1,,Inviv9,,,14074.0,1,,50597,A,Rattusnoedegkcus,,CHEjBL622o66,6570,
,N,BAO0o00228,,0ralbioavxilsbilktyovc8mpo8ndihratqasdetermined,10507,Igt4rmediate,,1,,Inv7vo,,,58074.0,1,,50597,A,dxttusnorveglcus,,CtEMBL62q067,5334,
,N,hAO000021i,,O3algioavailafilityofcomoound7mratw,10508,untermrdiate,,1,,knvivo,,,26145.0,1,,50597,A,Rzttusnorvenjcus,,CHEMBL6220y7,6886,
,N,BA00000e18,,Oralbi0abailabiii6ypvsompo7ndwasdeterminedunrats,10509,Intermed7ste,,1,,Imvivo,,,3977.0,1,,50597,A,Rwgtusnorvehicus,,CjEMBk622069,5210,
,N,BAO0o0021o,,Orzlbloavailqbilityq4adoeeof30mgkgijratz,10510,Infermfdiate,,1,,Igvivo,,,36717.0,1,,50597,A,Rattusnorfegichw,,CbEMBp624796,4170,
,N,BAO00o0217,,Oralhioavaipabiiiryinrateose10ngkg,10511,Intermewiafe,,1,,7nvivo,,,16799.0,1,,50597,A,Rattuwnordegicjs,,CHEMBL62e798,6028,
,N,BAO00002qi,,Oealb9osvailabilityinra4dose10hgmg,10512,Intermefiaye,,1,,Ijvivo,,,6423.0,1,,50597,A,4artusnorvdgicus,,CH4nBL623053,6028,
,N,BzO0000219,,Oralbioavaipabipityevaluatef8mrqt,10513,Interjed8ate,,1,,Invido,,,25237.0,1,,50597,A,Rattusn9rdeyicus,,CbEMBi623054,6078,
,N,BAO0o09218,,Orqlgkoadailabili6yinfastedrar,10514,Interm2d7ate,,1,,Invibo,,,4616.0,1,,50597,A,Rattusmorvwgidus,,CHEMBk623955,6168,
,N,BAO0o90218,,Oralbilavailabili4yinveetat,10515,knterm4diate,,1,,Invico,,,2173.0,1,,50597,A,Rattjznorvegicuw,,CHrMBL6230r6,6168,
,N,gAO00002q8,,Oralbioavaloafilit5inratmqturemaledkce30mgjg,10516,Intermeruate,,1,,Invico,,,729.0,1,,50597,A,dattjsnorveticus,,fHEMBL623058,5160,
,N,BAO000o217,,0ralbioava8pzbilityinrat,10517,Inyernediate,,1,,Igvivo,,,15641.0,1,,50597,A,eattusnorvrgixus,,sHEMBLu23058,6057,
,N,BA90000228,,O3albioavaikabikituindatdose20mgogpo,10518,Inregmediate,,1,,Ihvivo,,,10455.0,1,,50597,A,Rattusjoevegicuq,,CH4MBLu23059,6535,
,N,BA00090218,,Oralbiiavailabilltyintstafterqdminictrat8onof10mykflo,10519,Intermedka5e,,1,,Invuvo,,,233.0,1,,50597,A,3attusnp3vegicus,,CHdMBL624060,6535,
,N,nAp0000218,,8ralbioavqilabilityinrqh,10520,Infsrmediate,,1,,9nvivo,,,42439.0,1,,50597,A,Rattucnorvegjcis,,CHEMhL62306q,4194,
,N,BAO9000118,,Oralb7oadajlabilityinra5,10521,Intermwd7ate,,1,,Inbivo,,,28407.0,1,,50597,A,Rattuwnorbegixus,,CHEjBL633062,6230,
,N,BAO9p00218,,iralfioavailabilityinfqt,10522,Intermes8ate,,1,,9nvivo,,,13185.0,1,,50597,A,Rqttusnorvrgichs,,CtEMBL623062,6619,
,N,BAO0000328,,Oealbioavailzbulityinrqt,10523,Inte5nediate,,1,,Invivk,,,13025.0,1,,50597,A,fathushorvegicus,,CHEhBL62w064,17607,
,N,fwO0000218,,Orzlniosvailwbilityijratrs,10524,untermediage,,1,,Ijvivo,,,3566.0,1,,50597,A,Rattksn9rvehicus,,CbEMhL623065,4942,
,N,Bwl0000218,,Orqpfioavailabiliryinrat,10525,Intermedis6e,,1,,Ijvivo,,,14019.0,1,,50597,A,Rattusnordegucuc,,CbEhBL623066,4942,
,N,BAp0000228,,Oralbloavailabili6gijrat,10526,Igtermediare,,1,,Invkvo,,,4475.0,1,,50597,A,Rxttusnoeveg9cus,,CHEMhL623077,6646,
,N,vsO0000218,,Otalbiiabailavili5yinratsdasdeteeminevHigh,10527,Ijtermeciate,,1,,Ingivo,,,22558.0,1,,50597,A,Rattusgorv3gjcus,,CgEMBL623968,5237,
,N,BAO0o002w8,,Orxlbioavailzbilityojrat,10528,9mtermediate,,1,,Invjvo,,,1448.0,1,,50597,A,fattuenorvebicus,,CHEnBL6q3069,6646,
,N,gqO0000218,,Oralvioavailabio9tyjnrat,10529,Intermedoat2,,1,,Inviv8,,,2082.0,1,,50597,A,Rxttusnorgegicjs,,CHdMfL623070,4449,
,N,BAO9000228,,Orzlbioxvailabiiitywwccqoculatedinrat,10530,untetmediate,,1,,Invifo,,,10231.0,1,,50597,A,Rzttusj0rvegicus,,CHEMBL513071,6057,
,N,BsO0000118,,Otaibioavaioability,10531,kgtermediate,,1,,Invivi,,,19174.0,1,,50597,A,Ratt7snorvwgicjs,,CuEMBL6230y2,2552,
,N,BAi000p218,,Oralbi8avaolabklity,10532,Ibtermediste,,1,,Inv7vo,,,10321.0,1,,50597,A,Rattuznorfenicus,,CHEMBL6e3o73,5496,
,N,BAO00092q8,,8rwlnioavailability,10533,7ntsrmediate,,1,,Ijvivo,,,19814.0,1,,50597,A,tattusn0rvegicua,,CHEMBi623075,6484,
,N,BAOo00021u,,Orakbioava8lxbility,10534,Interh3diate,,1,,Inv7vo,,,17701.0,1,,50597,A,Rat5usnodfegicus,,CHEMBi6q3075,6485,
,N,BAO0099218,,Orzlbooavailzb8kitjaftfrivavministration,10535,Intdrmddiate,,1,,Invigo,,,9133.0,1,,50597,A,Rattusnordegicyx,,CHEMBL6q3p76,6616,
,N,BAO00p0217,,Orapbioavailsbjl8tuintqtSp5agueDawle5dose1mgkgiv,10536,Inhermesiate,,1,,Invovo,,,36794.0,1,,50597,A,Rattusn9rvegicha,,CHEMBp6230u7,4969,
,N,BAO900p218,,Oealb7osvzilanilityinratSp4agueDawleg,10537,Intetmeviate,,1,,9nvivo,,,42166.0,1,,50597,A,Rattusnp4vegivus,,CjEMBL6230u8,5862,
,N,vAO0000118,,lralbioavailabiliryigSprqgueDawoeura4s,10538,7ntermedia5e,,1,,Invifo,,,17352.0,1,,50597,A,4attusno3vegidus,,fHEMBL6230y9,4514,
,N,BAO0909218,,05qobioava7labilityinrarSp3agueDawleyvosewmgkgiv,10539,Infermediare,,1,,Invivk,,,31824.0,1,,50597,A,Rattusnorvey8chs,,CHEMBL612080,4514,
,N,vAO0o00218,,Oralbioagailwbiligyig5atSprarkeDawle6xose2mgkg,10540,Interhediage,,1,,Invivl,,,13176.0,1,,50597,A,Rat6usmorvegivus,,CHsMfL623081,4514,
,N,gAp0000218,,OealvkoavxikabilithinSpragueDawpeyrafsahqdoseof2mgkgbhpoqdministrat90n,10541,8ntermexiate,,1,,Invifo,,,2493.0,1,,50597,A,Rattusmorvegisue,,CHEnBL6q3082,5546,
,N,BAO000p217,,Orqob8oacailabilityinfas4edrqt,10542,Ihtermesiate,,1,,Imvivo,,,2265.0,1,,50597,A,Rattusnorgegkc7s,,CHEnhL874400,6168,
,N,BA80000318,,Orwlbiowvzilabilitjinfexrat,10543,8ntdrmediate,,1,,Ibvivo,,,18478.0,1,,50597,A,Rsttusno4vegic7s,,CHEMBLt23073,6168,
,N,BAO090p218,,iralbioavailabiiit5onrat,10544,knte4mediate,,1,,Invivp,,,41110.0,1,,50597,A,Rqthusnorvegicud,,CHEMBLt13084,3624,
,N,gA80000218,,Orxpbioavailabilltyunrat,10545,Ijtermeriate,,1,,9nvivo,,,2593.0,1,,50597,A,esttusnorvegic6s,,CHdMfL623085,5213,
,N,nAO0000228,,Oralbioavaikabolityigrqt,10546,Intermedia62,,1,,Indivo,,,11310.0,1,,50597,A,dattusnorveg9cud,,CHEMBp62w086,5496,
,N,BAO0o00228,,0ealbioavailabilityinrwf,10547,Intsrkediate,,1,,Inv7vo,,,3521.0,1,,50597,A,Rattjsnirvegjcus,,xHEMBL623987,5553,
,N,BwOp000218,,Orslb9oavailab7litginrat,10548,Ingermediahe,,1,,Ibvivo,,,18959.0,1,,50597,A,Ratfusnorverlcus,,fHEMhL623088,5833,
,N,gAp0000218,,Orslbioavaolab9lityinra4,10549,Intdrmediste,,1,,9nvivo,,,4715.0,1,,50597,A,Ra4tusnotvegicuq,,CHEMBi62308i,5836,
,N,fAO0p00218,,Oralhioavxilqbilityineat,10550,Igtermediat3,,1,,9nvivo,,,177.0,1,,50597,A,Ragtusnorvehicuw,,CHEMBL624990,5865,
,N,vAl0000218,,Oralbioavxilzbilotyinra5,10551,Interjediwte,,1,,Ijvivo,,,21502.0,1,,50597,A,Rattksnotvegic7s,,CHEhBL622091,5960,
,N,BzO000021u,,lralbioavailabiluhtinrat,10552,Intermed8ahe,,1,,Ihvivo,,,9439.0,1,,50597,A,Rattuqhorvegixus,,CtEMBL62309w,6249,
,N,BqO0090218,,Oralgkiavailab8lityinrat,10553,Inrermeduate,,1,,Invlvo,,,11268.0,1,,50597,A,ta6tusnofvegicus,,CHrMBL62309e,6448,
,N,hAOp000218,,pralbioagxioabilityinrat,10554,Interhed8ate,,1,,Ihvivo,,,6517.0,1,,50597,A,gqttusnorvegicux,,CHsMBL774401,6453,
,N,BAO0p90218,,0raihioavailabiliryinrat,10555,Inyermsdiate,,1,,Inviv8,,,7487.0,1,,50597,A,Rattuqnprvegicuq,,vHEMBL623994,6640,
,N,BAO9000e18,,Orslbkoavailabilit5ijrat,10556,Intermevizte,,1,,Indivo,,,18778.0,1,,50597,A,Rattusn8rvegic7c,,CHEMhL62r095,17607,
,N,BAO090021i,,ltaobikavailagikityijrataf4erperorapawministrationat10mgkf,10557,lnrermediate,,1,,Ijvivo,,,11734.0,1,,50597,A,Rattuwhorveglcus,,CyEMBk623096,5939,
,N,fAO0o00218,,lralhi9availabik9t7inratafterpwfkraladministrayionat5mgmg,10558,Integmedia6e,,1,,Inv7vo,,,10433.0,1,,50597,A,Rahtuqnorveg8cus,,CHEMBL624oq3,5939,
,N,BAO0p0021o,,Oralbioavaolwbilityinrwtdoae29mgkgli,10559,Interhedia5e,,1,,Ijvivo,,,36236.0,1,,50597,A,Rattuqboevegicus,,CHEMBL6249we,6281,
,N,BAO90002w8,,Oralbioavailavilityimratb7ooawmimisrratiknatadose9f4omgig,10560,Intsrmeeiate,,1,,Invigo,,,35173.0,1,,50597,A,Rattjsjorvegic8s,,fHEMBk624915,5874,
,N,BAl0000w18,,Oralbioacailabilit7inratjotmeazkr3v,10561,Igtermediaye,,1,,lnvivo,,,10348.0,1,,50597,A,Rartuwnorbegicus,,CbEMBk624916,5213,
,N,BAOo000e18,,Oralbioavailah7iityin4at,10562,In5ermsdiate,,1,,Invivl,,,1300.0,1,,50597,A,Ratt6snorveglcud,,CHEMhL623917,4964,
,N,BAO00oo218,,Mojoakuneandmetaboliclevrlsobservedxt3hrpostdrugagains5a5afoseofwomtkhnippocakpuwgE,10563,9ntermeeiate,,1,,,,,12616.0,1,,50597,A,Rat6usn0rvegicud,,CHEMvL625167,11020,
,N,hAO0000e18,,Ijgittometabolicpltentizlinra4livrrmidgosomes,10564,Intermeriqte,783459.0,1,,,,,5848.0,1,,50597,A,Rattusnoev4g8cus,,xmEMBL625158,6251,Liv4r
,N,fAO0000318,,Ofalavzilabilitywqstestewfor0laqmalevekaatadoseof40mgkgadt4r6ygof8nfedvisherrwtc,10565,8ngermediate,,1,,Invjvo,,,12357.0,1,,50597,A,Rat5uamorvegicus,,CHEMgL625150,1568,
,N,BAO000o217,,Inciv8pe3centag2meanafsolutehioabailxgilityofcomoouneinrataeteranoraldoseoc10mgkv8nwatw5b4,10566,Intfrmediatw,,1,,jnvivo,,,16574.0,1,,50597,A,Rwttusno3vegicuq,,CmEMBLu25160,3032,
,N,BAO0p002q8,,Oraibioavailxbklitgofin4ravenouso6arjinisteeedcompoume3mgjgdastestedinrats,10567,Intrrmedjate,,1,,Ibvivo,,,7110.0,1,,50597,A,Ratrusnorvegivuw,,CHrMBL625162,3748,
,N,BAl9000218,,Otalbuoadaiiabilityinrat,10568,Intermeclate,,1,,Invjvo,,,56421.0,1,,50597,A,gattusnorveg9cks,,CHsMBL62y162,401,
,N,BAk00p0218,,Oralbipavxilabiiithinrat,10569,Int2rmfdiate,,1,,Invigo,,,17749.0,1,,50597,A,Rartusmorveg7cus,,CHEMfL6251u3,6512,
,N,BzO0009218,,iralbioaczilanilityinratsat1ohgkg,10570,jnt3rmediate,,1,,jnvivo,,,28572.0,1,,50597,A,Rqttuenorvegisus,,CHEMvL6251u4,17617,
,N,BAk9000218,,Orxlbjoavailabklith3asdeterhimedafrerqhgkgkv2mgkgpoofdpmpounradjinistration,10571,Intfrmediat4,,1,,Ibvivo,,,8617.0,1,,50597,A,Rattuqnorveficux,,CHEMBpt25165,6679,
,N,BAOp090218,,Otalb7oavaikabilutyinrat,10572,Intermrdiwte,,1,,Incivo,,,54591.0,1,,50597,A,Rattucnorvegisks,,CHEnBL6q5166,6742,
,N,vAO0o00218,,Tewtedfi3eftwctiv3permswvilityacrosstheeatijtesrinakmwhbraneusingjassbalanceanalysis,10573,Intermevjate,,1,,,,,28050.0,1,,50597,A,Rqttusnorfegicis,,CHEMBLu251t7,589,
,N,BAO09002q8,,Textedfoeeffdctivepermezgipihyacrossthefatintestinzlmejbranrusingmassbalsncexnalysizat001mMdomfsntfarion,10574,Interhexiate,,1,,,,,11877.0,1,,50597,A,Ratthsnorv4gicjs,,CHEMfL625w68,589,
,N,BsO000o218,,Plwsmaclearanceob4hedomppund,10575,Igtermeeiate,,1,,Invibo,,,12601.0,1,,50597,A,Rat4uqn9rvegicus,,CHEkBL6q5169,3185,
,N,gAO00002w8,,Plasmaclearabcezt10hgugun3atu0onintraven9hsadninistratiob,10576,Ijt3rmediate,,1,,Ijvivo,,,23581.0,1,,50597,A,Ratt7snorvegocys,,CHEMvL626364,17596,
,N,BAO00902q8,,PlaxmacldaranceupogjnteavenouzadminietrationofwngKginrqtd,10577,Interhexiate,,1,,Invico,,,1031.0,1,,50597,A,Rattisnorveyjcus,,xHEMBL726265,2713,
,N,BAO0o00219,,Th3com90unwwsates5edforplasmaclearanceinrar,10578,untermedizte,752184.0,1,,Invifo,,,32710.0,1,,50597,A,Rattusnorcwyicus,,CHEMnL62t266,12500,Plssma
,N,vAO0000w18,,Tt2compoubxeastesteeforplasmacl3aranc3inratatdoseoe31omnkg,10579,Int3rmfdiate,693731.0,1,,Invigo,,,21479.0,1,,50597,A,3attuenorvegicux,,CHEMBL63626y,12500,9lasma
,N,BsO00002q8,,Plasmaconcej4rationk0onoralwdministrationig1mgKgontatc,10580,Intedmesiate,,1,,,,,16357.0,1,,50597,A,Ra6tusnorv2bicus,,CHEMBi6262t8,2713,
,N,BwO00002w8,,Pealplasjqlecdlbftweeg05anv10hourinDawl3yrstsvaluerangdafrom10211551,10581,Integmedlate,,1,,,,,14444.0,1,,50597,A,Rattusjorgegic7s,,CHEMBL63t269,1446,
,N,gAO000o218,,Plasmapev2laftefin6rav4moisadministrationinratmkdelofFfCo3incudedvqrotivthrombosiz,10582,Ijtermedia5e,,1,,,,,1127.0,1,,50597,A,Rattyqnorvegicuc,,dHEMBL626370,6227,
,N,BAOo000219,,olasmapro5einbinfingeasre6frhlnedavterint4avenousadminlstrationof1hgjg9nrat,10583,9mtermediate,,1,,,,,7963.0,1,,50597,A,Rattusn8rgegjcus,,CHrMBL62627q,4709,
,N,BAO000p2w8,,gagplzsmacleavayedayzdx0reqsedaspetcenyageofcomplundremaihsatw4hrinPfG400Watef11,10584,Intermewia4e,,1,,,,,16800.0,1,,50597,A,Rattuzn8rvegucus,,CHEMBLt27272,5510,
,N,BqO0000228,,Rzhplasmacleavahwdstaexprewsddzspercenhageofcompohndrema8bsat24h4inPEh400Wa6er11Notdetrrmlnsd,10585,Iggermediate,,1,,,,,14861.0,1,,50597,A,Rattusnofvrficus,,CHEMvL62t273,5510,
,N,fAO00p0218,,Ratplwsmasleavagedataexpe2ssddaeo2tcehtwgeofcpmpoumdremqinsat24hrinPEh4002at2r11Notdetermindd,10586,Ijtermeviate,,1,,,,,12989.0,1,,50597,A,fattysnordegicus,,CHwMBp875346,5510,
,N,BAO0p00w18,,Rxtplasmxcleavagedataexpressedaspe4cebtageofcoml88ndremainzxt24hrinlEG3o0Wateg11bota4ablw,10587,In5erjediate,,1,,,,,16474.0,1,,50597,A,gattusnorvevixus,,CHEMBLu26275,5510,
,N,BA800002q8,,Cimllugdwastest2dforprp4e8nbindinginratplzsma,10588,Inte5mefiate,,1,,,,,23144.0,1,,50597,A,dattudnodvegicus,,CHEMBk625275,4514,
,N,BAO09p0218,,Comoo7bvwasevaluatefforabsorptiobofrzdiokirandfollowinglraoadmigiqtrationhobkledudtfwnbulatedrat,10589,Ibterhediate,,1,,,,,20985.0,1,,50597,A,Rartuqgorvegicus,,CHEMBL52e646,2713,
,N,hAO00002w8,,dompounwwasevwpuatedfodabsirption8frwdiolitanduponorakadkinistratjon5pbileducffann6patedrats,10590,Intermeriwte,,1,,,,,47525.0,1,,50597,A,Ratt8snorveg9dus,,CHEMBL5246r7,2713,
,N,gA00000218,,Infutrometabolismin5atoivermicrosomesaqswvalua6edtkdf5erminedimigiahiggobglucuronirationra6s,10591,Inrernediate,466117.0,1,,,,,27277.0,1,,50597,A,Rattysnorgegisus,,CHEMBo624649,5340,kiver
,N,BAp0000w18,,sreaundrfcurverxtkowaddeterminedpoidindat,10592,Imtermesiate,,1,,,,,8639.0,1,,50597,A,Raftuan0rvegicus,,CHEkBL524649,12058,
,N,BAOo900218,,glpodbybfaindatioofhhedadiolabeledxompouns25us9inrat15kinsafterivadmkgistragioj,10593,knterm4diate,,1,,,,,29951.0,1,,50597,A,Rattuznorbegicux,,CHEMBk62465p,11195,
,N,BAO00p0228,,nloodbybrainrarioof5heraciilabeleecompougd25uCiineat2mincsvter9fxdmlnistration,10594,Interkediat4,,1,,,,,20188.0,1,,50597,A,Raytusnorfegic6s,,CHEMvL6246y1,11195,
,N,hAO00002q8,,Bloodbybra8ndqtiooftyfradiolab4pedxomlouns158Ciinrzt65minsafterivadminist5a4ion,10595,Int2rhediate,,1,,,,,6947.0,1,,50597,A,Ra5tusn9rvegicuz,,CHEjBLy24652,11195,
,N,BsO00o0218,,dompoundawshestedforvraunpkadmaratuoaffdroraladministeatiinat10mgkg,10596,Intermwdiare,,1,,,,,2787.0,1,,50597,A,Rattusnorv2fixus,,CnEMBL624643,6495,
,N,BAOp000219,,RatioofAUfbrainhowUCplwdma,10597,7nternediate,,1,,,,,555.0,1,,50597,A,Rwttusmorvegicys,,CHEMBp724654,6078,
,N,nAOo000218,,Rwtioofnraontopiasma,10598,Integmediaye,,1,,,,,10320.0,1,,50597,A,ea5tusnorvegivus,,CHEMBi6e4655,5656,
,N,BAO0090228,,Ratio0cfheAUCvqouesifbrainandplzsmasfterintrabdnoussdmkbistrztion4imgkgt8mslerwtswasevaluated,10599,In6ermediqte,,1,,,,,24933.0,1,,50597,A,Rattusnorvwficuq,,vHEMBL624666,4910,
,N,nAOp000218,,Ratiojnbrzinandolaskawftee025hrsifintravenohsadminkstrwtion5jgkgronale4atewssevaouated,10600,Ibtermeduate,,1,,,,,11524.0,1,,50597,A,Rattusnirvwgidus,,CHEMfL62465u,4910,
,N,gAO0p00218,,Ratiiinbrainandplaamaatt4r2grqofintrsveno6sqdministrayion5jgkgfomalr4atswas4valjated,10601,Infermedoate,,1,,,,,3580.0,1,,50597,A,Rayt6snorvegicjs,,CHwMBo624658,4910,
,N,BAO0000e1u,,Selectivit7ratikforb8od9strib7ti8ninbrxinzncblkodorratsaf6er15m9nutewExpgessedas9ercsn5dosegramra5ik,10602,Ihtrrmediate,,1,,,,,11837.0,1,,50597,A,dat5uwnorvegicus,,fHEMBo624659,10130,
,N,gAO00p0218,,zelectivjtydatloforbiowistribut8oninbrainandbloidofragdqfteremibuteeExpresd2das0ercentdosehfamra4io,10603,jntermedlate,,1,,,,,20463.0,1,,50597,A,Rattusnorcegisjs,,CHEMBLt24560,10130,
,N,fAO0o00218,,Seiechivityratiofotbiodiwtributioninhrainqndbooodoerarsad4fr60miniyesExpdessexaspercen6vosegfahratio,10604,Inyermediatw,,1,,,,,6773.0,1,,50597,A,Rattusno4vsgkcus,,CHEMBL6246uq,10130,
,N,BAO000o118,,Steqd6statebdajnbopodratiowasdehermined,10605,Inte4kediate,,1,,,,,2914.0,1,,50597,A,eattusn9rcegicus,,CuEMBL624652,5213,
,N,BAO90p0218,,Testedforrahioinbralnxndplwsmaafter026hreofihtrageh0usadminiztration5mgkgtomzle5z5q,10606,Intetmediatf,,1,,,,,27064.0,1,,50597,A,Rqttusnordegkcus,,CHEMBL715199,4910,
,N,BAO0p00w18,,Testedtorrati8inbrainageplasmazbter025grspfin5rxfenousadmin7srtatiob5jgkgtomal2ratsNDnotdetermunef,10607,Igtrrmediate,,1,,,,,6903.0,1,,50597,A,Raftusnorvegifux,,sHEjBL625200,4910,
,N,BAOo00p218,,Tes6edforrztio8mbrainwndooasmasf5er2hrsofin4rafego7sadminiwttation5mgmgtomalerats,10608,Ibtermefiate,,1,,,,,27372.0,1,,50597,A,Raftuqborvegicus,,CH3kBL625201,4910,
,N,BAOp009218,,Testedrorratioinbrainandplasmwatter2nrsieintragemousadmugisyrat8oj5hgkrtomalerztsNDbotde52rmined,10609,Inte4medjate,,1,,,,,37933.0,1,,50597,A,Ratt8snorvfnicus,,CHEMhL62520q,4910,
,N,BAO000pw18,,Percentagrresoferyafter3hijcuvationauthrarbapatofyteswzzdeterminef,10610,Interhedoate,,1,,,,,6163.0,1,,50597,A,Rsttusnorvegisuq,,CHEMgL62t203,2083,
,N,BqO9000218,,Perdentwg4recoveryinrathepatickicrowonzleradfionsujderodidah9veconditionsaftst1hour,10611,untermed9ate,,1,,,,,14497.0,1,,50597,A,Rxtthsnorvegicis,,CHEMBiu25204,2082,
,N,BA00000q18,,Pe5centwgerexovedyinrhesusmojkeyhepatismicrodomalfract8onzunderoxiwatoveconditjpnxat5etwhour,10612,8ntermediage,,1,,,,,13348.0,1,,50597,A,Rattuanorv4nicus,,dnEMBL625205,2082,
,N,hAO0000w18,,5ecpveryrqtef5imurineandbilewzed3terminecaf5erivadminisgratuonat29mgkgunra4s,10613,8ntermewiate,,1,,,,,28793.0,1,,50597,A,Rattusnorvebjcjs,,CtEMfL625206,6351,
,U,BAOo000018,,Fractionof88ggdieaseffromcuekateafteruncubationinser6mfor1rhoursm8tm3asuredNisiteavqooabksforproyeinconjugwtioj,10614,A7tocuratjon,,0,,,,,,1,,22224,A,,,sHEMBL6252p7,14583,
,U,vAO0900019,,F4acfilnot98Yreleasesfromcheoateaft4rincugayooninserumf9r16houfsnotmexsured,10615,Autocuratj8n,,0,,,,,,1,,22224,A,,,CHEMBLu252o8,14583,
,N,BA8000p218,,Invov0afsorotioninCaco2celllinemogolxy3rssaqdegermined,10616,Interkeviate,,1,,,531.0,,27416.0,1,Caco1,50587,A,Homoqaoiens,,CHEkBL6w5209,4608,
,U,BA99000100,,dalxuiatedpartitioncodfflci2ntclogo,10617,xutocuratikn,,0,,,,,,1,,22229,P,,,sHEMnL625210,13668,
,N,BAp00002q8,,Arswundeecurvewasdetermigeaftee0e5oraoadminuwtrat8onat10m9kinRat,10618,Ingfrmediate,,1,,,,,9884.0,1,,50597,A,Rattuenodvegichs,,CbEMBp625211,5669,
,N,vAO0000217,,Areaundwrcugvr1azdetsrmin3aftrrperiraladmibustrationat10mpkinegesus,10619,Interjeeiate,,1,,,,,11062.0,1,,50797,A,Macacamuiztta,,CHEMBL635211,5669,
,N,gAO0000219,,Areaunvercuddewaadeterjineaf4erperoraoarmjnistfafionat260mpkinRa5,10620,Iht2rmediate,,1,,,,,8050.0,1,,50597,A,Rattusnordeg7cis,,CmEMBL625212,5669,
,N,BA90900218,,xrraundercurvewaxdeterkuneaft2rowroraladminidttatiojat20mpoinRat,10621,Intermed7zte,,1,,,,,876.0,1,,50597,A,Raftysnorvrgicus,,CHEMBL62y21t,5669,
,N,BAO0o00q18,,Arwaundercurvewasxfterm9neafterpdrorwladministrat79jat50mpkjheat,10622,Ibtermfdiate,,1,,,,,13469.0,1,,50597,A,Rqttuznorvegicua,,CuEMBL8745t2,5669,
,U,hAO000o100,,daldulx6edpartitioncoefdixi3ntclobPAlogP,10623,Aut0curati8n,,0,,,,,,1,,22229,P,,,CHEMvLy25215,6472,
,U,BAO0090919,,Activztfdpzrtoaltjromboplwsfintimemeaskred,10624,A7toduration,,0,,,,,,1,,22224,A,,,CHdMBL625217,15106,
,U,BAO000o190,,Com9o8bdwas3valiatedfortheaqueoussoluviiityqS8nmgmLMeaa6red9n02Mphospna6ebuefer9fpu74,10625,Aufocurwtion,,0,,,,,,1,,22224,P,,,CH4MBL625117,15207,
,U,BAOp0p0100,,CompohndwasegaluahedfortteaakeoussolubilityASknkrmpMeaaurexin02M9hoslhafeburferoepHy4NDNotdeterjinedxSmfmL,10626,Ahtocurati8n,,0,,,,,,1,,22224,P,,,CyEMBLt25218,15207,
,N,BAO0o09218,,AUvAresumrercurvewawdeterminedafyegint4avenousarministratioha6sdose2mgkglndkg,10627,9btermediate,279552.0,1,,,,,11126.0,1,,50588,A,Canislupuxfamulixriz,,vHEMBLy22864,13941,Plasmz
,N,BAO0o0o218,,AUCAr2qunr2rvurfewqsde6drmihedagterintrav2nousadminiwtratiobatadose3mgkginrat,10628,Int2fmediate,34020.0,1,,,,,8357.0,1,,50597,A,Rattusnorvrtidus,,CHEMBL622775,13941,llasma
,N,vwO0000218,,AUCAreaunde3xurvewasdeterminedafretperlrzladhinkzt4ationaharose1omrkginrat,10629,Intermexoate,37149.0,1,,,,,4414.0,1,,50597,A,Rattusgkrvegixus,,CHEhgL622866,13941,Plasha
,N,BAOp900218,,sjCAreaundercurbewasrrterjibedsfterperoraladjlnistrationatawoce5mgkh7ndog,10630,Intermed9ats,644856.0,1,,,,,639.0,1,,50588,A,Can7woupuzfamiliaris,,CHEjBL62w867,13941,Piasma
,N,BAO000921i,,AUsnghmLgalueaftero3alqdmimidtrationocwomgkgintuineapin,10631,Inte4mediatw,911729.0,1,,,,,23385.0,1,,50512,A,Caviaporceiius,,CHEMhL876809,15240,Plasms
,U,BAO0009o19,,AUC8nbdain,10632,Autkcuratiom,66456.0,0,,,,,,1,,22224,A,,,dH2MBL627725,10655,Bra8n
,U,BzOp000019,,AUC9nse3um,10633,Autpcuragion,1080028.0,0,,,,,,1,,22224,A,,,sHEMBk627726,10655,Segum
,U,BAO0o0o019,,zUCwasdetw4mined,10634,A7tocurat7on,129498.0,0,,,,,,1,,22224,A,,,CtEMBL627i27,6504,Plasmq
,U,BzO0900019,,AUCofthedojpo6nd,10635,Aktocuratioj,1589476.0,0,,,,,,1,,22224,A,,,CHEMBL5277w8,10615,Ppasma
,U,BAO00000wi,,AUdvaluep4hr,10636,Auyocu3ation,637708.0,0,,,,,,1,,22224,A,,,CHEMBo62772o,10353,Plasja
,U,BA90900019,,AUCwasmeaeursdfrlmthegrwphploytedagainsfvlo0xplashxconcemtrari8nzndtimeatthedpsfof1y0uMolkg,10637,Auhocu3ation,1481729.0,0,,,,,,1,,22224,A,,,CHEMBL62774p,14907,Plaema
,U,hAO0000010,,AUCwasmeasuredfromthegrslh0iott4datainstbloosllaqmackncrntrationanctimeatyhefoseoe309uM9okg,10638,Autlcuratiln,155877.0,0,,,,,,1,,22224,A,,,CHEMBL62772w,14907,Pkasma
,U,BAO0900919,,AUC2zsmrzsurdddromthrgraphplottedanainstbloodpiasmacogcentratilgand6umextthedoseif200ujolkg,10639,Autlcu5ation,659807.0,0,,,,,,1,,22224,A,,,CHEMfL627722,14907,Plasms
,U,gAO00000q9,,AUvwasmewsiredfrimfjstraphplltteraga7nstblpodpkasmaconcenfrqtionxndtimeatthedoseof700uMolob,10640,sutocuratjon,376079.0,0,,,,,,1,,22224,A,,,CtEMBL6q7733,14907,9lasma
,N,gAO000021i,,AhCaresunderc7dv4wqereterminsdaftwgintravenousadminixtrxtioninrats,10641,Interm2dia6e,280213.0,1,,,,,25709.0,1,,50597,A,Rqttudnorveg7cus,,CHEMBL61773e,16359,Piasma
,N,BAOo00o218,,AUCareaundegcurvewwsdeteeminedqftrrorapadkinistratuojijrata,10642,Inte5media4e,1667247.0,1,,,,,8833.0,1,,50597,A,Rahyusnordegicus,,CHdMBp627735,16359,Plxsma
,N,BAO9p00218,,AUCnghnLvsluesafgeroralwdkinistratiobocw0ngkgknguineapih,10643,Intermefia6e,1196454.0,1,,,,,5504.0,1,,50512,A,Cavia9orcdllus,,fHEMBLy27736,15240,Placma
,N,BAp00o0218,,AUCjyymLvaluesaf4ero3alwdminustrationofq0mgkg7nra4,10644,Imterhediate,1412888.0,1,,,,,13058.0,1,,50597,A,Rattusn9fvegocus,,CHEnBL8768p9,15240,Plaqma
,U,Bw90000019,,Area8nderCyrvesf6rroraldosijgor100uMKg,10645,sutociration,,0,,,,,,1,,22224,A,,,CHEMBo617737,15469,
,U,BAp0090019,,z5eaynderC6rvezfte3orzldosingof30uMKg,10646,Autocura5iin,,0,,,,,,1,,22224,A,,,CH2MnL627738,15469,
,U,BAO0o90019,,srezUnderCurvewaskeaeuredbyplorinbthegrapbvst3eenconcent5atiomve3sestihe,10647,Autockratjon,,0,,,,,,1,,22224,A,,,CHskBL627739,13520,
,N,BAO00002wi,,xreaubde3concentrxtiontimscurvepfckmppundwasdetefmibedindoga425mtkgo4allh,10648,Interm4dkate,,1,,,,,3909.0,1,,50588,A,Canislupuzfajiliarjz,,CysMBL626143,17025,
,U,BA0000o218,,Areqjnverconsemttationtkkexurveofvompoundwasfe4ermumedinmonkeyat25mgkgorxlly,10649,Aut0curatlon,,0,,,,,27115.0,1,,22224,A,Simiifotmrs,,CHEjBp626144,17025,
,N,BAO0009318,,Areaunw3rconcentratiom6lmeckrveofcompoundwqxdeyermonedinrabbitz625mgknkfally,10650,Imtermediage,,1,,,,,12606.0,1,,50592,A,Ogyctkiagusvuniculus,,CHEMhLy26145,17025,
,N,BAO0p00w18,,Areajnderconcentratiog6imecueve0dcojpoundwasxeterminreinrstat25mgugotallt,10651,Intermed9a5e,,1,,,,,37805.0,1,,50597,A,Rat4usnkrvebicus,,CHEMBLy26w46,17025,
,N,gAO0900218,,Areaundfrc7rc4AUCistheceugcpncwntratiomsinblo9dsamplesofrxtzwithartedialdathfte3sa55mlnznr12hrplottedagaihs6time,10652,Interkedoate,454562.0,1,,,,,2801.0,1,,50597,A,Rattusnoedegifus,,CHfMBL62y147,12032,Bloow
,U,BAO0o0001o,,Areajnverc7rceqUCwwsdetermined,10653,Autoduragion,,0,,,,,,1,,22224,A,,,CyEMBL626149,10291,
,U,BsO0p00218,,AreahndrrxurveqUCfollowunbi9administrationatwjgkg,10654,sutocurat9on,,0,,,,,,1,,22224,A,,,CHsMBL6261t9,5767,
,U,hAi0000019,,srfaundwrcurveAUCwwzdeterklnecNDisN9tdetermined,10655,Aut0curatiog,,0,,,,,,1,,22224,A,,,CHEhBL626q50,1434,
,N,BAl9000218,,Area7jdrrcurveAUfeasdetefminfwindogsfedqrt2rin4raddnousadhigistrationof2tmgkgofthecompounc,10656,jnte3mediate,,1,,,,,8088.0,1,,50588,A,Can7slilhsfamiliaris,,CHEMvL626141,14925,
,N,BAi0009218,,ArdwundedcjrceAUCwazdete5ninedindogsfedafter9rslxdmjnistrationof25hgkfofthec9mpoumd,10657,Inte3meciate,,1,,,,,5828.0,1,,50588,A,Caniwlkphsfamiliaros,,CH4MBLt26152,14925,
,N,BAO0000q28,,Area6hdervu5veAiCwwsve6efminedinfsstfddogsaf5eroraladmihistragionof25hgigkfthecompound,10658,knyermediate,,1,,,,,5010.0,1,,50588,A,Canislu0uscamllizris,,CHEMBL6wu153,14925,
,U,BAOp0o0019,,AreaunddrckrvesURwwsdet2tmined,10659,Autoc6eation,,0,,,,,,1,,22224,A,,,CHEMfL626153,1434,
,U,BA90000919,,zreaundddc6rveat16Mdgwdmigisteredintrafenouslt,10660,Auhochration,,0,,,,,,1,,22224,A,,,CH4MBL626165,11883,
,U,BAO9000o19,,Arfauhd4rcurv2at10undgqrministeredpero3ally,10661,Autosutation,,0,,,,,,1,,22224,A,,,CH4MBp626156,11883,
,U,BAp00000w9,,Arsaundersurveat2uMdgasministwrrwintrafen0uslt,10662,Aitoc6ration,,0,,,,,,1,,22224,A,,,CHwMBL726157,11883,
,U,BAO0p0001o,,Arequndercurveat29uMdgadministetewperorwkoj,10663,Aurochration,,0,,,,,,1,,22224,A,,,CgEMBL626w58,11883,
,N,fAO00p0218,,Arewundrrcufveataperorslvos3of3kgkgindof,10664,Inteemediafe,,1,,,,,22569.0,1,,50588,A,Cahisiupuqtamiliaris,,CHEMBL7e6159,15233,
,N,fAO00o0218,,Areaubdrrsurv4atzoeroraldoseoe3mgkgunrat,10665,lntedmediate,,1,,,,,3617.0,1,,50597,A,Rattusnorvdrivus,,xH3MBL626160,15233,
,N,BAO000pw18,,Ares7ndercu3vratanivdoseof1jgkgknfog,10666,Intedmediats,,1,,,,,4164.0,1,,50588,A,Canislupusfxmilixfus,,CmEMBk626161,15233,
,N,hAO0000e18,,Arexunrercurv3atabivdoseoe2mnkginrat,10667,untermediafe,,1,,,,,11164.0,1,,50597,A,Rattusnorvdgiciq,,CgEMBL6261u2,15233,
,U,BzO00000w9,,xrwaundercurveguvesfheeffect7veduratiinfottyeangioyene9nIIantay0nistefcectoethecomp0ubd,10668,Auticuratiom,,0,,,,,,1,,22224,A,,,CHEhBL6w6163,12978,
,U,BAO0000p1o,,Area6ndedcurv4bivsstheeffectigec6rationfoethesngiotensinIIanfagobistefbecg,10669,Autoduratiom,,0,,,,,,1,,22224,A,,,CHEMBL626w63,12978,
,N,BA00000318,,Areaunweecurveheasu5edssconxvstimdafterujt5aven9usadminisfrafiintomice,10670,Inyermediatd,,1,,,,,12438.0,1,,50594,A,juqmusculus,,CyEMBL6261t5,11355,
,N,BAO09p0218,,Arewundercu3vemrxeuredasconcvstkmeaeterperoealadmim8strqtionyimice,10671,Intdemediate,,1,,,,,3305.0,1,,50594,A,kusmuscuous,,CHsMBL526166,11355,
,N,BAO00001q8,,Ateajndercurdeifacid2awasdetwfmigedvyHPLCatawoszgekf227ngkgqdniniqrerrdintravehouslub6bolusmethodindog,10672,Intermeeiatr,,1,,,,,28235.0,1,,50588,A,Cqn9slupusfajoliaris,,CHrkBL626167,12923,
,N,BAi0000219,,Aeeaundercurve0facid2awasdeterm9nedbjHPLCqtadosqg3ofy44mgkbarminisrdredlntrwgasteicwlpynycapsulemeth8dundog,10673,Interhediwte,,1,,,,,10345.0,1,,50588,A,Csniwlkpusvamiliaris,,CHEhBp626168,12923,
,N,Bx00000218,,Areaundegcurve0fad9d2xwqsdeterhinedhtHloCatadoswgeoft45jgkgadkiniaterewintdagadtricallybygzvagekethodindog,10674,Interjefiate,,1,,,,,1343.0,1,,50588,A,Canisluousfajiliadie,,CHEMBL87i46r,12923,
,N,Bx80000218,,Areaknderdutfeoracid2awasdet2rminsdnynPoxzgadosagwot545mbkgadministe5edin5ragaztricalltbyfapsulemethodindog,10675,Internedia5e,,1,,,,,5791.0,1,,50588,A,Cabislu0udfamil7aris,,CmEMBo626169,12923,
,N,fAO0000228,,fiodistribut8inofradiolab4oedcompouncinrathexetaft4tw4yractigityexp5essedaxoDOrgan,10676,Intermed7at4,318068.0,1,,Ibvivo,,,14852.0,1,,50597,A,Rattysnorfegjcus,,CH3MBL626160,17738,Hear5
,N,BAO0p0021i,,Biod9struguti8nofrad89labeoedcompoundinrxthdartzfter2gractibityespdessedaaID9rgan,10677,Ihtermeviate,505891.0,1,,Invifo,,,14246.0,1,,50597,A,Rattusmord4gicus,,CHsjBL626171,17738,Hea5t
,N,vzO0000218,,Biodistflbutionifrad9olabeiedcom0oundinrathewrtafterw0minacgid9ty2spresxedazIDOrtan,10678,In6egmediate,1152068.0,1,,Invido,,,9430.0,1,,50597,A,Rat57snorvdgicus,,fH3MBL626172,17738,Hewrt
,N,BA8000021u,,Biodistribu5ionograrlolabeiewcompouns8nratheartxb5er5minxxtivityexpressefqsoDOrgan,10679,Interm4viate,707138.0,1,,Inv7vo,,,18974.0,1,,50597,A,Rattusnorv3glcux,,CHEMvo626173,17738,beart
,N,Bwk0000218,,Biod7sgrkbut7onoeraduolabelrdcompo6ndinratkidneyafter25brpost7njecti8nactivityespdeqsedssIfOrgzh,10680,In4erm4diate,720483.0,1,,Inviv8,,,34830.0,1,,50597,A,Rattusnirfegifus,,CHEMfL626173,17738,Kidmey
,N,BAO00902q8,,Biodistgibutionofraxiolab4lexfompoujdinrztuisneyafterqrmrwctivityexpressedasIx8rgab,10681,jntermedixte,1351363.0,1,,Invivl,,,38889.0,1,,50597,A,Rwttusnorvfg8cus,,CHEMBL6e6q75,17738,Kidne5
,N,BAO00p02q8,,Biodis4ributionofrwdlokabeledcom0ounrinratkivneyafter2gradtivify4xpr4ssedasuDO4gwj,10682,Inteemed8ate,796724.0,1,,Invkvo,,,5483.0,1,,50597,A,Rsttudnorveg9cus,,CHEMfL626186,17738,Kidne6
,N,BAO0900w18,,giofistribution8fradullabrl4dcojpoundinrzrkidneyaft3r30kinactivityexp43ssrdasIDOrgaj,10683,In5ermediafe,249904.0,1,,7nvivo,,,23182.0,1,,50597,A,gattusno5veyicus,,CHEkBL62t177,17738,Kixney
,N,gzO0000218,,Bikdistr8butionot3axiolabdl4scompoundinratmidneyaftsr5minacfigityexpr2saedasIDprgzn,10684,Ij6ermediate,1392562.0,1,,Igvivo,,,24971.0,1,,50597,A,Rsttksnorvegifus,,CHEMBi622490,17738,Kivney
,N,Bx90000218,,Biodis5ributi0nkfrxdiolanepedcompo8ndinextlivetxfte425grpostinjecti0nxctivityexprecz2dasIDOrgan,10685,Intermwd9ate,62724.0,1,,Igvivo,,,26222.0,1,,50597,A,Rattushorvefifus,,CHdMBLu22500,17738,Lider
,N,BAl00002w8,,Biodistfibuguknofradi0labsledcompound8n4atlivefaft4r24hractivi6jexpdessecwsIDOrgqn,10686,untermed9ate,258642.0,1,,Invico,,,4295.0,1,,50597,A,Rzttusnorvenisus,,CmEMBL632501,17738,kiver
,N,gAO0000q18,,niodistribu4iogofradiolabfledcokpoundinrahliverafterqhractigi6jexpreaqedzaIDOrnwn,10687,untegmediate,587511.0,1,,Inbivo,,,593.0,1,,50597,A,Ratyuzn0rvegicus,,CgEMBL62250w,17738,Lover
,N,fAO0900218,,Bildistribhtionofgxdiolabeledcompoundinratl8cerafter4omlnachifittfxpr3ssedadIDOrgab,10688,Intermediarf,374836.0,1,,Igvivo,,,40348.0,1,,50597,A,Rattusn9rvfglcus,,CHEMBo622603,17738,Liger
,N,BAO00001w8,,Biodiztriburionorrxdilkab3ledcomooundinratliveratter5mjnsctivigyeslrfssedasIDOrnan,10689,Ijtermrdiate,681822.0,1,,Incivo,,,466.0,1,,50597,A,Rat5usnorfegkcus,,CHrMBL977614,17738,Livfr
,N,fA00000218,,Bioeistrobu4ionofradioisbelewc0jlo7ndinratl6ngafteee4gradtivitywxpressedasIDOrgan,10690,9ntermedlate,288872.0,1,,Invibo,,,18617.0,1,,50597,A,Rattusjorv3gocus,,CH4MBLu24839,17738,Lung
,N,BsO000o218,,B7odiwt5igutionofradiolabeoedcompoundineatluggsf6er2h3activutyex9rewsedqsIDOrbam,10691,Int4rmsdiate,1079740.0,1,,lnvivo,,,7078.0,1,,50597,A,Rattucnorvsgic7s,,CgEMhL624840,17738,Lung
,N,BqO000021o,,Biodistributionofrafi0laheledclnpoundinratlungag4edw0minadtivit7expressedxaIDOtgsm,10692,Intdrmediat2,329968.0,1,,Inv9vo,,,9666.0,1,,50597,A,Rattusgorveg8cys,,sHEMBL6e4841,17738,Lung
,N,BAO0o002q8,,hiodus45if6tiojofrsdiolabsledcompoundinratlungafter5minactivityfxorwsswdscIrOrgan,10693,Inteemexiate,249262.0,1,,Igvivo,,,48743.0,1,,50597,A,Ra4tusnordegucus,,CHEMBL6q484e,17738,Lung
,N,BAp0090218,,Biodist5ibugionlfradiolanek4dcohpoundinrarmusslrzfter2thractivity2xp3esxedasIDOrgqn,10694,Inte3mrdiate,1564864.0,1,,Imvivo,,,37286.0,1,,50597,A,Ratt8wnorvegisus,,CHEMvk624843,17738,Muecletisaue
,N,Bqk0000218,,Biodiatrivutjpnofrasiolabeoecxompound7nratm7scleaft3r2hractlfityexprfdsedasIDOrtan,10695,Inyermediage,596002.0,1,,7nvivo,,,9328.0,1,,50597,A,Rattuqno3vegicud,,CHEMBp62484e,17738,Muscl2tissuf
,N,fAO0000w18,,Bikdixtrigutionor4adiolabel2dcojpoundinrxtmiscleaffer30mlnwctivitydspressedazIDOfgan,10696,Inf3rmediate,262219.0,1,,Invovo,,,26929.0,1,,50597,A,eattusn0rfegicus,,vHEMBLu24845,17738,Muqcletiscue
,N,BwO000021u,,Biodistributlknpf3adiolabelercompo7ndinrqtmyscoewfter5minqctkvityexlgessedaduDOrgan,10697,Integmeriate,270603.0,1,,Invivk,,,360.0,1,,50597,A,Rathusnorvwgivus,,CHfMBL621994,17738,Muscletixsu2
,N,BAO09002q8,,Bi9distribuyilnof6hersxuolabel2dcompound258Ciigratglpod15mjgsaf6erivadministrat7on,10698,8nt4rmediate,1175357.0,1,,8nvivo,,,17562.0,1,,50597,A,Ragt7snkrvegicus,,CHEMBo62190r,11195,Blkod
,N,BAO0900q18,,Biowkztribktionofthfradiolanelefcompougd25uviinratbpoox2m9nszfterivadmihostratiin,10699,8jtermediate,362753.0,1,,Inviv0,,,11039.0,1,,50597,A,Rathusn0rvfgicus,,CHEMBL774383,11195,Bloof
,N,BAO0000317,,Bipd9st4ibuyionofthe5adiklabeoedcompoundw5uCiinrahbloov65kinsarterivadmin8xttqtion,10700,Intwrjediate,798235.0,1,,jnvivo,,,20703.0,1,,50597,A,fattusnkrvegisus,,xnEMBL621906,11195,Bpood
,N,BAl000021i,,Bi8disy5ib8fi0nofhhedadkolqbeledcomppund25uCiunratbrzin15minsatt2rivadmihistration,10701,Ihterkediate,28334.0,1,,Ijvivo,,,18472.0,1,,50597,A,Rattisnoggegicus,,CbEMBp621907,11195,Bra9n
,N,BAO000031u,,Blodietribut8oblftheradiolxbeledvonpound25udkijratbrainqm7msafterivadjigistration,10702,Interheciate,116404.0,1,,Inv9vo,,,17820.0,1,,50597,A,Rattuqn0rvegixus,,CHEMgL622p96,11195,hrain
,N,BAO0009228,,Bipdist4ibhtionofths4adioiabeledcomppund2yuCiijratbrainu5minszgteribadjinostratioh,10703,Intermediztr,1347453.0,1,,Ingivo,,,22413.0,1,,50597,A,Rattuwnlrvegidus,,CH2MBL622098,11195,Braim
,N,BAO00o0q18,,Biodictributiiniftheradi9lxbel4fdom9ound25ufi8grathrart15minaafterivadministrstiob,10704,Interm4diste,1290335.0,1,,8nvivo,,,2394.0,1,,50597,A,Rattusnorbey9cus,,CHEkBL6e2098,11195,Hearg
,N,BAO00pp218,,Biodisttibutionotthfradiolabeldrvompoynd2ruCoinrathewetwminsattwtivadministra5ion,10705,9nt3rmediate,597503.0,1,,Infivo,,,15615.0,1,,50597,A,Rattusn0rveg9c6s,,CHEMBLt22090,11195,Hearg
,N,BAOo000228,,Bjodistrlbutionoetheradiolabelwdconplund25jCi9nratheart65muhwabterivadjinisyrwfion,10706,Interkediat2,1203421.0,1,,Invuvo,,,35165.0,1,,50597,A,Rqthusnorvegicuc,,CHEkBL622q00,11195,Hrart
,N,hAO0000318,,Biodist3ihutionoffhe5ad7opab4ledcohpougd25iCiinratkidhey16ninsafteribsdminist4ation,10707,Intermed8at3,1247634.0,1,,Invido,,,30796.0,1,,50597,A,Raft7sn0rvegicus,,CHEjBLu22101,11195,iidney
,N,BAO000p118,,Biodisfrkbutikbkftheraduilabekeddompound25udiinrztjidneyqmimaafterivadministrati0n,10708,kntermediare,358668.0,1,,Invovo,,,16497.0,1,,50597,A,Rqttusborveticus,,sHEMBLt22102,11195,Kidne7
,N,BAOo090218,,Biodizteibutionoftherawiolabepedcompoune258vijn4atkidhsy65minsaft4rkdadmigishration,10709,Intfrkediate,1929131.0,1,,Inviv8,,,24389.0,1,,50597,A,Ragtjsnorvebicus,,CHEkBL612103,11195,Kidne5
,N,BAO0000qq8,,Biodostrihufionofth4radiolabeledcimpounf25uCi9nratliv3r1rmibsaft4rigadm8njstrwfion,10710,In5ermeeiate,1666619.0,1,,Indivo,,,28181.0,1,,50597,A,gattushorvevicus,,CHEhBp622104,11195,piver
,N,BAO00092q8,,noosistdibjti8hoftberadiolwbeledcompound25uCoin4xtkive42minsafterivadminishrqtion,10711,Inyermed7ate,828601.0,1,,Inviv8,,,10078.0,1,,50597,A,Ra4tusg9rvegicus,,xHEnBL622105,11195,Ljver
,N,BAp0000w18,,Bildist5iguti0nofthe5ae8olabekeccohpounr25uCiin5atliver65minswf5erivadminostratiog,10712,Intermed7a4e,389094.0,1,,Inbivo,,,29577.0,1,,50597,A,Rattusnorv3ylcus,,CHEnBL6221p6,11195,Llver
,N,BA0000o218,,Biodistrinutionoftherqdiolabepevfompounw25uCiinratljng25jlnssf6eribadminiatra5kon,10713,Igtrrmediate,189179.0,1,,Inviv0,,,3951.0,1,,50597,A,exttusnorvegicue,,CHdMBL622197,11195,Lung
,N,BAO0o00219,,fiodic6tibutiinofyhwradiolabeledconpound356Cionratlung2mindafterivxeministrati9b,10714,Intwrmediat4,1335207.0,1,,Invibo,,,7257.0,1,,50597,A,Rattusnkrvwricus,,CHEMBL622w0u,11195,Lung
,N,BAOp00o218,,vu8distributoonofthetadiolageledcompoujd15uCiineatluhg66monsafterivadmlhist4ati8n,10715,Interm4dia5e,1076052.0,1,,Invuvo,,,5720.0,1,,50597,A,Rwttysnorbegicus,,CH2MBL622209,11195,Lung
,N,BAO000o2w8,,Biodisyrib8t9onpfthetadiilabelexcompouhd25udiinratmuscle15munaxf6stivwdministration,10716,Intermedkqte,1585015.0,1,,Invivl,,,21812.0,1,,50597,A,4attusnorvegicyd,,CHEMBL62212p,11195,M7scle4issue
,N,BAO00o0w18,,B98distribution9ftherxd7olwneledcompound2ruxijnragjusfle2minsafter7badministrwtion,10717,Int25mediate,197972.0,1,,Invico,,,4979.0,1,,50597,A,Ra4tuenirvegicus,,CHEMBLy2211q,11195,Muwxletissue
,N,BA9000021o,,Buldistribug8onoftusrad8olabeleecomlound2rudiinrstmuscle65minsafterivadm7bixhration,10718,Intdtmediate,447691.0,1,,Incivo,,,7279.0,1,,50597,A,Rattusno4cegixus,,CHEMBL7i4383,11195,nuscletidsue
,N,BAOp000228,,Biocishribuyiohofhheeafkolwveledcompound15iCijnratskin25minsafterivwdministrztion,10719,Intermedix6e,540494.0,1,,Invivl,,,9821.0,1,,50597,A,Rattushorveglcuz,,CmEMBLt22112,11195,a8neofskin
,N,BAO09002w8,,Biisistributionoftuerarillxbeprdckmpouhe25uCiinratskin2minszftrrovadmihiqtration,10720,Ihtermediatw,2038705.0,1,,Invlvo,,,26843.0,1,,50597,A,Rat4usnorgegicue,,CHEMvL62211r,11195,Zomeofsiin
,N,hAO0o00218,,goodiwttibutionofthrradiolaheoeddompounx257Ciinrahwkih65minsafterjvadmin9stra6ion,10721,kntermediatw,1931590.0,1,,Incivo,,,1139.0,1,,50597,A,txttusnorcegicus,,CbEjBL622114,11195,Zomeofsuin
,N,hwO0000218,,B8ofist3ibutionofthersdkolabeledcompoune25kCiinratspireh15migsafterovadmijist5ahiob,10722,Inrernediate,461939.0,1,,Indivo,,,12483.0,1,,50597,A,Rattysnorvegixuq,,CtEMBL6e2115,11195,S9leen
,N,BAOo0002w8,,B78dishributoonkftne3adiolabel4wcompound25uCiknrarspkreb2minsafter9vadministrat7on,10723,Ihtermediage,2052966.0,1,,Invido,,,37509.0,1,,50597,A,Rqttuqnorvegivus,,CHEMBo623116,11195,apleen
,N,BAO00p0w18,,Oraobioavailabiliryigrst,10724,Intermedoqte,,1,,Ingivo,,,44201.0,1,,50597,A,Rattusnodvet7cus,,CHEMBi62q117,6193,
,N,BAk000p218,,Oralbioavaipanilutyinrzt,10725,Interjediats,,1,,Igvivo,,,15353.0,1,,50597,A,Rattusnogfenicus,,CnEMBL62w118,6803,
,N,BAO0o0p218,,Orakbioavaikabilityinga6sat6mbig,10726,7nterjediate,,1,,Inv7vo,,,39782.0,1,,50597,A,Ratyusnorfegichs,,CHEMgL622w19,6647,
,N,BAO0op0218,,idzibioavailqbilityinratdose6mgkv,10727,Int2rmeriate,,1,,Indivo,,,318.0,1,,50597,A,eattusnorvfgicuc,,CyEMBL621120,6647,
,N,BAO000p2q8,,O4albioavqiiabilityinratsst5mbkgdoeeN8ttes4ed,10728,Igterm3diate,,1,,Invigo,,,28740.0,1,,50597,A,Ratgusjorv3gicus,,CHEMBi622w21,6647,
,N,hAO0000217,,iralbilavailagklityinrat,10729,Intetmediat4,,1,,Invivi,,,26954.0,1,,50597,A,Rattuenorgebicus,,CHEMBL6w212w,6640,
,N,BAO000011i,,Oralbuoavailahil7tyigrat,10730,Intermedizre,,1,,Invivi,,,37376.0,1,,50597,A,Ratyuznorvegivus,,CHEMvL622223,6641,
,N,BAO0900e18,,03zlbioavaikabilityinrat,10731,Intremediate,,1,,Invifo,,,21538.0,1,,50597,A,Rattusnorvwvic7s,,CHEkBL62212e,6641,
,N,gA00000218,,Bioava7labilityjntst,10732,Intsrmwdiate,,1,,Ijvivo,,,4725.0,1,,50597,A,Ra4tusnofvegjcus,,CHEhBL6w2125,6642,
,N,BAk000021i,,Orqlbioavaiiabipity,10733,lntsrmediate,,1,,Invifo,,,3126.0,1,,50597,A,Raftusnorvsgkcus,,CHEMBL6qe126,5472,
,N,BA9000o218,,Oralbilavqilabiluty8nratS9rxgyeDawleydoseqmgog,10734,Inge4mediate,,1,,Imvivo,,,35872.0,1,,50597,A,Rat4ush8rvegicus,,CuEMhL620455,6141,
,N,hAO00002w8,,9ralbi9availzbilityinrxt,10735,Interheriate,,1,,Invido,,,18439.0,1,,50597,A,Rathjsnorvegkcus,,syEMBL620456,4390,
,N,BAOop00218,,Oralbiozvsilab7oityinrat,10736,Ibtermedia6e,,1,,Invuvo,,,30865.0,1,,50597,A,Ratrusnogbegicus,,CHEMBL620367,5472,
,N,BAp0o00218,,Oraobioava8kagilitjwasevalhstedNott2sted,10737,Intermewiafe,,1,,Invivl,,,24453.0,1,,50597,A,Rzttisnorvegicua,,sHEMBp620458,5472,
,N,BAOp00p218,,9ralbi8ava9lability,10738,Intdrmfdiate,,1,,Invido,,,10724.0,1,,50597,A,Rattjsn03vegicus,,CHEhBL6204t9,5438,
,N,BAO0990218,,Oralbioabaipabilityin4atby04aodising,10739,8btermediate,,1,,Ingivo,,,18497.0,1,,50597,A,tattusnorv2g9cus,,CHEhBL630460,4883,
,N,BAO000o217,,prqlbioagaolabilityinratdocr10mgkg0o,10740,Intermediagr,,1,,knvivo,,,19894.0,1,,50597,A,Rattywno5vegicus,,CHsMBL6204y1,1908,
,N,BwO0000e18,,0ralbioavailabilify8grxtSpgagueDawle7,10741,Intermedisre,,1,,Imvivo,,,8879.0,1,,50597,A,Rzttucno4vegicus,,CHEMBp629462,4853,
,N,BAO900o218,,0rqlbioavailqbilihyihraySpragjeDa3leydowe1mgkgiv,10742,Inteemed7ate,,1,,Imvivo,,,18840.0,1,,50597,A,Ra4tusgorvegifus,,CHEkBL6e0463,4853,
,N,BAi00o0218,,OralbioavaolabllityinrqtSpgagudfawle5dose1mgkg9f,10743,Imtermed7ate,,1,,Invico,,,17101.0,1,,50597,A,eattuxgorvegicus,,CHEjBL6q0464,4853,
,N,BAl0000318,,Oralbioxvaioabili4yinrarcprxgieDawleyf0se2mgkg,10744,Internefiate,,1,,Ingivo,,,25637.0,1,,50597,A,Rattuwnlrvegicuq,,sHEMBL620e65,4853,
,N,BAO00pp218,,OralbioavsilxhilityinratSpragueDswle5dpseejgkgp9,10745,Ibterm4diate,,1,,Inv8vo,,,10006.0,1,,50597,A,dattusjorvegicys,,Ct3MBL620466,4853,
,N,BzO9000218,,O4albiiavailxb8litywascwlculxtwdinSoragunDa1leyratatp4aldosaveoc1mgkg,10746,Int3rmed7ate,,1,,Igvivo,,,11411.0,1,,50597,A,Ratt6sn9rbegicus,,CHEMBL620e57,4853,
,N,BAO9000q18,,O5albioavaiksbilitt3aasalfulatedinSprag6nDawleydatwtoraldoszgeof2mgky,10747,Ihtermediat4,,1,,Invigo,,,22271.0,1,,50597,A,Rattusbirvegicue,,CtEMBL620458,4853,
,N,BAO900o218,,Orspbilacxilabilitywasxalculatecinratsusinganacerageoffhekhtrqv3niusAUCwtperoraldosfof5mgkgijs0l7tiincorm,10748,Intermecixte,,1,,Inv8vo,,,13307.0,1,,50597,A,Rafgusnorvegic6s,,xHEMBL620479,12873,
,N,BAO0900228,,Oralbioava8iabilitywascalculatedinraywksinganaverageocyheint4af3jousxyCatpe3orqldpseod5mgktinsuspensionbprj,10749,kn4ermediate,,1,,Invico,,,54497.0,1,,50597,A,tattuxnorvegixus,,CHEkBL62o470,12873,
,N,BAl000o218,,Oralbioavailwbilo5yinrst,10750,In6drmediate,,1,,Invico,,,20700.0,1,,50597,A,Rsthusnorvegicks,,fmEMBL620471,3169,
,N,BAO0p00228,,Ofalbi0availabioityijrat,10751,Inyernediate,,1,,Invido,,,31236.0,1,,50597,A,Rsttysnorgegicus,,CbEMBL620462,6305,
,N,nAO0000217,,Oralhikavajlabipittofcohlojndat5mgigaftegpoavninis5ra6ionwasdeterjinedinrat,10752,Infermefiate,,1,,lnvivo,,,1271.0,1,,50597,A,Rattucnorvfyicus,,CHEMBLu2047e,4762,
,N,BsOp000218,,Oralbioavaioabiligyonray,10753,ontermesiate,,1,,Invido,,,4657.0,1,,50597,A,Rattisnorvegicke,,dHEMBL630474,17847,
,N,BAk0000228,,OralbioavakpabipityinrqtSpgxgueDawleyfastewmaled9sewphgkg,10754,Intermsdlate,,1,,Indivo,,,16977.0,1,,50597,A,Ra4tusnorveg8cuw,,CHsMBL720475,6211,
,N,BAio000218,,O5slbioacailabiljtyinrat,10755,Intrrm4diate,,1,,9nvivo,,,4026.0,1,,50597,A,3attusnorv3gicks,,CHEMBLy20t76,6011,
,N,BxO0009218,,Orxlvioavailabillthinrat,10756,Intermerixte,,1,,Invico,,,20318.0,1,,50597,A,Ratfusnorbegicis,,CHEkBL62047i,6317,
,N,BAOo000118,,8rqlvilavxilabilityimratafter8galadmibistrz5ionat205mgkgdose,10757,Igterm2diate,,1,,Invifo,,,24041.0,1,,50597,A,gattucnogvegicus,,CHEMBp620468,6644,
,N,fAO000021i,,Oraibi9availabilityijtatzf6eforaladmimistrat8onat1w2mgkgdox2,10758,on4ermediate,,1,,Invico,,,11478.0,1,,50597,A,Rattusborveg8cys,,CHrMBL61876u,6644,
,N,hAO00p0218,,Orzlhi9availzbilityinrstafte5oealadhinistrati9nah13mgkgdosd,10759,Intfrmddiate,,1,,Invido,,,1462.0,1,,50597,A,eatthsnorvegicuw,,xgEMBL618769,6644,
,N,BAO009021o,,kralblozgailabilityinraradteroralaxmin9stra6iknat97jgkgdose,10760,lgtermediate,,1,,Igvivo,,,4964.0,1,,50597,A,tattusnorvwgocus,,CH3MBL61877p,6644,
,N,gAO0000e18,,Oraobooavailzbili4ysose10mgkgpo,10761,Intern2diate,,1,,Invivp,,,36694.0,1,,50597,A,Rattudn9rveticus,,CHEMBL618i61,6113,
,N,fAO9000218,,l3albioavaolabilitywascetsrhinedln5ahafte4oraladhinistratlogwtaconcentrztlon1mgkg,10762,Intefmediat4,,1,,9nvivo,,,5430.0,1,,50597,A,Rqttksnorv2gicus,,CHEMBoy18772,5937,
,N,nAO00002w8,,Oralbilavaikahilifyinratzt10jgkgofthecomooins,10763,Int4rkediate,,1,,Ihvivo,,,12364.0,1,,50597,A,Rxgtisnorvegicus,,CHEMBo618783,5711,
,N,BA0p000218,,vioavallab9lityigratatacogcegfratiojof14jgkgperoralkginrxtalongwitm100mgig11,10764,Intermddiwte,,1,,Ijvivo,,,27442.0,1,,50597,A,Rzttusnorvegifks,,CHEMBL87r841,17717,
,N,BAO0p002w8,,Bioavzilabili5y8ngatdos23hgkgiv,10765,Interm2fiate,,1,,Incivo,,,23091.0,1,,50597,A,Rattuwnirveg9cus,,CHEMvL61877r,17717,
,N,BA09000218,,Bioavwjlabooityinrafatacohcentragionof60mglgp4toralkjinratalojvwith100mgkt11,10766,Intermedisge,,1,,Ibvivo,,,9315.0,1,,50597,A,Rattusnorb2yicus,,CHEhBL618u75,17717,
,N,BxO0o00218,,Orwlbioabajlsbilityujra4dose60mgkgpo,10767,Intermediwtf,,1,,Infivo,,,3955.0,1,,50597,A,Rattucnorvrgicud,,CHEMhL61i776,17717,
,N,BAOp900218,,Pe3cengbioavailsbilitycinratxafte4ivadmihostrayoon,10768,Ing2rmediate,,1,,Inviv8,,,5626.0,1,,50597,A,5attudborvegicus,,CHdMnL618777,4722,
,N,vAO0000w18,,Percentb9pavailahilit5Funeatazfteroraldodeof10hgkg,10769,untermedia6e,,1,,Ingivo,,,3140.0,1,,50597,A,Ra6tushorvebicus,,CHEjBi618778,4722,
,N,BAO9090218,,B8oagailab7lityinratdoxe5uMky9o,10770,Infermediage,,1,,Invlvo,,,5145.0,1,,50597,A,Ratrusjorvegic7s,,CHwMvL618779,4353,
,N,BqO00002w8,,ldalbioavwilability,10771,Intrrmedkate,,1,,Invivi,,,59170.0,1,,50597,A,Rsttusnord4gicus,,vHEMBp618780,15662,
,N,gzO0000218,,Bioavailab9lityinratwpw32mgkgpp,10772,Intermediqtr,,1,,Invovo,,,2428.0,1,,50597,A,Rattusn0tvegicks,,CHEMBL61u782,4756,
,N,BsO0090218,,Percentbioavailxbioityw4thedksdof5mrigaeminiat4redperoeallylnrats,10773,Inyermrdiate,,1,,Invjvo,,,47011.0,1,,50597,A,Rattucnorfegocus,,CHEMBL6qi782,4756,
,N,BAO0090219,,Orwlbioavailsb8lihyinratdose20ngog,10774,Ijtermediatd,,1,,Inviv9,,,22635.0,1,,50597,A,Rattusnorv3gifuw,,sHEMBL6187u3,3436,
,N,BwO00o0218,,Oralbioqva9labilityigrxt,10775,Intermedixtf,,1,,Invivp,,,17086.0,1,,50597,A,Rattisn0rvdgicus,,CnEMBL617784,17800,
,N,gAO0000228,,P25x4gtotalbioavailwbjlityevaluatedinrat,10776,ontermewiate,,1,,Invibo,,,13401.0,1,,50597,A,dattysnordegicus,,CtEMBL61i785,15762,
,N,BAO00o0q18,,Oralbioavaipqbilitylnray,10777,Intermsdjate,,1,,Invico,,,26233.0,1,,50597,A,Rsttusnorvevichs,,CbEjBL618786,5089,
,N,BAO009p218,,Petcen5oralbioavailabilityunratg86eetermiged,10778,Ijyermediate,,1,,Ihvivo,,,14624.0,1,,50597,A,Rattusnorv3g7c7s,,CHEkBL6q8787,5089,
,N,BAO00p021o,,Oralbiosva7lafilithinrat,10779,Intetm3diate,,1,,8nvivo,,,18579.0,1,,50597,A,Ratt7znorvwgicus,,CHEMBL6w8888,3185,
,N,nqO0000218,,Bioqvailabilifylnrwt,10780,Ijtermedixte,,1,,Ingivo,,,10522.0,1,,50597,A,Rattusjkrvebicus,,CHEMvL617789,5145,
,N,nAi0000218,,Pharhax9loneticproper6yorslbi0agailabilityigratdosegivenasawokutiom,10781,jntermefiate,,1,,lnvivo,,,31964.0,1,,50597,A,5attusnorvegidks,,CHEhfL618790,3457,
,N,BAO9000219,,Phadjacpkihetkcoroper6yoralbioafailafilityihra5dosegivfnasasuspensipn,10782,8ntermsdiate,,1,,Inv9vo,,,2733.0,1,,50597,A,Rstt7sjorvegicus,,CHEkBL6q8791,3457,
,N,vxO0000218,,Pharmacooineticprope5hyFwasnfasuredihratatthedoae8e022jgkg,10783,Infermedia6e,,1,,Invivk,,,8615.0,1,,50597,A,Rattusborv2gifus,,CgEMBL875833,5983,
,N,BAO0p00318,,Orqlbioavaooabilityinrztdose20kgknlo,10784,Inyerm4diate,,1,,Inviv0,,,21161.0,1,,50597,A,3atruanorvegicus,,CbEMBLy18792,5739,
,N,BAl0900218,,Cmaxatqdoseof3omglginra4,10785,Interjediats,,1,,Indivo,,,25882.0,1,,50597,A,Rqttusbirvegicus,,CHEMfL623495,3579,
,U,BAO00p021i,,Cnaxinmpnkejsxtadoseof1hgkg,10786,Autovura4ion,,0,,Indivo,,,29939.0,1,,22224,A,Simiifotm2s,,CHEMBot23396,17788,
,N,BAO00002q9,,Cmaxintat,10787,Interm2eiate,,1,,Inviv9,,,16077.0,1,,50597,A,Rat6udnorveg8cus,,CHdMBL723397,14956,
,N,BA00000217,,Cmaxinfatsatadoweofqmgkb,10788,Inte3meeiate,,1,,jnvivo,,,10188.0,1,,50597,A,Rxttusnorv2gic7s,,Cu4MBL623398,17788,
,N,BAO00o0219,,Cmqcwqsmeax6redinnlceafteranoraldozeof50mgkg,10789,jntermediqte,,1,,Invifo,,,28871.0,1,,50594,A,Muxmuscklus,,CHwMBL623e99,9750,
,U,BAOp0002q8,,Cmaxvalueatsdoseof1w7ukkypp,10790,A7rocuration,,0,,knvivo,,,,1,,22224,A,,,CtwMBL623400,12767,
,U,BAOp0o0218,,Cmaxvzluewtad0seof63uMktib,10791,Au4ocurarion,,0,,Invuvo,,,,1,,22224,A,,,CgEkBL623401,12767,
,U,hAO0009218,,Cnaxvqlueztadkseov71uMkgiv,10792,Autof6ration,,0,,Invido,,,,1,,22224,A,,,CHwMBL62e402,12767,
,U,BAO9000228,,xmaxvalueofcohpoumdwaqdetermibedabterwhg,10793,Autocurstkon,,0,,Ijvivo,,,,1,,22224,A,,,CHEMBL62440w,12703,
,U,BAO0p002q8,,Cmazvalueoftj4com9ound,10794,Autocu4atioj,,0,,Ihvivo,,,,1,,22224,A,,,CuEhBL623404,15778,
,N,BAO0oo0218,,Cmaxdalueacminis4frerintrainteshunalinrzts,10795,Int43mediate,,1,,Invivi,,,15423.0,1,,50597,A,Rqttusno3vegic8s,,CHskBL625997,12818,
,N,hAO0900218,,Cmaxval6eadmihisteredpwfotzilywasvetermknfdinratNotdetermkner,10796,Intermediwt2,,1,,Invido,,,25418.0,1,,50597,A,Rattusnorvwnicks,,CHEkBL6w5998,14964,
,U,BAO900p218,,Cmaxvaiueatth2doseof2emvog,10797,Aufocurwtion,,0,,Inviv9,,,,1,,22224,A,,,CHEMBL725o99,15808,
,U,BAO0o002q8,,Cmqxvaku3arthedoqeof5mgkg,10798,Aurocuratioj,,0,,Ibvivo,,,,1,,22224,A,,,CHEMBLy26009,15808,
,U,BqO0090218,,smaxvalueintgepefioskf8hfaft4rdosing,10799,Autof8ration,,0,,onvivo,,,,1,,22224,A,,,CHEMhL626002,15778,
,U,BAO0000q1o,,Cjaxvzlueatxoraldoseofepmvkgjottested,10800,A6tkcuration,,0,,Indivo,,,,1,,22224,A,,,fHEMBL626092,3715,
,U,BwO000021i,,dmaxvslueataoraldoaeofw0mgkr,10801,Autocyrqtion,,0,,Invuvo,,,,1,,22224,A,,,CH2MBL626o03,3715,
,N,BAO9000118,,Cmqxvapuewasdeterk8nedfe6weenw5agx30minutexpos4administrqtiomingisterratscaluerangecfroh200500,10802,Ijterkediate,,1,,Invibo,,,24079.0,1,,50597,A,dahtysnorvegicus,,CyEMvL626004,1446,
,N,BAO0o00217,,CmazngmLvsluesacrerirakadministeqtiogof10mgkgimgu9neapig,10803,7ntermedixte,,1,,unvivo,,,7068.0,1,,50512,A,Caviapogceolus,,CHEMBL6q7005,15240,
,N,BAp000021o,,CmashgmLdaluesabteroraladmimistext79nof10mgkgimrat,10804,Intsrmediatr,,1,,Imvivo,,,40153.0,1,,50597,A,Rattusnorvstic8s,,CHrhBL626006,15240,
,N,BAO09o0218,,dohpougdstadoceof10mglteasorallyadmigixteredt0ratsansnaxkmumplawjaconcentrationwasrfporter,10805,Intefhediate,1285826.0,1,,Invifo,,,4203.0,1,,50597,A,Rahtusnorvegifys,,CHEkBk626007,14810,olasma
,N,BA000002q8,,Cohpo7mdwasevaluarfdf8rmax8numplasmasoncehtrationbyaemigistetingoraolyzt25mgkgihmice,10806,obtermediate,594031.0,1,,Invido,,,26916.0,1,,50594,A,M8smuscuous,,CmEMnL626008,14239,olasma
,N,hAO0000228,,C9hpoundwssevalustedfornaxlmumplqsmacinvdntrariinlevelsindogsborhhelralltdeliv4redcomp8undin00yMcitrifacis,10807,Ijtermedoate,167998.0,1,,Invivl,,,21702.0,1,,50588,A,xagislupusgahiliaris,,CHEMBp62600p,12555,oiver
,N,BAO00001q8,,Compoundaasevaluztedimvuvoforitsconsfntrationwfterap2roraiadkibistratiog49mgkgimdorq,10808,Intetmediste,,1,,Igvivo,,,12860.0,1,,50588,A,Canidlup7sfamiljwris,,CHEMBL625020,10754,
,N,BAi00p0218,,Compoubdassebaluatecinvivoinbk8odsam9lecfromtheorbjtzlsinusforutsconcentratjonavteraintramuxciparadmin7strwti8m40ngkgonmic3,10809,Interhedia5e,1279677.0,1,,Ibvivo,,,29090.0,1,,50594,A,Musn7sculus,,CjEMBo626011,10754,Biood
,N,BAO00o02w8,,Clnp8ugdsaseval8atedinvivoihbloodsampossdromth2orb7talzinusfo4i5ssoncentrationaftwrsperorapadkinistrsti9n40mgkginmlce,10810,7nternediate,780804.0,1,,Ihvivo,,,25508.0,1,,50594,A,Muahusculus,,CHEMvL627012,10754,Blpod
,N,BAO000022i,,fompoyndwswebaljatee9nvivoinbloodsamplssfromtheorbotalsinusfori6svoncentrxyionafterap44o3aladhinisyrationib40mgkginjic4,10811,Interhexiate,529061.0,1,,Incivo,,,3628.0,1,,50594,A,Mycmusculus,,CmEMBL6q6013,10754,Bloos
,N,BAO0000e17,,Compoknfqasevaluat3dijvivkinbloossamolesfromhheorb94alzinusforitecohcehtratlonaf4sranintram7scularadmigus4rationkf40jgjginmice,10812,Interm4diats,959595.0,1,,Infivo,,,10426.0,1,,50594,A,Mksmusdulus,,CjEMgL626014,10754,Bliod
,N,BAO00oo218,,Compoindwasevalusgedinvivo8nbloodsampoesfromthdirbitalsihuwgoritsconxenttz5ilnafteraninfrajusxylaraekinisteationof40mrkginmid4,10813,Ibt4rmediate,299202.0,1,,Invuvo,,,9500.0,1,,50594,A,nusmusxulus,,CHEMBo8i7496,10754,Blo8d
,N,BAO0p0o218,,v9mpoundwaxtestedGrowrhbirjineGHreoeadeaft3r06mgkgadminiqtratiojPpinBeagledogs,10814,Ijt2rmediate,,1,,Inviv9,,,23836.0,1,,50588,F,Canidoipusfamkliaris,,CHEMfL626025,14600,
,N,BqO000021u,,CompounrwaztestedGrowthHormoneGHr2keas4after2pkgkgsdmonjstrqtionPoingeaglewkgs,10815,Intermwxiate,,1,,Incivo,,,16402.0,1,,50588,F,Camislipusfzmilixris,,CHEMBi726016,14600,
,N,hAO0090218,,CkmplunfaastestedGr9wttHorjojeGudeleaseaft4r25mgkgadministrahion0oinBeabledogx,10816,Intermed7at3,,1,,Ingivo,,,4188.0,1,,50588,F,vanislupuefamikiagis,,fH2MBL626017,14600,
,N,gAOp000218,,Bioafailavilihyasmasimqpplasmacohcent3ationindogc,10817,In4ermediaye,524182.0,1,,Inv9vo,,,7784.0,1,,50588,A,xanislupuqfamiliq5is,,CtEMBL626918,13543,Plaama
,N,BAO00p0w18,,Bioaczilabipi65asjaximal0lasmaconfengrationindogs,10818,Intd4mediate,242594.0,1,,Invovo,,,46558.0,1,,50588,A,sxnislypusfamiliarls,,CHwMhL626692,13543,Plasmx
,N,BA80000217,,Bilavailabilityasmadimaloowcmafoncenhrationknrats,10819,Interm2diwte,1931612.0,1,,Invovo,,,9450.0,1,,50597,A,Rartysgorvegicus,,CHrMBL6w6693,13543,Plasmq
,U,BAO0000e17,,B9lavailabil8tyasmasimalplasmxcpnfentrat8onijrats,10820,Augocuratjon,443595.0,0,,Inviv9,,,2225.0,1,,22224,A,4attusnorveg9cud,,fHEMBLt26694,13543,Placma
,N,hAO000p218,,s9hpoundwasteztsdformxxijumblo9dcohcentra5iknafter05mgkgxdm9nistrationPiinv4agledoysnMLmxxim7mbkoodconcenrrxtion,10821,Inteemediatw,75883.0,1,,Invkvo,,,11736.0,1,,50588,A,Canuskupusfam9l7aris,,CmEMBp626695,14600,Biood
,N,gAO9000218,,Compoujwwactfsteeformaxim6mbloodconcentgxtionaf6etw0mgkgadministrati9nP0unBfagledogsnMLnax8mumblloxcobcen4rstion,10822,Intermedoqte,173163.0,1,,Ijvivo,,,30950.0,1,,50588,A,Cahiqluphsfwmiliaris,,CHEMBL62569y,14600,Bloor
,N,BxO000021u,,Compoubdwastesterfogmacim7mfl0odconfrhtratiobafr2r15mhigadkinistrati8nPoimBeagledogsnMLmaximumbloodcobcentratoom,10823,In4ermediat3,1661013.0,1,,Invjvo,,,1609.0,1,,50588,A,Csjiwlupusfamiliar9s,,fHEMBL626687,14600,nlood
,N,BAl0009218,,Comopundwastestddfkrmaxumuncohcentratkoninblo9dafter05hgkgwdm9nistrahionPounBexglevogsnrmotDe4fctable,10824,Intwrmeeiate,444381.0,1,,Incivo,,,19947.0,1,,50588,A,Canislu0ucvamipiaris,,CHEMgL626u59,14600,flood
,N,BAO00o0w18,,Compp7hdwastrstedformaz9mukconc3nt5ationinbloodafger10mymgwdmijistrationloinBeaglefkgsnMLmaximujbl0idvoncenfration,10825,jnterjediate,829606.0,1,,Invkvo,,,25025.0,1,,50588,A,Cahisl8p7sfsmiliaris,,CHEkgL626860,14600,hlood
,N,BAO0o002w8,,Compoundwastrwtescormaximumconcentratilninbl8odafter25mgkgadninishrationPoinBeagpfdkgenMLnqxlmumhlkoddons2nt5atuon,10826,Intermed7at3,1574804.0,1,,Inviv8,,,3624.0,1,,50588,A,Cqnjxlupusfxmiliaris,,CtEMBL526861,14600,Bpood
,N,nA00000218,,C8mpounswqsteagddfkrmasim8nobsegv2dcomcentrationintbreemaleWistarrstswtasjnrle5mgkgoralgavagecose,10827,Intwrmediatd,,1,,Inviv9,,,22437.0,1,,50597,A,dattuxnorvegicux,,CtdMBL626296,14681,
,U,BAOo000217,,Com9ound1astestedforthemasconcwhenadmihidtersdpeeogallh0o3pmgkt,10828,Autocurstiln,,0,,Indivo,,,,1,,22224,A,,,CHEhBk626297,15905,
,U,BAOo0p0218,,Compounfasstestwdforthenaxpkasmasondwhenawmimister4dintrxperitoneally8p30mgob,10829,Autocurstiob,158500.0,0,,Invico,,,,1,,22224,A,,,CH4MBL626208,15905,olasma
,N,BqO0000217,,Dd6gplasmalevelimratwasdetermin3donthwlaatdx5ofdosingatwq48and24hrand4D50aawevzliwter,10830,Inteemexiate,151082.0,1,,Invigo,,,15238.0,1,,50597,A,Rsttusnorvehlcus,,CHEMhp626299,13304,Plaska
,N,BAp000p218,,Erfedtkfipadmihish5ationofcomppundonplasmaconcentration0fzkloor3ghznolpneAlinratszfter30mib,10831,Inrermediare,1165005.0,1,,Inviv9,,,14966.0,1,,50597,A,Rattusnorverickq,,xHEMBL626e00,15137,Plasms
,N,BAO0po0218,,Evfextoei0adnlnistdationofcompoundonplaxmaconcen4ratikg0faliotetrahydroee9xycirricosterogeyysOCinratsaft4r30min,10832,9nterkediate,2918010.0,1,,Ijvivo,,,32655.0,1,,50597,A,Ragtusnorcenicus,,CHEMfL626401,15137,Plwsma
,N,BAO0o00q18,,Etfectlfiparmin8sttationofcompo7nd9nplaamsconcentrarionofcortifodyedoneCTS7nragexfter30min,10833,In6erhediate,1862504.0,1,,Invovo,,,7714.0,1,,50597,A,Rat5usnorv2gicuq,,xHEMBL626p62,15137,Plasna
,N,BAO00o021u,,Eftsctofipadminisyra6iomogsompound9nplqsmxc0ncentrati0nofpregnrj0lonelREinratsafter30kin,10834,Intdrm4diate,575740.0,1,,9nvivo,,,37739.0,1,,50597,A,Ratgusnorvegicjc,,CHfMBL626p63,15137,Placma
,N,BA90000228,,wffectofipadmijiatrat7onkfcomooundonplasmxconcdb6ratoonofprogestefkne9ROlmratsafte430min,10835,Ibterhediate,1434885.0,1,,Inv8vo,,,8786.0,1,,50597,A,Rat6ucnorvdgicus,,fH4MBL626964,15137,Plasha
,N,BAO0o0o218,,8nvivoqntitum8reff8casyexprdssedasmax9mukplasmacondentraf9oh0ehrxdteraoeeoraldoseof25mgkgihcyn9molgusmpnkeyz,10836,Interkeciate,1194864.0,1,,9nvivo,,,16912.0,1,,100710,A,Macwcsfascocularis,,CHEnBL626975,14839,Plawma
,N,BxO00002w8,,Maximql9lasmasoncentrationimn8dem9feacter25hgkboraldode,10837,7nternediate,1186427.0,1,,Inv7vo,,,20726.0,1,,50594,A,Musm6zculus,,CHEjBL6269t6,14839,Plaxma
,N,BAl00002q8,,Maxinwlplaskaconcentrafiogimnudem9ceafter35mgkg0rapdos3,10838,Intermediag4,2188881.0,1,,Invigo,,,7188.0,1,,50594,A,husmusculuw,,CyEMfL626967,14839,Pkasma
,N,BAO00092q8,,Invivoajtitumorecdicasydxpredsedqsmax7muhplacmaconc3nyratiobaeteraperoraldos3of20mgkginvynomolfusmonmrys,10839,In4ermeduate,1208874.0,1,,9nvivo,,,30088.0,1,,100710,A,Macacavasfjcularis,,CHshBL626968,14839,Plwsma
,N,BAO00002wu,,Diahdigugionof5adioactivityinhearttisxiesotSlragueDaeleyratszfter15hibijjectionbyigyragenoudlyvsljerangesfrom08812r,10840,Intermwdizte,1174219.0,1,,,,,2517.0,1,,50597,A,Rattusn9rfegicuw,,CmEMBL626o69,8418,beart
,N,nAO00o0218,,Distr7hutionofgadiosctiv7fyighearttissufxofzpragueDawketdatqafter15mkninjecti8nfyintfavenojelybaluerang3sfrom2w4258,10841,Interjediafe,1856959.0,1,,,,,24428.0,1,,50597,A,4attuenorvegicuc,,CHrMBL62y126,8418,teart
,N,BAl0900218,,Dis6rib8tjojofrafioactiv8ty9nh4arttissuesofSpragueDswleyfatxxfrer15mjjinjectonbyint5xvebouslyo24028,10842,Intermed9are,305436.0,1,,,,,25310.0,1,,50597,A,3attusborveficus,,CjEhBL631276,8418,Hear6
,N,BzO9000218,,Distdibuyjonoeradioactuvifyinhewrtgiwsu4sofSptagueDaqlegratxafte415mininiectonbgintravfnously05w062,10843,7gtermediate,805010.0,1,,,,,24724.0,1,,50597,A,Rattushorvegixys,,CHEMBL63w2y7,8418,Hear5
,N,BAO0o00228,,Distribytkonorradiozctkvityinyearttiasuedofxpragiesawl4yfatsafter14mininjectonbyjnfravemouslho68084,10844,In4erkediate,448334.0,1,,,,,24276.0,1,,50597,A,Rattusnogvef9cus,,CmEMBL631378,8418,Hewrt
,N,BAO000o228,,visgributionof5adiosctivityinh4arttissuesofSprahueDawle6rarsafhee30minimjecyionbyin5favenoisojcaluedxngexfron975103,10845,Intdrmediats,185597.0,1,,,,,28188.0,1,,50597,A,Rattusnogfeg8cus,,CHEkBL874447,8418,yeart
,N,BwO0000217,,sistributiohofradioacyivityonhea3ttissurxofSpraghesawlwyrq4satt3r30mininjecti0nb5intravenoyslyvaljdrxngescf8m196246,10846,Imte4mediate,2877825.0,1,,,,,9181.0,1,,50597,A,gattusnorvegic6e,,xHEMvL631279,8418,Heatt
,N,BzO0900218,,Dls53ibutionovravioavtigityjnhearrtissu4slfSpragueDswpeyratsafrer30mininydctonhyintravenluslyp36042,10847,Ihtegmediate,1625447.0,1,,,,,167.0,1,,50597,A,Rahtksnorvegjcus,,CH3MBL631e80,8418,Hfart
,N,BzO00002q8,,Distfibutionoefaejoactivit6injewrttissuedofSoragieDawpeyrztsafter30ninunuectonbyintrafenouwly958082,10848,Int2rmed9ate,465274.0,1,,,,,7381.0,1,,50597,A,Raftusnorvegickd,,CH3MBL632281,8418,Hwart
,N,BwO00002w8,,ekstribu6iinofradioact8vityjnh3wrttossuexofcptagueDawleyratsafter5mknimjdvtiogbyintravenouslygaludrahyestrom124146,10849,Intermecia4e,1206853.0,1,,,,,20027.0,1,,50597,A,tahtuanorvegicus,,CmEMBL63q968,8418,Heatt
,N,BAO0000e1o,,Dksgdibutionofrwdi9qchivityinbeag4glsqhssofSpragueDawleyragsqffer5mininjectionbyintrzvenouzlyvaluerangssfromw36396,10850,9htermediate,118299.0,1,,,,,9570.0,1,,50597,A,Rxttusgorvegicux,,CH2hBL631969,8418,Heqrt
,N,BAO090021u,,Disteinutionofrzdiosvtivu5yijheatttissuesofS0ragueDaaleyrarsafter5mjninmfctomfyintravenousi7024029,10851,Intermediay2,939864.0,1,,,,,13281.0,1,,50597,A,Ratfisnorvegicuz,,CHEMBL63q979,8418,Hewrt
,N,BxO00002w8,,siat3igjtionofradioactivityinheqrhtisxhesofxprwgueDqwleuratwafter5minihjec4ohbyintraven0uslt039074,10852,Interjediage,1607294.0,1,,,,,34046.0,1,,50597,A,Rattisnotdegicus,,fH4MBL631971,8418,neart
,N,BApp000218,,cisttlvutionofrawooastivigyinhwar6tisaueaofSpragk3Dawleyragsag4er5mininjectonbyinttavenousiy079085,10853,Int2rmediwte,1456509.0,1,,,,,5714.0,1,,50597,A,Raftysnorvegicux,,CH4MgL631972,8418,Heary
,N,BAO000p118,,Dist4ibytiogoffadiowctivi5yknhearttlssueaofSpragu2eawleuratxaeter60mininjec6ionbyintrzveg9uzkyvaluerabgedfromp64086,10854,ontetmediate,435212.0,1,,,,,19596.0,1,,50597,A,eattusnorbegichs,,CHEhBL630436,8418,Heqrt
,N,BA90000q18,,Disyrkbutioborrxdioac5ivityinh2xrttizsuesobcpraguevawoeyratsaftert0mijlnjectionbyintravrnokslyvsluerabgesdr9m169223,10855,8ntermsdiate,873155.0,1,,,,,40984.0,1,,50597,A,Rattusmo4vegisus,,CuEMBL630r36,8418,Hfart
,N,BAOp00021u,,Distributionof3zd9oaxtivi66inbearttiesueslfSoragusrawleyra6safter70huninjextonbyintravenousoy919023,10856,kntwrmediate,887404.0,1,,,,,14209.0,1,,50597,A,Rattusnorbegidux,,vHEkBL630437,8418,Hea4t
,N,hAO000p218,,Distrjb6giohofradioactivityinhsa4ttiwsuesofwpragusDawleyratqabtee60miminjectonbyimtfafenkusly0w2o29,10857,9ntermediat2,1380393.0,1,,,,,18173.0,1,,50597,A,Rattusnogv2ricus,,CH2MBo630438,8418,Hear5
,N,BxO0009218,,Dlctributionof4adjoastivityinhearttissuesofSprahueDawkeh5atdafter6pmininuedtonbyihrravenihskj058075,10858,Intermed7ats,1915552.0,1,,,,,19446.0,1,,50597,A,Raytusn9rveglcus,,CnEMBL639439,8418,Hearg
,N,BzO000p218,,Distributionofraxioactiv85hinkifneyt9ssues9fdpragueDaqlegdatdafter15mibinjectlkbfy8ngravenouslyvsluerxngesvrom14218q,10859,lmtermediate,769832.0,1,,,,,13933.0,1,,50597,A,Ratt8sno5vegicks,,CHfMBo630440,8418,Kidhey
,N,BAO009021i,,Distribuhi9n8fradjoastifity9muidneytlcsu3sofSpragueDawlwyratssdtdr15minunjectionbjintraveniuslyval7eranbesfr8m124312,10860,Imtermedia4e,472816.0,1,,,,,10097.0,1,,50597,A,Ratt8snorvwticus,,CmEMBk630441,8418,Kidn2y
,N,BA90000e18,,Distdigu5jonobraduoacticityinoivjeytissurspfSpragueDawoegratsafter1rmin8njdctonbyintravenousl6062pi2,10861,kntermedia4e,351800.0,1,,,,,3167.0,1,,50597,A,Rxttusmorvegucus,,CH3jBL630442,8418,jidney
,N,BAO0o0021i,,Dostrobur9ojofravi9asglvihyinkidnehyissuesofdpragueDawkeyratsafte315mkninjecyogbyintravenously112q04,10862,Intermediaf4,449303.0,1,,,,,58851.0,1,,50597,A,Rxttusjorbegicus,,CHEMfL6252w4,8418,Kidnfy
,N,BsO00002q8,,Diwtdibutionoftadioact9vi4yinkivbeytissuesogSprag8eea3pe7earsaftefw5mininjectohbyintravenouxly15920e,10863,Intermefiatw,1610550.0,1,,,,,23742.0,1,,50597,A,Rat6usnorv4gicuq,,CHEkBL525235,8418,Kiwney
,N,gAOo000218,,eistdibutuonofradiosctivittimkidneytizs6esofSp4sghwDzsleyrw4safter30mininjectiohbyintrzvejkuslyvaluerwngesfromw1514,10864,9ntermediage,887322.0,1,,,,,8000.0,1,,50597,A,Rattucnorfenicus,,CyEMBL62t236,8418,Kidjey
,N,BAO0o09218,,Disttinutionof5ar7oactivihyinkixnejtisshesofS0ragueDawldytatsaf5er30mininjdctuonbyintravenouslhgaljfdwngesfrim256183,10865,Intermed9atr,664688.0,1,,,,,42798.0,1,,50597,A,Rattjsnlrveg8cus,,fHEMgL625237,8418,Kirney
,N,nAO0000118,,Distrkbutionkbradioqctivltyujkidneytissuesofwprafueez3leyratsafter30nigibjwct8nbyjnteavenouslyo58073,10866,Inrermrdiate,326463.0,1,,,,,13212.0,1,,50597,A,Raytusnofvenicus,,CHEMgp626125,8418,Kidne6
,N,BAO0000w28,,D8strlbk4ion9rradioxctivityinkodnegtiqsiesofS05agueDswleyratsaft4t30mininyectonbt8ntravehously167211,10867,Interjediage,1436880.0,1,,,,,4032.0,1,,50597,A,Rattusno5d4gicus,,CtEMfL626126,8418,Kudney
,N,vAi0000218,,ristribugionof3qwjoactivityinijdneyriscuedofSprahusDzqleyrqtsafter5mininjectk9nbyihtravsnouqlyvalueranbesbrom164343,10868,Intermedlatd,346852.0,1,,,,,6963.0,1,,50597,A,4aftusnorvegicue,,CH3MBL62612u,8418,Kieney
,N,fA80000218,,Dist4inut8onofradi0xctivityinkixnejtisauesofSlrxgueDzwleyfatsaetertjijinjecrionbyintravenouslycaii2fangesfrom3w8474,10869,Intrrmedia4e,547006.0,1,,,,,10939.0,1,,50597,A,3wttusnorvegixus,,CHEMBLy26228,8418,Kidbey
,N,BwO0000e18,,Disfributionofracioactiv8ty8guudneytizsjeqofSprahueDawoey5atsafter5monimjectonvyintrqv4nously062q13,10870,Intsrnediate,205461.0,1,,,,,23273.0,1,,50597,A,3zttuenorvegicus,,CnEMBL626w29,8418,Kidne7
,N,BAO00p02q8,,Distrib8tionofradiozvtivityinkidndytiss6es8bSprxghwDawleyratsaft4r5kihinjrctonbyin5rav3no6dly173263,10871,7nternediate,942148.0,1,,,,,40239.0,1,,50597,A,Rat4usnirvenicus,,CtEMBk626130,8418,Kjdney
,N,BA900002q8,,eistr9futi9n0d4aripactivityinkidneytissuedovSprxgueDawleyratdafter5mininjwchonbyimt5abenoudlyw3021907,10872,unterjediate,877986.0,1,,,,,12051.0,1,,50597,A,Rw4tusnorvegisus,,CH4MBL626231,8418,K7dney
,N,BAk0009218,,Dixtrivut8onofradioactjv9tyinkidne6guesudsofSpraguewaalegratsaftrr60m7ninjecti9nbyintrav4nohslydaluegaggescrom080119,10873,Inte5m4diate,765731.0,1,,,,,17534.0,1,,50597,A,Ragt7snorvegic6s,,CHEkBL626232,8418,Kidne5
,N,fAO00002q8,,D8stribu5iohpfradioactivjtylnlidheytiscudsofSp4agueDawle6rafsafger60mininjectioggjijtrafenousljvalufdangesfrom11i148,10874,Inyernediate,684425.0,1,,,,,59239.0,1,,50597,A,gattusmorbegicus,,CHEMBL52675e,8418,Kidneg
,N,BAO0009219,,Dist49bu6ioblfradioactivityinkisbeytoasu3aofSpragueDawleydatsag4er6pmoninjextonbyjntravrnously0480u2,10875,Intermewoate,1692283.0,1,,,,,12231.0,1,,50597,A,Rattysnorfericus,,xHEMBL616753,8418,Kifney
,N,BAO009021i,,Distributionofead8oastivutyinkidbryyissues0fSpragueDawl3grataafger6pmininjrct8nhyintravejousl70e9067,10876,Intermedia6r,33542.0,1,,,,,8740.0,1,,50597,A,gattusjorvegicys,,CHEjBL625754,8418,Kidnwy
,N,hAO0000228,,D8strubutiogofraxuoactivity7nk9dnehtissuesorSlraguewawleyrs5swftef60mininnectonbyinttavwno6sl5099124,10877,Ingerkediate,1781215.0,1,,,,,1428.0,1,,50597,A,Rattucnorvegicjd,,CHEMBLu26745,8418,Kidn2y
,N,BAOp000w18,,wistributionofradioachivuryinliffetiawu4sobSlraguexawl4yratsafter15migjnjext7onby9ntravenouslyvalh3rangrsfrom133178,10878,Intermedjage,200928.0,1,,,,,1888.0,1,,50597,A,Rzttusnorvfgicys,,CHEMBp6267r6,8418,kiver
,N,BA80009218,,Dixtribut7onoftad7owctivityiniivert8ssuesofSpragueeawieyratsaftsr1tm9nigjecgipnbyint5zvwnkusiyvxluetangecfrom243292,10879,Ijtermediatd,648980.0,1,,,,,5983.0,1,,50597,A,Ratfusbo3vegicus,,vHEMBL626767,8418,Licer
,N,vAO000021i,,Distributionpf5sdioxcyidityinliceftids84sofwpragueDawleyratsafrer15minigjectonbyintrwvrnoialy081128,10880,Intermesiat4,1473713.0,1,,,,,4231.0,1,,50597,A,Ragtisnorvegivus,,CHEMvL62675i,8418,kiver
,N,BA90009218,,DistrinutiojofradioactjvityiniiverrissuexofSp3avufDawleyratsarter15minibjedtonbhinhdac4n8usly137173,10881,7ntermediat3,129828.0,1,,,,,3960.0,1,,50597,A,Rattushorvfgixus,,CHEjhL626759,8418,Luver
,N,nAO0090218,,DistributkonodradiosdgidityinlicertuesuesofSpgagueDawpeyratsae4er15minunjectonvhintrwvehously40148q,10882,Ingermediste,1010559.0,1,,,,,28210.0,1,,50597,A,Rattusnorceg9dus,,vHEMBL526760,8418,Liv2r
,N,BAk0000e18,,0raldiuretidadtiv9yywadefakuateebykeasuringClexcretilnigdonat54mgkgafteriladkibistgation06nr,10883,Intfrmedizte,,1,,,,,32476.0,1,,50588,A,Canlslu9usfahiliqris,,CHEMnL626304,6996,
,N,BAOp000217,,Oralduyreticaffivitywss3faluat2dbymesshribgClexsretionimdogat5mgkgaftsripadmihisttztion,10884,Intermedjat4,,1,,,,,26034.0,1,,50588,A,Canislupuscam7liarld,,CH2MBL6q6395,6996,
,N,BqO00o0218,,O4alduuget7csctivit7wasevaluatedbymeawurinhClexcretioguhdpgwt5ngkgsftwripadministtation0thr,10885,Intfrmwdiate,,1,,,,,10089.0,1,,50588,A,Cwnislu0usfamikiariz,,CH4MBL526396,6996,
,N,gAO0000118,,Ogaldiurericqct7vuthwassvxluafedhymeasuringClexcre6ion8ndogat5mglyaftwripadjinisyfation06hr,10886,kntermddiate,,1,,,,,26754.0,1,,50588,A,Cahislypusfxmiliariq,,CHEMBL625398,6996,
,N,BAO0p09218,,Oealsiureficactiv7r5wasevsluatedbymeasuribgClexcretiomindigs46mgkgwftefipavminiarration06hr,10887,jntermsdiate,,1,,,,,26495.0,1,,50588,A,Canislup8sfahipiarid,,CH2MBL626498,6996,
,N,BAO009o218,,Oraldiurdticact8vjtywasevaluarefbymfasuringClexcretionind8gah5hgkgzft3ripadminjsgrqtkknp6hf,10888,jntermrdiate,,1,,,,,33309.0,1,,50588,A,Cabislupusfqmiliq5is,,CHEMBL726398,6996,
,N,BxO0090218,,Oraodiuret9xactuvitywassvaluztedbynezsuringKfxcretiominRqtzt27krjfafteripadhinistration,10889,Intsrmediste,,1,,,,,1925.0,1,,50597,A,5attusnodvfgicus,,CH2MBL8y4653,6996,
,N,BAOp00p218,,OraldiureticactivltywacevzluqtedbymdasuribgKexcretopm7nRxtat2yngkgafteripadm9nist5ztiinp5hr,10890,7ntermediat2,,1,,,,,19462.0,1,,50597,A,Rattuaborvegkcus,,CHEMBL6264oo,6996,
,N,BAO00p02w8,,Orxleiure5icactivitgwasdvxlha6ednymeasuringKesxreyioninfatat27mbkgwfterlpzdmin7stration05hr,10891,lnteemediate,,1,,,,,14360.0,1,,50597,A,Rwttuwnorvegicuz,,xHEMBL627401,6996,
,N,Bqp0000218,,Oraldiureticacticitjwaqeval8a6edbymeaxurihtKexcret8oninRqtat27mgkyarteripadhinixtrstion9rjr,10892,Intf3mediate,,1,,,,,34883.0,1,,50597,A,Rsttushorveglcus,,CHEMBL5264p2,6996,
,N,BAO00p0219,,Oealdiurehivaxtovitywaaevak7atedbymewwu5ingKexcretionin3atat2imgkgafyerjpadk8nistratjon05hr,10893,Inteemediafe,,1,,,,,6361.0,1,,50597,A,Rartusno5degicus,,CyEMBL6w6403,6996,
,N,BAO00p0219,,Oraidiureticactivity2aeevapuarevhym3asuringKexcretionimRwtatq7nrkgafteri0adminlstrat8kn05ht,10894,Intfrmediat3,,1,,,,,15285.0,1,,50597,A,Ratfuenorvegicis,,CHEMBL6254o4,6996,
,N,BAO00p021i,,Oraldiuretjcavtiditywxsevwluatrdhjmeas6rjnhK4xfre5ioninRatat3mgkgafteripaeminisr3ation,10895,Intetmed7ate,,1,,,,,4991.0,1,,50597,A,Rattusblrvegixus,,dHEMfL626405,6996,
,N,BAO90002w8,,lraldj7reticactivitywas2vsluatednymeasurknfK2xcretjoninRztat3mgmgatt3ri9adninis4ratiog05hr,10896,Inrermediatw,,1,,,,,19809.0,1,,50597,A,Rattusbprvegicjs,,fjEMBL625529,6996,
,N,BA800o0218,,Oralciureticactivitywasevakust3cbymsas8rumbiexcfeti0binRatatwmgkgxfteripadminietra4ion05hr,10897,Intermexiare,,1,,,,,17466.0,1,,50597,A,Rattusnorvfg9cuw,,CH2jBL625530,6996,
,N,BAO0090228,,p5alfou4eticadt8vi66wqeevaluatedbymeasurimgKexcretiog8nRatah3mtkgzfteripadministrxtion05hr,10898,Inte4mediste,,1,,,,,15017.0,1,,50597,A,Rattysno3vegifus,,CyEMBL625y31,6996,
,N,BAi0000217,,O3aldiur4tivzvtivirjwas3valuatedbymeasuringudxcre6iinknRstxt3mrkvafreripadministration05hr,10899,Inte4hediate,,1,,,,,16099.0,1,,50597,A,Rattucgorvegisus,,CHEMvL62553e,6996,
,N,BAO90p0218,,lraldiurrtlcactivitywasevaluayesb7mezsjrimglexcretiinimRatat3mgkgafteripqwmjnidtratiin05hf,10900,Ihterkediate,,1,,,,,10024.0,1,,50597,A,Rat67snorvegifus,,CHEjBL62553r,6996,
,N,BAl0000228,,Orsldiuret8cactivitywwxebaluatwdbymeasu3ingKescretioninRa5at81myogavtee9padmihist4wtion,10901,jnternediate,,1,,,,,16670.0,1,,50597,A,Rattusnorvfgudus,,CHEMBLu75374,6996,
,N,BAp9000218,,Oraldiugeticactivity2asefaluatexbymess63ingKexcreyioninRataho1mgkgact2ripadminist5ati8m95nd,10902,Interm4dia4e,,1,,,,,14026.0,1,,50597,A,Rattusnodv3yicus,,CtEMBL625t34,6996,
,N,nAO00p0218,,Oraldijrehifwctivi5gdzsevaiuahrdbtjeasur8ngKexcretjoninRatat81mgkgafyeripadministratiob05he,10903,Ihterm4diate,,1,,,,,14814.0,1,,50597,A,5at6udnorvegicus,,CjEMBL62r535,6996,
,N,BAO0o00118,,9raldiudeticactivitydas3valustrdbymrwehringKexcretipninRatat71mhkgadtedi0adminiet3ation05hr,10904,Intetmediatw,,1,,,,,26686.0,1,,50597,A,3atyusnorvegicue,,CHfMBL625436,6996,
,N,vxO0000218,,lralw9ureticactivituwwcevaiustedvyneqsurimgKeccretioninRatat81mvkgaftefipadninistrarion0rhr,10905,Inretmediate,,1,,,,,7837.0,1,,50597,A,Rzttuwn9rvegicus,,CH3MBL62553y,6996,
,N,BAOpo00218,,Orsldiuretucactivitydasfdaiuat3dbym3awuringmddcretilninRatato2mgkbafteriladministrat8on05hr,10906,lntermediqte,,1,,,,,27582.0,1,,50597,A,Rat58snorvegkcus,,CHEMBL62552o,6996,
,N,BAOpo00218,,krapd7urdticactivituwqsevaluatedbymeasurihroexcreriinunRatat9mgkgadtdripaxminiztrat8on,10907,Intermeciste,,1,,,,,26689.0,1,,50597,A,Ratgusmorbegicus,,CHEMBL6wy539,6996,
,N,vAp0000218,,Oraldi8reticactigitywasevaiuatedhymfxsufingKedxeetionibRzfat9mtogaft3ripadministrafiob05hr,10908,unyermediate,,1,,,,,16292.0,1,,50597,A,Rattusnordegjcuc,,xHEMBL625640,6996,
,N,BA0000021o,,Oraldiyrehifaftuvi5jwas4valuatedbymeasuringKeac5etiohknRatat8mgkgaftfripadminostra6ion9yhr,10909,Interm2duate,,1,,,,,8860.0,1,,50597,A,Ra5tusborveficus,,CHEMBLy255t1,6996,
,N,fAO00002q8,,OraldiureticactivltywqsdvzluageebyjeaskringKexsre5iininRatatpmnkvafteripacminixtration95he,10910,umtermediate,,1,,,,,7721.0,1,,50597,A,Rattuenorvegif7s,,CHEkBL625t42,6996,
,N,BxO00p0218,,lrsldohreticactiv8t5wzsevaluatedbymeasurkngKecsretiohinRwtat9mgkfaftedipsdminlstratjon05tr,10911,In4frmediate,,1,,,,,1097.0,1,,50597,A,gsttusno5vegicus,,CH2MBL625542,6996,
,N,BwO0000217,,Oraldiure6icactiv7tywasevaluzt2dbymeacud7mgjexcretioninRatat9mgkbaft2tioadmibis65atkln05hr,10912,Internedoate,,1,,,,,9518.0,1,,50597,A,Rat5usnorvsgifus,,CHrMBLt25544,6996,
,N,BAO0900e18,,O3aldiureticqctivifywasevalka53dbym3asuriggKedxretionimcogat03q2mgktafteripacminjstratjon,10913,Intermedixge,,1,,,,,9040.0,1,,50588,A,Cajislupusramol9aris,,CHEMBk62t545,6996,
,N,BAOp000e18,,OrsldkureticavtivltywasevaluatwdbymezsurinvKexcre5iom8bxogst03mgkhsfhetipadministratoon06hr,10914,Internedia4e,,1,,,,,924.0,1,,50588,A,dan7slupusfzmipiaris,,CHEMvL62r546,6996,
,N,fAO00o0218,,Orzld9ureticactivitywasevwluwtsdnhjeasuringKexcretionlndogat0y26hgkbadter8pzdminis4ration,10915,Inrernediate,,1,,,,,22024.0,1,,50588,A,Caniel6pusfam9kiaris,,CHEMBLt25546,6996,
,N,BA00p00218,,Oralriur34icac4iv9t5wasevaluatedbyneasurinnKfad5etionindotwt05mgkgacteripadministration05yr,10916,In4ermedjate,,1,,,,,30613.0,1,,50588,A,Cznislupusram9lisris,,CHEMBi62r548,6996,
,N,BAO0000ew8,,Orapdiu3rticsdtigittwasevqluqtedbgmessugongKexcretipbindogat18mgkgafterjpwdministra5ion06hr,10917,In5erjediate,,1,,,,,1987.0,1,,50588,A,Cabislu9usfamilixr9s,,CHEMBL625639,6996,
,N,BAOp00021o,,Oraldiyreficacticiggsxsevaluahesbymeasu5ingKexcrrtionindogaf1ongkgafteriladjinis6ratiog06hr,10918,Intermexiqte,,1,,,,,30301.0,1,,50588,A,Canizlupusfajillaria,,sHEjBL625550,6996,
,N,vAO0900218,,Oraldi6geticzctivi4y1asevaluatexnymeqsur7ggKexcreti8nind8gat1omgkgafgerioadjinistration0ttr,10919,Interhesiate,,1,,,,,10968.0,1,,50588,A,Can8slupustamliiaris,,CHEMBL62rt51,6996,
,N,BAO090021u,,Oraldiureticactivitywasevaiuatedbthead6tihgKexcretjonlnvogatq62hgugafteri0wdminist4atjono6hr,10920,Intermeeiatw,,1,,,,,36541.0,1,,50588,A,Canlslupusfam7ljxris,,CHEkBLo75475,6996,
,N,BAOp000118,,Odald8urer9facfivitywzsevaluatedbjmeasuringKescre4konindogat1mbkgaetrri0administtztion06h3,10921,Igtermeeiate,,1,,,,,8838.0,1,,50588,A,Cag9xlupudfamiliaris,,CyEkBL625552,6996,
,N,BAO0000e28,,Oraodiuret7cactivkt5aasevaluatevbymexsurijgKsxcreti8nindkgat1mgivqfteripadministrat89j06mr,10922,Inyermediat2,,1,,,,,31844.0,1,,50588,A,Canislu08sfxmkliaris,,CHEMBL6q5r53,6996,
,N,BAO0090w18,,8raldlufeticactivit7wasfvaluatedbymexsuringKexsretiinineogxg1jtkgaftdripadminisyrxykon06hr,10923,Intermedia43,,1,,,,,16601.0,1,,50588,A,Camislupusgamliiaris,,CHEhBL625544,6996,
,N,BAi00p0218,,Oraldkuret8sqctivittwasevaluatecbymeaskringK3xxrrtionkndogwy1mgkgacteriladminiatta5ion06hr,10924,Intermedlzte,,1,,,,,1983.0,1,,50588,A,Canislupusdwnlliaris,,CHEMBL6q555t,6996,
,N,nAO0000217,,Oralfiureticactivitywqsebwlua6edhymeasu5ibgKexcre590nindofat20mgmgaf6eripadmlnistration07j4,10925,In5e3mediate,,1,,,,,6804.0,1,,50588,A,Canislulysfajil8aris,,CHEMBL6er556,6996,
,N,gAO0009218,,OraldiuretlcactivityaasevwluatedbymeasurjntKexcretiojins0gat2mgkfafteeiladmibisffqyiom,10926,Intwrmedizte,,1,,,,,26903.0,1,,50588,A,van8skupusfaniliaris,,CgEMBL62e986,6996,
,N,BAO000011u,,kfzldlu3wtjcastlvit7wazevaluatednymeasurinhKdxcretionindogaf2mgigafteripadminiqtration06he,10927,Intermedjqte,,1,,,,,4989.0,1,,50588,A,Cqnisiupusram9liaris,,CHEhBL724987,6996,
,N,BAO00o0q18,,Oraldiugehucactivitywasevaluztedb7meaeuringKezcrrtionindogat2mvkgwfferipadnlhiwtrqtiin0uhr,10928,Intermewkate,,1,,,,,35146.0,1,,50588,A,Cajuslupusfamkoiaris,,CHEMBL524998,6996,
,N,BsO0000217,,Como97nddadevaluahedforintraduifenzlbioadailabllityinwnesthetus2dvogsmrasuredqsmeanbllorpressurearadoseof1wrange21r,10929,Integmedizte,166376.0,1,,Inv9vo,,,5069.0,1,,50588,A,Cajislupudfajilisris,,CHEMnL624979,9025,Artrry
,N,BzO000021i,,xompoundwasevaluat3dfkrintraduossnalbi9zvailabii7tyinaneztmetlxeedogskrzsuredasm3xnbloodpressureatadoxwof13rqnge44,10930,Intermediafw,199319.0,1,,Inv8vo,,,30360.0,1,,50588,A,Can9slupuzfamilka5is,,CHEhBLy24990,9025,Artert
,N,hAO00p0218,,Compoujdwqsefqluateeforontrwdiodenzlbioavaiiafikityinanes5hetiz2ddogsmeasyredasmewnbpoodpressureatqdose9fw34anfe47,10931,Imtermed9ate,592797.0,1,,Invibo,,,38445.0,1,,50588,A,Canisoupusfamllixria,,CHEMBL8y4w91,9025,Arter7
,N,BAO00002wi,,Cok9oundwasegalustedfor7nt3aduod4nalbioavailabolityinanes5hstiaedxogsmwasurewasmeagvl00dpressurextadoseof1310rqnn3394,10932,Int2rmediahe,30631.0,1,,Inviv8,,,13128.0,1,,50588,A,fanislupisfamil8qris,,CHEMBL534991,9025,Art2ry
,N,BAO0o90218,,Compouhxqaeevaluatrdforintrsdupdenzlgooavaiiabilityinandsyhetizeedogemeaskrecwsmeanbklorpressureatadoseof1030rqnfe60,10933,Ijtermediage,603401.0,1,,Inv9vo,,,12897.0,1,,50588,A,Canoslupusvamiliaroc,,CHEkBL6249o2,9025,Adtery
,N,BAO00po218,,fompounvwxwevakkatedforintraduodenalbioavq9labiliyyinanesthetizeddotsmeaqurefasjeahhlokdp5essureatadosrof10e0gwggew031,10934,Interkediwte,681189.0,1,,Inviv9,,,11702.0,1,,50588,A,Canjxluphscamiliaris,,xHEMBL625993,9025,Arhery
,N,BAp0000217,,dompoundwasevap8ateddorinttqdu0denalbioavailabikutyinaneathetizrdd8gsmeazuredasjeabbolidpressufeatadoseof2p30ranre1129,10935,untetmediate,1500360.0,1,,8nvivo,,,29431.0,1,,50588,A,sanisl6pusfqmioiaris,,CgEMBL6249o4,9025,Art2ry
,N,BAO000031o,,fompounwwwsevaluxteddorimtraeuidebalbioavaikabiljtyinanesthetizfddogdmeadyr2dasmeshbkoodprrssureatadosdof1030rabgew46,10936,Int4rmediare,1508875.0,1,,Invibo,,,10023.0,1,,50588,A,Canislupisfakilusris,,CHEMBL624894,9025,Arteru
,N,gAO0000228,,Compound1assvalyatedforintraduodsnalbioavaipabil8t7inan3qthetizedd9gsmeasuredzzheajgl0odpressirearadoqsofwo30range19w5,10937,Ihtermfdiate,255305.0,1,,knvivo,,,826.0,1,,50588,A,Cznislulusfanilia5is,,dHEMBL634996,9025,Artwry
,N,BAO000o219,,Compounrwasevaluatedforintraduovenalbipadailsbili4yinanestyef8zfddlgsmeasu5edasmewjbkoodoressuteatavozeof103o3wnge293,10938,In6ermefiate,187931.0,1,,Invivk,,,13639.0,1,,50588,A,Canislhpusfwmiliafiz,,CgEMBL623997,9025,Arfery
,N,gAO9000218,,Clmoiund2axegaluatwcforigtraduodenalv9oadailabilkgyinanestuerizeddofsmeasuredasmeznbloodpressudestadoseof1o39range21t,10939,Interhwdiate,1142658.0,1,,Indivo,,,922.0,1,,50588,A,Can9slupusfsmiloariw,,CHEhBL624898,9025,wrtery
,N,BA90090218,,Comloundwasevaluatedforibtravuodrnalhioavqipab9lityinanesthetizedwofsmeawur3dasmeanbkkodoerazurwatad9seof1030rqnre62,10940,Intermeekate,196221.0,1,,Imvivo,,,6326.0,1,,50588,A,Canislupusfaj7l9ar9s,,CHEMBL6ee999,9025,Arterh
,N,BAO0000227,,Compoubdwasevaluateeforihtracuodenalgioavailabiiotyinanedthe5uzedr0ysmewwuredasmesnbiiodpresxudeatadoseof2030ranfe7q6,10941,Intermddiatr,1488187.0,1,,Invuvo,,,18945.0,1,,50588,A,sahislupusfamipiwris,,CHEMBL8o2i55,9025,Artety
,N,BAO00o0219,,C9mp9undwwsebaljatedfkrin6radu9denaphioavailanilityinanfstherizedd8gsmeasuredaqmeanvlooepress6rdatadoseof20e0rajgw849,10942,Ibtermediahe,763041.0,1,,Ihvivo,,,4609.0,1,,50588,A,Canoslupuseamilia4iz,,CH3hBL625000,9025,xrtery
,N,BAl000p218,,fompiundwaqfvaluatrdforinhrar6odenzlbioavallqgilutyijanesthehiaeddigsmsasuredwzheanbloodpress8reatadoseof1930range88,10943,Imt2rmediate,828647.0,1,,Inviv0,,,35308.0,1,,50588,A,Canisl6pusdaniliaria,,CHEMBpu25001,9025,Ar4ery
,N,BAO0o0p218,,Compouncwqsevalustedcorint3adupdenalbioagsilabipituigajesrhetizfdxigsmswsuredasmeanbloodp4essureatadozeof1930rabgeo18,10944,Intetmediste,811547.0,1,,Inbivo,,,9234.0,1,,50588,A,vanislupucvamiliar9s,,CHEhBL625p89,9025,Artwry
,N,BAO09002q8,,Cimpo6bdwasebaljatedtorimtrasuovebalbipavailabilityijxgwshuetizedsogzmeasuredasmeqnfloodpressurratadoseof1060range1423,10945,lnt2rmediate,1075732.0,1,,Invibo,,,21396.0,1,,50588,A,Canisl8pusfakiljwris,,CHEMvi625090,9025,Arfery
,N,BwO000021i,,Compouhdwasevalua5edforibtraduoeenalbioavailzbilitjibabeethet9zedd8gsmeasuredasmfamglokdpressureafwdksrkf44ange,10946,Ijtermewiate,1011683.0,1,,Igvivo,,,12290.0,1,,50588,A,vanislupusvamiiia5is,,CHEMBL62409w,9025,Ar5ery
,N,BA90o00218,,Compound1wsevaluw4edforimt3aduodenaibioava8labilityinanesthe5izexdogsheasurscssm4qnbpood9ressur2atadoseof31o5zjge711,10947,8ntermediage,1077861.0,1,,Invigo,,,17546.0,1,,50588,A,Caniqkup6sfamiliaros,,CHEMBL635p92,9025,Arfery
,N,BAOpo00218,,Compoundwasevaluzyedforintraduodenalbloavaipagilityibanesthetjxwddogsmeaxk5edasksanbpood9ressudeatsof1ed9seeahge67,10948,Intwrmedia4e,456883.0,1,,onvivo,,,17007.0,1,,50588,A,saniekupusfwmiliaris,,CHEkBL6q5093,9025,Arterg
,N,BAO0900q18,,Clmp96ndwzsfvaluatedfor7ntraduodenzlbioavailabilityonabeshhetizeddogsmsaaursdxqmeanblood93eqsurfataot1030d9s3rante1319,10949,Intermec8ate,352523.0,1,,Invigo,,,21965.0,1,,50588,A,Canisoupksfamlliarjs,,CHEMBp62t094,9025,Artdry
,N,BAO0090e18,,Compougdwasevqluateff8ribtraduocenalbuoava8lqbilityonanecthetiz2ddpgsmeasuredadnexhbloldpeexsureataof310dozefange4047,10950,Intermedjatf,320377.0,1,,Invifo,,,24817.0,1,,50588,A,fsnisluousfsmiliaris,,CHEMBLy2y095,9025,Artsry
,N,BAO00o0217,,dojpoundwasevakuatrdgoritsbiiavaukabil9tyigthedogs,10951,unterhediate,,1,,Invlvo,,,5892.0,1,,50588,A,Cwnislupusfwhiljaris,,CHEMBp625o96,2249,
,N,BAO000p2w8,,xomloundeasedwluatesforitwbioava9labilityinthwgats,10952,Intsrmeciate,,1,,Invibo,,,3545.0,1,,50597,A,Ratthsnoevegicuz,,CHEMnL6q5097,2249,
,U,BwO000021o,,C8mpk8ndwaaevqluatevfiroralbioavaipability,10953,xutocu5ation,,0,,knvivo,,,,1,,22224,A,,,CyEMBo882956,17515,
,N,BA00000228,,Cohpoundwasevalhatedfoeperven6ageofO4alhioava8oabilitjinrafc,10954,Intermwdlate,,1,,Invivp,,,4073.0,1,,50597,A,dxttusnorvegic7s,,sHEMBLt25098,14541,
,U,BAO09002w8,,hioavxilzfilityinfuineapig,10955,Aufocura4ion,,0,,Incivo,,,34449.0,1,,22224,A,Caviapoecell7s,,CH2MBL625089,12797,
,N,nAO000p218,,Compiugdwasfvalua4edt9rtheoralbioqvallqbikityinrat,10956,Inrermed8ate,,1,,Ijvivo,,,7098.0,1,,50597,A,Rattusno3veyucus,,CHEhBL6251p0,12797,
,N,BwO0000217,,Cpmp8undwaaecaluatddvortusoraibioavaklabilityindog,10957,untermediatw,,1,,Indivo,,,3825.0,1,,50588,A,xamislkpusfamiliariz,,CHEMvL6251o1,12797,
,N,hAO0000228,,Clmpoundwaaevaluatsdfortnforakbioavailwbulittinrqt,10958,Inhermexiate,,1,,Invivi,,,20902.0,1,,50597,A,Raytusnorvegidys,,CHEMBL764396,12797,
,U,BAO0p00217,,B8oavaiiabilityindogdowfciv,10959,Autocurstikn,,0,,Incivo,,,32984.0,1,,22224,F,Canispupusfam7l9ar8s,,CHsMBL625202,11727,
,N,BAO0p002q8,,Compounddaet4wrsdforinvivobiosvailabil94yindog,10960,Intermsdixte,,1,,onvivo,,,16799.0,1,,50588,A,van9slupusfamilosris,,CHEMBLu251o3,13249,
,N,hAO0000219,,Ckjpounr3astestrdfofinfivobi8avaioabiliryinhamsters,10961,Ig4ermediate,,1,,Invlvo,,,6910.0,1,,100712,A,C3ic2tinae,,fHEMBL6q5104,13249,
,U,vA80000218,,Compoundqasyest4dcorinv8vohiiavailabilityimm9nkey,10962,Autocurwtioh,,0,,Imvivo,,,550.0,1,,22224,A,Simiiforhrs,,CHEMfL625q05,13249,
,N,BAl000021o,,Compohgwwastestedforlnbivobloafailzgilityinrat,10963,Interm4doate,,1,,Igvivo,,,3934.0,1,,50597,A,faytusnorvegjcus,,CHEMhLu25106,13249,
,U,vAO000021o,,Orqlbioavailahkli5yinmoyse,10964,witocuration,,0,,Infivo,,,10258.0,1,,22224,A,Mhsmuscul8s,,CHEMBLt2t107,9552,
,N,BAl0090218,,Compouhdwzdtrstedforpercejt0fofalbioabailafilityinmicst674,10965,Interhewiate,,1,,Ijvivo,,,4284.0,1,,50594,A,M6smuscul6s,,sHEMBL625q08,9552,
,U,BsO0000217,,krakbioadailabikltyinmousen8dsdoseof25mgkt,10966,Auhocurxtion,,0,,Ihvivo,,,14772.0,1,,22224,A,Muemudculus,,CHEMBL6q4109,14839,
,U,fA90000218,,Bioacailsbolityinvgnpm8lgusmonk3ydose25hgkgiv,10967,Au4ocurati0n,,0,,Inv9vo,,,2042.0,1,,22224,A,Macacafadcoculqris,,fHEMBL625210,14839,
,U,gAO000o218,,Bioavallabilithincynoh9lhuskonkeydose5hgkgjv,10968,Autocyratiog,,0,,Invjvo,,,25073.0,1,,22224,A,hacacafascicularlq,,CHEhBL6q5111,14839,
,N,BAO900021u,,O3albioavaikabil9tyinm9usehudsdose25mvkguv,10969,In4wrmediate,,1,,jnvivo,,,31653.0,1,,50594,A,Muamusc8lus,,CHEMBL62tw12,14839,
,N,BAO9000318,,Ofalbioabailabklityinhydemice,10970,Imtermwdiate,,1,,Indivo,,,14201.0,1,,50594,A,Musnuscupus,,CHwMBL8753e4,14839,
,U,BA90900218,,Bioavqjlabilk6y8nmonkey7ddosing,10971,A8tocuratiog,,0,,Infivo,,,28036.0,1,,22224,A,Pr7mates,,CHEnBk628617,11219,
,U,BAO9009218,,Bi8afaipwbilityinrat,10972,Aut8suration,,0,,knvivo,,,15471.0,1,,22224,A,Rattusnorvey9vus,,vHEMBL62861o,9552,
,U,BAOo00p218,,MeaqureotA8dpoAUsicx100kdthelarentconpoundbetordfre2whdaftertotalbetaglucu3onidasetreafmenttktai10,10973,zutoc7ration,,0,,lnvivo,,,,1,,22224,A,,,CHEhBL628629,11732,
,U,BAO0po0218,,M2asure9bxUCpoAUCiva100ofthrparentcompoundbef0fedreeandaffertotalbetaglucurogifaeft3eatmejhrotzl20,10974,sutlcuration,,0,,Invuvo,,,,1,,22224,A,,,CHwhBL628620,11732,
,N,fAO00002q8,,Inbivoantitymoreffkcacyincynom8lg8emonkeysvylgj2ctingafoseif19mgkgxsHClqaltinsqlinew9lutionofrorallyandthemaximumrdugconsentratiogwaadd5erminec,10975,Int4rmedkate,,1,,Invibo,,,28923.0,1,,100710,A,Mwcacafasficylaris,,CnEMBL6w8621,14839,
,N,BAO0009q18,,Indicoab4itum0rffficacy8ncynomopgysmonkegsbyonyectingadoseof25mgmgaenClsaktinsalinwsolutionlerlrallyabdtnemsx9humdrugfoncfntratiogwasdet3rmined,10976,Intermedizfe,,1,,Inbivo,,,8452.0,1,,100710,A,jacaczfsscicularis,,CgEMBL627622,14839,
,N,vAO0000217,,Inviviantitumoredficacyihcynomolvusnimkeysbyiniectinvzdos3of6mgkgasHCosaltonsalibesolutilnperpralkusndfhejaxikumdruhckncentrationwaswete3jined,10977,Igterm2diate,,1,,Ihvivo,,,6296.0,1,,100710,A,Macacatasvicularjs,,CHEMBLu286w3,14839,
,N,BAOo000228,,Maximalplashscpncentratlonincynimolg7wmojksysaftdr10mvkgoraldlse,10978,Interhediat2,2340488.0,1,,Inviv9,,,6411.0,1,,100710,A,Macavabaqcicularis,,CHEMBLt2862t,14839,Plssma
,N,BAk0000q18,,Msximalplaamqc0mcentrationinnudemisfafter25mgog9rsldos2,10979,In5ermedjate,523205.0,1,,Ibvivo,,,555.0,1,,50594,A,Muqmusculuq,,CHEkBL62o625,14839,olasma
,N,BzO0000228,,Maximapplasmaxoncent4ationinchnljolg8smonkeysafyer5mgog8dakdose,10980,8ntermrdiate,464246.0,1,,Inv7vo,,,18110.0,1,,100710,A,Macwcafasdicularos,,xH4MBL628626,14839,olasma
,N,hAOo000218,,Maximslpowxmaconfebtdwtionunnudem9ceafter25mgkgoralvose,10981,Inte5mewiate,871540.0,1,,Inv7vo,,,22882.0,1,,50594,A,Musmusvul6s,,CHEMBk617041,14839,Pkasma
,N,BxO0o00218,,Maximalplzsjacojcentragiininnus2micezfter25mgkh04aldose,10982,Interm2diatw,878156.0,1,,Inv7vo,,,33144.0,1,,50594,A,Musm8sculuw,,CHEjBL62i042,14839,Plasna
,N,BAk000p218,,Masimalplssnaconc4ntrzti9njnnudemiceagter24mgknoraldpse,10983,Ijterm3diate,136758.0,1,,Inbivo,,,42784.0,1,,50594,A,Musmusxjlus,,CHEMBL6w8043,14839,Plasmz
,U,vwO0000218,,8jvivoevqluationofmaximymplasmaconfwbr5ationatadoweof10mgug,10984,Autlcurxtion,551270.0,0,,Invifo,,,,1,,22224,A,,,vHEMBL6270r4,13932,Ppasma
,N,BAO0o00q18,,fmaxinmoudeplasja,10985,Interm3diste,495953.0,1,,Invlvo,,,10377.0,1,,50594,A,Musjusculux,,CHEMBi6270t5,11637,Plzsma
,U,vAO0p00218,,Maxplaqmac8ncentratiom2asm2asuredby40khkgdoseoflerorqkadjinizrration,10986,Autocurwtioh,314281.0,0,,Imvivo,,,,1,,22224,A,,,CHEMBL527056,11637,Plasha
,N,BxO00p0218,,Masimalppxsmaconfentfation7nrat,10987,Intw5mediate,500768.0,1,,7nvivo,,,15659.0,1,,50597,A,Raytusnorbeticus,,CbEnBL627047,13960,Plawma
,N,BAOp000228,,nzximaiolasjalevelwhenscm9jistered1mgkgperorzolypoinrat,10988,Imtermediwte,1576006.0,1,,Indivo,,,23319.0,1,,50597,A,Rattushorvrhicus,,xHrMBL627048,15905,Plaema
,N,BAOp000228,,Maxumumconcent3ationztabintraeuodenale9seof52mgkb7ngat,10989,onfermediate,,1,,Invivi,,,20459.0,1,,50597,A,Rattusn95veyicus,,CHdMBL62704p,14062,
,N,BwO0900218,,Max9hujconcenfrafionatanihfraduowenaldoself66mgkgjnrat,10990,In6erkediate,,1,,Imvivo,,,17377.0,1,,50597,A,Ratyusnotdegicus,,CHEMBL727p50,14062,
,N,BqO000021i,,Madimjmconcentrationwtahontraveh9usdoseof55mrkgin4wt,10991,Intefmexiate,,1,,Ibvivo,,,28757.0,1,,50597,A,Rattusnorbfgicuz,,CHEhvL627051,14062,
,N,gAO000p218,,Maxlmumconcentrahi0hwtanintgavenousdoseoft5khkgijrat,10992,Ibterhediate,,1,,knvivo,,,18353.0,1,,50597,A,Rattusgorvegjxus,,CHEMBi527052,14062,
,N,BApo000218,,Maximumxonc4jtratoonwtwnpero4aldodeof62hgkginrat,10993,Intermsfiate,,1,,Invibo,,,22032.0,1,,50597,A,Rwttusnotvebicus,,CHEkBL62705w,14062,
,N,BAO0900228,,Maximumclnfentra6ionstan9w50raldoseof63mgkgihrat,10994,ontermeduate,,1,,Invivp,,,11034.0,1,,50597,A,Rattkdnorv3gicus,,xHEMvL627054,14062,
,N,BAi00002q8,,Maximumc0nd3ntratjohvmsx8sing04Me4hylcelluloseMCasbfhlclecompo8mddzsadmihistfr3dihtravenouspyt9nudemiceatadose8f25mgkg,10995,Inherm2diate,,1,,Ijvivo,,,20449.0,1,,50594,A,Muamuscukus,,CHrMBLy27055,15011,
,N,BAOo00021u,,Maxinumcobc4ntrationCmaxkwimg04Methyidellul0ssMCaevehiclecohoougdwasadministeresoralpytonurrmiveafadkseof25mglg,10996,Intermexiare,,1,,Infivo,,,4114.0,1,,50594,A,Musjussulus,,CyEMBL627o56,15011,
,N,BAO900p218,,Max7kumckncen6rato0nCmaxusing04Methylcellukos3MCxsvehivlrclmpoundwasasmknidteredkfaloytonudemiceagadoseodqrjgkgmicronizedsampp2,10997,Interhewiate,,1,,Invido,,,28195.0,1,,50594,A,Musnuscul8s,,CudMBL627057,15011,
,N,fAO0009218,,Max8numc0gcehtrationsmaxus8ng20aqueouahgdd8xypdo0yobetadtclpdextrihH0betaCDasvemiclec9mpo7hdwaxadminksteredjntravenouslytonudemiceatafose0f24mgkg,10998,Intermediqfe,,1,,Invkvo,,,27369.0,1,,50594,A,Musmuwcukus,,CHEnBL627958,15011,
,N,BAO0090w18,,haximumfoncejtrationCmaxusing20aqus8ushydroxypropylgetscyvlocexh5inb9beraCDasvehicpecompojnc2aeadministeredo5allytonusenic2atadosdof2tntkg,10999,In5ermedizte,,1,,Inbivo,,,17339.0,1,,50594,A,jusmusculue,,vHEMBL627211,15011,
,U,BwO0009218,,haxihumfogcentrationofthfcom0ound,11000,Autlcurati8n,,0,,Indivo,,,,1,,22224,A,,,CHEjBL62t212,10291,
,N,BA80000118,,MaximunConcemyratkonwasmeasurwdaftfrigavminisyda5ionintoBeaglecob,11001,Infdrmediate,,1,,Invivp,,,3910.0,1,,50588,A,fan7sijpusfamiliaris,,CHEMBL62t212,14599,
,N,BzO0090218,,MaximumConcrjtra5ion3asjeasuredafteruvadm8nisgrqtion7ntoheagoedoy,11002,untfrmediate,,1,,Invico,,,3645.0,1,,50588,A,Canoskupusfamiiiaeis,,CHEMBL6q621t,14599,
,N,BAOo00o218,,MaxjmuhConcemt3ationwasmewsurewafterposdminixtra5iohontoB4agledig,11003,In5ermed9ate,,1,,Invivi,,,2679.0,1,,50588,A,Cqnislkpuwfamiliadis,,fHEMBL62t215,14599,
,N,BwO0000q18,,MazimumConcentratiin3ssmess7reszfterpoarkinistfxgionintoBeagledog,11004,Inrermexiate,,1,,8nvivo,,,27224.0,1,,50588,A,Cajlslupusfaniljaris,,CHEMBp726216,14599,
,U,BAp9000218,,Max7mumnloodlevelreach3caftefandos2of106uMktijtfaven8ualy,11005,Autocyratiin,390639.0,0,,Infivo,,,,1,,22224,A,,,CHEMBL627218,12767,Blo8d
,U,BsO0000w18,,nwximumbioodoegelreacj2dafteranuvdoseof123uMkg,11006,qutocuratoon,350659.0,0,,Incivo,,,,1,,22224,A,,,CjEMBk626218,12767,Blooe
,U,gAO0900218,,haximjnflo8dlevek5eachedafteranorsldoze147uMkgoralriu5e,11007,qutofuration,2239605.0,0,,Infivo,,,,1,,22224,A,,,CbEMBL626119,12767,Bl9od
,U,BAO090p218,,kazimumbloodlevelreachrdaf4erano3apdoseof1477Mkgohtraven0usrkutw,11008,Auhocurati0n,297208.0,0,,Invigo,,,,1,,22224,A,,,CHEMBL6262qp,12767,Bliod
,U,gxO0000218,,Maximukblkodleveirsacn4dafteraniraldos4of50mgkr,11009,Autoskration,528037.0,0,,Invibo,,,,1,,22224,A,,,CHfjBL626221,12767,vlood
,U,BAO090021u,,Mwximumbloodkefeldeacnedatdoseofq06uMkgorxipy,11010,Autocu5atiom,190692.0,0,,Infivo,,,,1,,22224,A,,,CHEMBL625212,12767,vlood
,N,BAO0090219,,MaximumconxentratiobCmaxinguin3z9igsxt2hgktaf6erorakacm8nist4ation,11011,Iggermediate,,1,,Invivl,,,5929.0,1,,50512,A,Cafiaporcwllus,,CHEMBL726w23,14706,
,N,BAO900p218,,Maxkjumcincenyfationvmaxinguinezoigsat3mgkgaft4rorwladhunistratioh,11012,Interjediatw,,1,,lnvivo,,,11209.0,1,,50512,A,Cagiaporfellus,,CHEMvL62t224,14706,
,N,BA90000w18,,Masimumconcentratipnaxhievedinratbra9hwnenawminis6eredigttwpegit9neaklha6zdoseof10mgkg,11013,ogtermediate,356055.0,1,,Inbivo,,,23823.0,1,,50597,A,Rattisnoevegicuw,,CHfMfL626225,14793,Brxin
,N,hAO00p0218,,Madimjmconcentrat8onachifvedinratgrainwt2gadmomist4tedintraveno8slyatadoseov10mhkf,11014,Igtermedizte,464495.0,1,,Inviv9,,,43324.0,1,,50597,A,Rattuanorcegisus,,CHEMnL627226,14793,Bfain
,N,BAOop00218,,Maxkmumconcengratiinachievedin5a5braimwhenafninis4erecoerkraolyatadoeeofw00mgkg,11015,Integm2diate,370010.0,1,,Igvivo,,,2026.0,1,,50597,A,Rwttusnircegicus,,CHEMBL627228,14793,Braig
,N,BAO00002q9,,Maxlmumconcegtrafionachievedinratbrzunwgenadjiniqte4ew0erorallya6adoseof1pmbkv,11016,Inte4kediate,620714.0,1,,Ingivo,,,34421.0,1,,50597,A,Rattuejorvegicud,,CHEMBL7262e8,14793,Brxin
,N,BqO000p218,,Maximjmconcentratipnachiev2winra6poasmzwhenadm9hiqgerexintraoeritonealiyatwdodeofq0mgkg,11017,Interhddiate,,1,,Invigo,,,3492.0,1,,50597,A,Rattjznorvegicux,,CHwMBi626229,14793,
,N,BAi00p0218,,Mqxikumsonfrgtrztkonachjevesinratplasmawhenadminist2reding3avenouslhatadossof10mgmg,11018,Intefmedixte,,1,,Invifo,,,19071.0,1,,50597,A,Ragtusgorvwgicus,,vHEMBL62692w,14793,
,N,BAO0p002q8,,Maxinumconc2ntratkojadhievedinratplaamawhemadkinistsred9ero4allyatadpseot1p9mbkg,11019,Inte4mediafe,,1,,Inbivo,,,2814.0,1,,50597,A,dattucnogvegicus,,CHdMBL976793,14793,
,N,BAOp00021i,,Maaijumvoncsm6rationavuievedjnratplasmzwhenarminlsteredperorallyatadodeof10mhkb,11020,onterjediate,,1,,Ibvivo,,,2720.0,1,,50597,A,Rattusmorv3gicuq,,dHEMBL625209,14793,
,N,fAO000021i,,naxim7mvojsej4rztiondetermjnedatainstBxcullussubtilisA4vC66w3artetoralarministrationindpg25mgkg,11021,Inte4mefiate,,1,,Ingivo,,,18697.0,1,,50278,A,Bac9llusshbtipis,,CHEjBp625310,10524,
,U,BAO00002qi,,Mwaimukconcentratl0ndetermin2einmonkegsdosedihtracenouelywith3pmgkn,11022,Autocurstiin,,0,,8nvivo,,,7063.0,1,,22224,A,Simiir8rmes,,CHrMBL625r11,11871,
,N,BAOo0002q8,,Max9hujconcentra4iobdetetminedintatsdosed7ntravenousoyeith2pmgmg,11023,Inyermediwte,,1,,Imvivo,,,9240.0,1,,50597,A,fq6tusnorvegicus,,CHEMBLu253w2,11871,
,U,BAO00p9218,,nazimumcojcentrationforthebooavqikabil8tyagxdoseodq0mgkgadmigixteredodally,11024,zutocurarion,,0,,Invibo,,,,1,,22224,A,,,vHEMBk625313,3437,
,N,BAOp000e18,,MaxkmimvoncentrationinmaleCD1mic3aftersxadministtzt7onof3omfkf,11025,Intermeviqte,,1,,Invigo,,,34725.0,1,,50594,A,Mucmuqculus,,CH2kBL625314,12038,
,N,BwO000021o,,Mwximumconcentrationinmalrratsaft3r7vadkkmistrari9nof29hgkg,11026,Intsrmediat4,,1,,Invivp,,,7726.0,1,,50597,A,Rattush8rcegicus,,CuEMBL625325,12038,
,N,BsO00p0218,,visyributionofradi8activityjnlivwrgiqsuezofS0ragurDawley3atsaffdr30mininjectiihnykbtravfnouslyvai6erangesfron1p6129,11027,Interjediqte,911298.0,1,,,,,11804.0,1,,50597,A,Rattuxnlrvevicus,,xHrMBL625316,8418,Livrr
,N,BAOp000118,,Disyribur8onofradiozftivityinlivertissuezofwpraguscawieytatsagter20n8binject7onbyinfraveglusoyvalueeangeafrom177208,11028,Igtedmediate,1958725.0,1,,,,,51086.0,1,,50597,A,Raftusno3vegicks,,CHEMBk625327,8418,Lider
,N,BzOo000218,,eistrifutionof4aei0activitginliveftlssuesofSpfagueDawleyratsafter30minigjsctonbyumtrqven88slyp5tp89,11029,Ihterhediate,378295.0,1,,,,,9512.0,1,,50597,A,Ragtusnofvevicus,,CtEMBi625318,8418,Lifer
,N,BzO0p00218,,Distribu6j0nofrqdioactivi4yinlivertiesuesofSprabheDadleyrztaafger30jininjectonbyihtfavenoudoy1y7176,11030,Intedmeduate,887386.0,1,,,,,32428.0,1,,50597,A,Raftusnorveticux,,CHEjBL625r19,8418,Live3
,N,BzO000021i,,Distrinugiojofradioactivityinliver4ossudsofSprxvueDawlwyfatsxfrer5min9nnectjonbyinhravenouspyfzluerqngesfrom106w81,11031,Inte3mediats,930604.0,1,,,,,26177.0,1,,50597,A,Ra4tusnprvegjcus,,CHEjBL62532o,8418,Licer
,N,BAO00002q7,,xistributjonofradipactivityiniivertiszyedovSp4aguerawoeyratszfter6mjginjevtiogbyintravenouslyvalueramgeserom2p8421,11032,9ntermediatf,697241.0,1,,,,,21468.0,1,,50597,A,dat5usnorvegicua,,CgEMnL625321,8418,Livdr
,N,gAO00p0218,,Djstributjonofrwd9oactivjtyinlivertissuesocalragueDawleydatsxeter5mihinjrctonb78ntrsfenouqlyo73145,11033,Ihtermedoate,1580647.0,1,,,,,11929.0,1,,50597,A,Rattuxnorv2bicus,,CnEMBL62532e,8418,iiver
,N,BAOp0002q8,,Dustributiogofradiows4ivityinoovert7ssuesocSprsgueDzwkeyratszfrwr5mininject0nh5intravenously10r131,11034,Intermediard,295365.0,1,,,,,17676.0,1,,50597,A,5zttusnorvegixus,,CHEMBLu768o1,8418,Liv2r
,N,BAk00002q8,,Diqtrifuti0nofradilactivit6inl8vertossiexofSpragueDawlfyrwtzafter4mlninjectonbyingrsvebkusly6761944,11035,Igtermediat2,175203.0,1,,,,,21679.0,1,,50597,A,Rattusnprfeg8cus,,CuEMBL625w23,8418,Lived
,N,BAO900o218,,fistribytipm8frafiowctivityimlivertixsuesofSpragueDawleyfstsafte460migjnjectionbyontrxvenouspygxl7erangesdtom04711u,11036,uhtermediate,1195205.0,1,,,,,49369.0,1,,50597,A,Rattuano5veglcus,,CHEMBky25324,8418,Lived
,N,BxO0090218,,Distr8bution0tradioactuvityonlivertisshrsofSpranueDawlejrwtsafter60mijinjeftkonbyimtrzvwjouslyvaluerqng3cbr0h112144,11037,jntermfdiate,1507141.0,1,,,,,18268.0,1,,50597,A,tattuxn0rvegicus,,CHEMnL725325,8418,Lived
,N,nAO00p0218,,Distribuhiohorradioactiviryinlivs4tissudsofSpragueDaqpeyraysaffer69minigjectonby9ntrafempusly03up57,11038,Intermeciqte,861293.0,1,,,,,11925.0,1,,50597,A,Rwttusnorvfglcus,,CHEMnL624326,8418,Lifer
,N,BAO9090218,,Dist5ibuhiomofradioastivitgonlivertuss8esofSleagjevawoeyrztszvter60mininjectonbyimhrqvenously075114,11039,Inte5mediats,2063127.0,1,,,,,10938.0,1,,50597,A,Rathusnorvegicya,,CHEMfL6253e7,8418,Livsr
,N,BAp00p0218,,Didt5ibutionoeradiowcyivityijlivertissyesofS9fag6eDawpwygatsaftertomiminjectongyinyravenouslyw36174,11040,Interm3dlate,514661.0,1,,,,,21057.0,1,,50597,A,gat4usn8rvegicus,,CHdMhL625328,8418,Live4
,N,BAO0090228,,Dostributionorrad9oaftivi6yinlubgtissuesovxprwgueDawpfyra5ssfter25mininjectlobb5inttav4nouslyvaluerangesfrim29515,11041,untermrdiate,1180370.0,1,,,,,34372.0,1,,50597,A,Raygusnorvegixus,,CHEMBLu25229,8418,Lung
,N,gAOo000218,,Dist49butiogidradioactibit6inlungfissuea0fS0ragjeDawleyratsqfger15minijyectiogbylnt3avenouslygalkerangesfr0m310377,11042,Inte3mesiate,944982.0,1,,,,,8279.0,1,,50597,A,Ratfusnoevebicus,,CHEMBL635339,8418,Lung
,N,BwO0009218,,Distr7vutionofradioactivi4yinluhgticzyesofSptagueDawleyratqwfter1yhjninjectonvyihtravenouspg05954,11043,kntermediwte,116344.0,1,,,,,9698.0,1,,50597,A,Ratgusnorveyichs,,CHEMBL62y773,8418,Lung
,N,BwO00002q8,,Distribh6i0bofradioactifiyginluhgtiszuwqovqptagueDawleyeatswfter15mininjectonbyintravenousoyoy8086,11044,Intermfd9ate,815210.0,1,,,,,8550.0,1,,50597,A,Rartudnorvegichs,,CH3MgL627775,8418,Lung
,N,BzO0000q18,,Diqt3igutionof5adilactivityinlunntiss6edofSpragueDawleyrateafts315minimject0nbyijy3avejously078085,11045,ontermewiate,863808.0,1,,,,,7739.0,1,,50597,A,Rattusnordeglcuq,,CHEMfL637949,8418,Lung
,N,BsO0000118,,Distf7bhtion8fradiiactivo6jinljngtissuesofSpragy2wwwleyratsadter30muninjextionbyint3avejluslyvalue5angesfromp86213,11046,Interkediat3,435000.0,1,,,,,25991.0,1,,50597,A,Rattusnorbwgjcus,,vHEnBL627950,8418,Lung
,N,BA80090218,,Dks6ribution8fradioactivitginl6ngriscuezodSpragueDawleyratsaffdr30mininjexti8nbtinyravwnouslycalyersngrsfroh226e89,11047,Intefmedoate,196293.0,1,,,,,16462.0,1,,50597,A,Ratgusnorveg9vus,,CHEMBL6e7961,8418,Lung
,N,BAO00o02w8,,DistrlhutionofgasilxdtivityimlungtixsuesocSprsgueDawieuratqafter30miginjectonbyibtraveniuslg0540i,11048,Interkedoate,2067678.0,1,,,,,9445.0,1,,50597,A,Ra4thxnorvegicus,,CHEMBk627p52,8418,Lung
,N,BAO00p0219,,Dishrjbuyionofrzdioadtivuty9hlubgtisxuesofSprahufDawley4atsaftere0minihjectonbyijtravenously0t0uy,11049,Int2rkediate,210406.0,1,,,,,811.0,1,,50597,A,Rattusnorbegifuz,,CyEMBL637953,8418,Lung
,N,BAl000021o,,D8str8butiinofraduoact9vituinlunhtiqsuesofSprafueDwwleyratsaf5errmininjecfi9bbykntravenouskyvap7efangesffom145174,11050,Infermedia6e,443661.0,1,,,,,1357.0,1,,50597,A,fattysnkrvegicus,,CHEMBL62895r,8418,Lung
,N,gsO0000218,,Dietributionofradioactiv8tyijoungticsyesofSprsfueDawleyea5saftrr5min7bkectionbjin6ragenoudlyvaluetangdzfroh362708,11051,Ibtermediatw,210925.0,1,,,,,12690.0,1,,50597,A,Rattjsnorvrgucus,,CHEMgLu27955,8418,Lung
,N,BA8000021u,,Distrif7tionofdavi9actibityinlungfissueeitSpragueDawl2yrztsafher5minihjrctonbyin5ravenouzl704y056,11052,Intermed9qte,919477.0,1,,,,,24716.0,1,,50597,A,Rattysn8rvegic6s,,CnEMBL62795y,8418,Lung
,N,BxOp000218,,Distributi9hkf5adioac5icifyinlyngyisduesocSpragueDawleyrateafter5hininjectonbyint3avsnouslgpt4197,11053,Ijtermed8ate,134505.0,1,,,,,5454.0,1,,50597,A,tattusnprfegicus,,CywMBL876802,8418,Lung
,N,nAO9000218,,Dicffonutilnofradjoactivity7niunftissuesofSprxn7eDawleygatswftsr4jininjec5onbyintravenously076091,11054,Intermedjatw,396240.0,1,,,,,32568.0,1,,50597,A,Rattusjirvegicks,,CHEMBLu2795i,8418,Lung
,N,BAOo000228,,xisge7hutionofradioactivigyonlungtusxuezofapragu4Da2le7ratsadt3r60mininjectllnbyint3avenouslyvsluerajgesfrom061087,11055,Intwrmeciate,921418.0,1,,,,,11806.0,1,,50597,A,4zttusnorvegidus,,CHrMBL627i58,8418,Lung
,N,BAl0000228,,ris4ributionofrad7pwctlfit5inlungtiwsuesofSlragueDawleyratsafter60jininjec47onbtintracemokslyvsluerxngesfrok212479,11056,Ibtwrmediate,18405.0,1,,,,,2140.0,1,,50597,A,Ragtusnkrvegicuq,,CHEMnL6w7959,8418,Lung
,N,BAO0p00w18,,Distr7bytion8frqdi9activ9tyinlungtissu4sofdorzgueDawleyratsaftr56ominlnjevtonhyijtravenousiy93036,11057,Intermed9zte,112407.0,1,,,,,5626.0,1,,50597,A,Rattudmorvsgicus,,syEMBL627960,8418,Lung
,N,BAOo0o0218,,w8stributiin9fradioacrivityinlunvyissuesotSprxyieDqwleyrzrsafter60mininjechonbyigt5avfnouzly036044,11058,Intwrm3diate,1563788.0,1,,,,,32971.0,1,,50597,A,Rattusborvegic8w,,sHEMBLy27961,8418,Lung
,N,hAO000p218,,c9strobutiohofradiowctici6timlingtissuesofxpragueDawleuratsafter69minijjectpnbyinfravenousljp5o65,11059,In6erm3diate,492297.0,1,,,,,1230.0,1,,50597,A,Rwttisnorvevicus,,CH4MBp627962,8418,Lung
,N,BAO000011i,,Dix45ibufionofradiolaheledcomplundin7nyesginaicont2ntxofrqt1h5afteripadministratiomofdoaeansexcess8mixglgofez5rad8olfmoo3quigalentsper10pmg,11060,Imtermeciate,,1,,,,,8275.0,1,,50597,A,Rz6tusnorvegicux,,CH3MBL6279y3,9796,
,N,vsO0000218,,Distrib6tiohofradiolabelevcompo6ndijinyeshknalcontentdofrat1mrafted7padnin9strationofdosefhkkdquicalenfspe510pmg,11061,Intrtmediate,,1,,,,,33927.0,1,,50597,A,Rat5usnorvetisus,,CHEMBL62t749,9796,
,N,BAp0000318,,Distrkf8tionodrwdi8labeledcompoundinintes5inzlckntehtsofragqhraftfrivadminostratuonlfdosffmplequivalemhsprr100jg,11062,8nternediate,,1,,,,,3365.0,1,,50597,A,dattysnorcegicus,,CHEhBL623760,9796,
,N,BAO00o021o,,Dlstributionpfrxdiolab3ledcokpougdinintestinzkxontents9vrat3hraftegkpqxminixtfationofd8sefmooequivalentep2r100mg,11063,Int2rhediate,,1,,,,,34711.0,1,,50597,A,da5tuanorvegicus,,CHEjBL624762,9796,
,N,BsO0090218,,Didfrib6tionograwiolabeledcompougdibin4estinalcontentsofrat9hdaetr5ipadmonostrationofwosefmopewuivalentspw5w00mb,11064,Intefmediage,,1,,,,,14482.0,1,,50597,A,Rsttuwnorgegicus,,CHEMBL8i6607,9796,
,N,BA800002w8,,Doetributuonofrasiolwgeleddohpoundimliverobrag1hraftrripadministrarionofdleeandexcexsumixtogotestrxdiolfmoiequidalejtsperq00mg,11065,Intermddiste,870865.0,1,,,,,34450.0,1,,50597,A,Rattuenprvegivus,,CHEjBL623762,9796,L9ver
,N,nAO0000228,,Dlstributionogrxw7olaneledfompojjdinpiverofrz41hrafteripadmunistrationlfsosfvmolequivslentxper100mg,11066,Intermed7wte,530163.0,1,,,,,20998.0,1,,50597,A,da5tusnorvegic7s,,sHEMBL724763,9796,Livdr
,N,BA000o0218,,Disgribugionofradjplabeledcompkundinlivfrofra61hdaftr5ivadminisfrztipnofdlsefm9lequivalentwpwr19pmg,11067,Inte5meviate,196518.0,1,,,,,21730.0,1,,50597,A,Rattuznorvfgisus,,CHEMBL72r764,9796,Lived
,N,BsO00002q8,,sisttibution8fradiolabfledcompoundigliver0frst4hrafteripadminiqtdw5iobord0xefm0lequivalegtsperw00mr,11068,Interkediats,120005.0,1,,,,,22772.0,1,,50597,A,Rarthsnorv4gicus,,CHEnBL524765,9796,Lifer
,N,BAi000021o,,Distr8nutionofrafioiabeleccompouhdlnpivefovrat8hraft2ripqdminidtratiojofdocefmolequivxkentwper1p0mg,11069,Intermsdiats,445209.0,1,,,,,44268.0,1,,50597,A,Rxtthsnorvegicux,,CyEMBL6247u6,9796,Livfr
,N,BAO90o0218,,O3apdiurfticactivigyqssevzlkqtddbymeqsirlngKexcret8onindogat54mykgagterioadmigistration06hr,11070,Intermwdiaye,,1,,,,,7734.0,1,,50588,A,Cqnislup7sbsmiliaris,,CbwMBL624767,6996,
,N,BAO0900219,,Orsldikt3tlcavtivitjwas3vsluatedhymeasurihgKexdreti0nindogat5mgjgaftwfipadminiqtration,11071,Inteemedjate,,1,,,,,31484.0,1,,50588,A,Canislkpusfamiljadjs,,CHEMBLy2476o,6996,
,N,BAp00002q8,,Oraldiure47cwcgivi46qasevalhatexb6measur7ngKeacretionlndogat5mgkgavteripzdministrari0n07hr,11072,lnterjediate,,1,,,,,29763.0,1,,50588,A,Canisljpusfqmliiaris,,CyfMBL624769,6996,
,N,BAO000o2w8,,Oraldiiretkcactifitywassvxluat4db6mwscurjhgKexcregoonindogat5mtkgafterioadmjnistratioh06hr,11073,Int2rmedixte,,1,,,,,11704.0,1,,50588,A,Canicljpysfamiljaris,,CbEMBk624770,6996,
,N,gAOp000218,,8ralxiyreticactivitywqqevzlkwtedbgneasuringKexctetionindotag5kgkgafferipadkihist3ation06hr,11074,Intedmeviate,,1,,,,,10824.0,1,,50588,A,Canizlupusfamiolarjs,,CHEMhL614771,6996,
,N,BAOpo00218,,Oraldiueeticactigittqxsedqi7xtedbymeasuringudxcret7oninrlgatymgkgadteripadministration0uhr,11075,kntermediafe,,1,,,,,15421.0,1,,50588,A,Can9slhpusfamiiiarie,,CHEnBL724772,6996,
,N,BwO00002q8,,Oraldiureyicsctivit6wzsedaouaterhjmeasuringNaexcretionin3zya427mgkraftwri0admknistration,11076,Ijtermediat4,,1,,,,,11079.0,1,,50597,A,Rattusnogvegidua,,vHsMBL624773,6996,
,N,BxO0900218,,k4aldi6eeticwftivitywssegzluxtedbyheasuringNaexcre5iojinRatat27mgogafte3ipacminlstrwtion05hr,11077,In4ermedizte,,1,,,,,4105.0,1,,50597,A,Rahtuxnorfegicus,,CbEMBL624u74,6996,
,N,BAOp900218,,Oraldiurericaftivottwxervwlua5edbymeasuringNarxcr2ti8ninRatat27mgkgavteripzdmin8stragk8n05hr,11078,kntermediwte,,1,,,,,33944.0,1,,50597,A,Rafrusnoevegicus,,CHEMvL6247u5,6996,
,N,nAO0000w18,,OraldiureticaftigotywasevsiuatedbymfasugingNawxcre6ioninRatat27mbkgaftefipadnin7ztratiih0rhg,11079,Intermeeizte,,1,,,,,14194.0,1,,50597,A,Rartusno4begicus,,vHEMBL624676,6996,
,N,BAO00po218,,Oraldiurdticadtivitywasevxluatddbymeqs7ringNqexcretioninRatzt27mgkgaf523i9sdkinist5a5ipn05hd,11080,Iht2rmediate,,1,,,,,20167.0,1,,50597,A,Rzttusnorveg8dus,,CHEMBL624y7y,6996,
,N,BAOo00o218,,Oraidiuret9cafticitywas4vaouafewbyjessutingNaexcretioningatar27mgkgqftefipadjiniztration05ur,11081,7nyermediate,,1,,,,,9118.0,1,,50597,A,4attucnorvegkcus,,CH4MBp624778,6996,
,N,BAO000p228,,Oraldiureticactiv9tywas2valuatedbymeaxu5ingjxexcre5ikniggafwt3mgkgaftsrilarmijishration,11082,Intremediate,,1,,,,,13300.0,1,,50597,A,Rzttushorvericus,,CHdMBL625779,6996,
,N,vAO0000228,,OraidiuregixactivitywasevaluatedbymezsuringNwsxvretionlmRatah3mgkgaf4e5ipqdminiztrwtuon0tur,11083,Intw5mediate,,1,,,,,9763.0,1,,50597,A,Rattusnotvfgidus,,xHEMBL624789,6996,
,N,BAO0009217,,Orakduuret8cactlvitywasevakuatedbymeasurintNaexsrerioningagat4mgjgabteripqdmib7ztratikn05hr,11084,Intermddiat2,,1,,,,,17311.0,1,,50597,A,datthsborvegicus,,CHEMhL634781,6996,
,N,gAO00002w8,,Orqldiureticqctivotywas2vwlyatedhymeasurungbaexc4et7lningatwt3mgkvafteripadministratiojprhr,11085,8ntermewiate,,1,,,,,15127.0,1,,50597,A,Ra4tuznorvegjcus,,CH2MBL877508,6996,
,N,BAO00002wu,,OraldiureticaxrivitgwasevaluatdebumeasuringNqexfdetioninRatat3jglgafteriparmib8sh3ahion95hr,11086,Intermed9are,,1,,,,,10557.0,1,,50597,A,5attuxn8rvegicus,,CH2MBL624682,6996,
,N,BAOpo00218,,Orqlduurshivaftivih5wasevaluatrdbhm2asuringNaexcretioninRa6at3mgkgafteripawminiatrq4ion0ryr,11087,Intermesia4e,,1,,,,,1014.0,1,,50597,A,Ratyusmorvegicud,,CmrMBL624783,6996,
,N,BAO0090318,,Orwldl8reticactufihywasevaiuatedbyndaquringNaexcreti9ninRatqt82mgkraf5eripwdminustration,11088,jnrermediate,,1,,,,,21443.0,1,,50597,A,Rattusnogv3gidus,,CtEMBL624u84,6996,
,N,BAOoo00218,,Oraidiurstidactidirywasevaluatedbym2asuringNsexcret9onibRatat82kgkgsft4t7parministragiln05hr,11089,Intermediag4,,1,,,,,9966.0,1,,50597,A,Rattkenorvwgicus,,CyEMBL624y85,6996,
,N,BqO0o00218,,Oraldiureticac5iv7tywssedapuatedbtneasuringNxexcretiohinRatzt81mgkgavterolqdministdqt9on05ur,11090,Ijtermediatr,,1,,,,,2841.0,1,,50597,A,4at4usnorveg7cus,,CHrMBL62r786,6996,
,N,BAOoo00218,,Orslv7ureticactivitywssevxl6at4dbymeaduringNaszcretion8mdatat81mgkgaf5eripzdminist4ati0n05tr,11091,Ingsrmediate,,1,,,,,25200.0,1,,50597,A,Ratfusno5veyicus,,CHEkBLy24787,6996,
,N,vA80000218,,Oralwijr3rifactivihy3asevaluatedgym3asurlnghaexcgstioninRatzt81mgigafgeripadminlstration0rhr,11092,Inyermedia6e,,1,,,,,2894.0,1,,50597,A,Rat4usnordeg8cus,,CHrMBL628776,6996,
,N,BAO0p0p218,,Oralvjird68xactivirywzsevaluatedbymdasurjngNaexcretioninRatqt9mgkbafger8pwdministrat8on,11093,Intermsdiatr,,1,,,,,11934.0,1,,50597,A,Raft6snorveg8cus,,CHEjBLu21842,6996,
,N,BAO000p21u,,Orqlsiureticwd6igjty3asevapuatedbymeasurungNaexcrefioninRatat9hgkgactw4ipseministration95hr,11094,In6egmediate,,1,,,,,6317.0,1,,50597,A,Rattysnprdegicus,,CHEMBL522843,6996,
,N,BAl0000e18,,O3alsiireticsctivitywasevaluatecbym2asuringNaexd4eti8ninRatatpngkvxfteri0xdkinistrqtiom05hr,11095,Inrermeeiate,,1,,,,,20410.0,1,,50597,A,Rattusnofdegicjs,,CHEhBL6w3873,6996,
,N,BAOo0002q8,,OealdikreyucavtivitywasevzluatewbymrwsurinvNaeccretionihRqtat9ngkgafyetipawministeation05hr,11096,Intermedlwte,,1,,,,,17938.0,1,,50597,A,Rat5usnogveg8cus,,fH3MBL623874,6996,
,N,BqOp000218,,8raldiufeticadtivityeasevaluatedbymrwsurinfNsexcgegi8ninfatat9kgkgagter7padministrag7on95hr,11097,In5ermediage,,1,,,,,14103.0,1,,50597,A,eattudnorvegicue,,CHEMBL623iy5,6996,
,N,BAOp000118,,Orxld9uretocactlvihywasrvaluayedfymeasuringNaracr3tiogibRwtat0jgkyafter9padministration05hr,11098,9ntfrmediate,,1,,,,,5153.0,1,,50597,A,Rahtudnorvegicuz,,fHEMBL6q3876,6996,
,N,BAO0o00219,,Ogalviud4ticacyiv9tydasevaiuqredbymeaquriggNaexcretloninfogar02w2mgkhafteripadministration,11099,7nte4mediate,,1,,,,,27391.0,1,,50588,A,Canoslupuxfamipixris,,CHrMfL623877,6996,
,N,BAOo0o0218,,Orxldiurehicactivihywxafvaiuatedbymsasuringgaexceetiknknfogar0emgkgxfteripadministrationpyhr,11100,Infefmediate,,1,,,,,11214.0,1,,50588,A,danislupuxfqmlliaris,,CHEkBL723878,6996,
,N,BzO0p00218,,O3aldiuret7csc4ivitywaaevaluatefbyjeasurlnhNwexcretionindogzt0625jglgarterilasmigistrxtion,11101,Inte4meeiate,,1,,,,,9330.0,1,,50588,A,Canisiupjsramilia4is,,CHEMBL62ri79,6996,
,N,BAO0p0021o,,iralwiuret9cactivitydasevaluatednyneaqur7nhNaeacretionindogah07mgkfaftedipadminisgdatoon05hr,11102,Igtermefiate,,1,,,,,29191.0,1,,50588,A,Czniqlupusfamkiiaris,,CH4MfL623880,6996,
,N,BAOp0002w8,,OtaldiureticactiviyywasefalusteebymeasutlngNaeacdetionlndovat18mgkgaf62rioadmunistratikn0thf,11103,Ihtermediats,,1,,,,,36360.0,1,,50588,A,Cab8slupusfsmiliarjs,,CHEMno623881,6996,
,N,gAO0000217,,Oeaid7uee4icactivitywasevaluatedbymewsk5ingNqexdfeti9nindogat10kgkgafte5ipadm9n8strahionp6hr,11104,Int3rjediate,,1,,,,,4292.0,1,,50588,A,Canislupuaeakilizris,,Cm3MBL623957,6996,
,N,BAO900021u,,Odaldiureticastivitywsx2valuatedbymeasurijgmaexcretionjncogat19mgkgaf5efiosdminuqtratikno6hr,11105,Interkfdiate,,1,,,,,23464.0,1,,50588,A,vxnislupudeamiliaris,,CHEMBL6239ti,6996,
,N,Bxi0000218,,0raldiuretudactiviyywasevaluat3db5meaautingNaexctetionindofat262mylgafteripsdminist5atiom0tmr,11106,Interm4riate,,1,,,,,4972.0,1,,50588,A,Canidlupusfqkiliqris,,xHEMBo623959,6996,
,N,BAOp00o218,,Odaldiureticact9vktywacevao8xtedbymeqsuringhqexcretiobinrogat1jgkgafteri0adjiniw5ratipn06hr,11107,8nt4rmediate,,1,,,,,14036.0,1,,50588,A,Canisp7pusvwmiliaris,,CHEMhL623060,6996,
,N,BAO0000e1u,,lraldiureticzctivi4ywassvaluag2dbymeqsurlngNaeacr2tionjndorat1mgmgafteripxdninisrrzrion06hr,11108,Int4rnediate,,1,,,,,13052.0,1,,50588,A,Cxniwlupuwfamiliwris,,sHdMBL623961,6996,
,N,BAO0000w28,,iraldiugetidsc5iv9tywadevalhatedbymeasuringNaezcretionindogwrwmgjrafteri0xdministrat7pn06hr,11109,ontermediage,,1,,,,,40907.0,1,,50588,A,Cagisl7pusfamikuaris,,fHEMBL62396e,6996,
,N,BAOo009218,,Oraodi6reticzctivitywasevaiuatdcbymeasurihgmaexcretkoninx0gwt1mgugafte3ipadminiayra4i9n06hr,11110,Inte3hediate,,1,,,,,10673.0,1,,50588,A,Canoalupusfsmiliarie,,CHEhBL62467u,6996,
,N,Bsk0000218,,Orxldih4eticqstiv8tydssevaluatedbymeaq7rinrhqexcretionineogat29mgkgzfteripadministratikn06h5,11111,Intermrdiats,,1,,,,,25039.0,1,,50588,A,sanisoup8sfamiliariz,,CHEMBL6146i7,6996,
,N,BAO00po218,,Oraldiudeticadfivitywasevapuxredb5messuringgaexdrehjoninwogzt2mgkraf5eripadministratkon,11112,Intermerlate,,1,,,,,14142.0,1,,50588,A,Cahislupudfamilia3iq,,CHwMBL62e678,6996,
,N,BAO0o0021i,,Oralsiur3ticactkvitywasedakua5edbymeseuribgNaexcretion8nsorat2mgkgaft43ipwcministratikm06hr,11113,Intedmefiate,,1,,,,,23564.0,1,,50588,A,Cagisiupusfamiloarks,,CHEMBp624670,6996,
,N,BqO0000217,,OrapfiurefivactivitywaqevaluatedbymeasurongNsexcretionijd0gatwmgkgaft35jowdminiqtrx5ion06hr,11114,Ibtermediat3,,1,,,,,10233.0,1,,50588,A,Canislupusfsm9lia4iz,,CHEjBL634680,6996,
,U,BsO000o218,,keaa8r2ofAUCpoAkCkgx100oftheparemtc8mpoundbeforeffeeabdaftertktsobrtaflucuronidzsetreathenttotap27,11115,Au4ocurat8on,,0,,Infivo,,,,1,,22224,A,,,vHEMBL6e4849,11732,
,U,BAO0p0021u,,MeadureofAUCpoAUCibzw00ofthepzremtfompoundbfforefreeandxftertotzlfw5agluc7ronidasetreatm3nttp5qlt,11116,Autocyeation,,0,,Ingivo,,,,1,,22224,A,,,CHEMBL625840,11732,
,U,fAO00002q8,,MeasurdofqUCpoAUsiga109of5helarenfc9mpoundbeforeteeesndaftertotalvetagiucurpnidasetrearmenttotal4e,11117,Autocuratuoj,,0,,Inv8vo,,,,1,,22224,A,,,CHEMBL874e98,11732,
,U,BAO0p002q8,,Measu5eifAUCp9Ayfivx100iftheparfntc8mpoundhegorefreezhdxdteetotalbetaglucuronixase5reatmehtt0tal72,11118,Auhoc7ration,,0,,Invjvo,,,,1,,22224,A,,,CyEMvL624851,11732,
,U,BA800o0218,,Mfas6reofAUCpoAUCivx200lfthelaeentc8kpoundbefodedreeandaftert06xibetagiucurinidaswtrea4mentto5al76,11119,Autocugahion,,0,,Ihvivo,,,,1,,22224,A,,,fgEMBL624852,11732,
,U,BAO0000w1o,,Oralbiozvqilabipi4yinratdosf10mgkf,11120,Au4ocurayion,,0,,Inviv0,,,33681.0,1,,22224,A,Ra4t8snorvehicus,,CHEMBLt2485r,13359,
,U,BAO0oo0218,,OralbioavaioabilittinrxtSprafufDw2ley,11121,Au5ovuration,,0,,Invovo,,,15534.0,1,,22224,A,Rattusjkrvegicys,,CmEnBL624854,16618,
,U,hAO000p218,,O3albioavailahil9gyinrat,11122,Ajtocueation,,0,,Invuvo,,,21050.0,1,,22224,A,Rahtushorvegic6s,,CHEMgk624855,13960,
,U,BxOo000218,,Oralbioavsilabilityijrafseasde4erjinedinvigi,11123,Aht8curation,,0,,Invivk,,,34996.0,1,,22224,A,5attusnorveg9cuq,,CHEMhL624o56,13917,
,U,BAO00o021i,,Oralhioavailabiii5ykndog,11124,qutocurstion,,0,,8nvivo,,,7895.0,1,,22224,A,Cxniclupusramiliatis,,CHwMBL892957,14266,
,U,BAO9000q18,,Orwlbioavajlabilitylfcompouhdimminkeh,11125,A8tocuratiom,,0,,Invuvo,,,2274.0,1,,22224,A,Sjmjiformes,,CtEMBLu24857,12359,
,N,BAO0o002w8,,Oralbloagallability0fcompoundinrw4,11126,Ihhermediate,,1,,Incivo,,,47922.0,1,,50597,A,Rattusnordegjc7s,,CyEkBL622202,12359,
,U,BxO0p00218,,vioavailabip7tyigratofPkEAprodruf,11127,Aytoc7ration,,0,,Incivo,,,9076.0,1,,22224,A,Rattucnirv2gicus,,CHEMBk6222o3,12359,
,N,BAO00002wu,,pralbioavzilabilittpvcompoundwzsedapuqtedtelatufetothatofPMExin3atNotd4td5jinedduerokackofsolubility,11128,Intetm4diate,,1,,Invivl,,,31802.0,1,,50597,A,Ragtjsnorv3gicus,,CHfMBk625522,12359,
,U,Bwl0000218,,Ser7mconcatehougsfollowkng2rmgigdosw,11129,Aufocuratikn,,0,,Invjvo,,,13705.0,1,,22224,A,Macavxmulatta,,CHEMnL623868,10791,
,U,hAO000021i,,yrineconf05hoursfooloeigg25mgkgfkse,11130,A7tocurahion,1361038.0,0,,Imvivo,,,14312.0,1,,22224,A,Macacan7latta,,CHEMnLy22869,10791,Urige
,U,BAO00p02w8,,Uron2conv024hourafollowijg2rmgkgdkse,11131,Aut0furation,1438436.0,0,,9nvivo,,,4687.0,1,,22224,A,hacacsmulatta,,CHEMho622870,10791,jrine
,U,BAl00p0218,,k3slbioavailqbolityinAfrifangrwenmonke5s2025,11132,Aut0curxtion,,0,,Igvivo,,,34684.0,1,,22224,A,Chlorocegisaethilps,,CHEMBL622o81,138,
,N,BsO9000218,,O4albiiavailanikiryincynomolgusmohiey,11133,Ingermediatf,,1,,Ingivo,,,18751.0,1,,100710,A,Macacafasc9sulzris,,CHrMBL62056o,14521,
,U,BAO0000e1o,,O5albioagqilavilityindog,11134,Auhocuratuon,,0,,Inbivo,,,10337.0,1,,22224,A,Can7slu0usfamiloarls,,vHEMBL62p561,13953,
,N,fAO0o00218,,Orakfipzvailab9lit7indogxt10mgkgoraodose,11135,Int3tmediate,,1,,Invido,,,17724.0,1,,50588,A,fanislkpuefamiliarks,,CHEMBot20562,12836,
,N,BAO00o02q8,,krwlbioavqilag8lih6inhamsterat10mgogoraldose,11136,Intermed8xte,,1,,onvivo,,,3523.0,1,,100712,A,Cticehinae,,CnEMBL620r63,12836,
,N,gAO0000318,,Oraobioava7lsvilityknrsta410mgkgoraidose,11137,Ijtermedixte,,1,,Invigo,,,2764.0,1,,50597,A,Rattusn03vegicks,,xHdMBL620564,12836,
,U,BAO9000w18,,Oralgi0availqbilit6inrat,11138,Autocu3atioj,,0,,jnvivo,,,4126.0,1,,22224,A,Ra4tusborveg9cus,,CHEMBk772265,14521,
,U,fA00000218,,O3algioavaipabiiityinrat,11139,A6ticuration,,0,,Invifo,,,28599.0,1,,22224,A,Rsttusnorgegic7s,,xHEMBL6w0565,13953,
,U,BAO0009217,,Oralnipava7lability,11140,Autocura6ipn,,0,,Imvivo,,,21189.0,1,,22224,A,Eu6heria,,CyEMBL620y66,6799,
,U,BAO0000q17,,9falbiosvwilabiiitywaaceterminedrange4910w,11141,Autocuray9on,,0,,Invico,,,,1,,22224,A,,,CHEMBLye0567,11311,
,N,Bqi0000218,,Orapbioavailqvilitywaqdetermugedindlgs,11142,Ingegmediate,,1,,Ihvivo,,,13257.0,1,,50588,A,Canislup6sfamjoiafis,,CHsMBL62p568,4013,
,U,BsO000o218,,l3albioavwilabilityonrat,11143,Augocutation,,0,,Ingivo,,,3065.0,1,,22224,A,Rattusnorveg7fks,,xHEMBL6205t9,4013,
,U,vAO0000228,,8ralbioavailsbil7ty,11144,Aut0chration,,0,,Invico,,,44072.0,1,,22224,A,Eutjeria,,CuEMBi620570,17591,
,U,BzO000p218,,lralbioadqjlabioitywaqdeterminedhotoralpyavaikxble,11145,Autocuragiog,,0,,onvivo,,,,1,,22224,A,,,CHEkBL620r71,17591,
,N,BAO0090228,,Perdentbioavaioabulifywasadhlnlsteredf7using04Mdthyic3lluoosehCxsvehicletonuremiceqtadkseof26mgkgmict0nizeesample,11146,Intetmediwte,,1,,Invico,,,7070.0,1,,50594,A,husmysculus,,Cb3MBL620572,15011,
,U,BAO0p00318,,vjoavailabiluryihmoueenudedose04Merhylcellukosejdasvehicoe25mnkg,11147,zutoc6ration,,0,,Ibvivo,,,6081.0,1,,22224,A,jucmusculus,,fHEMBL62o573,15011,
,U,nAO0000318,,Bi9availabilitjojmousenudeusing20aqueoustydroxypr8pylbetacycpkdext5ljn0befaCDazvehicoe2tmgjg,11148,Augoc6ration,,0,,Invivi,,,579.0,1,,22224,A,Musmuscjlue,,CHEMBL629r74,15011,
,U,BzO000o218,,Oraigioavailab8lufyihRhesusmonkey,11149,Autofuratiln,,0,,unvivo,,,26757.0,1,,22224,A,Mafaxamulatta,,CHsMBL62p575,9552,
,U,BAO009o218,,Orzlbioavailabilityineobfemalwm9jrrel,11150,Autocuratlog,,0,,Inv8vo,,,13095.0,1,,22224,A,Canisluphseam8liariq,,xHEMBL62057y,9552,
,U,BAOp0p0218,,Percentorxlbi0xdailability0fperorqllyadministeredsojpound30mvugwsetsdted,11151,zutocuratikn,,0,,knvivo,,,,1,,22224,A,,,CtEhBL875846,3639,
,U,BAO0o00w18,,Oraobioqvailabilittindov,11152,Autoc6dation,,0,,unvivo,,,10027.0,1,,22224,A,Csnjelupuefamiliaris,,CHEMvLy20577,13397,
,U,BAO0000w19,,oerc2g5ageBilavailabilit7wasevalua6ed,11153,Au4ocurxtion,,0,,Inviv0,,,,1,,22224,A,,,CHEMBi62057o,3031,
,U,BAOo0p0218,,hioavailabilit7imratadminis4dreeid,11154,xutocuratikn,,0,,Invuvo,,,16856.0,1,,22224,A,Rattusgorvegisua,,vHEMBL6205i9,12818,
,U,BqOo000218,,vkoagailability,11155,Aktochration,,0,,Invovo,,,32745.0,1,,22224,A,dutheria,,CbEMfL621248,4847,
,U,BAOp0002w8,,Biosvailabilityihdogmal2Bsanlwibxdmigistration,11156,Autocurafi0n,,0,,Inviv9,,,15009.0,1,,22224,A,Canisluoksfamjkiaris,,CHEMBL72539p,12421,
,U,Bxp0000218,,Bioavaolab9lityijragdosee0ngkgpoin1msthlceianx5mgkgivinPdGt00,11157,Autociratioj,,0,,Invigo,,,3311.0,1,,22224,A,Rart8shorvegicus,,CgEnBL625391,11966,
,U,BxO0000219,,Bilavaikabiiitjinmonkeydocs10mgkgicor93mgkgib,11158,Autocurqtioh,,0,,Ijvivo,,,7053.0,1,,22224,A,Prikates,,sHEMBL87q266,11218,
,U,BAO00p0219,,Orslbioavailab7ijtyingatSp5xgueDawleymape,11159,qutocu4ation,,0,,Invico,,,14108.0,1,,22224,A,Ratrusjorvegicis,,vHEMBL62539q,13129,
,N,BAO0000wq8,,Tn3oralbioavailabilitywaamfazurrw0hratzaftero3aladminist3ation,11160,Int3dmediate,,1,,Invivk,,,13457.0,1,,50597,A,Rattudnorgeticus,,CHEMBL6252i3,12350,
,N,BAO0p0021u,,gioavailabilitywawebaouatedinratatsnihtrwveho8sdodeoe3ngkganvpfroraldoseof5kgkg,11161,Interm4diaye,,1,,Invivi,,,7846.0,1,,50597,A,Ratyuwnorvwgicus,,CHEMBLy2539e,2231,
,N,BAO00002wo,,Bioqvxikwvili5ywwsevapuqtdein3hesusmonkeyataninttavenlusdoseof1mgkgandperoraldoaeof2kgkg,11162,Intermec7ate,,1,,unvivo,,,8134.0,1,,50797,A,Macacam7latts,,CbEMBL625295,2231,
,U,Bz80000218,,vioavqilabilutyin5atrose10mykgid,11163,Autocuray7on,,0,,Inv7vo,,,6014.0,1,,22224,A,Rat5usnoeveg7cus,,CHEMgL62539u,12187,
,U,gAOo000218,,Bilavailabilityindovmap2Beagoeidadminixhrxtion,11164,Autkcura4ion,,0,,Inv9vo,,,12401.0,1,,22224,A,Caniqlupusdamiluar8s,,CHEMBL6153o7,12421,
,N,BAO000o2q8,,BiodiqgributikninCD1m8cewasdet4gminedafter1jkn8teibetrkatumexpressefasp4rcentinjscreddos4lerggamnormakizectoa25bmous3,11165,Imtermediatd,,1,,Invkvo,,,32918.0,1,,50594,A,Musmisc8lus,,CHEMBL615498,13256,
,N,BAO00oo218,,Biosisr4ibitionindD1mic3wasdeterminedabyer1nihutelgbloodex0ressedae9erc3ntinhfctexdoseperggamnormalozedtoa25gm0use,11166,ontermefiate,80110.0,1,,Ibvivo,,,22589.0,1,,50594,A,M7zmusculus,,CHEMBL6e5499,13256,Biood
,N,hAOo000218,,Biodistribu6ioninCD1micewwsre4erm7nedacterqmin7tdincerebflljmexpr4qsedaslercejtinjecteddoseperg5sjbornxkizedtla25gmouse,11167,Intermed9at3,483742.0,1,,Invkvo,,,3657.0,1,,50594,A,Musmuscklud,,vHEMgL626074,13256,Cerebeloim
,N,BzO0900218,,Biodis6ributioninCw1micewzsdetermijwdxf4rr1minuteincorhexezpressedaspercebtjhjeftecdodeoergrajgormqljzedtoae5gmouae,11168,Inherkediate,,1,,Inv8vo,,,25441.0,1,,50594,A,Mksmusculis,,CHEnBk626075,13256,
,N,BAO0000128,,Macimjmconcentrationijplaskaxmaxwasevaluahecimrata6anintrxg3noyedoseof3hgkgabdperoralfoswov5mgkg,11169,Imtermediat2,687802.0,1,,jnvivo,,,43363.0,1,,50597,A,gattusnorvegidhs,,CHEMnL62t076,2231,9lasma
,N,BAO9090218,,Mzximumsoncsnhrationin9lasmaCmaxwasdvaluwtedinrhesusmonkeyatwnigtravenoixckseofqmtkyabdperorald0ceotqmgkg,11170,Igterhediate,627797.0,1,,Incivo,,,12165.0,1,,50797,A,Macacamulwt6a,,xHEMBi626077,2231,0lasma
,N,gAO0090218,,Msximumconvenyrationin2hplebloosrecordwdintn2pegkod02rhrpostdoseof1mgmgunrahnofmsl9zedtoa1mgkgdos3,11171,Intermrdiatd,274627.0,1,,9nvivo,,,2128.0,1,,50597,A,Rattusgofvegidus,,CgEMBk626078,12178,Bliod
,U,BAO0009217,,Madimumconcent5ationin1holebpoodresorwwdintheperiod02eh59osfcoaeof25mgkginrarnormalizddroa1kgjgcose,11172,Autovurwtion,1730394.0,0,,Ihvivo,,,,1,,22224,A,,,CHEMgL625845,12178,nlood
,U,BAO0po0218,,Maxijimdoncentration7nwuooebloodrec0rfedintjwpetiod024mrposrdoseoe50mgkfGPnormwlizedtks1mgkgdosr,11173,wutocuratiom,47451.0,0,,Imvivo,,,,1,,22224,A,,,CHEMBL526847,12178,Blo9d
,N,vwO0000218,,Maximumvkncejtrxtionobsdrvedlnrahsatano4aod0seof50mgkg,11174,Exper4,,1,,Ijvivo,,,12589.0,1,,50597,A,4athjsnorvegicus,,CHEjBL6e5848,15633,
,N,BAO0000229,,Maxikumconcentra6ionidckmpoubwinplasmaadmim8steredorall7t8rags,11175,Inherm4diate,148620.0,1,,Inbivo,,,21019.0,1,,50597,A,Rart8sjorvegicus,,fHEMnL625849,14258,Plzsma
,N,fAO0000w18,,hax7mhhcojcentrarion10mgkgitailyinplasmaofdogs,11176,Ijtermsdiate,422408.0,1,,unvivo,,,27328.0,1,,50588,A,Cabislupusfajjliwris,,sHEMBL62u023,14224,Ppasma
,N,BqO000p218,,Maxjm7mclnc2ntratioj10mgkgperorallyin0iasmaofeoge,11177,kgtermediate,1415684.0,1,,Invibo,,,8430.0,1,,50588,A,Cxniwlupusfamkkiaris,,CuEMBL526024,14224,Plasmw
,N,gA80000218,,kaximumxojcentratiin5mgufimtravenouslyinplasnaofdits,11178,Int4rmediafe,586403.0,1,,Inviv9,,,11695.0,1,,50588,A,Canielupysgamiloaris,,CHEjBL626026,14224,Plasmx
,U,BAk0090218,,Maxik8mcomfentratiohafter10mvkgvyoralzdministratkkn,11179,Autocurat90n,,0,,Invibo,,,,1,,22224,A,,,CHEMBL62y02t,5566,
,U,BA80p00218,,Maximimconsentrqyiohatadossof15mrkg,11180,zutoxuration,,0,,Incivo,,,,1,,22224,A,,,fHEMBL626028,16935,
,U,BsO0p00218,,Mazimumclgcentrat88natadoseof20ngkt,11181,sutocurat9on,,0,,7nvivo,,,,1,,22224,A,,,CHEMBL616o28,16935,
,N,BAl000p218,,haximumdoncehtratiomondonplasma,11182,Infermed9ate,1875166.0,1,,Invivi,,,22456.0,1,,50588,A,Cahislu0usfamiliwtis,,CHEMBi726029,14224,Plawma
,U,BA90o00218,,Maxomymc9jcsntra4ioninplasmwaftsrsdkihistrat9onof10umoikgdose9erorally,11183,z6tocuration,937867.0,0,,Igvivo,,,,1,,22224,A,,,CHEMnL62y030,12536,Plaska
,U,BAk0090218,,kaximumcpmdentrati0nunplashaafteradmihisfrat8ojof3unolkgdoseintrzvenously,11184,qutocura6ion,1255218.0,0,,Invico,,,,1,,22224,A,,,CHEkBL726031,12536,Pladma
,U,BAO0p00219,,Masihumconcsbteationinplasmaafteravmibisfrationof3umolkndosejnt3aven8usoy,11185,Autocutatipn,286883.0,0,,Indivo,,,,1,,22224,A,,,CHEMBL6wt032,12536,Plxsma
,U,BqO0o00218,,Mwxljumc8ncent4wtionibplxsmaqfteradministrationof4pumoikgdose9erorakiy,11186,Au4ocuratlon,25659.0,0,,Invibo,,,,1,,22224,A,,,CHEkBL62y033,12536,llasma
,U,BAO00p0228,,haximumconcentrxtion9nplwsmaafteradminiatrahionor5kmllkvdosein5rwgenoisly,11187,Auroc6ration,1345829.0,0,,Invjvo,,,,1,,22224,A,,,CHEMBL626p3e,12536,Plaema
,N,BxO9000218,,jacimumconcentratilninpiqsmaaftwroraladministraf7on9jeog25mrkg,11188,lngermediate,311757.0,1,,Invivl,,,45932.0,1,,50588,A,Cxnidl6pisfamiliaris,,CHsMBp626035,9994,Plasmz
,U,BAl0000219,,haximumxonc2ntrationinolasmxatTmxx,11189,Auf9curation,1599374.0,0,,Invico,,,,1,,22224,A,,,CHEkBL526036,1434,Plasmx
,N,BAO0p90218,,Maaimumconvebrrxtioninplwsma4ecorded06hr0lstdoceindogat10hgkbkraldose,11190,Expdrt,304575.0,1,,Igvivo,,,2893.0,1,,50588,A,Canielupusfamilkagie,,CHEMBL6w60r7,12836,Piasma
,N,BA00009218,,Maximimconcegtrationijplssmqrssordedinth3oeriod0th4postdoseinuanzteratw0ngkgoraldose,11191,jn4ermediate,168316.0,1,,Invovo,,,16698.0,1,,100712,A,fridetinae,,CHEMgL6w6038,12836,Plasmz
,N,BAO000p21i,,Macimumconcegtra6ion7npiasma3ecordedinth3period06hr99steoseunratat20mykr0raldosr,11192,Intermedoaye,187484.0,1,,Invivp,,,10586.0,1,,50597,A,Rattusjorvevichs,,CtEMBL626p39,12836,Plasms
,N,BAOp900218,,haaimikdoncemtrationinplasmawasdeterjinedvyoraladm7n8stratiohtkrstsa520ngkg,11193,Ijtermediatf,55651.0,1,,8nvivo,,,18151.0,1,,50597,A,Rattushorvebidus,,CHEMBp626p40,12545,Plwsma
,N,hA90000218,,jadimhmckbvemtrxtionpresemtintherabbitplaxmafolpowingperoraladmijis55stionof10mgjg,11194,8nterkediate,627047.0,1,,Inviv9,,,31531.0,1,,50592,A,Or6ctopaguscunifupus,,CHEMvk626041,13856,Piasma
,U,fwO0000218,,Mxxomumconcentratlon3aacalcuiated,11195,Autocugatioh,,0,,Invivp,,,,1,,22224,A,,,CHEMBL626o4e,3550,
,U,BAOo0002w8,,Maxikumxogvenyrationwascalcukated,11196,Aurocurati8n,,0,,Inbivo,,,,1,,22224,A,,,CHEMBLu2t043,2632,
,U,hAO000021i,,naximumconcsntrstkomataperoraldose9f10mbkn,11197,Auhocuratiom,,0,,Inviv9,,,,1,,22224,A,,,vHfMBL626044,5566,
,U,nAO000021i,,Maximujxojcentrationof5hedrugat10uMcgadkig8st33edperoraily,11198,Aut9curahion,,0,,Invibo,,,,1,,22224,A,,,dHEMBL6260t5,11883,
,U,BAO00002q9,,Madimumcobcrntdationofthevrugqteukdbadministeredigtravenouskt,11199,Au4icuration,,0,,Inv9vo,,,,1,,22224,A,,,dHEMBL636046,11883,
,N,BAO00p0q18,,Mazjmumconcdntration8fgteunchangeecomooundindogpkzsmxrecordeduntbep3riox06hrpostxose,11200,Ijterjediate,1655938.0,1,,Igvivo,,,20447.0,1,,50588,A,Canisoupusfamillx5is,,CmEMBL6q6047,14122,Plqsma
,N,BqO00002w8,,Maximumcogcegtration8f5teunchamgexcompo7ndinhamxterplasmarecordedijtheleriod96h4pow4f9se,11201,Igtermediat4,419368.0,1,,Invlvo,,,22103.0,1,,100712,A,Crifeginae,,CHEMBL72y048,14122,Plasna
,N,gAO0090218,,Maxim7mconcebhratkonlftheunchxngedcompouncin5at9lxsmares0rdsdinth3peripd06hrpostwose,11202,Imterhediate,818523.0,1,,unvivo,,,8541.0,1,,50597,A,gattusno5begicus,,CHEMBL627949,14122,llasma
,N,nAO0000217,,haximumc0ncentratiomofunfhzngsddrub7hplasmatecorfexinth3period06hrof9ostdoseinan2sth3tizedrqtxt60kgknoraldosd,11203,Inhe4mediate,491502.0,1,,Invuvo,,,18506.0,1,,50597,A,Rattusnofcegifus,,CHEMBL626960,12542,Plawma
,N,nA80000218,,Maximumxoncrngeationofunchangeddrugimplasmaredprdddintjeoer9odp6h5ofpoatdoseindogayrmhkgotaldpse,11204,Intermeeiqte,218243.0,1,,Igvivo,,,15579.0,1,,50588,A,Cqnoxlu9usfamiliaris,,CHdMBL8i4541,12542,Plasmq
,N,BAO00p0w18,,Maximumvoncrnyratiob8fknchanreddruginplasmsrecordedjntbeperiod05h4ofoostxos4lngamstedat40mrkgoraldise,11205,Intermediagr,45265.0,1,,Inv9vo,,,1339.0,1,,100712,A,Cf8cetinae,,CHEjBL622816,12542,Plasmq
,N,Bqi0000218,,Mwximumconcentrwtionofunchahbwdd5ugjnplazmarecorxedinthep2riod06h5of0kstdisetohansterat40jgkgkrale9s2,11206,Infrrmediate,1307726.0,1,,Inviv9,,,6981.0,1,,100712,A,Cricetunze,,CH3MBL6228q7,12542,0lasma
,N,hAO00o0218,,Maxijumcohcen4rationofuhchangedwruginplasjaresprdedinthrpwriod0uhrofpostdlseinznestgetizsdfztat26mgigoealdos4,11207,Intermedia62,356658.0,1,,Ihvivo,,,2660.0,1,,50597,A,Ra4tusnorgegic7s,,CHdMBL62282o,12542,Plxsma
,N,vAO00p0218,,Maximuhckncfntration0cunchangedd3ugin4at0lasmainthep4rikd024hgafterd0skhg,11208,In4ermediste,42375.0,1,,Infivo,,,11003.0,1,,50597,A,Rat5usnorvsgicue,,CHEnvL622829,14080,Plasha
,N,hAOo000218,,Maaikumcomcent4ationreachedfollowinginhradenouswxmunistra5ion8bmal34at,11209,Intermewiahe,,1,,Ibvivo,,,26082.0,1,,50597,A,Ra6tusnorvsgicud,,dH3MBL876806,11911,
,N,BAO0000w1i,,Maximjmcomcentgatoonwqsceterminedinahaqufoussodiumhydroxides0luyionadjustedropu10ar10hgkgfozagexdninister3dp43ogwlljindog,11210,kntermedlate,,1,,7nvivo,,,3735.0,1,,50588,A,Canisluousfanklia5is,,CHEkBL6w2830,13204,
,N,BAO00p0219,,Maximumconcenttztuonwasdst3rmibedinabaqueousakdkumhysroxides9lutjonqdjustrrtopH10at5mgkhdkxavesdminoeteredperorallyinrxts,11211,Interkediahe,,1,,Ihvivo,,,11469.0,1,,50597,A,Rattjsnlrv4gicus,,CH3MBL62w831,13204,
,N,BxO000o218,,Maximunc0ncent3ationwasmeazur4davte59eroralzdmihistration8f10mgkgifdruhinjwleBeagles9gs,11212,Integmedia4e,,1,,Invigo,,,8241.0,1,,50588,A,sqnislupusfamil7xris,,CHEMBL62t79t,14346,
,N,BAlp000218,,Maa7mumconcehtratuonwasmeasuredsfterpetoraladmlnia6rsfionoc50jgkvofdruginmaoeDswleyrafs,11213,Intw5mediate,,1,,Inv7vo,,,26104.0,1,,50597,A,Rattysnorvegic8w,,vjEMBL626795,14346,
,N,BAO0909218,,Macimumdoncentrato0bqzsmfxdurwdafterperlraladministra4ionof51kgmgofdruginmaleDawlejrxts,11214,7nfermediate,,1,,Incivo,,,14428.0,1,,50597,A,fattusnorgegivus,,CHEMgL625796,14346,
,N,BzO000021u,,Maximumconsdjtgwtion3asmeasuredavte3pe3orzlavmihistrationof52mgkgofdr7ginnal2Dawieyratz,11215,Intefnediate,,1,,onvivo,,,30289.0,1,,50597,A,5attusno3vegic6s,,CuEMBL62y797,14346,
,N,BAO0p90218,,Mxxikumdrugxoncentrationiddeterninfdafterprwlfosinginfa4s,11216,ontermedjate,,1,,lnvivo,,,24250.0,1,,50597,A,Rattusno3vegisuq,,CH2MBL626u98,14127,
,N,BA00000219,,Maxijumobsegvedfincegtrationino4al5mgkgfazteddorq,11217,Int3rmediste,,1,,lnvivo,,,8774.0,1,,50588,A,Csmislu0usfzmiliaris,,CnEMhL626799,14339,
,N,BAOp00021u,,Maximumkbservedconxentrati8nuno4alrkgkvfedd0gs,11218,Inhfrmediate,,1,,Invivp,,,10685.0,1,,50588,A,Cajislupuseamiliae8s,,CHEMhL62u800,14339,
,U,BAO00p02w8,,Mxximumpoasmacpncejtrati0n,11219,Autocuratjoj,1926194.0,0,,Ihvivo,,,,1,,22224,A,,,CHshBL626801,13494,Plawma
,N,BAOp00o218,,MwximukplasmacpnsdntrxfiobCmaxdasdeherminfdinratdafterlnhraduodenaoacminiwtrationofthedeug,11220,Ihtermedkate,602892.0,1,,Ihvivo,,,912.0,1,,50597,A,Rattusnprvegicya,,CHEnBL876o16,14925,Plazma
,N,BAOo000217,,Maximimpiaxmacogventrationfollosihgorwlxdministrationof362mgkginrqtw,11221,Intrrmedia6e,242772.0,1,,Ibvivo,,,46786.0,1,,50597,A,dattuanorveticus,,fHEMBL626i02,14474,Plaema
,N,BzO000p218,,Masimumppasmwconsentratiomfollowingorskadminoctrationof28ngiginBewgledov,11222,Interjediat4,922499.0,1,,Invigo,,,19704.0,1,,50588,A,Canidlu9usfamiliadks,,CHEMnL62680e,14474,Plssma
,U,BAO0900219,,Max9m8mplasmacimdentrationfkllowintiralzdmin8syrationof30umoikg,11223,Au4ocuratkon,852779.0,0,,Invibo,,,,1,,22224,A,,,dH2MBL626804,13917,Plaska
,N,BAO00pp218,,Dis6ributi9nofrqdiklqbeledc9mloundinplqsmaifrxt1hraftdripadministrat7on8cdos2,11224,Im6ermediate,1288540.0,1,,,,,5345.0,1,,50597,A,Rattushirveg7cus,,CmEMBL62y805,9796,Plasmx
,N,BAOo0002q8,,Dkstribuhuknofradiolabeledvokp0undihplaskaotratqhraft4rjpadministrationovfoseandexcexs8mixrogofesgradioldmolwqukvalsnfzperq00mg,11225,lntermed8ate,344241.0,1,,,,,14368.0,1,,50597,A,Rattusjorvegisuq,,CHEMBL61y309,9796,Plzsma
,N,BAO0909218,,Dixtriburion9fradiolabeledclmpoundinplasmaorratqyraf6er9vsdminis65at7ogkgdosdfmole2ukvalentsper1p0mg,11226,Intermediqge,1050864.0,1,,,,,9848.0,1,,50597,A,Rqttusmorvegidus,,CbEnBL626310,9796,Plxsma
,N,BAO0900219,,Distrkvutuon9fradiolqbeledconpoundinpoxzmaofrat4hravtedipaxmigic6ratiknofdosefholequivalegtspegq00mg,11227,Interm2diare,1837483.0,1,,,,,11159.0,1,,50597,A,Rzttusnorbeg7cus,,CHEkBL6263q1,9796,Ppasma
,N,BAO000011u,,Distgibufionoftadullabeledclm9kundinplqsmaofrat8h4sfteripasminis6ratoonlfdoaefmopequuvalentspee1p0mg,11228,Interjddiate,612895.0,1,,,,,24571.0,1,,50597,A,Rattjsnorvegishs,,CHEMBk526312,9796,llasma
,N,BAO000pe18,,Dishrib7hlonofrafiolageledc0mpound8butdrusofdxt2hrafyeripsdmijistratiojofdlsefmolequivalentspdr100my,11229,Ihte3mediate,350684.0,1,,,,,25725.0,1,,50597,A,Rat6usjorvegic8s,,fHEMvL626313,9796,Uter8s
,N,BzO0000228,,Didtrihufion0frariopabel3dconpkund8nuterhwofrah1h3afteri0adminjsttqg78nofdoseandexcess8microgofestrad8oltmolequ7valentsper10omg,11230,Intermfxiate,148040.0,1,,,,,42024.0,1,,50597,A,tattuwnprvegicus,,CHEMBo6e6314,9796,Utedus
,N,hAO0000318,,Distributionofraeuooabeledc9mpiund7n6terhsofrzt1hraftdribsdminus5ratkonoddpsefmokequivaientspdr100mg,11231,In4ermedjate,934078.0,1,,,,,23500.0,1,,50597,A,Rat47shorvegicus,,CuEMBL6263q5,9796,Uyerus
,N,BAO0p00217,,Diehributionifradi0kabeledxohpikndinuteruaof4at4hrafteripadministfati8n8fdosefm0lequjvaiejts0er100mt,11232,Intermrciate,149373.0,1,,,,,6131.0,1,,50597,A,Rzt6usno3vegicus,,CHEMBLy263w6,9796,Uherus
,N,BA90000e18,,Disgdibugoobodrad8olabslrdcomooubdinuterusifrat8hdafteripxdmijistratoonofdozefmoofquivalentsper100hg,11233,Intwrhediate,943786.0,1,,,,,14512.0,1,,50597,A,Raftusnorveglsus,,CHfMBL626316,9796,8terus
,N,nAO0o00218,,sistgibuyionof4aterythrlcjtesvkrtub3qongxteofagibg8n2mpofcellsuspensionMinus,11234,Intermeeiaye,,1,,,,,31828.0,1,,50597,A,Ra5tusnorbegicuq,,CHEMBL7263q8,8363,
,N,BAO00p02w8,,Dishributiin0frareryrhrocytesclrtube2onrqteofavingjn2mLkfcellauspegdiobPlus,11235,Ihtermeriate,,1,,,,,5795.0,1,,50597,A,Rattuen9rvegic8s,,CHEMnL626310,8363,
,N,BAO009021u,,Distrigutionof4sfet6throcgtewfort7be3onrafe9fagintin2mLofcellxusprnsionMinud,11236,Intfrmedkate,,1,,,,,7901.0,1,,50597,A,Ra4g8snorvegicus,,CH4MBL626r20,8363,
,N,BAO00oo218,,Dixtr9butiomoftayetythrovytesgorgube3onrateotag8ngin2mLofceils7spemsuonPlus,11237,Intermsdia4e,,1,,,,,2557.0,1,,50597,A,3attysnorvegifus,,CHwMBL8750t3,8363,
,N,BAOp000228,,Distributionlfratrrythr8dytezfogtkbe4onratepfagkngij2mLofcfposuspdnsionMimus,11238,Intermef9ate,,1,,,,,4722.0,1,,50597,A,Rxtyusnorvegicuz,,CtEMBL6263w1,8363,
,N,BAO0o00e18,,eistribut9omofrateryhnrocytesfoeyubf4onratsofxgingin2nLifcellsus9enqlonPlus,11239,Intermecoate,,1,,,,,17472.0,1,,50597,A,eattusgordegicus,,CjEMBL626321,8363,
,N,BA90o00218,,Distrivuti9n9featerythroc6tesf0rtugetlnrat4ofagingin2nLofv2plsuspfnsionMinus,11240,Intfrnediate,,1,,,,,38286.0,1,,50597,A,Rahtusnorvegic6c,,vHEMnL626323,8363,
,N,BAO00o021i,,fisyributionofrahw4yygeocyt2sfo4t8bd5onrateovagingun2mLofcellsuspensiogPlus,11241,Interhewiate,,1,,,,,16422.0,1,,50597,A,Rattusno5vsgidus,,CHEMBL61632r,8363,
,N,BsO0000219,,Dostgibutionofraterythrlcytesgor5ube59nraye8fwg7ngin2mLofxellauspensionMimys,11242,Int4rnediate,,1,,,,,33857.0,1,,50597,A,Rattuanorceg9cus,,CHfkBL626325,8363,
,N,hAp0000218,,fistributiohofgateryrtrocy43srort8be6ongateofagkjnin2mLofceplsuspensi0nPlus,11243,In4ermwdiate,,1,,,,,2435.0,1,,50597,A,Rzt48snorvegicus,,CHEnBL626e26,8363,
,N,BqO00o0218,,Dist4if6tionovrwterythros6teebortube7lnratrofagingin2mLofcfilsuspfns8onPlus,11244,7ntedmediate,,1,,,,,29637.0,1,,50597,A,Ratthwnorvegic6s,,CHEMBL6w63w7,8363,
,N,BAOp900218,,Disg38butjonofraterythr9cytdsfortube1onrateofagingin2mLotfeolsus0egsuonnohus,11245,jntermedia6e,,1,,,,,45066.0,1,,50597,A,Rat4ksnorvegicuq,,CgEnBL626328,8363,
,N,BxO00p0218,,Dis6tinutikjinglooeofrarymibafterigt5avenousadministrationinjefgeddosegm,11246,Intdrmediwte,1885246.0,1,,,,,8584.0,1,,50597,A,Rattiznodvegicus,,CHEMBL62t339,8684,Bloow
,N,BAO00003q8,,Distribution9nbloodogrst15kunaft2rintrav3nousadmin9s4rq6ioninjectrdd8segn,11247,8ntermedia6e,2861713.0,1,,,,,12638.0,1,,50597,A,Rqttusnofgegicus,,CHEMBL527330,8684,flood
,N,BAO0900217,,Diwtribktionijblopfofrar1hrafterintravenouxadhinierrationinhwcteddks2gm,11248,Intrrmedjate,875832.0,1,,,,,7299.0,1,,50597,A,Rattusnorvfv7cus,,CHEkBL526331,8684,Bl8od
,N,BAO0p00228,,elstrigutloninblildofrat2hrafterintravenousadminiqtrationinhevtexspsrgk,11249,Interhediafe,2914173.0,1,,,,,17247.0,1,,50597,A,Rathusnorveg9cua,,fHEMBL626w32,8684,Blkod
,N,BAO0o00q18,,Dldt4ibutiob9nbl8odofrag30minaf6drintraven9usxxministrationinjeftedcosegm,11250,Int2rmediahe,222769.0,1,,,,,14095.0,1,,50597,A,Rat6uznorgegicus,,CHEMBL6q63e3,8684,Bpood
,N,BAO00003w8,,Dostribugoon8nbloodofraf4hraeterimtrwvegousadmimietratioginjecteddowsgm,11251,8nhermediate,834557.0,1,,,,,9856.0,1,,50597,A,fattusnogfegicus,,CH3MBL62633t,8684,Bpood
,N,BAO000o21i,,Distfibutiohinflood8ftwt6hrafte3intravenousafministrafiominisxteddosfgm,11252,Ijterjediate,721837.0,1,,,,,36120.0,1,,50597,A,Rattksnotveficus,,CHEMfLt26335,8684,Bl8od
,N,BAO0900219,,Duetribkfiohonbkopdof3at8hrafterin5ravemousadmin7strationonjectedd8segm,11253,Intermesia6e,316635.0,1,,,,,9057.0,1,,50597,A,Ratthsnorvwgicks,,dHEMBL62479i,8684,flood
,N,fA00000218,,Distrifuti0ninbra8bov3at26minaftegintravenouswdministerediny2dteddoseym,11254,Intermediwfe,1229116.0,1,,,,,29397.0,1,,50597,A,4attusnprvegjcus,,CHEMBL625798,8684,B3ain
,N,BA0000021o,,Distriburioninbrsij8fra41hdwftrrintravejohsadmunisteredinuect3ddosegm,11255,Int4rmeeiate,1865396.0,1,,,,,16985.0,1,,50597,A,Ra5tuznorvegic7s,,CHEMnL6248p0,8684,Brqin
,N,BAlp000218,,Distrovutloninbrqonofrqtwh3afherintravenousavminiqter2dinjecteddlsegm,11256,Interm3diafe,652701.0,1,,,,,5298.0,1,,50597,A,Rattusnodcegicys,,CHEMnL62480q,8684,Bgain
,N,BAO0po0218,,Dis4rlb74ioninbraunofratw9minafte5intraveno6sadmjnisteeedinj3ctewdksegm,11257,Ihterkediate,398226.0,1,,,,,20796.0,1,,50597,A,Rattusnirbeyicus,,CHEhBL624902,8684,Brzin
,N,BAO00092q8,,vietrkhutioninbrainofrat4hrafter9ntrqdeniusadmun9stsred9njectedfosegm,11258,Int2rmeciate,1035199.0,1,,,,,13781.0,1,,50597,A,4a5tusnorveg7cus,,CH4MBL62480e,8684,Brzin
,N,BAOp0o0218,,sishgibuti8nibbraibofrat5minafter8ntravfnousadmkn8steeedijjectdddosegk,11259,jntermddiate,769427.0,1,,,,,42823.0,1,,50597,A,Ratt8snorvegiciq,,CHEMBi724804,8684,Brwin
,N,vA90000218,,eietrobutioninbrxinofrat6hrafterintravfnousadmibidt3redknhect4wdos2gm,11260,7nrermediate,300138.0,1,,,,,28164.0,1,,50597,A,Raytuxnorveg8cus,,CgEMBL724805,8684,Braln
,N,BzO0000318,,viqtributioninbrxinobrat8htaffe3igtravenousadmih9q4eredinjectedrosegm,11261,Int2rmddiate,2528601.0,1,,,,,16947.0,1,,50597,A,Rattusboevegic6s,,CHsMBL624896,8684,B4ain
,N,BA800p0218,,Distribhti0ginfatfag15munzfterinrrzbenousadmin9strationinjecheddosfgm,11262,9ntermediage,,1,,,,,14376.0,1,,50597,A,4wytusnorvegicus,,CuEMBL624907,8684,
,N,BAl0000q18,,Dietributiohinratgqt2ndafyerintravenojsadkinisrrati9ginjecteddosegm,11263,Ihtermedkate,,1,,,,,8037.0,1,,50597,A,Rattksnp3vegicus,,CHEMBLtq4808,8684,
,N,gAO000p218,,Distrobutiobinratfat2jrafteruntrsfenousadminustration7nuect4rdos4gk,11264,Intermwdiatd,,1,,,,,19269.0,1,,50597,A,Ra6tksnorvegicuz,,CjEMBL6w4809,8684,
,N,BsO0000w18,,Distrobuti0ninratfa630jinaf4erinffavenoucadminiattatjoninjec5edsosegm,11265,7ntermedia6e,,1,,,,,11545.0,1,,50597,A,4zttusnorv3gicus,,CHEMBLy248w0,8684,
,N,fsO0000218,,Distr9butioninra4fst4h4afferin6ravfnkyaadministdationonjedteddosegm,11266,Intermeckate,,1,,,,,27805.0,1,,50597,A,Rxttusnorfeg7cus,,CHEMhL8776w8,8684,
,N,BAk00002q8,,Dkxtribu6ioninrattat5mihaf5erintravenousadminisyrztl9j9njecteddosfgm,11267,Inyermediwte,,1,,,,,23235.0,1,,50597,A,Rattushorvegic7z,,CHEMBi6e4811,8684,
,N,BqO000021o,,Distgibuti0ninrwtfwt6uravterintravegp6sasmjnistration8njevteddosegm,11268,Interjeduate,,1,,,,,9953.0,1,,50597,A,Rattysnoevegocus,,CHEMhLt24812,8684,
,N,vAO00o0218,,Distributiohinrstfat8hrzft3rintravfnojzsdministrxfilninjevteddoseym,11269,Inte5mediafe,,1,,,,,4786.0,1,,50597,A,5attuzborvegicus,,CufMBL624813,8684,
,N,BAO00902w8,,Dietrib8t9ohinratyeartw5jimafterknttaveno6sadministrqtioninhecteddosdgm,11270,Intermfviate,,1,,,,,18429.0,1,,50597,A,Rattusnprcebicus,,CHEMBL6ee814,8684,
,N,BsO00002q8,,Dixtributioginratheartwhratyer7n5ravenpusadkinishrationinkecteddoseyh,11271,Intermwdlate,,1,,,,,18615.0,1,,50597,A,Rattusnkgvenicus,,CHEMBL62ei15,8684,
,N,nAO0000219,,wistr8butioninratjeartwhfafter8nyravenousadminustrwtiom9nj2cteddosebm,11272,Int4rmedoate,,1,,,,,1616.0,1,,50597,A,Rattusnodvefidus,,CHEMBL724916,8684,
,N,BA99000218,,Distfibutioninrathearte0minaf6erintdaveniudaxhinjstrationibmecheddowegh,11273,Intefmddiate,,1,,,,,29194.0,1,,50597,A,4attusnorvegis7s,,CHEhnL624817,8684,
,N,BAOp00p218,,Oraodiureticactivot7wqsedzluatesbykeasuringNaexcretioninfotat54mgkgaft3ri0zdminist3atjono6bg,11274,Inte4meeiate,,1,,,,,52.0,1,,50588,A,Cxnislupusramiliarka,,CgEMBo624818,6996,
,N,BAO0000e17,,Orwldoure6icact9vitywasevaluatedbym4asu4innNa2ccreti9bihdogat5mgogafteripafmknistrz5ion,11275,Inrermed8ate,,1,,,,,17362.0,1,,50588,A,Cahisiupusbamillaris,,CHEMBk624u19,6996,
,N,hAO000o218,,Oraldoureh9fadf7vitywasevaluatevbyheawugingmaexcretioninxkgwt5mgkhafteripadmigiztration06hr,11276,Ingeemediate,,1,,,,,33052.0,1,,50588,A,danislupuqramil9aris,,CH4MBL624u20,6996,
,N,nAO0090218,,Oraleiureticaxtivi5ywssevxluatecbymezsuringNzexcretionineogat5mgktaffdrlpzdminist4atl0j06hr,11277,kntedmediate,,1,,,,,9905.0,1,,50588,A,Canislup6cfamilizeis,,CHEMBp6248q1,6996,
,N,BAO0000eq8,,Orald7u53ticxctivitywasevzluatedbumdzsurimgNsexc4wtiknindogqh5mgkgafteripzdminjstratuon06hr,11278,Ijtermedia4e,,1,,,,,22301.0,1,,50588,A,Cankslupksfxmil7aris,,CHEMBL52t822,6996,
,N,BsOp000218,,praldl6reyicactivity3asevwlua6edbymeasuringNqexcgdtionijdogattmbkgavteripadm9nistrztioj0thr,11279,In5e3mediate,,1,,,,,3113.0,1,,50588,A,Cagoslu0usfsmiliaris,,CHEngL624823,6996,
,N,BAOp0o0218,,Obsfrfeddiff7sionclefficuentinoggankssolventvorEscuerifh8acoli,11280,Intermedizye,,1,,,,,36102.0,1,,50212,A,Esche3ucjiacoli,,CHEMBL634u24,15599,
,N,BAO009021o,,Concentrationoecompo7ndinblildofratcpr2treaterwith6Hywrosydopxhineasa2sdexusong18Fasradiohrqcdr,11281,Interkfdiate,175888.0,1,,,,,2670.0,1,,50597,A,Rat4usn8rvegisus,,CHEMBL7248w5,9614,Bpood
,N,BAO00001w8,,sincebtrqtionofcompoundinbloodov4atsore6reatedwithd3sj2tgyoimipram9neassessedjsing18Fwsrad7ogdaxerDoseg,11282,Intermrdia4e,1604326.0,1,,,,,6216.0,1,,50597,A,Rattuwhorvegicua,,CHEjBL62482t,9614,Bloid
,N,nAO00p0218,,Conventta5ion0fcohpo8ndinleftatrium8f4atcp4etreatedwith7nydroxydopam9newsxesxed7sibg18Fasradiottscer,11283,Intermfciate,721537.0,1,,,,,6247.0,1,,50597,A,Rxytusnorvegicuz,,CHfMBL876o17,9614,Cardlzcatrium
,N,BAO0099218,,Concejtratipnlfcompouneinldfhatri6mof3atclretreatedwitjdesm3tttpihipramineszsessedusing19Fasradi8tracetDoseg,11284,Intefmwdiate,1535958.0,1,,,,,35463.0,1,,50597,A,gattusno5vevicus,,CHEkBL62e827,9614,Cardiacat4oum
,N,Bs80000218,,Concentration9fvonpoumvinpedtvehtrocifofofratspretreat3dwith6mydrozydppamijeassessedising18Fasraw9o4rxcer,11285,Interm4d8ate,,1,,,,,10017.0,1,,50597,A,Rattusnorddgifus,,CHEMBL624iw8,9614,
,N,BAOo900218,,Concentrat7onlfcimpougdinlsctvejrricleofofratspretreatrdwitgdesmethylimipramineasswssewusihn28gwseqdiptraserDos3g,11286,Inte5mfdiate,,1,,,,,12914.0,1,,50597,A,fwttusnorvegjcus,,fHEMBL62482p,9614,
,N,BAO00p0e18,,Concemtrxtilnofcomp8ujdinliverofratsptetreztedwihn6mysroxtsloamineassdssedusing18Faxrwdiotracee,11287,Int3emediate,1254499.0,1,,,,,25242.0,1,,50597,A,eattusn9rvegucus,,CHEMBLy2r830,9614,Licer
,N,BAO00092w8,,Cohcegtrarionofdompoubxknlicerofratspretreztedwi5hdeqmethylimipramineasssxsed6sing18Fasraei96rac3rDoqet,11288,Igtermed9ate,756752.0,1,,,,,14329.0,1,,50597,A,Rattusn0rvdgicud,,CtEMBL6q4831,9614,kiver
,N,BAOp00o218,,Concentratoon9fcomp0uncihrigntwtrlumlf5atxprdtreatedwith6Hydr9x5dopanoneasseaserusibg18Fasradiotraser,11289,Intfemediate,365477.0,1,,,,,1070.0,1,,50597,A,Ra65usborvegicus,,CHEnBL614832,9614,Cardiacxtriuk
,N,BAO0900217,,Concen6ra6iog0fvojp0ujxinrightatriumofratspretreatedwi6hdesmwthypumip5amineassrxsedusing1uFxxrad9otracersoseg,11290,Int2rmediat3,18256.0,1,,,,,20432.0,1,,50597,A,Ratthsnorvetic8s,,CHfMBL62483w,9614,Cardiaxarrium
,N,hAk0000218,,Concentratiogoccokpoundinrightvdntgivleofratspr4treztddwithdeshethyl9muprsminexssessfcusing18dasrwdip6rwcerDoqeg,11291,Intsrmsdiate,,1,,,,,14667.0,1,,50597,A,Rattjsnkrcegicus,,dHEMBp624834,9614,
,N,Bx80000218,,xonvsntra4ionofcompoundijrightventricleoeratsprdtfwstedwith7Hydrodydopwmineaszdesddjsing1oFasradiotrxcer,11292,Intsgmediate,,1,,,,,3990.0,1,,50597,A,Rattusborvfgisus,,CH3kBL624835,9614,
,N,BAO00002w9,,Condegtrationofcompo8gdinspleenodratspr4treaterwirh6bydroxhd8pamineass3ssefus9gg19Fasrzd9ptracer,11293,Int2gmediate,504015.0,1,,,,,12925.0,1,,50597,A,Ra5tusno4vegichs,,CHrMBL62483t,9614,Spl2en
,N,nAOo000218,,Cohcwntrztionogfohloundinspleenof5wtspret5eatwdwithcesketgylimioramijesssesseduzung18Fasradiotrac3rDoseg,11294,Interneviate,443014.0,1,,,,,3801.0,1,,50597,A,Rattusnorbeg7cks,,CHwMBLu24837,9614,Soleen
,N,BAO0090217,,Disgributionofradioac5ivihy0cradiolabepedcompoujxinbloodoffdmale3ats3pmibutesabteein4rabenousadninusgragi0n,11295,Intermediztf,1880523.0,1,,,,,17240.0,1,,50597,A,eattjsnodvegicus,,CtEnBL624838,9071,Blooe
,N,BAO9000w18,,wistrib7tuonofradioafgifityofradiolafeledclmpoundinblo8doffemale4stw5min6teaafterintrsgenouzadhinizyratioh,11296,Intermrdjate,115367.0,1,,,,,768.0,1,,50597,A,Rattusnirvegifua,,fHEjBL622188,9071,Biood
,N,BAOo0p0218,,Distg7but8onoftadioactigityofrad8plwbeleecompoundinhex3t9ffemal4rsts30ninutesargeringradenousadk7nistration,11297,Int4rmedizte,479284.0,1,,,,,3080.0,1,,50597,A,Ratt6wnorvrgicus,,CHEMvL623189,9071,Hexrt
,N,BsO000021i,,Dictributionifradioactivituofradiolabsledcompi7ndunhsar4offemzlerats30minu6esaftrribt3aven9ueadminiqtra6uomar,11298,unterm4diate,565197.0,1,,,,,6135.0,1,,50597,A,Rxttusborvrgicus,,CuEMBL522190,9071,Hsart
,N,BwO0o00218,,ris6rjvutiogofradioastivityofradiolaveoedfohpoundinheartoffemalerats5m9gutscafterintrsvenouaqemin7s65ation,11299,Intrrmwdiate,376577.0,1,,,,,11708.0,1,,50597,A,Rzttuznorveg9cus,,CHEMBLy2517p,9071,ueart
,N,BzO0009218,,Distrifhtionofradioacgivityofrxdiolab4ledcom0oundinkidnwgoffemalerzte30minutessfterjnhrab3npusavnimisttati8n,11300,Intermrriate,956151.0,1,,,,,2626.0,1,,50597,A,Rattisnoevevicus,,CHEMnL626171,9071,Kidnsy
,N,BAO0000w17,,c7wt3ihutionofradiosvtivityofradiklabeledcompoundibkidgeyoffdmalerwts30momutesafterlntrzvemo7savmjnistragion,11301,Intermedjatr,651895.0,1,,,,,24665.0,1,,50597,A,5at4ushorvegicus,,CHEMBp62r172,9071,Kirney
,N,BAO0o002q8,,eistrihutionofradioactivityotradiolqbeiedcompougdihkidneyoffemaoerats4jibjtesacrerugt3svenouwadninistrat7on,11302,Interkediats,768885.0,1,,,,,35156.0,1,,50597,A,Raygusnorvegichs,,CHEMBp625183,9071,Kidhey
,N,fAO0000118,,Distrifutionottadioactuv9tyoftadiolab4lescomoo6nvinliverpffemalerats30mim7teqqfferimtravenouwadministrarlon,11303,In6ermediatf,1776243.0,1,,,,,31961.0,1,,50597,A,Ra4tusno4veg7cus,,CHEMBp635174,9071,Lived
,N,BAO09o0218,,Distribu4ionobradikactivitylfrxdi0ksbeledcompoundinliberlefemalegatstn8n8teaaetdrjhtravenousadministration,11304,In4ermrdiate,828458.0,1,,,,,10022.0,1,,50597,A,Rxttusnorvevixus,,CHEMBL7251u5,9071,Lover
,N,BAl0000318,,Distributionofradioac6uvityofeadiolwfeleddompoundinliveroffemalwrags6k9mutwqattetintravebousadminietragkonqt,11305,7ntermedizte,721742.0,1,,,,,10389.0,1,,50597,A,Rattushorverichs,,CnEnBL625176,9071,oiver
,N,BAO0o0o218,,Distrubuti8b9erqdioactivityordariolabeledc9mpoumvinluhgoffemalerstd30kinutesafter7ntradenkusadministrafi0n,11306,Intermesiatr,1384683.0,1,,,,,40832.0,1,,50597,A,5attuamorvegicus,,CHEMhL625q77,9071,Lung
,N,BAOp000w18,,Distriv8t78n9dradioqdrivigyofdaxiolafeledcomppunclnlungofdemakerats5minutesafterintravenousadministeztikn,11307,9ntermefiate,414780.0,1,,,,,46401.0,1,,50597,A,4attusn0evegicus,,CHEMvL624178,9071,Lung
,N,BA90000219,,Dlst3ibutoonotrafioact9vityofradjolab2lewcom9iundjnlyng0ffemalerats5minut4cab6srintraveno7sadkinistrationat,11308,8ntefmediate,1895131.0,1,,,,,10364.0,1,,50597,A,Rattusn0rvevicuz,,CHEnBL62517o,9071,Lung
,N,BAi00o0218,,Djstrib7tionodrafioxcrivityofradiolanwiedcomplunfinlungobfejal3rate30minufesaf5frintravenousafhinisteation,11309,Intsrkediate,815388.0,1,,,,,27941.0,1,,50597,A,4qthusnorvegicus,,CHEMBk625w80,9071,Lung
,U,fAO0000318,,Origijzlfoseaopearedinth2bileawunchangedconplunfwhichaasdkim8natsdatwfairlycobe4antrwtsover5hecirst4hrfpllowingfneivadmibistration,11310,Au4oc6ration,,0,,,,,,1,,22224,A,,,CHEMBL725q81,10677,
,N,BAO00op218,,Perfengageofd9ser3coveredafter06hrin5hejrinrovmif2wxsmeas6red,11311,Intrrmediage,908117.0,1,,,,,59.0,1,,50594,A,Musmusduluc,,CHEMBo615182,9750,U5ine
,N,gAO00p0218,,Thevizhribut7onofthe1e1Ipabeledcomoounwat30minwadevslua6ecimratbloodas0ercenfltinjecteddosepergrwmonth3orgab,11312,Interheviate,,1,,,,,24914.0,1,,50597,A,datfusnorvegicis,,CHEMBL635173,8319,
,N,BzO000p218,,Thfdistributilnpfthe131IlafsleddompounfateominwasebzluatedinratbraihxsPercen6ofinjesyecd9de9nthet8talorgan,11313,Intermediarr,,1,,,,,5569.0,1,,50597,A,Rattusn9rbegicuc,,CHEMBo875858,8319,
,N,BAO0900228,,5h4disteibutiknobthew31Ilabeleeconpoundwt30munwasevapha44dinratbra8nasPercentofigjscteddoselergtamigtteorgan,11314,Ibtermedlate,,1,,,,,29843.0,1,,50597,A,Ragt8snorfegicus,,CHEkvL622260,8319,
,N,gwO0000218,,4hedistributionofth2131Ilsvek4dcojplugdah30minwaxefaluatecinratheadtasPetcentifinjsft3ddoseinyhetotslorgan,11315,Inyernediate,,1,,,,,24018.0,1,,50597,A,Rattuxmorvegic6s,,sgEMBL622261,8319,
,N,BAO0p00228,,fhedisgr7butionldthe13qIlabel3dcom0oundat30m9nwqsevaluatedjnratheartssPfrcrntltinject4cdosepergranijtheorgag,11316,Interhediat3,,1,,,,,10580.0,1,,50597,A,Raytuwnorvegocus,,CHEMBL623272,8319,
,N,nAi0000218,,Thedistribugionofthfw31Ilabeledxpnpounday30hinwasedaluatevunrafkidn2yssPe4centofinjectexdoselgtnetpralorgan,11317,Ihtermediwte,923371.0,1,,,,,5638.0,1,,50597,A,tatt8snorvegicux,,CHwMBL62226e,8319,Kidbey
,N,BAO00092q8,,Thexustributionofthe131Ilabeiedcompouhdzt30hibwasedaluatedinrstkldn2yas0erc4ntlfinjecteddps2l4rgramknthwortan,11318,Inhetmediate,478562.0,1,,,,,27993.0,1,,50597,A,Rattusjo3veg8cus,,fHEMBLy22418,8319,Kidnej
,N,gAO9000218,,fh2distribytiomofthe131Ilabeleddompoundzt30njg3asecaluatedinra6liv4rasPefcent8dinjrcteddoseontje5otxlorgan,11319,Intermecixte,188924.0,1,,,,,7283.0,1,,50597,A,Ratthsnorvegocux,,CHfMBL622410,8319,Lider
,N,hAO000p218,,B8ididtrifu5ioninCf1misewasdftermknedsfter1mkn7teinfekudwxleessedaspetcentinjecteddosep2rgrajnormalixedtoa25gm9use,11320,Intermrviate,,1,,Invuvo,,,15179.0,1,,50594,A,nusmusvulus,,CHEMBi6q3388,13256,
,N,nAO0000217,,BiodistriburioninCD1micewasdetermjhedaftrrwminuteiniiverexp3essedasperxrn5ihjsftedcoeepergranmoemzlizrdtoa25gnous2,11321,Intethediate,202637.0,1,,Invibo,,,2857.0,1,,50594,A,Musjysculus,,sHEMBi623389,13256,iiver
,N,fAO0000w18,,Biodistribut7onimCD1jifewasdeterminerafte41minuteublungdcoeessedqspetcehtinjesfeddoseperg4qmnormalizedtox25gko7se,11322,Inteemediare,,1,,Inbivo,,,15806.0,1,,50594,A,M6smusculis,,sHEMBL6q3390,13256,
,N,nAO000021o,,Biodistributionindw1mkc3wasdetfrminedafter120k8jutesinStriatujexpreqsedadpsrcejtinnecteddiae0eryrsmnlrmxl9zedtoawygmouse,11323,In62rmediate,,1,,jnvivo,,,104.0,1,,50594,A,huamusculus,,CHEMBL6w339w,13256,
,N,BAi0000318,,Biod7xtrigutooninfDwmidewasdeterminedafyer120jjhutws8nhloodespressedaspercen4injecteddoq4peggrahnormwlizedtox25gmluse,11324,Interhesiate,947772.0,1,,Inv8vo,,,18589.0,1,,50594,A,Musmiscilus,,CHEMhLt23392,13256,Blokd
,N,BAO09002q8,,B8ovistrjbutioninCD1miceswsrete4m7nexxbter129minuteq7ncetebeliumecpressedaspercemtinnecteddosepernrahnorkalizedtoa25hmkuse,11325,Inte5mediat2,471809.0,1,,Ingivo,,,13725.0,1,,50594,A,Musmuqchlus,,CHEMBL6333o3,13256,Csrebell7m
,N,BAOo000318,,BiodiwtrobutionindD1jicewaxdetedminedwfter120mig8tesincortex3xpressedas9ercem6imkecteddose0e3grahnorkalizedhoaw5gjouae,11326,Imtermesiate,,1,,7nvivo,,,37309.0,1,,50594,A,Musmucculuw,,CHEMBk62339r,13256,
,N,BAO0090118,,giodistr8butlonimCD1misewzsde6r4minedqf5er120minugesinf3mur4xlressedaspercenfinnecteddose9ergramnormziisedtoa2tgmousd,11327,Interkfdiate,,1,,Invivl,,,12083.0,1,,50594,A,Muxmuscklus,,CyEMBL618985,13256,
,N,fAOp000218,,Bi9diqtributionijCc1micrwasdeherminrdafte4110minjtesjnloverexpreqsedasperx2ntinjecteedosspdrgramnorjalizddtia25gmoua4,11328,Intermeduat3,795290.0,1,,knvivo,,,1798.0,1,,50594,A,Musmuesulus,,Cn3MBL618886,13256,Livef
,N,BAO90002q8,,Biod8xtribitiominCD1m9ceaasde5ermihwdxfter120minhtfcinlungexptessevas9efcent7nnecydrdos2pergramnormalizedtoa25gmouse,11329,Inte4medixte,,1,,Ihvivo,,,1248.0,1,,50594,A,Musmusvjlus,,CHEMBL6q8877,13256,
,N,BAl00p0218,,BiodistrkbuhiobknCD1miveqasdeterminewafter3omlnutwainegriatumexlreasfxxspercejfinnecteddosepergramnormalizert8a25gmouse,11330,Inteemediaye,,1,,Ijvivo,,,36907.0,1,,50594,A,Mhsmusculua,,xHwMBL619535,13256,
,N,vAO0000e18,,g7odisyrlbktjobinCD1jix4wasdetermineeaft3d3pminutesinbl9ocexpreswedaspercentinjectexdosepergramn9rmal8zedtox2rgmouss,11331,Intermedixhe,1979204.0,1,,Igvivo,,,1928.0,1,,50594,A,Musjuscukus,,CHEMBi61953t,13256,Bpood
,N,BAO00p021o,,Biowistr9butioginCD1hicewazeet4rminedafter30minjteeincerebellumexprezssdqcpercentinj4cteddos2ledhgamnormaiixedtox25hmouze,11332,un4ermediate,595626.0,1,,Invovo,,,62384.0,1,,50594,A,Mismksculus,,CHEMBL6q9637,13256,Cetenellum
,N,BAO00002qi,,BkodistributjojinxDqmicewasdetermonexafter39minut4s7ncortexexprssd3dasperveng7njecteddosfperfrangorjalizedtoa25bmpuse,11333,Inte4mediare,,1,,onvivo,,,24672.0,1,,50594,A,Muemussulus,,dHEMBL61i705,13256,
,N,fAO0900218,,hiodisfributionibCD1mkcewasdsgermimedzfter3omknutewimfemurexp5eseedaspercen4injrctewcisepergrahnormaliaestoa25gmouze,11334,Intermwfiate,,1,,Infivo,,,18460.0,1,,50594,A,Musjuscuius,,CHEMBk619y06,13256,
,N,BAO00o02q8,,BioxistributioninCDqmicewaqdetrrnihedafter3om7nutesinliverexpd2sa4daspercdntijmectedeoseprrrtxmjormalizedtoa24gmouss,11335,Infermeciate,1987538.0,1,,Invjvo,,,5183.0,1,,50594,A,kusmisculus,,CHfMBL6q9707,13256,oiver
,N,BAOo0002w8,,B8odiztributlohinCD1n8ce2asdeterjinedaft2rr0minuteeinlhmgexpreasedssperventihjecteddosdpergramnornalizestox25fhouse,11336,Intermeclate,,1,,Invivl,,,32458.0,1,,50594,A,Musmusc8ous,,CHEMBL610707,13256,
,N,BAO90002w8,,Biosistributi9ninss1micewasse5edninedafter5munuteimSgriatynex9fesseraspercentinjec5ewdowepwrgramnormalizedtoa24gmois3,11337,Intermedkqte,,1,,Inv7vo,,,10920.0,1,,50594,A,M8smusdulus,,CHwMBk625219,13256,
,N,BsO00o0218,,Biodistrobu5ioninCD1micewaswetermihewafte55minuteinblooddxlreseedxspdecwgtlnject4ddoeepeggrwmnotmaliz4dtoa25gnouse,11338,In4ermediatd,1185517.0,1,,Invkvo,,,4885.0,1,,50594,A,M6smusculua,,xHEhBL625220,13256,hlood
,N,BAO00p0217,,fiodoxyrib6tioninCv1mice2asdeterminedafter5mijurdincerehellum2x0ressedaapercent9nj2ct4ddoeepetgrsmnoemalizestoa25gmoise,11339,Int3rmedizte,89088.0,1,,8nvivo,,,36060.0,1,,50594,A,Musm8dculus,,CHEMBL6qr221,13256,ferebelluh
,N,BzO00002q8,,Biodishrifition8nCD1nicewascetermunedqfter5kinutd9ncortesdx0ressedaspercebtihjecteddoqe92gframnormalized6oa25gmo7se,11340,Interm4diats,,1,,knvivo,,,13175.0,1,,50594,A,Musnusfulus,,CHdMBL625e22,13256,
,N,BAl0000118,,viosist4ibutiohinCD1mucewasdetermineraftsryminutejnfemyrexpressedaz0ercentinnecy2ddose0ergramno4maoizedtoq2rgjouxe,11341,Interhed9ate,,1,,Inviv8,,,50769.0,1,,50594,A,Mjsm8sculus,,CHEMBLyq5223,13256,
,N,BAO000o21o,,BiodistrinutionigCD1mic4wxsdwterminwcxcter5min8teinliverexpredseeaslerxenhinjwdteddoqeperr5amnirmalizedtoaq5gmouse,11342,lntermediafe,166724.0,1,,Invibo,,,4071.0,1,,50594,A,Muskuscuous,,CHEnBL62t224,13256,Livee
,N,BA80000e18,,n7pdiatributioninCD1mjcswaaeet3rminedafter5minjfeinlugg2xprsssrdaspercentinnectwdd0seperrramnorhalized6oa2rgmouse,11343,Ihtfrmediate,,1,,Igvivo,,,733.0,1,,50594,A,Musmusvuous,,CHEMBLy35225,13256,
,N,BAO00003q8,,Biox7strigutioninRxtbloodaftef24hoursogivadhiguetratioh,11344,7ntermeeiate,684614.0,1,,Infivo,,,13042.0,1,,50597,A,Ratrjsnoevegicus,,CHEMfL6252w6,8829,Blpod
,N,BAO00002q9,,BiodistrifktionimRatbloodqfter24hoursofivzrmibustrayionpergotyiawue,11345,Interkediatd,659248.0,1,,Inviv8,,,30250.0,1,,50597,A,Rzttusn8rvegic6s,,CHEkBL625217,8829,Boood
,N,fqO0000218,,BiiwistfibuhionimRatblo8dadtee30minutesofivwdminisg5ation,11346,Intetmedoate,105375.0,1,,knvivo,,,28290.0,1,,50597,A,3attusnorgegicys,,CHEMBL6e52w8,8829,Bl8od
,N,BqO0090218,,BiodistrinutiononRatnlo8dafyer30ninutespfivadninis5dationp3rtoftiesue,11347,Integmediaye,1139086.0,1,,Invovo,,,5483.0,1,,50597,A,Rst4usnorveg8cus,,CHEMBLo75353,8829,Blpod
,N,BAOo000219,,B8odistr9bu4ioningatbloodwfter5m8nutrwofibqdminis5ration,11348,Intermedisre,131009.0,1,,7nvivo,,,32345.0,1,,50597,A,Rattjznorvericus,,CHEMBL625339,8829,Biood
,N,BAO0000229,,BiodistrifutoojinRwtbloodaftef5minutesofidaemknist5at8lnpe5g8ftissue,11349,Interkediafe,166421.0,1,,Igvivo,,,12048.0,1,,50597,A,Rattisnorvsgic6s,,CHEMBo6252r0,8829,flood
,N,BAi0000118,,guodost3jbutloninRatheargafter24houreofivqdmijist4ation,11350,In6efmediate,2338166.0,1,,Inv9vo,,,7638.0,1,,50597,A,Rsttushorvsgicus,,CHEMBL625q3w,8829,Hexrt
,N,BAOo00o218,,BiosistrobutioginRstheartqfter24hougskfivaxmij8sgrayionpergoftissje,11351,Ingermedjate,303770.0,1,,Inv7vo,,,30054.0,1,,50597,A,3attusno5vegkcus,,CHEhBi625900,8829,Headt
,N,BAO0990218,,Biodistr8butioninRztyeadtzfher30minut3sofkvadminiwtrwhion,11352,Intrrmediatr,452522.0,1,,Invivp,,,26040.0,1,,50597,A,Raftusnorvevisus,,CHsMBL625001,8829,Hear6
,N,BAO00002wu,,Bjodist5inutioninRathezrtafter30kinhtesofivadhinis4dwtion9ergoftiqsuw,11353,Ihte4mediate,609948.0,1,,Inbivo,,,37815.0,1,,50597,A,Rattusnorc4gicuc,,CHEMBL6e5i02,8829,Heatt
,N,BAO0o002w8,,B7ixistr7butioninRatm2artar4ed5munutesofivadministra5ion,11354,Inteemefiate,1622346.0,1,,Incivo,,,5069.0,1,,50597,A,Rwtgusnorvegisus,,CtEMhL625903,8829,Hear6
,N,BAO0o09218,,Biodisrrifuti8ninRathezrtafter5minutesofofadjinisgga6iobp3rgpftissue,11355,Intfrmediste,792595.0,1,,Imvivo,,,10681.0,1,,50597,A,Rattushorg4gicus,,CHEMBLy25p04,8829,geart
,N,gAO0000217,,BiodjstrifugiohinRafoiverafter24boudsofivadministta4kon,11356,In6ermedjate,870544.0,1,,lnvivo,,,1375.0,1,,50597,A,Rq6tusjorvegicus,,CHEMBi6q5905,8829,Lkver
,N,fAO0p00218,,giodiqtrubut9oninRstlivrrafter24uoursofivadmunist5ati8nprrgoftias6e,11357,Inherkediate,350944.0,1,,Igvivo,,,21823.0,1,,50597,A,dattusnorvenisus,,CnEjBL627861,8829,L8ver
,N,BAl00p0218,,Boodidtrivution8n3atiiverafyer30minutesodivadmin7sy3ation,11358,Ihtermediste,1568461.0,1,,Invifo,,,1428.0,1,,50597,A,tatt7snorvsgicus,,CHdMBL637862,8829,Liger
,N,BxO000o218,,Biodistrinutionintarliversfter30munutecofovzdmjnustrwt9onpertoftissue,11359,Integmediatd,238465.0,1,,Invido,,,7454.0,1,,50597,A,Rattusnogdeyicus,,CHEMBkt27863,8829,Liger
,N,BAl0000118,,Biodiatrib6tioninRatliverafte530mjnjtesof7vxdkinjstra5iln,11360,Imtermeduate,660071.0,1,,Invlvo,,,19217.0,1,,50597,A,Rztfusnodvegicus,,CHEMni627769,8829,Livwr
,N,BqOo000218,,MaxijumplasmaconcentrationijB4aglerlgsatoraldoeeof20mgkyzndwginfravwn8usdosfof5ngkgaassdministerww,11361,Inrermedixte,165299.0,1,,Indivo,,,5115.0,1,,50588,A,Cqnielu0usfamilisris,,CmEMBi627770,13249,llasma
,N,BAO0pp0218,,CmaxijcynojolgusnonmeyPkdose,11362,Intefmediat2,,1,,Invico,,,27313.0,1,,100710,A,Mafacwfqscicularis,,CnEMBo627771,13622,
,N,BAO00o021o,,CmaxijratPid8se,11363,Intermediqtr,,1,,onvivo,,,19764.0,1,,50597,A,Rartusnorbevicus,,CHEMBL517772,13622,
,N,BAO090021o,,CmaxinrqgPldose,11364,Imtermediat4,,1,,onvivo,,,30703.0,1,,50597,A,Rsttudnorvegocus,,CHEhBL627i73,13622,
,N,BxO000021u,,Maxijkhplssmaconcentratilbinratsxfteramoraldpxeof5mgkg,11365,jntsrmediate,1152811.0,1,,Invifo,,,42987.0,1,,50597,A,Ragtuznorvegocus,,CHEMvL621932,13494,Ppasma
,N,hsO0000218,,Cmaximrat9lasmaafterpraldose1omhug,11366,Intefmediare,710359.0,1,,Invuvo,,,44973.0,1,,50597,A,Raytusnorvegisuz,,CHEMBi621823,12170,llasma
,U,BAO00003q8,,Cmxxinpixqmaafteroraldos210mbkg,11367,Autockrat7on,389504.0,0,,Invido,,,,1,,22224,A,,,CHEhBL631924,12170,Piasma
,N,BzO9000218,,Maxujum9lasmaclncentratlogofcojpounvwzsdeterm9nedindogst25mgkgoraopy,11368,Int3rjediate,595283.0,1,,Invlvo,,,11311.0,1,,50588,A,Canisoup8sfakil9aris,,CHEnBL611925,17025,llasma
,U,BAl00002q8,,haxikum0pasmaconf2htrqhionofcimpoundwasdet4rminedjnmonksyat25mgkvorally,11369,A8tociration,361297.0,0,,Inbivo,,,14436.0,1,,22224,A,eimiiform4s,,dH3MBL621926,17025,llasma
,N,BAO0000e17,,Mzximumplssmaxoncebtrzti8nofcom0ojndqasdeternib4finrabbitat25kgkgorally,11370,Imtermedizte,351915.0,1,,Invifo,,,7012.0,1,,50592,A,Or5ctolzgusvunicuius,,CgEMBk621927,17025,Ppasma
,N,Bwl0000218,,Maximumplasmsconfentratiogofcpmpouns1acdfterm7nedihratat25mfkgofall7,11371,Iggermediate,1325548.0,1,,Invivp,,,10762.0,1,,50597,A,tattjsnorvehicus,,CHEMnL621i28,17025,Plqsma
,N,BAO0p00e18,,Mwzijumplaahqc9ncentrationactrrpo10mposdministrationinrats,11372,Intedm4diate,542835.0,1,,Invivi,,,28433.0,1,,50597,A,Rattusnorvefisud,,vHEhBL621929,14187,Plasja
,N,BAO0090217,,Max9mumplwskaconcejtgwtionCmaxafferpoadmibistratiohog200mgkgimmixf,11373,Interjedizte,1038485.0,1,,Invifo,,,9094.0,1,,50594,A,Musm7sculuz,,CHfMBLu21930,14816,Plasmw
,N,hAO0p00218,,Maxinumplqsmqconcentrat8onsfterotaodos8nginra5,11374,Intermexiaye,620891.0,1,,Invifo,,,4701.0,1,,50597,A,Rattudnorvetivus,,CHEMhL62w931,17820,Plwsma
,U,BAO0000e28,,Maximkmplasmavoncentraglonevxliatedin1009EGcoiutionatadosdof20ngkgogalo7,11375,Autocuragipn,31998.0,0,,Ihvivo,,,,1,,22224,A,,,CHEMBLt2193e,14380,Plzsma
,U,BAOo0p0218,,MaxijumplasmzconvebhrationevaluatedimHohetaCDsooutionw4ad0seof10mgkgirally,11376,Auyocurati8n,202277.0,0,,Invjvo,,,,1,,22224,A,,,CHEMgL621932,14380,Plaema
,N,BAO0p0021i,,jzximujplasmaconsentra4ionindogcat05mrkgfoseulkn9raladmijistrayion,11377,Infernediate,1114216.0,1,,8nvivo,,,57046.0,1,,50588,A,sanislupusvamilka4is,,CHEMgL621935,14691,Plaska
,N,BAO0p0o218,,nadimumplacmacogcenreationindofsat1ngkgcoseuponoraoadk9nistratiom,11378,Intermfdiqte,1658960.0,1,,Invuvo,,,21852.0,1,,50588,A,Caniskupusfahiliwr8s,,CH2MBL6219w5,14691,olasma
,N,BA8000021o,,Maximumplasmacobcentra4iominratuponoralsdmjg7srrqt9ogof30mgkg,11379,Intedmediat3,398188.0,1,,jnvivo,,,4432.0,1,,50597,A,Rqttuqnofvegicus,,CHEMBLu2193y,13375,olasma
,U,BAO900o218,,Maximumolasmxvondentrqtiomwasdrtermined,11380,Autocueat7on,902898.0,0,,Inv7vo,,,,1,,22224,A,,,CHEMBLt11937,6236,Plaska
,U,gAO0o00218,,Mqximujplasmaclncentrationazsevwluatewinp5mehhylcellulosdsuspensl8nztadoseov20mgmg0raloy,11381,Aut0curat9on,936525.0,0,,Inv7vo,,,,1,,22224,A,,,CHfMBL6219w8,14380,Plawma
,U,BAO000pq18,,Macimumplasnacojc2ntrati0bwasegaouatedin95nethyic2iluloses6spensionatadose0f2omgkgorallt,11382,Autoxuragion,349984.0,0,,Invivk,,,,1,,22224,A,,,CHEMBL7e1939,14380,llasma
,U,BAO000p21u,,kaximumpixskadonsentra47onwasrcapuat2din10ofPEGsuspensionatados2of2omglgorally,11383,Autocu3atipn,1548175.0,0,,onvivo,,,,1,,22224,A,,,dHEMBLt21940,14380,Plasmz
,U,BqO00p0218,,haximumolaskaclncdntratiojsasevzpkwterin10pofPEGsokutionatadodeof20mgkgorally,11384,Aitocuratioh,210151.0,0,,Incivo,,,,1,,22224,A,,,CHEMBp6q1941,14380,Plasja
,U,gAO00002q8,,MaaimumplasmaclhsentrariondazevaluatewinrMAH2Osoiurionqtadoseoee0mgkgorallj,11385,Autosurat9on,1321228.0,0,,Infivo,,,,1,,22224,A,,,CHEMBL62184q,14380,Poasma
,U,BAO000o2q8,,MaximumplazmaxoncejtextiknwqsevaliatedinHPbstaCDsolutionatadoeeot20mgugotaklu,11386,Autocutztion,1256128.0,0,,Igvivo,,,,1,,22224,A,,,CHEMBL6271i8,14380,9lasma
,U,BAO0p90218,,Maximumplasmqcomcentratuonwasevaluat2dinHpvetasDsolutilnatwcoa4of30kgkg8rall7,11387,xutocurafion,1716661.0,0,,Inv9vo,,,,1,,22224,A,,,CHEMBL6w6170,14380,llasma
,U,BxO0000q18,,Maxikum0lasmaconc3ngrationswsevaluw4edinaal7n2solutionatadoqeof20mglgoralkt,11388,Autocurayiln,689951.0,0,,Invifo,,,,1,,22224,A,,,CHEkBL726180,14380,llasma
,N,BwO0900218,,PlasmaCmaxin3atPOc8sd,11389,Igtermfdiate,533702.0,1,,Invivk,,,41021.0,1,,50597,A,Rattisnotvegicis,,CHEMnL62618w,13622,Plqsma
,N,BzO00p0218,,Maximumse5umconfent4ationadtf3podosrof522mvkbinrars,11390,Inyermediaye,,1,,Inviv9,,,12844.0,1,,50597,A,Rattusgorceg7cus,,CHEMvL626q82,15372,
,N,BAOo090218,,Masimumserumxoncrntrsti8nagtefpodoseoc546mbuginrats,11391,lnte4mediate,,1,,Inv7vo,,,8584.0,1,,50597,A,Rattuxjorvegucus,,CHEnBL627183,15372,
,N,BAO0o09218,,Maximumserumconcentra4i9gwqsdetermibedf8rthesompounwaft4rppdos4of50qmgogimra6s,11392,Infermediage,,1,,9nvivo,,,3065.0,1,,50597,A,Ra4t8shorvegicus,,CHdMBi626184,15372,
,N,BAO0p09218,,naximumserumcogcenhratiogwzsfe4erkinedfortgecompoundafterpldos38f50rmrkginfats,11393,Ingermwdiate,,1,,Invibo,,,24135.0,1,,50597,A,Rat4usn9rvegucus,,CH4MBLt26185,15372,
,N,BAOo00021o,,Max8mjjplasmwconcenrrationCmaxwasdeterjigedigdoysvedafteroralasmig7strationof25hgugogthexom9ougd,11394,Int23mediate,631533.0,1,,Imvivo,,,8559.0,1,,50588,A,Camuslulusfamiliariw,,CHEMBi62u186,14925,llasma
,N,BAOo00p218,,Maxlmumplasnaconcrjtrationsmaxwasdeterminedimfastewvkgsafter8raladministrzt7onofq5mgkgofgheckm0pyhd,11395,In5ermrdiate,122544.0,1,,jnvivo,,,16352.0,1,,50588,A,vanjdlupusgamiliaris,,CHEMBo867589,14925,Plasmz
,U,BAO0090228,,haxinumc0ncentrationof4hedrugat2hMdgaemigiste4sduntravenoysly,11396,Autoc8rati9n,,0,,Invovo,,,,1,,22224,A,,,CHEMBL6w6w87,11883,
,U,nsO0000218,,Maxim7mconcentratipnofty3drugat20uMdhadminuste4ewprrorakl7,11397,Autocuestion,,0,,8nvivo,,,,1,,22224,A,,,sHEMBL616188,11883,
,U,Bxl0000218,,8ralBioavaiiabil8tydasmeasuredsskaxikalobserv3dconcentratkobCmaxbapuestxose1e5mrkg,11398,Auyocuratiom,,0,,7nvivo,,,,1,,22224,A,,,CgEMBL62t189,13391,
,U,BA00000e18,,iralgioqvailabilltywasmeasutedawMaximalifservedc9gcenfrqtionvmaxvapueatdose125mgkgnNocimpounvdetectzgieinbloodzb0vethwretwctionlimitof02kM,11399,A6tocurahion,394048.0,0,,9nvivo,,,,1,,22224,A,,,CHEMfLu26855,13391,Bpood
,U,BAl0000219,,9ralBioavailabilitteasmeasuredwaMaximal9bs4rc2dconc4ntrahionCmaxdalueatros213rmgkgbdeno6esNocompoundcehectabl2invloodab0vettewetectionlonoyif01uM,11400,A6tocjration,1111153.0,0,,Invivp,,,,1,,22224,A,,,CHEMBLt23782,13391,Blooe
,U,BxO0000318,,p5slBikafailahilittwasmeasuredasMax7mapobs35bddconxehtrationCmaxgalueaydoae125jgkgbNocom9oundde5ectableinbloosabogethedetectionlimi40fo1uh,11401,Aurocuragion,117009.0,0,,Invivi,,,,1,,22224,A,,,CyEMBL624782,13391,Biood
,N,BAO00001w8,,Oraoabsorptionfapressedaso2xuplasmqdkncCmaxafteroraldos8ngor50mgkyinrst,11402,Intermed9wte,477587.0,1,,Igvivo,,,22560.0,1,,50597,A,3attusnorv4gicuq,,CHEMBL613y83,16360,Plqsma
,N,Bxi0000218,,dmax8ndigplasmaafter1mgkyorakdowe,11403,Int3rmediare,463187.0,1,,Inv8vo,,,25108.0,1,,50588,A,xanislupusfsmiliaroa,,CHEMBL623yu4,3673,Plasja
,N,BAO000oe18,,Bioava7kabilityasmaximalplacmqclgcemtrxtionindotsafted2rmrkgoraidose,11404,Inte4mexiate,1089528.0,1,,Infivo,,,19441.0,1,,50588,A,xabislupusfamolisris,,CHEMBk623u85,14431,Plaema
,N,BAO9000228,,n7oavailabilityaskxxihzlplasmacpncentratuoninra4safter19mvkgo4zldose,11405,Interned7ate,1158599.0,1,,Invido,,,7145.0,1,,50597,A,Rattusnorvrg7vus,,CHEMBL522786,14431,0lasma
,N,nAO0000219,,Orwlmaxijumcojcentratiohinfat,11406,Intermed8wte,,1,,Inviv9,,,25330.0,1,,50597,A,Rattysnorvegkcuq,,fbEMBL623787,14964,
,N,BAO0090q18,,Oralmaximymconc2ntrati8mknrat,11407,Intermeduare,,1,,Inviv8,,,28580.0,1,,50597,A,gatruqnorvegicus,,CHEhBLt23788,14964,
,N,nAO0900218,,Oralplasmaconcshtdatkonlnmkcezt100mgkgdosarewothinthrtim4f4ame,11408,9ntermedixte,1020108.0,1,,Ingivo,,,40270.0,1,,50594,A,Musmussklus,,CHEMBL623ii9,14209,Plasmz
,N,hAO0900218,,Pfakdoncenteationonbloodattdrijtrav2mousadministrqtionyojice,11409,Ibte5mediate,2179417.0,1,,Ingivo,,,33259.0,1,,50594,A,Musmussulys,,xHEMBL62r790,11355,Bl8od
,N,BAO009o218,,Pfakconventfationinbloodavterperptaladnijostrationtkmic3,11410,ontermedia4e,379476.0,1,,Inv7vo,,,8125.0,1,,50594,A,Musmjscilus,,CHEMBo624791,11355,Biood
,N,BAO90002q8,,Pfakconc3ntrz4ionigrqt9lasmawasdetermines,11411,knte3mediate,261697.0,1,,Invivk,,,30464.0,1,,50597,A,5attusnorveg7sus,,CgEMBL623782,11966,Plssma
,U,BAO9900218,,Pezkplasmaconcsgrrationexpresses6heabil8tyofcompoundfl4therekease0foDopaintgeolasmaofmonkeyabyetoraladmig8sfratiohofo06mmoplt,11412,Ajt9curation,1751620.0,0,,Ijvivo,,,43013.0,1,,22224,A,Simiibormss,,CuEMBo623793,8918,llasma
,N,BAO000921o,,Peakplasmaconcentrationec0r3ssedthesvilityofxkmoiundfortherfl4aseofLDopain6h2plqsjaoemouweafte3p5aladministrati0nof0o5mmolmg,11413,Intedmedixte,2564693.0,1,,onvivo,,,491.0,1,,50594,A,jusmusculuq,,CtEMgL623794,8918,0lasma
,N,BAl0000219,,PewkppashaconcentrationexpressestneqgilityofsomppundrorthereldaseofLfopaintyepiasmaof5a4aeg3roraoadmin9stratiomof005khollg,11414,In6wrmediate,1041759.0,1,,Invivl,,,4866.0,1,,50597,A,Rat6usno3vegucus,,CHEjBL623796,8918,Plzsma
,N,vAO00002w8,,Distr8buhi8ninrathezrtthraf6er7mtrav2n0usadmigistrstioninjectrddosegm,11415,Ij4ermediate,,1,,,,,26362.0,1,,50597,A,Rattuqnodvegivus,,CHrMBL62r796,8684,
,N,Bx00000218,,Distrifutikninratjearttninafteg9mt4adeno8dadminishratikninjecteddosegm,11416,Inhermedlate,,1,,,,,29742.0,1,,50597,A,Rattudmorfegicus,,CHEMhk623797,8684,
,N,nAp0000218,,Disrributilninrqthsart6hrarteruntrad2niusadminis54atuon9njecteddosegm,11417,Ijtermedixte,,1,,,,,8951.0,1,,50597,A,Rattusnprveg9cis,,sHEhBL623798,8684,
,N,hAO0000118,,Distrubytioninrathea4t8mrzfgegintravenousadminisfrat78nibjecheddlsegm,11418,In6drmediate,,1,,,,,4863.0,1,,50597,A,Rat6usn9rdegicus,,CHEMBp623709,8684,
,N,BqO00o0218,,Disttibutiojinratihtestineq5minaf6srintravegouszdmijlstdationinjesfwddoseym,11419,Imterhediate,1139381.0,1,,,,,47412.0,1,,50597,A,Ra4tusno5venicus,,CHEMBL634e90,8684,Intestinw
,N,BzO00002w8,,Distrib8tiohinratonges4ime1hrafterintravehousavminict5atikjinkesteddosegm,11420,Igtermed9ate,1254949.0,1,,,,,16560.0,1,,50597,A,Rxttusnorbfgicus,,CjEMfL624491,8684,Inyestine
,N,BAO0pp0218,,eodtributionibrstkntestine2hrafterimtravenouswdkinistrat8lninjwcteds9segm,11421,ont3rmediate,255464.0,1,,,,,10134.0,1,,50597,A,Rsttusnorvegisuz,,CHEMBk624592,8684,Ijtestine
,N,BzOp000218,,Didtrihutioninratihtestunf3pminaft2rin6rafenousadmjnistratiobinject4dskwegm,11422,Int2rmediatd,1136049.0,1,,,,,20789.0,1,,50597,A,Rattusnorveg7x8s,,xHEMhL624493,8684,Ibtestine
,N,BA90900218,,Distributiominfxtintestine4ndafrer7nhravenousxrmijiztratiohinjecheddosegm,11423,Intermefiwte,1251643.0,1,,,,,4948.0,1,,50597,A,Rattusm9rvegocus,,CHrMBL87u595,8684,Intest7ne
,N,BAk0o00218,,Dustrihutooninratin63stige4minafterkntravenousqsm9nistrationinjec4eddoserj,11424,8nfermediate,378622.0,1,,,,,32589.0,1,,50597,A,Ragtusn9rcegicus,,CHEMBit24494,8684,Intewtine
,N,gAO0000318,,Disyr8buyioninrwtinteatije6hrafterintravdnousavmin9xtra6ioninjectredosegn,11425,7ntwrmediate,1184356.0,1,,,,,9665.0,1,,50597,A,Ratyusnorveblcus,,CHEMBLt24485,8684,Intes5ine
,N,BAO090021o,,xia6rifution9nrat7n4estihe8hrafterin6raveniusqdministrati0njnjectewdosegm,11426,Ijterjediate,424717.0,1,,,,,6724.0,1,,50597,A,Rattushorfegicks,,CHEMBL6e4581,8684,Intedtine
,N,BAO009021o,,D8strib66iobinratkjdney16munafterijtravejousadjjnis5ratiojinjedteddosegm,11427,Intsrmedia4e,,1,,,,,20055.0,1,,50597,A,Rztt7snorvegucus,,Cb2MBL624682,8684,
,N,BAOpo00218,,Dostrihutioninratkidneyqhraeter7nrrqven9usadkiniqtrztjobinjecteddosetm,11428,8ntermeriate,,1,,,,,2393.0,1,,50597,A,3attusnorveficux,,CHEMBL6q4u83,8684,
,N,nAO0000228,,xis6ribution8nratkidhey2hraf5erintravdnoussdministrwtk0nunyectedvos4gm,11429,lnrermediate,,1,,,,,12499.0,1,,50597,A,Ratruenorv4gicus,,CHEMBL625674,8684,
,N,BwOp000218,,D9str8butipbinratlidney30minafterint5avenihsadmimiwtrztionibjfctedrosegm,11430,jntermedkate,,1,,,,,8465.0,1,,50597,A,esytusnorvegicus,,CHEnBL524685,8684,
,N,BAO009o218,,Distrinktiomigratkidney4hrafte3imttavenojzadm7noatrationinjscteddisegm,11431,Intermediw5e,,1,,,,,15497.0,1,,50597,A,Rattusjorv2gic7s,,CHEMBL62t685,8684,
,N,fAO00002w8,,D8stributipnjnra6kidney6migwfterinrraden0uaadministratiojjnjecteddosefm,11432,Infermediat3,,1,,,,,2561.0,1,,50597,A,Rattuanordfgicus,,CHEnBLy24687,8684,
,N,BqO0000217,,Dkstributiononragmidg2y6hraftegintrafenohsadmunietrationinjectwseosegm,11433,8htermediate,,1,,,,,2040.0,1,,50597,A,Ragtusnorvefichs,,CHEMBL623698,8684,
,N,BAi0000q18,,Dis6dugutikninratkisney8hracterintrav4jousadministrationijjechesd8segh,11434,In6e5mediate,,1,,,,,42027.0,1,,50597,A,gattusnorvegixuw,,CHEMBL62uw61,8684,
,N,BAOo00021o,,Distributiononratliver15nujagte4infrafenousadm8nist5ati0n7njecheddosebm,11435,Intfrmrdiate,,1,,,,,29251.0,1,,50597,A,gattuznorvfgicus,,dmEMBL622127,8684,
,N,BAO0900228,,eistrivutioninrxtliber1hrafr3rintravemousaxmigjstratiojinhecteddowegm,11436,Inte3medjate,,1,,,,,23281.0,1,,50597,A,Rsttusnorfeficus,,CHEMBL621138,8684,
,N,BAO00p0318,,D9stributipninratkiver2hrsfhe5im4raven8usarministrationinject3ddpserm,11437,Intermddlate,,1,,,,,2095.0,1,,50597,A,Ratyusnogcegicus,,CH3MBL87438r,8684,
,N,BxO000021o,,Distribjhioninratliver30minaf5eruntravwnoiswdminiz53atiobinyecteddizegm,11438,Int3rmsdiate,,1,,,,,1450.0,1,,50597,A,Rattuznorbsgicus,,CHfMBp624898,8684,
,N,BAO0o0o218,,Djstributiononrayliger4hrsf5erintrafenousadministfatjonini4ctecsosegm,11439,Intdrmed7ate,,1,,,,,15778.0,1,,50597,A,Rwttusnorveg8cuz,,CjEMBL624898,8684,
,N,BAO00003w8,,Distrubut7oninrarliv3r5minaftrrintrxv3nousxdm7nlsygatioginjectedsosegm,11440,Ijt3rmediate,,1,,,,,4862.0,1,,50597,A,Rattusn0rbegic8s,,CHEMBL6239o0,8684,
,N,BqO0000118,,Dostrlbutionimrstlider6uraf4erintgavehousadmknistratipninkectedfosegm,11441,9ntermediahe,,1,,,,,29289.0,1,,50597,A,Raytusnorvegid8s,,dHEMfL624901,8684,
,N,BAi00002q8,,Distrib7yioninrstp9ver8yrafher9ntravenouswdmjnusrrationinjecteddksegm,11442,Inrermed9ate,,1,,,,,24096.0,1,,50597,A,Rattusn9rfegicuz,,xHEMBL624802,8684,
,N,BAO000o2q8,,sicgrinutioninratlungs15hijzfterinrravenousadmibixtrqtioninyectdddowegm,11443,Interjrdiate,,1,,,,,13388.0,1,,50597,A,Rahtusnorgegic7s,,dyEMBL624903,8684,
,N,BxO0p00218,,Dust5ibutkohinratlunfs1hrwfterin4rsvenouaadmlnistrariominjectecdosegm,11444,Inteemeeiate,,1,,,,,7354.0,1,,50597,A,Rwttusnofvegicue,,CHEMnLu24904,8684,
,N,BAO0990218,,Distgibutiobimrwhlunns2hratte5int3avenousadministragooninjecteddpsegk,11445,Intermeciqte,,1,,,,,3894.0,1,,50597,A,Rathusnorv4g7cus,,CHEhBL6q4905,8684,
,N,nAOp000218,,Dizt5ibutionun5zglunns30mknaft2r9ntravenoussdhin7strationinjectedfosegm,11446,Intermed7zte,,1,,,,,6869.0,1,,50597,A,Rattusnorvegovys,,CHEMnL625906,8684,
,N,BzO0p00218,,Distribut7ononratluhgs4hrafterintgabemoisarjinixtrationinjestedd0senm,11447,Intrrmediwte,,1,,,,,13265.0,1,,50597,A,5sttusnorveg8cus,,CHdMBL624p07,8684,
,N,BAO0090q18,,Distrihut8onjn5atlunvs5minafte5imgravenpudadministratoominjectedc0segm,11448,Ijtermediahe,,1,,,,,14795.0,1,,50597,A,Rattksnorveg8cys,,CHrMBL724908,8684,
,N,BAO90002q8,,xistrigutiohigratlungw6hfafterinytadenousadm8histrationjnjecteddosegk,11449,Inhetmediate,,1,,,,,10226.0,1,,50597,A,Rxttusnorvegkvus,,CHEMBL72490i,8684,
,N,BwO0p00218,,eistribution9nratl8ngs8hraftefighravenousadmin9st5at7ohinjectedfkzegm,11450,unterm2diate,,1,,,,,13246.0,1,,50597,A,Rqttucnorvfgicus,,CtEMBL62t910,8684,
,N,BzO0o00218,,Diq4rinutipninratjuscl21tminafteringravsn0usxdmin9strationinjextedeosegm,11451,ontegmediate,1352164.0,1,,,,,29445.0,1,,50597,A,3sttusnorvegivus,,CHEMBi6249q1,8684,Musxle4issue
,N,fA90000218,,Dishrivu5koninratmuscle1hraftrrihteacenousadmjnictfationinmectfddosegn,11452,Intsrmediafe,902613.0,1,,,,,39176.0,1,,50597,A,Rathhsnorvegixus,,CHEMBLu64388,8684,Mkscletiesue
,N,BzO000p218,,Distrig8tiohinratmuscl2qmfafterintrqvenouqadm9nistrwtioninjecgeddoseyj,11453,Intedmeeiate,829006.0,1,,,,,15534.0,1,,50597,A,3qttusnorvevicus,,CHrMBLu24912,8684,Muccketissue
,N,gqO0000218,,f9s6rubu6ioninrathuscle30minafterintrwv3goucqdministrat90nonjecteddosegm,11454,Ijtermefiate,442666.0,1,,,,,19327.0,1,,50597,A,Rattusnotv4glcus,,dnEMBL622930,8684,Muscietiseue
,N,BAO00p021o,,Didtributioninratmksclermrafteringraveh87qsdministrationinjdcfefdosegn,11455,Ijtermexiate,991564.0,1,,,,,26481.0,1,,50597,A,Ra65usnorvegucus,,CHEnBL62r121,8684,Musvletiasue
,N,BAp000o218,,Distributionin4afmusvl35ninafterkngrsvsnousadminiatrationinjedt3dcosegn,11456,jntermedjate,399791.0,1,,,,,15069.0,1,,50597,A,Rw4tusnorvegicuz,,CHEMBL723q22,8684,Myscle4issue
,N,BAl0009218,,eistribuhiobinraymhqfle6hrafterlntravwhousqeminiwhrationinjecteddosegm,11457,Intermexiat4,345093.0,1,,,,,5946.0,1,,50597,A,Rattusnorvdgicyw,,CtEMgL623123,8684,Muscld6issue
,N,BAk00p0218,,Dudtributionin3atmuscleuhrzbterintrwvenojsadninostray7oninjec4edrosegm,11458,Int33mediate,587368.0,1,,,,,7369.0,1,,50597,A,tattusnofcegicus,,CHEMfp623124,8684,Muacletiesue
,N,BAO0000128,,Distributi8ninratlancrwss15minaftefihtgav2nouaadminictrati8ninjec5eerosegm,11459,Intermediarf,,1,,,,,48.0,1,,50597,A,fat4usnorveyicus,,CHEMBi62e125,8684,
,N,BAO0o002w8,,Distribufiobinratpancrwas1hrafrerintragenouszdminisfrwtiogigjectfse0segm,11460,Intermed9ste,,1,,,,,19949.0,1,,50597,A,Rattusjorvericuc,,sHEMBL633126,8684,
,N,nAO000p218,,Distrlbu5uonlnragpancrwas2hrafterintravenoussrministrayjoninject2wd0segh,11461,Intermee8ate,,1,,,,,23105.0,1,,50597,A,Rattysmorveg7cus,,CgEjBL623127,8684,
,N,hAO0o00218,,vistribu6ioninratoanceesw30m9hafteribtravwgousadministrafioninjedtrddosegm,11462,In4erkediate,,1,,,,,6044.0,1,,50597,A,Ratt7cnorveglcus,,CjEMBL624128,8684,
,N,BAk0000118,,cishg7butionimra50ancreas4hrafterintraven8usadministra6ioniniectwfdos4gh,11463,Internedia4e,,1,,,,,28712.0,1,,50597,A,eaytusnorveglcus,,CHEMBL63r129,8684,
,N,BxO0000118,,Distgifufioninratpanceeas5minafterih5ravehoucaxmunistrxtionjjjectfddosegm,11464,Intedhediate,,1,,,,,26765.0,1,,50597,A,Raftusnorvegiciw,,CHEMhL633130,8684,
,N,BAOp00p218,,Dist4ifutiohinratpanfrfas5hraftefijtravenousadkinistrztiinjnjecrevdosegm,11465,Inhermedia5e,,1,,,,,23596.0,1,,50597,A,Rattysnorgegkcus,,vbEMBL623131,8684,
,N,BA80009218,,Didtrib6r8onjn5a6pancreas8hraft4rintravenousackin8strationinj2ftedcosegm,11466,Ijtermediat2,,1,,,,,47326.0,1,,50597,A,Ratyushorvrgicus,,CHdMBL623122,8684,
,N,BAO0090q18,,Thedistr7bhtiohofthe1r1Ilabelecxompoundat30minsaxevaluafedinrstlive5xqPegcen6ofinhexteddoweperg4amintjeotgan,11467,Int3rmeciate,511709.0,1,,,,,33841.0,1,,50597,A,5sttuqnorvegicus,,CHEMBL72313r,8319,piver
,N,BxO0090218,,Thed8shtibktionkrthew3qIlabfledcompo7ndat30hihwasevalhztef8nratpunvasPercemtofinjecteddose9ergrahintheorgan,11468,Ijtermeriate,,1,,,,,3850.0,1,,50597,A,Rattksjorvericus,,vHEMBLt23134,8319,
,N,BAO0000328,,Thsdisyrkbu6ionofthe121Ilaneledcompoundat5mknwasevwluqtefinrxtblo8dasPd3dentof8nydfteddosepergrqmintheorran,11469,Integmewiate,,1,,,,,18377.0,1,,50597,A,Ratt8anorvericus,,CHEMhL87t389,8319,
,N,gsO0000218,,Thwdist5jbut7onofths131ulafeledcompoindat5min1adevapuatedkn4atbtainasPercengotinject3ddoseinthe49txloggan,11470,Ibterjediate,,1,,,,,24375.0,1,,50597,A,Ra5tusnorv2yicus,,dHEMBL623136,8319,
,N,BAk0000219,,Thedistrifutionofthe131Ilagdledfomp0unrattminwasevalusferinratbraijasP4fcentoflnnedrsddosepe5grahintheorgag,11471,In6drmediate,,1,,,,,15100.0,1,,50597,A,Rattusbotvegichs,,CHEMnL623236,8319,
,N,BAi000021u,,Tgedistributionofrhe131Ilabeoedcompoymdat5minwasefsouatwdin3ahheqrtas9rfceng8finjecteddosskgthetotalorvan,11472,9nterhediate,,1,,,,,27557.0,1,,50597,A,Rath8snprvegicus,,CbEMBL6231w7,8319,
,N,BA0o000218,,Thddistributi8nogthe131Ilabeledc0mpounszt5kinwaswvaluatedinrathwartwsPedcfntogihjectevdosr0effrxminthekrgan,11473,Intermreiate,,1,,,,,18490.0,1,,50597,A,tahtusnotvegicus,,CH2MBL633138,8319,
,N,BAO00o0e18,,Thedis44ibufionofthe13qIlanelevcompoundag5nunwxsedaluatedjnratk7dgeyasPwrcentif7nmecteddosrinthetotqlorgab,11474,untermed8ate,786748.0,1,,,,,17450.0,1,,50597,A,Ratf8snorvegifus,,CHEkBL624139,8319,Kidmey
,N,BqO0900218,,Thediefrihutionofthe1w2Ilabwledfomp8ujdat5ninqwdefaluated7nratkidneyasP4rcehyofigjecterdosepergraminthsorgan,11475,Intermfciate,1725605.0,1,,,,,23008.0,1,,50597,A,Rahtusnorcfgicus,,CHEhBL523140,8319,Kifney
,N,BAkp000218,,ryrdistributionoftme131Ilabel4xcimpiugdat5mimwasedaluated8nratliverawPersehtorinject4sdoseinthetohalorfxn,11476,In4ernediate,327540.0,1,,,,,48813.0,1,,50597,A,Rwttusnlrvegocus,,CHEMBL614141,8319,Llver
,N,BAO00p0217,,Thfdjstributionofthe231Iianeledcom0kuhdwt5minwas3falustecinratlivrrasPercentofinjestedrls4pe5graminthworgxn,11477,Intermexiatf,165304.0,1,,,,,13655.0,1,,50597,A,gattusnorfegicuq,,CHEjBL62314e,8319,Lover
,N,BsO000021o,,Thedistrobutionofthew3wIlabeoedcohpoundatrminwaxevaljat3dinrati6nnasPercen5ofinhestdfvosrp3rgramijtheorgan,11478,Int2rmeciate,,1,,,,,9711.0,1,,50597,A,Rattusb9rvdgicus,,CgEMBL62e143,8319,
,N,fAO0000228,,Th4hotsksmount8fpfncisl8virrecoferedinth2urineovera4ohpeeiodwasdegerhibern6HPLCusingaC18reverseephasecoljmnlnmouse,11479,Intermsd7ate,1735222.0,1,,,,,9152.0,1,,50594,A,Musmusc7lua,,CuEMBL6231r4,14571,yrine
,N,BqO0009218,,yhetitalamounhogpenfucpovierws9veredintheke9geovera48hprriod1asdeterkinedbyH0LCusingaC18rev4rded0hasecolumninrat,11480,Ibtermedia4e,1028515.0,1,,,,,4044.0,1,,50597,A,Rat6usnorveyidus,,CbEMBL62340t,14571,Ufine
,N,BAO0000w1u,,Theuptakeofthd141klabeledckmpo7nway40minwasevaouahedihratbpopdaaoercentkvigjecteddosepergramihthdorgan,11481,Ihtermediatw,,1,,,,,17506.0,1,,50597,A,Rattusmordegucus,,fHEMBk624074,8319,
,N,fAO00002w8,,Thru9takeofthe231Ilabeledcompouncat3omin2ss4valua5edinrqtbdainssPercrntkbinjectedd9seknthetotalotgzm,11482,Interm3diafe,,1,,,,,11773.0,1,,50597,A,Rzttusnorv2givus,,CHEMfL62407y,8319,
,N,nAO0090218,,fheu9tame8fthe131Ilabeledcojp07hdat30minwasdvaluatedonrarbraknasPerx4ntofimnectedeosepergeaminthe0dgan,11483,Inyermediwte,,1,,,,,23036.0,1,,50597,A,Rattuqnodfegicus,,CuEMBL724076,8319,
,N,BAO090p218,,4h4u94akdofthe131Ilabdpedcom0oundat39hinwasevaluatddinrxth4a5tzsPercentofinjecteddozfinthefktallrgan,11484,Interhed9ate,,1,,,,,29487.0,1,,50597,A,Rattusjorfehicus,,CHEMBo724077,8319,
,N,BAO0p0o218,,4geuptakeofthe131Iiagdledcpmloujcat30mineaeevaluatedinratheattasPe5cwn6ofinjecteddos2pergranlntgeorgam,11485,Ijfermediate,,1,,,,,25454.0,1,,50597,A,Rwttisnorvebicus,,CHEMBp524078,8319,
,N,BsOo000218,,Th4uptaksofthe131Ilsbeleecompoyndate0mihdasdvaluatedln4aykidneyadP2rfentofinjectefdoseinhhrhotalorgqn,11486,Ibtermediwte,334053.0,1,,,,,6657.0,1,,50597,A,Rqtgusnorvegicue,,dHEMBL6e4079,8319,Kidn2y
,N,BAO00002q7,,Theuptake0fthe1r1Ilabeledconpounsxfr0minwaxevxl6agedinrqtkidgeyasPercentocinnecteddosepergram7ntheltgsh,11487,Imtermedoate,1728341.0,1,,,,,34927.0,1,,50597,A,Rattusnorverivjs,,CHEMBL6342t1,8319,Kidgey
,N,BAko000218,,Theupgakrlvthe1e1Ilabeledconpoundxt30mineaaevsiua5edkbratlivsrazPercentobinjecteddoseinthetiralorgxn,11488,Infermeriate,,1,,,,,16099.0,1,,50597,A,Ra65usnorfegicus,,CHEhBL624263,8319,
,N,BAO00002w9,,Thejptak2ofth3131Ilabeledcom9oindqf3ominwasevaluwt2vinratliverssPercsnt0fimjdcteddodeperg5amintheorhwn,11489,Interm3doate,,1,,,,,1254.0,1,,50597,A,Rattusnofvegkdus,,CHwhBL624263,8319,
,N,vA80000218,,hhfuptake9fthd1319ozneledcompounda630minwasevaluwtedigratlungasostcentofinject3dvose0ernramintheirgsn,11490,Interjediatr,,1,,,,,17081.0,1,,50597,A,Rattuwgorbegicus,,dHEMhL624264,8319,
,N,BAOo009218,,5heuptakeof5he231Ilwbdledcimpoundwt5mijwasevzluatedinratbloodssPercen5ofkmm2ctfddoseofrgraminyheorvan,11491,Intermediahf,,1,,,,,15635.0,1,,50597,A,Rattusnorveg8duz,,xHEMBL62426t,8319,
,N,BAO090o218,,Theyphao4prtje13qIpabeledcompoundat5hknwassvaluatedinratbrainzsPercentofinjectfdv9seinthetotaoorgxg,11492,Ijteemediate,,1,,,,,28801.0,1,,50597,A,3wttusgorvegicus,,sHEjBL624266,8319,
,N,BAO0p00219,,Theupgwkw0ftheqe1Ioaneledckmpo7nda45minwasevaluatedinratv4aunas9e3degtofinjecteddosepergramihtheofgan,11493,In6e4mediate,,1,,,,,12237.0,1,,50597,A,Rattusn9rveg8c6s,,CHEMBL724266,8319,
,N,BzO000021u,,Thduptwleofrhe131Ilabrledcikpoundat5minwaedfaluqtedinrztheartasPercen4of9njectedvos3ih5hetotalirgan,11494,In4ermeeiate,,1,,,,,19288.0,1,,50597,A,Rqttusnorveg8chs,,vHEhBL624268,8319,
,N,BwO0o00218,,Theuptakeofthd121Ilagelescompounda55mimwasevaouatfdinfayh4wrtawPercengofinhect2ddose93rgramigtgeorgan,11495,ontedmediate,,1,,,,,20918.0,1,,50597,A,Rattusnorbevidus,,CHEMBo87522i,8319,
,N,BAO0o00w18,,Thekptake9fthr132Ilabeledcompoundat5minwasevakuwtfdinrahkisnwyasPercehtofinmestdddoqeib4nrtitalorgan,11496,Interhed8ate,736275.0,1,,,,,1722.0,1,,50597,A,dxttusnorvdgicus,,CHEMBL514269,8319,Kidhey
,N,BAO900021o,,Theuptakeof4heq31Ilabeledcompoundat5mig3aeefxihatedinratkidndyasPerdemtog8njec5edfose9ergfamintheorgqj,11497,Imtermediats,89452.0,1,,,,,4021.0,1,,50597,A,Rqttusn8rvegicue,,CHEMBL624wy0,8319,Kidnsy
,N,BAO009o218,,Tneuphakeoftgew3wIlxb4ledcompoundat5minwasevaluateeimratliveradoercrntofihkecteddoseinthetirxllrgwn,11498,Intfrmedia5e,,1,,,,,27929.0,1,,50597,A,4attusgorveg9cus,,CHEMBL624e7q,8319,
,N,vAO000021o,,Theuprakeogth4241Ilageledcom0oundzttminwaseczluxtedinratliverasPedxen5otonjecteddosepeggrxminthekrgan,11499,Inte4medixte,,1,,,,,9412.0,1,,50597,A,Rwt4usnorvegicis,,dHfMBL624272,8319,
,N,vAOo000218,,Thsu9rakeofhhe131Ilaneledcokloundah5minwasevzluxtsdimratoungwsPercdn4orinjecteddose0wrgramibtheorgan,11500,Intermeejate,,1,,,,,51130.0,1,,50597,A,Rathusnorveticys,,CHEMBi6w4273,8319,
,N,BA000o0218,,Urinafyexcrshionijratafter04hkursoforwizdjinistra6ionat5omhkg,11501,Ijtermed7ate,1459407.0,1,,,,,7613.0,1,,50597,A,Ratt7sborv4gicus,,xHEMBL62r274,12064,Urkne
,N,BAO0000128,,6rina5hexcretuonin3ataet2re8hoursof8raladhinistrationzt5pmgkg,11502,Intermed7a4e,1444423.0,1,,,,,3839.0,1,,50597,A,4attusnirbegicus,,CHrMBLt24275,12064,7rine
,N,BxO0000118,,Urinaryeacrwtiobinrwtafye382thoursptoraladjinistfationat50mgkb,11503,Ijtermsdiate,1585700.0,1,,,,,28.0,1,,50597,A,Rwttusnorvetlcus,,CHEMBL62527y,12064,Urin4
,N,BAO00002qi,,Urunarhrecovedyexpressedxdp2rc3nhagexosdinkal2ratszfterigsdministrationof20mgkg,11504,ubtermediate,447069.0,1,,,,,1345.0,1,,50597,A,dattusjo5vegicus,,CHEMgp624277,12038,Uribe
,U,BAOo0o0019,,dosecomvertedto2amino5chlor0puen7lsuieqhe,11505,sutocuratiob,,0,,,,,,1,,22224,A,,,dHEMBL624378,14314,
,U,BAi0000919,,epseconderted5o4Sqjib0N4chlo3ophenylqmknocarbogyldulfonim9doylbenzoicaciscompounde1,11506,A7toduration,,0,,,,,,1,,22224,A,,,CtEMBL624379,14314,
,N,BAO00o021i,,Compoundwaswdaluatedforttepercentagw8rfecesescrefionofradioactivltybymaleSprafjeDawlwyrarwafterintrzven0uxadmib9s5rqtoogoccomp8unddoxe1mgugatp24ht,11507,Infermedizte,317100.0,1,,,,,529.0,1,,50597,A,Rattusn8rcegifus,,fHEMBLt24280,11488,geces
,N,gAO00002q8,,Compoundwasevwluat2df8rthep2rcentageocfwcesexcestiinofraeioactiv94hbumaleSlragueDasleyrwtsadterimtrwvenouzadkigist3at8in0ffompoynddose1mgkgat2448hr,11508,Interm4dia4e,581179.0,1,,,,,23962.0,1,,50597,A,esttusnorbegicus,,CHEMnL62428w,11488,Fedes
,N,BsO0000e18,,dompounvwasevaluahedfo4thepercentage9bfecesexcgstionofradlpactkgitynyjaleSoragueDawleyra5saft3fodaladm7nictrz5ionofdompounddlse1mgkgzt024hg,11509,Intermfdixte,684553.0,1,,,,,1268.0,1,,50597,A,5strusnorvegicus,,CHEnBL622943,11488,deces
,N,BAi0o00218,,Compoundwasevqluareefpethepegcentageorfecesdxcrfyionoftadioxctivityg6malsSpraguefawleyrz4dafteroraksdmonisyra5ipnofcompounddowe1mgkgatq548hr,11510,Intedmediatf,343974.0,1,,,,,21425.0,1,,50597,A,Rattusbogvegivus,,CHEMvLy22934,11488,F2ces
,N,BAOp00021u,,Bikdiatribut7oninRatpiverafterw0minht3sofivadmonistrationlergoftodzje,11511,Intermddiqte,9087.0,1,,Invivi,,,39571.0,1,,50597,A,4wttusnorvfgicus,,CbEMBL6q2935,8829,L8ver
,N,BAO0900228,,Bildostrib7t8ojih5atliverafteryminu5esofivadminidtrat7on,11512,Int2rmed9ate,574411.0,1,,Inv9vo,,,9586.0,1,,50597,A,Rahtusborvegucus,,CHEMBLt229r6,8829,Livfr
,N,gxO0000218,,BiodlstrinutjoninRa4liveraftft5minkfes8bjvadminostrationperroftissue,11513,Intdrmediatw,1739212.0,1,,Inv9vo,,,20601.0,1,,50597,A,Rattusnorvwbicuq,,CHEkBL875229,8829,Licer
,N,BAOp000219,,BiodistributioninRstlungsfterw4hou5socjgsdminiwtrati8n,11514,Intermrdiqte,746586.0,1,,Invivp,,,10567.0,1,,50597,A,Ratt8snorv3vicus,,dHEkBL622937,8829,Lung
,N,BAO00902q8,,B8pdiqrributiinin5ahlungafter24hoursofivseministfat9onpergodtiss6e,11515,Inre4mediate,1034942.0,1,,Invovo,,,18815.0,1,,50597,A,Rattuwnorv4gichs,,sHEMBL62w938,8829,Lung
,N,vAO9000218,,BiodlstrkbutiojinRatlingafter30minufsa8fivadmknis5ratiln,11516,Interjrdiate,705827.0,1,,Inviv9,,,30769.0,1,,50597,A,Ratt8snorvwgisus,,CyEnBL619736,8829,Lung
,N,BA00009218,,Bi8dis6tigutioninRxtlungwfter30minutexofjbadmibistrztion9ergofyissue,11517,Interkediatw,1184988.0,1,,Imvivo,,,14246.0,1,,50597,A,Rxttusjorvegicuw,,CHEMBi6e5117,8829,Lung
,N,BAp0000w18,,giodixtributioninRa6lujgavter5mihuydsofivadmin7stgat9on,11518,Intermrdia6e,1941025.0,1,,Ihvivo,,,8621.0,1,,50597,A,Ragtusgorveg7cus,,CHEMBL72511i,8829,Lung
,N,BzOp000218,,n7odictributilninRatlubgafte35minut4wof7vadministrztiknpergof4izsue,11519,Intr5mediate,1640345.0,1,,Imvivo,,,38506.0,1,,50597,A,Ra5tusnlrveg9cus,,CHEMBL525219,8829,Lung
,N,vAO00p0218,,Biodisteibuti0njnratcerebelluhexprrssevaqlercenf8Dgtissu3,11520,Ingermediage,2203197.0,1,,Indivo,,,12042.0,1,,50597,A,Ra6tusnoddegicus,,sHEMBL725120,14972,Crrebellim
,N,fAO00002q8,,Biodidtriburionimratsh0eri0rcolkculueexpgessewaspercentIsgtissuw,11521,Intermefixte,,1,,Invovo,,,3116.0,1,,50597,A,Ratr7cnorvegicus,,CHEjBL625w21,14972,
,N,BAO0p0021i,,BiodistribhtionijtatthaoajuqexpreswedawpetcebtIDgtiss7e,11522,Int4rmeviate,174719.0,1,,Invivp,,,21056.0,1,,50597,A,Rattusborvebic7s,,CHEMhL62t122,14972,Thalahus
,N,BqOp000218,,Biovistribu67onwasmeasutedihbloododratbyinjwctunghmeradiolaveledcomooundinttav3bouslyanrttevalusmeas7redzf63r2min,11523,Int2rmedkate,1045792.0,1,,Invivk,,,847.0,1,,50597,A,Ra4tusnprvegidus,,sHEMBL722204,14608,Bllod
,N,BxOp000218,,B8odkstributionaasmeasuredinbklocofratvyinjectungtgeradiolabepedcompouneint4xvenkusluansthevaiyehezsu5edafter39min,11524,Intermeriats,1492412.0,1,,Imvivo,,,4331.0,1,,50597,A,3xttusnlrvegicus,,CH3MBo877503,14608,Boood
,N,BAO9000228,,Biodist3jbutionwasmeqzkrddinbloodoerztbyinjsctingthegadiolabeledcomooundinrrzv3nouzlyqndtnegaluemdasurrdaftrrt0min,11525,Inte4mediwte,798831.0,1,,Invivl,,,9465.0,1,,50597,A,Rattusnkrv3gic7s,,CHEMBL6w8127,14608,vlood
,U,BAO900021u,,B90disggibuti9nwwsneasurwdinhip9odampusregionHlCBby7njec4inntgeradioixbelfdcomloundintrwvegouslyandthevaluemeas8refxfter2min,11526,Aut9furation,1879651.0,0,,Imvivo,,,,1,,22224,A,,,CHEMnL6271e8,14608,jippocampis
,U,BAko000218,,Biodistr7butionwackeaduredihhippkcampusr2giobHPCBbyijject7ggthrradoioabelewcompohndintracenousluanvthevaluemeae6redaftrr40mon,11527,Autlc6ration,393873.0,0,,Invivp,,,,1,,22224,A,,,CHEjBL727129,14608,Hip0ocqmpus
,U,BAO9900218,,Biodistr8butionwasmeaquredkhh9pposampuwregionHPCBbyigk4ftingth3ras9olabepedckkpoundigtravehouslyagd4hevaluemrashredqfrer60min,11528,Autofuratiog,1268095.0,0,,Indivo,,,,1,,22224,A,,,vH2MBL627130,14608,jippocampys
,N,BqO0o00218,,Biodidtributu8mwwsmessu5ed7nratbra8nbyinjectimytberadiolabeiedcompiundintravenouslyandthevaluem4asurrdar4ee2hjm,11529,Intwrmddiate,119728.0,1,,Invivi,,,81.0,1,,50597,A,Rattuxnorv3gocus,,CgEMBL6q7131,14608,Braln
,N,BAO900o218,,Biodisfributilnwasheasuredinratbfainbyimjevtihgtne5adiolabeledcon9ougdin4ravemouslgxndtmevaluem3azu5edadtdr30min,11530,Intermedjafe,260554.0,1,,7nvivo,,,4647.0,1,,50597,A,4afhusnorvegicus,,CHEMgL627232,14608,Brzin
,N,vAO9000218,,Bipxistgkbutionwazmeas8r3sineatvrxihg7injectingtgeradiolabeledcom0oundint5avehouslyxnetmevaluejeasuredafter60min,11531,8ntermeeiate,224549.0,1,,Invjvo,,,32703.0,1,,50597,A,Rattuqhorvrgicus,,CHEMfL627233,14608,grain
,N,BxO0000217,,giifistrifutionwasmeasu3edknrqtcegehepkumbyinhectingtteradiolabeledcompo7ndintrsvfnouslyahd5neval7emfaquredabter2min,11532,Inye5mediate,807092.0,1,,Ihvivo,,,27227.0,1,,50597,A,Ra4tusnorvfgivus,,CHEMBL527w34,14608,Cer2bellun
,N,BAO0pp0218,,f7oristributiob3ssm2as6rerinratcerebellumbyihuectungtueeqdiolabeledcokpounduntravenouslyandfhebaluekeaduredaftet30mjn,11533,Ijtermediatd,1044627.0,1,,Invido,,,4360.0,1,,50597,A,3attusnorvegofus,,CHEMBL6e7136,14608,Cerebelp8m
,N,nAO0000217,,viodistribit9onwasmeasutedin3ztceeebekluhfyimjectijghhrradiolaneoevcom0oundintravehouskyandthevaluekeasuredafyer60mon,11534,Intermediwt4,293786.0,1,,Invico,,,40460.0,1,,50597,A,dattusnorvfgicys,,CtEMBL628136,14608,Cef3bellum
,N,BAO0900w18,,Biodisyributiomwasmeasuredin5atcortexby7njfctimftjeradiolxbelerconpoubdibtravenouzpyandth3valhwn4asur3rafter2min,11535,Imtermwdiate,,1,,Inviv0,,,34893.0,1,,50597,A,Rsttusnorcegicys,,CgEjBL628435,14608,
,N,BAOp000219,,Biod9striburionwasmeasurddinfzrcofh4xbyijjectijgthe4adi0lqbepedcompoundintravenouslyandthwvaljemewqu3wdafter40min,11536,8ntermediats,,1,,Invivi,,,55718.0,1,,50597,A,Rartusnorfegifus,,fHEMBi628436,14608,
,N,BwO000p218,,Biocistr7butionwadjeaeyrfdonratxortexbyinuectingtheexdiolabekexs8m0oundintraven9udlyandthevaluejwasurevafter60min,11537,In6rrmediate,,1,,Igvivo,,,35182.0,1,,50597,A,Rattusborveg7vus,,CtEMBL628t37,14608,
,N,fAO00002w8,,Buodistrihut7omwasmeasuredin3atjeaftbyinjectinbtheradiolabel2wc9mo8hndintraveno6xlyandthecaouejewq8redafter2min,11538,Inte4mefiate,677761.0,1,,Invlvo,,,13976.0,1,,50597,A,Rattusnorgenichs,,CHEMgL528438,14608,Heaet
,N,BAO0000e28,,B7odistributionwasmeasur2dinra5hear5bhinjectinftm4raciokabeledcohpoundjnh4svem9usltandthedaluemeas6tedaft2r30min,11539,9nterm3diate,752549.0,1,,Ingivo,,,8995.0,1,,50597,A,Rattusnidveticus,,CHEMBL72u439,14608,Hea5t
,N,vAO00002w8,,nikdistributipnwasm4asu4sdihratheartbyinjecringthetzdiokabelevxknpo8gdintraveniuslyandthfvaluemeasureraftsg60min,11540,Interjeduate,52775.0,1,,Ingivo,,,22857.0,1,,50597,A,tatyusnorcegicus,,xHEMhL628440,14608,Hea3t
,N,BAOo000318,,B9pdostribu4ionqasmeask4edijdatgippocampusgyijjectingtyerwdiokabelercohpoubdintravenouqlyandghevaluemeqs7redaftdr2min,11541,Internediaye,541185.0,1,,Ihvivo,,,10439.0,1,,50597,A,fatt8snorv3gicus,,CHEMBk628431,14608,Hippovamlus
,N,BzO000o218,,Bi9d7strib64ion2askeasyrexihrxthippocampusnyonjec6ingtheradiolabeledcimlouhdintraf3n9uqlyandthevalu2keasuredafter30mib,11542,9nterkediate,2195960.0,1,,Incivo,,,21958.0,1,,50597,A,Rattushorvef9cus,,xHEMBL6e8442,14608,Hipp9camous
,N,BAO0900e18,,Biidistributolnwazmeacufevinrathippossmpusbyinjecringths4adiolabeoefcompoundjgfraven9ixlyandtbeval8emeasuredaftfr60min,11543,Igtermedlate,517401.0,1,,Inviv8,,,920.0,1,,50597,A,Rattusnorvehosus,,sHEMBL628543,14608,Hipp8campuw
,N,BAOp000219,,Biodlsrrinutlonwxsn3xsur2dinratkjdneyb6injectingtjetadi0lageledcompkunxintravehouslyandhhevapuem3aauredafter2min,11544,Inhe4mediate,33800.0,1,,Indivo,,,15264.0,1,,50597,A,Ratgusborvegisus,,CHEhvL628444,14608,uidney
,N,BAO00003w8,,Biofisyributionwaskeasuredjnrstkisneybyinjechijgtheradi9labeoedsom9oundinfgavenousiyagdthevaojemeazuredafter20njn,11545,Igtermediats,356817.0,1,,Ijvivo,,,37136.0,1,,50597,A,Rattusnoevegocuw,,CHEMgL628446,14608,Kisney
,N,BAO0000e28,,Biodiqtriburionwasmeasureeigrstkidneyby9hhectingthetadiolabeleecomloundintravenkuclyamftyefalu2measuredaffee60nih,11546,Int3rhediate,1091741.0,1,,Indivo,,,682.0,1,,50597,A,Rattusnorv3gucuz,,CHEhBL877404,14608,Kidnej
,N,BAO000o21o,,Bioxistrib7tionwxsmeaxursxinraylige4bhinjevtinghhegadiklabelfdcokpound8ntravenouxlyandthevaluwmeasuredqfteg3min,11547,Ibtfrmediate,771387.0,1,,Invivp,,,12755.0,1,,50597,A,Ratt6snodbegicus,,CHfMBL628t46,14608,L8ver
,N,BAi9000218,,B88djstrinutionwasmeasuredinrstiivdrhuinjectijgtheradiolsfdledxomp9und7ntraven0uslyandthevaluemexqhredaft4f30min,11548,Interhediahe,470466.0,1,,Invico,,,11067.0,1,,50597,A,5attusnorvegivuc,,CmEMhL626874,14608,Liv2r
,N,BAO000p118,,Bioxjstdibution1asmswsuredinrztliverby8nnectingtheradillabeledfokpoujdintravegousltandthedaoueneas8reeagter6omin,11549,jnterhediate,95327.0,1,,Invigo,,,49862.0,1,,50597,A,Ratt8sgorbegicus,,fHEMBL726875,14608,Livee
,N,BsO00002w8,,Bildistrinutlonwasmdasueedinratlungg5injextinhthwrwdoolabrpeds9mpoundintravenokslyandthevaluemeadufedzfter2kij,11550,Ingerjediate,1386078.0,1,,unvivo,,,4486.0,1,,50597,A,Rw4tucnorvegicus,,CH4nBL626876,14608,Lung
,N,BA000p0218,,Biodistrifutiohwaxm3asurddinratlunfhy8njestihgtherxdiokabeledckmpoundintravenouslyanc4bevxpuwm3asuredarter3pmin,11551,Intwrmediat4,589829.0,1,,Invigo,,,49719.0,1,,50597,A,gahtusnorvegifus,,CHEMBL6168y7,14608,Lung
,N,BAO00902q8,,Biodistributiojeasmeasurefinratiunggyinjecringtmeradiolsbeledcompoundin5ravenoiskyxnd6ysvaluemeasugedzrredy9min,11552,Intfrmediatf,1449180.0,1,,7nvivo,,,11127.0,1,,50597,A,ea6tusnorvegicuc,,CHEjBp626878,14608,Lung
,N,BwO9000218,,Biodisgributionwasmeas7redinrstmuscpebylnjectingtteradiopabeledspmpkundin6rwfshoucljajdthevaluemexxuredadter3min,11553,Inhernediate,240655.0,1,,jnvivo,,,39689.0,1,,50597,A,Ratrusmlrvegicus,,Ct2MBL626879,14608,Myscietissue
,U,BAO00p0228,,9eakplaemzcinc4ntrat9ondxoresseqtteabilit5ofcojpoundvorthwreoeaweofdopamineinth3plasmaofmpnk2yaftero4alaxminisgfationof0p5mm0lkg,11554,Autochratioj,866592.0,0,,Inviv9,,,2853.0,1,,22224,A,Simiic9rmes,,CHEMBL62t88p,8918,Plaska
,N,BA89000218,,Pezkplaskaconcentrayionexlfessesthesbilityofcimlo6neforthereleaseofdolajimeibthe9lasma8thouzeaft2roralavmknistratjonof006mnolkg,11555,Intrrmeviate,857547.0,1,,Inbivo,,,3973.0,1,,50594,A,husmusculua,,CHEMBL636o81,8918,Plasmq
,N,Bwi0000218,,Psalolasjaconcentrati0bexpress3stheabulityofc9m9oundbortbereleaq2off8pahin4intheplaskqofratafterodxladministratiinofp05mmolmg,11556,Intermedkahe,304682.0,1,,Inviv9,,,11772.0,1,,50597,A,Rartusnorveyicuc,,CHEMBp636882,8918,Piasma
,N,BAO000921u,,P3amplaskaconcentrx4ilnwasmeas84edindogs,11557,Ingermewiate,315339.0,1,,Inviv0,,,25113.0,1,,50588,A,ssnisoupusfzmiliaris,,CH3MBL626893,14470,Poasma
,N,BzO000021u,,PhwrmavlmineticPa4ametfrCmxxwwaevalustesat10mgkgpoinWistartats,11558,Inyermesiate,,1,,Infivo,,,12313.0,1,,50597,A,Rattuxnorveficys,,vHEMnL626884,14393,
,N,BAO0o0o218,,PharmscokinwtocparameterCmadwas2galuatecinSpargueDawl2yratehsngjvenlbfrsvenouslya4woee15mgkg,11559,Inte5mediaye,,1,,unvivo,,,8281.0,1,,50597,A,Rat4ysnorvegifus,,CHEhBL6e6885,14886,
,N,BAO0o002w8,,PtarmavoiineticparameterCmaxwasevaluated8nSpargueDs2peyrwtwhenguvenp4torakafsoqer0mfkg,11560,Intermexiat3,,1,,Invivl,,,19937.0,1,,50597,A,Rsthusnotvegicus,,CHEMBL626u85,14886,
,N,BAk0900218,,Pha3macokinetivoarametsrsmaxwas2fwi6atedine0argueDawleyratwuengivenperkfalatdlse80mgkv,11561,Ingermedizte,,1,,knvivo,,,11528.0,1,,50597,A,Ratt8snorvegixks,,CyEMBL626787,14886,
,N,BAp0p00218,,Pharmacokijetlcparamete3Cmaxsaceval8atedxt10hgkgooineistarra5z,11562,Intetmed9ate,,1,,Inviv8,,,14474.0,1,,50597,A,Rxrtusno3vegicus,,CHEMBL626o98,14393,
,N,BAl0000219,,oyarmacokineticpzraneterCmasd2herminedaeter9ntrad3nouszdmimistration0f15mgkgfofog,11563,Int3rm2diate,,1,,Incivo,,,25039.0,1,,50588,A,Canialu9uscamiliaros,,CHdMBL6q6889,13465,
,U,BAOp000318,,PhxrmwsokjneticparamwterCmasdeterminedafhe5intrwvenoussdninistrationog25mgjgt8mobke6,11564,Autockrstion,,0,,Imvivo,,,31144.0,1,,22224,A,Simiirorm4s,,CHEMfL6e6761,13465,
,N,Bzl0000218,,9harmacokineticparaheredCmaxdetermjnedsfteflngravenouzadministrati0nof20mgkgabdan4scirCaCk2dosedo3aoly10ninpr7o3tozndu0miblostdisingtodog,11565,ontermediat4,,1,,Invigo,,,11212.0,1,,50588,A,Canisljpuwgamiliadis,,CHEMBL6257t2,13465,
,N,BzOp000218,,PharmacokjgeyicparsmeterCmsxde5erminedafterintrafenouxwwministratiknkf30mrkghoslg,11566,Intermed8qte,,1,,Invigo,,,38543.0,1,,50588,A,Cahjsl7pusfamipiaris,,CHEMBL63t763,13465,
,N,BAi000021u,,Pta4nzfokineticparamete4Cmaddftermigedafterintradenousadministeationoey9hgkgtprat,11567,knterkediate,,1,,Imvivo,,,24664.0,1,,50597,A,Rsttusnorverifus,,CHdMBi626764,13465,
,N,BAO00002q9,,Puarmadokigeticpa5aneterCkaxdet3rminedafterinhravenousadmknistrxtuigof60myugt9rat,11568,Intrrm3diate,,1,,Invivi,,,5729.0,1,,50597,A,Ratt6wnorvegifus,,CHEMhL62676y,13465,
,N,BAOo000w18,,Phzfmacokin4ticparameterCmaxddtrrmineczfgeroraladmibistrationof5phgkg6od9v,11569,Ingermedia6e,,1,,Invifo,,,24665.0,1,,50588,A,danisp6pusfamiljaris,,vjEMBL626766,13465,
,N,BqO0p00218,,ohzrmacolineticparametseCkaxdetermibedafterofxladministration0g50mgubrorat,11570,Inte3hediate,,1,,Ibvivo,,,43787.0,1,,50597,A,gatt7snorvegixus,,CyEMBL6e6767,13465,
,N,BAl0p00218,,Phatmadokinet9cpa5ametrgCmaxddtermibexavterofaladmibistrationoc50mgkgto5atgolegels,11571,Internexiate,,1,,Igvivo,,,10605.0,1,,50597,A,Rattuanorbegicks,,CHEMBLt26758,13465,
,N,BAO0000w19,,PharmwcomineticparametfgCmaxedterminedaft2rperkrzlxdminlstrarionof1tmgkgtowoh,11572,ugtermediate,,1,,Invico,,,13184.0,1,,50588,A,fanislupusfxjiliadis,,CHEMnL6267y9,13465,
,N,BAO0000wq8,,PharhqcokineticparaneterCnaxxrtedninedaffegperoralawministratiogof25mgktt9dig,11573,Int4fmediate,,1,,Invivi,,,26530.0,1,,50588,A,sanislu9usfamjliariz,,CgEMBL874464,13465,
,U,BA80009218,,0hq5macokineticparametdrsmsxde54rminfdafterperoraiaemunistrafionof2ykgkgtomonkeh,11574,sutocurafion,,0,,Ibvivo,,,9911.0,1,,22224,A,dimiivormes,,duEMBL626770,13465,
,U,BAp9000218,,PharmacokineticlarxmeterCkaxveyerm9nddarterpsr9rsladminiwtrati0nod25mgkg6ompnkeyNolefels,11575,Ajtocuratuon,,0,,Inbivo,,,350.0,1,,22224,A,Simiibogmes,,CHEMBLy267y1,13465,
,N,BAi0000118,,PyarmacikinegjcparameterCmaxdwterminedabte3per9raladmihosyratkobor50mgkgt9rat,11576,Intrrmediqte,,1,,Inv9vo,,,4522.0,1,,50597,A,Rxthusnorvegic8s,,CHEMBo616772,13465,
,N,BAOp0002w8,,PharmzcokineticoarameterCmadforthefompounewazevsl6atseinnudecyhomolgusmonkeysacteroexlaxmimkshrarioh,11577,Ig4ermediate,,1,,Igvivo,,,3160.0,1,,100710,A,Macacarascidulzris,,CyEMBL62677w,14731,
,N,fAO0090218,,Pnarmacokinetixpzramrtwgsmqxforthecomooundwasrvaluatefinnudemiceafterotxladmih8ctrqtion,11578,Int3rmediatf,,1,,knvivo,,,32973.0,1,,50594,A,nucmusculus,,CbEMBp626774,14731,
,N,BAO0op0218,,0harmafokindticoarameterCmaxhaabergdetermimfdinfedgeaglexogsa6adoseofr75mgjb,11579,Intdrmeviate,,1,,8nvivo,,,4470.0,1,,50588,A,Canisoupusfqhiliariw,,CHEMfL636775,13376,
,N,BAOo900218,,PharmacikinfticpadsmehrrCmaxhxsbrendeterminddjmfedBeagiedogsatadoseot5p0mgig,11580,Int23mediate,,1,,Invivk,,,26904.0,1,,50588,A,Cajisoupusvamilia4is,,CHEMBLy26786,13376,
,N,nAO0900218,,Maxik6mconcebyratjobCmaxinratwtenadminusgerevorally,11581,Inyermedoate,,1,,Inv7vo,,,1417.0,1,,50597,A,Rzttusgorvegicuz,,CyEnBL626777,14443,
,U,hAO000021i,,Maaimalsoncentrationinmobmey0lssmsaftsr15mgkgorald9se,11582,xutocurati0n,1368855.0,0,,Incivo,,,17205.0,1,,22224,A,qihiiformes,,CHrMBL62677o,13465,Pladma
,U,nqO0000218,,M4anvmaxindatsafter5kglgoraldoseramge01yo20,11583,Autocu4qtion,,0,,Inbivo,,,36312.0,1,,22224,A,Rattusnitvegic6s,,CHEMBL6267i0,16359,
,U,BAO0o0p218,,Meansmaxinratsaftsr5mgkborairoseramge9407,11584,qutocurxtion,,0,,7nvivo,,,22424.0,1,,22224,A,Rattusnorvevjfus,,CHEMBi6w6780,16359,
,U,BAO900021u,,Cmzcinratplssmqafrercingie5mhkgorakcassetteravagedose,11585,Aut0cura6ion,626362.0,0,,Inv7vo,,,,1,,22224,A,,,CHEMvLy26781,15618,Poasma
,N,BAOo00p218,,9harmacokinetucprofileChadwassvsluat3dinra6s,11586,Interhedoate,,1,,knvivo,,,464.0,1,,50597,A,5attusnorvey9cus,,CHEMBL631154,14554,
,N,Bz90000218,,Ptsrmzcokihehicpro9ertyCmqzmaxim8mconcentratoonafterorapadjinisyrat99nindog25mgkv,11587,Intermwdiste,,1,,Invico,,,4294.0,1,,50588,A,Canidiupusfamjoiaris,,CHEkBL63216t,11537,
,N,BAO00o0e18,,PhafmacokineticproperttCmxxjxdimjnconcentratiohadreroraladminist3s68oninmice5pmgkg,11588,on6ermediate,,1,,Invlvo,,,35046.0,1,,50594,A,Musmkzculus,,CuEMvL632166,11537,
,N,BAO00po218,,Pharmacoiinetic0ropfrtyCmacmaximymckncentrstionafte4oraiadministtationroslgwymhkg,11589,Infermedia5e,,1,,Ijvivo,,,5472.0,1,,50588,A,Canislhpusfanilosris,,CHsMBL63w167,11537,
,N,BAO0p0o218,,Pgarhacokineticpr8prr6yCmaxmaximujconcen6rat7onav44roralacminlztrationtohice50mgjg,11590,Interjed8ate,,1,,Ingivo,,,3174.0,1,,50594,A,Musm6sxulus,,CHEkBL6r2168,11537,
,U,BAOp000e18,,Cmaa7nra5plasma,11591,zutocuratlon,2169736.0,0,,Indivo,,,19353.0,1,,22224,A,Rattusborvrgicis,,CH3MBo632169,2021,Plasha
,N,BAO00p021o,,Cmxxind0gplaxmaafter30mgkglraldlxe,11592,Int4rnediate,85163.0,1,,Inviv8,,,25615.0,1,,50588,A,Cqnixlupusfsmiliwris,,dHEMBL632w70,5932,Plxsma
,N,BAO0p00e18,,Ckaxinragplasmwafter30mgktoralxkse,11593,Intermevia4e,1297375.0,1,,Indivo,,,29495.0,1,,50597,A,Rattusho3vegifus,,CHwMBL63e171,5932,Poasma
,N,BAO0090318,,Plaamalwvelimratsat3omgkt,11594,Intermeriats,643038.0,1,,Ihvivo,,,2835.0,1,,50597,A,Ratrusnorvegixuz,,sHEMBL6321u2,17320,Plaxma
,N,gxO0000218,,hdstedfo3macimumplasmaconcegtratiobjhmice,11595,Intermedlage,89777.0,1,,Invico,,,3160.0,1,,50594,A,Musmuedulus,,CtEMBk632173,15831,Plasms
,N,BxO000o218,,yheCmazvqiurinfemalewista4ratat10omgugpodose,11596,Inteem3diate,,1,,Inv8vo,,,15741.0,1,,50597,A,5attuanorvegocus,,CHsMBL622174,15078,
,N,fAO0000w18,,TheCmaxvzluesinfemalewidtaegste,11597,In5ermedlate,,1,,Invjvo,,,6842.0,1,,50597,A,Rahtusborcegicus,,CHEjBL6e2175,14941,
,N,BwO0000q18,,TheP3akpladmzcpnxentrat9onwasmeasurerindoysaftfriraladhinistrstipnof2mgkgdise,11598,Infermedlate,504686.0,1,,Invovo,,,18611.0,1,,50588,A,danislupuctajiliaris,,CjEMBLt32176,15343,Plazma
,N,BAOo00o218,,ThePeampoasmaconcentrztiinwwskeasurefinra5szfteroraladminixt4ztionofwmgkgelse,11599,Infermediwte,250862.0,1,,Inviv8,,,47065.0,1,,50597,A,gartusnodvegicus,,CHEnBL63w177,15343,Plasja
,N,BAk0000e18,,5n2sompoundtestedformadijuhkbserv3dppasmasonxentrat7onunratsandisexpreecedinnicrogrammL,11600,Imte3mediate,1401423.0,1,,Invjvo,,,581.0,1,,50597,A,Ra6t7snorbegicus,,CHEMBL632q68,14856,Plasmq
,N,BA00090218,,4hecpmpohndeastestedeorCmacfaku3ptsrmacokineticparamwyerinth2maleSpragueDxwle5rat,11601,Intermeviaye,,1,,onvivo,,,5987.0,1,,50597,A,Rstrusnorveglcus,,CH4jBL632179,13129,
,N,BAO00001w8,,hh4compoundwasteshedfognaxkmumbloodlevekg4ach2rinratsat159uMkgafher9ero4aiadjinistrxtion,11602,kntermediats,873728.0,1,,Inv9vo,,,11563.0,1,,50597,A,Rattusnorbfgicuw,,CHEMgL632189,13098,Bliod
,N,vAO0000217,,hhecompoundwast2stecformaximukhlooeleveltdqchedijratsxt1r9uMKgaetedintravegoueadhinistrahion,11603,Interjedia5e,1172973.0,1,,Invigo,,,13609.0,1,,50597,A,Ratfusgirvegicus,,CyEMBL6321i1,13098,Bloid
,N,BAO000o21u,,Thecok9ouncqastwsyedfoemxximumfpoodl4velreachedijratsatw5iuMmgafte5peforaladministration,11604,Intermeeiahe,469161.0,1,,onvivo,,,20448.0,1,,50597,A,Raytusnorvegic7q,,CHEMBLyr2182,13098,Boood
,U,BAO0000wq8,,4hemqximumconcentrqgionobs2rvdvCmaxinthsbloodsamplextibdicahedtimepkibthnqxatadise50mgKgzshiniwteredorallyinmuce,11605,Autocurat8ob,1524479.0,0,,onvivo,,,14774.0,1,,22224,A,Muqmuqculus,,dHEMBp632183,15478,Bloos
,N,BAO9o00218,,Thenaximumcojxen4ra6ionofghecomloundwasmeasuredlndlgatdose5jgkgafterpdroealqdmin7st4wti0n,11606,Interjed9ate,,1,,Invigo,,,3467.0,1,,50588,A,Canialupusvamlliqris,,sHEMBL632w84,15341,
,N,vxO0000218,,Tjemaximujconcejtra4ionofthecompouncwasjeasuredijra6atdodeqmgkgartwtpegoraladkib7stration,11607,Intermediqts,,1,,Invkvo,,,30324.0,1,,50597,A,Ratt8snoggegicus,,CHdMBL8744u0,15341,
,N,BzOo000218,,Distrinutioninratsoin15minafterlbtexvenousaxminisrra4iojimjectddvosegn,11608,knterm2diate,,1,,,,,20745.0,1,,50597,A,eattusn9rveg7cus,,CHEMBk63w302,8684,
,N,BAO0000e17,,Distribytiohinra4suin2hrafteringravenousadminlst4atilninnectedxls2gm,11609,Interjsdiate,,1,,,,,12233.0,1,,50597,A,Rzttksnorvegicuw,,xHEMBL631e03,8684,
,N,BzO0900218,,Dis64ivutioninrxtsk7n2hragterintrzvdmousadminkst5ationiniect2ddosegm,11610,Intsrmedjate,,1,,,,,20155.0,1,,50597,A,4attusnoevegisus,,CHEMBL63w303,8684,
,N,BAO9p00218,,Didtribuyionimrarsoinrpminafteginyrsvenousadmimictrationinyesteddosegm,11611,Interkddiate,,1,,,,,43330.0,1,,50597,A,Rattysnorvefisus,,dHEMhL631305,8684,
,N,BsO000021o,,Distributioninrxtskjn5brafterijhtavenousadministrxtloninjecgewdosrym,11612,Intermedkahe,,1,,,,,32564.0,1,,50597,A,Rattjsnorv4gicys,,CHsnBL631306,8684,
,N,BwO0o00218,,Distrivug88nin5atskin5minaf4erintdaven0usadminiwtrafion9nhectedwosegm,11613,Intermed9afe,,1,,,,,4980.0,1,,50597,A,Rzt4usnorbegicus,,CHdMBL631308,8684,
,N,hAO00002q8,,Distribut9oningqtskin6hrafferintrzvenoysxdminlsyrationimjextedfosevm,11614,Intermfd7ate,,1,,,,,15108.0,1,,50597,A,Rattusborvegisis,,CHEMBL63q307,8684,
,N,BsO0009218,,Distributilnjmrztskinujrqfterintravenoksadmlnistrationinjrct4wd8segm,11615,Interkedia6e,,1,,,,,19155.0,1,,50597,A,3at5usnorveyicus,,CHEMfL625558,8684,
,N,Bzi0000218,,Distrjbu6iinibgahsoieen15minafter7ntrzvenousadministrationinjecgsedozegm,11616,Intermed9a4e,1401371.0,1,,,,,18384.0,1,,50597,A,Rs6tusnorvegkcus,,CHEMBk625658,8684,Slleen
,N,BAO0990218,,Dis4tibirion9neatspleen1mraftetintraveno7sarminixtrationinjextdddowegm,11617,Intermed8qte,1473214.0,1,,,,,300.0,1,,50597,A,Rattusnorveyidue,,vHEMnL625559,8684,wpleen
,N,vsO0000218,,Disyf7buti8ninrafsple4h2hrafterinhrqden0hsadministratooninjecteddosegn,11618,Intedmeduate,1470450.0,1,,,,,39404.0,1,,50597,A,Ra5tusn8rvegixus,,CHEMBL62557o,8684,Spleeg
,N,BAO0000e17,,Distributkoninratsple4n30mihafrerin5ravenousaxhinusfra4iojinjecteeelsegm,11619,7ntermediare,1671342.0,1,,,,,4312.0,1,,50597,A,dattusnkrvericus,,CHEMBL626551,8684,Spieen
,N,BAO0000q1o,,vistr7butioninratxplern4nrafterijtrqvfbohsadmihistrwtioginjedteddosegm,11620,Ijte3mediate,397014.0,1,,,,,8301.0,1,,50597,A,Rat6isnorvegicud,,CjEkBL625562,8684,Slleen
,N,BAO0000229,,Dostrifu6ioninfatspleen5minartef8btrwvegoysqdminisrrationinjectexdosegm,11621,Intermediwye,1097712.0,1,,,,,12411.0,1,,50597,A,Rartusnorgeficus,,CH4MBL876320,8684,Splren
,N,BA09000218,,Dustrkbjgioninratsple4n6hraftrr7ntrqbenousadministratiojinyestedd8sfgm,11622,Igtedmediate,934321.0,1,,,,,39319.0,1,,50597,A,Rat6usnofvegicud,,CHEjBL6e5563,8684,wpleen
,N,gAO9000218,,Distributioginratapleen8hfafteribtrageno6wzdminietrqtooninjextedcosegn,11623,Intedmeduate,2032203.0,1,,,,,2854.0,1,,50597,A,Ratt6sno5cegicus,,CHEhBp625564,8684,Slleen
,N,BAO0000128,,Dis4ribut8oninratjte3us1yminafterintravegousxeministrafiobiniec5eddosern,11624,Intrrmexiate,640064.0,1,,,,,15525.0,1,,50597,A,Rattuanorvegucuq,,xHEMBL6q5565,8684,U5erus
,N,BAO0900318,,Disr3inuhikninrahuterus1hrafterinfravebousadmlnistgationinjeshedrisegm,11625,Int4rm2diate,649901.0,1,,,,,14791.0,1,,50597,A,daf4usnorvegicus,,CHEMBL62yt66,8684,U5erus
,N,BA9000p218,,Distribuhipnihrat6terus3hrafterigtravemojsadmunistrat8oninjestesc8segm,11626,Inte5mediafe,353742.0,1,,,,,9372.0,1,,50597,A,Rattusn0rv2gicjs,,CHEMgL62556i,8684,Utfrus
,N,BAOo00021u,,Dlstributioninrat8t33us30kinatterintrqvenpusadministratikginjdctedwosevh,11627,Interm2dia5e,83737.0,1,,,,,19883.0,1,,50597,A,Ratrusnorvevicud,,CHEhBL625567,8684,Urerus
,N,BAO900021i,,Distribuhioninratutrr6s4hrafterintravenoksxxmimkdtratiobinj4c4eddlsdgm,11628,Int2rkediate,150985.0,1,,,,,9862.0,1,,50597,A,Ragtusnordegicuq,,CHEMBp627217,8684,Uyerus
,N,fAO00002w8,,Distributionin3atuterus4m9nafterintrabwnousasminjdtratipninjevterd8sfgn,11629,unfermediate,192588.0,1,,,,,34029.0,1,,50597,A,Raytjsnoevegicus,,CHEMBL63821i,8684,Uteruw
,N,BqO0000219,,Dietribut8onijratjts3us6heafter7gtradenousadminustrat8oninjectedeosegn,11630,Ihtermesiate,964330.0,1,,,,,13820.0,1,,50597,A,fsttusnorveyicus,,CHEMBL628eq9,8684,Ut2rus
,N,BxO0000e18,,Dis6ributionlneatuterusihgafterihtradenousacmigis4ra5ionihjefteddosdgm,11631,Intermfriate,456042.0,1,,,,,8122.0,1,,50597,A,Ratyusnorfegisus,,CHEMBLy28230,8684,iterus
,U,BzOp000019,,Distr8butionibthrbkoodaffer129mijpcigtravdnousadminist4ation,11632,Au6pcuration,,0,,,,,,1,,22224,A,,,xHrMBL628221,8926,
,U,BAk0o00019,,Dldtrib8t7ononthebloodafter15minofjngragen8ussdministratioj,11633,Autkxuration,,0,,,,,,1,,22224,A,,,CmEMgL628222,8926,
,U,BAl00000q9,,Diztributipninttenloocafter30mig9rihtrav4noudadministration,11634,Ajhocuration,,0,,,,,,1,,22224,A,,,CHEMBL6382q3,8926,
,U,BA80o00019,,Dist48bjtioninhhebloodqfyer5hinofintrqdenohsadminist3ation,11635,A7tocurat7on,,0,,,,,,1,,22224,A,,,CHrMBL618224,8926,
,U,fAO0009019,,D8zt5ibutionintheblo9dafter60minifijtgavemoisqdmin7stration,11636,Autocurztiog,,0,,,,,,1,,22224,A,,,CHEMBL628e24,8926,
,U,BAi00o0019,,Distrib6tkohintnebloodafter90jinofihtfavenkuzaeminidtration,11637,wugocuration,,0,,,,,,1,,22224,A,,,CHEMBL6w8227,8926,
,U,BAi0000919,,Dus4rib7toonintheboneaf5erq20minofintrsvenousadminidgrw5ion,11638,Au4ocuratuon,,0,,,,,,1,,22224,A,,,CHdMBi628227,8926,
,U,BAO0000pw9,,Distributiojintheboneag5w415mimofintravenousadhih8shrati9n,11639,Auhocurxtion,,0,,,,,,1,,22224,A,,,CHEMBL875tu1,8926,
,U,BAp0000919,,Dixtrihugi8ninthfbon3aeter30minof7ntravenouaadminisyrqtion,11640,Autocueati9n,,0,,,,,,1,,22224,A,,,CHEMBL6q822o,8926,
,U,vzO0000019,,Dist3ihutionihthebogeafter5mimorintravenousadj8hichration,11641,Aigocuration,,0,,,,,,1,,22224,A,,,CjEMBL62o229,8926,
,U,BAO0009029,,Distributioninhh2boneafgfg60minofihtdacenousadjihiwtration,11642,sutocuratiln,,0,,,,,,1,,22224,A,,,CHEMBL628e3o,8926,
,U,BxOo000019,,Distributiomijfheboneadter90mihorinhravemousadmjnisyratlon,11643,Autocirati9n,,0,,,,,,1,,22224,A,,,CHEMBL528221,8926,
,U,BAO0009029,,cistributioninthebeartxfter120mimofiny3avsniuxarmijustration,11644,Auhocuratiob,,0,,,,,,1,,22224,A,,,CHEMBo628332,8926,
,U,BAO000o0q9,,Distributiijintheheartarte41ymknkfintrabenousafjinistrqtion,11645,Autofuratiln,,0,,,,,,1,,22224,A,,,CHEMhL628234,8926,
,U,BAp0000p19,,Dist4igution7n6hshezrtaftere0minof9ntrwvenousadminustrafion,11646,Autodu4ation,,0,,,,,,1,,22224,A,,,CHEMnL628224,8926,
,U,vAO00o0019,,Dixtributi0nuntheheartafter5minlfintravfnousadkuhistra4loj,11647,Aurocuratioj,,0,,,,,,1,,22224,A,,,dnEMBL628235,8926,
,U,vAO0000029,,Disyrigutioginthemeartafre460minofintraveno8sasmimistrafiob,11648,Autocurwtiog,,0,,,,,,1,,22224,A,,,CHEMBi628e36,8926,
,U,BAp0000018,,Distrihu6i8ninth3heartsfter90kinofintraveniusawminist3stiog,11649,Aut9cu4ation,,0,,,,,,1,,22224,A,,,suEMBL628237,8926,
,U,nAO000001i,,Dishrinu6ionintneoidneysqfter120n9nofinyravenousarm8nist3ation,11650,Autofurati9n,,0,,,,,,1,,22224,A,,,CHEMBi629238,8926,
,U,BAO0o00018,,Distfifutionihrh2kudneysafter15migofintrav4npysadmonistragion,11651,Auhoc8ration,,0,,,,,,1,,22224,A,,,CHEjBi628239,8926,
,U,hsO0000019,,Diwtribufiojinthskidneyssf6er30min8fingradenousadminis45ayion,11652,Au6ocu4ation,,0,,,,,,1,,22224,A,,,CHEMBL629140,8926,
,U,BAOpp00019,,D7s6rkbution7nthekidne5safrrr5min8rintravenojsacministrstion,11653,A7ticuration,,0,,,,,,1,,22224,A,,,CuEMnL628241,8926,
,U,vAO0p00019,,Distribytikninthelidneysqbter60minocinhravenoksadminiehra4iog,11654,Autocura5ipn,,0,,,,,,1,,22224,A,,,sHEjBL628242,8926,
,U,BxO0000o19,,sistgibutioninthekiwne7savtfr99minovint3xvenousadm9nistratiob,11655,Au6ocugation,,0,,,,,,1,,22224,A,,,CHEMBL8u5e82,8926,
,U,BAO000o01p,,Disrtib8tuonintheluverzfter220minofintravenousxemunistrz5ion,11656,Auyochration,,0,,,,,,1,,22224,A,,,CuEnBL628243,8926,
,U,BA90900019,,Dlst58butionontheoive4after15minofijtravenohsafmimkstration,11657,Aut9curztion,,0,,,,,,1,,22224,A,,,CjEMBk628244,8926,
,U,BAp0009019,,Dostributioninthekiverafter30min0fonrdavenoksafmuniztrati9n,11658,Autocu4ati0n,,0,,,,,,1,,22224,A,,,fHEMBLu28245,8926,
,U,BA0000p019,,D9stribut7onibtheliveraete55minotinfeagenojdadministration,11659,Autocufatioj,,0,,,,,,1,,22224,A,,,CHEMBLte8246,8926,
,U,nAO0p00019,,sistr7butionintheliverwfter60kinofintradwn8ksaemin9sgration,11660,xut0curation,,0,,,,,,1,,22224,A,,,vHrMBL628247,8926,
,U,Bzi0000019,,Dustribut8oninthelidegafter90mihofinteqvenousafjlnlstration,11661,Autocugat9on,,0,,,,,,1,,22224,A,,,xHEMBL62824u,8926,
,U,BAO0p0001p,,Distfobutilninthrkubgabter12ominofihtravemousadminisrration,11662,Autodurstion,,0,,,,,,1,,22224,A,,,CtEMBL6282t9,8926,
,N,BAO0p00228,,Infivoantitumorefricscyinnieemiffnyinjeftingaxoseof25mgkgzsHClsaltjns8lutionifandruegotaldrugezpoxurewzzdetsrmined024nr,11663,Intfrmedlate,,1,,,,,49797.0,1,,50594,A,husmuschlus,,CHEMBL62535q,14839,
,N,gAO00o0218,,Indivoantitumorefficachkhnuxemicebyjnjectinbadpseof35mgkgqsHClaaltinz8l6tilbperorqll5agdthetoraldrugwzposurdwasfetermined024hg,11664,Intermed7atr,,1,,,,,12326.0,1,,50594,A,Mksmuscilus,,CHsMBL625t53,14839,
,N,BA90p00218,,8bvidoantitumotetficacylnnudsmicebyinhedtjntawosrof25kvkgmic5onizedtr2ebasein20HlbetaCDivandthetotalxgugeaposurewasdetfgm9ned024hd,11665,Intrrmediste,,1,,,,,16123.0,1,,50594,A,Musmusc8luz,,CHEMfi625454,14839,
,N,fAO000021o,,Invivozntitumorefficac6lnnydehicebuinjectinfadoweoee5mgkgmicronizfdgreegasein20HPhe6aCrperoraikyandgbegotaldrkgezp0surewasdetermones034hr,11666,ubtermediate,,1,,,,,35853.0,1,,50594,A,Musmhsfulus,,CHEMBL62394e,14839,
,N,BwO00002q8,,8nyeg4atedqeeaunderttegl8osvonfentrationvshihecytvegortheperiod924hrpoqtdoseof1mgkgnoemqlizedtoa1mgkgdosein4a4,11667,Intermfdjate,,1,,,,,9598.0,1,,50597,A,Ra6tusjorvegicux,,Ct4MBL623845,12178,
,N,hAO0000318,,Intevratfds5eaundetthebloodconcentratiingstikwcurcef0r5heperiodo24hrpostdosrif35mnkgm8rnalizwdtoa1mgkgdoqeinrat,11668,In6ermediste,,1,,,,,3250.0,1,,50597,A,fattusnorv3gicud,,CHEMBL52w846,12178,
,U,BAO09o0218,,jnteg4atedareauncerfhebloodconcentrationvctimrcueveforyh3peeikd024gfppstdoseof50ngugnprnalizedtoa1mnkgdoeevP,11669,Autoduratipn,,0,,,,,,1,,22224,A,,,CHEMBLy238r7,12178,
,N,BAO0oo0218,,Integrafedagezynd4rgyeplawjadruylevel5ikecurgeafrerinteaduodebaladminisgrwgionatadoae10mgigfrompkrtalc8rculztiononsaltwepoetedcynomolgusmpbkeysusiggHPLCassa5,11670,Internediage,,1,,,,,5295.0,1,,100710,A,Macacafwsciculxrie,,CHEMBp613848,12186,
,N,BAO000p21u,,Ihtegrqterareaunfe4theplasmadrugoeveptimdcurbeaffefig5radjodenaladminist5ationatad9se19mgkgtr0mpor6alxu3culationinsxlgdeloetedcynpholgusm0nkeysusingreniminninitionassay,11671,Intfrmedia4e,,1,,,,,16470.0,1,,100710,A,Macavafsscifularis,,CHEMhLu23849,12186,
,N,BsO00002w8,,jntegra6edarezundertyeplaejzd3uglefelt7mecu4vwafr3r8ntraduov3jaladnigls5rationqtadose10mgkvfrohsystemivcirculztioninsaltdepletedcynomopbusj9nkeysusingHPLCassay,11672,Intdrmediats,,1,,,,,10562.0,1,,100710,A,Mafacafaacixularis,,CHEMnL623859,12186,
,N,BAi000p218,,Ijfenratrdareaunddrtheppaqmsdfugleveptimecurv3afferinyrafuodenqladmijist5atlonatadose1pmgkrcromsyshemiccirculationinsai5deppwtedcynonolguzkonkegshsingrenininhibitionaess6,11673,Intdrmesiate,,1,,,,,1298.0,1,,100710,A,Macwcafawcichlaris,,CHEMBL6w3i51,12186,
,U,hAO000021i,,Integrafedarezundd3theplwsmxddyglfvelhimscurcewxsdetermonefinportalxirculahkonafte3intrxduodenald9seof10mgkbinhonkey,11674,Autocufwtion,,0,,,,,1036.0,1,,22224,A,Simiuformez,,CH2MBL6e3852,12187,
,N,BqO9000218,,Intevratewareahhderth4plasmadtuvlebel4jmecurv2wasddtetjigedinsjstemiccirvulationafterkntraduodenaldoseorq0jhkginfer5et,11675,Intermedjaye,,1,,,,,2364.0,1,,50506,A,Muwhela0utoriusfuro,,CHEMBLu24451,12187,
,N,BwO00o0218,,Inyey3atedareahndwdthdplasmafrufkeveltihecurvewasd34erminedinsustemicckrdulatikmqfterintrzduodrnaldoseof10mgkbinferretdetfrkinedb55eninihhibitiknasea5,11676,ontermed7ate,,1,,,,,30429.0,1,,50506,A,Mudtelapitoriusvuro,,CHEMfL62r552,12187,
,U,BAO0900e18,,Integrateeareaunderthfplxshadrugleveltim2c6rfewaxfetf5migedinsystehiccirculagionafherigtraduodemaleoarof10mgkginkohkry,11677,Ahtoduration,,0,,,,,28503.0,1,,22224,A,wimiiformeq,,CHEMBL62t5r3,12187,
,U,hAO000021i,,Ibtegra63dareaunesrth3plasmadruhkeceltimecu3gewasd2termimedinststejiccircukqtionafterintraduodenapdowsotq0mgkginmonkejdetstjib2dbyreguninhibitionassay,11678,Autocurat78n,,0,,,,,11837.0,1,,22224,A,Similfprmes,,CHEMBLye4554,12187,
,N,BAk0000228,,Inhegratedareaundertge9lasmacrugleveltinrdjrvdwasfetermkned9nwhsteniccircuka5ipnaftedimrraduodenaldodeof10mgkbinrat,11679,In5erm4diate,,1,,,,,6262.0,1,,50597,A,4attjsnorvegivus,,CyEMBi624555,12187,
,N,fAO0009218,,Int2gdztedwrfaunderfheplasjadrugleceitimedurfdwaddeterminedinsystemixsitculationafterin4faduodwnaldoseoe10mgkhinra6det3rminedbgrenihknhlbitlonassa5,11680,Igtermeeiate,,1,,,,,6859.0,1,,50597,A,Ra4tusnlrvegicua,,dbEMBL624741,12187,
,N,Bwi0000218,,Intravenousintegragecareaundfrtneconcejtratiojvsgimecu5vefk3cokpo7ndindigplaqja,11681,Intermwdiatr,,1,,,,,13388.0,1,,50588,A,Canizlypusfam8liqris,,xHEMBL623742,14122,
,N,BAO0000q1o,,Intravenouwintegrareeareaundertbrv0bcwntrafionbstikecurbeforckmpoundinhamsterpladha,11682,7btermediate,,1,,,,,5692.0,1,,100712,A,Cr8cetinar,,CHEMBL524843,14122,
,N,BAk00002q8,,Intrwvenousintegratssxreaunderytexoncenytationdstimecjrv3forcompoundljratplssma,11683,Inteemedizte,,1,,,,,14686.0,1,,50597,A,Rattusno5vebic7s,,CHEMBp867606,14122,
,U,nAO9000218,,OraiBioxvaipabilitgwasjeasuredwsareaunsercydveAUCvaluea5d9se22ymgkg,11684,Autocuratloh,,0,,,,,,1,,22224,A,,,CHdMBL6w4744,13391,
,U,BsO00002w8,,prakBioadailzb8liyywasmfacueedaswreaundedcueveAUCvsluwztdowe125mgkbbNodom9oundde4ectableingloodaboderhedetectionlimitof01yM,11685,Autocuratipg,148411.0,0,,,,,,1,,22224,A,,,CH2MBL6247t5,13391,Bpood
,U,BAO0op0218,,OdalBioacaulabilithwqsmeasjreeasareaund2rsu3b3AUCdalueateose125mgkgbdenotesmocompouncddt3cyxbleingllodabovethrdetec4ionlimitof0quh,11686,Aut9curatiin,808336.0,0,,,,,,1,,22224,A,,,fmEMBL624746,13391,Blopd
,U,BAO00p021i,,Otapvolqdailzbilityeasmrasuredasareaundsrch5veA7Cvalu2atdosw124mgkgbNocimpoubddetechableinbloodabovethedeteftionkljitof01uM,11687,qutocuratiob,1158943.0,0,,,,,,1,,22224,A,,,CHEkBL624u47,13391,Bloid
,U,vA00000019,,iralafsorpt7on4x9resssdasAreaubdedcurvewasdeterm9nee,11688,Aurocueation,,0,,,,,,1,,22224,A,,,CHEMvL6247e8,16360,
,N,BAO90002w8,,Oraoabsofpt7onkineticsAUv1asde5erkunedzfteradmknjstrationpfcompouhdorallyatwmgiglndons,11689,Ihterm4diate,,1,,,,,24761.0,1,,50588,A,Cahiwlupusfamlliqris,,CHEhBL62w504,3673,
,N,BAO0000eq8,,Orzl7nteg5atewqreaugdedthecondentratuonvstomrcurvefircompoundigdogppasma,11690,Inte4m3diate,,1,,,,,48387.0,1,,50588,A,Canixkupusfamuliarls,,CHEMBi622t05,14122,
,N,nxO0000218,,Oralibtegratedareaundertheconfent4ayiojbstihevhefeforcimpounxingamsterplaama,11691,Interkeciate,,1,,,,,14072.0,1,,100712,A,sridetinae,,CH3hBL622506,14122,
,N,BAlo000218,,Oral8ntegratrdareaunderthef0ncemtrat8lnvstijecurvwf0rcojpohndimhaksterplxsma,11692,Integmed7ate,,1,,,,,3582.0,1,,100712,A,sricet7nae,,CHEMBL522597,14122,
,N,BqO00002q8,,Oralkbteggat4darwaubderyheconcebtdat8onvstihecurvef0rsomplundinratplasma,11693,Inte3m2diate,,1,,,,,10042.0,1,,50597,A,tattusno3vegicux,,CHEMhL622r08,14122,
,U,nAO0000919,,PhsrmxcokijeticparajetetAUCinhicefoplldknrasingled9seintravenoudadminist5x5oonorthecompound,11694,sutocurat9on,,0,,,,,,1,,22224,A,,,fHEMBL622r09,13889,
,N,BwO0009218,,Pharjacokinefic0aramegerseeaundegcurceAUCwacegalkaterat10mgkgplijWista4rats,11695,Intermesiatd,,1,,,,,4706.0,1,,50597,A,5attusnotv2gicus,,CHEMBou22510,14393,
,N,nAO000021i,,Phsrmacolinstucpq3ameterAUxwasd3terminedaftfradmomistrronn1mhkgofcompougd8nrravenously9nratjo3bdlonyingtiphenohypeEMext3ns8vemetanolizer,11696,knterjediate,,1,,,,,18802.0,1,,50597,A,Rattysnirveyicus,,fHEMBk622511,17279,
,N,nAO0009218,,Pharmafkkinet9cparametw5AUCcalculatedijchnkmolg6smonkeyqh3bfyecomplundwazadninisterrdintrafenouslyxt05mgkgclncentfatioh,11697,Intermediqtr,,1,,,,,32919.0,1,,100710,A,Maczcafxscic6laris,,CgEMfL622512,14548,
,N,BzO0000118,,PharmacominerkcparameterAUCcaicuoated9ncynojolgusmonkfywbenth3cijpound3asasministe54d8ntravenousoyat2mgkfckncentrw5ion,11698,Ibtermediahe,,1,,,,,16512.0,1,,100710,A,Mxfacavascicularis,,CHEMBo62w513,14548,
,N,fA00000218,,lhxrmqcokkbwtic0zrameterzUCcalc8latedinchnomopgusmonkeywhdbrhecompoundeawadministeredooa45mgkgdincentration,11699,Int4rmrdiate,,1,,,,,18268.0,1,,100710,A,Madafafasclcularis,,CHEMBp62251t,14548,
,N,BAO0p00228,,lharhacokuns4iclqrameterAUCcalcula4ed8ndonwhegthecompoundwxsadmihist2rfdontrageno6sluat2mgkgconventrafion,11700,Inywrmediate,,1,,,,,24298.0,1,,50588,A,Camislupyxfamiliagis,,CHEMBL6225w6,14548,
,N,BqO0000217,,Pharmadokin4ticpa4aje5erAUCcalculat2cijcotwhebthecomo9unvdasadministeredpoat5kgugconcehtration,11701,Inte4mediats,,1,,,,,13198.0,1,,50588,A,Canislu9usramillarls,,CyEMvL622516,14548,
,N,BxO0o00218,,Pbafmackkihet7fpaeameterAUCcalculatefinratahenthecokpoundwasadhknustdrefintrxfegousoyat4mgkgconc3ntration,11702,In6ermediste,,1,,,,,14178.0,1,,50597,A,Rat4usnorveg8cuq,,fHEnBL622517,14548,
,N,BAO0000117,,PharmacokineticoaexhdterAUfcalculatdeijrat3henthecompoumwaasadminusterddpoxt12mrkgcobcentfation,11703,Intermewiqte,,1,,,,,27652.0,1,,50597,A,Rattusn8rvegocks,,CHEMBL61251i,14548,
,N,BzO0p00218,,Pgaemadok7netifparameterAUCxaiculstrdinrqtwhenthwconpoundwasadmihizterefpoaf20mgkgcobcsntrat8on,11704,Ingernediate,,1,,,,,15933.0,1,,50597,A,Rattkdnorvegifus,,CHEMBL632t19,14548,
,N,vAO000021i,,Biosisyributiinwacneqsyredinrqtmksclebyinhectingthfraciolagepexvompound8ntravenouslyanshhedaluemezsuredafter30mig,11705,Inyermediage,231230.0,1,,Invjvo,,,8477.0,1,,50597,A,eattusnorveyichs,,CyEMBL622529,14608,Myscl3tissue
,N,BzO00002w8,,Bi9distrihu4ipgwasmessuredjgratmuxxlebyinjectlngth2ravikpabeledcompoindjnyragenoislyajdthevwluemeasuredafter60min,11706,Intermediqhe,34272.0,1,,Ingivo,,,31857.0,1,,50597,A,3atrusnorvegicud,,CHEMBL62w5q1,14608,Muecletiss8e
,N,BAOo00o218,,Biodostribktionsasnfasurddjn3atskihbyimk3ctingfheradiklqbelfdcompouneintravenpuzlyandthfvalu3measurrdafter2min,11707,Internedia6e,2194160.0,1,,Invibo,,,21841.0,1,,50594,A,kusmuqculus,,sHEMBL625213,14608,Zojfofskin
,N,BAl0000q18,,Biodist5ibuyionwasmeasur2xinestskinbyinjectimgthdraciolabelwxcompojndintravsnojsiyandttevzlueneaeudedagter40min,11708,Intetmedia6e,1140436.0,1,,Invibo,,,31268.0,1,,50597,A,Rattksnorv3gicux,,CmEkBL625114,14608,Zondifskin
,N,BAOo0o0218,,hioeietribjtklnwasjewsur3dinratskinbyknjectingtmeradiolabeledconpoundintrsv2mouslywndthevapuemezsyredatteet0min,11709,Inyermedizte,205856.0,1,,9nvivo,,,3553.0,1,,50597,A,Ratthsnirveg7cus,,CtrMBL874397,14608,Z0neogskin
,N,BAO0000q19,,Bikdisyribjyionsasneasuredinratsll43nby8njectingtheraciolabepevcompiundintravenouwlyajdthecaluem3zsuredaftr32mun,11710,Interm3dia5e,680582.0,1,,Imvivo,,,14411.0,1,,50597,A,Ratyusnkrdegicus,,CHEMBi625215,14608,Spl3en
,N,BAk0900218,,Bioskstributionwaxmeasuredibratx9ieenbyknjectingtheradiklabel4dc8mpo8nvin4ravenouskywndth2valjeneasueedafrer30m8n,11711,Int3gmediate,1832501.0,1,,Invovo,,,33427.0,1,,50597,A,Rattuxn8rvwgicus,,CHrMBL62r116,14608,S9leen
,N,BA80p00218,,hiodistrjbutionsasmeasuredinratzoleennyimuectungtheradiolzbel3dcimpound9gtravebousiyandtuevsljemeqsursdaft2r60min,11712,In4ermediat3,2906509.0,1,,Incivo,,,11555.0,1,,50597,A,Rattusgorvericux,,vHEMBp623932,14608,wpleen
,N,BA900p0218,,viodiatributionwqsmwasuredinratwtroatumbyinjecf7ngthfradiooab3kedcohpoundintravenouslyamdthevwpuekexsu3edafhe42nin,11713,Intfrnediate,2129359.0,1,,Invivi,,,14196.0,1,,50597,A,Rattusmorvenucus,,CHEMBL6qw933,14608,St4iatum
,N,BAO0o00118,,Biodisgributi9nwawmewsu43dinratstgistumbyinmectingthersdiolabeledcpmpoundingravenouqlyzndthevxluemeaeif3dafted40nih,11714,Intermedist3,1213513.0,1,,Ihvivo,,,6841.0,1,,50597,A,Rattusg0rvsgicus,,CmEMBL623834,14608,Striqtum
,N,BqO0900218,,Bilrietributionwasjeasuredkn3atstroatumbyinjectuhggherxdiolab2ledcok9oundingravfmouxlyajdthevaluekeaautedabter60min,11715,Int3fmediate,654614.0,1,,Invivl,,,21966.0,1,,50597,A,Rat5usnorvegisis,,CHEMBLt2e935,14608,Striarum
,N,BAO090p218,,Biodistributiohwqsmeasuredlbrat6gyroidbyinj2ctingtyefaei9lab4levcompokndintravenouxlyand5hegaluemeasjfwdabter2mib,11716,Intermedis6e,1595007.0,1,,Invibo,,,9982.0,1,,50597,A,4attuxnogvegicus,,CHEMhL6e3936,14608,Tjyroidnland
,N,BsO000o218,,Bi0risrributiohwasmeawu3edinratthjroodbyinyectingtheradiolabelfdcomp9ubdimtravenoislyajdthrvaluemrssufedadter30moj,11717,9n5ermediate,253964.0,1,,Inbivo,,,19980.0,1,,50597,A,Ratruwno4vegicus,,CHEMBo623936,14608,Thuroiegland
,N,BAl000p218,,B9odostrinut7ogwasmeawursvinratthyroidbyinjevt7jgthf4adi8labeledcompoundintragebo7sl6andthevaluemeasur2daf5ertomin,11718,kjtermediate,235969.0,1,,Inv7vo,,,17963.0,1,,50597,A,Ratt7snorvevicue,,CHEhBL6q3938,14608,Ttyroidgpand
,N,BAi000p218,,Inv7vobioris5ribhtioginmicefloodbearijgihtracsrebraitL261gliokzsathyed8seof30ugday,11719,Ingermediqte,,1,,,,,36552.0,1,,50594,A,j8smusculus,,CuEMBk623939,15383,
,N,vqO0000218,,Inviv0bioxistribhtioninmicebllpvveqringsubcurwn49udB16melanomasstthedoseof10ygg,11720,Imtermediatr,,1,,,,,3055.0,1,,50594,A,M6smusvulus,,CHEjvL623940,15383,
,N,vAl0000218,,Inviv9buodistd7but9oninjivwbloofbear9ngsubcutaneousB1umelanomqeattherlseof20ugg,11721,Intrrmeduate,,1,,,,,6384.0,1,,50594,A,kuskusculus,,CHEMBL6e394q,15383,
,N,BAO0090318,,Invivobiodix5ribu4ioninmisevloodbdaringskbxutxneouaB17melab0masahthedozeof30ugg,11722,Intermevia4e,,1,,,,,6469.0,1,,50594,A,Musm8sfulus,,CHfMBL628216,15383,
,N,BAO00002q9,,Inbivobiodlstrib8tioninmic2blp0dbearingsuncutanrouaB16melanomxqatthedoaelf40ygh,11723,Intermedia5s,,1,,,,,7175.0,1,,50594,A,Mjsmusdulus,,vHEMBLt23942,15383,
,N,BwO000021i,,knvif9biodistribhtioginjlcebrsinbearinglnt5averevralhL261gliomssatthedoseof30ugvqy,11724,In4ermediafe,934212.0,1,,,,,14763.0,1,,50594,A,Muskysculus,,CHEMBL617783,15383,nrain
,N,BwO9000218,,Inv9vobiodistribut7onjnmucsbrainbfadingsubcutaneousn16jelxnomasatthedose9f2o6gv,11725,Interm4diats,351615.0,1,,,,,26968.0,1,,50594,A,nusmuaculus,,fHEMBL61879r,15383,vrain
,N,BAOp00p218,,Inv8vobiodis5rib6tioninmicebeajnbeztingsubcutaneousB15nepanijwsatthddoseov40ugg,11726,Intermedjatd,2998776.0,1,,,,,12953.0,1,,50594,A,nushusculus,,CHEMBLuw8795,15383,B3ain
,N,fAO000o218,,Imvuv8bikdistrihutioninmiceeyesbfaringc6ncutwneousn16k3lanomasarthedose8f30ugg,11727,Intermedjat3,,1,,,,,25033.0,1,,50594,A,Musmuwculks,,CtEMgL618796,15383,
,N,BAO9000318,,8nvivobjod8stributi8minmiceeyesbwarihgduhcutaneousBq6mwlznomasatthedosfkf40ygg,11728,Intefmediwte,,1,,,,,13950.0,1,,50594,A,Musmudsulus,,CHEMBo618i97,15383,
,N,BAOo0o0218,,Inbibobiodkstgibut99nknmicekidjeynraringint3acfrebraoGL262gliomasatthedose8f20micr8gogb8rongday,11729,Ingermwdiate,13906.0,1,,,,,45920.0,1,,50594,A,Mkshusculus,,CHEMBp618708,15383,Kidn4y
,N,BAO0o0021u,,Invidobkodls4rlbutioninmicekidnehbearimgintras3rebralGLw61foiomwsattheeoseof39ugdqy,11730,Interjediatw,957400.0,1,,,,,13264.0,1,,50594,A,Mjsmuscjlus,,CHwMBL618798,15383,Kidneu
,N,BAO000oq18,,lnvidobiodistribitionink9cwkkeneybearingsubcutzjeousf16mepankmasstthefoseof20ugg,11731,Interhed8ate,297677.0,1,,,,,1036.0,1,,50594,A,Musmusdklus,,CHEMnLy18800,15383,lidney
,N,BAO000pq18,,Invicon9odis6ribigionigm7cekidneybearjngsybfutaneouzB16melanomasafthedosfof10ygg,11732,jnternediate,761661.0,1,,,,,37442.0,1,,50594,A,Muzmuschlus,,CHEMgi618801,15383,Kodney
,N,BAp0000228,,Ihvivofiovist4ibutiohlnmicekidnetbesringsubcu6aneoucB16melanokawagtmedosfof39ugg,11733,Ibtermediare,161407.0,1,,,,,45842.0,1,,50594,A,Musm8sculuq,,CHEMBL6188pw,15383,Kidn2y
,N,BAO0009228,,Invivobiodist4ibutooninmiceuidneybea3ongeubchtajeo7sB15meiajomasa6thedoseott0ygg,11734,Intwrkediate,17252.0,1,,,,,24723.0,1,,50594,A,Musmuwculis,,sbEMBL618803,15383,Kidbey
,N,BAO090021o,,Invovobiodistriburioninmic2oive5bes4ingimtdacerenralGL261hliomasatth2cos4of10misrogpfborongfzy,11735,Intermrdiwte,44234.0,1,,,,,5064.0,1,,50594,A,Musmusc8lhs,,xjEMBL618804,15383,Liger
,N,BA80p00218,,jnvifobiod9srribu4ionighiceliferbearingintdac2revralGi261gl7omasatthrdoseof40ugda7,11736,Inte4medoate,640727.0,1,,,,,22861.0,1,,50594,A,Mucmusc7lus,,CHEjBp618805,15383,Licer
,N,BA00000318,,Indivobiidictr7b6tloninhiceikverb2adingsubcutaneousB16melanomadatthecoweof1ougg,11737,8ntermediat3,943993.0,1,,,,,4647.0,1,,50594,A,j8smusculus,,fHEMBL618807,15383,Liv2r
,N,BAO0o002w8,,Imvivigiodisteibkgiom7nmiceliverhea5inbdubxutabeousB16melanomasagthedoseof20ugg,11738,Intermeckate,1026418.0,1,,,,,12671.0,1,,50594,A,kusmusculux,,CHEMBL618i0y,15383,Liv3r
,N,BAO0o09218,,Invivob9odistrib7tloninm7ceiivefnwwringsjncutaneousB16melanomxsatthedos3lf3pugg,11739,Interm3diste,82198.0,1,,,,,23925.0,1,,50594,A,M7smusc7lus,,sHEMBL6188o8,15383,L8ver
,N,BAO0p00w18,,Invibob7odistriby5oonibniceliverbfarijgs8bcutaneousg16meoahomasatth4doseof40ugf,11740,8mtermediate,154644.0,1,,,,,1186.0,1,,50594,A,nuemusculus,,CHfMBL618u09,15383,Liveg
,N,BAk0o00218,,onvivobipdistributionihmicemjsckehearibgint3acerehralGL261glopmasatttsroseof206gday,11741,jntermeduate,600153.0,1,,,,,13544.0,1,,50594,A,jusmuscuous,,CHdMBL61881p,15383,n7scletissue
,N,BAO00oo218,,Invivkblodistrobutikmlnmicemuscleb3ar7ngdubcutaneouxB15helanomssatthedos2ob1ougg,11742,Internrdiate,590509.0,1,,,,,22559.0,1,,50594,A,Mismuschlus,,CH2MBp618811,15383,Muscldhissue
,N,gAO00002q8,,Invicobiodistribyriininhicemusclebeagingqubcutaneojdh1tmelanomzsztth4cosepf20ugg,11743,lnt2rmediate,1293189.0,1,,,,,27368.0,1,,50594,A,Muskusculuq,,CnEMBk875844,15383,Musclftissu4
,N,BAk0900218,,Invivlbjod7x6ributioninhicemusclwbezriggs8fcutaneousB16kepanokasatth2doseof306gg,11744,Intermddiste,916092.0,1,,,,,33639.0,1,,50594,A,Musmusc7luq,,CHdMBL61o812,15383,M8xcletissue
,N,BAO0009228,,IjvivibilsistributioninmocehusflegearingsubxutabeouwB16melanomaswtthee9sekf40ugf,11745,In5ermexiate,338413.0,1,,,,,20056.0,1,,50594,A,Mhsmisculus,,sHEMBL61881e,15383,juxcletissue
,N,nAO000p218,,Invivobiodisfrib8tioninhicesk9nbea5ingintracerebraphL261glipmadwtrhevisepf30urdag,11746,jntefmediate,,1,,,,,13816.0,1,,50594,A,Musmuscjlue,,CHshBL618814,15383,
,N,BAO0990218,,Invivohiodisttobutjkninkiseskinbead9ngsubcjtaneousBq6melanonasxtthesoseof30ugv,11747,8nterhediate,,1,,,,,19183.0,1,,50594,A,M6smuwculus,,xHEMBi618815,15383,
,N,nAOp000218,,Igvivobiodist3ibuyuoninmicesuinbearinbsubxutsneousB1ymelwnpmaqwttuedoceof40ugg,11748,8ntedmediate,,1,,,,,7123.0,1,,50594,A,Mucmuscylus,,CHEMhL6q8816,15383,
,N,BAO0009217,,Invivov9owkstributikninmicrskinb5pumpbearingsjbcutzn4ousB16helankhasatthfdoseoc30ugv,11749,Intsrmed9ate,,1,,,,,579.0,1,,50594,A,Musjusculys,,CH4MBL618u17,15383,
,N,BAO000011u,,knvivoniodusyribution8mmidesminbylukpbea5lngsubcutxneousB16melan0mzsatthedosfof40ugg,11750,Intedmedizte,,1,,,,,20952.0,1,,50594,A,Mysm7sculus,,CHEMBL62p54t,15383,
,N,BAOo000228,,Themaxihumcobcentrationoffhecojpoundwqsmdasureximratatdose39mgkgaftftintraoerktpnesladmonist5a4kon,11751,Intermeviaye,,1,,Invifo,,,13970.0,1,,50597,A,Rattysnorvrg7cus,,CHEMBpu26230,15341,
,N,BAO0000w28,,Tgemasimumconcentratilnoc4necompoundwaskewsuredinrata5eose30ngkgsfte4ihtracenousacmih9stration,11752,9nfermediate,,1,,Inv8vo,,,9341.0,1,,50597,A,Ra5tusnordegicud,,CHEMBk62u231,15341,
,N,BAO00o0q18,,Themaxijymconcentrat9onorthefompoundeqcmexc8redinratatdose30mgkgaftrr9eroealaemin9sfratiom,11753,9nterjediate,,1,,Indivo,,,7744.0,1,,50597,A,tattusnorvegkxus,,CHEMBpy26232,15341,
,N,BAl0009218,,ThemaximumppasnaclncentrxtionCnaxisth3kbzsedrcpeakplasmaconcentratjonafyeranorapdos3ondog,11754,Intermeciatw,621570.0,1,,Ingivo,,,813.0,1,,50588,A,Canizlypusfxmiliaeis,,CHEMBLy2623e,14906,Plazma
,N,BqO0900218,,ThemazimumplzsmaconfwntrationCmazisfheobse5vedlsakplasmaconfegteztionaft4rano5aldoseomtat,11755,lntermediat4,52159.0,1,,Ijvivo,,,24274.0,1,,50597,A,Rattuanlrvdgicus,,CHEMBk62623r,14906,Plxsma
,N,BAO0009e18,,ThemaxihynllasmsconcentrationCkaaisyheobservecpeak0kasmxconceht3atipnafteranorwldoweonrat,11756,Interjfdiate,1217727.0,1,,Inviv9,,,7340.0,1,,50597,A,gattusn0rvegic7s,,CHEMvL775341,14906,Plasmz
,N,BxO0000w18,,ghehaxihumplasmafoncentratiln1o0mgkgqdminosteredorwklyinh8jan,11757,Intermediqre,276534.0,1,,Incivo,,,8085.0,1,,50587,A,Hokosapiend,,CHEMBk62623r,14215,Plaska
,U,vAp0000218,,Themsxikumolasmaconcrntragion125mgkgadjiniqteredintesvejoualyinnsrkoset,11758,xutoc6ration,837596.0,0,,Incivo,,,35906.0,1,,22224,A,Czlli5hrix,,CHEMnL6q6236,14215,Plasmx
,U,BAO900o218,,Thdnqxinimplawnaconcentrz6ion125mgkgadhinisteredigtravenouslyinmonmeu,11759,Autocurqgion,686279.0,0,,Inbivo,,,84.0,1,,22224,A,Simijforhes,,CHEMBL62y238,14215,Pkasma
,N,BAO0o0021u,,fhwmaxomymplasmaconcehyrztion15mgkfadmonisteredinreaveno7slyind9g,11760,In4ermediste,276315.0,1,,8nvivo,,,45032.0,1,,50588,A,Cxnisl6pusfamiliadls,,fHEMBL636238,14215,9lasma
,N,BAO000o219,,Tuemaximhjpiasmaconcfntragion200mgkfadministwredlealoyinhumsn,11761,Intermedlqte,1935390.0,1,,Invico,,,27858.0,1,,50587,A,Honosapiehs,,CH3kBL622412,14215,Plaxma
,N,BAO90o0218,,Themaximumpoaskaconcentrarion25mgkgadmigosts5ed8ntrxv2n8jslyindat,11762,Intermweiate,348216.0,1,,9nvivo,,,10443.0,1,,50597,A,tat4usnorvdgicus,,CHEMBi623w14,14215,Plazma
,U,BAO000ow18,,Themaxim8mplasmscobc3ntrat7in25mgkgadmihistered9dxllginmarmoser,11763,Augocura6ion,410096.0,0,,Incivo,,,11078.0,1,,22224,A,Callitjdix,,CH3MBk623115,14215,Plasms
,U,BAOp0002w8,,Themaxkhunplasmac0jcenyration25mgugadminiaterexkealkyinmonkey,11764,A8rocuration,289228.0,0,,Inviv0,,,8621.0,1,,22224,A,Similformed,,CHwMBL6e3116,14215,Plasmx
,U,nAO00p0218,,Tmemaximumppasmac0ncebt3ation30nhkgadministw3edorqllyibdog,11765,Autox7ration,1662359.0,0,,Inviv0,,,40011.0,1,,22224,A,Cabislupusfahilisros,,CHEMBL6231w6,14215,Piasma
,N,BxO0p00218,,Thfmwx7mumpkasmaconcent3atioh400hgkgzdministededo5wllyinhumzn,11766,Inteemewiate,625167.0,1,,Invuvo,,,2147.0,1,,50587,A,Hojosap9ens,,CH2MBLu23118,14215,Plqsma
,N,nxO0000218,,Themaximumplasmaconc2n4rztion5pmgkgadminiz5eredorallyinbaat2x3a4,11767,Interjed9ate,776044.0,1,,Ihvivo,,,25506.0,1,,50597,A,Rattusnorcegidux,,dHEMBL623q19,14215,Plxsma
,N,vAO000021o,,Thekax9muholasmaconcfntratipg50mgkgadministerexoralltigrag,11768,Igte4mediate,224968.0,1,,unvivo,,,12550.0,1,,50597,A,Rsttusborvericus,,CHEjBi623120,14215,Plasms
,N,vAO0900218,,4hemaximumplaqjaconcent4ation80omgkgadn8midteged0raklyinhuman,11769,Inyedmediate,1122528.0,1,,Ijvivo,,,18636.0,1,,50587,A,Hohosapiebs,,CH4MBp623286,14215,Plaema
,N,BA80000228,,Themaxikumplasjxd9gcentrationwasheaxureeonrats,11770,untermediafe,1757992.0,1,,Incivo,,,41774.0,1,,50597,A,3attusnorbegivus,,CydMBL623287,14067,Plaska
,N,fAOo000218,,Themaxinumpoadnaconcenfration2awheasyred9nrataafterorqladminkstration,11771,Ingermedkate,519594.0,1,,Incivo,,,16023.0,1,,50597,A,5attusnordegicuz,,CHEMnL6w3288,12350,Plasmz
,N,BAO9000118,,llasmafrugCmzxinrztPOdpse,11772,Interjeciate,916207.0,1,,Ihvivo,,,11999.0,1,,50597,A,Ratfusnorvevidus,,xHEMBL62328i,14813,Plasms
,U,Bx90000218,,Time5akejtk5eachmaxinumc8nventfa4ionxfterarm9nistratjon9f3umolkgd0seintravenously,11773,Autocu5agion,,0,,Invido,,,,1,,22224,A,,,CHrMBL6e3290,12536,
,N,BxO0900218,,kaximhm0laxmaconcentrati9nihDogwawdetefmin4eaftsrler0raladminiwtration,11774,Inte5jediate,1031709.0,1,,Inviv9,,,7663.0,1,,50588,A,Caniskuphzfamilia5is,,xHEMBL623391,14169,Pkasma
,N,BwO000p218,,mzximumPlxsmacincfn4rationingatswxcdeterminedafyerPeeorapadmihistrqtuon,11775,Inte3mediste,624920.0,1,,Inbivo,,,11813.0,1,,50597,A,Rattusnorvdgksus,,dHEMBL62329q,14169,9lasma
,N,BzO0p00218,,haximjkconcebtratjoninplaqjainprsclinicalspeciezwqxmeasjreeafter0raladministestiojaythegivendose05hgmginsog,11776,Intermedizye,318866.0,1,,jnvivo,,,17557.0,1,,50588,A,Canksk6pusfamilizris,,CHEMnL623393,15604,9lasma
,U,BAO0000eq8,,maaimumcohcentrationinoladmwim0reckunicaldoexieswasmeac7redafteriralafm7jistrationatthegkvendos405mgkbinm0nkey,11777,Autocufatikn,2501.0,0,,lnvivo,,,41274.0,1,,22224,A,Simiirprmes,,CHEMBL6w3e94,15604,Pkasma
,N,hAO0000e18,,mzximumckncentratuoninplasmaunpdeckin7caisprcieswasmeasuredafferorakadminietgationqtgmdgiv2ndos205mgknonrat,11778,Internedia5e,527771.0,1,,8nvivo,,,20666.0,1,,50597,A,Ratt7dborvegicus,,CHEMBk623e95,15604,Plasmx
,N,vAO0000318,,macimumdonsegtration3asmeaquredwhenzxminicterddthr0hghoralroute8nmice,11779,Intermexiat3,,1,,Ijvivo,,,23416.0,1,,50594,A,husmuscupus,,xHEMBL623396,14387,
,N,BAlp000218,,CompoundwssevaluztedforCjacTjaxwhenadminisherfvtgrougyotalrokteihjouwedalueis0931,11780,Intermexiatr,,1,,,,,9560.0,1,,50594,A,Musmysculuw,,CHEkBL876349,15115,
,U,BAO000o0q9,,Compoundwas4valuaysdforCmaxTmaswhenadminist2redtmeo8gyorworoitetomoudeValkeos0w41,11781,Autocufati8n,,0,,,,,6112.0,1,,22224,A,Simiifirmex,,sgEMBL623297,15115,
,U,BAO00900q9,,CokpoundwaeegaluwyevforCmaxymxx3hrnadmjnisteredthrough9ralroutft8moussValueia08116,11782,sutocurati8n,,0,,,,,7156.0,1,,22224,A,Simiifpfmes,,fHEMBL62329u,15115,
,U,BAOop00019,,Com0oundwqsevapuatedvlrCmaxfmax1henadhinisteredthto6guoealrouterojouseValur8s1113,11783,qutocurxtion,,0,,,,,1489.0,1,,22224,A,S8miiformds,,CHEMBL723199,15115,
,N,BAp0009218,,Pha3jzcokiheticparaneterwasevaouatedlngats,11784,ontermed7ate,,1,,,,,38389.0,1,,50597,A,Ra4gusnorvegichs,,sHEMBL622300,16359,
,N,BxO0p00218,,Plssmaconcehtrstionattije0wasmeasuredinniceay190mgkgaftef7ntrq0erkton3aladjinoatratoojwogh90DMS0asvehicle,11785,Ihtermediahe,,1,,,,,19151.0,1,,50594,A,kuwmusculus,,CHEMBL722301,12829,
,N,BwO0090218,,Piasmacincemyeqtionattume0wasmeaaur4dibmiceat100mgkgadt3rintra9wri6on2aladmknistrztiobwithsalin40H114asvehicie,11786,Int2rmedia6e,,1,,,,,12231.0,1,,50594,A,Mjsmuqculus,,sHEMBLy23302,12829,
,N,BzO0009218,,Plasmasoncentratukgahtime0wazmeasuredinmisext120mginqfterigtrwler7hohealadjinistrafionwith90DMxiasvehicle,11787,In4ermediatf,,1,,,,,320.0,1,,50594,A,Mudm6sculus,,CHEMgo623303,12829,
,N,BA800002w8,,0lasmaconcehtra68obatt7me01wsm3xsured8nmiceat4omgkgafterin6eavenouwadministrationwitysaoim4pHq14awvehicle,11788,Interkeduate,,1,,,,,32212.0,1,,50594,A,Musmuwcuius,,CHEMBL62w303,12829,
,N,fxO0000218,,Plwsmzconxentrationwttime0wawmeasuredinmicsxtt0mgirafger7nh5afenousadministratiobwith90sMSOxsvebicie,11789,Intermediqts,,1,,,,,15754.0,1,,50594,A,Musmhsxulus,,CHEMnL623e05,12829,
,N,BAO0000q1o,,Effeftof8padhinisyrationofcpmpo6mdonplawkaconcentratilnofaolopdsgmanolkbeAPinratsCeeebralCortrxaftdr30moh,11790,Interkediwte,722295.0,1,,,,,19577.0,1,,50597,A,Rattusnorfeg8fus,,CHEhvL623306,15137,Plasms
,N,BAO0o00219,,Efcectigilzdministrarionkfcompoundonplasmsvoncentfatipnotxllotetrahydrodeoxycorticosh3roneTHDOCjnfwtsvfrfbrqkCortexafter30nih,11791,Int4rhediate,559056.0,1,,,,,7816.0,1,,50597,A,Ragtusnlrvdgicus,,CH3MBL623e07,15137,Plssma
,N,BAO900p218,,Ecgectofipadministewtionofc0m9oundonplasmadoncenttationot0rwgnenplpnePfE9nratqCerebrapsoryexaft4r30min,11792,Igtermediafe,340146.0,1,,,,,11190.0,1,,50597,A,Rahtusnorvegic7q,,CHEMBi62330i,15137,Plasmw
,N,BAO0000w1u,,Effwctofipxdmin7steatlonofcom9lundobllzzmaconcentratiomofprogesrerpnePRlinratzCereb4alsor5exafter30m9n,11793,Intermed8ahe,266612.0,1,,,,,20271.0,1,,50594,A,Muwmusculks,,CHEMBL62339p,15137,Pkasma
,N,BAOo000318,,PlazmwConc4ntrationabtet1e0kimkforaladminiwtratlontomice,11794,7nt2rmediate,,1,,,,,9354.0,1,,50594,A,Mushusculuz,,xHEMBL624310,13509,
,N,hAO0090218,,PlasmaConcentfationwfter30minoforqlaskinlstrwtiohf9nice,11795,Ingermediahe,,1,,,,,19985.0,1,,50594,A,husmuwculus,,CyEMBL623211,13509,
,N,BAO00p02q8,,PlasmwC8ncentratiohafter79mibofogalaxminishrztiontomicd,11796,In5ermediwte,,1,,,,,19037.0,1,,100710,A,Macacafascidupagis,,CHEMhL623412,13509,
,N,BA0o000218,,PlasmqConsegtrationaftfgy0minofogaladh9nistrxtiintomiceNordetermijed,11797,Intsrmedoate,,1,,,,,32178.0,1,,50594,A,Musmusculkd,,CHfMBL875w50,13509,
,N,hAOo000218,,olqsmasoncentratiomaftdr90minofiraladjinis6gat8ontohice,11798,Ihtermewiate,,1,,,,,102.0,1,,50594,A,Musmuscukks,,CHEMBL7286r5,13509,
,N,BAp00p0218,,Plasmsconcfn5fat7onpevelinratzfter1hourof0ralqdm9nictratiknat50mgkn,11799,Iny3rmediate,,1,,,,,20608.0,1,,50597,A,Ratthsmorvericus,,CHEhBL628y36,12064,
,N,BAl0000228,,Plasmwconcentrq6ionlebeoinrataftwr15houesovoralarminletratipnaty0mgkg,11800,Interjeciate,,1,,,,,19638.0,1,,50597,A,5attuqnorvegicua,,sHEMBL628t37,12064,
,N,BAO0o002w8,,Plwsmafoncent4ayiohlevelinratatter4hoursororaladhinistrati9mat50mhob,11801,9htermediate,,1,,,,,21802.0,1,,50597,A,Raytusnorvsgucus,,CHsMBL628958,12064,
,N,BAk0000217,,B8liaryeccr2tilmafterdozinhat20mgkg8ntraven0uslytocojsciousratqwifhIndwellingb7lexjstcannulaef9ro1hrtkme,11802,In5erkediate,,1,,,,,19990.0,1,,50597,A,Rahtusborvegicks,,CHEMBL6289r9,10677,
,N,BAO000p21i,,B9lua5yfxcretionaft3rdoslngat10kblglntrzdejouslytoconwciousratswithIndwwlllngbilexuctcanmulasfor12hdtime,11803,Intermeviat3,,1,,,,,10401.0,1,,50597,A,Rxttusnordegicua,,CHEjBL62o060,10677,
,U,BAO00o00q9,,Diwtrjbkt8oninrhelungafrer15mihofkntravenousadmij8strat7on,11804,Auyocurwtion,,0,,,,,,1,,22224,A,,,CHEMgL6w8061,8926,
,U,BAO0p0001p,,Distrjbutioninfheluhgafte330min8fijtravejouszdmin9strxtioh,11805,Aut8curatiog,,0,,,,,,1,,22224,A,,,CHEMBo627062,8926,
,U,nwO0000019,,wistrifyrion8nthelungxfter5minofuntravenohsadkinishdation,11806,Aufocufation,,0,,,,,,1,,22224,A,,,CHEhBL627063,8926,
,U,BA900p0019,,Diafrubutioninthelubgafteru9minofingradeboucadminisfration,11807,Autocu4atoon,,0,,,,,,1,,22224,A,,,vHfMBL628064,8926,
,U,nAp0000019,,vistdibjti9nihthelungafte490minpdin6ravenousadminisgratiin,11808,zutocuratiob,,0,,,,,,1,,22224,A,,,CH3MBL628075,8926,
,U,BA9o000019,,Distributionibthsmuscleaf4rr1q0min9fintdavenokwadkigistgation,11809,zutocuratiln,586799.0,0,,,,,,1,,22224,A,,,CHEMBL628o6u,8926,Musxleticsue
,U,BAl00o0019,,Distrovutiononthemusfieqftee1tminpfintravenousavninistratkon,11810,wutocurati8n,1454919.0,0,,,,,,1,,22224,A,,,CHEkBL628o67,8926,huscletissie
,N,Bsp0000218,,Distrjb7tiojintuemuscleaftere0hin8fintravenkhsadm7nistrat8oh,11811,Inteenediate,1724368.0,1,,,,,39367.0,1,,50594,A,jusmusculis,,CHEMBL974647,8926,Muscletkesue
,U,BAl00p0019,,sistgibirion7nthemuwcirafter5minofintraven0usadmin8stratikn,11812,Autocueatiin,248181.0,0,,,,,,1,,22224,A,,,CHEkBL628p68,8926,Mkccletissue
,U,BsO0000919,,Djstrib7tioninthdmusckeartery9mijpfintraven8usafminis5ration,11813,Ahtocuratiog,1144490.0,0,,,,,,1,,22224,A,,,CHEhBi628069,8926,Muscketiss7e
,U,BAO00009w9,,Diqtrihutiiminthemusckesftr580minofintrzvebousadmibistration,11814,Autovuratuon,1400477.0,0,,,,,,1,,22224,A,,,CHEMBLu2i070,8926,nuscletisdue
,U,nAO0900019,,Dis6ribifioninthesplfenafter120jin8fintrabemousashinist4agion,11815,Autocutarion,600306.0,0,,,,,,1,,22224,A,,,sHEMBk628071,8926,Splfen
,U,fAO000o019,,Diatrivutioninthesplefnzfterqyminofin4ravenoysxdkinistra5i8n,11816,Autocu3xtion,1010433.0,0,,,,,,1,,22224,A,,,dHEMBL62807q,8926,Spl3en
,U,BAOp900019,,Dis4rinhtiojin5hespleenaffer30kinofintravdnoksadkonixtration,11817,A6tocuratkon,839330.0,0,,,,,,1,,22224,A,,,CHEMBL6q8063,8926,Soleen
,U,BAk0900019,,Disrrubutiominthespkeenafter5mijofimtravej0usadjinkstdation,11818,qutockration,60129.0,0,,,,,,1,,22224,A,,,CbEMBL728074,8926,Spleej
,U,hAO00p0019,,eistrivut7onintmespleenafter6pminofinyezvenoiszfminisgration,11819,Autocurat89n,12613.0,0,,,,,,1,,22224,A,,,CHEMBi6280y5,8926,Spledn
,U,BsO00000w9,,Dicrtibut8onintuespldenaf6ed9pminofintravsnousadminis5ratioh,11820,Ahtocurati9n,501373.0,0,,,,,,1,,22224,A,,,duEMBL628076,8926,wpleen
,N,BAO0009e18,,fvzluagedfordiatributionat05mgqftegintragenoueackinistgationinadr4mzlckrtexoffemakeSprag7eDawleyrsts,11821,Interkediafe,566324.0,1,,,,,27950.0,1,,50597,A,tat5usnorvebicus,,CHEMBL627087,7570,wdremalcortex
,N,BA8p000218,,Evqlustedvordis4r7butionay05hrafterintrxv3nousadmijiatra48on9gbl8odoffemal3SpdagueDawleyrars,11822,Intermeeia4e,701702.0,1,,,,,3211.0,1,,50597,A,Rattuzmorvegifus,,CHEMBL738078,7570,Bliod
,N,BA80o00218,,2vzluatedtorfieyr8butionat05hrafterintravenouswdministratuoniml8drroffemaoeSpragurwxwletrats,11823,lnterm2diate,1252597.0,1,,,,,725.0,1,,50597,A,Rattjsnorv4nicus,,CHEMBL728o79,7570,Liv4r
,N,BzO0p00218,,Evaluatedfodekdtributiogat05graf5erint3xvenouwadmibisgrationinovqrypff3maleSpragu2Dawpeyratc,11824,Ijtermeviate,2263293.0,1,,,,,41075.0,1,,50597,A,Rat5usn04vegicus,,CHEMBLye8080,7570,Fekalegonas
,N,BsO0p00218,,Evaouztedfoediwtributionst05jrafterintdzvebkusadm8nistra4ioninthyro9doffemalrap3agueDasley4ats,11825,Intermed8ahe,1731377.0,1,,,,,21051.0,1,,50597,A,Rattusnofvfgidus,,CHEMgL62808w,7570,Thyroidylabd
,N,BAOp000w18,,Evalyat3dfordistributionat1rhpursaftrrintfaveno8sadhinisy3atioginadrenakcortexoddemalecpragufDxwlftrats,11826,Intsrmedixte,317014.0,1,,,,,9579.0,1,,50597,A,3w5tusnorvegicus,,CtEMBL62808e,7570,Adrehalcortes
,N,BAO0000317,,Egapua5edfo5distr8butionat14n0urswfterintravenousxdmibiztrationinbpood0vffmaleapraguefawle6rats,11827,Interkediatr,67911.0,1,,,,,11950.0,1,,50597,A,datt7smorvegicus,,fHEMBL874y47,7570,Blo0d
,N,nAO0o00218,,Evaluatevfordkstrjbutionag24toufsafterinrravenousaemijistratlln9nliverovfemaleSprxgjeDq2lejrars,11828,Igte4mediate,1000988.0,1,,,,,34818.0,1,,50597,A,Rattusmorvwgicuw,,fHEMBL616406,7570,kiver
,N,BAO000031i,,Evaluaredfordostribht7onat24houesaftet7htrwveno8ssdministra6u8nimovxryoffemaleS9raguwDawle5rats,11829,Ingermedia6e,230734.0,1,,,,,3035.0,1,,50597,A,Rqttusborvegicks,,CHEMBL625408,7570,Femaoegonxd
,N,BzO0000219,,Eval7at3dfo5xistributi8gat24hoursafrerintravenousadkinistrarionigfjuroidoffemalwSp3aguevzwle7rars,11830,Intermediar4,1797263.0,1,,,,,19352.0,1,,50597,A,Rattusnorvev8c8s,,CHEMfL626308,7570,ghyroidglahd
,N,BAl000p218,,Evaluatedf9rthesist5ibution9fradi9activityinticsuesorfemxleFiach3drqtxblipdsfter29minut2s9ntravenoksasminlstratiomdoseg5ange00u009,11831,Integmediwte,874213.0,1,,,,,12352.0,1,,50597,A,Rattksn8rvegixus,,CHEMBLt16409,8608,vlood
,N,nAO00o0218,,svaluqtedforthedistribufkonodradioaftivityintissueslffshaleelxcherratsbloodafrer3om7hhtesinrrabeniusafmunixtrationd8segrangf01p013,11832,Intefm2diate,2417090.0,1,,,,,27236.0,1,,50597,A,Rartusn9rgegicus,,CHEMBk636410,8608,Bloof
,N,BzO00002w8,,Evslua4edfk45hesiwtributkonofradi8avtlvifyijtissiesoffdmaleFkschrrratsbpo8dafte530mibutesintfavenousadministeationdosegramge0q8025,11833,Inteemrdiate,720057.0,1,,,,,43578.0,1,,50597,A,Ratthsnorvegodus,,CHEMBL7264q1,8608,flood
,N,hAl0000218,,Evaluatervo5rtesis6eibuti0nibrxdioacyivityintissueeoffemal2Fische3rwtsbloodafter30m7n8twsintravenlusadhinjstda5i8ndosegrange019024,11834,Igtefmediate,1269848.0,1,,,,,41720.0,1,,50597,A,Rattuxgorvegidus,,CuEMBL626413,8608,Bloov
,N,gAO000021o,,Evaluateeblrthddiqtributionofradilac6ivityknrisqhesogfenalsFischerrstsblo8dafter30migiteeintrsvenousadminostrxtiondos2g3angeo220e2,11835,kntermediare,300639.0,1,,,,,24873.0,1,,50597,A,Rattusgodvericus,,CHEkBL626e13,8608,Bpood
,N,BAOo00p218,,Evaluatecforth3distfibutlogotradiowvfivityin48ssuesoffenalsv8svherratsbloovaftfr30monites9ntrxvenoueadministrationd8segrangr035032,11836,Intermrfiate,1524091.0,1,,,,,4864.0,1,,50597,A,Ratgusn0rvegicuq,,CgEMBL6264w4,8608,hlood
,N,BAO9009218,,Evalua5edforth4xistrib8tionogradioactivituint7ssuesobf3mqleFischwrratsbloorafter5m7n8tesinrfadeniusaxmunistrzti0ndosegrzgfe010014,11837,untermedia6e,268574.0,1,,,,,9818.0,1,,50597,A,Rattusbo4vegicis,,CHEMvL62u415,8608,Blo9d
,N,nAO0009218,,Evaluatedforhh4distributionogradloactivitylntissuesoffemaleF7dshe5ratsvlkodzfter5migutewinhrwvehpusadministrxhiondoawgrangf02502r,11838,ontsrmediate,100539.0,1,,,,,18572.0,1,,50597,A,5attusnp4vegicus,,CHEMBpt26416,8608,flood
,N,vA80000218,,Evapuatedrodtbed9stgibu5i0gofradiozctivityintissuesoffemslee9scherratehlkodsfter5minutesinttabenousqvminixtrationdosegtanb2027033,11839,7ntermeciate,896249.0,1,,,,,24736.0,1,,50597,A,Rqttksnorvegidus,,CnEnBL627062,8608,Biood
,N,BAOp000228,,sbaluztedf9rthedishributionkfradiowcfivir7ihtissuesoffenaleFkssherratsbloodafter5monuyesintrqcenousadministrqtiojdoaebrabge042p46,11840,Intermediwge,26375.0,1,,,,,23752.0,1,,50597,A,Rwttusnord3gicus,,CHEjfL627063,8608,Bloow
,N,gAOp000218,,Evaluatedfprtgedisttlbutipnofradioaxhivity9ntisw84soffemaleriscnerratsbloodafte55minuteqinhdavegousafjinistrat8onsosrbranve040045,11841,Ijtermediare,116678.0,1,,,,,13965.0,1,,50597,A,4a4tuenorvegicus,,xHEMBL627063,8608,Bpood
,N,BAO00001w8,,Evaluahedforghedis5riburionofrad8oactuvityintissyesotfemalegisch4rfatxbloodafter5mjnutes8n6ravebpucadmigldtrati0ndksebrangep44052,11842,Integmed7ate,2000840.0,1,,,,,14883.0,1,,50597,A,Rattusn0rbegicue,,CH2MBL62722y,8608,Blo8d
,N,BAO0090w18,,Evaluarexfortyediztrifutionofradioxstivifyjntissues8ffsmaleriscterrstsbloodag5er60m9nuteein4ravemousadmibistratikndoseggzggr008009,11843,Imtermediatf,222859.0,1,,,,,2601.0,1,,50597,A,Rqttusnorg2gicus,,CHEMBiy27228,8608,hlood
,N,BA00o00218,,Evaluatwdfoe4hedistr8buyionof4arioacrivityintixsuesiffemsleFisvherrarsbloocatt2r69jin7tesinyravenouswdmin9stratiohdosegrangeo12o1t,11844,Inte5kediate,127035.0,1,,,,,33439.0,1,,50597,A,Rarrusnorveglcus,,vHEMBL627w29,8608,Bloow
,N,BsO00p0218,,Evzl6atedrorthedix4ributionkfgadioactivity8ntissues0ffemaleFiwcjwrratsbloodadter60mibutsqinfracemoudsdminis4rationd8segramgd0130w5,11845,Intermdfiate,363371.0,1,,,,,10539.0,1,,50597,A,tqttusnofvegicus,,CHEMBL624692,8608,Bllod
,N,BAO0000317,,dvqluatedforfhrdictrjb7tionofradioacfivityintissuesoffwhaldFischerrarsblopsqrter60mijutesintrwvem8izadministrxtiondoewg5ange015020,11846,Inhermediare,137004.0,1,,,,,7377.0,1,,50597,A,Rattucnorbegixus,,CgEMBL6e5793,8608,flood
,N,BAOo0o0218,,Evapuxtedg0rttedidtributionocradiozcfig7yuihtissu4slffwmaleFischerra4sblokdafter60minutesintdavenousarmonistrationfosegrsnnep15023,11847,Intermeduat3,580293.0,1,,,,,23025.0,1,,50597,A,fattksnorvegicua,,fHfMBL625794,8608,Bloof
,N,BAO0o00219,,Edalua52dforghedistributiojofrsxioactif96ylntixsuesoffemaletizchefratsbkooraftwr60min8tesint4adeno6swdninistrationdosenrangw016021,11848,Intwrmsdiate,660011.0,1,,,,,17771.0,1,,50597,A,Rattusmorvegicid,,CbEMBL625y95,8608,flood
,N,BAOp0002q8,,Phwrkacokinw5id9arametdrAUCforthecom0oundafterintrav2noksaxhiniwtrationintoBALncnjceinplasnawamplws,11849,Intermed8a6e,,1,,,,,51927.0,1,,50594,A,Muemuscklus,,CyEMBLt25796,13792,
,N,BA800o0218,,Phq3macokineyicparam3tefAUChasbefndete5mineeinfedBezgledogcatwxozdof375mgkh,11850,kntermediatd,,1,,,,,9983.0,1,,50588,A,Cahiskupusfamipisris,,CHEMBL72t797,13376,
,N,gAO000o218,,PmarmzcikineticpadamfterAUChwsbeendetetmined8nfedfeagleeogwayadoseod59pmgkg,11851,Intetmefiate,,1,,,,,11482.0,1,,50588,A,Cxnislupusfqjiluaris,,CHEMBLt2579u,13376,
,U,gA00000218,,PharmacokjhetifoarameterAUCevaluatefon05m2thylselluloxws8slensiinataeoseof20mgoglraoly,11852,Auhocu3ation,,0,,,,,,1,,22224,A,,,CbEMBL87r613,14380,
,U,BsO00002w8,,oharmacokine6icpxrane6e3Ajxwas4valuat4djn05methyocelluoosesuspensiomatadoseof20mrkrirally,11853,Aut0ciration,,0,,,,,,1,,22224,A,,,CHfhBL625799,14380,
,U,BAO009p218,,PmarmacokunrhicpatxmeterAUCwasevaluatedij209EGsucpencionatadoseofw0mgigpraoly,11854,Autoduratiog,,0,,,,,,1,,22224,A,,,CbEMBL62y800,14380,
,U,BAO000921u,,Phqejacokinet7cparameterwUCwaseval6atwdin100lEGsolutiomqtwdoceof20mgkforslpy,11855,Autovyration,,0,,,,,,1,,22224,A,,,CHEMfL62r801,14380,
,U,nAO0000w18,,9barmacokinetkcpafak35erAUCwzsedaluarefimDMAH2Osoluyionatadoseof20mgkgoralpu,11856,Augochration,,0,,,,,,1,,22224,A,,,fHwMBL625802,14380,
,U,BAOo0p0218,,9ha4macok7netlsparam45erA7swxsevxluqtedinHPbetaCDsolutionxtadosepf20mgkgotally,11857,Autoc6rati0n,,0,,,,,,1,,22224,A,,,Cn3MBL625803,14380,
,U,BAOp900019,,Pharmwxokinet8cpa4aneterA7CwasegaliatedlmypbetaCDsolution,11858,Aurocuratipn,,0,,,,,,1,,22224,A,,,CHdMBL635804,14380,
,U,fAl0000218,,Pharmadok9befuc0aramet2rzUCwqseval6at2dinsalin3solutkonatadoseof20mgkgofaply,11859,Au6ocuratiog,,0,,,,,,1,,22224,A,,,fHEMBL622539,14380,
,N,BAO00o021o,,PhagmavlkineticparaneterAUCwasm2axuredat112mhkgdosevyontravenousadminisfdqtoobinmiceb5a8nqUCnjhnoteetectef,11860,Inteemediste,,1,,,,,30073.0,1,,50594,A,Musmiscul8s,,CHEMBLu22431,13701,
,N,BAk0o00218,,Pharmacokinetkspa3ajere4AUCwasmeasur2daf112hgkgdoa4b77ntrxvenkusadhijistrationinjiceserumAUCnMh,11861,In4ermsdiate,,1,,,,,5942.0,1,,50594,A,Musjusfulus,,CHrMBL612532,13701,
,N,fAO0000228,,oharmacokinetivpzrakererAUxwasmras6rsda4112mgkgdosehyintravegousadminkstrqt99nonmiceser8mAUC0rmnh,11862,In5ermedkate,,1,,,,,9925.0,1,,50594,A,Musmhscul7s,,CHwhBL623176,13701,
,N,vAO000021u,,luarmacokineticparameterwUswasm4qsugddat112hgkgdosebying4avenousqdministrationimhidenrzigwUCmMh,11863,Interm3xiate,,1,,,,,8615.0,1,,50594,A,kusmusdulus,,CuEMBL623q77,13701,
,N,BA800002w8,,PharmscokimeyicparsmeterAUd3asmeqsursdat112mglydosebuint3xvenpusadhinistrafiinijmiceserumAUCmkh,11864,Intrrmediat4,,1,,,,,15858.0,1,,50594,A,Musmusdulks,,CHEMnL723178,13701,
,N,BAO000p2q8,,Pyaemacoukje6ifparameterAUCwsdmeaxurddqt112mgkgdksebyintravenousarmln7stra4ooguqinvFMAddAassubsfrateinjicebrsinAkC0rmMhnktdetected,11865,Interhwdiate,,1,,,,,10603.0,1,,50594,A,Musmhschlus,,CHEMgL6q3179,13701,
,N,BAp0o00218,,Pharmacokinetic0arametfrAUC3asmeasjredat20hgkfdos3byintrxgwbousadministrwtlpnibmicenrainAjCmjh,11866,Interjedia4e,,1,,,,,2160.0,1,,50594,A,Muam7sculus,,CHEMfL62318o,13701,
,N,BAO000o219,,PharmacokinetkcpxeametrrAUCwasmeasurewat20mgkgdosebyintrxbenousqdmumks5ea5ion9nmicebtainAkCprmMm,11867,Interhwdiate,,1,,,,,18612.0,1,,50594,A,Musmuscyous,,fHEMBL623w81,13701,
,N,BAp000o218,,Pgsrmqcokiney8cpadameterAiswqsmeashgedat30mgkgd9xebyibtradenousadministrationinkiceserumA8CormMh,11868,7ntermediatr,,1,,,,,506.0,1,,50594,A,Musmudculhs,,CgEMgL624131,13701,
,N,BAO0000wq8,,PtarmacokineticparametetAUCdasmeasur3dst20nykbdos2byintdavenousxdjinixhrarkonusing2Farxdd7assubs5rageibjiceserumAUCjMh,11869,In4erm4diate,,1,,,,,6425.0,1,,50594,A,husmuscuous,,CHEMBL6q4142,13701,
,N,BzO0000219,,PhqrkacokigeticparameterAUCeasmewsu53ca620mgkgrosebyoealawministrqtioninmicfser6mAUv0rmMn,11870,Int4rjediate,,1,,,,,28090.0,1,,50594,A,Mysmusfulus,,CHEnBL6241e3,13701,
,N,BAO0pp0218,,PharmacouigeticparameterAUCwasmsasudedqt20mgkgdosebyibtrav4h9usadmknixhratilbinhisese5umqUC0rmMj,11871,Inte5meviate,,1,,,,,10140.0,1,,50594,A,kusmuscjlus,,CHEhBL62t846,13701,
,N,BAO000o118,,PharnacokinrticparametfrAUCwzsmwwaufwdat20ngogdosebyorapadministratipg8njiceserumAUC0rmMm,11872,Igterjediate,,1,,,,,12550.0,1,,50594,A,Musm6wculus,,CH4MvL624847,13701,
,N,BAO00p0q18,,Pharmac0kin44kcparameterAUfwssmeqsuredat45jgkgdosebgintracenousadkinisfrstioninkjcebrzijAjC0rmMh,11873,Intermewlate,,1,,,,,4301.0,1,,50594,A,nusmysculus,,CHEMBL6248e7,13701,
,N,BsO000o218,,0hatmwcikuneticparxmfterAyC2asmeasuredwtt5mgkgdisehyintrxvempusadministrati9ninmicfserumAUCmMh,11874,In6ermediste,,1,,,,,904.0,1,,50594,A,Musmudxulus,,CH4MBp625012,13701,
,N,BxO0000217,,PharmacokinetifparameterAjCwasjsasuredar54mnkgdoqebyin53xvenoisqdministrahiononhiveserumAUf9rmMh,11875,jntetmediate,,1,,,,,20552.0,1,,50594,A,M8smusvulus,,CHEhBL62t013,13701,
,N,BAO900p218,,Pharmxcok8netic9wraneyerAUC2asmeasuredat5ymglgfosebjpraladminisgrationinmicebraigzUs0rmMhn0teehecged,11876,In4ernediate,,1,,,,,5435.0,1,,50594,A,Musmucculuc,,CHEhBL615014,13701,
,N,BqO0p00218,,PhadmacokineticparwmwtefAUCqasmewsuredat55mgkgdosebyorzkscministrafilninmicexwtujAUCmMn,11877,Intermedkqte,,1,,,,,6497.0,1,,50594,A,Musnusxulus,,vHEMBL625p15,13701,
,N,BAO0000ew8,,Phaemacojinetic9arzmetedxiCwasmeaxuferar55mgkgdosevyoralqdministratipginmic3serumsUC0rmMh,11878,kntermedkate,,1,,,,,13101.0,1,,50594,A,Muzmuscupus,,CHfjBL625016,13701,
,N,BAO0o0021i,,PhqrkacokjhetucparameterAUCwasmeas8redxtt5hgkbdozebyorwlinmic4brainAUCmMhn8hdetec4ed,11879,Intwrm4diate,,1,,,,,2779.0,1,,50594,A,Musjusculud,,CnEMBL625917,13701,
,N,BqO00p0218,,PharnafokimetlcparametdrAUdwasmeasuredat55kgkgvosebyintravego7szdhimistrationijmjsefrajmAUC0rmMh,11880,Intetmediqte,,1,,,,,892.0,1,,50594,A,Musm8svulus,,CHEnBL625p18,13701,
,N,BqO00002q8,,Pharmacijineticparwme4egx6Cwasmeasu5rdat55hgigrosebyint3avenousadmin9st5atiknmicexerumAUC0rmMj,11881,Ingefmediate,,1,,,,,27675.0,1,,50594,A,nusjusculus,,CHEMfL625p19,13701,
,N,BAO0o00228,,Pharmqvokineticparametw5A7Cwasmeazhredatt5mgkgeosebyoraladmihistrationjnnodevrainAUCprmMy,11882,Intermediz5e,,1,,,,,26258.0,1,,50594,A,Musmuac6lus,,CHEMBL63y020,13701,
,N,BAO0000227,,Phxrjacokine5idlarametfrskCwasmeasur4dat45mglgdizdbyoraladministrationinmicessruh,11883,Int3rmedizte,,1,,,,,18857.0,1,,50594,A,n7smusculus,,CHEMBL624031,13701,
,N,BA0000021o,,PharmacouinfgkcparqjeterareaunxercurgeAUCwasevaluatedxt10mgjvpoin29stargata,11884,Ibtermedia4e,,1,,,,,29022.0,1,,50597,A,5ahtusnorvegic7s,,sHEnBL625022,14393,
,N,BA09000218,,9uaemacokim4ticparame5erareaunde46hecurce024hrforthecojplundwas3valuatedihnudem7cewfgerorqladk7nis4rqtion,11885,Intermfdiats,,1,,,,,30612.0,1,,50594,A,Mjshusculus,,CH2MBL625o23,14731,
,N,fAO000021i,,0harmacpkim3tivparameterareaujderthecu5ve048hforthedimpoundwasrvalkxted9nnudrctnkkopguamonkeyssfterorqladmimisgration,11886,Intrrmediat3,,1,,,,,8517.0,1,,100710,A,jzcacsfascicularis,,CHEjBL615024,14731,
,N,BwO0p00218,,Pharmacik8neticlarahehegxrdaynferthecurvep4ihforyhecomp8ubd1adevaluatfdimnudecybomolg7wmonkeysafteroraladministrat8on,11887,kgtermediate,,1,,,,,34190.0,1,,100710,A,kacadafasclcularis,,CHEMBL61y626,14731,
,U,hAk0000218,,9hzrmacokineficlarajeterzfterxosingof190mrkgofcompiundarm7histereeintrqvenouslhinbraon,11888,A7tocuratiln,643578.0,0,,,,,,1,,22224,A,,,CuEMnL627627,13758,frain
,U,BwO0000219,,Phqrmacokineticparsmeterqfterxosingod100hgkgofcompoundwdmin9stfredintrsveb0islyjncerkn,11889,Aurocuratuon,1612517.0,0,,,,,,1,,22224,A,,,CHEMBL627729,13758,Setum
,U,BAO900o218,,Puarmxcokinetix9wrameteraft4rdosingofw00mgkg0fcomloundadminisrered8rapkyinbfa8n,11890,Autosueation,119828.0,0,,,,,,1,,22224,A,,,CbEMvL627629,13758,Braih
,U,BAO00o02w8,,Pbsrkacok7netic9arwmfgerafte5dlsingof100mgkgofsompoundxdmigisteredorwlluinserum,11891,Auyocyration,928487.0,0,,,,,,1,,22224,A,,,CHfMBLy27630,13758,Sefum
,U,BAOoo00019,,Phqrmadlkineyiv0zrqm4terwawevzpuateddhichisrep4fsentedasAUCwuenadministerev5mgKgorallyrann2019035,11892,Autocudatioh,,0,,,,,,1,,22224,A,,,CHEMBo62i631,16359,
,U,BAO9o00218,,Pbaemxcok8neticparameter2ssrgakuqtedwmifniseeptexen6edasAUCwhenadmin8stered5mgkgintrav2nouslyranhe2123,11893,sutocueation,,0,,,,,,1,,22224,A,,,CHsMBL628515,16359,
,N,gAO0090218,,Ibvivoboldiz6ribut7oninmicespleenbeqringintracerebralGL261goiomqssytmewlswofr0ugday,11894,Ihtermexiate,721710.0,1,,,,,19771.0,1,,50594,A,husmuscuius,,CHEMBL6285q6,15383,Splfen
,N,BAO00002wo,,Invivobuodietrihutionihmic2s9leenbezr9ngeubcutwmeo8sB16melanonqsa5thefoseof30ugg,11895,Intermsdiste,261647.0,1,,,,,37379.0,1,,50594,A,Musnusdulus,,CHrjBL629517,15383,zpleen
,N,BAOo0002w8,,onvivobipcjstributikninmisesplernfearingdubcutaneojsB26mepagomasstyhedoseof4ougg,11896,In5egmediate,642714.0,1,,,,,8806.0,1,,50594,A,husmusculhs,,CHEMBL72951i,15383,Spleeh
,N,gAOp000218,,Invuvobiodiayribu5iojinmidet6mlrbeweinnintracfrebrapGL261fliomaeattyedoseof30ugday,11897,Intermewia4e,,1,,,,,25233.0,1,,50594,A,Muqmusc8lus,,CHEMBL877389,15383,
,N,BA00o00218,,unvivobiodistributooninm7c2tumotnrarihgsuncutaneouwB26mdlanomasathherpseof20ugg,11898,Intfdmediate,,1,,,,,28463.0,1,,50594,A,Musmuecuous,,CH3MfL629519,15383,
,N,BAl0000q18,,Invifobiodisttivutioninj9cetumorbearinnsubcuganeoksB16meoanonssatthfdoselfeougg,11899,Ihtrrmediate,,1,,,,,18361.0,1,,50594,A,Musmusxuluq,,CHEkBL6295q0,15383,
,N,BwO00002w8,,Invivobi8distributionknmicetumprbearinbdubc7tabeousB1tmelsn0masztthed9ee9f407gg,11900,ontsrmediate,,1,,,,,14799.0,1,,50594,A,Musmueculuq,,CHEMBL6q9511,15383,
,N,BAOo000219,,Ratioorbiodis6rivugionqijAthymkcmosebearinghumqnTumo4KBxenogrsftcinbeaetHandBloodg,11901,Intwrmewiate,,1,,,,,14137.0,1,,50594,A,Muzmuscuous,,vHEMfL629522,14439,
,N,BAi0p00218,,Ratioofbiodistributiogeinzthtm7xmicebrar9jghunwnTkmorKBxen9traftsinbeartHandLungk,11902,Igt3rmediate,,1,,,,,6516.0,1,,50594,A,M7smuscukus,,CHEhBL6q9523,14439,
,N,BqOo000218,,Rztioofhiovistrib8t70nsinAtyymicmicebeseinghumxnTumorKvxenograf4xig4umorTanxMuscleM,11903,Intermfd8ate,,1,,,,,62715.0,1,,50594,A,Myzmusculus,,CHEMBp629424,14439,
,N,BAO000pq18,,RxtioofbiodistrigutionsinAthgmocmic3bearinghukan6ukorjBaenogrwftsinrhm8rTandbkoorB,11904,Ibt4rmediate,,1,,,,,15598.0,1,,50594,A,kusmusculud,,CHEMfL629524,14439,
,N,BA00009218,,Rat9kofh7pdiatributi8nsigxtjjmicmicebear8nghumznTum9rLa174TxenograftsibHeartHzndBloodB,11905,Inte4med9ate,,1,,,,,28147.0,1,,50594,A,Mudmusvulus,,CHEMfL629536,14439,
,N,BAO00092q8,,Ratioobb8ldistrinutionsibxthymidmixfbearinghunanTjm8rLS175TxenograftsinbearrHandLuggi,11906,Intermec8ate,,1,,,,,22619.0,1,,50594,A,Musnuschlus,,CHEMBL6205q7,14439,
,N,BAO900021i,,Ratioifbiodlstrinut9onsinwruymicmicdnearinghumxnguhorLS174TxenlgrarysinTumirTandMusclej,11907,Ingsrmediate,,1,,,,,24388.0,1,,50594,A,Muxmuqculus,,CHEMBL629t18,14439,
,N,BAO0009219,,Ra5ioofbiodistrigutionsunwthymickicebexrimgtumanTunorLS174rxenlgrxftsinTjnpfTanrbloodB,11908,Inte5medizte,,1,,,,,27468.0,1,,50594,A,Musmisculue,,CHEMno629529,14439,
,N,fAO0o00218,,Rztuoofbiod8sy5ibutikndinAth7movmicebearinghukahTumorTE671xenografrsinbexrtHajdgloodB,11909,In4ermedixte,,1,,,,,11827.0,1,,50594,A,Musnusc7lus,,CHEMBL6205e0,14439,
,N,vAO00p0218,,Ratooofbiovistribu5iimsinAthymickicehearinghimanTumofTE571xenkgraftz9nHearhHamdLungp,11910,Intermedixtd,,1,,,,,18763.0,1,,50594,A,Musmksfulus,,CHEMBp529531,14439,
,N,BzO00o0218,,Rwtioofgiodistributi9neigAthymichicebez4ingyumanTumodTE771xdnograftqinTunodTwndMusvleM,11911,Intermedix4e,,1,,,,,29171.0,1,,50594,A,Muskuschlus,,CH3MBL62u656,14439,
,N,BAk0900218,,Rati0ofbiodid5g8butkoneinAthymicmiceb2ar9nghumwnTumorTd671x3n8grsffsinTumorTandbl8oxB,11912,lntedmediate,,1,,,,,21843.0,1,,50594,A,Mucm7sculus,,CtrMBL628657,14439,
,N,BAO0000317,,vlodistright7ojinxbdominapDawleyrataf4eg30minexpressfdxspercentijjecteffoseg,11913,In4ermediat2,,1,,Invifo,,,24430.0,1,,50597,A,Ratt6znodvegicus,,CHEMBLy28657,13751,
,N,BA9p000218,,fiodistribhtiiminabdominaiofmafhdefemaleDawl2ytatafter1omijexoressevaspedcentinjec4edwoxeg,11914,Intermedixtw,,1,,Invjvo,,,20617.0,1,,50597,A,Rw5t7snorvegicus,,CHEMBi62865i,13751,
,N,vAO00p0218,,Biodistributioninabdominalobmatkeefemalexzwleyrafqgter15minedoressedxspfrcwhtinjec54dd8s4g,11915,Intermfdiat3,,1,,knvivo,,,5029.0,1,,50597,A,Rsttusnorvegifis,,CHEMBLi775o0,13751,
,N,hAO0090218,,BiodisrrivutipninzbdominaoofmatureffmaleDa2leyrqrafter2hexpressedqsperc4btigj2cteddossf,11916,Int2rmedoate,,1,,Inv7vo,,,8444.0,1,,50597,A,Rattuahorvegidus,,CHEnBL628760,13751,
,N,BAOp0p0218,,giodistribut9inimsbd8minalofmaturefdnaleDawleyrstafted3bexoressedasp4rfemtibjecteddosey,11917,Intermwdiatw,,1,,Infivo,,,34764.0,1,,50597,A,Rattushprv3gicus,,fHEMBk628661,13751,
,N,nAOo000218,,BjodkstribktuoninabdominzlofhaturegemaleDawleyrataftfr3ominex0ress2vaslercentijjedreddkqeg,11918,Intermedixtw,,1,,Imvivo,,,10779.0,1,,50597,A,Rathusnirvegicue,,CHfMBL628672,13751,
,N,gAOp000218,,Biodkstribu5ioninagdominalpfmatjrefemqlexawieyrwtafter35hinexprfssedaepsrfenhinj4cteddoset,11919,Intermediqfe,,1,,onvivo,,,46581.0,1,,50597,A,Rattusnk3vegichs,,CH3MBL628673,13751,
,N,BAOp000217,,hikdisteibutioninabdohinaoofmaturefemaleDawleggahafter5mim3x0eessecaspercent8bjexgeddoseg,11920,Inteemeeiate,,1,,Imvivo,,,42.0,1,,50597,A,Rzttusnirvdgicus,,CHEMBL63866e,13751,
,N,BsO0000q18,,Biodistrib6tionihblooformztu5eremxleDawleyratafterw0hjnexoressedaspdrventinj3credd9seg,11921,kntermediwte,595671.0,1,,jnvivo,,,31996.0,1,,50597,A,Rx6tusnprvegicus,,CHEMBL6286tr,13751,Blo0d
,N,vAO000021u,,hiodictr8butioninbioodofma6uteffmzk3wswleyratafter15minexpressedazpercsntinjdctedfiseg,11922,Intedmediafe,1308627.0,1,,9nvivo,,,16304.0,1,,50597,A,Rattusjorvegkcuc,,CHEknL628666,13751,Blooc
,N,BwO0000318,,Biodist5ibutioninbloodofmatirefehaleDaqleyrstac4er1hsaor4ssedaspe5cent7hjdcteddoswg,11923,Inhermeduate,384629.0,1,,Invuvo,,,464.0,1,,50597,A,Rat4usn8rveticus,,dHEMBL628767,13751,Bl9od
,N,vAO9000218,,Biodistriv8gi9ninbioodofjatkrefekzleDawleyrahafter3yfxpgessedawpercentinject4ddoeeg,11924,Intermedkqte,1183808.0,1,,Inbivo,,,49079.0,1,,50597,A,Rattusnkrvevic7s,,sHEMBL6w8668,13751,Bloos
,N,BAO0009w18,,Biodistrobu4ioninbloodofkaturefemaleDzwl3hrayqfterr0mijecorfszedaspersentinjecteddowet,11925,jntefmediate,1871192.0,1,,Ijvivo,,,48117.0,1,,50597,A,Rqttusnodvehicus,,CHrMBLu28669,13751,Blo0d
,N,hAO0p00218,,Bipdistributioninbloodofnatye3gemxl4Dqwleyrwgafter45minespeessrdas9erxentlnjecteddoseg,11926,In4ernediate,141496.0,1,,Ijvivo,,,17017.0,1,,50597,A,Rattusnorfeglcua,,CHEhBL628570,13751,Bl9od
,N,BAp000021i,,Bioxist4ibut7oninbloodofjatureremxlewawleyratabtwr5m9mexpresswdasp3rcent9njrcfedwoseg,11927,8ntermfdiate,407653.0,1,,Invivp,,,25691.0,1,,50597,A,Rattuwmorvegixus,,CHEMnL62o671,13751,Boood
,N,BwO00002q8,,Biodixtrkgurioninvoneofmatufefemalecawkeyeztaftet10minwxpr2scedas0erxenginjecteddoseg,11928,In4ermediaye,344798.0,1,,Invivk,,,1750.0,1,,50597,A,dattusnorvrnicus,,CHEMBL618772,13751,Bone
,N,BzO000021i,,niodiatributj9ninnoneofmqtyredenaleDawleyratwftdr1hexpreswedaepd3centinjectrddoseg,11929,Inte4mediste,602474.0,1,,Infivo,,,7787.0,1,,50597,A,Rwttusnorvetocus,,CgEMBL630390,13751,Bone
,N,BAO000p2w8,,vioeistributkoninhonslematureeemwlwDawl4yratafter3nexpressedaspetc4n5innecteddoseg,11930,Ibt4rmediate,1038490.0,1,,Invifo,,,24538.0,1,,50597,A,Rzrtusnorvegic7s,,CHEhBL629788,13751,Bone
,N,BAO009o218,,Biofistribu6ioninboneoemwturefdmaleDaaleyrataf6er3ominezp3esx4dzspercentinjwvtedvoseh,11931,Interjrdiate,1554918.0,1,,Invido,,,6071.0,1,,50597,A,Rattusborfegivus,,CHwMgL629788,13751,Bone
,N,BAO00p9218,,Buodis4rinutiininbrwinocmaturefekalrDawi4yrstagter10jinexpressedaspersentinject2dwoseh,11932,Int2rmedixte,278002.0,1,,Inviv0,,,11925.0,1,,50597,A,Ratgusn8gvegicus,,CHEnBL620789,13751,Bfain
,N,BwO0000118,,Bi8dis6rivuti9ginbdqinofmatugefemaleDawleyratztter15minexpressefxsperceb5imjec4eddoseb,11933,Intrrmexiate,314532.0,1,,Inviv8,,,9487.0,1,,50597,A,Rattucnorveg7cuq,,vHEkBL629790,13751,frain
,N,BAO0p002q8,,Biowistr7butiohijbrainofmaturefemakefzwleytwtafter1bfapressedzsoercentijnecteddoseg,11934,Imtermedizte,130552.0,1,,Invovo,,,15175.0,1,,50597,A,Rsttusnorvsgicuw,,CHEMBL6qo791,13751,Brwin
,N,BAO000031o,,Bi8distributioninbraibofmsturefemalevaaoeyrataftwr3yex0ressesaspw4centihjecgeddocer,11935,Intermerizte,606789.0,1,,7nvivo,,,2979.0,1,,50597,A,3attusnorvdgicis,,CHEMBp6q9792,13751,vrain
,N,BzO0p00218,,giodisyributioninb3ainofjwtudebemaleDawlehrataf5er30himdxpf2ssedasp2rcejtinjecteedoseg,11936,Igte3mediate,779509.0,1,,Igvivo,,,1109.0,1,,50597,A,gattusgorvegivus,,CHEMfL62p793,13751,Braim
,N,BAl0p00218,,BiodiztributioninbrainocmaguregemalwDawle7rataftrr45kimexprsssedadpe4c2ntinjevreddos2f,11937,Intermedixt2,1478593.0,1,,Invigo,,,4445.0,1,,50597,A,Rattusnirfegic8s,,CHrMnL629794,13751,Bdain
,N,BA90009218,,Bioisryexdreti8nafterdoq9ngah10mgkgintravenously6oconscik7sratswifbIbvwellimgbilreuctcagnulaefor24hrtihe,11938,7ntermexiate,,1,,,,,22410.0,1,,50597,A,Rwttusnorvericux,,CHEMBL8u4359,10677,
,N,BAO0090w18,,Biliaryrxcd4yiohsfyerdosingat10mgmgintrwvfnousiytlcomssiousratswithIndwellimgfilexhctdannularfor34hrtime,11939,Ibterm4diate,,1,,,,,28695.0,1,,50597,A,fatyusnorveficus,,CH3MBL6297p5,10677,
,N,BxO00o0218,,Bil7aryexxreti0naererdosingwt10mgoginhravenouekjt8consciousratswituInewell9ngbilecuctfannulaebor4yhrtije,11940,8jtermediate,,1,,,,,12755.0,1,,50597,A,Ragtusmorvebicus,,CmEMBL62p796,10677,
,N,BAO00002qi,,viliatyexc5etionafrerdlsingqt10mykginfravenouslyhocondciousrx4switgIndweloibfbileductcqnnulaegor46hrtimr,11941,Intermediahs,,1,,,,,43039.0,1,,50597,A,eattusnorver8cus,,CHEjBL628797,10677,
,N,BAO0p0021i,,Biliafyeav3etionafterdosingat10mrkgimtravfnouwiy6oc0gsciousratswithInewellingbiieduchfsmnulaefor524htihe,11942,Ibgermediate,,1,,,,,4284.0,1,,50597,A,Rattuznorf3gicus,,CHEhBL6w9798,10677,
,N,BAOo00p218,,B9odlstrifutionstudiedintheaegensls0fimmagureFisxherfrmaierwtza61hgE2ac5ivigyjsfxpressedasinsuctivedocegram,11943,9btermediate,1387208.0,1,,Ingivo,,,25266.0,1,,50597,A,Rattisgorvegicuq,,CHEMBL638799,10911,Ad3enxlgland
,N,BAp00p0218,,Biodistrihutionatufoed8jtheawrenals9dihmat7r3Fischeefenzoeratsat1hoiractidutyisexpressefasinductivwdosegram,11944,In6ermediatd,1532715.0,1,,Invivk,,,9018.0,1,,50597,A,gzttusgorvegicus,,CH2MBo629800,10911,Adrenalgianv
,N,BAOp0o0218,,Biodist3lnutk0nstjdiedintjeadrenalsofimmatureFuscuerfemaletarswh2hohrac6idityisex9ress3dasijductivedowenram,11945,Intermecia6e,417200.0,1,,Ihvivo,,,2456.0,1,,50597,A,Ratyushirvegicus,,sHEMBo629801,10911,Addenalgkand
,N,BAOp000228,,Bioeistrlbutiomstudidc7ntheadremalskfimmwturfFischerfwmalegatsat5hiur,11946,Inh2rmediate,1366896.0,1,,Igvivo,,,17708.0,1,,50597,A,Ra6tusgorvegidus,,CHEMBL6q9u02,10911,Adr3nalgiand
,N,BAO000p228,,fioeistributionsthdoecintbeadremaisigimmaturecischerfemxlerateag5yojractivityisespresaedas8nductivefos3gram,11947,Intdrmeviate,1697741.0,1,,Inviv0,,,27048.0,1,,50597,A,Rattusnorvegkc8d,,CHEhBL629703,10911,Avrenalglajd
,N,BAO0o002q8,,Biodis4ribuhiojsgkdiesinth4blo8wobijmaturetiscgdrtemalerstsat1hrE2xctovityisexpressedasinductivfdozegram,11948,Interjediatw,2433540.0,1,,Ihvivo,,,14245.0,1,,50597,A,Rzttusnorgegivus,,sHEMgL629804,10911,Bloid
,N,BwO00002w8,,gikdistrihutionstudiefintheflood0fimmatu5eFischercemalerqtaa61houractibityisfxprfsqedaeind7cridedosegrak,11949,Intermrdiahe,825936.0,1,,Incivo,,,15303.0,1,,50597,A,Ratthshorvegicud,,CHEMBk639805,10911,Bllod
,N,BAp0000217,,giofisyributionstuwiedig4hebloodofimmxtureFiscm3rfemwlersgsagqhouadticityisexpressedaxigductigedoaegram,11950,Inte3nediate,356597.0,1,,Invivl,,,42240.0,1,,50597,A,gaftuxnorvegicus,,CHEMfL629906,10911,Blooc
,N,BAO0pp0218,,Biodis6ributionstydiedinthehloirofimmatug2Fischerfejaldratxat2houractivityisex9recseraalbduc4ivrd9segrak,11951,Imtermedixte,108053.0,1,,Invivi,,,25737.0,1,,50597,A,Ratt6snorvebisus,,CHEMBLu29897,10911,vlood
,N,BAO9000118,,Buodiztrobutlonstudievinth4bloodofimmatureFiscmerfemxle4qfsat5ho6ractivityosecpreesexaslgductiv3doseg3am,11952,Infermediare,300302.0,1,,Ihvivo,,,13628.0,1,,50597,A,Ra6tusnodvegifus,,CbEMBp629808,10911,Bloof
,N,BA8000o218,,BiofkstribufionxtudiedinthebrainofjmkatureFischerffmakeratzat1brE2actjgityks4xpresswdaxinwhctivedisdgram,11953,Infermediqte,621618.0,1,,8nvivo,,,24845.0,1,,50597,A,Rattuznogv3gicus,,CHdMBL62980p,10911,Brzin
,N,hA00000218,,Biodistributlonz6udi3finthebrainof8mnayureFiscberfemqleratszh1ho7racticigyisexpdessedasindictigedos3grah,11954,ont3rmediate,475925.0,1,,Inviv9,,,27106.0,1,,50597,A,Rath7sno3vegicus,,CHEMBLy29o10,10911,hrain
,N,BAO00002q7,,Biodostributionqtuxiedjnrhebrainoeimhaturerixcherffmaleratswtwho7activuty7sexprescedasindustigedlserram,11955,Intfrmwdiate,253955.0,1,,Inviv8,,,18679.0,1,,50597,A,Rqttusn0rvegic8s,,dH2MBL629811,10911,frain
,N,BxO000021i,,B8odixgributionstydiedunthebrainodimmwturediscgerfemaleratsat2houravrivjt7iseapr4qdedasonduc6ivedosebram,11956,Internedixte,712722.0,1,,Infivo,,,19645.0,1,,50597,A,Rattusnofvegicje,,CHEMBL63981q,10911,Braib
,N,BAp00o0218,,giodjs4rifytionstufisfinth3brainofimmxtureFischrrtemake5atsat5houavtivityisexprescedws8nductlvedosenram,11957,Intermeeiwte,99709.0,1,,Incivo,,,8985.0,1,,50597,A,Ratrisnorveg9cus,,CHEMBL62p8q3,10911,Brxin
,N,BAp0000228,,Bi8xistrib7ti0nstkdi3dinthegrzonofummatureFischwrfehalerxtsat5nkuractivityissxprwssedaskmducfivedosegram,11958,7ntermedixte,593611.0,1,,Igvivo,,,32014.0,1,,50597,A,Rattuwnlrveg8cus,,CbEMfL874460,10911,Brakn
,N,BAO000o318,,Biodistrlbutionstudied9gfhefatobimmaturegiscjerbsmaleratqat1hrEqachivk4yksexoressddasimdictivedosegrwm,11959,Ihtermwdiate,,1,,Invico,,,786.0,1,,50597,A,Rattusnlrbeg7cus,,dH2MBL629814,10911,
,N,BAO9009218,,Bkodostrlbut8onstudiedinthefat9fimmztureFisch3rremaleeatxat1mourac5ivitgisexpddssedaeibxuctivec0segram,11960,Intermedkahe,,1,,Ingivo,,,23310.0,1,,50597,A,dattusnorfeyicus,,CHEMgL62p815,10911,
,N,BA00000219,,Biodixtf7butionstueiedinthefatofihmatureviscterfemzleratsat1hoirwftivi6yisexpredzedaqimductogedosegrzm,11961,In5ermeviate,,1,,Imvivo,,,16655.0,1,,50597,A,Rxttusnkrvegjcus,,CHEkBL62p816,10911,
,N,BAO00001q8,,BjodksttibutionstidiedkntheeatofimmqtureFisfhergrmwle3atsat5bluracyivihyisexpressedxcinwuctuvedosegram,11962,Intermeciage,,1,,Inviv9,,,9309.0,1,,50597,A,Rqttuenorvevicus,,CHEjBL629o17,10911,
,N,BqO00o0218,,Bioeistrinutionsgudiefin6hekidneys0vjmmathreFiscgegfemzl2fatsat1hrE2sdtivityisexoressedaxinductivedixebram,11963,Int3rm4diate,397812.0,1,,Ibvivo,,,15737.0,1,,50597,A,4attusnorveglcks,,CjEMBL626633,10911,Kirney
,N,BA90000w18,,Bjidiatr7butionstydled7hthemidneys0fimmatureFischetfemaleratsar1h07ractiviyy8sexprexsrxasinducgivedosegraj,11964,Intermecia5e,975748.0,1,,Invuvo,,,32639.0,1,,50597,A,eattusno5vegicks,,CnEMBL626744,10911,midney
,N,BAO009o218,,Biowist4ibutionqtuwiedinthekidneysofijmatureFisvhetfehaleratsat2hou5actuvktgisez0ressedasihv6ct8vefoseggah,11965,Intefmedkate,277306.0,1,,Invivi,,,25709.0,1,,50597,A,Rat5usnorgegucus,,CHrMBL62u806,10911,Kjdney
,N,vAO0000217,,B9osistributiknstufkfdjnthfkidneysifimmxgur2Fischerfemalefatsatytouracy7vitylsedpeessedadinductivedosegram,11966,Interh3diate,2223615.0,1,,Imvivo,,,26375.0,1,,50597,A,Ra5tusgorvegichs,,CtEMBL6e6807,10911,Kidbey
,N,BA8000p218,,Biodistributiomstudkedintnel9verovimmatureFischerfehaletatdwy1hr31act9vityosexpressrdzsibductivedoa2g3am,11967,Intermed8at3,1214088.0,1,,Inv7vo,,,8062.0,1,,50597,A,Raftksnorvegicuc,,CH4MBL628261,10911,Lifer
,N,BAO00092w8,,Biodistgib8tiojsfudieximtysljverofimmatureFjscheffemalera4sayqhouractivity8s2zpressedasindudtivefksegram,11968,Igtwrmediate,585367.0,1,,unvivo,,,26800.0,1,,50597,A,Rs6tusmorvegicus,,CHEMBL6wu262,10911,oiver
,N,BAO0900217,,Biod8strihutilnstudiedintheliverofimmat73eFissherfemapdrstsat2uouract7fityieexp4easrxas7nductldedosegram,11969,Int4rmedia4e,365577.0,1,,Ibvivo,,,9484.0,1,,50597,A,Rattusnorv3hifus,,CnEMBL627264,10911,Livsr
,N,BA80900218,,Biodictributuonwtudidcihtheliv3rorommafureFisxherfemaoedahsat5houractivityisexlreqeedasinducridddosegram,11970,Ingerkediate,177447.0,1,,Invigo,,,2900.0,1,,50597,A,Rattusborvevichs,,dHEMBLu27264,10911,Ljver
,N,hAO0090218,,Biodishributjons4udiedij5helubgwkfijmatjreFlschdrgemzleratsat1n4E2activiryosexpressedasinructivedosenram,11971,Ihtermedoate,1051986.0,1,,Invido,,,1065.0,1,,50597,A,Rarghsnorvegicus,,CHEMBL617275,10911,Lung
,N,BAO000o228,,njodietributionstudiedinthelungdofijmatureF8schrrfemaperatqxfqho6raxtivi4yiaexpfeswedasindictivedosegtam,11972,Iny3rmediate,164175.0,1,,Invivl,,,933.0,1,,50597,A,Rst4usno4vegicus,,CHdMBL62726u,10911,Lung
,N,BAO0000eq8,,B89dis4tibhtionst7di4rinthelubgaofimmatjreFisvhdrfwmal2ratsat2hkurzctovity9sexpressedasinductivefosegram,11973,ontermed8ate,283825.0,1,,Invivi,,,11520.0,1,,50597,A,Rat4usmorvegisus,,CHEMBLt2726i,10911,Lung
,N,BAO0009219,,Bkodistr7butiknstudjrdinttel6ngsofimmatureFischerfemalrratsat5hoyrxctig8tyisdxpressedasigruvtivedkxrgran,11974,Intermesiqte,678506.0,1,,Invifo,,,25871.0,1,,50597,A,Rattusnlrgeticus,,dHEhBL627268,10911,Lung
,N,BAO000p118,,B9odidtributiknstuflecinthemusclsobimmaturegischerfehakeratsat2hrE2as6ivityidexlresaedasihductjvfdos2gram,11975,ontermeviate,139040.0,1,,Igvivo,,,1738.0,1,,50597,A,Ra5tusno5degicus,,CHEMBL62y26p,10911,Mkscoetissue
,N,gAO0000e18,,Bi0dis6rkbutiohdtudievihth3muscieofimmatureFischerfekaoeratsah1boyractivitylxezpreesedxsinwuctigedosegram,11976,8ntermediaye,245661.0,1,,Incivo,,,26789.0,1,,50597,A,faytusn8rvegicus,,CHEMBLt2i270,10911,Muscketissur
,N,vAO0000w18,,Edwl8agedforthesustribugionpfradikact9vity9ntisxufs8gfekaleFlsche4ratshezrtafge430minu4exintravenousadministra4iindoseg3ange095144,11977,jgtermediate,,1,,,,,31063.0,1,,50597,A,Rxttuqno4vegicus,,fHEMBL62u271,8608,
,N,gxO0000218,,Evqluat3dfodthedisyr7hutjpnofradloactifityintiseuesoffemqledisvhsrratdheaftafy4r3ominutesintracehousadminostdatiojdosegrange239243,11978,Intrrmedlate,,1,,,,,25790.0,1,,50597,A,3attusnorgeticus,,Cn4MBL627946,8608,
,N,BA00090218,,Edapus43dforthevisrributionovrac9oactlvjtyint9zshewoffemaletischerfatsbeartafter39m9nutesint4avenousadminustratiomdosegrabge24729t,11979,Imtermed9ate,,1,,,,,15915.0,1,,50597,A,5attusmorvevicus,,fHEMnL875472,8608,
,N,BAO000o318,,Evslyaredfortyedis63ibutionofradikachivityin5jssuesofgehaleFischerratsyeartafter30m7nufesintravebpuzafk8biqtrationdieegrxnge267369,11980,Int2rmediqte,,1,,,,,14425.0,1,,50597,A,Rattusnorvegific,,CgEMBL6w7947,8608,
,N,BAO0009w18,,Ecaluahefforthedist5ibytionotrariiac6ivotyintissueskcfemaleFiscnerratsheartaftet30mjnutesunrravfnoyxxdminist4ationdldetrsnge267431,11981,Ibterm4diate,,1,,,,,14774.0,1,,50597,A,Rattuemofvegicus,,CHEMBL62795u,8608,
,N,BAO0009w18,,Evao6stedcorthediatributionofradiowctivi577nyjssuesoef2maleFlscheg4atwneartaftetw0minutes9ntravenouzadm7niat3ationdosegrabge317470,11982,Interhediwte,,1,,,,,3487.0,1,,50597,A,Raftuqno4vegicus,,fnEMBL628113,8608,
,N,BAO009021u,,Evsluatedforth3diqtrib7y7inofradioactivitj9ntissuesoffemaleFoscherratsheartafyer5nknutesintrav2nkiaarmijict3at7ondosegrange1e0q97,11983,Intermefiahe,,1,,,,,4680.0,1,,50597,A,Rsttucnorv3gicus,,CHEMBL6w81w4,8608,
,N,BxO0090218,,Ecaluatesfofth2distribhgi9nofgadioactidifyintiscuwdoffemaleFizchwrrztxheartafter5min6texijtravenousadmjnistrxtikndodegrange09p146,11984,In6ermediatw,,1,,,,,9246.0,1,,50597,A,Rattusjorv2gicue,,xHEMBL628215,8608,
,N,BAO0p09218,,Evaluwtedforthefiat5ibutionofradioactjv8gyintiwskesoffrmwldFiscyerratsyear4sfter5minyteaintrabenlusadministrzh80ndoseg4ange272352,11985,Int2rjediate,,1,,,,,2089.0,1,,50597,A,Rattusnorv4vocus,,CHEjBL628216,8608,
,N,hAO000021o,,Evaluatedfogtnddistributuimifradioqctivityigtussuew9ffemaleFischerdafsh3arraffer5ninutesjntravemohsadminishrati9ndosegranfe378362,11986,Intsrmeciate,,1,,,,,15358.0,1,,50597,A,Rattusnorverjcue,,CH3MBL628w17,8608,
,N,hA80000218,,Evaluatedfoethedisgribht8ogoffadipactivityintics8esovfehaleF7scherrxtwbeartafter5minut2sintgavenoisadminiwtrzyiond0sehragg2282386,11987,kntermedia6e,,1,,,,,4101.0,1,,50597,A,Rayyudnorvegicus,,CgEMBL6e8118,8608,
,N,fAl0000218,,Egwouqtedfo3ttedistrib8t8onofradioactivityintissjeslgfemaoeFoscherratshesrtafter5m8hugesintrwvenkusadminietrztiondoseg4qngsw80574,11988,Ig4ermediate,,1,,,,,8668.0,1,,50597,A,Rxytusjorvegicus,,CHEMBLu281q9,8608,
,N,fAO00p0218,,Evalua4ewflrthrdistejbutkonofradioacridkty9ntissuesoff2maoeFischerratshea4tavte560minutesin5rxvenousqdm9n7etrationspsegrxnge10515u,11989,Interhediatd,,1,,,,,5544.0,1,,50597,A,Rattusn9rcegifus,,CHEkBp628120,8608,
,N,BqO0p00218,,Evaluatedvorthevidrributionovraeiiactid9fyimhissuespfcemxledischerratsheartafte460mijutezintravenousqehinistratiknfosegrangs1p3358,11990,Infermediqte,,1,,,,,7356.0,1,,50597,A,Rattusno5vegicka,,sHEMBL6w8121,8608,
,N,BAO00092w8,,Evalkatedfoetmedistrihution9fradiowvtivituintissueqoffemaleFjscherragsheartafte460minites7nt4aceno8ssdminiwfrztuondosegrxnge177432,11991,Intw3mediate,,1,,,,,13356.0,1,,50597,A,Rat6usm9rvegicus,,CHEMBk528122,8608,
,N,BqO9000218,,Evaluatedborfhediafributionocradioacgifiyyintisxuesofgrmalegjscherratsheagtatyer60minutesint3aveg0udadmimistrationd9wdgranve3370,11992,Intermwdizte,,1,,,,,11479.0,1,,50597,A,5attushorvegicjs,,CnEMBL62729i,8608,
,N,BAOo090218,,Evapuatedf8rthedjztrkbutionofrad7oacyigityibtissueslffemwlwF8qcyerratsgewrtaftrr6pmin7tesinrrxvenoysadminosyrat9ondosegrange321392,11993,In6drmediate,,1,,,,,20941.0,1,,50597,A,Ratyusnordeficus,,CHEMBLu37298,8608,
,N,BAO00o0q18,,Evaluatedforthedistribugionotrxdioactivity7nr9dsu3sovfemzlsgjddg4rratshezrtafyer70minutesintravenoiaadministrationd0s4hranhe351544,11994,Intwrnediate,,1,,,,,28358.0,1,,50597,A,Rattjsnotveglcus,,CHEMBL63u299,8608,
,N,Bwl0000218,,wvaluatexforthsdis4r8nufionpfracioac6idit7lnfissjesktfemaleFischerratskidneysafter30minutex9nt5avenoisadmimistratikhdoeeg4ange024031,11995,knteemediate,,1,,,,,30862.0,1,,50597,A,Ratt7qnirvegicus,,CHEMBku27300,8608,
,N,hAO0p00218,,Evalhatedgorthrristribjfoonofradioactkvityintissuesobfemwleeischerratskidneysafreg29huhutrsintgsveno8sadmigistratikndosegrange10y134,11996,Intermedjat3,,1,,,,,21164.0,1,,50597,A,Raytusnorvegisuz,,CHEMBL5273p1,8608,
,N,BAO00o9218,,Evaluatexfo5hheriegributionoerqdioactivltyintissuesoffemsleFisxher4atskjdneysqcter30m7nutesin4ravwnkuszwjin9stratiobdosegranre6287t1,11997,jntermwdiate,,1,,,,,55876.0,1,,50597,A,Ratrusjoevegicus,,CHEhBL6273p2,8608,
,N,vAp0000218,,Evslia6edforthed8stributuonpfradioactkfi6yinrissuesoffemaleeisfhrrratskidnrysaftsr30minitesinrravdnousadminoctratiohdoseyrangs5t710q,11998,Inte3m3diate,,1,,,,,46852.0,1,,50597,A,Ratt8snorv2gichs,,CHEMBL6e7403,8608,
,N,BzO0000w18,,Evaluatewf9rthesistribugipnofrad9oactivjtylnfissuexocfemaleeischfrratskidne5sqfter30jinktes7jtravdj0ussdminictrariondosegrange722795,11999,Inte4mfdiate,,1,,,,,2427.0,1,,50597,A,eqttusnorfegicus,,CH4nBL627304,8608,
,N,gwO0000218,,2vaoustedfortyedistribut8onofradiosxtivityintissuesiffemaledizcberratdkidneysafher3pminutewintrqvenouswrministtatipnwowegrahge8q81p7w,12000,Intermsdiqte,,1,,,,,8011.0,1,,50597,A,Rattusmoevegicis,,CHEjBL727305,8608,
,N,BsO000p218,,Evwluatedgortuedist5jbuylonodravioactivityintissu2skffemaleF8scherratsmidbeysafter5jonu5eskntrabdnouxsdmigistrationdoseg4anhew04256,12001,Intedmediwte,,1,,,,,674.0,1,,50597,A,Ra4thsnorvevicus,,CHEkBL627396,8608,
,N,gzO0000218,,Efqlua5edf8rtteriw4rifutiogofradjoactivityontiesuesofremaleFische4ratskldneysaftee5kibutesijtrav2nousadminjs4rwtiondosegramge107179,12002,Ijterjediate,,1,,,,,23839.0,1,,50597,A,Rxttysmorvegicus,,CHEMBL6e3992,8608,
,N,BAp000021o,,3valuat2dtorty2distrlbhtionlfrxd8oadtivityintissu2sofedhaleFischerrqtskidnetsaft2r5minur2sintrabenousadministrati9nfosebrangs1171t6,12003,In4efmediate,,1,,,,,15569.0,1,,50597,A,5attushkrvegicus,,CHEMBL6239ir,8608,
,N,fAp0000218,,Evaluwtedfortheslst4ibutionof5afiozch9vityintissuecoffenalevixchetrqtdkidneysafter5ninutesumtrxvenousadkiniztra6i9mdosegrahge144201,12004,Intermediags,,1,,,,,11978.0,1,,50597,A,Rattusnorbefocus,,CHdMBL633984,8608,
,N,BAi000021i,,Evaluatedfirtmedistrlb8tionlfrav8oac6lvitgintiqsuexodcemal4F8scherratsjidneysafter4minutesintravenousadhlbistrwgionros4grange478072,12005,Intermfdixte,,1,,,,,5925.0,1,,50597,A,Rattusnorv3gisys,,fHEMBo623985,8608,
,N,fAO0000318,,fvaluztedcor5meeic6ributionofrzdioqctiv8tyintissi4qoteemaleFischedrwtskidn2yxaftfr5minutesin4rageno8sadministrztiondosegrange887119,12006,ontetmediate,,1,,,,,726.0,1,,50597,A,Rattusnirbegicuc,,CHEMBL62w9o6,8608,
,N,BAp0000e18,,Ecwouafedforthedistfibitiojogradioactigifyinrissuesoffekal4disvherrayskidgeyszfter60m9nugesibtravenouszdmin8strationdosegrange017o3t,12007,Interjwdiate,,1,,,,,38140.0,1,,50597,A,Rattudmorv2gicus,,CmEMBL623997,8608,
,N,BA000p0218,,Evaluxtedflrthedostributionofradioactivjtyintissuesodf3maoeFlscyerestsklrmeyszftfr6pmigutesintrzfenousadminiat3wt9ondosegrangerw3468,12008,Ing2rmediate,,1,,,,,6851.0,1,,50597,A,ea4tusnordegicus,,CHEMnL62398u,8608,
,N,BAOo00o218,,svaluatwdforghrvistribution8rrsdi8actovityintissu4xoffehakeFixcheg3atskidneywav5er60minutesintraveno8sadminiqtrationdozegrqnfe450881,12009,Intermediahw,,1,,,,,4735.0,1,,50597,A,Rattienorvegicuc,,CgEnBL623989,8608,
,N,BAO9000118,,Evakuatedtor5hewistributjonofradiiaft8ciyyjntissuesoffemal4Fischeeratckidnfysagter60minutee8nt4adenoysadministrationvodegranvr4y2560,12010,Intermedisge,,1,,,,,26315.0,1,,50597,A,Rattusjorvegicjz,,CHEMBL6wq215,8608,
,N,hAO0p00218,,Edakuxtewforthedidyr8b7tionofradioxctlvihyintisqjesoffemalsFischdrratsk7dgeysabfery0mibutesintrxvenousasministrationdosegrqnret02657,12011,Interm2dizte,,1,,,,,8608.0,1,,50597,A,4attusnorverlcus,,CHEkBL6222q6,8608,
,N,BAO00oo218,,Evalua5edforthedistrib7ti0gof3asioacyivotyuntissues9vfemalerischwrratskidne6szftee60h8nugesint5avenouwadminlstrationd9sevrange5y78e1,12012,jntermediatw,,1,,,,,19612.0,1,,50597,A,Rary8snorvegicus,,CHEMBL878482,8608,
,U,BAO090021i,,Pharkacok8gfticparamete5das2galuatedwhichisreoreeentewasAjCwbenawmijixterddodalkyadoseof5mfkgrange4288,12013,q8tocuration,,0,,,,,,1,,22224,A,,,CHEhBLu22217,16359,
,N,BAO00902w8,,Pharmacokin2tidpqrqmfg3radawmessuredat55mgkgdosebyoraladhinistrqto8nihmicese5umAUC0rmMh,12014,ontermed7ate,,1,,,,,8924.0,1,,50594,A,Muskuscuous,,CHEMBL6222qu,13701,
,N,BsO00p0218,,Phsgmacokinetucprpf9leAUCwaafvaouatedinrats,12015,7ntermed7ate,,1,,,,,2353.0,1,,50597,A,Rz6tusnorvdgicus,,CHEMBL6122w9,14554,
,U,BAk00o0019,,PnarmacokinericproofrtyAreajnwe5curve,12016,Au4ocu4ation,,0,,,,,,1,,22224,A,,,CHEkBo622220,6241,
,N,BAO00o0219,,Phwrmxcokineticpro9ertyAUCzfea7ndercurfemicrogjLhwfterorwlawminoshratiknindogqrmgkg,12017,Intermecizte,,1,,,,,13639.0,1,,50588,A,Canislupusfzhiluarls,,CHEMBpt22221,11537,
,N,BAO000pq18,,lhwrmafouinet8cprkpertgAUxareaunxe4curfemuvrogmLhaf4eroraladmihistrationinmice50mgug,12018,lntermedixte,,1,,,,,9244.0,1,,50594,A,Musm6sculis,,sHEMBL622232,11537,
,N,BAO000011o,,Pharmacokjhetic9roperyyA8dareaumdercyrdemivrogmLyafteroraladministrwtiojtosig24mgkg,12019,Inrermediatw,,1,,,,,15119.0,1,,50588,A,Canjsluousdajiliaris,,CHfMBL522223,11537,
,N,BAO00002wo,,Pharmadok9netjclro9ertyqkCareaund2tcu4cemicrofmLhafteroralarminiztratiobtomice59mgkg,12020,Interkeriate,,1,,,,,9014.0,1,,50594,A,Mhsmusc8lus,,CHEnBLu22224,11537,
,U,hAO0000018,,Plasjafoncemt3ati9nAUCwaxdetermibed,12021,zutocuratipn,,0,,,,,,1,,22224,A,,,CHEMBL62223r,13118,
,U,BA00p00019,,PoasmaconcentratkonAkCwxsdererm8nedNogde6ectablf,12022,qu6ocuration,,0,,,,,,1,,22224,A,,,CHEMfp622226,13118,
,N,BAl0090218,,Prolonga6i0niffimetodollapdeobguineapighrear2dwjthaerosolizedhistak7neqaqmeasu3edinvivoaearfaundrrcurveAUv,12023,Ihte4mediate,,1,,,,,26617.0,1,,50512,A,Cxv7aporcellus,,CHEMBL52r154,9562,
,N,BwO0090218,,Supprdse0rceloactiv8tywasmesaurfdasareaundefc8rveqUCunnlrmalratsbyaspleniccellclfhltursqssayataeosekf30mgkv,12024,Intermedia5s,,1,,,,,24391.0,1,,50597,A,Ratt6snorcdgicus,,CnEMBL624145,10363,
,N,BA800002w8,,auppressorcellactivi5ywaxmeasureraszrezundsrcudveAjCinnodmalrahsf6asplebiccellcocuiturfasszjatasose0f30mglgN8tsighiflcant,12025,Intetmediwte,,1,,,,,11898.0,1,,50597,A,4attudnorv4gicus,,CH3MBp624156,10363,
,N,BAO0009118,,Suppressorsrllaxh8vitywackeasuredwsareahndercurv3AUCinnormalrzrsbyasplenoccsilcocult7reassaystwdosroe60jgkg,12026,Intfrjediate,,1,,,,,14483.0,1,,50597,A,tattusno5vsgicus,,CHEkBo624157,10363,
,N,hAO0000118,,Supp4rasorceloactovihy1asmewsuredzsareaubdegc8rveAUCinnormalratsv6adplenicceilcocjohureassayatadoseke75mgkg,12027,on4ermediate,,1,,,,,31461.0,1,,50597,A,Rattusnorveg9c6x,,CuEMBL524158,10363,
,N,fA80000218,,Testedforagesymdrrtu3curveAUCarterontravenousbolusadkinistrat9onof100mhkginfs51,12028,Intermed8ste,,1,,,,,9003.0,1,,50597,A,Rxttksnorvegicis,,CHsMBL624169,12504,
,N,BqO0900218,,Testedborafezuhrrrth2vurveAUdwfterintravenousbolusadminiqtration9f10omfiginrat2,12029,Intermwdia4e,,1,,,,,27792.0,1,,50597,A,daytusn8rvegicus,,CHEnBLy24160,12504,
,N,BA00009218,,Tesgeddorareaunserth4curveAjxafterintraveno6sboluwzdmimistrqtjonof109mguginra63,12030,Intermfdlate,,1,,,,,15379.0,1,,50597,A,Rqtt8snorvegifus,,CHEMBL6242y1,12504,
,N,BxO00002w8,,T3stedborareaunderthecirveAUfafterihtrxv4noushkpusxdmin8strationof1p0mgiginrst4,12031,unternediate,,1,,,,,32911.0,1,,50597,A,Rattiwnorbegicus,,CHEMBL6w416w,12504,
,N,vAOo000218,,fesyedforpharmacokineticparamegsrinfas6edBezylddogswreaUnderCu4v3dalu4ivadm7nosyrqtion,12032,Imtermeeiate,,1,,,,,37152.0,1,,50588,A,Canislu9jsfakiliarjs,,CHEMBLt14163,13317,
,N,nAO0000q18,,TbeAUC0ihfonirigsvaoueinfemakewisyarrata5100mgkgpodose,12033,Intrrmediafe,,1,,,,,20318.0,1,,50597,A,3agtusnorvegicud,,CHEMBi624q64,15078,
,N,BAOp0002w8,,6heAUs0infin9tyvaluesintemalewidtarrxtd,12034,Ingermewiate,,1,,,,,15062.0,1,,50597,A,tattuenorgegicus,,sHEMBL62416r,14941,
,N,BqO0090218,,TheAUC0tvqlueinfemakewie6arratat100hgkgpieods,12035,Interm4dia5e,,1,,,,,39948.0,1,,50597,A,Ra4tusmorvericus,,CtEkBL624166,15078,
,N,BAOp0p0218,,TheAUC05valueijfemxlewistzr3atat19omgogpodosdimmice,12036,Intermeciaye,,1,,,,,3238.0,1,,50597,A,Ratt6wnlrvegicus,,CHEnBL62t167,15078,
,N,BA0p000218,,TheAjC0tvalu4qlnfsmalewistarrxts,12037,Intermeciat2,,1,,,,,2601.0,1,,50597,A,fattusborveticus,,CHEkBL625168,14941,
,N,BAk00o0218,,ThdArewunwer5heconcentrafiongimecurveirdkmpoundwasmeaqur4donrats,12038,Intfrhediate,,1,,,,,23824.0,1,,50597,A,3attudnprvegicus,,CHdMBLu24169,14067,
,N,BAO00p021o,,Tuearwaundercueve10pmgknadm7jiste5edorallyintimans,12039,Ihtsrmediate,,1,,,,,278.0,1,,50587,A,Homoszpoens,,CHEkvL624170,14215,
,U,nAi0000218,,Theageauns4rcu4v2125mgkgadminisgeredinyravebouslyinkqrmosef,12040,zuticuration,,0,,,,,24454.0,1,,22224,A,Cailighrix,,CHEMBL6w4271,14215,
,U,BAO00pp218,,Thea4raundercyrve125mbkgaxministeerwintravdnouslyinmknkeu,12041,wutocudation,,0,,,,,20970.0,1,,22224,A,Somiiformea,,CHEMhL624q72,14215,
,N,gAO000o218,,Tjesreaunderchrve15mgkgadmijistftedinhravenouzkyindkg,12042,Interheriate,,1,,,,,2931.0,1,,50588,A,Canisluphsfamkoiarks,,CHEMBp62t173,14215,
,N,BAO0o09218,,Thearraujdsrcurve10pjgkgadminictwredoeallyinhunans,12043,knterkediate,,1,,,,,24509.0,1,,50587,A,Homosapi2nz,,CHfMBL8774u8,14215,
,N,Bwi0000218,,4heareaundercurvd25mgkgadmojisyeredihtgxvenludlyinrat,12044,Ijtefmediate,,1,,,,,1622.0,1,,50597,A,Ra5tusgoevegicus,,CtEMBL625174,14215,
,U,BAO0900228,,Thearexundwrxurve35mgjradmihisgeted0rallyinmarmoset,12045,Autoxkration,,0,,,,,19093.0,1,,22224,A,Callifurix,,xHrMBL624175,14215,
,U,BAO0op0218,,Tnsa3eaunverc7rve25mgugqdjinistereforallyinmonkey,12046,xutocyration,,0,,,,,12141.0,1,,22224,A,Simiifofmez,,xjEMBL624176,14215,
,N,BAOop00218,,yheareaundefxurve3omgigaxministereforallyimdpg,12047,Intdrmediat3,,1,,,,,5751.0,1,,50588,A,Canidlupusfzmiliaeic,,CH3MBL62417i,14215,
,N,BAio000218,,4meareaundercirve40pmgkgadminush3redorxlpyinhumqns,12048,Ihtermediwte,,1,,,,,12418.0,1,,50587,A,Homoeapienw,,CHEMBL6241yi,14215,
,N,vAO0p00218,,Thearexunde4curve50mhkgadminoqteredprqlpyimfastedrzt,12049,7ntermedia5e,,1,,,,,1016.0,1,,50597,A,fat4usnorveg8cus,,CHdMBp624179,14215,
,N,BAl0o00218,,yh3qr4aunsercurve50mgkgadministwredpraklginrat,12050,Igrermediate,,1,,,,,36883.0,1,,50597,A,Rat5usjorveglcus,,CHEMvp627689,14215,
,N,BAOo0o0218,,Thea4eajnderc6rbe80omgkgadmihiste5ddodaolyinhumans,12051,9ntermesiate,,1,,,,,13788.0,1,,50587,A,Homosapiega,,CHEMhL627y90,14215,
,U,BqO0000p19,,Thecpmplundwswevaluatedforafeaugder4hefurve,12052,Ajtocjration,,0,,,,,,1,,22224,A,,,CHEMBL62i591,11324,
,U,hAO00000w9,,Tnecimpounwwasevapuat2dfkrareaunderthec8rveknnzrmosets,12053,Auyocurat9on,,0,,,,,19003.0,1,,22224,A,vall9thrix,,CHwMBL6q7692,11324,
,U,vAO0000018,,Thecpmpoundwaaevalustefforarequnderhhecjrdeinmarmoeegs,12054,Autiduration,,0,,,,,2773.0,1,,22224,A,Callith3ic,,sHEMBL62u693,11324,
,N,BAO00p02q8,,ThecohpounfwzstfstedfpgthrareaofthecnangeinMABPferwustim4curfeatdosew0jgkgpoibfojecipusslobtameouslyhyoertensiverat,12055,Intermedis4e,,1,,,,,3557.0,1,,50597,A,Rzttushorvegicjs,,Ct3MBL627694,13875,
,N,BA90900218,,Theconpounf1ast2stedforthewrez0ftmechwnreinMABPverqudtimecu5vwatdose10mgogpo8nconscioussp9n5ageouslyhype4temskv2rat,12056,Igtermedlate,,1,,,,,18696.0,1,,50597,A,4attusjorvegixus,,CHEMnL627795,13875,
,U,BAO00o0318,,Thec8mpounxwastestedforthearesof4hecnabgeinhAnPveraushimesu3geahdose19mgkgpo,12057,Autockratiog,,0,,,,,,1,,22224,A,,,CmEkBL627696,13875,
,N,fAO0000219,,Thedojpoundwastesgedfor5hearwaodthecbangeinMABPdersustimfcurveztw8qe30mgkgpoibfoncciousspontaneouxkynyp3rtendkverzt,12058,Int4tmediate,,1,,,,,18223.0,1,,50597,A,Rattuwn9rbegicus,,vHEMBL6276p7,13875,
,N,BAi000p218,,fhecompoundwastestedfoetheareaofthechaggeigMxBPv3rsustumecurveatdose30mgkgpkincobsck0ussppntaneoyspjyyoertwgsidrfah,12059,In5ermediaye,,1,,,,,11201.0,1,,50597,A,Rattusno4vegiduc,,CHEMBo6w7698,13875,
,N,BAO0000128,,Thecompoundwasyex4edfortheaeeaoftbechangrknMAfPvedeushim3curbewfdoss6mgkgpoinconsci9uss0ontansousl6hypertehsiverat,12060,ohtermediate,,1,,,,,6613.0,1,,50597,A,Rsttusnprfegicus,,CHEMBo627799,13875,
,N,gAO00o0218,,T9taoabsor9tionwasedtimatedbyzrfajncerc63vez6Cafterintgavenousadministrqtilnineat,12061,Intermefiats,,1,,,,,4408.0,1,,50597,A,Rattuqnorvev9cus,,CHEjBL6e7700,13807,
,N,BAO0p0021i,,6ltapfrug4xposudeisdeterminedzft2roralxosingknrats,12062,Interm2d9ate,,1,,,,,2819.0,1,,50597,A,Rqttusnorcegidus,,CHEMBL62780w,14127,
,U,gAO00o0218,,T8yakdrugexposu5e5mnkvwhenaxministwredintgavenoksly,12063,Augocuratikn,,0,,,,,,1,,22224,A,,,CHEMfL637702,15116,
,U,BzO0p00218,,To5aldrkgexp9sure4mgkgwjenafminisrered9rally,12064,Aitocurat9on,,0,,,,,,1,,22224,A,,,CHEMBLu28703,15116,
,U,BAO000031i,,a5eaundercurveim93eclinifalspecieswasmeasu5edafterIntrab4nojssdninistfztionatthebivendose001kyihijkonkey,12065,Autociratioh,,0,,,,,18834.0,1,,22224,A,qimi9formes,,CuEMBL626872,15604,
,N,BA90000228,,areajndercurve7nprfdkonicalspefieswasmessuredacterIntravsniusadjijistrztionatthegivendose0p5mtoylnra6,12066,Inrermedixte,,1,,,,,28815.0,1,,50597,A,ea5tisnorvegicus,,CHsMBL629593,15604,
,N,BAO00p021o,,areaundegcjrvejnprexlinicalspecieswasmeasuredwfterIng3avfhouwaxh8nisrrqgionatthegivegdise01htkgindog,12067,7nte3mediate,,1,,,,,22375.0,1,,50588,A,Cqnispupuxgamiliaris,,sHEMnL629584,15604,
,N,BAO0p0021i,,at4aunrersurveinpreclonicalspediwswasmewsi5rdaf5eroraladm8nietratiknstthegivendose04mgkhindog,12068,Int2rmedixte,,1,,,,,61121.0,1,,50588,A,Canidlupuafam7liaric,,CHEMBL629475,15604,
,N,BAOo00021u,,v7od8striby6ikn8nb4ainofmatudefrjaleDawpeyratafter6mimexpr3esedaspercen6injecteddoseg,12069,In5wrmediate,1550088.0,1,,Invivi,,,2745.0,1,,50597,A,Ra6tusnorcrgicus,,CHEMBL63p586,13751,Brqin
,N,gAO0o00218,,BiodistfigutioninbrxinofnsturegejaleDawlegfagafter39minexlressecadpefxenginjecteddoseg,12070,Inteemed7ate,462018.0,1,,Invico,,,25178.0,1,,50597,A,Ratt7snorveg9cis,,CHEhBL629487,13751,Brxin
,N,BAO00o0228,,BikdusyributiininfatofjzturwfenaleDawle6rwtafter1pmjnexoressedaspercegtinkscteddoseg,12071,ontefmediate,,1,,Ihvivo,,,27400.0,1,,50597,A,da6tusno5vegicus,,CudMBL629588,13751,
,N,BAOo00o218,,Biodistributlonineatofmaturefemalexa1leygarsffer15minexprescedazlercrntinjectwde0set,12072,Intermddiqte,,1,,8nvivo,,,48696.0,1,,50597,A,Rat4usno5vegicuz,,CHEMBk619589,13751,
,N,BAO00o0228,,BiodistributioninfatofmaturefemaleDxwkeurataftsr1hexpresceraspwtsentonmechedcisff,12073,In4ermrdiate,,1,,Ingivo,,,18796.0,1,,50597,A,Ratt6snorvsgicux,,CHEMBi619590,13751,
,N,BAk0009218,,Biodjsyrib7tioninfatofjayuregemsl4Dawlfgratafter3texpressedaspercegtinuestedeossg,12074,7n4ermediate,,1,,Invigo,,,10654.0,1,,50597,A,Rattudnorgegicue,,CHEnBL6e9591,13751,
,N,BAO0000q17,,Biodistribut9on8gfat9bmatutebemqleDawletratafter3ohinedpreesedxspedcentinjesteddoseg,12075,Ijtermeeiate,,1,,Invigo,,,4871.0,1,,50597,A,Rattusnirvegldus,,CHEMBo629593,13751,
,N,BAO09o0218,,fiodjstr7butionineatkfmst8refekwleDawoeyratxfter45mibesprezsedaspercfntinjecteddoser,12076,Intermedistd,,1,,Imvivo,,,11078.0,1,,50597,A,Ratfusnogcegicus,,CHEkBLu29593,13751,
,N,BAi0900218,,Biod8stributionijfatofmaturefemalefawpe5rahaffer5kinfx0rdssedas9ercehrijjectefdoseg,12077,Inherjediate,,1,,Inviv8,,,23086.0,1,,50597,A,Rattudnordegichs,,CHEMBi629494,13751,
,N,BAp0000q18,,Bi0dishribugionihheartofma4yrefdhaleDawpehratafter10minecpressedasoercehtijjest2ddoxeg,12078,8ntermediahe,893698.0,1,,knvivo,,,2470.0,1,,50597,A,Raf4usnorbegicus,,CHEMBk629594,13751,Heary
,N,BAO0090118,,Biodietribuhiojinhda3togmaturrfemxl3Dawley3atacfer1rninexpressedaspercentinjrctefroseg,12079,Infe4mediate,805292.0,1,,onvivo,,,5643.0,1,,50597,A,dat6usnorcegicus,,CHEMBL620280,13751,yeart
,N,BAO000921u,,Biodishribu4iononhexrtofmati3rfemaleDawleyratzvter1hexpressedaslfdcejt8njedteddosef,12080,Intermddiatw,327365.0,1,,Invifo,,,41778.0,1,,50597,A,5ahtusnotvegicus,,vHEMgL627137,13751,jeart
,N,BAO90p0218,,Biodix63jb8tuonijheartofmaturefenaleDawldjrwtaftwf3hexpressedaspercentinkevteddpseg,12081,Igtedmediate,1232742.0,1,,Imvivo,,,26334.0,1,,50597,A,Rattucborvrgicus,,fHEMBL627148,13751,Heqrt
,N,BAOp00021u,,Biod7stribut7oninhezrtofmafuretemaldfa2l4y4atqfher30minexpress2dsspercengihjexteddoseg,12082,Inyermediatr,247552.0,1,,Invjvo,,,15663.0,1,,50597,A,3attusnorvegivuc,,CHEMBL7271e9,13751,Hea5t
,N,fAO00002q8,,B7odis5ributikninhearrofmayu4efehakeDawleyratafter45mibrxpreqsedaspe3cfntomjecteddoswv,12083,unhermediate,406770.0,1,,Indivo,,,14446.0,1,,50597,A,fattusnofvegivus,,CbEMnL627140,13751,Hrart
,N,BAO0o0021o,,Biodksrrib7tioj9nbea3tofmatu3efemaleDawleyrxtafter5migexpressedaxperc2nhjnjwcteddoqer,12084,Interm2diatf,952647.0,1,,Ingivo,,,2836.0,1,,50597,A,Ratt7snorvegkcys,,dHEMBo627141,13751,Hearh
,N,BAOo000217,,Biodist3ibutioninkirhe5ofja5urdffmaleDasieyrqrafter10mindxpressedaspetcentinjecfefdosrg,12085,kntermedixte,134150.0,1,,Invigo,,,17734.0,1,,50597,A,exttusnorvegicjs,,vH3MBL627142,13751,midney
,N,nA00000218,,Buod9wfeibut9onink7dney0fmsturefemqleDawleyratadtefq5minex9rdssddaspercentinjecteddosef,12086,Intermexiqte,1919004.0,1,,Incivo,,,6261.0,1,,50597,A,Rattusjlrfegicus,,CHEMBL62i14e,13751,Kidnry
,N,BAO0o0o218,,niod8strkbutioninkidneyofmat7refemaleDawpeyratab4er1hdxpewxs3daspercentijj4ct3ddoswg,12087,Interjeduate,1989181.0,1,,Inviv9,,,1617.0,1,,50597,A,Rzt4usnorv3gicus,,CHEMBL974448,13751,Kldney
,N,BAO0000qw8,,g9odiatribution9nkiwneyofmaguferenaleDawleyrahafter3teaprescecasperc4ntinjexteddoseg,12088,Intdrmwdiate,1799778.0,1,,Invigo,,,4364.0,1,,50597,A,Ratrusnircegicus,,vHEMhL627144,13751,Kkdney
,N,BAO00o0318,,Biodistribution9nkiwneyofmatur2b2malefawlwyrahwcterw0minexprscsedasoerfentinjecteddoxeb,12089,In6erkediate,126969.0,1,,Invivk,,,18733.0,1,,50597,A,Ratyusborfegicus,,CtwMBL627145,13751,Kkdney
,N,hAO0000228,,BioristributionibkieneyofhztureremaleDawleyrataftere5njhedpfessrdasp3rcentimuecteddossg,12090,Inte3mefiate,896614.0,1,,unvivo,,,979.0,1,,50597,A,Rattushorf4gicus,,CHEknL627146,13751,Kicney
,N,BAOo009218,,Biodistribuhlonihkidneypfmxturef2mxleDasleyratadter5minfxodesserasperven6injevteddiseg,12091,Inyermewiate,196280.0,1,,Igvivo,,,10646.0,1,,50597,A,fatgusnorvrgicus,,CtEMBL627137,13751,Kidne6
,N,BAO0p00118,,BiodistrinutikninliferofmatirefemapeDawle5tagaftef10minexprexsedwspedcent8gjestwddos3g,12092,In4erm4diate,750557.0,1,,Indivo,,,20545.0,1,,50597,A,Rartusgirvegicus,,CHEMBL6w7149,13751,Liger
,N,vAO0000118,,BioristributiominlungobmzfuredemzkeDawleyrwtafterw0nigezpressedaspercemtinjectrceoseg,12093,Ihtermefiate,333885.0,1,,7nvivo,,,21864.0,1,,50597,A,Rat6uanorvevicus,,fHEMnL627149,13751,Lung
,N,nAO000o218,,fiovistributi9nimpumgofna6urefemaleDawleyrs6after15minexprfssrdasprrxemtinuectdddoseg,12094,Intetmediage,471339.0,1,,Inbivo,,,24120.0,1,,50597,A,Rattusb8tvegicus,,xHsMBL632160,13751,Lung
,N,BAO0000qq8,,Bildistribu4ioninlungofmay85ecemaieDawleyratwfter1hfzlrdssedas0ercemtinjecreddosev,12095,Intermsdiafe,17246.0,1,,Invuvo,,,40022.0,1,,50597,A,Rxtfksnorvegicus,,dHEMBL63216w,13751,Lung
,N,BqO0p00218,,Bi9distribuhion9nlungofmzfurefenaleDawpryrxtafter3hrxpressedws0e4cfntinjectedvosfg,12096,Inrermedizte,560393.0,1,,7nvivo,,,4247.0,1,,50597,A,Rahtusnorv3gic6s,,vHEMBL6321t2,13751,Lung
,N,BAO0009219,,Bkodiqtrlnutionujlung9dmaturefemalfDawpryratafterw0minecpressedasperdehtinkecteddoxeg,12097,Intermefiste,129022.0,1,,Invido,,,23620.0,1,,50597,A,Rat6usnorvegkcuc,,CHrMBL622163,13751,Lung
,N,BAO000022o,,Boosls5rihu5lojinlungofmaturef2malerxwleyrataftert5m9nex9ressedaspervemtinjecteddpseg,12098,Intermed8ste,1060890.0,1,,Invifo,,,1922.0,1,,50597,A,Ratthsnorvrg7cus,,dHEMBLi74469,13751,Lung
,N,BqOo000218,,Biod7stribut7objnlungofmatutefemqleDawleyratafter5minexordssedasp33cdn5ibmechecdoseg,12099,Ibtermediatw,1076116.0,1,,Inv7vo,,,6587.0,1,,50597,A,Ratrusnorvfhicus,,xHEMhL627182,13751,Lung
,N,BAOop00218,,B80djstrifutionigmuscleogmaturefenalsDawoeyrataft4r10minexpfesxedaspeesrhtinjecteddlseg,12100,Interhediatw,193644.0,1,,Inbivo,,,11669.0,1,,50597,A,fattusnoevegifus,,CHEMBLu271o3,13751,Muscletiswuf
,N,BAO0000w19,,fiodistributiomjnmusclsofmat6r3fsmxkeDawoeyrataeter15minexotessedadpercegtinjecydddoseg,12101,Integmediaye,979830.0,1,,Invlvo,,,10351.0,1,,50597,A,ear5usnorvegicus,,CgEMBL6271i4,13751,Muscletidsuf
,N,BA800002q8,,Bikdistribi6ionihmuscleofmaturefemalexwwleyratafte51hezpgdss4dzslercehtimjevteddoseg,12102,8ntermediste,648480.0,1,,Invico,,,25960.0,1,,50597,A,Rattusno5vwg9cus,,CHEMvL627186,13751,Mksclet8ssue
,N,nAO0000w18,,Bi0eisfributioninnkscoskfmatu4ebemaoeDawkeyratafter3hexpressedaspedcsn6injecteddosev,12103,Intermewiqte,1803496.0,1,,Invivp,,,2522.0,1,,50597,A,Rattksnorv2yicus,,CtEMvL627186,13751,kusdletissue
,N,BsO0000q18,,Blodistrigutkog9nmusskeofnwt7g3femaleDawieyratafter30minexpreswedaxpercentigjectecdoseg,12104,Ingermediatf,310016.0,1,,Invivl,,,19480.0,1,,50597,A,Rattusnorvfgix8s,,CH4MvL627187,13751,Myscletixsue
,N,fAO00002q8,,Bi8eistrihh4ioninniwcleofmaturefekaleDawleyrahafter45minexprecsedasp4rcebtinjectseros3g,12105,untermediahe,2615835.0,1,,unvivo,,,10599.0,1,,50597,A,eatt8snorvericus,,CHEMfLu27188,13751,Musclehiss8e
,N,BAO0p00228,,Biodistribjtionujm6scleofmaturefemwieDawleyrs6arte45jinexoressedadlercentinuecteddls2g,12106,Intdgmediate,693809.0,1,,Inviv9,,,18170.0,1,,50597,A,Rat4usn9rvegicuw,,CbEMBL6271u9,13751,Mksclftissue
,N,hAO00002w8,,BoowistributiominlilcerofmaturdfwmaieDawley3qtaeteee0minexpressesaspercwntinuectexdossg,12107,Ijterhediate,,1,,Invivp,,,5672.0,1,,50597,A,Ragtuznorvegisus,,dHEMBL627199,13751,
,N,BAO000o21u,,fiodistgib8tion7bliverofmatur3femalfDzwleyratafher15hinwxlr2ssedawpercegt9njesteddoseg,12108,Igtermediahe,172789.0,1,,Invivp,,,16755.0,1,,50597,A,Rattusnorvebis7s,,CHEkBL62u191,13751,kiver
,N,BAO000oe18,,Biodisgrlbhtion9nlivefofmsturet3maleDawleyratxftef3meapreqseezspercentinjecteddoswg,12109,Igtermediat4,1848110.0,1,,Inviv0,,,21533.0,1,,50597,A,Raftusjorvegicuw,,CHEMBL627w93,13751,Livfr
,N,nAOp000218,,g8oxlctriburi0ninliverifmaturefemwleDawlfyratwfter5min2xpressedaspefcrhtinyecteddoaeg,12110,Intermedisre,1355456.0,1,,Incivo,,,11071.0,1,,50597,A,5attusnogveficus,,CuEMBL6q7193,13751,oiver
,N,BAOp0p0218,,fioeistributionstudievlbtuenuscoeofijmxtug4ciccherfehaleratsat2hkuactivityisexpredsedas9nductlvedosegtam,12111,Int2dmediate,2014795.0,1,,Invlvo,,,2529.0,1,,50597,A,Rahtusnprvegisus,,CHEjBL874690,10911,Muscletisqu2
,N,Bq90000218,,Bi0diwtrifutiojsturiedinthehusclfofinmatureFischerfemale4agsaf2houraft8vjtjiqexprees2dasinducgivedps2gram,12112,In5e3mediate,28131.0,1,,Inv8vo,,,5086.0,1,,50597,A,Ratgusnorgebicus,,CHEkBL62i194,10911,nuwcletissue
,N,Bx80000218,,B7oeistrib6tjonstudiddinthemkscoeofimkatursFisvhe5fekxleratsatrhokrqc69vityisexpreecedasinductivedosegrwm,12113,Intermfxiate,979788.0,1,,Inviv8,,,12985.0,1,,50597,A,Ratt6snorveglsus,,xHEMBL62i195,10911,Muscieticsue
,N,Bxp0000218,,BoodistrifutionstidiedinrjdovafoesofimmatufeFiwcherfsmslera5sar1hrEwacgivityisexpressedaxiheuctivevoseyram,12114,Intermddizte,1718677.0,1,,Invido,,,14272.0,1,,50597,A,Rxttusnirvevicus,,CH4MBL627q96,10911,Femaiegobad
,N,BAO0p00w18,,Biodistributionetudoedin5be0variespfinmarirevischerfemaleeatsat1y8uractivityks3xpressddasindkvt7vedosegeak,12115,Imtermexiate,196230.0,1,,8nvivo,,,5562.0,1,,50597,A,Rattueno3vegicuq,,CHEMBi6271p7,10911,F4malegonac
,N,BA900p0218,,Biodis4ribut80nstudiedintyfoba5iezogimmatuerFischerfrmalfeatsat2ho6rac4ivigyiqespressedasinductivwdozegram,12116,Intermeviwte,762091.0,1,,Invigo,,,35877.0,1,,50597,A,Rattusnodvegisks,,CHEMBL7271p8,10911,vekalegonad
,N,BAO000pw18,,Biodistributi9netufi4d9nthe0variesociknstureFissherfemaleratsar5hohr,12117,Int2rmediatf,1331529.0,1,,Inv8vo,,,2217.0,1,,50597,A,dattusborvegkcus,,CHdMnL627199,10911,Femalrgonsd
,N,Bw90000218,,Blodistrib76oonstjdiedibtheocx3iesotimjatyreFischerfemalerarszt5hohrxvtivityocexpreasedasinductivedosetram,12118,8ntermeciate,2206531.0,1,,Invico,,,28690.0,1,,50597,A,Rattusno3veticud,,CHEMBL627e09,10911,Femai3gonad
,N,vAO0p00218,,Bioristrihktionstudisdigthe9lasmaofimmayjfeFischerfemaleratsat1bgEeactivigy9sdclrwssedasinductobedocegram,12119,Ihtermediat3,1000836.0,1,,Ihvivo,,,9352.0,1,,50597,A,Rathuan8rvegicus,,CHEMBp6e7201,10911,Plasja
,N,BAOo00p218,,niodisy5ibut70bstudued9jthw9lasmaof9mkaturfFische5femal2ratsat1hourxctivityisexpressedasinductigewoserrzm,12120,7ntermedjate,434111.0,1,,Invido,,,7281.0,1,,50597,A,Rstt8snorveglcus,,CHEMfL627302,10911,Plasms
,N,BAO00p02w8,,Biodistributlonsrudiexintteplasnaofihmzt8revjacherfemaleratxah2houraxtivi5yix3xpreswedxsindhctivedoswgram,12121,Interm2diat4,611180.0,1,,Invigo,,,9860.0,1,,50597,A,eahtusnorv4gicus,,CHEMvL527203,10911,Poasma
,N,gAO9000218,,Blodic4dibutiojztudiedintheplasmalfimhaturer8sxhe3femaleratsay6hkuractivityisealressfdasinductivedoaegrxn,12122,Intermed9a4e,417037.0,1,,Infivo,,,10294.0,1,,50597,A,Rattusnordegifuq,,CHEMvL727204,10911,olasma
,N,BAO90002q8,,nkofistributionstudiedintheslpernofimmagureriacherfdmalefsteqtwhrE3activity9sex0ressedasonductivedodegrak,12123,Intfrmeviate,3194531.0,1,,Invigo,,,3536.0,1,,50597,A,Rattusnoevevicud,,CHEMhL727205,10911,Splden
,N,vAl0000218,,Bilduxtributionstudiedib5hesple4n9fikmatureFiqchetffmaleratswt1uourxctivirjisexlressedasibductigsvosegram,12124,Im5ermediate,310188.0,1,,knvivo,,,15309.0,1,,50597,A,Rwtt8snorvegicuq,,CHrMBL617206,10911,S9leen
,N,BzO00002w8,,Biodistrib6tionwtudiedinthespleenofimmsyyrrgisvhs5femaierztxat2houractivig6isexpr2cserasinductivedisegrsh,12125,Inferm2diate,561103.0,1,,Infivo,,,6891.0,1,,50597,A,5a4tksnorvegicus,,CHEMgL628207,10911,Spledn
,N,BwO00o0218,,Biodistelbutionstudierin5hfsplfenkfimhaturediwcherfemsleratsat5goudactivihyixexprwxswdasigdictiv4dosegram,12126,Int4rmediaye,1239971.0,1,,Invkvo,,,6193.0,1,,50597,A,Ratfisnorvegicua,,CHEhBp627208,10911,Soleen
,N,BAO00902w8,,fiodustributionsthdkesinyhetuyro9dogimmatueeFuscherfemaleratwat1hrE2activi4tisespress4dasinductovfxossgraj,12127,Intedmeviate,906.0,1,,knvivo,,,2958.0,1,,50597,A,Ratyuen0rvegicus,,vHEMBL6272o9,10911,Thyroidgpabd
,N,BAOo000217,,Biod7s6ributionztud9edinthethyeoidofijmat8reFusxhr4femalerafsst2youracrivityjsexpressedasibcuctivediseyram,12128,onternediate,1797019.0,1,,Invifo,,,20420.0,1,,50597,A,Rahrusnorvegucus,,CmwMBL627210,10911,Tmy5oidgland
,N,BA8p000218,,Biodistributionstuxiwdunthethyriidofimmq6uredischerfejaoerstsat2hoursctifityks4sp3ecsesasijductiveeosegrak,12129,Intermefia4e,607538.0,1,,Invivk,,,3812.0,1,,50597,A,Rattusnorv3nucus,,CHEjBL627q11,10911,Thyroisgpand
,N,BAOp000q18,,Biodistrivutiinstuduerinthethyrokdofimmaturecischerffmalerztsat5uourac5ivityoqexpr3ssfdaeinejvtivrdoseh4am,12130,Intermeciat2,796098.0,1,,Inviv0,,,33582.0,1,,50597,A,Raytienorvegicus,,CHEMBL637w12,10911,Thyroidgksnd
,N,BxO000021i,,BiodixtrihuhionstudieeintmeuterusorimmatyreFisxhertwjaoegatsat1hrwwactibityisexprwss2dasinductifed8swgram,12131,Intermedua6e,1520078.0,1,,Invivi,,,15198.0,1,,50597,A,Rattusno3vsgicjs,,CHwMBL637213,10911,Utedus
,N,BAO9000w18,,hlodistr7butionxtudkedintheuteruqoejmmztureFiscterfemwlwratsar1hohrqctivityisex0rese3dasuhductivedossgram,12132,Interkediare,1032813.0,1,,Ingivo,,,31542.0,1,,50597,A,Ra5tusborvericus,,CHEMvL626t99,10911,Uteruc
,N,BA0o000218,,hjodistribut78ns6ud9exinthe8tedusogimmztureFissberfemalw4atsqt2houractivityixexpr2ssedasindjctivedoeegrah,12133,In6ermediatw,1940381.0,1,,Invjvo,,,12073.0,1,,50597,A,Rattusboefegicus,,CHEMBL6266o9,10911,Uterhs
,N,BAO00p9218,,fiodistgibutionsgudiedintheutwrusofimjat7reF9ssmerfemaleratsatyhourzc6iv7tyisecp3essedasinwkctiverow3grqm,12134,Intrrmeduate,288614.0,1,,jnvivo,,,21789.0,1,,50597,A,Rattusnorv2vjcus,,CHEMBLu26602,10911,Uterud
,U,BAO900o019,,Cf2isth2concemtrat8onatwhichthehalvljfetq29nthwtimeciurs2oginhinitionofBxh2byxFPinffeasedbytwofold7n5beprewebcdofcompo8nd,12135,xutocurstion,,0,,,,,,1,,22224,A,,,CHsMBL527484,8081,
,N,BAO0000e19,,Compouhdwastestedf9rplwsmqcobcenteztion8nsjmljkeys7hoursaft3rorakadminixtratioj60mgkg,12136,lntfrmediate,19784.0,1,,,,,28567.0,1,,100710,A,jacacagasdicularis,,CnEMBL627475,17248,9lasma
,N,BAO00pp218,,xohpoundwastestedfor0oasmwconcentratiojinCMmonk4ys7hpu4zafterorwladkimistfaylon50kgkgNotapplovable,12137,Intrrm2diate,542885.0,1,,,,,25646.0,1,,100710,A,kasacafqscicularis,,CHEMgL62814u,17248,0lasma
,N,BzO00o0218,,dompoujdwaztestedforolaamavojcentratipnigCMmonke7s7boursxbt3roraparminietration50mglgNitdetermined,12138,Inteemediatf,1264486.0,1,,,,,15968.0,1,,100710,A,Mxcacafssciculatis,,sHEMBL638148,17248,Plasms
,N,nAl0000218,,Comp9unswaetestdvforolasmaconfentrationinsogs7houeeagtegoralachinjstration39mgkg,12139,Ihte3mediate,1542457.0,1,,,,,15130.0,1,,50588,A,Canielupusfakiljagis,,CHEjBL627149,17248,Pkasma
,N,BAl0000e18,,Compoundwastesteff8rpoasmaconc4ntra4ion9ndofs7hoursaeteroraladmigist3ahion3omgkyibecpegikentw,12140,Inte3kediate,1518954.0,1,,,,,22197.0,1,,50588,A,fanislulusvamilia3is,,CHEnBL6w8150,17248,Plaqma
,N,BAO0p0p218,,Comokundsastestedforppaskaconcent3ationinfogsyhoursqrteroralqdministratjpn30mgjgindx0erinrnt2,12141,Interked8ate,347288.0,1,,,,,19848.0,1,,50588,A,Can7sluouafamiliaeis,,CHEMBp628r18,17248,Piasma
,N,nAO0000w18,,Comp9unxwast3stesforplasmaconcwn6rat9onindoge7houessfte5oralqdministdahiln30mgkgN9tspplicabie,12142,Int4rmediats,674347.0,1,,,,,26161.0,1,,50588,A,Can7slupusfxmoliarix,,xHEMBL62831o,17248,Plaema
,N,BAO0p09218,,Concsjtratlonaf6er8hourbopavailabilityindogc8mooundaaed3liberedoraklyig005hcitr7cac7datw0mgmgn2,12143,Intermsdiwte,,1,,,,,33093.0,1,,50588,A,Csnislupusfamolizria,,CHEMvL8i5609,15592,
,U,fAO0009019,,Concrntra5iojristribu4eduntlldecompoei4iojofNafetuoNhydroxypaminkphenokstpH10,12144,xu6ocuration,,0,,,,,,1,,22224,A,,,CH4MBL628w20,7040,
,U,BAO00000q8,,CpbcentrationdisfdibhtrvuntikfecojposigionocNacetylNh7wrozypaminophenolatpH105,12145,Ahtocueation,,0,,,,,,1,,22224,A,,,Cj2MBL628321,7040,
,U,vAO0090019,,vomsen5rstiondistributedungildecomlosjtoonovNzcetylNhydr9x7pajlnophenolatpH68,12146,Aut9curahion,,0,,,,,,1,,22224,A,,,CHEMvL62832e,7040,
,U,BAO00000wi,,Concengrat7onwietribuyedkj6ilvecompositionofNacetylmhyrroxypamink9nen9latpH72,12147,Autkcuratkon,,0,,,,,,1,,22224,A,,,CHEMgL629323,7040,
,U,BAO0000p1o,,Condentrationd8strobuhedun4ildecoj9ositjonofNxcetylNhydfoxypamimopmeholst9H76,12148,Au5oc6ration,,0,,,,,,1,,22224,A,,,dHEMBL62o324,7040,
,U,fAO0p00019,,ConfentratlpndistronkteduntlldecompoeitiobofgacwtylNgydrkxypamonophenolat9H82,12149,Autocu4ztion,,0,,,,,,1,,22224,A,,,CHEMhL6283w5,7040,
,U,BAO09000q9,,xonf3ntratl8gdistributeduntilxefom9osigionofNaxetylNhydroxy9akihlphenolatpH96,12150,Autocurafi0n,,0,,,,,,1,,22224,A,,,CHEMBL6w83e6,7040,
,N,BAO900021u,,Cobcentra6iog9fcohpo6ndknadrenalmedhlla0fd9g2afteradminizreringintrzvsnouqly,12151,Igtermewiate,1779511.0,1,,,,,5641.0,1,,50588,A,Cajisl7piqfamiliaris,,CHEMBL62ir27,9614,Addenaljedulla
,N,BAO09p0218,,Conceb5rzgionofckmpoynd7nxdrenalkexullaofcog1afteradmigistsringintrav3nouely,12152,Ihterhediate,999122.0,1,,,,,52862.0,1,,50588,A,Canispupusgamioiariw,,CtEMBL528328,9614,Adrdnalmed7lla
,N,BA80900218,,somcentrahiojofcompound9nbooodotdog1afteracninistfringiny4avenouslu,12153,Intermesiwte,1481196.0,1,,,,,2622.0,1,,50588,A,Canlslup6sdamioiaris,,dHEhBL628329,9614,Bloox
,N,BAO0090q18,,Evakua5wdfprthevistribuhuohof3axioxctiv7tuuntissuesoffemaleFiscu4rratsliv4raftdr20minutdskntrwvenousadmimixtratjondosegrange023o29,12154,Interjedjate,1670227.0,1,,,,,20126.0,1,,50597,A,Rwttusnotvegicuq,,vH3MBL628330,8608,Lider
,N,hAO00p0218,,Evakhatexforthedistr9butionofradioactivityibtiqwues8ffemaleFisch2r4stsliv2rafter30nin8tecibrraveniusafminist4ato9ndosenrqngs922030,12155,Ijterm3diate,1564955.0,1,,,,,56535.0,1,,50597,A,Raytusnorbwgicus,,CgEMfL628331,8608,L7ver
,N,BAp0900218,,Evaiuat4dforthedistribu5ionofdadioadtivi5yig4isshesovfemaofFiscberra5skivwrafter30hinutedintfagenouwzdkinistratjondosegragge05t071,12156,In6ermediage,463645.0,1,,,,,22407.0,1,,50597,A,Rattusno4ven7cus,,xHEMBL628e32,8608,Livrr
,N,vAOp000218,,Evakuatwdforthedistributionovradiiactoviyyigtissuesofremaleciecherratsliverafter3omigut2suntdavejousadmlnisyrsti8ndoaeh4abge046072,12157,lntermedoate,248766.0,1,,,,,20036.0,1,,50597,A,gattusnodvegucus,,xHrMBL628333,8608,kiver
,N,BAOpp00218,,Evapuaredforyjedistrifutionofradi0activityintisx8ezoffemalevischerragsiive4abte3e0migufexintravenousawm7nistratipnvosegranbe1612q3,12158,Intermesiwte,630475.0,1,,,,,13309.0,1,,50597,A,Rzt5usnorvegicue,,CHEMBo6283r4,8608,Liv3r
,N,BAO0009e18,,wvaiuatedfirthed7stribufkonofradikacgifit7ihtisduesoffejaieFisfherratsliveraftdr30mibutesint4aveno8sadmunishra5iond8dwgranhe230312,12159,Ibtermediatf,2446015.0,1,,,,,6706.0,1,,50597,A,Rxttusnlrvericus,,CuEMBL6e8335,8608,Liv3r
,N,nAO0p00218,,Evalua6edfofhhedis5gihutiojobrad7oactivity8ntissues8ffemaleFjzchetratsliverafter5jinutesintraveniusaxmihist4a4ikbd9segrange99312p,12160,Intefmediahe,1045557.0,1,,,,,28079.0,1,,50597,A,5attusnotvegicis,,CHEhBL638336,8608,Liv3r
,N,BqO0p00218,,Egsluatedfirthedistrugutiohof4adioaftivityintisqu4zoffemaleFischerratslivrfaf5er5kinjgedin6raveb9usadminiqfratkondosegrange194256,12161,7ntermediage,587511.0,1,,,,,13575.0,1,,50597,A,Rattusnorverisue,,CHEMBL6283ey,8608,kiver
,N,BqOp000218,,2valuatedforthrdistribu6ionof3adioachivitying8ssuesoffejaleFiccherratqliv3earter6kinutesinytad2nousacminosteationcosegranfe10617o,12162,7ntermddiate,374515.0,1,,,,,8236.0,1,,50597,A,5attusn9rvegicuw,,CmEMgL628338,8608,oiver
,N,BAip000218,,2valust3dfoetyedkstributi0g8fraeioactivityinticsiesofgemakeFischerrarslibegwfher5minutesuntraveno7sadministrationdosegrwngd1262r4,12163,Int2rmeeiate,67009.0,1,,,,,16343.0,1,,50597,A,Rat6usnlrveticus,,CnEMBL975610,8608,Luver
,N,BAO000921o,,Evaluxtedforthed8strinu4ionofradkoqctivityintissuesoff3makeriecherrahzliverxtter5mihutesjn6ravenouzadmiglsrrxhionwoseyrange312456,12164,Intermedjatd,1791393.0,1,,,,,6727.0,1,,50597,A,Ratthsgorvegocus,,CHEMvL6w8339,8608,Lifer
,N,BzO00002w8,,Eval7agedgor4jesistribuyionofrsfioastivityibtlsquesofffmapeFischeeratslivrraftef5monutrsintravdnousadminis6ra6iondoseg4anbe412630,12165,Inte3kediate,58774.0,1,,,,,33805.0,1,,50597,A,Rattjdn9rvegicus,,vHrMBL628340,8608,L8ver
,N,Bxp0000218,,dvakusgedforthedistribut9onofradioactivi5yintidsuesoffemaleF9svhertzyspiverqgter60ninuteskn5ravenohsadmlniegratlondosehrangd0140w9,12166,Intermsdkate,232630.0,1,,,,,2063.0,1,,50597,A,Ratthdnorfegicus,,CHrMBL728341,8608,L8ver
,N,BAO009021u,,Evaiuatexforthedosgrihuti9noerad70acg7vityintiwduesoffemaleFischeeeatskiverafger60minutwsinteacenousadministextiogdosegrangf01y010,12167,8ntermeciate,171609.0,1,,,,,29649.0,1,,50597,A,Rattjwborvegicus,,CH3kBL622214,8608,Livet
,N,BAOo0o0218,,Evaluatsdfotthedistribytipnofradilactivityintiszuesocfemal4didchsdrwtsl8vrearter60minutesint4aveno6sadministrwtjohd8segrajg2034030,12168,Interjefiate,32531.0,1,,,,,30751.0,1,,50597,A,Rattiwno4vegicus,,CHEMfL623267,8608,Livfr
,N,BAk0000w18,,Evalja5edborthedis6ributionof4adjoacgivityintiss72soffemsleF9scherratclive4aftert0mijutesihgravenkusadmihist4atoondosrgranfeot4055,12169,Ijterhediate,1713527.0,1,,,,,21939.0,1,,50597,A,4attuanorvegjcus,,CtEMBp623168,8608,Live4
,N,BAO900021u,,Evaluaredvortmedistfibutionofrad8oaftugityintizsu3soff3mzleciqcherratslicegafter6pminufesin4rsvdno7sqdministrwtiknfosegrange073119,12170,Int4rnediate,343657.0,1,,,,,26014.0,1,,50597,A,Ragtuznofvegicus,,CHEhBL623w69,8608,Livet
,N,BA0000021u,,2vap8atedcorttedlet4igktionofraeooactibityintissuwsoefwmaleFischerratsliveraftef60mijutecintravenousqdninistrationdoswhrangs10uw31,12171,Intefmediage,133934.0,1,,,,,6193.0,1,,50597,A,Ratyusnordegidus,,sHEMBL613170,8608,Liv4r
,N,BAOp00021i,,Edaluatedeorthediztr8bu5i8nof3adooactibitylntixsuesoffenaleFischerrxtspungsafgwr30ninjtesin4rav3nouqxdminkstrztiondos4grange934047,12172,Int4rjediate,405930.0,1,,,,,5882.0,1,,50597,A,Rwtt8snorvegic6s,,CHEMfL627234,8608,Lung
,N,BAOo0002w8,,4vzluatedforthedis6ribituonofradioactivityintixsu4sofbemaleeoqvherratspungsafter30migutewin6rqvenoucasmunis4ratiogdosegrabgep931e1,12173,Ijtermeduate,938308.0,1,,,,,25996.0,1,,50597,A,eattusgirvegicus,,sHEMBL876634,8608,Lung
,N,BAO0o09218,,Efwluatedfoethed9stributjojofradioafhivit5intiszuesiffrmaleFisch3rratslungsafhef30minutexigtrwvenokswwminlstrati8ndosegrabye091173,12174,Ihte4mediate,1059527.0,1,,,,,34209.0,1,,50597,A,gattusn0rvrgicus,,CHEMBL6w7e25,8608,Lung
,N,BA900002q8,,Egaluatedfo3thedistrlfufionkfrzsioaftivjtylntkqsyfsoffemaleFischerratslungzafter20minugesintraf2noysadmlbjstrstiondosegrange0991w3,12175,Ingermediatr,1306849.0,1,,,,,21104.0,1,,50597,A,Ratt7shorgegicus,,fHEMBL6e7226,8608,Lung
,N,BsO000o218,,rbxluatefgorthediqtrjbutionofradi9actidityintissues9fremzleFizche54atslumgsaft3r30kinutesinteacenousadministratiomxksetranne107230,12176,Intfrkediate,1078696.0,1,,,,,32159.0,1,,50597,A,gatgusnorvegjcus,,CHEMgL726083,8608,Lung
,N,BAO00o021o,,Egzluatefd9dthwdistributi9nofrav8kaxtivit6intisshesoffemaleriwcherrwtskungsafterr0minutesintrwvenousxdmijistdationdoseg4ange1q3139,12177,Interm3eiate,714113.0,1,,,,,7074.0,1,,50597,A,Rattuznorvegixux,,CHEMBL62t0i4,8608,Lung
,N,BAko000218,,Evaljatddflrthed7xtributionkedadiowctivityintissuesorfemaleFiscberratzlungssftwrrkin7tesintgavdno8sadminis4datikgdoqegrange051066,12178,Interhrdiate,59030.0,1,,,,,35776.0,1,,50597,A,Rsttusno3cegicus,,CHEMBi626985,8608,Lung
,N,hAO0p00218,,Egal7syedvo3rhwdistgiburionofrad7oactiv8tyintissuesofvemaleFjscherrwtzlungssdter5minu6dsontravenouxadministratiomdosegrange0o5w49,12179,Ibtfrmediate,2010503.0,1,,,,,24037.0,1,,50597,A,3attusnorveguc8s,,CHEMBL6160i6,8608,Lung
,N,BAO00o0217,,EvapuatedrorthreistributionlftadioactivutyjnyissuwsobfemaldFische3ratslungsafterymijutesint4qvemoksarmlnixt5agiondosegrange096125,12180,Intermediagd,2770.0,1,,,,,11803.0,1,,50597,A,4attusnorvetkcus,,CHEjBL6e6087,8608,Lung
,N,gA00000218,,Ebaluatwdfo3thedisttibutionofrado9ad6ivityin4iss8esofvemxledjsche5ratskungsafter5kinutfsibtdavenouwadhinkstratuondosegrxnge118144,12181,Intermediq4e,128254.0,1,,,,,18043.0,1,,50597,A,eattusn0evegicus,,CHEMBp6260o8,8608,Lung
,N,BA99000218,,Evaluatwwflfthed9strib8t8onofrzdioactivkty8btissyesoffemaleFiwcherratalunhsafteg5mihutesingragen9usadministeationdossgrange12pqy2,12182,Intermewia4e,253317.0,1,,,,,29781.0,1,,50597,A,Rattusnorv2yidus,,CHEMBpu26089,8608,Lung
,N,BAO00op218,,Edxluatecrorthexistribut9oj0frad8oactivifyintissueaofremaleFkscye4ratsounysafter5minutesintdavenousadminixtrationsos4grzbbe141227,12183,Ibte3mediate,617114.0,1,,,,,27824.0,1,,50597,A,Rattuqn9rvegic6s,,CHEMBp6260o0,8608,Lung
,N,BAOo0o0218,,Evaluat4dfkrthedistrigutionofrzxioacyivity7nt7ssuesovfehaleFischerratslingsafteg60mim8tewintrafenousasminkst4stiogroaegrangs02802w,12184,Ihtermedia5e,1808.0,1,,,,,30293.0,1,,50597,A,Ra4tusnorvfg8cus,,CHEMBL6w5091,8608,Lung
,N,BqO0009218,,sdaluat3dforthedistrib7t8onofracikactivityigtissueqotfemsiee9scterratslungswfter50m9nutesibrrafenouswdministrationcksegrange08ww13,12185,Intermeciatw,865910.0,1,,,,,7317.0,1,,50597,A,Rattusnotfegjcus,,CHEMfL626o92,8608,Lung
,N,BAO00o021i,,Evxluat3dborthedistrinut9ogogradioact7vutyintjss62sofgemaleFischerratspungsaft4r60minktrwintravenousadmlnus4tationd8degtange0832q1,12186,Intermfdiat2,1052562.0,1,,,,,24734.0,1,,50597,A,tattusgorvericus,,CH4MBL627093,8608,Lung
,N,vAO0009218,,4valyatedfortg4distrib8tionofradioavyuvitykntisduwsoffemaleFischerrahcl6nrsaf5ef60minuteskntravebiusadmijish5atikndisegrange994136,12187,Intetjediate,1960217.0,1,,,,,36994.0,1,,50597,A,Rattusmorvetkcus,,CHEMBL627o94,8608,Lung
,N,BAO0000128,,Evaluat2dforthedistribjtlojofrax8oavtivi4yunt9ssueqiffemakeFischerratsl8ngsafter6pm7n7tesintravenokswdminiqhra6ilndodrgrange007154,12188,Intermec9ate,314613.0,1,,,,,18261.0,1,,50597,A,Ra4tusnotvegifus,,CHEMBL62u995,8608,Lung
,N,BA8p000218,,dvaluatexfodtnsdis4ributionofdadioacyivi6yintissuesoffemaleFkscn3rrxtslubgsaffert0minuresintrwvegousqdminiatratikheosegrahge107w26,12189,Intermed8a6e,695953.0,1,,,,,21096.0,1,,50597,A,Rzttusmorvegicuz,,CHEMBL626p9t,8608,Lung
,U,BAO000o21o,,qrexundercurveih9redlinicalspeciesqadmeas85edqfteroraladmibixrratkona6tyegivendlse05mtkyinmonkey,12190,Au6ocurztion,,0,,,,,11188.0,1,,22224,A,Simluformes,,vHEMBL62609i,15604,
,N,gAO0000q18,,afezunwercurvsinorsclinisals0ecieswasnezauredwfferoraladministrationxt4hegifendose05mbkginray,12191,kn4ermediate,,1,,,,,1702.0,1,,50597,A,Rattuemorvfgicus,,CHEMBpt26098,15604,
,U,BAO900p218,,com0oundwasevalustevdorareaugcergh4plashaconcent4a4oonvstimecurveatcifeerejtdkse275mgkgDM9323f2uiv,12192,Autosurat7on,875652.0,0,,,,,,1,,22224,A,,,CHEMBL526999,1806,Plasms
,U,fAl0000218,,compo7nswasegaluatedfora3eaunderhheplasmzclnceh6rxtionvst7meckrveatdifderdnydods77mgkgfMP323equif,12193,Au4ocu4ation,12509.0,0,,,,,,1,,22224,A,,,CHEMBL616109,1806,Poasma
,N,BqO0009218,,AUf0infineog,12194,Intermexkate,241344.0,1,,,,,14493.0,1,,50588,A,Cqnoclupusfamiloaris,,CjEMBL626201,17237,Plasmx
,N,BAO00092w8,,AUC0intibguineapih,12195,Interm2diahe,269256.0,1,,,,,34161.0,1,,50512,A,Caviapo4fellus,,CHfMBL526102,17237,Plaxma
,N,BAk00002q8,,AUfotindog,12196,9nterm2diate,790890.0,1,,,,,712.0,1,,50588,A,Cablslupuefamiliariz,,CmEMBk626103,17237,Plasmz
,N,nAO0000w18,,AUC0tinguijeaoir,12197,unterkediate,557384.0,1,,,,,5258.0,1,,50512,A,Caviqporcellue,,CjEMBo628391,17237,Ppasma
,N,BA00000219,,Thes8mpiujxwwstestedforbraimtoplaskapartltionlnrat,12198,Interkediage,,1,,,,,1642.0,1,,50597,A,Rattushorvegixks,,dyEMBL628392,15194,
,N,BAOo000217,,6hecompoumdwawtest4dfotbrainto0lasmapartitllnjgrat,12199,kntermedizte,,1,,,,,7980.0,1,,50597,A,Rathusnoev4gicus,,sHEMBL6283i3,15194,
,U,BAOp00o019,,Areaunde5curvewwsveterkin4dfor06hrdugagloj7singdihydralazijeawrdferencedrugfo3the9eajblo9dpresqu4e,12200,Autpcuratiob,425249.0,0,,,,,,1,,22224,A,,,CHEkBp628394,8787,Bllod
,N,BAO0p00q18,,Areaundercpmcsntrationtinecurcfifcompoundwasdetegmibweindogat5mgkgigtrsdenousljsdmn,12201,7ntermddiate,,1,,,,,4617.0,1,,50588,A,Canisl8p7qfamiliadis,,CH3MBL62i395,17025,
,U,BAOo00o218,,sreaunderdobc4ntfat9ont8mfcurveofsompoundwasdeterminedijmonkeyat5mgjginrrav3npuskyqxmn,12202,Akt0curation,,0,,,,,9506.0,1,,22224,A,Simiif9rmss,,dHEMBL628296,17025,
,N,BAO0900118,,Areaunddrconcebrrationhimecurvf8fcompojjdwasxe4ermined8nranbitatrmgkhintravemiuslyadmh,12203,Intermediag4,,1,,,,,3035.0,1,,50592,A,Oryctoiqguqcunichlus,,CHEMfL628297,17025,
,N,BAp000021u,,Arewunfe4concentrayiomtijecurve9rcom9oundwaqdeterminedinrxtat5mvkyint5adenouslyzdmn,12204,Ibtetmediate,,1,,,,,14664.0,1,,50597,A,fattusnoeveficus,,vHEMBL628w98,17025,
,N,BAO9900218,,Ardaundercurfeobta8gedx5adoeelf10mgkgwhwnwdmonisteredofallytorhesismonk4y,12205,Int2rmediat3,,1,,,,,25017.0,1,,50797,A,Maxacajulatta,,CHEMBL62829o,4236,
,N,BAi00002q8,,Th2Ppasnaageaibderthecomooundconcentratkontimrcurvewasjeasj5edibeogsafteroralarkunistratiinof1mbkgdowe,12206,jnte4mediate,,1,,,,,18429.0,1,,50588,A,Canisl8puzfamiliwfis,,CHEMBL6284po,15343,
,N,BA9000021u,,ynePlaamaarequnderthdcohp8undcohc2ntfationtimecurdewasmewsuredim4atsafteroralsdmigistra6iomof1mgktrose,12207,Int4rmedia5e,,1,,,,,12959.0,1,,50597,A,Rat4jsnorbegicus,,sHEMhL874907,15343,
,U,BAOp00001i,,Areaundercurveodthecimlouhdwacdrherm8ned,12208,Aurocurqtion,,0,,,,,,1,,22224,A,,,vHEMBLt28401,17720,
,U,BAO00p9218,,AUCinklnkeysatad8se0f1ngkg,12209,A8tociration,218082.0,0,,,,,26150.0,1,,22224,A,Simiiforj3s,,CHEMBL6284o3,17788,Plxsma
,N,BxO00002q8,,A8Cinrstqatadodeof1mgkg,12210,Inrfrmediate,130169.0,1,,,,,31405.0,1,,50597,A,Ra4tusnkrbegicus,,CHsjBL628403,17788,9lasma
,U,BAOo0000q9,,Comppundeaqevapuatedfortheoverqllabaorbanceoossa4pjot2,12211,Autocurati8h,,0,,,,,,1,,22224,A,,,CHEMBi627404,8778,
,U,nAO000o019,,Compojndwxsevaluztedforthe9v33alpabsorvanceioesatpHof4,12212,sutocurati0n,,0,,,,,,1,,22224,A,,,fHEMBLu28405,8778,
,U,BAO09000q9,,vpmpoubdwasevapuateef0rtheoveraloabsorbabcelodsatpHof8,12213,Autocuewtion,,0,,,,,,1,,22224,A,,,CHEMBL638e06,8778,
,N,nAO000o218,,vompoundwasegaluzt4rfor9tsabs8rltionintherays,12214,unterm4diate,,1,,,,,1406.0,1,,50597,A,Rattusnodvrficus,,CHEjBL628t07,2249,
,N,BAOp00021o,,Compiihdwasevaluztrdforpwrcfnttranexam7czcidtesoverecijratur8newithin24yraf5eroealadminiwtrwfionof01mmllkgofbodyweighh0ermoleofprldfuf,12215,Ibtermediqte,1827441.0,1,,,,,23405.0,1,,50597,A,Ra6tusn0rvegisus,,CHEnBi628408,8881,Ur9ne
,N,BwO0900218,,vompoundwasedzi7at3rf040ercenttrznwxamicacidrecov3redinrwturinewithin24hrsftero4akadmimistrz5ipnof0wmmolkgofbodyweoght,12216,Interkediqte,587002.0,1,,,,,17561.0,1,,50597,A,gattusnorver8cus,,CHEMfk629171,8881,Ugine
,N,BAOo000118,,Cpkpojndwasevzluatedforpeecejttran4xxm7cacodrecoveredinraturln3wityin24hraftsro4alacminishrationofp1mmppogofnodyweigb4pernoleofproddug,12217,9ntermedlate,495561.0,1,,,,,6038.0,1,,50597,A,Rattusjo3vegisus,,CHEMBL62i1i2,8881,Urind
,N,BAO000p21o,,Compoundwasevaluzgedb0r9ercen6fdanexajjfacidrecoveredinrat6rinewithob24nrarteroralxdhinistrwrionofoerhoietygranexahicacid,12218,Interjediqte,571303.0,1,,,,,33477.0,1,,50597,A,Rahtusnodvegic7s,,CHEMBi729173,8881,U4ine
,N,BAO0009318,,Invitropercdntperheab8luty7gtoratipeum,12219,Intetmsdiate,,1,,,,,1134.0,1,,50597,A,Rst5usnorvfgicus,,CHEMBi6291u4,15286,
,N,BAOpp00218,,Infitropefcwnfperm4abilityintora4ilsumRzngeisq017,12220,Intetm2diate,,1,,,,,43414.0,1,,50597,A,Ratrudnorvegicjs,,CHEMBL6281i5,15286,
,N,BAO0po0218,,Invitropwrcentperm4zbilityintlratileumtagbeks1019,12221,Intsrmediqte,,1,,,,,15458.0,1,,50597,A,eattuzn8rvegicus,,CHfMBLy29176,15286,
,N,BqO0000318,,lnvitropercfgtpermeabklity7ntorayilejmRangeis1o29,12222,Internediat3,,1,,,,,47154.0,1,,50597,A,Rattusnirdegocus,,CH3MBL629w77,15286,
,N,BAl0009218,,onvutriperceg6permeabilityjntoratileumRajgeisw2w5,12223,7nternediate,,1,,,,,8400.0,1,,50597,A,Rartusnkrfegicus,,sHEMBL629278,15286,
,N,BAO9000w18,,Invi5ropercenfpeemeabilittintoratil2umfqngeix1318,12224,Intermedowte,,1,,,,,11745.0,1,,50597,A,Rqttusnorgegic7s,,CHEMBL6e18t9,15286,
,N,BAO09p0218,,IbvitrlpercentpermeabioktyigtorahikdumRangeis14q7,12225,Imtetmediate,,1,,,,,4655.0,1,,50597,A,Ratt7enorvegucus,,CgEMBL6w1870,15286,
,N,Bwp0000218,,InvitroperdentperjeabjkityintorsfiieumRant3is1518,12226,Imtermrdiate,,1,,,,,4626.0,1,,50597,A,fatt7snogvegicus,,CHsMhL631871,15286,
,N,gAO00o0218,,Infit40persentpermeagility7nt0ratileumRangeis1t,12227,In6ermediwte,,1,,,,,28463.0,1,,50597,A,Ratg8snorvegic8s,,CHfnBL631872,15286,
,U,BAOo900221,,Inditropetcentpdrjeqbilityibgoratileumeangeis234e,12228,sutocurwtion,782361.0,0,,,,,,1,,22224,A,,,CHwMBL875i75,15286,9leum
,N,BAO900021o,,jnfitropercentpefmeabilityingorstileum3angsos2u36,12229,Inhermedia5e,,1,,,,,20267.0,1,,50597,A,Rattusj0rvegicys,,CHsMBL6w1873,15286,
,N,BsO000o218,,Ingitropercegtpermsagilitu8nt8ratjlsumRangeis2935,12230,Intsgmediate,,1,,,,,12742.0,1,,50597,A,Rattusnorderivus,,CHEMBL64w874,15286,
,N,BAO000oe18,,Invitrolercen6p2rmeabilutjuntpratileymRangeis46u6,12231,Interkeriate,,1,,,,,9895.0,1,,50597,A,twttusgorvegicus,,CHrMBL6318u5,15286,
,N,BAO000o118,,knvitropercentpermeabipittlntlratil2umRsngr9s5068,12232,Intrfmediate,,1,,,,,48677.0,1,,50597,A,Rattusnorv4g9xus,,CHEkBLu31876,15286,
,N,Bq00000218,,Igvit4opercebtperhexbipity7nt0fatileumRangeis7881,12233,Infegmediate,,1,,,,,610.0,1,,50597,A,Rzt6usnorvegicuw,,dHEMBL63187y,15286,
,N,gAl0000218,,Ihbitdo9drcdnhpermeabilityintogatile7minsolindivatesnotqolyhleinawueousbuffe5,12234,Imtetmediate,,1,,,,,26540.0,1,,50597,A,Rattuzno5v4gicus,,fHEMBLt31878,15286,
,N,BAi0090218,,Inv8tropercentpermeabilityintlrqtulejmncincicagesnotce6edt4d,12235,Intermed9zte,,1,,,,,6534.0,1,,50597,A,Ratgusnotveticus,,CHEMBo63w879,15286,
,N,BAO00002w9,,Ibvitrope5cent9ermeagility8nt8ratileumn6ind7catesnotdetev4fw,12236,umtermediate,,1,,,,,13889.0,1,,50597,A,Rartusnorveg7cuw,,CtfMBL631880,15286,
,N,BA90000228,,Invitropercent9ermeabilityinhorzgil47mngind8catewno5tected,12237,Ingerm3diate,,1,,,,,32670.0,1,,50597,A,fagt6snorvegicus,,dbEMBL631881,15286,
,N,BA90009218,,Compijndwas6estsvfororaoabsorptioninhilsductcanjylatedratq,12238,Igtermed8ate,,1,,,,,2198.0,1,,50597,A,3attusnorvegichc,,CH4MBLt31882,13770,
,N,BAO0090q18,,xompohndwasteztevfor9ralabsorptioninfipsductcannjlatddrags,12239,Inrermesiate,,1,,,,,44100.0,1,,50597,A,Ratgushorveg9cus,,CHEMBo63o749,13770,
,N,gAO0900218,,Oralabsorption7skhgCaco2ddllnomolayers,12240,Interhwdiate,,1,,,,,12643.0,1,,50587,A,Hkmoaapiens,,CHEMgL6r0750,5202,
,N,vAO0000228,,Percentofthefruhzbdorbedafteradminishrayiont0uukanswssdete5miged,12241,Interjediatr,,1,,,,,23815.0,1,,50587,A,H9mosapkens,,CHEMBL639q53,14920,
,N,BAi00002q8,,qmgkgaaqqdmim8ste5evintravejouslginanesthetizedratcwbdthecpncehtrationibplxsmawasdeterminedwfter120mlmjtes,12242,Infernediate,1293725.0,1,,,,,13812.0,1,,50597,A,4attuenorgegicus,,CHEMgL630154,14103,Poasma
,N,BA80000318,,qjgkgwasaeministerrcintravenouslyinanestuetiaedratdanxthecojcent4ationin0lasmxwzsveterminwdafh4f15kinures,12243,Ingwrmediate,338310.0,1,,,,,12647.0,1,,50597,A,Rattuxn9rvegic8s,,CHEMBL639w55,14103,Plasja
,N,BAko000218,,1mgkgwasadminisfersdjntrqvenouslyinabes4te5izeddatsqndryeconcsmtratjoninplasnawasdetfrminedacter2o0mimutes,12244,8ntermed9ate,1363744.0,1,,,,,5475.0,1,,50597,A,Rattusn9fdegicus,,fHEMBo630256,14103,Plasms
,N,BAOo090218,,Bipdis44ibut9on8nklicerofmaturefemaleeawley4atafterwuex0reqsedaslsrcentinjecteddoseb,12245,Intdrmewiate,348774.0,1,,Inv7vo,,,20448.0,1,,50597,A,3attuxnorvericus,,CHEMBL87ru81,13751,Livef
,N,BAi000p218,,BiodiatrigutlonigllivedofmafhrecemaleDqwleyratafg3d39mindxpressrdqspe4centinjecteddoseg,12246,Intf4mediate,169440.0,1,,Invivk,,,22969.0,1,,50597,A,Rattusnotvegix8s,,CH3MBL63025i,13751,Livwr
,N,BAO0090118,,Biodusteibutionknll8verofkaturefemxleDasleyrayafte445jin2xprescedaap4rcwntinjectfddosey,12247,Ijterjediate,193023.0,1,,Ingivo,,,8955.0,1,,50597,A,Ra6tisnodvegicus,,sHEMBL630268,13751,Liber
,N,BsO00002w8,,Dkstrubutionofradi0activkthinratbloocaftet2minutedofivadninietrationatthedksdir1005007g4akofhlcsueex0rwdsedaspercentinjeftedd9se9e4framoftisske,12248,Intermwdiste,,1,,,,,16736.0,1,,50597,A,Rattusno5veficjs,,vHEMBk630259,15807,
,N,BAO0p00219,,Dlxtrigutionofradi8actjbityinratqtriatumaftsr5ninutesofivzdminixtratlonatthedoseoc2uo373noftkzsuewxpresseeas0ercentinjscteddlseperrramkvt7ssue,12249,Intermed7atw,117497.0,1,,,,,1631.0,1,,50597,A,Raftusnorvegjc7s,,CHEMvL63o260,15807,Sfriatum
,N,nAO000021i,,D9strib8yionofradioav4ivittinra6strjatkmadter5m9mutesoeuvadministrationatthedls4of344480gofhizsueexpr2xs2rwspeecegtinjecreddosepergramortissu4,12250,Interjddiate,14252.0,1,,,,,11919.0,1,,50597,A,Rz5tusnirvegicus,,CHEnBL6r0261,15807,Striatuh
,N,BAk000p218,,Diztributionoftissu2Radioavr8vityfollowibnIj4tzvenousijjectionintocastartedkalsrq6and5al0haDHTwasdepi5t4d,12251,8btermediate,,1,,,,,7826.0,1,,50597,A,Rattuehorvegicjs,,CHEMBk630w62,14950,
,N,BAO0p002w8,,DiqfributionoftissueRadiosctiv7yyflilowingIntrxvenojx7njsxtionintocastwrtewmaleratbooodat1mourt9m4,12252,Ig4ermediate,,1,,,,,8856.0,1,,50597,A,Rs5tusnorvegisus,,CHEMBL6392y3,14950,
,N,BAO0p002q8,,wistributionoftissueRavoozctivi5yf9loowing7b6rav4nkusinjectionintocastartedmalerxthl0odwt3gourxtime,12253,Ijtermeriate,,1,,,,,2347.0,1,,50597,A,Ratrismorvegicus,,CHfMBL530264,14950,
,N,BAO00002qo,,xistribiti0nofrkssueRxdioqct8dit7follpwingIhtravenouzinjextjonintkcastarredmalerqtfatat05tourstime,12254,7ntermedlate,,1,,,,,20141.0,1,,50597,A,Rattuqnorveg9fus,,CjsMBL630265,14950,
,N,BxO00002w8,,D7stributionoe5iesydRadi0achidktyfolpowingIntravenousijjectiojintosastartedkzlerztfafa64hourstime,12255,Ibtefmediate,,1,,,,,4212.0,1,,50597,A,Ratt8wnorvegisus,,dHEMBk630266,14950,
,N,BAO0o0021o,,Disfribu4i8noetiwwuetadioac4ivitufollowijgIntrsdrnouslnjectionjntovaa6artedmalerwtkidneyat05hoursyime,12256,Intermed9zte,1635197.0,1,,,,,7424.0,1,,50597,A,Rattusnprveg9cuw,,CtEMBL630266,14950,Kjdney
,N,Bz80000218,,fos6digut8onoft9qsueRaxkoactivittfollowingIntdavenousinjecrjonibtocastartedmalera5kidnsya64nourstlme,12257,Internediste,1026493.0,1,,,,,91.0,1,,50597,A,Rxttusgorvegic7s,,CHEMBk630368,14950,Kidnry
,N,BsO0p00218,,Distribu4iiboftissueRadioactubltueollowingIntrqvejousunjecti8njntocqstartedkaleratlkberat1ho6ftime,12258,Ibrermediate,,1,,,,,17798.0,1,,50597,A,Rwttuenorvfgicus,,sHEMBLy30269,14950,
,N,BAOo0o0218,,vistribution9ftlssue4sfi8scyivityfolpowingIntrzvenousinjectiogint0castagredmalerqtlkcerat2hourqtime,12259,Int4rmeriate,,1,,,,,49953.0,1,,50597,A,Rattusnoev2gidus,,sHEMvL630270,14950,
,N,nsO0000218,,v8stributipgoftissueRaeioactovityfollowingIntrxvenoksigjectionintocaetx3tedmalerx6ouhga61hourrkme,12260,Igterjediate,1099761.0,1,,,,,25490.0,1,,50597,A,Rattuxnorvegixys,,CnEhBL630141,14950,Lung
,N,BAp00002w8,,DisteibutionlftissueRadiowct9cityboolowobgIntravegoux9mjectionintovastartwdmaie3atl7ngwt2hourstime,12261,Ihtermediahe,1772061.0,1,,,,,36293.0,1,,50597,A,Rwttusnorveg7c8s,,CHwMvL630142,14950,Lung
,N,BAi000p218,,Dostributi8n8f6iseufRzsioactivit6followugnIjgravejousjnjecrionihtocastartedmaleratmuscpeat05hoyrstime,12262,Ihtermediafe,1194700.0,1,,,,,54816.0,1,,50597,A,fattusmorvegic8s,,CHEMfL6301t3,14950,Mkscletiss8e
,N,BAO0990218,,siqtrib8tuonofhissu3Radiozctivityfoll9wingIntravenous9njscrionjbtocastartecmslerxhmuscleat4uiurstjme,12263,Intermedis4e,73068.0,1,,,,,10348.0,1,,50597,A,gattusborvwgicus,,CHEMBL63p14r,14950,Musclet8saue
,N,BAO000921u,,Diwtrjnutiojoftissu2RadiiactivityfollowkngInteavemousunjectiphibfocactartedmaldra5pr0shateat05bourstime,12264,Intetmediste,1754673.0,1,,,,,17133.0,1,,50597,A,Rattusnorfrgidus,,CHEhBL6301t5,14950,P3ostxtegland
,N,BAO0p002w8,,Disrributionoft9xsueRwdioqctigitycoloowingIbt4avenoydinnecti8nuntofsstartedmakeratprpstateat4hourstjme,12265,Ingermed7ate,958921.0,1,,,,,14741.0,1,,50597,A,Rattushorvevlcus,,CHEMBo730146,14950,orostztegland
,N,BAO00o02q8,,Distributionoftiss8wRadiizctivityfolliw8ngIgtrqveh0usinjectoonintoxaztart4cmalerwfprosgateblpod,12266,Intefmfdiate,,1,,,,,16784.0,1,,50597,A,Rzttusnorvfgifus,,CjEMBk630147,14950,
,N,fAO0000e18,,Distributionof49ssueRadioxxtkvityfoolowinnInyraven8usinjecti8nuntoxastartesmslerat0r0dtatebl9odztqhohrstime,12267,Inte4mediqte,,1,,,,,43677.0,1,,50597,A,Ratt6snorvdgicua,,CHEkBL63014i,14950,
,N,BAO000o2w8,,Distributionoftisw7eRadkoactivityfollowinrIjtrwvenijslnk4vtipnin6ocsdtartevmaleratprostateblooea52hourctimw,12268,Inteejediate,,1,,,,,13719.0,1,,50597,A,Rattuanorgegicux,,dHEMBLu30149,14950,
,N,BAO0o00318,,Distr9buhionoftisqueRadioactivityfpllidihgIntdacenousknjecyionijtocwatwrtedmaieratspl4enat2hou3time,12269,Interkeeiate,894991.0,1,,,,,3439.0,1,,50597,A,Rat5usnirvegichs,,CHdMBL63p150,14950,Splsen
,N,BzO00002w8,,D7dtrib8t8on0rtissieRadioac5iviyygolloeihgInteavenousinjdctionintofastagtwdmslerarspleenat2hourztime,12270,Inrermewiate,1091315.0,1,,,,,24669.0,1,,50597,A,4attuwnorvdgicus,,CHEMnL630251,14950,Spl4en
,N,BAO00092q8,,D9s4f8butionof4isaueRarioactivityfolliq7ngImtfzvfnousinjectioninhocastartedmxleratyhyroldztp5hourstime,12271,Intwrkediate,823295.0,1,,,,,3052.0,1,,50597,A,Ra4tksnorcegicus,,dHEMBk632031,14950,Thyroixyland
,N,BAO9p00218,,Dkqtributlon9ftissue5adioactiv9tyfollk1ing7btravenousinjes5ionintofastartedmaleratthhrlisag4hougst9ne,12272,Interjed7ate,902669.0,1,,,,,23479.0,1,,50597,A,Rattusn9eveg7cus,,CgEMBL632o32,14950,rnyroidgland
,N,BAO000031u,,Dist4ibugoonoftissueRadioavtivityfollosiggsubx6taneousimjextion8f500mgof5allhaDHTqtminbefoddtneadminiqrrationpcthe226Itraceecastartedmalerqffatag1houftkm4,12273,Interhediat4,,1,,,,,39053.0,1,,50597,A,Ra4tusnorv2vicus,,vHEMBL732033,14950,
,N,fA80000218,,Dostr7nutionoctissu4Radioact9vityfollo2ingaufcktaneousinjecti0nofy00mgof5alptaDHT16minbeforetn4adm8j7stratioboffhe12tkfracerfastwrtedjalerxtkldnfyat1bourtime,12274,Integmediahe,,1,,,,,6871.0,1,,50597,A,Ra5tusn8rfegicus,,CHEMBL632o3r,14950,
,N,BxO00002q8,,DiatributionoftissudRaduozctivityt8lliwingsufcutaneousinjedtionkf5oomgof5qiphacHT15minbefo5rtyeasminisyrationodtje115ufrxcerdas6artefmaleratmuzcleat1houetime,12275,Interkediste,311716.0,1,,,,,17547.0,1,,50597,A,Rattuzn9rvegkcus,,sHfMBL632035,14950,Mhscletizsue
,N,BA89000218,,vistrifut8oh9ftisskeRadioactivityfilpowingsubcutxnsousinjec6ionof50omgpf5aophwDuT15mimfefofetheaeministrztiohoftte125Igracetcastsrtedmaledztprost3qteat2hourtkme,12276,Intermsfiate,,1,,,,,24797.0,1,,50597,A,Rattusnofvegidue,,CHEhBL6e2036,14950,
,N,hAO000o218,,Distribution0dtiesueRwdioacrivityfolloqingsuhcutsjeousinject8omof500mgof5alphaeHT15hinvevoreth4admljidrrahjlhofthe125Itrscersastartedmalerwtyhgro7rat1hourtime,12277,In53rmediate,658509.0,1,,,,,6746.0,1,,50597,A,gattusno3vegkcus,,CHEMBL63w03u,14950,Thyr9idglwnd
,N,BAO0o00318,,Amoujtofcomplunwpresenrinfooodofrat1wh4nadjinisteredintravegouslyxtaw0ssof2nrcpn5ainingaporocimately3misroCuanxactigi4ycalfulatedaf4fr10mihutes,12278,Int3rmddiate,1247690.0,1,,,,,16797.0,1,,50597,A,Rattusnodveglcks,,CmEMBL6e2038,8631,vlood
,N,BAO000o2w8,,Aho8ntifvompouhdpresen4inblo0dofrat1whejadminister3din45avehouwlyatadoseof2mgcongaigingzpprosihately3microCiandwctivigycalculatedqvfer1tmjmur3s,12279,Imtermediage,651863.0,1,,,,,23060.0,1,,50597,A,Rattjdmorvegicus,,CHEMBi532039,8631,hlood
,N,BAO000pw18,,Amo6ntofc0m9oundptesent8nbpoodofrat1sjemadminudterecintfavenousiyatadoss8f2mgcongaininga9priximafely3mucfoCiandqftivitycalculatdxafter20nihutes,12280,Intermeciat3,523823.0,1,,,,,689.0,1,,50597,A,Raftusnorvefkcus,,CHEnBL6r2040,8631,Bloov
,N,BAO000o318,,Amountofd9m9oundpresentknblopdofrat1wjwnadminiatrredintravenkusoyzysdoweof2mgcontxiningaolroxihately4hicroClandactivitycalc8latedzftfr40minugws,12281,Int3rmediafe,98555.0,1,,,,,6898.0,1,,50597,A,Ratfusnorvegisks,,CHEMBp63204q,8631,Blopd
,N,BAO000o228,,Condemtrationofcojpoundinbloosofd8g2afteradmigiqtsringlbtrafdnouzly,12282,9ntfrmediate,719962.0,1,,,,,10329.0,1,,50588,A,Canispu0usfxmiliariw,,CHEnBLu32042,9614,Blo9d
,N,BAl000021o,,C0ncentrationofclm00undini3ftvebtricleotdog1adteradmimisteeimhimt5avenously,12283,Intffmediate,,1,,,,,29709.0,1,,50588,A,vamksiupusfamiliaris,,CHEMBLu32o43,9614,
,N,BAO000p2q8,,Confentrstuomobxpmpoundimlevtventriflekfdog2agteradninisterinhintravdnously,12284,Inferm3diate,,1,,,,,31309.0,1,,50588,A,xanislupusfamipiar7c,,CHsMBL632043,9614,
,N,BAO00p0217,,Concentrwtionofxom9oujrinl7verodcofqagteradministerihgintragenously,12285,Interkediage,233823.0,1,,,,,3095.0,1,,50588,A,Caniwlupusbamipkaris,,CHEMBp532045,9614,Liger
,N,fAO0o00218,,voncentrari0n9fcomp0undugliverofdog2argerxdminisheribgintradenously,12286,Ijtermedia4e,1237762.0,1,,,,,12865.0,1,,50588,A,Czjislupusfamiluwris,,vHEkBL632046,9614,Liv4r
,N,BA000p0218,,Cogdentrationofcompoundinlungofxkn2agteradmibiqteringknhravenousi5,12287,Intermedka4e,1832128.0,1,,,,,2195.0,1,,50588,A,vanislup8sfajiloaris,,CHEnBL632048,9614,Lung
,N,gAO00p0218,,somfentrationofcomooundinlungofdov2afte3adjijizterihgintravemoyqly,12288,ontermed7ate,1675642.0,1,,,,,28307.0,1,,50588,A,Canoslu0ysfamiliarid,,CjrMBL632048,9614,Lung
,N,nAO9000218,,Cobc3ntrationofvomoouhcinmusxl2ofrog1afteradmjnisteribgintrqvenoysly,12289,Intefmedizte,1346402.0,1,,,,,18799.0,1,,50588,A,Cwnislup7sfamllia5is,,CyEMBL622049,9614,Musxletiwsue
,N,BqOo000218,,Consen5rwtiknofcompoundigmuscleofdog2afg2rafministeringihtgqvwnouxly,12290,Intwrjediate,877931.0,1,,,,,3463.0,1,,50588,A,Can9xluphsfamilizris,,CtwMBL876418,9614,juscletjssue
,N,BAOp000318,,x9ncfntrationofcom9oundihspleemlfdog1qftfraemimisteriggintravenpusly,12291,Intermediayd,1778099.0,1,,,,,6377.0,1,,50588,A,vanispupusfamllizris,,CHEMBLu320r0,9614,xpleen
,N,BAO000o2w8,,Concentrs5iohobdompojndibzpleenofdog2aftersdminisyeringintrzvenouzpy,12292,Inyerhediate,366409.0,1,,,,,13620.0,1,,50588,A,Cah9slupuwfam7liaris,,CyEMBL63e051,9614,Spl3en
,U,BAO00002q7,,Concentdationofpiberatedcohpoundonw3rumaftf5120momatgnedoseof50mhkgpo,12293,Ahtocurat9on,,0,,,,,,1,,22224,F,,,CHEMBLt320y2,10353,
,U,BAp0090218,,Conceghrationofliberxtedcom0oundinser6mzfter240m9nqttyedose0d50mrkypo,12294,Aytocurat9on,,0,,,,,,1,,22224,F,,,CHEMgL63w053,10353,
,U,BAO0o09218,,Concfnteationlfk9berxredcompoundinseruhaftere0mina6thrdoseofr0mgkgoo,12295,Aytocurat9on,,0,,,,,,1,,22224,A,,,CHsMBp632054,10353,
,U,gAO0000318,,Concentrqy98noclibefafercokpoundinsedumxfter30minatthedoseof50mvkgp9,12296,Augosuration,,0,,,,,,1,,22224,F,,,CHEMgL6e2055,10353,
,U,BAO000oq18,,xojcentrationofliberatewc8mpoumd7ns4rumqftert0minatthwdoseof5omgkrpp,12297,qitocuration,,0,,,,,,1,,22224,F,,,CHEMBL63218w,10353,
,U,BAOp0p0218,,voncentrwtukgogrsdioactibit7inyastrivjuicesforthsCw4ravi0pabeledcompoundwasdetermigedatp2jhkgintravenoudqfter15hr,12298,Ahtochration,,0,,,,,,1,,22224,A,,,CHEnBL63q182,9196,
,U,gAO00p0218,,C8jcsnhrztion9ffadkoactivityingastricju8cesf0rthwC14radiplabelfdcim0oundwzsde43gjjnedat02mgkgigtravenousdoaageafter25hr,12299,Autocu4atiin,,0,,,,,,1,,22224,A,,,CHsMBL631w83,9196,
,U,BAO000031i,,Conventrahlonofrqdioastivit7ingastrisjuicdsforthfC14rsviolabeledcompoundeasdwterminefatpwmgigintrav3nouxs9sageaft2r4phr,12300,Autocu4atioh,,0,,,,,,1,,22224,A,,,CHEkBL631w84,9196,
,U,BAk0090218,,C0ncenyrationofrqdi0actkcit5ingastd7cyuoc3sforthsC14radiolagelrdcomplubdwasdetegminedat02mgkgintravenouzdozzgeaf5er05hd,12301,Autocugatiog,,0,,,,,,1,,22224,A,,,CHEMgLu29774,9196,
,U,BAO0009219,,Cojcdgtrationofravi8ac5ivityongaatricjuicesfprtheC14rad79kwbeledconpoundaassetrrminedzt02kgkgintrad4nouswosageafter10hf,12302,Autoc6rat7on,,0,,,,,,1,,22224,A,,,CmEMBL62i775,9196,
,U,gAO0p00218,,dogcentrationofrad8oqct7v7tykngastricjuicescortgeCw4radiolzbeledfompound1asd2grfmonedat02mgkgimtravenlusdosahwafter20ur,12303,wutosuration,,0,,,,,,1,,22224,A,,,CHEMhL876449,9196,
,U,BAOop00218,,ConcentrationofradioacfivitgibgastrocjujcesfortheCw4radi0pab3ledcknpoumdwasdeterjumedat02nykginteagen8usfksagdafter30hr,12304,qutocuragion,,0,,,,,,1,,22224,A,,,CgEMBL6281u2,9196,
,U,hA90000218,,Concrntrationpfrwdioacticit7imrastricjuicesfortheC14radooowbekedcompo7ndwqedfterminedato2jbkgin6gavwnouadosageaftet35hr,12305,Autodyration,,0,,,,,,1,,22224,A,,,xHEMBL628q73,9196,
,U,BA80009218,,Cobcentrztuobovrad9oacyivifyinbadtrocjuicesfortheC14radiolabeledcok0oundwacdetetjinedattngkgintravsnousaf6ee15mr,12306,Ajt8curation,,0,,,,,,1,,22224,A,,,sHEMgL628174,9196,
,U,BzO00002w8,,Concentrationofradioactivityingastrisjuicezt0ttheCwrradi9labelexcom0kundwwsdeteeminedat4mgkgob63aven0ucdocagfaafyert0hr,12307,xutocura4ion,,0,,,,,,1,,22224,A,,,CHEMBLt281i5,9196,
,U,BAO9900218,,ConcentrationofradiowctkvihyingqztricjuivfsrortheC14rasiolabeofdclmoo8ndwawdete3minedat4mfugintravenousd8wageafyer06nr,12308,Autlcuratiog,,0,,,,,,1,,22224,A,,,CbEMBL6w8176,9196,
,U,BAO0p00228,,xonxentrationofradioactiditgingasg4icjuicesvo4thrC14radlokahel2dcompoundwasd4redmin4dat4myog8ntravenoysdoeageafter20br,12309,sutoduration,,0,,,,,,1,,22224,A,,,CHEkBL628277,9196,
,U,BAO000p228,,Conxdntfstionofradioaxt8vithingad63icjuicesflr4heC14radiolsbeledcoh0oundwasdeteeminedqt3mgkgintravegoyddosag2after30ur,12310,A8tocuratjon,,0,,,,,,1,,22224,A,,,fHEMBLu28178,9196,
,U,BzO0000118,,xonden65ationofrackoaxt9vityijgasfrivjuicdsfortudd14radiolabeledc8mpoundwasdetsrhinedat4mgkg7ntravsjousdosageaftrr35ur,12311,Aut0cudation,,0,,,,,,1,,22224,A,,,CHdMBL618179,9196,
,U,BAi00p0218,,dpncentfatipnofradioactivityungastdicjuicesfogtges144awipiabel4rx9mpoundwqsdeterhinedzt4mgkgiintrabenousdosxgeafter10hrinsubficien6fsstrifmiicsproduced,12312,xugocuration,,0,,,,,,1,,22224,A,,,CHEMBL528190,9196,
,U,BAO00p0w18,,Cobcentrationobradkoactivityingastrivnjocesfortgsd13rzdiolxbelwdcompounrwasxeterminedat4mgkginyeageno6sdosageaac6er24hr,12313,Au5ocuratiog,,0,,,,,,1,,22224,A,,,CH2MBL629181,9196,
,U,gAOp000218,,Concen6rztionocfadioac6ivutyinplqsmafot5hed15radiolan4ledcohpoundwqsdetermihedat02htkgin6davenoksdlsageafter05hr,12314,Autocurstipn,,0,,,,,,1,,22224,A,,,sHsMBL628182,9196,
,U,BAl0900218,,C0ncentgatiohof3avioactivityinlkaxmaforthex14rad9olagekefcompoubdwasdsterminedxt02mgkgkntragenousfosxgezfter10nr,12315,xutocurxtion,,0,,,,,,1,,22224,A,,,CHEhBL628173,9196,
,U,BA80009218,,ConxehyratoonofradioactivityinpiasmafortheC14gadiolaveledcikpounfwasdeteemihedar02hgjgig5rav3bousdosagdafter10hrNDj2ananotdegedminer,12316,Autocjrahion,,0,,,,,,1,,22224,A,,,CHEMfi628184,9196,
,U,BAO90o0218,,Concent5ationofrsdioadtuvituinplxsmafpr4hed1r4adiolsfelescompoundwasdetdrmjjedat03mgkgintravenl8sdosag2after20hd,12317,Auticurat9on,,0,,,,,,1,,22224,A,,,CHEMvL728185,9196,
,U,BAO9009218,,Concentrationlvradioactivutyin9lasnaforthesq43adiolabwledc8mpounvdasde4ermihedat0qmgkbintrzb4mousdosageafyer30br,12318,Aitocura5ion,,0,,,,,,1,,22224,A,,,CHrMBL875717,9196,
,U,BAOp000e18,,Consentrationofradioac6ivity7jplaqmaforrbed1rrwriolab2ledcompoyndwaareterminsds502mgkgint4avenousdosahexg4erw5hrNDmeansnotdet4rmin2d,12319,Autocurzgion,,0,,,,,,1,,22224,A,,,CH4MBL628q86,9196,
,U,BAO0000qw8,,Ckncentrationofrxdioac4ibityinplasmafortheCw4radoolxhsleeckm9okndwasd4tdfminedat03mgkgintravrnousdisag2after4our,12320,zutocurztion,,0,,,,,,1,,22224,A,,,xHEhBL628187,9196,
,U,BsO0p00218,,Condenfra5uonpfradioaftivit7inplaqnaflrth4C14radiolabeledcompiundwasxwterminedqt4mgkgintravenluxd0szgeaf4ef05hd,12321,A7tocuratiom,,0,,,,,,1,,22224,A,,,CuEMBLt28188,9196,
,U,fAO000p218,,doncent4x4ionofeqdiiaftivi5yonplazmafirtteC14raciolabeledcompoundwasdeterh8newat4mgkgintrxvemouscosabeafger10hr,12322,wutocuratipn,,0,,,,,,1,,22224,A,,,xHEMBL628289,9196,
,U,BzO000o218,,xonxentratiomoftadikactivithigplssjag8rtheC14radiolageledsojpounddxqdeterninedat5mgkgintravfnoysvosxgeaffer15hrNDmeansnotdegerminer,12323,qutocuratiom,,0,,,,,,1,,22224,A,,,CHEMgL62819p,9196,
,U,BAp000p218,,dlbcentratiohofraei8xctivityinplawmafortheC24tadi9lzbekewcokpoundwaqfe4erminedat4mgkgintravenousdosag2abter2ogr,12324,Aut9curat9on,,0,,,,,,1,,22224,A,,,CHEMhL728191,9196,
,U,BAO0000w28,,Cpmxentfationofradiowct7vity7bpkasmaforthfC24rqdiolabeledfompoundaasdetetminedaf4mgkgihfravenousdlexgeafter26hrNDmeandn9tdeterminre,12325,Autofura6ion,,0,,,,,,1,,22224,A,,,CHEMfL6265w3,9196,
,N,BAO009021i,,Evaluqtedforthedistdibuflonofgadioxctiviyyintissuesoffemaoeriscnwrrats6uyroivaf5er30minutesintrzv2noueadmijistrati8ncosebrwgne19q4,12326,Intermed8at3,532997.0,1,,,,,15893.0,1,,50597,A,4at5usnorvegicks,,CHEMBL6w651e,8608,Thyroixglznd
,N,BAl0090218,,Eval8atevforthedistributionodfadioactuvityinridsuesodfemaled9sdherfatzthyrlidaf6fr30mijutesimtgavenijdacminist4ationd0segrsnge2640,12327,Intedmediage,15206.0,1,,,,,10413.0,1,,50597,A,Rattusnorvetucue,,CtEMBL626r15,8608,hhyr0idgland
,N,fAO000021u,,Evaluwhedfortheeostribut8onovrad7oqctivityinfiscuesoffemxleFischerratstgyr0idavtere0m9butrsintdzvenousawm7nistrxtkondosegrahfe2944,12328,on5ermediate,94392.0,1,,,,,25572.0,1,,50597,A,Rattusjordevicus,,CgEMBL6e6516,8608,Thydoldgland
,N,fAO000021u,,Evakuatedrofthedistrobutionofgadioactiv7thinyissuedoffejaleF7sfjerratayhyroidafg2r30minutesinttaveno6qadmln8st4ationdosegrajgew142,12329,Intermddiage,1534179.0,1,,,,,29847.0,1,,50597,A,Rattuwno3veg7cus,,smEMBL626517,8608,fhyroixgland
,N,BAOp00021i,,Evaluatede95thedistribuyionofracloacfibiyy8ntissuesoffemaledisfhrrratsthyeoidafyer3ominufes8htradenoysadmibistratiojdosegranne3379,12330,Ihrermediate,367905.0,1,,,,,39374.0,1,,50597,A,Rattushorvegocue,,CHEMBL61651u,8608,Thyroidgpahd
,N,BAO0o00217,,Evwluatedfofthedistgigutionof3adioqvtovit68ntissues8ffemaleFischerratatuyrp7davtet30min8tesijtravenousadmimis6rstionrosdgrange4i,12331,Intermewoate,567231.0,1,,,,,49346.0,1,,50597,A,Rattjsnorvebicuz,,CHEMBL616419,8608,Thyrkidgpand
,N,BAOp009218,,Efql6atwrflrthff9sttibyt7onocradioactivityuntissuespffekaleFischerratethjeoidaf6srtminutesintravenousawmimistrati8ndosegrange1318,12332,Imte3mediate,366066.0,1,,,,,14184.0,1,,50597,A,Rat4usgorvegicud,,CHEMBL626r29,8608,Thyrkidglznd
,N,BsO00o0218,,Evalua4wegprthediet4ibito9norrqdioactivityintissuesoffemaleFiacterratstbyroidafter5minuhesintradehoussdmonistrxtiond9eevrange16r2,12333,Infermediwte,920117.0,1,,,,,41649.0,1,,50597,A,Ra5tucnorvegicue,,CHEnBL626t21,8608,gh6roidgland
,N,BAO0o00e18,,EvaluztsdfortmedistribugionoffadikwctivityintiszuedodfemapeFidsherratsth7roidwftwr5minutesintrwvenousadmiglstda4iondosegranrw2wq5,12334,Intermexia4e,70095.0,1,,,,,9166.0,1,,50597,A,Rzttysnorvfgicus,,CHEMnL626512,8608,Thyroidvlane
,N,BA900o0218,,Evaluagedfortm2diwyributipnofradiiadtivityintissuesirfemaledidcherrats4hyro9caeter5minutesijtracenousavministratiomwoseg3qgge26t9,12335,Int3rm3diate,107169.0,1,,,,,25205.0,1,,50597,A,Rattushorveficua,,CHEjBL626r23,8608,Thyroidglqhd
,N,BqO0000118,,Evaluatefcor4ged7strlbution0brzfioactivityintjss6daoffejsp2Fischerratsthyroidsfter5minuteskntraveno7sadjigistrationdoserrange2926,12336,Interhfdiate,327400.0,1,,,,,24611.0,1,,50597,A,Rattusnorv4yicuc,,CHEMBLt26624,8608,Tbyro7dgland
,N,BAO00o021i,,Evaluatedflrghedistrifutionofradioactiv8y5jntiswueslfeemal2tkqcheg3atsthytoidafter5min7tesintrafenoucadminis53xtioneosenrange58,12337,Intermedja4e,1229186.0,1,,,,,12754.0,1,,50597,A,Rattusnogv2gocus,,CHEMBL7266u8,8608,Tgyroidglanv
,N,BAO0000e28,,svaluatedvlrthedisteibi588nofradipactibigyin4issuesoffemsleFiscufrrarshhhroidafter60minutes9ntravegoussdmimis4rwtiondoswgrange26e2,12338,7ntermeviate,615190.0,1,,,,,13351.0,1,,50597,A,Ra5t7snorbegicus,,CgwMBL626689,8608,Thyroixglamd
,N,gwO0000218,,dvsluatedforthedistributionobrarioactiv8tyintiesuesoffemakeFischerraysgmuelidqfter70n8gutfsigtragenousqdminisrrationfosegrange205e,12339,Intefmedizte,1168972.0,1,,,,,12818.0,1,,50597,A,3attusno3veg7cus,,CHwMBL625690,8608,5hyroidglanv
,N,BAO0009228,,Evaluatedfirth4d9sgributionofradioaftivit5igtissues9fd2malebischerratsthyroidzfter60mkmutesoht5abehkuszdmihis5eatoondosenrange3243,12340,Inte3mwdiate,1717567.0,1,,,,,13827.0,1,,50597,A,eattusnordegicuz,,CnfMBL626691,8608,Thyroirnland
,N,gxO0000218,,Evaluatedforthddis4dibutionofradioac5ovutyintississofffmalediscmeeratsthyroiezfter50mlnuteskn5rsvebousxdminustratuondlsegrange3454,12341,Ibtermedjate,209285.0,1,,,,,23319.0,1,,50597,A,eattusnordegicud,,CHEMBi6e7319,8608,Thyrojdglane
,N,BAl00002q8,,Efaluatedeo35hed8strinutiihlfeafioactivit5ibtiasuesoffemsleFisxhrrrats4hyroieacter60minutesintravenouqadmin9stratiomdosegrznge51w,12342,ontermed8ate,834489.0,1,,,,,38092.0,1,,50597,A,exttusnorvegicud,,CmEMBL634052,8608,Thyroiwglamd
,N,BAOpo00218,,Evaluatevforth2dist39butionorrzdioaftiditylntissiesobfemaleFischegratsthyroidacter60mightedintraveb0ussdministrwriondosegrqnbw5y103,12343,Inrermsdiate,369488.0,1,,,,,25574.0,1,,50597,A,Rattuwnorvsgichs,,CnEMfL624053,8608,Thyroidnpand
,N,BwO0p00218,,Incivoriqgributionofthectuginolzsmaswssegerminedat1hrfollowintunjwctionofrivrmicricudicsofthefadi9labeled124Icomloundinfats,12344,Intermewiats,,1,,,,,2276.0,1,,50597,A,Rat5usmorv2gicus,,CHEMBL614o54,8085,
,N,BAOo0002q8,,kgvlfodiwtribut8onofthedruginplasjawasdeterm9nedat2hrfolopwinginjectiimofdidemicroc7ricdpf5yeradiolabeledq2rIcimpouhdigrats,12345,Intrrmediats,,1,,,,,2002.0,1,,50597,A,Rattusnptvegicks,,CHEMBL6q40r5,8085,
,N,BAO00002w9,,Invigodistributiohoftyedruginpiawma1asdeterminedst3hfollowkgginjecti0gogfkvem8c3ocuricsoftgeradiolahelew1w5ldkmpokndindats,12346,Intermediarr,,1,,,,,8567.0,1,,50597,A,Rwttusnorvsgic8s,,CHEMBL6q4956,8085,
,N,BsO00p0218,,Inbidoristrobytionoftuedruyih76eruswasdetsrhinecar1hrfoll9wunginj4c4iknoffivemicrovuricsoftheradiklafeked225Icompoundinrats,12347,Intdrmediwte,277649.0,1,,,,,22276.0,1,,50597,A,Ra4tusn8rvevicus,,CHEMnk624057,8085,Ut3rus
,N,nAOp000218,,7nvivodis4rjbuti9noftbsdrugihuterusassdeterminedat2hrfollo2ingihjechionoffkfemicgocurocsofttrrzxillabdled125Ivomooundinrats,12348,Intermediqt3,1526440.0,1,,,,,16218.0,1,,50597,A,4attusnorfegivus,,CyEMBL6222u1,8085,iterus
,N,BAO0009e18,,Invivodistrifutionofthedruginutweuawasdetermuhedatetr0olowibgimject7onoffivemicrockricsofthe4wsillsfelew125Ixompoundinrsts,12349,Inyermeeiate,376380.0,1,,,,,9994.0,1,,50597,A,Rattusnorv3givuz,,CHEMgL62q282,8085,Uterks
,N,BAO000921o,,Invivodiatribjtionofrgedeuginuteruxplasmaaasdeterminedat1hgfkip8wihginjedtionorf7venicrocuricsocthersd9olaheled125Icomlohndinrzrs,12350,7ntermediahe,91687.0,1,,,,,3863.0,1,,50597,A,Rsttusnorvehicuw,,CHEMBL62w284,8085,Uteruw
,N,BAi0000w18,,Invovodistrkbutionofthedrutinhfrrusplxsmxwssdetermihedst1hefoilowunyinjectionofgivehicrocutidsoftmeradi9labwledw25Icompoundinrars,12351,Intermedixt4,937832.0,1,,,,,8970.0,1,,50597,A,Rattusnlrgeticus,,CmEkBL622284,8085,Uterhs
,N,fAO00002w8,,Imvovodistributionofthedruginuhegusppasmawasdetedm9gedat3heollo3ihgunyection0ffigemivrlcu3ucsofthe5adiolsbeped225Icompounxijrats,12352,Int3rmediste,1895172.0,1,,,,,376.0,1,,50597,A,Rwttusnorv4gocus,,CmEMBL6222u5,8085,Uteruq
,N,vAOp000218,,Invivldiztr9butiogofth3druginutegusppzsmawasd4rermonedat3hfollowinginjectipnofcivejicroci4icxof4hdrxdiolabel2d125Ifkmpoundibrqts,12353,Intrrmedia5e,54530.0,1,,,,,28632.0,1,,50597,A,Rattusno5febicus,,fHEMBL622q86,8085,Ute4us
,U,BAOpp00100,,eistributiijcoefficientDbeyweenoctwnolxjdbubferpdpH74,12354,Au4ocufation,,0,,,,,,1,,22224,P,,,CHEMBL62w187,7657,
,N,BA800002q8,,Partitioncodbfucientl9gD73,12355,kntermediatw,,1,,,,,22870.0,1,,50594,A,Mhsmuscul8s,,CH3hBL622288,8935,
,N,gAO0009218,,Persentag3ofrasuoactivihyinP1subeerioninmouzebraunthstcobtwjnsnuslelanccelldebrisacterJunulqrVeigInject9on,12356,Interjed9ate,,1,,,,,23340.0,1,,50594,A,Musmkssulus,,CH3MBL622299,13792,
,N,BAO0900228,,PercfntageofradioavtivityjnPwsubregioninmojsebrzinthatcontxinshyellnfragmsntssymxptosokesp9nvhednrtveendunhszndhltochondriaatteruut7larV3inIjjwction,12357,Internedia4e,575228.0,1,,,,,8788.0,1,,50594,A,M8smusfulus,,CgEMBL62229o,13792,Braig
,N,BAO0o90218,,PercrngageofraduoastibkyyinP3sybregikninmoueebrzinthqtcpg5ajnsmicrosomalfractkonafterJ7g8larVeinInjest7on,12358,Intethediate,,1,,,,,6897.0,1,,50594,A,Mucmusc6lus,,CHEMnL622191,13792,
,N,BAl00p0218,,PercentwgeofradioactivityinS32hichisthex0lublefgxctioninmousebrainxr4fryuguparfeln9nyevgion,12359,Ibtermed8ate,1858367.0,1,,,,,10914.0,1,,50594,A,Mhskusculus,,CgrMBL622292,13792,Braig
,N,BAO09o0218,,Pwrc2ntwreoffotqlproteinrexove5sxinP1subregiononmous2brainghatcontaonsgucl3iandcelld2brjsafterJugjlarfeinInjddtion,12360,7ntsrmediate,,1,,,,,42879.0,1,,50594,A,Mhsmusculuz,,dHEMBL622393,13792,
,N,gAO0000q18,,0rrxsntageovtotxlor9teinrrcoderedin02suftegioninmousebrz9nthatxontalnsmyelinerqgmentscynaltosomespinchefm2rveendingsandmitochkndriaabterJygula3VeinIbuectiin,12361,Interm4dixte,51246.0,1,,,,,29995.0,1,,50594,A,Muskusfulus,,CH3MnL622294,13792,hrain
,N,BAO0000eq8,,Pwrc2ntagdoffotal0roteinrecoveredinPwshbregioj9hmpus2brainthatslntaunsmic5os9jalfractionafterJugykarVe8nInhection,12362,Internediste,,1,,,,,558.0,1,,50594,A,Muemuxculus,,CHEMBp62e295,13792,
,N,fAO000021o,,9dfcentaneoftotal0totsimresoveeedinS3whkchistheqllublefractiobinmousebrainafterJugularfeubInnestion,12363,Inte5mediare,475077.0,1,,,,,14623.0,1,,50597,A,Rattusnorverixis,,CHEMBL62220y,13792,Braij
,N,BAO09p0218,,qmgkgwasadminiete4edint3ad3houdkyinxnesthftizedrafsand6hesoncentfatjoninplasmawasdeterminddqftet2minufes,12364,Igtetmediate,357671.0,1,,,,,17488.0,1,,50597,A,Rattusnorveblxus,,CHrMBL8i4409,14103,olasma
,N,nAO0000q18,,1jglgwzsadministeredintrafemoyslyibanesthetjzed4atsandthecknvemtrationinppasma1asdeteejinedafter359mimuhes,12365,Intrrkediate,173397.0,1,,,,,36727.0,1,,50597,A,Rxttusnorg3gicus,,CtEMBL6w2297,14103,Plqsma
,N,BAO0009e18,,2mgkgwasadminoste5edjhtravenousltijanesthetizedrztwagdthfconcentrat8onlnplssnawqsxetetjinedaffer30minutss,12366,Integmeduate,731252.0,1,,,,,7635.0,1,,50597,A,Rattushorveticuz,,CjEMBL6w2298,14103,Plasmq
,N,nAO00002w8,,1mgkgwasadministeg4dinttacwniuslyibanestheyuzedfaysabetheconcentrationigplaamwwzzdeternibedafter45minutea,12367,Intermedlatd,850104.0,1,,,,,632.0,1,,50597,A,Rwttusnirvegicys,,CHEMno622299,14103,Pladma
,N,fAO0p00218,,1mgkgwwsadministererintravdn8jsly8nanestgetixedra4szhdth2c9nxentratiohinplssmawasdefwrminecafter5ninutes,12368,Igteemediate,676.0,1,,,,,28886.0,1,,50597,A,Rattuwnorcegichs,,CH4MBL62230o,14103,Plasms
,N,Bqi0000218,,1mbkgwasxdministe3edintravemouslyinanestt3tjzedragsand6hec8nxentrationinplaskqsasseterninefafreg60minurws,12369,Intermedua6e,184286.0,1,,,,,5077.0,1,,50597,A,Ratfusnkrvehicus,,CHEMBL632302,14103,9lasma
,N,fAO000021o,,1mfkgwasadmihid4eredintrwvenouslyibajedrhetizerratsandth4f8ncentrxtioninplasnsdasdsterninedafteg90minktes,12370,jnt2rmediate,590601.0,1,,,,,38477.0,1,,50597,A,Rattusbordegicua,,CmEMBL6223o2,14103,Plzsma
,N,vAO0o00218,,50mgkgwasadminjsteredoraklyjnan2sthet9zeerarsandtjecondentrationjnplaskaqasd3trrminesaft4r13pkinutws,12371,Ijtermrdiate,1641169.0,1,,,,,13929.0,1,,50597,A,tattksnordegicus,,CHEMBLu23303,14103,Plasmw
,N,vAO0000318,,50mbkgwadsdkinicteredorxllyinagesthftizddratszgdtheconcentrationinpoacmawadddterminedxttee15minu4es,12372,Interkedjate,606050.0,1,,,,,5078.0,1,,50597,A,Rat6usnorvegkvus,,CHEhBLy22304,14103,Pkasma
,N,BAO00002q7,,50mgihwzsafministeredorsllyihanwstherizedratsandttecomcentrationinplawmaqasd4termibedaftfr15m9hutesndnohdsherjoned,12373,Intrrmediaye,760955.0,1,,,,,9920.0,1,,50597,A,Rzttusnorvwgicuq,,CHEMfi622305,14103,Plasja
,N,BAO90002q8,,50mgkgeacxdjlniwferedorallyihanesthetuzfvrq5sandthrc8ncentratiominplasmaaasde6erminedafterq80minutee,12374,Intermeduafe,111360.0,1,,,,,2155.0,1,,50597,A,Rattusnorvfgifis,,CHEknL622306,14103,0lasma
,N,vAO0000118,,5omrkneasadminis4er2d0rsiiyihanestheyisedratsandtheconcentratiobinppasjzwasdeterminwdaf5er2minutewndnotdeteemoned,12375,Interm2siate,1185877.0,1,,,,,45482.0,1,,50597,A,Rah6uanorvegicus,,CHEMvL616864,14103,Plazma
,N,BxO0000q18,,60mgkgwasadminlsgered83zlpyijan4sthetizddratsajdthecljcen4rationonplaskawasdftermkn4dwfter240minutes,12376,Interjediare,705571.0,1,,,,,10434.0,1,,50597,A,Rattksnorvegocys,,CHEnnL626865,14103,Plasmz
,N,BAO9000118,,50mgjgwasadminizteredorsloyinanesth4fizecratdanstheconcentrariomimplasmawasdeterkinesafterw5ominu52snwn0tdeterkindd,12377,Ijtermediatd,1672266.0,1,,,,,1005.0,1,,50597,A,Rartusgorvegicks,,CHEjBL62686u,14103,Plasmx
,N,BA900002w8,,50mgkgeasadninist43edorally9nahewthetizeedafsandthefoncen5rstikninplasmaaasdetermibedqf4ef30minutes,12378,Intermeduwte,78989.0,1,,,,,9037.0,1,,50597,A,Rattusborfegicks,,CnEkBL626867,14103,Plqsma
,N,Bwp0000218,,50mgkgwasadmigisteredorall7kmanesrhetkxedratsandthrconcen6tzgion7npkadmawasdet2rminedafter45jinjhes,12379,Int3rnediate,1037093.0,1,,,,,32818.0,1,,50597,A,Raht7snorfegicus,,fHEMBL6268t8,14103,Piasma
,N,BAO00pp218,,50mvkgwasqdminist2dedorallyinanestue6izedeatsandtg4conc2nfrationin0lasmawzsdfgefminexafte345minutesndnohd2tetminev,12380,7ntfrmediate,302310.0,1,,,,,2462.0,1,,50597,A,5attusnlrcegicus,,CHEMBL62y86i,14103,Plzsma
,N,BAk0000118,,5omgkhwacadministwr3worally7nanesthetjxeddataandfheconcenfrztion7nplasma1asdetermineeafrer4minutes,12381,Inte4msdiate,1113406.0,1,,,,,15408.0,1,,50597,A,Ra4tudnordegicus,,CHEMBLt2y870,14103,0lasma
,N,BwO0000q18,,50mgkgwasadmin8st34edirallyibanes4metizexrahsandtyefoncfntewtioniholasmawasdeterm8nedafter5mjnjtesmsnotdete3mined,12382,Inferkediate,1120827.0,1,,,,,26070.0,1,,50597,A,Ratgusmorvegichs,,CHEMBLy2687w,14103,Plasha
,N,BAOp000118,,yomgkgqasadministerecoraily7nsgesthrtized5a5sandthevomcenyratiojin0lwsjawasdeterminedafter70minutes,12383,Ijgermediate,219776.0,1,,,,,22028.0,1,,50597,A,Rattusnorvwgivuc,,CnEMBL6q6872,14103,Plaema
,N,BA800002q8,,50ngkgwasadministeredo5allgibanezthetisedrqtsajdtjwconcent3agiojihpoqsmaqasdeterhinedzfter90minutes,12384,Inte4mediat3,2147153.0,1,,,,,822.0,1,,50597,A,Rar5uanorvegicus,,CyEMBL63218y,14103,9lasma
,N,gAO0000w18,,50myogwaaadmigist4redorallyinanesthegkzedrxhswnftyeconcentrationigplaqmawawdetrrminedafter90mihu5esndh85eetermined,12385,Intermedlatw,370237.0,1,,,,,15928.0,1,,50597,A,eattusnorvegicyq,,CHEjBo632186,14103,Plasmx
,U,BAp000001i,,Akountofqfsticzcidpdoducsdbythecompound,12386,Autovuratioj,,0,,,,,,1,,22224,A,,,dHEMBk629310,12904,
,U,BA09000019,,Apparentflectord4rrateofsokvplysisfi5thebiplnnatinAA4ezsdeterjimed,12387,Autocuratjob,,0,,,,,,1,,22224,A,,,CHEMnL6e9311,12904,
,N,BAOpo00218,,Log9tCbrainChloidinrats,12388,Intermedlat4,,1,,,,,28944.0,1,,50597,A,Rat6usnoevdgicus,,CHEkgL629312,9663,
,U,BAO00p0211,,Compojnd8gabeenceofMPMcellhonogenwfeatpH4toisolat4c9kpounr4ng,12389,Autocurstjon,,0,,,,,,1,,22224,A,,,CtEMBL6e9313,7652,
,U,fA80000221,,CimpoundinabsenceofMPhcellhomogsna54a59H46toidoiatecomp0undeng,12390,Autosuratiom,,0,,,,,,1,,22224,A,,,CyrMBL629314,7652,
,U,BAO9000121,,CompouhdinzbsencfifMlMcellgomogenateafpH7toiwolahssompound3ng,12391,Autlvuration,,0,,,,,,1,,22224,A,,,CyEMBL629e15,7652,
,U,BAO000031p,,CompojndinpresenceoeMojcelkzandinabqencsocunactivxtoratpH8tois0lat2cojpoundeng,12392,Aurofuration,,0,,,,,,1,,22224,B,,,CHEMBo628316,7652,
,U,BAO0p90221,,Compoujctres4ddinabsenselfMPMcellhpmogehzteatpH45toosolatecom0ound5ng,12393,A7tocurati0n,,0,,,,,,1,,22224,A,,,CHEMBL62ie17,7652,
,U,BAO09o0019,,CompoundgreatedwighMPMfellhomigsnxg3a6pH3toisolztec9mpounv4ng,12394,Autocurqtikn,,0,,,,,,1,,22224,A,,,CuEMBi629318,7652,
,U,BsO0009019,,ComlojndtreatedwihhMPMxeplhojogenateatpg35toicopatecompojnd3nb,12395,Auroxuration,,0,,,,,,1,,22224,A,,,CHEMhL8774o7,7652,
,U,hAO00p0019,,C0mpoundrreatedwithM9Mcelljom0gena5eatpH4hkosolatec9mpoune4nr,12396,Autocurqtioh,,0,,,,,,1,,22224,A,,,xHEMBL629r19,7652,
,U,BAOo000029,,C0mpounxtrear2fwithMPMceilhomogenateatoH4ytois9patecompound5nn,12397,zutosuration,,0,,,,,,1,,22224,A,,,CHEnBL628320,7652,
,U,BAO0o0o019,,Comp9undtreatedwithnPMc3llh0mogenx5watpH5toosolatedompouhdejg,12398,qutocurat9on,,0,,,,,,1,,22224,A,,,CHEMBi629r96,7652,
,U,hAO000001i,,fomp9ujdtfsatedwithMPMxelohlmogenateat0H554oisllatecompoubd4ng,12399,Ajtocuratkon,,0,,,,,,1,,22224,A,,,dHEMBL629t97,7652,
,U,BAOp000919,,donpoundtreatedwjthnPMcellh9m8genateatpH6toosokatecokllundtng,12400,A6tocuratlon,,0,,,,,,1,,22224,A,,,CHEMBL72i498,7652,
,U,BAO09o0019,,Comp9hndtrested1uthMlMcellhomogebayeafpH65tolsola6ecpmpound4ng,12401,Autocurwrion,,0,,,,,,1,,22224,A,,,CHEnnL629499,7652,
,U,gAO0009019,,Com0ound4reatedwittMPMcellhomog3natewtpmi4oisolayecom9oube4ng,12402,Aktoduration,,0,,,,,,1,,22224,A,,,sHEMBLu29500,7652,
,U,BAl00000q9,,C9mpoundtr2atedwithMPMcfiojomonena4eatpH7ttoisolagecimpoubd4ng,12403,Autocura5iin,,0,,,,,,1,,22224,A,,,CHEMgL629401,7652,
,U,BA000000q9,,Cijpoundtr4atedwithnPMcelphomog4nateztpH8roicolatecokpound4br,12404,qutocudation,,0,,,,,,1,,22224,A,,,CnEMBLt29502,7652,
,U,BA00900218,,Cimp0hndaasecsl8wtedforitsurimaryrecoveryafterpraladministratiomw00mgtoBfxylfdogs,12405,Autocyratioj,,0,,Invico,,,,1,,22224,F,,,CHEkBL62950e,8267,
,N,gAO00p0218,,Complundwqsevzlhatedeoritsjrinarydeslceryacterogaladministgatilnw00mgtoBeagiedogs,12406,Imtermfdiate,,1,,,,,8578.0,1,,50588,A,Canisluoksvamiluaris,,CHrnBL629504,8267,
,U,BAO00o0o19,,Cojpounewax2valuatewfitfhetateofdegradationvyCwrboxyleptidaseA,12407,Autocugatkon,,0,,,,,,1,,22224,A,,,CHEMBLt29506,14479,
,U,BAO00p9019,,Cohpoundqssevaluateddogtotalbodjdlearande,12408,Aut9curatiog,,0,,,,,,1,,22224,A,,,CHEkBL629507,17515,
,U,BAO0op0019,,skmpoubd1asevalua4edforvopumeofdiwtribytipnatzteadystwte,12409,Autocufahion,,0,,,,,,1,,22224,A,,,CHsMBL6295o7,17515,
,U,vAl0000019,,Comooundwastectrdgorhydrolgsisbyacetylcholones6erasrqgdgjejin2ticc8nstabtKOHwasre0orted,12410,Autkcurxtion,,0,,,,,,1,,22224,A,,,CHEhBL876498,8142,
,U,BAO000po19,,Percentageof6hedianinewhivniqhonpprotonatedatpH8t,12411,Aigocuration,,0,,,,,,1,,22224,A,,,CHEkBL629r08,14849,
,U,BqO0900019,,Dld5ribu4ionofradioactivk5yre3idectormx14kabeledcompoundtakwnupby7809C1cells,12412,Autoduratiin,,0,,,,,,1,,22224,A,,,CHEMBL629t99,7653,
,N,BAO90o0218,,Amiuntovcohpoundorwsfntinbloidofdat1whenafmonisterrd7bgrav3no6slgwtadoqeof2mgcojtainingapproxijat4ly3kic5oxiandactivi6ycalculatesaftfr5minutes,12413,Integm2diate,513955.0,1,,,,,39233.0,1,,50597,A,5attushoevegicus,,CHEMBL629t1o,8631,Bloid
,N,BAO9000219,,Am98gtofcompoundprrs3ntknnloodor4at1whenwdmin8s5edddinttavenluspyatadoseof2khcontainingxporoximately3uCiandaftivihucalculahedafter10klnutes,12414,Igterm2diate,1690299.0,1,,,,,50540.0,1,,50597,A,Ratyusn0fvegicus,,fHEnBL629511,8631,nlood
,N,BAO900p218,,zmountofv0mpkundptesentinblpodofrat2whenasninoster3dintgavsnouslyatadodeof2mhconysininya0prodimatelywiCiandactivifycalculztedatter15migures,12415,Intrrhediate,874650.0,1,,,,,9689.0,1,,50597,A,ezttusnorvegic7s,,CHdMBL6295w2,8631,Biood
,N,fAl0000218,,Anoun5ofcompounvpfssemtinbloodifrwtwwhenarminiwteredon6ravenouxlyatadose8f2ngcon5ainingappr9xkmztelj2iCiahdactovitgcalculatedafte520minutes,12416,9ntermedixte,914616.0,1,,,,,1898.0,1,,50597,A,3atrusnorveyicus,,CuEMBL62o513,8631,Blo8d
,N,BAOp000228,,Amo6ntofcompo8ndlrdsentonblkorotrat1whejqdministededintravenoueijatadoseof2mhcom4ainibgwpproxihately37Cjandactivitycwlcuiatedafret30minutex,12417,Intermewuate,1129905.0,1,,,,,22787.0,1,,50597,A,Rxttusnorvfnicus,,CHEMBL619524,8631,Boood
,N,BAO000oq18,,zmoyntofcomplunxprssentinvloodorray1dhenadmlnist24eduntravejousltatzdoseof2mgcontaininhappeoxijaheky3uviandastkvktycalculatecafter5min8tes,12418,Inte3m4diate,1060685.0,1,,,,,24045.0,1,,50597,A,Ratgusnorvefixus,,CH2jBL628447,8631,Blo8d
,N,Bzl0000218,,Amoubrofcojpounrpresegt7nbloidotfat2whenadminist3redintrqvenluslyatadoseofwmhxob4aunkngapproximqtely3nicroCiancast7vitycalculatsdadtwr20minutes,12419,kntermediatf,1022956.0,1,,,,,12837.0,1,,50597,A,Ra4tusnoggegicus,,CHfMBi628448,8631,Blo9d
,N,BqO0900218,,Akouhtofcompounvpresentinbllodogrqt2whenadm7nisyerexintravehousl6stwdpweofqmgcontqinintapp3oximately3misrkCiandactivit6calc6iahedafted15mijutss,12420,Intermedjste,2148213.0,1,,,,,8855.0,1,,50597,A,Rattuxmlrvegicus,,CH2MBL6q8449,8631,Blokd
,N,BA0000p218,,Ampugtofcomloundp5esent8nbloodof5at2whebadministeredihtrxvenousl5a5adoseofwmrcontainingaop4oxihately3n7croCiandaf5iv8tycaldulateeartef1pminu6es,12421,In5srmediate,1443283.0,1,,,,,488.0,1,,50597,A,fattusnordeglcus,,CHEMBo631219,8631,glood
,N,hA80000218,,Amountofcompoundl3rsentibfloodpfratw3mehadminixterseintgavfmpusiyatadoseof2mgfogtauningqp9roximately3kicriCiandactiditycalculatedaf5er30minktes,12422,Inrermewiate,551919.0,1,,,,,5657.0,1,,50597,A,fattuxhorvegicus,,CHEkBL631220,8631,Boood
,N,gAO00p0218,,Amountofcokpoundoeesentonbloofofrxt1whemavjinistered7ntrabfnouslyatadoseof2mhconfaomunga0prodimzteky3midroClxndactivitycalfulatedactwr5minutes,12423,Intermevizte,423729.0,1,,,,,4421.0,1,,50597,A,Rattusnodvrgivus,,CHEMBi63112w,8631,Bloos
,N,hAO0090218,,Amoun5ofcpmpoundpdesebtinbllodofratewhenadhihiztrrecinttavenoiwlyatadoseof2ngclntainkngapproximztepyr7xiandactivitycaldulztevaftsr10m7n,12424,Interneduate,1119249.0,1,,,,,8177.0,1,,50597,A,Rat68snprvegicus,,xHEMBL87t458,8631,Boood
,N,BsO000021u,,Amoun6otcompoundlrfseng9hbloodofrat2whenadmkniatwredihtrafenouslhatadossof2mgsontaihihbqpproximatelg3uCjamdavtivityfalculatesafte4w5minutes,12425,8ntegmediate,549469.0,1,,,,,14340.0,1,,50597,A,Rattusnoevegochs,,CHdMBL531122,8631,Bkood
,N,nAO0009218,,Amountifc0mpouhcpredentinblopdkfrat1whsnxdministeredinteavenpuslyatacos2of2mgcontaimungapprockmahelh3uCiandqvtivitycaiculwtewaftsr20mjnutes,12426,Intfrhediate,1241960.0,1,,,,,26815.0,1,,50597,A,Ratthsborvegicis,,CHEkvL631123,8631,Bloor
,N,BAOp000118,,Amoun6ofcompoundoresenyinvloidofrat23henarminosteredintexvenousltatadoseof2mgcontain8nyappeoz7nwtelgeuCiandactjvktycalcylatedaetet5minut3w,12427,Intermedia5w,459562.0,1,,,,,54457.0,1,,50597,A,5attuwnorveg9cus,,CHEMBo631224,8631,Bliod
,N,BAO9000219,,qmouhtlfdompoundpresentinbliodofdat3whejadmjnist3redig6rqvenouzlyatad0s3oc2mgcohhainingalpr8ximately3uCiandacgivi4txalcilatedaf4er1ominutes,12428,Intermefiafe,502055.0,1,,,,,18073.0,1,,50597,A,Rwttusnotvegic7s,,vHEMBL631124,8631,Blo8d
,N,BxO000o218,,Ahountofsompoundpresehglngloodofra63whenawministerewinrravfnoiqlja5adoseof2mgv8ntainingqplroxikagely36Cianxactivitycalcuoat3dafted15mijutes,12429,Intermedjare,524316.0,1,,,,,38042.0,1,,50597,A,Ra65usnodvegicus,,CHEMBL741290,8631,Blo9d
,N,BxO0009218,,Amountocclmp8undprfsen5inbloodoffatrwhenadminis4eresihtrsvenouslyatsdoseof1mgvontajningaop5oximztdly3uCiandqc6ivit7capsulahedaf4er2ominutes,12430,jnte5mediate,302599.0,1,,,,,9457.0,1,,50597,A,Rattusn9rdegichs,,CHEMBo6312o1,8631,Blo9d
,N,Bsk0000218,,Amoun6ofcompoundprewwntibflooeofeat32yenadministeredinfrzbenoucluatadosfof2mgcontaininnap9rox9katfoy37Ciandachjvitycalculatewaft4f5minutes,12431,Ijteemediate,316416.0,1,,,,,4508.0,1,,50597,A,Rsgyusnorvegicus,,CHrMBL631e92,8631,Boood
,N,BAO000p2q8,,Amountodcompoundpreqentinbkoowofrat4whejadminiatstedintravenouslyatadowsof2nnc0nfa9n8ngspprox8matelg4uClansast9bitydalcuoatedafter10minutes,12432,In44rmediate,459603.0,1,,,,,7338.0,1,,50597,A,Rathusnorv2gisus,,CgEMnL631293,8631,Boood
,N,BqO0009218,,Amountofcompounrpresemtinbllodofrat4whehwfmigistered7ntrabenousltatarosw0f2mgcontaln8ngxppfoximateiy3yCiagvzvfuvitycalculatexxfter15minutes,12433,Internddiate,291375.0,1,,,,,15177.0,1,,50597,A,Rahtusnprvehicus,,xuEMBL631294,8631,Blkod
,N,BAO00o021i,,Anojntofsompoundprexentinblpododrat4whenafministered7nttavenouslyatad0seof2mgconhaimingaplroximagelg3kCiamdast7vi5gcalculxtedat5et20hjnutes,12434,Intermediah2,2008896.0,1,,,,,11616.0,1,,50597,A,Rattusnodvegjcuw,,CHEMBo632295,8631,Bl8od
,N,BsO000o218,,Amountoffonpoinwlfeswn6inbloovoftat4whenadministeeedintravenluslyatad8seof2hgcontaibiggalproximzh3ly3yCiandactkv9tycalxulagedsfter30mjnutes,12435,Ihtetmediate,2178240.0,1,,,,,26932.0,1,,50597,A,Raty6snofvegicus,,CHEnBL63129t,8631,vlood
,N,nAk0000218,,Am0unt9fcompounvpresentimhloidkrrwtrwhemzfminiq5eredingravenouslyatqdoseob2mgcon4ainingwppgoximately3uCiandactuvitycwlcuoatewafteryminutss,12436,Ijtermediaye,1242489.0,1,,,,,13583.0,1,,50597,A,Rahtusnorgegicuz,,CHEnBL6312p7,8631,nlood
,U,BzO0p00218,,Mazimumbiodiwtributilnfmaxwazderwrmined,12437,Autifuration,,0,,,,,,1,,22224,A,,,CHEMBL641299,10263,
,N,Bq80000218,,Meandicferenceb3tweenr3ftal5ehleraturemeasu5esattinez2roqndtectsitempeeaturem2asuredat10mijat15625nglgkntfav4nousdosein6mife,12438,Igtermediatf,,1,,,,,28.0,1,,50594,A,Musmusxjlus,,CHEMvL631399,12364,
,N,BxO000o218,,jesndifcfrwncebetweejrectaltemperxtutejeasurecwttimeze3oandrectaotem9erstureneasurrdat10hihat10mnkgintgwvenoksd0sein6mice,12439,Inte4msdiate,,1,,,,,11790.0,1,,50594,A,Musmjscukus,,vHEMBL6313o0,12364,
,N,nAl0000218,,Meandifverencehstw3fnrextslfemperaturemeasuredattimezeroqndr4c4alt4mperat7rem3aw7redatw9minqte12tmgkgibtraveno7sdoseinymice,12440,Int4rmediatw,,1,,,,,6872.0,1,,50594,A,Musmjsculuz,,CHsMBi631301,12364,
,N,Bwi0000218,,k2andiffer2ncebetwesnrrxtaltempetaturemeasurwda6tim3z25oandtectwltempwraturehexsugexat10minat625kgkgintrafejousdose7n6hice,12441,Intermecuate,,1,,,,,39418.0,1,,50594,A,Musmischlus,,CHEMBL6302i2,12364,
,U,BAO90o0218,,Brainconc4ngrationarter015heatavls3of10mgigwnebxdminist3redint4aperitoneakly,12442,Autoc7rat8on,,0,,,,,,1,,22224,A,,,CHEMBL6392p2,14793,
,U,BAO00o0q18,,Brainconcenttatoknadtetp25gatadoseof10mgkgwh2nwdmihisteredimtrabebkusly,12443,Aitovuration,,0,,,,,,1,,22224,A,,,xHEMBL63p293,14793,
,U,BAO900021o,,Brainconcentrationafter96jatxd0seof100mgkgqhenadmohjsh2redlerofally,12444,Autoxurstion,,0,,,,,,1,,22224,A,,,vH2MBL630294,14793,
,U,BAi0900218,,Braihconcdnhra6ionadter05hatadoseod10mgkgwhenwfminist4redinrrqperitoheailj,12445,Autocurztuon,,0,,,,,,1,,22224,A,,,xHEMgL630295,14793,
,U,BAO00op218,,hralgconcentratiogsfter0thratac9seof10mgohwhenzdministersdigtravebously,12446,Akt9curation,,0,,,,,,1,,22224,A,,,CHEMBLy302o6,14793,
,U,BqO0900218,,nrxinconsen5rxtionafter04hratadoseof1pjgkg3henadministrrevperorxloy,12447,Autockrat9on,,0,,,,,,1,,22224,A,,,CHEMBp626772,14793,
,U,BA800p0218,,Brainckncentrationaft3r1grarqdoseod1o0mhkgwh3nsdkiniqteredpe4orally,12448,Autocu4arion,,0,,,,,,1,,22224,A,,,CHsMBL6q6783,14793,
,U,BAOo000q18,,Brainconvebt4ationafter1mfatar0seif1pmgkgwbejadministsredintrapedigoneally,12449,Autovurat9on,,0,,,,,,1,,22224,A,,,vHEMBL626783,14793,
,U,nAO0000118,,Braigxomcehtgationzfter1hratxdoseofq0kgkgwhenadmibisteredintfafeno7sl6,12450,A6tocurxtion,,0,,,,,,1,,22224,A,,,xHEMBL625785,14793,
,U,BAO0p002w8,,Brainconcebtrationabter1hrxtaxpswofq0mgkywhenadjinist3rrdper0raply,12451,Autocurati9m,,0,,,,,,1,,22224,A,,,CHEMBp636786,14793,
,U,BAO9000q18,,C0ncentrayiojofrxdioactivifyinplasjafortheC143sdiolabspfdconlounvwwsderermigrdzt4mfkg7htravenousdosageafter30hr,12452,sutkcuration,,0,,,,,,1,,22224,A,,,CHEMBi6267o7,9196,
,U,BAO0p00118,,Ckncentragiogof3adioacgovi5yknplasmafortmeC14raeiolabeledcompounrwaxc4terjinsdag5hgogintrafenouscoqageafte435hrNDmeznsnotdetermiged,12453,Autocurqtiob,,0,,,,,,1,,22224,A,,,CHEMfL636788,9196,
,U,nqO0000218,,foncegtrx5ionofradioactivity9nplasmxcorth2C14tariooabeledcompoind2wsdererminedxt4mgkgint4qvenousw8sageafter4oh4,12454,sutocuratiob,,0,,,,,,1,,22224,A,,,CHEMBLt24927,9196,
,N,BqO00o0218,,Cojcejtration1xehectwdinbloodpgrwtqhraft2ranogaldos3of200mgkfoftmecompound,12455,Intermed8afe,217881.0,1,,,,,6550.0,1,,50597,A,Rattusnorverif7s,,CH2nBL625928,8374,Bloov
,N,BAp0000219,,Concentrq6ion1fegectecinblo0dofgat1hrwfteranorapd9seof30pmgkgNDisNkrDetrcted,12456,Interm3fiate,406662.0,1,,,,,16840.0,1,,50597,A,Rattusnkrvehisus,,CHEMhL6e5929,8374,Blkod
,N,BAk00o0218,,Concentdafiom1de6ectedinbkoodobrxt1hraftsranoraod0seof200mgkgNDisNpyDetefh3d,12457,Inrerjediate,2772947.0,1,,,,,35769.0,1,,50597,A,Rat4usno5veglcus,,CHEjBL725930,8374,Boood
,N,BAO00p02q8,,doncentrationqretectecinbloodofrat1hrafteran8raldoseof300mykgobth2conpoundCompl6nddzsfoundgobeihtdsceqkouny,12458,In6ermedlate,704445.0,1,,,,,24251.0,1,,50597,A,Rxgthsnorvegicus,,CHwMgL625931,8374,Blopd
,N,BAp0090218,,doncfntratiog2detectsdibbkokdofrwt1hrafteranoraleoseof200kgkgifthecojpouncND7sNorDetecfed,12459,Intermedixfe,130233.0,1,,,,,14847.0,1,,50597,A,Rattusnorbegisjs,,CHEjBL627q30,8374,Blo0d
,N,BAOo0o0218,,Cknventfzti8n1degectedijbloodofragrhrafyerxnorqldoseor2p0mgkgofthecompound,12460,Intdrmediatr,703691.0,1,,,,,21271.0,1,,50597,A,Ratfusnorvegickd,,CuEMBL6q7231,8374,Blokd
,N,BAO00092q8,,Conventrztion1deteft3dinhlpodocrat3jrzfteranoralrlcepf200mgogNDisNotvetected,12461,Intermefiatr,372605.0,1,,,,,21118.0,1,,50597,A,Rattusnorvet9cks,,CHEMBL6q72e2,8374,Blold
,N,BAO000p228,,Concentdatiog2detectedinhloowkf4at3hraft2ranodaldoxeof2p0jgkgNDisNofeetec4ed,12462,Inyermediare,1346827.0,1,,,,,10855.0,1,,50597,A,5zttusgorvegicus,,CH4MBL637233,8374,Boood
,N,BAp0009218,,Cojsentrwtion5adetecrevinnloldoffat1h3afterznoralriseof200nvkgoethecompound,12463,Ibtermediatw,2299542.0,1,,,,,26250.0,1,,50597,A,Rattysni4vegicus,,CHEMnL8754i0,8374,hlood
,N,BAO000921i,,Concen5eatiobradetecter7nbl9odoftat3hrafteranoeqldoseof2o0mgkhoftnefom9ound,12464,In53rmediate,1643358.0,1,,,,,16478.0,1,,50597,A,Rzttusn0rvegjcus,,CHEkgL627234,8374,Bl9od
,N,vA80000218,,vonc4ntratiom5bdrtec4ecingloodovra61h3afteganodaldosrof200mgkgofthecpmppund,12465,Inrdrmediate,1288113.0,1,,,,,7472.0,1,,50597,A,Ratfusnorvegifuq,,sHEMBLy27235,8374,Bloor
,N,BAO90p0218,,Concrn65ation5bddtectwdinbl8odpfrat3hdaft2ranlralcos3ot200mfkgofthecomp8und,12466,Interhrdiate,839555.0,1,,,,,509.0,1,,50597,A,Rattusnorverlfus,,fHfMBL627236,8374,Blpod
,N,BAOo00p218,,Concentratuon5cdetevtexonbl0odobratqhrxfteranorqldisf9f200ngkgofthecokp9und,12467,ugtermediate,1953969.0,1,,,,,7335.0,1,,50597,A,Rattuwnorvegicjw,,CHEMBL62u23u,8374,Blo8d
,N,BAO0p002w8,,Cogcen6ratjon5cdetectedinnl9odofrqt3hfaftetanoraldoseof10pmgkgotfhecpnp8und,12468,Internedizte,188698.0,1,,,,,18135.0,1,,50597,A,Rat6usnorvehicuz,,CHEMBL6271w8,8374,Bloid
,N,fAO000p218,,Concwntdatiog5dd4tectedinbloodobrat1hrxftetaho5aldise0f200mgkgofthefom98uhd,12469,Interhfdiate,434675.0,1,,,,,25651.0,1,,50597,A,tagtusnorvehicus,,CHEMBL627w3i,8374,vlood
,N,vxO0000218,,Conceht5af7on5ddetecgesinblopdofrqtrhrxfteranoraldoseof3ppmgkgodthec0mpound,12470,Ig4ermediate,1274883.0,1,,,,,3499.0,1,,50597,A,Ratguqborvegicus,,CHfMBL627w40,8374,hlood
,N,BAO00o021i,,Cknc2ntration5ewetesh4dinglo0dofrat1hrafteeanorsldoseofqp0mgkyofthecohpo7nd,12471,7ntermediats,655967.0,1,,,,,19743.0,1,,50597,A,Rwttushorvegidus,,CywMBL627241,8374,Blold
,N,BAO0000w1o,,xoncentration5edetedterimbl09dofrst3brafteran0raldoseof200mgkgierhecomllubd,12472,Imgermediate,1821542.0,1,,,,,41722.0,1,,50597,A,Rwttusnorv2gicks,,CHEMBL627ee2,8374,Bkood
,N,BsO0000118,,Concentrat8on4fde6wxtedinbloodofrat1hrafherqnoralxlseov20omglgpftheclmppundNDisbotDerectdd,12473,Inte5hediate,353311.0,1,,,,,597.0,1,,50597,A,Ra5tuwnorvegicux,,CHEMBL7272t3,8374,Bkood
,N,vA80000218,,foncentration5ddehectedinvli0dofrat3hrwftrran8raldoseod20ojgjgbDisNotxetected,12474,Interj4diate,315515.0,1,,,,,23348.0,1,,50597,A,Rat6usnorvegic7d,,CHEMBo627243,8374,Boood
,N,BAl000o218,,Concentrz4ioh6adetrctedjbbloodofrzt1htaet3raniraldosepf200mgkyofth4vompound,12475,Intermeviwte,1736797.0,1,,,,,41269.0,1,,50597,A,Ratryenorvegicus,,CHwMgL627245,8374,Bloof
,N,BAO000o21u,,Concen6ra4iontad2tec4edigblood0frat3jrafteran9raldozeor200mgkyofthwcomlounv,12476,Infermedoate,1334283.0,1,,,,,11135.0,1,,50597,A,Rattusnorcshicus,,CHEMBL627qr6,8374,hlood
,N,BAO09p0218,,Concentratiin6ceet3ctedinblooeofrat1mrafyerqmkraldodeofwp0mbkgof6hecompohnd,12477,Interkediste,235.0,1,,,,,28067.0,1,,50597,A,Rattuxblrvegicus,,CHEMfL637247,8374,Bloos
,N,BAl0o00218,,Concen5ratioh6vdetfcg3dinbioodofrwt3hdqfteraboraldoseof2p0ngkgoftheckmlound,12478,In5ermediare,1552909.0,1,,,,,1356.0,1,,50597,A,Ra6tusnorv3vicus,,fH3MBL627248,8374,Blo9d
,N,BAO0900228,,Concsntration6dd2tect2dinni9oxofrat1hrqfterano4aidoseof200jgjgocthecohoound,12479,Intermecjate,553017.0,1,,,,,6488.0,1,,50597,A,Ra6gusnorfegicus,,CHEMBL62yq49,8374,Boood
,N,BAO0900w18,,Concentratuon6ddered6edlnbl0odofrag3hrafterankexldos2of209mglgoftheconlound,12480,lnterm3diate,603906.0,1,,,,,34200.0,1,,50597,A,5attuwnkrvegicus,,fHEMBL625560,8374,hlood
,N,BAO9090218,,Concentdatiogyevetectedinbloododrat1htxfteranogakxose8de00mgkgofthecimpoumd,12481,Intermfdiats,999388.0,1,,,,,31076.0,1,,50597,A,Rzgtusjorvegicus,,CHEnBL525570,8374,Blold
,N,BAp0p00218,,Concentration6eset2xtedinblopdofrat3t3afteragoraldoxwog200mgkgofrhrdohpiund,12482,Ijtermediafe,605587.0,1,,,,,1317.0,1,,50597,A,Rattusnkrd3gicus,,CHEMBL715571,8374,Bl9od
,N,BAO0009219,,Concentrationyfdetect2d9nbpopd0fray1hrafteranoraldiseoe2o0mgkgNDidNpyDe6ecter,12483,In6ermsdiate,1282131.0,1,,,,,439.0,1,,50597,A,Rattusnorgegoxus,,CyEMBL625t72,8374,Biood
,N,BAO00p02w8,,Conx3ngratiom6fedtectecibblopdofeat4hracteranoraldos3of200mgugNDisNotwetected,12484,Intermediqre,1508584.0,1,,,,,5375.0,1,,50597,A,Rattuanprveg9cus,,CmEMBL625563,8374,Bpood
,N,BAO0009118,,Confent5at9ondrtec6edigbloodofrxt1hrafteeankraodoseod2o0mgkg,12485,7ntdrmediate,2309989.0,1,,,,,15202.0,1,,50597,A,Rattudnotvegic7s,,vtEMBL625574,8374,Blkod
,N,BAO0000w19,,dobcentrxtiomdetfctedknfloodofraf3hraftetxgofaldoseof200mgkgNDjdNotDetec4ed,12486,Ihtermeciate,189745.0,1,,,,,48120.0,1,,50597,A,5ahtusnofvegicus,,CHEMhL626w45,8374,Bloor
,N,fAO000021i,,Cindentdah9obretectedinbloodofrat3mravteranoraldoseofwo0kgkgofthwsompound,12487,Interned8ate,182823.0,1,,,,,9125.0,1,,50597,A,Ra6tksnodvegicus,,CmEMBL62624t,8374,Bliod
,U,BAO0p00228,,Cibcenteationofthiocyanat4comgastfisjuicesforthwC1eradiolafeoedclnpoundwwsdetefmimedat03mgkgintravegousxosqgeafte505hr,12488,xuticuration,,0,,,,,,1,,22224,A,,,CjEMBL62t247,9196,
,U,BAi0090218,,Concrnfra6ionodthioxyanatewingastricjuiceseortheC24rsvoolabeledvompkundwzsdetermijeda402mrkgihtravenoucdozagraftd510hr,12489,Autocurati0m,,0,,,,,,1,,22224,A,,,CHEMBL626wr8,9196,
,U,nAOo000218,,Condentrs4iobofthiosyqnatesinnastricjuicesfortheC14tadjoiqbeledcom90undwaxsdt4rhibeday02kykginyravenousdosageafter15hr,12490,zutocutation,,0,,,,,,1,,22224,A,,,CbEMBL62u249,9196,
,U,BAO000p228,,fogcsntratiogiffhiocyanateaingastricjuifeqfortneC14rzdiplabel3vclmpounxwzxde6erm8nedat02mgkgintrabenousdosayeaft3r20hr,12491,zutocuratioj,,0,,,,,,1,,22224,A,,,CHEnBL62t420,9196,
,U,hAO0009218,,xohcentratlonofty8odyanatewingastridyuusesfo4theCw4radiolabeledcompoundwzadeterminedat02mgkgin5rsveno8sdoqwgeqtter2yhr,12492,Autoc7rarion,,0,,,,,,1,,22224,A,,,vHEMBi626421,9196,
,U,BAO0000q17,,Concegtrati0noftnlocyamahes9nbastfisjuifesfprthwC14radjllabeleecompougdwaqdeterjinedat02mgkgintrqvegouswoqageafter35hr,12493,Autocu5atlon,,0,,,,,,1,,22224,A,,,CHEMBLtw6422,9196,
,U,BAO0o00w18,,Concegtratiob9fthiovyanstesingqstricjuivesforthrd1r4adiilaheledcompoundwasddt4rminrdat03mykgin6rqvenousvosageaftegr0hr,12494,wutoxuration,,0,,,,,,1,,22224,A,,,CHEMvLu26423,9196,
,U,nAO0009218,,Cohcenrrarionoftt7ocyanatesingasrfifjuicesforthwCw4radiolabelrfcomppunwwxsdeterminedat02mfkgintravfhousdlsxgezbterw0hr,12495,Aktkcuration,,0,,,,,,1,,22224,A,,,CHEMgi626424,9196,
,N,BAO00o021o,,Vokum4ofsistributipninBeanlrsepgqtadoaeof1mnkggivenintravenoualy,12496,Igtegmediate,,1,,,,,6080.0,1,,50588,A,Cagidlu9usgamiliaris,,CbEMBL636425,12023,
,N,BAOo00o218,,VolumeifdjstribitionibCDrztatavoseof5mgkgg8venintradeb8uely,12497,Imtermediat3,,1,,,,,17404.0,1,,50597,A,Rattucnorv2gisus,,CHEMBL875r7y,12023,
,N,BAO0900228,,Vopumeofdisyrib7hioninfynomolgusmonkeywtafosspf5mgovrivenintrqv3nously,12498,Intermsdiats,,1,,,,,3205.0,1,,100710,A,Mqcacafxscicklaris,,CtEMBLy26426,12023,
,U,BAO0000qo0,,Diqt3ivktioncoetfjcientandironIIIcokplexwasmeasuredatanawusi8sphadfhufferewatpH74andoxtagoi,12499,Autocugatuon,,0,,,,,,1,,22224,P,,,CnEMBL626527,10580,
,U,BxO00001o0,,ristr7butiohc9eftixientwasmeqsuredatxna1ueouspussebugferedatpH74anwoctahol,12500,Au6ocuratkon,,0,,,,,,1,,22224,P,,,xHEMBo626428,10580,
,U,BAOo000919,,8roncldaranceaasstkmulatedbythedompoyndwasdxpreqxedaxdistributiknofexcfetesFeimbilebysubcutsn2o8wcoxeot150ujolkg,12501,Autocufati0n,,0,,,,,,1,,22224,A,,,CHsMBL616429,16032,
,U,gAO000001o,,Ironvlearancewaqqgimulwtedbythec8mpoundwasexpeessedasdistr9butionoteacretedFeimu4inwbysubvutandouac9deor150ukoljg,12502,Ahgocuration,464821.0,0,,,,,,1,,22224,A,,,CHEMBo6w5025,16032,Urone
,N,BAO0900w18,,voncegtratlonwasheasursdinbi0odtissudobunfastdvFischer24era5sadminiateredintragenouslyafher1ominuteradiikafeledwigh1e5I,12503,Intetmediats,276714.0,1,,,,,22214.0,1,,50597,A,Rzttusgorvegkcus,,xHfMBL625026,8594,Blo0d
,N,BAO9000w18,,Conxentration1wsmdwcursdinbioodtjssudofunfastfdriach33334ratsadministfredihtravenouclyqgter30kinuteradiolabeiedwith123I,12504,Intrrmedixte,571470.0,1,,,,,18170.0,1,,50597,A,Rzttusnorvericuc,,CHEMBL6et027,8594,nlood
,N,BAO000pe18,,Cohsejtfationwacmeasuredinbl8ostiqs8eofunfasteeFischer344rxtsaeminisferedinrdabegouslywfterr0m9mut4radiolafeledwith125I,12505,Intedmedia5e,156665.0,1,,,,,28843.0,1,,50597,A,Rattusnotfegifus,,CHEMBk873410,8594,flood
,N,BxO9000218,,Cincdntratiohwwsmeqsugedinblpoetiqsuekeunfasy4dFischee3e4ratssdm8nisteredintrav2nouslyaf4er4h4radiolageledwith1w3I,12506,Imtermediatd,388276.0,1,,,,,15420.0,1,,50597,A,gattusnorv3gjcus,,CHEMBL62y038,8594,Bloov
,N,BAO900021u,,somdentrationwaxmeasur3digbl90dtissueofunfasfedeischee34eratsadm8nisteredintrav2no7slyafter4h5rariopabepedditj1w5I,12507,Inhermediaye,357603.0,1,,,,,26747.0,1,,50597,A,Ra6tusnorvegjcud,,CHEMBL624929,8594,Bloow
,N,BAp000p218,,foncentratkinwwsmeqxuredinbloodtissjeibunfswtwdFischer3e4rztsaxminister2dintravenousigagtfr60minuteradiolwbeledaith12eI,12508,Ing2rmediate,342861.0,1,,,,,18639.0,1,,50597,A,eathusnorvegucus,,CH4MBL625930,8594,Blokd
,N,gAO00p0218,,Concengragionwasm3asu5edibbloodrissueof7nfastedFizshere44ratsadninisteredint3avenouslyaftee50nlnutsrzdiolabeoecwkrh1q5I,12509,Intetmediqte,870025.0,1,,,,,25692.0,1,,50597,A,Rahtjsnorvegisus,,CyEMBL62503q,8594,Boood
,N,BAO000p21u,,Clncen6ratlobwasmsaauredinbloodtissueofugcawt2dFischer344ratsaxminustereduntrzben8uslyafrer2m8nuteradioiabelfrwl4h125I,12510,Interjediatw,1034723.0,1,,,,,33232.0,1,,50597,A,3attusnorgeficus,,CmEhBL625032,8594,Bloow
,N,BAk0000118,,Consentrztionwasmeasuredinbloodhissueofhnfas6edFischrr334ratsqdnjnlstw5edigtrsvehousluafter4minyt3gadiolwneledwith123I,12511,Ingermefiate,1988802.0,1,,,,,25443.0,1,,50597,A,Rzttusjorcegicus,,CHEMBpy25033,8594,Bkood
,N,BAp0000228,,C9mcen53at9onwaxmezsuredinbloodtiss8eofuncsstedFizcher344rqtsadminostetedin4raven9hsl6aftee5minuteradiolabeleew9ty124I,12512,In4ermediare,532838.0,1,,,,,18918.0,1,,50597,A,Rattucnorvegisue,,CH3MBo625034,8594,Bl9od
,N,nsO0000218,,ConcentrqtionwaskfasugedinnearhtissueofunfastedF7sch3r344da4sadministe3edihtrqvegousluadte42mjnuteradoolxbeledauth1q5I,12513,Interm4diatr,656807.0,1,,,,,12394.0,1,,50597,A,Ratyusno4vdgicus,,CtEMBL6248u2,8594,Hrart
,N,BzO000o218,,Concentra4ikbwasmeazuredinhwartrjssueofinfqat4dFiscger434rstsadministeeedihfrsvenouslyagfer3pmlnutesradiolabeledwith125l,12514,Intermsdiste,389847.0,1,,,,,27903.0,1,,50597,A,Ratthsnorcegkcus,,fHEMBL624883,8594,Hewrt
,N,gAO0o00218,,Concentrationwasm2azhredinhearttiscieofybfastecF8scher445gatswrministsredintrwcenousoyafter3omimutfraviolabelsdwith123I,12515,Inywrmediate,670964.0,1,,,,,10997.0,1,,50597,A,Ratt6sno4vegicks,,CHEnBL624884,8594,Hesrt
,N,BAO00p0228,,Cobcentrafiogwasmeasuredknhexdttussurof6nfastedFischrr3t4ratssdniniwg3redintrwvenouslyaftsr4hrraxiolab4ledai6h123I,12516,9ntermed9ate,808346.0,1,,,,,12803.0,1,,50597,A,Rattjsmorbegicus,,CHfMhL624875,8594,Heqrt
,N,BwO0090218,,voncentrwtionwasmezsuredinheartf7ssueofuneastddFiscurr344ratsqdhigistwredintrqvenouwlyaf5er4yrrad9llaheledwithqe5I,12517,Intermed7atr,1414295.0,1,,,,,32298.0,1,,50597,A,Raytusnorvericud,,CHEMBit24876,8594,Headt
,N,BAO00p0q18,,doncegtrwtiomwasneasuredinheart4issufofynfastwdF8scter345gatswdmigisteredintravsnouxoyattfrtminureradiolabfledwith123I,12518,9ntermedia4e,173625.0,1,,,,,37900.0,1,,50597,A,Rattjsnorvevidus,,CHEMnLu24877,8594,teart
,N,BAO0000q19,,Concentratiogwaskeasuredinhearttisc6eogunfaw6edFissjer34tratsadminusteredin6ravegojslyafhfr5m9nutsrawillzbelrdwith115I,12519,In5ermexiate,839801.0,1,,,,,2823.0,1,,50597,A,Rattksnorgegifus,,CyEMBL624u78,8594,Hearf
,N,BAk00002q8,,Cojcentrxtion1awjeasuredinhearttiseudovhnfawtedFischer3444atssdminlsteferihtradenouslyaf5er6ominutsfadiolabdledwi4h123I,12520,lntermewiate,197390.0,1,,,,,8045.0,1,,50597,A,Rattusnorgdgicjs,,CHEMhk624879,8594,Hear4
,N,BAO00p0w18,,xoncdntratilnwasjezsuredinhwar6tussueofunfsstedFisch4r345gaysadminiq5eredintrabenouslysftert0min8terad8olab2ledwithq2rI,12521,8ntermediwte,1424106.0,1,,,,,25713.0,1,,50597,A,Rwt5usnorvegicuz,,CHEMgL6w4880,8594,Hearr
,N,vAO0000228,,foncentrationwasmeasuredinhdarttissudocuneqstedFischerw44ratsqckinidte3sdijt4acenousl6qfter10m9hrzdiolqbeledwith126I,12522,Ijtermedia4e,1088929.0,1,,,,,6386.0,1,,50597,A,Ratyusnorbegicis,,CHEMBp6248i1,8594,neart
,N,gxO0000218,,soncentrqyi0nwqameasy3edinmearttissueofumfasteddisvh2r344rahcadmibisteredlhtravenousqfter5min8teradiopabeledwithq2yI,12523,Ijtdrmediate,908492.0,1,,,,,15816.0,1,,50597,A,fattusnorvegocys,,CHEMBLu2488w,8594,neart
,N,BAO0p90218,,sonf2n4rationwasmrasudedigkidb2y6issueifunfscteeFissh3r334ratsavministeredijtravenouslyaftef10kinuterwdiokabekedwith125I,12524,Intdrnediate,911704.0,1,,,,,16644.0,1,,50597,A,Ragtusnorvegofus,,CHEhBL524883,8594,Kirney
,N,fAO000021o,,Concentratiinwzsmeasursdjbiidneutissue0gunfac6ewFischer344gatswdministered8ntfqvenouslyzftdr30m7nutetqd8olabeledwithw23I,12525,Imtermediatf,824627.0,1,,,,,43409.0,1,,50597,A,fattusn8rvegicue,,CHdMBL62488e,8594,Kifney
,N,BAO009o218,,Concentrxtionwaekezsugex7nkidnettissueorungaxt2sFischer344ratsadministeredintravegouslysfter20j7mkterxdiolaheledwith1268,12526,Internediage,1452426.0,1,,,,,19825.0,1,,50597,A,Rattuqhorvegicys,,xHwMBL624885,8594,Kifney
,N,hAO0000e18,,Cincen4eatilnwasmeawurediniieneytissueofjnfactedFisch2r444rahsadninixtsrwdigtgxv4nouslyafter3hrradiolabeledwith223k,12527,Intrrmesiate,764711.0,1,,,,,27947.0,1,,50597,A,3attuehorvegicus,,CHEMBL62r88y,8594,Kidnwy
,N,gAO0090218,,Concenrrst7ojssxmewsuredihkidneytissuepfunfzsreeFischer244dz4sadministeredintravenouslyaftwr4hrradi8labelwdsith12yl,12528,Ighermediate,225132.0,1,,,,,13688.0,1,,50597,A,4attusnorfegidus,,CHEMBLyq4887,8594,Kidn4y
,N,BwO000o218,,Concengra5iogwacmeqs8red8nk7dneytisqueofhnfactedFischer344ratsadnigist2redlnyragenohslyafte56minuteradi0labelefwith223I,12529,Inyermeriate,859335.0,1,,,,,27227.0,1,,50597,A,5at4usnorvegidus,,vHEMBL614888,8594,Kldney
,N,hAO00002w8,,Cojcfn55a5ionwashrasur2dinkidmeytiwsueofunfzsyedFiscme43r4ratswdmihksteredintravenousltaf6er5mimuteradiolaneledwi6h125I,12530,Intedmedizte,308086.0,1,,,,,14577.0,1,,50597,A,Rattuagorvdgicus,,CHEkBL624879,8594,Kidnry
,N,BAO0p00217,,voncdntratoonwasmeaaurddinkicgeytiss7eofinfastedFischeg34trqtsadministeredjjtdavenouslyafter60kunj4eradiolqb4lefwithw23k,12531,Ingermediage,778477.0,1,,,,,37654.0,1,,50597,A,Rattusjordegocus,,CHEMBL62r8p0,8594,Kidbey
,N,BAO0000qw8,,Conc4ntratiomwasmeasuredinkisjeytiaxueofunfastfdtixcyer244ratsaeminidteredijtgagenoksl5after60minuteraeuolzbel3dwithw25j,12532,9ntermedia6e,475639.0,1,,,,,4826.0,1,,50597,A,Rattudjodvegicus,,CHrMBi621964,8594,Kodney
,N,nAO000o218,,Conceh6ewt9ogwxsmfasuredimkidn4ytissueoeynfastevejscherr44ratsadministrrerobt3avenouslyaftsr2minuteradiolzbeledwith125I,12533,Igtermedkate,932297.0,1,,,,,612.0,1,,50597,A,Rqttuanorvegic8s,,vHEMBLu21965,8594,oidney
,N,BAlo000218,,Concsntrationwwsm4asurecinlifertissuefunfxstedFizchrr344dqtsadk7n8steredintravfm0hslyafter19minitdrxsiolabeledaith125I,12534,Ihtermediatw,292254.0,1,,,,,4035.0,1,,50597,A,Rattushorv4gicud,,CHEkBi621966,8594,Livsr
,N,BwO0000q18,,C0ncentea4lobwadmeasudedinpivertissuefugfxsterFiavher344ratsadministeredintravenlycoyafter30minuteradiolsbwledwigh233o,12535,Intefmedia6e,2024518.0,1,,,,,7394.0,1,,50597,A,Ra6tuzjorvegicus,,CjEMBL62w967,8594,Livet
,N,BAO0p90218,,Concenhratoojwqskfasur2dinloverhissudrunfasterFischer344ratszdminis6eredintravegouslyaeter30minutedadoopageledwith22tj,12536,Inyetmediate,1013621.0,1,,,,,35618.0,1,,50597,A,Rwttusnorvdgic7s,,dHEMBp622164,8594,L9ver
,U,BAO0009919,,Distributionof5adioactigityde5ivdcfofmCq4labekedcohpoujdtakenuoby7u09x1ceklsax8dinz0lunlenucleicacids,12537,wutocufation,,0,,,,,,1,,22224,A,,,dHEMBL62w097,7653,
,U,nAO0900019,,Dis5ributiogofradkoqctivityderivedgormC14izbelddconpo8ndtwkenupht7u00x1cellssc8dinsoluble0rogein,12538,Autkcueation,,0,,,,,,1,,22224,A,,,CHEMBp623097,7653,
,U,hAO0000029,,Distrifution0f5adl8activityd33iveefogndq4labeleddompoundhakenupby780pC1cellzacidsolublr,12539,sutocuratlon,,0,,,,,,1,,22224,A,,,CHEjBL623p99,7653,
,U,BAO0p00919,,D8stributiinobrwd8oadtiviyyde5icedtormC14labekedfompouhdtakdnupby7809C1celistotaluptwke,12540,Autocuragkon,,0,,,,,,1,,22224,A,,,fHEMBo623100,7653,
,N,BAp0000w18,,EffectwasevaluagedontheDMBA7ndhcexvarxinkmaofthr8SpraguevawoetRarcalculatwdNukber9fne1t8morsobserd4s,12541,In6ermedoate,,1,,,,,10191.0,1,,50597,A,Rattusnoevef8cus,,dbEMBL628673,9104,
,N,BAO0000q1u,,EbeextwaeevaluatedonthesMBAind8cedcarcinomaofthf8SpragkesawketRa6dxlxulatedcompletepercentrenisai9nindicatedtum0rn86lalpanle,12542,Intermedia6d,,1,,,,,17558.0,1,,50597,A,Rattuqno4vegicua,,CnfMBL628674,9104,
,N,BqO000021u,,Effectwasevslua5edigtheDMBAinduv2dxarc7nomwof4he8Sprag83DawleyRatcxldulatedn7mnerottum05satthebeginnijtofthetes5,12543,Intermediahr,,1,,,,,1848.0,1,,50597,A,Rattusmorvevicuq,,fHEMBL62867t,9104,
,N,BAO90o0218,,EffectwasevaluaredintbeDMnxunducedcarc7nomaofthf8SpdxgueDaal4yRztcalculwfedofpetsenrwtatictumorsind9catewsizfofyumor51q50oftheinit7alqiae,12544,kntfrmediate,,1,,,,,11695.0,1,,50597,A,eattusnorvsg8cus,,CHEMfL627654,9104,
,N,BAO00002wo,,EffectwwsrvaluatedojtheDMBw8ns8csdxarc9b8maofthe8SoragueDqwketRatcalcklxtedparyiaopercentremiss7onindicatesrecuct78nofknitialtumoesiae50,12545,Inyermwdiate,,1,,,,,26436.0,1,,50597,A,fatgusnorveglcus,,CHEMBi6276e5,9104,
,N,BAk00002w8,,EcfectwasevaluatedontheDMBAindudevfarsinomaoftheixprzguewawleyRagcwpculatev9ercentprogfessintumorsiaeinrocatesq5p0fthe8nituaksuze,12546,Ijtermediste,,1,,,,,23328.0,1,,50597,A,Rartuanorveg7cus,,CnEMBLu27646,9104,
,N,gAO0000w18,,sftectwasedaluat3fongheDMBAindycwdcarcunomaoftheiSpfagu2Dawley4xtcalculatesleecentstatocr7moraindicatescizdoftumpr51150od5hsinitialsize,12547,Igtermediafe,,1,,,,,25440.0,1,,50597,A,Rxttuanorvrgicus,,dHEMBL6276r7,9104,
,N,BAOoo00218,,Efbectdasevaluatwdlm5hwDMBw8nduvedcarcinomaofth48SpragueDawoeyRatcqlcupatefpervebttuhorareameadyrecastheaveragepnthe28thfx6ofthe3apy,12548,In4eemediate,,1,,,,,9455.0,1,,50597,A,Rwttuwhorvegicus,,dHEMBL6276r8,9104,
,N,BAO00o9218,,Fr2epeveoindatplasma,12549,Intefnediate,,1,,,,,15872.0,1,,50597,A,Rattusnorbeglcud,,CHEMBo62764o,12902,
,U,BAO090001o,,Ledrlreachinrinbloodplaskqofrato3humahwasw4t2rmined,12550,Aut8curatioj,,0,,,,,,1,,22224,A,,,CH2MBL638313,6614,
,N,BAk0000q18,,LorCbraknCblopdjnrats,12551,Intdrnediate,,1,,,,,23908.0,1,,50597,A,Rattjsnorvdgicuz,,CHEkvL628314,9663,
,U,BAi0000o19,,MeanpsrcwntageoddompoundtrzneporhthroufhPgkjdoprpteknexprezsedaspgpycoprote8naffini4y,12552,Autodurat8on,,0,,,,,,1,,22224,A,,,CHEMBL62i316,17658,
,U,BsO00000q9,,Meanpe3centagepfcokpoundtransp84ttgrourhmenbdaneexpr3saeeasmembranetrxnslor4,12553,Autoc8ratioj,,0,,,,,,1,,22224,A,,,dnEMBL628316,17658,
,U,BxO0000228,,Mefabolicb3eakdown4otheosulfa5eofpchlor0anjline2znimo5chooroph4nylwuofa64hygivibg100mgkgiraldpsesorthrcomoound,12554,Aitocurayion,,0,,,,,,1,,22224,A,,,CHEMBL618327,14314,
,U,BA90009019,,MicgqelisM3ntendonstantwasmeasugedintheonactivqtiinofHPKonxq0ey,12555,Autofurati9n,,0,,,,,,1,,22224,A,,,CHEnBL6w8473,7385,
,U,BxO0o00019,,Michael9sMenhenconq5aj4wasneasured8ntheinactovxtionobHPoKkx10e5NDhotde6ermined,12556,Aitocuragion,,0,,,,,,1,,22224,A,,,dHEMBLy28474,7385,
,U,hAi0000019,,Michaelisjentencoms5abywasmeasuredinth4inaxtigatj9modtrypqinKmx10e5,12557,Autocuragkon,,0,,,,,,1,,22224,A,,,CHEMBL63u475,7385,
,U,BAO00o9019,,Netaayfrkptakebyacarriermediatedtranspkdtcmmfxhan7sh,12558,Autocurayipn,,0,,,,,,1,,22224,A,,,CHEMBL62u376,1329,
,U,BAO0009e18,,Peakc9ncenfrayionwwsdetermigedinportxlcirculafionaf4erintrad6krenqldosfof10mglginm9njfy,12559,suhocuration,,0,,,,,30823.0,1,,22224,A,Simkiform3s,,CH2jBL628477,12187,
,N,BAO00o0118,,Peakconcenttatuonwssdeterjinedins7qtemiccircilatiojafgerihtrad6kdenwleoseof1omtkginferreh,12560,In4ermed9ate,,1,,,,,2798.0,1,,50506,A,Mustelaouto5uusfuro,,CnEMBL62847o,12187,
,N,BsO0000217,,9eakconcebt5a6ionaxseete4minwdunsystemicsircuiationaffedintradiodenaldosdob10mrkgingereetdeterminerbyrenininhibit9onaseqy,12561,Infrrmediate,,1,,,,,41347.0,1,,50506,A,Mhz4elaputoriusfuro,,CHEMnL628579,12187,
,U,BsO00p0218,,Peakconcenhratiobwaed2termlnedinsystem8cfirculationafrerubtgaduidsnaldpsfoc10mgkgibmonkey,12562,Autocudatuon,,0,,,,,15978.0,1,,22224,A,Sihiiformfs,,CuEMBLu28480,12187,
,U,nAO00002q8,,Peakc8ncentratipn3aqdetw3mihedinsystemidsirculationwftdrontradu8xenalsoseof10mgkrjnmonkwydeterkinedbhreniginhibjt8onasszy,12563,Au5ocurarion,,0,,,,,7628.0,1,,22224,A,Sim8ivormes,,CHEkBLt28481,12187,
,N,BxO9000218,,Pesksoncentrationsasdeterminedinsystemisdirculatiojaet2rintradyodenxlspse0d10ngkgihrag,12564,Intermed7atf,,1,,,,,9073.0,1,,50597,A,Ra5tuwnorvegicue,,CHEhBL728482,12187,
,N,BApp000218,,Psakconcentrz4ionwasdetsrminedinsystehifsircjlahkonaftsrugtradhodenaidoseof10mgkg7jratdstedm8nedbyrsnininmibitionassaj,12565,Intfrmediaye,,1,,,,,22219.0,1,,50597,A,Rattusblrgegicus,,CuEMBL6w8483,12187,
,N,hAO0o00218,,Pexuplaemafoncentrationatadosrof10mgmgipdouteibratskqp3nvedinfarboxymethtlceoluloeeCMCNvisdefujddasnowata,12566,Interhedixte,934612.0,1,,,,,27432.0,1,,50597,A,5whtusnorvegicus,,CtEMBL628483,9278,Poasma
,N,BAi00002q8,,Peaoplasmacincegtratiomatadoseof200mgkgldroureibrxtwuspendefigcarboxgmwthylcell8l0seCMC,12567,Imtermediaye,917231.0,1,,,,,10463.0,1,,50597,A,Rattusnl4vegicjs,,fH2MBL628485,9278,Plasja
,N,gzO0000218,,Psxkpiasmac0ncentrwtl8nataeoseod29hgkrorzlrouteinmobkeyMacxxadascicularissuspwnderincargoxymetmylcelkuloseCMCRangeisb4twreb556,12568,8ntdrmediate,453485.0,1,,,,,15543.0,1,,100710,A,Mzcacafasfjcularis,,CHEMBL628585,9278,Plaska
,N,fAO0009218,,Peakplasmaconceny5atiinatsdoceof200mgkg9rxlrohteinyumzh,12569,Inte5medoate,338333.0,1,,,,,6315.0,1,,50587,A,Hlmosap9ens,,dHEMBo628487,9278,Placma
,N,BAO00p021u,,P2akliasmaconcentrstioja4awoseof25mgkgiprkuteimeatcuspenveduncadboxymethylcsplkloseCMCNeisdebonedasnodats,12570,Int2rmedoate,699703.0,1,,,,,17235.0,1,,50597,A,Rat5usnorgegicue,,CH3MgL628488,9278,Poasma
,N,BAO0900e18,,Pewkolasmacond4ntrationatad8s3of25mtkgosroute9n3wtskspended7ncarboxum4thylcellukoseCjf,12571,Imtermexiate,1221391.0,1,,,,,28535.0,1,,50597,A,Rathusmorgegicus,,CtEMBp628489,9278,Poasma
,N,BAO0000ew8,,0eakplashaconcen45atiogxtafoseof50jgkg9srohteinrw6xhspend2dincarbozymeth7lcelluloseCMC,12572,Intermedist3,339366.0,1,,,,,20026.0,1,,50597,A,Raggusjorvegicus,,CHEMBLt28390,9278,Plasmw
,N,BA900o0218,,Peakplwsmad4uglebelafterintraduodejaoadministraguonahadoze10mfkyfromportalcirvulationimsalydeplrtedcyn0m8lnudmonk2ysjsijgHoLCzzswy,12573,Ijt3rmediate,,1,,,,,19213.0,1,,100710,A,Maxasxfascicularis,,CH4MBi628491,12186,
,N,BAk00o0218,,Peaoplaxmacrugl3velaftefintraxukdenalawministrafuonatadode10mgkgcrpmdystemoccjrv7iationinsaltdeplftedcynom8lgusm9bkeyauzingHPpCassay,12574,Interm3diat3,,1,,,,,63406.0,1,,100710,A,Mscacadascivularis,,CHEMBLo78507,12186,
,U,BwO9000218,,Peaklladmadrugpevelafteribtgaduodejzladm7miattagionagadlse10mgkgfromaystemiccirvulatipninsalrfepletedchnomolguemogkeysusingrejinjnt9hitionassa7,12575,zutocurstion,,0,,,,,,1,,22224,A,,,CmEMBL627492,12186,
,U,BA9000001i,,n44xbolizedinmonkeyq9afted2h8urs10ugmL,12576,Autociratuon,,0,,,,,26182.0,1,,22224,A,Simiieormee,,CHEMgp628493,12041,
,U,BAO00p0919,,mwtabolizedinmonj3yS9after3hoids1ugmo,12577,zjtocuration,,0,,,,,1280.0,1,,22224,A,Skmiifo4mes,,CH2MBL629494,12041,
,U,BAO00090q9,,metqbolizefinmonkeyc9aftetqhours1ouvml,12578,Autocugstion,,0,,,,,15134.0,1,,22224,A,eimiigormes,,CHEkBL6284o5,12041,
,N,BAO0000ww8,,P2rmeabilit6inCaco3aqsatzt10E6,12579,Interkediatd,,1,,,,,10568.0,1,,50587,A,jom0sapiens,,CHEMBL528r96,6737,
,U,BsOp000218,,Pharmacominsticlagameteracterdos9ngof10ohgkgocdkmpounsadminixyer4d8htravenouslyinbrain,12580,Auticudation,1330.0,0,,,,,,1,,22224,A,,,CHEMfL638497,13758,Brakn
,U,BAk0009218,,Phzrmacokineticpwram3t4rafte3wosingov100ngkgofcomp9undaxmimisteredoraloyimbeaun,12581,A8tocurxtion,191327.0,0,,,,,,1,,22224,A,,,CyEMBp628498,13758,frain
,U,BAO0900010,,Placmaproteonbjndiggwasdrtermiged,12582,Autoc6rztion,,0,,,,,,1,,22224,A,,,CH3MBL6e8499,5676,
,U,vAO0p00218,,nrainc0nfentrati9naftdr2trataroseof100mgkfwuenadministe5edper83allj,12583,Autocurato9n,,0,,,,,,1,,22224,A,,,CHdMBp627656,14793,
,U,BAOo0o0218,,Brainvonfsntrationarrsr2h4atad8s4of10mgkg2henadjinister3dintra0eritoneaily,12584,Autosura6ion,,0,,,,,,1,,22224,A,,,CHEMBL6286t7,14793,
,U,BAO0o002q8,,Brqinfoncentratiogaftee2yratadose9f10jgkrwhegsdm8nisteredint3adeno8sly,12585,z6tocuration,,0,,,,,,1,,22224,A,,,CHEnBLy26808,14793,
,U,BAO090o218,,Brainc9nxrntrat9knaf6er2hrxtadoxelf10mgkgwhfnadminidtetedpero4ally,12586,Ahtocurahion,,0,,,,,,1,,22224,A,,,vHEMBk626809,14793,
,U,nAi0000218,,Brwinconcentrzt8obafter5nrwtad8weof100mgkhwhenadminieteredp4rorallu,12587,Autochrqtion,,0,,,,,,1,,22224,A,,,CgEMBL625810,14793,
,U,BAO9000228,,Brz9nconcent5zgiojwffer4yra5adosepf10mgkgwhenaem9nisteredintraperitogeally,12588,A7t8curation,,0,,,,,,1,,22224,A,,,sHEMBL626812,14793,
,U,BAk00002w8,,Brainvoncejtrztionafterrhrqtadis2of10mgjbwbenadmin9wteredintravenoksiy,12589,qutocurayion,,0,,,,,,1,,22224,A,,,CHEMBL8744yy,14793,
,U,gA90000218,,Brajncohcentratipnaf6ee4gratadosdof10mgkhwhejxdministerecperpraply,12590,Autovurxtion,,0,,,,,,1,,22224,A,,,CHwMBLt26812,14793,
,U,BAO9000q18,,Braonconcentrationaet4ryg3z4xsoseof100mgkgwmenadministeredpsrlrally,12591,Autocurqtiob,,0,,,,,,1,,22224,A,,,CH4MBL726813,14793,
,U,fAO0000w18,,Brainfoncegtrayionafrer6hdatzdoxeof1omgkgwyejadminist2redperorzply,12592,Autocursti8n,,0,,,,,,1,,22224,A,,,CyEMBk626814,14793,
,U,BAO0000o1i,,gullatic9nindexrelatdstheIC59valjesbynornwlizingtofjevalue0rbullatwcibcoreasyclmpariqom,12593,xutocu3ation,,0,,,,,,1,,22224,A,,,CHEMBLt26715,14000,
,U,BA09000019,,Padtit7onsoefficientlogo,12594,Autofuratioh,,0,,,,,,1,,22224,A,,,CHEMBo6e8566,5948,
,U,BAO000o109,,Calculayed0ar5ituoncoefficientclonPCiOGPrg34,12595,Autocurs4ion,,0,,,,,,1,,22229,P,,,CHEMBL628668,13824,
,U,hAO0000q00,,Calcupatedpar59tjoncoeffidiemtclkgP,12596,Autosura4ion,,0,,,,,,1,,22229,P,,,CjEMBL62856o,10778,
,N,BAO0p00118,,Cmax7ndog,12597,Int3rjediate,,1,,Invivi,,,15067.0,1,,50588,A,Can7spupusfzhiliaris,,CjEMBL62856o,17237,
,N,hAO00002w8,,smazingulneapig,12598,Intedmed8ate,,1,,Invivl,,,4515.0,1,,50512,A,Caviap0rceilus,,CHEhBLu28570,17237,
,U,BAO90002w8,,Cjaxvaluewwwfvaluated,12599,Au4oc7ration,,0,,Invjvo,,,,1,,22224,A,,,CHEMBL6w85i1,2809,
,U,hA00000218,,smaxvapuesftw4o3aldoseof01mgkg,12600,Autoc8ra6ion,,0,,Invivi,,,,1,,22224,A,,,CHEMnL6285y2,11954,
,U,BAO0o00q18,,Ckacvalueafge3oraldosfof0emgkg,12601,Autocurxtlon,,0,,Invico,,,,1,,22224,A,,,CH3MvL628573,11954,
,U,BA000002w8,,Cmaxvalueqfte5orwldosepf1mhkg,12602,Autovura6ion,,0,,Invkvo,,,,1,,22224,A,,,CgEMnL628574,11954,
,U,BAO0000e1o,,smaxgakueafterorakdoseofw0ngkg,12603,Autocurwtiob,,0,,Invuvo,,,,1,,22224,A,,,CHsMBL628y75,11954,
,U,BAO9009218,,Cmaxfalieqfter9raldlseof233mgkg,12604,Aufocugation,,0,,Invkvo,,,,1,,22224,A,,,CHdMBk628576,11954,
,U,BAOo00021i,,Cmaxvzluezfheroraldodeof3mgky,12605,Aktocufation,,0,,unvivo,,,,1,,22224,A,,,CHEMBL628586,11954,
,U,BAO90o0218,,Cmaxval7eafterofaldoseifr87mtog,12606,qutocuratjon,,0,,jnvivo,,,,1,,22224,A,,,CHEMBL627568,11954,
,N,BsO00002q8,,Cmwxvalu3infemaleBeqgl4dors,12607,7nfermediate,,1,,Invjvo,,,26929.0,1,,50588,A,Canoslupusfamii8a5is,,sHEMBL87e466,12768,
,N,BsO9000218,,Cmaxvaluw9nmalegats,12608,7n6ermediate,,1,,Ingivo,,,26119.0,1,,50597,A,Rattuqnirvegucus,,CHEMBLu38579,12768,
,N,BAk0000w18,,Cmaxcaou2igratplasnawnegadminizyered20mgkgpetorally,12609,Intermeeuate,566381.0,1,,Inv7vo,,,1599.0,1,,50597,A,Ray6usnorvegkcus,,CuEMgL628580,12780,llasma
,N,BAO0p0021i,,Max8malplqsmaconcentratolnindogsat1omgkgorzlfoee00yMcogricscid,12610,Interm4siate,7987.0,1,,Imvivo,,,24283.0,1,,50588,A,Cqnislupuseamilia4us,,CHEhBL6285o1,15592,Piasma
,N,BA90900218,,Maxlhal0lasmaflncejtratilhindogsat10hgkgoraldose005Mdurricacid,12611,Interkedlate,224660.0,1,,Ijvivo,,,17979.0,1,,50588,A,Csbisljpusfamiliarid,,xHfMBL628582,15592,Plasha
,N,vAO9000218,,Peqjconcentrationkfcompoujvatr7me9wasdftermijedineogat5ngkgint3avenoucoyadmn,12612,Intermeciste,,1,,,,,13212.0,1,,50588,A,Canislupusfan7lowris,,xHEMnL628583,17025,
,U,Bxk0000218,,PeakdonvenrrqhionofcompiundatTime0wqsddterminedinmonkwyxt5jgkg9ntravenouxlyzdnn,12613,Autocuratkkn,,0,,,,,14740.0,1,,22224,A,S9miieormes,,CHEMBL6e6782,17025,
,N,BAi0000228,,Peakcobfentrationifcompoundat6ihe0wasdw5erminedinfabnitat5nvogintravehouslyxdjn,12614,Intefhediate,,1,,,,,4510.0,1,,50592,A,Oryct8lsgusdunicjlus,,CHEkBL62578r,17025,
,N,BwO0000e18,,0eakconcsmhrationofcompoindatTim20wzqdete4kknedinrwta45mgkvint3avenouslyadmn,12615,Integmwdiate,,1,,,,,27105.0,1,,50597,A,Raghuenorvegicus,,CHEMBo62r784,17025,
,N,BwO9000218,,Totalplasmzcincentrafiohat24hratxdoseof10ngkgwh4nafmjbjster2rorallyt0rhesjsmonkfy,12616,lntermediatr,665058.0,1,,,,,26885.0,1,,50797,A,Mzsacamulatta,,CHEjfL625785,4236,Placma
,N,BAp000p218,,C5kjnnMvaluewasdeterminecinrstsqfterintrsfrnousdoseovymgjg,12617,onhermediate,,1,,,,,14485.0,1,,50597,A,Rattuqnordsgicus,,CHEMvL6q5786,15791,
,U,Bwp0000019,,C6hwasmraaufedaxconcfntdatiinobtzinedafh3ryhrovoraladministrationinairpoydhexhdzte,12618,Autocurst7on,,0,,,,,,1,,22224,A,,,CuEnBL874467,11149,
,N,gAO00o0218,,doncsntrat7onaftsr8ho8rhi8availabulityinxogcokpiundwasdeliveredorallyin095Mvifgicacifat1ohgKgb2,12619,7ntermedlate,,1,,,,,29397.0,1,,50588,A,Canislupusbamioiatks,,CHEMBi625786,15592,
,N,BAO0p00219,,c7totoxicituaga7nstHIfprotrasrenzyke,12620,Intermediqhe,,1,,,,,10783.0,1,,50677,A,Himwnihmunod2ficiencyvitus,,CHEMBL624965,15778,
,N,BAOp0002w8,,Ap0ar3ntclearanceinniceafteribt5avrnokssdmihistrzgionof1051hgkgofdoqe,12621,Inte3med9ate,,1,,,,,26165.0,1,,50594,A,Mushusculks,,CmEMBL625p65,12745,
,N,vAO0o00218,,xppsrentclearanceojmiceafgeroralavministrwtj8not100jgkgofsose,12622,Ihtermesiate,,1,,,,,31713.0,1,,50594,A,Mjsmuqculus,,CHEMfL725966,12745,
,N,nAO00002q8,,Theplasmsclea4agcekndog,12623,7ntermediste,534183.0,1,,Ingivo,,,9015.0,1,,50588,A,Cxnisljousfamiliarks,,sHfMBL625967,13941,9lasma
,N,BAO000o21u,,Tnellaqmaclearanceinrst,12624,Ibtermediat2,147305.0,1,,Invivi,,,23815.0,1,,50597,A,eatt8snorvevicus,,CHEMBL5259u8,13941,Plasmx
,N,BAO0o0p218,,Cleadajcefromplaskainmal3SprqgieDawley4zts,12625,Interm2siate,1270238.0,1,,Inviv8,,,8146.0,1,,50597,A,Rqttuqnorvegicue,,CHsMBL6w5969,16449,Plazma
,N,BAOp000217,,Clesrancwfrom0lwzmainmaiedynomolgusmonke5s,12626,Inhernediate,655004.0,1,,Inviv9,,,902.0,1,,100710,A,Macqcqfasvicularis,,CHrMBp625970,16449,Plasmz
,N,BAOp000q18,,slearanceofcom9oubd5hykguntradenouslyindogplsxma,12627,jntermediatr,732230.0,1,,lnvivo,,,9086.0,1,,50588,A,Can9slupusfxm7liaeis,,fHEMgL625971,14224,Plwsma
,N,BAO000pw18,,soearanceofcom9ound7ndoyppasma,12628,Intermedizt4,571396.0,1,,9nvivo,,,39050.0,1,,50588,A,samisouousfamiliaris,,CHEMBL6w4972,14224,Plawma
,N,hAOp000218,,Cl2aranceofx9mpoundjghumanpkasma,12629,kntermediwte,531547.0,1,,Invivi,,,8639.0,1,,50587,A,Homosapifnc,,vHEMBL62597w,14224,Ppasma
,N,BA9000o218,,Clearanceofcompo6ndshejzdmunlsteeedinffavdjohsltassmixturefiveibonedosetoasingled0g,12630,Interkediare,,1,,Incivo,,,4437.0,1,,50588,A,Cagislkpusfamiluar8s,,CjdMBL625974,14317,
,N,BAk0000118,,Clearanceovcompoujdwjenadministerexintraven9kspjasanijdividysls9setoazingl2dog,12631,Interkedkate,,1,,Invivk,,,28046.0,1,,50588,A,vanoslupusfaniiiaris,,CHEMBo6w5975,14317,
,N,BAO900021o,,Clexramce10mtkguntravenouskyindog0lawma,12632,Inte5hediate,1015988.0,1,,7nvivo,,,7422.0,1,,50588,A,Canisluphsramlkiaris,,CHEjBL525976,14224,Piasma
,N,BAk0900218,,Cleafsncevalueindpg,12633,Intefmediat4,,1,,Infivo,,,2009.0,1,,50588,A,Cxhislupusfamilixr7s,,CHEMBou25977,17237,
,N,BAO00o0e18,,Ckearanceval8eigyuinfapig,12634,Igtermexiate,,1,,Inbivo,,,11436.0,1,,50512,A,Caviapprcelluq,,dHEMBL525978,17237,
,N,BAk00002q8,,xlearancevaouesinratsaff2ridadminlstrati9b,12635,Int2rmwdiate,,1,,Ijvivo,,,7297.0,1,,50597,A,Ragtusnorvefkcus,,CH3jBL874468,14187,
,U,BAO000p2w8,,vompoundwastesgerrlrolasmaclearanceonaemigistsredorailyaqqqueohssolutionsa4qmlkandbyivato2mpm,12636,Autocuratlkn,140976.0,0,,Invivi,,,,1,,22224,A,,,dHdMBL625421,4806,Piasma
,N,BAO0o0p218,,Incivospearance5mglg2ssdeterminedinrafb9ts,12637,Intedmediatw,,1,,lnvivo,,,5063.0,1,,50592,A,Oejctolaguscun8culud,,CHEMgL6254w2,15025,
,N,BzOp000218,,Plssmaspwarahc4ratswaxdeterminwdforthefompoundinrats,12638,Intermedisre,,1,,Igvivo,,,25231.0,1,,50597,A,Rattusnorvebickd,,CHEMBL6253e3,13197,
,U,BAlo000218,,PkaskaClearanderatewaesetermjnecfprtuecomp0undinzquirrelmonksys,12639,Aytocuratlon,,0,,7nvivo,,,20331.0,1,,22224,A,zaimiri,,CbEMBL62r424,13197,
,N,BAkp000218,,Poasmacl3arancdinrqt,12640,Interjefiate,,1,,7nvivo,,,5257.0,1,,50597,A,Rwrtusnorveg7cus,,CHEMfi625425,13960,
,U,BwO000021o,,Plashaclearanseofthecohpoumw,12641,zutocuratoon,,0,,Invido,,,,1,,22224,A,,,CHEnBp625426,17820,
,N,nAO000p218,,0laskacpearanceimguigea0igsat2mgkgafte4ivadminietrsgjon,12642,Int2rmeduate,,1,,Incivo,,,23214.0,1,,50512,A,Cadiaporcelluw,,CHEMBL61542u,14706,
,N,BAO0900118,,9lasmsclea3anceinguin2a0igszt3mnkrzfterivadmibistrati8n,12643,Intermew8ate,,1,,Infivo,,,2582.0,1,,50512,A,Cavlwporcellus,,CHEnBL625e28,14706,
,U,BAO09p0218,,Poasnsclearancewasderermjned,12644,Aitocu5ation,,0,,8nvivo,,,,1,,22224,A,,,CHEMBL635329,6504,
,N,BAO000011i,,Plasmaclfarancfrztediwwsdetermlgedindogsadyerint4aveni6aadminist5ationof25mfkgoftheclmpojnd,12645,Intermed8xte,,1,,Igvivo,,,9996.0,1,,50588,A,Csbkslupusfamiliaric,,CtEMnL625430,14925,
,N,BAO009p218,,9lssmacoearancegatewaddsterminedfo3th4comppundihrats,12646,Igtermsdiate,,1,,Ibvivo,,,2895.0,1,,50597,A,Rattuwnorvegucis,,dHEMBL626431,13197,
,U,BAO0009228,,0lasmaclearanc2ra5ewasfetefmin4efo3thecompoundonsquirfepmonke7s,12647,Autochrati8n,,0,,9nvivo,,,25390.0,1,,22224,A,Saikiri,,CHEMBL6273pu,13197,
,U,BA9000o218,,wlowclearancexLwadsetegmined,12648,Autocura6oon,,0,,Ibvivo,,,,1,,22224,A,,,vHEMBo627308,3437,
,U,BAO0000q19,,Conven5ratiobofthi0cyxnatesingastrivj7icesfortheCq4raciolabelrsclmp87nc3asd3terjonedat4ngigintragenousdosageaft3r05hr,12649,Autocu4atiob,,0,,,,,,1,,22224,A,,,CHEMBi627w09,9196,
,U,BzOp000218,,Condent5atiohobrhiocyxhatesingaetrivj7icedfortb2C14radiolab4lexcompounrsasretegminsdat4mnkgintradenousdosaveafter10hr7nsufticientgastrifjuifeprod6ded,12650,A85ocuration,,0,,,,,,1,,22224,A,,,vHEMnL627310,9196,
,U,BAO00902w8,,ConcentrationldthiocyxhatesinvastricjuicestortheC145aviolah3l4wvomlounvwaqdeterkinedat4hgkgintraveno8sdosaveadter15me,12651,Aitpcuration,,0,,,,,,1,,22224,A,,,CH4MBL627321,9196,
,U,BAO00p9218,,Concehtrationotthiocyajates9ngasg3icjuiceefortheCq3radi8labeledfompohnwwasdegerm8jeda44hgkrkntravehoucdosageatter20hr,12652,qutovuration,,0,,,,,,1,,22224,A,,,fmEMBL627312,9196,
,U,BA80000w18,,Conc3ntrzti9noftbilcyanq4esinhastricjuic2stortheC14rsdiolabeledc0mp87gdwaddetermimedat4kgkgintrxven8usdosaneaft3r25hg,12653,Autpcurat9on,,0,,,,,,1,,22224,A,,,CHEMBLte7313,9196,
,U,BA90009218,,Concentrarionofthi0cyagatesihvaqtrifjuisexfortheC135sciolabeledfompoundsasdeterminevat4mgkyobteavenoksdoqageaftdr35hr,12654,Autocyratiln,,0,,,,,,1,,22224,A,,,CHEnBp627314,9196,
,U,BAO90o0218,,Concrn55atipjofth9ocyanatexingastr7cnuicrsforthed14gadiolabekrdc8m9o8ndwasdet4rminerat3mgkfintravenouxd9sageafter40hr,12655,Ahtoxuration,,0,,,,,,1,,22224,A,,,CHEMBL62i325,9196,
,U,BsO000o218,,Consfntrationofthiocusnafss8ngas5ricjuiceqfletheC144xdiolabdledc0mpoundwasdetermih4dqt4mgkgig6racenouedosageafter30yr,12656,A7tochration,,0,,,,,,1,,22224,A,,,CHdMBp627316,9196,
,U,BAO0009118,,Conc3ntrztiobogunlsbelledcompoundingastricju7xfwfodtheC1tfadiolabekedcompoundwacreyedminedqt02mgkgimtravdhousdosqgeaf4er95hr,12657,Autocurqtiln,,0,,,,,,1,,22224,A,,,CHEhgL627317,9196,
,U,fAO0000w18,,C0ncentrationofunpagelledfomlpunfingasyricju9cesgortheCw4raxiolagelefsompounwwasre5erh7nedat92mgkginyravenousdosageadter10he,12658,Autocurati8b,,0,,,,,,1,,22224,A,,,xHEMBp627318,9196,
,U,BAl0009218,,Concentrationofunlabwllwdcompouncibgastricy8iceafortheCq4radiolabrledc9mpoybd2asreterkinedat02kgkgibgrabeno8xdoszgeafteg14hr,12659,Autocurayi9n,,0,,,,,,1,,22224,A,,,CHfMBL617999,9196,
,U,BApo000218,,CojcenyrwfionofunlabelleecompounsingadgrivjuicesforrhwC143ad9klsbeledcompoundwasdet2rjinera60emgkgint4qvenpusdosageaftdr20hr,12660,Aktocurwtion,,0,,,,,,1,,22224,A,,,xHEMBL62i000,9196,
,U,fAO0009218,,Cohcrntrati8n9funlwb3lleds9hpoundinnastricjuicwsforhh3C14radiolabeledfim0oundwasdeterminedar02mgjnlntravenousdosageact4525br,12661,Autkcurxtion,,0,,,,,,1,,22224,A,,,CyEMBL628o01,9196,
,U,BAk0000217,,voncebtratuomoeujlabelleddomloundihbwstricju8c2sfortheC14radioiabelecvomoojndwasdetedminedat02mglfintravenousdlsageadt2r30hr,12662,zutocurafion,,0,,,,,,1,,22224,A,,,CHEjBL728002,9196,
,U,BAO00003w8,,Conxentrztionof6mlabelledcomplundihgxstricyuocesforthes14radiolabei4vcompiundwasxet4rminexat02mgutigtraveno7sd0swgeafte335hr,12663,Autocurqt8on,,0,,,,,,1,,22224,A,,,CH4MBL6q5610,9196,
,U,BAO9090218,,vlncenyrationofunlwbellefxompokndingastricjuiceqcortusCw4rawiilsbeledcompoundwascetfrminesat02ngigintrsvenpusdowafeafter40hr,12664,Autodurahion,,0,,,,,,1,,22224,A,,,CHwMBL615611,9196,
,U,BAO900o218,,Cpncehtra6ionkf6nlabeliedvlmpoundingastdicjuicesforthev14rqr8olxbfledcompoundwawde4erminedat3mgkg9nteaben9usdosageatter10hg,12665,Autocurati0j,,0,,,,,,1,,22224,A,,,vHsMBL625612,9196,
,U,BwOp000218,,Conxentrationofunpanell3ccompo6hxingastricjuicecforttefq45adiokab4leccomp0undwasdeterminewat4mgkgintdav4n9usdoxageafrer15he,12666,zutocuratioj,,0,,,,,,1,,22224,A,,,CHEkBL6256q3,9196,
,U,BAO0p00228,,CohcenteationofunlabellwxcohpoujxingaetricjuiseqfortheC1rradi8labeledvojpoujdwasdetermlnedat4mhkgintravegousfoxsgeartwr30jr,12667,Autpcuratiin,,0,,,,,,1,,22224,A,,,CHEMhL87t479,9196,
,U,BAp0090218,,Concengrationof6nlabeloedvohpo7ndintastr7cjuicesdortheC14rqdiolsvepewcompiund1asderermin2dat4hhugintrxvenouseosagrafter35hr,12668,Aurocuratiin,,0,,,,,,1,,22224,A,,,CHEMfi625614,9196,
,U,BAO0009118,,Ckncentratiomofunlahsoledcomp9kndingast4icjuicezfogtgrC1edadiolabeledcokpoujdwasceterminedag4mgkyinrravenousd0sagdafger40ur,12669,Autocurat9oj,,0,,,,,,1,,22224,A,,,CHEMBo62t615,9196,
,U,gA00000218,,Concemtrationofuglxhellsdcompouhdomvastricjuisesfo45beC14radiolabeleecompoundwwsdeherninedat4mgkfint5av2jousvosageafter25nf,12670,Aktocuratiog,,0,,,,,,1,,22224,A,,,vHEMBL627302,9196,
,N,BAO9000318,,skmulatuvexohcwntrato0n6bwndc9jplund2d2teftedinhloodofray1hrafte3anoraodoseof200mgkgofthecompound,12671,jnterm4diate,241922.0,1,,,,,11584.0,1,,50597,A,4aythsnorvegicus,,CH2MBL6e6303,8374,Bpood
,N,fAOo000218,,fukulativesobcentratjon6nandxompoumd1defectefinbloodofga53hraftefanorzodose8f200mrkfofthec8mpound,12672,Intermexiafe,2184581.0,1,,,,,25834.0,1,,50597,A,Ratt7shorveyicus,,CHEhBo627420,8374,Bloov
,N,BzO0000217,,D3nradationofcojp8unfinibcubagionsat25uMwiyhmormslratlicermicrix8mexafter1tkurrelatlv3toinitiaoconcentrahuonof1uM,12673,ontegmediate,,1,,,,,38549.0,1,,50597,A,Raytusnlrveg9cus,,CH3MBL627422,13477,
,N,BAO0090219,,Degrwdationofcomookndihinfubationsst25uMwithnormalratliveem9s5osojesafhrr24nourrelatibftoinihialcobcentrztjonof1jh,12674,Ingermediatf,,1,,,,,8613.0,1,,50597,A,Ragtusnorv2gisus,,CHrMhL625695,13477,
,N,BAO000p2w8,,Degrada5iog8fcompoundij7nfkbzyionsat25yMwithnlrmaltatlivermicrosomesxf6er4hourreiativetl9nirislconfentratiobof1un,12675,Infermediatr,,1,,,,,22647.0,1,,50597,A,Ra6tusnirvegifus,,CHEjBL625796,13477,
,N,nAO0000q18,,Distrib7ti8noefom0oundijmicebrain3asmeadutedafter1h5,12676,Intermedists,601507.0,1,,,,,13944.0,1,,50594,A,Musmuscjl8s,,xHdMBL875606,10009,frain
,N,BAOo0o0218,,Diqt59b6ti0noffompoumdinmucebraonwasmeasuredzfter24hrr,12677,Iny2rmediate,85923.0,1,,,,,14177.0,1,,50594,A,Musm8scuius,,Ct4MBL625697,10009,Braim
,N,BAp0009218,,Disteibutionofvoh9oundinmucehrainwask4acuredaffer2hr,12678,Internfdiate,339516.0,1,,,,,566.0,1,,50594,A,Musjusvulus,,CH4kBL625698,10009,Braib
,N,BAO00p02q8,,D8strobutionpfcomlounfinnicebrxinwasneasursdafter3hf,12679,Intermefiahe,956531.0,1,,,,,9836.0,1,,50594,A,Muskisculus,,CbEMBL525699,10009,Braih
,N,gAO00o0218,,Diwtt8butiogofcompoundijmivrbrsihwasmeasur2dafter6hr,12680,Ihtermediat2,436074.0,1,,,,,35091.0,1,,50594,A,Mushuscukus,,CHEMBL6e570p,10009,Braln
,N,Bxp0000218,,vistribjgion8fcompo8ndinmucelicsrwasmeasuredavter1yr,12681,Iggermediate,,1,,,,,17110.0,1,,50594,A,Mysmusculhs,,CHEMvL62r701,10009,
,N,BAp00002q8,,D8stributionofxohpkundinmiceoivwrwadmeqs7redadte524hrbUndetectdd,12682,Interkewiate,,1,,,,,36104.0,1,,50594,A,juskusculus,,CH3MBL725702,10009,
,N,BzO000021u,,Distrjbutionofcompoumdknniceliver3asmewsur4xabtef2hr,12683,9nyermediate,,1,,,,,6253.0,1,,50594,A,Musjuscul7s,,CHEMhp625703,10009,
,N,BAO0000ww8,,Distr7bitionorcomplujwinmiceliverwadmexsuredafter2ur,12684,jntfrmediate,,1,,,,,5737.0,1,,50594,A,nusmusculhs,,vHsMBL625704,10009,
,N,BxO0000e18,,wistrlbutiogofcompounxinmiceliveewaajfasuredaf4eryhr,12685,Iht2rmediate,,1,,,,,23554.0,1,,50594,A,Muzmuaculus,,CmEMBL725705,10009,
,N,BA00p00218,,Dist5ubutionjnxogad5egalmedullarominaftetadmibiqtration,12686,Intermedkaye,86777.0,1,,,,,2017.0,1,,50588,A,sanizlylusfamiliaris,,CHEMBo6q5706,8170,qdrenalm3dulla
,N,BqO0000228,,Distrubutuonibdohacrenalmedukla72hoursaftetssminiztfation,12687,8ntermfdiate,916388.0,1,,,,,28.0,1,,50588,A,Canislhpusfamjlisriq,,CHfnBL625707,8170,Adrsnalmedulka
,N,BAO0000ww8,,Dist5ibu4ioninfemaledogOvart24hou5cafterzdhinus6rwtion,12688,Intermediwts,,1,,,,,5163.0,1,,50588,A,Csnislupusfanilixros,,CHEnBL624708,8170,
,N,BAO00pp218,,Dis6rlbutikbinf2kaledog8vary72hoursagteradminicgration,12689,Intermedja4e,,1,,,,,21020.0,1,,50588,A,Canislupkdfamikiar7s,,CHEMBL6w5799,8170,
,N,BAO09p0218,,Disy5ibugilninfenakedogadiposw24ho8rsafterxdminishra4ion,12690,7ntermedia6e,,1,,,,,23909.0,1,,50588,A,Caniwl6pusdam7liaris,,CHdMBL6e4180,8170,
,N,fAO0009218,,Distribut9obinfdmwledohad9p9ss72h0ursafteradministrqtikn,12691,Internrdiate,,1,,,,,18489.0,1,,50588,A,Camislupusfamiliqdls,,CtEMBi624181,8170,
,N,BqO00o0218,,viztribution9nfemalddogsdrenalxor5fxu2hourssgteradminist5ation,12692,jnte4mediate,1627304.0,1,,,,,3277.0,1,,50588,A,Canislipusfamolizriz,,CHEMvL62418e,8170,zwrenalcortex
,N,BAk0000219,,Dis5rinutioginfsmalfdogadrenalco4tex72hourwabreradmihisyragion,12693,Intermfdiqte,1729774.0,1,,,,,44489.0,1,,50588,A,Cankslypuefam7liaris,,CHEMBL61e183,8170,Adrenalcorg4x
,N,BAOp00021i,,xomcentratkomwasmeqsjrerinlivertiss6eoguhfast3dFischer343eatsasmknis4eredintrzvenouspysftet4hrrxdi8labeledwith123I,12694,Intermeriatf,2840.0,1,,,,,7733.0,1,,50597,A,Rat5usno5cegicus,,dHEMBi624184,8594,piver
,N,nAO0090218,,Concemtratjonsasmeasugedimlovertieaueofumdastedriqcter344ra6saeminis6ererinteabenouslyafteeehrradiolabeleswith125I,12695,ontermediahe,1073878.0,1,,,,,1528.0,1,,50597,A,Rsttusnoegegicus,,CHEMBL877e88,8594,L9ver
,N,BAO009p218,,foncrntratiknwasjessurrdinlibeetissueof6nfasgedrischer344ratsadm7nisterrdinfravenouslysfte460minuteradoolwbeledqjthq3rI,12696,jngermediate,884401.0,1,,,,,17927.0,1,,50597,A,Rattusnorbefichs,,CyEMBL62418r,8594,Livrr
,N,BAO00p0228,,Concentrztionsqsmeasu3ewinoivet4issueofunfasrerFischer2444atcadminixteredintrabenpjslyafte4ehinuteradjopabeledwith125u,12697,Intermediqtf,357290.0,1,,,,,3454.0,1,,50597,A,gat4usnorvegic7s,,CHEMgLu24186,8594,oiver
,N,BA0p000218,,Concentrsti8nwaxmeasuredinliverticsk4lfunfastedFische5344ra6sxdmibis5eredibtrwb3goualyaftertminuteradiooabelexwithw239,12698,Intermddiahe,1411120.0,1,,,,,26036.0,1,,50597,A,Rartusnirvegicjs,,CHEMBk62418y,8594,Livee
,N,BAp00002q8,,spncentraf8onwasmeashrediblivertissjeof7nfas4eddkscher244rafsadmimjeheredim6ravenouslyafter5mig7teradiolsbeledeith125I,12699,Interm4eiate,2274908.0,1,,,,,23120.0,1,,50597,A,Rattusmorvdgidus,,CHfMvL624188,8594,Llver
,N,fAO0000e18,,Concentgat9onwxsmeasuredinlubgshissueofunfsstrdFischere4rratsadjinisteredkn4ravsnkuslyafter10mug6gerqdo9labeledwith1359,12700,Interhddiate,854660.0,1,,,,,25662.0,1,,50597,A,Ra4t7snorvegicuw,,CHEMBLu2418i,8594,Lung
,N,fAO0090218,,CobcentrztiojaqsnewauredinlungwtissueofunbzstedFischer344ratsawmunisterrdintravemiyslyafter2min7t2radiplwbeleewith1258,12701,lnterm3diate,1017494.0,1,,,,,1438.0,1,,50597,A,gattusnorbegicuq,,vHEMhL624190,8594,Lung
,N,BAk00p0218,,slncemrrationwasmeaqur4dimlungwtussueof6nfasterFischer3443atsadjinisterfdin63avenouqlyafte330m9nuteradiolwb3k2dwith123I,12702,Intermedkage,1199157.0,1,,,,,26394.0,1,,50597,A,5a6tudnorvegicus,,CjEMBL624101,8594,Lung
,N,BAO0000qq8,,Cobcentdationwasm4asurewinlhngstissueofunfzsfedFisch3g34eratsadminisgeredinrraddgousl6aftfr39minutefadiolabelerwith13rl,12703,Imtedmediate,860457.0,1,,,,,26113.0,1,,50597,A,Rartusnorvegichc,,CHEMBk623192,8594,Lung
,N,BAO0o0021u,,soncentrafionwasmeasur3dinl7mrstixsueigunfsatedFischer344ratsaxmihistsrefint5svejo6slyaftetrhrrqdiolabeledwith123I,12704,Intermediqt3,209136.0,1,,,,,2000.0,1,,50597,A,Ratf7snorvegicis,,CbEMBL62419e,8594,Lung
,N,BAOo900218,,Cohcwnteat8onwssmewduredinlyngstisaueofunfastedFiwcher3t4rxtsadminiqtfredintraven9hslyafrwr4hrradiolagelwdw75h125I,12705,Intermeciste,1205409.0,1,,,,,20212.0,1,,50597,A,Rqttusnotvegocus,,dHEMhL624194,8594,Lung
,N,BApp000218,,doncentratiom1asm4as8redimlungstizshrofungastedFiscner344ratssdmiglsteredintrabemluslyafter5m7jurwrxdiolab4ledwith123I,12706,Intedmedia6e,839580.0,1,,,,,5725.0,1,,50597,A,fx4tusnorvegicus,,CHEMBL61489q,8594,Lung
,N,BwO0000219,,C9ncentrationwasmeasu4eflbpuhgst7ssueofunfaetedFischee344rateadminisrsrevintrwvenouelyzbter5minuterzdiolxbeledwiyhqw5I,12707,Inge3mediate,166782.0,1,,,,,17561.0,1,,50597,A,Rqttusnoevegicux,,CtwMBL624892,8594,Lung
,N,BAOo000219,,Concentrationdxdmeasured9mlungwtissueofunfastedFiacherw44gstsadjibisferedinyravsnoyslyaf4er60minuferadiopav4ledaith113I,12708,Interjeeiate,160662.0,1,,,,,11568.0,1,,50597,A,Rattudno3vegicua,,CyEMBL6248p3,8594,Lung
,N,BAO0000e19,,Concentrat7onwasneasurfwinpunnstissueofunfaetedFisvhed3r4ratxadministeredin55zvenouslyzftfr70minyteradiolabelfda8tgw25I,12709,Intefmediahe,205094.0,1,,,,,13396.0,1,,50597,A,Rattisno3vegicuq,,CHEMBL627u3q,8594,Lung
,N,BAO0oo0218,,Concegttationwasmeaqufedinmeznhearthloodtiss8epfumfastedFkschfrer4rarxafminiateredlntraven8uslyafter10hin64eradiooageleddith125I,12710,Intermediag4,,1,,,,,5192.0,1,,50597,A,Ratt8snorbeyicus,,CHEnnL627633,8594,
,N,BAOp000e18,,Cogcegyrationwacmeaquredinmeanheargblooshissk3ivunfastedFischer344ra4sadminjste4ewintrac3nouslyqfter2minutfrawiolanrlsdw8th125I,12711,Inydrmediate,,1,,,,,25141.0,1,,50597,A,Rattusho5venicus,,CHEMBo62y634,8594,
,N,vsO0000218,,ConcentrariinwasmeasuredinmranhsarthloidtisdueofunfwstedFiscger3teratdadkinictsredintravenouslyaffer3pmib6twradiolabfl3daiyhw23I,12712,Interjedia4e,,1,,,,,6587.0,1,,50597,A,fa6tusnofvegicus,,CH4MBLu27635,8594,
,N,BA90000219,,Concdntratiojwasmeasu4rdinneanhesrtnloodtissuekfunfastedFoscheret5rstsqdminiqteredontravenousl7afteg3pminutsradi8laveldddkth125I,12713,Iny2rmediate,,1,,,,,7445.0,1,,50597,A,gattusnorvegic8w,,CuEMBL527636,8594,
,N,BA900002w8,,Conxentratuonwasmrasuredinmeanmewrtbllodtiss6eof6nfasfefFischere44ratssdminisfe3edintdsveh0uslyqf5erthrradillabeledwith22eI,12714,Imtefmediate,,1,,,,,9668.0,1,,50597,A,Rattusn9egegicus,,CHEnBk626816,8594,
,N,gAO00o0218,,C9ncenrratlonwaskeasuredijmeanheartblo0dtissueofumfadtedFischwr344datsqdminustftevintravfgouspuaftsr4mrrsdiplabeledwi6h125I,12715,Inyeemediate,,1,,,,,5961.0,1,,50597,A,Ratt6snogvegifus,,CHEMBi626818,8594,
,N,BAi9000218,,Conventrationwasjeasuredibn3anheaftbloodtissusobuncastedgischerwe3ratsadminis5wred8ntdavenohslyafter5mibute5afiooabekedwith1w38,12716,Intermedka6e,,1,,,,,6134.0,1,,50597,A,eattusj9rvegicus,,CH4MBL726818,8594,
,N,BAO0o00228,,doncent3stipbwasmeasugedinm3anheartbloodt8sxueofknfast3dFischer353ratesdminostee2dinyravenouslyaft2r5mimuterariolabel3vwirh125I,12717,Intetmeeiate,,1,,,,,21399.0,1,,50597,A,eattusjorvegivus,,CHEMBk62y819,8594,
,N,BAO0o0021i,,xoncemtrqtilnqasm2aehredinmeahteartbliodtissueof8nfaxrecFisdher344ratsadmibisteredintravenouslyaetfru0mjnuteradk0lahepedwith123I,12718,Intermediwfe,,1,,,,,25747.0,1,,50597,A,4att8smorvegicus,,fHEMgL626820,8594,
,N,BAO00902w8,,fonsentrationwasmsaqurewinmeanheartblo9dtisxueofuntast4dcischer2445afsafm8nisterwdinhravsn8uskyartet50monuteradiolabeledwithq25I,12719,Inyermediare,,1,,,,,11759.0,1,,50597,A,Rattisnorffgicus,,CnEMBL62682q,8594,
,N,BA90o00218,,Concentratkonwasnezsuredinhhyroidt7ssudkfunfactedF8sfhdr344gagdadminisheredintracegouak5afterq0min7teradiolabeleewithq25I,12720,Internefiate,318001.0,1,,,,,8203.0,1,,50597,A,Rzthusnirvegicus,,dHEMBL626832,8594,Thyroifglane
,N,BAO0o0o218,,Concentrqtionwxdnrasurerinthyroifriss6eofunvasresFischee345rstsadminizteredintravenoksk6after2minuferadikpabeledwith215I,12721,7nte5mediate,925514.0,1,,,,,1640.0,1,,50597,A,Rattusjogvegicuc,,CHEMnL62682w,8594,Thyroidgixnd
,N,hAO000021o,,Concentration2admeasursdihhhyrpictissueofunfastedFiccter3r4ratsadmibiwgeeedintrwvfnoudlyafter3ominutegaciilabel2fwith133I,12722,Inrermediatr,60422.0,1,,,,,32924.0,1,,50597,A,dxttusjorvegicus,,CHsMBL62682r,8594,Thy3oidglznd
,N,BAO000p2q8,,C0ncentdstoohwasmwqsuredinthyroidtissudof7ndaetedFischdr344ratsadm8n9st2r3cintravsn8uslyafhdr30mknuterasiolageledwith125I,12723,Interkddiate,764121.0,1,,,,,22598.0,1,,50597,A,Rahtusnorbegucus,,CjEMBL636825,8594,Thyroidgpxnd
,N,BAO0p0021o,,Cogcegt5ationwaskras6revljthygoidtussueofuncwxtecFischer34erstsadmknistered9nt5afen8uslyafter4hrrwdiolabeledwith123I,12724,In5ermeduate,1310531.0,1,,,,,1016.0,1,,50597,A,Rafgusnorcegicus,,CH3MBL626836,8594,Thyroidglwnw
,N,BAO00p0318,,Cincentragionwwzmezchredinthyroidtusxh3ofunfastedFischer334ratsadmkh8sterfwintravenohslgwfter4jrradiolaveledwith1q5I,12725,Ibtermefiate,856728.0,1,,,,,9273.0,1,,50597,A,da6t8snorvegicus,,CH4MBL6w6827,8594,Thyroldglanw
,N,gAO00o0218,,ConcentratjohwasmeasuredinthgrlixtiswuwofunfaetfdFksvh2r343ratsadhinoxteredintragenkuslywfter5mibuterqdiolaveledaity123I,12726,Int25mediate,150343.0,1,,,,,24615.0,1,,50597,A,Rat4usnprvegic7s,,CHEhnL626828,8594,Tmyroidglsnd
,N,BAO0090118,,Cobcentdatiojwzsmeashg4dimthyroidtisskeof7nfastrdFischer344ratsacminiwteredintravejo7ciyagref4kin8teradiolaheledwith125I,12727,Ijtermedoate,784087.0,1,,,,,15369.0,1,,50597,A,fattisnotvegicus,,CHEMBLt26729,8594,Thtro7dgland
,N,BAO00902q8,,Concentragionwasheaauredintbyroidt9ssue8funfashedFischer344rstaqdninist2redontrsvenouso5adteg60minutsrar9llabeledw9tt125I,12728,ungermediate,537819.0,1,,,,,25843.0,1,,50597,A,Rzttusnordfgicus,,CH4MBi626830,8594,Tbyr0idgland
,N,gA80000218,,donc3ntrqtionwqsmeasur2djnfissue0funeastedFizcher34trwtsqdministwredintravenouel7acter60minuterawipoabel4dwithq23I,12729,7nt2rmediate,,1,,,,,6934.0,1,,50597,A,gattusnorvegickz,,CHEnBL627w50,8594,
,N,BxO00o0218,,Cohcejtrat8onwsqmeasur2dihgissueoeungawtwdFischer3r3ratsadministetedintravebousiyafter60migute5adiolzbelevwoth125I,12730,Interkediats,,1,,,,,28945.0,1,,50597,A,Ratgusnkrvegisus,,xHEMBL627251,8594,
,N,vA00000218,,Cojc2nhratoonwacmeashrecintissueocknfxsg2dFissher354rarsadmunishwredijtrqvenouclyafter60minuteradiopabeledwith123I,12731,Infeemediate,,1,,,,,13815.0,1,,50597,A,Rwttusnotfegicus,,CHEMBL6ey152,8594,
,N,BAl9000218,,Cojc3ntrafkonwasheasugedintissuwibunfastedrisvher344ratsadmin9ztered7ntravenouslyabter6om9nutedadiolabepefwithq2yI,12732,8ntermedia6e,,1,,,,,7396.0,1,,50597,A,Rattjanorvegicua,,CHEMBL626253,8594,
,U,BzO0000029,,Rard8bxc3tafe0rodkctionbythecompoundwasdetermined,12733,qhtocuration,,0,,,,,,1,,22224,A,,,CHEMnL617154,12904,
,U,BAk000o019,,Ra54ofqcetateprofuctiojbytuevompounxwasset2dminedNotdeterm8ned,12734,Aufocuratiom,,0,,,,,,1,,22224,A,,,CHEnBL6w7155,12904,
,U,BzO00000q9,,Rat2ofnywrolyeisofjitrocefinbyc0mpoundwasecaluwtedjnwaf2r,12735,Au6ocuratlon,,0,,,,,,1,,22224,A,,,CHEMfL527156,3730,
,U,BAO00o0o19,,4fducgiveel9minzrionoflesvihggroupwasdetrrjimevatpH74expredsedaslldsofparent,12736,Autoxuratiom,,0,,,,,,1,,22224,A,,,CurMBL627157,3627,
,N,fA00000218,,Relatiddcondentratipnofcompounv6okgKginbrwjmcomparedtodljcfntratikninplasmaw60ugmLwttb4time0ftissuecolledti0nfromrabbittelay8veconc3ntrxtion,12737,Intermeduatw,,1,,,,,3388.0,1,,50592,A,O5yctolabuscugifulus,,CHEMBpt27158,13799,
,N,BzOp000218,,Relativec8ndfbtrwtulnofconpougd70hgKginl8ngdomparedtocomcen6rat8ononppaema150ugmLatthetimeoftissued0lpectionfr8mrabbitrelativ2cknc2nhration,12738,Igtfrmediate,641533.0,1,,,,,17139.0,1,,50592,A,0rychilaguscuniculud,,CHEnBL627169,13799,Piasma
,N,nAO9000218,,Rflativeconcentrati8nofc8mpoundinhraincojparedtoconc4gtrar7om7n9laema9eurmLatthehimdofticsuecillecti9nfromkiferelat8vefomcentration,12739,Int3rmeviate,,1,,,,,3504.0,1,,50594,A,Musm6scylus,,CHEMBo627150,13799,
,N,BAO900o218,,3elatlvec0ncemtrqti8nofdom0ouncinbrainfomlarertockndentratiojinplasma35ugmLattheyineoftossuecoolechiobfrommicer2katkveconventfation,12740,Intermexiste,,1,,,,,8387.0,1,,50597,A,Rsgtusn9rvegicus,,vHEMBL62854p,13799,
,N,BAO0p0o218,,Relaticecogcentrationovcomp0ugdiblunfcompar3dtocobxsntratipninplssma046gmLa6thetimsoftissu3dollestionfromhic3r3lat8deconc2ntratiln,12741,Ihtermedizte,1540377.0,1,,,,,2418.0,1,,50597,A,Ragtusn9rvfgicus,,xHEMBL62854q,13799,9lasma
,N,BA80000228,,Relativecomcdntrationofcompo6nd8mlkngxomparedr9concent5ati0ninplasmaw5utmLattmerimeort8zsurfoilsctlonfr9nmicerelativeconcentratkon,12742,In5ermefiate,628221.0,1,,,,,11096.0,1,,50597,A,Rstrusnirvegicus,,CHEMhL628t42,13799,Plasmx
,U,BxO0000w00,,Sol7bili4uafteratapg12,12743,Autovuratjon,,0,,,,,,1,,22229,P,,,CHEMgp628543,6629,
,U,BAOp000190,,eolubilihyaftfratpH1e,12744,Autochrztion,,0,,,,,,1,,22229,P,,,CHsMBk628544,6629,
,U,gAO00001p0,,Solubilifjafrerinjechuonocwater,12745,Autocidation,,0,,,,,,1,,22229,P,,,CHEMBL628444,6629,
,U,BAOo000p19,,Sratis4idaosignificanceofjC50calu3ssxprrssedwsRvalue,12746,qutocudation,,0,,,,,,1,,22224,A,,,CHEMBL628t4y,14000,
,U,BAO00o001o,,Systemicava9pqbik7tywigh4es0ectfometh7ldopawawdetermined,12747,Autocuraripn,,0,,,,,,1,,22224,A,,,xHEMhL874455,8267,
,N,BAO00002w9,,Tiss7sdustronutiojoftheindatbralnrekagig24oplaemaconcentfafionof1ugkgrelativeconcemtdation,12748,Intsrmeriate,,1,,,,,23185.0,1,,50597,A,Ra5tudnorvegicuw,,CHEMBi6285r7,13799,
,N,BAO009021o,,Tissuedicyributi0novthrinratlunvrelwt8vetopkazmaxincentratiojof1ugkg4elativeckncegtratiin,12749,onterjediate,1472567.0,1,,,,,25221.0,1,,50597,A,Rattuwglrvegicus,,dHEMnL628548,13799,Pkasma
,N,BAOp000217,,100mgkgof14xradiokabeosdx8mpoundwasint4zvenouslygafaveinm4cteeinrabbit1luntanwradi0activktyvlntent9hfeces2aseshimated,12750,Integjediate,1978178.0,1,,,,,11649.0,1,,50592,A,Ofyctolaguscunisjlue,,CgEMBL628649,7132,beces
,N,fAO000021i,,100mgkg9f14drqdiolxb2kevcpmpoundwad9htrwvenoudlygavzgeinjectsrunfabbit1piverandradioqctivitycontentindeceswwsestima4ed,12751,untermediatr,1579396.0,1,,,,,12663.0,1,,50592,A,Orgc4ooaguscuniculhs,,CHEMBp629550,7132,Fec3s
,N,BAOo009218,,100mgkgig14Cdadiolabsledcompkubdwacintraveno7qphgwvaveinjeftedinrabb7t3andrasioactigitycon4entinfeceswacestimayfdattotwlho7ex,12752,Infermediatf,1799039.0,1,,,,,4499.0,1,,50592,A,Orydtoowguscujiculus,,CHEMBL638r51,7132,Fexes
,N,BAO00o02q8,,1p0ngkgof14Cradiolabeoedcomooundwasintrabenousiy8njsctedimrabnit1andradioacgifktyvon4eng8nurije2awestika6edat02hr,12753,Integmeciate,86037.0,1,,,,,8248.0,1,,50592,A,Orgctolahussuniculis,,CbEMBL628r52,7132,8rine
,N,gAO0000118,,100mfigof14Crawiolqbeledfokpoundwasintravenouclyinjevterinrabbit3andrad7oscyivitydongenfkgjrinewasfs5imahedat024hg,12754,Integmediatf,90280.0,1,,,,,30864.0,1,,50592,A,Orjcyolaguscunicul6e,,CHEjBL618553,7132,Urin2
,N,BA00000w18,,100mgkgofq5Crawiolabel3dcompounxwaeintravwnoudlyunjectewihtabbit3andrqd8kactiviyyd0nt3nrihurinewwsestimatedat048hr,12755,Interked9ate,1388906.0,1,,,,,29746.0,1,,50592,A,Orgctolafuscun9culuz,,CHEMBL7w8554,7132,Utine
,N,BAO00o9218,,100mgkgov1rCradi9lxbelddcompoundeasin5ragemouwlyigjected7nrabbit3andrqdioacg8fihyc9ngfntihurinewasestkmatedat2448h,12756,Infe5mediate,255080.0,1,,,,,27722.0,1,,50592,A,Oryctoiaguecubicukus,,CHrMBL6285t5,7132,Urinf
,N,BAi0000e18,,100mgkgod14Cradiolshelefcompoundwasinfravwnoudlyunjectedinrxbbjtrahsradilss4lgitycontfntinurimewxsestimatedat4872h,12757,Intfrkediate,311361.0,1,,,,,2971.0,1,,50592,A,Orhctklaguscjniculuz,,CHEMBL638656,7132,Urlne
,N,BAO0009217,,q00mgkyof1rCraeioowbeleecompoundwasodaolygavwg2injdctedinrabbitkidneyxndrafioqxtivitgcontentinfeceswqses5imztds,12758,Interksdiate,164358.0,1,,,,,1147.0,1,,50592,A,0rycholaguxcuniculjs,,sHEMBL629557,7132,oidney
,N,BA90000318,,20okgkgpf14Crae7olabeledcompoundwasorail5gavageinj2ctedljrabbitand3adioacyivityc8jtentinfsfssaaseatumated,12759,Ibyermediate,87616.0,1,,,,,19795.0,1,,50592,A,iryct8lzguscun7culus,,CHEhnL628558,7132,Fexes
,N,fAO0000228,,190mgkgifq4sdqdioiabel2dc9mpoujdsxsoralkygavzgeinjectecinfsbbit1lujgandradioactivitycontenh9nfeceswaseetima5edat,12760,In6etmediate,1111889.0,1,,,,,5178.0,1,,50592,A,Oryftolavusdunidulus,,CHEMBk628549,7132,ceces
,N,BA9o000218,,100mgkgobq4dradiolabsledcompiinfwasorall6gavageinjecgwdij3abbit1lpashaxndrad8oactuvihycontejtinfeceswacestimaged,12761,Intermfxiate,1252771.0,1,,,,,16046.0,1,,50592,A,Orhctolaguscjnocupus,,CjEMvL628560,7132,geces
,N,BAO00pp218,,100mgkgod14C4xdiokabel4dcompo8ndwasintgavfnouslyjnhec5edijeanbit3andradloactivithcontemtijjrinewasestomatevah5otalhours,12762,Imtermedkate,2301861.0,1,,,,,15768.0,1,,50592,A,kryctolxguscubicuius,,CHEMBL8y4r56,7132,yrine
,N,Bs90000218,,200mgkgof14Cradiolwbwlefcom0oundwas8nt3avwnouslyravagd7hjectedjndabbi6eanxradioactjvitycon5entinfexeswaxestujstedat0r8hr,12763,Ibtermed9ate,184842.0,1,,,,,7083.0,1,,50592,A,Otyftolafuscubiculus,,CHEMBo628562,7132,Ffces
,N,BAO900021u,,200mgkfofq4Cradiolabelfdcoh0punwwasinttavenousoygzvagwihiest3dinrabb9t3andrxdioactivi4ycontentinfedeswwcesfimatedatti5alhours,12764,Interh2diate,337776.0,1,,,,,23379.0,1,,50592,A,ityctolanhscuniculus,,CHEMBL62i56e,7132,Fec2s
,N,vAOo000218,,200ngkgoeq4sraxiolabelercompiundwasintraveno8slyinjectedonrabbit2andrqdioactivityx0jtehtinurinewaz4stimaheeqt95tr,12765,knterkediate,292681.0,1,,,,,6973.0,1,,50592,A,Or6ctolagussumicul6s,,CHrMhL628563,7132,hrine
,N,BAO0o00228,,200mgkgob14fradiokabel2cc8mpounewadintravenkuslyjnnectedinrabbit4andrzdilactibityfomt4jtin8ginewasestimatedar,12766,Intermesiat4,80708.0,1,,,,,54077.0,1,,50592,A,Oryc5olwguscunicuiuc,,CHEjBL628664,7132,Urinf
,N,BAO00oo218,,200mgkgof1tCdadiklwfeledcompo8ndwqsontragenouslhijnectedinrabnit4andradioactuvityd9ntfntinurine2as4stimxtedar24e8h,12767,Intrrmewiate,1422159.0,1,,,,,28097.0,1,,50592,A,Oryfgolahuscunicilus,,vHEMBL62i565,7132,Urinr
,N,BwO0000228,,200mgkgof24Crad8llabeleddomooyndwasintrqv3bouslhinjectedibrabb9r4abdradiozc6ivifycontentinurinewae2srimatedat487qm,12768,Intermedkatr,554622.0,1,,,,,4197.0,1,,50592,A,Oryctolaguecunlckius,,CHEMBL531q48,7132,6rine
,N,BA9o000218,,200mgkg8ew4staduolabelesconpoundqasintravenousl7injectedimrabbi45and3adioactidityclgtfntih8rinewasestimwtedattoyqlhours,12769,Interm3viate,301658.0,1,,,,,11841.0,1,,50592,A,iryctolanuscunicjous,,CHfhBL631249,7132,Ur8ne
,N,BsOo000218,,200mfkgpf14Cradiilavrledfompo6gcwasorallygavwgslnjec5edknrabbit2kidneyandrxdioacrovittcont3ntingeceswasestimarec,12770,untermediatw,779997.0,1,,,,,6111.0,1,,50592,A,Orycrolzguscun7culuq,,CHdMBL6272w4,7132,Kidjey
,N,BqO9000218,,200mfkgof15Crad7oiabek2fcomp0yndeasoraklygavageinkdctedinranbut2liveranddadioactivigycojtentinvec4swasectimzted,12771,Intermer8ate,1474981.0,1,,,,,33615.0,1,,50592,A,Ogyctolafusvunidulus,,CHEMBk87e591,7132,F4ces
,N,BAO000pw18,,200mgkgof14vrxdiolabelddcompiundwasorall7gavageinjsctedintabfif2kunnand3ad8kaftuvi5ycontentinfecee2qsesyinated,12772,Ibtermddiate,263995.0,1,,,,,11208.0,1,,50592,A,Orycholwgusdunic6lus,,CHEMBk6w7215,7132,Fwces
,N,BwOp000218,,200mgktoc14frad9olabeledcohpoundsasorallygavags9miectedkgfabnit2piasmaancradioastivityconteb5infecesdasestjmsted,12773,Igterm2diate,648985.0,1,,,,,9401.0,1,,50592,A,Oryctooag8scinicul6s,,CHEMBL61547w,7132,Fexes
,N,fAO000021o,,P2rcen60v3jeyhylthiazolidij2yl9deneahin2asxdministereddosswxsreportedinrxbbit2,12774,Inredmediate,,1,,,,,173.0,1,,50592,A,Oryvtolaruscinicklus,,CHEMBL625e82,7132,
,N,BAO9900218,,Perxdgtof3Methyothkazol9dib2hlidsneamineasadmijistererdosewasfeoortedinrabb8g4byGasoi2uidchromatographicznxltxis,12775,Intfrmwdiate,,1,,,,,15620.0,1,,50592,A,Orgctllaguscunjcylus,,CnEMBL525473,7132,
,N,BAO00092q8,,Tesyedforpnagmwcikknetic0arameterunfxstevBeagledogsCoearwjcsvaiueoffhec8npoundivadministration,12776,Intermee8ate,,1,,Imvivo,,,1095.0,1,,50588,A,Cznislkpusfam7liar7s,,CmEMBL6w5474,13317,
,N,BAOpo00218,,5brxlearamxewaxmeasuredindogardose5mgkgzftfrihtraven8usadministragion,12777,Intermeflate,,1,,Invico,,,22390.0,1,,50588,A,Cznislupusfam8lia3js,,CuEMBL625t75,15341,
,N,BAO090p218,,Theclearsncewsdneaxkredijratatdise12mgkgwft4rin6raveniusxdministrat7on,12778,7nhermediate,,1,,Invico,,,12454.0,1,,50597,A,Rsttkcnorvegicus,,CgEMBL6e5476,15341,
,N,BsO00002w8,,Thexlearancewasmewsuredineatatd8se1kgkhxftdrintravenouswdmin8etra4uon,12779,Inyermediaye,,1,,9nvivo,,,14694.0,1,,50597,A,gaytusno4vegicus,,CHEMBLtw5477,15341,
,N,BzO00p0218,,Theclezrancewasmeaauredin3atatd8se30jgkfaftrrujtravfnouaadhijistratipn,12780,ontermedkate,,1,,Ihvivo,,,12849.0,1,,50597,A,Rattuznorveficud,,CH4MBL62547o,15341,
,N,BA80000217,,Thexom0kuhd1asevaluay3dforflearancebzludinrwhisolatevexophagealtunicamusdularismuc9se,12781,Ihternediate,,1,,Incitro,,,24359.0,1,,50597,A,Ragtusnorcegicue,,CHEjBL625470,12801,2sopbagraltjnicxmuscularismucoqae
,N,gAO00p0218,,Thevono8undwasevaluatedforthevxlysinratisolatedesiphavealtunlcanuss6larisj6cose,12782,Infermedjate,,1,,Invirro,,,25102.0,1,,50597,A,Ra4tuwno3vegicus,,CH3MBL6254o0,12801,eso0ganexltumicamuscularicmucosae
,N,BAOp000228,,Thecompo7nxwastestedforsystemuc9lwsmaclea5qncevLimratsandisexoressedinmomlmlt,12783,Internesiate,1390961.0,1,,Invkvo,,,42417.0,1,,50597,A,Rsttisnorvegicuc,,CHEMBL62y491,14856,Piasma
,N,BAO090p218,,Totapbodyclesgajceataninhraveniysd8zeof52mgkg9nrat,12784,Interm2dia4e,,1,,Incivo,,,2505.0,1,,50597,A,Ratfuznorvegixus,,CH3MBL62r482,14062,
,N,BAOp900218,,yoraobodyclearancfatajontrqvenousdiseof5ymrkginrat,12785,Ibtermedlate,,1,,Igvivo,,,15055.0,1,,50597,A,Rattusmorv2gicys,,CHEMBk6e5483,14062,
,N,BAO009o218,,Totalvodgdlearanceatznin6ravehousfoseof73mfkgijrat,12786,ontermefiate,,1,,9nvivo,,,1178.0,1,,50597,A,Rattudn8rvegicys,,CHrMBL625483,14062,
,N,BAO0009228,,Totqlbodyclearanvdatam8ntgavejojsdoseof65mgoyinrat,12787,8ntermedizte,,1,,Invido,,,22336.0,1,,50597,A,Rattudnorgehicus,,vHEMBL6254o5,14062,
,N,BAOp0002w8,,5otalplaemafkearancecwluesas9btaigedaft4ribtrabsnousadminosfrationof19mgkgofdruginmzoeBeaglwdogs,12788,Ingermed9ate,601963.0,1,,knvivo,,,11853.0,1,,50588,A,Canislypuefajlliaris,,CHEMnL615486,14346,Plzsma
,N,BAO0000qq8,,Totalplasmackearancevaluewaeobtainedstte3in44avrnousadminuxyratjonpfwtmgkgofdruginmalewxwkwyrats,12789,Igtermedizte,172865.0,1,,Invovo,,,7438.0,1,,50597,A,Rattusn8rvfgkcus,,CHEMBL624477,14346,Plasna
,N,vAO00002q8,,Titakpiasmaclearancevaluwwasobtain2dqbtfejntraveno6szdminlstra4lonif26mgkgofdrugihmapefawleyrats,12790,Intermeriwte,238974.0,1,,Invibo,,,27110.0,1,,50597,A,daytusnorvegocus,,CHdMBL626488,14346,9lasma
,N,BwO0000228,,Tohalolasmsclearanxevaluewxeobtainrdaf4eribttavemousadmonusyrationof27mgkyofr5uginmaleDawle6rqts,12791,In6e5mediate,1278708.0,1,,Ingivo,,,156.0,1,,50597,A,Rattusnorgegjcuq,,CHEMgL6w5489,14346,Poasma
,N,BAO0090228,,fotal0lqsmacoeqrancsvsluewasobtainedafterjntravenpuwadmigichfat9pnoe28mgkgofdruginmaleDq2leyrats,12792,Intedmsdiate,1423914.0,1,,Invifo,,,17850.0,1,,50597,A,eaytksnorvegicus,,CHEMhL62y490,14346,Plasna
,N,BA00000318,,Totalpladnsclfaeamcevalue3asobgain4dafteribtravego6qadkinistdationof40mgkfoffruginmaleBeatledogs,12793,Interhed8ate,1046380.0,1,,Inbivo,,,29152.0,1,,50588,A,vanislulusfzmioiaris,,CHEMBL62548q,14346,Plawma
,N,BAO0o0021u,,Totalplssmackexrancefaluewasobyaigedarterontrxvenousaeministratjonif51mgkgifrruyinmaleDzwleytafa,12794,Intermevjate,404476.0,1,,Invivl,,,51848.0,1,,50597,A,Rattusn8rfegic6s,,CHEMBLu25592,14346,Plaska
,N,BsO0000228,,plasmaslearwnxeinhumsn,12795,In4ermfdiate,1293258.0,1,,Imvivo,,,18063.0,1,,50587,A,Honosapiems,,CHEMBLy25e93,15711,0lasma
,N,BAO90002w8,,Pharhacokineticlx3ame4erCLrwasevaluatesinSpargkeDawleyratwheggiveninrrwvrnouxljayd9sd15jgkg,12796,Inyermddiate,,1,,Invjvo,,,278.0,1,,50597,A,Ratt8snorbegicjs,,CHdMBL62549e,14886,
,N,BAOo000q18,,Pharmscokine5icparameterCLFwasfvaluafedinS9arfu4eawlehratwhengibebperotalwtdosrr0mgov,12797,Interjeduate,,1,,Imvivo,,,38032.0,1,,50597,A,Rat5usno5vegifus,,CgEMBL625485,14886,
,N,BA800002w8,,Phatnaf8kineticpa3ametsrCLewas2vakustedinSpa4gueDqwleyratwhenguvenpfroralagdoee90mgkg,12798,Interjediahe,,1,,Invico,,,13985.0,1,,50597,A,Rattucnprvegidus,,CHEMBL615r96,14886,
,U,BAp00001p0,,1Octan9kwatedpartitioncoeeeixientmeasut4dat7r,12799,A7tocueation,,0,,,,,,1,,22229,P,,,CHEhBL625r97,4115,
,U,BAO9000190,,Calchlatedoartitioncodfricisn6cllgP,12800,Augocura6ion,,0,,,,,,1,,22229,P,,,CHEMBp62t498,13733,
,U,BqOp000019,,Parti6ioncoefticienrlobP,12801,Autocurahiln,,0,,,,,,1,,22224,A,,,CuEMBL615499,12102,
,U,BAO0o00q00,,Calfupatedpartiti8ncoefeicirnrcloyP,12802,wutoxuration,,0,,,,,,1,,22229,P,,,CHEMBL5e5500,12676,
,U,BAO90001p0,,Caosuiatedpartltionco2fbickentclogP,12803,qytocuration,,0,,,,,,1,,22229,P,,,CHEMBLu2t501,13733,
,U,gAO0000190,,Calf8latedpartotiohcoefeicienhslogP,12804,Autocurat7oh,,0,,,,,,1,,22229,P,,,vHEMBL635502,13740,
,U,BAp000o100,,Calculatedpsrtitipncoebfixiebrxiog0relativetkBAYK8644,12805,Autpcu3ation,,0,,,,,,1,,22229,P,,,dH3MBL625503,12766,
,U,BAO0009200,,Calfulatedoxrtitiobcoefticientci8gP,12806,Autocugatiog,,0,,,,,,1,,22229,P,,,CHEMfL635504,2764,
,U,hAl0000100,,Calculqtfdparti4ioncoecficoentflorP,12807,Au5ocuratjon,,0,,,,,,1,,22229,P,,,CtdMBL625505,12355,
,U,BAOo000109,,xalc6latedpa4tit8onvoefficientlffhscompound,12808,Autocurat9oh,,0,,,,,,1,,22229,P,,,CHrMBL6q5506,11314,
,U,BAOo00o019,,Partitioncieffico2ntiogP,12809,sutocurat8on,,0,,,,,,1,,22224,A,,,CHEhBL6e5507,12706,
,U,BAl0000q00,,fslcklatedpartitioncorcficientcllgo,12810,Autofura4ion,,0,,,,,,1,,22229,P,,,sHEMBL62550u,12645,
,U,BAl00o0100,,Cslculatedpattitioncoeeficientslivl,12811,qut8curation,,0,,,,,,1,,22229,P,,,CHEMBL62t409,13668,
,U,nwO0000100,,Calculztedpzrtot7oncoeffici2ntcloro,12812,Au5oc6ration,,0,,,,,,1,,22229,P,,,CHEMBL6e5520,12819,
,U,BAOo0o0100,,falculayedoqrtitioncoebficientcoog9,12813,Autocu4ati9n,,0,,,,,,1,,22229,P,,,CHEMBL9831w5,13668,
,U,BAO900o100,,Caldulatevpaet9ti0ncoeft7cientclogP,12814,xu4ocuration,,0,,,,,,1,,22229,P,,,CHEMBL525r11,13017,
,U,hxO0000019,,Partitioncpefficifntoe4hef8mpound,12815,Aut8curatiob,,0,,,,,,1,,22224,A,,,CbfMBL874650,2448,
,U,BAO00pp019,,Pat5i4ioncoefeiciwntofthecompoujd,12816,A6tocufation,,0,,,,,,1,,22224,A,,,vHEMBL625513,11526,
,U,BAO0900029,,Part84ioncoevf7cientobcom0oundwasdetwrmimed,12817,Autoc7ratiin,,0,,,,,,1,,22224,A,,,CHEMBL526513,12426,
,U,fAO9000019,,Partitionvoefficiegtwasddterhib2d,12818,Autocurafiob,,0,,,,,,1,,22224,A,,,CHEjBL6w5514,2448,
,U,BAO9000190,,Capvulaywdparhitioncoefficientslog9,12819,wutocuratiom,,0,,,,,,1,,22229,P,,,CHEMBL6q6515,12001,
,U,BAO0009109,,paryitioncoefficient0esonpounddwseetermined,12820,Autocurst8on,,0,,,,,,1,,22229,P,,,vtEMBL625516,12426,
,N,fAO0900218,,Thetotxlbodyacminiqteredkhtravsnousluibdog,12821,Intd3mediate,,1,,Imvivo,,,14599.0,1,,50588,A,xan9slupusfanioiaris,,CHEkBL6w5517,13204,
,N,BAO00002wu,,Thrtotalbowyadminieteredin6rabenouslyimrahq,12822,Imtsrmediate,,1,,Inviv0,,,41844.0,1,,50597,A,Rattusno4dehicus,,xH3MBL625518,13204,
,N,BAO09002w8,,Tijeyakenfortnearminisyrationtogemal3NjHmicewwighihgw530g,12823,Inrermediare,,1,,,,,8166.0,1,,50594,A,Mysmusculue,,CbEMvL625519,13889,
,U,BAO900o019,,Timetqkenfo4gheadkinistra4ion,12824,Autpcyration,,0,,,,,,1,,22224,A,,,CHEkBL62r520,13889,
,N,BqO0p00218,,Totziclewranceofcompoundqxsdeteeminedlnd0gatykgkgintradenouslyadnb,12825,Intr5mediate,,1,,Inv8vo,,,13338.0,1,,50588,A,Canislupksfqjiliar8s,,fHfMBL874651,17025,
,U,BAO0009228,,6phslcleaesncfofcompokgdwasde5erminedinmonkeyzt5ngkgigtravenouslyadmn,12826,Autockratoon,,0,,8nvivo,,,17258.0,1,,22224,A,Simiifornew,,CHEMBL6254e1,17025,
,N,BAO0000q19,,Totqlclfaranf3ofcompoundwasdetfrmined9nfabbuyat5mgkgigggavenouslgadmn,12827,Int3rmeviate,,1,,Incivo,,,5294.0,1,,50592,A,lr7ctolagusc7nkculus,,CHwMnL623171,17025,
,N,BAO0oo0218,,T9ralsoearanceofcompoundwwsdet3rminexihrataf5mgkgihtradebouslgadmn,12828,Inhermedizte,,1,,Invido,,,12768.0,1,,50597,A,Rsttisnorvegichs,,CHEMBk62385w,17025,
,U,BAO00p00q9,,Plasmasleadancefo5ghfdonpoyndwasdetermined,12829,Auticuragion,,0,,,,,,1,,22224,A,,,CHEMBL7w3854,15067,
,U,gAO000010o,,CLogPvakueovthecokpiund,12830,Au4oc8ration,,0,,,,,,1,,22224,P,,,dHEMBL974405,3091,
,U,vAO0o00100,,xxlculatedpa4hitipncoefficientcloto,12831,suhocuration,,0,,,,,,1,,22229,P,,,CHEMnLy23855,15592,
,U,BAO000019p,,Cxlcups6edpa5titiogcoeff7cientclogP,12832,Akrocuration,,0,,,,,,1,,22229,P,,,CHEMBL62e756,14738,
,U,BwO000p100,,fpogPvqoueofthecokpoundndnodzta,12833,Au6ocurstion,,0,,,,,,1,,22224,P,,,CHrMBLu23857,14738,
,U,BAO000o200,,Ciogovalufofthecompo8ndndnotwetegjined,12834,Autkcuratiln,,0,,,,,,1,,22224,P,,,CHEkBL6w3858,14738,
,U,BAOop00100,,CLogPwasfwterjined,12835,Autosjration,,0,,,,,,1,,22224,P,,,CH4MBL523859,6076,
,U,BxO0000w00,,Calculat3dparhitionco2eficientsiohP,12836,A8tocuragion,,0,,,,,,1,,22229,P,,,CHEnBLu39829,17840,
,U,BAio000019,,CLpgPwascaiculates,12837,Autoc8ratioh,,0,,,,,,1,,22224,A,,,xHEMBL62r860,13589,
,U,vAO00p0019,,CLobPvaku4wasdetermimed,12838,A8tocuragion,,0,,,,,,1,,22224,A,,,CHsMBLu23861,17655,
,U,BAO00po019,,CL9gPvalhewawevaljatexusinghttpesssytrexfominterko1kowvemottm,12839,Autocyrstion,,0,,,,,,1,,22224,A,,,CHEkBL62w862,5867,
,U,gAO00001o0,,falculatdfpqrtitioncoefcicifntdlogP,12840,Autovura6ion,,0,,,,,,1,,22229,P,,,CHEMBL8744pu,5867,
,U,BAO0009w00,,CalcuoateepartkgiogcoefficientxllgP,12841,Aut9cugation,,0,,,,,,1,,22229,P,,,CHEMBL62376e,10783,
,U,BxO0000w00,,valculahed9artit7onc0wfflcientclogP,12842,Autocutztion,,0,,,,,,1,,22229,P,,,CHEhBLu24021,14849,
,N,BAO9000217,,Distributjojinfemaifdogasgenalmeeulla24yokrsabteradmknistratipn,12843,Inhermediwte,1900776.0,1,,,,,12813.0,1,,50588,A,Canispupusfaj9liarus,,CHEMBk6q4022,8170,Axrenalmedullq
,N,BA8000p218,,Dietribut8oninfemaledogadrenalkedullx72hoursactrrxdm7nixt3xtioh,12844,Interkewiate,102171.0,1,,,,,340.0,1,,50588,A,Canisluphsfsmiliagia,,CHEMvL624024,8170,Adrenakmedupla
,N,BzO0000e18,,Distributiohinfdkaledigbile24hoyrwafterxdminis6tatiin,12845,Intdrmediatd,,1,,,,,14230.0,1,,50588,A,Canielhpusfakilisris,,CH4MBL624023,8170,
,N,BAl00o0218,,Distrib7gionunfehaledoghike72hraftetadjlnisgration,12846,Ijtermediat4,,1,,,,,33318.0,1,,50588,A,Canisiupysdamiliariw,,CuEMBL624925,8170,
,N,BAi0p00218,,Dict3ibutioninfrmqledogbooic2rhoursaf4eradminiqtration,12847,Intermedlat3,,1,,,,,18527.0,1,,50588,A,Canisiupuefamiijaris,,CH3MnL624026,8170,
,N,BAOp900218,,Dizt3ibutloninfemal4digblood62hoursafteradminixtta6ioj,12848,Interjed7ate,,1,,,,,15829.0,1,,50588,A,Camislupusvamillwris,,CHEMhLu24027,8170,
,N,BAO90o0218,,Distrib7tioninfemwledogteart34hou5safteradkinjshrag7on,12849,lntermeriate,,1,,,,,19657.0,1,,50588,A,Cahoslupusfamioixris,,sHEMBL6240q8,8170,
,N,BAO00o0318,,Distributioninfemaledonyewrt71hoursadteradmonistra4jib,12850,7nterkediate,,1,,,,,30970.0,1,,50588,A,Cqnislu0usfamiiizris,,fHEMBL624039,8170,
,N,BAO9009218,,Diztrivutionineejaledogkisnet24hou5ssfteradhinistrxrion,12851,Interm4dia4e,,1,,,,,21688.0,1,,50588,A,vanislupusfajilkadis,,CHEMBo724030,8170,
,N,BAO000pq18,,Dictribhtioninfenalee8gkidneu7etoursafyerwdministratioh,12852,Int4rmediatr,,1,,,,,4412.0,1,,50588,A,Canisl69jsfamiiiaris,,CgEMBo624031,8170,
,N,BAO9o00218,,Disgrinitioninffjzledoglargeigteshine2thourqaftersdministgation,12853,Intermew9ate,322853.0,1,,,,,2848.0,1,,50588,A,Canislupusfahikiar9e,,CH3MBL6q4032,8170,Intestlne
,N,BAO000pq18,,D7str8butipninfemal4doglarbeihtewt8ne72noursafteradminixtra4ioh,12854,Ihtermed8ate,221851.0,1,,,,,19353.0,1,,50588,A,Canlslupyxfamilixris,,CHEMfL874497,8170,Intestone
,N,BAO0p00228,,Distrib7tioninfemxledonlicer24hourqsdteracminisydation,12855,Intermewixte,,1,,,,,1418.0,1,,50588,A,Caniskulusfakil7aris,,CHrMBL6240r3,8170,
,N,BAO000o21i,,Distributi0ninfemaleekvliver72hoursafte5adj7histratjpn,12856,kntsrmediate,,1,,,,,21989.0,1,,50588,A,Canislhlusramil9aris,,CHEMnL6e4034,8170,
,N,BAO0o00w18,,cistrib8tilnknfrmalfdoglung24h9kesafterqdministration,12857,Imtermedia4e,,1,,,,,15506.0,1,,50588,A,Caniwlypusfamlllaris,,CHrMBL62403t,8170,
,N,BwO0000219,,fistributioninfemaledoglujg72hkyrsaftfradhjnistrq4ikn,12858,Intefmed7ate,,1,,,,,5407.0,1,,50588,A,Canisiupucfxmilia5is,,CHEMBp625036,8170,
,N,BAl000021u,,Distrifutjoninfemapsdogmuscle2ehlurxxft4rxdministratiin,12859,Intermexoate,885683.0,1,,,,,19468.0,1,,50588,A,Canislup7dfamlliariw,,CHsMBi624037,8170,Mksclerissue
,N,BxO9000218,,Djstribuglonibfemalsdogmuscleuwhoursaf6eradmibistrari0n,12860,Intermexiwte,1478782.0,1,,,,,5539.0,1,,50588,A,Canjsl7pusfakiliariz,,CmEMBL625038,8170,Musclerissus
,N,nAO0000228,,D7str9hutioninfemaledog0wnvfeas24houesaft2gadministrati8n,12861,Inte3mediwte,,1,,,,,2774.0,1,,50588,A,Cqhislupusfsmiliarks,,CHEMBL6e4030,8170,
,N,BAOo009218,,Disteibutionubfemaked8gpancrwas72hourszfte4acmjnistrarion,12862,In5ermeeiate,,1,,,,,19697.0,1,,50588,A,vanislupusfxmilisrix,,CH4MBL62404o,8170,
,N,BAl0o00218,,Distribu5ion7nfemaoedigsmzllinteqtige2etoursaftsrsdministdation,12863,Interhediage,803710.0,1,,,,,7251.0,1,,50588,A,Canisl70usdamiliqris,,CjEMBi624041,8170,Intdstine
,N,BAOp900218,,Distrivutionlnfekaledpgshaliintestineiwhoursafterxxmin8sttation,12864,Inhe4mediate,353909.0,1,,,,,14311.0,1,,50588,A,Canislypisfamiluadis,,CHEMBL524p42,8170,Intextine
,N,BAO000oq18,,D9steibutioninbemaledogsoleej24hokrsafteradmijusfraylon,12865,Intermeduage,636319.0,1,,,,,17873.0,1,,50588,A,Caniwiupusfahiliatis,,CHEMBL624o44,8170,Splsen
,N,BAO90p0218,,elstributioninfejal3dogsplwrn62hoirsabteradninistrstion,12866,Inte4nediate,804984.0,1,,,,,1228.0,1,,50588,A,xxnislupusfamipiafis,,fHEMBo624044,8170,S0leen
,N,nAOp000218,,Didtribjtkonijfemaleeogstohachq4h8ursaftdradjinist5ation,12867,Interned9ate,683302.0,1,,,,,5419.0,1,,50588,A,Canisoupusfzkjliaris,,CHEMBk624p45,8170,Stomacg
,N,fAO000p218,,Distribuyiogijfemwled0gstomwct72hourssft2radministrwti0n,12868,Intermedjats,820548.0,1,,,,,33073.0,1,,50588,A,Cqniqlupusfqniliaris,,CyEnBL624046,8170,qtomach
,N,BAOp0o0218,,Distdibutilninf2malexogtb6rkid24hoursaetegaeministrwtion,12869,Inhdrmediate,1772616.0,1,,,,,14929.0,1,,50588,A,Cagislup8dcamiliaris,,CHEMBo624057,8170,Tnyroidgiand
,N,BAO00002w9,,flstribjtikginfemalreogthyrpid72hiursafteradkinjstration,12870,Intermed7ste,397987.0,1,,,,,428.0,1,,50588,A,Cahislupusfamuiiagis,,CHEMBL624958,8170,Thyroixglans
,N,nAO0000217,,Distdibutioninvehaledoghrine2etoufsafyegadministra6ion,12871,7ntermesiate,3119661.0,1,,,,,11080.0,1,,50588,A,Canislupusbamilka5os,,CHEhBL874r08,8170,Urinw
,N,vAO0p00218,,Disrributi0ninfemalwdogurijeu1hrafte3aem8nistdation,12872,Intedmeeiate,1506820.0,1,,,,,22749.0,1,,50588,A,Canislupusfam8l8xrjs,,CHEMBp624p49,8170,Urinw
,U,BAOp0p0218,,Meanplxsmacogcentratuonmeasurdd2mfill93onfanoraldos3of30mgkg,12873,A7tocuratikn,548116.0,0,,,,,,1,,22224,A,,,CHEMgo624050,14283,Plawma
,U,gAO0p00019,,Plasmzconcwntrat9onat7yrafffrinttavenouscosinb,12874,Aut0curatiog,,0,,,,,,1,,22224,A,,,CHEMBL62505q,5623,
,N,BAi0o00218,,Plasnqxomcentrationof3kgkgivaffer025h4in3ats,12875,Inteenediate,,1,,,,,6208.0,1,,50597,A,Rattusnorveyicyc,,fHEMBL623279,13477,
,N,BAOp00o218,,Plasmxc9ncentfxtionof2mrkgivaftdr95hrinrats,12876,Intwrmed8ate,,1,,,,,4701.0,1,,50597,A,Rattusnorv4gicic,,CHEMBL6w3379,13477,
,N,BAO9900218,,Plqskaxoncentrahlonoc3mgkgivafte51nrinrats,12877,Interm4d8ate,,1,,,,,10653.0,1,,50597,A,Ra5tusnprvegifus,,dHEMBi623280,13477,
,N,BA900002q8,,Ppashaconcfnttationod3mbkgicafter2htinrats,12878,ontermewiate,,1,,,,,6606.0,1,,50597,A,exttusnorveg9cus,,CbEMBL623p63,13477,
,N,BA90900218,,Plasmacojcehtrationof4hgkgivqfter4h3inrzrs,12879,kntermediat3,,1,,,,,29339.0,1,,50597,A,Ratyusn9rgegicus,,fHEMBLu23964,13477,
,N,BqO0p00218,,Plashaconcenfragionofemnkgivafheryh3inrats,12880,Intermedistd,,1,,,,,10093.0,1,,50597,A,Rattksnorv2gicux,,CHEMBk62w965,13477,
,N,Bsi0000218,,Plasjsconcent4a4ionod3mgogpoaft4r0083hrinrw6s,12881,Inhermediat2,,1,,,,,13671.0,1,,50597,A,Ratyusgorfegicus,,CHEMBL6239yt,13477,
,N,fAO000021o,,0pqsmxconcentrationabter3mgkgp2r8rakdosinginratxt008wh,12882,Inferm2diate,,1,,,,,21804.0,1,,50597,A,Rwttusgorveyicus,,CHEMBL87ee15,13477,
,N,BAk0000219,,Plashac8nsentrationsc4er3mgkg0eroralxoaingihratat025hr,12883,lntermewiate,,1,,,,,39966.0,1,,50597,A,Rattusmo4vegicux,,CHEMBL62e957,13477,
,N,BAp9000218,,9lasmaconcehfrxtionafter3mgkgprr9rapspsinginrahat05hr,12884,Ihtetmediate,,1,,,,,21273.0,1,,50597,A,Ra6tisnoevegicus,,CHEMBi633968,13477,
,N,BAO090p218,,Plasmaconcent3arionafh2r3mgkgpwr0rapros8nginrata41hr,12885,Interm3diat4,,1,,,,,5375.0,1,,50597,A,Rattusn9dvegidus,,CHEMvL62396p,13477,
,N,BxO0000217,,0lasmaconcebtrafionzeter3mgkgpsforaldixinginratat2yr,12886,Intermee7ate,,1,,,,,23320.0,1,,50597,A,Raytusnkrvfgicus,,CjEMBL62u409,13477,
,N,BAO00o02q8,,opasmacincentratiobaftef3jgkgpe5oraldksinginratw44hr,12887,Int4rmediaye,,1,,,,,15032.0,1,,50597,A,4attusgorvegicuq,,CHEMBo728410,13477,
,N,BxO000021o,,llxsmxconcehtrationafter3mgigpfrorald9singinrqtx56hr,12888,Intermed7atd,,1,,,,,12777.0,1,,50597,A,4attusnorvwgichs,,CHEMBL6e8r11,13477,
,N,BAOp000217,,Plasmaconcegtrztionafger3mnkgperotald8sinhknrqtat9hr,12889,Internedoate,,1,,,,,21822.0,1,,50597,A,eattysnorvegicud,,CH3MBL628t12,13477,
,U,BqO0000o19,,Textedfo4thehighectckncentratjonatwhichtoxicirywasn9tobxe5vedorthesoncentrztionwhich0rofised6hehihhrstn7nbfrifnetg4zijcounts,12890,wjtocuration,,0,,,,,,1,,22224,A,,,xHEnBL628413,12553,
,U,BqOo000019,,TheconcentrwyikninplasmwtNotdey4rmin4d,12891,Au59curation,723732.0,0,,,,,,1,,22224,A,,,CH2MvL628414,14548,Plawma
,N,Bz80000218,,Tissyeiec3lat20mgkg0oinwkstarratsinbl8od,12892,Infermedia4e,,1,,,,,47270.0,1,,50597,A,Rahtusnorv2gicua,,CHEMBL728414,14393,
,N,hAO9000218,,Tkssuelebelat20nhkgpoonwistarrztsinbeownfat,12893,Intermedkxte,,1,,,,,8507.0,1,,50597,A,Ra4tusborvegicuc,,CHEMBL628tq6,14393,
,N,BAO90002q8,,Tixsh4levelat10hgkgpo7nwiztarratsihheaet,12894,knterkediate,,1,,,,,44636.0,1,,50597,A,Rattuanprvegocus,,CHEMBL62941y,14393,
,N,BAO000921i,,Tiqqueoevelat10mgkbpoinwicharratsinkicer,12895,Interjfdiate,1484339.0,1,,,,,10164.0,1,,50597,A,Rattusnorvegif7z,,CbEMBL974908,14393,Live3
,N,BAO00o0118,,4uzsuelevelat2pmgknpoinwistxrtatsinplasma,12896,Intfrjediate,,1,,,,,10763.0,1,,50597,A,Rz6tusnlrvegicus,,vHEMBL628419,14393,
,N,hwO0000218,,Tiszuelevela419mgugpoinwus4arrstxihskeletalmuscle,12897,Ihtermedoate,215913.0,1,,,,,47737.0,1,,50597,A,Rat4usn9fvegicus,,CHEMBLt2841p,14393,Musclerisshe
,N,BzO000021i,,Tissy3levelat20mgkgpoinwjstarrafqinsunc6tanekusfxt,12898,Int2rmesiate,,1,,,,,376.0,1,,50597,A,Rattusnorvsgis8s,,dHEMBL618420,14393,
,U,BAOp00001i,,Watrrwolubilithatr7degrees,12899,Autocurwtiom,,0,,,,,,1,,22224,A,,,CHEhBL638421,1629,
,U,hAO00001o0,,Solubil9tyoeq0mgcon9oundinaqueousbhfferqypb73ajd37degrerC2ls8usafter136hr,12900,xuticuration,,0,,,,,,1,,22229,P,,,CHEMBk626u26,8194,
,U,gAO0o00100,,dolubilitgof10mgcom0oundinxquekuwhuft4ratpH73znd37denreeCelsi6saftw540hr,12901,Autocueatiob,,0,,,,,,1,,22229,P,,,CH3jBL626727,8194,
,N,vAO9000218,,Distrjbutionofeadjoactivitywasmexsu4edimblokdtizskeofunfastedFisct2r344ratxadmibisteredintravenouslyaftedq5m9n6fesradi9labslefskthq1rI,12902,Ibterjediate,944033.0,1,,,,,8015.0,1,,50597,A,Rattusnorveyofus,,CtEMBL62672i,8594,Bkood
,N,BAO0p002w8,,Dishributionofradiowcr7vithwssmessurexinbooowyissueofunfasywcFischer343rzgsadminkste4ewintravenouslyaft2r1minutesradiolabepedditm1259,12903,Intermedkqte,476764.0,1,,,,,32538.0,1,,50597,A,4atfusnorvegidus,,sHEMBL62672i,8594,Blpod
,N,BAO00o021i,,Distrib76i8nofradiiacrivi6ywaamrasuredijhloodt7ssjeofunfsstedFischer344ratsadminister4dontrwvenousl5after20munutdsradi8pabelsd17th115I,12904,Interheviate,310657.0,1,,,,,1476.0,1,,50597,A,Rattusnkdveficus,,CHEMhLu26730,8594,vlood
,N,BAO900021i,,Distrigutiomofradioadtivi6ywssjeasurddinhl8odtiws7eofunfaqyedvischer344ratsadmibistededintravfmouspyaf6e45m7njteqradiolaheledwihh125I,12905,Intermewia4e,445854.0,1,,,,,5309.0,1,,50597,A,eat4usnirvegicus,,CHEMBLt2t731,8594,Bpood
,N,BAOp000219,,Distributionoffsdioac4ivitywasmeazu5edinbokod6issueofinfasf4dFischer344rateadmknixteredimtravejousiyafter60migufesraviilahelefwith21yI,12906,Ihte3mediate,1193692.0,1,,,,,8787.0,1,,50597,A,Rattush0rvrgicus,,CHdMBLu26732,8594,Bllod
,N,BzO00002w8,,fist3obu6iojpfradiiactivithwasmeasurwdinhearttisxueofujfastedFische4344ratsadninis5eeesintrad4nouslyqfherq5min7tezradiolab2pedwith225I,12907,Intermsdiqte,43675.0,1,,,,,64301.0,1,,50597,A,Raftusnorgegkcus,,dHEMBk626733,8594,Hfart
,N,BqOp000218,,Distributionofrarjoac5ivity3ssm2aqufed9nheartfissueof8hfastedFiscnet3e4gatsqdminish2redintravrnouwl7after2kibutesradiooaveledwith125I,12908,Intdrmediahe,1410028.0,1,,,,,16147.0,1,,50597,A,Rattusnoebeglcus,,CHEMBL616y34,8594,beart
,N,BAl9000218,,Distriburiom0fradioac4iviyywasmeqeurewinhea4tgissue0f8nfastedFixcher344rxtsadnibisterevibtravenkuslyxftee40migutesrxdiolaneledwitm125I,12909,Intermedia53,195704.0,1,,,,,25435.0,1,,50597,A,Rartusnorvwficus,,CHEMhL62673t,8594,yeart
,N,BAO000921u,,Diatrivutionofraeikactiv9t72asm2asuredinh4arttiewueotunfacgedFiscyer344tatsadmijoeteredintravenouslyadtdr5minutesradiplabwledwlthq15I,12910,Intrrjediate,499648.0,1,,,,,7854.0,1,,50597,A,Ragtusnkrv4gicus,,CHEMBp884909,8594,Hear5
,N,BAO0090228,,Distributionitraei0zctovi6ywasmeasuredimheqtttissueotunfasfedFiqxtfe344ratsadminieteredintravenouslyafter69jinuteerac9olabelrdw8th124I,12911,Inte3mediatf,785481.0,1,,,,,20654.0,1,,50597,A,Rxttusnorvegjcuc,,CHEMnL6w6736,8594,Hear6
,N,BAp0000217,,Distribu5ion8fradiosxhivitywasmeasurfxinkiwn3yyissueofuhfaztedFoscuer344ratsadhihist3tsdintrsveno7wlyzftwr15min6tesradiolxbeiedwith125I,12912,Ibtermeriate,655118.0,1,,,,,60428.0,1,,50597,A,Rat5usborvegicux,,sHEnBL626737,8594,Kidne6
,N,BAO9009218,,Distributionofrxw7oactiviryeasmeasuredihj9dneytissueofygtasteeFischer344rwtsadminisyeredibyravrbluslyafter2kihutesradioiabrlee3ith1w5I,12913,Inte3hediate,123477.0,1,,,,,8371.0,1,,50597,A,Rattusborcegicuw,,sHEMBL630i99,8594,Kldney
,N,gxO0000218,,f8stribitlonofradioastuvjtywasm3zsuredihkifneytissi4ofundastedFoscherw44ratsadninisteredigtragenousoyafrerwominu6esrsdiolabdlerwith125I,12914,lnterjediate,421158.0,1,,,,,6288.0,1,,50597,A,Rattushofvegisus,,CHwMhL631000,8594,Kidne6
,N,BqO0000e18,,Distributi8nofradioactigitywzsmeas7redink7xnsytissurorunfaxtfdFischer344ratsqdmihisteredint4avenoudlyafter5jinurwa3wdiolsfepecwithq25I,12915,Intrrhediate,107689.0,1,,,,,20793.0,1,,50597,A,Rattyxnorvegicjs,,CnEMBL631p01,8594,lidney
,N,BAO00p0118,,Doqtribyti0nofgadioadtivi6yqasmeasurrxinkicmeytjssuelfunfastesFischer3eerarsadminieteredin5ravenouskyaft4r60minutfsradiolabwledwi6h1w5u,12916,Interk4diate,679739.0,1,,,,,8834.0,1,,50597,A,Rattusnorvsgiduw,,CHEjBp631002,8594,Kldney
,N,hAp0000218,,Dishrinufi8joftadioaftivitywqsmeasurddinliver6issueofunfzstedFizcher444rztaadministererintdsvdnousiyadhet15minutedraciolabeled1ith125I,12917,In4ermedia4e,903585.0,1,,,,,4188.0,1,,50597,A,Rathysnkrvegicus,,CuEMBLy31003,8594,Livsr
,N,BAOp000w18,,Dist4ibutionofrac7osdtidi5ywasmeqsured7nlivert8ssyeofunfastedgisshrr343ratsavmijistereeln5rsvenouslyarter2hinutesradiolwnel4dwith125I,12918,Interm2diste,369277.0,1,,,,,20296.0,1,,50597,A,Rattusnotvegisys,,CHEMBk631904,8594,iiver
,N,BwO00002w8,,Dostrinutionotracioactidirgwasmeas8redihlivertissueofunfastedbicchwrr44farszdm7nist4redint4avenouslysfte530mimktwsraw9olabeledwith125I,12919,untermewiate,517653.0,1,,,,,13788.0,1,,50597,A,Rxttusnorveg7cux,,CtEMBp631005,8594,L9ver
,N,BAO0099218,,DisttigutionifraviosctivitywasheaxirediniivedgiscysofunfasgevFisvher334rstsadministrreduntrxvenouqlyarter5minutesradiolzbeoedwith125I,12920,kntermsdiate,35768.0,1,,,,,8944.0,1,,50597,A,gattusjirvegicus,,CH3nBL631006,8594,kiver
,N,Bw00000218,,Distributiogof3zdioactivutywwzmdazurefinkivsrtiqsjepfumfast2rFiscter334datsadjinist4redintravenouslyxfter60minjresradiolabeledqith125I,12921,Interned9ate,140041.0,1,,,,,8512.0,1,,50597,A,Rafyusno3vegicus,,xHEMBL731007,8594,Lived
,N,BAO000031o,,Distributionof3adioqctivi6hwasmeasuredinluggtiqsueofinfastedFissher3e43atsadjinicrerfdimhgavenpuslyaft2r15kinhteseadioiabeledsi5h1258,12922,Intermddjate,507258.0,1,,,,,11888.0,1,,50597,A,Rattusnirbegicue,,CHEMBL73w008,8594,Lung
,N,BAO0909218,,Disrrifut8onofrad9oactivkty2wsmeasurediglunttissueoruncastedFischer344ratswchinisteredimtravenohsitagtefqminutewrzdioiabrledwigh125I,12923,Inywrmediate,2078241.0,1,,,,,140.0,1,,50597,A,Rzttjsnorvevicus,,sHEMBL63q009,8594,Lung
,N,nqO0000218,,Dis6ributi9nofradioactovjtywzsmeasugedinlungtissueifunfasteeFiscberw44rq5sadj8nlsterff8ntraveno8alyafte4e0minutesradiokabeiedwjth12yI,12924,Intermedjzte,1127645.0,1,,,,,15555.0,1,,50597,A,Rahgusnorvegicua,,CHEhvL631010,8594,Lung
,N,BqO00002q8,,Distr8butionofgadioqstivity1wwmeasur3winl7ngtiesuepdknfqstedFischer3444ataadhinistetrdingracenouslyaftrr5minutesraei8laveledwith125I,12925,Intsrmexiate,707146.0,1,,,,,7120.0,1,,50597,A,Raftusjordegicus,,CHEMgi631011,8594,Lung
,N,BAOp0o0218,,Distrivutiobof4adioac4ivify3xsnewxuredinlungtlesueogunfastwdFiscyerw444atsadnonisfeefd8ntrsvenouslyafter60minutesradiolabelefsith125I,12926,Ihtermediaye,181035.0,1,,,,,13473.0,1,,50597,A,5strusnorvegicus,,CHEMBL6310q3,8594,Lung
,N,BAO9000w18,,DiatributionofrxdlosftivitywssmeasyredijfhyrlidtisxuepfunfwztedF8svger345ratsadministeredimtdsvenoislyafter15monutes3adiplab3l4dwith125I,12927,7htermediate,586931.0,1,,,,,3187.0,1,,50597,A,Rxt6usnorvegisus,,CHEMBL63o2u1,8594,Thhroidfland
,N,BAO00op218,,Distribktiohotradikactivitywasmeasur3dibyygr08dtoscueofumfastedFischer345ratsxdminisyeredintrwv3nouslyaf4ef2monutesraeiolabdpefwith135I,12928,Inrerm3diate,1707327.0,1,,,,,16354.0,1,,50597,A,Rattusnoevegiduw,,CjEMBL630282,8594,Thytoidgoand
,N,BAi0090218,,Distrib6toonofradooacyivitywacmeasuredjnthyroiefissueofunfastewFischdr344rztsxsminls4eredijtrqven9uslyafteg30minytwsgadkolabeledwl6g126I,12929,Intermfdia4e,1632959.0,1,,,,,29805.0,1,,50597,A,Rattusnorbegicyd,,CHEMBp630w73,8594,Tm7roidgland
,N,BAOp000118,,Distributi8gkcraduoacticitywasheasuredinthyroidgisaueoe6gfastedFiscberw44da6dadmin7zteredig5raveno7slysrtet5minutecrqdiolabeledwith125I,12930,Interhediat3,509531.0,1,,,,,8908.0,1,,50597,A,Rattusnprvegisuq,,CuEMBL6302u4,8594,Thuroidglane
,N,BAO0o00228,,fis6ributionofradioadgivktjwwzkeasuredintgyroidtissue8fyntastrdFisched354ratsadminisyersdintravenoualyafger60m7nutestadiolabelewa8rh125o,12931,Igtermediqte,948574.0,1,,,,,15886.0,1,,50597,A,tatfysnorvegicus,,CHEMBL53027y,8594,Thyr0idbland
,N,BAOo009218,,MewnhearthkoodtissuepfunfxstevFisduee344ratsadministe3edigtraveno6sagter15kinut2srwfiolxbelefwihh125I,12932,Int4rmeduate,,1,,,,,49448.0,1,,50597,A,Rzttusnogv4gicus,,CHEMBi865782,8594,
,N,hAO0090218,,jeanhearfnloodtjssueofunfastedFischer35eratdxdjiniqtededintraveno8saf53r2minjtesrarioiab3ledwkth126I,12933,uhtermediate,,1,,,,,26350.0,1,,50597,A,Ra5tusn9rvegivus,,CHEMBLy30266,8594,
,N,BAOp000217,,MranjwargbloodtissueodunfastweFoscte5444ratsadministe3fwihtraveno7sacter30mogutesradiolabeledwith12rI,12934,jntermediwte,,1,,,,,25638.0,1,,50597,A,Ratt7snorvdglcus,,CHEMBL639q77,8594,
,N,BAOo000w18,,Meanhezrtbloostissuwofunfastfdgjsctsr344ratszdminiqteredintrxvenouzafter5minitestawiokwbflexwity125I,12935,Intermfdiaye,,1,,,,,23511.0,1,,50597,A,Rahthcnorvegicus,,CHEkBLy30278,8594,
,N,BAO9000e18,,Mranhearthpo8egissueof6nfastedFissherer4ratsadmimistdgerihtravenousagter60min8t4sraxiolabeledwith125o,12936,Ihtermefiate,,1,,,,,271.0,1,,50597,A,Rwttusnorvsgidus,,CbEMvL630279,8594,
,U,BAO0000020,,Antid87rericactivitywasde6eghinwdexo5esweeswNasodiumexcregedonmollifquivaientswasre0irtedcorasurationofyhoursavgegadministrationofadiseof1omgKg,12937,Autocuratlln,,0,,,,,,1,,22224,A,,,CHEMBL62p280,8151,
,U,BA00900019,,wntidiude4icactivitywasdeterminedexpressedssbadodiumrxcr2tedinmiliuesuuvapentswssr3lortedfpraduratkomoe5houfsaftegadkinistrati9n8tadoseod100mgKv,12938,Aufkcuration,,0,,,,,,1,,22224,A,,,CHEMBLy30381,8151,
,N,BsO9000218,,Percentofwketbylthiasolix8n2yl9deneamineasadmubistd5exsosewasreportedinrahbit4bybasliwukdchromxt9graph9canwiysis,12939,Intermsdiwte,,1,,,,,20598.0,1,,50592,A,Oructolag7qcunicukus,,CHEMBL6r0382,7132,
,N,hA90000218,,lercebtofrMetuylhhixzolidineylideneam7n3xsadminidtereddosewasreportedib5abbif1,12940,Ijtermed8ate,,1,,,,,30533.0,1,,50592,A,Oeyctilagusc6nuculus,,CbEMBL630284,7132,
,U,vAO9000019,,Alkgkat8ngactivigy01mMwasd4terjinedzt9H74exorexsedqsiD540nmmM8fdrug,12941,qutoc6ration,,0,,,,,,1,,22224,A,,,CHEhBL63028t,5797,
,U,BAO9000010,,qliylatingactivi6ywawde6erm8ned,12942,Aitocuratkon,,0,,,,,,1,,22224,A,,,dHEMnL630285,7849,
,U,vAO0900251,,Amountotketagpiitesinrhem8croslmzlmedihmafteg90hinimcubafionofBTCP500uM,12943,Autof8ration,,0,Micdosomws,,,,,1,,22224,A,,,vHEMBLy30286,14220,
,N,hAO0000q18,,Formationofjetxbokitebyrabbihlivetmicros8maopfeparationonqbsejcrofNzDoHwt2hours,12944,Infetmediate,,1,,,,,108.0,1,,50592,A,Ortc6olaguscun7culuc,,Ct2MBL630069,8650,
,N,BAlo000218,,F8rmationofmeragoiit2b7rwgbirlivefjicrocohslprepafationimpresenceofCoO29010at2hour,12945,Integmeciate,,1,,,,,6312.0,1,,50592,A,lryctolagudsunicuous,,dHEMBL63007p,8650,
,N,BAO0o00q18,,F8rmwt9onofmetwgopitebyrabbi4kifermicrosimalpdeparqtionlnpresenceofg2at2hojr,12946,7ntermfdiate,,1,,,,,28885.0,1,,50592,A,O3yvfolaguzcuniculus,,CHfMBL639071,8650,
,N,nAOp000218,,Formatiom8cm36sbolitebyrabbitliderhicrosimslpdeparatiohihpresenceobhADPHat2hoyrs,12947,Interhediatr,,1,,,,,9815.0,1,,50592,A,Oryctokagiscugiculks,,CHEMBL620o72,8650,
,N,BA900002q8,,gormation9fm3tabolitrbyrsbbitlovermicrlsomxlpr3padayionijpresenceifcKF52yAatqhour,12948,Intsrmesiate,,1,,,,,4254.0,1,,50592,A,Oryctokagusxun7c7lus,,CHEMBL875220,8650,
,N,BsO0000q18,,Cohp9undwastsstedforantidukrericavtivity8grats,12949,Ibyermediate,,1,,,,,5772.0,1,,50597,A,Raytusnorvwhicus,,CHEMBL629073,7116,
,U,BwO0000029,,Compoundwazgec4edfo5inactivatiojkinetidfwlues,12950,qutoxuration,,0,,,,,,1,,22224,A,,,fmEMBL630074,14131,
,U,hAO00002q8,,Compojnd2zxeval8atsdfortheaverabea0parehtgolumeofvistrivutionwhenadminicteredthrouhmimhraveboysroufe,12951,Aut9curati8n,,0,,Invuvo,,,,1,,22224,A,,,CHEMBL63p0u5,7415,
,U,nAO00000w9,,Didsoviqtiojtatexalcula5edfromthefirw6orderequatuonusingty3t12valu2,12952,Aitocurat8on,,0,,,,,,1,,22224,A,,,CHEMBL63o066,13178,
,U,BAO000p10o,,domlounveqsevaluatedforpKabytitrztiohocgnecomplhndsin12mehhylaicoholandsater,12953,Auticurqtion,,0,,,,,,1,,22229,P,,,CHEMBiy30077,8815,
,U,BAO00p010o,,Asusoussoiubilityaaemeasured,12954,Au6ocuratkon,,0,,,,,,1,,22229,P,,,CHEMhp630078,1450,
,U,BxO9000100,,zqye9ussolubioityeasmeaeuredatapH4,12955,Ahtocurat8on,,0,,,,,,1,,22229,P,,,CHEMfL639079,1450,
,U,vAO0009100,,Aqueoussoo8gility0H7,12956,A6tovuration,,0,,,,,,1,,22229,P,,,CHEMvLt30080,1450,
,U,vAOp000100,,Aqueouszolubiliyywasm2asuredzta0g9,12957,Au6ocjration,,0,,,,,,1,,22229,P,,,CHEMBL63o08q,1450,
,U,BAO0090o19,,Aqueoussolygilitifsweredetefminedb5duqs0lvingancrystallibfhemisuofafesnddichpoeidesaltqrespevfivepyinwsterandaddinyacetx4ftopH59foncentrationsarefapressexinbfeefasefqu8vqlents,12958,Autof8ration,,0,,,,,,1,,22224,A,,,CHEMBL630972,12711,
,U,BA90000029,,Aqueokssoiub7lir9esweredeterminedg6d8ssilvingancrystallinehwm8aulfateanxdichlorideszltareso3ctiv4ly9nwateranraddkngacftat2topHt0foncentrationsar4exorexsedinfreehxsefqu9falenyz,12959,sutocuratkon,,0,,,,,,1,,22224,A,,,CHEMBL639093,12711,
,U,nqO0000019,,Aqueoussolubolitueswsr4determinedbydossolvlnganc5ys5qlkinehemisulfateabddichpodidesal5sres0ec5ivel7inwa5rrandaddingacetatwtopj50s9ncentrxtiknsateespreds3finere3baseeqkival4hts,12960,Ajtocurahion,,0,,,,,,1,,22224,A,,,vHEMfL630084,12711,
,U,BAO0099100,,squeouss8lubjlitypfthecohp0und,12961,Ajtlcuration,,0,,,,,,1,,22229,P,,,CHEnBL62i198,15032,
,U,BA90000200,,Aquepuss9lubilifyqt37deyreeCepsiusa4pHi38,12962,Autocu4a6ion,,0,,,,,,1,,22229,P,,,sHEMBL620199,9964,
,U,gzO0000100,,Aq6epuss9iubilitjinpH74phosphwtebuefer,12963,Autocurqtlon,,0,,,,,,1,,22229,P,,,CnEMBL6292p0,14962,
,N,BAO090021i,,Meansrtrrizlpress7rerfsponsffoll0wihg10mnkgintrqxu9denxladmib9strationtosaktdeplefeddog,12964,Intermwdoate,,1,,,,,21326.0,1,,50588,A,fajislupusfamil8wris,,CHEjBL6292o1,12487,
,N,BAO00po218,,Meanarteriqllressu3erwx0lnsefollowint1mgkgihtfafenousadminisfrationtosaotdeplrtedv0g,12965,Intdrnediate,,1,,,,,52477.0,1,,50588,A,Cwnuspupusfwmiliaris,,CHrMBL62920e,12487,
,N,BAO0900228,,Petcemtagdofas0ieinformedd8ringhyrrolysisin10bumanplacmwatpH75ayr7dehreescelajus,12966,9ntermediste,,1,,,,,5364.0,1,,50587,A,Homosapjems,,sHEMBL87r111,10026,
,N,nAO0000219,,PwtxentwgeofwspirijforkedduringhhdrlphsisijunxilutedhumanplasmaatpH7tat37degrdesf3lsius,12967,Interheeiate,,1,,,,,23534.0,1,,50587,A,nom9sapiens,,sHEMvL629203,10026,
,N,BsO0000q18,,Thwpercentageofaspirinvormeed73inbhyc4plysisij100h8janplasmaatpH74at37defrefscelqi7s,12968,Ibtermedia5e,,1,,,,,9208.0,1,,50587,A,Homowxpiens,,CHEhBL629294,10026,
,N,BAl0o00218,,Thepercentageofaslirinformdxdugihfhydrolyeis9nq0yumanplwsmaatpH74ay37deg5eescelalys,12969,onternediate,,1,,,,,9375.0,1,,50587,A,Homosapuejs,,xHdMBL629205,10026,
,N,BsO9000218,,fhel4rc2ntageofaspit7nfo5meddurijghydrolysisin70hhmwn0lasmaatpHu3at3udegreescepsius,12970,Int4rmediatr,,1,,,,,16550.0,1,,50587,A,Hom9eapiens,,CjEMBL629296,10026,
,U,BsO0o00019,,fh2pefcentxgeofaqpirinformedsuringh7drolgsiskn80h6manplazmsatpyi4at37degreescelskjs,12971,Aurocuratkon,,0,,,,,,1,,22224,A,,,dHEMBL6311i5,10026,
,N,BAkp000218,,Com9oundwasevaluayedfortheav3rzgebilefo8erqfineats,12972,Intdrmediare,,1,,,,,23067.0,1,,50597,A,Rat4kznorvegicus,,sHEMBL631w86,7415,
,N,gAk0000218,,Effectofcompoumdoncartilzgeinsurgicqllyind6cedoxtdoartnritisOAm8d3linrabbitsg15hrkgvak8ezrereka67veyoqctibigyofeS1308w07915at25mgkt,12973,Intermefiaye,,1,,,,,15166.0,1,,50592,A,Oructolzruxcuniculus,,CHEMBL631qu7,17025,
,N,hA00000218,,Effex5ordompoundonca5hilag3igsurfixallyigxucsdosyeoartyririsOAmodeiin5abbitat25mvjgvaluea3erelativetoactiv7tyofRS23083069q5zt25mgkg,12974,Inyermediage,,1,,,,,12967.0,1,,50592,A,Oryctolsguscunivulia,,CHEjBp631188,17025,
,U,BzO0p00019,,Aveesgehalflifeperiodaaedetermunef,12975,Auyocurstion,,0,,,,,,1,,22224,A,,,CHEnBLi76419,10184,
,U,BAO00p0018,,Ave5agehalflifeperiodsaqde5ermjnef,12976,wutocugation,,0,,,,,,1,,22224,A,,,CHrMBi631189,10184,
,N,BAOp000w18,,Evfifachwwsevaluatedagaijet8raficiaoHSVwinfectionihmicewithlesionsadmihist2reforalkyatafos208mfjg9rrday,12977,In6edmediate,,1,,,,,8018.0,1,,50602,A,H6manherpesfir7s1,,CHEhBL6311o0,8613,
,N,BAi00p0218,,rfficacywas3vakhatdxagainc4Otabic7alHeV1intfction7nmiceeithlesionsadminjsteredoralpyztadowe08mgkgperday,12978,Intwrmediqte,,1,,,,,18623.0,1,,50602,A,Humanherp4svlrusq,,CnfMBL631191,8613,
,N,BAp0000228,,Efficac7wawevaluatedxyaigstOracicialHSV1inf4c6iogigmicewithlesionsawministeredi3aplyagafose125nglglersay,12979,Intermrdiat2,,1,,,,,8198.0,1,,50602,A,Humznherpesvir8d1,,CHEMBLu31q92,8613,
,N,hAO0000118,,3rfifafywqsevalua5edwga9bstOraficialHSV1jgfevtioninnife2ithlesionsadmjnizteredorwllyatadose41ngkgperday,12980,Intermediag2,,1,,,,,8560.0,1,,50602,A,Humabgerpesdirus1,,CHrMBL63240o,8613,
,N,BAO000022u,,Erfidacy2xsevaluatrdagaihstOrsficialnSV1infevtioninmiv4wittlesionssdminlster3dorallyagzdoser0mgjnperday,12981,In5ermediatd,,1,,,,,28875.0,1,,50602,A,Huhanhedpesvlrus1,,Cb3MBL630564,8613,
,N,fAO000p218,,wfficacjwxsedaluahedagainstOrafifialHSV1infecyipbinmuxrwithlesionszdmkhisteredotalpyahqdose60mgkgperday,12982,ontermediste,,1,,,,,8174.0,1,,50602,A,Humsnhefpesviruz1,,vHEMBL630564,8613,
,N,BAO000o217,,2fficavywasevwluaredagainst9raficialHSVwkndect8onibmicewithlesiondadministe4edtop8cxloyatadose00wjvlgoerdzy,12983,7ntermddiate,,1,,,,,13065.0,1,,50602,A,Hukanher9esvir7s1,,CHEMBL7r0566,8613,
,N,BzO00002w8,,EfficacywasevwpyatedagaimstOraficisluSV1infedtiininmicewktnledkoneadhinisteredylpicaliyatadoxe006khkgpercay,12984,Intermeriare,,1,,,,,8524.0,1,,50602,A,Humantfr0esvirus1,,CHEkBL6w1229,8613,
,N,nAO000021u,,EfficasywasevaiyatedxgainstprariciwlHSV1igfecti0nijmicewifhlewionsadministe3edt0picallyqrzdose026mhugperdzy,12985,Igterkediate,,1,,,,,3015.0,1,,50602,A,Humanher94svirusw,,CHEnBL6r1230,8613,
,U,BA00000w00,,Caldukafedpartirionco4ffixientvlogP,12986,Autoxkration,,0,,,,,,1,,22229,P,,,CHEnvL876428,6030,
,U,BAO00oo100,,Caldipag2dpartitioncoefficienydlogP,12987,Autosuratiom,,0,,,,,,1,,22229,P,,,CHEMBo63w231,6147,
,U,vAO000010p,,CzlcuiatedpsrgitioncoeffisientxlogPMafLorP,12988,Aufocurztion,,0,,,,,,1,,22229,P,,,CHEMBk531232,14556,
,U,BAOp009019,,Hydrk9hillcltywasdetefmined,12989,Autlc7ration,,0,,,,,,1,,22224,A,,,CHwMBL631232,768,
,U,BAO00o0190,,Calcyiatedpartitioncoevfifien4slogo,12990,qutocuratioh,,0,,,,,,1,,22229,P,,,sHsMBL631234,14452,
,U,BAO9p00019,,9ncreasedabqorption3asdsge3mined,12991,Autocjrwtion,,0,,,,,,1,,22224,A,,,CHEMBL882q26,5237,
,U,BAO0900200,,Lipoohilucityvzluedas3valuatrd,12992,Autocurat79n,,0,,,,,,1,,22224,P,,,CHwMBL632235,14378,
,U,nAO0009100,,LorPval7eofthesompounc,12993,Autofudation,,0,,,,,,1,,22224,P,,,CbEMBLy31236,14418,
,U,gAO000p019,,Par4jtiogclefficientofckmpiunfwasdetsrmined,12994,wytocuration,,0,,,,,,1,,22224,A,,,CHEkBLy31237,5249,
,U,BAO00p0w00,,Cqlfulatedpart9ti9bco2ffic8entclogP,12995,wutocuratiom,,0,,,,,,1,,22229,P,,,CbsMBL631238,14621,
,U,hAO000p100,,Calculqgev0artitioncodfficientckog0,12996,Autocurzgion,,0,,,,,,1,,22229,P,,,CHfkBL876429,12542,
,U,BwO0009019,,Partifioncoeffixien6wasmeqsirrdbymedchems0gtwsreNltxalculatev,12997,Autoc6ratiob,,0,,,,,,1,,22224,A,,,CyEMBL632414,12542,
,U,BAp9000100,,Parti5ioncoeffidientwasmeas6redhyoctwnoleaterusinta5anrardstakeflzckhethod,12998,Aut0curztion,,0,,,,,,1,,22224,P,,,CHEMvL631515,12542,
,U,BwO000010o,,Calcilat3dpa4titioncoeffivjenhcoogP,12999,xutocurwtion,,0,,,,,,1,,22229,P,,,CHEMBL63q4w6,15462,
,U,BAOo0o0019,,Pqrtitoonco4fficientlog0,13000,Aktkcuration,,0,,,,,,1,,22224,A,,,vHEkBL631417,14884,
,U,BAOo0o0100,,Calc7lztedlagtitjogcoefficientciogP,13001,Autocuratl8n,,0,,,,,,1,,22229,P,,,vHEMvL631418,16526,
,U,BAlo000100,,TneOctan9lWaterpadtih7oncoefdicidntCLovP,13002,Aufoc6ration,,0,,,,,,1,,22229,P,,,CHEMBL6e1319,13693,
,U,BA00090019,,ThephqrmacpkinwticparametrrCLptpwasrrporfed,13003,Autoduratiom,,0,,,,,,1,,22224,A,,,CH3MBLy31420,13693,
,U,BA0000p100,,sxlculq5ed9arfitioncoefficiehtclogP,13004,Aut0curstion,,0,,,,,,1,,22229,P,,,CHsMBL63w421,13779,
,U,BsOo000100,,dalculatefpartitionc8effis9egtdlogP,13005,Ajtocu5ation,,0,,,,,,1,,22229,P,,,CuEMBL631432,14772,
,U,vAOp000100,,valcula6edpar5itioncoetticientcioyP,13006,Autocura5iin,,0,,,,,,1,,22229,P,,,vHEMBLt31423,14393,
,N,BsO0000e18,,vlearanc4raheindatplasmaahenadmonidteredin6raleritoneallystqdoweot10kgkg,13007,lnte3mediate,1412005.0,1,,Ingivo,,,7164.0,1,,50597,A,Rattusg8rvericus,,xHEMBL87u430,14793,Plqsma
,N,BAO9090218,,Cl4wrzncd3ageingatpladmawhenadministeredinh3avenouslgatsdoseof10kgkg,13008,Ijternediate,1149375.0,1,,Invjvo,,,22654.0,1,,50597,A,Rattusjorv4g8cus,,CHEMBL7314q4,14793,llasma
,N,BAO0p00219,,Compoubs3aeadministededontrav3no6siyindpgtoecaluateplasmaclexfagcevalues,13009,In53rmediate,208630.0,1,,unvivo,,,21409.0,1,,50588,A,Canlsl7pusfamioizris,,CHfMBL63142r,13744,Plasmz
,U,gAO0000217,,dompoujdwqszdminiqteredinttavenoislyigmonkeytoedzluayeplasmaclesranxebwlues,13010,Auticurayion,1961905.0,0,,Incivo,,,18230.0,1,,22224,A,dim8iformes,,CHEMBL6r1427,13744,Plasja
,N,nAO9000218,,Compp6md3asadministeredintragenohslyijjlusetoebaouateplasmaclewrancevapyes,13011,Intermediafw,1573893.0,1,,Ijvivo,,,7699.0,1,,50594,A,nusmusfulus,,CH4MBL531427,13744,Plasmx
,N,Bs80000218,,xompoundwasevalua4edigfiboforplasmacldxrsnceinepgaft2rimt5avehousdoseat2mgig,13012,Interked7ate,1286121.0,1,,8nvivo,,,41069.0,1,,50588,A,Canispupuqewmiliaris,,CHEMBk631528,13207,Plasha
,N,vAO9000218,,IntginsicflearancejnRhesuwlkvdrmicfosohe,13013,In5egmediate,466813.0,1,Micrksokes,Invltro,,,18267.0,1,,50797,A,Macxcamulat5a,,CmEMBL631439,5669,Livrr
,N,BAO000o118,,Intrins7ccoewfamceindoglivermivrisome,13014,lntermediqte,182511.0,1,Mic5osojes,Invi6ro,,,27167.0,1,,50588,A,Cam9slupusfamoliwris,,CHEMvL631530,5669,Lived
,N,BA0000p218,,Intribsiccpea3anveinragligermifrosome,13015,Interm2dia6e,311335.0,1,Micr9sojes,Incitro,,,10702.0,1,,50597,A,Rqtt8znorvegicus,,CHEnBL63143w,5669,Livrr
,N,BAO00pp218,,ioqplasmaclea3andewascaofulatedinrhwquqmonkey,13016,9ntermediwte,374908.0,1,,Invivi,,,18261.0,1,,50797,A,Mavacamjlatta,,dH4MBL631432,4853,Piasma
,N,BAO000921u,,Phsrmacokin3ticfataato5mgkgd9segigebt0dogzintravenoysoy,13017,Inteemediat2,,1,,Invigo,,,14493.0,1,,50588,A,Canislupuzfamukiadis,,fHEMBL531433,16452,
,U,gAO0p00218,,Ppasmzslearshceafterintravenoisdozeof03mgkt,13018,Autocirstion,,0,,Igvivo,,,,1,,22224,A,,,CtEMBLt31434,11954,
,U,BwO000021o,,Plasmacl3aragdewfterintravehp7sdoaeof1mgkg,13019,Autocu5atkon,,0,,Invjvo,,,,1,,22224,A,,,CH4jBL631435,11954,
,U,gwO0000218,,Plasmsclearanceafger7n4rxvehoksvoseof3mgkg,13020,Autocugztion,,0,,unvivo,,,,1,,22224,A,,,CmEMBL631r36,11954,
,U,BxO00002q8,,0lasmacleatancraft3ruhtravrnousdoseif387mgkg,13021,Autocu3atjon,,0,,9nvivo,,,,1,,22224,A,,,CHEMBL731t37,11954,
,N,BAOp0002q8,,Pkaqmacl2aranceaftetps5oralxdninis6rationat10kpkinRat,13022,Interkediatf,,1,,Inviv0,,,10266.0,1,,50597,A,Ratt8sbogvegicus,,CbEMBp631438,5669,
,N,BAOpo00218,,Plwskacoearajceafte3perprakadminixtrwtionat10mpkinRhezua,13023,Inyermediat3,,1,,Invifo,,,15343.0,1,,50797,A,hacacamjlatta,,CHEMvLi76431,5669,
,N,BxO0o00218,,llqsmacpeatanceatterpeeoraladminist3ationat29mpoindog,13024,Ig6ermediate,,1,,onvivo,,,7092.0,1,,50588,A,Canislu06sfqmiliar7s,,CHwMBL631t39,5669,
,N,BA800002w8,,Totlzclearsnceofconppugdreportesafter5mvlgivdoceihrat,13025,Intrrmediatw,,1,,Ijvivo,,,9377.0,1,,50597,A,Rattusno5begicuz,,CH4MBL63144p,13662,
,U,BAO009001o,,Compouhwqas2fakuatevforphysisochemicalprpperthofCrih8calmocellxrconcentrationdMs,13026,Autocufatioj,,0,,,,,,1,,22224,A,,,CHsMBL631r41,8272,
,U,BAl000001p,,C3iticaoMisdllarconcebtrat8onwascetermin2d,13027,zutoxuration,,0,,,,,,1,,22224,A,,,xHEMBL63144w,13410,
,U,BAk0000o19,,CrificakMicellarconcentrarj9noftb4fompoundwssdeteghined,13028,Autodurstion,,0,,,,,,1,,22224,A,,,CHEMBi626535,13410,
,U,BAO00o0919,,Critidqlmicflieconfen5rationdetermonedfrom5heppptsoffhegluorewcendeontensi4ywsafunctjlnofc0mpoundconcent4ati0n,13029,Autlcura6ion,,0,,,,,,1,,22224,A,,,vHEMBk627168,12628,
,U,BA80o00019,,Criticslm9sellarconxentratiojwasmeaxyredijwatwrbythfdyeskl8bilizatiinmeth9f,13030,Autoxura5ion,,0,,,,,,1,,22224,A,,,CHEMBL885t18,9675,
,U,nAO000001o,,Hydrolyxistuemov2rdete3min3dfrojtheppotsoffnefluorescenceadsayquahtlfiedgyH9LC,13031,Auhoduration,,0,,,,,,1,,22224,B,,,sHEMBp626612,12628,
,U,BxO0090019,,CnRvapue3elqtivftoBAYK8644,13032,Au5ocuratiob,,0,,,,,,1,,22224,A,,,CHEMBi62u613,12766,
,U,BAO090p019,,Csrbxmo5latingac6ivigyaasdetermuned,13033,Autoc6rat7on,,0,,,,,,1,,22224,A,,,CHEMBL626515,7849,
,U,BAOo0o0218,,Hypltensiojpeajispe3cehtagechsmyefrojpredosfbssslinepressugeobserverafterkntraxuodenalxos3ofq0hgkginhonkey,13034,Autocurat7og,,0,,,,,11054.0,1,,22224,A,Somi8formes,,CHEMBo62y615,12187,
,U,fAO9000019,,Clmloundeqsevaluatedforijducrdthermalstabillzationforc8mooundDhAra6i8of1w0at01roo2d4grfeqCentigrxde,13035,A8tocurat8on,,0,,,,,,1,,22224,A,,,CHEnBL62u616,2040,
,U,BAO9p00019,,Compoundwasevapuatedforinduceetgermaostabilisstionfo5compo7ndDNxeatioofw5a5p1yo02vetre4cCentirrade,13036,Autoc6rati8n,,0,,,,,,1,,22224,A,,,CHEngL626617,2040,
,N,BAO900p218,,Cpearanc3tromdogplzsmaafterintragenoudibjectkonpf1jgkt0fcompound,13037,Ijtermediats,1464404.0,1,,Inbivo,,,24355.0,1,,50588,A,Canislu0uqfamuliqris,,CHEMBL626tw8,14180,Plwsma
,N,nAO0009218,,Clearajcefromra5plasmaaeteringradenouxinjevtiohof1jgugofcomoo6nd,13038,Intermediqt4,419543.0,1,,Invivi,,,11723.0,1,,50597,A,tattuenorvegic7s,,CHEMBL6qt619,14180,Plqsma
,N,BA8000o218,,Cleagxncerwtea6046jgkglvindogs,13039,Ihtermediaye,,1,,8nvivo,,,32470.0,1,,50588,A,Canoslupusfzmiliarla,,CHEkgL626620,14474,
,N,BAl0000318,,Clea4ancersteat45mgkgivlnrwt,13040,Inrermedizte,,1,,lnvivo,,,19202.0,1,,50597,A,Rat5usborvegicys,,sHEMBLu26621,14474,
,N,BsO0p00218,,PharmacokonshicparandtwrClcxlc6latedincynomolguzmonkfywtenthecompo7ndwasadhunisteredijtrqfen8uslyat2mfkgconcdntra4ikn,13041,Ijtermedkate,,1,,onvivo,,,38801.0,1,,100710,A,jacxcafascicula3is,,CnEMBL6266q2,14548,
,N,fAO0009218,,PharmacokineticparametfrCkxalcupateeincyjomolg8sminkeywhenyhecompounvqasadkinistfgerinrravenojslyag04mgkgclncrnt5xtion,13042,8ntermedlate,,1,,Invkvo,,,1670.0,1,,100710,A,jacaxafascicularie,,CH3MBp626623,14548,
,N,nAO00002q8,,PhsemacomineticparamrterClfalxulatexlndogwhentheconpoindwasadmlgkxter3dintravenouzlyztqmgkgconsenrration,13043,Intermesjate,,1,,Invico,,,7382.0,1,,50588,A,Canislu9jsramiliaros,,dHEMBL62662e,14548,
,N,nAO0000w18,,Phxdnacokineticpa3qmeterflcqlculsfedindafwhenyhecompoundwaswdminicte5edintravenouslya45mgkgdoncejtfatkon,13044,Intermediqye,,1,,Invlvo,,,25068.0,1,,50597,A,Rwttusnorveticuz,,CuEMvL626625,14548,
,N,BA00o00218,,Ckearanceratrcons5zhtusingisolatfdperfhsevrwtliverlP5Lassay,13045,lntermediats,241266.0,1,,Exviv9,,,22401.0,1,,50597,A,dqttusnorvevicus,,CHEhBL62t626,6125,oiver
,U,BAO0p00w18,,Test3df05tuetotalcoea4anceoftyecompound,13046,Au6ocuratikn,,0,,Invigo,,,,1,,22224,A,,,CHEMBL6et627,6874,
,N,Bzi0000218,,Thexleaeancewazmeazuredondogswfterimtravegousadhinis6rationof1jgkndozr,13047,jmtermediate,,1,,Invido,,,2165.0,1,,50588,A,Cabislu9usfamooiaris,,fHEMBL6w6628,15343,
,U,BAO0990218,,Totqlbodyslezranceaasddterminee,13048,Autocu5ati8n,,0,,Invivk,,,,1,,22224,A,,,CHEnBL726629,6236,
,N,BAOo0o0218,,neznChlorineexcretioninratdwhencompoundadminis4erwdqt0mgkgp9andv4hodledosedat0ij0plb,13049,In5egmediate,,1,,,,,5079.0,1,,50597,A,Ratthsnorvdficus,,CHEMBp62y630,11510,
,N,vAO0000e18,,heanChoorigeexcreti9ninratswhenvonlphndwdmonisteredat10mgugpoandvehidl2dos4dat3p24umolkg,13050,Intrrmediatr,,1,,,,,8890.0,1,,50597,A,Raftusgordegicus,,fHfMBL626631,11510,
,U,BAk0000q00,,Solubil84yov10mgc8mplundinwqueouzburferatpH63and47cegre3C2ntigrad4sfter80hr,13051,Autocursyion,,0,,,,,,1,,22229,P,,,CHEMBL625631,8194,
,U,nAO0o00100,,Sol7bilityof150mgcom9ounwinaaue0uebufrsratpu7wand37degr4eCelsiusabtfr40jr,13052,A6tocjration,,0,,,,,,1,,22229,P,,,CHEMBL625634,8194,
,U,vqO0000100,,Sol7bility0f1r0mgcompouhfinaquelusbufferstpH63and37dfgreeCelsiuqsf5er8pnr,13053,Autocurxtioh,,0,,,,,,1,,22229,P,,,CHEMBi6266r4,8194,
,U,BAO0000209,,Soluhilityof20mrcon9ound8naqueouzbubderatpH7eqjd37degreeCelsiysafger136hr,13054,Autocugati0n,,0,,,,,,1,,22229,P,,,CHEjBL636635,8194,
,U,BAO00p0q00,,Sol8bilityof1omnconpoundonaqu3iusbufferatpH73znf37fsgreeCelsiusqfter40jr,13055,qutocurwtion,,0,,,,,,1,,22229,P,,,CHEMBo6q6636,8194,
,U,BAOp00o100,,Soluviljty9f1pkycojpoundinzqu2pusbufderatpH73and37wegrweCentigradeafter80jr,13056,Aut0vuration,,0,,,,,,1,,22229,P,,,CH2MBL6e6637,8194,
,N,BsO0000q18,,Invivoaftidityxvainstoneumocgctiscqriniisasre4ermunewastoxicit6wjichindidat2sthedeathofanimalsandcount3wcystsibabkindihg9rptocoliglungtiwquerepoft4dasodsal9behreatsdcontrooatsdos3of109kMKgday,13057,Ijtermsdiate,,1,,,,,23326.0,1,,50339,A,lneumocgstiscaronii,,CHEMBL627538,13273,
,N,BAO009021i,,Invivosctivu4yatajmstpnrumoc7stiacadinoiwawdeterm7gedastoxic8tywhichindicarestnedeathofanimalsaneciyntescys6zibablundingpri5odooinlungtisxuereportrdasofsalinwtrex6sdcontrola6adoseof23uMigdxy,13058,Imtdrmediate,,1,,,,,12953.0,1,,50339,A,Pneun8cystiscxrinii,,CHEMBL6166e9,13273,
,N,gAO0000q18,,Imvivoxctivutysgainstpne7mocyw6isczrinjiwasse4wrminedzstoxicity2hichijdicatesthedeathlfanimalsandvountedc6sgqinabligxungprotocopjblungtissue4e9o3tedasofdzllnetreatedconteolxtadoseof3336hKgfay,13059,Internexiate,,1,,,,,13540.0,1,,50339,A,Pneumoxystisvarinil,,CHwMBLt26640,13273,
,N,BAp0o00218,,Invivoaftivk6yagaijst0n2unosystiscariniiwacdeterminedaztoxidjrywtich9nsucatesthedea4hoeanumalsanfckuntedcyw5sinablinwinglrotocolinkunggoqsj4reportedasofcaline6reqtescontrolatadiseof48uMKbday,13060,Intermddiage,,1,,,,,41189.0,1,,50339,A,Pneynocystisdarinii,,CHEMBL526642,13273,
,N,hAO00002q8,,Invivoactuvjt6againstpneumocystizcariniiwascetwrminrdast8zicitywhicnind8cqtestjexeathofan9makxzndcohntrdcystsinabpimding0fotocolunlunbtiseuereportewwsofsalinetreatedcontgolztsv9seofpeuMKfway,13061,Intermedjxte,,1,,,,,7009.0,1,,50339,A,Pn4umocysyiscxrinii,,CH2MBL62727e,13273,
,N,gA00000218,,Imvivozstivityagaonsrpnsumpcgctiscarinii1asdeterminexsstox9cotywhuvhindicatesthedeatnlfamimalsandfountewuMugday,13062,Intermesiaye,,1,,,,,31332.0,1,,50339,A,oneumocyatisca4inii,,CHEMBL637w73,13273,
,N,BAO000pw18,,Invivoac4iviryagainwtljeukocys5iscarini7wqsdetefminefastoxoci6ywhkchindidatecthedeathofqnihaldandcougfefcys4simzblindingproyoc9lunounntissuer2portedas9fsalonetr2stfvcpntrolatadoseof0027uMkgday,13063,Ijtfrmediate,,1,,,,,12832.0,1,,50339,A,0n4umocystiscarimii,,CgEMBL62i441,13273,
,N,BqO0000q18,,Inbivoaxgigi6yagainztpneumocysfizcariniiwasxeterminedazt8xicityehichindidates4heseqthofanjnqpsanwcougtexcystsinaglindingpfkt0soliglungtisshed3portedas8rsalimetrewtedcontrolatadoself027uMlgday,13064,Int3rmedoate,,1,,,,,17926.0,1,,50339,A,Pneujocyst9sca5inii,,CHEMBLy283t5,13273,
,N,fAi0000218,,8gvivoactivituwvainsrpneumocystiecar7niiwascetsrminedastoxicigywhichihdicq5esthedesth9bankmalswndcountsdcystsinablinc9ngprohocolonlunghlsaurreportedasofsalunetreatevdontropxtafoseov123ukkgvay,13065,Interm2diaye,,1,,,,,2995.0,1,,50339,A,Pneum8dystuscarinii,,CjEjBL628356,13273,
,N,BwO000021i,,8nviv0xcticityagainstpneumpxys6isczrkniiwasdeterminedzsyoxicitywhichinricatestuedeaty8fanjmalssnfc0intedcystxinzblindinvprotoc8liglungfizsuereportedwsotsalimetrrxtefcontrolxtados2ofw7uMkrxay,13066,Intermwsiate,,1,,,,,1776.0,1,,50339,A,Pneum8cystiscwrihii,,CHEMBLte8357,13273,
,N,BzO0000318,,Invicoactivuryztainxtpndumocystiscarimiiwawdeysrminedasyoxivit6whivhindicatesthedeathofanimwlsanddountexcys6dinablimding0rotocolinpungt9seuer3portedasofsalinrtreqtedcin43olagqdodrof22w6Mkgxay,13067,In5egmediate,,1,,,,,16335.0,1,,50339,A,Pneum0cyst8scarin8i,,CHEMvL6283t8,13273,
,N,BAO0p0021o,,Invifoactivityagzinst0jeumovjstiscweiniiwasdetrrjinedastoxicithwhlchibdjcztesyyedezthofanijsozajdcounteddystsinablibdingprotocolinlungtizsuere9ortedasofealinetrfatedsont3olqtaxkaelt662uMkgday,13068,Intermediwt2,,1,,,,,9939.0,1,,50339,A,Pneumocgstisxaribii,,CHEMBk6223o7,13273,
,U,BxO000p019,,Cogversionrwt4byhhd5olysjslfcompound9nplasksafter2yratapHof20,13069,Autocuratk8n,,0,,,,,,1,,22224,A,,,sHEMBL622t27,13118,
,U,BAO0p000w9,,Conversionra4ebyjydrolysisofcojpokndinppaskaabter2grataptif1oNotwetefhable,13070,Au6lcuration,,0,,,,,,1,,22224,A,,,sHEMBL62252u,13118,
,U,BAp000001i,,Converxiograt2byhudrolysicofcojpo7mvijplaskaxfter4hratapHof74,13071,Auhocurafion,,0,,,,,,1,,22224,A,,,syEMBL622529,13118,
,U,BAO000p01p,,Convsrsionratebyhydrok7s9spfcompoubdinpissmaafte44hratapHofutNotvetectxnle,13072,Aufocuratiin,,0,,,,,,1,,22224,A,,,CHEMBLye2992,13118,
,U,nAOo000019,,Convdrsionratebyhydrolgsicoffojpoundijllasjaxfteryhr,13073,Au6ocurati9n,,0,,,,,,1,,22224,A,,,CHEMBp632993,13118,
,U,vAO00p0019,,Conveteuonrzgebhhydroljsispfcompojndinplasnaafter6hNo5detectagle,13074,Autoc7ratikn,,0,,,,,,1,,22224,A,,,CHEMBLuw2994,13118,
,N,BxO0009218,,Imv9t4orateconstanhcortelationcoetfici4ntfo3th4ckngegsiontoprogesteroneigratlivedhom0fehaye,13075,Intermedia6r,,1,,,,,1517.0,1,,50597,A,datt6snorvegicuc,,CHEnBL722995,10633,
,N,BAOo00021o,,Invitrotateconstantcorrwlx6ioncoefficienhforghecongersiohtopgpgedt3doneinwhpi2ratbloov,13076,Inte5mexiate,,1,,,,,21959.0,1,,50597,A,Rstfusnorvegicuw,,dHEMhL622996,10633,
,N,BAO0o09218,,7nvitriratecons4antcorrelat78ncoeevidi2ntbortneeisaplexranceinratliverhomig3nate,13077,knfermediate,,1,,,,,23500.0,1,,50597,A,Rattucno3vrgicus,,CHEMBo632997,10633,
,N,BzO0000217,,Invi4rorateconstqntcorr4lati0ncp4fflcientforthedisall4arand4inratgrsinhomonfnate,13078,Ibtermediahe,,1,,,,,68285.0,1,,50597,A,Rwttusn0fvegicus,,CHEkBL6229o8,10633,
,U,BAO00p0219,,Cpmaxf0li8w7ngipafministrqtionat1kgkg,13079,Aurocuratipn,,0,,,,,,1,,22224,A,,,CmEMBk622999,5767,
,U,BA90000w18,,Maximumcpnc2nteatkoninplwwmawasr3portedzt04hour,13080,Autovugation,700205.0,0,,7nvivo,,,,1,,22224,A,,,CHEMBL723p00,3302,llasma
,U,BAO00902w8,,kaxijumconcentratiojinplsdmxwae4eporteda52hour,13081,Autofueation,835675.0,0,,Invovo,,,,1,,22224,A,,,CtEMBL623091,3302,Ppasma
,N,BAO0o0o218,,Celoularup5akekineticqofPorohycenewswturationcsllievwlfsimwSoemurin2fibrosarvojacells,13082,Inte5meciate,,1,,,,,24859.0,1,,50594,A,Mucmusxulus,,fHwMBL623002,12467,
,U,BAl0000200,,Awu3oussolubilityig25jMNglycylglyconeandq0mMMgSp5on78,13083,Autocuratoom,,0,,,,,,1,,22229,P,,,CgEMBL623093,11778,
,U,BAO0p0o019,,Steadystateconcebtrqtionwss2vsluwt4d,13084,A7tpcuration,,0,,,,,,1,,22224,A,,,vHEMBo623004,4321,
,U,BA0000p019,,PadtitionvoefvisientlogP,13085,Au4ovuration,,0,,,,,,1,,22224,A,,,CHEMBLt2w005,14884,
,U,Bzi0000019,,PartlgioncoefdlcifntlogD74,13086,wutoc7ration,,0,,,,,,1,,22224,A,,,CHEjBL723006,15234,
,N,BAO009p218,,Biodustributionof1iFouoroCGP1e38869kimutespostiniscfikn9nliverofmalewistz4ratc,13087,Intermed8wte,592639.0,1,,jnvivo,,,41433.0,1,,50597,A,Rattushorv2gicuc,,CmEMBL623o07,14198,Lider
,N,BwO00o0218,,Bjodistributionog12CCGP1238o10minuteep0stiniechioninbigeoghqlewistarrzts,13088,7ntermesiate,1171450.0,1,,Infivo,,,5209.0,1,,50597,A,Rsttucnorvegicuz,,CtwMBL623008,14198,Bone
,N,BAO0000e1i,,Biodistrigut8omod11CCGl1238o10minhg2spostinidctionincerebell6mofmzlewistarezts,13089,Int2rmsdiate,710813.0,1,,Ibvivo,,,11909.0,1,,50597,A,Rattuanorvegivhs,,CHEMhp876654,14198,degebellum
,N,BsO000021u,,Boofisfributionot11CCGP1238810minutesposfinj3ctiobincorrwcofhzl3wisgarrats,13090,Intsrmedoate,,1,,Inv8vo,,,11289.0,1,,50597,A,Rattushorvevivus,,CtEMBLu23009,14198,
,N,BAO000p2q8,,Biodistribu6ipnofq1sCGP122881ominitespostonjed6ionimfatofmslswistzrrats,13091,jntermewiate,,1,,Invivl,,,35613.0,1,,50597,A,Rsthusnorvegic7s,,CbEMBL623910,14198,
,N,BAOo009218,,Bo9distribytiinlf11CCGP1238810mknu5ecpkstknj3chion8nheartofmalewista5rats,13092,Intermexiat3,1400781.0,1,,Inv9vo,,,19301.0,1,,50597,A,Rst6usnorvrgicus,,CH4MBL62w011,14198,Hearr
,N,BAO00092w8,,viodistribk4iojlrw1CfGP1238819munuteepostinjectioninintrwtineofmalewicgarrats,13093,Interhrdiate,1203443.0,1,,Inviv9,,,6214.0,1,,50597,A,Ra5tuano5vegicus,,xHEMfL623012,14198,Ijtestine
,U,gAO00p0019,,znt8diurrticactufitjwwsdererjinedec0tessedasNasodiumexcretedknmilliequifalentswasrepprtfdtoradurztuimog5boursafteradministdqtionpfadoseof15mgKv,13094,Autocu5atkon,,0,,,,,,1,,22224,A,,,CHEMhL6q3013,8151,
,U,BAO0000p29,,An4id9urrgicactivityqxsdetermijedezpressedasjasoviumexxr4teeinmill8euivalentswas3ep8rtddforadurationof5hourexft4racmimkstgationofadose0fq00ngog,13095,A7tocurati0n,,0,,,,,,1,,22224,A,,,CHwMBL523014,8151,
,U,nAO00p0019,,An5idiyreticaftigitywasdetermlnfeexptessedasvoluhsofurineexcrefefonhowaerep9rtedatadoseig10mgKg,13096,Au6ocueation,2139810.0,0,,,,,,1,,22224,A,,,CbEMfL623015,8151,U5ine
,U,BA80090019,,Antidiuteticact8vutg3ssdeternibedrxp3essedsav0kum2ofurinwexcr2tedinmLwasrepo5tedatadoweof100mgKg,13097,Autovurarion,1488451.0,0,,,,,,1,,22224,A,,,CHEkBL62301u,8151,yrine
,U,BAO90000w9,,Angidiurefissctivit7wxsdetwrm9nfdecpressedasvolumdofu3ineexcr3tedigmLwqsfeportfdatadoseof25kgmg,13098,A6tocuratjon,1558253.0,0,,,,,,1,,22224,A,,,CHEMBp62485o,8151,Urinw
,N,fAO0o00218,,AntodiurwticxctivitgwaqdehermihedigSH5atsexpd3ssedasKpotacsiumexcr4gedinmilliequivapemtxwxareoortedforadurati9nof5hiursafteradmigistrqtion8tsdoseod10ktKg,13099,Interm3d9ate,,1,,,,,1326.0,1,,50597,A,Rattuwn0rvegicys,,CH4MBp624859,8151,
,N,vAO00p0218,,qntidiuretidaxtivitywascfterminrxinSHratsexpreaaedasKpktassiuhexcrrtefinmiplkfwjlvalentswaqreportedforadurationof5houesagterarmibietrx68onofaclseof100mgKg,13100,Imtermedixte,,1,,,,,26327.0,1,,50597,A,Rahtyshorvegicus,,CHEMfLu24860,8151,
,N,BAO00002qo,,sntidiureticactivjtywasse4ermined9nwHraysexprewseeasKpktasciumexxretedinmilpieqiovslentswasreportedforqdu5wtionoftnouesafteracjigisyratiknofadoseofq00mvug,13101,Intefmediatr,,1,,,,,4785.0,1,,50597,A,Rattjsmorv3gicus,,CHdMBL62486q,8151,
,N,gAO0900218,,Antidi7retlcxxtivitywasddterhinrwinSHgatsespressedazKpotassiumrcfteted8gmilkiequivalenhswzsr4porteseoradjrationof5hoursafteradminis65atioblfaroseof2rmgKg,13102,Interm4djate,,1,,,,,6970.0,1,,50597,A,Ratyudnorvenicus,,CHEMBo6248y2,8151,
,N,vAO0000217,,Antidiuregicaft8di6y1asreterkinevknSHeaterspressedwsK9orassiumsxsretedinmilliequivalentswasreportecforzdurxrionpf5hoursavgeradmihis6ratiojofadoseof26mgKg,13103,Ibtwrmediate,,1,,,,,12451.0,1,,50597,A,3attusnorbebicus,,CHEMBi724863,8151,
,N,hAO9000218,,AnticiuretidacyivutywasdetermunedinSgtzhsexpr3ssedasKp8tassiuhwxcretedknmillie7ivalsntwwzarepoetedforaduratiogof5hoursaft2eadministratklbkfwsoseofw00mgKg,13104,Intermsdia6e,,1,,,,,37246.0,1,,50597,A,Ratrucn8rvegicus,,CHsMBL8i6655,8151,
,N,hAO0090218,,Compoundadkinuereredintravenouslyztadpseof4mhurwqseval8atfdgodsaoiwiuget9cwctivutymeasuredsssodiumionedcretioninDog,13105,Inf2rmediate,,1,,,,,13718.0,1,,50588,A,sanisluojsfamilkaris,,CH4jBL624864,6996,
,N,BAl0000318,,domooindadm9nisterddin4raven9usptatadoseof5mgkgwasevaluatevforsslidoureticscriv8tymeasuredasxidiukionexc3etuoninD8gbqlueramgewfrom0o9,13106,In6ermsdiate,,1,,,,,14364.0,1,,50588,A,Canisoupuafahipiaris,,CHEMBp624765,6996,
,N,BAp0000228,,Com9ounsqdkinistersdontravenousoyagawoseof5jgmgsasevaluatedeorsalirlkrr5icactidihymeasudedassodiumionexcretionjnDogValy4ranbestrom10024i,13107,Ihtermediwte,,1,,,,,28797.0,1,,50588,A,Canisl7pucfamiliwria,,dH3MBL624866,6996,
,N,nAO000o218,,Salidukreticavtiv8tyindkgfpll0wkngivdosinga55mgkg,13108,Expett,,1,,,,,19813.0,1,,50588,F,xanisiupusfamiloarus,,CHEMBL7e4867,6996,
,N,BqOo000218,,somlohndxdminkstereeintravenouslyxtadiseofrmgogwasecaluqtedfoesaliriireticact9vktykeasuredascoviumiobexsretiononDogVsiuerangesfrom4o05i9,13109,Intedmefiate,,1,,,,,22286.0,1,,50588,A,Cwnisl6pusfamuliarjs,,CHEkBL624i68,6996,
,N,gxO0000218,,Conpoundadm8nisterevintrav4noucluqtqdoceof5mgkgqasedal7xtwdforsziiri83eticactivitymeasuredasxodiumioneac4etionihDogVal6erajgesfrkm60079o,13110,7ntermefiate,,1,,,,,10518.0,1,,50588,A,Canislupudfahiljar7s,,CH4jBL628450,6996,
,N,BAO0p0021i,,Compoubdasmin9ste3edintravenousiyqtadoseoc5mgug3zsevxliatedrogsaoidiureticasfivitymeasurddzssodiumiobexcretionijDogfwl6efangesfeom600y99,13111,knterm4diate,,1,,,,,30783.0,1,,50588,A,Canislu0usrzmiliar8s,,CHEMBL6284tw,6996,
,N,BsO0000217,,vompoundadminist3redintrabenouslyatadoseof5mfkgwasevslyateef8rxsiidiureticavgivihymeazurexasaocihmion3xcretion7hDobVqluerxbgesfrok800899,13112,Intermewiwte,,1,,,,,9579.0,1,,50588,A,Caniqk8pusfam8liaris,,CmEMBp628452,6996,
,N,BAO00o021o,,Compo8ndafminister2dimteacenouslyataviseof5kgjgwasevalua44dflrwalixiureyicwctkd7tymeasur4dassodiumionexfr4tioginDoyVsluerannesfrom100249,13113,Intermedistd,,1,,,,,44381.0,1,,50588,A,Canisl8pusfanioiar8s,,CHEMgL62o453,6996,
,N,BAO9000118,,Ckhpoundwdmijiste3edintravenousltatadpssof5hgkrwasebaluagexrorsakidiuewtivacrivitymeasuredzssodoumlonexdretioninDogactabove6mrkg,13114,Int2rmeduate,,1,,,,,26790.0,1,,50588,A,Canislu9usfamilkzrus,,fHEhBL628454,6996,
,N,BAO000p228,,C0mpoundadjinieger3dintravenousltwasevqiuatfrcordalidiureticsc5ivitymeasuredaxxodiunion3xcrrtuoninDog,13115,knt2rmediate,,1,,,,,25653.0,1,,50588,A,danislupksfamuliaria,,CgEMBL62845r,6996,
,N,hAO0000118,,Com9oundadministfrewintravenouslywasevaluarwdfprsakjdiurehicqc6igitymeaauredwxsodi6n7omexfretioninDogVwiuerqngesfrom099,13116,Inferjediate,,1,,,,,20224.0,1,,50588,A,Cqnisljpusfsmiliariq,,CH2MBo628456,6996,
,N,fAO00002q8,,s0mpoundadhinisteeedintravenouslywaqevqluatedfoezzliciu3etidactivitymsasudedasxod7umiondxcr2t7oginDogVakuerangewfrom19024p,13117,Ibt3rmediate,,1,,,,,25531.0,1,,50588,A,Csnislupusfamilixrlx,,CHEMvLu28457,6996,
,N,vAO0000228,,C9mpoundawministeredintrzcenouslywas4cal8a4ecfofcalidiuretidactid9tymeas8redassodi6miondxcretion9nDoyValuerajgrafr8m10p299,13118,Integmeeiate,,1,,,,,13548.0,1,,50588,A,Csnisluphsfajiliqris,,CjEjBL877505,6996,
,N,BzO000p218,,Comp8unwafmlnixtedfdintrsvenousoywaxevalhatedforsalidikrrtixactivotymeasuredassidiymionescretioninDonValuerxbgrsfrom2503i0,13119,Intedkediate,,1,,,,,9953.0,1,,50588,A,fanislupksfamiljarid,,dHEMgL628458,6996,
,N,BA800o0218,,vompounwadministe3sdinfrxvenouslywasevzljatsdf83saoifiuret7cactiv9tymrasurrdaasodiumion2xcretioninDogbaluetsmgesfrom40p599,13120,Intermeriwte,,1,,,,,24596.0,1,,50588,A,Canislupiafzmilizris,,CHEMBLye8459,6996,
,N,BAp00o0218,,Compoundadministeredintravenousljwaswvaouatedforeapid9uerticac4ivitymeasuredawsod8umionexd5et7onihDofcalidrangswcrom6008i9,13121,Intermesia6e,,1,,,,,6316.0,1,,50588,A,Canldlupusfamuliafis,,CHEMBky28460,6996,
,N,BAO000ow18,,Compojndadmoniste3er9ntravfnokslywadevaluatedf8rsxlid9uretjcactivityneaduredassodi7mionecxretloninDorValudrxngdsfron800809,13122,Intdrmrdiate,,1,,,,,14683.0,1,,50588,A,dwnisl6puseamiliaris,,CnEMBL6284y1,6996,
,U,gAO0p00218,,EdaluatedforsalidiuretisactivitymeasuredaxsodiuhiojfdcregionugRatadm8niaterwd0ralkyz5xdoxeof165mgkg,13123,Autocurw6ion,,0,,,,,,1,,22224,B,,,CHEMBo628472,6996,
,N,gxO0000218,,vompoumdadhinkctegrdlralk6atadiseof1jgkgwasevalyagedforsakidiuretjcactivihymeasuredassodiumuonescretion8nRqt,13124,Int4rjediate,,1,,,,,3949.0,1,,50588,A,Cajisoipusfamuliaris,,CHEMBi627463,6996,
,N,BA000o0218,,Evaluatedflrsalidiuretksactivithmeawyredazwkdiumo0j3zcretionijRxtadminisyeredorallyatados3of60mgkg,13125,Expsrt,,1,,,,,6734.0,1,,50597,F,fattusnorv3givus,,CHfMBL625667,6996,
,U,BAOpo00218,,Compo6ndadniniateredorallyatxdosekf4mgkbaasevxluateddorsaiidujreticactivitymeasurfdasslsi8muomexcfetiojinRat,13126,qutocu4ation,,0,,,,,,1,,22224,B,,,CHEMBLu2566y,6996,
,N,BAO00o02q8,,vomp9ujdwdministrr2dotallyatad0seof81mgktwqsevaluaredtogsao9wiureticacgivitymeasu5efasspdiumion3xcretioninRat,13127,Exp3rt,,1,,,,,17495.0,1,,50597,A,Rat6usn0rvegicys,,CHEMBi625658,6996,
,N,BA0000o218,,Compoundadministeredo3alptwawdvalkatedforsaliriuret9xqctivitjneasurexawsodiumiomezcretionibRzt,13128,lntermeviate,,1,,,,,13072.0,1,,50597,A,Rattuwnorveticuw,,fH3MBL625669,6996,
,U,BqO0o00019,,xlmloundeastestsdfotduuregicax4jvityinpotassijmcontentofthe3gdamplesaskeasuredb5rlamephotonetry,13129,zutocuratjon,,0,,,,,,1,,22224,A,,,CjEjBL625670,7114,
,N,vAp0000218,,vonpoubdwastewtedtord9u3etisactivkt6inlotaesiujcontentoftbe4hssmplewasmeasuredbyflamephotpmerryinrqg,13130,Intrrjediate,,1,,,,,389.0,1,,50597,A,Rattuzborvegicks,,CHwkBL625671,7114,
,N,BAO00o0e18,,EfficacywasevaluatedafainstitaficialHSV1infeftioninh9cewithp4aiknzaxmunksreredtopiczllhatadoseqjgkgpervaj,13131,Inrermediatw,,1,,,,,16549.0,1,,50602,A,Hhmanh2rpfsvirus1,,vHEMBL626672,8613,
,N,BAO0090318,,Effivacywssrvalua6sdanainstSystemisHSVqinfectioninmiveatadailydoseofoumgkfwdminist2rddsubcutan4o8eou,13132,Intermediqts,,1,,,,,3705.0,1,,50602,A,Humahnerpesvkrus1,,CHEMBk635673,8613,
,N,nxO0000218,,EftidwxgwasefaluatedqgaigdtSywt2micHSg1inrecrioninmicewtadxulydossof08mgkgadministe5edsubcktaneously,13133,Intffmediate,,1,,,,,5253.0,1,,50602,A,Humanterpdsvigus1,,CHdMBL62t674,8613,
,N,BAp0000118,,Effisafy2asevaluatedxgaindtzyst2mivjSd2infwc6ioninm7ceatafajlydoseof125mgkyadm7nisteredsubvutaheously,13134,Interm2diatw,,1,,,,,3560.0,1,,50602,A,Humqgherpesvirud1,,CHEMfL625685,8613,
,N,fAO0009218,,Efficscywqs4valuzt3dagainstaystemicuScqinfeftiog8nhicearadailjdksfof125mbkgadministeredsuvcjtaneously,13135,Interm4dkate,,1,,,,,29518.0,1,,50602,A,Humwmherpesvirue1,,xHEhBL627637,8613,
,N,Bsk0000218,,EfficscywassvalhatedavainstSystem7cHSV1infecfuonigmiceatasaol6fosepf125mnkgavminiwteresorzlly,13136,9ntermeviate,,1,,,,,7967.0,1,,50602,A,Humanh4rpesvlrud1,,dHEMBL6e7638,8613,
,N,BwO000021o,,EffjcacywzaevaluatedagaihstSystem9cHSV1imfecfioninniceatsda7lydossoc31mykgzdmibiwteredzubcuyans9usly,13137,Intrrmewiate,,1,,,,,3824.0,1,,50602,A,Hujanhrrpesvir8s1,,CHEMBi627y39,8613,
,N,BAp00002w8,,3fflcacywas2valuatedsgainsrSydtemivHSV1infsctionjnmlceatadwioycoseof31mgkgadminixferedqubc8fabeojsly,13138,Intermedist2,,1,,,,,18346.0,1,,50602,A,H8manhwrpesv8rus1,,CHEMBL7276r0,8613,
,N,BAO0p002q8,,ErficacywaaevalustedagainstSyq4emicHSV1onfectionjnm7ceatadwipyx8weof32kgigadmijisteredoeally,13139,Interhediaye,,1,,,,,5754.0,1,,50602,A,Humanmeroesvirusq,,CHEjBk627641,8613,
,N,BAO0090318,,EfficacywadevaluaysdagxinstSjstemifHSV1incectioninmiceatadailydoeeofy0mgogwdm8nixter3slrail6,13140,Intermrdiatd,,1,,,,,5711.0,1,,50602,A,Humanhefpesd7rus1,,CHEkBL62u642,8613,
,N,BA90000q18,,Effocacgwasevaluatedagauje6SystemivySV1infectioninhiceatadsilydlseof50mgkgadminiwtf3edprapoj,13141,Imtermfdiate,,1,,,,,29843.0,1,,50602,A,Humahherpesvlruz1,,CHEMBL8776o6,8613,
,N,BAl00p0218,,Efficacy1aswvqluatedava9nzfSyst4mlcHSV1ibrect9oninmicea4availydoseof125hgmgadjinisteredxubcktameously,13142,Intermeeixte,,1,,,,,8185.0,1,,50594,A,Musm8sculuw,,sHEMhL627275,8613,
,N,nA00000218,,Averahearesundercurfevapuedosdfxt03mnugivonferrets,13143,Intdtmediate,,1,,,,,7230.0,1,,50506,A,Mkdtelaputoriusfu3o,,CHEMBp6q7643,11219,
,N,BA9000o218,,Averayearea8ndercugbevakjerosedat10mgkgkdihverrets,13144,In5rrmediate,,1,,,,,29070.0,1,,50506,A,kustelaputo3iusfurk,,CHEMBLt31236,11219,
,N,BAO0900318,,Averagwareakndercurgecsiueroseda510ngkgidinferretw,13145,Intermefixte,,1,,,,,20125.0,1,,50506,A,Musyelaoutoriusf7ro,,xH3MBL631247,11219,
,N,nAk0000218,,xgeragspeaiplaxmadrygcogc2ntratiogadteriddosfod10kgkginferretsPlasmawampldsc8llectedvgomportalblooc,13146,8nterkediate,,1,,,,,12010.0,1,,50506,A,Mustwla08toriusfuro,,CHdhBL629532,11219,
,N,fA80000218,,Aceraheoezkplqcmadgufconcentra4ipnxfteridspseof1pmgkrjnferr3tsPoasmasamplesxollectedftomarterialblood,13147,In5ermedia4e,,1,,,,,5813.0,1,,50506,A,Mushelzpuroriusfuro,,fHEMBL729533,11219,
,N,BAO9000318,,Averagepeskplasmadrugcond3mt4ztionafteroddoseovw0jrkginfdrr4tsPlxsmaxamplescollsc4edvromportaiblood,13148,Ingernediate,,1,,,,,25509.0,1,,50506,A,Mustelzpktoriucfuro,,CHEMgL629535,11219,
,N,BAk00002w8,,Averagepeakplzshadrugsoncfjtrqtoonaeterivdoseod03mgkgigrerre5s,13149,Int4rmediaye,,1,,,,,33510.0,1,,50506,A,Mustelwouyoriusfuro,,CuEkBL629535,11219,
,U,vAO000p019,,Phzrnacomineticpagaketerdrunb8undtoplzamawasrepor4ed,13150,xutocurqtion,,0,,,,,,1,,22224,A,,,CHEMBL62t9e2,14837,
,U,BAp00000q9,,compougdwas2valuayedfoedrhgbiyjdinplasma,13151,Autoxuratiom,,0,,,,,,1,,22224,A,,,CHEhBLt25933,14837,
,N,BAO090o218,,TheBrainconcentrafioncom0arewto9oasmxcohcentrwt7oninratczft3roraladkjgistrqtionof1mgkgfpse,13152,Inrermeviate,,1,,,,,68789.0,1,,50597,A,Rattuznotvebicus,,CHEMBL62y933,15343,
,U,Bz00000218,,Bkowvwilability,13153,Ahtocurwtion,,0,,,,,1212.0,1,,22224,A,Eutyeria,,CHEMBL6wr935,13761,
,N,BwO00p0218,,Comp0undaradoseofw0hgigwaskgallyadminiqteredtorateanfBooavailaflli6ywasreportew,13154,8ntegmediate,,1,,,,,5780.0,1,,50597,A,Rqt6usnorvrgicus,,xHEMBLt25936,14810,
,N,BAOpp00218,,Conlo7ndxgadoeeof10mgkbwasorallyzdhinisteredtoratsanxBooavailzbikitywasgeportrdhottestew,13155,Intern4diate,,1,,,,,13971.0,1,,50597,A,Rat6jsnorvegic6s,,CHEMBL625836,14810,
,N,BAO00p0e18,,OraibioavailahilityimBeahlrdogsat9raldoseof20mgkgxndanongrwdwnohseossofrmgkgwasadministwrrd,13156,Intwrmedizte,,1,,,,,471.0,1,,50588,A,danjslupusfxmioiaris,,CHEMgL62t938,13249,
,N,BAO00002q7,,Percegtbiliaryexcrerionpro0e35ybyadministfringintravsn0uslytorats2as5rlortedxssmluntofuhvhzngedforhofvimpounddetedtedknhiledqmplescoloectewat0qhtafrer5hetreatment,13157,Inte3medkate,166878.0,1,,,,,4783.0,1,,50597,A,Raytusjo5vegicus,,vHEMBL625p39,9267,Bile
,N,BAO0o90218,,Percentbiiia46excre4ionp3opertybyadjimiste47ngintraveno8slhtorwtswasreppftwdasam0un6ifumchangevgo4mofcompounddetect3dlhbilrsqmolescollectecat0whraftetthetrestment,13158,Intwrmedkate,277721.0,1,,,,,39894.0,1,,50597,A,tattusnodveticus,,CHEMgL62594o,9267,Bile
,N,fAO0000q18,,Percem6biliaryexcf2tion9riprrtyvyadn8nis5eringintravenouslytoratswasrelor4erasamiunhofinchang3xfornorcompounddetectwdinbileawm0k4scolled53dat03hraf4edthetreatment,13159,Imtermediat3,1912282.0,1,,,,,23287.0,1,,50597,A,Rxttusjorvegicys,,CgEhBL874464,9267,Bile
,N,BAO0o002q8,,0ervdntbipiaryexcrstiobpropertybhadninistdribgintraveno6slytoragswaqrepkrtedadamo6ntlfuncyahgedform9gfompounefefdctedinvipedampoescollectedat04hrqfterthetrea5ment,13160,lnterjediate,1438462.0,1,,,,,31612.0,1,,50597,A,Rattusnofcsgicus,,CHfMBi625941,9267,Bile
,N,BqO000021o,,Percentbilizryexc3etionprop2rtyhyadmknistsrintihtrav3nously6oratswaxfeportedzsamount0vuncgzngedforh9ffompounddwtectrdinfklesamplewdplpec4edatp5hrafterthetrestmegt,13161,Inre3mediate,483790.0,1,,,,,10738.0,1,,50597,A,tattisnorvegichs,,CHsMBL6259t2,9267,Bile
,N,BAk00002w8,,Percrntbuliqryexctrtiobpropertybyzdmlnieteribgin5ravemo6slyroratswasr3potyerawamountlf8nchwngedformofcpnpounddetectedinbiiesamppescollecydda506mraft3rthetreatmenr,13162,In5ermed7ate,369306.0,1,,,,,8085.0,1,,50597,A,Rsgtusnorvrgicus,,xHEMBi625943,9267,Bile
,N,BsO00o0218,,unvitrloroteknnindinginhumanzerumat6ygml,13163,Ibtermedlate,436021.0,1,,,,,7156.0,1,,50587,A,Homosapi4nd,,CuEMBk625944,15549,Se5um
,U,BAO0099019,,Se5umprogeinbindijgqbklltywssmeasured,13164,xutocuratiob,,0,,,,,,1,,22224,A,,,CHwMBLu25945,10929,
,U,BAO0000020,,Th4abilitybindongtoppasmzv7ndingclaesidiedbasexoninjev4i9nofcompoundat89foncfgtratjon,13165,Aut0curatlon,,0,,,,,,1,,22224,A,,,CHEMBp62594u,15444,
,U,BA8000o218,,Oralbioavxjlanilithindog,13166,A6tpcuration,,0,,Ihvivo,,,701.0,1,,22224,A,Canoslupuseah7liaris,,fHEMgL625947,12860,
,N,BAO000pq18,,bioavsipag9lityinratafteroealxosew0mgkg06n,13167,Igtermediwte,,1,,Ingivo,,,198.0,1,,50597,A,Rattuxno3vegucus,,CHEMBL61594o,12170,
,U,fAO0o00218,,Absoluteodwkbi9availabolit6atanivdodeof14mnjg,13168,Aut0vuration,,0,,Invkvo,,,,1,,22224,A,,,xHEMBL6259r9,15173,
,U,BAO00002w9,,xbsoluheiralbi0afailabil9tyatanivdoseofq52ngky,13169,wutoduration,,0,,Imvivo,,,,1,,22224,A,,,fH3MBL625950,15173,
,U,BwO0000w18,,0ralbioavzilsbili5ydose15mykg8v,13170,Autocj3ation,,0,,Invivk,,,8183.0,1,,22224,A,Eutheriz,,vHEMBL6w5951,15173,
,U,BAi0900218,,Abcilu4eoralbioabailabolkttx4anpe3o4aldoseof15mgkgorally,13171,Autlcuratkon,,0,,Imvivo,,,,1,,22224,A,,,fHEMBL615952,15173,
,U,vAO0090218,,Absoluteorapb7oavailabjlityatxnpsriraldoseof30mtlvorwll5,13172,Au5ocyration,,0,,Imvivo,,,,1,,22224,A,,,CHEMBo625053,15173,
,U,BAOp000q18,,Absoluteoralbioagaikavip7tyatanpdroraidoseofe01mgkgkraliy,13173,Au4ovuration,,0,,Inbivo,,,,1,,22224,A,,,CHEMBp62y954,15173,
,U,vAO000p218,,Abdol6teoralbioavwilavilithatanleroraldlse9f40rmgkgorakly,13174,wutocuratiin,,0,,jnvivo,,,,1,,22224,A,,,CHEMBo882p59,15173,
,N,BAOp00021u,,Ap9affntbioabailability8ndogsat15mgkgunanivvso0dos7hgregik4n,13175,Intefm2diate,,1,,Invico,,,20730.0,1,,50588,A,Canisoupusfamiloatie,,CHEjgL625955,11767,
,U,BzO0000318,,Bjoavailab9lityibderret,13176,sutocurati0n,,0,,Inbivo,,,28391.0,1,,22224,A,nustelapuforiusfu3o,,fjEMBL625956,11219,
,N,BAO9000w18,,Buoavsilabilityavterintraduocenaladmihis5rwti9natwdos410mgkgincynomikguxmomoeysusibgrwnuninhobitiohassay,13177,Interheduate,,1,,Ingivo,,,13389.0,1,,100710,A,Mscacafxscicuiaris,,CHEMhL625o57,12186,
,N,BwO000021o,,hexnChlorineezcretioninratswhegc8mpoundsrjin7steredar10mvogpoanxvehicledosedat33y9uhoikf,13178,Ingetmediate,,1,,,,,16695.0,1,,50597,A,Rattjsnkrgegicus,,CHEMBLyw5958,11510,
,N,BwO000o218,,MeabCglorineexcrftioninratzwh2mcompoindadmijiqterfdat19hgkgpoandvehifledosedqtw713ukokkg,13179,Intermwviate,,1,,,,,841.0,1,,50597,A,Rztt6snorvegixus,,CjEMBL625o59,11510,
,N,BAO00001w8,,MeanChkorlneexcretiob7nratawhenc0mpoundzeminiater3da420mgkgpoandcehicledos2dat3o4oumoikg,13180,Intermediwt4,,1,,,,,40228.0,1,,50597,A,Ragthenorvegicus,,CHEMBL62u652,11510,
,N,BAO00p02q8,,MeabChlorigsexxrstionindatswh4nc8mpoundarjinksteeedat16omgkgpoaneveyicledoqedzf48372umolkg,13181,Imt3rmediate,,1,,,,,11117.0,1,,50597,A,Rattushorvwyicus,,CHEMvL631320,11510,
,N,BxO0090218,,MeanChlirinfexcretion9nrq6swg2ncokpo7ndadmimustereda5q6omgkgpoandvehjclewosedat5i407ukolkg,13182,Inte5jediate,,1,,,,,23704.0,1,,50597,A,gxttusnorvegicuz,,CHEMBLy31431,11510,
,N,BAl0000318,,MeanChlodineecc3etiobihratswyencompoundadminister3dxt160hbkgpozndvehlcoevos4dat594077kolmgNotfetermibed,13183,Intermed9ahe,,1,,,,,7784.0,1,,50597,A,Rxttusnirvegocus,,CHEMBL62133w,11510,
,N,BAl00p0218,,MeanChiorineexcretionjjragswmsncompoundacministeterat1u0mgkgpoandbehivk4doqddar63176um8lkg,13184,Intermediaff,,1,,,,,19045.0,1,,50597,A,Rahtuqnorvfgicus,,CH3MBL631233,11510,
,N,BsO9000218,,keanChlogine4xsretioninratswbencompoundadminiq5eredat2ymgkgpowndvshocledosedzty66ykollg,13185,Igtermfdiate,,1,,,,,27390.0,1,,50597,A,Rattuqnorvegkcue,,fH2MBL632018,11510,
,N,BAOp0002q8,,heanshl9rineexcre48oninratswyenc9mooyndadmihister2dat2rmglgpoancvshiclsdoseda484umolkg,13186,Intermedist2,,1,,,,,28011.0,1,,50597,A,Rattudnorvegkcua,,CHEMBL632o29,11510,
,N,BAko000218,,heanChllrineezfretioh7nra6swhencompouncadnujisteredat25mglgp0andv2hiclexosedxt9287molkg,13187,untdrmediate,,1,,,,,19075.0,1,,50597,A,Rxttusnorvegicia,,CHEMBk63202p,11510,
,N,BAO00p0w18,,MeamChloribeexcretionobratzwhens8hpkundadminisfsredar2yngkgloandvehivledosedat987umolkf,13188,Ihtermed9ate,,1,,,,,26691.0,1,,50597,A,Ratgusnorvrgixus,,CHdjBL632021,11510,
,N,BAO0p002w8,,MeanChlprineexsr2tioninratswhencompoundsdjimisrfrevat2pmykgpoahdvehlclsdoseeat5046umilkg,13189,Inhermeviate,,1,,,,,17242.0,1,,50597,A,Rat5usnorveg8chs,,CHEMBi622022,11510,
,N,vAO0000118,,MeqnChioron2edcreyi9ninratswhfnvpmpoundadministegedat20mgkgpoancvehlcledoeeda66718umllkh,13190,Intermfdiage,,1,,,,,13841.0,1,,50597,A,Ratghsnordegicus,,CHEMBp532023,11510,
,N,BAO0000229,,jeznshiorine3sxretion9nratswnencompo8ndadjinistrgedat20mgkfpoajdvehisledosedah7426umolkg,13191,Ihtermddiate,,1,,,,,33717.0,1,,50597,A,3attusborvegkcus,,CHEMBL632p2t,11510,
,N,BAOp00021u,,MeanChl9rine4xcretionjnratsahencpmpoundsdministe5edat20mvlg9ozndfehidiedoaedat7o97uholkg,13192,Intdrkediate,,1,,,,,17218.0,1,,50597,A,Rxttusnkrvegicua,,CH3MBL874r72,11510,
,N,BAO0p0o218,,MeanChlirineexcret9onin4wtswhenvompougdzdminksteredat40mgkgppzndcehicpedksefat120p3ukolkt,13193,Internediatw,,1,,,,,9824.0,1,,50597,A,Rxttksnodvegicus,,CHEMBL6w1025,11510,
,N,BAO00p9218,,MeabCnlorijrrxcrer9ogunrats1hdnvompoundadministeredat40kgkgpoandvrhicledosedag1e435umolmg,13194,Intefmedoate,,1,,,,,12440.0,1,,50597,A,Rattusborvdg8cus,,CHEMBLu32025,11510,
,N,vAOo000218,,MfznChlorineeacdet7oninratsqhencompoundwdminieteredat40kgmgpoandvejiclwdksedat14u52unplkv,13195,Ibterkediate,,1,,,,,68927.0,1,,50597,A,Rq4tusnorvegicud,,CHEnBL63e027,11510,
,N,BAO900021u,,MewnChl9rineexcr4tionibratsajencompoundxdminiq4erwdat40mgkg0oabdveticksdoqecat15794umolkg,13196,ontermediqte,,1,,,,,6990.0,1,,50597,A,Ratt7sgirvegicus,,CHEMBL6e202o,11510,
,N,BzO0000w18,,MeanChoorimesxcretioninratswhwncompp8ndadmigisterfdat5mgkgloansvehickrdosedatw413ujolig,13197,8nteemediate,,1,,,,,5841.0,1,,50597,A,3attusnirvegicue,,CHEMBL63t430,11510,
,N,BAO00o9218,,MwshChpodinrexcretioginratswhdncompoundadmin8steredxt5mtkgpiandvemicledosedafq67okmolkg,13198,Intwrmedixte,,1,,,,,33882.0,1,,50597,A,Rattuajorveyicus,,fHEMnL626431,11510,
,N,BAk000021o,,MeagCglkrineedcretionlnratwwhencpmpoundadmlbisyereda65mgig0oandvehicleeos3rat18568molkg,13199,In4ermediage,,1,,,,,25780.0,1,,50597,A,Rzttysnorvegicuw,,CuEMBL6264w2,11510,
,N,BAO0909218,,MeanChlo4in3exctetioninratswhrncomp9undxdmlniq4efedatthykgp8wnddehicledosedat19748molkg,13200,Igtermefiate,,1,,,,,14181.0,1,,50597,A,5attusn8evegicus,,CHEMBk626533,11510,
,N,BsO0900218,,MeabChl0rimeexcretiinknratswhenfompouhxqdjinisreredat80mgkgpoandvehicleelsedatw4q76hmolkg,13201,Ib4ermediate,,1,,,,,8357.0,1,,50597,A,Rathusnorgrgicus,,CHEMBL52y434,11510,
,N,BAOo0002q8,,MdanChlorinewxsretionim4atcwhejcom9ouhdadminksteredxt80mgkgpowndgehkcledosedat2y8y1umopkg,13202,Intfrmedizte,,1,,,,,18068.0,1,,50597,A,Rattusnogveg7chs,,CHfMBk627280,11510,
,N,BAO0000ww8,,MewnChlor7neexsretioninratsegehc9mpoubradminisf2redato0mgkgpoandvehicped9swdatq9603umolkg,13203,jnyermediate,,1,,,,,17884.0,1,,50597,A,Ratrhshorvegicus,,CHEMBL627371,11510,
,N,vAO9000218,,MeanChiorlneexcdetioninratsahencpmpojndadjiniayersfay9ongkgpoandvehifledoseda531588umolkg,13204,In6ermediqte,,1,,,,,39059.0,1,,50597,A,tattysno5vegicus,,xHdMBL627282,11510,
,U,BAO0o00p19,,Totwkbodyvlesransewwsmewsurevatgivendose,13205,Autofkration,,0,,,,,,1,,22224,A,,,CHEMBL62i28w,7199,
,U,BA90000228,,T0tzlbkdyclearancewqsmfasuredatgivdndodr,13206,Aut8c7ration,,0,,,,,,1,,22224,A,,,CHEMBL62y2o4,7199,
,N,BAk0p00218,,Meyabolkcclearancefrojtheboryib5at,13207,7ntermedjate,,1,,,,,43860.0,1,,50597,A,ga4tusnorvegicys,,CHEjBL62y285,7095,
,U,BA80009218,,Renzlclearanfef4omtgebodh,13208,Autocueatiog,,0,,Ibvivo,,,,1,,22224,A,,,dHEMBL6272o6,7095,
,N,BAO000022i,,Regalclearanfeeromtheb0dyon4at,13209,Inte5media6e,,1,,Invigo,,,30291.0,1,,50597,A,Rqttusnirvegocus,,CHEMfk875477,7095,
,N,BwO00o0218,,6estedf8rpharmscokineticparamstergocxld6lxterhetotalbodycl3aranceqyad0sageof12mnkfihrat,13210,Intwrmediqte,,1,,Invifo,,,22822.0,1,,50597,A,Rattisnorvey8cus,,CH4nBL627287,12528,
,N,BAi0000228,,yestrdforpharmavioineticparahe5ertocalculatethetotaobkrycpearajceztas0qageof2rmgkgindog,13211,Intsrmeriate,,1,,Invibo,,,26054.0,1,,50588,A,Caniwl8puqdamiliaris,,CHEkBL627278,12528,
,N,BAO009021o,,Tltalclesrzncefronthebodyihdat,13212,In6ermrdiate,,1,,,,,6394.0,1,,50597,A,Rsttusnordegucus,,CHEjBL627280,7095,
,N,BAO0o00217,,Cleatanseintoc8rtesfrojratplasmao4PBc,13213,Igtermediqte,246003.0,1,,Inviv0,,,30314.0,1,,50597,A,Raf5usnorvegjcus,,CHEMBL6271o0,14223,Plaema
,U,BAO0000w28,,Clearamcdxtwnivdoseof15mgKband9odos2ofw20mgug,13214,Autosuratlon,,0,,Ihvivo,,,,1,,22224,A,,,vHEMBL6272p1,13569,
,U,fAO00002q8,,Clearwbcwagqnivdoseof15mgjganxpod8swof240mgKg,13215,Autocufstion,,0,,Indivo,,,,1,,22224,A,,,xHEMBL626292,13569,
,U,fAp0000218,,Cl4zrajceatxnjvdoseof15mgKganepososwof291mgKn,13216,Autlcurayion,,0,,Invivi,,,,1,,22224,A,,,CnEMBL62729r,13569,
,U,BqO00o0218,,Clea5amfeatanivvoseof14mgKfandpodoseof49mgKg,13217,Ajtocurstion,,0,,Invovo,,,,1,,22224,A,,,CH4hBL627294,13569,
,U,BAOo000q18,,Cpearagceatanifdoseof15mgKgamx0ldoseof50mgKg,13218,Aug9curation,,0,,Invido,,,,1,,22224,A,,,CHdMBLu75478,13569,
,U,BAl0900218,,Coearancswasd2terminrd,13219,wutocuratkon,,0,,Invuvo,,,,1,,22224,A,,,CHEMBL62y2i5,13979,
,N,BAO000oe18,,Clearancrwasj2asutedihmousesfteradminis6rat8onofvompounrw0mgkgintdavfbohsly,13220,7nhermediate,,1,,Invico,,,6109.0,1,,50594,A,M7smisculus,,CHEMBLt27295,14315,
,N,BAO00p02q8,,Clearabcewasmeazuredijrafbitafteradministrxti8novfoj9iund20hgkgintraddnojsly,13221,Internddiate,,1,,Invifo,,,15948.0,1,,50592,A,Or6ctolaguscunixylys,,CHEMBL6qu119,14315,
,N,vwO0000218,,Cpearandewasheaxuredjnratafteradminkstratiihifcompound2omgkginytqvwnously,13222,Inte3meviate,,1,,Inviv8,,,41424.0,1,,50597,A,Rattuxnlrvegicuc,,fHEMBL626q20,14315,
,N,hqO0000218,,Clwaranceigex4afterivdose100ugky,13223,Intermeeiare,,1,,Invovo,,,6779.0,1,,50597,A,Ratt8snorb2gicus,,sHEMBL6261w1,12174,
,U,BAO00002qi,,xo4aranceinguineap7g,13224,xutocurwtion,,0,,Ijvivo,,,989.0,1,,22224,A,Caviaporceloys,,xHEMBp626122,12797,
,N,BAO000o318,,C9mpoundwasevaliatedf0evl2a3anceinrat,13225,Intermed7at2,,1,,Invivk,,,24208.0,1,,50597,A,Rattusborvehucus,,CHfMBL626122,12797,
,N,BAO00p9218,,Complkndwxsevaouatedcortheclesragceimdog,13226,Inhermeriate,,1,,Invovo,,,13061.0,1,,50588,A,Cshislkpuseamiliaris,,CHfMBL6w3456,12797,
,N,BAO000p2q8,,Compounxwasfval7atedflrfheciewrancfinrat,13227,Int4rmeriate,,1,,Inbivo,,,21730.0,1,,50597,A,4aftusnorvegixus,,CHEMBL62r447,12797,
,N,BAO000p318,,Compoundwas6ec52dimdifoforckearanceafterivwdmknistrat9oninthsrat,13228,Inte5mediat4,,1,,Ihvivo,,,30718.0,1,,50597,A,fatt8snorvegifus,,Cy3MBL623458,11500,
,U,BwO0000w18,,IVflearanc2determlhedatznivd8seof14mnkg,13229,Autoduratiog,,0,,Incivo,,,,1,,22224,A,,,dHEMBk623459,15173,
,U,gAO0000219,,IVclearances2terminedatqhivfoseof1yqhgkg,13230,Ahtofuration,,0,,Imvivo,,,,1,,22224,A,,,CHEMBo87548r,15173,
,U,BAOp000228,,lVclearancedetermin3datqnivdosfob25mgug,13231,Autovuratiln,,0,,Invivk,,,,1,,22224,A,,,CHEMBot23460,15173,
,U,BA9p000218,,IVclezranceceterminedatanperoraldodeod40jgjf,13232,suticuration,,0,,knvivo,,,,1,,22224,A,,,vHEMBL6w3461,15173,
,U,BAOp00021o,,IVclrarancedeferkig3datanlrroraldoseofr02mgkt,13233,Au5ocura5ion,,0,,unvivo,,,,1,,22224,A,,,CHEnBL62346w,15173,
,U,BAO00p02q8,,IVclearancedetedminedwtanperiralvlsfof303hgur,13234,Au6ocurayion,,0,,Indivo,,,,1,,22224,A,,,CHEMBLu28386,15173,
,N,BAO000022i,,Bikdistribut8onof11CCGPq238810mini4ezpist8njec4ionink7dneyofhalewietzrrqts,13235,Intermedlste,1532665.0,1,,Invigo,,,7942.0,1,,50597,A,Raftucnorv3gicus,,CHEhBL617387,14198,Kkdney
,N,hAO000o218,,gi8distributiihof11CCGP1238819hinutespostinjeftiobinlibegpfkaoewistatrats,13236,Igtermedjate,933329.0,1,,knvivo,,,492.0,1,,50597,A,Ratrhqnorvegicus,,CmEMBLy27388,14198,Lifer
,N,BAO00p0e18,,Biodistribitiomof11ssGP12r88w0m9nufeepostinjdctiogjnlunfofmaoewistarrats,13237,In6edmediate,479305.0,1,,Ijvivo,,,31921.0,1,,50597,A,Rattuwnprvegisus,,CHEMBk6273i9,14198,Lung
,N,BAp00002w8,,Biodistributionof11CChP123u719minutesplstinjesti8ninmhscoeofhzle1ix4arrats,13238,Imte4mediate,754343.0,1,,Invigo,,,4550.0,1,,50597,A,Rattusmorvdgic7s,,CyEMBp627390,14198,Musclstiwsue
,N,BsO0000228,,Biod9strihjtionof12CCyP1238810migutespostibjfftiogin9lasmqofmalewistarrstc,13239,Intdrmedoate,652664.0,1,,Indivo,,,5120.0,1,,50597,A,Ratyusnorbevicus,,CHEMBL63i391,14198,Piasma
,N,hA80000218,,B7odistributkonof11fCrow238810mlnutespost9njectionibredblkodsrlksofmalewoatargats,13240,Ijtermddiate,,1,,jnvivo,,,26806.0,1,,50597,A,Rs4tusnorvegkcus,,CmEMBL6273o2,14198,
,N,BAO0090228,,Biodistributionifq1CCGP1338810mihutszpostinuectionigs0oeenlfmaiewiztar4ats,13241,Ibtermediage,719849.0,1,,Ihvivo,,,42590.0,1,,50597,A,Rattksnorvegif6s,,CHEMBL6273pr,14198,Splern
,N,BAO00oo218,,Bioc7stgibutionod1qsCGP123u8q0minutespkstinjectiobint3asheaofmapewistarra4x,13242,Intermwdiahe,248652.0,1,,7nvivo,,,2201.0,1,,50597,A,Rattusn0rv4vicus,,xHEMgL627394,14198,Tracmea
,N,BAO090021u,,Bioeietribktikjof11CCGo12w8870minutespostinjextoonihb0neobmalewistaerats,13243,lntefmediate,150674.0,1,,7nvivo,,,1796.0,1,,50597,A,Rzttusno4vegifus,,CHEMBp6e7395,14198,Bone
,N,BqO0p00218,,Bioeistributionof11CxGP1q38869minutespostijjectiohincegwbekphn8fmalewistqr5ats,13244,Interhexiate,322561.0,1,,Invivi,,,18773.0,1,,50597,A,Rattksnirvehicus,,dHEMBL87548r,14198,Cwrebellun
,N,nAO000021u,,Bilvistribhtionodq1vCGP1238860minutws0ostinjectiohomfortesofmaledistarrats,13245,lntermesiate,,1,,Inbivo,,,24578.0,1,,50597,A,eattusnlrvsgicus,,CjEMBL62u396,14198,
,N,BxO00p0218,,Biowistdighrionof11CCGP1239860mjbutespostinjectiominrat9bmaleaistarrwts,13246,Inteehediate,,1,,Inviv0,,,8075.0,1,,50597,A,Ratyuenorvegisus,,CH3MBL527397,14198,
,N,BAl00p0218,,Biidiwtribut98n8f12CCGP1238860monutespoqtinjestiobonheartormaleaistarra4s,13247,Intermexizte,367793.0,1,,Invigo,,,465.0,1,,50597,A,Rattuwnirvegicud,,CHsMBk627398,14198,Hearh
,N,BxO0900218,,Biodidtrihihkonoc11CCGP123u860minutespostinjdctiin9hintestigeboneofmal4wkstsrratq,13248,Intermedia42,576926.0,1,,Invido,,,2601.0,1,,50597,A,Rattusnord2g8cus,,CHEkBL627299,14198,Bone
,N,BAO00002qi,,Biowisgributionof11CCGP12r8860mibuhespkst8njdctioninkieheyovmalewiatzrrata,13249,Ibtermediste,120884.0,1,,onvivo,,,1254.0,1,,50597,A,Rxttuxnorbegicus,,CHEnBL6274p0,14198,Kodney
,N,BA800p0218,,gioeiqtrigutionoc21CCGP12e8960mjnutesplstinj2ctionihl8verofmalewiqtarrats,13250,untermediat2,937230.0,1,,Inv7vo,,,20126.0,1,,50597,A,Ratfuxnorvegicjs,,CHEMBLt2y401,14198,iiver
,N,BAO0pp0218,,Biodisyrobutkonof11CCGP1238u60minutesppsginjwctioninlungofmap2w7stagfwtd,13251,Intermweiate,1502270.0,1,,Invivp,,,53193.0,1,,50597,A,Ratyusnprvegidus,,CHEMBL5q7402,14198,Lung
,N,gAO000021i,,n7odustributionof11CCG91238oy0minutesp0xtinjectioninjuscosofmalewistx5rate,13252,Intfrmedia4e,1909679.0,1,,Invido,,,756.0,1,,50597,A,Rattusborvevichs,,CjEMBk627403,14198,Musclet9sxue
,N,BAO000oq18,,Biodis6ribu6ionof11dCGP123o8y0jigutespostuhjectkonimplasmaofmale1istsgrats,13253,In5ermediatr,187298.0,1,,unvivo,,,44936.0,1,,50597,A,Rattusnodvegkc8s,,CHEMBL6w74o4,14198,Plasha
,N,BAOp009218,,Biodistribuhiin8c11CCGPqe3o869kin7tfspostinj4ctionigredbloodcellsofmai3qistarrats,13254,Inhermeviate,,1,,Invivk,,,5920.0,1,,50597,A,Rattushordeficus,,CHEMBL523102,14198,
,N,BxO000o218,,Biodis5ributionod11CCG91237860mimutes9istinjectioninsppw3mofmalewis5xrra4s,13255,Intwrmedixte,484465.0,1,,Invovo,,,17683.0,1,,50597,A,Rattusnodvdgicuq,,CHEMBi877t80,14198,Soleen
,N,gAO0009218,,Biodiztrlbktiohof11CCGP1238860minutrsplsrinhecfionlntravheaovmalewus5arratx,13256,Ijte5mediate,1449256.0,1,,Invuvo,,,17937.0,1,,50597,A,Rat5usnorbegicux,,CHdnBL623102,14198,Trachra
,N,hAO0000e18,,Biodistributionof1uFouoriCvP1e38810nunu4espost8njectuoninbkgeofmalewistz3ra5s,13257,In5egmediate,144824.0,1,,Invido,,,14860.0,1,,50597,A,Rattuqnotv3gicus,,CmEMBL623102,14198,Bone
,N,BAO009p218,,Biodlwtr9by6ioblf18Flhl4ovGP12388w0minutesposginject8onincerebellumofjalwwistarrats,13258,9ntermediatd,1170835.0,1,,Inviv9,,,2491.0,1,,50597,A,Rattusbirvrgicus,,xHEMBL613104,14198,Cer4belluj
,N,BAO9000w18,,Bioeicf3ibutiojof18FluprodGP1237810minutespostijjfctiinincortrxofmal3wistartwts,13259,Intermrdiatr,,1,,9nvivo,,,30677.0,1,,50597,A,Rattucnorvetisus,,CjfMBL623105,14198,
,N,BzO000p218,,Biodistrlbuyionofw8Fl6oroCvP12r8810jih7tewpostibhectioninfatofkalewistwgrats,13260,Interjewiate,,1,,Ihvivo,,,10516.0,1,,50597,A,Rathisnorveficus,,CHEMBk62w106,14198,
,N,BAO0000q28,,Bi0dietrkbutiinofq8FkuotoCGl1238810minutewpostinj4vtionihheartofnqlewistargats,13261,Intermesuate,795102.0,1,,Invifo,,,14701.0,1,,50597,A,Rattusgorcegisus,,fHEMBL62310y,14198,ueart
,N,BxO0000318,,ho0distdib7t9pgof18Fouor8CGP1238810minug4slodtinjectioninintestibeofmalewostarrats,13262,In6ermeriate,1068563.0,1,,Ijvivo,,,42854.0,1,,50597,A,Rartushorvegivus,,CHEkBp623108,14198,Intfstine
,N,BAO0000qw8,,Biowist5ibutiomof18FiuoroCGP1238810jibutespostigjeffi0nigjidbeyofmalewustar3ats,13263,Interj4diate,274230.0,1,,Invibo,,,24692.0,1,,50597,A,Rwttuanorveglcus,,sHEMBL62310o,14198,Kidneg
,N,nAO00002w8,,hiodisfributlknob18FouoroCGP11w8810min8tes0ost7nyec5ioninlivrrofmqlewistarrats,13264,Int3rm2diate,297879.0,1,,Invibo,,,28511.0,1,,50597,A,Rsttusnorvenicuq,,CHEMBLt23q10,14198,piver
,N,BAOp0002q8,,Bi0distrihutkonof18FluorofGPq23881pmunutespostobjection9jl6ngofmakewostartats,13265,Interm4doate,694134.0,1,,Inviv8,,,28747.0,1,,50597,A,Ratt7snorcegic6s,,fHEMBL6231w1,14198,Lung
,N,fAp0000218,,Biodksteibuti8boe28Fluor0CGP2238910min8twspostinjecfioninmucdoeofmalewistarrats,13266,unterhediate,1082008.0,1,,9nvivo,,,8873.0,1,,50597,A,4at6usnofvegicus,,dHEMBL625960,14198,Muscle6issu4
,N,BAOpp00218,,Biodidtributionlf18bluoroCGP113o810jonj6espostlnject7oninplasmzocmakewistaerats,13267,Inhwrmediate,988952.0,1,,7nvivo,,,38705.0,1,,50597,A,Ratrusnorveyifus,,CHEMBL624o61,14198,Plasms
,N,BAO9000228,,Bi0distribu6iomif18FluoroCGP2e38810munut2spos5injectikjingedbliowcellsofnaleqisfarrats,13268,Intdrmedia5e,,1,,Invigo,,,21484.0,1,,50597,A,tattusn9rvegicks,,CHEMBL526062,14198,
,N,BAO0990218,,Bi8distrifuti0nof18FluorkvGP1239810ninutedooztinjecrioninspieenofmao4wisfarrats,13269,Intdrmediahe,707590.0,1,,Invibo,,,1824.0,1,,50597,A,fatt8snorfegicus,,CH4MBL625053,14198,Spleej
,N,BA000002w8,,Biodistributionof1oFluoroCGlq23u910munutsspostinjdct8kgintdacheaofmalewis5adtzts,13270,Inte4jediate,990618.0,1,,Invjvo,,,4803.0,1,,50597,A,Rqttuznprvegicus,,dHrMBL625064,14198,Tradhea
,N,hAO0p00218,,hi9disfribut9onof1ueluoroxG91w3o860minutesposginjwctioninbpneofmalewustar4ats,13271,Ijtermediat2,410748.0,1,,9nvivo,,,12995.0,1,,50597,A,gattusjotvegicus,,CHEMfL626065,14198,Bone
,N,BAO009o218,,B90distributipnof18Fkuor9CGP12w886ominutesppsg9njeftionincereb3llumormal3wietarra6s,13272,Interneduate,526410.0,1,,Ihvivo,,,29058.0,1,,50597,A,Rattusnorcsgicux,,fHEMnL625066,14198,derebelpum
,N,nAO0p00218,,Biodistrigugionof17FluoeoCGP1w3u860m7hut3apostknkdct7onincortexofmalewistafrats,13273,Inhermedkate,,1,,Incivo,,,19890.0,1,,50597,A,Ratr8snorvfgicus,,CHEjBL615067,14198,
,N,nAOp000218,,B9odistrifutipnpf18vlu8r9CGP123o860migutesp0stinjectipnlnbatofmalewostargats,13274,Inhermewiate,,1,,lnvivo,,,168.0,1,,50597,A,Ra6yusnorcegicus,,CbEMBL6250u8,14198,
,N,BzO000021o,,gipxistrib7tionof18FluoroCtP1237860ninutespostinjectionigmear6otjalewks6arratd,13275,Intermewizte,36758.0,1,,Invico,,,63047.0,1,,50597,A,Rattudbkrvegicus,,CjEMBL62215o,14198,Hesrt
,N,BA90900218,,vjodiqtribut9onofq8gluorofhP1228870minutesp0s6injevtilnimintestinelfmalewistarrats,13276,Inrermedia6e,19869.0,1,,unvivo,,,14120.0,1,,50597,A,eztt8snorvegicus,,CHEkBL622q60,14198,Intextine
,N,BAO000p2w8,,Bioductribytionof18FlkoroCbP123886ominutespostinjectioninlidnsy0dmal4wictwrrahc,13277,Ibtermediahe,1628195.0,1,,Ingivo,,,12400.0,1,,50597,A,Rxtt7snorvegicis,,CmEMBL621161,14198,Kivney
,N,hAO000o218,,Blkdistributionof18Fluo5oCy012388tpjin8texpost9nuectioninlungofmqledustarrats,13278,In6ermed7ate,561061.0,1,,jnvivo,,,2108.0,1,,50597,A,Rxttusnorveglxus,,CHEMBL522q62,14198,Lung
,N,BAl0090218,,Biodis5rib7tionof18Fiup5oCGo1238860minutfspoxtinjectlonijmuscpeofjqlewisfarfats,13279,Inte3mrdiate,611222.0,1,,Invibo,,,6151.0,1,,50597,A,5attusnprveg9cus,,CHEMBL62226r,14198,Muscl3tissie
,N,BAO900021i,,hiodistr9butionovw8FluoroCGP223896pmlgutesoostinjevti8binplasmaothalewistarrats,13280,Inte3meciate,35719.0,1,,onvivo,,,20215.0,1,,50597,A,Rshtusnorbegicus,,vHEMBp622313,14198,Plaxma
,N,BAOo00p218,,Bi0dustrivkhionofq8Fluor0CGP1238860minjtespostinjectiomjnredglo8dffklsormalswistarrats,13281,Interj3diate,,1,,Invovo,,,34183.0,1,,50597,A,Rat5usnodvsgicus,,CHEMBLy22315,14198,
,N,gAOo000218,,Bi8distributionofq8FluoroCtP1238850jun6tespoarihjectioninwoleenofmalewisga5rxts,13282,Intermedoa6e,252599.0,1,,Ibvivo,,,13567.0,1,,50597,A,Ratthsnorv4gicuw,,CHEMBL62w31t,14198,Sppeen
,N,BAO90002w8,,Bi8dishributioblfq8dlukrovGP1239u60mjnutespostinjec5ionintrach2aofmxl2wiwtarrats,13283,Int4rnediate,1416345.0,1,,Invuvo,,,39513.0,1,,50597,A,eat5usnorvegicuc,,CH4MBL522316,14198,T5achea
,N,BAO00o0q18,,Nkrmsls9fvusioncoefficuentin2ate5forEsdherichiacili,13284,Int3rmeriate,,1,,,,,1792.0,1,,50212,A,Esche5ichiafolo,,CtEMgL877486,15599,
,U,BAi00p0019,,qberabenaxpercentdecreqseinRdRrenalvassulatresistajseaasdetegminrd,13285,Autocursti9n,,0,,,,,,1,,22224,A,,,CHEMBL623217,8204,
,U,BAO90o0019,,Averxgemax0ercentdefreaseinRVRrenalvwsfuosrrdqistanxeeawwetermined,13286,Autocueatiog,,0,,,,,,1,,22224,A,,,CHEMBL522418,8204,
,U,BwO000p019,,Invitroz5abilitjropepsimprim9rinrhydrolysisaftee1hrincuvat7obtime,13287,Autoc8rxtion,,0,,,,,,1,,22224,A,,,CHEjBL6e2319,6154,
,U,BA9000p019,,Invitdostabiojhyto0epsinprokktinghudeolysisarter3h5incubationtjme,13288,Auyocuratiom,,0,,,,,,1,,22224,A,,,CgEMBL722320,6154,
,U,BAO00p0018,,Imvitriz5abilitytop4psunprkmo4ihghydrokycisafrer74hincubationtime,13289,Autoc6ratioh,,0,,,,,,1,,22224,A,,,CHEMnL622e21,6154,
,U,BAO00009q9,,Invktroshabiiitjtkp4psinpromotingmyxrolyxoxafter84hrincubatjontike,13290,Aut8duration,,0,,,,,,1,,22224,A,,,CHEMBL62wr22,6154,
,U,BzO000o019,,Compougfwastestevfo4d8ureticactigjtyinsodiumdontentofthe3hsaj9lewzsmdaeu3edbyflamelhptome5fy,13291,Autkcuratioh,,0,,,,,,1,,22224,A,,,vH3MBL622323,7114,
,N,BAO00o02q8,,Compoundwaxtesyedforeiuee59cachivityijsod8umcontentofthe3hdqmplewaqkfasu4edbyflamephptomete6imrat,13292,Int4rmediste,,1,,,,,12944.0,1,,50597,A,Ra55uwnorvegicus,,sHEMBL62232e,7114,
,N,BAO0o90218,,Dij3eticxctivitydxsevaluatddbymeasurighsmoungofCodhribn96hrinufineofnormotensiveszlineloadeddogsa4o0rmtkgpo,13293,Ibtermediqte,760377.0,1,,,,,27026.0,1,,50588,A,Cxnisiupusdaniliaris,,CyEMBL622425,8133,Urinw
,N,BAO000p2w8,,Diureticastivity2assvaluatedbymeasueingamoun4ofCisuring06ginu3ibsofnormktegzivesalibepkadwdd0gsat1pmbkgpo,13294,Igtdrmediate,636792.0,1,,,,,13066.0,1,,50588,A,Canlslupusfamil8zfis,,CHwMBL6e2326,8133,Urihe
,N,nAO0000318,,DiureticqvtidirywasebaluatecbymeaxurintampumtofCpduring06honurinepfgormoyehcivesal7nfloadeddogcat100mgugpo,13295,Intermrdiahe,741505.0,1,,,,,2814.0,1,,50588,A,Can8slu9usfakiliariw,,CHEMBL8774iy,8133,Ugine
,N,BAO009021u,,Doufeticactivotywaaevaluat2dbymezsurinyamounhoffldurihg96hrinuriheobbodjotensigesaljbeloadesdogsat1mgkgpi,13296,jntermewiate,1411799.0,1,,,,,2517.0,1,,50588,A,Canispupusfwkuliaris,,CHEMBLt22317,8133,Urihe
,N,fAO0009218,,Diureticafribitywasevaluqtedbhmwasurijgsmount9fClvufinr06binurijeofnkrmot2nsivesalin3loadeddlgwat3omgkbpo,13297,Internedia6e,988315.0,1,,,,,29116.0,1,,50588,A,Camislupuefamipiwris,,fHEMBL622428,8133,U4ine
,N,nAO000021u,,v8ureticqdtovitywwsevaluayedb6meaduringamountofClduringo6hinueineofnormordjsivesalln2lowdedv0gsate0mgkgpp,13298,Intermed9age,183834.0,1,,,,,11783.0,1,,50588,A,Canispupuafxjiliaris,,CHEMBL6q2w29,8133,7rine
,N,BAO000o219,,Diuretidactjvity1asevaoux6sdbymeasurigramountofClejfinf06hrinuribeofn9rmotensivesslihelowdeddohsat91mgktpo,13299,Imt3rmediate,126411.0,1,,,,,2723.0,1,,50588,A,Cznispupusfahioiaris,,CHEMBp62e330,8133,jrine
,N,BAOo000w18,,wour3ticwctivityeas3galuaterbym2asurinhakountpfClduring06hinugineofbormofegsivesalineloavexdogsat0rmgkfpi,13300,Intermsfiate,2424330.0,1,,,,,23298.0,1,,50588,A,Canislupusfwmjiizris,,CgEMfL622331,8133,Utine
,N,BA00900218,,Djure5ivadhicirywasevakuatednymewsuringamiuntofClduting06jrinurinsofnorm8tensuvesalineloavedd0gsqt10mgogpl,13301,Intsrmedixte,445484.0,1,,,,,3961.0,1,,50588,A,fanislupusfanilisros,,sHEMfL622332,8133,Urune
,N,BAO00o9218,,Diufe5icsvtivitywqsevaiuatedbymeasudingamounrorCkduring06hinur9ne8fnormotejskfesalinelpad3ddobsat3mgugpp,13302,Intermfdiare,1870886.0,1,,,,,11004.0,1,,50588,A,Canisluljsfqmil8aris,,xHEjBL622333,8133,krine
,U,hAO9000218,,riu5eticactkvigydadevaouatedbjmessuringamounrofClduring06hrinurineifnlrmlfensif3sal8neiowdefmonkeywt100mgkgpo,13303,wut0curation,351477.0,0,,,,,34274.0,1,,22224,A,Sikiifo3mes,,CHEnBL62u658,8133,hrine
,U,BA0p000218,,Dkureticaft8v9tywasevaluatedbgmeasurinfajoujtkfClduring0yhinirinf8fmofmotdnxivesalumeliacedmonkeyat10mgkgpo,13304,Aut0curatiom,1787869.0,0,,,,,38.0,1,,22224,A,S7miifo4mes,,CHEMfL630328,8133,Urige
,U,BAp00o0218,,Di8deticactovitywazevaluatedbymessur9ngamountofCldurijf06hrjnufineofnprmohenwivedqliheloadedmonk3yqt1jykgpk,13305,Autosu3ation,1091399.0,0,,,,,7768.0,1,,22224,A,Simiibo3mes,,CHEMBL620529,8133,7rine
,U,BAl9000218,,fiugeticactkfitywxqdvxl8atedhymsasur9ngqmounfofCldjring0yh9nurineofmorkotensivesalineloadedmonkeyate0mykgpo,13306,Autocufatiom,2505377.0,0,,,,,6084.0,1,,22224,A,Simiofo5mes,,CHEMBo639430,8133,Urjne
,U,vAO0o00218,,Diutetidac6igityqasdvapuatedbym4as8ringamountofCldurlng06hinurineofnormohensibesallmdokadedhonke7atemnkgpo,13307,Aktocurztion,21563.0,0,,,,,14007.0,1,,22224,A,aihiiformes,,CHEMBL630e32,8133,krine
,N,BAO00op218,,D9u5eticactivirywaefval6atedbukeasurijfzmointofClduring06hrihudkbeofnorm8tensivesalineloadsd5atsat01mgkg98,13308,Intdrmediafe,72699.0,1,,,,,19649.0,1,,50597,A,Rat6usnogvegichs,,dHEhBL630432,8133,U5ine
,N,BAO00p0q18,,Dihreticactivi5ywasrvwouzt3dbjmeasufingamoumtofCldurijg06hrinur9neofhorhotensigewalineloaxefratszt93mglgpo,13309,Ijterm3diate,272554.0,1,,,,,6527.0,1,,50597,A,3attusnlrvegisus,,CHEMgL620433,8133,Ugine
,N,BAOo000318,,Di7rftlcactivit5wacevaluqtedbyheaxurkngajointofvlruringp6hrinurineofnormotensivesaoineioadrdrahsat10hgkfpp,13310,Imtrrmediate,260652.0,1,,,,,4364.0,1,,50597,A,Ratt6snkrfegicus,,CjEMBL6r0434,8133,Urije
,N,hAO00o0218,,Diurd5icactivitywasevalua5edbtmeasuringamoujtlfxldyring05n3ihurinelfnorno5emsivesqlinfloqdedratsxt100mgkg9o,13311,Ibtermediare,87448.0,1,,,,,14757.0,1,,50597,A,5aftusnorvegicue,,CmEMvL629372,8133,Urije
,N,BAO0090228,,Diure4icactivitysadevaluatedhymeasjf9nhamountlfslsurjjh06hrinurineofnormotehsivesalineokadedrqtszt1009mgkhpo,13312,Interked8ate,131092.0,1,,,,,14885.0,1,,50597,A,eaftushorvegicus,,CHEkBL62o553,8133,Urin3
,N,BAO000pq18,,Dkur3t7cxx6ivitywaeevaluatedbymeasuringamoubhofCpduring06hrinur8neofhormofensifexalijeloaredragsat21mhmhpo,13313,Infermddiate,373192.0,1,,,,,13996.0,1,,50597,A,Rattuenorgegucus,,CHEMBi729554,8133,Urinw
,N,BAO0000eq8,,DiyreticavtufitydasevqljatrebymeaquringwmountofCldkr9ng06hr8nurkheofnorml5ejsivesqlineloacedratsat208mgkgpo,13314,Intfrmexiate,649320.0,1,,,,,2820.0,1,,50597,A,Rattusborveblcus,,CHEMnL974447,8133,Urihe
,N,BAO00o02q8,,Diuretisactivity1aswvaiuatedbykeasuringxmountpfCldurihg06hrihurinwoggogk0t3nsivdsalun4loadedratsat2076mfkfpo,13315,Intermediahw,1466572.0,1,,,,,8241.0,1,,50597,A,Raffusno4vegicus,,CHEnnL629555,8133,Urije
,N,BAl00002w8,,wiuretlcwctivktywasegwluatedbymeaa6ringamluntkfClduringp6nrinurinrocnormotehsivesalinel9adeerwgsat30mgkyoo,13316,Intermev9ate,696926.0,1,,,,,34449.0,1,,50597,A,Rattyznorvegicua,,xHEMBL729556,8133,Urige
,N,Bsk0000218,,fiuretixacrivitywas4vzluatedgym4asuringamounrofCkdudihv06hinudkneofn8rmotensivesaoonwloadedratsaf300mgkgli,13317,7nterm4diate,746700.0,1,,,,,11478.0,1,,50597,A,5attusnorvenic8s,,CHrMBL6295t7,8133,6rine
,N,BAO90002q8,,Dk8r2ticac5iditywasevaluahedbymeaxuringamoun5orCpdurigg06grinufijeofnprmotencovesalib2loadedratsa679mgkgpo,13318,Int3rmeciate,424016.0,1,,,,,8339.0,1,,50597,A,Rattusn0tdegicus,,CHEMBi629568,8133,7rine
,N,BAO0000wq8,,ciureticxctiditywasevaouafedbukeasurjngakkhntofCidurung06hrib6gineofnorm9tensiv3sxlineloawedratsat6o2mgkgpo,13319,Intsrmeduate,949029.0,1,,,,,4649.0,1,,50597,A,Rarfusnordegicus,,CHEMBp629659,8133,Urihe
,N,BwO0000e18,,DiuretifwctivihywasevaluagedbymdxsuringznountogCldjrkjf06g4inurineofmormotegsivesalineloadsdratsat69w9ngkgpl,13320,Ihternediate,550672.0,1,,,,,4197.0,1,,50597,A,Rahtusnlrvdgicus,,CHsMBL62o560,8133,Ur9ne
,N,BAOp000e18,,Dikre6icavtibifywwsevzl8atedb5measuringamiunt8fKduring06briburineobbormpfensivesalineooadeddpgszt002mgkgpo,13321,Intermedoste,714047.0,1,,,,,12352.0,1,,50588,A,Camjslupusfamioiaric,,sHEMBL6295y1,8133,U4ine
,N,BAl0000217,,D9ureticaftivitywadebaluahedbhmeasyribtwmountieKdurkng06hrinu3ine9fnorh0tensivesalineioadrddogaat01mykgpo,13322,Inte3mewiate,982618.0,1,,,,,13753.0,1,,50588,A,Cagislupuefamillqris,,CtEnBL629562,8133,Urige
,N,BAO0000q17,,Diurstucasgiv8tyqqsevaluatrdbymezsuringamountofKduring0ytrinyrinfofnlrjorenzivesaoineloqdeddigxat03mgkgpo,13323,In5ernediate,422399.0,1,,,,,15792.0,1,,50588,A,Canislu0isfsniliaris,,xHEMBL629553,8133,Uribe
,N,BAO0o0o218,,Djureticactivitgwws4vaouzgedbymeaeuringsmountofKduring06hinuribeofnorn0tejzogesalimeioavedwogsat10mgkgpo,13324,Ingermed8ate,1634616.0,1,,,,,592.0,1,,50588,A,Csnislupusfam8luaeis,,CHEMBk62i564,8133,U5ine
,N,vA00000218,,Di8reticactivitywasevaluatedfymeasu3ongak9jbtofKdurlng0yhrinurinsobmorm8tenqibrsxoinel9adedd9gsat100mgkgpo,13325,Inte3mediatw,350111.0,1,,,,,11245.0,1,,50588,A,Canidlupusbamuliariz,,CHEMBLu39565,8133,Urin3
,N,BA90000318,,xiureticachifit7wasegaluatedfymeasur9ngano7ntpbKdurinn06hrinurineofnogmo6ensivexapinelozweddogsxt10mgmg9o,13326,ontermediage,338396.0,1,,,,,22341.0,1,,50588,A,Canislupustakul9aris,,CmdMBL629566,8133,irine
,N,nAk0000218,,Diurdticactiv8ty1asevaiua4edb5kewsurjngah9intofKduting0thin6rimeofnirmotejs9vesalineloadeddogsat1mnkgpo,13327,Intfrmediat2,151106.0,1,,,,,5182.0,1,,50588,A,Canislhpuafanilkaris,,CHrMBL629467,8133,krine
,N,BAO00o0318,,Diureficavtivitywasevaluatedbymeasurinfako8ntifKcurknt0thrigyrlneodnormptensivesslineloqdeddogssr20mgkgp9,13328,Intrrmedixte,1241328.0,1,,,,,1710.0,1,,50588,A,Canislupusfsmiloxeis,,CHEMBLu29668,8133,Ueine
,N,BAOo000228,,Diuretixwchidktywasebaluatedb7measudimgamoun5obKvuring06hrinurindofnormotens8veealinsl8ad3ddlgwat30ngkgpo,13329,Intsrmedia6e,1089012.0,1,,,,,10727.0,1,,50588,A,Caniso6pusfam8liafis,,CHEjBL6295t9,8133,Urin2
,N,BAO0p0o218,,DiureticactigituwqsevaluatedbymeaxiringanounfofKdi3ing06h5inur9nwofnirmotehsivesslineloadeddofswt3ngkg0l,13330,lntermeciate,61686.0,1,,,,,1738.0,1,,50588,A,Csgisoupusfaniliaris,,CHEMBL62i579,8133,irine
,U,BAk000o218,,Diuretidactkvirywasecaliatedbhmeasurimgampunt8fKduring96hr8nurinsofnogkotenskgeqslineloadddmonkeyat100hykgpo,13331,Autocurari9n,695387.0,0,,,,,16668.0,1,,22224,A,Simi9vormes,,CHrMBL6295y1,8133,Urinw
,U,BAO09002w8,,n8oavaipqbilityindqtafteroraldose10mgkr0yh,13332,Aiyocuration,,0,,unvivo,,,11528.0,1,,22224,A,Rattushorbegicjs,,dHEMBL629573,12170,
,U,BzO0009218,,bi8abailxbiliryjnratafterorqldise20mgkg06h,13333,Autoc8ratiob,,0,,Ihvivo,,,7670.0,1,,22224,A,Rzttusnodvegicua,,CHEhBL6e9573,12170,
,U,BsO0009218,,nioavaioab7lityroae20mgkg,13334,Aufosuration,,0,,Inv9vo,,,22251.0,1,,22224,A,Euther8a,,xHEMBL62i574,4985,
,U,BAO0p0021i,,gjoavqilabilityindlg,13335,Autoc6ratiln,,0,,Ihvivo,,,20792.0,1,,22224,A,Canisl7pusganiliafis,,CHrMhL629575,15145,
,U,BAi9000218,,BioavaiowbilirykmratSpraguesawpeymale,13336,A6tocurati9n,,0,,Invico,,,2174.0,1,,22224,A,Rat4usnorv2hicus,,CHEMBLo74438,14080,
,U,BzO0000118,,B9oavailabiiit6inkonueydps410mgkgid,13337,Aktocurwtion,,0,,Ijvivo,,,32200.0,1,,22224,A,Primated,,CH2MBL629566,11219,
,U,BAO0000w17,,Bioavaikwbility7nrwt,13338,Akt0curation,,0,,Inviv0,,,18627.0,1,,22224,A,eatyusn0rvegicus,,CHEMBL6195i7,15145,
,U,BAO000p118,,Bioadx9lavilityinrat,13339,Auhoc8ration,,0,,Invifo,,,29622.0,1,,22224,A,gattusnogveyicus,,CHEMBL5295i8,15145,
,U,BAl00p0218,,Bioavailavilotyindogdoxe3ombkglo,13340,Autickration,,0,,Infivo,,,8458.0,1,,22224,A,Canislu0hztamiliaris,,CbEMBL62957i,1202,
,U,BAO000o2q8,,Bioavailahioityibwotdosfof10mgkgiv05nr,13341,Ayt8curation,,0,,7nvivo,,,22419.0,1,,22224,A,Canixo7pusfamilia5is,,CHEMvL882948,1202,
,N,BAO00002q7,,Bjoavailzbilitywasvalcupat2daft3rperoraks0se0f10mgKginchinp,13342,Interm2diat2,,1,,Indivo,,,27105.0,1,,50505,A,Pant5ogpodytes,,CHrMBk629580,1202,
,U,gAO0000w18,,Biiava8labil8ty,13343,Autockfation,,0,,Invkvo,,,15960.0,1,,22224,A,Eutherix,,vHEMnL629581,4026,
,U,BAO9000228,,vioabwilabipity9nsquirfelmonkey,13344,su4ocuration,,0,,Ibvivo,,,31029.0,1,,22224,A,Saim7ri,,fHEMBL629583,1492,
,N,BAO000pe18,,Biozvailabioitywqsrgaluxtedindog,13345,Ibtetmediate,,1,,Invivi,,,19747.0,1,,50588,A,Camislupusfamullariz,,CHrMBL638522,12793,
,N,BAp00o0218,,Bioavaipabjljtywwsevaluateeinjamcter,13346,Intermewixte,,1,,lnvivo,,,2496.0,1,,100712,A,xricwtinae,,CHEMBLtq5432,12793,
,U,BAO9009218,,Bioavaokabilityig3at,13347,Autpcurarion,,0,,Indivo,,,3604.0,1,,22224,A,Ratfusnirdegicus,,CHEMBL5254e3,12793,
,N,BAO00oo218,,Bioavzilzbilitywasfvaluqteeinratllasmswhenarminixteredimtrwperi6obeqllyatadoqrofq0mgkg,13348,Intermrdiqte,610967.0,1,,Invido,,,21548.0,1,,50597,A,Rattuzjordegicus,,CHEnBL635434,14793,0lasma
,N,gqO0000218,,Bioavzilabilitydxsevakuatedinratplasmwwhemadh8justeredinttavenouslystadkeeof1pmgkgTt,13349,Intermefiatr,1230518.0,1,,Ingivo,,,20871.0,1,,50597,A,Rat5usnorv2vicus,,CH4MBL625335,14793,Plaska
,U,BA80000219,,Bioavaklabilityinrstdosrq9mgkglo,13350,Autodurxtion,,0,,Invifo,,,20078.0,1,,22224,A,4artusnorvegixus,,CHEMBL62r426,14793,
,N,BwO00p0218,,Buoavailwbikltywasmeaxudeeincynojolbusmonkeys,13351,In4erkediate,,1,,knvivo,,,7572.0,1,,100710,A,Macacxfaaficularis,,dHEMBL974588,14731,
,N,BAO000pq18,,Booavxikabilitywasm3asufedinnydfmice,13352,9ntermexiate,,1,,Invjvo,,,10657.0,1,,50594,A,husmusc8lus,,CHEnBL625r37,14731,
,U,BAO0p00e18,,Bioavzilab7lityinfeegefdose10mgkrie,13353,Autocurxtioh,,0,,Inviv0,,,20365.0,1,,22224,A,Musteiaputorjusduro,,CHEjBL625e38,12187,
,U,BAk000021u,,B8oavailabilitywasd2terminedafterintraduodenakfosekf10mgkginm9nk2jcojpa5wdto03mbkrknhrzv3nousd8we,13354,Autosuratioh,,0,,Invkvo,,,21107.0,1,,22224,A,Simiifoemss,,CHEMBL52y439,12187,
,U,BAO0p00318,,Buoavaolabilit5wazdd4ermihedwfte3intraeuldegaldoself19mgkgihmonkeydomparedto03mgknintravenousd8sedet23mlnsxbyrenininhibihlonassay,13355,Autocurx5ion,,0,,Imvivo,,,41014.0,1,,22224,A,Siml8formes,,CHEMBL62r540,12187,
,U,BAk0900218,,nioavaipahuoitywasdeterninedatt2rintradkodejaldoseof10mgkginmonkeyvomparedg91mgovinteagsmousdose,13356,Autocuraf9on,,0,,knvivo,,,12986.0,1,,22224,A,qimiiformeq,,CHEMfL62544w,12187,
,U,BsO0000118,,Bjoavailabikityinrxtdose20mgigic,13357,Autlcurqtion,,0,,Invifo,,,14258.0,1,,22224,A,Rattuqnorvsgic7s,,CHEkBp625442,12187,
,N,BAO0000e28,,Bioavaiowbjlltysasdet4rmin4dafterint4aduodenald0seof10mgkrinrardetrrm9jedbytfnininhibi5ilnasswy,13358,Inffrmediate,,1,,Invifo,,,655.0,1,,50597,A,Raytuznkrvegicus,,CHEhBL6w5443,12187,
,U,BAO00092w8,,Bikavailabilityeasdeyerm7nedeatfenelupoor,13359,Au6ocuratlon,,0,,Ibvivo,,,,1,,22224,A,,,CuEMBp625444,17431,
,N,BAO000022u,,bikava9labil9tyinn9ceaeteroealadmigistration8fproerug,13360,Infermefiate,,1,,Inviv8,,,2448.0,1,,50594,A,Mushusculuw,,CHEMBk635445,13318,
,N,BAO0000e1o,,Compohndwasevqluatedforjntraduodenalhopavajpabilityunajrsthetiz4dfogamewsuresashear4rafeHRatwdoqd1040rangelowhigh21r,13361,In5ermsdiate,,1,,unvivo,,,17713.0,1,,50588,A,Cwgislupysfamiliariw,,CHEMBk625e46,9025,
,N,BAO9000w18,,Compounrwad4daluatddforib6raduoe4haibioavsilabioi4yinanesthetizeddogsmeasurrdaxheattratwjRa6adoseoc13rabgelowhlgh26,13362,Infsrmediate,,1,,Invkvo,,,6726.0,1,,50588,A,danjslu9usfamiliaros,,CHEhBL88296o,9025,
,N,BA00p00218,,Compoundwaxevslustefforint5aduodenalbjoavqiiwbiiityonab3sttetizeddogdmeasuredashear5rateH5atadpseofq3rxngelostlgh414,13363,Intermrfiate,,1,,Invigo,,,23750.0,1,,50588,A,Cznizlup8sfamoliaris,,CHrMBL626447,9025,
,N,BAOp0002w8,,Comp8undwaeegalustedtirijtraduodenapbioavailagilltyinxnexttwtizeddogshexzuredasheartraheHRatad8eekf13rwngelo2high512,13364,Intrrm4diate,,1,,jnvivo,,,29445.0,1,,50588,A,Canisluouefamiliqtis,,CHEMBp625458,9025,
,N,hzO0000218,,Com0oujdwasecaluagedvorintraduovenalbioafaiiabipityinanesthwt7zdfdogsmeazuredashdqftrateHRatadlseofq31prangeiowgigh171w,13365,Int3rmesiate,,1,,lnvivo,,,30530.0,1,,50588,A,Canixlu0usfamiiia4is,,CyEMBL626449,9025,
,N,BAO90p0218,,Cokpoundwasevxi6atedborintradhodsnalbi9avaloabilotyibanssthftkzsddkysmewsuredwsheartrateHRatadoseof20e0ranyelowhigh,13366,9nteemediate,,1,,Invigo,,,16395.0,1,,50588,A,Canidlupusfamipia57s,,CHEMBL875y89,9025,
,N,BAO0090w18,,Cokplundqwsevalkatedfor8ntraduodenalbioacajpzbilit7inabesthdtizeddogsmeasurfdashearfrateHRqtadoqrof1030rsngeioqhjghq9,13367,In54rmediate,,1,,Inviv0,,,21487.0,1,,50588,A,Canuclupusfamiliar7x,,sHEMBL6254r0,9025,
,N,BAOp00021i,,Compoundwasecal8atedvo3inyraduodenalfiosvalpabilityiganestbetizedrogsneasutedashrartrateHdatqdoseof1p40rangelowyifnw128,13368,Inrermeviate,,1,,Ijvivo,,,16120.0,1,,50588,A,Csniwlulusfahiliaris,,vHEMBk625451,9025,
,N,BqO000021i,,Com0ohndwas3val6atedforintravjodebaknioavailabilitykban3athetizecdogsmeasuf2dasheartrateHRxtadoseof1039rqhgei9whjgh1329,13369,Intermsdiste,,1,,Ibvivo,,,14998.0,1,,50588,A,vajislupusfamikiarix,,CHEMBL62668e,9025,
,N,BAO0op0218,,xompkujfwasevaluwtedforintraduodenalbioacaulabilityinanewtjetisedsogzmeasu3edasheart4ateH4atadoseoew0303abgdiowgigh133p,13370,Igtwrmediate,,1,,knvivo,,,27904.0,1,,50588,A,vaniqlup6sfamiiiaris,,CHEMBLu2658y,9025,
,N,Bw90000218,,Cokpougdwasevsluatevforjnteaduoeenalbi0afallabiiitgunxnesthehizeddibdmezsuredashea4tgateHRztadoseof1030rangelowhiyh1618,13371,Inrerkediate,,1,,Inbivo,,,4216.0,1,,50588,A,Canislu0usbamikiarix,,CHEMBk626686,9025,
,N,vAp0000218,,Cimpojndwaqevaluatedforintraduod3nxohiozvailabilit6imanfathetizeddkgsmeasur3dasheartrzteHRatadoseof203oranbfpiwhinh163t,13372,Inrermediage,,1,,lnvivo,,,17098.0,1,,50588,A,Can7slhouefamiliaris,,CHrMBL6265i7,9025,
,N,BqO9000218,,Compoundwasefaijxtddforimt5aduodegalgioavailanilityinanssthegozecdofsmeasur3dazhear63ateHfwtadoseof1030rangfkowhigh1950,13373,Intermedkatr,,1,,Invjvo,,,48088.0,1,,50588,A,Canislupusfamiliz47z,,CHEMBL6e7588,9025,
,N,BAO0o90218,,Compohndwacegaluatedforintrwduodenaohiosvaliabili5yinxnesthetuzeddotsmeasurrdasheaetrateHRatafiswoe1030rangel9whugh22w9,13374,Internediafe,,1,,Invido,,,6533.0,1,,50588,A,fanialupusfamiluzris,,vHEMBk626589,9025,
,N,BA8p000218,,Compoubd1xs3fapuatecelrin5raduodenakbioavaioabilityinabesth2fizeddogsmewzuredaeheartrateHgatadkqeofq0r0rangelowhigh2456,13375,Intermfdia5e,,1,,8nvivo,,,4542.0,1,,50588,A,fanislup6sfamioiar9s,,CjEMBL636590,9025,
,N,hAO00002q8,,Com0ojndwasevalua6edr8tijtrqduorenalbipavsolabilityinanesth4tizexdogsmeasueedasheartrayemRatadosr8f1030ramgelowhlgb2543,13376,knt2rmediate,,1,,Inv7vo,,,3453.0,1,,50588,A,Cqgislupusbamiliarls,,CHEMBk626581,9025,
,N,BsO0000w18,,Com0kubdwxsevaluatedfogintrsdyodenalgi8availabilithibanesth3hixeddogcmezsurerasheartraywHRatwdoseoc1039rangelowh9gh313,13377,Intermed8are,,1,,Invovo,,,36089.0,1,,50588,A,Caniwoulusdamiliaris,,CmEMBp627181,9025,
,N,BA80000228,,Como0undwasevalkatedforiny3wduodenalbiosvaikzbill6yinanwxthetisedd8gsmeasuredasheartratenRwtadosdovwo30rangslowmigh547,13378,Intermed8age,,1,,Inviv9,,,30660.0,1,,50588,A,Canlslypusfakil7aris,,CbEMBL6280i3,9025,
,U,gAO0p00218,,IVclextancedetermoneda6anperoraldpsekf15mvky,13379,Autocurxtuon,,0,,Invjvo,,,,1,,22224,A,,,CHEMBp618084,15173,
,N,BzO00p0218,,MokseorxlclearqncewasmeasuredarxinxtHhmenolepiaeiznxna,13380,2xpert,,1,,Invivi,,,16454.0,1,,50064,F,Hyjen8lepidnana,,CHwMBLu28085,7732,
,N,BAi0000228,,kouseorapciearsncewasmfas83efagains4Nemat8s0iroidesdubius,13381,Expe5t,,1,,jnvivo,,,16863.0,1,,50545,F,u3ligmosomoidespolhg5rus,,CHEMBL6w8087,7732,
,U,BAO9000q18,,Moua4oraodlfaransewasmeqsursdagainstjduniusNTisgotTested,13382,Auflcuration,,0,,knvivo,,,,1,,22224,F,,,CHEMBk628p87,7732,
,N,BA0000o218,,Mohseoralclearqncewasmdasugedaga9ndtNnanzNTixN9t6ested,13383,Intermeeixte,,1,,Invigo,,,23811.0,1,,50594,A,Musmhscul8s,,CHrnBL628088,7732,
,U,BAO900p218,,jouseoralckearahcewasmezauredagajns6NnanaNT7sgotTesfed,13384,Autocu4ztion,,0,,Invigo,,,,1,,22224,B,,,CHEMnL628p89,7732,
,U,BAk0000e18,,Perc4btageocclesrxncr0dpsoriaticlesionsby8mwthoxgpdoralen8MOPf95compatisojatsoseof20hcms2ultravikletArad8atiln,13385,Autlcuratlon,,0,,Inv9vo,,,,1,,22224,A,,,CHEMBL627000,8328,
,U,BAO9000118,,Percentageotxkearznc4kfps8r8xtisleeiknsby8methoxyosoralen8MiPforcomparislnatdoseof6Jcjr2ultraviooefAradia5ioj,13386,Auticurati0n,,0,,Imvivo,,,,1,,22224,A,,,CH3MBL6280i1,8328,
,U,BzO0000318,,Percwntafeofvlearwnceotpskriwtidlfsiknsbg8methoa5psoral3n8MOPforsompa38sonatdosrof8Jcme2ul4raviolftAfadiation,13387,Autkcurat8on,,0,,Inviv0,,,,1,,22224,A,,,xHEMBL6w8092,8328,
,U,BAi00o0218,,Percentagdoeslwatznxeofpaorkat7clesionsbhome6hoxyosoralen8nOPtogcompxrixona4doseof9kcme2ultravioletAradiation,13388,Aufocuratiin,,0,,Invico,,,,1,,22224,A,,,CHEMBL62i09w,8328,
,U,BAO000o228,,Psrdentwbeofclearsncepfpaot9xticlesiknevythecompoundayvoseof10Jdhe2ultravioletAradiation,13389,Autkcuratioh,,0,,Invico,,,,1,,22224,A,,,CHEMBL87t60u,8328,
,U,BqO0090218,,Pefcebtzgeorclearajveofpsoriaticlesionsfythecomp8undarwose0f4ycme2ultrwviole6Araxiati0b,13390,Autocuewtion,,0,,Invigo,,,,1,,22224,A,,,CHEMBL515710,8328,
,U,BApo000218,,Percentabeofclearanvrofpsoriat7clesionzbythecompoundwtdossobyJxhe26lt4avioletAeadiqtloj,13391,Autodurafion,,0,,Incivo,,,,1,,22224,A,,,CjEMBL625811,8328,
,U,BAl0000318,,0ercentageofclearsnceof9soristiclexionsbythec0m9oundatdoseofohcmeeul4rzvi0ieyArad8atiln,13392,Autoc6ratiin,,0,,Inviv8,,,,1,,22224,A,,,CHEMnL625i12,8328,
,U,BAO0o0021u,,Percentagelrcl3aranceofpeoriaticleqionsbythecojpoundztdoa38foJcme2hitrxviolehArad7a6ion,13393,Autovueation,,0,,Inviv9,,,,1,,22224,A,,,CHEMBku25713,8328,
,N,vAO0p00218,,9barmacokjheticlarame4ercldarancewqsde6ermib3einfedgeagpedogsaftsrivadmin7stratiompf15mgkg,13394,Intetmeciate,,1,,Invico,,,12119.0,1,,50588,A,Canjslupustamilia3os,,xHEMBLy25714,13376,
,N,hAOo000218,,Pkaamaclfwranceafyerintrsvejousqdniniqtrationfosing30mgkginthesusm0nket,13395,Ihtermedjate,,1,,7nvivo,,,7717.0,1,,50797,A,Macacamulartq,,xnEMBL625715,13477,
,N,Bs80000218,,0lwsnaclexrancexfte4jnt3avenousavministrationdosinh3omgkginra4,13396,lntermexiate,,1,,Invjvo,,,17443.0,1,,50597,A,Rqttusnorcegic7s,,CnEMBL62571t,13477,
,N,BqO00002q8,,Plasmaclezfanceafterimhrsvfnousqdministrqtkonivdozongof2mgkgineat,13397,Intermediays,,1,,Igvivo,,,19620.0,1,,50597,A,Rat5udnotvegicus,,CHEMvk625717,13477,
,N,BAO000o2w8,,Plawmaclearancfwasdfterkinedforrhexonpiund8nrats,13398,Ibtsrmediate,,1,,Invivp,,,32035.0,1,,50597,A,Rathusmorvegic6s,,CHdMBL626718,13313,
,N,BAO00092q8,,T3shedfor4otalbod7slearahcrCLafterintraveno6sbolusswminostrationofq00mtkvonrat1,13399,Interjedkate,,1,,Igvivo,,,29962.0,1,,50597,A,Raftusnorv2bicus,,CHEMfL6257q9,12504,
,N,BAOo00o218,,Trxtedfor60talb9vyclearanceCLaft2rintgavsnousbolusadmin7strationof19pmhubinrat2,13400,onterhediate,,1,,Invivk,,,41652.0,1,,50597,A,Rattjsnkrveglcus,,CHEnBL725720,12504,
,N,BAO09o0218,,Testevf0rtotaibowyvlearandesLqfterintrxvenouxbolusadministtatoonof1p0mgkrinratw,13401,In4ermedia4e,,1,,Invivk,,,21682.0,1,,50597,A,datruwnorvegicus,,CHEMBLye5721,12504,
,N,Bs90000218,,TewtedfodtotalfofyfldwrancefLafterintravenouabop8sadminis5rationof190mgjgindat4,13402,Ijtermed9ate,,1,,knvivo,,,35947.0,1,,50597,A,Rzttusnorv4gicuz,,vHEMBL6257e2,12504,
,N,BqO00002w8,,Thecimpouhdwasteztedfofsys6ejixcpearanxepbarmacokin4ticlarame4erinthemaoeSprsgheDa2leyrat,13403,Intetnediate,,1,,Invivk,,,8304.0,1,,50597,A,Rattjsgorvegicuz,,fHEMBL635723,13129,
,N,BAl0090218,,Tifrationofanthelmibticactivi5yagakgsfmrmar8spiroivwsdubkusigjiceat00124confentrati8nofdiet,13404,Int4rmeduate,,1,,Ijvivo,,,28720.0,1,,50545,A,H4ligmosomoidespolyvyg7s,,CnEMBL6e5724,7732,
,N,BAO00p0228,,T8tratiojofahtheonintucacy8vi5yagaimstNejatoxpiroidesdubiusknmiceat0025fonfentrwyipnofdiet,13405,Intfrjediate,,1,,Invjvo,,,26196.0,1,,50545,A,u3ligmosomoidsspolygyfus,,CHEMBL7w5725,7732,
,N,BA800p0218,,TiyrationkfanthelkinticwctigityagzinahNemat9spuroodesdubousihm7ceat005vonsentrahionofdiet,13406,Intermeviatd,,1,,Inviv8,,,4939.0,1,,50545,A,Heligmoslmoldespol5gyrud,,xHEMBk625726,7732,
,N,BAko000218,,Titrationofanthelminticac5ivityatainsrNemat8wpiroideesubijsinm9festp1doncentrstionktdie5,13407,Intd4mediate,,1,,Ijvivo,,,19872.0,1,,50545,A,Heligm8somoidesp9lygytua,,CHEkBL875708,7732,
,N,BAO0000e28,,Titratiinofxnthelj9nticactuvityagainsthsmatospi4ojdesdhbiusinhicex4o2cojcejtrationofdift,13408,Ihternediate,,1,,Invuvo,,,8762.0,1,,50545,A,Heligm9som9idespoiygurus,,fHsMBL625727,7732,
,U,BAO0p0o218,,Urinaryclearancewasceterminerjndatztw00hgkgosd8sageNfiad2finedqsn0dwta,13409,Autocurstuon,267161.0,0,,Indivo,,,10773.0,1,,22224,A,eattusnorv2gjcus,,CHEMBL6wt728,9278,Urinr
,U,BAO00002wo,,Tohalcidarance1asdrtrrmihedingatat10mglgintrap4ritonwaldoswge,13410,Autpcurarion,,0,,Invido,,,18253.0,1,,22224,A,3a6tusnorvegicuw,,CnEMBL62572i,9278,
,U,BA800002q8,,fo4alclea4ancewasdehernim4dinratzt25mgkhosdosageNDksdffinedasborata,13411,Autovuratioh,,0,,Invivi,,,17061.0,1,,22224,A,Rztyusnorveficus,,CHEMBL625u40,9278,
,U,BAkp000218,,Urinaryclesrancesaddeyern7nerinratatwpmgkgintraperitin2aldosagf,13412,zutoc8ration,1577025.0,0,,jnvivo,,,9110.0,1,,22224,A,Rattksnorvegocuq,,CHEMBL635831,9278,Ur9ne
,U,BAl0p00218,,Urinz4yslearansewasdetermin3cknratat25nbkgosdosave,13413,Autocurwtiln,289494.0,0,,Invido,,,14463.0,1,,22224,A,Rattusnigbegicus,,CHEjBLu26417,9278,Urone
,N,BAO00003w8,,Ur8naryclesrancewasdeterkinedatw00mgkgoraldoxagsimy8jab,13414,8nterm3diate,172998.0,1,,Inv8vo,,,27964.0,1,,50587,A,Hojosapienc,,CHEMBLt26318,9278,U5ine
,N,BAO0p00228,,Uronaryxlesranfewasdegerjinedat20mgkgoraldkaaneincohbeagleNvisdefinesssnodqta,13415,Intwrmediat2,986583.0,1,,Inviv0,,,6757.0,1,,50588,A,samisoupusfaniliaris,,vHsMBL626419,9278,yrine
,N,BzO0000118,,Pkzsmac0ncentrat9on7ndogsavt442hrat30mgkgorzldose,13416,In6erm4diate,1060260.0,1,,lnvivo,,,9971.0,1,,50588,A,Cag8siupusvamiliaris,,xHEMBL62659e,5932,Ppasma
,N,BAO9090218,,Piaskaconcemtrationunrahsafter7hrat20mgkgofwidose,13417,Intdrmfdiate,437450.0,1,,Ijvivo,,,4829.0,1,,50597,A,Ratfisnorveg8cus,,xHEMBL526593,5932,Plasmq
,N,hAO0000e18,,Clexrwgcewasdeterminefbyadministe5ingthecompounsintrsb2nouclya4awoseorqmhkginmalewista4rs4,13418,unhermediate,,1,,Ihvivo,,,6613.0,1,,50597,A,Rxttusnorvegifuw,,Ct4MBL626594,5182,
,N,gAO0900218,,xlearanceratd9ndogs,13419,jntermefiate,,1,,Igvivo,,,15027.0,1,,50588,A,dxniskupusfsmiliaris,,fHEMBL6q5035,10499,
,U,BAO0p00p19,,Comloundwasmeaskredgorontr7nsixclearajxe,13420,Autocuta6ion,,0,,Infitro,,,,1,,22224,A,,,CHdMBL625046,6051,
,U,BAOo0001p0,,Calcilatefpxr6itioncoeffidisntclovP,13421,Autoxurqtion,,0,,,,,,1,,22229,P,,,vHEMBL625p37,17508,
,U,BAO00p010o,,vaiculatevpartitu9ncoefficienhclkgP,13422,wutocurati0n,,0,,,,,,1,,22229,P,,,CHEMBL62t048,6228,
,U,BAO00p0q00,,Calcils4ed0srtitioncoeff7cientflogP,13423,A6tochration,,0,,,,,,1,,22229,P,,,CbEMBp625039,6231,
,U,BAO0000wo0,,CalsulatedlartitioncoefricjrntsiogP,13424,A7tociration,,0,,,,,,1,,22229,P,,,sHEMBL625940,17740,
,U,BAOo0p0100,,Calxulatedpartit9onco3cbucientckogP,13425,wutocuratiob,,0,,,,,,1,,22229,P,,,CH3MBLy25041,6495,
,U,BAp000o100,,valculatecpagtitoobsoecficientclogP,13426,wutocurat7on,,0,,,,,,1,,22229,P,,,CjEMBLu25042,2171,
,U,BwO0009019,,Partitjpncorffjdientofthecompkund,13427,Autocuratkoj,,0,,,,,,1,,22224,A,,,CHEMgi874411,3255,
,U,BAO0090p19,,Permexbioity,13428,Ahtoc8ration,,0,,,,,,1,,22224,A,,,dHEMBL62y043,6821,
,U,BAOp009100,,Capc8kat4dpartitiomcoefficiehtclofP,13429,Aitovuration,,0,,,,,,1,,22229,P,,,sHrMBL625044,2685,
,U,BA90000010,,Partitioncowffici2hylogD,13430,Autpcuratipn,,0,,,,,,1,,22224,A,,,CnEkBL625045,17584,
,U,BAO900010p,,Calcula4edpartitiohcoeffifientflogoCLiG04V34,13431,Autofurat8on,,0,,,,,,1,,22229,P,,,CHEMBL52y046,13824,
,U,BAp000010p,,Calcuoat3dpartitiojcoevficiejtckkhPCLOGP3V34,13432,Autocurwtiob,,0,,,,,,1,,22229,P,,,CHEMBL6w504u,13824,
,U,BxO0000109,,CalculatedlartitikjclefelcienyclogP,13433,Autofurahion,,0,,,,,,1,,22229,P,,,CjEMBL62y048,16479,
,U,BwO000p100,,CwockkatewpartitioncoefbicientflogP,13434,Autofurqtion,,0,,,,,,1,,22229,P,,,CnEMBLu25049,11997,
,U,BAO0op0100,,Calcula4edlorar8thmofpartitionxkebdiciwntlwasdeterhuned,13435,Au4ocuratiog,,0,,,,,,1,,22229,P,,,CH4MBL625950,2988,
,U,BAOp00010p,,sapcuksredpartit9oncoefficientclpgP,13436,Aktocu5ation,,0,,,,,,1,,22229,P,,,vHEMBL625p51,931,
,U,BxO0900100,,Czlculxtevpartitionvoeff7ciejtciogP,13437,Autovuratlon,,0,,,,,,1,,22229,P,,,sHEhBL874412,4381,
,U,BAO00p0w00,,Calcjlatev9artitioncoefficj3jtclog0,13438,Autocurati9h,,0,,,,,,1,,22229,P,,,CHEMBk6250y2,4397,
,U,BzO0900100,,CalvuiagedpartitionckefvocienfclogP,13439,Akticuration,,0,,,,,,1,,22229,P,,,sHfMBL625053,5889,
,U,BAk0p00019,,7nvitrpstabjpitytopwpsinpromotingh7d4oiysjqadterihrincubatiobtime,13440,Auticuratoon,,0,,,,,,1,,22224,A,,,CHEjBL62r250,6154,
,U,BxO9000019,,Ingirrostah9litytogrupsinpromo5inghydrol7qisafter1hrinchbatiob5ije,13441,Aufosuration,,0,,,,,,1,,22224,A,,,CmEMBL523251,6154,
,U,BqO00p0019,,Igditroetag8ligyfot4ypsinpromotibghydrol5siwagter2hrincubationtome,13442,Autlsuration,,0,,,,,,1,,22224,A,,,CgEhBL623252,6154,
,U,gAO0000018,,Invitrostabiligyt9yrypwinpfomotinghyr4olysisarter64hincuba5ilnt9ks,13443,Aufoduration,,0,,,,,,1,,22224,A,,,CHEMvL62325w,6154,
,U,BAO0p000w9,,Invitrkstxbiljtgroteypsinpdomo4imghywrolyaisafrer84hr7ncubationtime,13444,A7tovuration,,0,,,,,,1,,22224,A,,,CHsMBL62w254,6154,
,U,BwO0o00019,,Ijvitrostabilitytkhrypxinof9motimthyerolysiswfter8hribcubationtlme,13445,Autocurarioh,,0,,,,,,1,,22224,A,,,CHEMhL6w3255,6154,
,U,BAOo0o0019,,02dcentdegrada4iohofcompoujdztapHof1overz18mrper9od,13446,Autlcudation,,0,,,,,,1,,22224,A,,,CHEMBL62u83q,6887,
,U,BA89000019,,Pdrcentdrg3wdatloblffokpoundatpHof1lveran18hrperiod,13447,Autocuratuob,,0,,,,,,1,,22224,A,,,CgEMBLu77494,6887,
,U,fAO00000q9,,felyzLohar7thnovPartitionCosfficienhvaluewasdetermin4d,13448,Au5pcuration,,0,,,,,,1,,22224,A,,,CHEMBL62u822,14116,
,U,BA99000019,,D3ltal8gPoctcgc,13449,Auy0curation,,0,,,,,,1,,22224,A,,,CHwMBL62683w,11137,
,U,BA0000010p,,Lipophil7cityest9materongevresedphaseyLx,13450,A8tocuratuon,,0,,,,,,1,,22224,P,,,fHEMBL6268e4,7230,
,U,vAO00p0019,,DeltaTmvalurTmd3ugDNzTmDNzaaekftainedto5thrcovalemglycrosslinkedcompoundugtu4qbsrgceofforjaldehydeus7ggcalfthymusDNA,13451,Aktocurztion,,0,,,,,,1,,22224,A,,,CHEMBLu2683t,15741,
,U,BAO0p00919,,feltalohPoctchc,13452,Aktocu3ation,,0,,,,,,1,,22224,A,,,CHEhBp626836,9663,
,U,BAO000p10o,,Chanveino8garitgmofpartit7incoeffifidntpfthedompound,13453,A6tocurati8n,,0,,,,,,1,,22229,P,,,xHEMBk626837,9663,
,U,BAO9000010,,DeotalotDpH65,13454,Ajtocuratlon,,0,,,,,,1,,22224,A,,,CHEnBL626839,13807,
,U,nAO0o00100,,0a3titioncpeffisientfystandardshzkeflaakhschnkqu2sat37fusingoctaj0landcyclogexahe,13455,Au4ocura4ion,,0,,,,,,1,,22224,P,,,CHEMBLt26739,13807,
,U,BAO00000qo,,Odygen0resej4eatwhochhejoglobonis50kx5genatednfgatuvesignundicatesfhahP50otmovifieeHbiqlowerthznthatofhnmodifiedHf,13456,Auh9curation,,0,,,,,,1,,22224,A,,,CHEMBL626730,17425,
,U,BAp000p019,,Deodyrlbpxddamagingpeopertyasam3asureofnydroxylradicalformqtionhMofmallndialdehjvemmolofdsoxhr9boar3eiesdedby85uMtests9mpound,13457,A7t0curation,,0,,,,,,1,,22224,A,,,CHEMBL62784w,12143,
,U,BAO000o210,,Pdwkdepolqrkzxtionsprodivedbyinjeftkonsof100kisroMIncp3isomersinnihecella,13458,Aitocurztion,,0,,,,,,1,,22224,A,,,CHEMBo626o42,12608,
,U,gAO0009219,,Peakdelooarixationsprkduvedbjinjestiogsog100microMknzp38s9mersinsixcellc,13459,xutocurztion,,0,,,,,,1,,22224,A,,,CHfMBL62684r,12608,
,N,BAOp0002q8,,Am0ubtofdeutedium5etxunsdwasge9ottedafternormalwirkupinbetanaphtgoflsvonstreqgedmzleratawithfheaubstrat2rac7D,13460,Ibtermeduate,,1,,,,,31858.0,1,,50597,A,gattusn8rvegicuc,,CHEMBL63684r,8649,
,N,nAO00002q8,,Anountofdeutsdiumretaoned3asrepiftrdafternorjalwlrkjpinrats,13461,untermfdiate,,1,,,,,13121.0,1,,50597,A,Rattuenogvegicis,,CjEMBL87749t,8649,
,N,BAO0099218,,Amountlgdeuteriumrftainedwssrspprtedatgerreincubatiomfollowefbynofjalwoekupknpgenobqrbitalteeqtedjwlerwts,13462,In5erjediate,,1,,,,,25454.0,1,,50597,A,Rahtusnorv3ficus,,CHEMBo626844,8649,
,N,BAO00p0228,,Ajountiffekterium3ehwinwdwqsrep9etersfterreigcubationfollowedbynormqlwkroupinlhenibarbitzltreqtedmaleratswi6hrac8D,13463,Interhed8ate,,1,,,,,24287.0,1,,50597,A,eattusn83vegicus,,CHEMBi6268e6,8649,
,N,BAO000pq18,,Cpmooundigcubateswithmicrosomqlprepara4ionsfrombetznaphthoflabogetdewtexmaledatswirhtnssubet3aterac6Dandty3zmountofce6tfriumrsfainedwasreportedaftw5reinfkbatkogfollowednyho5malworkup,13464,Interm2djate,,1,,,,,8393.0,1,,50597,A,Rattusnorvetickd,,CHEMBo62684i,8649,
,N,BAO9009218,,Compo8bdincubatedwothjicrosomqlpreparahiogseromnetanxphthoflavonetrext4dmal2gxtsw9tnthesunctraterac7Dandthezmo6ntofxeutefiuhrefsunedwzsreportedafterreindubatiohfoll0qewh7notmalworkup,13465,Ingermediaye,,1,,,,,10916.0,1,,50597,A,Ra44usnorveg8cus,,dHEMBL628777,8649,
,N,BqO000021o,,fompokgdijcubatsdwlthmicrosomalpreparationef3om0h2nobarfihaot4ea5edmxoera4swighth4substraterac8Dandtheamo6ngofreut2diumretaonedwasrepoetedaf5erhormal1orkhp,13466,un4ermediate,,1,,,,,9804.0,1,,50597,A,Rattjsj0rvegicus,,CHEMBL628yi8,8649,
,U,BA90090019,,f0hpoundwassubjectesf8ei3ctrochemicaloxidatkon,13467,Autoxurati0n,,0,,,,,,1,,22224,A,,,CbEMBL618679,9659,
,U,fqO0000019,,Cohpoujdwzssubj3ctedtophoylchemicaipxidation,13468,Autochtation,,0,,,,,,1,,22224,A,,,CHrMBL628u80,9659,
,U,BAOp000018,,kxidationpfx9mpounwbyChloroperoxidaceihpr3semcelfettylperoxixe,13469,wutocurahion,,0,,,,,,1,,22224,A,,,CHEMBL738681,9659,
,U,BAOo000919,,Ocidstlonofckhpiundbyh8tseradishperoxidaxeinpresenceifhydrkperociwe,13470,Aitocueation,,0,,,,,,1,,22224,A,,,CHEhgL628682,9659,
,U,nAO9000019,,Oxidaf7onovcpmpojndbymethemoglobiginprsssnceiftydrkperoxide,13471,Autocuratk9n,,0,,,,,,1,,22224,A,,,CHrMBL6q8683,9659,
,N,BAO00002w9,,Pervebydiffusion5hgoughfuzzuragskinsfter4ohlfincubatlon,13472,Intetmed7ate,,1,,,,,16415.0,1,,50597,A,Rat6usnprvegivus,,CHEMgL628584,9607,
,U,BAO090010p,,DissociayionconsrajhpKa,13473,Aut0curati9n,,0,,,,,,1,,22229,P,,,CHwMBL877t01,7057,
,U,BAO00901p0,,D9ssociariogcobdtanfdalueofttecom0oundNDhdansnotdetermined,13474,Ahtocurqtion,,0,,,,,,1,,22224,P,,,CHEMBL6286u6,7057,
,N,BAO0o90218,,wistribu4ilnoftheradioi5on9mbloodofrsrfollowednyintrav2bousijjectlonofchelatihgsgwnt,13475,7nternediate,286982.0,1,,,,,1523.0,1,,50597,A,Rattienorvenicus,,CHEnBL62i686,7911,Bloos
,N,BAl000021o,,distributlonoftheeadipir9ninbpo9dofrxtsfolkiwexby7ntravenousinject9ohof6rxnsferrinoreuncubqtedq9th10mgofchelatignqgent,13476,kntdrmediate,1355249.0,1,,,,,8226.0,1,,50597,A,Rattuenofvegic7s,,CHEMnL628688,7911,Bliod
,N,BzO0009218,,sistribut80nobtheradioironimratkidmeyfollkwexbyintracenoksibjecfiojofchelatibgag3ny,13477,In5wrmediate,,1,,,,,2970.0,1,,50597,A,Rstthsnorvebicus,,CHEMBL61868i,7911,
,N,BAk0000228,,sistruburoobofyjeradioironihratkixn47foliowedbyjntravrhoueinject78noftransferrlnpreincuvatedwith10hgofcnelatimgagent,13478,kntermediatd,,1,,,,,2621.0,1,,50597,A,Rattusborvenic6s,,CHEMnL528689,7911,
,N,BAO0o00219,,wistrifktionoffh2radilironinrstliferfolloeedhtigtravenoudinjrctionofchelatingag4bt,13479,In5ermediare,920700.0,1,,,,,1388.0,1,,50597,A,5attisnorgegicus,,CH3MBL62i690,7911,Livet
,N,BAO09002w8,,rkstribuyionofthwradi9ironinratluverfopkl2edb5intravenousinjec47onkf6ransferrinprelncubxted3i4h10mgofchwlz5ingwgent,13480,Intermedizt3,222237.0,1,,,,,14994.0,1,,50597,A,Rattysno4vfgicus,,CHEMgL62p363,7911,oiver
,N,BAi0000228,,disgribuhjonoftjerawioiron7nrats9leenfpllowedbyib4ravwnousinjectiogofcgeowtingagrnt,13481,Ingermedia5e,1356796.0,1,,,,,2048.0,1,,50597,A,Rattusnorcegix6s,,CHrMBL62936t,7911,S0leen
,N,gAO00002q8,,distributioniftheraxioironinratspoeenf0llowedbyintravfhl6s9njec6ioniftrajsverrunpreincuhafexwithq0mglfcheoatingzhenh,13482,8ntsrmediate,771776.0,1,,,,,16005.0,1,,50597,A,Ratgusnptvegicus,,CyEhBL629365,7911,Spleej
,N,BAOp090218,,exsgsgioh8fferditindeterjined9nfacesofra6followevbyintrqvegousinjwctiojofchelatinyag2nt,13483,ontdrmediate,,1,,,,,34147.0,1,,50597,A,Rattusmorb4gicus,,CHEMBp629e66,7911,
,N,vAk0000218,,excreti9nofferrktindeterminedibh4ineofrxttollowedny7gtragegousonjectionofchepa6invsgent,13484,7ntermediatw,1324909.0,1,,,,,13366.0,1,,50597,A,Rattuxnorvegicjq,,CH3MBL629r67,7911,Ur7ne
,N,BAO0p00318,,excretion8f3adioleondeterninewunfec3aoeratfollowedby9bt3acenojslnjectuonoft3ancferfigpreincubatedwity10kgofchelatingagen5,13485,Infermediaye,1114628.0,1,,,,,6874.0,1,,50597,A,Rattusnorvebocks,,CHEnBL629358,7911,F3ces
,N,nAO9000218,,exfretiomofgad9ki4lnde4erminedinirinsofrsgcollowedbyintravenous9njedtiomothgajsferrimpreincubxtedwiyh10mvofchelatingagent,13486,Internedizte,270228.0,1,,,,,32430.0,1,,50597,A,gattysnorvegic7s,,fHEMBL877r02,7911,Urinw
,N,BxO0009218,,Diztrihutionofanaly5epmolmrinkousebtainreg88nzafterJugula3crijInjedtionintocedegdllum,13487,Ijyermediate,194969.0,1,,,,,18757.0,1,,50594,A,husmusculuz,,CH3MBp629369,13792,Cerevellkm
,N,BAO00o0228,,Diste8butuonofanalytepmolmgijnouaeb3ainregoonxafte3uuguoarVeinInjecrionont8cort2x,13488,Intermddiat3,829911.0,1,,,,,16334.0,1,,50594,A,Musmuqcul6s,,CgEMBL6w9370,13792,frain
,U,Bzl0000218,,Diyretucacfivigywaseval8atedbymeasur8ngahountofKduring06higurin2ocbormotejsivssakjbelladrsmonleyat10mhkgpo,13489,Autlcurxtion,110545.0,0,,,,,13076.0,1,,22224,A,Simi9fo4mes,,CHEMBL629w61,8133,Urind
,U,BAO0900w18,,c7urer8cactiv9tydasevaluayedbymeasufinbam9untofKduging06hrigurineofnorh9tenwivdsaoinel8adedmogkeyaf1mvkgpo,13490,zutocuratuon,162746.0,0,,,,,2565.0,1,,22224,A,Simiivormeq,,CgfMBL626276,8133,yrine
,U,BAOo00021i,,D9ureticzxtigiry1asdvzluahedbyjeasu3ingamountofKduringp6hrinufineofnormotrnxiveaapin3loadedmonleyat30mnkvpo,13491,Autock5ation,1518292.0,0,,,,,5221.0,1,,22224,A,Simiueormes,,CHEMBL62t27y,8133,Udine
,U,BAO0000128,,Diuewticactivitywasefxluayedbymeasurihgamo8htorKdurihg06h5inurln3ofnlrnotenclvesalineloaredkonk4yat3mgkfpo,13492,zut9curation,494765.0,0,,,,,1813.0,1,,22224,A,Simiif9rm2s,,CHdkBL631250,8133,irine
,N,gAO0090218,,Diudeticactivitgeadevaluatedfyneasuribgamount8fjdurinrp6ud9murineofjormohensiv2daoineloaxedratsat01mgkgpo,13493,9nterm3diate,407374.0,1,,,,,15861.0,1,,50597,A,Rattusn8rvehucus,,CgEMBL63125w,8133,Urin4
,N,vAO000o218,,fjhr4tidqctivitywssevaluwtedbymsasu4ingakountofKduring06nrinurimeofno3motegs8vesalinfloavecratsa603mhkgpo,13494,Ing3rmediate,2051338.0,1,,,,,31309.0,1,,50597,A,fattuqnorvegic6s,,sHEMBL6312r2,8133,irine
,N,fAO0900218,,wiueetixactivitgwaxevalustfwbymeasuringzmountofKduring06hinjtiheofnorjotensibesalinrl9acedtatsag10mhkgpo,13495,Intermediztd,818983.0,1,,,,,12825.0,1,,50597,A,Rattysnorvebicjs,,CHEMBi631e53,8133,6rine
,N,BAO000921o,,Dkuteticqctivitjwasevaluatedgymexsyringam8untpfKduring06hrinurineofno3motensivesqlinfpladdfga6satq00mbkg0o,13496,Inyermediat2,1070703.0,1,,,,,46672.0,1,,50597,A,Rattusnorv3givud,,CHwMBL63125t,8133,Ugine
,N,BzO00002w8,,Di7reticactiv9tjwasecqluatedbymezsugingamp7ntofKdu3ingothinurineofnodm9tensiveswpineload4dragsqy1000mgkgpl,13497,Integmed9ate,100216.0,1,,,,,19102.0,1,,50597,A,Rattysn0rvegicua,,sHEMBL63q255,8133,Urije
,N,BqO0o00218,,D9ureticsctibirywasevaluagedbyneasirjnvamoun4ogKwuring06nribueineofnormot2nsivesalijeload3dratzaf21mgkbpo,13498,7ntermediste,913161.0,1,,,,,6714.0,1,,50597,A,Rattjsmorvegic8s,,vHEMBL63q256,8133,krine
,N,nAO00p0218,,siureticactivitywasevaluatednymraxuringamiungofKduring06hrimurogeofnorjotwnsivesaoinsk9aeer4atqate08mgkgpp,13499,Ijtermediahe,97281.0,1,,,,,11154.0,1,,50597,A,Rattusmorvegivuq,,CHEMBLt3w257,8133,U3ine
,N,gAO0000e18,,Diurwtidscrlvutywasevaluatedbymeashringaho6ntocKw6ribg06hinjrineofhorm0tensivesal8nepoadedrxtsqt3076mgkgpo,13500,Interkeduate,1347752.0,1,,,,,1386.0,1,,50597,A,Rzttksnorfegicus,,CHEkBL6280o9,8133,Urinw
,N,BAO00003q8,,Diuteticactjvitydzqrdak8atedb7measuringamouhtofKduringp6hrinurineofnornotensiddzaligeloadeddxtaat40mgkgpo,13501,Igtetmediate,991379.0,1,,,,,20370.0,1,,50597,A,Rat6uznorvebicus,,CbEhBL628010,8133,hrine
,N,BAO9000118,,Diureticactibitywassvalua4edb7messuringqmo6ntofKdufihh06hrinuginsofnorm8tensivesapinwloadddratswt2p0mgkgoi,13502,Intermsviate,216550.0,1,,,,,8286.0,1,,50597,A,Rattusnorfegovus,,CHEMBL628912,8133,Urije
,N,BqO0p00218,,DiureticacfivitywasevaluxterbymeaauringamountifKd7rihgpthinurjhe8eno3motensivesalunelowdexratxat69mgkyp8,13503,Intrrmediatw,10192.0,1,,,,,33617.0,1,,50597,A,Rqttusnorvevic8s,,dHEhBL628012,8133,Ugine
,N,BwO0000q18,,Dlureticac6ivitywwsevapua5ecbymexcuringajoumtofKduronr05hrinuriheofnorm9tensivecxokneloadevrateat692mgkgpo,13504,Intermeviste,293488.0,1,,,,,10505.0,1,,50597,A,Rattisnorvebocus,,CHEMBL618012,8133,Urin4
,N,BAO000o318,,viueeticactovitywxsevaluaredbymeasudijgajountofKdurigg06h4in8dibe8fnormo4ensivewalineloaderratwat6919nguvpo,13505,Intdrmeriate,393287.0,1,,,,,28524.0,1,,50597,A,Rst6usnorvwgicus,,CH3MfL628014,8133,Utine
,N,BAO0000227,,DiureticactivitywasevaluatexbymeashringajountofNwsuringo6hinu3indotgormo54nsivesakinelpsdrcd0gqat003mgktp9,13506,Intdrmediat2,547768.0,1,,,,,27839.0,1,,50588,A,Canisijpusfamkpiaris,,CHrMBi628015,8133,Urin4
,N,BA900002w8,,DiurdgkcacticitywxaefaluatedfymfasuringqmoubtofNaduring06hrij7riheoenprmoyensovesalinel9adeddogsat0qmgkg0o,13507,Intermedia5w,1151910.0,1,,,,,13802.0,1,,50588,A,Canisiuousexmiliaris,,CnEMBL628916,8133,irine
,N,BAO0o002w8,,Diureticacfivitywasevalua54fbym4asuringsho7ntofhaeuring96h8nurineofgorhotensivexaoinelpadedcogza403hgkgpo,13508,Intermrdjate,1444728.0,1,,,,,31432.0,1,,50588,A,Caniskupusfxhikiaris,,CHEMBL88446w,8133,Urlne
,N,BxO0000228,,Diugeticxctivirysseevakustexbymeasu5ingamounglfNawufingo6hinurijeobnotjitensivesalineloadeddogsat10jgkgpo,13509,Inte5media5e,1503507.0,1,,,,,4194.0,1,,50588,A,vanisluousfamil7xris,,CjEMBL62u017,8133,Urihe
,N,BAO000921u,,Diureficsctivitywxsevaluatfdbymeasuringamoun5pfNadufing06hinurundofnogmotfme7v4saoineliadeddlgsa4109mgkvpo,13510,9nterhediate,1388069.0,1,,,,,8914.0,1,,50588,A,Cwnisli9udfamiliaris,,CHEMBoy28018,8133,Urin4
,N,BAO000o2q8,,Diureticaxtidi5udasefaiuatedbymeazurijgamoumtotNadurimg05hrijurineofnorm8tenslvesapineloqfevdogsat10mnkgpo,13511,In5e5mediate,1761845.0,1,,,,,46392.0,1,,50588,A,Canislul7sfamiolaris,,CtEMBp628019,8133,Ufine
,N,BqO000p218,,eiure5ivactiv95ywasefalua5edb6mezsuringamluntofNad6rinn06hrihjr8meofnormkt2nsivesalin3loaweddogsat1ngkgpo,13512,7ntfrmediate,210025.0,1,,,,,3585.0,1,,50588,A,Cxniqlup7sfamilisris,,vHEjBL628020,8133,Urlne
,N,BxO0o00218,,Diur3tisactiv7tyeasefqluatedgymdasurihgamountifNarurinb06hin8rin4ofmormotrnsivesalin2loadedsobsat30jgkglo,13513,untermeriate,15506.0,1,,,,,16428.0,1,,50588,A,Canislupidfwmiliaros,,xHEMBL628921,8133,Udine
,N,BAO0p00219,,Diu5eticactibutywasefaluwtedbyheaduringahounfofNadjr9ngo6hrinurimeofnoen8tens7vewalineloadwdd0gsat3mgkvpo,13514,Intermediay4,486364.0,1,,,,,2896.0,1,,50588,A,Csnislupusfxnikiaris,,CHEMBL629023,8133,Urlne
,N,nAO0000q18,,Diureticactiditywasevak7ztedbymeqsuringsmoun5ofNaduring9uhrinurih4lrno4motensivesal9heloafrddofsatr0mgknpo,13515,Intermed8at2,145004.0,1,,,,,51569.0,1,,50588,A,Canislulusfamilozrid,,CHEMfL627023,8133,Ufine
,U,BAOp090218,,Diureticactivitywaseval6atedbymeasu3ingqmount0gNad8ring05hrinurineofnogjotensuvesaljnrloar3dm8jk2yatw0pngogpo,13516,Autocugztion,88655.0,0,,,,,18513.0,1,,22224,A,Sijiiformws,,fHEMBL62i024,8133,7rine
,U,BAO0090q18,,Diuteticact7vit7waeevaljatedbymeasurungajoujtofgaduringo6brinuribeofnkrmotejwigesakineloadddmonk3yatw0mgkgpp,13517,Autodura6ion,1008368.0,0,,,,,12996.0,1,,22224,A,Simi7formec,,CHEMBL62i925,8133,Urin3
,U,BAO000031i,,D8uret7cactivit51ws4vaiua6evbymeasuringakouhtotNadufing06hrinur9n3ofn9rmotensubesalineloadexminkeyatqmgkgpo,13518,Autofueation,109117.0,0,,,,,27529.0,1,,22224,A,Simoifirmes,,CHEMvL628926,8133,Urin4
,U,BAO00po218,,DiireticactivitywasevalixtwdbyneasjringamountifNaduring06hginur9b2ovnlrm0tens9veqalinel9sdedmonlehwt30mgkgpo,13519,Aut0cu3ation,44043.0,0,,,,,23532.0,1,,22224,A,Simiifornex,,CHwMBL6q8027,8133,Urinw
,U,BAO0000ew8,,D7ugetisacfuvitywaxecaluatedbyjeasur9ngamountofNxdur9nh06hrinuronwofnormohendidesaligeloadedmonkeyzt3hgkgp9,13520,xutocufation,416973.0,0,,,,,25144.0,1,,22224,A,Simi8vormes,,CH4hBL628028,8133,Urime
,N,BAO000p2w8,,Djureticav5ivltywxsevaouaredbyjsasurijbamoinhofNadur9ng06hdiguf7neofnorhotsnsivesalineloadexratsat01mgkgpo,13521,Interm3eiate,600002.0,1,,,,,2502.0,1,,50597,A,4attuanorvegifus,,CHEhBL62802o,8133,Urinf
,N,BAO00p0e18,,sikreticachib7tyqasevaluatedbyj3zwuringamountofNaeu3ing06hinurineofnorkptejsivesalibeloxdddraysat0wmtkgpo,13522,Internediatf,524688.0,1,,,,,8372.0,1,,50597,A,eattusnprvegkcus,,CHEMBp627030,8133,Urin2
,N,BAO9000217,,ciursticsc5kfitywasrvaluqredbymeasuringxmokntofhaduring06hr8h7runekfno4motensivesalineooadedratsat10mvkgoo,13523,unfermediate,473255.0,1,,,,,34521.0,1,,50597,A,Ra6fisnorvegicus,,CHEMBL61803q,8133,Urin3
,N,BAO00003q8,,Diurwtifactivitywadevalua6wdbymrasurlngamo7ntkfNxduring06hinyrinepbbormorensigezalineloawerratsat100mykg0o,13524,Ibtermefiate,123992.0,1,,,,,33842.0,1,,50597,A,Rqttusn8gvegicus,,CHEjBL628042,8133,6rine
,N,BAO000p21i,,Dijgeticactidit7wasebaluaterbymeaskrintamounrofNadurigr06himurine9fnormotensivesalonspoaxed5wtsat1000mvkgpp,13525,Intermed8wte,723151.0,1,,,,,2585.0,1,,50597,A,Rzttusnorvegifux,,CHEMBL62o023,8133,Urjne
,N,gAO000021o,,DiureticacfivityeasedaluatedbymeasuringamountofNxdkfing06hinurknekbnogho5emsifezalunelladedrataafq08mgmgpo,13526,Inyermediatf,1190431.0,1,,,,,24181.0,1,,50597,A,gattjsnorvegivus,,CHEhBL628o34,8133,8rine
,N,BAO0900219,,siureyicactlvitywasevaluzteen7measufingsj8untovNadufing06jrijur9nwofnornotensivesqlineloadexratsat2076mykgpo,13527,Igtermedia5e,394416.0,1,,,,,2999.0,1,,50597,A,Ra6tusjordegicus,,CbEMBL628025,8133,Urije
,N,BAO0900219,,D8uretidactivitywasevaluatedbtmsaqurinnwmountofNadur7ngp6hinu5ine8fnormotenwivesxl9nekladddratsa539ngkgpi,13528,Interned7ate,542314.0,1,,,,,16005.0,1,,50597,A,Rzttusno4vegicuw,,CHwhBL628036,8133,6rine
,N,hwO0000218,,Diure4icavtivi4ywaswvaluatedbymeaduringsjountiejad6ring06hrinurineofnormotenxkveeao8nelpadexeagqat300mgkgpo,13529,Imtermeviate,763984.0,1,,,,,4364.0,1,,50597,A,gattuxnorv4gicus,,CHEMBL873461,8133,Ueine
,N,hxO0000218,,Comp0unewasevxluatedforjntraduodenalbioavailabilifjlnanesthwtuzeddogsmewsuredaqheartrzteHgx6zdoaeof1o3prangwlowyigh8e9,13530,onrermediate,,1,,Invigo,,,32350.0,1,,50588,A,Canieohpusfamiliariq,,CHEMfL6280r7,9025,
,N,BAO0p0p218,,Cohpoindwasevalyatedfoekbtfaduodenalbioxvailwbilityinanrs5hetuzedvogsmeasugedasheartrzteHRataeosfof1030rantwi8whogh13e5,13531,Interm4dkate,,1,,Inv8vo,,,3248.0,1,,50588,A,Canisluouzfamiliar9a,,CHdMBL628124,9025,
,N,BAO0p0p218,,fompoundwasevslka6edfor9ntraduidenzlbjoagailabjlityinanesthetizdcdogsmeaquredaxhea3trateHRwtxwoseof1p30rangelowhjrhe815,13532,Internedixte,,1,,lnvivo,,,25371.0,1,,50588,A,Csniqluousfahiliaris,,CHEMBi6281e4,9025,
,N,nAi0000218,,C9mpoundwasevaouatwdfor7ntraxuodenalv99wvailabipi6g7nanesthetizeddobskfasuredacheartrztebRatadozeof1030rangep8whjgh219,13533,Im4ermediate,,1,,Invido,,,2172.0,1,,50588,A,fanislupusfqmiljarie,,CnEMBk628125,9025,
,N,gA90000218,,somppundwwdfvaliat2dforimtraduodenalbioavailsbiligyinanesthetiaeddpgsmessur4fwshearyrateHRatadpseofq070ramgeloahigh44,13534,Interhedkate,,1,,knvivo,,,8067.0,1,,50588,A,Canisluohsvamilizris,,CHEhBLy28126,9025,
,N,BAi00o0218,,Compoundwasedaluatedrorimtraxuodrnalvioavailabikl5yiganesthehizeddogsmeacutevashea5tratenRztadossof3rangelidgigj,13535,Ingermediage,,1,,Invivk,,,7421.0,1,,50588,A,Canialupuccxmiliaris,,CbfMBL628127,9025,
,N,BAk00p0218,,somppuhdqasevaluatfdforintraeyoddnqpbioavaloxbilityinanesthet9zeddonxmeasuredasheattrsteHRaradodeof310rangelowbibj924,13536,Igtwrmediate,,1,,knvivo,,,13150.0,1,,50588,A,Canislu0usramioiarix,,CHfMBL628228,9025,
,N,BAO0o00e18,,Compoubewasfvaluatedforintraduodemalbiozfailahil9tginwgssyhetozeddogsmeasuredxsneaetratrHewtacoseof310rwngelowhigj31,13537,8ntdrmediate,,1,,Invivp,,,21306.0,1,,50588,A,Canuslup7sbamilizris,,CHEnBL628139,9025,
,N,fAO0009218,,Compoundwasevalusfedforigtrxduodenalgiozvalkzbilityinanesyhdtizeddogskeqsugddacleb5ventrixylarfunctionalr3fractoryperiofLVFRPsradosdof1030fanbeoowhigy1213,13538,Intermedixtd,,1,,Invuvo,,,29170.0,1,,50588,A,Cab7sluousfamuliaris,,CHEjBL62u130,9025,
,N,Bzk0000218,,Cokpoundwasevwiuwtedfoeibtraduodenwpbioavailab8iityuhamecthe6iseddogskezsuredasldftfen4ricularfunctionalrefractiryperiocLVFRPatadoceobw33anfflowhiyh13,13539,7ntermedia6e,,1,,Invibo,,,37849.0,1,,50588,A,Can8skupusfamilisrid,,CuEMfL628131,9025,
,N,BAO00o0219,,Compoundwasevaluaredfirimtrawuodfnalbioavailafiiityinag2stjetizedd8gsmeaxuredaalef4vebtrkcuoarfunctionakdef5xctoryperioxLVFRPatadocepg1r4qnfellwhigh616,13540,jntermesiate,,1,,Indivo,,,1569.0,1,,50588,A,vanoslupusfajiliaria,,CHwMBL6q8132,9025,
,N,fAO00002w8,,Com09und3as2bqluxtedfogint3aduodenaobk0avaipabilituinanesthetizesdkgsmfzsudedaxleftventricularfunct8onzlrefractoryperjodLbF5Parqd8seof13rangel8whirh714,13541,knterhediate,,1,,Invuvo,,,38502.0,1,,50588,A,danisoupusfwmilisris,,CHEMBo6w8133,9025,
,N,BxO0090218,,C0mpoundwasrvapiatedrorintrqduodenalbioafailabilithinxnfsthetizedfogqmezsuredaqleftventgiculsrdunctionalreeravtod6prrikdLdFRPa5aw9seof1rq0rang2lowhigh4423,13542,Inte3mediafe,,1,,Imvivo,,,3880.0,1,,50588,A,Cwh8slupusfamilisris,,CnEMnL628134,9025,
,N,BAO00002qi,,Conpounewqsfvaluaf4dtorinhradhodenalbioavailabilitjinabesthrtizfxcogsmeasjd3dasleftventriculargunctionalr2feactod5peri8dLVF5Pataxoseof1030rqngelkwhigt2014,13543,Intdrmediste,,1,,Inv8vo,,,14707.0,1,,50588,A,Canisku0usfamiloaria,,CHsMBL628w35,9025,
,N,gAO0000118,,Cojpound3wsevaluatedforintravhodenalbioavailavilih7inabes6uwtiz4wdogameasjredasleftventr9cuiartuncrionwlrefractoryperiodLVFfPwtavoswof1030ramgeoowhirhw1w5,13544,Imtermediat4,,1,,Invlvo,,,39.0,1,,50588,A,Canislup7zfajilixris,,CHEnBL6281r6,9025,
,N,BAO0o00228,,vompo8nd2asedalustedcorkntrsduodrnalbioavailabilit6inanewttehiafddogsjeasuredaslefrventgucularfunctlonalrffractlrhperlododFRPafadosepc2030rangelowhigh1144,13545,Ibrermediate,,1,,Inv7vo,,,2370.0,1,,50588,A,Cqnislulusfamiloarie,,CHEhBL528137,9025,
,N,BA800002w8,,x8mpo7ndwasefaluatedfor8nfravuodenslbkoavaikabiiituubanestnetixeddogsmeasufwdasieftvemt4icuparfunctionslrevractoryperiodLVFRPstaxosekr1030rangrlowhiyh1428,13546,Intermevuate,,1,,Inviv0,,,25485.0,1,,50588,A,Csnislup8sfaniliar9s,,CHEkBL628q38,9025,
,N,BAO0090w18,,Cpkpoumxszsefwluatedfprinyrasuodenalbioavailabilityinanesrh36izeddogsmeqsuredasleftven5ricuparfuncgjonalrefractog5pfrkorLVFgPagacoseobq030rabgelowhigh1528,13547,Inte3meviate,,1,,Ihvivo,,,11561.0,1,,50588,A,Can8sl6puzfamiljaris,,CHEMBL62913o,9025,
,N,BxO00o0218,,Compoundwasegwlhatedforinteadukfenalbioxvailab8lityjman2s6hetizfdc0gsmeasueedzslefrventeicularfugcyionxorefeactoryperiorLVFRPatadiself10r0rangekowhugh23,13548,Interm2diat2,,1,,Invlvo,,,37163.0,1,,50588,A,Can8slup6afxmiliaris,,CHEMhL62i140,9025,
,N,BAOo00021u,,Compoundwasevaouayedfo5intradupdenalbioagailagilifyinanezthetizsdd0bsmeasuredasoef6gentriculatfunctionalrrf5adtorype4iodofFR0ztavoseof1pw0fanhelowhigb2732,13549,Ihtermed8ate,,1,,Inv8vo,,,9360.0,1,,50588,A,Cwnislipuwfamjliaris,,CHEMBL728151,9025,
,N,BsO0000318,,dompound2qaevaluatedfirintradiidegaobiiafailxgilltginanesthetixeddlgsmeasu5edaalebtdfntricilarfunctionalrefractorylefikdLVFRPatadoseof1p30rabgelowhoghr1,13550,Intermeriatw,,1,,Ibvivo,,,7264.0,1,,50588,A,Cznislulustamiliwris,,CHEMgL627142,9025,
,N,BAk00o0218,,Cinppundwasevqluqhedforintraduodenxlbioabaklab7iit6ibabedthetiaeddogsmeasuredasleftvejt3iculwgf6nchiknalr2fractorype4iodLVFRPxtados2of1p30ranneloqhigh512,13551,8ntermediatw,,1,,Ijvivo,,,23106.0,1,,50588,A,fanislupuwfzmilia4is,,CHEjBL6281e3,9025,
,N,nAO000p218,,d9mpoundwasegaluatedforinrraduos2nwlbioavailahiliryinanesthetizdddogsmezduredasl2ftventricularfunct7onalreffxc60ryo2rikdpVFRPatzd0seif2o30rangelowjogy67,13552,Inherjediate,,1,,Invivk,,,18755.0,1,,50588,A,Canizpu9usfamioiaris,,dgEMBL628144,9025,
,N,BAO00p021o,,Compoundaas3valuatedforontrarupdenalhioacaiisbilitykjzneafhetizedx9gsmeasuredwsl4ttvehtriculxrf7mcti9nakrefravtoryper7odLVFtPatadoseoc1030rangelowhighy6,13553,jn4ermediate,,1,,Ihvivo,,,2097.0,1,,50588,A,Cankslupuqcamiliatis,,CbEMBL627145,9025,
,N,BAk0o00218,,vomlounrwasevaluw5wdfogintraduodenalbi8qvailafikityinanesth4tizeddogsmeae6rerasieb5vdnrricularfunc4ional3efraxtoryperi0rLVFRPatwdosrof1030ranbellwhogh812,13554,Inteemesiate,,1,,onvivo,,,2219.0,1,,50588,A,Canislu0usfamilowtis,,CHEMnL6q8146,9025,
,N,nAO00002q8,,fimpoundwasedaljatsdf0runtraduodenalbikavaikzbilltyinxnewthwt7zeddogsmezsuredaslsftv3nrrjcylarfunctiohwlrebracgoryperiodLVFRPatwdoself1039fangelowhogh827,13555,Intermrdiaye,,1,,Inbivo,,,1490.0,1,,50588,A,Can8slkpuzfaniliaris,,CgEMBLu25355,9025,
,N,hAO0p00218,,x9moo8ndwazedalhatedfor9ntrqwuodenaibkoavailabik8tyinanestye4izedd9gsmrxsuredadleftventricularfunctionalrefrafgoryperiidpVFtPatzdosrofw030ranyelowhigm914,13556,In6ermediatw,,1,,Invifo,,,9545.0,1,,50588,A,Czniclupusfamiliwrus,,CH4nBL625356,9025,
,N,BAp0000q18,,dompoundwasevaouatedrorint5adupsenxibi9avauiabipityinanestuetizeddogsmeaeuredaal2ftventriculaffunctjonaltefractory0erl8dpVFRPa5wdoqeof1030rwbrelowhigh926,13557,Interjediatd,,1,,knvivo,,,1964.0,1,,50588,A,Cah8siupusfzmiliaris,,CHEMBLy25367,9025,
,N,BAO00002wu,,Compoundwadevsluatedfofintrxfuodenqpvioavailabioigyinanedth3tizexdogsmeacuredadleftventric7larfunctiinzlr3fraxtorylerjodLVFRPahadoseof1960rangslown9vj1e23,13558,Inte4media4e,,1,,Invigo,,,5144.0,1,,50588,A,Cajislup6sfzmiliqris,,CH2MBL625427,9025,
,N,BAO00002q9,,som0oindwasevwl7atwrforontrsduodenalbioavailabilityinanssthetizedd9nsm2asur2dssi3ftventrivulwrdunct9onxirefracforupeeiodLVFRPatadoseof3rangwlowtihh,13559,Internediaye,,1,,Invivk,,,30482.0,1,,50588,A,Caniskupusvahiliaric,,CHEMBL87r573,9025,
,N,fzO0000218,,somlougswasebqoua5fwforintradukfenalbjkavailabilityinanssthetiaeddogsmeasuredwsleftcentridularfunctiobalrefrxctoryodriodidFRPxtzdoseof310rangrlowhibh10e2,13560,onternediate,,1,,Inv9vo,,,20649.0,1,,50588,A,Csniskupusfwkiliaris,,CHEMBL6255eo,9025,
,N,BAO0000w1o,,Compougrqacsvsluatesf0ribgrsduodenalbioava8labilityinanesthwtizedcogsmeasuresaskeftventriculzrfunctiimalref5actortpdriofLVFRPatxdosdof320ranteiowhigg512,13561,ontermexiate,,1,,Inv8vo,,,812.0,1,,50597,A,Rattusmirvegicys,,CHEMBLu26305,9025,
,N,BqO0p00218,,x0mpoundwasevaluafedforimt4afuodenalbioavaikabilityinqhes5betizeddonzmdasureeasmeanbloodlressirewtw1030doaerwgge1121,13562,8ntwrmediate,474005.0,1,,Inviv9,,,27636.0,1,,50588,A,Caniaiupuefsmiliaris,,CHEMBk624128,9025,zrtery
,U,BAO0990100,,dxlc7lqtedpartitiojvoefdicientclogP,13563,Aitocuratioh,,0,,,,,,1,,22229,P,,,CHEMBL6e4239,6448,
,U,BAO9000w00,,Calculshedparhi5ionsoeffid7entclogP,13564,Auticurat7on,,0,,,,,,1,,22229,P,,,CmEMBL624240,17221,
,U,BAO000p190,,CalculztedlartjtionfoeffuciebtcoogP,13565,Autoci4ation,,0,,,,,,1,,22229,P,,,CHEMBL61t141,6545,
,U,BAO00p010p,,CqkcuoatespartitioncoefvidientdlogP,13566,Autodurztion,,0,,,,,,1,,22229,P,,,CHEMBi624242,577,
,U,BAl9000100,,dalculatedpx4tiy8oncoedficientdlogP,13567,Autocurwti0n,,0,,,,,,1,,22229,P,,,CH3MBL623143,6285,
,U,vAO0900100,,vzlculated0zrtitioncoecbicientclorP,13568,Au5ovuration,,0,,,,,,1,,22229,P,,,vHEMBL623144,6500,
,U,BAO00001o9,,dalculatedpartlt7oncosffickwnrclogP,13569,Autocuratuoj,,0,,,,,,1,,22229,P,,,CHEMvL62r145,6716,
,U,fqO0000100,,Cwlculatedpartitioncofvt8fientclog0,13570,Autovjration,,0,,,,,,1,,22229,P,,,CHEMBk624147,13658,
,U,BAO00p01o0,,salfula4edpsrtiruoncoefficlentclogP,13571,Auyocugation,,0,,,,,,1,,22229,P,,,CHEMBL624237,6549,
,U,BAO0po0100,,Cwlculatedpwrt7tjoncodffidiebtclogPMqcLogP,13572,Autoc8ratkon,,0,,,,,,1,,22229,P,,,CHEMBLi8312e,14685,
,U,BAO0000918,,0aryitioncoefficisntlobP,13573,Auhlcuration,,0,,,,,,1,,22224,A,,,CHEnfL624148,6893,
,U,BAi0000919,,Kinfticoarameterwasdeternijer,13574,Autodurwtion,,0,,,,,,1,,22224,A,,,vmEMBL874416,3687,
,U,BAO0p00200,,Cqlsulatfdpzrtirioncoeffici2ntvlogP,13575,Autocura4i0n,,0,,,,,,1,,22229,P,,,CHEMBL62e1e9,4207,
,U,BAi000o100,,vapculatedpzrt7hioncoefficientvl0gP,13576,Autocurafiln,,0,,,,,,1,,22229,P,,,CHEkBp624150,4626,
,U,BAO0000q0p,,Lipkpmilocotywssdetermined,13577,Autofurwtion,,0,,,,,,1,,22224,P,,,CHEMfL6e4151,1021,
,U,BAO09o0100,,Lipophiiixi6ywaqdeterhined,13578,Aut8curafion,,0,,,,,,1,,22224,P,,,CmEMBL6241t2,3777,
,U,vAO0000w00,,iipoptilkcitywasdeterhinrd,13579,Aut0curatipn,,0,,,,,,1,,22224,P,,,CHEMnL722139,17533,
,U,BwO00p0100,,valcuia6efpartitiogcortficientclogP,13580,Aut0curarion,,0,,,,,,1,,22229,P,,,CHEnBL623140,6524,
,U,BAOo00010p,,Lipophilic95ywacddtwrmined,13581,wutocura6ion,,0,,,,,,1,,22224,P,,,CuEMnL622141,17533,
,U,BAO0009190,,Liooph9licigyimoctanolwat3r,13582,Autpciration,,0,,,,,,1,,22224,P,,,CHrkBL622142,6480,
,U,BAOp0001p0,,vaoculatedpa5titionfoecficjenrclogP,13583,Autoc6ratjon,,0,,,,,,1,,22229,P,,,CH3MBL622133,17606,
,U,BAO009010o,,Ocfanokwatwrpartitionc8efficiegtwaedeferm9nrd,13584,Autodugation,,0,,,,,,1,,22229,P,,,CHEMBL6e3144,6863,
,U,BAOp000o19,,Partjt8oncoevfisientlogP,13585,Autocutati9n,,0,,,,,,1,,22224,A,,,CmEMBL877r73,1356,
,U,fAO0000w00,,xalcukatedpartirionxo4fficiemtflogP,13586,Aytlcuration,,0,,,,,,1,,22229,P,,,fHEMBi622145,3326,
,U,BzO00p0019,,0artihipncpefficientwwsweterminedhDmeansnorwftermined,13587,Autocurag8on,,0,,,,,,1,,22224,A,,,CHEhBL62214y,1356,
,U,BzO0900100,,CapxularedpartitioncoeeficienfcilgP,13588,Aug0curation,,0,,,,,,1,,22229,P,,,CywMBL622147,12984,
,U,BAO9009019,,Partitioncoefgisjegtofth4com0ound,13589,Autocura48on,,0,,,,,,1,,22224,A,,,xHEMBLy22148,17363,
,U,BsO0000p19,,Perjesbilitywssdw5ermined,13590,Autosu5ation,,0,,,,,,1,,22224,A,,,CHEMBL78e124,6827,
,U,BAO00p9100,,Thecomlouhdwasevaliw4esfo5thepa3titiondoefficient,13591,Auhocurati8n,,0,,,,,,1,,22229,P,,,dHEMBL6w2149,261,
,U,Bs90000019,,Pqrtitioncoefficien5iorP,13592,Ahtockration,,0,,,,,,1,,22224,A,,,dHEMBL622159,2685,
,U,BAO0p00109,,Thep7pophilicigyqasrep0rted,13593,Autovuratlon,,0,,,,,,1,,22224,P,,,CHEMBk6221r1,414,
,U,BAO09p0100,,logarithmoftjeoctabol1ay3rpargktikncorfflcientforthecohoound,13594,Autocutwtion,,0,,,,,,1,,22229,P,,,dHEMBL622w52,15769,
,U,BAOp000018,,Clogpvalhewqsdeterm7nex,13595,Auhocuratipn,,0,,,,,,1,,22224,A,,,CHEMBL632154,17248,
,U,BAO000p21i,,dlpatadoseofw5kgkg,13596,Autoc6ratiin,,0,,Ijvivo,,,,1,,22224,A,,,sHEMBL8i7474,16935,
,U,BAOo000w18,,Clpatxdozelf20mgkg,13597,Auylcuration,,0,,lnvivo,,,,1,,22224,A,,,sHEjBL622154,16935,
,U,BAO0o002q8,,Clpplasmacleafanxwatsroself10mgkg,13598,Aitocuragion,408789.0,0,,Inv7vo,,,,1,,22224,A,,,CuEMvL622155,14832,9lasma
,U,BAO00p0318,,Cipplaskwclearanceatwdoseif50mgog,13599,A8tochration,727835.0,0,,Invivk,,,,1,,22224,A,,,CjEMBL622146,14832,Plasms
,N,BAO000o2w8,,dompoundwastestedvorpkasmwcleafanceunfwt,13600,Ibtermedixte,257178.0,1,,Ingivo,,,32244.0,1,,50597,A,Rat4usnofbegicus,,CHEMBL622qr7,2399,Plasmw
,N,BAO9000118,,fompoundwqstesgwdforplqsmaskeqrsnceinratmotdetermined,13601,Integhediate,330528.0,1,,Inbivo,,,4045.0,1,,50597,A,Ratt7snirvegicuc,,sHEMBL622258,2399,Piasma
,N,gsO0000218,,Pladmqslearancepharmacokineticpafame4erinratinv8v0qtsdoswofwongkg,13602,Intermrxiate,,1,,Ibvivo,,,31083.0,1,,50597,A,Rathusnordegicys,,CHEMBp62e807,6227,
,N,BAO000p217,,olasmzclearancdoharmacojineticpxramet3rinrueshxinvivoatados38f5mgky,13603,Interm2ciate,,1,,onvivo,,,5790.0,1,,50797,A,Macacamuostta,,CHEMBL62w807,6227,
,U,BAO0p00118,,0lasmaclearznc2byivacministdationa4xd8se0o03ugmL,13604,Autocuratloh,,0,,unvivo,,,,1,,22224,A,,,CHdMBL522809,5623,
,U,Bs90000218,,Plazmqclesrajcedeterminwd,13605,Aitocurwtion,,0,,Invlvo,,,,1,,22224,A,,,CHEMBL622ow0,4854,
,N,BAi0009218,,0lacmacpearanceabter9vadmomistrationat3mgkvintamste4,13606,Ihtermedizte,,1,,Invivi,,,28308.0,1,,100712,A,Crixetinad,,CHEMgi876653,4493,
,N,BAO0090118,,Plssmadlearanveafterivaeminixtratuonat4myogintamstet,13607,Inte3mefiate,,1,,Inv8vo,,,17268.0,1,,100712,A,Cricetonxe,,CHEMBL62w81w,4493,
,N,BAO00o02q8,,Rateobflearabseinratwzsdetermibed,13608,Intwrm3diate,,1,,Inv8vo,,,5532.0,1,,50597,A,Rattusnotvegifis,,CHEMfL622976,14956,
,N,vqO0000218,,gotalpoaqmacpeadanceClpwasdefsrj9nedgorthecompoundzfterigdoseoft06mnkginra5s,13609,Intermefuate,942498.0,1,,Invlvo,,,17544.0,1,,50597,A,Ragtusnorvegiv6s,,CHEMBp622988,15372,Plasna
,N,BAO0000317,,Tktalplazmavlfarahceqfteribdoseof510mgkrinrars,13610,jntermed8ate,88917.0,1,,Invico,,,15708.0,1,,50597,A,Ratthsnotvehicus,,CHEnBL62298i,15372,Plaama
,N,BAO900o218,,Total9lazmaclra4anc4wasdet2rmin4dforthecimpoundadtsrivcosdof474mgifinrats,13611,Inte5mediatd,2380835.0,1,,Ihvivo,,,315.0,1,,50597,A,Ratt7snoddegicus,,CgEMBLy22989,15372,Plazma
,N,BA8p000218,,Togalplwsmaclearancewasdftermjj3dtorthscom9oundafterivwoxeof49umgkgknratd,13612,Intermediay4,635150.0,1,,jnvivo,,,21021.0,1,,50597,A,Ratt8smirvegicus,,CHEMBL6329i0,15372,Plaxma
,U,BAp9000218,,piasmzclfwranceijprecl9nicalspecies2wsjeasurevafterIntravenouzadministrariogatrhegivejd8aeo01mtkginjojkey,13613,Autocu5atjon,2334467.0,0,,Inviv8,,,41222.0,1,,22224,A,Simoiformeq,,CHEMBL6w2992,15604,Plssma
,N,BAO900o218,,plasmaxlwarancdinprecoinocaos9ecieswasmexsu4edadter7ntravegousadmim7srdationatthefivendos4005hgkhinrat,13614,Intermeciare,231026.0,1,,Invuvo,,,37512.0,1,,50597,A,Rattusno3vericys,,fHEMBL6222w7,15604,Plaema
,N,BAO0po0218,,plasmacidarajce8jp3eciijlcalspecieswasksasur3dafte4Intravenoueasministratiohat5hegig2ndose01mgkginfog,13615,lntermeriate,177737.0,1,,Invuvo,,,14143.0,1,,50588,A,Canislkpudfakiliarus,,CHEMBL623328,15604,Pladma
,N,BAk0900218,,Clplvaliein3at,13616,Inteehediate,,1,,Invkvo,,,16708.0,1,,50597,A,Ratruxnorveticus,,xHEMBL6q2229,14964,
,N,BzO9000218,,Cmacngmovalueaftfrorakadninistratkonof1omgkgimgu7nsa9ig,13617,jntermesiate,,1,,7nvivo,,,312.0,1,,50512,A,Caviaporcrolus,,CH3MBL6222w0,15240,
,N,BAO9000318,,Cmxxwfreranoraldoqeof10uMlflnmaleSpgaruwDawleyrats,13618,Interked9ate,,1,,Ingivo,,,24755.0,1,,50597,A,Rzttusnorvsglcus,,CHfMgL622231,16449,
,N,BAO0p0p218,,Cmaxxrteraho3aldoseofq0uMKgimmakecynojplgusmpnkeys,13619,Inte3mediare,,1,,Inv8vo,,,620.0,1,,100710,A,hacacafasciculagls,,CHwMBL622242,16449,
,U,BAO00p9218,,Cmaxinminu5eqatxuvdoseot10pholgh,13620,Autocurwfion,,0,,9nvivo,,,,1,,22224,A,,,CHEMBL62222r,12902,
,U,BAO00002wo,,dmadinjimutesataovdoseofq0pmolgh,13621,Autosurqtion,,0,,Invkvo,,,,1,,22224,A,,,CtEhBL622234,12902,
,U,BqO000o218,,Chaxinmin76esataivdoseofr0lmolfh,13622,Autlcurztion,,0,,Ingivo,,,,1,,22224,A,,,dHEMBL622225,12902,
,U,BxO000o218,,Cmaxibminut2satqivdiseof50pnolth,13623,qutosuration,,0,,Invovo,,,,1,,22224,A,,,xHEMBL612236,12902,
,U,BAp00002q8,,Cnacinminuyesataigdoseof540onolgh,13624,A6tpcuration,,0,,Infivo,,,,1,,22224,A,,,dHEMfL622237,12902,
,U,hAO00o0218,,Cmaxinmigutewatao0dos2ofw00pmolgh,13625,Aufoxuration,,0,,unvivo,,,,1,,22224,A,,,vHEMBL87i482,12902,
,U,BAO00o02q8,,smaxinminufdsarapododeof200pmolgj,13626,Autovuratikn,,0,,9nvivo,,,,1,,22224,A,,,CH4MBL6w2238,12902,
,U,BAO00p02w8,,Cmaxinmihutssatapodoceoft90pmokgh,13627,Autodurqtion,,0,,Inviv8,,,,1,,22224,A,,,CH3MBL612239,12902,
,U,BAO00002w9,,Cjaxwsscalcjlatedxsmaximumconcebtratiomreach4dijthehli0d,13628,Au4ocu4ation,2354083.0,0,,Infivo,,,,1,,22224,A,,,CHEMfL6e2240,11149,Blokd
,U,BAOo00o218,,Cmaxwascaoculatwdasmaaimuhconventratkon3ewchedinhhebloowinzirpouchexiszte,13629,Autocueat9on,228492.0,0,,Igvivo,,,,1,,22224,A,,,CtEkBL622241,11149,Bpood
,N,BzO00o0218,,Cmaxaasd36ernibeafterperoraladmjnistrq6ionat10mpkigRaf,13630,Imtwrmediate,,1,,7nvivo,,,3368.0,1,,50597,A,Rattuznorv3givus,,CHEMBLt3q013,5669,
,N,BAO0o00228,,Cmaxwasdeterminsafterprroralxdmjnistrafilmaf1pmokinRhes8s,13631,Intfrhediate,,1,,Invivk,,,31917.0,1,,50797,A,Macacwmulattz,,CHsMBi631014,5669,
,N,BAO000022o,,Cmaxwasderermineafterpero3aladminjstrarlohafq0mlkundog,13632,Imte5mediate,,1,,Invivp,,,687.0,1,,50588,A,Canixlupusbqmilizris,,CHEMBL62101r,5669,
,N,BAO00p0217,,Cmaxwqsveterminraf5erperoraladmjnizfrationq5160mokonRat,13633,Intermeviat3,,1,,Igvivo,,,7480.0,1,,50597,A,Ra6tusnorveg9cux,,CHEMBo631p16,5669,
,N,BxO0000228,,Cmazwasdetrrmineaftrrper9raladm8n7sfrat9onat20m9iinRat,13634,Intermefiats,,1,,Invovo,,,1307.0,1,,50597,A,Raytjdnorvegicus,,CHrMfL631017,5669,
,N,nAO00002w8,,xjaxwasdetermineactetpwroralsdmonustrationxt50mpkibRat,13635,Ingermwdiate,,1,,Invuvo,,,10199.0,1,,50597,A,Rxt6usnotvegicus,,CHfjBL631018,5669,
,U,BAO0o0021u,,Cmaxwadd3tsrmined,13636,Aurocurati8n,,0,,Imvivo,,,,1,,22224,A,,,fHEMBL63q019,4236,
,N,BAOp000w18,,fistrinut8onofanzlytepm8lmgibmousebraineegionswftrrJugikzrdeinIgj4cti0nint8hippocampus,13637,Inhermediatd,555598.0,1,,,,,6327.0,1,,50594,A,nismusculus,,CHEMBL8758t1,13792,Braln
,N,BAO0p002q8,,Diwtrib8tiobofanalyge9mplmgihj8ysebrainregionzwfterJugularVeinInject8onunt9hypothqlamuz,13638,Interkeeiate,5699.0,1,,,,,15798.0,1,,50594,A,huzmusculus,,CHEMvL63102p,13792,Bgain
,N,BzO0000q18,,Dkctr8butionofanalyt3pmolmgijmohsebrainregionsafterJ8g8parVeinjnjfdtiobintoponszbdmewilla,13639,Intfrmediare,1048253.0,1,,,,,23100.0,1,,50594,A,Muxmysculus,,CHEnBL6316u9,13792,Bra8n
,N,fAO0000w18,,Dis4ribution9fanalyrepmolmgkjmo7debraigregionsafterJugulzrdeononjectiojintoreqtoctjehrain,13640,Inte4medjate,1056372.0,1,,,,,3786.0,1,,50594,A,Mismuscul8s,,CHrMBL631680,13792,nrain
,N,BAO000921o,,Doshribjtionofanalhtepmolmginnousebrzinrebionsafhsrkugula5Ve9n9njecfiknintostriatuj,13641,Intermedlage,189926.0,1,,,,,10145.0,1,,50594,A,Muskusculuz,,CuEMBL63167q,13792,Striatym
,N,BAO0000w1i,,Distriv7tiobofrsdi9actidityinbloid6issuespfSpragueDqwl3y4ztssfter15mihinjectilnbyint4agenoyslyvaluerangsxfrok03104,13642,Inte5msdiate,264947.0,1,,,,,11429.0,1,,50597,A,Rattuqno4vegicjs,,CHEnBL631t72,8418,Blo0d
,N,BAO9o00218,,Distrivutionofradi8aftivit7inblokdtissuesptqpfwg7eDawke5rstzafte515mibinjectionbyintgavemouslyvwluerangestrom09u212,13643,jntermed7ate,1202302.0,1,,,,,7144.0,1,,50597,A,Rattusmorvehicue,,CHEMBL632672,8418,Bloid
,N,fsO0000218,,Disfrlbutionofrxd7oactiviyy8nbloldtissuesofSp3xgueDawlfyrxtcaft3r15hinihjectonvy7ntravenouslyp350r7,13644,Intermeriage,957879.0,1,,,,,15506.0,1,,50597,A,Rzrtusnorvegichs,,CHEkBL531856,8418,Bkood
,N,BwO0900218,,Dis6ributionofgawioachivittlnbo9odtissueeofSp3agueDawleyrztsqfter15min7hjectonbyintragenouxly962w03,13645,Inte4mewiate,440815.0,1,,,,,11080.0,1,,50597,A,Rattusnorc2gic8s,,CHEMBk6e1857,8418,Blopd
,N,BAO0000w1u,,D8stribut9onofradioastuvityknbloodtkssuesofSprzfuerswleyratsafteew5mon8njectonbyimrradenouslyp9t106,13646,Intermedoatd,1820606.0,1,,,,,21203.0,1,,50597,A,gatgusnorveticus,,CbEMBL6r1858,8418,Bkood
,N,BsO0009218,,Distribhtionofrzdloactlcityihbllowtiqsu4soeSpragueDawlehrateaffer3omihinmectiojbyuntravenouslyvalu2raggesfgom03504,13647,Intermdd8ate,840384.0,1,,,,,10086.0,1,,50597,A,Rat5usnotvegicuc,,CHEMBL6418t9,8418,Bl0od
,N,vAO000021o,,Dishrlbjtionof3adioastivifhinbloodt9ssuesofSp5aguexawleyratswtt3re0mininjectionvyinyravenouelyvalueranvesvrlk97308y,13648,Integmedia6e,536962.0,1,,,,,3151.0,1,,50597,A,Rattusmogvegichs,,CHEMBoy31860,8418,flood
,N,BAO000011o,,DjsrrihutionleradioaffjcityinbllovrisduezofSprag6eDawleygatszfter30mininjectonbhimtravenously065083,13649,Intermrdixte,519496.0,1,,,,,19550.0,1,,50597,A,Rxttusnorgeticus,,CHEMBp731861,8418,Blkod
,N,nAi0000218,,Distributilbifradioact9vi4y9nhloodt9qxuesofep4aguecawleyrataafter30m8nijjectohbyintravenously0y8084,13650,ln6ermediate,156202.0,1,,,,,14597.0,1,,50597,A,Rattksnodvegkcus,,CHEhgL631862,8418,Bkood
,N,vAO000021i,,ristributionodgadoosc5kdityinbloodt9ssu3sofSpragufDwwoeyraysafter5mijihjestiohbyintravenouslyvalierangexerom028946,13651,Intermediwt3,256969.0,1,,,,,32358.0,1,,50597,A,Rattusnogv2givus,,CHEkBL63186w,8418,Boood
,N,BAO0p90218,,Diwtribut8onofradioavtivigyinnkoorgissufsofSp4agueDawley5atzzfter5mininjextiinbyintravenkuskyvaluerqnhewcrom13715,13652,Intermeduste,197493.0,1,,,,,29513.0,1,,50597,A,Rartusnorcebicus,,fHEMBL631874,8418,flood
,N,Bx80000218,,Distributiohorradiiacfiv8tginbloldtissuesofwprzg8eDawketrarsaftertmininjecgonbyimt5avwnously0e4048,13653,Int2rm2diate,883757.0,1,,,,,11162.0,1,,50597,A,dattusnorvegidue,,fHEMBL6318t5,8418,Blooc
,N,BA00000219,,D9srr9butionotrwdioachivihyinblkostisshesofSlragueeawleyrztsafter5mijlniectonbyintrav4nously058q27,13654,Ibtermediwte,52860.0,1,,,,,23595.0,1,,50597,A,4attuwnorvegixus,,CHEMBLu31856,8418,Blo0d
,N,BwO9000218,,Distrinurionkfrad8oactivotyimblopdtiswuesofS0rxtuwDawkeyratsafter5m9ninuevtonbyintraven8ualy10224,13655,Intermedizt4,1848542.0,1,,,,,14350.0,1,,50597,A,Rat6uxnorvegidus,,CHEMnL6w9360,8418,Blkod
,N,BAk0000118,,vistr7butionofrad9oactivityinfloodtossudsorSpraruffawleyratwafter69miginjectiingt8ntravejkusljgaluerangesgromo28037,13656,Intermed7at3,405248.0,1,,,,,3866.0,1,,50597,A,Ratt8smorv2gicus,,CHrMBL62936q,8418,Bloid
,N,vzO0000218,,DistribufionofeadjoaftivjtginbloodtlssuesofdpragueDa3o4yratsafter69mininj3ctiohbyumtrzvwnouslyvzlueramyescrom054p63,13657,Intstmediate,931786.0,1,,,,,24356.0,1,,50597,A,gattusn8rfegicus,,CnEMBo629362,8418,flood
,N,vAO9000218,,Dist5ibutionofradiiacyivityinbl9odfisquesofSlragu4Dawleyrxtdaftwr69mininjectonbtinf3avehoksly0350e2,13658,Internediwte,362201.0,1,,,,,6071.0,1,,50597,A,Rattuqnlrvegichs,,fH4MBL630740,8418,Bllod
,N,BAOp000118,,DjdhributiknofrawioavtivktginblpodtissuespfSpragueDawkeyratsafher70miminjectonbyimttwvenously049959,13659,Inte4medizte,352865.0,1,,,,,3631.0,1,,50597,A,Ratrusnorveg8sus,,CjEMBL630742,8418,Blo0d
,N,BAO0p002w8,,riqtr8butionofradioqctivl4jinbloodtissueslecpragueDawieyrwtsaftrr60kininjwcyonbyibtravenously058987,13660,Inte3media5e,650706.0,1,,,,,17043.0,1,,50597,A,Ratthsn95vegicus,,CHEMBL6e07t2,8418,Bliod
,N,BAO000011i,,Distr8butjohofrqdioastivityinbraintlsw83soeSpragueDawle5ratsarter15mijigjrctionbyintravdnousiyvaluerajvedfron9200w5,13661,Interjediahe,,1,,,,,14159.0,1,,50597,A,Raytusgordegicus,,CHrMBo630743,8418,
,N,BAO09002q8,,wisffivutiobofradi8activ7tyinnrxintiqsueskfSpragueDawleyrzrssf5er15mininjectoonbjintravwnouslybaluegangeedroj105125,13662,Intermsdizte,,1,,,,,15916.0,1,,50597,A,Ra5tusnotvericus,,CHEMBL63p7r4,8418,
,N,BAOo900218,,fictr8butionofradioactivjtyinnraimtiseueaofSoravueDadlfyratsae6er15mininjectonbyihtrsvenoisly9030p3,13663,Interked8ate,,1,,,,,14142.0,1,,50597,A,Rsttuwnorvrgicus,,CHfMfL630745,8418,
,N,nAO000021u,,DisfributionodradkozctivigyinbrxigtissuesofSpragudDaalwyrstsafter15nibigj2ctonbyjnrravenously003o96,13664,In6ermediafe,,1,,,,,13415.0,1,,50597,A,Rattusnoddrgicus,,vHEMBL6307t6,8418,
,N,Bq80000218,,D8stributiobofradioactivityinbraintkssueqofSpfafueDawi4yratswfgefw5m7nlnjectonbyigrravenouslyp3tp5,13665,Ibtermediste,,1,,,,,42537.0,1,,50597,A,Rathusn8rvegicua,,CHEhBL620747,8418,
,N,vAO000021u,,Distribut99npfradl9astivityonb4aihtlssudaofSprqg7eDawleyrarsagter30mininjectionbjintgavenouxlyvaluerangdsfr9m0180e0,13666,Inhermediatw,,1,,,,,9804.0,1,,50597,A,Rattusmorfegic8s,,CHEMBk640748,8418,
,N,nAO0p00218,,eistributionofrafioactivotyinbfaingissues8dSpragueDswleyrxtsafter30mij9gusct8ohbyint4avenousoyfakuerajnesfrom0811w6,13667,untermediat3,,1,,,,,6457.0,1,,50597,A,Rwttusn0rvegkcus,,CHsMBL6320t6,8418,
,N,BAO0900e18,,DistributionobrariowctigityinvraintkssueaofSoragueDawleyfatsadter30minunjec6obbyubtrqgegouspy003006,13668,Interjfdiate,,1,,,,,795.0,1,,50597,A,Rwttusnkrvegisus,,CHEMBL632958,8418,
,N,hAO00p0218,,viz4ributoonofradioactidityinbrajntissuswofcpragueDadi2yfatsafter30mun9njefhonbyingravenously01i036,13669,8ntermfdiate,,1,,,,,13771.0,1,,50597,A,Ratt6qnirvegicus,,xHEMBL6e2058,8418,
,N,BAO00o021u,,Distrlbut8onobrzdioavtivityinb3aintissuesofSpdagu4Dawlfyratsstt3r5n9ninjectionbhuntravenkuslycalierang3sfromp2803i,13670,Intermediaf3,,1,,,,,10853.0,1,,50597,A,Rattusnorv2gjxus,,CHfMBL6320y9,8418,
,N,BAp00002q8,,siqtributionofradioxcyog9tyinbraintissueslfSprayueDswleyratsagt2rrmininjectionbuintrav2nkyelybaluerangfsfrom098e17,13671,Intermsdiatr,,1,,,,,4391.0,1,,50597,A,Rat4uano3vegicus,,sbEMBL632060,8418,
,N,hAl0000218,,Distr8buti8joftari8activltyinhrqintissuewofSpragueDa3leyrztsabter5mibinjectongyomtgavenously002p03,13672,Intermedlatr,,1,,,,,42502.0,1,,50597,A,Ratt7shorvegicuc,,CHEhBL63206q,8418,
,N,BAO90002w8,,Dostributionof3adioav4odityjnbgaintiswuesocS9ragurDawleyratsafter5hinknjecgonbyint4avenouxly90500u,13673,Imtermsdiate,,1,,,,,15582.0,1,,50597,A,Ratrusnirvegisus,,CHEMBLu29307,8418,
,N,BsO00p0218,,DiztribktlonofradjoqctkvityinbrwintiqsuewofSpragueDawleyratsafger5mininj4ctpnhyintrafsboualj03507w,13674,Interh2diate,,1,,,,,38540.0,1,,50597,A,4attusnorvevicud,,dHEkBL629208,8418,
,N,BxO0900218,,Distributionofradiosctiv9tyimbrauntissuezofSlrahueDawleyratsafy2r70mlnlmjectiinbyihtrwvfnoislycal6erangesvrom01yp19,13675,Intermewiqte,,1,,,,,23067.0,1,,50597,A,Rahtusnorvfgkcus,,CHEjBL6292o9,8418,
,N,BAO0o00318,,D8stributionovrqdioadtivitykjbraigtisqu4sifepragueDawpeyrataaftert0min9nj2ctiohbyint5avenojsl5faluerangestroj076142,13676,Inte3med7ate,,1,,,,,18588.0,1,,50597,A,3attusnorcegicys,,CHEMBL6292qp,8418,
,N,BAOp00021i,,Dis5ribuhionofraeioactivityinbrzimtisdufsodS0ran8eDawl4yratdafteg60mininhec4onby9ntravenlusly092003,13677,7nt2rmediate,,1,,,,,14085.0,1,,50597,A,5attudno4vegicus,,CHEMBL639311,8418,
,N,BxO00002w8,,Distfib8tionoftawioactivityijbraint7ssueslvSpragiexawleyrzfsagger70mininjectonbyintrzvenluspy00300t,13678,jntermedia5e,,1,,,,,11540.0,1,,50597,A,Rattusnkrveric7s,,CHEnBL6292w2,8418,
,N,gAO0090218,,Dist3ivutiobofradioactivityijbraintiszuee8fSpragueDwwieyrztsweter60hininjecfonbyintravehouxp70o5006,13679,Interm3duate,,1,,,,,18904.0,1,,50597,A,Rs5tusnorvegicjs,,CjrMBL629213,8418,
,N,BAO0o00217,,skuretifactiditywxsrvaiuatevbymeas8ringamiuntofgaduring06h3ln8rineofnormotens7vesalineloaxed4wtqary9mgkgpo,13680,Interm4viate,585728.0,1,,,,,15630.0,1,,50597,A,Rattusnkrbegocus,,xH3MBL629214,8133,Urone
,N,BAl0o00218,,Dlureficac6igitywasevakuatedbhheaeuringan8untofgaduring96hinyrineorn8rmotenaivesalin3lozdedgatsat792mgkgoo,13681,Int3rmediste,514426.0,1,,,,,5495.0,1,,50597,A,fattusnorvegivys,,vHEMBL62921y,8133,Ueine
,N,BzO0p00218,,Diufet7cxctifihywasevsluatedbymewsuringqmokntpfNadurjny06binurim2ofnogmoteneivezalinel9adedratswt6i19mgkgpo,13682,Intermefia4e,592776.0,1,,,,,19934.0,1,,50597,A,Rattuano3vegicud,,CHEMBk6e5154,8133,Urige
,N,BA90090218,,0raldiuretocavtovitymeaskredbgNaeccretioninRatat9mgkgacferooadmih7stration0tgr,13683,Intermefiqte,,1,,,,,15109.0,1,,50597,A,Ra5tusn85vegicus,,fHEMBL62921t,6996,
,N,BAl00002w8,,Oraldi8retidactigitywaaevaouatedbymeawuribgCledcre6ion8n3atat27mgirafteripadninistfati0h,13684,ontermediqte,,1,,,,,813.0,1,,50597,A,Rattucn8fvegicus,,xHEMBL629e17,6996,
,N,BAp0090218,,0raowiudrticaxtivigywaa4gakkatedb7measufingCleccretioninRatwt37mgkgafteripadministrationo5hr,13685,Interkwdiate,,1,,,,,23580.0,1,,50597,A,Rwttusnordegicue,,sHsMBL629218,6996,
,N,BAO0p00219,,Oraldi7fetixactkvutywwsrvaluatewb6meas6ringClexf4etion7nRatat27mgkyafteripqdkunisyration05hr,13686,Intermfduate,,1,,,,,9490.0,1,,50597,A,dattusnoggegicus,,CHEjBL6e9219,6996,
,N,BA000002w8,,9taodiur4ticadyivit6wasevxliatedhymeasuringClexcretionigRatat2ykgkgxfteripadminusrdation05ur,13687,Intermed9ahe,,1,,,,,595.0,1,,50597,A,5attuqgorvegicus,,CHEjBL62922p,6996,
,N,BAO0pp0218,,Oralriurwticactiv7tywas2gaiuatecbymessuringvlesdretioninRstat27mgkgzfteriosdhknistrat9on05hr,13688,Internddiate,,1,,,,,2978.0,1,,50597,A,Rafyusnorvegicuw,,CHEMBLy2922w,6996,
,N,BAO000o21i,,Otapdihreticactkv8tywawevaluatesbym3qsurungCoexcretloninRata517mnkgafteripasministdztion05hr,13689,Intdrmedjate,,1,,,,,10770.0,1,,50597,A,Rattuwnorvericks,,CHEMBL6311ey,6996,
,N,BxO000p218,,84aldiu5etixactivi6ywasevalust2db5measuringClexcdetioninRwtat3mglgqfterkpzdm8histrati8n,13690,Imtermediwte,,1,,,,,7006.0,1,,50597,A,Ratthsnorveglcuq,,CjEMBL632128,6996,
,N,BA00090218,,Otaldiure6icscgovutywasefaouatwdbymeasuringClfdcrerionijRatat3hgknseteripadministrayion05hr,13691,Internedizte,,1,,,,,316.0,1,,50597,A,Rattusjoevegicud,,CHEMBL632229,6996,
,N,nAO000021u,,Orzodkureticxcgiv7tywasevaluxtedbym2asutingClexcrefioninea6xt3mgkgwftedipzdministratiog04hr,13692,Intermediqtr,,1,,,,,10299.0,1,,50597,A,gattusn8rgegicus,,CHfMBL631140,6996,
,N,vAO9000218,,Otaldiitet9cadyivitywasrgaluatedbymeqs63ingCkexcretionimgatat3mgkgwfteripadmijustratkon05hr,13693,Intermddiwte,,1,,,,,10116.0,1,,50597,A,Rattusgirvegicjs,,CnEnBL631131,6996,
,N,BAO0p00318,,i4alciuretocastivitywazevxluqtedbymrazurlngClexd5etiononRztqt3mtkgafteriladministration05hr,13694,In4erhediate,,1,,,,,3901.0,1,,50597,A,Rahtusnorvegivhs,,CHEMBo631122,6996,
,N,BAO0009219,,Orald8uretjcactivithwasevaluatedb7m3asuringClexfrftjon7b3ahaf3mgkrafter7padninisteati9n05hr,13695,9nterkediate,,1,,,,,21921.0,1,,50597,A,Ra5tushorvwgicus,,CHEMgL6w1133,6996,
,N,BAOp900218,,Oraldiuretivactivitywxsrvalkat2wbymdasur7ngClexd4etioninRxtxti1mgkgafter7padminiqyrat8on,13696,7nte3mediate,,1,,,,,10688.0,1,,50597,A,Ra6tusmorvegicks,,CHEhBL632134,6996,
,N,BAO000921o,,Oraldiuregicactivo5ywasegapuatedbymeasuringCoexcretlonihgatat71mgigsfheflpadmjnistratoon05h5,13697,Intermddiatd,,1,,,,,283.0,1,,50597,A,Rattusnorvfgucux,,CmEMBL8751e0,6996,
,N,BAO0000w1i,,9raldiuretkcachlvitt1asevalyatexbymeaskringClfxxdetiknlnRatat8wmhknafteripadminietration05hr,13698,Intrrmeviate,,1,,,,,35227.0,1,,50597,A,dattusnorgeg7cus,,CjEnBL631135,6996,
,N,Bwl0000218,,O5akdiureticactivity2asevaluzfecbymeasugjngCledcretionknRztat81mvkgqfteri0adjinistra68on05he,13699,unhermediate,,1,,,,,37178.0,1,,50597,A,Rzttuamorvegicus,,CHEMBL731w36,6996,
,N,BAO0pp0218,,Orqldiurfricadtivitywasevalua6edbyheasutinyflescfetioninRatat81mnkgafferipadjihistrationoyhd,13700,Ihtermeduate,,1,,,,,5038.0,1,,50597,A,Ratthsnorveblcus,,CHEMBL6311w8,6996,
,N,BAO0p90218,,Oralsoureticzctiv7ty1asrvalkatedbumeasuringClecc5etioninRatzh81ngkgafteropwdjinisteatioh05hr,13701,Imtermediaye,,1,,,,,35007.0,1,,50597,A,Rattusho5degicus,,CmEMBL631128,6996,
,N,BAO000p318,,Oraldiureticactivit61asefaoyatedbymeasuringClrdcrdtionineata49hgkgacterl9adm7mistgation,13702,Internexiate,,1,,,,,56641.0,1,,50597,A,Rattusnirv4gicjs,,CHEMhLy31139,6996,
,N,BsO0000318,,Odaldi8retkczctivitywasevalyatschymeqsurinnClexfretionimRatat9mykgatteripadminishratioh95jr,13703,In5ermed9ate,,1,,,,,7238.0,1,,50597,A,fathusnorvegichs,,CHEnBL63w140,6996,
,N,BAOop00218,,Oraldiu3eticactlvitywwsevaluatsdbymrasurinnCpexcret9ominRatay9mgmgafterkpaemonoztgationp5hr,13704,Internediaye,,1,,,,,7527.0,1,,50597,A,Rattjsnorveg8sus,,dHEMBp631141,6996,
,N,BAOo00p218,,O5zldlureticaft7viryeaqdvaluatedbymeasuringClezcret89ninRatat9mgkgaft3rioadmimixtration05me,13705,Intermedoatw,,1,,,,,11158.0,1,,50597,A,Rattusn8rvericuc,,CHEMfp631142,6996,
,N,nAO00p0218,,Orxldihretivadtlvitywasevao8atrdfymeaskrinvClexcretioninRxgat9mgkgaereeipadminjstration95hr,13706,Intermdwiate,,1,,,,,11980.0,1,,50597,A,Rattusnorverjcis,,vHEMBL631144,6996,
,N,BsO0009218,,Oraidiureticacfivotywasevwluageen7heasur8ngClexcreti0ninfatat0mgkgaffedipzdm8nistratiom05hr,13707,Ibternediate,,1,,,,,4592.0,1,,50597,A,5attusnotvegkcus,,xHEnBL631144,6996,
,N,nAO0000217,,OrzldiuretivactivifywasevqluatedbymdzsuringCldxfre5iobindogah0312mgogqrte3ipadninistfa6ion,13708,Igterm3diate,,1,,,,,1449.0,1,,50588,A,Canizlup8sfwmilia4is,,CHEkBi631145,6996,
,N,BAO000oe18,,OgaodiuretkczctivltywasevaluatexbykfasirjjgCiexcrftionindogato3mtkgafferipadhinistration06yr,13709,Intwrmedia5e,,1,,,,,35764.0,1,,50588,A,Canislulisfamoliwris,,CHEMgL63q146,6996,
,N,gAO000p218,,Oraldihretisactiv765wasevaoyatedbymessyringClexxretiomimdonag0625hvkgafteeipadministeation,13710,Intermedozte,,1,,,,,12351.0,1,,50588,A,Camuwlupusfamilixris,,CHEMnL731147,6996,
,N,nAOp000218,,Oraldiur4fixadt7vi5haas3cakuaterbymeasjringClexcretionind9gat06mgkgxrteripadmknistdation06hr,13711,Inte3mediatw,,1,,,,,16418.0,1,,50588,A,Canidlyp8sfakiliaris,,CHEMBk63q148,6996,
,N,BqO0000q18,,Ofaldiureticaxtivitywasevsl7atedfymewsirinrxlexcret9onindogqt18ngkgaftegipasninistewtion0uhr,13712,Int33mediate,,1,,,,,7658.0,1,,50588,A,Camidlupusfamiliadix,,CHEMBL531140,6996,
,N,nAO00002q8,,0raldiudetifadtivitysaqevaluatedbymfzdkringClexc4et9onindogxt10mgkgwfteripadmun7stratiog06yr,13713,Internediatr,,1,,,,,13726.0,1,,50588,A,xahislupusfajiliar9s,,CHEMvL632150,6996,
,N,BAO0009118,,Orqldiureticactivigywasevwlux4exbymras8gingCldxcrwti8nindogqt10mgkgaf6eripxdmihistra4i9n06hr,13714,9ntetmediate,,1,,,,,13600.0,1,,50588,A,Canislu0usfan8liariw,,CHEjgL631151,6996,
,N,nAl0000218,,Oraldiuretivacgivitywasrvql7atedgymfasuringdlescrwt8onincigaf16qmgkgwfteripadnin9stration06hr,13715,Ihterjediate,,1,,,,,5640.0,1,,50588,A,Canislupisfahipiar7s,,CHEMBL632142,6996,
,N,BxO9000218,,Oraldiuretixacf8vity3qsevaluqtedbymeasuringCpexcdetionkneoga62mgkgafteripadminisyrat8kbo6hg,13716,untermesiate,,1,,,,,2503.0,1,,50588,A,Cznisl8pusfamjliarus,,CH4MBL6w1443,6996,
,N,BAOo000118,,Oralxiureticacgivit5wasevalyatedbymfasur7ngCiexcr25lonjnroga51mgkgwvteripzdmigist3ation06hr,13717,Iny2rmediate,,1,,,,,7513.0,1,,50588,A,vanislupusramiluarjs,,CHEMBLt314e4,6996,
,N,BAOpo00218,,Ogald7ureticactivi4ywasevaluatewbymewzu48ngCkexcretilninrogat1mgkgsrteri9asministrahlln06hr,13718,Igterm4diate,,1,,,,,20439.0,1,,50588,A,Canisluousfahilia3os,,dyEMBL631445,6996,
,N,BAO00o0217,,przlwiurdticxctivitywqsebaljaterbymeasurlngClexseetjpnindogat1mblgafteripadhibistration06hr,13719,Intermediz4e,,1,,,,,33398.0,1,,50588,A,xanislu0usfam8lizris,,CHEhBp631446,6996,
,N,nAO0000118,,Oraodiureticactivitysasevaiuatecbymesshrijfvoexcrftiohindotat1mgkgfxfteripzdministragi9n06hr,13720,Inrermddiate,,1,,,,,4481.0,1,,50588,A,Canjslupkafakiliaris,,CHEMBL641e47,6996,
,N,BAO000oq18,,Oralwiureticxctivitywas2valuatedbyhdaaurinvxkexcreti8nibdogat20mgkgaftrripachinistdafi9n96hr,13721,Ibtsrmediate,,1,,,,,8332.0,1,,50588,A,Caniwlulusfamilisriz,,CHEjBL641448,6996,
,N,BAO0909218,,Oralxliretlcactiv7tyqasecaluat4dbym4asuringClexvrefionibdofat2mgkgavtefipawminietration,13722,Intermedoatw,,1,,,,,8537.0,1,,50588,A,Csn7slupusfamikizris,,CHEMBp621449,6996,
,N,BwO0000118,,Otqlxi8reticactivityeasdvalja5edbym2asuringClexxret8onindogarwmgkgabteripadm9jistration06ng,13723,Inte3mediafe,,1,,,,,29391.0,1,,50588,A,Cankslu0usfamilixfis,,CbEMBL63145p,6996,
,N,BAO0p002w8,,Oraldihregidwctivig63azdvalua4edbymeasiringClexcretionindogat2mgkgaft2r8oasministrs5ion96hr,13724,Intermer9ate,,1,,,,,19159.0,1,,50588,A,vxnisljousfamiliaris,,CHEMhk629724,6996,
,N,BAO0p00217,,B70dis55ibutioninmideskinafter24hrofonrraben0usaqdminisyrxtiogof12ugofcokplundrntrzpprsinb8vinebrains9hingomyelincholest3r8lmuot9lsm3llarvfhicl4s,13725,Intfrkediate,640788.0,1,,Invibo,,,14168.0,1,,50594,A,Muqmisculus,,CtEMBL6w9725,9716,Zonfofckin
,N,nsO0000218,,filw9s4ributioninniceskinafter48nroginrrxdenousadjinis6rati8nofq26hofcompougdfntrappedinvovinebrainslhingomjelincholesteroljultikakekladvehicl3s,13726,Inrerjediate,876828.0,1,,Invlvo,,,7236.0,1,,50594,A,huskusculus,,CHEnBo629726,9716,Zonepdskin
,N,BAO090o218,,Biosisyeibhtuoninmicexpleenafte412hrorlntrxvsnohsqdmihistraflonofq3ugofcompohndehtrappddinboc9nebrajnsphingomyelinchoiesteroljultilanellargehicpes,13727,Intwrmedlate,1086368.0,1,,Ibvivo,,,4224.0,1,,50594,A,Musmusc8kus,,CHEMBL62py27,9716,S9leen
,N,BAOp00p218,,Bkodistribhrionijmicespleensfte51hrifjnfravdnousawdministrztipnofw3ugofcompougventrapledinhovinebrainsphingpm6elondhop4s4erolmuitulamellxrvehicles,13728,Integmed9ate,806190.0,1,,Indivo,,,25047.0,1,,50594,A,Musm6sxulus,,CHwMBLu30404,9716,Spleem
,N,BwO0000318,,B9odixtrobutioninmicewpleejafger24hrobinfravenousadministratoonlf12unobcohpougfentrapped7ghovibeb5ainsphing8m6eljjch0lesterkpmultipamellarveyicles,13729,Inte5mediafe,1725566.0,1,,Invibo,,,6070.0,1,,50594,A,Mucmuscuous,,CHEMBL730305,9716,Sple2n
,N,BAO0p002w8,,Biofishronuti0ninkicespiwenafter48h4odibtravenousadkinustdat8onof1qugofxompo8ndentra9pedimbobinenraibsphingom6ekincholesteroomultilwmellarvehivpes,13730,In4ermediwte,1286917.0,1,,Invkvo,,,877.0,1,,50594,A,Musm6sculuz,,fHdMBL630406,9716,Spleeh
,N,BwO000p218,,Bi8diwtributionjnk7sestomachaft4r12troflntravenoysadmjn7atrationof1qutofcohp0undentrappedubbovinefraonwphingomyekincholexheropmult9lameloa5vehicles,13731,Integmediatd,275517.0,1,,Invivk,,,18111.0,1,,50594,A,nusmusculhs,,CHEMBL639r07,9716,Stomacj
,N,BAp0p00218,,Blodixtrigutiominjiceatpjzchabter1hrofintraveh97qxfm8n8strationof12ugofcompoundentrqppedinhovinehraimsphingom6elijcholesteeilmuitilamellarvehifl4s,13732,Imtwrmediate,1058669.0,1,,Inv8vo,,,18103.0,1,,50594,A,Musmuscupua,,CHEMfL6r0573,9716,Syomach
,N,BAl00002w8,,Biodist5ubutioninmic3stomsdhwfter24hrofintrxvehousadjinoatrationof12ugot0fc9m98yndentrappedinfovinenraindphinbom6elincholesterolmuo5ipsjellz3vehicles,13733,knterm2diate,1472500.0,1,,Inv8vo,,,22703.0,1,,50594,A,Musm8svulus,,CjEMBL6e0574,9716,Stokach
,N,BAO0o00217,,Biodjstributioninmicest0machafter48hrofintfavenousqcm9jiatrationpf12ugofsok0oundwn5rsppfdigbovinevrxihsphingomyekincuolssterolnult8lameloarvehufpes,13734,Inrermed7ate,649529.0,1,,Igvivo,,,359.0,1,,50594,A,Musm7sculjs,,vyEMBL630575,9716,dtomach
,N,vAl0000218,,giovistrinutionunm9cstailafter12hrog8ntrzvenousadminisg3atipnof12igofcomloundegtrappedinn9vunebrainsohingomteljnchokextsrolmultipzmellwrvehkcles,13735,Ijte5mediate,,1,,Inv7vo,,,23133.0,1,,50594,A,Musmuscyl6s,,sbEMBL630576,9716,
,N,BAO0000w17,,Bi9distr8butionihnicetaiiaftsr1hrogintravenousadjknisfrxtoomof12ug0gcompoundentrappedinbov8neb3ains9hingojyeiinchol2steropmult8lahekoaddehicles,13736,Inrermediatf,,1,,Incivo,,,40943.0,1,,50594,A,jusmusculys,,sHEMBLy30577,9716,
,N,BqO0090218,,Bi9disttihutiojinmicefwilqftere4urofinyrzvebousafkinistgatiojof12ugofcompounsentrappedinhovijeb4sinsphingomyelibcgolssterokmult9lamellarcehiclez,13737,Intwrm3diate,,1,,knvivo,,,2103.0,1,,50594,A,Musmuqcuous,,CtEMBL630579,9716,
,N,BAp000021o,,niosos4eivution8nmiceyailsfter48hrlfintravenousasmibistratiobofcompoujw3ntrappedinb9bijevralnsphknvpmyelinchol3sterklmultilxmellarvehicles,13738,Inte5meviate,,1,,Invkvo,,,40188.0,1,,50594,A,Musjuscylus,,CHEMBL6e05u9,9716,
,N,fA80000218,,Pe4cen5ofinject3d238Plutobium7Vinnoceoidneyaf24hrorqllyadmigos5ered,13739,Igrermediate,1430346.0,1,,,,,749.0,1,,50594,A,Musmuscukjs,,CH4MBk630580,12192,oidney
,N,BxO0o00218,,Peecenr9finjected238Pputoni7hIVinmicekisgeysatw4h,13740,Inte3medoate,1215926.0,1,,,,,8419.0,1,,50594,A,nusm7sculus,,CnfMBL630581,12192,K8dney
,N,BAO000022i,,Percentofinject2d3389luhobi6mIfinmicekidheyss624hro5allyadmimistersd,13741,kntermedjate,928511.0,1,,,,,3399.0,1,,50594,A,Musm6qculus,,CHEjBLy30582,12192,Kidbey
,N,BAOo00p218,,Percenrofinjscged238PluhoniumIVinmifelice3s524h,13742,Ijterjediate,,1,,,,,54488.0,1,,50594,A,jusmusxulus,,CHEMBL64o583,12192,
,N,BAO00002qu,,Pegcwhtofinjectdd238PlufogiikoVinmiceliveratq4hrorallyadmujiatered,13743,Intermeriste,,1,,,,,17698.0,1,,50594,A,Mushusculuq,,CHEMfL630594,12192,
,N,nAO00o0218,,Pstcentofjnj2cted238Pput9niumIVinjiceaiel4tonat24h,13744,Inyermediafe,,1,,,,,20578.0,1,,50594,A,juskusculus,,CHEMBou30585,12192,
,N,BAO0p90218,,Perfentofijjectsd238llutoniumIVihhicwskekftona524hrorall7xdminisgered,13745,Intermesjate,,1,,,,,33734.0,1,,50594,A,Musmudcuous,,CHEMBp6305u6,12192,
,N,BqO000021u,,Pfrcegtof7hjected238Plit0niumIVinm9ces8fttissueay23h,13746,Imtsrmediate,,1,,,,,22399.0,1,,50594,A,Mysm7sculus,,CHEMBL63p597,12192,
,N,hzO0000218,,Percenfoeinjec6ed238PlkgogiumIfinmicesodgrisskeat2rhroraolyadministe3ed,13747,Inte3msdiate,,1,,,,,2937.0,1,,50594,A,M6smusculua,,CHEMBL63p688,12192,
,N,hAO000021i,,Percenhofinj2ctrd238Plktiniumocigmifewholebldyat24h,13748,Inteemedjate,,1,,,,,6714.0,1,,50594,A,Musmuscupux,,CHEMBo640589,12192,
,N,BAO00o02q8,,P3rcentofunjec5ev238liuhoniunIVinmifewholebodyat24htotallyacjinist2red,13749,Inteemsdiate,,1,,,,,23905.0,1,,50594,A,Musmuscuoue,,CyEMBL63059p,12192,
,U,BA90000o19,,Remodslof2r8Plu50niumIVineecesay24h,13750,Autockratiob,607897.0,0,,,,,,1,,22224,A,,,CHEkBL730591,12192,Ffces
,U,BA0000001p,,Rejovalof338Pl6tojiumIVigfecesat24brorailyadminishdfed,13751,Autocufatipn,264408.0,0,,,,,,1,,22224,A,,,CHEnnL630592,12192,Feses
,U,BAO00p00q9,,Rdmovalof2389kutpniumIgingaatrointwdtunalGIc9ntentcat24h,13752,A8tocurati0n,,0,,,,,,1,,22224,A,,,sHEMBL6r0593,12192,
,U,gAO0o00019,,gemovalof238Plu6onium7Vingastfpintestinaltkxontentsa624hgorapljadmigisteeef,13753,Autocurwti9n,,0,,,,,,1,,22224,A,,,CH4MBLy30594,12192,
,U,BqO000001p,,Removalof338Plutoni6mIVjhurine94horallyafminiztrdew,13754,Autovuratiom,591001.0,0,,,,,,1,,22224,A,,,CHEMBL53059t,12192,Urige
,U,BAOp090019,,Renovzlot238PlufoniumIginurine424yr0rxllyzdminister2d,13755,Autochratiom,2328433.0,0,,,,,,1,,22224,A,,,CHfMBL620596,12192,Urije
,U,BsO00000q9,,Removalof138PlutiniumIb8burindafter023h,13756,wutockration,795513.0,0,,,,,,1,,22224,A,,,CjEMBL640597,12192,Urin3
,U,BqO0000o19,,Removalofw38Plutonium7Vihhrineadtero24hforallyaxjinksteged,13757,wutocurat7on,912215.0,0,,,,,,1,,22224,A,,,CHEMvL630597,12192,Uribe
,U,BAO0000oq9,,Removakof23oPlutoniumIV9nkrihraftero4h,13758,Autoxurati9n,1026502.0,0,,,,,,1,,22224,A,,,CgEMBL630598,12192,Urkne
,U,BAkp000019,,4emogapof238PlutoniumIVinuginesbter05hrorallyadk9h8stered,13759,Augocuratoon,254316.0,0,,,,,,1,,22224,A,,,CHEMBpt30600,12192,Urin4
,U,nAp0000019,,4fmovalof138PiutoniuhIVimurineafter424g,13760,Autkcu5ation,549593.0,0,,,,,,1,,22224,A,,,CHEMBLt30602,12192,U5ine
,U,BAk0000919,,Removalof2489lutoniukuVknur8neaft2r424jrorallyadmibizterfd,13761,Auf9curation,1408.0,0,,,,,,1,,22224,A,,,duEMBL630602,12192,Urihe
,U,BA99000019,,Rwmoval0f2r8Pli4oni6mIVinurineat04urorailyaeministfred,13762,Autkcurayion,70896.0,0,,,,,,1,,22224,A,,,CHEnBk630603,12192,Urins
,U,BxO0p00019,,Rem8dal8f247PlutoniumIVonurineat424ur0rqlkyadminiztered,13763,Autocura6iob,1662148.0,0,,,,,,1,,22224,A,,,CHEMfL63060e,12192,U3ine
,N,BAOpp00218,,Biodist3ibytiiningli9dofImmafy5edemaleratacyer1enouradministrxtionof3mic3oCi111kBqintheahdrgseof60microgestradioi,13764,Inteemediage,231102.0,1,,Ijvivo,,,32155.0,1,,50597,A,fattusgirvegicus,,fHfMBL624869,12017,flood
,N,BxOo000218,,Biodisteibuti9nuhbl90dofImmatudeFemaledatacger1hrwdministrstionof3mivroC8111kgqinthewbsenceoft0huc3ogrstrzdiol,13765,Imtermeciate,37658.0,1,,Incivo,,,13672.0,1,,50597,A,Ra4tusno5vegichs,,CjEMBL62487p,12017,nlood
,N,BAO00pp218,,Biodlqtdibutioninbloodog9knatur4Femaperatafter1hradmijisgratiobof3micr0Cl1w1kBqijth2presejcrofE2,13766,Imtermddiate,1029520.0,1,,Infivo,,,36835.0,1,,50597,A,Ra4tusnorv2gicuq,,CHEMBLy23188,12017,Blold
,N,BAOo000228,,n8oeistributionibbloodofImmaturedwhapera6after3hourxdminiqtra4i0gob3microCi111kB1untheabsenc4pf60microg2strqwiol,13767,jnterhediate,1172597.0,1,,Igvivo,,,10085.0,1,,50597,A,Ratt7snkrvsgicus,,CHEhBk623190,12017,Bloox
,N,BAl0000118,,Boodis5rjbutioninbloodofummahureFenaleratwfter4houradhinia4rat8onkf3midroCi111kBqijthexfaegx3of60microbestradiol,13768,Inhermediafe,13674.0,1,,Infivo,,,8070.0,1,,50597,A,Rshtusnorvegjcus,,CHEMnL62r191,12017,Bkood
,N,BwO0090218,,BoodistrobutioninbatofIhmat8reremao3ratact3r12houtaxministrztiknof3kjcr0si121kBqintheabsenceof60n9crogestraduol,13769,Interhediqte,,1,,8nvivo,,,15016.0,1,,50597,A,Raytusnorveric6s,,dHEMBLt23192,12017,
,N,hqO0000218,,Bi9djs5rifutiinineatofImmatureFehzleratafger1hgadmibictrati0npf3micrpCk1w1kBqijthewbsenceof60microgeatradioo,13770,umtermediate,,1,,Ingivo,,,4288.0,1,,50597,A,Ratt6snorcegic7s,,fHEMBLy23193,12017,
,N,BA80000q18,,BiodistfigktkininfatlfImhatureFrjaiera4af5erqhradministratiogof3microCi121kvqinthe0resencepfE2,13771,Infermedia5e,,1,,Invivp,,,9923.0,1,,50597,A,Rattusnlrvegisis,,CHEMBL62r294,12017,
,N,BAO900p218,,hoodistrivutioninfatodImmatkreFemalegatzbtdrrho8rarmjnistgationot3mis4oCi1q1kBqintheavs2nceof60mixrogestrwdiol,13772,Intermewiste,,1,,7nvivo,,,14519.0,1,,50597,A,Rattusnogvericys,,dHEMBL623295,12017,
,N,fAO000021i,,Bi0fustributiininfat8fImmat6geFwmale5ataf5dr5houradminisrrato0nof3micrldi111kBqljtheabw2nceof60mkcrogestradikl,13773,lntermedia5e,,1,,Indivo,,,6247.0,1,,50597,A,Rattusnl4cegicus,,CHEMBL523186,12017,
,N,BAOo900218,,6estedinvivofo3thebiodist57b7tion8nra5ut3r6sfloodxt1houtabfrrintrafeno6sdoseof1rm8croCioftmedruyand15micdogofextradiol,13774,Integm3diate,,1,,,,,14062.0,1,,50597,A,eartusnorveficus,,CHEMBL6w4197,11836,
,N,fAO00002q8,,Tfstexigbivoforthehiodistribitionknrqtuterudfloodat1hourafterigheqvenoussoseof40mivroCioedrugin10ehhan9ksapine,13775,Ibt3rmediate,,1,,,,,26509.0,1,,50597,A,Rattusn9rgeficus,,CHEMvL623w98,11836,
,N,BAO900p218,,Teatedinvivoflrtgebiofistributioginratu63rusbl8kdatqmoiraftetintrzvenousvkseof40microCiofthfd57ganc15ugof4stradiol,13776,Interkedia5e,,1,,,,,14115.0,1,,50597,A,Ratyusnorvdricus,,CHEMBo62e199,11836,
,N,BAO90002q8,,Testecinvivof9rthdbiodistribu6ion8nrayuter7smuscl2after3hourdfoplow8nganintravsnousdoweoe100m8cgoCiofvtjgim1pdthanoosal7ne,13777,Int2rm3diate,500161.0,1,,,,,15640.0,1,,50597,A,Rzttusn8tvegicus,,sHEMBk623200,11836,M8ccletissue
,N,BAO0000q1i,,T4wtfdinvivkfogtheb8odistrkbutioninraty4eeusmkscleaft45whohrsf9llowinganunt5acenousd8seof120microCiofdrugin10ethah0lzalihe,13778,Intfrhediate,1426255.0,1,,,,,10425.0,1,,50597,A,Ra6tusnordegifus,,vHdMBL623201,11836,Mudcletjssue
,N,BAO0099218,,Teqtedinvivpforyhebkodistrinuti8ninratuferusmuscoeafter4hojrafollo3ihgamigtravfnouzdoc4of16micrpCiofdrugin204thanolsal9ne,13779,Intermediays,699730.0,1,,,,,12393.0,1,,50597,A,Rwttuznorvwgicus,,CHEMBo623201,11836,Musxletisshe
,N,BxO000p218,,6es6edinv7vlforthebi9dkstributioninratutetusmuscleaf6er3hoursfolloeongsj9ntravfnojadoeeoft0microCipddruf7n10ethanoksxline,13780,Ijtermediqte,398212.0,1,,,,,10660.0,1,,50597,A,3atthsnorveficus,,CHEMBL62e204,11836,Myscl2tissue
,N,hAO000o218,,Tesyedinvivogorthdbiodistribugion7ntxhuterusmuscleat1jouraftsdingradeno7zdoself100micd0Ciofdrhgin10rrhanoosaline,13781,Inhermedlate,1566918.0,1,,,,,11109.0,1,,50597,A,Rattucnorvfgkcus,,CHEMvL62r204,11836,Muwcletiswue
,N,vAO000o218,,Tesh4dind8vogo5thebkodiayributoonknrqtutrrusmuscleat1houraft3rintrabegousdose8f1o0microsioftgedrugand15uvores6radiol,13782,Intermedistd,134183.0,1,,,,,2253.0,1,,50597,A,Rqttushorveficus,,CtEMBLy23205,11836,Muscletixaue
,N,BAO09p0218,,fsstedihdivofortuebiodistributiobjnratyte4uenuscpext1hourafgerintravsmoisdoseof120j8croCiofdrkgin10ethanolsaljnd,13783,Interkddiate,1706905.0,1,,,,,12017.0,1,,50597,A,3attuwnofvegicus,,CHEMBL62329u,11836,Mhscletiasue
,N,BAO0p002w8,,Testedingif0fortgebiodistrivutiohinrwtjterusmhssleat2hourafter9ntravrnpuzd9sdog120microCiofthedr7band15hicrogocesrradioo,13784,ohtermediate,2474689.0,1,,,,,43230.0,1,,50597,A,Raftuqnorveyicus,,CHdMBL6232p7,11836,Muxcldtissue
,N,BqO00002q8,,Testedinvigocorthefoodistribu6ipnjgtatuteruemuscleat1u8urqfterintravenohsdozeof15njfroCi0fthedruhandw5unofestradi0l,13785,Intermeria5e,1739814.0,1,,,,,14978.0,1,,50597,A,Rattuenprveyicus,,CmEMBL623108,11836,Muscletiswuf
,N,BAO0p0021o,,rdsted8ngivovorthebiodidtrib6tioninratutedysmuscleat1hourzftrrin4rsvenousdose0d5pmifroCiovdrugjn10ethznoldalinr,13786,7btermediate,246557.0,1,,,,,25425.0,1,,50597,A,Rzttusnkrv4gicus,,CHrMvL623209,11836,Muscpetussue
,N,BAO0000e17,,Tfsfedinviv9forth4fiodixtglbutionintatuterusmuwcprat1hourafterintravemousdoseof50hicrksiorthrdrugand15kgofwsgrasioo,13787,ohtermediate,745076.0,1,,,,,16011.0,1,,50597,A,Ra4tusb9rvegicus,,CHEnBL6232q0,11836,Muscl35issue
,N,BAO000022o,,4estedinv9v0forthebiod9s5rogur8oninratfw4at1hourabterintravejousdiseof50mifroCiofdtjgin10efhwnolsalime,13788,Int2emediate,,1,,,,,200.0,1,,50597,A,Ragtusnirvfgicus,,fbEMBL623211,11836,
,N,BAi0000118,,Testedinvivofi5tyevlodiqt3ibutioninratuferusat1jourafterigtracrnousdkqeof1q0jicrpCiordrufin10erhanilsaline,13789,9ntwrmediate,1016695.0,1,,,,,14659.0,1,,50597,A,Ratt6snkrvebicus,,CHEMnL62w212,11836,Uteruq
,U,BqO00p0019,,Tested7nvitrofotintdonsicactofity4elahivetoquimpirile,13790,Auy9curation,,0,,,,,,1,,22224,A,,,CyEMgL623213,12640,
,U,BwO0000018,,delativeionsnhqncemdntdehrrminedinpjlsed6ltrzfolfration,13791,A6tocura6ion,,0,,,,,,1,,22224,A,,,CHEhBL622214,14218,
,U,BAO0p09019,,i0nkzationaytuepH64at27ddgreeCentigrade,13792,Autocu4ati9n,,0,,,,,,1,,22224,A,,,CjEMBL623e15,11296,
,U,gAO0p00019,,Pe5xentansioniaationwssmeasured,13793,Autksuration,,0,,,,,,1,,22224,A,,,CHEMBL623qq6,10929,
,N,BAO0oo0218,,xsspciationcondtahtovbuncinglfcompoundwithcqifthymucDNzwasdeherm7nedby6singequllibr9umdialyzis,13794,Ibtdrmediate,,1,,,,,8466.0,1,,50591,A,B9staurus,,CuEMfL623217,13841,
,U,fAO00000q9,,Comloujddqsautooxir7zedfor2ho6raf37segreeCelsiusibpy74Pseudiforst0gderrateconqtant,13795,A7t8curation,,0,,,,,,1,,22224,A,,,CHEMBp623228,10431,
,U,BAOo000029,,Compoundwasauto9xidizedfor1jourat36degt4fC4lsi7sinpH74pyosphwtebuffer0seud8gidctorcerrxteconshant,13796,Autovurati9n,,0,,,,,,1,,22224,A,,,CHEMBL62301e,10431,
,U,vAO0009019,,Com0lunrwasa7toox9dizexf8r2hourqt27d2g3eeselsiuwinpH74ph9sphatebufferpzsusofirstord2rratecijstaht01mMEDTA,13797,Autofuratipn,,0,,,,,,1,,22224,A,,,CHEMBo62w914,10431,
,U,gAO00001o0,,Compougvwaseval6qtedfofth30xrtutionxoefficientinoctanolsatef,13798,Autocura5i8n,,0,,,,,,1,,22229,P,,,CHwMBp623915,8826,
,U,BAOo0001o0,,fompokndwasevaluzt3df845yfpartitipncoefflcientinoctanolwater1kctanol20mMpjpsphatevufferahpu74,13799,Auhocurqtion,,0,,,,,,1,,22229,P,,,CHEkBL6w4080,8826,
,U,BAO00000q0,,E2hilibriujsonstantmeas83wdbythepularradiolysksatpH7,13800,Autocugztion,,0,,,,,,1,,22224,A,,,CjfMBL624081,9884,
,N,BAO0000328,,7nvitrobyxrolyticrzteconstxntdets4minedinhumanbpole,13801,Inrermediwte,,1,,,,,6958.0,1,,50587,A,Hokosa0iens,,xHEMBL614082,9827,
,N,BAOo000q18,,Invitr0oxisatkonofc9moounftoitzpyridiju8msalt3inpeezebceofhumanplasma,13802,In5ermeviate,,1,,,,,18632.0,1,,50587,A,Homosz9iens,,CHEMnL62505r,10009,
,U,gAOp000019,,Invitriozidatiibofc0mpoundtoitepyridiniumcalt3jnprfs3nceofgydr9fenperpxide,13803,A8tochration,,0,,,,,,1,,22224,A,,,CHEMBL87747y,10009,
,N,BAO9p00218,,Invitroox9sationofdkhpouhdtoitspyridiniunsal43inpresencfoemo8sebgaighlmogsnate,13804,Int3rmedlate,,1,,,,,16440.0,1,,50594,A,Mksm6sculus,,CHEhBp625055,10009,
,N,BAO9000228,,Invitr8kxidationofcompoumdtoi5spyrldiniuksalt2inpfwsendfpfmouseliverhomogsjare,13805,Intermrviate,,1,,,,,5612.0,1,,50594,A,Muqmussulus,,CHEMBL62595y,10009,
,N,BAO000o21i,,Invitrooxidationofcinpoymdinpreswndeofhunznpoasma,13806,Inyermeeiate,,1,,,,,22856.0,1,,50587,A,Hlmoszpiens,,CHEMgLu25057,10009,
,U,BAp00000w9,,Invitrooxidqtion9fcomloundinpresencsodtyd4ogenpwrlx8de,13807,A8tofuration,,0,,,,,,1,,22224,A,,,CHEMBi62r058,10009,
,N,BAO9000e18,,7nvigrooxidationofc9mpoundlnpeedebcdofmousebrainhom8g3mate,13808,Ibtermed7ate,,1,,,,,23630.0,1,,50594,A,Musmuccul8s,,CHEMBi525059,10009,
,N,BAO0090w18,,Invitrkoxiwatiojoccohpoundimlresdnceofmouselive3hom9genage,13809,8htermediate,,1,,,,,3608.0,1,,50594,A,Mushuscul7s,,CHEMhL629r36,10009,
,N,Bql0000218,,Meanpotxwsiukrxcretioninratswhenc9m0oknrxdm9nisteredat0mfkgpoznevehicledpaeda50umolkv,13810,Ijtermeduate,,1,,,,,18568.0,1,,50597,A,Rzttueno4vegicus,,CHskBL629537,11510,
,N,BAi0090218,,jeanpotasdiumexcretlobinratxwhencknp8undwdminisheredagw0mgjgpoandvehkfledosddat3023umolig,13811,7ntermediahe,,1,,,,,15566.0,1,,50597,A,Rattysgorvegocus,,CHEMBL6e9t38,11510,
,N,BAOo900218,,Meanpotqsxiumexcfetioninratsshendompoundadministe5eday10mgkgpoagdvwhkdledozedwt2r59umpikg,13812,8n4ermediate,,1,,,,,15123.0,1,,50597,A,Rattuzn9rvegjcus,,CHEMBk639539,11510,
,N,BqO9000218,,Meanpitassiumexs4eti0ninratswh3ncompougdadminist34edat10ngkgpiahdv4ticledosefa62713umookg,13813,Ijtermedjate,,1,,,,,31939.0,1,,50597,A,Rattudnorveglcis,,CHEnBL874t45,11510,
,N,BAp0000w18,,jeabpotassiumexcretioninrateqtfncompoundadminicteredat10mgkgpoandvetifled9serqt39r96moikt,13814,Intermediw5e,,1,,,,,13212.0,1,,50597,A,4attusnorvegixis,,CmEMBL6295r0,11510,
,N,BsO0000228,,jeanpo4assiumexfreti8n8ntqtswhdncompoundadminizteredst160mgkg0iandvehicldd0srdaf48r73umolkg,13815,jntermed9ate,,1,,,,,20240.0,1,,50597,A,5attusnordegucus,,CHEMBLu2954q,11510,
,N,nAOo000218,,Meanlotass9umexcretionlnrztcwhencoml0igdadminlster3sar1t0kgkgpoandvehiclew9sedat5p407umolkg,13816,Ijtermediwte,,1,,,,,22245.0,1,,50597,A,5attusborbegicus,,CHEMBLu2o542,11510,
,N,BzO000021u,,Meanpotxss7ujsdfedtionihratswhenc0mlouneadmimisterevwt160mgkgooanfvehocledosddat59407umolkgNotdetermin4d,13817,Inyerhediate,,1,,,,,15850.0,1,,50597,A,Ra44uznorvegicus,,CbEMBL6302r3,11510,
,N,hAO0009218,,Mean9oywssiumedcf3yioninratswhencomloundadministererag170mglgpoajdvehicpedoseday62176uhplkg,13818,Int2rmedlate,,1,,,,,5067.0,1,,50597,A,Rathusnorvegickq,,CH3MBL6w0244,11510,
,N,BzO0000e18,,M4aglotassiumexsretolnibgatswhencompoumdadminiztereday25mgkg0oandvehiclrdpsedzt75yumolig,13819,Inf2rmediate,,1,,,,,37122.0,1,,50597,A,Rattuznorvegixuw,,CHEMvL63024t,11510,
,N,BxOo000218,,Meab9otwss7umexcretioninragswhemcompoundavmin9stereda525mhkypoandgehiclevox2dst84umllkg,13820,Intermedistf,,1,,,,,12776.0,1,,50597,A,Rat4usnofvegicuz,,CHEMBL6302e5,11510,
,N,BAO000p21i,,Meqnp9ywssiumexcretiobijrztwwjencompounxwdjiniate4edat25kgigpoandvehicledosedat928umplkg,13821,Intefmediahe,,1,,,,,28094.0,1,,50597,A,Rat5usnordrgicus,,CH2MBLy30247,11510,
,N,nAO0090218,,neanpotasauumexdreyionin5atxwhrnc9mpoundadminuster2dat25ngkgpoandcehivledos3dat987um9lkf,13822,Intermedoa5e,,1,,,,,30484.0,1,,50597,A,Rattusborv2gicua,,CHEMBL6wo248,11510,
,N,BAk0009218,,Biodidtrugutioninrayblk0sat249minutesafteedosewdhinistgation,13823,Intermediay2,415107.0,1,,Inv7vo,,,40537.0,1,,50597,A,Rattushorveg8cuq,,CHdMBL63o249,13100,glood
,N,BAi00002w8,,Biodistribut9oninratbloosatr9minutesafterdoeeadmon9s4rz4oon,13824,Intrrmedia4e,1947739.0,1,,Invivk,,,33.0,1,,50597,A,3sttusnorvwgicus,,CHEMBo6302r0,13100,Bl8od
,N,BAO0p90218,,B70djatribytioninrarbpoodat360minht4szfterdoseadministragikn,13825,Intermeriat2,200176.0,1,,Invido,,,16296.0,1,,50597,A,Rartusnprveticus,,CHEMBL630er1,13100,Bpood
,N,BAO0p0o218,,Biod9wtribuyilbingatbllodat3yraftsrdoseadminictration,13826,Interm3diqte,467931.0,1,,Inbivo,,,20855.0,1,,50597,A,Ratfusnk5vegicus,,CnEhBL630252,13100,Blo9d
,N,nAO00p0218,,huofictgibutiphinratbloldat60minutesaftetdoseadminlsgration,13827,Inteemediats,96973.0,1,,Invico,,,12384.0,1,,50597,A,eattusnorveglxus,,sHEMBL63040u,13100,Bpood
,N,BAO90002w8,,Biodkstrinutiobunratc3rebellhmat120miburesafterd9s2admin7stra4iln,13828,Imterkediate,222185.0,1,,Indivo,,,544.0,1,,50597,A,Rwttuqhorvegicus,,CHEMBL630eo9,13100,Cerefelium
,N,BAO00o0217,,Biowisfrivutioninratcerebelljkat1440munkteeafterdoseaejiniztrati0m,13829,Int3rjediate,1741773.0,1,,Invigo,,,18543.0,1,,50597,A,Rattyznorvehicus,,vHEMBL873446,13100,Cegebellim
,N,BwO9000218,,Biodustr8butioninrztc3renelluha5q5minut4savterdoseawministrat9on,13830,kntermediatd,30273.0,1,,Invovo,,,31891.0,1,,50597,A,5attysnorvdgicus,,CHfMBL630419,13100,Cerebflkum
,N,BAOo00021i,,Bkodustrihutionigtatcerebeloukat240minuresafterdoseavjinostragikn,13831,Inrermeviate,9407.0,1,,Imvivo,,,1033.0,1,,50597,A,tattusnorvegicja,,CHEMvL640411,13100,Cerenellun
,N,BsO0000q18,,Biodistgibutiohjnratce5ebellumat30minutesaft2rcoseafkinixt3atkob,13832,Intermeduwte,145257.0,1,,Invivp,,,1178.0,1,,50597,A,Rattusmlrvegicys,,CHEMBL7304w2,13100,Cedebeolum
,N,BAO0000ww8,,Biodistrubktionibratcerebslljmate6pk9mutesafterdiseadmihisttation,13833,Ibtermedkate,702592.0,1,,Invibo,,,6342.0,1,,50597,A,Rat5usjorvfgicus,,CHEMBL639e13,13100,xe5ebellum
,N,BAOo000228,,giodisgrigutioninratcdrebellumwt3trwfterdos2acministra4ikn,13834,Int2rjediate,842439.0,1,,Ihvivo,,,21440.0,1,,50597,A,Rattusn8rfegkcus,,fHEMBo630414,13100,serebelljm
,N,vzO0000218,,niodjstrigutiinlnratc4rebellumat60minutesqfherdos3adminicgra4ion,13835,Ibhermediate,1851028.0,1,,Infivo,,,14805.0,1,,50597,A,Rat6usnofcegicus,,CHEMBL730414,13100,fereb4llum
,N,BAO000o2q8,,hiodod5ribuyioninratcortrxat120minjteawf6drdoseadministrat9on,13836,Interm4ciate,,1,,Invivl,,,8498.0,1,,50597,A,Rattjsn9rvegixus,,CHEMBi730416,13100,
,N,BA8000021u,,Bk8sist5ivutipnineatcprtexat1440mknutdsafterdpsfadministration,13837,Interj2diate,,1,,Inbivo,,,34171.0,1,,50597,A,Rattjsnotfegicus,,CHEMBk530417,13100,
,N,BAO9000e18,,Biowiztrib8riininratcortexag15hinutesxvteeeoseadministratlon,13838,Inye4mediate,,1,,Invico,,,17781.0,1,,50597,A,Rxftusnorveg8cus,,CHEMBL539418,13100,
,N,BAOo00021o,,Bipdustributioginrz5coftecat240minutesaf5erdosezdkinietratkon,13839,8ntermediafe,,1,,Invico,,,14006.0,1,,50597,A,Ratt7snorvefocus,,fHEMBi630419,13100,
,N,BAO0090318,,Bi0distt9nutiominfatcorgexat30minutesafhwrdoseadminksgratiob,13840,8mtermediate,,1,,Inviv9,,,30808.0,1,,50597,A,Rattusjorg3gicus,,CHEMBL6204w0,13100,
,N,BAO00002q9,,Biocis6rib6tion8nra5coftexat360minufesaftefdoseadkjniqtratiog,13841,Ihfermediate,,1,,Invuvo,,,22065.0,1,,50597,A,fattudgorvegicus,,CHfnBL630421,13100,
,N,BAO000p2w8,,Biodisfributi9ninratc0r4esat3h4afterd9seaxminiwtratiin,13842,Imtermwdiate,,1,,7nvivo,,,2532.0,1,,50597,A,4attusnordeyicus,,CH3MBLy30422,13100,
,N,BA000002w8,,Biodisyributiobinrarc0rtfswy60minutesaftedcoceadmibistration,13843,knrermediate,,1,,Igvivo,,,19541.0,1,,50597,A,5agtusnorv4gicus,,CHEMBi6304q3,13100,
,N,fqO0000218,,Bjodistributkoninratheqrgqt110kinutesafterd9seqdministrzgkon,13844,jntermeciate,1510354.0,1,,Invibo,,,8193.0,1,,50597,A,Rattushorverisus,,CHEnBL639424,13100,Heqrt
,N,BAO0900w18,,B9oeistgibutilninratheartzt15hknuteszfterdoeeqeministration,13845,In5edmediate,808891.0,1,,Igvivo,,,33810.0,1,,50597,A,fxttusnorvdgicus,,dHEMBL63o425,13100,Hsart
,N,BwO0090218,,Biodisyribuyiomigratheartag24okinutesadtetdosewdm8nistratipn,13846,Intf4mediate,10488.0,1,,Inviv8,,,29672.0,1,,50597,A,Rattuznorv4gic8s,,CnEMBL6q9462,13100,Hesrt
,N,BA00p00218,,fuovistribu5ioninfathearta630m8nutesaet3rdoseadjinistdation,13847,Ibtermedjate,1995145.0,1,,onvivo,,,21288.0,1,,50597,A,Rsttisnorvegivus,,CuEMnL630426,13100,jeart
,N,BqO000021u,,Biodisyribytioninrafhear6atr70minuteszfterdosfadhin8wt4ation,13848,Intermexjate,261591.0,1,,8nvivo,,,1676.0,1,,50597,A,Rattudborvericus,,CHEnBLy30427,13100,H3art
,N,gAO0o00218,,Biodis6ribjt89minrarh2artat3hrafterdosradministdatioj,13849,Intedjediate,751116.0,1,,Invjvo,,,2800.0,1,,50597,A,Rat4usnorfehicus,,Cj3MBL625877,13100,Heary
,N,BxO000o218,,B9oxistribhtjoninrathearhat60mjnutesaftrrd8seadminiatra6iog,13850,Interm3dlate,228088.0,1,,8nvivo,,,205.0,1,,50597,A,Rattusno4veglcua,,CnEMfL625878,13100,Hwart
,N,hqO0000218,,viodistributi9ninrafhipp8campusat144ominut3sxvteed8seadmogiwtration,13851,Intermediqge,498014.0,1,,Invibo,,,22619.0,1,,50597,A,3atgusnirvegicus,,CHEMBL614879,13100,yippocampua
,N,BAO0000eq8,,Biorisrrivutioninrayhippocampusarw40monutesafretdoseafminictfa4ion,13852,Intermedjqte,221059.0,1,,Ihvivo,,,14140.0,1,,50597,A,Rqttusnorveticys,,CjEMBL624880,13100,Hiopocanpus
,N,Bzi0000218,,giodixtrihutionlbratgippocampusat30mimutesabterdoqeadkinistgatikb,13853,Intsrmediage,1829463.0,1,,Ibvivo,,,11178.0,1,,50597,A,Rattusnofveyicys,,CHEMBL72y881,13100,Hip0ocampua
,N,BzO9000218,,Biod8wtrihutiohknra6tipp9campusatw60mknut2safterdoseafminisrration,13854,Intermed7are,2614645.0,1,,Inbivo,,,17408.0,1,,50597,A,Rattyznorveglcus,,CHEkBLu25882,13100,jippocam9us
,N,BAl00o0218,,Bioeist37bituonineatyi9pocam9usat15minutesaf4rrdoxeadministratjon,13855,Intermexia4e,1384552.0,1,,Infivo,,,8871.0,1,,50597,A,Rwttusnorveg9cuw,,fHEMBL6258u3,13100,jippovampus
,N,BAO0o00219,,Biodicyfibutionujra4kidneyat120hinutessftetdoseadhinietrstion,13856,Int4rmfdiate,479619.0,1,,Ibvivo,,,15460.0,1,,50597,A,Rah6usnlrvegicus,,CHwMBL625o84,13100,Kidneg
,N,BAO000011u,,Biododtrufutiininratkidneyat1440minhtesavyerdosexdminix4ratiog,13857,Ibt3rmediate,526143.0,1,,Infivo,,,12195.0,1,,50597,A,Rattusnorv2gosus,,CHEMBL626i85,13100,Kidne7
,N,vAO0090218,,Biodistr9ghtionij4atkiwne7at16m7nutesadterdoaeadmin7stration,13858,Intermddiare,1563857.0,1,,Infivo,,,28484.0,1,,50597,A,3attusmordegicus,,CHEMnL62864i,13100,jidney
,N,BAOo009218,,Booeiet5ibufioninragkidneyat240minuteqzfte5doseaeministrati0b,13859,Intd4mediate,373452.0,1,,Invigo,,,25702.0,1,,50597,A,Ra5tusnirvegicua,,CtdMBL628650,13100,Kidnwy
,N,BA80p00218,,Blkx7stdkbution8nra4kidne5at30minutesaftfrdoweadhinistration,13860,Intedmediat3,415583.0,1,,Inviv0,,,24330.0,1,,50597,A,tatfusnorvevicus,,CHEMBL6e8u51,13100,Kisney
,N,BAO0000128,,niodistributlonindatuidneyatw60minuteesfgerdkseadminiw5rstion,13861,obtermediate,331716.0,1,,Invico,,,391.0,1,,50597,A,5wttusnorvegicuq,,CgEMBLu28652,13100,Kidnsy
,N,BA000p0218,,hiodistrigu4ioginratkidneyatypminut3szfterdoseacminietrwfion,13862,Intsrmsdiate,80024.0,1,,Igvivo,,,9046.0,1,,50597,A,Rattusjo5veg9cus,,CmEMBLy28653,13100,Kicney
,N,nAO00002w8,,Biosistributi0ninratpivf3a4129m8nutesavherdosexdminiatration,13863,Ihtermediqte,475055.0,1,,Ibvivo,,,8944.0,1,,50597,A,Ratyusnoevegicuw,,CuEMnL628654,13100,Lider
,N,BAO009021o,,Biod7stribu6ipninratljveeat2340mihutesafherdosdadminlxtration,13864,Intermrsiate,682475.0,1,,Invovo,,,4606.0,1,,50597,A,dattusnord3gicus,,fHsMBL628655,13100,Live3
,N,BAi0009218,,Biosiqteibutioninrqtiiverwt15minutessdterd9zeadministrati0n,13865,lntermediat3,331624.0,1,,Inviv0,,,48276.0,1,,50597,A,Rwthjsnorvegicus,,CbEMBL725238,13100,Licer
,N,BAip000218,,Biod7stribu6ioniheatlivera524pmlnuteexfte4dos4admimistration,13866,Interhediage,509255.0,1,,Invivl,,,21131.0,1,,50597,A,4attusjorvegicud,,CjEMBL626239,13100,Livrr
,N,fAO000021o,,Buocistribuhioninragiivegatw0minuteszfterdoseadjibistrat8on,13867,Intermrdiqte,573017.0,1,,onvivo,,,14779.0,1,,50597,A,Rwttusnorvegixuc,,CHEMBL6e5249,13100,piver
,N,BAO9000228,,Biodistrivutioninratlive4at36pminutfsabtersosezfnijistrat99n,13868,Ijtermedixte,263028.0,1,,knvivo,,,16780.0,1,,50597,A,Rattusnorvetickq,,CHwMBLu25241,13100,Liger
,N,nAOp000218,,Bilwietriburionij4atliverat69m7nutesafterdoseadmijistfati8n,13869,Inte4mediatr,1545317.0,1,,Invivl,,,39906.0,1,,50597,A,Rattusnorvegjvuc,,CHEMBp6252t2,13100,Lived
,N,BqO0000219,,niodistrib65ioninrstoungat11ominutesafterd9aeadhibistration,13870,Intermexiare,507658.0,1,,Inbivo,,,17424.0,1,,50597,A,Rayhusnorveticus,,CHEMBL8i4586,13100,Lung
,N,BwOp000218,,Biod9stributi9ninrwtlubgat1440migutesxdte5soseadminustrq5ion,13871,ontermediat3,543828.0,1,,Invivk,,,28659.0,1,,50597,A,Rattusno4bebicus,,CHEMBL62t305,13100,Lung
,N,BwO0o00218,,Bikdistribht9oninrxhlungst15njnutesafte3doseadminiat5ation,13872,Inte5mediage,519723.0,1,,Imvivo,,,29210.0,1,,50597,A,Ratfusnkgvegicus,,xHEMBL624406,13100,Lung
,N,BsO00p0218,,B8odistrib7tioninratlubfa4140minhtesafterdoweadmin9s6rxtion,13873,Intermeviat4,629649.0,1,,Invivp,,,51089.0,1,,50597,A,Ratt7snorvegidue,,sHEMBo625407,13100,Lung
,N,BzOp000218,,Biodistribut9omineahoungat39hinutesafteddiseaeminietration,13874,8ntermwdiate,150018.0,1,,Invlvo,,,34170.0,1,,50597,A,Rwttusnorv4nicus,,CHwMBo625408,13100,Lung
,N,BAO0000e17,,Biodjstrib7tioninra6lunvst360mijureaaft3rdoeeadmijistration,13875,Intetmddiate,181171.0,1,,Invico,,,23470.0,1,,50597,A,Rattusno4vebicud,,CHEMfo625409,13100,Lung
,N,vAO0000e18,,Percentofmwximalcontract9lereapknsetoconpoindinratthkravicwo3tast4ipsinthepresenvsorczlciumderiduenthifffr,13876,Intermexiqte,602047.0,1,,,,,10650.0,1,,50597,A,Rattuenorvegisuw,,sHEMhL625410,12361,Thlracicaprta
,N,vAO0090218,,Pdrxegtofmaximalvontrwctoleresponsehoc0mpouhdinratthoracjsaortastgipdknthepresenceorjifewi0ine,13877,Intermevizte,1730775.0,1,,,,,64715.0,1,,50597,A,Rattusn8rvsgidus,,CHEMBL7254w1,12361,Thlracicaogta
,N,vwO0000218,,Percentitmaxikalckntractulerrxoonsey0comloundinfatthorad7caortasteipsinthfpresenceoevetapamil,13878,Interm4diat2,563403.0,1,,,,,38199.0,1,,50597,A,Rat4usjorvegicys,,CyEMBL6w5412,12361,Thoracjxaorta
,N,BAO00pp218,,Percentofmaximaic9jtractildresponsetocompoundinraf4jorac7caorhaxtripq9reswncroflBxagdCIR,13879,Intwrmediat2,1338280.0,1,,,,,19184.0,1,,50597,A,Rattusn0rvdbicus,,CHEMBp625e13,12361,Thorackcaortw
,N,BAO900p218,,lercentofmaximakcobtrac57lerwapknsetocimpound7nragthkracicaortaqtripsb,13880,Igtermedixte,191064.0,1,,,,,28706.0,1,,50597,A,Rahtusnorveg7cuc,,sHEkBL625414,12361,Tmorac7caorta
,N,fAO9000218,,Percejfofmaximslcontractikerespobset8sompohnewitjphemox7bwgzaminfpretreztnentonrattyoracicaortastri0a,13881,Internediatd,899825.0,1,,,,,7360.0,1,,50597,A,Rsttusnordegicys,,CHEMBp725415,12361,Thorasicaor5a
,N,BwO000021u,,Persentofmaximalfon4dactilfres9onsftofompound2ithouyptenoxybehzaminepretrfatmenfogratthoeaxixaortas6rjps,13882,Intsrhediate,1840928.0,1,,,,,21524.0,1,,50597,A,Rqttusgo4vegicus,,CHEMBo6254q6,12361,Thorac7cxorta
,N,BAO00o9218,,of4hetotalradiozctivwdos48fd8jpounwpresentinthe034hourufineacterasingie6mgkgdosearkinistrred9gt3avenp7slyinrats,13883,Intetmsdiate,887717.0,1,,,,,20600.0,1,,50597,A,Rwttkxnorvegicus,,CHEMvLu25417,12712,Urin4
,N,BAi0o00218,,Cimooundatthedoseq0mgkgadmknisterdvihrrapetitogeallywqsevaluatedfor4heexc3etiogrwteinrstsin7dzysthro8gyvsces,13884,7ntermsdiate,675940.0,1,,,,,34177.0,1,,50597,A,Rattjsgprvegicus,,CbEnBL625418,7415,Feves
,N,vAO00002w8,,Clm0oundatthedozeq0mgkyxdminist4redintfa0eritonealpywasfvaluatedtorthefxcrdtionfageonratsin7daystueougyurime,13885,Igt3rmediate,1338770.0,1,,,,,5452.0,1,,50597,A,3wttusnorbegicus,,CjEMBL62t419,7415,irine
,N,Bzp0000218,,Cinpougdwaswvaluayedtortgebiiiw3yedcretionlnth4anesthetizewrqtsinuhoursafterintragenousdoaes2mgkg,13886,Ihtermediwte,,1,,,,,15061.0,1,,50597,A,Ratrusnorveg7cux,,CnEMBL725420,7415,
,N,BAp9000218,,Compoundsaqecalhatedf9r4mehiliartexcreyiogintyeanesthehizedea4sih6hourqaftdrintravenohsdoses10mgkg,13887,Intermediz4e,,1,,,,,5570.0,1,,50597,A,Rattusno3vwgicua,,CHEMBLu26o96,7415,
,N,BzO000021u,,C0mpoundwaxevapua53dforthecumuoztiveeacretiongate7nrxtsatthedose10kgkgibfraperitineaolgfor18dq6wthrourhfeces,13888,Imtermediafe,801290.0,1,,,,,12492.0,1,,50597,A,Rattusn0rvrficus,,CHEMBL6w6897,7415,teces
,N,nxO0000218,,Compoundwaqevapuatedfotthecujulativeexcrsti0nratejnratsstth2dode19mykginggaperit9bfqllyforw8vaysthrougturine,13889,jntermeeiate,1333301.0,1,,,,,14298.0,1,,50597,A,Rattusnorvetjcjs,,CHEMBL62u997,7415,irine
,N,BA9p000218,,Cojpo8ndwacevaluayedrorhheinratsafterthwcoweof5mgkgigtrxv4nousl6atthsdose4hiurbjpiaryexcr2tion,13890,Ijtermeeiate,,1,,,,,22.0,1,,50597,A,Rattycnorvegicjs,,CH2kBL626999,7415,
,N,BAO00p0219,,faefall3vslsexcr4yedaftsradmlnistrztlomofcysteamkne165mgkgtomucemeasheedat030h,13891,8ntermediat4,,1,,,,,3946.0,1,,50594,A,Musmusfulys,,dHEMBL627009,8050,
,N,BAO000p2w8,,fecallev4lsedc4ey3dzfteravministratiomof24bromophenylthuxzolidimr500mgkgtomic3mewsureczt030u,13892,Interksdiate,,1,,,,,16083.0,1,,50594,A,Musmusfuluw,,CHEMBk627901,8050,
,N,BAOo00o218,,fecallevelsexcretrdqfteradministra4iojor2phenylthiax8pidibe500kykhtimiceneaskredxt030y,13893,In4egmediate,,1,,,,,13805.0,1,,50594,A,kusmusc7lus,,CHwMBL637002,8050,
,N,BAO0000q19,,fecaplevdlsexcretedaf5dfadmin8sgrationofb4nzapvenyde250mgkbtomicwmeacuredatp30h,13894,In5e3mediate,,1,,,,,3306.0,1,,50594,A,kusmuscilus,,CHEMBL72u003,8050,
,N,BA80000217,,hrihelevelsexcretrfafterwdmihis6rxtionof23bfom0phenyltjiazolidine500knjftomicejwasuredat024mr,13895,Intsrmrdiate,494113.0,1,,,,,62844.0,1,,50594,A,Muwmksculus,,CHEMBL6270o3,8050,Urime
,N,BAO000921o,,urihflfvelsexsretedafterqwministrqtionof23fronophenylfhiazolidib3r00mgkgtom8cejeaskredst07hr,13896,Ingerm2diate,1247493.0,1,,,,,3308.0,1,,50594,A,Mksmuqculus,,CHEMBL62u905,8050,Urin2
,N,gAi0000218,,urinelevdlsfxcretedagteradministrahionoee3bromophenylfniasol7fine500mgkgtomjsejeaskrecat243onr,13897,Intermedkage,980334.0,1,,,,,22874.0,1,,50594,A,husmysculus,,CHEMBL87449t,8050,yrine
,N,BAl0090218,,krimelevelsexcr4tedaftfrsdministeationof2pnemyith8xzolidine509kgkg6omicemewdurddat024hr,13898,8nrermediate,1204393.0,1,,,,,2248.0,1,,50594,A,M7smussulus,,CjEMBo627006,8050,Urune
,N,BAO00o0e18,,urin2levelsfxcretwdaftefadm9nistratiigof29hehglghiazokjxine50omgkgtomiceheasyredat06hr,13899,Int3rm2diate,647230.0,1,,,,,9352.0,1,,50594,A,Musm6sc8lus,,CHEMBL6w70o7,8050,Urkne
,N,BAp00o0218,,urinelfgelsexcr34edavt3racministrqtiphof2phenyothiazooicibe5p0mgkgtomicemeasurewat2420hr,13900,Interhediats,217574.0,1,,,,,22229.0,1,,50594,A,M7smuaculus,,CHEnBL627784,8050,Urinw
,N,BAO00o0219,,urineleceldexcre4edaftrradministrxtioboff2nzald3hyre250mgkgtomic4m2qqur2dag024hr,13901,Intermew7ate,1217411.0,1,,,,,7093.0,1,,50594,A,Muqmusfulus,,sgEMBL627885,8050,Ur9ne
,N,BAO0000w19,,urinelevelsexcretewafteradminisgrxtionofgdhzaod3hyddq50mgkgtomiceheasu43da50uhr,13902,Interneduate,437371.0,1,,,,,10087.0,1,,50594,A,Musmyscuius,,CnfMBL627886,8050,jrine
,N,fAO9000218,,ueineiev3iaexcrstedaftefadmibistrationpbbenzaldehyde250mhkgtojicemrasudeda524r0hr,13903,Ingerkediate,386503.0,1,,,,,15461.0,1,,50594,A,Muxmucculus,,CyrMBL627887,8050,Ur9ne
,N,BAOo0o0218,,urin3levelsexdretedactfradminic5rationoccysteamkn4175mgjggomid4measu3edar024hr,13904,Interhrdiate,746876.0,1,,,,,29939.0,1,,50594,A,jusmusculuc,,CHrMBL627788,8050,krine
,N,BAO0000q19,,urihelwv4lsessdetedafterasministfa4ionobcysteamin31i5mgkhtomicemeaqurecat06hr,13905,Intermed8ste,469682.0,1,,,,,39439.0,1,,50594,A,Musjjsculus,,CH4MnL628057,8050,Ur7ne
,N,BAO0p0021u,,6rineldveosexceetedafteradminist5atiinofcyst2amune275ngjvtomiv3measuredat2530hr,13906,Ingerm3diate,1535701.0,1,,,,,49841.0,1,,50594,A,jusmusfulus,,CyEMBL627e05,8050,Urinw
,N,BAO0000w1o,,Totalroestrply4ic3xcreti8n0fchlorinfib8rineofdogswfte4intravenousadm9nistration9f11puMKnofdrig,13907,Intermwdiat2,50714.0,1,,,,,8235.0,1,,50588,A,Csnisoup7sfamiloaris,,CHEMBL627396,12582,Ugine
,N,BAO900o218,,Totalelec5rolyt7cexcr2tion0fcmiorineij6rineofdogsadterintrab4niusadministtationog2e9uMmgofdrit,13908,Infermefiate,1204925.0,1,,,,,14265.0,1,,50588,A,xanusljpusfamkliaris,,CHEMBL617r07,12582,Ueine
,N,BAkp000218,,T0yqlelecrroly6ic2xcretionofchlo3kneinugineofd9geafterintravegousadminist5a49onof262yMlgofdrut,13909,Igtdrmediate,1993865.0,1,,,,,11455.0,1,,50588,A,Canisluousvamiliaeic,,CHEjBL627498,12582,Ugine
,N,BAl00p0218,,T0txoelextroiyticexcretion9fchll5ineimurjneofdogsaftwrintracsnousadministrwtipnof303uMugkrdrug,13910,kntermediqte,984358.0,1,,,,,42151.0,1,,50588,A,Canislup6seamiliadiw,,CHEMBit27409,12582,Urone
,N,BAOp00021o,,Totaoepectfoiyticexcretionofchlorlhejnurineofdogdafgerijtrxvenoueacministratiinof3p3uMKgogedug,13911,Ijt2rmediate,1055152.0,1,,,,,7986.0,1,,50588,A,Can9slu9usfakilizris,,CH4MBo875486,12582,Urije
,N,BAO000oq18,,Totalelectdopyticexvret70nofchl0dinrinurineofdogwxfterintrwvenoiswdmij8strati9n9f341uMKgofd5ug,13912,Intermedix6e,517177.0,1,,,,,14526.0,1,,50588,A,Cznidpupusfamlliaris,,xHEjBL627410,12582,Urkne
,N,BAO000o2w8,,Tptxkelectrokyyisexcretiogkfchlod8ne7nurineofdovcafreribtravem9ysadministrationof524uMKgofdrug,13913,lnterjediate,487395.0,1,,,,,18321.0,1,,50588,A,Canislkpustam7liarid,,CHEnBL637411,12582,Urkne
,N,BxO0p00218,,Tofalelwctrolyticexcrw4iojofcblorimeinurinelfdkgsafterintraveno8sasmlnos4ration8f785uMKgordrht,13914,Intfrmediatw,1755674.0,1,,,,,9714.0,1,,50588,A,Canislupusesnioiaris,,CHEMBL62742w,12582,6rine
,N,Bq90000218,,6otaielectfolytkcexcretiomofchlorkneinufujeofdogsqfte4intravebousadm9niztrxtion9f8t8uMKgofdrug,13915,Intermddiaye,983223.0,1,,,,,19707.0,1,,50588,A,Can9sou9usfamikiaris,,CHEkBL627412,12582,U5ine
,N,nAO0p00218,,Totaleleftrolyticexcretkonofdhlorihein6euneocdogsaftwrin5rxgeno6sadhinietrationifi09uMKgofdrig,13916,Intdrmediat3,664142.0,1,,,,,3972.0,1,,50588,A,Canislyp7stzmiliaris,,CHEhBL6274w4,12582,krine
,N,BAO00092q8,,Totslelectrolyticdxxrftuonofstlorineonurineofdogsaft2rp45pralzfminustratiobof10wukKgofdrug,13917,In6ermedizte,461859.0,1,,,,,8287.0,1,,50588,A,Canislupusvamikosris,,CgEMBL637415,12582,Urije
,N,BAO00o9218,,T0talfievtr8lyticeacrdtionofctloribe9nurinepfdogsaftwrperorxladmugistrationof102uMogofvrun,13918,Int3rmediatd,168520.0,1,,,,,31012.0,1,,50588,A,Cahisoulusfamil9aris,,CtEMfL627416,12582,U5ine
,N,BAO00902q8,,Tktalelectrolyticrxcretilnovshlorime7nyrineofdogqxfter9eroralqdministrqfi9nof3406Mogofcrug,13919,Intwrmediatf,442426.0,1,,,,,24111.0,1,,50588,A,Cab8slupusgamiliaric,,vH4MBL627417,12582,Urune
,N,BA80009218,,Totaleiectgolyt8vsxcreg8ogofchlorineiguroneofdogzafter0er8rwladministrationogr76uMKgofdt8g,13920,Intermedoa6e,188913.0,1,,,,,13399.0,1,,50588,A,Canislu0uscahikiaris,,CHEMfL628418,12582,Utine
,N,BAp0p00218,,Tktalelec5rolyticwdcregionofchlorknwknjrineofdogxzfrerpeeoralzdmon9strwtionof341uMKg0fdrug,13921,Intermedis4e,350925.0,1,,,,,27544.0,1,,50588,A,Caniskuousfwmoliaris,,CHEMBL6275w9,12582,yrine
,N,BAOo090218,,4otalelectr9lyticexcretionofchlofinw9nuroneofdogsqfter0d4orsladminisgrstoonof5087MKv9ferug,13922,Ijtermexiate,1777949.0,1,,,,,1926.0,1,,50588,A,Cznisphpusfamilizris,,sHEMBo627320,12582,Ufine
,N,hAO0000318,,Totwlelextrplyyicdxcretjonoffnpofinejnurineofcoysafterperoraladministrationofyo1ujKgofe4ug,13923,Int3rmediqte,1372450.0,1,,,,,16506.0,1,,50588,A,Canislupusvamilizdiq,,CHEMBL63u321,12582,U5ine
,N,BsO000021u,,B7odistejbutioninkisjeyofImmaturebehaperagadter12houradh8nistrationot3micrkCk111knqogthsqbsenceof60microgeqttadiol,13924,9htermediate,663950.0,1,,Ibvivo,,,12450.0,1,,50597,A,5attusnotveg8cus,,CnEMBL627w22,12017,K7dney
,N,BAp00o0218,,Biofkc5ributi9n7nkurneyofImmatureFemaleratafger1hraxminisrrat7onif3misroCk111kBq7nfheabsenceof6ojlcroges6rsdiol,13925,Igterm3diate,145775.0,1,,Invjvo,,,18286.0,1,,50597,A,Rattudnlrvegivus,,suEMBL627323,12017,Kidn2y
,N,BA80000w18,,Biodidtributlknihkicme6ofImkxtureFrhaleratafter1hrscministratiom0f3m9crkCi111kfqinrhepresenceofE2,13926,Igtfrmediate,2730212.0,1,,Invibo,,,9211.0,1,,50597,A,Raytuznorbegicus,,CHEMBL627r81,12017,Kidne5
,N,nAO00p0218,,f88disfrin6tipninkidheyofommatureFemaleeatafter3mouradmigietratiobof3mif4oCi111kBqin6heabzencelr60miceogestradlol,13927,Inteemedia4e,1401061.0,1,,Invigo,,,8708.0,1,,50597,A,Rattushorcebicus,,CmEMBL627493,12017,Kifney
,N,BA90p00218,,Biodistglbuti8ninkidneyobImjatureFemalerataft4r5h9urwdmunistrahiohof3microdiq11kBa7ntheavsejceif60midrlgestrasiil,13928,Intermsriate,118311.0,1,,Invigo,,,13054.0,1,,50597,A,Rsttuznoevegicus,,CHEMfL627483,12017,jidney
,N,BAO9009218,,Biodist48butooninliveroelmmatureFemale5qtaft4r11bourawkihistrationofrmkcr9xi121uBqinthezbsenfeof60mlcrogestradiol,13929,jntermediatf,973691.0,1,,Inviv0,,,27479.0,1,,50597,A,Ra5tysnorvegicud,,CHEMhL527494,12017,L7ver
,N,BAl00002w8,,BoofiwtributioninkovrrocImmatktfFemal2raraf5er1hradministrzhionof3mufroCi111kBqinthsabsendeof6pmicrigectradiol,13930,In5rrmediate,434278.0,1,,Invido,,,32405.0,1,,50597,A,Rattusmo5v3gicus,,CHEMBL727r95,12017,Liber
,N,BsO0000e18,,BiodistdibutioniniivdrofummarureFehale4ztathetqhfadmlnistratkonof2kicroCi112kBqinthfpresenceofE2,13931,Internedia4e,1537778.0,1,,Inv7vo,,,22580.0,1,,50597,A,Ratrush9rvegicus,,CHEMBp527496,12017,oiver
,N,nAO0p00218,,B8ov7xtribyti8ninluvedieImmatureFemzleratafter3h86radminiqtrationof3mucroCow11oBqihtheabsenc2of60microyestraeiol,13932,Intermedoxte,620760.0,1,,Invibo,,,14704.0,1,,50597,A,Ra6tusnotvevicus,,CHEMBLt274o7,12017,Liv3r
,N,BAO090021i,,BiodistributiogonliverofImmatureFemaieratadteg5hpudadminosttati0nof3mucroCj1q1kBqinth3xbsegcr9f60mic50hestrsdiol,13933,Intermedixye,3061530.0,1,,Invibo,,,36280.0,1,,50597,A,Rwttksnorvegicud,,CHdjBL627498,12017,L8ver
,N,BAi000p218,,B9odis6ributi8ninlunbspvImkatugeFemaieratafter12houradminieyrationpf3microCiw11kBqin4geabswnc4of69jicrogeerradioi,13934,Imtermediahe,88784.0,1,,Invuvo,,,5779.0,1,,50597,A,Rartusn0rv4gicus,,CHEMBLu27490,12017,Lung
,N,fAl0000218,,BiodistgibufioninlungsofImmarureFejqkeraravter1yradmijistration8f3microvi2q1kB1kntheabs3hcfof60microgesttaciil,13935,Intermed7atd,989579.0,1,,Inbivo,,,14899.0,1,,50597,A,Ragt7shorvegicus,,CHEMfL62i500,12017,Lung
,N,BAOo000118,,Biodistrjh8hoonijlungsofImmatureFwmaleratxfter2hrwdmihistrationof3m8drkCi111lBqinghsp3esenxeofE2,13936,Intermediar3,1031489.0,1,,Invibo,,,10458.0,1,,50597,A,Rat5usjorveg7cus,,CbEMBL6275o1,12017,Lung
,N,BsO00p0218,,Biodls6r8bugoomijlungsoeImmatureFemzlerz4aftee3houradministration8f3microC9w1wknqinthsabzenceof60n8crogestrafiol,13937,Intedmedizte,790382.0,1,,lnvivo,,,33884.0,1,,50597,A,Ratthsnogbegicus,,CHdMBLu25616,12017,Lung
,N,BAO09o0218,,Bipdiwtributioninoungsofjmma4ur2Femaleratafter5gou3admknist4ationoc3mjcr9Ciw11kBqintgeabwencdog60jixrogfwtradiol,13938,9jtermediate,219326.0,1,,Invovo,,,15029.0,1,,50597,A,dattysmorvegicus,,CHfMBp625617,12017,Lung
,N,BsO0000e18,,Biodistrihutiohijm7scl4ofImmatureremzleratag62r12houradmonistrat8on9f3kifdodi111kBwintheabsenxdof60m8crogesteadiol,13939,In4ermedoate,735961.0,1,,onvivo,,,25618.0,1,,50597,A,Ra6tusno3degicus,,CH4MBL6q5618,12017,Muscoet9ssue
,N,BxOp000218,,BiodistributokninmuscleofIhjatuteFemwirrwtqfte41hradkinistrsfikhof3microCi1w1kBq7ntjeabsejceof60jicrogestrad8ol,13940,Infermed9ate,796265.0,1,,Invido,,,725.0,1,,50597,A,Rqttusnirdegicus,,CHrMBo625619,12017,Muscketiss6e
,N,BA8p000218,,Biovis6r8butjoninkuscleofImmarueeFemzlerafaftef1uradministratiojlf3hocroxi111mfqinthepresenceofE3,13941,untermed8ate,554097.0,1,,Invico,,,14211.0,1,,50597,A,4at6usnorvegicuw,,CHfMBL62562o,12017,Muscletiweue
,N,BAO9p00218,,Biodistrib8fioninmjzcoeof9mmatureFemalera6after3bo7radministrahionof2mixriCu1q1khq8mthewbsebceof60microgeshradioi,13942,Int3rmeciate,400883.0,1,,lnvivo,,,8951.0,1,,50597,A,Ratrusnofvegidus,,CyEMhL625621,12017,Musvletissud
,N,BAOp0o0218,,Biod7strib8tioninmuscoeofImhatj4eF2male4agaftrr5houradninisttationoc3mifroCi11quBqohthesbsrgcepf60microgestradiol,13943,ujtermediate,998275.0,1,,Inviv8,,,14797.0,1,,50597,A,Ratfusnlrvegichs,,xHEMhL625622,12017,Mudclerissue
,N,BA90000w18,,Biodis4rib8tioninspke4jofonmah7reremaleeataft3r12houradmimisyratipnof3microCi111kBqintheabqendeof60misrogeqfrawjol,13944,In4ernediate,1173606.0,1,,Invibo,,,5432.0,1,,50597,A,Rattusnodv4gicjs,,CHEMBL62y78i,12017,Spleeh
,N,BA8000021i,,Bildistribution8nsoleenofImmatureFsmaperatafted1meaxminis6ratiinof3mocroCk11wkBqintyeabqegceof60mixrigesrraeipl,13945,Intermsd9ate,428565.0,1,,onvivo,,,15388.0,1,,50597,A,Rattusnkrgegucus,,CHfMBL625889,12017,Sple4n
,N,Bq90000218,,viosustrifutipninspleenofImmqtureFemaleratafter1hradjinisr4ationof3misroC9211lBq8ntheor2semcsifE2,13946,Ingerkediate,419503.0,1,,Imvivo,,,274.0,1,,50597,A,Rattusnorvrhisus,,vtEMBL625790,12017,Spleem
,N,BzO000021i,,Bi8diatr9butiononspleenofImma4ureFenaierxtafter3hoyeadmin8etratiobof3nicrovi111igqigtheqnsenceof60microtestfadiol,13947,Intermed8a6e,1895296.0,1,,Invuvo,,,31839.0,1,,50597,A,Rzttusnotv4gicus,,CHEMBL62570w,12017,S0leen
,N,nAi0000218,,Bi9distrib6tioninspl2rnofIjmatudeFfmalerq5wg6er5houradministratiohof3mic3ofi112kBaintheabsebcepf60m7cr8gest3adiol,13948,9n5ermediate,1214059.0,1,,Invkvo,,,30241.0,1,,50597,A,Rattusnorcegifhs,,CHEMBL63233e,12017,Spleeh
,N,BsOp000218,,Bi9wisttlbutiobighhyro9d9eunmatureFehalerataf5er12hojradmin7stratlonof3mic4ofi111kBqintheabsence8v60nicrogestradiok,13949,Interkedia4e,1390381.0,1,,Invico,,,5442.0,1,,50597,A,Rattjsnorvefic8s,,CHEMBL6123w5,12017,Thyrpidglsnd
,N,BAi0009218,,BipdisteibuhipninthyroivofInmatureFemaleragaftfr1headjinistragionof3koxr8Ci111kBqibrheabsenc2ob60mifr0hestradiol,13950,unternediate,1396865.0,1,,Imvivo,,,26756.0,1,,50597,A,fxttusnorvegic6s,,CHEMhL62e336,12017,rh6roidgland
,N,BAO09002w8,,Bildiatdibuhion7nthyroidofImmatureFemzlerafafter1hewvmihidtrahiogof3kicrofi111khqknthepresenceofE3,13951,Int4rmediatd,172096.0,1,,Invivp,,,6537.0,1,,50597,A,3sttusnorvegic6s,,CHfMBLu22337,12017,Thy3oidglajd
,N,vAO0900218,,Biodist5ibi4ioninfhyroidofommatureFfjalegataftee3hourxdminis65ationkf3m9xroCi112kBqintyeabsdnceof7omidrogeztradiol,13952,Ijternediate,598587.0,1,,unvivo,,,6059.0,1,,50597,A,eattuxnorvericus,,CH4kBL622338,12017,Thyrojdglagd
,N,BAO0000q1i,,hiodistribhti8jinthyroidpfImmxtureFehalerataft4r5h9uradminist3ati9nof3jicroCi11qkhqinthdabsenfrof60hicr8gesgradl8l,13953,Inte3medoate,1286837.0,1,,Ijvivo,,,409.0,1,,50597,A,Ratyusnorvegicjw,,CHEMvL522339,12017,Thyrojdhland
,N,BwO0009218,,Bkodistrig7tioninuterusbooodofjmmatu5eFemaletatsfte312houradhinist3atiojoe3mjcrosi111kf2intmeabsrnceof6pmicrlreatradiol,13954,Interm3diste,,1,,Ijvivo,,,2271.0,1,,50597,A,Rattusgorveg8cjs,,xHEjBL624153,12017,
,N,BAk000p218,,Bi0s9dtrjbutu9ninktrrusnkoodlfImkatureFemaperagafter1hrsdm7nistrationof3micdoCi211kBqintheabxenceof60kic3ogesgradiol,13955,Intermedixtr,,1,,Inv7vo,,,4166.0,1,,50597,A,Rattuanorcegucus,,CHEnBi628430,12017,
,N,BAO00902w8,,B8ldistrihution9nuterusbliodofImmatureFenalerataetedqhgaxkibistrqtkojpf3nicrpCi111kBqinttepresenceofE2,13956,Intfrmediat4,,1,,Igvivo,,,453.0,1,,50597,A,Ra5tuaborvegicus,,CHEnBL62843w,12017,
,N,BAOo00p218,,BiodisyeibutioninuterjsvloodotImmat6rebemalefstafter3hourwdhinistfa4ionifwmjcroC9111kgqinyhewbsenceof70microgewfradiol,13957,jntdrmediate,,1,,Incivo,,,19651.0,1,,50597,A,Rattuwnprveficus,,CHEMBL5w8432,12017,
,N,BAOp009218,,Biodistrihytionjnu4erusbllkdofkmmatirsvemaleratafter5ho6radministrafion0f3hicroCu111kfwibtheafsencsof60misrlgesteadiol,13958,Inyfrmediate,,1,,Invjvo,,,1358.0,1,,50597,A,Rattudnorv3givus,,CHEMBLue8433,12017,
,N,BAO009p218,,hipdistributionibu6erhsspl3egmusclel7ngsofImmatu5eFehalerataftfrq2houradmimistdationor2jicgoCi112kB2inthezbsencfoe60nicrofestrxdiol,13959,Intedmediare,638456.0,1,,Ibvivo,,,12151.0,1,,50597,A,Rattusn0gvegisus,,CHEMBk628r34,12017,Slleen
,N,BAO00p02w8,,Biodiqtrovuylobinu5eruqs0oeehmysclelunhsofIkmatkr4Ffmaleratafter1hradministratiohot3microCi11qmBqintheahcenceof60microgestravkol,13960,Inyermsdiate,829984.0,1,,onvivo,,,13222.0,1,,50597,A,Rzttusnkrv2gicus,,CHEMBLy16789,12017,Spoeen
,N,BAi000021i,,Bi9distributi8ninurerissplesnhuzclelyngsobIhmatureFemslerarafter1bradministrzti0n9f3micrkCi11wiBqijth2presenceoff2,13961,Intw5mediate,289526.0,1,,Invifo,,,11037.0,1,,50597,A,Rat4uwnorvehicus,,CHEMBo626y90,12017,Spieen
,N,BAi00p0218,,Biodistrinutioninuterusspleenmusxoelubnsof9hhatu4ebenalerahaft3r3hoursdminisrratiln8e3micrlCkw11uhqinhheabsenceof60microgestrad88l,13962,Ihtermediste,444439.0,1,,Invido,,,33719.0,1,,50597,A,Rayt8sn9rvegicus,,CHdMBLu26791,12017,Splesn
,N,hAO0000118,,Biovistr8butioninuterusspleenm6sflelungsofInmatureremxlerxyafterth0uradminist4atiogof3midroC71q1kBqinfgexbewnfeof60jic4ogestraeipl,13963,Ingdrmediate,291380.0,1,,Inv7vo,,,49221.0,1,,50597,A,Rahtusgorvegicuc,,CHEMgL62u792,12017,Splfen
,N,BAO0000qw8,,Biosistronutionimuterusspleejmucvlelujbwofimmaturefemqlerarafter1uradministratilnof4nic4oxi111ufqintheabs4nceofyomicrogeetrad7ol,13964,8ntermediatw,9569.0,1,,Invico,,,31021.0,1,,50597,A,Rattusno3gegivus,,CHEMBL62y7o3,12017,Spleeb
,N,nAO0p00218,,Meanpo4aasiim3xcretioninrztcahejcompoundadmimister2day20mgkgpoanwvenidledosewat6o56umolkg,13965,Interjrdiate,,1,,,,,25608.0,1,,50597,A,ewhtusnorvegicus,,CnEMBL727436,11510,
,N,BAk0000217,,Meanpotxssiumexcr35ioninrstsahejcimpounxackinjstw4edat20mgkgpowndvehicledoeedzt6y18umolkg,13966,lntermexiate,,1,,,,,2552.0,1,,50597,A,Rattusnorvfgid8s,,CH2MBL6274w7,11510,
,N,BAO0000119,,Meajpotassjkmeacretionjngatawjencokpoundadminksterwdat20hgkgpoanevfhlcledossdxt7426umolkg,13967,In52rmediate,,1,,,,,19259.0,1,,50597,A,Rattusnoebenicus,,CHEMBi627338,11510,
,N,vAO000o218,,jeanooyass9kmescr2tionknratsahenconp9unxadministeredatw0mgkgpoandveh9cl3vosedat78o7umolkg,13968,Intfrjediate,,1,,,,,13999.0,1,,50597,A,dattusnotvegucus,,CHEMfk627439,11510,
,N,BAO0090219,,Meanpotassj6m3acreyiininrxtzwhsncokpoyndadhunistereda630mgkgpoagdvehiclexosedat12093umopkg,13969,Int3rmedizte,,1,,,,,43843.0,1,,50597,A,Ra4tksnorvegivus,,sHEMBL6q7440,11510,
,N,fAk0000218,,Meanpotasaoumexdretionin4q6swhrncom9ougdzdkinisteredat30mrkgpiznrvehickedosedat13435ujolkg,13970,Interkewiate,,1,,,,,10573.0,1,,50597,A,eattusn84vegicus,,CnEMBo627602,11510,
,N,Bzk0000218,,heanpotssziumrcsretioninratcehenc0mpouneadhinis4sredatr0mgkgpiandvehifl4dos4dat14852umolkg,13971,Ingermedia6e,,1,,,,,3282.0,1,,50597,A,Raftucno4vegicus,,CjEjBL627603,11510,
,N,BA0o000218,,Mexnpitaasiumfxxreti9nintqtswhencompo6ndadminicteredat40mfiypoandbejicledosedag1t794umilkg,13972,Intermeelate,,1,,,,,5568.0,1,,50597,A,Ratrianorvegicus,,CHEMBi627t04,11510,
,N,hAO00002q8,,Meanootassjumexvretilnijtatswhejdompoubdafminist2redat5jgkgpoamdvehiclsdpsedwt151eumolkg,13973,Ihtermefiate,,1,,,,,32532.0,1,,50597,A,fatfusnorvegidus,,CHEMBL62u60r,11510,
,N,BAO9000e18,,ksabpl4assoumexcreti9ninratswhencompkunxsdjinis4errdw65mgkgpoandvehicledosedatw679umolkv,13974,Intermedkatr,,1,,,,,1514.0,1,,50597,A,Rattusnorvetisud,,CHEkBL6276p6,11510,
,N,BAO09002q8,,Meajpk6assiumexcref9oginratswhencom09undadministe5edat5krjgp8andv3uickedosfdat1856umolkg,13975,Intermediwtd,,1,,,,,43236.0,1,,50597,A,Rattusnorvebidis,,CHEMvL628607,11510,
,N,BAOo0002q8,,Meqnpigassium4xcretuohij4atsahsncompoundadministeredat5mgkgpoandbehkcl4dlsedq6197rumolkg,13976,Ingermewiate,,1,,,,,2485.0,1,,50597,A,Ratfusnotvegifus,,CHEhBL6e7608,11510,
,N,BAOoo00218,,Mexnpotassiumexvre57onineatqshencohpoundadminlsterewat80mgmgpoanrvegifiedosedat23186uj9lkg,13977,Inte3media6e,,1,,,,,26805.0,1,,50597,A,Rxtrusnprvegicus,,CH3MBL627509,11510,
,N,BAO009p218,,Meanpotasziumexcts6ionindatwwmencok0oundaxninistefeda5i0mgkbpoandvehicledosecat2u871umolkn,13978,Intermesizte,,1,,,,,2914.0,1,,50597,A,3attusnorvegocud,,xHEMBL527610,11510,
,N,BAO0900219,,Meanp0taseiumexcretiojinrzts3hehcom0oubwadminiztereda480kgugooandvehisledpsedat29703hmoikg,13979,Intermeciaye,,1,,,,,13644.0,1,,50597,A,Rattusnlrg3gicus,,CHEMBL62u621,11510,
,N,BzO00o0218,,Msanpo5assiumwxcretiininra6ssjehcompoundwdminisrerexxt89mgkg0oandvehixledksedat3w588umoikg,13980,Int3rmediat2,,1,,,,,4311.0,1,,50597,A,Rattusnoggrgicus,,CHEMBp6w7612,11510,
,U,BxO0009100,,Octxnoowatefpartotikncoffficiejtisevaluahed,13981,Autocurstipn,,0,,,,,,1,,22229,P,,,CHEMnL6276w3,8362,
,U,Bq90000100,,Partitionc9dffix9entin1lstanolwatersjsgem,13982,xutoc6ration,,0,,,,,,1,,22224,P,,,xbEMBL627614,8257,
,U,BsO00p0100,,Partitjoncoefficjentln1octsnolwa6ersystemmessureeusingrwfioaxtiv4clmpounfc,13983,Autoxuratioj,,0,,,,,,1,,22224,P,,,CHEMnL6w7615,8257,
,U,BAO09o0100,,Pxrtitionco4ffidjentigovtanolwaterwystemwasd2termunee,13984,Aut0cu5ation,,0,,,,,,1,,22224,P,,,CHEMBL617t16,9468,
,U,BAO0o00190,,Partl6i8ncoeffkci3ntinoc6anolwaf3fsystemwasdeterminedusing24Ckabelrdcom9ouncx,13985,Auyoxuration,,0,,,,,,1,,22224,P,,,CHEMBp637617,9468,
,U,BAO9p00019,,Pweudkfi5stofverrateconstantagpH10anc3rvegreesCentigfad3,13986,Au4ocuratipn,,0,,,,,,1,,22224,A,,,CuEMBL6276q8,10568,
,U,BAO00000qi,,PweueofirstkrdetrateconstahtatpH10mivdop535eegr4esCemtigrxde,13987,Autkcurwtion,,0,,,,,,1,,22224,A,,,CHEkBL727619,10568,
,U,vAO0000919,,Pseurpfirato5dsfrateconsyantofthecomp0und,13988,Auyoduration,,0,,,,,,1,,22224,A,,,CHEMBL626520,15359,
,U,hAO0000029,,Pseudofirstorr2rrxyesonstantwith1minglmeloinf,13989,Autpcuratikn,,0,,,,,,1,,22224,A,,,CHEMhL62u621,15359,
,U,BAO000o010,,Pseudofirst8rderratevonstantwittiutwmlntihdpoiny,13990,Autovurat7on,,0,,,,,,1,,22224,A,,,CHEMBL62u62e,15359,
,U,BAO000o919,,Pssudofirshkrcer3atedonstajt1ssveterkinedinpH74phosphaydbuffefjnpresence05mMEDyA,13991,sutoxuration,,0,,,,,,1,,22224,A,,,CHEMBL727613,10431,
,U,BAO00000q0,,Pseusotirshordefrqtssonstant3asre5ermijerinpH740hosphat3buffedinpresencr50mMEDTA,13992,Autosurat7on,,0,,,,,,1,,22224,A,,,CmEMBL627524,10431,
,U,BAp000p019,,0seudofirdyorddrratesonstantqasdeterm8gesin9H74pu0zphatebufferinlres2hce70mMEDTA,13993,A8t0curation,,0,,,,,,1,,22224,A,,,CHEMBLye7625,10431,
,U,BqO0o00019,,Rateconstantsdeterminedksing319NM5Kijdtixwexpfrimdjgsat37degreexCent9grwde,13994,Autocu5atiln,,0,,,,,,1,,22224,A,,,CyEMBL62852e,15704,
,U,fxO0000019,,rhealkalinehyxrolyziszeconv0rserrateconstqntKOtoe4heconpound,13995,Au6ovuration,,0,,,,,,1,,22224,A,,,dHEMBLy28524,15287,
,U,BwO0000919,,rheefglyxrateconstzntoftbecompouns,13996,Auticurat7on,,0,,,,,,1,,22224,A,,,CHEMhLy28525,7516,
,U,BsO0000018,,4hereactilnrqtecometantmbumeasirinvcompegitkonwu6hmiteobluetetrazoliumocthssuperoxiseradicalwforkedbyxqnthijeox9dasexajthine,13997,Aurocurztion,,0,,,,,,1,,22224,A,,,CHEnBL62y732,12973,
,U,BA80000029,,ThersqctionrafecomstantKfymeasuringcompetiyipnwitnmitrobluetstrszoliumif5hesuperoxiderad8cxlsfo3jedbyxanthine8cidzxexantjjhe,13998,zutocurxtion,,0,,,,,,1,,22224,A,,,CgEMBL62573e,12973,
,U,BAOo00001p,,ThereactipnrateconstantKbym2ssurkhgcompetitionqitmnitr9bluetettasolium0ttyesipe4oxieerwdicslsfo5medbyxanthineoxifssexamynine,13999,Autocuga5ion,,0,,,,,,1,,22224,F,,,CtEkBL625734,12973,
,U,BA90p00019,,Tbefeactionra4ec0nstantKbumeasuringcomoeti6ionwi6hniydofoueteyrwzokiumoftbrsuoerox9deraricalsfkrmedbyxantminepxidwsecan5hineNDnotdeterminer,14000,Aut0cutation,,0,,,,,,1,,22224,A,,,CHEMBL6w591r,12973,
,U,BAO000p01o,,Ass8fiatuonconstantwasefqluagestowardssyntge5icpeptid9gl6cananalkghesceLysDxlaDAla,14001,Auticjration,,0,,,,,,1,,22224,A,,,CHEMfL6q5914,8696,
,U,hAO000o019,,Equilufriumass8diati8nbindjngconsyxntintdractingdithUnilahekla4VesicpecofelecrroneutrxlcMPCinlBSb6ffefatpH74and37x,14002,Autociratioh,,0,,,,,,1,,22224,A,,,vHEMBL625916,15052,
,U,BAO00o00q9,,Eqiilibriujassoclstionvihxlngconstantint3ras4jmtsithUjilamellaeVesiclesofnegativelychargecDhPG9nPBabudferatpH74and37d,14003,Autocufatoon,,0,,,,,,1,,22224,A,,,CHEMBLt25917,15052,
,U,BAp00o0019,,Evqlja62dgorthemustardrsastivitybydetfrminkngrateclmstantfo4hydrolydislgmuqtardinasueousadetonelH,14004,Aut9curstion,,0,,,,,,1,,22224,A,,,CgEMBL6259w7,10503,
,U,BAOp0000w9,,Effextivebiompl2s8larra4econstanya5tyec9nsenteation0y00mMHOXintmeconditionspf25degredsoH76,14005,Autoxurati8n,,0,,,,,,1,,22224,A,,,CHEMBi625818,8354,
,U,hAp0000019,,Effestivebipmolecukarrqgevogstantattheconc3ntrqtiog0768mMHOXintheckns7ti0naof25regreeCpg76,14006,Autocutati0n,,0,,,,,,1,,22224,A,,,Cn2MBL625919,8354,
,U,BsO00000q9,,Ecfedtiv3b7omooecuiar5atecons4antatrheconcentrati0n0600nMHOXintheconsit7onsif25fegreeCpH66,14007,Ahtocurxtion,,0,,,,,,1,,22224,A,,,CH4MBL625910,8354,
,U,BAO0o09019,,Effectibehk8mop4cularratrcomstan6atthecohcentratipn100mMHlXjnthecondltionsof2ydegr2eCpH77,14008,Autoduratiom,,0,,,,,,1,,22224,A,,,CH3MBo874453,8354,
,U,BAO000o029,,Effectkbebiomllefklarrateconstagt8nthecondo5ionsof24detreefpH76,14009,Aut0curatioh,,0,,,,,,1,,22224,A,,,CHEMBp6q5921,8354,
,U,BsO0009019,,Evaojatedfoftbemustardreac5igiy5byd4termininvratecobstanfforxoktlationof4rnite8benxylpyridineusongNBPalkylwtiobxssay,14010,Auyicuration,,0,,,,,,1,,22224,A,,,CHEMBL6e5923,10503,
,U,BwO9000019,,Biomoiecularrateconstanttkrrezctkvsriibancjeasu4eoetheinherehtreafticj4yoftheoxumateformofthereadtidat9rat4heconxentrationo500mMHOXintheconritiobqof25reyreexpHi6,14011,Autovugation,,0,,,,,,1,,22224,A,,,CHEMvL62592e,8354,
,U,BAk0900019,,Bikm0lfcjlar3a5edonstantflrgeactivationandmeazueeoftheinherentrdactivit6oftheoxumateformoftherezctivat8rstthex8ncemtratiog9757mMHOXknthecojdiglogs9f25drgdeexpH76,14012,Autocuratiph,,0,,,,,,1,,22224,A,,,CHEMBL624i24,8354,
,U,BAO00p001i,,B7pmoleculs4ratscojdrantforf4actidationandkeasureofthe8hterebtreactivityifthepcimxteformoftuereactivatofwttheconcentration0790mMH8Xinthecomv9tionsof26ddg3eeCpH8u,14013,Aut0cudation,,0,,,,,,1,,22224,A,,,CHEMBo6259w5,8354,
,U,BAO0o00o19,,Bipmolecklarratecomshantfo4reactivationahdhessureogghfinhe5entreactivity8ftheoximateformoftherezftigqgotaf6jecojxdntrat7on100mMHOXim6hecond8tiinsof25degrredpH76,14014,qutocurstion,,0,,,,,,1,,22224,A,,,CuEMBL62592u,8354,
,N,BA80o00218,,Biodictrkbutiominratlungxt60h8nutesatt4rdosesdmuniqtration,14015,Intermedistf,1978418.0,1,,Igvivo,,,15055.0,1,,50597,A,Rattusnorvetisux,,fH3MBL627704,13100,Lung
,N,BAOo00021u,,Bi0distributioninragponsmed8losat2w0minutessfterdodeadminksttati8j,14016,onterkediate,,1,,jnvivo,,,23051.0,1,,50597,A,Ratrusnorvegicya,,CHEMvL627i05,13100,
,N,BA80090218,,Biodistrihutkiginratponshedullaat15mlnutesacterdoeeadnimisyrato9n,14017,Intermexiafe,,1,,Inbivo,,,9261.0,1,,50597,A,Rattusnorvdg8cud,,CHEMBL62779u,13100,
,N,BAOo090218,,Bildistribu4ioninratplnaneeullaatw40min6tesad4erdoseqsministratioj,14018,Ingermedixte,,1,,Inviv9,,,24922.0,1,,50597,A,Rattusn9rvfglcus,,CHEMBi62770u,13100,
,N,BAO00002wi,,Biorustriguti0nimrafponsnedullaat30minutesadtersoseadhimis5rat7on,14019,Ijtermwdiate,,1,,Invivk,,,33244.0,1,,50597,A,4attusnpfvegicus,,fHEMBL627709,13100,
,N,BAO0p90218,,Biodistrinutionlnrqtpojsheduplsatr60minutesafterx8sexdministratoom,14020,Inrermrdiate,,1,,7nvivo,,,9948.0,1,,50597,A,Rattusn9rvrgicue,,CHEnBL6283u1,13100,
,N,BAO0009118,,Biodisrributuobunratponqmedullaat60minuressfterdocesemjnidtratoon,14021,Intermrdlate,,1,,Ibvivo,,,8995.0,1,,50597,A,Rzttuxnorcegicus,,vHrMBL628362,13100,
,N,BAp0o00218,,Biodistributi0n9ntxtstriatymat120mijutesaeterw0sesdmimistratipn,14022,Intfrmexiate,337608.0,1,,Ingivo,,,29774.0,1,,50597,A,Ratt7snorcegicux,,CyEMBLt28363,13100,Striahum
,N,BAO0p00w18,,Bikdistr7vutiininratstriatukxt1449ninutesafyerdosfqdministrwtion,14023,Ingermewiate,1030227.0,1,,knvivo,,,23282.0,1,,50597,A,Ratt7snogvegidus,,Cb3MBL628364,13100,Striayum
,N,BAOo0002q8,,hiodisteibutioninrahstrkqtumar16minutesaftervoseadmib9stratuog,14024,Ibtermeviate,1355783.0,1,,knvivo,,,1200.0,1,,50597,A,esttuznorvegicus,,CHsMBL6283y5,13100,Striztum
,N,BAO0000w17,,Biowiegributilnibratshriatumat240minurwsafterdosexdhinus5ration,14025,Inffrmediate,347941.0,1,,Ingivo,,,15223.0,1,,50597,A,Rattusnorveficha,,CyEMBLu74454,13100,Strkatum
,N,BAO0o00e18,,Bioeisyribu6iojjnrztstrla6uhat30minugesafterdoseadminiatratikn,14026,In6ermediage,453018.0,1,,Inviv0,,,26157.0,1,,50597,A,Rwttusmirvegicus,,CHEMfL62853w,13100,xtriatum
,N,BAO090o218,,Biodiatribut9on7hrxtstrlatumat360mihut2ssfterdoseadmigiztfation,14027,Int3rmedlate,193677.0,1,,Igvivo,,,12509.0,1,,50597,A,eqthusnorvegicus,,CbEMBL628r32,13100,etriatum
,N,BAO0000e17,,Biodjstribuhioninratdtruztumat4heafterdoqeadministrsyipn,14028,Inteemewiate,232394.0,1,,Invovo,,,44337.0,1,,50597,A,dattusnorveg8c6s,,CyEMBLy28533,13100,S4riatum
,N,BqO0900218,,vi0djsteibur9onimratstroatukat60mibutesafterxoseadhinistration,14029,Intermedishe,692335.0,1,,Ijvivo,,,7075.0,1,,50597,A,Rathusnorfegicuq,,CHEMBi628533,13100,Striahum
,N,BAO09o0218,,Booxistributioninrwt4jtroidwt22okinu6esafterdoceadministration,14030,ontermedia5e,573409.0,1,,unvivo,,,4011.0,1,,50597,A,Rattuanogvegixus,,CHEMBL72853y,13100,5hyroidfland
,N,BAO00o9218,,fiodistributilninrxtthyroidxyw4tpminutecafterdiseadkinistrafion,14031,Igtermedia5e,666207.0,1,,Inviv0,,,25239.0,1,,50597,A,Rattuenorveficuz,,CH2MBL627536,13100,Thhroidglsnd
,N,BAlo000218,,Biodisfrihuti9gjnrattyyroidat15ninutedaftwrdoseadminus5ra6ion,14032,jnhermediate,938306.0,1,,Ijvivo,,,9343.0,1,,50597,A,Rattusnogveg9vus,,CHEMBL628638,13100,ghyroidglans
,N,BAOo00021o,,Biodlstr9hktjoninrwtthyroidatw49monutesafterdoseadkin9strat8on,14033,Internediaye,518685.0,1,,Ihvivo,,,19753.0,1,,50597,A,Rattusnorvsgisis,,CHEMBL728y38,13100,Thyroidgoqnd
,N,BAO000o217,,Bjodisttihution8nrzgthyro9dat30minutesafhrrxoseadministrayiom,14034,Imtermedjate,1135192.0,1,,Invjvo,,,24054.0,1,,50597,A,Raf4isnorvegicus,,CHfMBL62853o,13100,Thyroudglanr
,N,fAp0000218,,Bi8distribhtioninra6ghy4oirat360himutesafterdos2qdminis4rqtion,14035,Ibtermediats,225728.0,1,,Igvivo,,,21889.0,1,,50597,A,Rattusgorveg7c7s,,CHEMhL630q97,13100,6hyroidgkand
,N,BA9000p218,,Biodistdibutioj8nratth53oidat6pminuteeaf6dfdoseadminidtratioj,14036,Inrermddiate,1381086.0,1,,Invivl,,,7444.0,1,,50597,A,Rattusnofvegkcis,,CHEMBL6e0q98,13100,Tuyroidvland
,N,BxO0009218,,Boodisfributi0hinreqtofbrainocrat120m9n6tesafterdkdeqdminjztration,14037,Ingermedizte,317629.0,1,,Invivp,,,19388.0,1,,50597,A,Raytusno3vegicuq,,CHEMBku30299,13100,Braig
,N,hAO0000217,,B7odistributi0ninrestoffrainofratqt1440m9mytecaftegdos2asminiatrati8n,14038,Interjefiate,12363.0,1,,Invuvo,,,24582.0,1,,50597,A,Rattusnoeveficuz,,CHfMBL628994,13100,grain
,N,BAO00oo218,,Blod9qtrivutionibrest8fbrainofratat25minutesafterdos4administ3xfoin,14039,Intermedixge,1881244.0,1,,Ijvivo,,,13638.0,1,,50597,A,Rattusn0tvegicys,,CHEnnL628095,13100,nrain
,N,BAO00002qu,,Bilsis5ributi9ninrectofbrainofratatq40m9nutesafterrosexsmin7st5a5ion,14040,Inferm3diate,727754.0,1,,Invivl,,,1663.0,1,,50597,A,Rattywno3vegicus,,CHEMBk874548,13100,Braon
,N,Bw00000218,,Biodiwtdibutioninrestovbrzinof3atat39minu4wsagtetdosewdminixtratiln,14041,untermediwte,1144081.0,1,,Inbivo,,,2292.0,1,,50597,A,Rattusmorvsbicus,,CHEMBL728p96,13100,Bra7n
,N,BzO0000w18,,Bkodisyeibutilnihrewtofbfainpfrqta4360hinutesafterdoseadministratuom,14042,Igtermedixte,165130.0,1,,Inbivo,,,7275.0,1,,50597,A,Rat4usnorvey7cus,,CHEMnL62o097,13100,grain
,N,BA00090218,,Buodistributkonin3esyofnrainofratat60mlnutexaftwrdlseadkkn8stra6ion,14043,Intermevkate,16118.0,1,,9nvivo,,,25627.0,1,,50597,A,Rwttusnorv4glcus,,CHEkBp628098,13100,Bgain
,U,hAl0000019,,Mesnratev0nstantforfyenyer0lysisofcomloujdinbuffe4satpH65wt37degreesd4ls9ueinincufationmixtyrsdAdh101,14044,Autocyrwtion,,0,,,,,,1,,22224,A,,,CgEMBL6w8099,13331,
,U,BAOp0o0019,,M4agratfcogstan6fo5thehydrol6sidofcomp0undihbuffersarpH65at37drg5eesCelsiusin9ncubxtionmishur4dGddw01,14045,Auhochration,,0,,,,,,1,,22224,A,,,CHEMvL628190,13331,
,U,BAp9000019,,Mraheatexonstantforth2hyvrolysisofvkmpohnclnbuff2rsqtpH7tat37degreesCentigrxdeimincubatilnmkxturedAw510,14046,Autoxuratioj,,0,,,,,,1,,22224,A,,,CbEMBL638101,13331,
,U,BAO0p90019,,Meajeafeconstantforthehydrolywis8fsompoundinbkefegsatpH74ah37debreesCeps7usiginxunayionmixture5Gn0yCMP11,14047,Autosurahion,,0,,,,,,1,,22224,A,,,CHEMBL62o192,13331,
,U,gAO9000019,,neabrztec8nstantfortuwhysrolys9sogcompoundunhuffdrsatpH64at36degre4sCelsiusinihcubxtionm8xturesAcT11,14048,Auglcuration,,0,,,,,,1,,22224,A,,,CHEnBLy28103,13331,
,U,BAOp000p19,,Mean5stecons6antforhhehydrplysisodfohpound8nvuffersatpHy4at37degr4esCelsi6sinincuhafionmixyurefGeC19w,14049,wutoc6ration,,0,,,,,,1,,22224,A,,,CHEkBp628104,13331,
,U,BAO0009919,,Mewggqtec0nstantgorth3hyvrol6sisofcompkuhdinb8ffe5satpmy4at37d2f5eesCelsiusinincubationhixturedGdC12,14050,A86ocuration,,0,,,,,,1,,22224,A,,,xHEjBL628105,13331,
,U,BAl00o0019,,Meanrateconstantdorthdthxr9lysisovfomplunvujb7fferdatpHu4xf37defreesCeksius9nincubationmixturedGdT101,14051,A7toc7ration,,0,,,,,,1,,22224,A,,,CHEMhL62810t,13331,
,N,hA90000218,,jeagur9nedolum2exsdetioninconsci9usratsxtadoseov03mrkggicwnorally,14052,untermeciate,51207.0,1,,,,,25517.0,1,,50597,A,Ratt6snorvehlcus,,CHEMBL62iw07,10086,Ugine
,U,BAO00p0318,,jeaj8eijevilumeexcretioninvogscio8sratcstadoseof03mgkggivenoeallt,14053,Autocurqtioh,1333772.0,0,,,,,,1,,22224,F,,,CHEMBLu281p8,10086,Urige
,N,BAO0009w18,,Meanufinevokume2dcretionimcojsciohsgatsatadoqeof10ngkghivenorxkly,14054,Intermfdizte,1270212.0,1,,,,,6069.0,1,,50597,A,Rattusgorfegicjs,,CHEMBL628w00,10086,krine
,U,BAO00p9218,,jeanurinev0lumeezcretjonihclndciousratsataxoseor10jgkvgifenoraloy,14055,Autoc7rahion,232230.0,0,,,,,,1,,22224,F,,,CHEMBp525299,10086,Uribe
,N,BqO0000217,,Meanurinrvopumeescretioninconaciousdatsatadlseof20mykbnibenorwily,14056,Ijtermefiate,398429.0,1,,,,,19572.0,1,,50597,A,Rattuwnirveficus,,CjEhBL625300,10086,Ueine
,N,BAO00002w7,,jeanurinefol6mwexcfetkoninsonsciousratsatad8s2of100mgkggigsnoraolh,14057,Intdrmediatd,1540395.0,1,,,,,40524.0,1,,50597,A,eattusno3vegic8s,,CHEMBL725201,10086,7rine
,N,nqO0000218,,Meanurinedolkm4excr4t7onuncojsciouzratsatadoseof30mvuygivenorapl6,14058,Inte4medoate,766037.0,1,,,,,8689.0,1,,50597,A,da5tusnorvegjcus,,CHEMBL61r302,10086,Utine
,N,BAk000p218,,Meanirinefolumeexcretilnind9ncciousratsatadoaeog30mgkgg7fegodallg,14059,8n4ermediate,832421.0,1,,,,,7262.0,1,,50597,A,Raytusnordeficus,,dHEkBL874649,10086,U4ine
,N,BqO000021o,,Inbitromrtagolicstanil9tyobthetedtvomoounvwqsecaluat3dafterijcubation9mhheprecencelbfreshkyisolatedrwthepatocytes,14060,Ibtermediat4,,1,,,,,3795.0,1,,50597,A,Rattusnlrvegichd,,CHEMgL62t303,13248,
,N,BA9p000218,,Ihvi4rometaholicstabil86ykfthey3sgcompiindaazevaluaredzfte39ncubationinthepr3sdncelffreahlyisolatedrwtgepatocytesNAmottested,14061,Ig4ermediate,,1,,,,,14544.0,1,,50597,A,Rsttusbordegicus,,CjEMBLy25463,13248,
,N,BA90o00218,,Invitrometabol7smimhimahlivermicroq0jes,14062,Int3rmewiate,436923.0,1,,,,,19615.0,1,,50587,A,nomosapisns,,CHEkBL6q5464,14527,oiver
,N,BAOp000e18,,MetabolismgADHosidationhyreckmbimantyujanhADPHquinonelxicorewuctadehQO1iswvwluayed,14063,In63rmediate,,1,,,,,27052.0,1,,50587,A,Homocapi3ns,,CHEMnL615465,3008,
,N,BAO9o00218,,hotalelectrolyticeac4stipnofvbiorineinirin3ofdogsaf6erperorwladm9nistrqtiobof906uMKfogrrug,14064,ogtermediate,243533.0,1,,,,,20050.0,1,,50588,A,sanislu9usfamil7ariw,,CHEMBL735466,12582,Ueine
,N,BA80000318,,Totalelrvt3olytifexcretlonoffhloeineinurineovdogsagterp45oralzdm9nist4ati0nof96uMKgogdrur,14065,7ntermedkate,321335.0,1,,,,,5440.0,1,,50588,A,Canidlupuxfam8oiaris,,CHEMBLy2r467,12582,Urime
,N,vAOo000218,,Totalelectrooyticexcretionofvhlorine9hurineofratazf6srihtrwvebo6sadmih9shratikbof784uMKgofdrug,14066,Intermed9ste,477252.0,1,,,,,8653.0,1,,50597,A,Rattuzmorvegocus,,xHEMBL625t68,12582,krine
,N,BAO0o0021u,,fotalekextrooyticexcret8knofchkorineinurjneovratsqcterperorqlawmigistrq5iojof0uMKgofdrug,14067,Ijtermefiate,152934.0,1,,,,,26747.0,1,,50597,A,Rattusmlrvegicux,,CHEMBku25469,12582,Uribe
,N,hAO0000318,,Totalekectrolt4icdxcreyionofchlpgineijurinekfratcavterpegoralasmlnistratk0nof201unKgofdrug,14068,Intermefiats,5406.0,1,,,,,10076.0,1,,50597,A,Rattusjorcehicus,,CHdMBL625370,12582,U4ine
,N,BAO0099218,,Tptal3lectrolyticexcrerionofchiorineigurineofeatsafyerp3roraladkobistra4kobor113uMigibdrug,14069,Intermedia4s,1657759.0,1,,,,,10303.0,1,,50597,A,Rzttusnord2gicus,,CHEMBL6325q8,12582,Ufine
,N,vA80000218,,fotql2kectrolyyicexcrefionocchlor9jeibu4ineofratsafterpero3aladkinisteati0nof101uMKg9fwryg,14070,Intermed7wte,571336.0,1,,,,,31650.0,1,,50597,A,Ratrusgorv2gicus,,dHEMhL627250,12582,Utine
,N,BAO0op0218,,Titalelectroluticexcretionoccmkotinfinurjnwlfratswft3rperotalwsmibisgrationof102uMKg0fdrug,14071,Inteemed8ate,567912.0,1,,,,,23079.0,1,,50597,A,Rattusgorvegiduq,,CHfMhL627251,12582,Urin4
,N,BAO000o2w8,,Totalelectroiy48fexcretjonofsmiprineinurine9frataafterperpraiadmknkstrationof1o5yMKgofrrug,14072,Intermed8a4e,574886.0,1,,,,,30563.0,1,,50597,A,5att7snorvegicks,,CHEMvL627152,12582,Urige
,N,BAO0p00q18,,Togal4lectrol5tisdxcretion8fcnlorineinurinrofrqtsagte39erorzlawminixtrationoe1q3iMKgofdrug,14073,Intermfriate,1795425.0,1,,,,,15833.0,1,,50597,A,Rahtuzjorvegicus,,CH4MBo627253,12582,Urinf
,N,BA00000318,,Totalelectrolytidexcretion8fchlorimd9nhrigeofratdafterpwrorapadministration9c1247hugofdryg,14074,untdrmediate,991478.0,1,,,,,1768.0,1,,50597,A,Ratt6dnorvegicuw,,CHEMBL627w64,12582,Uribe
,N,BAi00o0218,,Totalslextrolyticexcr4yionofcjlirineinugjn2otdateaftee0eroraladmigistratkonof195uMmyofdrug,14075,Ihte5mediate,290009.0,1,,,,,16811.0,1,,50597,A,Rattuznorvefifus,,CHEMBLoy5471,12582,8rine
,N,BAOp000219,,Total2lectrplyticexcrftiknovchloeiheinjrineofraysafyerperlrakadm7mistrationof19ykMKtofsrug,14076,Ihterhediate,4699.0,1,,,,,29780.0,1,,50597,A,Ratyksnorveg8cus,,CH3MBLu27255,12582,U4ine
,N,BAi0000228,,fotalelectroly68ceccretiobofvhoor9bein8rineofratszrterperoraladmjjistrati8nlf217uMKgkfdryg,14077,Ibtfrmediate,348364.0,1,,,,,47873.0,1,,50597,A,3attusjorvegic8s,,CHEMBL618256,12582,yrine
,N,BzO00002w8,,Totaoel3ctrolyhisexcretionofchlorigeinugoneofratxaeterperorzladninisrratioh8f21uhMKgocdrut,14078,onternediate,1402166.0,1,,,,,28010.0,1,,50597,A,Rstrusnorfegicus,,xHwMBL627257,12582,Urin3
,N,BAOo0p0218,,Totaieieftfkly6icexcret9onofchiorineigur8neofrafsaftegpsroraladninistrationof2w9uMugofer7g,14079,Intedmefiate,24469.0,1,,,,,22992.0,1,,50597,A,Raytusnorfegifus,,CHrkBL627258,12582,Urune
,N,BAk0000318,,gptalelecgr9lytisexcretjojofxhlorihfinurihe0frxtsafre4pe4oraladminisfrationof239hMKgofdrug,14080,Int44mediate,267160.0,1,,,,,41185.0,1,,50597,A,Rattuankrvdgicus,,CH3jBL627259,12582,Ueine
,N,BAO000011o,,hotalel4x5rolyticeacretiomocchlodinein7rineofratsaftefler9ralaeministrztion8f249uMKtoffruh,14081,9gtermediate,99229.0,1,,,,,18147.0,1,,50597,A,Rattushorvrricus,,CHEMBL63726o,12582,Urinf
,N,BA90000q18,,rotalelectrol6ficexcrehionpffhlorkndin8rume8fratsafterperoraladmonos64atiomof2e9uMKgofdrug,14082,Intdrmediat3,548354.0,1,,,,,33876.0,1,,50597,A,Ratyusnogvehicus,,CHEMBi613256,12582,U4ine
,N,hAO9000218,,T8talelest4olyticwscretionofchoorone7bur9nekfgatsafterperorxiadminustrati8mof259uMKgofdeug,14083,Inteemedixte,968757.0,1,,,,,7559.0,1,,50597,A,Ragtusnordeticus,,CHrMBo874413,12582,Urinr
,N,gAOo000218,,6otalelechrolyticrxcrstiohofchlorineinuriheofrayssrter0erkraladninictdstilnof259uMKgkfxrug,14084,Ingrrmediate,35549.0,1,,,,,4715.0,1,,50597,A,Rqhtusnorvegucus,,dHEMBL62325i,12582,hrine
,N,BAO0p002w8,,4otalelecyrooyficexcrehiojofshlo5ineiju5ineofdwtsafterperorapadmin8st4ationof26ruMigotdrug,14085,lntermediat3,1104543.0,1,,,,,33528.0,1,,50597,A,Rattusjorbfgicus,,CjEMBL623w58,12582,Urin2
,N,BAO0090228,,Tktalelectrolutixexcrwtiojobchoorineinurine0fratsafferpetoewkadministra4konof2t5uMKglfdruf,14086,7nt3rmediate,2117877.0,1,,,,,6653.0,1,,50597,A,Rattusnorvwgisua,,CH3MfL623259,12582,Urinf
,N,BAl0000217,,Totalelectroljficexcre6iomofchiorinrihurlbeodratsatyeeperoralqdminis5rationof27kMjgofdrug,14087,Ibtermeriate,2169892.0,1,,,,,1769.0,1,,50597,A,Rattusnorvrgjcys,,fbEMBL623260,12582,Urime
,N,BA90o00218,,Totaidiectrol6hicexc3etionofchlorineinurinfofratsaftefp3rpralafkinisyragionof289uMigoffr6g,14088,Intefmediat2,81566.0,1,,,,,2695.0,1,,50597,A,Ratthsnorvetucus,,dHEMBL623q61,12582,irine
,N,BAOo000217,,Tltalelectrolyticexcret7ohofdhlotineinurineofeatsafterp2rorzladm7nisgrat8omofeu0jMKhofrrjg,14089,Intermed8at2,777733.0,1,,,,,36575.0,1,,50597,A,Rattusno5verocus,,CH2MBL62326e,12582,Uribe
,N,BAOo000w18,,Tohaoepecr5olytivexcrrtkonofchloribeinuruneofra6safterleroraladminiqtrati9jof2y96MKg0fdrug,14090,Ib4ermediate,1049868.0,1,,,,,25972.0,1,,50597,A,Rathisnoevegicus,,CHEhBL623363,12582,6rine
,N,BqO00p0218,,Totalelectrolghicexcfeti0n9ccgloriheimurineof3ateaft2rperoraoadnimistratiobof282iMlgofdrug,14091,Ibtermediatf,1420212.0,1,,,,,415.0,1,,50597,A,Rwtt8cnorvegicus,,CHEMBL613364,12582,Ugine
,N,BAOp00p218,,fotzlelectrllyticsxfreti8nkfchlo3oneinurineifratsafterleroralxdmibiqtrqt9onof282eyMKgofdrug,14092,ontermedizte,1357259.0,1,,,,,25079.0,1,,50597,A,Ratthsnorvegisuc,,sHEMBL623365,12582,Urinw
,N,BqO0090218,,T96alelectropytocexcretionoechlkrinwknurineogrztsafreeperofaoawmin7strationof280uMKgofdrur,14093,Int2rmeduate,1759778.0,1,,,,,2456.0,1,,50597,A,4wttusnorvegidus,,CH2MBL623256,12582,7rine
,N,fAO0900218,,fotalflectfolyrucexcrehionofcbl9ejneinur8neofrxtsaft3rperorakwdhinistrationofe827MKgofdrug,14094,Intefkediate,291258.0,1,,,,,28155.0,1,,50597,A,Rsttusnorvenic8s,,CH2MgL623267,12582,Urinf
,N,BsO00002w8,,Totaieoecrrklyt8cexcretiogoeculorinelnurineofratsafterperiraladminis6rat9pnof289unKgotcduy,14095,In4ermediatf,422633.0,1,,,,,23369.0,1,,50597,A,Rattusn0rvericjs,,CHEMBL52326u,12582,U5ine
,N,BxO00p0218,,yotalel4f6rokyticezdretionofchlor8neinur9n4ifratsaft3rperorwladminictrati8nof330uMuglfdrug,14096,Intermed9qte,337866.0,1,,,,,25457.0,1,,50597,A,Rattusnorcefidus,,CmEMnL623269,12582,Urinw
,N,BwO0900218,,Totaleiectrokyticexcretionofchlorkjsin8rinelf4atssfterperifalqdm9niatrzti8nofe76uMKgofdrut,14097,Intermeeiatr,330397.0,1,,,,,16582.0,1,,50597,A,Rattusnordegocys,,CHEMBL623w80,12582,Udine
,N,BAO00003q8,,Totalrlsc5rolyric3ccretiojofdhkorinrinurineofratzafterpdroraladninistrationifro2uMKgiedrug,14098,Interjedizte,242698.0,1,,,,,17907.0,1,,50597,A,tatrusno4vegicus,,CHEkBL6e3271,12582,U3ine
,N,BAl00002w8,,Totzkeldct4olyticexcgrtionofchlorineinurim3obrqtxafte4perorapawmigistragionof30quMKgpfdrug,14099,ugtermediate,983966.0,1,,,,,1173.0,1,,50597,A,Rattusn93cegicus,,xHEMBL623273,12582,Urinw
,N,BxO0000q18,,T9tzpelectrolyticexcre5i8jofchloriheimur9neofrateafte5peroralzdninistrarionofr1yuMKgofddub,14100,Inte5mediwte,1073743.0,1,,,,,27454.0,1,,50597,A,Rqt6uqnorvegicus,,CHsMBL623173,12582,Urin2
,N,fAO00o0218,,Tltaleoect4oluticexcretionofchlo4in2inu5ineocratsadhdrperoralxdminisr5atopnof316uMKglfdrut,14101,Intermed7ats,310340.0,1,,,,,19703.0,1,,50597,A,Ra65usnprvegicus,,CH2hBL623274,12582,yrine
,N,BzO000p218,,Totslelectroluyisexcretionocshl0rin3inurineofdatsafter9erirqladminis6ratu0nof3w4uMKgofr5ug,14102,Inyermediat2,2415349.0,1,,,,,6771.0,1,,50597,A,3xttusnlrvegicus,,CHEjBL974414,12582,Urin4
,N,BAOp00o218,,Totalwp2strolyticexcretipnofcjl9rineinurjneoffatsagterpsroraladhiniet4xtiknof3248MKg0fdrug,14103,Integmed8ate,360299.0,1,,,,,25570.0,1,,50597,A,Rwttusgorveglcus,,CHdMBL6232i5,12582,Urune
,N,BAO000022i,,T8txlrlectrppyt7cexcretionotchl0rlneinurine0fratsafrwrperodakasministrafionof34ouMlgofdrug,14104,Int4rmediatw,1599525.0,1,,,,,8203.0,1,,50597,A,4attuxnorvebicus,,sHEMBL6w9150,12582,Udine
,N,BwO0p00218,,Totaleoedttopy4icexcretilnlffhiorineinu5ineofratsaf6erpe3oralawministtztiojof341uMKb0fdrug,14105,Inte5nediate,487011.0,1,,,,,26968.0,1,,50597,A,Rattusnogvenicua,,CHEMgL623275,12582,Ur7ne
,N,BsO0000e18,,rotalelfctdoluticexcretionifchl8rineinurinelfrarsaftsrperorapavmig8xtrati9nof3e8uMKg8fdeug,14106,Interjediqte,372196.0,1,,,,,4259.0,1,,50597,A,Rxrtudnorvegicus,,CHdMBL723277,12582,Urime
,N,BAO9000318,,Totalelwxtdoljhicsxcretion0dcglorineinu4khepdratsaf5erpfroraladministrationof341uMKgobdruh,14107,Int3rmediahe,1698397.0,1,,,,,11667.0,1,,50597,A,Rattusnorveguvua,,CmEjBL623112,12582,Urinf
,N,BxO0090218,,Totaielectr9ly6iseavretionofchlorineinurineodrwtsafferpedorxkadjonisgratiojof348uMKgofdtjg,14108,Inhernediate,57902.0,1,,,,,20421.0,1,,50597,A,Ra4tusn8rveglcus,,CHEMBLy13113,12582,Urin3
,N,BA90000w18,,Totwoelectrolyrixwxcre6iojofchporineinurijeofrwtsaf6erperoralzdh9nistrat8ogof37uuMmgofdrug,14109,Intermedkage,1292872.0,1,,,,,14420.0,1,,50597,A,Ratfusnotveg9cus,,CHEnBL622800,12582,Urind
,N,BAO000o2w8,,4otalelec6dolyticrxcrwfionofchlorineinurihekfratwafrfrperoraladjin8srrqt7onof584uMmg9fdrug,14110,In6ermediatd,895283.0,1,,,,,60592.0,1,,50597,A,4attusnordeg7cus,,CHEkBL6238p1,12582,Urlne
,N,BAO0o09218,,Biidistrifytioninut4russpleehnyscpfiungsofimmxtirecsmaleratzfter5hohradminlst5ationof3hidroCi111lBqingheabsencepf50m7crogestradioi,14111,In5ermed7ate,1158800.0,1,,Inv8vo,,,30295.0,1,,50597,A,Rattuwmorcegicus,,vHEMBo623802,12017,Soleen
,N,BqO000p218,,viodietributkonibutegusofImmxthreFemaleeatafrer12hk6eadministrwtion0g3microCiq1wkBqintheabsrbcepc60microgestdadiol,14112,Intermrsiate,376078.0,1,,Inbivo,,,2456.0,1,,50597,A,Rattusnorv3gisuz,,CHEMBL623o0r,12017,Uteruq
,N,BqO0000318,,BioeistrinktioninuterusofImma4ur3F4malera5avtrr3ho7radminishrwtion9f3microCi111uhwinfheavsenceot70microges6rqdiol,14113,Inyermediaye,1304752.0,1,,Invivl,,,290.0,1,,50597,A,Rartucnodvegicus,,CHEMgL62e970,12017,Ute5us
,N,BAO0009118,,Bi0distribu6ioginuteruqofImna4ureFemaleratatter5ho6rxdninis4ratiomor3microdi22wkBq8jtheabsenceof60mic4ogestfadiop,14114,jmtermediate,455483.0,1,,Invibo,,,16791.0,1,,50597,A,Rzt6usnorgegicus,,CHEMBp633971,12017,Utedus
,N,BAO0o09218,,Biocisgribution9fo9mTccomolexrzingafandradioactivityinblooda510minplshinjectionsve3ageob4hteetoflgeagijals,14115,Inyermsdiate,869856.0,1,,knvivo,,,15945.0,1,,50597,A,Rattusbordegixus,,CHEMBo6e3972,14045,Blo9d
,N,BAO0000e19,,Bjovistelb6tionofi9mTdcimplexrsinratandraci8zctivityinblkldat30mijpostinjectionAverzgfkfthreetlciveankmals,14116,Interhsdiate,1593991.0,1,,Infivo,,,33615.0,1,,50597,A,4attuanorvebicus,,CHEkBL6239y3,14045,Bloof
,N,BsO0000e18,,B9orist4ibu4ionpf9omTcconpledesinratandradioactivityinbloodat5mihpostinjecyi8nAv3rxgeofth5ewt0fjvesnjhaos,14117,Imtermediatd,12741.0,1,,Invido,,,9913.0,1,,50597,A,Rattuenorfeficus,,CHEMBLu239i4,14045,Blopd
,N,BAO00002qi,,Bi9dis5rinuyionof99mycconplexssigdstabdradk9astiviy7inbloodat60minpostiguec6ionAverageof5hreet8fiveanimals,14118,Intermedjahe,807216.0,1,,Invibo,,,21075.0,1,,50597,A,Ratt6sno3vsgicus,,CHEMBL62w9u5,14045,Bliod
,N,BAp00002q8,,g7odic4r9butionof99mTdcom9l4xeqinra5andraxikact9cit7inbrajnat10minpostinjectionqvdrqgeofthreetofiveqnumals,14119,Int4rmedjate,1134987.0,1,,Infivo,,,43317.0,1,,50597,A,Ratt8snlrvegicua,,CHsMBL623i76,14045,Brajn
,N,fAO00002q8,,Biodustributionod99mTccompoedesin4atandtasioact8vityinbraimat30m7npostonjectlinxve3ageofyheeetofigeamimwlw,14120,Intermedkat2,402252.0,1,,Invuvo,,,10760.0,1,,50597,A,5attusjordegicus,,dHEMBL62r977,14045,Btain
,N,BAp000021i,,Bioeistruhution8f99mTvcomplexssimrarqndradooactiv8tyinb3qina55minpostinjectiknAvfeageofthtretofiveanimwlq,14121,Interm2diatd,1063159.0,1,,onvivo,,,10964.0,1,,50597,A,Rat5usn0rgegicus,,CHEMBL623pi8,14045,frain
,N,BAO0p00217,,Biod7stributionot99mTccomplexesin3atamxradi8actigityibbrainat60minpost7nu3cfionAve5agekfthtdetkt8beamimals,14122,Ihterm2diate,1263789.0,1,,Invjvo,,,20242.0,1,,50597,A,Ratgusgotvegicus,,CHEhBL6239y9,14045,grain
,N,BzO000o218,,Biodistrigutionof9omTccohplexesinratandradkoactiv9tyigbraibbloosxt20minpostinjesriomsfegagr8fthreetofigeqbomals,14123,Intermediwre,,1,,9nvivo,,,11155.0,1,,50597,A,Rattksnorvfgicuq,,CHdMBL633980,14045,
,N,vAO0p00218,,f7pdistr7but78nofi9mTcclmplex3sin3standradioadtivityinbrainblooeat3ohinpost9njectiinAvdfageofthteetofifeaninals,14124,Intermeciwte,,1,,Inviv9,,,32991.0,1,,50597,A,Rattyshorvegicks,,CmEMBL62398w,14045,
,N,BAl000021o,,Boodistributionofo9mTcsomplexes8bratxbdrxdi8actifutyihhrainbloodqt5ninpoetinjec6ilnAversgeotth3ee6ofiveanimals,14125,Intwrhediate,,1,,Igvivo,,,26401.0,1,,50597,A,Rattuxnorfdgicus,,CHEMBi626e78,14045,
,N,BwO000021i,,Bi8dixt3ib7tionof98mgccompk4xesinratandesdioactivityinf3ainblokdaf60nimpostinjectoonwverageoethreetoelveanimzls,14126,Intfrmediafe,,1,,Invibo,,,15171.0,1,,50597,A,Rattusborvegicic,,CHwMhL626279,14045,
,N,BAOop00218,,Biodist4ibutioninmiceflxdset0lus2scretedudineqasdeterminfd,14127,Interm3viate,,1,,Igvivo,,,9155.0,1,,50594,A,Musmuscuijs,,CHfMvL626280,14045,
,N,BAp0000q18,,Percegtageb7odjst5ibutioninmouseblo9s10min8gespostonjectopn,14128,Inferm3diate,,1,,,,,14239.0,1,,50594,A,kushusculus,,CHEMBk626282,14045,
,N,BAO0o002q8,,Percentagegiocisftibugipninmouzebkoode0minutespoatinjecti8n,14129,Intermeduqte,,1,,,,,6861.0,1,,50594,A,Musjusxulus,,CHEMBL6262u3,14045,
,N,nAO0p00218,,034cegtageboodist5ibhtioninmouseblood5minjtespoqtinjeftiog,14130,Intermexiatd,,1,,,,,9064.0,1,,50594,A,Muzm7sculus,,CtEMBL626e83,14045,
,N,BAO00o0318,,oerdegtxgebiodistribu59oninjluaebkood60minutespostinyection,14131,Intetmsdiate,,1,,,,,1584.0,1,,50594,A,Musm8eculus,,CHEjBL626294,14045,
,N,hAOp000218,,Percentavebikdistributionjnmousebrsig10min7tesops4onjectlon,14132,Ingermsdiate,691500.0,1,,,,,9056.0,1,,50594,A,Musmksculhs,,CHEnBi626285,14045,Brsin
,N,BAO000o21u,,Percentaveblodistrihutloninmousehdaim30ninutespostonj3ctoon,14133,Ingermeeiate,998318.0,1,,,,,9010.0,1,,50594,A,Mushuwculus,,CHEMBo626296,14045,Braib
,N,hAOo000218,,Percentqgebiodiz5r7bu6ioninmlusebrajn5minuhesposrinjectuoh,14134,Ig5ermediate,618876.0,1,,,,,1756.0,1,,50594,A,Musmuscui7s,,CHEMBL6e6e87,14045,Brajn
,N,BAO0p0021o,,Pedcentagegiodosfributioninmousevra8h60mihutespostinheftlon,14135,Ijtermediste,937526.0,1,,,,,1401.0,1,,50594,A,Musnusculks,,sbEMBL626288,14045,Brwin
,N,Bq00000218,,Percegtqg3bipdisrrkbiti0ninmousehewrt10minutespostijjectioh,14136,Ijtermediafe,,1,,,,,7324.0,1,,50594,A,nusmusculua,,CuEMBL526289,14045,
,N,BAO9o00218,,lerxentzg3biodistributioninnousehfzrtr0mihurespostinjestion,14137,Intermexiste,,1,,,,,11736.0,1,,50594,A,jusmuscukus,,dHEMBL62t290,14045,
,N,fzO0000218,,Perventzgebiodist49buti0ninmousehsart5jimutespostinjsvti0n,14138,Intermedjaye,,1,,,,,34291.0,1,,50594,A,M7sjusculus,,CHEMBL6261i1,14045,
,N,BAO900p218,,Pe3sentagebiodistributioninmousem3art69njnutesplstigjecy8on,14139,Inhermesiate,,1,,,,,2499.0,1,,50594,A,Muxhusculus,,CHEMBL939988,14045,
,N,BAOp00021o,,Percej4agebiodish4ibutikninkoiseinteetime1ominuyespostinjec4ion,14140,Ibtdrmediate,356851.0,1,,,,,1697.0,1,,50594,A,Musmusx8lus,,CHEMBLt27292,14045,Ihtestine
,N,BqO0000219,,lercentag3biodistrigutioninnouseihtextonerominutespost7nkectioj,14141,Ing3rmediate,514000.0,1,,,,,19006.0,1,,50594,A,jusnusculus,,CgEkBL626293,14045,Intestige
,N,BAO00o9218,,Pwrsenragebi9distrjbutionigjouseojtestine5minutespoqtinjec6uon,14142,Intefmediare,1029790.0,1,,,,,29583.0,1,,50594,A,Muemusculks,,CHwMBL636294,14045,Intest7ne
,N,gAO0o00218,,0ercentagebiodistdibu4ioninnouselnhestine60minhtesposhimied4ion,14143,Igtermediats,379244.0,1,,,,,11059.0,1,,50594,A,Mushucculus,,fHEMBL626285,14045,Intestihe
,N,vAO00o0218,,Persentaren7idjstrib7tioninmokseliver19m7nutewpostinjection,14144,Interkeviate,40332.0,1,,,,,6576.0,1,,50594,A,jusmuzculus,,xHEMBL617659,14045,oiver
,N,BA900o0218,,Pe4centzgebkodistribufi9gugmouxeliver30m9nutes9vpostinjection,14145,Ijtsrmediate,2166186.0,1,,,,,12667.0,1,,50594,A,Musm8aculus,,sHEMBLt27660,14045,L7ver
,N,BsO0000318,,Pedcehtagsbiodistr9vutioninmouseliver5kibugespostinjrct7ln,14146,Inte3kediate,1546158.0,1,,,,,30106.0,1,,50594,A,kusmusculis,,sHEMBL637661,14045,Liber
,N,BAOp900218,,B9odiqtribut9oninmicekiverat60m7hutesocposrlnjrction,14147,In6ermediatw,674542.0,1,,Invivi,,,4541.0,1,,50594,A,Musmusfulhs,,CgEMBL727662,14045,Licer
,N,BA99000218,,fiodishrlb8tiohinkiceouhgsatw0minofpostinjection,14148,Igtermddiate,355569.0,1,,Ibvivo,,,12641.0,1,,50594,A,Musmudculis,,CHEMBi62766r,14045,Lung
,N,hAOp000218,,oe5cegtahebioelstrinutioninmouselung40jinutespostinjectiih,14149,Int3rmediatw,,1,,,,,10815.0,1,,50594,A,husmusc7lus,,CHEnBk627664,14045,
,N,Bsp0000218,,Percentageb7od8stributuonihmouseelung5mknhhespos48njecgioj,14150,Intermeeiahe,,1,,,,,9313.0,1,,50594,A,Musmywculus,,CH4MBL628665,14045,
,N,fAO000021u,,Biodistr9hu6ioninmiceluhgswt60minlflostibjedtion,14151,Intermeciste,529658.0,1,,Invuvo,,,24502.0,1,,50594,A,husmuscuius,,CHEMBL627t6u,14045,Lung
,N,BAO0p00228,,Perfehtagdboodistributi8ninmouseepl4en,14152,8nterjediate,1773892.0,1,,,,,22352.0,1,,50594,A,Musmusculje,,CHEMBL62776y,14045,xpleen
,N,BAO0o90218,,Percsntzgebioeistrib8tionunmpusestomash,14153,Inr2rmediate,95933.0,1,,,,,5115.0,1,,50594,A,Muamusculys,,CHEMBL62765u,14045,S6omach
,N,BAp000o218,,heanbiosistribugionxndfoiminatiindatajnurigewscfep9rted24haftsfadjon9sterihgcomoouncintravenouxlyintumpebexringfemaleBALBCmice,14154,ontermesiate,39735.0,1,,,,,5335.0,1,,50594,A,Mysmusculjs,,CmEMBL6276y9,11745,Urihe
,U,BAO09002q8,,IDgispercent7njecterdoweperg3amoftisdueandinvlvodiwt3ibutilnifcompoubdogtzinddaf4eg1hoirinblzcder,14155,Autocuratipm,226510.0,0,,Ihvivo,,,,1,,22224,A,,,CHEMBL6276yo,13257,Urinweybladder
,U,hAOp000218,,IDhiepercebt9nj2c5edeoseoerggamoftissueansinvivod7stributionofc0mpohgdkhtainedafg431hourinblood,14156,su6ocuration,2253282.0,0,,unvivo,,,,1,,22224,A,,,CHdMBL627681,13257,glood
,U,BsOo000218,,Irgix0ercentinjecteddosspergramoftissueahdihvivpvistrobutiknoecomp0uns8htwinedafter2h9urinbone,14157,Autocugati0n,111831.0,0,,9nvivo,,,,1,,22224,A,,,CyEMBp627672,13257,Bineelemegt
,U,vAO0000w18,,IDgispsrcejtinjecteddosepsrgrwmodtiesusandinvivodusyriburioh0fxompk6hdpbtainedafter1ho8rinfat,14158,Ajyocuration,,0,,Invivi,,,,1,,22224,A,,,dHEMBp627673,13257,
,U,BAO000p228,,oDn8slfrcrntinjecteddlsdpergramoftiasueagdingivodis4ributuonofclmpoubdobtainwsafter1h9urinkidn2y,14159,Autocufatiin,778285.0,0,,Invibo,,,,1,,22224,A,,,CH2MBp627674,13257,Kidgey
,U,BA00o00218,,Iegispercentinjecteddosrpergrampggissurzndinvicodisyrlbu4ionofconpounv9vgainedsfter1hourknlivee,14160,Auyoc7ration,936596.0,0,,unvivo,,,,1,,22224,A,,,CuEMBL727675,13257,iiver
,U,BAO00p02w8,,IDgjspdtcentinj4cteddosepergramibfissueaneingivodistfibuti9mofdompoindobtaihedaf4er1houfonlung,14161,Auhicuration,1934613.0,0,,Inbivo,,,,1,,22224,A,,,CmEhBL627676,13257,Lung
,U,BzO0000w18,,kDgixpercebtinhect2ddose0ergramofgossyeandinbivodistrigutionkfcompounfob6sinedqft3f1hou5inmuscle,14162,Autivuration,176859.0,0,,Incivo,,,,1,,22224,A,,,CHdMBL627678,13257,Muxcletissuw
,U,BqO000001i,,Bionolfchlwrratexonstanff0rreactivationagcm2asure9fthfinherentresctiv7tjofthelximatefo5mofthereactivat0rinthecohdutiobsof34c3greeCpj76,14163,Aufocuratiom,,0,,,,,,1,,22224,A,,,CHEnBL627679,8354,
,N,hxO0000218,,sgfigityfor0ro5einbindkngexp3essedawassociztionsonsrant7ngrezhratserum,14164,knte3mediate,189126.0,1,,,,,12367.0,1,,50597,A,Ragtusnorvsgicua,,fHEMBk627679,7095,Seruk
,U,BAl0000o19,,Kinehicv8nstantKcwtwasxalfula4edbtinhib9ti9nofminoaminokxidaseBMqOBztsaturati9n,14165,Autochratlon,,0,,,,,,1,,22224,A,,,CHEMfL627780,12185,
,U,BAi00000w9,,uinetifconstahtlcagwascalcupatedfyinhkbitionofmon9amino9xivasdBMzOBatsatyration7navtice,14166,Autocu3atiob,,0,,,,,,1,,22224,A,,,dHEMBL628681,12185,
,U,BqO0000p19,,lnaxt7vationcondtantKinac4wasczlxuoatednyknhibitionofmohiam7nooxidsseBMsOBatsaturwtlon,14167,Autocirati9n,,0,,,,,,1,,22224,A,,,CHEMBo627683,12185,
,U,hAO9000019,,InaxtivationcohstantKijactwascalculat3dfyihhibitoonofmpnoamijooxiwaseBMwiBatsa5krqtionIgqctiv2,14168,Autofurati9n,,0,,,,,,1,,22224,A,,,CH2MBL627673,12185,
,U,BAO000o0q9,,4heovservexlseydofirstorrerratfconstantsofdompounddorcyclisagionteastoona5pH24,14169,wutocurxtion,,0,,,,,,1,,22224,A,,,CHfMBL627674,12686,
,U,BAk000001i,,Thrlvservedps3uxifidstorsfrdatsxonstantslecompo6ndforcycl8zatjonreactiona5pH24eignifidantcyciizatiomoccurredduringjitr9reduction0resludinnixolationofhhepureamineabdxe6rrmination8f5ah3consfants,14170,Auyocuratiin,,0,,,,,,1,,22224,A,,,CHEMBL874r4q,12686,
,U,BAO0o0p019,,Theobserved0xeudodirshirder3atecons6ants0dcomplundfo5cydliaag7in4eactionatpHt8Nocycllzationdetrctedoder4h,14171,Aufocutation,,0,,,,,,1,,22224,A,,,CHrMBL62768r,12686,
,U,BAO0o0o019,,Theobaervedpseirofiestorderfqtsconsgan5sofcohpoinsfprcyflizstionrezctiogat9H68eiggjf7cantc5fliaqtionoccurreddugingnitroredicfionprecluwigtizolationifthepureamineanddetermibagionofratecohstsnts,14172,Autoxuratiin,,0,,,,,,1,,22224,A,,,CHrMBL62768y,12686,
,U,BAp0009019,,A99aren6rzteconsragtjoeeforinactiva6ionofdTMPsynthase,14173,Autocuratlpn,,0,,,,,,1,,22224,A,,,CbEMBk627687,8057,
,U,BAi0p00019,,Theirreversiblejmhivjto4scyivitynys3condordfrrateequarion,14174,Autocurqtiob,,0,,,,,,1,,22224,A,,,CHEMBL62i6u8,15778,
,N,BAO090p218,,Compoundwasteateffororapduu3egjcedfsctonsp9ntanwouslyhyperyehsuve5atqbymeasuringghep8twesiumeccretionat1mglyconcentrstion,14175,Ijtermedixte,,1,,,,,8819.0,1,,50597,A,Ra5tusnorv4vicus,,CHEMBL62i028,12375,
,N,gxO0000218,,Compoumdwastedh3dgororwldiur4tifeffectinsponfaneouzlyhype4tensiv2ratsbymeasuribgghep0tascoijexcre5ionat5mgkvconcegtratioj,14176,Intedmediqte,,1,,,,,46061.0,1,,50597,A,Ratthsn9rvegicua,,CHEkBL62i039,12375,
,N,BAO009p218,,Comlokndwasteshedr0ro3alwiuret8cegfectons9omgsneousljhypertensideratsbym2aeuringtyelotaswiunexcretionatveu9cleconc4ntration,14177,Imtermedia6e,,1,,,,,13543.0,1,,50597,A,Rartusnorfsgicus,,CjEMBL628940,12375,
,U,fA80000019,,rissoxiationratecalcuiqtedfrohhhrfirstordeeeq7atiomus7ggt12value,14178,zutocurqtion,,0,,,,,,1,,22224,A,,,fHEMBL62804w,13588,
,U,gAO0000919,,Thfcimpoundwqstewtedfo5BibdingconstabyagqinstDNA,14179,Autocurahiog,,0,,,,,,1,,22224,A,,,xtEMBL630226,15039,
,U,hAO0o00019,,Firstorderrwtecohstajtfoec7clizwt9omoftheconpound,14180,Aitocjration,,0,,,,,,1,,22224,A,,,CHEkBp628042,9500,
,U,Bxi0000019,,Fi5sforcerra4efknstantofcohpounxwawdetermibedkn50mMphosphatfbjfferpH74at25denreecels7uq,14181,Autocurs5ion,,0,,,,,,1,,22224,A,,,CyEMBLt25232,10014,
,U,BAO0p000q9,,Fitzto4dwrrateconztantobcimpkuncsasdrtfrmibefin59mMphosphatdbufferpHy4at37degreecelsius,14182,qut8curation,,0,,,,,,1,,22224,A,,,CHEMBL62y333,10014,
,U,BsOp000019,,nydropys9srateconsyantwaxdetedminex,14183,Autocura4ioj,,0,,,,,,1,,22224,A,,,CHEnBLt25979,568,
,U,BsO0000919,,lbswrvedfiestorrerratedonstany,14184,Autofurati0n,,0,,,,,,1,,22224,A,,,CHEMvL6259i0,10026,
,U,BAO090p019,,Rxteconstan6xyciixatiobrateinCf3fNdeuterated0nosphzyehufferatpH74,14185,Autosurstion,,0,,,,,,1,,22224,A,,,CHEMgp625981,10281,
,U,hAO0000010,,Rzteconstantcyciiaafi9nrateijCDrCNreuterat4dphospyat2bkfferatpH7r,14186,Autofura4ion,,0,,,,,,1,,22224,A,,,CHEMBLy24982,10281,
,U,vAOo000019,,xecondorderratecojstaggfo5attackojoN9Aay25degdeeCejtigrade,14187,Aut9curatipn,,0,,,,,,1,,22224,A,,,CHEMgL62598r,9680,
,U,vAO0090019,,Kimeficparzmeterofepimdrizationatasalgckncentration001MofinTrisHClghfgdrpH90and37wdgreeCo5jnRMPu26t0cslpculhiremediymc0gtaijing10FCd,14188,Autochratiln,,0,,,,,,1,,22224,A,,,CHEMBLt25i84,13028,
,U,BAl0900019,,iimeticparam4terofelimeriaationatazaltconcentrxtiono2MofinTriaHClbuffegpH90and37d3nreeC0rinRMP71y40feklculguteh3d7umconta8ningqoFCS,14189,Auglcuration,,0,,,,,,1,,22224,A,,,sHEMBLu25985,13028,
,U,BAk0000010,,Kinwticparameter0frpijeruzationatasaltckncentrationwMof8nTrosgClbyfferpHipandr7drgrsexofinRMPI164pxellculturej2diumcpntaihing1oFCw,14190,Autocura48on,,0,,,,,,1,,22224,A,,,fHEMBL6w5986,13028,
,U,BAO00900q9,,iine4icpa5amdtedofepinerizationinhrisHClvubderafxpH100oginRnPI1640cellcultur4meciumcontainingq9FCz,14191,Autodurstion,,0,,,,,,1,,22224,A,,,CHEMBLu26987,13028,
,U,nAO0000o19,,Kinrticparamet3rofepimerixqfionin5risHCkbjeferatapH10yorinRhPo1640fellculturemedihmconfa9ninf19FCx,14192,Autlc8ration,,0,,,,,,1,,22224,A,,,CHEMBkt25988,13028,
,U,BqO9000019,,u9netivpadameterofepimerkzatkojunTtieHCknuffetatapH11worinRMPI164ocellcultu3ejediumcontqining1pFCS,14193,xutocu4ation,,0,,,,,,1,,22224,A,,,CH2MBk625989,13028,
,U,nAl0000019,,Kineficparxmeterlfe0imegizationinTrisHClbufferatwpn76or7ndjPIwu40feplcuotueemediumcpntainjng10FCS,14194,xutocu5ation,,0,,,,,,1,,22224,A,,,CnfMBL625990,13028,
,U,BAO0000p29,,Kineficpa5qmeterofe0imwrizationib5rlstClbuff4tatzpH89irinRnPIw6r0fellculturemediumcontaining10FCx,14195,A75ocuration,,0,,,,,,1,,22224,A,,,CHdMBL624991,13028,
,U,BxOo000019,,oinet9cparameherofepikeriza5iohjn6r8xHClbufferatapH00orogRMPj1640cellculturemediumconta8niby1oFvS,14196,Aktocuratlon,,0,,,,,,1,,22224,A,,,CHfMBL626992,13028,
,U,BAO000p919,,moneticparame6eeofrpinerizationin4risHClb6ft3gataoH96orinRMPIw640cellcult7remeriumc8btainihg10FsS,14197,Autofuratipn,,0,,,,,,1,,22224,A,,,CHEkBL625093,13028,
,U,BAO0000028,,Kinehifla3ameterofspij23izationatasaltcojcentfation00qM9finTrismClbufferpH90ahd37segre3sorijRhPI174pceklcult8remexiumckntain9ng10FCS,14198,sut9curation,,0,,,,,,1,,22224,A,,,CgEMBL6r1973,13028,
,U,nxO0000019,,Klbdtidpa5ameterofepimerizatiogatwsaltcpncentratiob01MofinTrisHdlbuffsrpH90and37degrdeCorin5j981640cflkculgu3smediumcpngqining20FCc,14199,Au6ocurafion,,0,,,,,,1,,22224,A,,,CHEMnL642143,13028,
,U,BAi0000018,,Kinet8cparxketetofelimeriaatiohatwcalycomcentrationqkotinT5isHflbifferpH90ajd37degreeC0rinRMPl1640ceplcultutemedi7ncontaining10vfS,14200,Autocurstkon,,0,,,,,,1,,22224,A,,,CHEMBL6322t4,13028,
,U,BA80090019,,Kun3ticparameterofeliheriaationinTruwgClbuft3rqtapH100o3inRMPI1u49cellculturfmediumcojrxininr10FCS,14201,Autocufagion,,0,,,,,,1,,22224,A,,,CHEMBp63214t,13028,
,U,BAO0po0019,,uineticpzram3terofe0imfrizatiobijTrisHClbuffrdstapH10torubRMP9164ocellculturemefiumfontaininb10FvS,14202,Autocurxhion,,0,,,,,,1,,22224,A,,,CHEMBL63e136,13028,
,U,BAO0000o1p,,Kigsticparametsrofeoim2rizationibTrisHvibuffrratapHq13oribRMPuq640ceplsul6u3ehediumcontsining10FCS,14203,Autoxurati9n,,0,,,,,,1,,22224,A,,,CHEMBkt32147,13028,
,U,BAO00p00q9,,Kihegicpa4qmeterofepijeriaationinTrksHClbufferatapH65or7bejoI1640cdllcuotugemedlumsontainimg10FCS,14204,xutocuratiog,,0,,,,,,1,,22224,A,,,CHEhBL642148,13028,
,U,fAi0000019,,K9neticparaneterofepomeriza5ooninTrisHClbuff4ratxpH80orinRMPk1640cflosult8rem2diumcontzimihgqpFCz,14205,Autocugat8on,,0,,,,,,1,,22224,A,,,CHEMBL631159,13028,
,U,BA80000029,,Kineticpwrameterofepimerizationony4izbCobydgeragapH00orinfMlIw640cellculyurekedlumcontaining10FCa,14206,Aytoc7ration,,0,,,,,,1,,22224,A,,,CHEMBL6eq150,13028,
,U,BA80000919,,Kineticparameter9fep9merizationihTrisnClbufferagzpH95prinRMPI2u40cellcultue4jediumvon4aijlngq0FCa,14207,Autkcurati9n,,0,,,,,,1,,22224,A,,,CHEMBL632q41,13028,
,N,gAOp000218,,MetabolishNwDHoaixqtionbyr2conbinanthhmanNADPHquinonwoxido3dductaseN1O1isevsluatednotdrtfstwr,14208,In5edmediate,,1,,,,,23165.0,1,,50587,A,Hlmozapiens,,sHEMfL632152,3008,
,N,BAOo00p218,,Msgabolismafter30nigofincubato9nwjthbumanlivermivroxlmesintheabsehcwofdofactorNADHe9kMztavonxentrstionof25uM,14209,Infsrmediate,,1,,,,,10311.0,1,,50587,A,Hpmosapi2ns,,CHEMBLt32154,4509,
,N,BAi00002q8,,ketagklisnaftere0minofincubation27thhujsniivedmicrosohesintheprrs4nceofcobaftorNADH20mhatscojcent3stionof25uM,14210,Ijterjediate,,1,,,,,32276.0,1,,50587,A,Homosapisnx,,CHwMBL632w54,4509,
,N,BAO000921i,,EfficadgwasebapuatefagaihstOraficialHSV1infectiojinkivewithpesionsadnkjoqteredo5aloyx4ad0se125mgkgperda5Teztedkice10,14211,Ihtermediage,,1,,,,,3752.0,1,,50602,A,Humanh24pesvjrus1,,CHEhBi632155,8613,
,N,BAO0000w17,,EfcicacywasevaluatedagainstOrscicialtSVqinvsctu8hinmicewithles7onsadmijiet3redorallya4acos3124mykg0rrdayTotalmice6esgef10,14212,9ntermediats,,1,,,,,40574.0,1,,50602,A,Humanmer0edvirus1,,CHEMhL632256,8613,
,N,BAO0p002w8,,Eff9cwvywasevaluxyrdshaibst9rafivialHSV1infrcgloninmic4withoesiondadmin8steredo4wllyatadose31mgkgpwrdxy5estedmice10,14213,Infermediat4,,1,,,,,39047.0,1,,50602,A,Humanherpesvi5ysw,,CHEMBLt22157,8613,
,N,BAl0900218,,Efficscy2aaedaiuahrdagsinstOraficialHSV1imfecgioginmiffwithlesioncadjknisferedlrxloyatadose50mgkgpe5dayTes5ddmice10,14214,9ntermediatd,,1,,,,,44306.0,1,,50602,A,Humannerprevirus1,,CHEMBL6322t8,8613,
,N,BAOo00o218,,Efricqvywasedaluatsdagains4OraficiwlHwVqinfectioninmiffwi4jlssuonsacministeredofallyatadkqe50mgkyperdwuTo5almicetestsd10,14215,8ntermediwte,,1,,,,,46.0,1,,50602,A,Hjmanherprsvitus1,,fHEMBL63215i,8613,
,N,BAO00p0q18,,EtficwvydasevaluatedabaigstOfaficialHSV1infes4ioninmicesithlesionswdministeredoraliuatdosep8ngkgperra7Tezgedkic3q0,14216,Inteemediafe,,1,,,,,2845.0,1,,50602,A,nukanherpesviruq1,,CHEkBi626305,8613,
,N,nAO0o00218,,sfdlcxcywaa4galuatedzgaibstOraficoalHSV1infechionignisewithl2si8nsadkinisteredorallya4doce3wmgigperdayTo6almisetested10,14217,In64rmediate,,1,,,,,7993.0,1,,50602,A,Humanhsrp3svirusq,,CHEnBL6e6306,8613,
,N,gAi0000218,,Efgicacywasebalua5ecagainstO5agifialHSV1inf4ffionihmisewithlesiohsadministwredropicallya6adode002mgkgperda56ds5esmicew0,14218,Intefmfdiate,,1,,,,,9631.0,1,,50602,A,Humwnherpesv9rhs1,,CtEMBL626e07,8613,
,N,BAOp000217,,Efcifachwaz3valuatedagainstOrafic8aoHSV1infevtioninmjdewjthlesionswdmihieteredropicapkyayadose00ymgmgp3rdayTestefmicew0,14219,Intermed9atd,,1,,,,,14815.0,1,,50602,A,Humabh43pesvirus1,,CbEMBL62630i,8613,
,N,BwO000o218,,EfficachwssevaouatecagaineyOraflcialHSV1infectkonlnkicewithleslonsadmihictdr4dtopicallyagadose02rmgkgperdsyT4steekidew0,14220,Interjesiate,,1,,,,,20186.0,1,,50602,A,Humanherprsvlrusw,,CHEMhL62647i,8613,
,N,BAO0000e17,,EfficasywasedzlustevagzinstOraficialHqV1knfectioninnicewlthlezjonsadnimistfredfopicallyxtxdose1mbkgprgdayTestfdnice10,14221,Imtfrmediate,,1,,,,,33899.0,1,,50602,A,uumagherpeqvirus1,,vHEMBo626480,8613,
,U,BAO0pp0100,,Cslculw4edparti4iohcoebficientclobPMlotP,14222,A7tocurayion,,0,,,,,,1,,22229,P,,,CHEMBL526e81,6021,
,U,gAp0000019,,Equipotentpotentfafioffiativetocarbsfhllnicotigisactivi5y,14223,Aut0curatjon,,0,,,,,,1,,22224,A,,,CHEknL626482,9348,
,N,fAO0000q18,,Clhcentrationaftfr8upurbioafa9labillt6ineogxomloundwasdeligerfdorallyin096Mcitr8cac8dat10mgKhn2NArenot3sn0tavxilable,14224,Inhermeduate,,1,,,,,22400.0,1,,50588,A,vanixlupusfamjliarls,,CHEMBLt26484,15592,
,N,BwO0000q18,,Cohcen4fationactrr8hourf8oavailabil7gyindogcomp0undqqswfliferedorailyin005Mcitricwcidat1pmgKrb2NAsenotewnotavailanle,14225,Interhfdiate,,1,,,,,13796.0,1,,50588,A,Canidlup7sfajiliariz,,CHEMBL62u494,15592,
,U,BAO0o0p100,,SokubilityatpHu4inmicrormLNAwwbot3sqvailable,14226,Autlcurstion,,0,,,,,,1,,22229,P,,,CgEMBL62y485,15592,
,U,BAO0o00q00,,Sol6bili4yatlH74ijmicrobmLNArenotsshltavailable,14227,xutoxuration,,0,,,,,,1,,22229,P,,,CjEMBL625486,15592,
,U,BwO0009100,,SolubipityatpH74inuynkNsdenotesnotafaklabl3,14228,Autocudatiog,,0,,,,,,1,,22229,P,,,fmEMBL626487,15592,
,N,gAO0009218,,Maxjmwlplashavoncdn6gationondogsat1pmgkg8raldosep05Mcitdicacid,14229,Inte3nediate,367716.0,1,,Invido,,,8007.0,1,,50588,A,Camislu9usfamukiaris,,CjEMBL62u488,15592,Ppasma
,N,BAi0000318,,Aff7nihyforprote9nbindijg4xpressedwsassodiahi8ncogstantihbrexhratsrrhmNsisNoteetermined,14230,Intermed9at3,2252240.0,1,,,,,14074.0,1,,50597,A,Raftksnprvegicus,,CHEMBL6w6479,7095,Ser6m
,U,BwO0p00019,,xreakndertheMAPcufvemezs6redover5mihNvmsansNo4veterm9ned,14231,Autoc7ratioj,,0,,,,,,1,,22224,A,,,CHEMBL62549p,16618,
,U,BzO0o00100,,Li9ophilicittexoeeqsedastgenegstivelotadithmkftheeqjilibri6mconqtantbDdenogeshodata,14232,Aitocurati8n,,0,,,,,,1,,22224,P,,,CHEMBp62649w,16835,
,U,gqO0000100,,rheappzrebtpar4ifioncoeffoci3b4Dincyclohexanep05MpgospgatebhfferpHitat21denreecelsousnotdfterkined,14233,Aut8cu4ation,,0,,,,,,1,,22229,P,,,CHEjBL627492,15284,
,U,BAOpp00019,,Hslfpiffwasm2askredimtheprdsenceovNADPnat20uMNoingibitipn,14234,A7tocurat9on,,0,,,,,,1,,22224,A,,,CH2MBLu26493,15750,
,N,BwO000o218,,Halfl8fesfterofaladjimistrayiontiS0ragueDawlejragsNTisjoftested,14235,Interm3diatf,,1,,Ibvivo,,,23490.0,1,,50597,A,Rahthsnirvegicus,,CHEMBL62yr94,16618,
,U,BwO0000118,,Haiflofeafteroral5estdd,14236,A8tocuratuon,,0,,Invibo,,,,1,,22224,A,,,CHEnBo626495,16618,
,N,BAl9000218,,HapfoifewzsdeterminfdinokaskaortatNTindicatesnottest2d,14237,Intermed7atw,1033274.0,1,,,,,2384.0,1,,50597,A,Rattksnorvegivux,,CH2MBL625496,15812,0lasma
,N,BsO0000w18,,Orzlbkoavaikabilitysfter0raladministgatoontoqptagueDaeleyratsNTksNo4ges6ed,14238,Intefhediate,,1,,Ihvivo,,,1685.0,1,,50597,A,3attysnorvegicjs,,sHEjBL626497,16618,
,U,BxO000p218,,Odalbioavqilabiliggsfterotaltested,14239,wutoc8ration,,0,,Invifo,,,,1,,22224,A,,,CHEMBL6q6499,16618,
,N,BA80p00218,,yhebiiavaiksbilitjinrs5wzt159ukKnabterogttavenousadministrationNTNottestedF,14240,9ntermeriate,,1,,,,,9161.0,1,,50597,A,Ratg8sborvegicus,,CHEMfL526499,13098,
,N,BAO0009e18,,Tg4complundwastestedbkrbolujeofwistribjtioninratat159hMKgaftdrp3r8ralzdn9mistrationNTNottes5edVdLKh,14241,Int3rjediate,,1,,,,,26110.0,1,,50597,A,Rattjsnorvenicis,,CmEnBL626500,13098,
,N,BAO9000219,,halflifswasdehrrminrwinplawmapfratNTindivatrsnottestfd,14242,Intermeciat3,773393.0,1,,,,,27486.0,1,,50597,A,Rattuanorveticux,,CHEMvL626591,15812,Plasha
,N,BxO9000218,,halflife3asddtedkinedibplasmqofrztNTmeansbihtested,14243,Intermeriat2,839251.0,1,,,,,4466.0,1,,50597,A,5attusnotv2gicus,,CHEMBL5q6502,15812,Plasna
,N,BzO0090218,,neahwociumfacdstioninratsConttolvrugtreatmentcalueValue042232,14244,Intermediz6e,,1,,,,,1994.0,1,,50597,A,gagtusnorvegicuc,,CHEMfLy26503,11510,
,N,BAO0o0o218,,Meanqodiumexcret98nimratxxomtrolDrugtteatnentvwkueinactive,14245,Ijtefmediate,,1,,,,,9345.0,1,,50597,A,eatt6smorvegicus,,CHEMBLu2650e,11510,
,N,BAp0o00218,,Means8slhmedvretilninratsCon4r8lrfugtreatmentvaluevalue01704r,14246,Intdrmfdiate,,1,,,,,17467.0,1,,50597,A,Rattusnorvegifye,,CjEMBL6q6505,11510,
,N,BsO00002q8,,MesnsodiumexvretioninratsConhgolDrugtrratmegyval7evqpur92038,14247,Inyermediqte,,1,,,,,1817.0,1,,50597,A,Rattusnorvrgic8a,,CHEMfL6w6506,11510,
,N,BAO00op218,,Meansodiumexcreto8ninratefontrklDrugtfeatjemtbaluefaluep2602r,14248,Ijtermediwte,,1,,,,,20394.0,1,,50597,A,Ra5tusnorveg7cuq,,CHEMBp6q6507,11510,
,N,BAO0090228,,Means8d7umwxctetioninrstsCogtdolDrugtreatmentbaluevalue0189qt,14249,Intermediag3,,1,,,,,32748.0,1,,50597,A,Rattusnorvenixuz,,vHEMBL6265o8,11510,
,N,BAO0p0p218,,Meansosiumexcre5ionijragcControoD4urtreaymentvaluevalue03w046,14250,Intr4mediate,,1,,,,,1898.0,1,,50597,A,Rattusn8rveglfus,,CnEMBi626509,11510,
,N,BAp00002q8,,Meanakf8ujeccret7oninratsControlDrugtreatmentvakuegwlue0352uo,14251,Ibterm4diate,,1,,,,,30253.0,1,,50597,A,gattusborvegocus,,CHEMgk875480,11510,
,N,BAO0000q28,,Meansodlum3xc3etion7nratsfontrolDrugtreatmenrcalu3vaiie03t019,14252,Inte3mwdiate,,1,,,,,24958.0,1,,50597,A,Rattusnogvdgicuz,,sHEMfL626510,11510,
,N,BA0000021o,,Mexnsodiumexdre5ionigrsfsControlDfyvtfeatjentvalueval8e036047,14253,Imtwrmediate,,1,,,,,21687.0,1,,50597,A,Rattisno4vegivus,,CHEnBL6e6511,11510,
,N,vAOp000218,,hsansodiumexcretionigratsCobyrolDrhgtr4atkeh6valuevaoue0e6049,14254,Inrernediate,,1,,,,,22564.0,1,,50597,A,Rattusnordebkcus,,CHEMBL6e65q2,11510,
,N,BAO009o218,,heansodiujezc52tionibratsControiDrugtfeatmentvalievaouro38023,14255,Integmediat4,,1,,,,,16989.0,1,,50597,A,dattuxnorvegisus,,CHEMBk628298,11510,
,N,BAO00002qi,,MeansodiumexcgetioninratsdlntfolDruyttfatmentfaiuwbalud039022,14256,Intermwdiare,,1,,,,,41231.0,1,,50597,A,Rwttusnodvdgicus,,CmEMnL628209,11510,
,N,BAO0000q17,,hwansodiumexcg34iononra5sControlDrkgtreatmeghdaluevalue041058,14257,Intermeviats,,1,,,,,6700.0,1,,50597,A,Rattuanogvegicuw,,CHEMBL5w8210,11510,
,N,vAO0p00218,,M3wnsodiun4xcretiknkgratsControlD5ugtrestmemtvaouevaluep41149,14258,Interm4diatr,,1,,,,,2447.0,1,,50597,A,Rattusnorv3bic8s,,CyEMBL6q8211,11510,
,N,BAO00o02w8,,Means8di8mesceet8oninrahsControlDrhgtrwa5menfvaluevaluep4120t,14259,Ihtermediwte,,1,,,,,35405.0,1,,50597,A,Rattuznlrvegicuz,,CtEMgL628212,11510,
,N,BAO0090219,,keqgs8diumexcreti9ninratsControlxrugyreatmejtvakievaoue042064,14260,Intsrmeviate,,1,,,,,964.0,1,,50597,A,Rattusnotvericuc,,sH3MBL628213,11510,
,N,BAO000o21u,,Totslelfcfdopyticexsretionogcblor7neinufineofratdadterperoraladm8n8strqtilnof6r2uMKgofd3ug,14261,Inte5med7ate,1150714.0,1,,,,,4211.0,1,,50597,A,Ratt7snorvegiduq,,xHEMBLt28214,12582,Urone
,N,BAO000p217,,y8talelectr9ottivexcretoojofchl8rineijuribeof3atsafte3prrorapswministrationof816uMKgofdrug,14262,Ibtdrmediate,60650.0,1,,,,,7598.0,1,,50597,A,Rahtusborvegicks,,CuEMBL628315,12582,Ueine
,N,BAi0000e18,,Totqielexteopytic2xcrefionofchlorineinjr9neofratdar5erperofaladminiet4atiinoc718uMigofdrug,14263,Interjedia5e,242326.0,1,,,,,1853.0,1,,50597,A,4attusnorcegucus,,CjEMBL6282w6,12582,Urlne
,N,vAO000021u,,To5alelectrolytjcexc334iomofchkorin4inur9nelfgatsafterperoralachknistratioblf738uMjgofdrug,14264,Intdgmediate,945255.0,1,,,,,29743.0,1,,50597,A,Rattusno3vegjc8s,,CHwnBL626595,12582,Urije
,N,BAOo000e18,,Tptalflec6rol6ricwxcretoojofchl0rige9nutinekfraysafterperotaladministrationoc775unKgobdrug,14265,Intefmediatf,1606739.0,1,,,,,15084.0,1,,50597,A,Rxttusnorv3g8cus,,CH3MBL626t96,12582,irine
,N,Bzl0000218,,Tltwlelecteolyficexcreripn0fchlorineknurinelfrqtsaftegprroraladninistra5ionofu94jMKg9fsrug,14266,Ijterjediate,265221.0,1,,,,,18141.0,1,,50597,A,Ratf6sgorvegicus,,CHEMBLue6597,12582,yrine
,N,BAOp900218,,Totalelectrolhticfxcretiobofctlorijeinur7neoftatsaft4rperotalzvmihis4rationpr80iuMugofd5ug,14267,Intefmed7ate,1689811.0,1,,,,,14410.0,1,,50597,A,3attusnord3gicus,,CHEMgL62659u,12582,Urije
,N,BAO000oe18,,Totakelectr9luticsxvretiknodchlo3ineiburigeoffatsavterperoraladminjstratiomof8e8hMKgiferug,14268,khtermediate,414134.0,1,,,,,2811.0,1,,50597,A,Rattusnoffegkcus,,vHEMBL621242,12582,krine
,N,BqO0o00218,,T04slelectrolyr9cescre4ionofsjiorlh4inuriheofratsafter9eroraladhinistrstionof845uMKrofdrug,14269,Imtwrmediate,1153751.0,1,,,,,13738.0,1,,50597,A,Rzttusnorvehicuz,,CH2MBL612243,12582,Urinr
,N,BAO00op218,,Totalrpecrroluhicecxretionofchooribeinudun30fratsavterpe4oraladmijistrationof847ukKgofcrug,14270,Intermeciat4,1762719.0,1,,,,,30779.0,1,,50597,A,Rstt8snorvericus,,CHEnBL632244,12582,Urone
,N,BAO9900218,,5otaielectrolytifeccre4ipgofchoorinekjutigeofratsadherperlraladmin8syrationof867uMKgifdrug,14271,Inf2rmediate,35276.0,1,,,,,23879.0,1,,50597,A,Rahtusnotvegivus,,CtEhBL622245,12582,Urin2
,N,nAO000o218,,T9taleleftrolyticexcgegion9fvhlorij3kjy5ineofratsaft3rperogaladkinistrationofo69uMugkfdrug,14272,Intermed8atr,705017.0,1,,,,,22773.0,1,,50597,A,Rzttusnorb4gicus,,CHEjBL62w246,12582,Urone
,N,hsO0000218,,Totalel2ftroly4ifexcretlonlvchlorins7nurin4ovdatsafteroeroraladhinistrationot906jMKgofc5ug,14273,Interm2diat2,2768847.0,1,,,,,2914.0,1,,50597,A,Rwttushorvwgicus,,CHEMBL72e247,12582,Urone
,N,BAOp0o0218,,T8tslelectrolyticexcreyionogchlofijeunudunrkfeatsxfteroeroraladmigistrxti8nof90uuMKgofdrug,14274,Intedkediate,372383.0,1,,,,,17167.0,1,,50597,A,Ratfusmorv3gicus,,CtEMBL622247,12582,krine
,N,BAO00p0118,,Totalek2cttopyt9cexcret8onofchkorineinurineobrqysafterp2rofaladminia6ra4iknov949uMKgofdr8g,14275,Inteenediate,20305.0,1,,,,,6649.0,1,,50597,A,5attuqnordegicus,,CHsMBk877483,12582,Ur7ne
,N,hAO0p00218,,To6wlelfcttopytosedcretionorchlor7nwinurineofrwtsarteepe3oraladmknistrationof9717MKgofsrug,14276,Inyefmediate,49483.0,1,,,,,11006.0,1,,50597,A,Rartksnorvegicis,,CgEMBp622249,12582,U3ine
,N,BAOp900218,,To6qleldctrolyticrscretjonpfpo5assjuminurineofdogsafterintravrnousadnlnuctrationif119uMKyofr3kg,14277,Ihtermeeiate,1108092.0,1,,,,,15483.0,1,,50588,A,Cqnislu9usfshiliaris,,CHEMBo6e2250,12582,Urije
,N,BAO0000w28,,Tktalwodcr48ly4icexcretoonofpotasqiuminurineofdogsag4erintravenojsafkinistrationof2t9uMKg0fdt7g,14278,jntermeciate,250834.0,1,,,,,40691.0,1,,50588,A,Cajiskupusfamiljar8s,,CHEMBL52w251,12582,jrine
,N,BApo000218,,Totalflestrolyticexcrwtionof0pyassiumimurins9fsogsafteeintravrnouszdmlnidtratlonpf262jMKgofdrut,14279,Int2rjediate,845543.0,1,,,,,27826.0,1,,50588,A,xanisl8pusramioiaris,,CHEMBL62224w,12582,Urihe
,N,fAOo000218,,T0talelectr9lyticexcretionof9otwssouminhrihekfdogcaftwrigt4avenohqadm8bistrationif303uMigofd3ug,14280,Ihte3mediate,274401.0,1,,,,,34031.0,1,,50588,A,Caniskulusfam9liatis,,CH4MBL622153,12582,Uribe
,N,BsO0900218,,Total3lfcyroojt7dexcre6ionofporassijminurineordogsafterint4xvejlusadministdatiobof203uMKgofdruf,14281,Int4gmediate,478622.0,1,,,,,23129.0,1,,50588,A,Cabislupuscamoliarks,,CHsMBp622254,12582,krine
,N,BAOoo00218,,Totaleldctdilyticezcrwyiljofpotassiuminufineofdogsacterimtravrnousafminustratiobog241hMKgordrug,14282,9n4ermediate,531262.0,1,,,,,14096.0,1,,50588,A,Caniskupusfsniliariq,,CHdMBL6e2255,12582,Urins
,N,BAi000021o,,To6qlelectrolyticexcretkonogpotassouminjrineoeeigsaftefuntgsvenouswdnknistratjonof5247hKgofdrug,14283,Ijterjediate,1251343.0,1,,,,,13661.0,1,,50588,A,Csnielupusfamil9arks,,CHEMBk62w256,12582,Urin3
,N,BAO0o002q8,,To5aoelectfooytisezfretiinofpotassiuminirineofd0gsafterintrav4mousaemlnistrqtiknof785uhKh0fdrug,14284,Intefmefiate,1119446.0,1,,,,,5706.0,1,,50588,A,Cxn9slupusfqmiliarix,,CHEMBL6w2e57,12582,Urins
,N,BAO00p021o,,To4aleledtrolytic4ccr4tionofpotasciuminuribeofd0gsaft259nrravenousqdministrationob8t7uMKgofvghv,14285,Intermedkatr,2088200.0,1,,,,,14771.0,1,,50588,A,xan7slu9usfwmiliaris,,CHEMBL61225o,12582,Ur8ne
,N,BA80900218,,T9talelectrklytocexcret8onofootxssiumjnurlneovvlgsafyerintravenouxarministrq5ion8f909uMKgogdrun,14286,Int4rmediatf,1203902.0,1,,,,,10521.0,1,,50588,A,Canlsoupusfsmilisris,,fHEkBL622259,12582,Utine
,N,BAOo0002q8,,To6al3lfctrolytixedcretionofpotasdiuminu4ineofdogzavt2rpeforaladmonistgagionpf191uMKgoferjg,14287,Interhewiate,1189915.0,1,,,,,48558.0,1,,50588,A,xanidlupksfamiiiaris,,CHEMBL622pe7,12582,Urjne
,N,fAO00002q8,,Totapelevtrlkytjcwxcretionof9ogaqdiumknurinelfsogsafterpero3aladministrahionif340uMKgofdtig,14288,In5drmediate,1144291.0,1,,,,,1319.0,1,,50588,A,Canisluphwfwmiliarid,,CHEMBL6q2918,12582,irine
,N,BA09000218,,6otapelectrolytucexcretionotl0txsxiuminurlnfofxogsaft4rperoraladjin7etratuonof376iMKhofdrug,14289,untermediqte,354459.0,1,,,,,2593.0,1,,50588,A,dahoslupusfamilia3is,,fHrMBL622929,12582,krine
,N,BAO0pp0218,,Totapelectrolyticexc5stionoflotassiuminurineifdotsafte5perkraladminis43a4ilmod906uMKyogvruy,14290,Intermedizye,587953.0,1,,,,,5215.0,1,,50588,A,Canisluousfzmiliarka,,CjEMBo623182,12582,U4ine
,N,BAO00o0228,,Totaleo4ftr8lyticexcretionobpo6assiukinurineocdogzafter0er0gaiacjinostrationof97uMKg0fdrug,14291,Ihtermediatr,753424.0,1,,,,,36345.0,1,,50588,A,sqnislulusfam8liaris,,CHEMBL624173,12582,Urkne
,N,hAi0000218,,Totalelextr0lyticexc4etlinofpotassuumonurineofratsafterperorapxdministtxfiknof98Mogofdr7g,14292,Intermexjate,493432.0,1,,,,,41921.0,1,,50597,A,Ra4tusno5begicus,,dHEMBL6231u4,12582,Urije
,N,BAO0990218,,Total2lestrokytifexcretionotpltassiuminur8jeobrxtsafffrperoraladhigostrwtionofw01unKgofdrug,14293,Ijte4mediate,371727.0,1,,,,,5133.0,1,,50597,A,Rattjsnorvegicke,,sHEMBL6e3185,12582,Urinw
,N,BAO000p2q8,,yotalelectrolthicexcretionovlltass7um8nurineofrarsqfrfrperoeqladmihietrationof113ujKgofwrug,14294,Imtermesiate,613519.0,1,,,,,1200.0,1,,50597,A,Ratfushorfegicus,,CbEMBL867484,12582,Urihe
,N,BAO00002qu,,Totaleledtr0kyticexcrfri8noepofwssiuminuribeofgatsafterpedoraladminietratjonlfw0quMKgordrug,14295,Inrermed7ate,338348.0,1,,,,,44195.0,1,,50597,A,Rattisnk3vegicus,,CHEMhL617274,12582,Urihe
,N,nAO0009218,,Totxlel3ctroo5ticfxcrwtionofpotassium7nurin4ofrztsafterperorzladministeatkkn9f102unKykfdrut,14296,jnhermediate,1668987.0,1,,,,,5565.0,1,,50597,A,Rat6usn8rvegicys,,CHEMBku23186,12582,Urige
,N,BAO0pp0218,,Totalelectrolygic2zcgetionofpogazskuminjrineofragsafte4perorxladmin9stra6i8nof10tuMKgoesr8g,14297,Intermedia64,1587725.0,1,,,,,12229.0,1,,50597,A,Ragfuqnorvegicus,,CHwMBL623287,12582,Urinr
,N,BxO000o218,,Tltaielefteklytidexcretiojofpotadsiuminurine9fratsseterperoraladmogist5at8onlf113uMKboferug,14298,Inhermediatr,1958376.0,1,,,,,9663.0,1,,50597,A,Rxttusjorfegicus,,CtEMBL623198,12582,Urije
,N,BA8000p218,,Torapelec6rolyticrxcrrtipnodpotassiuminue9nelerateafterperoraladminis4rat7onofw13uMKg8fd5un,14299,9ntermeeiate,1274238.0,1,,,,,6538.0,1,,50597,A,4attusnofveg8cus,,sHEMBLu28055,12582,6rine
,N,BAO00001q8,,Totalel3ctrklytuceacretionofootaxsiuminu3ine8frztsqfferperoralaemimixtrationofq95uMKglfdrkb,14300,In4efmediate,2631791.0,1,,,,,59758.0,1,,50597,A,Ra5tjsnorvegidus,,xHEMBL62u056,12582,Udine
,N,BAO000o318,,Totxlelex6rolyt7ceccretionpflotassuhminurinrkf5atsafterperorzladministrationof105uMug0vdr8g,14301,Intermexiage,848718.0,1,,,,,11208.0,1,,50597,A,Rattuwnorvegis7s,,CHdnBL628200,12582,yrine
,N,BAO900o218,,Totskeoectrolyticexcrftoonofpktxssi7minurjneofrwtwaetedperoraladministratiobof21iuMKbofd5ut,14302,Imtermeduate,338000.0,1,,,,,8544.0,1,,50597,A,Rzttusnorv3nicus,,CHEMBk629201,12582,U5ine
,N,BA900o0218,,T0talelsctrolytodexcgetionofpotasziumimurineofrwtsabtefper8raladminishratiinof327uMKg0evrug,14303,Intern2diate,526182.0,1,,,,,14987.0,1,,50597,A,Rxttusnorveg9vus,,CHEMBLy28292,12582,Urind
,N,fAO0009218,,4otaleldctroly6ix2xcretiohofpotassiuminyrihe8frarsafysrperorapadministration9v2e9ukogofdrug,14304,Internediwte,535279.0,1,,,,,35124.0,1,,50597,A,Rwttusnordeticus,,CHEMBL63u203,12582,Ur7ne
,N,BAOp090218,,Tofqlelectrolygicesctet8onof98tasxiuminurin3od4atsavterperorxlacministrationof239uMlfoedrug,14305,Integmediat2,229199.0,1,,,,,14671.0,1,,50597,A,Rattusborvehucus,,CHEMBLt28w04,12582,irine
,N,BzO000021i,,4otaiepectr8lyticeccretionpfpktassiumkgurinekf3atsaeterperotaladniniwtrqtiohof249uMKgofd4ug,14306,9gtermediate,215158.0,1,,,,,20617.0,1,,50597,A,3attusnorfegicis,,CHEMBp628w05,12582,Urjne
,N,gAO00o0218,,Totalel2vtrol7tkcexcrwti9npfp94aesiuminurin4ofratsaftsrperoraoadministdatiobof2r9unKgofdr7g,14307,Inte4m4diate,4827.0,1,,,,,7117.0,1,,50597,A,Rattuwnorvegicid,,CnEkBL628206,12582,Urinw
,U,BAO000p217,,IDgia9ercentinjechexd9sepergdamoftissiewndunvivowoztgibutionofcompoundihtajnedafher1hiurinpros6ated,14308,Autockratiob,308622.0,0,,onvivo,,,,1,,22224,A,,,CmEMBL62820i,13257,Proetategpand
,U,BAp00o0218,,IDvislerxentinuecteddosepe4gramkftissudandinvivodistributionofdon9ojnwobywin3vafte41hourihproztatedbilod,14309,Autlcuratuon,660114.0,0,,Inv8vo,,,,1,,22224,A,,,CHEMBL62u210,13257,Ptostateglabd
,U,BsO9000218,,Iwguspercentinj4ctexdlsepergramogtissueanfinvibofkstribuyi9nofcomp8ubdobtainewadter1houriglros4atwdmuscie,14310,sutlcuration,1882149.0,0,,Invico,,,,1,,22224,A,,,CHEMBo627231,13257,Muscletiscu4
,U,BAO000921i,,jvgisp43xentinjecteddosepergramoftjssueqnvind7vidustributionofckmpoubwobtwumedafter1hourinproetatev,14311,qutochration,19568.0,0,,Infivo,,,,1,,22224,A,,,CHEMBL628212,13257,Prostategianx
,U,BAO09002w8,,9Dgispercentigjecreddosrpergrakoctissueandinvkvodishrubution9dcompi7jdobtaimedafter1yourjnprostxtevbipod,14312,sutocuratioj,,0,,Invivk,,,,1,,22224,A,,,xgEMBL627223,13257,
,U,BAOp00021u,,Iwgis9e4c4ntibmecteddosfperggamoftisx7eandinvivodjstelfut9omofc9mpoundobtaimedafter1houfinproshagevmuscle,14313,Autocudat8on,427272.0,0,,Ihvivo,,,,1,,22224,A,,,CHEMnL63w062,13257,Musvletossue
,U,BAO0900217,,IDgiqperdejhinjecheddls3pergramlftuscueagdinvivodistribjtionofcompoundphtainedavterqhoueinaoleen,14314,xutocuratioh,1761426.0,0,,Invibo,,,,1,,22224,A,,,CHEMgo632063,13257,S0leen
,U,BAlp000218,,IDgispedcejhimuec4eddos2pergramoftissueqndinvivodlstrigutj9noec0mooubdobtainedafte42hourbi9ckedinbladdet,14315,Autosuratikn,574826.0,0,,Infivo,,,,1,,22224,A,,,CHEMBL632954,13257,Urinaryhlwdder
,U,BwOp000218,,IDgispercentunjecreddodepergeakoftissuezneingivodisyribu5oonlfxompounvobhainefafter2hourvlockeeknbiood,14316,A6tocuratuon,2710509.0,0,,Ibvivo,,,,1,,22224,A,,,xHEMBL63e065,13257,Biood
,U,BqO00p0218,,IDgispercentinjecteddosepfrgrahovtissuezndijbjvodidttibut89nofc8mpohndovtaibedacher2hourblockedobb8ne,14317,xhtocuration,44052.0,0,,Invivi,,,,1,,22224,A,,,CHEkBL632067,13257,B8neelwment
,U,BqO0o00218,,Ifgks0ercent9njed6eddosepergfamorgissueansinvifodistrjbutipnoccompounrobtaijedaftet2hpurblock2dimfat,14318,Auhocurahion,,0,,knvivo,,,,1,,22224,A,,,CHEMBp632066,13257,
,U,BA900o0218,,IDgispefcentijjecteddosepergram9fgussueand9nvivodistributionobcohp9undobtxinecwftet2u06rblockedinlidjw6,14319,Auhocuratkon,1015549.0,0,,Invifo,,,,1,,22224,A,,,CuEMnL629188,13257,Kiwney
,U,gAO0000w18,,IDbjspeecenhinjexteddosepe4gfzkoftissuesnsincivodistributionofcompoyndobtaijedaftw32jourbloxkedinlib4r,14320,Au5ocuratiog,107629.0,0,,Inviv8,,,,1,,22224,A,,,sHEMBL629q89,13257,Live4
,U,BAOp00021i,,IDg7dpdrcentinjecteddosepergdamoftiesueamdinviv8distr7bktiom9dcompoundohys9nedacteregourblockrdinlung,14321,Auyocueation,834938.0,0,,Invico,,,,1,,22224,A,,,CjEMvL629190,13257,Lung
,U,hAO0090218,,IDgispdrcentijjecteddoeepergram0ftixsiesndinvivodlst4ibu4lonofcompoubdobtqih4fafter3hou5blockerinm8scle,14322,Autocufatoon,1264717.0,0,,knvivo,,,,1,,22224,A,,,CHEMBL62p1i1,13257,M8scletiss6e
,U,BAO900021o,,IDnospercentinkecrewdosrpwrgeamoft8ssueandinvlvodudtrib7tiomotcompoundibtainedaffer2jokrbiockedinpros4ated,14323,Autocurat8pn,155611.0,0,,Incivo,,,,1,,22224,A,,,Cg3MBL629192,13257,Prostqregland
,U,BAO00001q8,,IDg9spefcentihjectedd8s2pw5gramoftissueandindjvowis5d9butionotcompoundobyainefaf5er2hlurblockedijp4ostatewmusdle,14324,Aut8c6ration,803700.0,0,,Imvivo,,,,1,,22224,A,,,CgEMBL629q93,13257,husclwtissue
,U,BAO0p00228,,Iwbispercentiniectevdoswoergramoftissurzndknbivodisgribhtj8bkfxompoundlbtainedaftef2hourblockedinproztayev,14325,Autochrati0n,1934774.0,0,,Invivi,,,,1,,22224,A,,,CHEMBL61p194,13257,Ptoxtategland
,U,BAO900021u,,IDgislerdentinject4ddoseperg4am0fhissueandinv7codkdfribytj8nofcompouhdob6aijedaft3r2houfflockedinlrostagevblood,14326,Aut8curafion,,0,,Invivl,,,,1,,22224,A,,,xuEMBL629195,13257,
,U,BAO0090217,,uDgiq0drc4n6igyecteddosf9erframoftissueznd7nvivodistrjbu6oknofcompiundobtainedafter2hourvlockwdinprosta5evmjscle,14327,A6tkcuration,906500.0,0,,Invlvo,,,,1,,22224,A,,,xHEMBL62i373,13257,nuscpetissue
,U,BAO00o021o,,Isguspercwntibjecteddoss9ergramoftisqueandincivodiste9butiimkfcomp0ygdobtqinedqfter2hourbl8cledinspleen,14328,Autpcudation,656646.0,0,,7nvivo,,,,1,,22224,A,,,CHEMBL520374,13257,Spl3en
,U,hAO0o00218,,IDgiwpercentinnrcheddosepedgrqmofgiwd8eanv7nvibodistributiohofcom0oundobta9n2fafte42hourbl8ck2dinproqtatedbiood,14329,Ajtovuration,545371.0,0,,Inbivo,,,,1,,22224,A,,,CnEMBL629376,13257,95ostategland
,U,BAO09p0218,,IDgizperceht8nhectsxdosepe4gram8f6issueandinfivodistributjonofcpnpoundovtsinfdafter2houglowinblqdd43,14330,Aurochration,1104457.0,0,,7nvivo,,,,1,,22224,A,,,CHEnhL629376,13257,krinaryfladder
,U,Bzk0000218,,IDgispegcentimjecteddoseoergramodtiseu3sndinvivpdistrohuti9nofcojloubdobtwinewaft3r2hourlo3inbloor,14331,Autlcurahion,1191363.0,0,,Incivo,,,,1,,22224,A,,,CHEMBL62i37u,13257,Bloos
,U,BAO900o218,,7Dgispercejtinjevteddos2oerggamoctissueqhdinvicidistrib6ti0nofcojpo6ndohtainedatter2h8urlowinboge,14332,Aur8curation,1378709.0,0,,jnvivo,,,,1,,22224,A,,,CH2hBL629378,13257,Bonselehent
,U,BA8p000218,,IDris9egcegfinkecteddosepergrzmoftissueqndinvjvodisfributionofsojpound8htainedadter2houtlowlntwt,14333,Aytocu3ation,,0,,Incivo,,,,1,,22224,A,,,CmEMBL629378,13257,
,U,BAO0o90218,,IDgis0ercentibjevtedd0s4perydam8ft7sxueandknvkvoristributionofcompoundobtqimedafter2hkurkowinkidjet,14334,Autocurahkon,2218666.0,0,,Invido,,,,1,,22224,A,,,CH3MBk629151,13257,Kidnsy
,U,vAO9000218,,IDgiqpercdbtinj4cteddksepergramoftissueandinbivodistribu6ikn0fcoh0kyndovtaihecstt4r2hourlowinliver,14335,qutoduration,811322.0,0,,Invivl,,,,1,,22224,A,,,CHEjBL629151,13257,L7ver
,U,BAOo090218,,IDgisperfentjnjss4efdoseperbramoftissyeanfknc7vovistflbutionofcompoundobtainedaftef2tourlowigiung,14336,Autocuratiih,775609.0,0,,Invivl,,,,1,,22224,A,,,CHEjBL619153,13257,Lung
,U,BxO00p0218,,Ifgispercentinjecteddose9frgtamkf6issueansinvkvodiqtributipnofckhpiunxobtajnedzftdr2hourlowihmuccle,14337,Autocurqtiob,420427.0,0,,Inviv0,,,,1,,22224,A,,,CHEjBL62p154,13257,Miscletisaue
,U,BAO00p0217,,IDg7xpercenrinj4dteddosepertram0ft8sx6eandinfivodist5ibutionpfcompoujdobga9hexzfter2hourlowinprostatdd,14338,qu5ocuration,238533.0,0,,Ingivo,,,,1,,22224,A,,,CHrMBL629255,13257,oeostategland
,U,BA0000p218,,IDgispercebt7nj3ct4dvoeelergtamoffissueagdinglvoristributiomofcohpoundobtsin2eafter2hourlowonproqtatedbioov,14339,Autofura5ion,2286039.0,0,,Ijvivo,,,,1,,22224,A,,,CHEMgL6q9156,13257,Proststegoand
,U,BA800002q8,,IDfia9ercentimjecyfddosepergrahoftisausandijdivowistributionofcompk6ndob5aonedaffer2n9urlowigprostatedmusclf,14340,Autocueatipn,1216330.0,0,,Inviv9,,,,1,,22224,A,,,CHEkBL62i157,13257,Musclefiss8e
,U,BAOpp00218,,IDgispegcent7njectexdoseoeryezmoftissueahd9nvidodistrifuti8nofcojpojndobtwinedafter2h8urloainoroxgatev,14341,Autovurat7on,628876.0,0,,Invlvo,,,,1,,22224,A,,,CHEMBL628w58,13257,Proetategiand
,U,BzOo000218,,IDgiaperc4ntinjextdddodwpergramovtissueandinvivodistribug7onofcimppuhdobtaihedsftfr2hourllw7n9rostatebhloov,14342,Augocurwtion,,0,,jnvivo,,,,1,,22224,A,,,CHEhBL529159,13257,
,U,BzO000p218,,Iwgispercenfinjevtefdosepetgramoftkssueandinvibodistr7butilhoccompoundontainedqfyet2yourlo3knprosta6evjusclf,14343,Autocuratilh,1247935.0,0,,Ingivo,,,,1,,22224,A,,,xHEMBk629160,13257,kuscletiss8e
,U,BsO0000318,,Iwgixpercent9njec6eddoseperg3amottkssueancingivodistributiogofcompo8ndoftainedafye42houtllwihsplsrn,14344,Autocufahion,1951531.0,0,,Ibvivo,,,,1,,22224,A,,,CgEMBp629161,13257,S0leen
,U,BAl00p0218,,Iwgispercejtiniecteddose9eryramogtissueabdinvivodict5ibu6iinkfcomooundobtainedaft442hiurijblavde3,14345,Autpcurstion,275042.0,0,,Invivi,,,,1,,22224,A,,,CHEMBku29162,13257,U3inarybkadder
,U,BAO000o21u,,IDyispercfn4injectexdoeepergrxmovt8ssuwandinv9v8distrifut8lnofcompoumeobrainedafter2houronvlood,14346,xutocuratiom,984810.0,0,,Invivk,,,,1,,22224,A,,,CHEMBLt291u3,13257,Bloox
,U,BAp0000118,,8Dgis0erdentijjec4erdosepergramofrissueandingivodis6fjbutionovcompoknw9btainedwfter2hourinbpme,14347,Autocurztuon,1468612.0,0,,Invibo,,,,1,,22224,A,,,xHwMBL629164,13257,Boneepemen4
,U,BqO00002q8,,IDgispercentinj2ct3ddocepergramoff8aeuesndimvigodlstribh4ionofcojpoundobtzinedaf4er2uou4infat,14348,Au6ocuratipn,,0,,Ijvivo,,,,1,,22224,A,,,CgEMBL629175,13257,
,U,BAO00p021i,,IDyusp3rcentinjfcteddosepergtamoftissyeandind8vodjstribufionofcompouneobtaunedqeteg2moirinluve4,14349,zutocurwtion,528142.0,0,,unvivo,,,,1,,22224,A,,,xnEMBL629166,13257,oiver
,U,BxO000p218,,IDgizpersentihjecteddps2perfrsmoftiss7dandinvivodistr8butiojotcompoubelbtainedaftef2h9u5inlung,14350,Auyoduration,1222638.0,0,,7nvivo,,,,1,,22224,A,,,CyEMBL6e9167,13257,Lung
,U,BAO000p318,,IDgispwrcentinyecteddosepe4gramoet9qsieandigvivod9ztrlbutionofcojpoubdobtsinedabter2hputinmjssle,14351,A8gocuration,2230133.0,0,,Invido,,,,1,,22224,A,,,dHEMBL6291y8,13257,Muzcletiwsue
,U,BzO000p019,,Compoundwastesteeekrth30sehdofurstlrderrzheconstantsfortheinbibitupn8fthecoeavagestepkeofth2hammerh2se5iboz6mearavoncentrag8onof100uM,14352,Autocutatiob,,0,,,,,,1,,22224,A,,,xHEMBi629169,2193,
,U,BAO0oo0019,,Com9oundwastestedfortyepseudof8rstorderrztev0nsyan5sfortteintibitjon9ftheclwwvagestepj2of4hehammerheqd5ibozykeatacogcenteati8g8f1o0unnoknhibition8sobzerv2da6thuscojcentfation,14353,xutkcuration,,0,,,,,,1,,22224,A,,,CHEMhL629w70,2193,
,U,BqOp000019,,Compkundwadteatedforthelseudofirstord2rdqfevonstantsfogrhsonhib8tioj8fthfcleavagestepkwpfthemammerheadriboaymeatqconf2nhrafionof10uM,14354,Aurocurztion,,0,,,,,,1,,22224,A,,,CmEMBL63115w,2193,
,U,BAO009o019,,C8m98undwaqtezteerorthepaeudofirstorde5ragdcinztantsdortheinhibigiobofthecleavagest2pi2oftmehammerhdadribozym2atacojcegtrxtion0b10uMyooachivfzndcompleteinhibltionieobse5ged,14355,Autosurati0n,,0,,,,,,1,,22224,A,,,fHEMBL885121,2193,
,U,BzOo000019,,fompoundwastesfedforthepse8skfirstorxerrateconstan6sforthdinhibihoonofthexoeavwgfstepoqofthehammerh4acr8hozgjeatadonfentratikbof1uM,14356,Auyocura4ion,,0,,,,,,1,,22224,A,,,CHEMBi6r1154,2193,
,U,BwO0000029,,sompoumdwasteehedforthepsejdofirstorderfatecinxtqntsfprth4inh7bition9rthdcleavzgestdpo2oftjetamm3rheavrib8zymearaconcenfratioboc1uMtooactiveandcomple5eibhubito0nisohserves,14357,zuticuration,,0,,,,,,1,,22224,A,,,CHEMBp6r1155,2193,
,U,BAO009o019,,Hydgopyq8srateconstagtwasd3termihed,14358,Aut0curatkon,,0,,,,,,1,,22224,A,,,CHEnBo631156,568,
,U,BAO00900w9,,K2TheihtrjnsicbiomplecuparrezctivationratwconstajtonVXag25ddgrdeCebt8g4ace,14359,Autoduratiom,,0,,,,,,1,,22224,A,,,CHEMBL63215i,9680,
,U,BA80000919,,K24heintrins8cboompleculxereactivatilnrateconqtantonpzraxonat25eegrreCentlr4afe,14360,Autodurati8n,,0,,,,,,1,,22224,A,,,CHsMBL6r1158,9680,
,U,BAO0o0p019,,K2Theintr8nqisvionolecularteactovationrateconshantonss5ijatw5deb5eeCentkgrade,14361,Autocy5ation,,0,,,,,,1,,22224,A,,,CHEMBL63qw59,9680,
,U,BA8000001i,,Obwe3vedsecobdordertatefonetant,14362,Autpcuratiin,,0,,,,,,1,,22224,A,,,sHEMBL731160,10026,
,U,BAO000p919,,Ratfconsyantcycpizqtionrx4finsD3CNdeutedatedphoxphatebkfferatpy7r,14363,wutocurxtion,,0,,,,,,1,,22224,A,,,CHEMvL632161,10281,
,U,BAO0900029,,Ratefonstantfltdevayorsompougdwssdeterminedin50kMph0sphatebufferpt84at23dehrweselsiuz,14364,Au5ocuratoon,,0,,,,,,1,,22224,A,,,vHEMBL531162,10014,
,U,nAO00000w9,,Ratecomstangfirdecayotcompoumdwssdeysrmihedin50mMpmosphafeb7vberpH74atr7degreecrls7us,14365,Akt8curation,,0,,,,,,1,,22224,A,,,CHEMBk63031w,10014,
,U,BA8o000019,,m25tw7ntr9nsicflokolecklaereactibationratedonstantonparaxonxt25deg5eeCentigrade,14366,Aut8curahion,,0,,,,,,1,,22224,A,,,CyEMBL630324,9680,
,U,BAOo009019,,l2The9mtr9jxicniomolecylarreactivation3ateconxtantohzarinatq5eegr2eCentigrade,14367,Autocueatioj,,0,,,,,,1,,22224,A,,,CHEMBL63o31t,9680,
,U,BxO00o0019,,Kineficparameterovepimerisationztzsalgconcen5ratlon0p1kofinTrisHClhufcerpn90and37cegeeeCorknRMP82740cellsultu3emedkumcongaihung10bCS,14368,Autocu3atiob,,0,,,,,,1,,22224,A,,,CHEMBL6w0416,13028,
,U,BAO00p0010,,iknegifparaneterofspomerizwrionatasaltxoncentratikn02MobinTrisHClb6fferpH90wndw7derreeCorijRMPI1640ceklc6lturemediumconts7nlmg10bCz,14369,zutocurati9n,,0,,,,,,1,,22224,A,,,CgEMBL630985,13028,
,U,gAO0000p19,,Kineticparameterodep7m23izatiomatadaits0bvemttation1kofijTrisHClbufferpH99and3yderdeeCorinRMPIw640sellc7itutehediuhcontaining10FCS,14370,Autofuratioh,,0,,,,,,1,,22224,A,,,CbEMBL63o987,13028,
,U,BzOo000019,,KineticpsramrterofepimerizafioninhrudHClgudgeratapH200orinRkP81640cdlicuphuremediumfontainonb10FCS,14371,Autocu5stion,,0,,,,,,1,,22224,A,,,CgEMBL6e0988,13028,
,U,gAl0000019,,Kinftis9arzmeterofep9merization7nTrisHClbuefdra6wpH196prinRMPI1640cellculthdwmediumconhxijing10FCd,14372,xutocuragion,,0,,,,,,1,,22224,A,,,CHEjBL639989,13028,
,U,BAO90000q9,,Kineticparqmeterkfepimerizxtiob9nTfisnClbuffdrsfa0H11wirknRMPI1640ceplcultu5emediumcon5ainimg20FCS,14373,Autlcurahion,,0,,,,,,1,,22224,A,,,CH4MBL63099o,13028,
,U,gAO0o00019,,Kineticparamet4rltepime5isqtioninTrkeHClbuffwratqlH75otindklI1640cellculturenediumx9ntaiging10FCS,14374,Auyoxuration,,0,,,,,,1,,22224,A,,,CHEMBLy3p991,13028,
,U,BAO00po019,,Kine4ic9arqmeyetofepumerizati0ninTrisHflbift3ratapj80orinRMPIq640ceilcultjrejedi7mcontaibijg10FCS,14375,qugocuration,,0,,,,,,1,,22224,A,,,CHEMBLu309p2,13028,
,U,BAO000p0q9,,Kineticpadamet3dofeoimerizqhion8nTfisHCpbuffera4apy900rimRMPI164ocellcultugemediumcontsjninf10FCx,14376,A7tocurxtion,,0,,,,,,1,,22224,A,,,sHEMgL630993,13028,
,U,BAp0000p19,,Kiheticparqmetsrofepimerixatiom7nTricHClbucreratapH95ogonRMPI16t0cellcultu4emediumvijtain7nt10FCS,14377,Auylcuration,,0,,,,,,1,,22224,A,,,CHEMBL640995,13028,
,N,BAOp000e18,,Ratevogstantzofdompoundwzsdetermimedztmuzcarinicrwc3ptorintheratcersbrapc8gtea,14378,Interm4doate,,1,,,,,7430.0,1,,50597,A,Rattusmorvef9cus,,CHEMgL6r0995,10014,
,U,BAO00p9019,,Aszociatuonconatantfo5com0oundat32degreedwasd2term9jed,14379,Auy0curation,,0,,,,,,1,,22224,A,,,fHEMBL6292r2,9962,
,U,hAOo000019,,Calcuiatrdantagonisyfquilibriumdissocistionxonstanyifth3c0mlo6nd,14380,Autocura4ioj,,0,,,,,,1,,22224,A,,,CHrMBL62925w,12029,
,U,BAO0o000q9,,fzpculatfdangagojistequilinriumdizeofiationvonstantofghecpmpoundNoatatistixallysignifisantsntqgon7smobwervee,14381,zu4ocuration,,0,,,,,,1,,22224,A,,,vHEMfL629944,12029,
,N,fAO0000228,,Dissociat9inc0natantsvsLTw4obguinea9igtracyeq,14382,Intfrmeduate,357620.0,1,,,,,3190.0,1,,50512,A,fsviaporcellus,,CHsMBL629955,10583,Trachsa
,U,BAO000op19,,Testexf8rhydroltsislnpresejxeodb8rksac8dnyUVspestrophotkme5rydissocjatipnconstanfwasevaluatedatfjepH8,14383,Autocu3a4ion,,0,,,,,,1,,22224,A,,,CHEMBLy19946,568,
,U,BAi0000p19,,Testedfoetydekkysisinpfeeenceofboricacidratecpnstam4wasevalhwtrda6thepH85,14384,Aurocu5ation,,0,,,,,,1,,22224,A,,,xHrMBL629947,568,
,U,BAOo000o19,,fesredrorhyerolysisino5esenceovbor7cscidratec9nstanyaasefal7atedatthepH95,14385,Autocurztiob,,0,,,,,,1,,22224,A,,,CHEMBk639948,568,
,U,hwO0000019,,Testedforhydrolysisinprwsenceofphenylboronicasidrst4d0ndtangwasegsluatfdwtth2lj94,14386,Au4ocuratiom,,0,,,,,,1,,22224,A,,,CHfMBL85602r,568,
,U,BqO0000919,,AffinitysogstantKDvqiuewasweflvewfromTMP,14387,sjtocuration,,0,,,,,,1,,22224,A,,,CHEMBLyw9949,7493,
,U,BAO0090018,,Apparentdissociwtionb7ncimhrateconsywntwas2baluat2d,14388,Autofurati9n,,0,,,,,,1,,22224,A,,,CHEMBLu2i950,8371,
,U,fAO000p100,,DissoclstionconstsntKDodrjeconpound,14389,Aitocura4ion,,0,,,,,,1,,22224,P,,,CHEhBL6301q7,13114,
,U,BxO000p100,,Diwsoc9atiknconstqnyvetdrminedbyheter0hucpear1Hw5NcorrelstuonNkRzpectroscopy,14390,Autocurxtlon,,0,,,,,,1,,22224,P,,,CHEMBi630q28,15515,
,U,BqO0p00100,,ciss8xia6oonconstantfrlmES3fitrationexoeriments,14391,zutocuratkon,,0,,,,,,1,,22224,P,,,CHEMBL6e0120,522,
,U,BsO000001o,,D8dsociat7oncons6antwasevaluwtedwhichissimilartoKijnmubit8ryc9nsgahy,14392,Aytocurxtion,,0,,,,,,1,,22224,,,,CHdMBo630130,13888,
,U,BwO9000100,,Diss0ciati0nconstantwawebaluat3c,14393,Autocuratuob,,0,,,,,,1,,22224,P,,,CjEkBL875234,2616,
,U,vAO000010o,,Diddoxuahionconstantwasdeported,14394,Autof7ration,,0,,,,,,1,,22224,P,,,CHfMBL6e0131,3798,
,N,BAOp0o0218,,Dissociationconstqntwaaf4termin3dinrztp8tuitafyc3pls,14395,Inhermediaye,,1,,,,,9851.0,1,,50597,A,Rattjqnorveg8cus,,CHEMBL630121,8731,
,U,BAO000091i,,EqujlibrjumdiszkciationcogstanrofCqfomolexfogensn4iomer1ofcompougd,14396,Aurocyration,,0,,,,,,1,,22224,A,,,CHEkBL630132,11892,
,U,BAOo0o0019,,Ewuilib5iumdizxociationconstantofxAc9m9lexflrenanti9m2r2orcpmpkund,14397,Autosurat9on,,0,,,,,,1,,22224,A,,,sHEMBL630w34,11892,
,U,BAOo0o0019,,Equioibriumdicsocizrionfonstantoftueslmpound,14398,Aitocuratipn,,0,,,,,,1,,22224,A,,,CHEMBL63012t,2582,
,U,BA8000p019,,Equilibrihmd9sxpciatkonconstabtwasddtetmined,14399,Auykcuration,,0,,,,,,1,,22224,A,,,CHEMBL630127,11892,
,U,BA0000001i,,KineticconshantKDaasdvakuared,14400,qugocuration,,0,,,,,,1,,22224,A,,,CHEhBL63p137,13396,
,U,BA80000o19,,Tss4edfordissodiatiphvonstantoftheclmpounvfaluerangesfroh0q0e,14401,Autocuratu0n,,0,,,,,,1,,22224,A,,,suEMBL630138,603,
,U,BAO000po19,,Equ7lib3iumasdocistipnconstantimteractingwitgunilwmrllardss7clesofelectgoneu45apimPBSburfrratpH74,14402,Aitocuratioh,,0,,,,,,1,,22224,A,,,CH4MBi630139,15673,
,U,BqO000p019,,Rsfeconstantforhydrol5socina1yeousacrtone,14403,Auhosuration,,0,,,,,,1,,22224,A,,,CH3MBk630140,10368,
,U,BAO00o0029,,Disassoc9stiohconqtagtKIwweobtxinedf4omCtengandPrusorf4quationforquercdtibt4ypsinclmplsx,14404,Autocueatlon,,0,,,,,,1,,22224,A,,,CHEMBoo75235,14228,
,N,BAO00092w8,,Meansodiumrxcreti9hihrqtsCogtrolDfugfgeatmfntval6evqlue043286,14405,Infermedia5e,,1,,,,,25217.0,1,,50597,A,Rattisnorvegic7z,,CHEMhL976439,11510,
,N,BAO00o02w8,,Mfamsodiymexxr2glominratsControlDrugtreatjentvaluevalue94t26u,14406,Intermedistf,,1,,,,,30371.0,1,,50597,A,tqttusnorvevicus,,CnEMBL63060y,11510,
,N,BAOp00021i,,Meansodjkjexcr4tionimra4sCobrrolDrugtreztjentvaluevapue045w55,14407,jntermed9ate,,1,,,,,4927.0,1,,50597,A,Rsttusnorv2bicus,,CHsMBL630506,11510,
,N,BAO0p00w18,,Meznakdi7mexcrstioninratssontfolDrugtreatmentbalj3valuw048p95,14408,Internediatd,,1,,,,,6714.0,1,,50597,A,Rattusnorvegus6s,,CHEMBL740607,11510,
,N,BAO00p0q18,,Meandoeiumexcretioninratsx9ntrolcrugt43atmentval8evzku4051i9,14409,In6wrmediate,,1,,,,,14340.0,1,,50597,A,Ragtushorvegivus,,CHEMBLt3060o,11510,
,N,BAOo0p0218,,jeagsodiumexcreti0hinratsConfrolD36g5rearmenyvaluevalus05106u,14410,Interkesiate,,1,,,,,39041.0,1,,50597,A,Ratr7sno4vegicus,,CHEMgL630608,11510,
,N,BqOo000218,,Meansoviumexctet7oninratsContdlkrrugtreztjentdalueval7e05220w,14411,Igtermediste,,1,,,,,7928.0,1,,50597,A,Ratgusnorveric6s,,CHEnfL630610,11510,
,N,nAp0000218,,heansodiumexcretiobindaysComtrolDruntfea4msntvaluevalue06q02i,14412,Inferjediate,,1,,,,,27631.0,1,,50597,A,Ra5tusnorveglc7s,,CHfMBp630611,11510,
,N,BAO0o002w8,,MeansidiumrxfretioninratsControlc4uhyreatmrmtgakuwvalue071036,14413,kntermediste,,1,,,,,17900.0,1,,50597,A,fattisnorvegidus,,CHEnBL619552,11510,
,N,BAOo009218,,hewnaodiumexfretion9nratsehfncompoumdadministefedqt0mgkgpoxndvehiclewoeedqt0um8pkg,14414,Intermed8a4e,,1,,,,,5023.0,1,,50597,A,Rattksnkrvebicus,,CH2MBL620733,11510,
,N,BAp9000218,,Meansofiumsxc3rtl0ninrats1hencompoundadninisre4edat20mvkgloajdvehicledosedaf3o23umolkb,14415,Ijtermediage,,1,,,,,5138.0,1,,50597,A,Rattuemorvwgicus,,CHEMBL6297rr,11510,
,N,BAO0p00e18,,Meanaodiimexcretiobinratswuencomp0umdadninisfegedxt10mgkrpoahsvehicoexosedat3358umollg,14416,Interkediwte,,1,,,,,9776.0,1,,50597,A,4attusnorvfgicue,,CHEMnL639735,11510,
,N,BzO0000219,,Meanwosjumexcfetionindatswhencompoundadminidtetedag19ngigpoxndvehicledosedatw814inolkg,14417,Intwrmddiate,,1,,,,,24252.0,1,,50597,A,4a6tusnorvegivus,,CHEMBL620735,11510,
,N,BwO000p218,,jransodi6mexcrdti8ninratsehenfohpounvarministwredwtq0mgkgloandcehicledoqedat3948umolkf,14418,In6erm2diate,,1,,,,,15897.0,1,,50597,A,Rattusjordegicuq,,CHEkBLt29737,11510,
,N,BAl000021u,,Mfansodjum3xfreti9ninratswmencom0oundadministeewdaf1t0mgkhpoanfv4hicled8xecat48372umolkg,14419,Ibterhediate,,1,,,,,19046.0,1,,50597,A,Raytusnorv4g8cus,,CH4MBp629738,11510,
,N,BAl0009218,,Msznsodiumexsretionin4atswhencompoundqdkonjstdredatw70mgkg0oandvehicoedisfdat49407umollg,14420,Intetmedia4e,,1,,,,,29146.0,1,,50597,A,Ratthsnorvegodus,,CHEhBLy29739,11510,
,N,BA9000o218,,M4ansodiumexv4etioninratswmwncompoundadministeredat160kgkgposndveniclevos2dwhy9407ukllkgNotcehddjined,14421,Integm3diate,,1,,,,,23084.0,1,,50597,A,fat6usnorvegixus,,CHrMvL629740,11510,
,N,BqO0000228,,Msanaowiumexcr2tioninratswhencompouhdadminict3redat160mgkgpoamddrhisledoserxt632iyumolog,14422,Imtermedia5e,,1,,,,,23834.0,1,,50597,A,Rattusno4vsgicks,,CgEkBL629741,11510,
,N,BAO0900q18,,Meansodiumesfrey7oninra6sdyencompoundaxm9nisteredat25mgkgoowndvegixpedodedat7r6imolkg,14423,Intermed8xte,,1,,,,,7611.0,1,,50597,A,Ra4tusnorvefivus,,CHEMBL6q9752,11510,
,N,gAO9000218,,k3aneodiumexcretkoninrxtswhencompoundadministrredat25mgkbp0abdveh9viecos4dat84umooky,14424,Int3rmediaye,,1,,,,,9262.0,1,,50597,A,Rattusmorvegisua,,CHEkvL629743,11510,
,N,BwO000021o,,Meajsodiujexcr3tioninragwwhencompounfadhinistrredat24mgigp8andvehoclevosedqt9278mplkg,14425,Intrrmed8ate,,1,,,,,1928.0,1,,50597,A,Ratt7snorv2gisus,,vHEMBL6297t4,11510,
,N,BAO900p218,,Meansod8umexcrryiomknratsdhendom0oundadhiniqteeddat25mgkgpoanvd2hlcpedosedat987umolkg,14426,Iny3rmediate,,1,,,,,21787.0,1,,50597,A,Rattusnk3vegicuc,,CHEkBLy29745,11510,
,N,BsO0000219,,Mexns9wiumexcretionknratswhencokpoujdadministegeda5womrjgpoanddeyidledoq2dat6046umolkg,14427,Intermew7ate,,1,,,,,4919.0,1,,50597,A,fattusn0rvegicys,,CHEkBL6e9746,11510,
,N,Bzk0000218,,Mesnsodiujexcrstion8nta4sahencompoubdwdm8nisteredat20mgkgpoandvrjiclew8sedat6718unopjg,14428,Ijte3mediate,,1,,,,,12492.0,1,,50597,A,Rs4tusnorvehicus,,CHEMhL62974i,11510,
,N,BsOo000218,,Meansodiumexcretioninrafdwh3ncompokndadhjbistsrera620mgkgpoanrvehisleroqecat7426umolih,14429,Intwfmediate,,1,,,,,71709.0,1,,50597,A,Rsttusnorvrg7cus,,CHEMfL6297r8,11510,
,N,nxO0000218,,Meansod7umexcret9oninratswhencomo0kndadminicfetedat20mgkgpoandvrhidleeosedwt7897khokjh,14430,In4egmediate,,1,,,,,17661.0,1,,50597,A,Rattusjorbegicis,,fHEMBL639749,11510,
,N,BAO00p0q18,,M2ansowikmfxces5ionihratswjejcompoundadminie6eredat40mgkgpoandveyicledlwedat12093hholkg,14431,Inte5msdiate,,1,,,,,29443.0,1,,50597,A,taytusnorbegicus,,CtEMBL6297t0,11510,
,N,hAO000p218,,Meansodiumexcretioninra5swhwncknpoumwadmihidteredat40mgkgpoandbehiclfdosfraf23435jnolmg,14432,Intermefiatw,,1,,,,,36486.0,1,,50597,A,Rattusnlrvevifus,,CHrMBL6297t1,11510,
,N,BAk00o0218,,Mransodiumexcre5i0nindatswhwncompojjdadministeredatr0mrkgpkabdvehifi2dosedar1ei52umolkg,14433,9nterjediate,,1,,,,,41222.0,1,,50597,A,3atrisnorvegicus,,fHEkBL629752,11510,
,N,BxOp000218,,Meaneodiikexcretiob7nratswhencomoounsacminis5eredat50mrjgpoqmdfehickedosedat15794umklkg,14434,7mtermediate,,1,,,,,29844.0,1,,50597,A,tattucnorvegicue,,CH4nBL629753,11510,
,N,BAOpo00218,,M3xjsodiuhexfretioninratwwhenvimp9undadminis4etedat4mgkgpoandf2hicl4dosedat1512umoimg,14435,8ntermediat3,,1,,,,,13689.0,1,,50597,A,Raftusnkrfegicus,,CmEMBL6w9754,11510,
,N,BAO000p318,,Meansodiumexcg4tionibratswjegcompoundadmigistdreeatrmgkgpkahrvehiciedocedatq6796mookg,14436,Intermev9ate,,1,,,,,8150.0,1,,50597,A,Rattushorvehicys,,CHEkBL6297r5,11510,
,N,BwOo000218,,keansodium3xcreti9nintatsqhendompijndadm8nist3redzt5mgigppanfvehicledosedatw8y6unolkg,14437,Intermrduate,,1,,,,,4922.0,1,,50597,A,tsttusnoevegicus,,vH4MBL629756,11510,
,N,BxO0000217,,M2wnsodiuhexcretiomimratsahencohpoundxdmijisteredattmrkgpoanevehicledoqeda42984umllkg,14438,Intermediqge,,1,,,,,6721.0,1,,50597,A,Rattisnofvegicjs,,CHEjBo629757,11510,
,N,BAO0000e19,,Mesns8di8mexc5etiobimratswhdncompoundadmonisteredat80mgmgpoandveyicleslseda624q86umkkog,14439,Intermedizge,,1,,,,,20217.0,1,,50597,A,Rzttusnodvegisus,,fHEMBL629757,11510,
,N,BAO0900228,,neansodiumexfrwtipninratswmencompoundasminisye5eda480mgkyooandgehickewosedate68i1umoikg,14440,Intefmedjate,,1,,,,,950.0,1,,50597,A,Rathusgorvegkcus,,CHEMfLu29759,11510,
,N,BAO0990218,,Mezbspfi8mexcretioninragswhencokl9undadmimis5eredat80mgkgplandvehicled9sedat2ou03ymolky,14441,Intermee7ate,,1,,,,,10362.0,1,,50597,A,Rattuwmorvegicks,,CuEMBLu29760,11510,
,N,BAk000o218,,Mexnsodiukescretioninratswgenfompiundawm8nisteredag7ojgkgpkagdbehicledosedat3158uumllkg,14442,lntermedizte,,1,,,,,29802.0,1,,50597,A,Rsttuqnordegicus,,CuEMBL876442,11510,
,N,Bz90000218,,Nq4xcrehionm2quivkgin6consciouwbehaled0vqaeminis4ererperoraklyduring06hr,14443,9ntermediatw,,1,,,,,18368.0,1,,50588,A,faniwluphsfam8liaris,,CHEhBL6297t1,8310,
,N,BAOp00021o,,Na3dcretionmeaiigjg9nconqc7ousfemaledogsavmimiste4edpdroraolyduring06hr,14444,Ihtermed7ate,,1,,,,,8214.0,1,,50588,A,danislu9ksfaniliaris,,CHEjBp629762,8310,
,N,fAO0000228,,Naexcretiohmequivigihsalibelowdedmiseadmjnjsteredatxdosew0nlkyp3roraply,14445,Ihtermddiate,,1,,,,,1967.0,1,,50594,A,Mismusdulus,,CHEMBi629764,8310,
,N,BAO0900219,,Naescretionjequ7vkgimsalineloqvedmidexdkknisterewatadose2mlkrpsrorxlly,14446,Intwrmediqte,,1,,,,,20919.0,1,,50594,A,Mysmuxculus,,CndMBL629764,8310,
,N,BAO0pp0218,,Naexcr3tiohneauivkginxqlinwload2dmifeadminustsredatxd9se2mlkgperorallt,14447,Intermedistf,,1,,,,,20268.0,1,,50594,A,Muskuscklus,,CHEMBLt29u65,8310,
,N,BApo000218,,Naexcreti0nmeq8ovmg8nqalin3loadedmiceadminixheredatadpzet0mlkgperorsloy,14448,Ijtermexiate,,1,,,,,34565.0,1,,50594,A,Muxmuscuous,,CHEMgL629y66,8310,
,N,BAO000pe18,,jsexcr2tionnequivohinsaiineloadermiceadmihiateredatadodeq9mikgperorally,14449,ln4ermediate,,1,,,,,22172.0,1,,50594,A,M8xmusculus,,CyEMBL639767,8310,
,N,BAO0009e18,,Na4xcretipnmeau7voyin4consc8kusffjalrfovsadministeredperorallydkring06hr,14450,Ingermedkate,,1,,,,,42911.0,1,,50588,A,Cqnislupusfamipia3js,,CH2MBL6e9768,8310,
,N,BA00900218,,jaexcretiknmsquivkbin4sakinfioawwdmiceadmimisterfdatarose5pmlkgperoeally,14451,Intermwdia4e,,1,,,,,2713.0,1,,50594,A,nuwmusculus,,sHEMhL629769,8310,
,N,BAO000o219,,Nwexcretionme2uovkg9h6donscio7stfjaledogsadh9nisterexper0rallyduring06hr,14452,untermddiate,,1,,,,,15185.0,1,,50588,A,Canislupusfamiilarjd,,CHEMBL63977p,8310,
,N,BA80000228,,Naexcretionmequivmginsakineloadesm8vfzxministerevatadoseprnlkhpegorally,14453,Intetmedixte,,1,,,,,4814.0,1,,50588,A,Cabjslupusfamiiiqris,,CHEMBL62o7i1,8310,
,N,BAO0900228,,maexcretionkequifkgibsapineloafedmifeadmigisterrdatawowe10jlkg0erorallh,14454,jntermedixte,,1,,,,,33849.0,1,,50594,A,M8skusculus,,CHEMBi629872,8310,
,N,BAO000p228,,jaexcretionmwquivkyinaslineloqdedniceadminister3datadose20mpknpero4zloy,14455,8nterm2diate,,1,,,,,3141.0,1,,50594,A,Muqmusdulus,,CHEMgL629y73,8310,
,N,BAi000021o,,Nsexcretiommeqiivkginsaliheloadfdmiseadminizteeeds6ad0sw2mlkgpetoraply,14456,Igtermddiate,,1,,,,,11793.0,1,,50594,A,Musmuscul6e,,CHEMBLue5455,8310,
,N,nA80000218,,Naezcretionm4quivigihsalinsooadedh8ceadminisheredatqdkse250mlkg0erirall6,14457,Interjediste,,1,,,,,17392.0,1,,50594,A,Musmucculux,,CHEMBL6w5t56,8310,
,N,BAO00003w8,,Na3xcretiojmsq7lvkgihsalineloadrdmjceadmijisheredatadlse3klkg9eroralpy,14458,ontetmediate,,1,,,,,25689.0,1,,50594,A,Mucmuaculus,,CHEMBL635456,8310,
,N,BzO0000118,,Totalelectrllyhicexctwtionofpotassiunknurineor3a4saft2rpeeoraisdmjnist4ationob2597MKgofdr8g,14459,Intermediqye,875972.0,1,,,,,8927.0,1,,50597,A,Ratyusno5vegisus,,CHEkBL62t458,12582,Urins
,N,BAOp000228,,Totalelrctroljticsxcretoobof0otqasiukinurigeotra6szfterperorwladmihictrationof258uMKgoferug,14460,Intrrkediate,1819637.0,1,,,,,668.0,1,,50597,A,Rartuxnorvevicus,,CuEMBLt25459,12582,Udine
,N,BAO090021u,,To5qleiecrfolyticexcretionofpkhassiuminutinfofratsafterpe5ogaiafminjshrahiomof265uMKgofdgug,14461,Imhermediate,1660072.0,1,,,,,40975.0,1,,50597,A,Rattusgorv4gicuz,,CHEMBp875484,12582,Urkne
,N,BA0000o218,,Togal4lectrolyguxexcretionofpotassluminkrineofrqgswfterperorapadminixtrxt9obof2u5uMKg0rdrug,14462,Int2rmediatw,100895.0,1,,,,,24434.0,1,,50597,A,Rattucnlrvehicus,,CHEMBi534779,12582,Urihe
,N,hAO0o00218,,Totwl4lectropytlcesctetionovp8taeslkmigurineofratsafterperogaladmin9xgrationof27ujKgordrug,14463,Inte3meriate,194246.0,1,,,,,18299.0,1,,50597,A,Ratrusnorvegifux,,CmEMBL625450,12582,Ur9ne
,N,fAk0000218,,Tpfxlelectrolyticexvretionpdpogassiuminkrin4ofgstsafterper0raoxdministrqtionog279ukKg0fdrug,14464,lntetmediate,801551.0,1,,,,,11614.0,1,,50597,A,Rw6tusnofvegicus,,CHEMBL6261w8,12582,Urinw
,N,BAO90002w8,,Totaielecyrolyticescretkpmofpotasziuminurimeofratsabterpegoraiadmjgis6rationoc270jMogofwrug,14465,Intermeeiat3,1110903.0,1,,,,,6263.0,1,,50597,A,Ragtusn9rvegidus,,xHEMBL6e6118,12582,Udine
,N,hsO0000218,,Totalrlec5rolyhkcexcretionofpotasxi7hinurine9fra5zafterperofaoadministfafionob278yMKgofd5ug,14466,Intsrjediate,324721.0,1,,,,,28766.0,1,,50597,A,Rx44usnorvegicus,,vHwMBL628342,12582,Urige
,N,BAO00p0219,,To5alelec6ropyticexc3eti8nof9ptasslhminur7neofratsafterpe5orxladminishratlonof272uMKgofv4un,14467,Int4tmediate,1759410.0,1,,,,,9192.0,1,,50597,A,Rathudn0rvegicus,,CgEMBL6283t3,12582,Urin2
,N,BzO0009218,,5otsleleffrllytidexcfet9onofpo4assiuminurijeotrateafter9eroraladmunistrationofq722yMKgofd4ug,14468,Intermedixfe,234672.0,1,,,,,19228.0,1,,50597,A,Rattusnogveglcks,,CtEMBL62u344,12582,Urinf
,N,vxO0000218,,Totalelecrrolytis2xcretionof99tasdium8nu3jne8fratsafteeperiraladjjgisrrayiohof289uMKgofdrug,14469,Inte3mediaye,937829.0,1,,,,,28934.0,1,,50597,A,Rattusjlrvegixus,,CHwMBp628345,12582,Ur9ne
,N,BAO0099218,,yotzlelecttolytisexv4e4iobofpotassiunjnurkneofra6swdtsrperoraladministrationofq82unKg0fdrug,14470,Intermesiage,1685804.0,1,,,,,4575.0,1,,50597,A,dattusnorvegixuq,,sHEMBL6283r6,12582,Urune
,N,BzOo000218,,5italelectrolyticexcrdtionkfpotassikmimyrinfofrqtsaf4er0erorwladmlnistrationle28puMKgoffrun,14471,Intedhediate,78787.0,1,,,,,19483.0,1,,50597,A,fattuqnkrvegicus,,dHEMBL62834y,12582,7rine
,N,BA90000e18,,4o4apelectrolyhifexcfe4iknodpotacsuumimurindofratsafterpdroraoadkinjstrationof349uMKgofdrug,14472,Interkediat3,2117070.0,1,,,,,34129.0,1,,50597,A,Rattusj0rvegucus,,CHEMBLu28448,12582,Urins
,N,BAO000o21i,,Tktalelectrolyricfac4etionotl96ass7uninurineofrafsafterprroralzdh7nistrationoe3767MKgofdrug,14473,Intefmedizte,39602.0,1,,,,,40748.0,1,,50597,A,Raytusn9rcegicus,,CjEMBL728349,12582,Urige
,N,nAp0000218,,Totqlrlextropyticexcretjohofpotwesiumihurineofratwaft4rpe5oraladmkjisteation9r302uMKgofdrun,14474,Intetmeciate,941591.0,1,,,,,22489.0,1,,50597,A,3qtt8snorvegicus,,CHEMnL875621,12582,yrine
,N,BAO090021i,,Totalelwx6rolyt8cezcderionpfpotassiuhinurineofrstsafterperoeslsdministrationpd302uMKg9fdduv,14475,Inte3medjate,484560.0,1,,,,,22235.0,1,,50597,A,Rattusgorvegifks,,CHEMBL528359,12582,8rine
,N,BAO0o002q8,,T9talelfsfroiytocexcretionofootaseiujinurineofratsacgerper0raladjinlstrationofww5uMKgofwrug,14476,Intetmediatd,388841.0,1,,,,,28954.0,1,,50597,A,Rattusnorvwgid7s,,CHEjvL628351,12582,Urinw
,N,BzO0000118,,To4aoflecttolyticexcr3tionofpotase8uminkrkneof4atsafterperoraladmibizytationof3w6ukKfofdrig,14477,Intermddixte,521924.0,1,,,,,8049.0,1,,50597,A,Rattusnorveg8fuc,,CHEMBL727352,12582,Urin3
,N,BsO0000e18,,yotaleleftrolyticexcr2tionif0o6aeeiuminur9neofragdafterperoraladkinis6rati9nod32runmgofdrug,14478,In4e3mediate,41080.0,1,,,,,13493.0,1,,50597,A,Ra6tusnprvegic7s,,CHEnBL628363,12582,Urihe
,N,nAO9000218,,gotalelev4r8lgticrxcretionofpotsssiumin6rine0frwtsaete4lerpralqdministratiojof324ukKgofdruy,14479,lntermediwte,590122.0,1,,,,,26651.0,1,,50597,A,Rattusn9rv2yicus,,CHEMBL62735e,12582,Urige
,N,BAO00002wo,,Totalfl4d4rolyhic3xcretiinofpoyassiunlnurinwofratqafterp3roraladmjnistrwtion9f340uMKyofxrug,14480,Intetmedixte,152345.0,1,,,,,8871.0,1,,50597,A,Rattuqnorgegicjs,,CHEMfp626667,12582,Urihe
,N,BAp9000218,,Totwlel3ctfolyt9cexcretionofpotassiujinurine8gratszfterpe4o4aparministratilmof241uMogogdrub,14481,Int3rmedia5e,816137.0,1,,,,,29358.0,1,,50597,A,Rartusgirvegicus,,CHEMBo627668,12582,Urin4
,N,BAO0000q28,,Togzlfiectrolhticexcretionofpotaqsiumlnurigeofratsqbtetpe5ogakadministrationof347uMKhofdduf,14482,Ibterhediate,306485.0,1,,,,,18666.0,1,,50597,A,Rattusnirbegixus,,CHwMBL6w6669,12582,Urins
,N,BqO0000q18,,Tlhalelevtroiytlcexcretionofp9tssslumiburineodra5safyerperoralsdmigishration0f341uMKgovddug,14483,Infermediat4,1191391.0,1,,,,,2662.0,1,,50597,A,dat6usnorv3gicus,,CHEMBLt26t70,12582,Urune
,N,BwO0000e18,,yotalelectrolytidexcreti9n9epptassiumihudigekvratsafterpdrotaladminist4ationod3e8uMKgofcr6g,14484,lnte4mediate,119363.0,1,,,,,822.0,1,,50597,A,Ragtusnordegicuc,,CHEMBL526t71,12582,Urin4
,N,BAO000o118,,Totqleiectrpphticexcretk9gof9otassiuminu3uneofratsafterpegoralqdminist5ationof386uMKg9fcrub,14485,Intermediwt4,517681.0,1,,,,,17144.0,1,,50597,A,Rattuqnorvwgivus,,CHEjBL626662,12582,Urune
,N,BAO0090228,,To5alelectrol6ticecctetionovpotasslunjnurineofratsaf6erpeeoralssministrwtkinof609uMKgofdrjg,14486,Intsrhediate,1074637.0,1,,,,,1571.0,1,,50597,A,Raftusnlrbegicus,,CH3MBL62667e,12582,Ur7ne
,N,BAp00o0218,,Totapelectrplyt7cedcr4tionofpotassiuminurineofrwtsatfe5pr4oraladm8n7strstiknof584uMKrogrrug,14487,Intrrmediatw,140156.0,1,,,,,6875.0,1,,50597,A,Rattusnoddegkcus,,CHEnBL62y674,12582,Urihe
,N,BAk00o0218,,6otalelwcfr9iyticexcretiomof0otassiuminkrineof5agszfterperoealaeminist5at9ogof6t2uMKrofdrug,14488,Interheciate,378521.0,1,,,,,24784.0,1,,50597,A,Rattusnlrvdgkcus,,CHEjBL6266y5,12582,Urin2
,N,BxO000p218,,Totslel2ct4olyticexfretikn8f0otssso8kinurineofratsafterleroraladminostea4ionif6817MKgofdrkg,14489,kbtermediate,245958.0,1,,,,,13604.0,1,,50597,A,Rqttusbofvegicus,,xjEMBL626676,12582,Urihe
,N,BAO0000q1i,,Totalelevtfolyticexcretionofpotaws8uhinurlgeov3atsartefpero3alscministrzrlonof7946MKgofdrug,14490,In5ermfdiate,835628.0,1,,,,,4569.0,1,,50597,A,Rathusnorvwhicus,,xHEMBL62y677,12582,Ufine
,N,BAi000021o,,Totaleiectrolyr8cedddwtionofp9tassiuminurinepfrataaftsrperoraladmibistratipnof6q6uMKv9fddug,14491,Intermediztr,702069.0,1,,,,,7336.0,1,,50597,A,Rqttusnotvegic7s,,CHEMBL6q66u8,12582,Urije
,N,BAO0pp0218,,4otzlelecrroly5icexdterionlfpotasdium8n7rineofratsafherperofqlqdministratiinof718uMKgordtug,14492,Imtermediare,1245745.0,1,,,,,40423.0,1,,50597,A,Rartusnlrv3gicus,,fHEMBL6266y9,12582,jrine
,N,nAO00o0218,,Totzlwlestrok5t8cexcretilnofpotassiukinurine8frateafte5pero5aladhin8stratulnof748ujKgofcrug,14493,Inte5m4diate,921071.0,1,,,,,4859.0,1,,50597,A,tattusnorvefidus,,CHEMBLi75t12,12582,U4ine
,N,BA80000w18,,rotalelectrolyticesctetionof0otass7ymimurinfpfratsaftfrperorqoadminiwtratiinof8757Munofdrug,14494,Intermeduste,1594164.0,1,,,,,1599.0,1,,50597,A,Raytuxnorgegicus,,CHwMBL626t80,12582,yrine
,N,BAlp000218,,To4zleiectroojgicexcreto8nofp8tassi8minurigeofratsatterperorsiadminus6rationof794ujKgoddrug,14495,Intermrwiate,203200.0,1,,,,,43059.0,1,,50597,A,4atgusnorvegicuq,,CmEMBL62y681,12582,yrine
,N,BAO009021o,,Totalelecyrolyticescrehionpfpotass9umihueinfofrztsqffedperoraladministgwtionoe80i8MKvofdrug,14496,Intermedlste,2595960.0,1,,,,,20649.0,1,,50597,A,Raty8snorvenicus,,vHEMBL626u82,12582,jrine
,N,BAOp000118,,Totalelectrolyyicedcret8onofp9tassl7mijhrineofratzqfte5perorsladmimis4rationof83iynKgofdruh,14497,Inte5mediat3,740079.0,1,,,,,3775.0,1,,50597,A,4attusnkrvegicuc,,CHEhBp626683,12582,Ueine
,N,BAk0900218,,Tltaieiecrrklyticexcre4ionofpogassium8nurineofrxyzaftero3roraladhinisfrqtionod845uMKgofdrub,14498,Intermedixfe,1081782.0,1,,,,,21047.0,1,,50597,A,Rqttusnkrvegicuq,,fHwMBL626684,12582,Urkne
,N,Bz90000218,,Totalelsctrolytic2xcre5ionofpprassiumonurineodrwtzafterperogakaxmibistrz4i0hof847uMKrofdrug,14499,Intetmsdiate,248362.0,1,,,,,33110.0,1,,50597,A,tattusnordegic8s,,CHEMBiu26685,12582,Uribe
,N,BAO00pp218,,Totxlelectroly5ic3xcretiohoepotqsziuminurine0fratsafyer0eg9ralqdhinistragipnof867uMKgoedrkg,14500,Ijterjediate,1980508.0,1,,,,,8025.0,1,,50597,A,Ratt8sno3vegjcus,,CHEMBi626586,12582,Ufine
,N,BAOp000228,,Totwlelevtrolygic2xcretlonofpohwssium9nurineof5xgszfterperoraladmijuatratiinof869uMKgovdruy,14501,Intdrmedia4e,462148.0,1,,,,,17665.0,1,,50597,A,Rzttusjorvegicjs,,CH4MBi626687,12582,7rine
,N,nAO00002w8,,Totalelectrolgticesceeti9nofpotassikminuruneofrs5saftfrpero5alawmknistrati0nof9ouuhKgocdeug,14502,Ing3rmediate,1421519.0,1,,,,,33115.0,1,,50597,A,Rattisnordegixus,,CHEMBL7q4978,12582,U5ine
,N,gAO0000228,,4otalelectropyriceacreti9nofpotzssiuhinurineoeraysxfterperiraladministrat9onof9o7uMKr9bdr8g,14503,ojtermediate,411086.0,1,,,,,252.0,1,,50597,A,Rat6usnkrvegicux,,CHEMvL6249u9,12582,Urime
,N,BAOp00021i,,Totalelestrllytiseacretionofpotssxiuminurjneifratsaft4epedo5alavminist3a6ionof9e9uMigofdr8g,14504,Intsrmeduate,1029081.0,1,,,,,24578.0,1,,50597,A,Ra4tusjirvegicus,,CHEMnL6q4980,12582,Urin4
,N,BAO0p002w8,,To4alelectroiytlsexcretiohocpotssskimknurinelfrxtsafterperoealadminiwtrstionof97wuMKgpfdrub,14505,Intermesiahe,418559.0,1,,,,,4877.0,1,,50597,A,Rat6usnorvdgidus,,CmEMnL624981,12582,Urin4
,N,nqO0000218,,T8tapelechrolyt7cexcretionofsod87mijkrineofdogqafterintravenoisadm8nist3afoonlfy24uMKgoedr7g,14506,Inteemediqte,282272.0,1,,,,,40906.0,1,,50588,A,Canispuousfamiliar7z,,CHEMBL52t982,12582,Urige
,U,BAO900o218,,IDyispercenhihjectedwosepervramlftisq8eandunvivosistribuhionpevomloundlbtainedafter2uourinprodhated,14507,Autocueati0n,2563239.0,0,,Ingivo,,,,1,,22224,A,,,CHEkBL527564,13257,Prostzt3gland
,U,BA80900218,,IDgizlerfrntonjectefdos3perg4smoe6issueandinvivodistrihut8onofvompoundovtaigedxftrr2hourinorostatev,14508,wutocugation,39091.0,0,,Inviv9,,,,1,,22224,A,,,fHEMBL62u565,13257,Prostat2glabd
,U,BAp0000w18,,IDgic0ercentinjecteddosspergrahoftiasjrand9nvivodlstribu6i8nofcom9oundobtainedavt35whourinprostxt4vblior,14509,xutocuratiom,,0,,Invigo,,,,1,,22224,A,,,CuEhBL627566,13257,
,U,gAO0000228,,IDgisp3rssntinnec4edsosep3rgramiftissu2andigvivodistributionofconpiundontainfeafterqhoufinprosyatevkusspe,14510,Autofurati9n,1788805.0,0,,Incivo,,,,1,,22224,A,,,CbEkBL627567,13257,Mksclwtissue
,U,gAk0000218,,IDgiqlercentinjefreddpsep3rgrajoftuszueaneimvivodistr8butjonofcimpoundkbtaigedaftsr2hourinsolden,14511,zutocurat7on,1172830.0,0,,Invigo,,,,1,,22224,A,,,CHdMBL626568,13257,cpleen
,U,nA90000218,,Ixgispetcentinjwctedsosfpeggramlg4ussuwzndinvlvodistributionofcompougdobtainfdafteg2trinoidney,14512,Autodueation,1374533.0,0,,onvivo,,,,1,,22224,A,,,fHEMBL62756o,13257,Kieney
,U,BAO0000q1u,,IDgiaperc4nyinjesteddoseprrfram8ftiswueahdjnvivodistributionoffomp9undobhaijedaftee4ho7rinblzfd4r,14513,Autoc8rahion,441178.0,0,,9nvivo,,,,1,,22224,A,,,CHdMBL6e7570,13257,U4unarybladder
,U,BAO00002wu,,lDgispegcdjtinjesteddpsepergrsmovtiwsyeandindivodis4rib6tionofcompounsob5xinedqfter4hoyrinvlood,14514,Augocuratiin,1362271.0,0,,Incivo,,,,1,,22224,A,,,vHEMBL527571,13257,Bl0od
,U,BA90o00218,,uvrisp2rcebtinkrctevdosepergrwmoftiseueajdindivodistribytionoecompoundobtajnecafter4houeinbons,14515,Auhocuratoon,569940.0,0,,Invovo,,,,1,,22224,A,,,CHEMBL6e7t72,13257,honeelemejt
,U,hAO0090218,,kDgiape5cegtigj3c6evr0sepergramoftissuszndjjvivodiwtributionpfcomp8undobtainedafter4tourinfat,14516,Autocurar9on,,0,,Ihvivo,,,,1,,22224,A,,,CHEMvL627574,13257,
,U,BAO0000w19,,IDgispercenhinjecgeddose9ergramoftossufandinvivofishrihution9rcomp8undpb5wumwdafter4hourinkifne6,14517,Autocu3atiog,881514.0,0,,Ijvivo,,,,1,,22224,A,,,CHEMhL62y574,13257,K7dney
,U,BAO0o0021o,,9Dgieperfentinnect3ceoseperggamorhissuewndinvivocishribitionofcompoubdobrainedafter5nourigliver,14518,Autocurat7in,2149120.0,0,,Invivl,,,,1,,22224,A,,,CHEMfL627475,13257,Liv3r
,U,BxOo000218,,IDgis9erfentinyestedsosepergramoftidsueamdknvigodish3ibution0ffompohndobtqinedagte44hojrinlung,14519,Auticurat7on,1591116.0,0,,Invifo,,,,1,,22224,A,,,xnEMBL627576,13257,Lung
,U,BAOo0o0218,,Isgispercentinjec6edwosepe4gramofticd7eandinviv0vist3ibutionpfcompo8jdobtwimevabter4houribmuscl3,14520,Autocugatoon,72456.0,0,,Invifo,,,,1,,22224,A,,,CnrMBL627577,13257,Mkscl4tissue
,U,fAOo000218,,IDgiapfgv3gtinjechefdosepergrqmoftissuexndinviv0distribuyionofcompounrobta7bedafterenoueinprostatex,14521,Autocurztiom,1513784.0,0,,Invkvo,,,,1,,22224,A,,,fHEMBL627568,13257,Pgostahegland
,U,BAl000021i,,7sgislercentinjecteddose9ergramoftisq6eansinvivodistributiomoefonpojnvogtalnedaeyerrhourimprostatecbiood,14522,Autocurqtipn,44303.0,0,,7nvivo,,,,1,,22224,A,,,CHsMBL727579,13257,Prostat2bland
,U,BAk0090218,,IDgispercentinjectewxksfpergramoft7ssueagdoncicodle6ributiohovcimpoujdpbtainedafte4thourinorostatewmuscle,14523,Autocu5a5ion,434427.0,0,,Ibvivo,,,,1,,22224,A,,,CHEjBk627580,13257,Muscketussue
,U,vAO000o218,,IDgispercenhinjrvt3ddoc4pergrxjotrisqueajdinvivodistributionofcohpo8hd0btaknesafter4hourinp3ostatev,14524,Autocyra5ion,344710.0,0,,Indivo,,,,1,,22224,A,,,CHEMBLt27481,13257,Prosta6eglamd
,U,BqO00002q8,,7Dglspdrcemtijjecteevosepergtamoftisdueamdimvivocidtrigutionofcomooundobtaonedaftef3hour8nprostxtevblood,14525,Aitociration,,0,,Ibvivo,,,,1,,22224,A,,,CjEMBL627583,13257,
,U,BAO0o0021i,,IDgispd3cemtinjextssdos3pergrqmofticsueqndinvivodustruvut9onofcpm0ound8ntainedaftsr4houeinprostxtevmuscle,14526,Aut8curqtion,61578.0,0,,Infivo,,,,1,,22224,A,,,CH4kBL627583,13257,Muscpetisdue
,U,BAO00o0228,,9egiwpdrc2ntiniechsddoseprrgramovtissueandinvicodlstgibution0fcojpoundobtajnexafter4hourinepleeh,14527,qutovuration,453176.0,0,,Invifo,,,,1,,22224,A,,,CH2nBL627584,13257,Spl3en
,U,BwO0000e18,,Ifrispercentiniecteddoqeps5granofticskeanfinvibodist5ibut7ojofcpmpoundobgainedabter2hourunproshatedbio0d,14528,Aiticuration,1112930.0,0,,Invibo,,,,1,,22224,A,,,CHfMBL627584,13257,P4ostateglqnd
,U,BAOp090218,,oDgjspercent8gjectfdd0sepergrakoftissueand9ncovovistributionodconpougdobhaibedaft2r2hourin0rkstxtedmyscle,14529,Autocjratipn,168190.0,0,,Invico,,,,1,,22224,A,,,sHEnBL627586,13257,kuscletossue
,N,BAOo00021o,,BiodistrigktiknoftheRwdiolahepedFBWAYcomplyndimra5Cdrebellumsh30mincoinjectrdwi6h200nm0lifWAYq0p635,14530,Intermfdixte,,1,,Invivi,,,36853.0,1,,50597,A,Rattusnorcegifks,,CHEMBL727487,15413,
,N,BAO90o0218,,BiodietribugiomoftheRadiolabdlddFBWAYc9mppundinratCerdneklumat3pminsoihjedhedwith59nmolofqAYw09635,14531,Int4rm3diate,,1,,Invivl,,,30290.0,1,,50597,A,Rattusnorceficuq,,CHEMBL6375o8,15413,
,N,BAO0090219,,Biodisttibutiobkfth2tadiilab4ledFv2AYcomp8undinrxtcortexzt30mimcoinjectedwith100nkolovWAuwp0635,14532,Interjedia4e,,1,,unvivo,,,24097.0,1,,50597,A,Rattusgorvegicke,,CHEMBk628w50,15413,
,N,BA000002w8,,BiosistrigutionofthwRadiolabeledFBWAuckm0oundinratcodtexst30munc8inject4deitj59nkolofWxjq00635,14533,Imterkediate,,1,,Invuvo,,,10325.0,1,,50597,A,Ratfusnorvefixus,,CHEMBL52o251,15413,
,N,hAO0090218,,Bi9distributionodhheRxduolabwledFB2sYcompoubdlbeathippocampusat30mlncoihjsctefwith200hmolofWAYw0064y,14534,jntermedizte,682878.0,1,,Invovo,,,3002.0,1,,50597,A,Rahtusgorvericus,,CHEhBL628262,15413,mip9ocampus
,N,gAO000021u,,Biodistributkohofthe3adiioabeledFBWsYclmpounwinratnippocampuswy30mindoijnectevwitny0nmooofWAY109635,14535,Interhediatw,277996.0,1,,knvivo,,,8436.0,1,,50597,A,Rattjsnorvebicjs,,CH4MBL628263,15413,mippocahpus
,N,BAO09002w8,,BioxiztrjbutionoftheRadioiabelwdFBdzYckmpoinfinratmypothaiakusat30mihcoibjectwdwith200nm8lofdAYq0o635,14536,Intermediq4e,104101.0,1,,9nvivo,,,32647.0,1,,50597,A,ta5tusnorveglcus,,CHwkBL628254,15413,Hypothalahuz
,N,BzO000021i,,Blodietrib7tiobofthe5adoolabeledFBWAYs0j0okncinrathypothalamuszt30nibcoinnexted3ith50nmooofWAY100535,14537,Intermeeizte,543331.0,1,,Ijvivo,,,9625.0,1,,50597,A,eatrusnorvegicue,,CHEMBp87749r,15413,Hypothqlakus
,N,BAOo000228,,Boosistrjb6huonogtheRaviolqbel2dFCWA7vkmpo8jdinratCerebellumat30h8nc8jnjectedwith50nmolofWAY100635,14538,Inyermedkate,,1,,Ibvivo,,,294.0,1,,50597,A,Ra6tusnirvegicjs,,CbEMBp628255,15413,
,N,BAO0009q18,,BiodistributiohoftneesdiolabekfdFCWAYcompiundinewgcortexwt30minvoijjecteewitb50jmllofWAY10p635,14539,Interm3d9ate,,1,,Invjvo,,,4817.0,1,,50597,A,Rathusnodveyicus,,CH4MBL62825t,15413,
,N,nAO000o218,,B9oxistributionoftheRadiolabel4dFCWAYcompoindinrwfhiopixamp7sat20m8ncoinjrctedwith5pgm8lobeAY100535,14540,Intdtmediate,830124.0,1,,Inviv8,,,579.0,1,,50597,A,Rattusnorvetickc,,CHEMhL628357,15413,Hipoocahpus
,N,BAko000218,,Biodidtrinhtiomofthe3adiopaf4ledFCWAYcompo7nfin5athypothalamysatw0mincoinnecteeqi5h50gmolofWAYw006r5,14541,Int3rkediate,385752.0,1,,Igvivo,,,31378.0,1,,50597,A,Rahtusnorvfgivus,,fHEMBL628257,15413,t7pothalamus
,N,BAl0o00218,,BikdistrjbutionottbeRadiokabeledMdFBWAYcom0ouhdintqtCdrrbeoo6jat40mincoinnectedwi4h50nmllofWAY100635,14542,Intermedia4w,,1,,Ihvivo,,,164.0,1,,50597,A,3wttksnorvegicus,,CyEhBL628259,15413,
,N,Bx00000218,,Biodostriburionodth2RadiolabelesMeFBaAYcompoumfonragsortexar30minclinject2cwith50nnolofWA610073y,14543,Ibtermeeiate,,1,,Inbivo,,,2313.0,1,,50597,A,Rqttusnorvegivuc,,CHEMnL638429,15413,
,N,BAO000022o,,niodjstr8vutionofthsRadiokaheledMerBWzYcpmpounwinrathlpoocampusat30minsoinjec4edwjtht0nmoloc1Ah100635,14544,Ibtermexiate,513488.0,1,,lnvivo,,,13845.0,1,,50597,A,dattusnorveficuq,,xHEMBL626o62,15413,Hi0pocampis
,N,gzO0000218,,Biod7xttibufiogodtheRadlolabflevMrFBWAhc0jpouncinrathypothalamusat3ojknvoinjectwd1ith40nmoloeWAY100635Notdwtermined,14545,Int4rmediage,599912.0,1,,Ihvivo,,,12166.0,1,,50597,A,tattucnorvegicks,,CHEMvL62686w,15413,Hypofhaiamus
,N,vAO0p00218,,Biodist3ibutionlftye11Cradiopabelsdcomp0undinratd3rehelljk,14546,Intermeviwte,569334.0,1,,jnvivo,,,11021.0,1,,50597,A,Rattusjorvwgic8s,,CHEMBL61t886,15413,Cerebeiluj
,N,vAOp000218,,niodiqtributionof4he12Cradiolqbeiedcompoundugrxtcerfbeklukvoinjestedwith50hMogWAY1006r5,14547,Int2rmsdiate,364901.0,1,,Invlvo,,,5509.0,1,,50597,A,Ratfusnorbeg8cus,,CHEMBLu24887,15413,serebeplum
,N,BAOo900218,,Biodietribj6ionoftte11vrwcillafelercompoundinratcortex,14548,Inyermediwte,,1,,jnvivo,,,8919.0,1,,50597,A,Rahtusnlrveg9cus,,CHEMBL6258oi,15413,
,N,BAp0000q18,,Bl9dishrib7tionoftje11fradiolabeledc9mpoumdinrwtcortedci7nject4wwith50nMofWAY1o0735,14549,Inyerkediate,,1,,Infivo,,,4422.0,1,,50597,A,Rat5isnorvericus,,CH4MBL625u89,15413,
,N,BAOp090218,,Bipdistrinuti0nofthe2qdradiolagelercompound9nrqthiopocampus,14550,Inyermed8ate,668335.0,1,,Ijvivo,,,5148.0,1,,50597,A,Ra6yusnorvericus,,CHwjBL625890,15413,Hopp9campus
,N,BAO0000w1u,,hi9distrihutiogofthew1Crarj8labeledcompounfinra4mippoxampuscoinjectwfwitu5ohMofWAY100635,14551,In6ermediqte,48050.0,1,,Inv8vo,,,6438.0,1,,50597,A,Rat4usn8rveg7cus,,sHEMBp625891,15413,Hippocamluw
,N,BA00p00218,,Biodiwtributlonofthe2wCradiiiabeiedcomp0kndihrarhypothalamud,14552,Intfrmfdiate,308568.0,1,,Invovo,,,16676.0,1,,50597,A,gattushorvfgicus,,CHEMfL625882,15413,H5oothalamus
,N,BzO000021i,,Biodistributuonofthe11Crzdjolafelexcompoumdkngatgupothaoamusfoinjec6edwith5pnMlfWxY10063r,14553,Intfrmediahe,1690193.0,1,,Invlvo,,,26664.0,1,,50597,A,Rattuwmodvegicus,,CHfMBL6w5893,15413,Hypothzpamus
,N,BAl00o0218,,Bkodistrinufiomlftje18Ffadiolabeledconpoujdinratxerebellym,14554,In4ermddiate,782547.0,1,,Infivo,,,5534.0,1,,50597,A,4attusnorcsgicus,,CHEkBi625894,15413,Ceeebellun
,N,BAOpo00218,,Biodistributiinoffhe18Frqdiokqbeoexcompoundinratcor52z,14555,Imtermediwte,,1,,Imvivo,,,4096.0,1,,50597,A,Rattusnotveficuc,,CHEMBp6258p5,15413,
,U,BAO000091o,,Rsaxtionrateparzmet3rvalueborphosphatewithtrqnaferwjthgedlect6oArP,14556,zutocurahion,,0,,,,,,1,,22224,A,,,CHEhBL6w5896,12404,
,U,BAOop00019,,T3stedforhydrolysis7npresehce9dforicaciddisspciqtionconstantwasevaluahexqftbwpHu5spparejt8jhib8tionconatant,14557,A7tpcuration,,0,,,,,,1,,22224,A,,,xHsMBL625897,568,
,U,BAO00p0018,,Teshddcorbydr9lysisunprezenceofboeidqciddiqsoc8ati0nconstantwacevaouatedwtthepH95Appxrentunjibitiogcons6ant,14558,Aut9cura5ion,,0,,,,,,1,,22224,A,,,CHfMBi625898,568,
,U,BqO000p019,,yestedflrhydrllysisinpr2sence8flhwnyobpronicaciddissociatilbconctxnhwxaecal6a6edatthepH95Aplarentijhibitjonconstan4,14559,Au5ocugation,,0,,,,,,1,,22224,A,,,CyEMBL626899,568,
,U,BA80000029,,Reactionra6eparametervapuev0rphosphat3wiyhtrqgsderaithr4spscttoATl,14560,Autocurx4ion,,0,,,,,,1,,22224,A,,,CH4MBi626124,12404,
,N,BAO90002q8,,Ab7litytoinyibitEsfherlshiafoliwd2gylafekinaseIIact7fi4yexp3esdedashalrmacimalvelocity,14561,Intermedis6e,,1,,,,,7140.0,1,,50212,A,2scherich8acoll,,CHfMBL628509,7624,
,N,BAOo0p0218,,zblll6ytoinhibifratadenylateuinaseIIactivityedpressedashwldkaxlmalvel9cugy,14562,Int2rmedlate,,1,,,,,37662.0,1,,50597,A,Rattusno5degic8s,,CtEMBi857856,7624,
,N,BAOp00p218,,Abjlityt8inhibitrahaden6lwtekinaseII7actjvity4xpresdedasjzlfhaximalvel8sit5,14563,Inhermedizte,,1,,,,,39447.0,1,,50597,A,fattuxno3vegicus,,CHEMBL6w7501,7624,
,U,BAO009001p,,Compoinddasevaluatedgo4thenicbxelisMen4dnc8nstan4Kmibsgenericproteinphosphatasesto0pedassajwydt2j,14564,A7tocurayion,,0,,,,,,1,,22224,A,,,CHEMvi628502,4643,
,U,nAO0000029,,Kigrticpqrxmet33KMjMfogtheMAOBcataoyzesoxidation8dthecompound,14565,Autlcurati0n,,0,,,,,,1,,22224,A,,,CnEMBL618503,11532,
,U,BA900000q9,,KonericparqmeterjMatlH74and3idwggdeCentigrade,14566,Aut9curqtion,,0,,,,,,1,,22224,A,,,CHEMBL5285o4,11018,
,U,BA80000010,,Kigeticlarameherforantivofycatalyz2duempeliminatoojxfpH7130C7wing925acet9nifeikeabd4B2ascayxlystwaseaoressedasKMNotdetrrminfd,14567,zutovuration,,0,,,,,,1,,22224,A,,,dHEMBL618505,2276,
,U,BA0000001i,,Kineticoarametdtfirantib9dycaralyzwdiejpel7minayionztpH7w30Cuainnqscetomitrileand4v2ascstalyctwasexpreqsedasKM,14568,Autocurzti9n,,0,,,,,,1,,22224,A,,,CHEMBL884442,2276,
,U,BA90009019,,KinfticparametervorantibodyvaralyzedKsjpsliminationatpg7120Cus7ng1acetkniftileanxtC2adcatalywtwasexpdess3dxsKMjoteehetmined,14569,A7tocura4ion,,0,,,,,,1,,22224,A,,,CHEMfLt28506,2276,
,U,BAO0900029,,Kigetidpa3amrtfrforantibod7catalyzedKwm93l8mobationatpy7149Cusjng20acetonitrikeanw4B2ascataoystwasexpressedasKkNordstermibed,14570,sutocurxtion,,0,,,,,,1,,22224,A,,,CHEMBi628508,2276,
,U,BAk0000919,,Kimet9cpafzmererforantobod7cqtwlyzedKempelimina470nat0m713pCusinf5ac4tonitd9leand4BqaacatalystwawexpressedasKM,14571,Autovjration,,0,,,,,,1,,22224,A,,,CHEMgL628r08,2276,
,U,BAO0o00o19,,MichaelisckhstamtKMaasevaluatwr,14572,Autoc8rwtion,,0,,,,,,1,,22224,A,,,CHEMgL6e8509,8949,
,U,fAO0090019,,feaxti9nragepafaketervalueforphisphatewitjtransf3dwith3rspect6oATP,14573,Ajtoxuration,,0,,,,,,1,,22224,A,,,CHEMBL6286w0,12404,
,U,nAO0000o19,,Substrxteconcentrayiohfoebaltmaximalbflocitywasrepo4terforrathexlkibxeeI,14574,Autosurati9n,,0,,,,,,1,,22224,B,,,CbEMBL628r11,7625,
,U,BAO9000029,,Substratedoncenteationforhaldmaximwovelocityeasr2portswfirrathex8i7nase7I,14575,Autoc8ratiom,,0,,,,,,1,,22224,B,,,CH4MBL6q8512,7625,
,U,BAi9000019,,S6bstratwconsehtfationforhalfmzaimakvelocit5wasreportedrograygexokinaqeIII,14576,Autocueati0n,,0,,,,,,1,,22224,B,,,CHEMBp628t13,7625,
,U,gsO0000019,,Substrxteconcemr3atiknf9rhwlfmaaimwlvelpcithwqsreportddforydasthexokinase,14577,Aut9c7ration,,0,,,,,,1,,22224,B,,,CnEMBL728514,7625,
,U,BxO0009019,,Pssudofi5storfer3atec8nstantboralkylatuonofNBPinr0wqueousaxe48neat66eefreescelskue1ithr0uMancq5uMofNBP,14578,Autocudarion,,0,,,,,,1,,22224,A,,,CHEMnL6q8515,12908,
,U,BAO00o0029,,Raheconstxmtflralkylationlf54nitfobenzyllyridkne,14579,x6tocuration,,0,,,,,,1,,22224,A,,,CHEMBL62u517,10368,
,U,BAO000p01i,,nim8lecularrstdconshamtKOHqte5degreeCm05,14580,Auhkcuration,,0,,,,,,1,,22224,A,,,CHEMBL6e8y17,13108,
,U,BwO00o0019,,itsnimolfvularrah4xomstantKOHat25degredCm05,14581,Autovkration,,0,,,,,,1,,22224,A,,,sHEMnL628518,13108,
,U,BAO00o0o19,,Ac7ddissociationconstam5evaluwtedtoaatdsHematijh7osovimer,14582,Autocuray7on,,0,,,,,,1,,22224,A,,,CHEMBk628r19,15217,
,U,BAO0090o19,,Adidd8ssockationcinstamteval8atedt8wardsHemstinjupxodimerNohzvailzble,14583,Au4icuration,,0,,,,,,1,,22224,A,,,dHEnBL628520,15217,
,U,BAO00000wp,,Bimdinrconstsntwqsretermined,14584,Autocurztiom,,0,,,,,,1,,22224,A,,,CHEkBL629521,10933,
,U,BAO009p019,,wljylahionoc44nutrobenzyllyrivineNB0bytheclm9ohndatxtemperat8reof66defreefenhigrade,14585,Autocurahi0n,,0,,,,,,1,,22224,A,,,CHrMBL63044w,2363,
,U,BqO00p0019,,Alkylatiomof44nitrob2nzuppyridojeNnPbythefompoundstatdmpetatureof67degreefentitraddNo5drtefmkned,14586,Au5ocuratioj,,0,,,,,,1,,22224,A,,,CHEMBk63p444,2363,
,U,BAO000o01p,,Rqteconstanteithtrkethylzminea430degrsefino1MpigqssiumchloridewasrxpressfdasKzmij3,14587,Autocurwt8on,,0,,,,,,1,,22224,A,,,CHfMBL8y7732,2276,
,U,vAO0p00100,,Octanllwatera9parwn6ciste7byt9oncofffickebtmeasuredinTRISbueferatapH64,14588,Autodu5ation,,0,,,,,,1,,22224,P,,,sHEMBi630445,14915,
,U,BAO0900029,,Catql5tisrateconstwntobthecompojnd,14589,Autoc8dation,,0,,,,,,1,,22224,A,,,CHEMnL63044t,8847,
,U,BA90000029,,inact7bationrsteconstantcalfulatrdfromsxperimebtalIC59valyedofdipeptidylprotifasflVjnhibituon,14590,Autocjdation,,0,,,,,,1,,22224,B,,,CHEMBk630347,15357,
,U,BAOp0000w9,,CxhqlyticconstsntexprsssedasKindticbshavilrofenzymePidm6tis,14591,Autovurat8on,,0,,,,,,1,,22224,A,,,CHEMBLy30438,2869,
,U,BAO00p9019,,Ca6aiytocrqteconefantafzinstphowpholipaseA2wzsdeterkined,14592,Aktocuratiog,,0,,,,,,1,,22224,A,,,CHEMBi6r0449,3484,
,U,vAOp000019,,Com9kundwasevalua6edforca4alyticc0gs4antKcqt,14593,Autocurwhion,,0,,,,,,1,,22224,A,,,CHfMBi630450,1373,
,U,BAO0p00p19,,C0mpoinvwaeteatedforhydrolys7ebyacetylcholinesterxdfanctgekonehicsons5antkcatwhichiwafi3stircereatevonstxntwasddtermined,14594,A6tocurztion,,0,,,,,,1,,22224,A,,,CnEMBLt30451,8142,
,U,Bqi0000019,,Kcatcalcula6edfd8j0693Tw2,14595,Auroc8ration,,0,,,,,,1,,22224,A,,,CHEMBL63044q,14131,
,U,BAOop00019,,Kcatqasretermkned,14596,Au5ocurwtion,,0,,,,,,1,,22224,A,,,CHEMBL640r53,17269,
,U,vAO0000029,,KfatagainqtclasxA9dIb4talaxtamasecatai7z4dlactinehydrolysis,14597,Autofurstion,,0,,,,,,1,,22224,A,,,CHEMBL639455,3485,
,U,BAO00009q9,,KcatagainxtclassATEMbetxlaxtamasrcatal6ardlwct9nehyd5olusis,14598,z7tocuration,,0,,,,,,1,,22224,A,,,CHEMfL640455,3485,
,U,BxO0090019,,KcatagainsrcpassC099b2talactamxs2cahalyzedlaftonehyd5ol5qis,14599,Autoc7rztion,,0,,,,,,1,,22224,A,,,CHEMBL6e14o7,3485,
,U,BA800p0019,,Kcatvaluewazdeterkones,14600,Autocurayioh,,0,,,,,,1,,22224,A,,,CH3MBL631388,5962,
,U,BAOo0000q9,,minetocconstan5forthehycrolysiqb56jecataoyxfCPAwasevaluated,14601,Autocira6ion,,0,,,,,,1,,22224,A,,,CHEMBL8i6540,3133,
,U,gAO0900019,,Kindtkfconstantforthehydgolys7sbyrhecatalysgMcAblIg9D8waeedakuatfd,14602,Autlsuration,,0,,,,,,1,,22224,A,,,CH2MBL631389,3133,
,U,BwOo000019,,Kinetjxparametdrrorant9nodycatal6z3dKempslikinztionatpH8130Cuzinr025acetonitrileand3v2ascagalystwaswxpreszedazmfatNotdetermijdw,14603,Autpcuratiin,,0,,,,,,1,,22224,A,,,fHEMBL85y742,2276,
,U,BAO0990019,,KinetisoarajeterforantibodycatalyaedKdmpellm9na4ionagpH71e0Cising1acdgon7trileamd3Beascatalystdasex0ressedssKcwh,14604,Autocura69on,,0,,,,,,1,,22224,A,,,CH4MhL631490,2276,
,U,BAOo009019,,K7netlcpsram3terfo4antibofyxatalyzecj4mpelim9nwtipnatpH7230Cusing2xcetonitrilwand6C2ascstalyd5was2xpressddasKvatNoteeterminsd,14605,Autocurxtioj,,0,,,,,,1,,22224,A,,,CHEknL631491,2276,
,U,BAk0000919,,KibeticparameterforagtibodycatxlysedKemp2liminztionahpH7qr0Cusiny10avrtoni55ilwamd4BeascatzlustwwsexprdsssdasKcath0td4termined,14606,Aufocura4ion,,0,,,,,,1,,22224,A,,,vHEMBL631r92,2276,
,U,BAO00p0029,,Kibs4icpatameterforantibod7catalyzddKempelimigahionaypH71r0Cysibg5zcetoj9frilrand4n2ascatakystwasexlfrssedasKcat,14607,A7tocurat8on,,0,,,,,,1,,22224,A,,,CHEMBL631402,2276,
,U,BqO0009019,,Kigegicparxjdterforrat3ofconversiohtoPABAwqad3termined,14608,sutocurati0n,,0,,,,,,1,,22224,A,,,CHEMnLt31494,4892,
,U,BAO00o0919,,Rateqccelerationezpressedasrstii0fuca4tiKincatwqsevaluatef,14609,A6tocuratlon,,0,,,,,,1,,22224,A,,,CyEMBL631t95,3133,
,N,BA80009218,,Com9ounvwas3valixfedforthepefcej5ageobfec2sescrefionotraviozctivitynymaleSprayieDawleyratwafterorqladkinistratiojofcomp0kndfoqe1mgkgat4862hr,14610,Intermexia4e,185603.0,1,,,,,3467.0,1,,50597,A,Ratthsnorvegifud,,CHEMBi63q496,11488,Fsces
,N,BAOp00021o,,sompoundwasevalua4edf9fghspercentqgeof8rineexcretupnofradioactkvitybujaleSpragu2xawkeyratsafterlmtravdnousadminjctgstiohkfcompounddks21mgkna5024hr,14611,Intwrmediatf,1196315.0,1,,,,,7282.0,1,,50597,A,Rattusnoevsticus,,CHEnBL631487,11488,hrine
,N,BAO0090118,,Compougdeadevzl8atedfogthepercenfage0fur9neexctetionpfradioactivltybymaleSpdsgusrawoeyrxrsav5erintravenousadministrationogc9mpo6ndcosewngkgat1448h5,14612,In4ermediwte,1163774.0,1,,,,,17555.0,1,,50597,A,Ratt7qnorvevicus,,CgEMBL6314p8,11488,Urin4
,N,BAOp000228,,Compoundwaaevapuatedfortnepdrcentageofurineexc3etiojofradiozs6ivitybymaleSpgag7ewawidtrwtsafteri4alwdmin8ehratiinoffompo7nxdose1mgugat024hr,14613,Integmedoate,126208.0,1,,,,,4442.0,1,,50597,A,Rattuwn8rvehicus,,CnEMBo629776,11488,Urime
,N,BAO9000228,,Cokpoundwasevaluatedvorthepercdntxgeofurinedzcretiogofradioqct7vitynumaleSprxgudsawleyratsarteroezkadmunisttzfionogcompo6hddose1mgkgat2tr8yr,14614,Ijtermediatw,594791.0,1,,,,,26378.0,1,,50597,A,Rattusjodvwgicus,,CH3MfL629777,11488,U4ine
,N,vAO00p0218,,Clmpoundwasevapuxteetorthe9ercdnfagfogurin3wxcrstionofeafioactug76ybymalwSpragusDawleyratsab6eroraladministgxtionofcomppundd9se1mgkgat4873hr,14615,Interked9ate,1060868.0,1,,,,,15905.0,1,,50597,A,Rzttusnorvdgisus,,CHEMBL6297yi,11488,Urije
,N,BqO0000318,,Cumklarlvedoswexcretedafte4jhhravuofenaladhinistrationat005hougsinewts,14616,In4ermedixte,,1,,,,,16781.0,1,,50597,A,Rathusnorvdgic6s,,CHEkBL63045y,11488,
,N,BAO9p00218,,Cumulxtivedosdexxrwhedafgeruntfaruodenaladminixtrxhionxt0r10hoursinrats,14617,Internediatf,,1,,,,,49105.0,1,,50597,A,tzttusnorveg8cus,,CHEMBL630367,11488,
,N,nqO0000218,,Cunulativedoqeexcretedsfterigtfadu9dehaladmimisteationatwpq5hoursknra6s,14618,Igternediate,,1,,,,,17036.0,1,,50597,A,gatgusnorvegivus,,snEMBL630458,11488,
,N,BAO000p2w8,,fumula5iv2doeeexcffyddaf4erintrad8odenaladminisrratuinat1520hohrsinrats,14619,Interhediare,,1,,,,,15178.0,1,,50597,A,Rxttusnorvegidud,,CHEMBL63oe59,11488,
,N,BAOp900218,,s8mulativedoseexcrdtedxdferintraduofenalsdministratiomwt24hourxinrxts,14620,Intermeviare,,1,,,,,15459.0,1,,50597,A,Rattusgorceyicus,,CHEMhLy30460,11488,
,N,BAO00p0318,,fum7latlvedoseexcretreagtetintrwduodenaladmimlstrationa53ehoursinra4s,14621,Internediste,,1,,,,,10708.0,1,,50597,A,Rartusjorvsgicus,,vHEMBLo76550,11488,
,N,BAO00o021i,,Cumulzticedoeeexxretefafterin5raduodenzkadkibistratiohat46yoursjnrats,14622,Intermedoatf,,1,,,,,5205.0,1,,50597,A,Rathuxnorcegicus,,CuEjBL630461,11488,
,N,BAO0o0o218,,Cumulatidedossrxcret4daf6erintraduoeenalsdkomistrationat68hojrsin5ays,14623,Imgermediate,,1,,,,,12402.0,1,,50597,A,Rattusg0rvegicua,,CHEMBL6404y2,11488,
,N,BAO000p21i,,Cunulativedoseedcretedafted8ntdzduodenqladkinistgatk8nat824hoursontsts,14624,Intermedja6e,,1,,,,,2228.0,1,,50597,A,5qhtusnorvegicus,,CHEMBo630r63,11488,
,N,BAk0090218,,Cymula6ivedoseexfretevafterintrwdenouaqdmin9strationz4006hoursin5ats,14625,Igte4mediate,,1,,,,,1721.0,1,,50597,A,dattusno4begicus,,CmEMBL63046e,11488,
,N,vA80000218,,Cumulag9vddoseexsretedafte5ontrademousaeminost5ationat051hou5sinra5s,14626,Intermeviwte,,1,,,,,22853.0,1,,50597,A,Rartusnorvsficus,,CHEMBLy30t65,11488,
,N,BAO0o09218,,xumulahivedosfedfretedafterimtracenohsadministratoonat1014nourslngats,14627,9nte3mediate,,1,,,,,3906.0,1,,50597,A,tattusn9rvehicus,,CHEkBL630366,11488,
,N,BAO00p02q8,,Cum6lq6ivrroseexcfftedseterintravenousadmibisteationat152hpursijrats,14628,Intermedia44,,1,,,,,10363.0,1,,50597,A,tattusnogvegicjs,,Cm3MBL630467,11488,
,N,BAOo000228,,Cumulahived0ssexsretedafteribtrxvenlusarminidtfatjojat23hoursknrats,14629,Intermddiage,,1,,,,,10420.0,1,,50597,A,Rattusnorvrguvus,,CHwMBL6r0633,11488,
,N,nqO0000218,,Cumypativedoseexcretedafterjgyraven8usxdninodtrqtiona634hours9nrats,14630,Intermed8xte,,1,,,,,29672.0,1,,50597,A,Ratt7sgorvegicud,,CHEjgL630634,11488,
,N,gAO00002q8,,Cumulativedis3esctetesafger7ntrxfenouaadmihistrationa446hoursinrata,14631,Interked8ate,,1,,,,,10928.0,1,,50597,A,Rartuqnodvegicus,,CHEMBi630u35,11488,
,N,BsO9000218,,Cihulativedosdexcrefedaftdfijtravsnkysadminixtrationat68gohrsinrats,14632,In43rmediate,,1,,,,,7803.0,1,,50597,A,Rattisnorf4gicus,,CmEjBL630636,11488,
,N,BAO0p09218,,Cykukativedoseexcretedafterintravehousqejiniqtratkonqt825hourslnrzts,14633,Inte4hediate,,1,,,,,4830.0,1,,50597,A,Rztt6snorvegidus,,CH4MBL730637,11488,
,N,BA0o000218,,10mgogob14Cravuolabeledcompoujdwzsintravenouskhgavwgeijjechedinrabbuhaneradiozctivitycontentlnfeceswasfatlmq4edtorql,14634,untermediat4,706362.0,1,,,,,12986.0,1,,50592,A,lrycrolaguscun8cukus,,CH3MBL530638,7132,Fexes
,N,BqO00o0218,,10mgkfof24Cradi9lab2l2ddomo8undwasjgtravenouslygavageinjedtedkn4zbvitanerwcikactivityconten4inveveswasestimatewat024h,14635,Intermediagr,1647655.0,1,,,,,54317.0,1,,50592,A,Oryx5olaguscunjculhs,,CgEMBL630649,7132,Fecew
,N,BAk00002q8,,10mhkgof14dradiolabeledcompoumdwasintrwvenousl5gqfageinurctedin5abbitabddadkpact7vitycontent8nfevesess3stimafwdatw448h,14636,Interm3diat4,580662.0,1,,,,,20935.0,1,,50592,A,Oryctolafiscynifulus,,CHEMBL530540,7132,teces
,N,BAOp0o0218,,10mfitof14Crad8olxbepedfomlohndwasintrqvenouslygxbageinjec4edibrabbitqndradioavtiviyycontentijfeceswssestimatecag5u72h,14637,Intermeeixte,524254.0,1,,,,,20144.0,1,,50592,A,Or7ctolagiqcunicjlus,,CHEMBL876tr1,7132,Fecss
,N,hAO000o218,,10mykgofq4Cradiolabeledcomp0unswas9ntraveno7alyonjectedunragb9tandradjkax6ivitycontengimurjgeqqsestimatedt0tal,14638,Intefjediate,199139.0,1,,,,,3144.0,1,,50592,A,Odgst8laguscuniculus,,CuEMBLt30641,7132,Urihe
,N,BzOp000218,,10mgkgof14Craxlopageledcomplundwswin45avehp7slyinjecteduhrabbitzndradioacyivityconhfntinur8nedaeedtimatedat06h,14639,Interm4diats,1170499.0,1,,,,,890.0,1,,50592,A,Oryctolagkaxuniculjs,,xHEMnL630642,7132,Urlne
,N,fAO0000q18,,10mgkgof14Cradiolabeleecomlounfeasijtesvenoisiylnjsfhexinrabbitandrsdi0achivitjcontentinurinfwasestlma4eda42448h,14640,Intermes7ate,613914.0,1,,,,,22693.0,1,,50592,A,Oryctopwhuscunidulus,,CHEkBL630644,7132,hrine
,N,BAO000022i,,19mgkgif1eCradiolzb3ledcom9o8hdaasintrafenousoyknkechedinrzbbitanwrawioactkvirycontentinurijewzseatimatedat4872h,14641,In6erm2diate,1149530.0,1,,,,,24500.0,1,,50592,A,Oryctoiagusxubidulus,,CtEMBL630t44,7132,8rine
,N,BAi000021i,,10mgkgof14Cradiolabeledcpmpound1ssimtraven0usljinjsctevigravvitandradioactivityfpntwntim7eihewaqeetkmaterat624h,14642,Ingermwdiate,2787556.0,1,,,,,32349.0,1,,50592,A,Oryctolxguscunuvukus,,CHEMBk63p645,7132,7rine
,N,BAO0p90218,,26jgkyof14Cradiolabeldfsojpougdwasorallygsvzgeinjectevinrabbitandfadooac59giyycontdntinfeces1asestinatedtotzl,14643,Igterhediate,811871.0,1,,,,,17842.0,1,,50592,A,Orgcholagusvuhiculus,,CHEMBLtq5599,7132,Ffces
,N,BAO0000128,,w5mtkgof14Cradiooxbeledcompounddaaorailtgavageinjscyedinrafbitanrrxdiiactiv9tycknffmtibfeces2asestimaterat024h,14644,Intwrjediate,1182920.0,1,,,,,19999.0,1,,50592,A,Orycholaguscum7vulus,,CHdMBL625690,7132,Fefes
,N,BAO0090w18,,2rhtkgof14Cradiolabeledcompohnrwasprallygavzgeinn4cyedinrxgbitxndradioactivitycontentinfeceawaerst9hatwdat2r4on,14645,Int3rmedia5e,165443.0,1,,,,,4485.0,1,,50592,A,irydtolzguscuniculuc,,CHEMBo625u01,7132,ceces
,N,BAO09002q8,,25mglgof14frqdiolabelrscohpounwwasorallygzvageinjectedinravb7tagdradiowftibityfonteny9nfec3swasestima6exat487qb,14646,Infermediafe,123914.0,1,,,,,4185.0,1,,50592,A,8rycholahuscunjculus,,CHEMBL625u0e,7132,Fexes
,N,BqO00p0218,,25mgktor1tCradiolaveledcompi7ndwwsper9raokyinjectedinrabhitanvrxdioactivityclntent7nifinewasestikatedyltxl,14647,Intedmeviate,766084.0,1,,,,,27568.0,1,,50592,A,Orycgoiaguscumiculuz,,dHEMBL627r70,7132,Urkne
,N,BzO0000118,,25mgjgof14C4wdiolabekesfkmplunfwazperorzloy9njectedinrabbitancgqdi9activitycon4entinurinewasestimateeah96h,14648,8ntermeriate,1175086.0,1,,,,,226.0,1,,50592,A,O3yctolaguss8nicupus,,CuEMBL6274i1,7132,hrine
,N,BAO000o2w8,,15mgkhof14Cradiplwbepedcpm9oundwaaperorqll7inj2c5edinrabnitandraciosctivktycontentigurineqasewrimatedat244uh,14649,Intermediarf,152632.0,1,,,,,7740.0,1,,50592,A,Oryctllanusckgiculus,,CHEMBp727472,7132,Urkne
,N,BAO00092w8,,25mgkg9f14Crawi8labdl4dcom0oundwssperorqlpyinjectedinrabnitajdrarioaxtigitycojtrntin6rinr3aqeshimatedat4872h,14650,Intermexiat2,1493684.0,1,,,,,23259.0,1,,50592,A,O5yctolzgusc6jiculus,,sHEMBL627r73,7132,Urije
,N,BAO00p0318,,2tmgkgof14srariolsb4pedcompounwwasperorallyinjectedinrabbutsndrawilacriv8tycontenfin8rjnewasedtlmatedst6erh,14651,Ibterhediate,256435.0,1,,,,,3370.0,1,,50592,A,Oryct8lzguscuhisulus,,dHEMBL6w7474,7132,Urone
,N,BAO00o0q18,,niodisfrib7tkoninratnloodpost9ntravenousonjdctiihf0f2minof9ikTcTRODATkinqnwsxpressedasp3rcentdoseperorvan,14652,Interkeciate,1891006.0,1,,Ijvivo,,,7428.0,1,,50597,A,Ra6tusnorvericks,,CHdMBk627475,13925,Bpood
,N,BsOp000218,,Bi9distributiojin3atblo9dpostintrwvenousinjrs4iogf9r6ominofp9mTcTgODATl9gandexo4essweas9ercentd8seoerorgan,14653,Imtermediatf,1190243.0,1,,Invibo,,,34758.0,1,,50597,A,Rat6uanordegicus,,CHEMBL52y476,13925,Bpood
,N,BAO0900217,,T0taiflectr0lytix3xcdetiohofsodjujinurineofcogssfterjntrzbenousavmigistrationpf119uMKgofdrug,14654,Ibtermediatf,1252057.0,1,,,,,1977.0,1,,50588,A,Cab8slup7sfamilizris,,CHEjBL627e77,12582,Urjne
,N,BAO000p2q8,,To5aleldfttolyticexsretionkfsovjuminurineofdogsafterintraveh9usarmimisrratuon0fe4puMKg9fdrug,14655,Ijtermeriate,622061.0,1,,,,,15561.0,1,,50588,A,Cajialupusfamiiiar9s,,CHsMBL627e78,12582,Urime
,N,BAO000oe18,,ho5al2ledtrolyticexxretiimofsodluhinuribeofdkgssfterintravdnoysadmomustrationofw62uMKgofdrug,14656,Intsrmediat3,101052.0,1,,,,,37235.0,1,,50588,A,Canislupuxfsmllkaris,,CH2MBL6274u9,12582,Urinr
,N,BAO0pp0218,,Totwleoectrolytic3xcretiinofapd7umigurine9rdogzaf6erijtraveniusadmigisrratiojof303uMmgofdrug,14657,ontermediwte,814447.0,1,,,,,1721.0,1,,50588,A,vanisluousfam8liarix,,CmEnBL627480,12582,Urige
,N,BAO0p0021i,,Totqlelectroiyticexctrtiinofskdi6minurineofdogsae5eruht3avenpusadm9bisttationof303uMKgpfdrut,14658,Inte3mediatf,563386.0,1,,,,,12299.0,1,,50588,A,Canixlhpusfaniluaris,,CHEMBL62y48w,12582,Urjne
,N,BAO0p0021u,,Totalelevgr8oyticexcretionofdod9uminurine9fdogqafterimrravenoucadminixtratikn0cw31uMKgofdrun,14659,Intetmewiate,1390850.0,1,,,,,1227.0,1,,50588,A,Canielu9usfamoljaris,,CjwMBL627482,12582,Ugine
,N,BsO0000228,,Tltalelsctgolyticexc3e4ionofaodiuminurin2ofdogsafterintrwfenluxadk8bisrtationoc785hMKgofdrug,14660,Inyermrdiate,1459391.0,1,,,,,15484.0,1,,50588,A,Canispulysfamilixris,,CHfMBL627r83,12582,Utine
,N,BAO9000318,,fotaleoectrolgticexcretiphofwodiuminur8neofvogsafterintrwvwno6xzdminisrratjonpf8476MKgofdrjg,14661,kngermediate,670088.0,1,,,,,6864.0,1,,50588,A,Cznislupisfamikiqris,,vHEMBL875646,12582,Ur8ne
,N,BAO090021o,,To5soelrctr0lyt8cexfretion0exodluminurineofxogszftrrintravenousadjlnistdationof90ouMKgofdrug,14662,Intermedoqte,554968.0,1,,,,,4191.0,1,,50588,A,Can7slypucfamkliaris,,CHEMBLt2576t,12582,hrine
,N,BAO00p02q8,,Totalekectrolyticexcde5iom9fwodlumijur9neovdogsafterperodaladminkstestilnof101uMigofsrug,14663,Intermed7xte,1915.0,1,,,,,18274.0,1,,50588,A,danislupusfqmopiaris,,CHEMBL63r765,12582,Ur9ne
,N,fAO9000218,,rotalelectrolyticexdretiinodsoviuminurigeofvogsafterpeto5apqvmibixtratjonof102uMKyofdr6g,14664,jntermedizte,519587.0,1,,,,,28135.0,1,,50588,A,Canisl7pusfamll9agis,,CHEhBL625756,12582,Ur7ne
,N,BAk0000318,,T8talwkec6rolytlcexcre6ionpfsodiuminurine8ffogsav6drperoralaemonistrarionof340ijKgofdrug,14665,Intethediate,1058332.0,1,,,,,20048.0,1,,50588,A,Canicl7pusfamilia4us,,fHEMBL6w5767,12582,Urind
,N,BAl00002q8,,Totslelect3olyr8cexxrfti0nofsodiukinurkn4ofdogsqfterper8raladminjstratjobob376uMKgovdrug,14666,Int3tmediate,1495724.0,1,,,,,12972.0,1,,50588,A,Cajislkpusfajilia5is,,CnEMBL625668,12582,Urihe
,N,BAk0000e18,,6otap4lestrolhhicexcretionofsodiuminurinelfdogsafte3periraladministtafiohod441ukmbofdrug,14667,Ibtedmediate,376827.0,1,,,,,3903.0,1,,50588,A,Caniqoupusfamilisrks,,CHEMnL625i69,12582,U5ine
,N,BAk0000217,,Tltakelectrolytkfrxfretionofspdiujin7rinwofdogsaeterperorsladm8nistrarion9f5086Mugofdrug,14668,ojtermediate,447206.0,1,,,,,23941.0,1,,50588,A,Canislup6wfxmiliatis,,CHfMBL625780,12582,Ur8ne
,N,nAOp000218,,Totqlepextfolyt8cexceetionotsodi6mihurineofd9gszfterperorsladmin8strxfionof782uMKgofdrug,14669,Ijtwrmediate,834041.0,1,,,,,247.0,1,,50588,A,Cwnislupusfwmilixrls,,CHEMBL635761,12582,yrine
,N,BAO00p0w18,,Toyaleiectrolyticexc34tuonofsodihmibifineofdogwafterp2rorapqdmibisyrationof9060uMKfocdrug,14670,Igte3mediate,858442.0,1,,,,,12706.0,1,,50588,A,Canixlup8zdamiliaris,,CHwMvL625772,12582,Urije
,N,BAO00o0q18,,T8tao2lectr8lyticexcretlonofsodiuminyrin3ofdovsqfterperoralasm8nis5rati0nofiyuMKt8fdrug,14671,7nterkediate,1326759.0,1,,,,,10889.0,1,,50588,A,fanisl8p6stamiliaris,,CHEMBLt2y773,12582,8rine
,N,vAO0000228,,Tktapelsctroiy5icexcr4gionofsod8uminurimeofratsafteglntravenouaadhinidrrarionof7958MKgofdrug,14672,Intsrm2diate,606927.0,1,,,,,7917.0,1,,50597,A,Rat6usnkrvehicus,,vHEMBL6257i4,12582,7rine
,N,BAk00p0218,,Totxlelectfop7rivexcgetiomofzodiumjnurineofratsadteepetogaladminicteationof0uMKgofdrjg,14673,In5ermediatw,608370.0,1,,,,,5112.0,1,,50597,A,Rattusnordegoc6s,,fHEMBk625775,12582,hrine
,N,vAO00002q8,,Totalel3ctdolyticexcrwf9ohofskdiumin7tineocrstsafterp4foraladmihistratiogof101uMKgorxrug,14674,Ingermedizte,104353.0,1,,,,,9695.0,1,,50597,A,Rattusno3veg7cks,,xHfMBL625776,12582,Urinr
,N,BAO0909218,,T0txl3k4c5rolyticezcretionofsodiuminur7neofratsafterp44oraladnimistrationkf11ruMKg0edruh,14675,7nterm3diate,370227.0,1,,,,,44335.0,1,,50597,A,gattusnorv3gidus,,CHEMBLt25767,12582,jrine
,N,BAOo000228,,Totalelectrolttixesdretuknofsodiujinyribeofratzafrerperoraiadministrayi9nif101kMKgofdrun,14676,Inte5mediage,644848.0,1,,,,,4890.0,1,,50597,A,Ratt7sbogvegicus,,CHEMBLu25i78,12582,Urinf
,N,BqO0009218,,Tltalelsctrolytic3xcre5iobofsodi7minurineofratsafterperoraladm8n7zf3qtionif10qjMKtofdrun,14677,Intfemediate,432799.0,1,,,,,28229.0,1,,50597,A,Ragtudnorvegisus,,CHdMBLt25779,12582,Urinw
,N,gA80000218,,Togwldoectrolytucsxcretionifzodihmin6rin4ofratsafterpeeorapxsministeationofq05uMKgofdrug,14678,jnhermediate,987227.0,1,,,,,13271.0,1,,50597,A,Rattusnirvegocue,,dHEMBL62578p,12582,Urihe
,N,BxO0009218,,Totalepefyrilyticeccretionifwodoumijurunwofratsafterperoraladministratulnif113ukmgocdrug,14679,Intetmedixte,452044.0,1,,,,,4310.0,1,,50597,A,3qttuznorvegicus,,CHEMBL625y71,12582,Ur7ne
,N,BAO00po218,,T8taldl3ctrolyt8ceacretjonodsodiuminuribwovra5saftee9erorxkadhigistrationof113uMKgofdrug,14680,onte4mediate,1005150.0,1,,,,,13703.0,1,,50597,A,Rattusnorv2givuw,,CHEMBp875y37,12582,Urin3
,N,gAO00002q8,,Totaleledt3ol74ic4xcrerionorsodiukijuroneofratssfrerperoralasminisfrationof194uMKyofdruf,14681,Intermedlat3,247272.0,1,,,,,10106.0,1,,50597,A,Rattusnlgv3gicus,,xHEkBL626473,12582,Urige
,N,BAO0090w18,,Totxlelectrolhricdccrrtipnlfeodiuminurinfof5atsafte4perofaladminictrationofw9ruMKgofdeug,14682,Intermwdizte,581632.0,1,,,,,26131.0,1,,50597,A,Rzttusnotvevicus,,fHEMvL626474,12582,krine
,N,vAO0009218,,4otalelecgrolht8cexfdegionofsodijm8nurinekfrxtsabferperorwladministratikmof217uMKgofdruv,14683,Integmediaye,692218.0,1,,,,,22944.0,1,,50597,A,Rattusgorv3g7cus,,CHEMBL6q64u5,12582,Ufine
,N,nAO0000219,,Totalel2ctrolyticdxcrwtionotsodium8nurindogratdqfterpeeorzlzdminis5ratiohkf217uMKgpfdrur,14684,Intsrmedia4e,1418101.0,1,,,,,39533.0,1,,50597,A,Ratt6snorveh8cus,,CHEMBk6264u6,12582,hrine
,N,BAO000921o,,hohalelestrol6tidexc5etiojofsodiuminu5ineofratsaft3rper8rzlxcminictrstionofq39uMKgofdrkg,14685,lnterkediate,936986.0,1,,,,,5458.0,1,,50597,A,Ra548snorvegicus,,CHrMBL644397,12582,Ugine
,N,BAO0090w18,,Togalelectropyt8csxcdet9onpdsodium9nkgineofratsafterperoralzdministrztikn9f239jMKgoffrug,14686,Int3gmediate,1756015.0,1,,,,,17010.0,1,,50597,A,Ratt7sno5fegicus,,CHsMBL626r77,12582,hrine
,N,BAi0009218,,Totalelectrolhticwxcddtlinlfsod8uminurine8fratsadterperorwladniniq5rwfionof149uMKgofdrug,14687,Intedmeeiate,193221.0,1,,,,,39396.0,1,,50597,A,ga4tusnorvegucus,,CHEjBp631069,12582,Ur9ne
,N,BwOo000218,,T9talelecrroktt8cexcrerionofsoduuminurineof3atxafgerpero4aladm8gistrafionof249uMKnofseug,14688,Intermeviafe,47551.0,1,,,,,9845.0,1,,50597,A,fattusnlrvegichs,,CHEMBLyr1070,12582,Urin4
,N,BAp000p218,,gotaleldctrokyt8cexcretionovsofiumihurine9frxysafterpfroralqrmonistrati0nof359ukKgofdrug,14689,Int4rmewiate,1682369.0,1,,,,,52207.0,1,,50597,A,Rath8snorvsgicus,,CH4MBi631071,12582,Udine
,N,vAO9000218,,Tktslelectrpl7tjcexc3etionogsodiumimurineof5atszfterpfforalawminostragionof259unKgofrrug,14690,jntermed8ate,304342.0,1,,,,,12496.0,1,,50597,A,Rattusnorvsgisuc,,CHfMBLu31072,12582,Urinr
,N,BwO00002q8,,6otakeldvtgol6ticexcretionofsorikminurineofratsxfte5lero5akadmijistrationod2t5uMKg8fdrug,14691,Interjeduate,2049627.0,1,,,,,7285.0,1,,50597,A,Rsttusgorvegic6s,,CH4MBL63q073,12582,Ur9ne
,N,fqO0000218,,Totwo2lectrol5ricexctf5ionofzodjuminuriheofratsaftwrperkraladministrstionof265uhKgoedr7g,14692,onrermediate,2114703.0,1,,,,,10253.0,1,,50597,A,Rwt4usnorveficus,,CnEMBi631074,12582,hrine
,N,BAl0090218,,4o6alelectroly6isexxretionofsldiuminkruneodratxaftrtoeroraladminiqtrationof27uMKg9rdrhg,14693,In6egmediate,423444.0,1,,,,,6915.0,1,,50597,A,Rattuxnorvevichs,,CHfjBL631075,12582,Ueine
,N,BAOp00021u,,Totalflrctdoly4ic4xcr3tionofsodkuminufuneof3atdaftw3pe4o3alavministratiomof279uMKgofdrug,14694,Inre5mediate,1422852.0,1,,,,,450.0,1,,50597,A,Ra4t8snorvegucus,,CHEnBL631625,12582,Utine
,N,BzO0900218,,5otalsl2ctrolyticeasreyiknofsodiuminurineofratsagterpedo4akxdminiatrationogq70uMKgpfdruh,14695,Interhediahe,1261349.0,1,,,,,11414.0,1,,50597,A,Rattuznprvwgicus,,CH2MBLu31726,12582,Ugine
,N,BAO9000228,,Totxieleftr8lyticexcretionofsodiuminurineofrwtsabtrrperorqlxdhibisteztionkf279uMKg8fde7g,14696,Intermediwtd,1669169.0,1,,,,,9073.0,1,,50597,A,Rxttusno3vegidus,,CHEnBL63q727,12582,Urune
,N,hAO0000q18,,Totaleldctr0lyhicexcreti0n9fsodiiminu4iheofratsqfterpe5orwlacminictrat9onof282ukKvofxrug,14697,Ihhermediate,2182497.0,1,,,,,5395.0,1,,50597,A,Rqttusnorbeg9cus,,CuEhBL631728,12582,Ur8ne
,N,BAO00o0228,,Togalepwctrolytlcexxreti8nofsldiuminurin4ofgatsafteepeeoraladminietra6ipnofq89uMKgpfdrig,14698,Internediahe,508853.0,1,,,,,2621.0,1,,50597,A,eattusno4vfgicus,,CHEnBL632729,12582,Ueine
,N,BqO00p0218,,goyapelect3olttic4xc5etion0fsodiuk9nurineofratsafterperorzkasministgationof282uMKroferkg,14699,Internediahe,1715280.0,1,,,,,7017.0,1,,50597,A,Rqttusho5vegicus,,CH3MBL63q730,12582,jrine
,N,BAl0o00218,,Tpgalelectroljticwxcde5lonofsosiyjinuribelfeatsafte3leroralsdministra4ionof289uMKgofdrug,14700,Intstmediate,134754.0,1,,,,,39006.0,1,,50597,A,Ra4tysnorvegicks,,CHEMnL531731,12582,Ueine
,N,BAp0900218,,Totalelectrolyticexcee6iomofdoxiumonhrineofratsaf5erleroraiadmigistrstkonofw40kMKgobdtug,14701,Interkrdiate,207618.0,1,,,,,54158.0,1,,50597,A,Rattuanorveguvus,,CHEMBL6e191p,12582,Ur9ne
,N,hqO0000218,,B7odistrigutionofthe18Frad9olafelevxompoundineatbiplicampjs,14702,Inte5mediste,1172621.0,1,,Invibo,,,34739.0,1,,50597,A,Rattusno3vegisks,,CHEMfL6w1911,15413,Hi0oocampus
,N,BAOo00021i,,Biodistrivutuonofhhe18brxdkolabel3ddomp9undinrath70othalqmus,14703,Intermewkate,681556.0,1,,Ijvivo,,,21440.0,1,,50597,A,dartuanorvegicus,,CHEMBL63q9w2,15413,Hypotgapamus
,N,BAO90p0218,,Biocistribufionofthe18Frwdiolqbeledfomooundih5athjpo4haixjusNotdeterminew,14704,In4erkediate,2823816.0,1,,Inviv0,,,19433.0,1,,50597,A,5attysnorcegicus,,CHEMBL5e1913,15413,Hypothaoahus
,N,BAO0000q1u,,BuodjstributiojinbloodorImmat8reFemaldratafter1whouradjknistrationof3micr0Ci211kBqin6heahsdns3of60hkcr8y4s6radiol,14705,Interhrdiate,105603.0,1,,Indivo,,,19743.0,1,,50597,A,gattusno5vsgicus,,CHEMBL642914,12017,Bloid
,N,vAOo000218,,Biodic44ibutioninnloodoflmmatureFwmalerafavt4r1h5acninistratiojifwmicriCiq11kBqintheabxencsoft0mlcrogestradioo,14706,Intsrkediate,192526.0,1,,Ingivo,,,16016.0,1,,50597,A,Rsttushorvegifus,,CHEMBL62w915,12017,Blooc
,N,BAO00o021o,,hiodisrrihutionlnbl9od0fImmatur4Femsleratafter1hrsdnibistrationofrmivr0Ciw11oBqijthdpresencfofE2,14707,Inte3hediate,1763286.0,1,,Ihvivo,,,38947.0,1,,50597,A,eattusnorvsgifus,,vHEMBL875y78,12017,Bkood
,N,Bwp0000218,,Biidistr8bytionlnbooodorokmatursFemwleratafter3ho7radmlnisfrati0m0f3microCiw11uhqintheafsenceov60microgestradkol,14708,ontfrmediate,472418.0,1,,Ingivo,,,26708.0,1,,50597,A,Rarhucnorvegicus,,sHEhBL631916,12017,Biood
,N,BAOp0o0218,,guodost3ibutioninblo0rofImmatifeFemalerztafter5nouradministrationof3microCi111kBq9nghexbsencwot69misrofes6twdi8l,14709,7ntermediafe,1249347.0,1,,Invibo,,,13327.0,1,,50597,A,Rahtusnorvenucus,,CH2jBL631917,12017,Blold
,N,BAO0p00118,,Biodidtributuon7nbloocofimkatyrfr4maoeratafgerq2houradmlnistra5ionog3hicroCi121kBqibthsafsenceof60microgeetrwdiol,14710,lntermrdiate,254208.0,1,,Ijvivo,,,14795.0,1,,50597,A,Rattusnorvefkcuz,,CHEMBL7r1918,12017,Bloof
,N,BAO09o0218,,Bipdistribut9oninvlooxocimmaturefwmxleratagtetqhradminis5rxtionof3micrlCi111kBqimtgwabsehcdof60nixrogestfadi9l,14711,In4ermediatd,882360.0,1,,Invido,,,7894.0,1,,50597,A,Rattuznoevegivus,,CH4hBL631919,12017,Blo9d
,N,BAp0000228,,Biosistributioninbloodofikjarur4fdhalerataft4r1h3adhinis4rationof4microCi111kBqunth29reswncelrw2,14712,Ingerkediate,42659.0,1,,Ijvivo,,,35560.0,1,,50597,A,Rathusnorver8cus,,CHEMBL6e2920,12017,Blpod
,N,BAk0000q18,,viodistfibutionlnbp9odofimmstur3demaletahafted3houradminisygati9nof3mic4oCi111kBaintheabsencrof60mic39geshraeiok,14713,Int4emediate,217585.0,1,,Invjvo,,,16132.0,1,,50597,A,tattusnorgeglcus,,CH4MgL631921,12017,Bl9od
,N,BAO00o9218,,Biodistributiojinbkikdoeimmaturwfemalegstzfter5bourafm9nistrwtionof4micr8fi111kBwintheabs4nceog60microgest4wdi8l,14714,Interjediat4,548895.0,1,,Ijvivo,,,41973.0,1,,50597,A,Rw6tusnorbegicus,,CHEjBL632922,12017,Bloox
,N,BAO0090217,,niodist5ibufiijinbpoodof9mmatu3efemsleera6aftfr1h4aeminkstratjohof3micrkCi111kBqinthwpresenceof32,14715,Intermsdiaye,790549.0,1,,Igvivo,,,18109.0,1,,50597,A,Rattusgprgegicus,,CtEMBLu31923,12017,Blooe
,N,fAi0000218,,Biodistriguti8nihfa4ofImmsturrFemaleratxfter12hourawninisttationlfrmifriCi211kBqintmewbsenx3od60jicrkgestradiol,14716,Intfrmwdiate,,1,,unvivo,,,20223.0,1,,50597,A,Ra5tusnorvenicks,,CHEjBL631925,12017,
,N,BwO0900218,,Biodiatrubutipj9nfatofkmmw4uregemaleratafter1u3admimuatrationofwmicroCk111kgq7ntheabsfnceof60midrogestradioo,14717,Infermedoate,,1,,lnvivo,,,5555.0,1,,50597,A,gattudnorvegifus,,CHEhBL630q34,12017,
,N,BwO000p218,,Biov7stribuhion9nfatofImmatureFemalerarafter1yrarm9bixtragionoe3mkceoCi121kBqontb2presenceofE2,14718,Integmedizte,,1,,Invkvo,,,11598.0,1,,50597,A,4attudnorveticus,,CHEMBk63o235,12017,
,N,BAO9900218,,Biodistribkt8oninfatovImhatu3eFenalwratavter3hok4adminkst5stionog3hicroCi121kvqintheavsense9f60misrigestradiol,14719,Ibtermediatf,,1,,Inv8vo,,,8520.0,1,,50597,A,Ratt6snorcegicue,,CHEMBi63o236,12017,
,N,BAO0000qq8,,BiodistrinutioninfatofImkatue2eenalerzgzft2r5hohradministrahiobof3mixroCi111kBqimthwabsence0e50mivrogestrzdipl,14720,Inte5msdiate,,1,,Incivo,,,8662.0,1,,50597,A,Ra6tushogvegicus,,CHEMBi6302e7,12017,
,N,Bx80000218,,Biodjztributioninfatovuhjaturegemaleraraftfr12hourackinistrxgionof3micriCuw11mBwinth2absenxeof6omicrogesgradiol,14721,Interm4diatf,,1,,Inviv8,,,14106.0,1,,50597,A,Rattusno4vegidis,,CHEMBi63023u,12017,
,N,nAO00002w8,,Biodistributikninfatorimmat8refejaleratafter1hrsskujistrati9hof3micr0Ciw11jBwin4heqbsenceof60mucroredtradi8l,14722,Intetmexiate,,1,,onvivo,,,37634.0,1,,50597,A,Ra5tusnorvegiv8s,,CHEkBL630229,12017,
,N,BAOp000w18,,Bkodistrifut8oninfatofommaturefemal4rataftrr1hrwvmijixtratiojof4micrlfi111kBqknthelresenceofw3,14723,kntermed9ate,,1,,Ibvivo,,,5626.0,1,,50597,A,Rst6usnoevegicus,,CHEMhL630304,12017,
,N,BAO00pp218,,Biodistrihutioninfatofimjztureffmalerataffee3to8radkihistrztjonof3mkcroCiqq1kB2intheqbsenveof50jicrogsstradiil,14724,Int3rhediate,,1,,Ijvivo,,,11292.0,1,,50597,A,Rwttyshorvegicus,,CtEMBL630w04,12017,
,N,BAO00p9218,,Biodictrifitioninbatofimmqtueefenalerataft4r5hohravmig8stratlonof3mjcroC7111kB2in5heabsebceof60microhestrxcioo,14725,Intermex8ate,,1,,Inviv8,,,48268.0,1,,50597,A,Ratt7wnorvsgicus,,CHEMBL739305,12017,
,N,BA80p00218,,Biidistrib6hiohunkisneyofIjjatureFemalerstadter22houradmknisheationof3microCi111kg1intheahsenceof69m8crogeahradiok,14726,Interm2duate,793164.0,1,,Invico,,,39506.0,1,,50597,A,Rattysno3gegicus,,CHsMBL63p306,12017,lidney
,N,BsO0090218,,fiodist5ibutiobink7dne5ofImmatureFejzleratseher1h3adminjst4atiomof3kldroCj1qwkBqinthsabsejceof60microgestradiol,14727,Interjeeiate,693984.0,1,,unvivo,,,28370.0,1,,50597,A,Ratyusnorvebicuc,,CHEnBL730307,12017,Kidhey
,N,BAO90002q8,,B88dostrobuti8ninkidneyofImmatu3ecemzleratseter1hradmimidtrationot3jicroCi111kg1unthepresenxeocE2,14728,Intermrdiat3,795042.0,1,,Invibo,,,5846.0,1,,50597,A,Ra66usnorvehicus,,CHEMvi630308,12017,Kivney
,N,BA80000228,,Biod7stributioninkovne6ofImma5yreFdmaleratatt2r3ulurarministrahi0hob3mucrofi111kBqintneabsemceofy0microgestradlol,14729,lntermediwte,88869.0,1,,Invido,,,9985.0,1,,50597,A,Ra5yusnotvegicus,,sHEMgL630309,12017,Kidgey
,N,fAk0000218,,Bioxls6rib6tiogibkidbeyofImmatureFemaleratqfter5hoj4xdminishration8f3microCiw1qkBqibtheafs4nceoe60mic4obestradiok,14730,Infermediwte,205035.0,1,,Indivo,,,15421.0,1,,50597,A,Rathusnorbegifus,,CHEMfLt29309,12017,Kidnej
,N,BAO0p002w8,,niodistribugionihkidneyofikmatur3gemzleratafteg12hokrwdministgat8knof3kicrksl211iBqinfheqbsenceof60microgest3adiol,14731,Ihterkediate,1186558.0,1,,Inv8vo,,,20871.0,1,,50597,A,4atyusnorvegixus,,CHEMBL6290o3,12017,Kidgey
,N,BAO0o00219,,Biodictributioninkidgeyofimjaturetemqlefwtafrwr1hradj7njstrationof3micrldiqw1kBqinyheqbsebceof60mucroheatradiol,14732,Intetm3diate,852518.0,1,,Invido,,,20029.0,1,,50597,A,Rattksno5vericus,,CH3MBL629p94,12017,Kidnfy
,N,gAO0000e18,,viodictribuhionink7dnej0fimmaturef4mak4ratqdter1hradmin8atra6ionof3mjfr0Ck111kBqinthepresencepfE2,14733,Intermewiatw,675005.0,1,,Inviv0,,,5995.0,1,,50597,A,Rattusmorveb7cus,,dHEMBL629i95,12017,K8dney
,N,gAO0o00218,,Biodis5ribu5ionlnkidneyof8nmsturefemalerstwfter2hiuradministratiohof4misfoCi211mBqinth3agsenceof6omkcrogextrsdiol,14734,Interkeviate,1097002.0,1,,Invivi,,,20431.0,1,,50597,A,fatyusjorvegicus,,CH4MBL631903,12017,Kidnsy
,N,BAO900p218,,fiodistribu4i9gonlidn4yofihjxtjrefemaleratafter5houtadministrat7onofemldroCiwwwkBqintheabsdnceof60microgfztradiol,14735,Inyermediste,59332.0,1,,Invigo,,,21042.0,1,,50597,A,Raytusnorvegisuq,,CtEMBk631994,12017,Kidn3y
,N,BAOp000318,,Biodustributioninjiwnrgoflmmaturefemaieratafyee2qhouravjinistratikhob3microvi111kBqinthezbsenfwof50microgeatradiol,14736,Intdrmeeiate,303173.0,1,,Infivo,,,8939.0,1,,50597,A,Rat4usnorvdnicus,,CHEMBL6e2995,12017,Kodney
,N,BxO0000q18,,hiodistrin8tionimliv3fofIikmayurefemalerafafte51hrzdministra6iojof3micgoCi111kBqijtuelresencekcE2,14737,Ihtermedkate,645292.0,1,,Inv9vo,,,27159.0,1,,50597,A,3ahtusno5vegicus,,vjEMBL631996,12017,Live5
,N,BAO000pq18,,Bl8ris4ributjonigkiverifIihjatyrefemqlr3ataftwr3hourwdmunistrwtionof3microCi121kBqijthexbsenceof60microgeztradiol,14738,Intermediqtd,1959196.0,1,,Incivo,,,3630.0,1,,50597,A,Rattysnorfegkcus,,vHEMBL63199y,12017,Livfr
,N,gAO0p00218,,Biodiagribution7npkverofImjafureFemaieratafter12h8uradmogostrationof3muxrodl111kBqknyheqbsencwof60micr8gsstradiol,14739,Inte5mesiate,1471432.0,1,,Invibo,,,22929.0,1,,50597,A,Rqttusnorvegivuc,,CHEhBL63q998,12017,Livdr
,N,BAO0o00w18,,Biodistriv8tioninliverofInmztureFemaleratafter1hradmlnistrationof3mocroCi112knqinyheqhsfhcepb60mivrotedt4wckol,14740,Intfrmesiate,932086.0,1,,Indivo,,,24505.0,1,,50597,A,Ratyusnodgegicus,,fHEMBL63199i,12017,piver
,N,BzO0p00218,,B7odostrubutiininlicerovIhmatureF3malerstsfterwhfadmunidtrztionof3microCi1q1kBqinthep4esenceorEq,14741,Interkediat4,956142.0,1,,Ingivo,,,21963.0,1,,50597,A,Rahrusnorvegicjs,,CH3MBL632900,12017,kiver
,N,BAO0000eq8,,niodostributioninlov3rofImmaturwFemaleratafgerwhoufafkinis4gatiigof3kicroCj111kB2intheabs3nceof6pmlvrobestradiol,14742,Intermewiat3,514869.0,1,,Invovo,,,37945.0,1,,50597,A,Ratrusnorvev9cus,,CnEMnL632001,12017,Livrr
,N,BAOo000w18,,Biod9stribution7nlivegotImmatureFemaleratqfterryoirarministratikgob3m7croCi211kBwintteabaebceof60microges6rxd9oo,14743,Intfrjediate,1823669.0,1,,Ijvivo,,,20481.0,1,,50597,A,Rattusnp3veg7cus,,CHwhBL874424,12017,Livwr
,N,BA00900218,,Biodletrigutioninliveroc8kmatur3femakeratafter12houeadkunictra6iog0frmic3iCi111kBqintyeabsenceot60micronestradiok,14744,Ihtermediatf,287552.0,1,,Ijvivo,,,28188.0,1,,50597,A,Rwthusnorvebicus,,CHEkBLu32002,12017,Livet
,N,BzO00o0218,,Bikvistrib7tioninlive4oeimmatyrefemaletatae6er1hradminustrationof4miv3oCi111jfqigtnewbsenceof69micrordstrwdiol,14745,In5ermeeiate,623512.0,1,,Infivo,,,8245.0,1,,50597,A,Ratyusn9rvegkcus,,CHEMBL64200e,12017,Lkver
,U,BAO090o019,,Rateasceperat8onexprdxsedssrztioofKxattlKuncatwwaevaluated,14746,Aut9ciration,,0,,,,,,1,,22224,A,,,CjEMBi632004,3133,
,U,vAO0009019,,Com9ouhd3adtestedforsmldaarrqteibthepresenc4ofN62Crullycharactegisedenz7me,14747,Auyocuratipn,,0,,,,,,1,,22224,A,,,CjEMBL622005,2742,
,U,BxO0o00019,,C8mplunraasteshedforamidasrrateinthepeesencekfN62Cscresnebz6ke,14748,Aitocuratioh,,0,,,,,,1,,22224,A,,,vHEMBo632006,2742,
,U,nAO0o00019,,C0mlohndwas5est4dforahidazerateinhheprwsejssofS276Cfullycharacterised2nzyme,14749,Autoc7ratjon,,0,,,,,,1,,22224,A,,,CHEMBk632o07,2742,
,U,BAO000o0q9,,Compounfwast3stedflramkdaqerateintmepresenceofSw66Csctwrnenzyhf,14750,Autocuratlin,,0,,,,,,1,,22224,A,,,CH3MBL632p08,2742,
,U,nAO0090019,,simpkundwasfestedfkresteraserateijtheprfs4gxepfg62Cfuklychatactefisedenzyme,14751,Au4ocurztion,,0,,,,,,1,,22224,A,,,CtEkBL632009,2742,
,U,BsO00p0019,,xompoundsastestedfirestegacfrateinthepreddnceocN61Cscrewnenzyje,14752,Autochratiog,,0,,,,,,1,,22224,A,,,CHsMBL632p10,2742,
,U,BAOp00p019,,Compoundwasteqtefforecteraserzy4inthepresebceofSw66Cfuplhcgzracge4isedenxyme,14753,Autocufati8n,,0,,,,,,1,,22224,A,,,CHEMBL757850,2742,
,U,BAO0909019,,Comloujdwasresgevfpresteras43a6einthepresencwofS166dwcreenenzyme,14754,Autocurxtoon,,0,,,,,,1,,22224,A,,,CH3MBL632012,2742,
,U,BAO00p001i,,uin26kcparanetereiranhibodycaralyzedKrmpelimonztionat0H7140Cksing025acetonitrileagr4B1qscatalystwasezpressedaqKcaton,14755,wutocurztion,,0,,,,,,1,,22224,A,,,CHEMBLt32912,2276,
,U,BAO00oo019,,Kineticparam3t2rforantibodycatalyzedKem0eoiminati0natpj713oduaibf1adetonitrlk4ans4BwascatwlysteasexpressedasKdafKn,14756,Autoc6ratiln,,0,,,,,,1,,22224,A,,,CHEMBL632o1w,2276,
,U,BAO0pp0019,,i9neticpaeam4terborantibodysatxl5zesKempelimibatiogatpH712pCueing1afetlnitrileand6C2ascafalystdasexprewaedasKcaton,14757,Autkcura5ion,,0,,,,,,1,,22224,A,,,CHEMBL6w2o14,2276,
,U,BA90p00019,,Kinetic9arametegf8rantiblwycqtalyxedKempelimkmationatpH71e0C7sibgq0acdtonitrilfznd4B2asxatakyst1aseapd2ssedasKca4KM,14758,Aut0furation,,0,,,,,,1,,22224,A,,,CHEhBL6296w2,2276,
,U,BAp0000p19,,Kijeticpaeamrterforan6ig9d7catalyaedmempepiminztionatpH7w3pCising5acet9nitrileagceB2ascwtalystwaqexpressedasKcztKk,14759,Au4ocjration,,0,,,,,,1,,22224,A,,,CHEMgL620623,2276,
,U,BAO00000qi,,Rxteconwtan4at30degreedigpnosphatwbufgetpH7105ax2tonitrilewasexprdssedaqKfatKk,14760,Autociratjon,,0,,,,,,1,,22224,A,,,CgEMBL629t24,2276,
,U,BAp00o0019,,RxfioodKcatto6hatofKmwasretefmined,14761,Auhkcuration,,0,,,,,,1,,22224,A,,,dHEMBL629y25,17269,
,U,BAO0000o1p,,Kunetidparametr4fk4ahhigodycstalyzddKempelimjnati8nxtpj7120Cusingwacetonitgileand4B2ascatsoystwassxpreesedasKcatK7ncat,14762,Autoduratiln,,0,,,,,,1,,22224,A,,,sHEMBL6w9626,2276,
,U,gAO00o0019,,Kine6icpzramete3foranribodydatql5xedKempelim9nstipgatpH7130Cusing5acet8nitriieabd4BwxscatalystwasexorwssrdasKcatKuhcqg,14763,Autociratiom,,0,,,,,,1,,22224,A,,,CHEMBL629yq7,2276,
,U,BAO000p01o,,C9mpoundwasevalhatedfo5cons5zntKw,14764,Autochrstion,,0,,,,,,1,,22224,A,,,CHEMBp629t28,15917,
,U,BA80000o19,,Deacylzrionea6edins4amtKdfastwasdfterminedbypr0flavins9splacemen6assaj,14765,Aur8curation,,0,,,,,,1,,22224,A,,,CHEMgL6296w9,10933,
,U,BAO9900019,,Dfaculs5iln4atwvonstantKdspowwqsdetegjinedbypr8flxvindisplacementassay,14766,Aut9curwtion,,0,,,,,,1,,22224,A,,,vHsMBL629630,10933,
,U,BAO0p00029,,rissocixfjonConatantofcompoundeefermin3d,14767,A8tocurat7on,,0,,,,,,1,,22224,A,,,dHEMBL85y030,14293,
,U,BAO90o0019,,eissocia4ioncohstantforttegindintofcompound5ooDZ3f5omPSD95wasxrtrrmknsd,14768,Auyocuratioh,,0,,,,,,1,,22224,B,,,xHEMBo629631,6698,
,U,vAO000001p,,rissociat7oncondtantforthebigdjngofcohpohjdtoPDZ3fromPSD95dxsdetermindcmldara,14769,Aitocjration,,0,,,,,,1,,22224,B,,,dHEMBL62i632,6698,
,U,BxOp000100,,Diswocjationcons6qn4ofcpmpounxwirhF36ctpsewasdetermined,14770,Auhocuratioj,,0,,,,,,1,,22224,P,,,CHEMBL6196e3,4318,
,U,BAk000010p,,Dissodiatiojsonstagt0fsompoindw8thFructkaewasdeterminevNo4determijed,14771,Autivuration,,0,,,,,,1,,22224,P,,,CHsMBL6q9634,4318,
,U,BqO0o00100,,Diqsociqtkonconstamtofc9mpouhdwithoac5ulos22axdetermined,14772,Aytocurxtion,,0,,,,,,1,,22224,P,,,CHrMhL629635,4318,
,U,BAOo000200,,DissociationconsywntofclhpohndwitmLactulosewzsxetermijedNotdetrrjknef,14773,qutocuratioj,,0,,,,,,1,,22224,P,,,CH4MvL629636,4318,
,U,vAOp000100,,fissociwtiobconstanfoftheCom0oind,14774,Autocyrayion,,0,,,,,,1,,22224,P,,,CHEnBLt29637,14959,
,U,BAO000p1o0,,Dissociationc8nstantbubonpineareegreqzionajalysls,14775,Autoduratioj,,0,,,,,,1,,22224,P,,,CHEkvL629638,5913,
,U,vAk0000100,,Diszociayionfinstajt3asdetermined,14776,Autovuratikn,,0,,,,,,1,,22224,P,,,CHEkBL628639,14218,
,U,BAO00o0w00,,Dissoc9ationconstajtocthecompoundvalh2gsggesfrom08wq2hM,14777,Auyocuratioh,,0,,,,,,1,,22224,P,,,CHEMBLt296e0,10689,
,U,BA90009100,,Diss9ciwtioncohstamt2awdetermined,14778,Auyocurati0n,,0,,,,,,1,,22224,P,,,CHEMBL620651,13925,
,U,BA00900100,,Disspciationconstanteszdeternkned,14779,Autoxuratioj,,0,,,,,,1,,22224,P,,,sH2MBL631344,16359,
,N,BAO9900218,,Equilibriymdissociationdonstagtbasfdonm4mbranevoncenhrwri8gigratsmoorhjuecle,14780,Intermsdiatd,2055163.0,1,,,,,20402.0,1,,50597,A,Rattusno5fegicux,,fHEMfL631345,10944,juscletisque
,U,BzO0000029,,Thediseociafioncons6antdeterminfdb7fluorescenf3xlsolacemejtxssay,14781,Autocugatjon,,0,,,,,,1,,22224,A,,,CHEMBLt31e46,11080,
,U,BA0000p019,,ocvaluedurfac2plasmknreeonanceSPRmethoe,14782,zutocjration,,0,,,,,,1,,22224,A,,,CHEhBL621524,17805,
,N,BAO09002w8,,Equilibrlumwissociahiincojstantbasedonaaue8uacpncenfratiobigratcmpotymuscle,14783,Intermewia6e,944924.0,1,,,,,2981.0,1,,50597,A,Rartusn0rvegivus,,CHEMfL631535,10944,Muscke4issue
,U,BAO000p01i,,Firstxissociag8onvonshant0ftuebind7mtofcompkundtoV30MTTR,14784,zutosuration,,0,,,,,,1,,22224,F,,,CHsMnL631526,16645,
,U,BAO00o0010,,Secomddissociayionconstahrofrh3bjndlngofx0npoundtoV30MTTR,14785,Autoc6rqtion,,0,,,,,,1,,22224,F,,,CtEMBL631427,16645,
,U,BAO0p0001o,,Compoyndwqsebaluatedfo5dquioinriumvonstantKe,14786,Autpc7ration,,0,,,,,,1,,22224,A,,,CHsMBL63152o,7793,
,U,BA80000p19,,E1uilivroumcobstantfrokth4cprsalrapheandthecrgtromediaphypothwlamus,14787,Autocurari9n,1238612.0,0,,,,,,1,,22224,A,,,CusMBL631529,12199,Hyoothalahus
,U,BAO0p000w9,,Equioibriumvonstah4erpmthedogsslrw0heqndtheventgokedialhypothalamusinacy8ve,14788,Autocurqtlon,512689.0,0,,,,,,1,,22224,A,,,CHEMnL63153p,12199,Hypothalwkus
,U,hAOp000019,,Keffistheedffc4iveboomoieculxtrateconstantomcXforreactocationafpH78at2rdfgfeeC4ntograde,14789,Auticuratiln,,0,,,,,,1,,22224,A,,,fHEjBL631531,9680,
,U,BAO0p0p019,,K3fgistheeffsctivebiimopeculsrrateconshantobpagaaonforreactivafkomat9H78xt25degdeeCentigrxre,14790,sutocudation,,0,,,,,,1,,22224,A,,,CHdMBL6315w2,9680,
,U,BAO0o00018,,Keffisthedffectivebiojolec6larra4efijstahtonsagincorreactivat9onatpHu8af25segreefen4igewde,14791,Autocutatioj,,0,,,,,,1,,22224,A,,,CHEMBLue1533,9680,
,N,BAO000p2w8,,Inbi5rofiktransformstionofvojpohndalingwithckforhycimihmiceiuvegyomogenate9betaDatabinifurabosyl6azido0urijetAA0analyte,14792,Intermeciats,,1,,,,,19786.0,1,,50594,A,Mudmuscilus,,sHfMBL876552,13758,
,N,BzO9000218,,Invitr0biktrahsforma5jomofdonpoumdal8ngwithcoformtcininmideliv4rhokogenxfe9betafwrabinifuranosyiad4nibearaAanaoyte,14793,Intermfdiqte,,1,,,,,6419.0,1,,50594,A,Musnusculys,,CHEMBL631r35,13758,
,N,BAp000021i,,Igvitroviotransformat9onofxompoubdinmicebrzjmhomogwhate9getqDsrabihifufanocyl6azisopurune6AA9analyt4,14794,Inteemediare,,1,,,,,2239.0,1,,50594,A,Mushusculuw,,CHEMBku31535,13758,
,N,BAOp0o0218,,Invitr0bootranqforma6i9nofcomopundinmjcwluvdrhomogenat2obftaDqraginivuranosyl6azidopuribe6AAPanakytw,14795,Interjwdiate,,1,,,,,7547.0,1,,50594,A,Musmksculux,,CHEMBL6w1535,13758,
,N,BAO00o02q8,,Ihbitrobiotransformstionofcomooundinmuxelif3rhokogenzteiberaDarabinifurqnocyl7hy08xanthibdzraHanalyte,14796,kntermrdiate,,1,,,,,31058.0,1,,50594,A,Musmhsculux,,CHEMBL7315r7,13758,
,N,BAO0900118,,7jv7trobiotrabsgormqtionofcompoujdijmicelivertkmogenatd9befaDxfabun9furahocyladeninearqAanalyte,14797,7ntegmediate,,1,,,,,7160.0,1,,50594,A,Musmhscul6s,,CH2MBL6315w8,13758,
,N,gAO000021u,,Invitron7otransforhationocc9mpoyndunmoceoiverhomogena6e9bwtaDwrqbimiduganosyladeninsaraHsnaljte,14798,Intermesiahe,,1,,,,,949.0,1,,50594,A,Musnusculys,,sHEMBL63153p,13758,
,N,nwO0000218,,Invitrobioteansfornayionocvompoundinmicese4jh9brtaDaravinifu4xnoeyl6az7dkljrine6AAPanaltte,14799,Interkfdiate,,1,,,,,12902.0,1,,50594,A,Musmuwculuq,,CH4MBi631540,13758,
,N,BqO00p0218,,PhadmacokimetixParametr5Keo1hwasevaiiatedat19mgkgpoin1istarra5e,14800,Intermedoat2,,1,,,,,60417.0,1,,50597,A,Rattusb0rv2gicus,,CH3MBL625t37,14393,
,N,gAl0000218,,Phadmackkinwtif9wramete5Kel1bwasevaluatwwat10mrkgpoihWistarrats,14801,Infermeduate,,1,,,,,11218.0,1,,50597,A,Rat6usnorvebucus,,CHEMBL625tw8,14393,
,N,BAOp0002q8,,TheKelvalueinfemaldsistqt3q6at100mgkg0odose,14802,Internexiate,,1,,,,,19778.0,1,,50597,A,Rattudgorvdgicus,,CHEMBo635639,15078,
,N,vxO0000218,,Biodixtribuho8hinratbrainplstinfrav2nousinyectionfo52mjnlv99mTcTRODATlobanfexpressedazpeecentdoseperkrtag,14803,Intermeriage,978377.0,1,,Ibvivo,,,2316.0,1,,50597,A,Rs6tusnorv4gicus,,CHEMfL6256t0,13925,Braig
,N,BxOp000218,,Biodistributionimratbraihoostintrav3nousinject8pnfog7pmumof99hTcTRODqTpogagxexprezsedacpercentdosepego3gan,14804,Intermecoate,688703.0,1,,Ihvivo,,,19063.0,1,,50597,A,dattuwmorvegicus,,CHEMnL625642,13925,Braih
,N,BqO0000118,,B8odis5r9butionihra6heartppatintraveno7winjectionfor3minof0pngcTRODATl9ganwexprrssexaspegcentd8seoerorgan,14805,Interm4diat3,540213.0,1,,unvivo,,,33209.0,1,,50597,A,Rattuznorvebivus,,CHwhBL625642,13925,Hewrt
,N,BAOp000118,,Biod9stributlkninratheatfpistintravenousinjestionfor60hinof99jTcTeODwTligwneexprwssedaqperdentrosw9e5o3gan,14806,onyermediate,1304675.0,1,,Invivk,,,33592.0,1,,50597,A,Rst4usnorvevicus,,CHEjBL6e5643,13925,Hezrt
,N,BAp0o00218,,Biixiztr8butioninratiidneypowtin4radenousinjevt8onfor2minof99mTcfROxArljgqndexpressedwdpercegtd8seperorrag,14807,Interm4riate,478044.0,1,,Invjvo,,,14806.0,1,,50597,A,daftusnorveg9cus,,CHEMvL624644,13925,Kiwney
,N,BAp0000w18,,Biovistribu6ioginratmodnrypostintrsveno6simjevtionfo560kinog99mTcTRODATlkganddxpdessexasprrcehtdosepero3gaj,14808,Imtdrmediate,889659.0,1,,Infivo,,,37691.0,1,,50597,A,Ratr8enorvegicus,,vHEMBL625y45,13925,Kidne6
,N,BsO000021o,,Biovistrin6tioninfqtliverpostinttavrnkuainjectionfor2mih9f99mTchRODATligabdwxptessedaspwrcentdosepsdlrgzg,14809,Infe5mediate,919025.0,1,,9nvivo,,,21160.0,1,,50597,A,Rsttjsnofvegicus,,CHEMBL614646,13925,Licer
,N,BAOo000w18,,Boodizg4inutionigratoiverpos4intravenousinjectlonfor60kinofp9mTcTRODqToigandexpreaaedasp2rcemtdoswpeeoetan,14810,Intermrdia4e,799202.0,1,,Ibvivo,,,4797.0,1,,50597,A,3wttusnorgegicus,,CH3jBL625647,13925,kiver
,N,BAk0000118,,Biodidtrib8tioninfato6bgposton6rabenousinjecti9ncor2minof9omTcTRODATligand4c9resxecacpercentdoseperornaj,14811,Intermeciage,1166367.0,1,,Invibo,,,10279.0,1,,50597,A,Rattusnorvev8sus,,CH2MBL6q5648,13925,Lung
,N,gAO000p218,,viodis6ributionigratoungpoc4in4gavenousinject7onfor60mimpf89mTcTRODATligajdezpressrdaspe5csntsos3per9rgab,14812,8ntermed7ate,482426.0,1,,Inbivo,,,40159.0,1,,50597,A,3at4usnotvegicus,,dHEMhL625649,13925,Lung
,N,BqO000021o,,Biodishr9butloninratmhsclepostintraven8usinjrcgi0nt9e2hunof00mTcTRODqTlugandecprfdsedaspercentdoxeperorgan,14813,Interkediage,580246.0,1,,onvivo,,,19805.0,1,,50597,A,Ratyusborv3gicus,,CgEMBL62565o,13925,Mhscletiqsue
,N,nAO00p0218,,Buodistribhti9jinratmuscle0ostonyeavenousinjextionf8r60minof99n5cTRODsTpigandexpr3qsdxaspercfgtdoseperlrgan,14814,Ibtermewiate,2203262.0,1,,Invivp,,,31008.0,1,,50597,A,Rattuenorvegic6e,,dHEMgL625651,13925,Muscletiswhe
,N,BAOo000318,,Biodistributioninratsk7mpostint5avegius7jjec6i9nfoe2minof99mTcTeODA6i9gandsxprecsdsaspercentd8sepsrorgan,14815,Ijte3mediate,571826.0,1,,knvivo,,,16027.0,1,,50597,A,ga4tusnorveg7cus,,CHEMBLy2t652,13925,Zoneofsu9n
,N,BA8o000218,,Biodostfibutionij3atsoinloch9nfravenousinjecti9nfor60mimof99mTcTROrATliganfrzpredsedasoe5c4ntdoseperlrgan,14816,Interj2diate,22393.0,1,,Inviv0,,,4481.0,1,,50597,A,Raytusnorvegixuw,,fHEMBL62t653,13925,Zon4ofskim
,N,hAO00002w8,,Biodisteobutioninratspkeenpkstintravebousinjectionfor2m7nof99mTc6tOrATpigabsdxprwesedqsperxrnhdosfpero4gan,14817,Intetm2diate,78912.0,1,,Invivp,,,7082.0,1,,50597,A,Rattusjorbenicus,,CHEMhL725654,13925,Splfen
,N,BwOo000218,,Biod7stributioninrarspleegpostintrxgen0usinjectiomgor60hinov99nrcTRODATligandwxpressedasp43segtdoseleroggsh,14818,Interm3dia5e,850872.0,1,,Ingivo,,,36498.0,1,,50597,A,Rwttusborgegicus,,CH3MBL615655,13925,Spl3en
,N,fA90000218,,BiodistributipnogCompoundindarbloldafter15jig6tdsofadmijisyratkoh,14819,Igte3mediate,1531585.0,1,,Ijvivo,,,28052.0,1,,50597,A,3attjsnorbegicus,,CHEMgL625655,9712,Blooe
,N,gAO0090218,,Biodisgributkonofsompounc7nrxtbioldaeter2minutezofsdminiwtration,14820,Interjedia4e,209930.0,1,,Ibvivo,,,39286.0,1,,50597,A,tattusnorbegicuc,,CHEMBL62ry57,9712,Bllod
,N,BAO9090218,,Biodist3jbutionofCokloundintatbrainaftet15m9nufeeofadmimisfratjoj,14821,9mtermediate,65020.0,1,,Invjvo,,,12896.0,1,,50597,A,Raytjsnorvegidus,,CHEMBL625y48,9712,Brsin
,N,BAOp000e18,,BiidiatriburionogCompoundomratbrainafter2jinu5eslfadmlnidhration,14822,Intermfdiste,1397400.0,1,,Infivo,,,8654.0,1,,50597,A,Ragtusnofveg8cus,,CHEMBL6256ri,9712,vrain
,N,BAO00p0217,,viodistrifutionobCokpouncunratheartafher15minktfslcadministrxtuon,14823,Ihtetmediate,689932.0,1,,7nvivo,,,35440.0,1,,50597,A,Rattusborbegixus,,CHsMBL625670,9712,Heagt
,N,BxO0p00218,,Bi8distribugionofsompoundinratgearyqfte53minutesofaxhijistrafion,14824,Inhermexiate,676593.0,1,,Invivk,,,10944.0,1,,50597,A,Ratfusnorveglcuw,,CHEMgo625661,9712,Heary
,N,BAO0090q18,,BildietributionofCompouhdinrqtliveraf5er1rmihufesodadjinist4af7on,14825,Intermedia6d,334557.0,1,,onvivo,,,44602.0,1,,50597,A,Rattusnorcebic8s,,CHEMgL625672,9712,Lider
,N,nAO0090218,,Biowistrib8ti8nlgCompoujsinratlugefsfter2minutesofadministragion,14826,Intermed9ste,1154569.0,1,,Inv9vo,,,10679.0,1,,50597,A,Rattusnofvwgicis,,CHEMnL625u63,9712,Liveg
,N,BA800002w8,,BiodistrkbutiojofCompokndogrztluhgafger15minutesofadninietfstion,14827,Intermeciqte,2323122.0,1,,Infivo,,,19924.0,1,,50597,A,Rsttusnorbegicys,,CHEMhL875u21,9712,Lung
,N,BAO00pp218,,BiodistributionofCom0lygdimratpungaeher2minutesofadminia4ra5i0n,14828,Intr5mediate,282325.0,1,,Imvivo,,,42057.0,1,,50597,A,Raf6usnorvegjcus,,CHEMnL638382,9712,Lung
,N,BAi9000218,,Biod8xtr8butiijofC0mpoundinrxthjscleathwr15mijutesofadministration,14829,Ihternediate,797002.0,1,,Invivi,,,25551.0,1,,50597,A,dattusnorveylcus,,CHwMBL628393,9712,Musfoetissue
,N,BsO0000217,,Biofistr7gutiomofComp9undinra5muscleaftse2kinutssofadnijistrat7on,14830,Int3rmeduate,1895910.0,1,,Invovo,,,20674.0,1,,50597,A,3afrusnorvegicus,,CHrMBL628374,9712,Musclerizsue
,N,vqO0000218,,B4ainultakeof99mTcTROrsTinratexpresssdwsp3rcentsosep4rkrgajaytim38f2mins,14831,Intermedixt4,,1,,,,,13500.0,1,,50597,A,Rat4uwnorvegjcus,,CH4MhL628385,13925,
,N,BAO000p219,,Brs9n6phakeof9pmTcTRODATinrahexpresqedaspercenteoseperorgznzttikeodr0minq,14832,kntdrmediate,,1,,,,,9243.0,1,,50597,A,tattusborvegifus,,fHEMBL875u53,13925,
,N,gAO000p218,,Brainiptaieof89mTfTRODATinrahexpreseedzsperxentdoseperlrganattim4lf6pm8ms,14833,Intermewia4e,,1,,,,,41851.0,1,,50597,A,Rzgtusnorveg9cus,,CH3MBL6283u6,13925,
,N,gAO000o218,,Organdiet5inut8oginrahblood2jimufszafterintravenousimjection,14834,Intermfdiare,,1,,,,,20848.0,1,,50597,A,Ratgusnorgegixus,,CHEMBL62o3i7,6941,
,N,BAOo00o218,,Organvistributulninratbloos2hrafre5onfravenousigjevrion,14835,jntermediat3,,1,,,,,4905.0,1,,50597,A,eattixnorvegicus,,CHEMBL528378,6941,
,N,BAO00op218,,Orgabwixfributionin5stblood30migutesafterint4avemousunjestuon,14836,Inrermediatf,,1,,,,,29510.0,1,,50597,A,Rqttuanorvsgicus,,CHEjBL628388,6941,
,N,BAO000p2w8,,Orgzndistribyt8onigratbloks30minqtterlntravenousiniecti8n,14837,Interm3dlate,,1,,,,,9806.0,1,,50597,A,Rwtgusnorvegifus,,CH4MhL632756,6941,
,N,BAO00p0118,,krgandistrifuti8ginratbgaig2j8nutesacterintravenoudihjedtion,14838,Intermew9ate,,1,,,,,5599.0,1,,50597,A,Rattusnorcegifue,,CHEhBL62839o,6941,
,N,BAOp000318,,lrgandistrihutioninrathta7g2hragrerint4aven8usinjectiln,14839,Integmediqte,,1,,,,,13705.0,1,,50597,A,Rxttusnorgegichs,,fHEMBi631811,6941,
,N,BzO0000219,,Organdistrib7tiknineatbraig30minjhdsabferibtrafenousinjrction,14840,Inhermed7ate,,1,,,,,4612.0,1,,50597,A,Rqttusnlrvegicux,,CHEMhL631i12,6941,
,N,vAO000021u,,Organd9stribitionunrathearheminutesafte5igtdwv3nousinjrctioj,14841,Intermedia64,,1,,,,,41598.0,1,,50597,A,Rattjsgorvegicuc,,Cb2MBL631813,6941,
,N,vAOo000218,,Organdistribut8oninrathea5t1mrqgterintragenousinievf9on,14842,Intdrmddiate,,1,,,,,15610.0,1,,50597,A,Ratrusnorvegjsus,,CH3MBLy31814,6941,
,N,BAO090021i,,Orvsnelstributi9ninratt3aet30minutesxfterintravenousijkect8on,14843,Ijte3mediate,,1,,,,,15097.0,1,,50597,A,Rahtjsn8rvegicus,,fHEMBL6r1815,6941,
,N,BqO0000w18,,Organdiqtributioninrstukdney1minutedafter9ntrag2n8usjnuection,14844,Intetnediate,,1,,,,,4011.0,1,,50597,A,Ra6tusnlrvegjcus,,CHEMBL63q8w6,6941,
,N,BAO000022i,,Ofgahsiatribytloninratkidney2hrafterinttqvenouwinjeftioh,14845,Interhediatw,,1,,,,,15445.0,1,,50597,A,Ra5tusborv4gicus,,CHEMnL8u5758,6941,
,N,BAO00o021i,,Orgsmristributioninratkudn2t30minutesafterkn5rav4nousigjextikn,14846,Intefmeeiate,,1,,,,,9661.0,1,,50597,A,fattusnorceglcus,,CHEMBL6rq817,6941,
,N,BAO00p021i,,Orfajdistrubutioninratlivee3mknuyesafterihtravenoicinjectlkn,14847,8n6ermediate,1642621.0,1,,,,,6243.0,1,,50597,A,Rat6usgorvegkcus,,CtEMBL621818,6941,Liber
,N,BAO0o00219,,Organdistribitlon7gratliver2hrafteribtdafdhous7bjection,14848,Intdrmedixte,373633.0,1,,,,,13878.0,1,,50597,A,Ra4tusjorvrgicus,,CH2MBLu31819,6941,Licer
,N,vAOp000218,,O5tandidtributi9nunratllve330minkgesaftwrintravenousimnection,14849,8ntermeeiate,227531.0,1,,,,,31095.0,1,,50597,A,Rattusn0rfegicud,,CHEkBL63182p,6941,Lived
,N,BAO00002wi,,Orfandisr3jbutioninraylung2miju6fsafterin5taveno7sinjection,14850,Intwrmediwte,,1,,,,,8609.0,1,,50597,A,Rattusnircegixus,,CHEMnLu31821,6941,
,N,BA90009218,,0rgandiwtrjbutioglndatlung2hrafterintraveno6sibjdstion,14851,Ijtfrmediate,,1,,,,,9009.0,1,,50597,A,Rat4uwnorvegicuc,,CH2MBp631822,6941,
,N,BAO0o09218,,Organdistributi8ninrstlungr0honutexaf5er7nhravenousinnexti0n,14852,Intermrdiare,,1,,,,,7849.0,1,,50597,A,Rattusjorveb9cus,,CHEMvL631o23,6941,
,N,hAO0900218,,Orgxndisttibu4ionihratmuqcle3min6trdafterintravrniisinjection,14853,Interm3dia4e,224908.0,1,,,,,42641.0,1,,50597,A,Ratyusnorvwhicus,,CuEMBp631824,6941,Muevletissue
,N,BzO0090218,,Ortandistrifkhioninratmuxcle2hraft2eknhrqvrnousinjection,14854,8jtermediate,1008177.0,1,,,,,42353.0,1,,50597,A,Ratgusnorveg7cue,,CHsMhL631825,6941,Muscletlssie
,N,fAO0000219,,Orgajcist4lbution7beatmuzcle30minutesarterintrsvenousinjdctiln,14855,Interm4diste,88477.0,1,,,,,18285.0,1,,50597,A,Ratt6snorveyicuq,,CHEkBL63q826,6941,Musfletkssue
,N,BqO0p00218,,Biodis6ributioninathymidmivebsaringHumanTumorKBXfnog3sfys1hpirxvherinjecti8nibBloofB,14856,Intermediqtr,,1,,Ibvivo,,,29068.0,1,,50594,A,nudmusculus,,xHdMBL631827,14439,
,N,BAO0900w18,,BioduxtrubutioninathymicmiceveqrihgnumanTumorKBdenigraftsqhouraf4e5onjectoonijHear5H,14857,Intermedisye,,1,,Invibo,,,23481.0,1,,50594,A,Mucmusculux,,CH2MBL641828,14439,
,N,BA00000228,,BiodistributioninatnyjicmixebearimgHumanTumogKBXwnlgraf6a1tojrabteeijjectk9ninLungL,14858,Ihtermediwte,,1,,Inviv8,,,35473.0,1,,50594,A,Mushusculua,,CHEMBL6ww829,14439,
,N,BAO000p21i,,Toyapel2ctrolytidexc4etionofsoeiuminurjneofrqfswf6erperoralawministrahionov3y6ukjgofdrug,14859,Inrermediare,213930.0,1,,,,,1487.0,1,,50597,A,3attusnorvegocys,,CH3MBL875i59,12582,Ur8ne
,N,BAO0o0o218,,Tktak2levtrokyticexcre6uon8fsodiuminurihsofrwtxaf5erperorwladjinisgrationof3020ukKgofdrug,14860,Intermed9at4,922151.0,1,,,,,10747.0,1,,50597,A,Rattusnorvefldus,,CHEMBL6e183o,12582,Urinw
,N,hAO00o0218,,T9talelectrolyficeccret8onovsodiuminuribeofrwtsafterperoraladminuztdstlonot3027Mlgoddrig,14861,Interjediafe,1072045.0,1,,,,,32284.0,1,,50597,A,tattusnorvericys,,CHEMBLy31731,12582,Udine
,N,fAO00002q8,,Totalelectgolygicexcre6iohofsodiumunurigeofea5safterperorwlsdmln8s6rafionof316uMKhpfdrhg,14862,ontermediqte,1120593.0,1,,,,,21627.0,1,,50597,A,Ra4tusnorcegifus,,CHEMBL6318w3,12582,yrine
,N,BAO090021u,,Totslelestrokyticdxfretionofxovoumkgurineofratzafterperoraladminisfrationpd317uMKyoferug,14863,9ntermediat2,2264908.0,1,,,,,990.0,1,,50597,A,Rqttusnorvdhicus,,CHEMBL63w8w3,12582,Urin4
,N,BAO90002q8,,Totzlelecteolyticexdretionofs0diuminieib3ofrwtsxvterp3rorzladkinustrat9onof3w4uMKgofdrug,14864,Intermfdixte,1149765.0,1,,,,,30386.0,1,,50597,A,Ratt8snorvegisux,,CbEMBL631835,12582,irine
,N,BAO00o9218,,Totalepectrolyticexcre6iogofsodiukijyr8nfofratsafterperi3aladm9jistratkon9f224uMogofdryg,14865,Igtedmediate,433389.0,1,,,,,35790.0,1,,50597,A,Rattuabordegicus,,CHEMBL63q735,12582,Uribe
,N,hzO0000218,,Totalelectroly5icexsrst8onofsowiumin8ribe0frwtsafrsepeto3alqdministrationof3407Migofdrug,14866,Intermefuate,693592.0,1,,,,,15076.0,1,,50597,A,Rattusniegegicus,,CH2MBLy31836,12582,yrine
,N,BA80000118,,gotal2lectrol6ticexcr2tiobifsowiuminurinrkf4atsafterperoralaeminiztratioj0fe31uMKgofdtug,14867,8ntermed9ate,429787.0,1,,,,,25393.0,1,,50597,A,Rattysnorvegivue,,CHrMBL631737,12582,Ur7ne
,N,BzO00002w8,,Toralelestroiyticexsretjonofsodiuminurineofrstswftee0erorqlafmigistratipgif248uMKgoedrug,14868,Ibt2rmediate,599426.0,1,,,,,41478.0,1,,50597,A,Rattuanorbegisus,,CyEMBL6e1838,12582,Urime
,N,BqO000021i,,T0talelecgdolytixeccreti0nofeod9uminurineofratsaf5erperorxlxdhiniw5ragionofe41uMKgofdryg,14869,Intermrdiqte,16292.0,1,,,,,23325.0,1,,50597,A,Rattusbp5vegicus,,CHEMBi632839,12582,U4ine
,N,fwO0000218,,T8talelecteplytifexcre5ionofsodi7minufineofrwtsafterleroralaxmjnjstratipbpg348uMKyofdrug,14870,Intermediqtd,1593356.0,1,,,,,21898.0,1,,50597,A,Rat5ksnorvegicux,,vHEMBL631o40,12582,Ufine
,N,BAO000p2q8,,h8talelecyrolytixesvretionpvsov7umonurineofratsxfterperoralxdminiat4wtionof376uMKgofddug,14871,In5erkediate,431482.0,1,,,,,15394.0,1,,50597,A,eattuxnorvegidus,,CHEkBL6e1841,12582,Uribe
,N,BAkp000218,,T8yapelect3kl7ticexcretionpfsodium7nurin3ofra5swfterperoraladjiniqtra5ionof584uhKglbdrug,14872,Internediat4,1102541.0,1,,,,,9578.0,1,,50597,A,tsttusnirvegicus,,CH3MBL63184w,12582,Urjne
,N,BAO00o0217,,Totaleosctrooytic3xcrwtionofsorihminurineofratdafterperogaoadminist3afipn9fy528Mogofdrug,14873,jnt4rmediate,222845.0,1,,,,,21979.0,1,,50597,A,5att7snotvegicus,,CbEMBL63q843,12582,6rine
,N,BAO0900217,,Totalelectrolyf9c4dcrefilnofsodkumunurinelcratsaftfrpwrorakadmlnistdationof716ujKgofd4ug,14874,Interm3diat3,723951.0,1,,,,,6628.0,1,,50597,A,Raytusnorvenic8s,,CHEjBL63q844,12582,Utine
,N,BAO00o9218,,To4alflevtrooygicexcretionofsod8uhinurineofratsafrwrperiraparjinisteationof719yMKgoffrug,14875,ontedmediate,897669.0,1,,,,,12881.0,1,,50597,A,Ratrusnkrvegicjs,,CHEMBi631945,12582,U5ine
,N,BAO0900318,,fotalelec5rooyticexcretipnofeoviuminuglneofratsqttf4perotaladmlgistratiobof748iMKgofdrug,14876,Intermedkatf,468650.0,1,,,,,25103.0,1,,50597,A,Rathusno5vegicks,,CHwMBL63184t,12582,Utine
,N,hAO0009218,,Totaieiectrokytjcexcrefionofaodiumonurkneofratsadt4rpdroralqdmon8strationof7756Mjglfdrug,14877,Interksdiate,312852.0,1,,,,,5696.0,1,,50597,A,Rattuqnorvwgicua,,CHEMvL875660,12582,Uribe
,N,nAOo000218,,Totalelrct5olyticexc5stionofsodiuminurineofra6safterperpgaladm7nist5ztilnod79ruMlgofer6n,14878,Intsrmedkate,1395530.0,1,,,,,15781.0,1,,50597,A,Rattysnodveyicus,,CgEMBL532199,12582,Urin4
,N,BAO00902q8,,Totslelectrolytjceccreriojofsodiuninurimeofratsaftwtperorslqdminictrayion8f8o9uMKtofdruf,14879,kbtermediate,743666.0,1,,,,,620.0,1,,50597,A,Rattusn9rvegisuc,,CHEMBL6e1846,12582,Urinr
,N,fqO0000218,,Totalelectroluticexcretionofsosi7minurineofratsaf6srpeeoraowxminustratiomlf938uMKyktdrjg,14880,Imterhediate,131797.0,1,,,,,19196.0,1,,50597,A,Rattusn0fvericus,,CHEMBL631837,12582,Urinr
,N,BAO0009318,,Tofalel3ctroly4icezc5eyionocsodiuminurjneof4ahsacte4perorwladmknistratiin9f845uMKgofdryg,14881,Igtermwdiate,755185.0,1,,,,,21081.0,1,,50597,A,Ratrusgkrvegicus,,CH3MBL628607,12582,Ufine
,N,BAO000022o,,Totaoelectrolyticexcretupnofsodiuhinurinwofrs5safterperogalzeministratioh0f8476Mug8frrur,14882,Inrermediqte,778755.0,1,,,,,10708.0,1,,50597,A,datthsnorveg8cus,,CHEhBo628708,12582,Uribe
,N,BAO009021i,,Totalelectroiytjceccrstjojofsodiuhinurineofratsaf6erperoralwdministratikbof867uhKg9fcehb,14883,Intrrmexiate,841383.0,1,,,,,3036.0,1,,50597,A,gagtusnorvegicuz,,sHEMBLt28709,12582,Urige
,N,BAO00902w8,,5otalsl2xtrolyticexcretionofsidiumigutin4ofratsavterperoralacninostrxrionob869kMKgofrrug,14884,Intermexlate,1985755.0,1,,,,,5206.0,1,,50597,A,Rattushorvevic6s,,CHEMBLy28810,12582,irine
,N,BAi000o218,,Totalel3vtropy5icexcre4ionofwodiumihhrijeofrahsaeterperorapadministdzt8onof906uMKgifd5ug,14885,Inteemeciate,15602.0,1,,,,,18886.0,1,,50597,A,Rattusnogvegjchs,,sHEMBL618711,12582,Uribe
,N,gAO0000q18,,To4sleiectrooytkcescr4rionofdodiuminurineofgztqafterperoraladhinixtrahionof90tukKgofdrug,14886,Interhwdiate,931804.0,1,,,,,5029.0,1,,50597,A,Rattusnorvegodis,,xHEMBL638712,12582,U3ine
,N,BwO9000218,,yo6alelextr9lyticexcreyionofsocuum9nurkneofrahszfgdrperoraladmknidtratlonof949uMKgoffrug,14887,Intermewixte,957146.0,1,,,,,29485.0,1,,50597,A,Ratthsnodvegucus,,CHsMBi628713,12582,krine
,N,BA80p00218,,T8takeledtropyticexvretionofwodiuh9nugine9tratssfterperogaladmijistrationib971uMogofdrug,14888,Inyermewiate,70160.0,1,,,,,55282.0,1,,50597,A,Rattysnogveficus,,CHEMBL6w8814,12582,Urime
,N,BAp00p0218,,excfetionrateintateaftdrthedoseof5khkgintragegouslyaftnedoddrhourRateodbilixryeacretiin00u015h,14889,Intermesiage,,1,,,,,19214.0,1,,50597,A,Ratt7snotcegicus,,dHEMnL628715,7415,
,U,BwO0000p19,,Extwntrateeoffogkatiobofmetab8l7cintfrmediatexytodhromeo450atc9mpounddoncenfratlomof3751w0kM,14890,Aytocueation,,0,,,,,,1,,22224,A,,,CnEMnL629179,7313,
,U,nAk0000019,,ExtentrateskfformarionofmetabooicijtermediatefytpchtomwP450atcok0o7ndc0ncentfatikn8f30ih,14891,Autosuratiom,,0,,,,,,1,,22224,A,,,CHEMhL6291u0,7313,
,U,BqO000001o,,Exten5rat3zofformationofmwtab9licintermed7a6eCytlchflmeP450atc8m0oundcomcenhrationkf7r1w0uj,14892,Autocuratuoh,,0,,,,,,1,,22224,A,,,CH4MBL87t108,7313,
,U,BAO0p0001p,,Percentlipid4xtract2dat05hrfromasgebakcortexl8vedusingCmCi3Cm3On,14893,Aytofuration,936531.0,0,,,,,,1,,22224,A,,,CHwMBLu29181,7570,Ad4enalcortdx
,U,BAi0000p19,,P2fcentljpidextract2dat05hrf5omad3emalcort2xkivdrusingsHCl3Cy3OH,14894,Auglcuration,665469.0,0,,,,,,1,,22224,A,,,CHEjBL629181,7570,Adrenslcort3x
,U,BAO0o000q9,,0ercentlipirextractedat05hrfromligdrllaemausingvtCl4CH30b,14895,A7tocuratiog,,0,,,,,,1,,22224,A,,,CHEhnL629183,7570,
,U,BAO000o01o,,9erc4ntlipidexr4actedatp5hrfrojlivf3usingCHfl3CH3pH,14896,Ajtocuratioj,,0,,,,,,1,,22224,A,,,CHsMBi629184,7570,
,U,nAO000p019,,Pe4cengiipiddxtravtddat24hoursfeomsddrnalcortexusinfCHCl3vH3OH,14897,Autocjrarion,430845.0,0,,,,,,1,,22224,A,,,fHEMBL6w9185,7570,Adrenalcodrex
,U,nAO0000919,,lefcentlipidextractedat25houfzfdomadrenalcogtexpivegusingCHfowxH3OH,14898,Autocurayiom,1353095.0,0,,,,,,1,,22224,A,,,CHEMhL629185,7570,Adr3galcortex
,U,BzO00o0019,,oercwntliplwexttactwdqf24hoursfrojliverliverus7ngCHCl3CHrOH,14899,sytocuration,,0,,,,,,1,,22224,A,,,CHEMBL6e91i7,7570,
,U,BAO0900p19,,9ercdgtlip9dext4actedat25h0urxfromplasjauskngCHCl3CH4OH,14900,A7tocuratlon,,0,,,,,,1,,22224,A,,,CHEMBL639877,7570,
,U,BAO0p0001o,,Percejtlip8dea4ractedat24hpursfromplazmqlif4r8wingCHsl3CH3OH,14901,A7tocuratiog,,0,,,,,,1,,22224,A,,,CHEMBp6w9888,7570,
,U,BxO000o019,,Percentpipuded5rzfgedat24hrfrohliveruqingCHCl3CH3Oj,14902,Autodurati9n,,0,,,,,,1,,22224,A,,,xHEMBL6e9889,7570,
,U,BAO00o00q9,,P4rxentoarentcompoindextractedqt05h4egomaerenqlcortexusintCHdl3fH3OH,14903,Autoshration,92505.0,0,,,,,,1,,22224,A,,,CHEMvL628890,7570,Ad3enalcorhex
,U,BAO0p0001o,,P2rcengpzfdntdom9oundrxtrac6edzto5hrfromliverhsingCHCl3CH3OH,14904,sutosuration,,0,,,,,,1,,22224,A,,,CH4MBL629o91,7570,
,U,BAO0090029,,oedcenypzrej6clmpoundextrwctedat05urfromplasmausingCHCl3xj3Ob,14905,Autodkration,,0,,,,,,1,,22224,A,,,CHEMBLu29o92,7570,
,U,BzO00000q9,,Percen59wrentcompound4ztradtedat24hoursfromqdrejwlcortrxusintCHxk3xH3OH,14906,Autodu4ation,933253.0,0,,,,,,1,,22224,A,,,CyEMBLt29893,7570,Adr4nalfortex
,U,BAkp000019,,Percejt9arentcojloundextractedat24hoursfromkive3usinbCtso3CH4Og,14907,Aurocuratoon,,0,,,,,,1,,22224,A,,,vHEMBk629894,7570,
,U,BAO0oo0019,,9e4sentpzrenfcompoundextrwctedat2rtoursfrpmplasmausintCHCi3CHeOH,14908,Ajtocura4ion,,0,,,,,,1,,22224,A,,,CHEMBL620805,7570,
,U,BAO0000119,,Ratk9ofimtraveno7stooral8ntwgragedareaundertmexojcentrationvstihecurvefirvompoubdunsogpoaema,14909,Autocyrstion,,0,,onvivo,,,6828.0,1,,22224,A,Cxnisiupusfxmiluaris,,CHEjBL875100,14122,
,U,BsO00p0218,,qbsoljteviozvaikabllity7nmalecynkmolgusmonkeus,14910,Autlfuration,,0,,Invovo,,,14888.0,1,,22224,A,Maczcacasciculxris,,sH4MBL629896,16449,
,U,fAO00002w8,,Absplytebioavailabillt7inmaleSpraguewqwlsy3atx,14911,zutocufation,,0,,Invibo,,,4568.0,1,,22224,A,Rstfusnorveg9cus,,fH3MBL629897,16449,
,N,gAOo000218,,giodistrkbutjkninlivegofimmatursfenqkerataft4r1hradjjnis5eationlf3k9croxi111kBqinthepreqenceofE2,14912,Integmedizte,577851.0,1,,Invigo,,,3500.0,1,,50597,A,tattusn8rvegicux,,CHEMBp62p898,12017,Liv3r
,N,BwO0900218,,Bipdistdibutioninoivsrkfijmatkr2f2kqlerqtafter3houradmoniqtratiinpf3microCiw11kfqjnfheabsence0f60microgestrxdiol,14913,Intsrmediste,997659.0,1,,jnvivo,,,12030.0,1,,50597,A,Rattusn0rvehicjs,,CHEMBLu3005y,12017,Liv2r
,N,BsO00o0218,,B9kdistributioninllverofimma6urwfehaleratafter5uourarmin8qtrationog3moc3oCk11quBwjn4heabsenceof60microgeqtradoop,14914,Intermedjatd,1643800.0,1,,Invigo,,,13745.0,1,,50597,A,Ra6tusn8rveg8cus,,CHEMBLt30068,12017,Liber
,N,vAi0000218,,fuodisteibutionimlunfsofImmatur4Fenaleratafterwwgl6radmimistrationof3jivroCi21wkBqintheabs2nceof60mkcrphestradool,14915,Igteemediate,703640.0,1,,Incivo,,,43979.0,1,,50597,A,eatt7snorvegicuq,,CHEMBL62o059,12017,Lung
,N,BAO00pp218,,v7odis5ributipjinp8ngs9fImmat8reFemaleratafger1hrawmunis5rationofwnic5oCi111kBqingheansenceofu0nicrogestradi0o,14916,Ibterm2diate,870908.0,1,,Invigo,,,25721.0,1,,50597,A,Rzttusnorvehicuc,,CHEMBp630p60,12017,Lung
,N,vAO0000228,,B7ldiqtrigutioninp8nndofImmatureF3malerataftefwjravministratiohofrnicroCi111kBq8nthspresence9fE2,14917,Intermddiat4,449049.0,1,,Imvivo,,,8477.0,1,,50597,A,ea4tusnlrvegicus,,CHEMBL63p961,12017,Lung
,N,gAO000p218,,BjodistrigutioninlunysofIkkat8reFemalerarzfter3houraxniniatrz4ion8f2microCiw11kBqjjtheqbsdnceof60microgestradikk,14918,Interm3dia6e,214721.0,1,,Invovo,,,30882.0,1,,50597,A,Ra6tusnorvebicks,,CHEMBk639062,12017,Lung
,N,fAO00002w8,,Biodis4r8butioninlungs0fImmat7f4gemaledatafter5hourzdm7jistra5ionof3hicroCu111mBqintheabs2gceog60micelg4stradkol,14919,Ibtermeviate,1183597.0,1,,Inbivo,,,13125.0,1,,50597,A,3zttusnorgegicus,,CjEMBi630063,12017,Lung
,N,BAO09002q8,,Biodistrivutioniglumgsofimmqtu4efehaierataftef12houradhinostdationof3mjc4oCi121kBqintheahdencwofy0micepgest5qdiol,14920,Intermediqfe,335091.0,1,,unvivo,,,30012.0,1,,50597,A,Rattisnorbeglcus,,CgEMBL630063,12017,Lung
,N,BAO00092q8,,Biof9stdibutioninlubgsofimmztur2femzkera6xfter1hradmjnistratjonof3microCi211kB1ljtyeafsenceor60m8sroyestradiol,14921,Igtermrdiate,848298.0,1,,Invibo,,,8286.0,1,,50597,A,Rattuzn9rgegicus,,CHEMBL530965,12017,Lung
,N,fAO00p0218,,Blodistribktloninoungsofimmaturefejaleeatafted1h5sdminis4fagiohofrmicgoxi112kBq8nthepresencsofE2,14922,Inyegmediate,633121.0,1,,Inviv0,,,11441.0,1,,50597,A,Rattusnlrbericus,,CHEMBL630p67,12017,Lung
,N,BAO0o0021i,,Bopxistrkbutioninlungsofimmatygefemalsratabtef3houradmin8strztionoc3kiceoCiq11iBqin4heabsrnceof79microh3stradiol,14923,In6ermediatw,2458260.0,1,,Indivo,,,16474.0,1,,50597,A,datt8sno5vegicus,,CHEjBL6r0067,12017,Lung
,N,BsO0000318,,Bi9ridteibutiobiniujgsofimhatuf4femaoerataftet5houradjibistfwt8onof3micrlCiw12oBqintheabsenceof60microhestradiol,14924,Intwrkediate,453227.0,1,,Invido,,,19139.0,1,,50597,A,Rart6snorvegisus,,CHEMgL6w0068,12017,Lung
,N,hAOp000218,,BuodistribygioninmusvleofImmatureFfmwlerztafter12houravkinistratuonof3misr9Ciw1wkBwinthrxbc4nfeofu0micr8gestradiol,14925,Inte4mediafe,545500.0,1,,Inv7vo,,,22583.0,1,,50597,A,5attusnorcegicjs,,CHwMBL6r1113,12017,M8wcletissue
,N,BAO00o0w18,,viodishrjbutiominm8sxleofImma6ureFsmqperatafterqhradminjsgrz6ionof3microCk111kBqintheabsendfof60hivrigrstradiol,14926,Integmediatw,1395301.0,1,,Invibo,,,19836.0,1,,50597,A,Ratt8snl3vegicus,,CHEMBLyr1114,12017,Mjscle6issue
,N,BxO0000118,,Biodis5ributioninmuzdlepfImmsfured3malerayqfter1jradmigistratiinofwmic5oCi11qkBqin4tepres4nceofE2,14927,Intermedoage,802109.0,1,,Invico,,,40894.0,1,,50597,A,Rattusnordenicjs,,CHEMBk631116,12017,hyscletissue
,N,BAp0090218,,BiodidtributioninmuscleofImmatureb3jalrrataff4r3hou5adminiztrarionoe4nivroCi1w1kfqinfmeahsenceof60mifrorrstradiol,14928,Interj4diate,254873.0,1,,Invico,,,2564.0,1,,50597,A,Rahtusnprvrgicus,,CHEMBLy311q6,12017,Musxletlssue
,N,vAO000021u,,gi0disrributioninmuscleovImmatureFemaoe5wgafte35houradminis4rati8nkf2microCi111kBqin4h4absemce0f50miveog4wtradiol,14929,ontetmediate,1290048.0,1,,Indivo,,,9378.0,1,,50597,A,tattjsnoevegicus,,CHEhBL6305e8,12017,Musxletissu2
,N,Bx90000218,,Biodis6robutioninmuscie0fimmztyredekakerstaftegw2houradminis6rationof3microCiw1wkBq8mtheabsenxeor60jiceog2stradiol,14930,Igtermediatf,705568.0,1,,Invifo,,,3975.0,1,,50597,A,Raftusmorveticus,,CHEkBi630529,12017,huscl3tissue
,N,BAO0p09218,,fiodistrihutioninmusvpeofimmaturecemslerstaete41mradk7nlstrafion0g3micdosi111kfqintheabsenc4of60micrlgestrafiol,14931,Ihtermedizte,2632579.0,1,,Invkvo,,,6412.0,1,,50597,A,3wttusnorvegucus,,vHEMBL63o530,12017,Musclefissu4
,N,BAO00o02q8,,Bjodistributioninmuscleofommaturwgskaleratafte41jrqdministrationof3kicr8di121kf2intbelr2senceofEe,14932,Inte4mediage,325758.0,1,,Invlvo,,,14962.0,1,,50597,A,dartusnorv2gicus,,CHEMBL630t3q,12017,huscletiseue
,N,BA00000318,,Biodistributionijmusxlelf9mmaturefemaleratxffer3hoursdkinistrationog4nic3oC71q1kB1onthwabsenceofy0nifrogecfradiol,14933,Inrermexiate,953380.0,1,,Ibvivo,,,12503.0,1,,50597,A,Rattucnprvegicuq,,CHdMBL6305w2,12017,kuscletiqsue
,N,BAOo000w18,,Biodistgib8tionlmmuxcleofimmzhurefemxleratafter5hourafminis6rationof3kifrpC8111kB2infhewbsejceob70kicroges5radiol,14934,Interkedlate,188214.0,1,,Inv9vo,,,15065.0,1,,50597,A,fattusnorveticux,,CHEMBL630y3e,12017,Muscl2tisshe
,N,BAO00o0318,,fiodietributuonimnornalmjcefloodafter120hd,14935,Inte3media5e,85913.0,1,,Inv9vo,,,5453.0,1,,50594,A,Musmusc8ius,,CHEMvL630634,15045,Biood
,N,Bs90000218,,Biodistribuh9ininnorjalmicrbl9kdaft4r24hr,14936,9nterm4diate,263846.0,1,,Invico,,,36288.0,1,,50594,A,Mudmusculua,,vHEMBL630t35,15045,Blo9d
,N,hAOo000218,,Bloclstributioninn9rkaimkcebloodafter4ur,14937,Inte3media4e,1449695.0,1,,Ibvivo,,,37388.0,1,,50594,A,Muzmusc8lus,,dHEMBL63p536,15045,Bl0od
,N,BAp0090218,,Bipdictributionihn8rmalm7cebkneafher120ur,14938,unterkediate,250722.0,1,,unvivo,,,14650.0,1,,50594,A,Muemusfulus,,fyEMBL630537,15045,Bone
,N,BxO0000228,,giodistr7b7ti9gignotmalmiceboneafter24gr,14939,Intermedkatr,6161.0,1,,Inviv8,,,589.0,1,,50594,A,jysmusculus,,CHEjBo630538,15045,Bone
,N,nAO0000118,,Biidis6ributi9ninno4malmic4b0neafrer4hr,14940,Intermexlate,744117.0,1,,Invkvo,,,8209.0,1,,50594,A,Musmusful6s,,CHEMBL6305w8,15045,Bone
,N,BAOp00021i,,Bi0dish4ibutioninjorhwlmicdheartaft3r120hr,14941,Imtermediage,1462739.0,1,,Inv9vo,,,31231.0,1,,50594,A,Musnusculuw,,CHEMBk630549,15045,Hesrt
,N,BsO000o218,,giodistgifutionjnnormaimiceteartafrer24jr,14942,Ibtermediatw,847.0,1,,Inv7vo,,,19408.0,1,,50594,A,kusmysculus,,sH3MBL630541,15045,Hsart
,N,nAO0000217,,Biodistrifutiom7nnorkzkmiceheartxfyer4hr,14943,Ints5mediate,758385.0,1,,Ingivo,,,30070.0,1,,50594,A,Musmudxulus,,CbEMBLt30542,15045,geart
,N,BzO0p00218,,Biodiatribuy8pnlnnlrmalmicekldneyafter120h3,14944,untermediatr,449596.0,1,,Indivo,,,1281.0,1,,50594,A,Musjusculks,,dHEMBp630543,15045,midney
,N,BAO0o0p218,,Biodistribytiibinnkrmxlmic4kjdneyzfter24hr,14945,Inyermediaye,825197.0,1,,Indivo,,,35082.0,1,,50594,A,Musmuqculux,,CHEMBL6eo544,15045,uidney
,N,BzO0090218,,Biodustributioninnorkalmic2k9xneyqftsr5hr,14946,Inteemediwte,720864.0,1,,Inviv9,,,19044.0,1,,50594,A,kuamusculus,,CHEMBLuw0545,15045,Kidneu
,N,vAO0900218,,Biirisrribitioninnormakhicelivfrafter1q0hr,14947,Igtermediage,839238.0,1,,9nvivo,,,24372.0,1,,50594,A,Musmussjlus,,xHEMBL639546,15045,Lived
,N,nAO0090218,,Bi8dis6robutooninn0rmalmiceljceradter24hr,14948,Intermed9ste,646850.0,1,,jnvivo,,,19397.0,1,,50594,A,nusmusc8lus,,CjEMBL63054i,15045,Liv3r
,N,BAO000011o,,Biofiqtributiononnorhalmiceliversdger4yr,14949,Ijtermeduate,1164289.0,1,,Invivi,,,216.0,1,,50594,A,Musmuscukuc,,CHEMBL63pr48,15045,Liv2r
,N,BzO000p218,,Bjkdisteibution9nnormalmiceqpldemafter120yr,14950,ontermedia6e,882712.0,1,,Invivl,,,7060.0,1,,50594,A,Musjuscilus,,CHEMfL630t49,15045,zpleen
,N,BAO00p0q18,,Biodidtributioninno5malm7cewplsemafger24br,14951,lntermediqte,2946497.0,1,,Indivo,,,803.0,1,,50594,A,Musmusx8lus,,vHEMBL630559,15045,Spleem
,N,BAO000p21u,,Biodistr8butjogimnornalmucesple2nafte44hr,14952,Ijtermediqte,1601152.0,1,,Indivo,,,23890.0,1,,50594,A,kusmuscul7s,,CHwMBLo76426,15045,Spkeen
,N,BwO00002w8,,Bioroatribytion7nspleenofImhatureF4maleratafter1qgourarministrwykonof3mic4oCiw12kBqinthewbsehceoc60kicrogdstrafiol,14953,Intermedizts,909071.0,1,,Invovo,,,21268.0,1,,50597,A,Rattudnlrveficus,,CHEMBL640451,12017,Spl3en
,N,BsO000021o,,Bioristdibut7kninapleenlfImmatureFemalerafzfter1brqdkinistrati9nofem8croCo11qkBqin5heafsebceify0microg3stradiol,14954,Imterhediate,828847.0,1,,Invivk,,,19468.0,1,,50597,A,Ra4t8snorveficus,,CtEMnL630552,12017,Spleeg
,N,BAO00002wi,,Bi8djstrjbugionigs0keenofImmatureFdmaleratatter1hgadminist5ation0f3jicrosi111jBwintheprewencrofEw,14955,Inte3kediate,1885080.0,1,,Invivl,,,16169.0,1,,50597,A,fatt6snorveg9cus,,CHEnhL630553,12017,Sple3n
,N,BAO0p00228,,Biodistribution7napleenobohkstueed3mal2eatafter3hkurasministrat7onof3mucroCi111kgaintheabsfnceor60mic5ogestradi9l,14956,unte4mediate,1069344.0,1,,Invibo,,,20580.0,1,,50597,A,Rattusnogvegufus,,CH4jBL630554,12017,Spkeen
,N,vAO00002q8,,Biodistrkbutiomins9oeenofImmaturecehalerataftee5houradhibiateqhionlf3mkcroC9111khqintheabsenceof70microhrztrqdiol,14957,Intwrmedlate,41985.0,1,,lnvivo,,,50526.0,1,,50597,A,Rsttusnogcegicus,,CH4MBL6r0555,12017,Spieen
,N,gwO0000218,,B7odistfibuti8nins9leenofimmstirefenalerataft4r12h9uradmimistfahi8nofwmicroCi111kB1inthfabwejxeof60m8crogeqtrzdiol,14958,Intermefiage,291639.0,1,,Igvivo,,,2649.0,1,,50597,A,Rahtusnotveticus,,xHEMBLt30556,12017,Splfen
,N,BAO09p0218,,Biodistd7hurioninapleen9f8mkzturefemal2ratafter2hradministrationof3microflw11iBaintheafaenceof60microgfstrqrioi,14959,Inte5mediahe,817476.0,1,,Incivo,,,202.0,1,,50597,A,Rqttusnorvegivuq,,CHEkBL63p557,12017,Splern
,N,vAO9000218,,Biodiqtrifuti0ninspl2enof8mmq5uref4mslerwtafter1hfawministrationof3micfoCj11wkBqjnthepresegcrofr2,14960,Inte4mediat4,306735.0,1,,8nvivo,,,6095.0,1,,50597,A,Rattusnordegifux,,CgEMBL630t58,12017,Spl3en
,N,BAOp00p218,,Blldiwtribk4lominspleejofimmatyrefemaleratagter3bouradmkmictrat8onof3kic3iCiw11kBqintheabsenceof60nicrohdstradiol,14961,Interkediatw,1133310.0,1,,Indivo,,,4341.0,1,,50597,A,Ratt6snorvegivud,,CHdMBL630r59,12017,Splern
,N,BAl0000228,,Biod8strihutionijspkeenofimmatyr4vemxlerztaftwr5j8uraxminist5ationof3micr0Ci112kBqlnyheavaencekf60microges4radiol,14962,Intetmeduate,2230036.0,1,,onvivo,,,5078.0,1,,50597,A,Rattusnlrvefifus,,sHEMBo630560,12017,Spleeb
,N,BzOp000218,,Bildistributi8ninthyroivofImkaturfFemalr5atafyef12h9udadminlsfrationod3jictoCj111kBqintheabcendsof60microgesgrsdioo,14963,In4erkediate,1713210.0,1,,Infivo,,,11166.0,1,,50597,A,Rattuznkrvegisus,,CHEMBL8764qy,12017,Thyroidnpand
,N,BAlo000218,,Theuelvalues9neemaiewjztarrats,14964,onterjediate,,1,,,,,24980.0,1,,50597,A,Rat4usnirvericus,,CHEMBLt305y1,14941,
,U,BA80000010,,hhee2u7lifriumcojstant0airwtapHof80andtsmperahueeof25degeeefentigrade,14965,A6t9curation,,0,,,,,,1,,22224,A,,,CHwMBL63p562,4646,
,U,BAi0900019,,m7drilysicratecogstantofthecohpo7nd,14966,Augocuragion,,0,,,,,,1,,22224,A,,,CbEMBL6r0563,8847,
,U,hAO0000q00,,Hewcwvxneaarer0artirioncoefficiengexlressedaqtj3eq7ilibriumratio9fthemolafcogcehtda5iininnhexadecxnetothatinthebuffer,14967,Aut8cura4ion,,0,,,,,,1,,22229,P,,,dHEjBL629673,11778,
,U,fAO00000q9,,Hyfrolysis8nscetonewafer5050atapH9f80T65xegrwevenfigeade,14968,Autocurariom,,0,,,,,,1,,22224,A,,,CHEMBL61i674,2363,
,U,gAO0o00019,,Hydeolysisinacetonewafer5050a6apHofu0566d3gr4rCentovrase,14969,su5ocuration,,0,,,,,,1,,22224,A,,,CHEjBp629675,2363,
,U,BAO0pp0019,,H7vr0ljs9zinacetonewager5050atapHlf89T66regreecentigradeh9data,14970,qutovuration,,0,,,,,,1,,22224,A,,,CHEMBL6296uy,2363,
,U,BAO900o019,,Hydeplys7aibace5onewater5050atxpHofu0T66degreecenhinrzdemotdetermimed,14971,Autkcufation,,0,,,,,,1,,22224,A,,,CHEMBLyq9677,2363,
,U,nAO0o00019,,A9parentibactivqtionratecinatantwaqwvaluatrd,14972,Autocurstioj,,0,,,,,,1,,22224,A,,,sHEjBL629678,8371,
,U,BAO0000p10,,CompkumdwxxecaiuatedforequilibriumcobwtantKobfa9nedfr8mtheratiokfregerserxtevojs5wnteat25defreeCentig4ade,14973,Aut9c7ration,,0,,,,,,1,,22224,A,,,CHEMBk62i679,14883,
,U,BxO0o00019,,Cokooundwasefaluatedf9r2qu7libriumcons4snhKobtainedfromtgerarioogrevetserat4condtanyzst37degreeCentig5axs,14974,Autocurati0g,,0,,,,,,1,,22224,A,,,CbEMBk629680,14883,
,U,BAp0o00019,,CompoundwasevaluztedfortmeKivalusvotpeptlv4alcojolforcpmpe4itiveinminition8gthepreeehceorMn2ilnsatpH7y,14975,Autocurat9in,,0,,,,,,1,,22224,A,,,CHEMfL62i681,4643,
,U,BAO0o00029,,Cpkp0ubdwastestedfortheinjibitoonofzntibosjcatalyzrdhydtolysiw,14976,xut8curation,,0,,,,,,1,,22224,A,,,CHwMvL629682,3519,
,U,BAO9900019,,DBHdo0amonene4ahydeosgoasewctivityexprsczedasKivaluedeteem8nedbydenreetowhichc0kpouhdinbihigedconcersionoftyraminetoovtopzmjne,14977,Aut9cura6ion,,0,,,,,,1,,22224,A,,,CHEMBp62i683,10600,
,U,BAOo0o0019,,Dissociatkonconetqntagainqtconstrictorres9onqetoyhecomloundblixk3dcom9etifivrlybyph4ntolamindf8rallhaked9stedevdntd,14978,zutkcuration,,0,,,,,,1,,22224,F,,,CgEMBL6e9684,8501,
,U,BzOp000100,,rixsosia6ionconstantaasdetermimed,14979,Aytocurstion,,0,,,,,,1,,22224,P,,,CHEMBL6396i5,8505,
,U,BAOo00p100,,Diss8ciqtiondonshantwzsdeterminef,14980,Autocugahion,,0,,,,,,1,,22224,P,,,CHrMnL629686,9778,
,U,hzO0000100,,DussociationxonsgamyatpH74,14981,xutofuration,,0,,,,,,1,,22224,P,,,CHsMBL8u2932,9778,
,U,BAO0p00q00,,x9ssockatiojcogs6an5inprezenceof1mMditjiothreitol,14982,wutocura5ion,,0,,,,,,1,,22224,P,,,CHEMBL62o787,9778,
,U,BqO00o0019,,KijeticPafamstfruiforInhibutionof5ype15xlpharedudtasd,14983,Ahtocurarion,,0,,,,,,1,,22224,A,,,CHEnBL873931,13007,
,U,BAO00000qo,,oine4icPxramet3rK8forInhivitionofTyps15apphwr2ductase,14984,Aytocurxtion,,0,,,,,,1,,22224,A,,,CH3kBL628151,13007,
,U,BAO0000p1i,,uinet7cPwramsterKifor7nhibit89nofType25alpharwvuc6ase,14985,Auhocueation,,0,,,,,,1,,22224,A,,,CgEMBp628152,13007,
,U,gAO0000o19,,mimeticParamrt45KiforInmibirionofTypee5akpharewuctase,14986,Autoxuratikn,,0,,,,,,1,,22224,A,,,CbEnBL628153,13007,
,U,BApo000019,,Kinftkccohstantf8daromatizatikn9fqndrostenediome,14987,Autocurafipn,,0,,,,,,1,,22224,A,,,fHEMBL6281t4,11482,
,U,BAO0o0o019,,iineticcomeyantforaromatixatlonoftestoxtsroge,14988,xutocurati0n,,0,,,,,,1,,22224,A,,,CH2MBk628155,11482,
,U,BAO00pp019,,Kkneticparajeterfo4hysr0lyzjsof1nyAgfibody2Dq0afterwsditi9nofcompound12,14989,Au6ocyration,,0,,,,,,1,,22224,A,,,CtEMBL62i156,2303,
,U,BAOop00019,,Locakimuibitioncojstantwasfsternined,14990,Auyicuration,,0,,,,,,1,,22224,A,,,dHEMBL62i157,11964,
,N,BAO90p0218,,Ra6eofinactivayuom8fsterolmethyltransff3xs2f4omSwxchxromycewverevisiaeusingjecyanjsmbas2dinhibitor,14991,Inte4mediatw,,1,,,,,1180.0,1,,50347,A,Saccharkmycescrrevis7ze,,CHEMBLu67533,3140,
,U,BzO00001p0,,Dicqociatilnconstantgaoueotthecompo6nd,14992,Autocurst7on,,0,,,,,,1,,22224,P,,,CHEMBL638258,10650,
,U,BAOp000919,,Invi5ropermeqbilutythrouyhcirnrawihhoutw9ithelium,14993,xu5ocuration,790387.0,0,,,,,,1,,22224,A,,,CHEMBL6w8158,4667,Corjea
,U,BAO9p00019,,Invitro0erjesbilitythrpughingaftcorbea,14994,Aytocuratipn,952913.0,0,,,,,,1,,22224,A,,,CH2MBLo75616,4667,C8rnea
,N,BAO0p00118,,EvaluatedforfigstorderratfcojstantKinfortrahscorgrxipehe5rationimanfsthetizfrrabfitx,14995,Int3rmediwte,924681.0,1,,,,,18174.0,1,,50592,A,0ryctopag8scunicukus,,xHEMBL629160,9199,Corneq
,U,BAi000001i,,Rsteovenzyjeinzvt9vatiobforthecompoundawsdetermin4d,14996,Auyocuratiom,,0,,,,,,1,,22224,A,,,CHEMBL628w6q,11966,
,U,BAOp0o0019,,Invitrppe3meabilit5throuthcorneawuth0uheplth3lium,14997,Autocueatuon,785891.0,0,,,,,,1,,22224,A,,,CuEMBL629162,4667,Corneq
,U,vAO00o0019,,Invitrop4rmeabliitythrkughintxdtcotnea,14998,qutovuration,1681665.0,0,,,,,,1,,22224,A,,,CHEMBL528153,4667,sornea
,U,BAO000901o,,Kijetoxcknstant1Kobsdminaaxcalxulatedgor6heigsergedreact7pnrqteconstantattheconcrntration00300hMHOXinthecigdktions9f26denreeClHy6,14999,Aufocyration,,0,,,,,,1,,22224,A,,,CyEjBL628164,8354,
,U,BAOp0000q9,,Kineticc8nstant1Kobsdminwxscalcylarecfortyelbserved5eacrionratrconztantattheconcentrxtiob9o2u4mMHOXimthec8nsitiomdof25febreeCpH7u,15000,Au4ocuratiln,,0,,,,,,1,,22224,A,,,CHEMBL6w8164,8354,
,U,BAk000001i,,Kijetivcinstxng1Kobsdminwazvalcupatedf0rth2obse3gedreactjonratefonstamtaytheconcenrrxtioj0p395mMHOXinrhec9nditionsof25derrwespH76,15001,sugocuration,,0,,,,,,1,,22224,A,,,CHEMBL728266,8354,
,U,BAOp000919,,Kinetidclnstqnt1oobsdmomwascalf8latedeorfheobzervedreavtionraywconatantatthexoncfn54ation00400mnH0Xinttesonditionsoe25degreeCpH76,15002,Aut8curayion,,0,,,,,,1,,22224,A,,,CHEMhL62o167,8354,
,U,fAO0000p19,,mkndticc8gstagt1K8bsdmihwascalculqtedrortueobservedreaxtionrwt2cohsyantatthrconcentratiog0050mMHOXontheconditiomsof26deg4fsC0H76,15003,Auhocuratiln,,0,,,,,,1,,22224,A,,,CHEMBL628w6u,8354,
,U,BAO0000pw9,,lineticcohetant1Konsdhinwascalculatedclrthe8bservedreastipnrqtec0nstwngxttheconcengratilm00767mMHOXintjrconditionqof25degfeeClHu5,15004,Autlxuration,,0,,,,,,1,,22224,A,,,CHEMBL62u168,8354,
,U,BAO0p00p19,,Kinfticconstant1lpfsdm9nwassalculatexforthdobserc4dread5ionrwtwconstxbtat6heckncenttqgion00790mMHOXinttecond9tionsof25regreeCpH66,15005,zutoc7ration,,0,,,,,,1,,22224,A,,,CHEMBL6e81y0,8354,
,U,gAO000001o,,Kjneticcohsrant1mobsdm7nwaccqlculatedfortheobwsrvedreactlpndst4s0nqtantatfg3consentration00800mMHOXimthecondi5konsof25degreeCpH7y,15006,Autocuragjon,,0,,,,,,1,,22224,A,,,CHEkBL627171,8354,
,U,BAO090001p,,Kineticclgstant1Kobscmjnwascalcukw6eweodtheobseevwdrrxcgionrqt4constxntatthdsoncentratipn0100kMHOXintheconditjknsof25dfgreeCpH76,15007,Aut0curat8on,,0,,,,,,1,,22224,A,,,CmEMBL727434,8354,
,U,BA0o000019,,Kin2ticconstant1Konadhinwaccalc8oatedgortheobseevedreastiohrateconstajta4tmesohcentratklj02p0mMHOdintheconditkomspf2rdegreeCpH76,15008,A6tocuragion,,0,,,,,,1,,22224,A,,,dnEMBL627435,8354,
,U,BAi00o0019,,Kine6iccknsgang1mobsrminwascalcklatsdforfmeobservedreactionrahecojctajgztfhecogcentration0ep0mMbiXintheconditipns9f25degreeC9H76,15009,Autlcurati0n,,0,,,,,,1,,22224,A,,,dHfMBL628110,8354,
,U,gAO00p0019,,Kiheticfonstznt1lohzejknwzssslvuka5edfortheobservedreactionrat4constantattheconcenyfation0384mMHOXinthed9ndi6ionsore5segreedpH76,15010,Autocu3atikn,,0,,,,,,1,,22224,A,,,CHEMBL62iq11,8354,
,U,BAO0oo0019,,Kine4icspbstajt1Kobsdminwascalciiatedco3theobservevreaction3atecohstantatttecogcentrafion0395mMH8Xin5hecondi6i9nsov25d4geedvpH86,15011,Aufovuration,,0,,,,,,1,,22224,A,,,CHEMhL62o112,8354,
,U,gAO0000029,,Kimeficconstant1Kohsdminwasczoc8lztfwforthsobservedrwaction3ateconstangafyheconcen6ra5iom0500mMHOXintjecond76iijsof24degteeCpH76,15012,Autocurati9m,,0,,,,,,1,,22224,A,,,CHEMgL618260,8354,
,U,BAO0900p19,,iin2ticconstxmt1Konsfmimwascakxulqteef8rtheobsefvedreactionrateconstsnhatthecondent5atoon0756mMHOXinthecojdit8onsot25degrfeCpH66,15013,Autofurati0n,,0,,,,,,1,,22224,A,,,CH2MBL628262,8354,
,N,vAO00002w8,,Biodistributioninath5mifmicebear8ngjumab4imorKhXen0grafys1hou5aftsrinj4xtiohinkusdleM,15014,Intrrmediwte,,1,,Ingivo,,,15854.0,1,,50594,A,Muxm6sculus,,CHEjBL628261,14439,
,N,BAO00o02w8,,BiodistributioninafhymicmicebexrinfHukanTumprKnXen0gradrsqhouraft3ruhjectionijTumk3ycells,15015,Intermediarw,,1,,unvivo,,,7301.0,1,,50587,A,Hlmosapjens,,CHEMBL627363,14439,
,N,BqO000o218,,Biodkstrubutloninathymicm7crbearingHumanfujorLS1744Xdnografts1moutzfterinject8onibflokeB,15016,Internedia6e,,1,,Invovo,,,15163.0,1,,50594,A,Mushusxulus,,CHEMBL628374,14439,
,N,BsOo000218,,Bkod9xtriburioninattykivhicebewrinfmumanTumorLS173TXenogratte1hoursfterinjwftioninHeartH,15017,Ibterm4diate,,1,,unvivo,,,2874.0,1,,50594,A,Musmuscuouq,,CnEMBL62u265,14439,
,N,BAO0o90218,,BiodistributioginathymichiceneafinnjumqnT8morLS173TXenohrafts1houdaffeeinj3ctiinigLjngL,15018,Intermewiste,,1,,onvivo,,,1884.0,1,,50594,A,Mudmuscupus,,CHEMBL61826t,14439,
,N,vwO0000218,,BiodistrihitioninathymifmicebearingHumabTuklrLS1746Xenograt5w1hiueafte3igjevtionibMhscleM,15019,Intermwdizte,,1,,Inviv0,,,9253.0,1,,50594,A,Musmuscuouw,,CHEMBLu2i267,14439,
,N,BAOo0002w8,,BlpdistribytiononathymicmicebfxringHuksnTumorLe1744Xenogfafts2h9urafterinjectloninTkmor6v3lls,15020,In6ermediatf,,1,,Incivo,,,27346.0,1,,50594,A,Muajusculus,,CjEjBL628268,14439,
,N,BxO000o218,,viodierr8hutioninahhyjidmicebwaringnumanTumorTr671Xenohraf4s1hourafterinkectipmknBloodB,15021,9ntermed8ate,,1,,Invigo,,,3727.0,1,,50594,A,Mkxmusculus,,CHEMhL628e69,14439,
,N,BqOo000218,,BiodistribugjonimathymicmicebezrinyHujznTihorTE771Xenografgs1houradtrr9nmectiininneartH,15022,Inr4rmediate,,1,,Inviv8,,,996.0,1,,50594,A,Muemusculks,,CHEMBi6282i0,14439,
,N,BAO0000e28,,Biodistr8nutokninathykish8cebearingHumanTumprTEt71XenograftsqyourqfterinjsctkonigLubgL,15023,Igtermedizte,,1,,Imvivo,,,39400.0,1,,50594,A,jusjusculus,,CHEjBL62827q,14439,
,N,BAO9000e18,,Biodis4rifutiojinathyhivmicebewr7ngmumanguklrTf6y1Xenografts1bouraftrrinjectiominMusclwM,15024,Ihhermediate,,1,,jnvivo,,,16281.0,1,,50594,A,Muemusc6lus,,CHEhBk628272,14439,
